PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chang, CH; Lai, LC; Cheng, HC; Chen, KR; Syue, YZ; Lu, HC; Lin, WY; Chen, SH; Huang, HS; Shiau, AL; Lei, HY; Qin, J; Ling, P				Chang, Chun-Hung; Lai, Li-Chun; Cheng, Hung-Chi; Chen, Kuan-Ru; Syue, Ying-Zhang; Lu, Hsueh-Chi; Lin, Wan-Ying; Chen, Shun-Hua; Huang, Huei-Sheng; Shiau, Ai-Li; Lei, Huan-Yao; Qin, Jun; Ling, Pin			TBK1-associated Protein in Endolysosomes (TAPE) Is an Innate Immune Regulator Modulating the TLR3 and TLR4 Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTOR-3; C2 DOMAIN PROTEIN; ANTIVIRAL IMMUNITY; MENTAL-RETARDATION; CYTOPLASMIC DNA; INTERFERON-BETA; CYTOSOLIC DNA; IKK-EPSILON	The innate immune system elicits the first wave of immune responses against pathogen infection. Its operational modes are complex and have yet to be defined. Here, we report the identification of an innate immune regulator termed TAPE (TBK1-associated protein in endolysosomes), previously known as CC2D1A/Freud-1/Aki-1, which modulates the TLR3 and TLR4 pathways. We found that TAPE activated the TBK1, NF-kappa B, and ERK pathways leading to IFN-beta and inflammatory cytokine induction. TAPE was shown to colocalize with endosomal marker Rab5 and lysosomal marker LAMP1 in mammalian cells, suggesting that TAPE resided in endolysosomes. Knockdown of TAPE selectively impaired the TLR3 and endocytic TLR4 pathways to IFN-beta induction. Furthermore, TAPE interacted and synergized with Trif to activate IFN-beta. TAPE knockdown failed to block Trif-mediated IFN-beta induction, whereas Trif knockdown impaired the TLR3 and TAPE cooperation on IFN-beta induction, suggesting that TAPE acts upstream of Trif. Together, our data demonstrate a central role for TAPE in linking TLR3 and TLR4 to innate immune defenses at an early step.	[Chang, Chun-Hung; Chen, Kuan-Ru; Syue, Ying-Zhang; Lu, Hsueh-Chi; Lin, Wan-Ying; Chen, Shun-Hua; Shiau, Ai-Li; Lei, Huan-Yao; Ling, Pin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Lai, Li-Chun; Huang, Huei-Sheng; Ling, Pin] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Cheng, Hung-Chi] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Qin, Jun] Baylor Coll Med, Verna & Mars McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Baylor College of Medicine	Ling, P (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan.	lingpin@mail.ncku.edu.tw	Huang, Huei-Sheng/F-9945-2011; shiau, A-Li/C-2885-2012; LING, PIN/C-6764-2009	shiau, A-Li/0000-0003-2449-8547; 	National Science Council in Taiwan [NSC 97-2320-B-006-014-MY3, NSC 98-2321-B-006-008]; National Cheng-Kung University [C023]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); National Cheng-Kung University	This work was support by National Science Council in Taiwan Grants NSC 97-2320-B-006-014-MY3 and NSC 98-2321-B-006-008 and by National Cheng-Kung University Intramural Grant C023.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; CHEN SH, 1993, ANTIVIR RES, V22, P15, DOI 10.1016/0166-3542(93)90083-U; Chen SH, 2008, J CLIN INVEST, V118, P3470, DOI 10.1172/JCI35114; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Nakamura A, 2009, J CELL BIOL, V187, P607, DOI 10.1083/jcb.200906019; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ou XM, 2003, J NEUROSCI, V23, P7415; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rogaeva A, 2007, J NEUROSCI RES, V85, P2833, DOI 10.1002/jnr.21277; Rogaeva A, 2007, EUR J NEUROSCI, V26, P965, DOI 10.1111/j.1460-9568.2007.05727.x; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seya T, 2009, IMMUNOL REV, V227, P44, DOI 10.1111/j.1600-065X.2008.00723.x; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhao M, 2010, J BIOL CHEM, V285, P24372, DOI 10.1074/jbc.M109.100057	46	24	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7043	7051		10.1074/jbc.M110.164632	http://dx.doi.org/10.1074/jbc.M110.164632			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189260	Green Published, hybrid			2022-12-25	WOS:000287737300021
J	Yu, WH; Hu, H; Zhou, QD; Xia, Y; Amar, S				Yu, Wen-Han; Hu, Han; Zhou, Qingde; Xia, Yu; Amar, Salomon			Bioinformatics Analysis of Macrophages Exposed to Porphyromonas gingivalis: Implications in Acute vs. Chronic Infections	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; SIGNALING PATHWAYS; COMPLEMENT RECEPTOR-3; BONE-RESORPTION; INNATE IMMUNITY; TNF-ALPHA; LIPOPOLYSACCHARIDE; ACTIVATION; COMPONENTS; CYTOKINE	Background: Periodontitis is the most common human infection affecting tooth-supporting structures. It was shown to play a role in aggravating atherosclerosis. To deepen our understanding of the pathogenesis of this disease, we exposed human macrophages to an oral bacteria, Porphyromonas gingivalis (P. gingivalis), either as live bacteria or its LPS or fimbria. Microarray data from treated macrophages or control cells were analyzed to define molecular signatures. Changes in genes identified in relevant pathways were validated by RT-PCR. Methodology/Principal Findings: We focused our analysis on three important groups of genes. Group PG (genes differentially expressed by live bacteria only); Group LFG (genes differentially expressed in response to exposure to LPS and/or FimA); Group CG (core gene set jointly activated by all 3 stimulants). A total of 842 macrophage genes were differentially expressed in at least one of the three conditions compared to naive cells. Using pathway analysis, we found that group CG activates the initial phagocytosis process and induces genes relevant to immune response, whereas group PG can deactivate the phagocytosis process associated with phagosome-lysosome fusion. LFG mostly affected RIG-I-like receptor signaling pathway. Conclusion/Significance: In light of the fact that acute infections involve live bacteria while chronic infections involve a combination of live bacteria and their byproducts, group PG could represent acute P. gingivalis infection while group LFG could represent chronic P. gingivalis infection. Group CG may be associated with core immune pathways, triggered irrespective of the specific stimulants and indispensable to mount an appropriate immune response. Implications in acute vs. chronic infection are discussed.	[Yu, Wen-Han; Hu, Han; Xia, Yu; Amar, Salomon] Boston Univ, Bioinformat Grad Program, Boston, MA 02215 USA; [Hu, Han; Zhou, Qingde; Amar, Salomon] Boston Univ, Sch Dent Med, Ctr Anti Inflammatory Therapeut, Boston, MA 02215 USA	Boston University; Boston University	Yu, WH (corresponding author), Boston Univ, Bioinformat Grad Program, Boston, MA 02215 USA.	samar@bu.edu	Xia, Yu/W-6150-2019	Xia, Yu/0000-0002-5596-5518; Yu, Wen-Han/0000-0002-1671-9744; Amar, Salomon/0000-0002-0017-5930	National Institutes of Health [R01 DE014079, DE15989, HL7680]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015989, R01DE014079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants R01 DE014079, DE15989 and HL7680 (SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Amano A, 2003, J PERIODONTOL, V74, P90, DOI 10.1902/jop.2003.74.1.90; Antonov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r179; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson FC, 2008, FRONT BIOSCI-LANDMRK, V13, P2041, DOI 10.2741/2822; Graves DT, 2005, J ENDOTOXIN RES, V11, P13, DOI 10.1179/096805105225006722; Hajishengallis G, 2007, FRONT BIOSCI-LANDMRK, V12, P4547, DOI 10.2741/2409; Hajishengallis G, 2006, INFECT IMMUN, V74, P5658, DOI 10.1128/IAI.00784-06; Hajishengallis G, 2008, ADV EXP MED BIOL, V632, P203, DOI 10.1007/978-0-387-78952-1_15; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Li L, 2002, INFECT IMMUN, V70, P3915, DOI 10.1128/IAI.70.7.3915-3922.2002; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; OGAWA T, 1994, MICROBIOL-UK, V140, P1209, DOI 10.1099/13500872-140-5-1209; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Srinivasan S, 2010, CLIN VACCINE IMMUNOL, V17, P699, DOI 10.1128/CVI.00510-09; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Walter C, 2004, INFECT IMMUN, V72, P5910, DOI 10.1128/IAI.72.10.5910-5918.2004; Wang J, 2008, J IMMUNOL, V180, P8011, DOI 10.4049/jimmunol.180.12.8011; Wang M, 2008, CELL MICROBIOL, V10, P2029, DOI 10.1111/j.1462-5822.2008.01185.x; Wang PL, 2002, CRIT REV ORAL BIOL M, V13, P132, DOI 10.1177/154411130201300204; Yoshimura F, 2009, J PERIODONTAL RES, V44, P1, DOI 10.1111/j.1600-0765.2008.01135.x; Zanotti- Cavazzoni S. L., 2009, CRIT CARE CLIN, V25, pvii; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777	38	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15613	10.1371/journal.pone.0015613	http://dx.doi.org/10.1371/journal.pone.0015613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203416	Green Submitted, Green Published, gold			2022-12-25	WOS:000285579200026
J	Cattoglio, C; Maruggi, G; Bartholomae, C; Malani, N; Pellin, D; Cocchiarella, F; Magnani, Z; Ciceri, F; Ambrosi, A; von Kalle, C; Bushman, FD; Bonini, C; Schmidt, M; Mavilio, F; Recchia, A				Cattoglio, Claudia; Maruggi, Giulietta; Bartholomae, Cynthia; Malani, Nirav; Pellin, Danilo; Cocchiarella, Fabienne; Magnani, Zulma; Ciceri, Fabio; Ambrosi, Alessandro; von Kalle, Christof; Bushman, Frederic D.; Bonini, Chiara; Schmidt, Manfred; Mavilio, Fulvio; Recchia, Alessandra			High-Definition Mapping of Retroviral Integration Sites Defines the Fate of Allogeneic T Cells After Donor Lymphocyte Infusion	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; GRAFT-VERSUS-LEUKEMIA; SCID-X1 GENE-THERAPY; VECTOR INTEGRATION; LENTIVIRAL VECTOR; HUMAN GENOME; SELECTION; IMMUNODEFICIENCY; TRANSPLANTATION; METHYLATIONS	The infusion of donor lymphocytes transduced with a retroviral vector expressing the HSV-TK suicide gene in patients undergoing hematopoietic stem cell transplantation for leukemia/lymphoma promotes immune reconstitution and prevents infections and graft-versus-host disease. Analysis of the clonal dynamics of genetically modified lymphocytes in vivo is of crucial importance to understand the potential genotoxic risk of this therapeutic approach. We used linear amplification-mediated PCR and pyrosequencing to build a genome-wide, high-definition map of retroviral integration sites in the genome of peripheral blood T cells from two different donors and used gene expression profiling and bioinformatics to associate integration clusters to transcriptional activity and to genetic and epigenetic features of the T cell genome. Comparison with matched random controls and with integrations obtained from CD34(+) hematopoietic stem/progenitor cells showed that integration clusters occur within chromatin regions bearing epigenetic marks associated with active promoters and regulatory elements in a cell-specific fashion. Analysis of integration sites in T cells obtained ex vivo two months after infusion showed no evidence of integration-related clonal expansion or dominance, but rather loss of cells harboring integration events interfering with RNA post-transcriptional processing. The study shows that high-definition maps of retroviral integration sites are a powerful tool to analyze the fate of genetically modified T cells in patients and the biological consequences of retroviral transduction.	[Cattoglio, Claudia; Mavilio, Fulvio] Ist Sci San Raffaele, IIT Unit Mol Neurosci, Milan, Italy; [Maruggi, Giulietta; Cocchiarella, Fabienne; Mavilio, Fulvio; Recchia, Alessandra] Univ Modena, Ctr Regenerat Med, I-41100 Modena, Italy; [Maruggi, Giulietta; Cocchiarella, Fabienne; Mavilio, Fulvio; Recchia, Alessandra] Univ Reggio Emilia, Ctr Regenerat Med, Modena, Italy; [Bartholomae, Cynthia; von Kalle, Christof; Schmidt, Manfred] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany; [Bartholomae, Cynthia; von Kalle, Christof; Schmidt, Manfred] German Canc Res Ctr, Heidelberg, Germany; [Malani, Nirav; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Pellin, Danilo; Ambrosi, Alessandro] Univ Vita Salute San Raffaele, Ctr Stat Biomed Sci, Milan, Italy; [Magnani, Zulma; Bonini, Chiara] Ist Sci San Raffaele, Div Regenerat Med Gene Therapy & Stem Cells, PIBIC, Expt Hematol Unit, Milan, Italy; [Ciceri, Fabio] Ist Sci San Raffaele, Hematol Unit, Milan, Italy	Istituto Italiano di Tecnologia - IIT; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Pennsylvania; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Cattoglio, C (corresponding author), Ist Sci San Raffaele, IIT Unit Mol Neurosci, Milan, Italy.	alessandra.recchia@unimore.it	Magnani, Zulma Irene/AAN-7588-2020; bonini, chiara/I-9202-2012; ambrosi, alessandro/H-4424-2011; Recchia, Alessandra/B-7954-2015; MAVILIO, Fulvio/J-6125-2013	Magnani, Zulma Irene/0000-0001-7612-6097; ambrosi, alessandro/0000-0003-1976-5663; Recchia, Alessandra/0000-0002-3467-1094; Mavilio, Fulvio/0000-0003-0459-4320; Bushman, Frederic/0000-0003-4740-4056; BONINI, Maria Chiara/0000-0002-0772-1674	Italian Ministry of Health; Italian Ministry of University and Research; Telethon [GGP08095]; European Commission; NIH [AI52845, AI082020]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082020, R01AI052845] Funding Source: NIH RePORTER	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Telethon(Fondazione Telethon); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Italian Ministry of Health, the Italian Ministry of University and Research, Telethon (GGP08095), the European Commission (FP7-PERSIST), and NIH grants AI52845 and AI082020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Barr SD, 2005, J VIROL, V79, P12035, DOI 10.1128/JVI.79.18.12035-12044.2005; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Bonini C, 2003, NAT MED, V9, P367, DOI 10.1038/nm0403-367; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Brady T, 2009, GENE DEV, V23, P633, DOI 10.1101/gad.1762309; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Ciceri F, 2007, BLOOD, V109, P4698, DOI 10.1182/blood-2006-05-023416; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Deichmann A, 2007, J CLIN INVEST, V117, P2225, DOI 10.1172/JCI31659; Felice B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004571; Ferrari F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-264; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Newrzela S, 2008, BLOOD, V112, P2278, DOI 10.1182/blood-2007-12-128751; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Recchia A, 2006, P NATL ACAD SCI USA, V103, P1457, DOI 10.1073/pnas.0507496103; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tiberghien P, 2001, BLOOD, V97, P63, DOI 10.1182/blood.V97.1.63; TRAVERSARI C, 2007, BLOOD; Verzeletti S, 1998, HUM GENE THER, V9, P2243, DOI 10.1089/hum.1998.9.15-2243; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wang GP, 2010, BLOOD, V115, P4356, DOI 10.1182/blood-2009-12-257352; Wang GP, 2009, MOL THER, V17, P844, DOI 10.1038/mt.2009.16; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154	36	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15688	10.1371/journal.pone.0015688	http://dx.doi.org/10.1371/journal.pone.0015688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203516	gold, Green Published, Green Submitted			2022-12-25	WOS:000285578000046
J	Ferreira, RS; Poteaux, C; Delabie, JHC; Fresneau, D; Rybak, F				Ferreira, Ronara Souza; Poteaux, Chantal; Delabie, Jacques Hubert Charles; Fresneau, Dominique; Rybak, Fanny			Stridulations Reveal Cryptic Speciation in Neotropical Sympatric Ants	PLOS ONE			English	Article							SPECIES COMPLEX; HYMENOPTERA; RECRUITMENT; ORTHOPTERA; EVOLUTION; BEHAVIOR; MIMICRY; MYRMECOMORPHY; COMMUNICATION; MORPHOLOGY	The taxonomic challenge posed by cryptic species underlines the importance of using multiple criteria in species delimitation. In the current paper we tested the use of acoustic analysis as a tool to assess the real diversity in a cryptic species complex of Neotropical ants. In order to understand the potential of acoustics and to improve consistency in the conclusions by comparing different approaches, phylogenetic relationships of all the morphs considered were assessed by the analysis of a fragment of the mitochondrial DNA cytochrome b. We observed that each of the cryptic morph studied presents a morphologically distinct stridulatory organ and that all sympatric morphs produce distinctive stridulations. This is the first evidence of such a degree of specialization in the acoustic organ and signals in ants, which suggests that stridulations may be among the cues used by these ants during inter-specific interactions. Mitochondrial DNA variation corroborated the acoustic differences observed, confirming acoustics as a helpful tool to determine cryptic species in this group of ants, and possibly in stridulating ants in general. Congruent morphological, acoustic and genetic results constitute sufficient evidence to propose each morph studied here as a valid new species, suggesting that P. apicalis is a complex of at least 6 to 9 species, even if they present different levels of divergence. Finally, our results highlight that ant stridulations may be much more informative than hitherto thought, as much for ant communication as for integrative taxonomists.	[Ferreira, Ronara Souza; Poteaux, Chantal; Fresneau, Dominique] Univ Paris 13, LEEC EA 4443, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France; [Delabie, Jacques Hubert Charles] Ctr Pesquisas Cacau, Convenio UESC CEPLAC, UPA Lab Mirmecol, Itabuna, Brazil; [Rybak, Fanny] Univ Paris Sud, Ctr Neurosci Paris Sud, UMR 8195, Orsay, France; [Rybak, Fanny] CNRS, F-91405 Orsay, France	Universite Paris 13; Universidade Estadual de Santa Cruz; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS)	Ferreira, RS (corresponding author), Univ Paris 13, LEEC EA 4443, Lab Ethol Expt & Comparee, F-93430 Villetaneuse, France.	ronara@leec.univ-paris13.fr	CHARLES, Hubert/B-9392-2011; Delabie, Jacques H C/F-3405-2010; Ferreira-Châline, Ronara/J-7952-2012	CHARLES, Hubert/0000-0002-0809-4705; Delabie, Jacques H C/0000-0002-2695-1061; Ferreira-Châline, Ronara/0000-0001-7335-2179; Poteaux, Chantal/0000-0002-6815-4650	Programme AlBan; European Union [E06D101212BR]; French Entomological Society; PRONEX FAPESB/CNPq [PNX0011/2009]	Programme AlBan(European Commission); European Union(European Commission); French Entomological Society; PRONEX FAPESB/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Programme AlBan, the European Union Programme of High Level Scholarships for Latin America, scholarship n<SUP>o</SUP> E06D101212BR, http://www.programalban.org/; the French Entomological Society (Grant Germaine Cousin), http://www.lasef.org/; PRONEX FAPESB/CNPq PNX0011/2009, www.fapesb.ba.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, INSETOS SOCIAIS BIOL; Balakrishnan R, 2005, SYST BIOL, V54, P689, DOI 10.1080/10635150590950308; Barbero F, 2009, J EXP BIOL, V212, P4084, DOI 10.1242/jeb.032912; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; BARONIURBANI C, 1988, INSECT SOC, V35, P241, DOI 10.1007/BF02224057; Berkov A, 2002, BIOL J LINN SOC, V76, P195, DOI 10.1111/j.1095-8312.2002.tb02082.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bolton Barry, 1995, P1; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brown W. L. jr., 1957, Bulletin of the Museum of Comparative Zoology Harvard, V116, P228; Broza M, 1998, SYST ENTOMOL, V23, P125, DOI 10.1046/j.1365-3113.1998.00048.x; Cade WH, 2000, T AM ENTOMOL SOC, V126, P117; Claridge M. F., 1997, V54, P247; CROZIER RH, 1993, GENETICS, V133, P97; Cushing PE, 1997, FLA ENTOMOL, V80, P165, DOI 10.2307/3495552; DELABIE JH, 2000, MEASURING MONITORING, P145; Devries P, 1991, AM MUS NOVIT, V3025, P1; DEVRIES PJ, 1990, SCIENCE, V248, P1104, DOI 10.1126/science.248.4959.1104; Emery C., 1890, ANN SOC ENTOMOL FR, V10, P55; Fernandez Fernando, 2004, Biota Colombiana, V5, P3; Ferreira R. S., 2009, LANGAGES CAHIERS INF, P71; Forel A., 1922, Revue Suisse de Zoologie, V30, P87; FRESNEAU D, 1994, THESIS U VILLETANEUS; Gavrilets S, 2003, EVOLUTION, V57, P2197; Grasso DA, 2000, ITAL J ZOOL, V67, P281, DOI 10.1080/11250000009356325; Grasso DA, 1998, ITAL J ZOOL, V65, P167, DOI 10.1080/11250009809386741; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HENRY CS, 1994, TRENDS ECOL EVOL, V9, P388, DOI 10.1016/0169-5347(94)90061-2; Hickling R, 2000, J ACOUST SOC AM, V108, P1920, DOI 10.1121/1.1290515; HOLLDOBLER B, 1978, BEHAV ECOL SOCIOBIOL, V4, P163, DOI 10.1007/BF00354978; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM BEAUTY; JANET C, 1893, ANN SOC ENTOMOL FRAN, V62, P159; JANET C, 1894, ANN SOC ENTOMOL FRAN, V63, P109; KERMARREC A, 1976, INSECT SOC, V23, P29, DOI 10.1007/BF02283904; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LANDOIS H, 1874, THIERSTIMMEN, P129; Latreille P., 1802, HIST NATURELLE FOURM, DOI [10.5962/bhl.title.11138, DOI 10.5962/BHL.TITLE.11138]; Lubbock J., 1877, MONTHLY MICROSCOPICA, V18, P121; Lucas C, 2002, BIOL J LINN SOC, V75, P249, DOI 10.1111/j.1095-8312.2002.tb01425.x; Majer JD, 1999, INSECT SOC, V46, P281, DOI 10.1007/s000400050147; Majer Jonathan D., 1993, Journal of Plant Protection in the Tropics, V10, P43; Mariano Clea S.F., 2006, Myrmecologische Nachrichten, V8, P277; Mariano CSF, 2000, NATURALIA, V24, P215; MARKL H, 1977, INSECT SOC, V24, P191, DOI 10.1007/BF02227171; MARKL H, 1968, Z VERGL PHYSIOL, V60, P103, DOI 10.1007/BF00878447; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; Markl H., 1973, Proceedings Congr Int Un Study Soc Ins, V7, P258; MASCHWITZ U, 1983, OECOLOGIA, V57, P175, DOI 10.1007/BF00379578; Mbu Nyamsi Ruben G., 1994, Bioacoustics, V5, P187; MCIVER JD, 1993, ANNU REV ENTOMOL, V38, P351, DOI 10.1146/annurev.en.38.010193.002031; Mercier JL, 2007, INSECT SOC, V54, P403, DOI 10.1007/s00040-007-0960-7; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Morales MA, 2008, P ROY SOC B-BIOL SCI, V275, P1935, DOI 10.1098/rspb.2008.0410; Noor MAF, 1998, ANIM BEHAV, V56, P115, DOI 10.1006/anbe.1998.0779; Pavan G., 1997, Bioacoustics, V8, P209; REISKIND J, 1977, BIOTROPICA, V9, P1, DOI 10.2307/2387854; RITCHIE MG, 1995, J EVOLUTION BIOL, V8, P463, DOI 10.1046/j.1420-9101.1995.8040463.x; Roces F, 2001, J ACOUST SOC AM, V109, P3080, DOI 10.1121/1.1370085; ROCES F, 1993, NATURWISSENSCHAFTEN, V80, P521, DOI 10.1007/BF01140810; Saez AG, 2005, NATURE, V433, P111, DOI 10.1038/433111a; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Sharp D., 1893, Transactions of the Entomological Society of London, P199; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; SPANGLER HG, 1967, SCIENCE, V155, P1687, DOI 10.1126/science.155.3770.1687; Specht R., 2008, AVISOFT SASLAB VERSI; SPJOTVOLL E, 1973, J AM STAT ASSOC, V68, P975, DOI 10.2307/2284534; *STATSOFT BREM, 2007, STATISTICA LOG AN DO; STUART R J, 1980, Psyche (Cambridge), V87, P199, DOI 10.1155/1980/46583; Sueur J, 2006, CONT T ENT, P207; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR RW, 1978, SCIENCE, V201, P979, DOI 10.1126/science.201.4360.979; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Travassos MA, 2000, ANIM BEHAV, V60, P13, DOI 10.1006/anbe.1999.1364; Walker TJ, 2003, ANN ENTOMOL SOC AM, V96, P433, DOI 10.1603/0013-8746(2003)096[0433:TRCOTG]2.0.CO;2; Wilcox TP, 1997, MOL PHYLOGENET EVOL, V7, P208, DOI 10.1006/mpev.1996.0388; Wild AL, 2005, ZOOTAXA, P1; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032	81	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15363	10.1371/journal.pone.0015363	http://dx.doi.org/10.1371/journal.pone.0015363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203529	gold, Green Published, Green Submitted			2022-12-25	WOS:000285578000032
J	Timmermann, B; Kerick, M; Roehr, C; Fischer, A; Isau, M; Boerno, ST; Wunderlich, A; Barmeyer, C; Seemann, P; Koenig, J; Lappe, M; Kuss, AW; Garshasbi, M; Bertram, L; Trappe, K; Werber, M; Herrmann, BG; Zatloukal, K; Lehrach, H; Schweiger, MR				Timmermann, Bernd; Kerick, Martin; Roehr, Christina; Fischer, Axel; Isau, Melanie; Boerno, Stefan T.; Wunderlich, Andrea; Barmeyer, Christian; Seemann, Petra; Koenig, Jana; Lappe, Michael; Kuss, Andreas W.; Garshasbi, Masoud; Bertram, Lars; Trappe, Kathrin; Werber, Martin; Herrmann, Bernhard G.; Zatloukal, Kurt; Lehrach, Hans; Schweiger, Michal R.			Somatic Mutation Profiles of MSI and MSS Colorectal Cancer Identified by Whole Exome Next Generation Sequencing and Bioinformatics Analysis	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; MICROSATELLITE INSTABILITY; JUVENILE POLYPOSIS; COLON-CANCER; HUMAN BREAST; GENE; GENOME; RESOURCES; GERMLINE; PATHWAYS	Background: Colorectal cancer (CRC) is with approximately 1 million cases the third most common cancer worldwide. Extensive research is ongoing to decipher the underlying genetic patterns with the hope to improve early cancer diagnosis and treatment. In this direction, the recent progress in next generation sequencing technologies has revolutionized the field of cancer genomics. However, one caveat of these studies remains the large amount of genetic variations identified and their interpretation. Methodology/Principal Findings: Here we present the first work on whole exome NGS of primary colon cancers. We performed 454 whole exome pyrosequencing of tumor as well as adjacent not affected normal colonic tissue from microsatellite stable (MSS) and microsatellite instable (MSI) colon cancer patients and identified more than 50,000 small nucleotide variations for each tissue. According to predictions based on MSS and MSI pathomechanisms we identified eight times more somatic non-synonymous variations in MSI cancers than in MSS and we were able to reproduce the result in four additional CRCs. Our bioinformatics filtering approach narrowed down the rate of most significant mutations to 359 for MSI and 45 for MSS CRCs with predicted altered protein functions. In both CRCs, MSI and MSS, we found somatic mutations in the intracellular kinase domain of bone morphogenetic protein receptor 1A, BMPR1A, a gene where so far germline mutations are associated with juvenile polyposis syndrome, and show that the mutations functionally impair the protein function. Conclusions/Significance: We conclude that with deep sequencing of tumor exomes one may be able to predict the microsatellite status of CRC and in addition identify potentially clinically relevant mutations.	[Timmermann, Bernd] Max Planck Inst Mol Genet, Next Generat Sequencing Grp, Berlin, Germany; [Kerick, Martin; Roehr, Christina; Fischer, Axel; Isau, Melanie; Boerno, Stefan T.; Wunderlich, Andrea; Bertram, Lars; Trappe, Kathrin; Lehrach, Hans; Schweiger, Michal R.] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Berlin, Germany; [Roehr, Christina; Isau, Melanie; Boerno, Stefan T.; Wunderlich, Andrea] Free Univ Berlin, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Barmeyer, Christian] Charite, Dept Gastroenterol, D-13353 Berlin, Germany; [Seemann, Petra; Koenig, Jana] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Lappe, Michael] Max Planck Inst Mol Genet, Otto Warburg Lab, Berlin, Germany; [Kuss, Andreas W.; Garshasbi, Masoud] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Kuss, Andreas W.] Ernst Moritz Arndt Univ Greifswald, Inst Human Genet, Greifswald, Germany; [Werber, Martin; Herrmann, Bernhard G.] Max Planck Inst Mol Genet, Dept Dev Genet, Berlin, Germany; [Zatloukal, Kurt] Med Univ, Dept Pathol, Graz, Austria	Max Planck Society; Max Planck Society; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Max Planck Society; Ernst Moritz Arndt Universitat Greifswald; Max Planck Society; Medical University of Graz	Timmermann, B (corresponding author), Max Planck Inst Mol Genet, Next Generat Sequencing Grp, Berlin, Germany.	mschweig@molgen.mpg.de	Bertram, Lars/K-3889-2015; Seemann, Petra/G-3606-2011; Kerick, Martin/AAD-8303-2022; Schweiger, Michal R/H-5270-2015	Bertram, Lars/0000-0002-0108-124X; Seemann, Petra/0000-0002-6056-6669; Schweiger, Michal R/0000-0002-4672-0623; Fischer, Axel/0000-0001-6130-6984; Kuss, Andreas/0000-0002-9401-4627; Garshasbi, Masoud/0000-0002-5508-7903; Kerick, Martin/0000-0002-6298-4514	German Federal Ministry of Education and Research [01GS08105, 01GS08111]; Max Planck Society	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society)	This work was supported by the German Federal Ministry of Education and Research (01GS08105 "Mutanom," 01GS08111 "Intestinal Modifers") and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bodmer WF, 2006, J HUM GENET, V51, P391, DOI 10.1007/s10038-006-0373-x; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DEGRASSI A, PLOS BIOL, V8; Fallik D, 2003, CANCER RES, V63, P5738; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Howe JR, 2004, J MED GENET, V41, P484, DOI 10.1136/jmg.2004.018598; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lipkin SM, 2001, HUM MUTAT, V17, P389, DOI 10.1002/humu.1114; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; PEINADO MA, 1992, P NATL ACAD SCI USA, V89, P10065, DOI 10.1073/pnas.89.21.10065; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	39	161	167	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15661	10.1371/journal.pone.0015661	http://dx.doi.org/10.1371/journal.pone.0015661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203531	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000042
J	Purdy, MA; Khudyakov, YE				Purdy, Michael A.; Khudyakov, Yury E.			Evolutionary History and Population Dynamics of Hepatitis E Virus	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; UNITED-STATES; BLOOD-DONORS; PIG LIVERS; INFECTION; HEV; PREVALENCE; TIME; IDENTIFICATION; EPIDEMIOLOGY	Background: Hepatitis E virus (HEV) is an enterically transmitted hepatropic virus. It segregates as four genotypes. All genotypes infect humans while only genotypes 3 and 4 also infect several animal species. It has been suggested that hepatitis E is zoonotic, but no study has analyzed the evolutionary history of HEV. We present here an analysis of the evolutionary history of HEV. Methods and Findings: The times to the most recent common ancestors for all four genotypes of HEV were calculated using BEAST to conduct a Bayesian analysis of HEV. The population dynamics for genotypes 1, 3 and 4 were analyzed using skyline plots. Bayesian analysis showed that the most recent common ancestor for modern HEV existed between 536 and 1344 years ago. The progenitor of HEV appears to have given rise to anthropotropic and enzootic forms of HEV, which evolved into genotypes 1 and 2 and genotypes 3 and 4, respectively. Population dynamics suggest that genotypes 1, 3 and 4 experienced a population expansion during the 20(th) century. Genotype 1 has increased in infected population size,3035 years ago. Genotype 3 and 4 have experienced an increase in population size starting late in the 19(th) century until ca. 1940-45, with genotype 3 having undergone additional rapid expansion until ca. 1960. The effective population size for both genotype 3 and 4 rapidly declined to pre-expansion levels starting in ca. 1990. Genotype 4 was further examined as Chinese and Japanese sequences, which exhibited different population dynamics, suggesting that this genotype experienced different evolutionary history in these two countries. Conclusions: HEV appears to have evolved through a series of steps, in which the ancestors of HEV may have adapted to a succession of animal hosts leading to humans. Analysis of the population dynamics of HEV suggests a substantial temporal variation in the rate of transmission among HEV genotypes in different geographic regions late in the 20(th) Century.	[Purdy, Michael A.; Khudyakov, Yury E.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Purdy, MA (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA.	mup3@cdc.gov						Albarella U, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P209; Bilic L, 2009, J GEN VIROL, V90, P863, DOI 10.1099/vir.0.007179-0; Bouwknegt M, 2007, J FOOD PROTECT, V70, P2889, DOI 10.4315/0362-028X-70.12.2889; Bradley DW, 1993, VIRAL HEPATITIS SCI, P379; Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970; Cooper K, 2005, J CLIN MICROBIOL, V43, P1684, DOI 10.1128/JCM.43.4.1684-1688.2005; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Davis K, 1955, AM J SOCIOL, V60, P429, DOI 10.1086/221602; DONOGHUE HD, 2007, P 6 WORLD C MUMM STU; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; EMERSON SU, 2004, VIRUS TAXONOMY, P853; Feagins AR, 2007, J GEN VIROL, V88, P912, DOI 10.1099/vir.0.82613-0; Holmes EC, 2007, CURR TOP MICROBIOL, V315, P51; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; Johne R, 2010, J GEN VIROL, V91, P750, DOI 10.1099/vir.0.016584-0; Kulkarni MA, 2008, J MED VIROL, V80, P1387, DOI 10.1002/jmv.21220; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemma E, 2008, FEMS MICROBIOL LETT, V283, P54, DOI 10.1111/j.1574-6968.2008.01150.x; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Moratorio G, 2007, J GEN VIROL, V88, P3039, DOI 10.1099/vir.0.83038-0; Morrison DA, 2006, AUST SYST BOT, V19, P479, DOI 10.1071/SB06020; Mushahwar IK, 2008, J MED VIROL, V80, P646, DOI 10.1002/jmv.21116; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; RAMBAUT A, 2009, FIGTREE; Reuter G, 2009, J CLIN VIROL, V44, P277, DOI 10.1016/j.jcv.2009.01.008; Sonoda H, 2004, J CLIN MICROBIOL, V42, P5371, DOI 10.1128/JCM.42.11.5371-5374.2004; Subramanian S, 2009, TRENDS GENET, V25, P482, DOI 10.1016/j.tig.2009.09.005; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Takahashi K, 2004, HEPATOL RES, V29, P212, DOI 10.1016/j.hepres.2004.04.004; Tanaka Y, 2006, J GEN VIROL, V87, P949, DOI 10.1099/vir.0.81661-0; Teo CG, 2006, CURR OPIN INFECT DIS, V19, P460, DOI 10.1097/01.qco.0000244052.61629.49; Zhang W, 2008, ZOONOSES PUBLIC HLTH, V55, P291, DOI 10.1111/j.1863-2378.2008.01136.x; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	42	85	86	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14376	10.1371/journal.pone.0014376	http://dx.doi.org/10.1371/journal.pone.0014376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21203540	Green Published, gold			2022-12-25	WOS:000285572900009
J	Antonellis, A; Dennis, MY; Burzynski, G; Huynh, J; Maduro, V; Hodonsky, CJ; Khajavi, M; Szigeti, K; Mukkamala, S; Bessling, SL; Pavan, WJ; McCallion, AS; Lupski, JR; Green, ED				Antonellis, Anthony; Dennis, Megan Y.; Burzynski, Grzegorz; Huynh, Jimmy; Maduro, Valerie; Hodonsky, Chani J.; Khajavi, Mehrdad; Szigeti, Kinga; Mukkamala, Sandeep; Bessling, Seneca L.; Pavan, William J.; McCallion, Andrew S.; Lupski, James R.; Green, Eric D.		NISC Comparative Sequencing Progra	A Rare Myelin Protein Zero (MPZ) Variant Alters Enhancer Activity In Vitro and In Vivo	PLOS ONE			English	Article							GROWTH-RESPONSE 2; SCHWANN-CELLS; GENE; MUTATIONS; EGR2; SOX10; TRANSCRIPTION; EXPRESSION; ZEBRAFISH; SEQUENCES	Background: Myelin protein zero (MPZ) is a critical structural component of myelin in the peripheral nervous system. The MPZ gene is regulated, in part, by the transcription factors SOX10 and EGR2. Mutations in MPZ, SOX10, and EGR2 have been implicated in demyelinating peripheral neuropathies, suggesting that components of this transcriptional network are candidates for harboring disease-causing mutations (or otherwise functional variants) that affect MPZ expression. Methodology: We utilized a combination of multi-species sequence comparisons, transcription factor-binding site predictions, targeted human DNA re-sequencing, and in vitro and in vivo enhancer assays to study human non-coding MPZ variants. Principal Findings: Our efforts revealed a variant within the first intron of MPZ that resides within a previously described SOX10 binding site is associated with decreased enhancer activity, and alters binding of nuclear proteins. Additionally, the genomic segment harboring this variant directs tissue-relevant reporter gene expression in zebrafish. Conclusions: This is the first reported MPZ variant within a cis-acting transcriptional regulatory element. While we were unable to implicate this variant in disease onset, our data suggests that similar non-coding sequences should be screened for mutations in patients with neurological disease. Furthermore, our multi-faceted approach for examining the functional significance of non-coding variants can be readily generalized to study other loci important for myelin structure and function.	[Antonellis, Anthony; Hodonsky, Chani J.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Antonellis, Anthony] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI USA; [Dennis, Megan Y.; Maduro, Valerie; Mukkamala, Sandeep; Green, Eric D.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Burzynski, Grzegorz; Huynh, Jimmy; Bessling, Seneca L.; McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Burzynski, Grzegorz; Huynh, Jimmy; Bessling, Seneca L.; McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Khajavi, Mehrdad; Szigeti, Kinga; Lupski, James R.] Dept Mol & Human Genet, Houston, TX USA; [Szigeti, Kinga] Dept Neurol, Houston, TX USA; [Green, Eric D.; NISC Comparative Sequencing Progra] NHGRI, NIH Intramural Sequencing Ctr NISC, NIH, Bethesda, MD 20892 USA; [Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Baylor College of Medicine; Baylor College of Medicine	Antonellis, A (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	egreen@nhgri.nih.gov	Burzynski, Grzegorz M/D-2800-2009; Hodonsky, Chani/AAC-8429-2020	Hodonsky, Chani/0000-0001-8566-5877; Pavan, William/0000-0001-8281-5120	National Human Genome Research Institute (National Institutes of Health); Charcot-Marie-Tooth Association; National Institute of General Medical Sciences [R01GM071648]; National Institute of Neurological Diseases and Stroke [R01NS062972, R00NS060983]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS060983, R01NS062972] Funding Source: NIH RePORTER	National Human Genome Research Institute (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Charcot-Marie-Tooth Association; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Intramural Research Program of the National Human Genome Research Institute (National Institutes of Health), a fellowship (AA) and grant (JRL) from the Charcot-Marie-Tooth Association, grant R01GM071648 from the National Institute of General Medical Sciences (ASM), grant R01NS062972 (ASM) from the National Institute of Neurological Diseases and Stroke, and grant R00NS060983 from the National Institute of Neurological Diseases and Stroke (AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonellis A, 2006, HUM MOL GENET, V15, P259, DOI 10.1093/hmg/ddi442; Antonellis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000174; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Brown AM, 1997, J BIOL CHEM, V272, P28939, DOI 10.1074/jbc.272.46.28939; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Elnitski Laura, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1002s00; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Inouye H, 1999, BIOPHYS J, V76, P423, DOI 10.1016/S0006-3495(99)77209-7; Ionasescu VV, 1996, NEUROLOGY, V47, P541, DOI 10.1212/WNL.47.2.541; Jang SW, 2009, J BIOL CHEM, V284, P20111, DOI 10.1074/jbc.M109.022426; Jones EA, 2007, NEURON GLIA BIOL, V3, P377, DOI 10.1017/S1740925X08000173; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kazakova N, 2006, DEV BIOL, V297, P1, DOI 10.1016/j.ydbio.2006.03.020; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LeBlanc SE, 2007, MOL CELL BIOL, V27, P3521, DOI 10.1128/MCB.01689-06; LeBlanc SE, 2006, J BIOL CHEM, V281, P5453, DOI 10.1074/jbc.M512159200; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Quarles RH, 2002, CELL MOL LIFE SCI, V59, P1851, DOI 10.1007/PL00012510; Roa BB, 1996, HUM MUTAT, V7, P36, DOI 10.1002/(SICI)1098-1004(1996)7:1<36::AID-HUMU5>3.0.CO;2-N; Schweitzer M, 2006, MOL CELL NEUROSCI, V31, P161, DOI 10.1016/j.mcn.2005.10.007; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; SU Y, 1993, P NATL ACAD SCI USA, V90, P10856, DOI 10.1073/pnas.90.22.10856; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Thompson AJ, 2002, J NEUROSCI RES, V67, P766, DOI 10.1002/jnr.10167; TODA K, 1994, J NEUROCHEM, V63, P1646; Warner LE, 1999, HUM MOL GENET, V8, P1245, DOI 10.1093/hmg/8.7.1245; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Yoshida M, 1996, NEURON, V16, P1115, DOI 10.1016/S0896-6273(00)80138-5	43	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14346	10.1371/journal.pone.0014346	http://dx.doi.org/10.1371/journal.pone.0014346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179557	Green Published, gold, Green Submitted			2022-12-25	WOS:000285381200004
J	Drame, PM; Poinsignon, A; Besnard, P; Cornelie, S; Le Mire, J; Toto, JC; Foumane, V; Dos-Santos, MA; Sembene, M; Fortes, F; Simondon, F; Carnevale, P; Remoue, F				Drame, Papa Makhtar; Poinsignon, Anne; Besnard, Patrick; Cornelie, Sylvie; Le Mire, Jacques; Toto, Jean-Claude; Foumane, Vincent; Dos-Santos, Maria Adelaide; Sembene, Mbacke; Fortes, Filomeno; Simondon, Francois; Carnevale, Pierre; Remoue, Franck			Human Antibody Responses to the Anopheles Salivary gSG6-P1 Peptide: A Novel Tool for Evaluating the Efficacy of ITNs in Malaria Vector Control	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; CHILD-MORTALITY; EPIDEMIOLOGIC MARKER; ARTHROPOD SALIVA; GAMBIAE COMPLEX; GLAND PROTEINS; AEDES-AEGYPTI; LYME-DISEASE; BED NETS; MORBIDITY	To optimize malaria control, WHO has prioritised the need for new indicators to evaluate the efficacy of malaria vector control strategies. The gSG6-P1 peptide from gSG6 protein of Anopheles gambiae salivary glands was previously designed as a specific salivary sequence of malaria vector species. It was shown that the quantification of human antibody (Ab) responses to Anopheles salivary proteins in general and especially to the gSG6-P1 peptide was a pertinent biomarker of human exposure to Anopheles. The present objective was to validate this indicator in the evaluation of the efficacy of Insecticide Treated Nets (ITNs). A longitudinal evaluation, including parasitological, entomological and immunological assessments, was conducted on children and adults from a malaria-endemic area before and after the introduction of ITNs. Significant decrease of anti-gSG6-P1 IgG response was observed just after the efficient ITNs use. Interestingly, specific IgG Ab level was especially pertinent to evaluate a short-time period of ITNs efficacy and at individual level. However, specific IgG rose back up within four months as correct ITN use waned. IgG responses to one salivary peptide could constitute a reliable biomarker for the evaluation of ITN efficacy, at short-and long-term use, and provide a valuable tool in malaria vector control based on a real measurement of human-vector contact.	[Drame, Papa Makhtar; Remoue, Franck] Inst Rech Dev, UR016, Cotonou, Benin; [Poinsignon, Anne; Cornelie, Sylvie; Carnevale, Pierre] Inst Rech Dev, UR016, Montpellier, France; [Besnard, Patrick; Le Mire, Jacques; Dos-Santos, Maria Adelaide] Malaria Control Program SONAMET Clin, Lobito, Angola; [Toto, Jean-Claude; Foumane, Vincent] Org Coordinat Lutte Endemies Afrique Cent, Lab Rech Paludisme, Yaounde, Cameroon; [Sembene, Mbacke] Cheikh Anta DIOP Univ, Dept Anim Biol, Dakar, Senegal; [Fortes, Filomeno] Minist Publ Hlth, Malaria Control Program, Luanda, Angola; [Simondon, Francois] Inst Rech Dev, VIH SIDA & Malad Associees, UMR145, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University Cheikh Anta Diop Dakar; University of Yaounde I	Drame, PM (corresponding author), Inst Rech Dev, UR016, Cotonou, Benin.	papa-makhtar.drame@ird.fr		cornelie, sylvie/0000-0003-3662-1450; Poinsignon, Anne/0000-0003-2921-4486; Fortes, Fabiane/0000-0001-6217-3474; Simondon, Francois/0000-0003-0395-1314	IRD (Departement Soutien et Formation); Research Ministry of France; Francois Lacoste (Fonds Inkermann); ACERGY-SONAMET Company; French Ministry of Defense (Delegation Generale pour l'Armement); IRD (Departement Expertise et Valorisation)	IRD (Departement Soutien et Formation); Research Ministry of France(European Commission); Francois Lacoste (Fonds Inkermann); ACERGY-SONAMET Company; French Ministry of Defense (Delegation Generale pour l'Armement); IRD (Departement Expertise et Valorisation)	Papa-Makhtar Drame was supported by a fellowship provided by the IRD (Departement Soutien et Formation). Anne Poinsignon was supported by fellowships provided by the Research Ministry of France then by Francois Lacoste (Fonds Inkermann). This work was supported by ACERGY-SONAMET Company (Malaria Control Program), the French Ministry of Defense (Delegation Generale pour l'Armement) and the IRD (Departement Expertise et Valorisation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade BB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-121; [Anonymous], 2004, COCHRANE DB SYST REV; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Barral A, 2000, AM J TROP MED HYG, V62, P740, DOI 10.4269/ajtmh.2000.62.740; Billingsley PF, 2006, PARASITE IMMUNOL, V28, P143, DOI 10.1111/j.1365-3024.2006.00805.x; Binka FN, 1998, AM J TROP MED HYG, V59, P80, DOI 10.4269/ajtmh.1998.59.80; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Calvo E, 2004, INSECT MOL BIOL, V13, P73, DOI 10.1111/j.1365-2583.2004.00463.x; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Calzetta M, 2008, AM J TROP MED HYG, V78, P169, DOI 10.4269/ajtmh.2008.78.169; Chouaibou M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-77; Cornelie S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-75; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Cuamba N, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-2; DAS MK, 1991, J AM MOSQUITO CONTR, V7, P319; Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Lane RS, 1999, AM J TROP MED HYG, V61, P850, DOI 10.4269/ajtmh.1999.61.850; Lombardo F, 2009, INSECT BIOCHEM MOLEC, V39, P457, DOI 10.1016/j.ibmb.2009.04.006; Maxwell CA, 2002, TROP MED INT HEALTH, V7, P1003, DOI 10.1046/j.1365-3156.2002.00966.x; Mussi ADH, 2007, ACTA TROP, V104, P108, DOI 10.1016/j.actatropica.2007.07.011; Nascimento RJ, 2001, AM J TROP MED HYG, V65, P219, DOI 10.4269/ajtmh.2001.65.219; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012; Peng ZK, 2002, J ALLERGY CLIN IMMUN, V110, P816, DOI 10.1067/mai.2002.128736; POINSIGNON A, 2010, TROP MED IN IN PRESS; Poinsignon A, 2008, AM J TROP MED HYG, V78, P750, DOI 10.4269/ajtmh.2008.78.750; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Remoue F., 2005, Update in tropical immunology, P377; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; REUNALA T, 1994, INT ARCH ALLERGY IMM, V104, P366, DOI 10.1159/000236693; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI 10.1017/S003118200400681X; SCHWARTZ BS, 1990, AM J EPIDEMIOL, V132, P58, DOI 10.1093/oxfordjournals.aje.a115643; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Takken W, 2009, TRENDS PARASITOL, V25, P101, DOI 10.1016/j.pt.2008.12.002; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004; World Health Organization, 2008, WORLD MAL REP; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	47	61	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15596	10.1371/journal.pone.0015596	http://dx.doi.org/10.1371/journal.pone.0015596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179476	Green Submitted, Green Published, gold			2022-12-25	WOS:000285292500028
J	Jiang, DS; Schwarz, H				Jiang, Dongsheng; Schwarz, Herbert			Regulation of Granulocyte and Macrophage Populations of Murine Bone Marrow Cells by G-CSF and CD137 Protein	PLOS ONE			English	Article							HEMATOPOIETIC GROWTH-FACTORS; COLONY-STIMULATING FACTOR; FACTOR-RECEPTOR FAMILY; HUMAN DENDRITIC CELLS; MONOCYTE ACTIVATION; PROGENITOR CELLS; PROLIFERATION; LIGAND; 4-1BB; DIFFERENTIATION	Background: Granulocytes and monocytes/macrophages differentiate from common myeloid progenitor cells. Granulocyte colony-stimulating factor (G-CSF) and CD137 (4-1BB, TNFRSF9) are growth and differentiation factors that induce granulocyte and macrophage survival and differentiation, respectively. This study describes the influence of G-CSF and recombinant CD137-Fc protein on myelopoiesis. Methodology/Principal Findings: Both, G-CSF and CD137 protein support proliferation and survival of murine bone marrow cells. G-CSF enhances granulocyte numbers while CD137 protein enhances macrophage numbers. Both growth factors together give rise to more cells than each factor alone. Titration of G-CSF and CD137 protein dose-dependently changes the granulocyte/macrophage ratio in bone marrow cells. Both factors individually induce proliferation of hematopoietic progenitor cells (lin(-), c-kit(+)) and differentiation to granulocytes and macrophages, respectively. The combination of G-CSF and CD137 protein further increases proliferation, and results in a higher number of macrophages than CD137 protein alone, and a lower number of granulocytes than G-CSF alone demonstrating that CD137 protein-induced monocytic differentiation is dominant over G-CSF-induced granulocytic differentiation. CD137 protein induces monocytic differentiation even in early hematopoietic progenitor cells, the common myeloid progenitors and the granulocyte macrophage progenitors. Conclusions/Significance: This study confirms earlier data on the regulation of myelopoiesis by CD137 receptor - ligand interaction, and extends them by demonstrating the restriction of this growth promoting influence to the monocytic lineage.	[Jiang, Dongsheng; Schwarz, Herbert] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Jiang, Dongsheng; Schwarz, Herbert] Natl Univ Singapore, Yong Loo Lin Sch Med, Immunol Programme, Singapore 117595, Singapore; [Schwarz, Herbert] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Jiang, DS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore.	phssh@nus.edu.sg	Jiang, Dongsheng/AAG-1284-2020	Jiang, Dongsheng/0000-0003-0961-2671	Singapore Stem Cell Consortium [SSCC-06-009]	Singapore Stem Cell Consortium	This research was supported by grant (SSCC-06-009) from the Singapore Stem Cell Consortium (http://www.sscc.a-star.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COOK N, 1989, EMBO J, V8, P2967, DOI 10.1002/j.1460-2075.1989.tb08446.x; Drenkard D, 2007, FASEB J, V21, P456, DOI 10.1096/fj.05-4739com; Gyger M, 2000, BONE MARROW TRANSPL, V26, P1, DOI 10.1038/sj.bmt.1702464; Heinisch IVWM, 2000, EUR J IMMUNOL, V30, P3441, DOI 10.1002/1521-4141(2000012)30:12<3441::AID-IMMU3441>3.0.CO;2-L; Heinisch IVWM, 2001, J ALLERGY CLIN IMMUN, V108, P21, DOI 10.1067/mai.2001.116864; HOGAN PG, 1988, BLOOD REV, V2, P50, DOI 10.1016/0268-960X(88)90008-2; Jiang D, 2008, STEM CELLS, V26, P2372, DOI 10.1634/stemcells.2008-0158; Jiang DS, 2008, J IMMUNOL, V181, P3923, DOI 10.4049/jimmunol.181.6.3923; Ju SW, 2009, INT IMMUNOL, V21, P1135, DOI 10.1093/intimm/dxp077; Ju SW, 2003, HYBRIDOMA HYBRIDOM, V22, P333, DOI 10.1089/153685903322538872; Kim YJ, 2002, J HEMATOTH STEM CELL, V11, P895, DOI 10.1089/152581602321080556; Kwajah MMS, 2010, EUR J IMMUNOL, V40, P1938, DOI 10.1002/eji.200940105; Laderach D, 2003, CELL IMMUNOL, V226, P37, DOI 10.1016/j.cellimm.2003.11.003; Langstein J, 2000, BIOCHEM BIOPH RES CO, V273, P117, DOI 10.1006/bbrc.2000.2889; Langstein J, 1999, BLOOD, V94, P3161, DOI 10.1182/blood.V94.9.3161.421k31_3161_3168; Langstein J, 1999, J LEUKOCYTE BIOL, V65, P829, DOI 10.1002/jlb.65.6.829; Langstein J, 1998, J IMMUNOL, V160, P2488; Lee SW, 2008, NAT IMMUNOL, V9, P917, DOI 10.1038/ni.1632; Lippert U, 2008, EUR J IMMUNOL, V38, P1024, DOI [10.1002/eji.200737800, 10.1002/eji.200890024]; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; MOORE MAS, 1990, CANCER, V65, P836, DOI 10.1002/1097-0142(19900201)65:3+<836::AID-CNCR2820651331>3.0.CO;2-X; Pauly S, 2002, J LEUKOCYTE BIOL, V72, P35; Saito K, 2004, J BIOL CHEM, V279, P13555, DOI 10.1074/jbc.M303791200; Santangelo S, 2001, ANN SURG, V233, P97, DOI 10.1097/00000658-200101000-00015; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; Schwarz H, 2005, J LEUKOCYTE BIOL, V77, P281, DOI 10.1189/jlb.0904558; Schwarz H, 1996, BLOOD, V87, P2839, DOI 10.1182/blood.V87.7.2839.bloodjournal8772839; SHAO Z, 2010, J LEUKOC BIOL; Shoup M, 1998, ANN SURG, V228, P112, DOI 10.1097/00000658-199807000-00017; Simon HU, 2001, SWISS MED WKLY, V131, P455; Simon HU, 1997, J IMMUNOL, V158, P3902; So T, 2006, INT J HEMATOL, V83, P1, DOI 10.1532/IJH97.05120; Soellner L, 2007, CELL SIGNAL, V19, P1899, DOI 10.1016/j.cellsig.2007.04.014; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839	34	27	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15565	10.1371/journal.pone.0015565	http://dx.doi.org/10.1371/journal.pone.0015565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179444	Green Published, gold, Green Submitted			2022-12-25	WOS:000285246900047
J	Jerke, U; Rolle, S; Dittmar, G; Bayat, B; Santoso, S; Sporbert, A; Luft, F; Kettritz, R				Jerke, Uwe; Rolle, Susanne; Dittmar, Gunnar; Bayat, Behnaz; Santoso, Sentot; Sporbert, Anje; Luft, Friedrich; Kettritz, Ralph			Complement Receptor Mac-1 Is an Adaptor for NB1 (CD177)-mediated PR3-ANCA Neutrophil Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; MEMBRANE PROTEINASE-3 EXPRESSION; SYSTEMIC VASCULITIS; ANTIMYELOPEROXIDASE ANTIBODIES; WEGENERS-GRANULOMATOSIS; ANTIGEN PROTEINASE-3; SIGNAL-TRANSDUCTION; SURFACE EXPRESSION; IN-VIVO; GLOMERULONEPHRITIS	The glycosylphosphatidylinositol (GPI)-anchored neutrophil-specific receptor NB1 (CD177) presents the autoantigen proteinase 3 (PR3) on the membrane of a neutrophil subset. PR3-ANCA-activated neutrophils participate in small-vessel vasculitis. Since NB1 lacks an intracellular domain, we characterized components of the NB1 signaling complex that are pivotal for neutrophil activation. PR3-ANCA resulted in degranulation and superoxide production in the mNB1(pos)/PR3(high) neutrophils, but not in the mNB1(neg)/PR3(low) subset, whereas MPO-ANCA and fMLP caused similar responses. The NB1 signaling complex that was precipitated from plasma membranes contained the transmembrane receptor Mac-1 (CD11b/CD18) as shown by MS/MS analysis and immunoblotting. NB1 co-precipitation was less for CD11a and not detectable for CD11c. NB1 showed direct protein-protein interactions with both CD11b and CD11a by surface plasmon resonance analysis (SPR). However, when these integrins were presented as heterodimeric transmembrane proteins on transfected cells, only CD11b/CD18 (Mac-1)-transfected cells adhered to immobilized NB1 protein. This adhesion was inhibited by mAb against NB1, CD11b, and CD18. NB1, PR3, and Mac-1 were located within lipid rafts. In addition, confocal microscopy showed the strongest NB1 co-localization with CD11b and CD18 on the neutrophil. Stimulation with NB1-activating mAb triggered degranulation and superoxide production in mNB1(pos)/mPR3(high) neutrophils, and this effect was reduced using blocking antibodies to CD11b. CD11b blockade also inhibited PR3-ANCA-induced neutrophil activation, even when beta 2-integrin ligand-dependent signals were omitted. We establish the pivotal role of the NB1-Mac-1 receptor interaction for PR3-ANCA-mediated neutrophil activation.	[Jerke, Uwe; Rolle, Susanne; Luft, Friedrich; Kettritz, Ralph] Fac Med Charite, ECRC, D-13125 Berlin, Germany; [Dittmar, Gunnar; Sporbert, Anje] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bayat, Behnaz; Santoso, Sentot] Univ Giessen, Inst Clin Immunol & Transfus Med, D-35385 Giessen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Justus Liebig University Giessen	Kettritz, R (corresponding author), Fac Med Charite, ECRC, Lindenberger Weg 80, D-13125 Berlin, Germany.	kettritz@charite.de	Dittmar, Gunnar/C-6333-2019; Dittmar, Gunnar/B-6383-2016	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623; Jerke, Uwe/0000-0001-6887-8010; Luft, Friedrich/0000-0002-8635-1199; Kettritz, Ralph/0000-0001-5821-6718	Deutsche Forschungsgemeinschaft [DFG: KE 576/7-1]; Experimental and Clinical Research Center (ECRC) Berlin-Buch; Transregional Collaborative Research Center [SFB/TRR84]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Experimental and Clinical Research Center (ECRC) Berlin-Buch; Transregional Collaborative Research Center	This work was supported by the Deutsche Forschungsgemeinschaft (DFG: KE 576/7-1), and a grant from the Experimental and Clinical Research Center (ECRC) Berlin-Buch and from the Transregional Collaborative Research Center (SFB/TRR84) supported this study.	Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Bayat B, 2010, J IMMUNOL, V184, P3889, DOI 10.4049/jimmunol.0903136; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BOHUSLAV J, 1995, J EXP MED, V181, P1381, DOI 10.1084/jem.181.4.1381; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; David A, 2003, J LEUKOCYTE BIOL, V74, P551, DOI 10.1189/jlb.1202624; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Hu N, 2009, ARTHRITIS RHEUM-US, V60, P1548, DOI 10.1002/art.24442; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Korkmaz B, 2008, J BIOL CHEM, V283, P35976, DOI 10.1074/jbc.M806754200; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Little MA, 2005, BLOOD, V106, P2050, DOI 10.1182/blood-2005-03-0921; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Petty HR, 1996, IMMUNOL TODAY, V17, P209, DOI 10.1016/0167-5699(96)30013-3; Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186; Pfister H, 2004, BLOOD, V104, P1411, DOI 10.1182/blood-2004-01-0267; PICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1; Pocock CF, 2001, BRIT J HAEMATOL, V113, P483, DOI 10.1046/j.1365-2141.2001.02779.x; Rarok AA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028642.26222.00; Sachs UJH, 2006, BLOOD, V107, P1217, DOI 10.1182/blood-2005-04-1744; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; SAVAGE COS, 1992, AM J PATHOL, V141, P335; Schreiber A, 2005, J AM SOC NEPHROL, V16, P2216, DOI 10.1681/ASN.2004070609; Schreiber A, 2004, KIDNEY INT, V65, P2172, DOI 10.1111/j.1523-1755.2004.00640.x; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; Schreiber A, 2006, J AM SOC NEPHROL, V17, P3355, DOI 10.1681/ASN.2006070718; Socher I, 2009, TRANSFUSION, V49, P943, DOI 10.1111/j.1537-2995.2008.02065.x; STOCKL J, 1995, J IMMUNOL, V154, P5452; VANDERWOUDE FJ, 1985, LANCET, V1, P425; von Vietinghoff S, 2008, CLIN EXP IMMUNOL, V152, P508, DOI 10.1111/j.1365-2249.2008.03663.x; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; von Vietinghoff S, 2006, J AM SOC NEPHROL, V17, P3185, DOI 10.1681/ASN.2006050522; Watanabe T, 2002, BIOCHEM BIOPH RES CO, V294, P692, DOI 10.1016/S0006-291X(02)00538-7; Witko-Sarsat V, 1999, J AM SOC NEPHROL, V10, P1224; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Xiao H, 2005, AM J PATHOL, V167, P39, DOI 10.1016/S0002-9440(10)62951-3	41	59	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7070	7081		10.1074/jbc.M110.171256	http://dx.doi.org/10.1074/jbc.M110.171256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193407	hybrid, Green Published			2022-12-25	WOS:000287737300024
J	Kim, JH; Lee, JO; Lee, SK; Moon, JW; You, GY; Kim, SJ; Park, SH; Park, JM; Lim, SY; Suh, PG; Uhm, KO; Song, MS; Kim, HS				Kim, Ji Hae; Lee, Jung Ok; Lee, Soo Kyung; Moon, Ji Wook; You, Ga Young; Kim, Su Jin; Park, Sun-Hwa; Park, Ji Man; Lim, Se Young; Suh, Pann-Ghill; Uhm, Kyung-Ok; Song, Min Seok; Kim, Hyeon Soo			The Glutamate Agonist Homocysteine Sulfinic Acid Stimulates Glucose Uptake through the Calcium-dependent AMPK-p38 MAPK-Protein Kinase C zeta Pathway in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PANCREATIC-ISLETS; DIABETES-MELLITUS; AMINO-ACIDS; VASCULAR-DISEASE; NMDA RECEPTOR; UP-REGULATION; FATTY-ACID; EXPRESSION; HYPERHOMOCYST(E)INEMIA; LOCALIZATION	Homocysteine sulfinic acid (HCSA) is a homologue of the amino acid cysteine and a selective metabotropic glutamate receptor (mGluR) agonist. However, the metabolic role of HCSA is poorly understood. In this study, we showed that HCSA and glutamate stimulated glucose uptake in C2C12 mouse myoblast cells and increased AMP-activated protein kinase (AMPK) phosphorylation. RT-PCR and Western blot analysis revealed that C2C12 expresses mGluR5. HCSA transiently increased the intracellular calcium concentration. Although alpha-methyl-4-carboxyphenylglycine, a metabotropic glutamate receptor antagonist, blocked the action of HCSA in intracellular calcium response and AMPK phosphorylation, 6-cyano-7-nitroquinoxaline-2,3-dione, an AMPA antagonist, did not exhibit such effects. Knockdown of mGluR5 with siRNA blocked HCSA-induced AMPK phosphorylation. Pretreatment of cells with STO-609, a calmodulin-dependent protein kinase kinase (CaMKK) inhibitor, blocked HCSA-induced AMPK phosphorylation, and knockdown of CaMKK blocked HCSA-induced AMPK phosphorylation. In addition, HCSA activated p38 mitogen-activated protein kinase (MAPK). Expression of dominant-negative AMPK suppressed HCSA-mediated phosphorylation of p38 MAPK, and inhibition of AMPK and p38 MAPK blocked HCSA-induced glucose uptake. Phosphorylation of protein kinase C zeta (PKC zeta) was also increased by HCSA. Pharmacologic inhibition or knockdown of p38 MAPK blocked HCSA-induced PKC zeta phosphorylation, and knockdown of PKC zeta suppressed the HCSA-induced increase of cell surface GLUT4. The stimulatory effect of HCSA on cell surface GLUT4 was impaired in FITC-conjugated PKC zeta siRNA-transfected cells. Together, the above results suggest that HCSA may have a beneficial role in glucose metabolism in skeletal muscle cells via stimulation of AMPK.	[Kim, Ji Hae; Lee, Jung Ok; Lee, Soo Kyung; Moon, Ji Wook; You, Ga Young; Kim, Su Jin; Park, Sun-Hwa; Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136701, South Korea; [Park, Ji Man; Lim, Se Young; Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan 689798, South Korea; [Uhm, Kyung-Ok] Natl Inst Geriatr & Gerontol, Dept Alzheimers Dis Res, Aichi 4748522, Japan; [Song, Min Seok] Cornell Univ, Weil Med Coll, Dept Med Genet, New York, NY 10021 USA	Korea University; Korea University Medicine (KU Medicine); Ulsan National Institute of Science & Technology (UNIST); National Center for Geriatrics & Gerontology; Cornell University	Kim, HS (corresponding author), Korea Univ, Coll Med, Dept Anat, Anam Dong 5 Ga, Seoul 136701, South Korea.	anatomykim@korea.ac.kr	Suh, Pann-Ghill/F-3610-2010	Song, Minseok/0000-0001-9561-8505	Korean Government [2010-0011053]	Korean Government(Korean Government)	This work was supported by Grant 2010-0011053 from the National Research Foundation of Korea, funded by the Korean Government. We declare that there are no conflicts of interest.	Ai H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1291, DOI 10.1152/ajpendo.00167.2001; Antonescu CN, 2005, ENDOCRINOLOGY, V146, P3773, DOI 10.1210/en.2005-0404; Bennett MR, 1999, NEUROCHEM INT, V35, P269, DOI 10.1016/S0197-0186(99)00068-6; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brunelli G, 2005, P NATL ACAD SCI USA, V102, P8752, DOI 10.1073/pnas.0500530102; CARLTON SM, 1995, NEUROSCI LETT, V197, P25, DOI 10.1016/0304-3940(95)11889-5; DO KQ, 1988, J NEURAL TRANSM, V72, P185, DOI 10.1007/BF01243418; Durand P, 2001, LAB INVEST, V81, P645, DOI 10.1038/labinvest.3780275; Frati C, 2000, J CELL PHYSIOL, V183, P364, DOI 10.1002/(SICI)1097-4652(200006)183:3<364::AID-JCP9>3.3.CO;2-O; Gill SS, 1998, BRAIN RES BULL, V46, P429, DOI 10.1016/S0361-9230(98)00012-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu YC, 2000, J BIOL CHEM, V275, P34252, DOI 10.1074/jbc.M004520200; Hankey GJ, 2001, CURR OPIN NEUROL, V14, P95, DOI 10.1097/00019052-200102000-00015; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Hofmann MA, 1997, DIABETES CARE, V20, P1880, DOI 10.2337/diacare.20.12.1880; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Joseph A, 2008, NEUROSCIENCE, V156, P298, DOI 10.1016/j.neuroscience.2008.07.022; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P277, DOI 10.1016/S0028-3908(98)00018-5; Kinnamon SC, 2009, ANN NY ACAD SCI, V1170, P55, DOI 10.1111/j.1749-6632.2009.04106.x; Levine J, 2002, AM J PSYCHIAT, V159, P1790, DOI 10.1176/appi.ajp.159.10.1790; Makinde AO, 1997, CIRC RES, V80, P482, DOI 10.1161/01.RES.80.4.482; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; Miller JW, 2000, NUTRITION, V16, P675, DOI 10.1016/S0899-9007(00)00307-5; Munshi MN, 1996, METABOLISM, V45, P133, DOI 10.1016/S0026-0495(96)90211-5; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; SANTHOSHKUMAR CR, 1994, ANAL BIOCHEM, V220, P249, DOI 10.1006/abio.1994.1335; Shi Q, 2003, J PHARMACOL EXP THER, V305, P131, DOI 10.1124/jpet.102.047092; Storto M, 2001, J ENDOCRINOL, V170, P71, DOI 10.1677/joe.0.1700071; Storto M, 2000, J NEUROIMMUNOL, V109, P112, DOI 10.1016/S0165-5728(00)00269-1; Thompson GA, 1996, PHARMACOL THERAPEUT, V72, P25, DOI 10.1016/S0163-7258(96)00097-6; Tomiyama M, 2005, MOL BRAIN RES, V136, P275, DOI 10.1016/j.molbrainres.2005.02.003; Tong QC, 2002, AM J PHYSIOL-ENDOC M, V282, pE1324, DOI 10.1152/ajpendo.00460.2001; Trudeau F, 2004, EUR J PHARMACOL, V490, P177, DOI 10.1016/j.ejphar.2004.02.055; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	39	27	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7567	7576		10.1074/jbc.M110.149328	http://dx.doi.org/10.1074/jbc.M110.149328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193401	Green Published, hybrid			2022-12-25	WOS:000287737300070
J	Ryu, JH; Li, SH; Park, HS; Park, JW; Lee, B; Chun, YS				Ryu, Ji-Hye; Li, Shan-Hua; Park, Hyoung-Sook; Park, Jong-Wan; Lee, ByungLan; Chun, Yang-Sook			Hypoxia-inducible Factor alpha Subunit Stabilization by NEDD8 Conjugation Is Reactive Oxygen Species-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL COMPLEX-III; UBIQUITIN-LIKE PROTEIN; FACTOR 1-ALPHA; HIF-ALPHA; FACTOR-I; CANCER; FACTOR-1-ALPHA; DEGRADATION; UBIQUITYLATION; HYDROXYLATION	Hypoxia-inducible factor alpha proteins (HIF-alpha s) are regulated oxygen dependently and transactivate numerous genes essential for cellular adaptation to hypoxia. NEDD8, a member of the ubiquitin-like family, covalently binds to its substrate proteins, and thus, regulates their stabilities and functions. In the present study, we examined the possibility that the HIF signaling is regulated by the neddylation. HIF-1 alpha expression and activity were inhibited by knocking down APPBP1 E1 enzyme for NEDD8 conjugation but enhanced by ectopically expressing NEDD8. HIF-1 alpha and HIF-2 alpha were identified to be covalently modified by NEDD8. NEDD8 stabilized HIF-1 alpha even in normoxia and further increased its level in hypoxia, which also occurred in von Hippel-Lindau (VHL) protein-or p53-null cell lines. The HIF-1 alpha-stabilizing effect of NEDD8 was diminished by antioxidants and mitochondrial respiratory chain blockers. This suggests that the NEDD8 effect is concerned with reactive oxygen species driven from mitochondria rather than with the prolyl hydroxylase (PHD)/VHL-dependent oxygen-sensing system. Based on these findings, we propose that NEDD8 is an ancillary player to regulate the stability of HIF-1 alpha. Furthermore, given the positive role played by HIF-alpha s in cancer promotion, the NEDD8 conjugation process could be a potential target for cancer therapy.	[Ryu, Ji-Hye; Li, Shan-Hua; Park, Hyoung-Sook; Chun, Yang-Sook] Seoul Natl Univ, Coll Med, Dept Physiol, Ischem Hypox Dis Inst, Seoul 110799, South Korea; [Park, Jong-Wan] Seoul Natl Univ, Dept Pharmacol, Coll Med, Ischem Hypox Dis Inst, Seoul 110799, South Korea; [Lee, ByungLan] Seoul Natl Univ, Dept Anat, Coll Med, Ischem Hypox Dis Inst, Seoul 110799, South Korea; [Li, Shan-Hua] Xiamen Univ, Dept Basic Med Sci, Coll Med, Xiamen 361005, Fujian, Peoples R China	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Xiamen University	Chun, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Physiol, Ischem Hypox Dis Inst, 28 Yongon Dong, Seoul 110799, South Korea.	chunys@snu.ac.kr	Chun, Yang Sook/J-2789-2012; Park, Jong-Wan/J-2758-2012; Lee, Byung Lan/J-5577-2012		Ministry of Education, Science and Technology [2009-0090188]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant 2009-0090188).	Adams J, 2002, CURR OPIN ONCOL, V14, P628, DOI 10.1097/00001622-200211000-00007; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chun YS, 2002, BIOCHEM J, V362, P71, DOI 10.1042/0264-6021:3620071; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jaffray EG, 2006, METHODS, V38, P35, DOI 10.1016/j.ymeth.2005.07.020; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kawanami D, 2009, J BIOL CHEM, V284, P20522, DOI 10.1074/jbc.M109.025346; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Liakopoulos D, 1999, P NATL ACAD SCI USA, V96, P5510, DOI 10.1073/pnas.96.10.5510; Lim JH, 2006, MOL PHARMACOL, V70, P1856, DOI 10.1124/mol.106.028076; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Meehan KL, 2002, PROSTATE, V50, P54, DOI 10.1002/pros.10032; Miyauchi Y, 2008, J BIOL CHEM, V283, P16622, DOI 10.1074/jbc.M710599200; Mori F, 2005, NEUROPATH APPL NEURO, V31, P53, DOI 10.1111/j.1365-2990.2004.00603.x; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Ravi R, 2000, GENE DEV, V14, P34; Russell RC, 2008, EMBO REP, V9, P486, DOI 10.1038/embor.2008.19; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shin DH, 2008, BLOOD, V111, P3131, DOI 10.1182/blood-2007-11-120576; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; SULAN RI, 2006, NEOPLASIA, V8, P956; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016	32	63	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6963	6970		10.1074/jbc.M110.188706	http://dx.doi.org/10.1074/jbc.M110.188706			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193393	Green Published, hybrid			2022-12-25	WOS:000287737300012
J	Kanda, T; Jeong, SH; Imazeki, F; Fujiwara, K; Yokosuka, O				Kanda, Tatsuo; Jeong, Sook-Hyang; Imazeki, Fumio; Fujiwara, Keiichi; Yokosuka, Osamu			Analysis of 5 ' Nontranslated Region of Hepatitis A Viral RNA Genotype I from South Korea: Comparison with Disease Severities	PLOS ONE			English	Article							ENTRY-SITE; NUCLEOTIDE-SEQUENCE; VIRUS-RNA; STRAINS; TRANSLATION; AMANTADINE; VACCINE; IRES	The aim of the study was to analyze genotype I hepatitis A virus (HAV) 5' nontranslated region (NTR) sequences from a recent outbreak in South Korea and compare them with reported sequences from Japan. We collected a total of 54 acute hepatitis A patients' sera from HAV genotype I [27 severe disease (prothrombin time INR >= 1.50) and 27 mild hepatitis (prothrombin time INR <1.00)], performed nested RT-PCR of 5' NTR of HAV directly sequenced from PCR products (similar to 300 bp), and compared them with each other. We could detect HAV 5'NTR sequences in 19 of the 54 (35.1%) cases [12 of 27 severe cases (44.4%) and 7 of 27 self-limited cases (25.9%)], all of which were subgenotype IA. Sequence analysis revealed that sequences of severe disease had 93.6%-99.0% homology and of self-limited disease 94.3%-98.6% homology, compared to subgenotype IA HAV GBM wild-type IA sequence. In this study, confirmation of the 5'NTR sequence differences between severe disease and mild disease was not carried out. Comparison with Japanese HAV A10 revealed (222)C to G or T substitution in 8/12 cases of severe disease and (222)C to G or T and (392)G to A substitutions in 5/7 and 4/7 cases of mild disease, respectively, although the nucleotide sequences in this study showed high homology (93.6%-100%). In conclusion, HAV 5'NTR subgenotype IA from Korea had relatively high homology to Japanese sequences previously reported from Japan, and this region would be considered one of the antiviral targets. Further studies will be needed.	[Kanda, Tatsuo; Imazeki, Fumio; Fujiwara, Keiichi; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan; [Jeong, Sook-Hyang] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea	Chiba University; Seoul National University (SNU)	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan.	kandat-cib@umin.ac.jp	Jeong, Sook-Hyang/D-5726-2012	Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Education, Culture, Sports, Science and Technology, Japan [15790338, 21590829, 21590828, 21390225]; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; Japanese Government	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government	This work was supported by grants for Scientific Research 15790338, 21590829, 21590828, and 21390225 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (TK, FI, and OY), a grant from the Ministry of Health, Labour and Welfare of Japan (OY), a Special Coordination Fund for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government (TK). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCAREK KB, 1995, J INFECT DIS, V171, pS70, DOI 10.1093/infdis/171.Supplement_1.S70; BROWN EA, 1994, J VIROL, V68, P1066, DOI 10.1128/JVI.68.2.1066-1074.1994; COHEN JI, 1987, J VIROL, V61, P50, DOI 10.1128/JVI.61.1.50-59.1987; Dagan R, 2005, JAMA-J AM MED ASSOC, V294, P202, DOI 10.1001/jama.294.2.202; Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1; Davidkin I, 2007, J MED VIROL, V79, P657, DOI 10.1002/jmv.20843; Fujiwara K, 2002, GUT, V51, P82, DOI 10.1136/gut.51.1.82; Gharbi-Khelifi H, 2006, J VIROL METHODS, V138, P109, DOI 10.1016/j.jviromet.2006.08.001; GRAFF J, 1994, J VIROL, V68, P548, DOI 10.1128/JVI.68.1.548-554.1994; Kanda T, 2005, BIOCHEM BIOPH RES CO, V331, P621, DOI 10.1016/j.bbrc.2005.03.212; Kanda T, 2005, BIOCHEM BIOPH RES CO, V330, P1217, DOI 10.1016/j.bbrc.2005.03.105; Kanda T, 2010, J VIRAL HEPATITIS, V17, P618, DOI 10.1111/j.1365-2893.2009.01221.x; Kanda T, 2010, HEPATOL RES, V40, P415, DOI 10.1111/j.1872-034X.2010.00617.x; KURAMOTO I, 1994, J GASTROEN HEPATOL, V9, P228, DOI 10.1111/j.1440-1746.1994.tb01714.x; Lee D, 2008, INTERVIROLOGY, V51, P70, DOI 10.1159/000127428; LEMON SM, 1992, VACCINE, V10, pS40, DOI 10.1016/0264-410X(92)90540-Z; Yun H, 2008, J MED VIROL, V80, P777, DOI 10.1002/jmv.21127	17	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15139	10.1371/journal.pone.0015139	http://dx.doi.org/10.1371/journal.pone.0015139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203430	gold, Green Published, Green Submitted			2022-12-25	WOS:000285792500022
J	Shein Idelson, M; Ben-Jacob, E; Hanein, Y				Shein Idelson, Mark; Ben-Jacob, Eshel; Hanein, Yael			Innate Synchronous Oscillations in Freely-Organized Small Neuronal Circuits	PLOS ONE			English	Article							SYNAPTIC MECHANISMS; ACTIVITY PATTERNS; NETWORKS; PLASTICITY; SYNCHRONIZATION	Background: Information processing in neuronal networks relies on the network's ability to generate temporal patterns of action potentials. Although the nature of neuronal network activity has been intensively investigated in the past several decades at the individual neuron level, the underlying principles of the collective network activity, such as the synchronization and coordination between neurons, are largely unknown. Here we focus on isolated neuronal clusters in culture and address the following simple, yet fundamental questions: What is the minimal number of cells needed to exhibit collective dynamics? What are the internal temporal characteristics of such dynamics and how do the temporal features of network activity alternate upon crossover from minimal networks to large networks? Methodology/Principal Findings: We used network engineering techniques to induce self-organization of cultured networks into neuronal clusters of different sizes. We found that small clusters made of as few as 40 cells already exhibit spontaneous collective events characterized by innate synchronous network oscillations in the range of 25 to 100 Hz. The oscillation frequency of each network appeared to be independent of cluster size. The duration and rate of the network events scale with cluster size but converge to that of large uniform networks. Finally, the investigation of two coupled clusters revealed clear activity propagation with master/slave asymmetry. Conclusions/Significance: The nature of the activity patterns observed in small networks, namely the consistent emergence of similar activity across networks of different size and morphology, suggests that neuronal clusters self-regulate their activity to sustain network bursts with internal oscillatory features. We therefore suggest that clusters of as few as tens of cells can serve as a minimal but sufficient functional network, capable of sustaining oscillatory activity. Interestingly, the frequencies of these oscillations are similar those observed in vivo.	[Shein Idelson, Mark; Hanein, Yael] Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Tel Aviv Univ, Sch Phys, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Shein Idelson, M (corresponding author), Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel.	eshel@tamar.tau.ac.il; YaelHa@tauex.tau.ac.il	Shein, Mark/M-9170-2018; Hanein, Yael/A-7179-2008; Hanein, Yael/AAG-5980-2021	Shein, Mark/0000-0001-8132-2826; Hanein, Yael/0000-0002-4213-9575	ISF	ISF(Israel Science Foundation)	This study was partially supported by an ISF grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Baruchi I, 2006, CHAOS, V16, DOI 10.1063/1.2183408; Baruchi I, 2008, EUR J NEUROSCI, V28, P1825, DOI 10.1111/j.1460-9568.2008.06487.x; Baruchi I, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.050901; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]; DeMarse TB, 2001, AUTON ROBOT, V11, P305, DOI 10.1023/A:1012407611130; DOUGLAS RJ, 1991, TRENDS NEUROSCI, V14, P286, DOI 10.1016/0166-2236(91)90139-L; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Feinerman O, 2007, J NEUROPHYSIOL; Fuchs E, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036018; Gabay T, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/3/035201; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Gross GW, 1999, J INTEL MAT SYST STR, V10, P558, DOI 10.1106/XC9U-BMJ8-FE1A-EUNQ; Hulata E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198105; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Kaiser M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/5/110; Kamioka H, 1996, NEUROSCI LETT, V206, P109, DOI 10.1016/S0304-3940(96)12448-4; KLEINFELD D, 1988, J NEUROSCI, V8, P4098; Koch C, 2000, NAT NEUROSCI, V3, P1171, DOI 10.1038/81444; KRIEGSTEIN AR, 1983, J NEUROSCI, V3, P1634; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Madhavan R, 2007, PHYS BIOL, V4, P181, DOI 10.1088/1478-3975/4/3/005; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Raichman N, 2006, NEUROCOMPUTING, V69, P1150, DOI 10.1016/j.neucom.2005.12.064; Segev R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118102; Segev R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.168101; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Selverston AI, 2010, PHILOS T R SOC B, V365, P2329, DOI 10.1098/rstb.2009.0270; SHAW GL, 1982, EXP NEUROL, V77, P324, DOI 10.1016/0014-4886(82)90249-7; Shefi O, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021905; Shein M, 2009, BIOMED MICRODEVICES, V11, P495, DOI 10.1007/s10544-008-9255-7; Shein M, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036008; Sorkin R, 2006, J NEURAL ENG, V3, P95, DOI 10.1088/1741-2560/3/2/003; Sorkin R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/1/015101; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stoica P., 1997, SPECTRAL ANAL SIGNAL; Streit J, 2001, EUR J NEUROSCI, V14, P191, DOI 10.1046/j.0953-816x.2001.01636.x; Suzuki I, 2007, BIOCHEM BIOPH RES CO, V356, P470, DOI 10.1016/j.bbrc.2007.03.006; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Volman V, 2005, PHYS BIOL, V2, P98, DOI 10.1088/1478-3975/2/2/003; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686	48	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14443	10.1371/journal.pone.0014443	http://dx.doi.org/10.1371/journal.pone.0014443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203438	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500019
J	Tsiperson, V; Li, XS; Schwartz, GJ; Raine, CS; Shafit-Zagardo, B				Tsiperson, Vladislav; Li, Xiaosong; Schwartz, Gary J.; Raine, Cedric S.; Shafit-Zagardo, Bridget			GAS6 Enhances Repair Following Cuprizone-Induced Demyelination	PLOS ONE			English	Article							ARREST-SPECIFIC GENE; RECEPTOR TYROSINE KINASES; CENTRAL-NERVOUS-SYSTEM; SUPERIOR CEREBELLAR PEDUNCLE; MULTIPLE-SCLEROSIS LESIONS; GROWTH-ARREST; APOPTOTIC CELLS; PROTEIN-S; CORTICAL-NEURONS; AXONAL DAMAGE	Growth arrest-specific protein 6 (gas6) activities are mediated through the Tyro3, Axl, and Mer family of receptor tyrosine kinases. Gas6 is expressed and secreted by a wide variety of cell types, including cells of the central nervous system (CNS). In this study, we tested the hypothesis that administration of recombinant human Gas6 (rhGas6) protein into the CNS improves recovery following cuprizone withdrawal. After a 4-week cuprizone diet, cuprizone was removed and PBS or rhGas6 (400 ng/ml, 4 mg/ml and 40 mg/ml) was delivered by osmotic mini-pump into the corpus callosum of C57Bl6 mice for 14 days. Nine of 11 (82%) PBS-treated mice had abundant lipid-associated debris in the corpus callosum by Oil-Red-O staining while only 4 of 19 (21%) mice treated with rhGas6 had low Oil-Red-O positive droplets. In rhGas6-treated mice, SMI32-positive axonal spheroids and APP-positive deposits were reduced in number relative to PBS-treated mice. Compared to PBS, rhGas6 enhanced remyelination as revealed by MBP immunostaining and electron microscopy. The rhGas6-treated mice had more oligodendrocytes expressing Olig1 in the cytoplasm, indicative of oligodendrocyte progenitor cell maturation. Relative to PBS-treated mice, rhGas6-treated mice had fewer activated microglia in the corpus callosum by Iba1 immunostaining. The data show that rhGas6 treatment resulted in more efficient repair following cuprizone-induced injury.	[Tsiperson, Vladislav; Raine, Cedric S.; Shafit-Zagardo, Bridget] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Li, Xiaosong; Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Raine, Cedric S.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Tsiperson, V (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	bridget.shafit-zagardo@einstein.yu.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	National Institutes of Health [R21NS061128, T32 NS 07098]; National Multiple Sclerosis Society [RG 4046-A-6, RG 1001-K-11]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098, R21NS061128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant (R21NS061128), National Multiple Sclerosis Society Grant (RG 4046-A-6) to BSZ and RG 1001-K-11 to CSR. VT was supported by NIH Training grant T32 NS 07098. CSR is the Wollowick Family Professor of Multiple Sclerosis Research at this Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1999, MOL ENDOCRINOL, V13, P191, DOI 10.1210/me.13.2.191; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; BARBARESE E, 1995, J NEURO-ONCOL, V26, P25, DOI 10.1007/BF01054766; Binder MD, 2008, J NEUROSCI, V28, P5195, DOI 10.1523/JNEUROSCI.1180-08.2008; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P63, DOI 10.1016/0022-510X(73)90118-4; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P73, DOI 10.1016/0022-510X(73)90119-6; Budagian V, 2005, MOL CELL BIOL, V25, P9324, DOI 10.1128/MCB.25.21.9324-9339.2005; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Gallicchio M, 2005, BLOOD, V105, P1970, DOI 10.1182/blood-2004-04-1469; Gao X, 2000, MOL CELL NEUROSCI, V16, P338, DOI 10.1006/mcne.2000.0883; Gould WR, 2005, J THROMB HAEMOST, V3, P733, DOI 10.1111/j.1538-7836.2005.01186.x; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hall MO, 2003, ADV EXP MED BIOL, V533, P331; Hall MO, 2002, EXP EYE RES, V75, P391, DOI 10.1006/exer.2002.2030; Hasanbasic I, 2005, J THROMB HAEMOST, V3, P2790, DOI 10.1111/j.1538-7836.2005.01662.x; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Hoehn HJ, 2008, BRAIN RES, V1240, P1, DOI 10.1016/j.brainres.2008.08.076; Irvine KA, 2006, J NEUROIMMUNOL, V175, P69, DOI 10.1016/j.jneuroim.2006.03.002; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; Jackson SJ, 2005, NEUROSCIENCE, V134, P261, DOI 10.1016/j.neuroscience.2005.02.045; Jurevics H, 2002, J NEUROCHEM, V82, P126, DOI 10.1046/j.1471-4159.2002.00954.x; Li RH, 1996, J NEUROSCI, V16, P2012; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Mark MR, 1996, J BIOL CHEM, V271, P9785, DOI 10.1074/jbc.271.16.9785; Mason JL, 2000, J NEUROSCI, V20, P5703, DOI 10.1523/JNEUROSCI.20-15-05703.2000; Mason JL, 2001, NEUROPATH APPL NEURO, V27, P50, DOI 10.1046/j.0305-1846.2001.00301.x; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McCreary CR, 2009, NEUROIMAGE, V45, P1173, DOI 10.1016/j.neuroimage.2008.12.071; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nakano T, 1997, BIOCHEM J, V323, P387, DOI 10.1042/bj3230387; OHASHI K, 1995, J BIOL CHEM, V270, P22681, DOI 10.1074/jbc.270.39.22681; OKEBE CO, 2000, BRAIN RES, V877, P85; Petzold A, 2008, EXP NEUROL, V213, P326, DOI 10.1016/j.expneurol.2008.06.008; Prieto AL, 2000, J COMP NEUROL, V425, P295; Sainaghi PP, 2008, J NEUROL SCI, V269, P138, DOI 10.1016/j.jns.2008.01.005; Saller F, 2006, BLOOD CELL MOL DIS, V36, P373, DOI 10.1016/j.bcmd.2005.12.038; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Shankar SL, 2003, J NEUROSCI, V23, P4208; Sidman Richard L., 1971, ATLAS MOUSE BRAIN SP; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Weinger JG, 2009, AM J PATHOL, V175, P283, DOI 10.2353/ajpath.2009.080807; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Xiong W, 2008, REPRODUCTION, V135, P77, DOI 10.1530/REP-07-0287; Yagami T, 2003, BRAIN RES, V985, P142, DOI 10.1016/S0006-8993(03)03043-9; Yagami T, 2002, NEUROPHARMACOLOGY, V43, P1289, DOI 10.1016/S0028-3908(02)00333-7; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861	54	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15748	10.1371/journal.pone.0015748	http://dx.doi.org/10.1371/journal.pone.0015748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203420	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200037
J	McComb, S; Mulligan, R; Sad, S				McComb, Scott; Mulligan, Rebecca; Sad, Subash			Caspase-3 Is Transiently Activated without Cell Death during Early Antigen Driven Expansion of CD8(+) T Cells In Vivo	PLOS ONE			English	Article							LYMPHOCYTE-ACTIVATION; SURVIVIN EXPRESSION; MEDIATES APOPTOSIS; VIRAL-INFECTION; MEMORY; FAS; DIFFERENTIATION; PROLIFERATION; INFLAMMATION; EFFECTOR	Background: CD8(+) T cell responses develop rapidly during infection and are swiftly reduced during contraction, wherein >90% of primed CD8(+) T cells are eliminated. The role of apoptotic mechanisms in controlling this rapid proliferation and contraction of CD8(+) T cells remains unclear. Surprisingly, evidence has shown non-apoptotic activation of caspase-3 to occur during in vitro T-cell proliferation, but the relevance of these mechanisms to in vivo CD8(+) T cell responses has yet to be examined. Methods and Findings: We have evaluated the activity of caspase-3, a key downstream inducer of apoptosis, throughout the entirety of a CD8+ T cell response. We utilized two infection models that differ in the intensity, onset and duration of antigen-presentation and inflammation. Expression of cleaved caspase-3 in antigen specific CD8(+) T cells was coupled to the timing and strength of antigen presentation in lymphoid organs. We also observed coordinated activation of additional canonical apoptotic markers, including phosphatidylserine exposure. Limiting dilution analysis directly showed that in the presence of IL7, very little cell death occurred in both caspase-3(hi) and caspase-3(low) CD8(+) T cells. The expression of active caspase-3 peaked before effector phenotype (CD62L(low)) CD8(+) T cells emerged, and was undetectable in effector-phenotype cells. In addition, OVA-specific CD8(+) cells remained active caspase-3(low) throughout the contraction phase. Conclusions: Our results specifically implicate antigen and not inflammation in driving activation of apoptotic mechanisms without cell death in proliferating CD8(+) T cells. Furthermore, the contraction of CD8(+) T cell response following expansion is likely not mediated by the key downstream apoptosis inducer, caspase-3.	[McComb, Scott; Mulligan, Rebecca; Sad, Subash] Univ Ottawa, Dept Biochem Microbiol & Immunol, NRC Inst Biol Sci, Ottawa, ON, Canada	National Research Council Canada; University of Ottawa	McComb, S (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, NRC Inst Biol Sci, Ottawa, ON, Canada.	subash.sad@nrc.ca		Sad, Subash/0000-0002-2462-7137	Canadian Institute of Health Research (CIHR); NRC	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NRC(National Research Centre (NRC))	Funding for this study was provided by a grant from the Canadian Institute of Health Research (CIHR) and NRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Albaghdadi H, 2009, J IMMUNOL, V183, P3778, DOI 10.4049/jimmunol.0900843; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2006, J IMMUNOL, V177, P999, DOI 10.4049/jimmunol.177.2.999; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Desbarats J, 1999, P NATL ACAD SCI USA, V96, P8104, DOI 10.1073/pnas.96.14.8104; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Dudani R, 2002, INFECT IMMUN, V70, P1957, DOI 10.1128/IAI.70.4.1957-1964.2002; Dudani R, 2008, J IMMUNOL, V180, P2933, DOI 10.4049/jimmunol.180.5.2933; Falk M, 2004, J IMMUNOL, V173, P5077, DOI 10.4049/jimmunol.173.8.5077; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fischer K, 2006, BLOOD, V108, p307A; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gao G, 2000, J CELL BIOCHEM, V80, P53; Grayson JM, 2003, J IMMUNOL, V170, P4745, DOI 10.4049/jimmunol.170.9.4745; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Kornacker M, 2001, IMMUNOL LETT, V76, P169, DOI 10.1016/S0165-2478(01)00186-9; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Luu RA, 2006, J IMMUNOL, V177, P1516, DOI 10.4049/jimmunol.177.3.1516; Ma SB, 2003, CELL BIOL INT, V27, P959, DOI 10.1016/S1065-6995(03)00170-7; Marshall DR, 2001, P NATL ACAD SCI USA, V98, P6313, DOI 10.1073/pnas.101132698; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nagy G, 2003, J IMMUNOL, V171, P5188, DOI 10.4049/jimmunol.171.10.5188; Nussbaum AK, 2004, J IMMUNOL, V173, P6611, DOI 10.4049/jimmunol.173.11.6611; Puga I, 2008, IMMUNITY, V29, P193, DOI 10.1016/j.immuni.2008.06.010; Ruckenstuhl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004592; Russell MS, 2007, J IMMUNOL, V179, P211, DOI 10.4049/jimmunol.179.1.211; Sabbagh L, 2005, MOL IMMUNOL, V42, P1345, DOI 10.1016/j.molimm.2004.12.011; Sad S, 2008, J IMMUNOL, V180, P5853, DOI 10.4049/jimmunol.180.9.5853; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Sharma AK, 2004, J BIOL CHEM, V279, P35564, DOI 10.1074/jbc.M401037200; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Stark FC, 2009, CANCER RES, V69, P4327, DOI 10.1158/0008-5472.CAN-08-3160; Strasser A, 2004, TRENDS IMMUNOL, V25, P610, DOI 10.1016/j.it.2004.08.012; Suzuki I, 2000, P NATL ACAD SCI USA, V97, P1707, DOI 10.1073/pnas.97.4.1707; TELFORD WG, 1994, J IMMUNOL METHODS, V172, P1, DOI 10.1016/0022-1759(94)90373-5; Wojciechowski S, 2006, EUR J IMMUNOL, V36, P1694, DOI 10.1002/eji.200635897; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhang J, 2001, J BIOL CHEM, V276, P29815, DOI 10.1074/jbc.M103838200	64	40	40	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15328	10.1371/journal.pone.0015328	http://dx.doi.org/10.1371/journal.pone.0015328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203525	Green Published, gold, Green Submitted			2022-12-25	WOS:000285578000029
J	Stokman, G; Stroo, I; Claessen, N; Teske, GJD; Weening, JJ; Leemans, JC; Florquin, S				Stokman, Geurt; Stroo, Ingrid; Claessen, Nike; Teske, Gwendoline J. D.; Weening, Jan J.; Leemans, Jaklien C.; Florquin, Sandrine			Stem Cell Factor Expression after Renal Ischemia Promotes Tubular Epithelial Survival	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; RECEPTOR C-KIT; ISCHEMIA/REPERFUSION INJURY; REPERFUSION INJURY; GROWTH-FACTOR; ADULT; ERYTHROPOIETIN; HEMATOPOIESIS; APOPTOSIS; MIGRATION	Background: Renal ischemia leads to apoptosis of tubular epithelial cells and results in decreased renal function. Tissue repair involves re-epithelialization of the tubular basement membrane. Survival of the tubular epithelium following ischemia is therefore important in the successful regeneration of renal tissue. The cytokine stem cell factor (SCF) has been shown to protect the tubular epithelium against apoptosis. Methodology/Principal Findings: In a mouse model for renal ischemia/reperfusion injury, we studied how expression of c-KIT on tubular epithelium and its ligand SCF protect cells against apoptosis. Administration of SCF specific antisense oligonucleotides significantly decreased specific staining of SCF following ischemia. Reduced SCF expression resulted in impaired renal function, increased tubular damage and increased tubular epithelial apoptosis, independent of inflammation. In an in vitro hypoxia model, stimulation of tubular epithelial cells with SCF activated survival signaling and decreased apoptosis. Conclusions/Significance: Our data indicate an important role for c-KIT and SCF in mediating tubular epithelial cell survival via an autocrine pathway.	[Stokman, Geurt; Stroo, Ingrid; Claessen, Nike; Teske, Gwendoline J. D.; Weening, Jan J.; Leemans, Jaklien C.; Florquin, Sandrine] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Stokman, G (corresponding author), Leiden Univ, Div Toxicol, LACDR, Leiden, Netherlands.	g.stokman@lacdr.leidenuniv.nl	Leemans, Jaklien/AAM-4958-2020; Florquin, Sandrine/B-8242-2012	Florquin, Sandrine/0000-0002-9676-1722	Netherlands Organisation for Scientific Research (NWO) [Vidi 917.36.336]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The present study was supported by a grant from the Netherlands Organisation for Scientific Research (NWO), project number Vidi 917.36.336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; ARGUELLO F, 1992, CANCER RES, V52, P2304; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Bengatta S, 2009, J AM SOC NEPHROL, V20, P787, DOI 10.1681/ASN.2008050515; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Cantley LG, 2005, NAT CLIN PRACT NEPHR, V1, P22, DOI 10.1038/ncpneph0021; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Erlandsson A, 2004, EXP CELL RES, V301, P201, DOI 10.1016/j.yexcr.2004.08.009; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Kato N, 2005, PATHOL INT, V55, P479, DOI 10.1111/j.1440-1827.2005.01856.x; Kim YH, 2001, J AM SOC NEPHROL, V12, P1795, DOI 10.1681/ASN.V1291795; KINASHI T, 1994, BLOOD, V83, P1033; Komuro T, 1996, HISTOL HISTOPATHOL, V11, P769; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Meldrum KK, 2001, J SURG RES, V99, P288, DOI 10.1006/jsre.2001.6201; Miliaras D, 2004, J CLIN PATHOL, V57, P463, DOI 10.1136/jcp.2003.013532; Miura M, 2001, AM J PATHOL, V159, P2137, DOI 10.1016/S0002-9440(10)63065-9; Molls RR, 2006, AM J PHYSIOL-RENAL, V290, pF1187, DOI 10.1152/ajprenal.00342.2005; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; Nishida T, 2000, HISTOL HISTOPATHOL, V15, P1293, DOI 10.14670/HH-15.1293; OKADA S, 1991, BLOOD, V78, P1706; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Padanilam BJ, 2003, AM J PHYSIOL-RENAL, V284, pF608, DOI 10.1152/ajprenal.00284.2002; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Reber L, 2006, EUR J PHARMACOL, V533, P327, DOI 10.1016/j.ejphar.2005.12.067; Reilly JT, 2003, BLOOD REV, V17, P241, DOI 10.1016/S0268-960X(03)00024-9; Roelofs JJTH, 2006, J AM SOC NEPHROL, V17, P131, DOI 10.1681/ASN.2005010089; RONCO P, 1988, LAB INVEST, V58, P210; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Rossi P, 2000, J ENDOCRINOL INVEST, V23, P609, DOI 10.1007/BF03343784; Schmidt-Ott KM, 2006, DEV BIOL, V299, P238, DOI 10.1016/j.ydbio.2006.07.026; Sharpies EJ, 2006, SEMIN NEPHROL, V26, P325, DOI 10.1016/j.semnephrol.2006.05.010; Stokman G, 2005, J AM SOC NEPHROL, V16, P1684, DOI 10.1681/ASN.2004080678; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Tamborini E, 2004, CLIN CANCER RES, V10, P8214, DOI 10.1158/1078-0432.CCR-04-1013; van de Water B, 2006, TOXICOL LETT, V162, P83, DOI 10.1016/j.toxlet.2005.10.014; Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x	43	23	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14386	10.1371/journal.pone.0014386	http://dx.doi.org/10.1371/journal.pone.0014386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200435	Green Published, Green Submitted, gold			2022-12-25	WOS:000285576900005
J	Boone, N; Loriod, B; Bergon, A; Sbai, O; Formisano-Treziny, C; Gabert, J; Khrestchatisky, M; Nguyen, C; Feron, F; Axelrod, FB; Ibrahim, E				Boone, Nathalie; Loriod, Beatrice; Bergon, Aurelie; Sbai, Oualid; Formisano-Treziny, Christine; Gabert, Jean; Khrestchatisky, Michel; Nguyen, Catherine; Feron, Francois; Axelrod, Felicia B.; Ibrahim, El Cherif			Olfactory Stem Cells, a New Cellular Model for Studying Molecular Mechanisms Underlying Familial Dysautonomia	PLOS ONE			English	Article							ELONGATOR COMPLEX; RNA-POLYMERASE; EXPRESSION; GENE; PROTEIN; IKBKAP; DIFFERENTIATION; CULTURE; TRANSCRIPTION; MUTATION	Background: Familial dysautonomia (FD) is a hereditary neuropathy caused by mutations in the IKBKAP gene, the most common of which results in variable tissue-specific mRNA splicing with skipping of exon 20. Defective splicing is especially severe in nervous tissue, leading to incomplete development and progressive degeneration of sensory and autonomic neurons. The specificity of neuron loss in FD is poorly understood due to the lack of an appropriate model system. To better understand and modelize the molecular mechanisms of IKBKAP mRNA splicing, we collected human olfactory ectomesenchymal stem cells (hOE-MSC) from FD patients. hOE-MSCs have a pluripotent ability to differentiate into various cell lineages, including neurons and glial cells. Methodology/Principal Findings: We confirmed IKBKAP mRNA alternative splicing in FD hOE-MSCs and identified 2 novel spliced isoforms also present in control cells. We observed a significant lower expression of both IKBKAP transcript and IKAP/hELP1 protein in FD cells resulting from the degradation of the transcript isoform skipping exon 20. We localized IKAP/hELP1 in different cell compartments, including the nucleus, which supports multiple roles for that protein. We also investigated cellular pathways altered in FD, at the genome-wide level, and confirmed that cell migration and cytoskeleton reorganization were among the processes altered in FD. Indeed, FD hOE-MSCs exhibit impaired migration compared to control cells. Moreover, we showed that kinetin improved exon 20 inclusion and restores a normal level of IKAP/hELP1 in FD hOE-MSCs. Furthermore, we were able to modify the IKBKAP splicing ratio in FD hOE-MSCs, increasing or reducing the WT (exon 20 inclusion): MU (exon 20 skipping) ratio respectively, either by producing free-floating spheres, or by inducing cells into neural differentiation. Conclusions/Significance: hOE-MSCs isolated from FD patients represent a new approach for modeling FD to better understand genetic expression and possible therapeutic approaches. This model could also be applied to other neurological genetic diseases.	[Boone, Nathalie; Sbai, Oualid; Khrestchatisky, Michel; Feron, Francois; Ibrahim, El Cherif] Univ Mediterranee Fac Med Nord, NICN CNRS UMR 6184, IFR Jean Roche, Marseille, France; [Loriod, Beatrice; Bergon, Aurelie; Nguyen, Catherine] INSERM, TAGC, U928, F-13258 Marseille, France; [Formisano-Treziny, Christine; Gabert, Jean] Fac Med Marseille, CRO2, F-13385 Marseille, France; [Gabert, Jean] Hop Nord Marseille, AP HM, Marseille, France; [Axelrod, Felicia B.] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; New York University	Boone, N (corresponding author), Univ Mediterranee Fac Med Nord, NICN CNRS UMR 6184, IFR Jean Roche, Marseille, France.	el-cherif.ibrahim@univmed.fr	Bergon, Aurélie/M-4977-2016; IBRAHIM, El Chérif/K-3899-2016; Nguyen, Catherine/M-4119-2016; loriod, beatrice bl/L-2948-2016; Feron, Francois/J-5639-2014	Bergon, Aurélie/0000-0003-1518-4562; IBRAHIM, El Chérif/0000-0003-3973-7862; Nguyen, Catherine/0000-0001-9376-6360; loriod, beatrice bl/0000-0001-5801-2264; 	Association Francaise de Recherche contre les Myopathies (AFM); Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT)	Association Francaise de Recherche contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT)	The authors thank the Association Francaise de Recherche contre les Myopathies (AFM) for supporting their work. NB was supported by a PhD fellowship from the Ministere de l'Education Nationale, de la Recherche et de la Technologie (MENRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; AXELROD FB, 1981, PEDIATRICS, V67, P517; Ballester B, 2006, ONCOGENE, V25, P1560, DOI 10.1038/sj.onc.1209178; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Carmel I, 2004, RNA, V10, P828, DOI 10.1261/rna.5196404; Cheishvili D, 2007, HUM MOL GENET, V16, P2097, DOI 10.1093/hmg/ddm157; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Cornez I, 2008, BIOCHEM PHARMACOL, V75, P2122, DOI 10.1016/j.bcp.2008.03.006; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cuajungco MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263; Delorme B, 2010, STEM CELLS DEV, V19, P853, DOI 10.1089/scd.2009.0267; Dong JL, 2002, AM J MED GENET, V110, P253, DOI 10.1002/ajmg.10450; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; Feron F, 1999, SCHIZOPHR RES, V40, P211, DOI 10.1016/S0920-9964(99)00055-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hims MM, 2007, GENOMICS, V90, P389, DOI 10.1016/j.ygeno.2007.05.012; Hims MM, 2007, J MOL MED, V85, P149, DOI 10.1007/s00109-006-0137-2; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Ibrahim EC, 2007, HUM MUTAT, V28, P41, DOI 10.1002/humu.20401; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-38; McCurdy RD, 2006, SCHIZOPHR RES, V82, P163, DOI 10.1016/j.schres.2005.10.012; Murrell W, 2005, DEV DYNAM, V233, P496, DOI 10.1002/dvdy.20360; Murrell W, 2008, STEM CELLS, V26, P2183, DOI 10.1634/stemcells.2008-0074; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Othman M, 2005, BIOTECH HISTOCHEM, V80, P189, DOI 10.1080/10520290500469777; PEARSON J, 1978, J NEUROL SCI, V39, P47, DOI 10.1016/0022-510X(78)90187-9; PEARSON J, 1978, J NEUROL SCI, V35, P77, DOI 10.1016/0022-510X(78)90103-X; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Pros E, 2010, EUR J HUM GENET, V18, P614, DOI 10.1038/ejhg.2009.212; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Resta N, 2006, J CELL PHYSIOL, V209, P67, DOI 10.1002/jcp.20708; Roisen FJ, 2001, BRAIN RES, V890, P11, DOI 10.1016/S0006-8993(00)03016-X; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Simson GG, 2009, PEDIATR RES, V65, P341, DOI 10.1203/PDR.0b013e318194fd52; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Talby L, 2006, LEUKEMIA RES, V30, P665, DOI 10.1016/j.leukres.2005.10.007; Tanabe S, 2008, J BIOCHEM, V144, P399, DOI 10.1093/jb/mvn082; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Valensi-Kurtz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009290; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Viktorov IV, 2007, B EXP BIOL MED+, V144, P596, DOI 10.1007/s10517-007-0385-3; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Winstead W, 2005, AM J RHINOL, V19, P83, DOI 10.1177/194589240501900115; WOLOZIN B, 1992, J MOL NEUROSCI, V3, P137, DOI 10.1007/BF02919405; Zhang XD, 2006, BRAIN RES, V1073, P109, DOI 10.1016/j.brainres.2005.12.059; Zhang XD, 2004, EXP NEUROL, V186, P112, DOI 10.1016/j.expneurol.2003.10.022	67	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15590	10.1371/journal.pone.0015590	http://dx.doi.org/10.1371/journal.pone.0015590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187979	Green Published, gold, Green Submitted			2022-12-25	WOS:000285575200045
J	Spallarossa, P; Altieri, P; Barisione, C; Passalacqua, M; Aloi, C; Fugazza, G; Frassoni, F; Podesta, M; Canepa, M; Ghigliotti, G; Brunelli, C				Spallarossa, Paolo; Altieri, Paola; Barisione, Chiara; Passalacqua, Mario; Aloi, Concetta; Fugazza, Giuseppina; Frassoni, Francesco; Podesta, Marina; Canepa, Marco; Ghigliotti, Giorgio; Brunelli, Claudio			p38 MAPK and JNK Antagonistically Control Senescence and Cytoplasmic p16INK4A Expression in Doxorubicin-Treated Endothelial Progenitor Cells	PLOS ONE			English	Article							KINASE INHIBITOR P16(INK4A); CARDIAC STEM-CELL; PREMATURE SENESCENCE; HUMAN FIBROBLASTS; APOPTOSIS; PATHWAY; CARDIOMYOCYTES; CANCER; DAMAGE; ERYTHROPOIETIN	Patients treated with low-dose anthracyclines often show late onset cardiotoxicity. Recent studies suggest that this form of cardiotoxicity is the result of a progenitor cell disease. In this study we demonstrate that Cord Blood Endothelial Progenitor Cells (EPCs) exposed to low, sub-apoptotic doses of doxorubicin show a senescence phenotype characterized by increased SA-b-gal activity, decreased TRF2 and chromosomal abnormalities, enlarged cell shape, and disarrangement of F-actin stress fibers accompanied by impaired migratory ability. P16(INK4A) localizes in the cytoplasm of doxorubicin-induced senescent EPCs and not in the nucleus as is the case in EPCs rendered senescent by different stimuli. This localization together with the presence of an arrest in G2, and not at the G1 phase boundary, which is what usually occurs in response to the cell cycle regulatory activity of p16(INK4A), suggests that doxorubicin-induced p16(INK4A) does not regulate the cell cycle, even though its increase is closely associated with senescence. The effects of doxorubicin are the result of the activation of MAPKs p38 and JNK which act antagonistically. JNK attenuates the senescence, p16(INK4A) expression and cytoskeleton remodeling that are induced by activated p38. We also found that conditioned medium from doxorubicin-induced senescent cardiomyocytes does not attract untreated EPCs, unlike conditioned medium from apoptotic cardiomyocytes which has a strong chemoattractant capacity. In conclusion, this study provides a better understanding of the senescence of doxorubicin-treated EPCs, which may be helpful in preventing and treating late onset cardiotoxicity.	[Spallarossa, Paolo; Altieri, Paola; Barisione, Chiara; Aloi, Concetta; Canepa, Marco; Ghigliotti, Giorgio; Brunelli, Claudio] Univ Genoa, Div Cardiol, Res Ctr Cardiovasc Biol, Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Biochem Sect, Dept Expt Med, Ctr Excellence Biomed Res, Genoa, Italy; [Fugazza, Giuseppina] Univ Genoa, Dept Internal Med, Lab Cytogenet, I-16126 Genoa, Italy; [Frassoni, Francesco] San Martino Hosp, Stem Cell & Cell Therapy Ctr, Genoa, Italy; [Podesta, Marina] San Martino Hosp, Div 2, Dept Hematol, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Spallarossa, P (corresponding author), Univ Genoa, Div Cardiol, Res Ctr Cardiovasc Biol, Genoa, Italy.	paola.altieri@unige.it	Spallarossa, Paolo/AAC-8981-2019; Podestà, Marina/K-3875-2016; Aloi, Concetta/AAS-6518-2020; Frassoni, Francesco/K-3971-2018; Passalacqua, Mario/W-1973-2019; Canepa, Marco/K-3850-2018	Podestà, Marina/0000-0002-6755-613X; Aloi, Concetta/0000-0002-5937-0781; Frassoni, Francesco/0000-0003-1262-0648; Passalacqua, Mario/0000-0003-2779-6259; barisione, chiara/0000-0001-8831-1054; CANEPA, MARCO/0000-0001-9063-5576; Ghigliotti, Giorgio/0000-0001-8484-542X	University of Genova	University of Genova	This work was supported by University of Genova (cofinanziamento di Ateneo). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaja Elena, 2004, Angiogenesis, V7, P323, DOI 10.1007/s10456-005-0368-9; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; BROWN BS, 1997, BIOCHEM, V323, P233; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Corselli M, 2008, EXP HEMATOL, V36, P340, DOI 10.1016/j.exphem.2007.10.008; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doyle B, 2008, STEM CELLS DEV, V17, P941, DOI 10.1089/scd.2007.0214; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Evangelou K, 2004, BIOTECH HISTOCHEM, V79, P5, DOI 10.1080/10520290310001659466; Gerland LM, 2003, EXP GERONTOL, V38, P887, DOI 10.1016/S0531-5565(03)00132-3; Hamed S, 2006, EUR HEART J, V27, P1876, DOI 10.1093/eurheartj/ehl044; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hu YH, 2003, CIRCULATION, V108, P3122, DOI 10.1161/01.CIR.0000105722.96112.67; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; KENNETH R, 2006, NEW ENGL J MED, V354, P789; Liu Q, 2009, MOL MED REP, V2, P169, DOI 10.3892/mmr_00000079; Londono-Vallejo JA, 2008, BIOCHIMIE, V90, P73, DOI 10.1016/j.biochi.2007.07.009; Maejima Y, 2008, AGING CELL, V7, P125, DOI 10.1111/j.1474-9726.2007.00358.x; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Mossmann T., 1983, J IMMUNOL METHODS, V65, P55; Multani AS, 2000, NEOPLASIA, V2, P339, DOI 10.1038/sj.neo.7900105; Murasawa S, 2005, ARTERIOSCL THROM VAS, V25, P1388, DOI 10.1161/01.ATV.0000168409.69960.e9; Nelyudova A, 2007, CELL CYCLE, V6, P2171, DOI 10.4161/cc.6.17.4610; Ottonello L, 2009, BRIT J PHARMACOL, V157, P294, DOI 10.1111/j.1476-5381.2009.00162.x; Shan K, 1996, ANN INTERN MED, V125, P47, DOI 10.7326/0003-4819-125-1-199607010-00008; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Spallarossa P, 2004, J MOL CELL CARDIOL, V37, P837, DOI 10.1016/j.yjmcc.2004.05.024; Spallarossa P, 2010, J PHARMACOL EXP THER, V332, P87, DOI 10.1124/jpet.109.159525; Spallarossa P, 2009, AM J PHYSIOL-HEART C, V297, pH2169, DOI 10.1152/ajpheart.00068.2009; Su DM, 2009, J BIOL CHEM, V284, P12153, DOI 10.1074/jbc.M807930200; Timolati F, 2006, J MOL CELL CARDIOL, V41, P845, DOI 10.1016/j.yjmcc.2006.08.002; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Verzola D, 2004, KIDNEY INT, V65, P1252, DOI 10.1111/j.1523-1755.2004.00497.x; Vigneron A, 2005, CANCER RES, V65, P8927, DOI 10.1158/0008-5472.CAN-05-0461; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Yang DG, 2008, AGEING RES REV, V7, P137, DOI 10.1016/j.arr.2008.02.001; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Zhang YM, 2009, FASEB J, V23, P1358, DOI 10.1096/fj.08-110296	48	60	61	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15583	10.1371/journal.pone.0015583	http://dx.doi.org/10.1371/journal.pone.0015583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187925	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200044
J	Braconi, C; Swenson, E; Kogure, T; Huang, NY; Patel, T				Braconi, Chiara; Swenson, Erica; Kogure, Takayuki; Huang, Nianyuan; Patel, Tushar			Targeting the IL-6 Dependent Phenotype Can Identify Novel Therapies for Cholangiocarcinoma	PLOS ONE			English	Article							MALIGNANT HUMAN CHOLANGIOCYTES; GENE-EXPRESSION SIGNATURES; CALCIUM-CHANNEL BLOCKERS; SERUM INTERLEUKIN-6; CANCER; GROWTH; INHIBITOR; MORTALITY; BILIARY; KINASE	Background: The need for new therapies for cholangiocarcinoma is highlighted by their poor prognosis and refractoriness to chemotherapy. Increased production of Interleukin-6 promotes cholangiocarcinoma growth and contributes to chemoresistance by activating cell survival mechanisms. We sought to identify biologically active compounds capable of ameliorating the phenotypic effects of IL-6 expression and to explore their potential therapeutic use for cholangiocarcinoma. Methodology: A genomic signature associated with Interleukin-6 expression in Mz-ChA-1 human malignant cholangiocytes was derived. Computational bioinformatics analysis was performed to identify compounds that induced inverse gene changes to the signature. The effect of these compounds on cholangiocarcinoma growth was then experimentally verified in vitro and in vivo. Interactions with other therapeutic agents were evaluated using median effects analysis. Principal Findings: A group of structurally related compounds, nitrendipine, nifedipine and felodipine was identified. All three compounds were cytotoxic to Mz-ChA-1 cells with an IC50 for felodipine of 26 mu M, nitrendipine, 44 mu M and nifedipine, 15 mu M. Similar results were observed in KMCH-1, CC-LP-1 and TFK-1 cholangiocarcinoma cell lines. At a fractional effect of 0.5, all three agents were synergistic with either camptothecin or gemcitabine in Mz-ChA-1 cells in vitro. Co-administration of felodipine and gemcitabine decreased the growth of Mz-ChA-1 cell xenografts in nude athymic mice. Conclusions: Computational bioinformatics analysis of phenotype-based genomic expression can be used to identify therapeutic agents. Using this drug discovery approach based on targeting a defined tumor associated phenotype, we identified compounds with the potential for therapeutic use in cholangiocarcinoma.	[Braconi, Chiara; Swenson, Erica; Kogure, Takayuki; Huang, Nianyuan; Patel, Tushar] Ohio State Univ, Coll Med, Dept Internal Med, Ohio State Univ Comprehens Canc Ctr, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Braconi, C (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Ohio State Univ Comprehens Canc Ctr, Columbus, OH 43210 USA.	patel.lab@gmail.com	patel, tushar/J-3976-2013; Kogure, Takayuki/AAI-3946-2021	patel, tushar/0000-0001-7021-9532; braconi, chiara/0000-0003-4835-1259	National Institutes of Health [DK 069370]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been funded by the National Institutes of Health (DK 069370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baradari V, 2007, WORLD J GASTROENTERO, V13, P4458; Braconi C, 2009, CANCER-AM CANCER SOC, V115, P3738, DOI 10.1002/cncr.24417; Cheon YK, 2007, AM J GASTROENTEROL, V102, P2164, DOI 10.1111/j.1572-0241.2007.01403.x; Chin GM, 2006, MOL CANCER THER, V5, P2580, DOI 10.1158/1535-7163.MCT-06-0201; CHIU LY, 2009, TOXICOL LETT; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coleman CI, 2008, J HYPERTENS, V26, P622, DOI 10.1097/HJH.0b013e3282f3ef5e; Debes JD, 2004, CANCER EPIDEM BIOMAR, V13, P255, DOI 10.1158/1055-9965.EPI-03-0093; Goydos JS, 1998, ANN SURG, V227, P398, DOI 10.1097/00000658-199803000-00012; Gregory J, 2009, PEDIATR BLOOD CANCER, V53, P1005, DOI 10.1002/pbc.22165; Huether A, 2007, BIOCHEM PHARMACOL, V73, P1308, DOI 10.1016/j.bcp.2006.12.031; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Khan SA, 2007, GUT, V56, P1755, DOI 10.1136/gut.2007.138859; Khan SA, 2002, J HEPATOL, V37, P806, DOI 10.1016/S0168-8278(02)00297-0; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Meng F, 2006, J HEPATOL, V44, P1055, DOI 10.1016/j.jhep.2005.10.030; Meng FM, 2005, AM J PHYSIOL-CELL PH, V289, pC971, DOI 10.1152/ajpcell.00081.2005; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Olsen JH, 1997, HYPERTENSION, V29, P1091, DOI 10.1161/01.HYP.29.5.1091; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Patel T, 2006, NAT CLIN PRACT GASTR, V3, P33, DOI 10.1038/ncpgasthep0389; Patel T, 2001, HEPATOLOGY, V33, P1353, DOI 10.1053/jhep.2001.25087; Patel T, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-10; Patt YZ, 2004, CANCER, V101, P578, DOI 10.1002/cncr.20368; Philip PA, 2006, J CLIN ONCOL, V24, P3069, DOI 10.1200/JCO.2005.05.3579; Singh P, 2006, CURR OPIN GASTROEN, V22, P294, DOI 10.1097/01.mog.0000218967.60633.64; Sugawara H, 1998, HISTOPATHOLOGY, V33, P145, DOI 10.1046/j.1365-2559.1998.00445.x; Tadlock L, 2001, HEPATOLOGY, V33, P43, DOI 10.1053/jhep.2001.20676; Tangkijvanich P, 2004, HEPATO-GASTROENTEROL, V51, P15; Vijapurkar U, 2007, CANCER RES, V67, P237, DOI 10.1158/0008-5472.CAN-06-2406; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Yamagiwa Y, 2006, LIFE SCI, V78, P2494, DOI 10.1016/j.lfs.2005.10.015; Yamagiwa Y, 2003, HEPATOLOGY, V38, P158, DOI 10.1053/jhep.2003.50257	36	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15195	10.1371/journal.pone.0015195	http://dx.doi.org/10.1371/journal.pone.0015195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179572	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000285381200017
J	Turgut, D; Atilgan, AR; Atilgan, C				Turgut, Deniz; Atilgan, Ali Rana; Atilgan, Canan			Assortative Mixing in Close-Packed Spatial Networks	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; PROTEIN STRUCTURES; RESIDUES; MORPHOLOGIES; MOTIONS; ENZYME	Background: In recent years, there is aroused interest in expressing complex systems as networks of interacting nodes. Using descriptors from graph theory, it has been possible to classify many diverse systems derived from social and physical sciences alike. In particular, folded proteins as examples of self-assembled complex molecules have also been investigated intensely using these tools. However, we need to develop additional measures to classify different systems, in order to dissect the underlying hierarchy. Methodology and Principal Findings: In this study, a general analytical relation for the dependence of nearest neighbor degree correlations on degree is derived. Dependence of local clustering on degree is shown to be the sole determining factor of assortative versus disassortative mixing in networks. The characteristics of networks constructed from spatial atomic/molecular systems exemplified by self-organized residue networks built from folded protein structures and block copolymers, atomic clusters and well-compressed polymeric melts are studied. Distributions of statistical properties of the networks are presented. For these densely-packed systems, assortative mixing in the network construction is found to apply, and conditions are derived for a simple linear dependence. Conclusions: Our analyses (i) reveal patterns that are common to close-packed clusters of atoms/molecules, (ii) identify the type of surface effects prominent in different close-packed systems, and (iii) associate fingerprints that may be used to classify networks with varying types of correlations.	[Turgut, Deniz; Atilgan, Ali Rana; Atilgan, Canan] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Sabanci University	Turgut, D (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey.	canan@sabanciuniv.edu	Atilgan, Ali Rana/A-7805-2011; Atilgan, Canan/C-7646-2009	Atilgan, Ali Rana/0000-0003-0604-6301; Atilgan, Canan/0000-0003-0557-6044; Turgut, Deniz/0000-0003-0543-3561	Scientific and Technological Research Council of Turkey [106T522]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was funded by the Scientific and Technological Research Council of Turkey Grant Number 106T522. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Inc, 2008, MAT STUD REL 4 4; Aftabuddin M, 2007, BIOPHYS J, V93, P225, DOI 10.1529/biophysj.106.098004; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Atilgan AR, 2007, BIOPHYS J, V92, P3052, DOI [10.1529/biophysj.106.099440, 10.1529/biophysj. 106.099440]; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Atilgan C, 2010, PROTEINS, V78, P3363, DOI 10.1002/prot.22843; Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Bahar I, 1999, J MOL BIOL, V285, P1023, DOI 10.1006/jmbi.1998.2371; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baysal C, 2001, PROTEINS, V45, P62, DOI 10.1002/prot.1124; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bode C, 2007, FEBS LETT, V581, P2776, DOI 10.1016/j.febslet.2007.05.021; Bollabas B, 1998, MODERN GRAPH THEORY, P394; Brinda KV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-296; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Can H, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3236518; Chung Fan, 1997, SPECTRAL GRAPH THEOR, P212; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Demirel MC, 1998, PROTEIN SCI, V7, P2522, DOI 10.1002/pro.5560071205; Erdos P, 1961, B I INT STAT; Fariselli P, 1999, PROTEIN ENG, V12, P15, DOI 10.1093/protein/12.1.15; Godsil C.D., 2001, ALGEBRAIC GRAPH THEO; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Higman VA, 2006, PHYSICA A, V368, P595, DOI 10.1016/j.physa.2006.01.062; Huberman BA, 1999, NATURE, V401, P131, DOI 10.1038/43604; Ipsen M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046109; Kacar G, 2010, J PHYS CHEM C, V114, P370, DOI 10.1021/jp908324d; Kleinberg J., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P163, DOI 10.1145/335305.335325; Lee CY, 2007, PHYSICA A, V386, P564, DOI 10.1016/j.physa.2007.08.030; Mohar B., 1991, GRAPH THEORY COMBINA, V2; Muppirala UK, 2006, PROTEIN ENG DES SEL, V19, P265, DOI 10.1093/protein/gzl009; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ozen AS, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2162885; Paperin G, 2008, DUAL PHASE EVOLUTION, P575; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sathyapriya R, 2007, PROTEINS, V68, P541, DOI 10.1002/prot.21401; Serrano A, 2005, PHYS REV E, V72; Tsolou G, 2006, MACROMOL THEOR SIMUL, V15, P381, DOI 10.1002/mats.200500088; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Wales D.J, CAMBRIDGE CLUSTER DA; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xiang YH, 2004, J PHYS CHEM A, V108, P3586, DOI 10.1021/jp037780t; Xiang YH, 2004, J PHYS CHEM A, V108, P9516, DOI 10.1021/jp047807o; Xulvi-Brunet R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066102	54	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15551	10.1371/journal.pone.0015551	http://dx.doi.org/10.1371/journal.pone.0015551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179578	Green Published, gold, Green Submitted			2022-12-25	WOS:000285381200029
J	Schwartz, AK; Weese, DJ; Bentzen, P; Kinnison, MT; Hendry, AP				Schwartz, Amy K.; Weese, Dylan J.; Bentzen, Paul; Kinnison, Michael T.; Hendry, Andrew P.			Both Geography and Ecology Contribute to Mating Isolation in Guppies	PLOS ONE			English	Article							MALE PREDATION RISK; POECILIA-RETICULATA; SEXUAL SELECTION; MATE-CHOICE; FEMALE PREFERENCE; NATURAL-SELECTION; TRINIDADIAN GUPPIES; PARALLEL EVOLUTION; MALE COLOR; REPRODUCTIVE SKEW	Local adaptation to different environments can promote mating isolation - either as an incidental by-product of trait divergence, or as a result of selection to avoid maladaptive mating. Numerous recent empirical examples point to the common influence of divergent natural selection on speciation based largely on evidence of strong pre-mating isolation between populations from different habitat types. Accumulating evidence for natural selection's influence on speciation is therefore no longer a challenge. The difficulty, rather, is in determining the mechanisms involved in the progress of adaptive divergence to speciation once barriers to gene flow are already present. Here, we present results of both laboratory and field experiments with Trinidadian guppies (Poecilia reticulata) from different environments, who do not show complete reproductive isolation despite adaptive divergence. We investigate patterns of mating isolation between populations that do and do not exchange migrants and show evidence for both by-product and reinforcement mechanisms depending on female ecology. Specifically, low-predation females discriminate against all high-predation males thus implying a by-product mechanism, whereas high-predation females only discriminate against low-predation males from further upstream in the same river, implying selection to avoid maladaptive mating. Our study thus confirms that mechanisms of adaptive speciation are not necessarily mutually exclusive and uncovers the complex ecology-geography interactions that underlie the evolution of mating isolation in nature.	[Schwartz, Amy K.; Hendry, Andrew P.] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Schwartz, Amy K.; Hendry, Andrew P.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Weese, Dylan J.; Kinnison, Michael T.] Univ Maine, Dept Biol Sci, Orono, ME USA; [Bentzen, Paul] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	McGill University; McGill University; University of Maine System; University of Maine Orono; Dalhousie University	Schwartz, AK (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.	amy.schwartz@glasgow.ac.uk	Hendry, Andrew/C-5765-2008	Hendry, Andrew/0000-0002-4807-6667; Kinnison, Michael/0000-0003-4211-2118; Bentzen, Paul/0000-0003-4288-7730	National Science Foundation [DEB 0235605]; Natural Science and Technology Research Council of Quebec; Natural Sciences and Engineering Research Council of Canada	National Science Foundation(National Science Foundation (NSF)); Natural Science and Technology Research Council of Quebec; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by the National Science Foundation (DEB 0235605), the Natural Science and Technology Research Council of Quebec (http://www.fqrnt.gouv.qc.ca), and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HJ, 2006, EVOLUTION, V60, P2352, DOI 10.1111/j.0014-3820.2006.tb01870.x; BAERENDS G. P., 1955, BEHAVIOUR, V8, P249, DOI 10.1163/156853955X00238; Becher SA, 2004, P ROY SOC B-BIOL SCI, V271, P1009, DOI 10.1098/rspb.2004.2701; Boughman JW, 2005, EVOLUTION, V59, P361; BREDEN F, 1987, NATURE, V329, P831, DOI 10.1038/329831a0; Brooks R, 2002, GENETICA, V116, P343, DOI 10.1023/A:1021228308636; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; CARVALHO GR, 1991, BIOL J LINN SOC, V42, P389, DOI 10.1111/j.1095-8312.1991.tb00571.x; Coyne JA, 2004, SPECIATION, V37; Crispo E, 2006, MOL ECOL, V15, P49, DOI 10.1111/j.1365-294X.2005.02764.x; Croft DP, 2003, OECOLOGIA, V137, P62, DOI 10.1007/s00442-003-1268-6; Darden SK, 2008, BIOL LETTERS, V4, P449, DOI 10.1098/rsbl.2008.0308; DUGATKIN LA, 1992, AM NAT, V139, P1384, DOI 10.1086/285392; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Evans JP, 2003, BIOL J LINN SOC, V78, P605, DOI 10.1046/j.0024-4066.2002.00193.x; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Gamble S, 2003, ECOL LETT, V6, P463, DOI 10.1046/j.1461-0248.2003.00449.x; Gordon SP, 2009, AM NAT, V174, P34, DOI 10.1086/599300; Hall M, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-1; Haskins C. P., 1961, VERTEBRATE SPECIATIO, P320; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; HOUDE AE, 1990, SCIENCE, V248, P1405, DOI 10.1126/science.248.4961.1405; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kay KM, 2008, EVOLUTION, V62, P2628, DOI 10.1111/j.1558-5646.2008.00463.x; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; KODRICBROWN A, 1993, BEHAV ECOL SOCIOBIOL, V32, P415, DOI 10.1007/BF00168825; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; LUYTEN PH, 1991, BEHAV ECOL SOCIOBIOL, V28, P329, DOI 10.1007/BF00164382; Magellan K, 2007, J FISH BIOL, V71, P1864, DOI 10.1111/j.1095-8649.2007.01640.x; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Millar NP, 2006, OIKOS, V113, P1; Neff BD, 2008, MOL ECOL, V17, P2975, DOI 10.1111/j.1365-294X.2008.03816.x; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2003, P ROY SOC B-BIOL SCI, V270, P1911, DOI 10.1098/rspb.2003.2457; Nosil P, 2008, BIOL J LINN SOC, V95, P305, DOI 10.1111/j.1095-8312.2008.01048.x; Nosil P, 2008, BIOL J LINN SOC, V95, P26, DOI 10.1111/j.1095-8312.2008.01091.x; Ojanguren AF, 2007, BEHAVIOUR, V144, P503, DOI 10.1163/156853907780713055; Paterson IG, 2005, MOL ECOL NOTES, V5, P269, DOI 10.1111/j.1471-8286.2005.00895.x; Pilastro A, 2004, EVOLUTION, V58, P665, DOI 10.1111/j.0014-3820.2004.tb01690.x; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; RODD FH, 1995, ANIM BEHAV, V49, P1139, DOI 10.1006/anbe.1995.0149; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schwartz AK, 2007, EVOL ECOL RES, V9, P71; SEGHERS BH, 1974, EVOLUTION, V28, P486, DOI 10.1111/j.1558-5646.1974.tb00774.x; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; SHAW PW, 1991, J FISH BIOL, V39, P203, DOI 10.1111/j.1095-8649.1991.tb05084.x; STONER G, 1988, BEHAV ECOL SOCIOBIOL, V22, P285, DOI 10.1007/BF00299844; Suk HY, 2009, HEREDITY, V102, P425, DOI 10.1038/hdy.2009.7; Watanabe T, 2003, MOL ECOL NOTES, V3, P487, DOI 10.1046/j.1471-8286.2003.00490.x; Weese DJ, 2010, EVOLUTION, V64, P1802, DOI 10.1111/j.1558-5646.2010.00945.x; Zajitschek SRK, 2008, AM NAT, V172, P843, DOI 10.1086/593001	57	17	18	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15659	10.1371/journal.pone.0015659	http://dx.doi.org/10.1371/journal.pone.0015659			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179541	Green Published, Green Submitted, gold			2022-12-25	WOS:000285340000029
J	Gill, DK; Huang, YD; Levine, GL; Sambor, A; Carter, DK; Sato, A; Kopycinski, J; Hayes, P; Hahn, B; Birungi, J; Tarragona-Fiol, T; Wan, H; Randles, M; Cooper, AR; Ssemaganda, A; Clark, L; Kaleebu, P; Self, SG; Koup, R; Wood, B; McElrath, MJ; Cox, JH; Hural, J; Gilmour, J				Gill, Dilbinder K.; Huang, Yunda; Levine, Gail L.; Sambor, Anna; Carter, Donald K.; Sato, Alicia; Kopycinski, Jakub; Hayes, Peter; Hahn, Bridget; Birungi, Josephine; Tarragona-Fiol, Tony; Wan, Hong; Randles, Mark; Cooper, Andrew Raxworthy; Ssemaganda, Aloysius; Clark, Lorna; Kaleebu, Pontiano; Self, Steven G.; Koup, Richard; Wood, Blake; McElrath, M. Juliana; Cox, Josephine H.; Hural, John; Gilmour, Jill			Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories	PLOS ONE			English	Article							VACCINE TRIALS; CELL; IMMUNITY; PROFICIENCY; RESPONSES; ENTERPRISE; CANCER; PANEL	Background: The Comprehensive T Cell Vaccine Immune Monitoring Consortium (CTC-VIMC) was created to provide standardized immunogenicity monitoring services for HIV vaccine trials. The ex vivo interferon-gamma (IFN-gamma) ELISpot is used extensively as a primary immunogenicity assay to assess T cell-based vaccine candidates in trials for infectious diseases and cancer. Two independent, GCLP-accredited central laboratories of CTC-VIMC routinely use their own standard operating procedures (SOPs) for ELISpot within two major networks of HIV vaccine trials. Studies are imperatively needed to assess the comparability of ELISpot measurements across laboratories to benefit optimal advancement of vaccine candidates. Methods: We describe an equivalence study of the two independently qualified IFN-g ELISpot SOPs. The study design, data collection and subsequent analysis were managed by independent statisticians to avoid subjectivity. The equivalence of both response rates and positivity calls to a given stimulus was assessed based on pre-specified acceptance criteria derived from a separate pilot study. Findings: Detection of positive responses was found to be equivalent between both laboratories. The 95% C. I. on the difference in response rates, for CMV (-1.5%, 1.5%) and CEF (-0.4%, 7.8%) responses, were both contained in the pre-specified equivalence margin of interval [ -15%, 15%]. The lower bound of the 95% C. I. on the proportion of concordant positivity calls for CMV (97.2%) and CEF (89.5%) were both greater than the pre-specified margin of 70%. A third CTC-VIMC central laboratory already using one of the two SOPs also showed comparability when tested in a smaller sub-study. Interpretation: The described study procedure provides a prototypical example for the comparison of bioanalytical methods in HIV vaccine and other disease fields. This study also provides valuable and unprecedented information for future vaccine candidate evaluations on the comparison and pooling of ELISpot results generated by the CTC-VIMC central core laboratories.	[Gill, Dilbinder K.; Kopycinski, Jakub; Hayes, Peter; Tarragona-Fiol, Tony; Cooper, Andrew Raxworthy; Clark, Lorna] Univ London Imperial Coll Sci Technol & Med, Int AIDS Vaccine Initiat Human Immunol Lab, London, England; [Huang, Yunda; Sato, Alicia; Self, Steven G.; Wood, Blake] Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA; [Levine, Gail L.; Sambor, Anna] Fdn Natl Inst Hlth, Bethesda, MD USA; [Carter, Donald K.; Hahn, Bridget; McElrath, M. Juliana; Hural, John] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Birungi, Josephine; Ssemaganda, Aloysius; Kaleebu, Pontiano] Uganda Virus Res Inst, Entebbe, Uganda; [Wan, Hong; Randles, Mark; Cox, Josephine H.; Gilmour, Jill] Int AIDS Vaccine Initiat, New York, NY USA; [Koup, Richard] Vaccine Res Ctr, Bethesda, MD USA	Imperial College London; International AIDS Vaccine Initiative; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; Fred Hutchinson Cancer Center; Uganda Virus Research Institute; International AIDS Vaccine Initiative	Gill, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Int AIDS Vaccine Initiat Human Immunol Lab, London, England.	d.gill@imperial.ac.uk		Cox, Josephine/0000-0003-1301-7373; Huang, Yunda/0000-0003-1546-6172	Bill & Melinda Gates Foundation [38650]; MRC [MC_U950097145] Funding Source: UKRI; Medical Research Council [MC_U950097145] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, ZIAAI005073] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Collaboration for AIDS Vaccine Discovery (CAVD) Grant 38650 from the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2005, STAT MED, V24, P729, DOI 10.1002/sim.1781; Almeida CAM, 2009, J IMMUNOL METHODS, V344, P1, DOI 10.1016/j.jim.2009.02.007; Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Cox JH, 2005, AIDS RES HUM RETROV, V21, P68, DOI 10.1089/aid.2005.21.68; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; Esparza J, 2005, INT MICROBIOL, V8, P93; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Herr W, 1997, J IMMUNOL METHODS, V203, P141, DOI 10.1016/S0022-1759(97)00019-7; Janetzki S, 2008, CANCER IMMUNOL IMMUN, V57, P303, DOI 10.1007/s00262-007-0380-6; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Moodie Z, 2006, J IMMUNOL METHODS, V315, P121, DOI 10.1016/j.jim.2006.07.015; Rini BI, 2006, CANCER-AM CANCER SOC, V107, P67, DOI 10.1002/cncr.21956; Russell ND, 2003, J INFECT DIS, V187, P226, DOI 10.1086/367702; Smith Jeffrey G., 2003, Journal of Medical Virology, V70, pS38, DOI 10.1002/jmv.10318; STILES T, 2003, GOOD CLIN LAB PRACTI, P1; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Todryk SM, 2009, EUR J IMMUNOL, V39, P3042, DOI 10.1002/eji.200939434	24	37	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14330	10.1371/journal.pone.0014330	http://dx.doi.org/10.1371/journal.pone.0014330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179404	Green Submitted, Green Published, gold			2022-12-25	WOS:000285292500008
J	Harley, E; Fowler, K; Cotton, S				Harley, Elisabeth; Fowler, Kevin; Cotton, Samuel			No Detectable Fertility Benefit from a Single Additional Mating in Wild Stalk-Eyed Flies	PLOS ONE			English	Article							POSTCOPULATORY INBREEDING AVOIDANCE; CHROMOSOME MEIOTIC DRIVE; ARTIFICIAL SELECTION; CORRELATED RESPONSES; SEXUAL-DIMORPHISM; MATE PREFERENCE; SPERM SELECTION; FLY; FEMALES; POLYANDRY	Background: Multiple mating by female insects is widespread, and the explanation(s) for repeated mating by females has been the subject of much discussion. Females may profit from mating multiply through direct material benefits that increase their own reproductive output, or indirect genetic benefits that increase offspring fitness. One particular direct benefit that has attracted significant attention is that of fertility assurance, as females often need to mate multiply to achieve high fertility. This hypothesis has never been tested in a wild insect population. Methodology/Principal Findings: Female Malaysian stalk-eyed flies (Teleopsis dalmanni) mate repeatedly during their lifetime, and have been shown to be sperm limited under both laboratory and field conditions. Here we ask whether receiving an additional mating alleviates sperm limitation in wild females. In our experiment one group of females received a single additional mating, while a control group received an interrupted, and therefore unsuccessful, mating. Females that received an additional mating did not lay more fertilised eggs in total, nor did they lay proportionately more fertilised eggs. Female fertility declined significantly through time, demonstrating that females were sperm limited. However, receipt of an additional mating did not significantly alter the rate of this decline. Conclusions/Significance: Our data suggest that the fertility consequences of a single additional mating were small. We discuss this effect (or lack thereof), and suggest that it is likely to be attributed to small ejaculate size, a high proportion of failed copulations, and the presence of X-linked meiotic drive in this species.	[Harley, Elisabeth; Fowler, Kevin; Cotton, Samuel] UCL, Res Dept Genet Evolut & Environm, London, England	University of London; University College London	Harley, E (corresponding author), UCL, Res Dept Genet Evolut & Environm, London, England.	s.cotton@ucl.ac.uk			UK Natural Environment Research Council [NE/E012620/1]; UK Biotechnology & Biological Sciences Research Council; NERC [NE/G00563X/1, NE/E012620/1] Funding Source: UKRI; Natural Environment Research Council [NE/E012620/1, NE/G00563X/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Biotechnology & Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a UK Natural Environment Research Council Post-doctoral Fellowship to S. C. (NE/E012620/1). E. H. is supported by a UK Biotechnology & Biological Sciences Research Council Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Baker RH, 2001, EVOLUTION, V55, P1373; Baker RH, 2001, BEHAV ECOL, V12, P732, DOI 10.1093/beheco/12.6.732; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BOGGS CL, 1979, SCIENCE, V206, P83, DOI 10.1126/science.206.4414.83; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; BURKHARDT D, 1985, NATURWISSENSCHAFTEN, V72, P204, DOI 10.1007/BF01195763; BUTLIN RK, 1987, EVOLUTION, V41, P221, DOI 10.1111/j.1558-5646.1987.tb05785.x; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Corley LS, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-53; Cotton S, 2010, EVOL ECOL, V24, P83, DOI 10.1007/s10682-009-9292-6; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Fry CL, 2004, EVOLUTION, V58, P1622, DOI 10.1111/j.0014-3820.2004.tb01743.x; Gershman SN, 2007, ETHOLOGY, V113, P1099, DOI 10.1111/j.1439-0310.2007.01418.x; Grant CA, 2005, HEREDITY, V95, P444, DOI 10.1038/sj.hdy.6800733; Hingle A, 2001, P ROY SOC B-BIOL SCI, V268, P1239, DOI 10.1098/rspb.2001.1647; Hingle A, 2001, ANIM BEHAV, V61, P589, DOI 10.1006/anbe.2000.1613; Hosken DJ, 2003, J EVOLUTION BIOL, V16, P485, DOI 10.1046/j.1420-9101.2003.00537.x; Ivy TM, 2005, EVOLUTION, V59, P152, DOI 10.1111/j.0014-3820.2005.tb00902.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Johns PM, 2007, HEREDITY, V99, P56, DOI 10.1038/sj.hdy.6800963; Kotrba M, 1996, ZOOL J LINN SOC-LOND, V117, P305, DOI 10.1111/j.1096-3642.1996.tb02192.x; Lamunyon CW, 2000, ANIM BEHAV, V59, P395, DOI 10.1006/anbe.1999.1294; LORCH PD, 1993, BEHAV ECOL SOCIOBIOL, V32, P303; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Orsetti DM, 2003, ANIM BEHAV, V66, P477, DOI 10.1006/anbe.2003.2263; Presgraves DC, 1997, GENETICS, V147, P1169; Reguera P, 2004, J INSECT PHYSIOL, V50, P103, DOI 10.1016/j.jinsphys.2003.10.004; RIDLEY M, 1988, BIOL REV, V63, P509, DOI 10.1111/j.1469-185X.1988.tb00669.x; Rogers DW, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-236; Rogers DW, 2006, ANIM BEHAV, V72, P1363, DOI 10.1016/j.anbehav.2006.03.027; Rogers DW, 2005, J EVOLUTION BIOL, V18, P642, DOI 10.1111/j.1420-9101.2004.00860.x; Rogers DW, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-37; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Small J, 2009, ANIM BEHAV, V78, P1213, DOI 10.1016/j.anbehav.2009.08.009; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Thornhill R., 1983, pi; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI [10.1111/j.1558-5646.1998.tb02252.x, 10.2307/2411345]; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Wang Q, 2006, J INSECT BEHAV, V19, P337, DOI 10.1007/s10905-006-9027-2; Webberley KM, 2002, J PARASITOL, V88, P707, DOI 10.1645/0022-3395(2002)088[0707:TEOAOO]2.0.CO;2; Wilkinson GS, 2006, J EVOLUTION BIOL, V19, P1851, DOI 10.1111/j.1420-9101.2006.01169.x; Wilkinson GS, 2001, P ROY SOC B-BIOL SCI, V268, P2559, DOI 10.1098/rspb.2001.1831; Wilkinson GS, 2001, HEREDITY, V87, P17, DOI 10.1046/j.1365-2540.2001.00898.x; Wilkinson GS, 2003, GENETICA, V117, P37, DOI 10.1023/A:1022360531703; Wilkinson GS, 2005, INTEGR COMP BIOL, V45, P500, DOI 10.1093/icb/45.3.500; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; Wilkinson GS, 1998, BEHAV ECOL, V9, P525, DOI 10.1093/beheco/9.5.525; Wright TF, 2004, GENET RES, V84, P27, DOI 10.1017/S0016672304006986; Zeh JA, 2006, NATURE, V439, P201, DOI 10.1038/nature04260	55	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14309	10.1371/journal.pone.0014309	http://dx.doi.org/10.1371/journal.pone.0014309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179210	gold, Green Published, Green Submitted			2022-12-25	WOS:000285246900015
J	Jors, S; Grimm, C; Becker, L; Heller, S				Joers, Simone; Grimm, Christian; Becker, Lars; Heller, Stefan			Genetic Inactivation of Trpml3 Does Not Lead to Hearing and Vestibular Impairment in Mice	PLOS ONE			English	Article							MUCOLIPIDOSIS TYPE-IV; VARITINT-WADDLER VA; RECEPTOR POTENTIAL CHANNEL; HAIR-CELLS; MOUSE; MUTATIONS; DEAFNESS; ABNORMALITIES; TRANSDUCTION; PHENOTYPE	TRPML3, a member of the transient receptor potential (TRP) family, is an inwardly rectifying, non-selective Ca(2+)-permeable cation channel that is regulated by extracytosolic Na(+) and H(+) and can be activated by a variety of small molecules. The severe auditory and vestibular phenotype of the TRPML3(A419P) varitint-waddler mutation made this protein particularly interesting for inner ear biology. To elucidate the physiological role of murine TRPML3, we conditionally inactivated Trpml3 in mice. Surprisingly, lack of functional TRPML3 did not lead to circling behavior, balance impairment or hearing loss.	[Joers, Simone] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Jors, S (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	hellers@stanford.edu	Grimm, Christian/ABF-9121-2020	Grimm, Christian/0000-0002-0177-5559	National Institutes of Health [DC004563, P30 DC010363]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC010363, R01DC004563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants DC004563 and P30 DC010363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Cable J, 1998, HEARING RES, V123, P125, DOI 10.1016/S0378-5955(98)00107-5; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Chow LML, 2006, DEV DYNAM, V235, P2991, DOI 10.1002/dvdy.20948; Cuajungco MP, 2007, BBA-MOL BASIS DIS, V1772, P1022, DOI 10.1016/j.bbadis.2007.01.002; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Grimm C, 2009, J BIOL CHEM, V284, P13823, DOI 10.1074/jbc.M809045200; Jero J, 2001, ACTA OTO-LARYNGOL, V121, P585, DOI 10.1080/000164801316878863; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Kim HJ, 2003, JARO-J ASSOC RES OTO, V4, P83, DOI 10.1007/s10162-002-3011-0; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LIBERMAN MC, 1995, HEARING RES, V90, P158, DOI 10.1016/0378-5955(95)00160-2; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Tabuchi K, 2005, NEUROSCI LETT, V382, P304, DOI 10.1016/j.neulet.2005.03.035; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	29	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14317	10.1371/journal.pone.0014317	http://dx.doi.org/10.1371/journal.pone.0014317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179200	Green Published, gold, Green Submitted			2022-12-25	WOS:000285246900022
J	Zlobec, I; Karamitopoulou, E; Terracciano, L; Piscuoglio, S; Iezzi, G; Muraro, MG; Spagnoli, G; Baker, K; Tzankov, A; Lugli, A				Zlobec, Inti; Karamitopoulou, Eva; Terracciano, Luigi; Piscuoglio, Salvatore; Iezzi, Giandomenica; Muraro, Manuele Giuseppe; Spagnoli, Giulio; Baker, Kristi; Tzankov, Alexandar; Lugli, Alessandro			TIA-1 Cytotoxic Granule-Associated RNA Binding Protein Improves the Prognostic Performance of CD8 in Mismatch Repair-Proficient Colorectal Cancer	PLOS ONE			English	Article							T-CELLS; INTRAEPITHELIAL LYMPHOCYTES; MICROSATELLITE INSTABILITY; TUMOR MICROENVIRONMENT; GENE-EXPRESSION; APOPTOSIS	Background: Evidence suggests a confounding effect of mismatch repair (MMR) status on immune response in colorectal cancer. The identification of innate and adaptive immune cells, that can complement the established prognostic effect of CD8 in MMR-proficient colorectal cancers patients, representing 85% of all cases, has not been performed. Methodology/Principal Findings: Colorectal cancers from a test (n = 1197) and external validation (n = 209) cohort of MMR-proficient colorectal cancers were mounted onto single and multiple punch tissue microarrays. Immunohistochemical quantification (score 0-3) was performed for CD3, CD4, CD8, CD45RO, CD68, CD163, FoxP3, GranzymeB, iNOS, mast cell tryptase, MUM1, PD1 and TIA-1 tumor-infiltrating (TILs) reactive cells. Coexpression experiments on fresh colorectal cancer specimens using specific cell population markers were performed. In the test group, higher numbers of CD3+ (p<0.001), CD4+ (p = 0.029), CD8+ (p<0.001), CD45RO+ (p = 0.048), FoxP3+ (p<0.001), GranzymeB+ (p<0.001), iNOS+ (p = 0.035), MUM1+ (p = 0.014), PD1+ (p = 0.034) and TIA-1+ TILs (p<0.001) were linked to favourable outcome. Adjusting for age, gender, TNM stage and post-operative therapy, higher CD8+ (p<0.001; HR (95%CI): 0.66 (0.64-0.68)) and TIA-1+ (p<0.001; HR (95%CI): 0.56 (0.5-0.6)) were independent prognostic factors. Moreover, among patients with CD8+ infiltrates, TIA-1 further stratified 355 (35.6%) patients into prognostic subgroups (p<0.001; HR (95% CI): 0.89 (95% CI: 0.8-0.9)). Results were confirmed on the validation cohort (p = 0.006). TIA-1+ cells were mostly CD8+ (57%), but also stained for TCR gamma delta (22%), CD66b (13%) and only rarely for CD4+, macrophage and NK cell markers. Conclusions: TIA-1 adds prognostic information to TNM stage and adjuvant therapy in MMR-proficient colorectal cancer patients. The prognostic effect of CD8+ TILs is confounded by the presence of TIA-1+ which translates into improved risk stratification for approximately 35% of all patients with MMR-proficient colorectal cancers.	[Zlobec, Inti; Terracciano, Luigi; Tzankov, Alexandar; Lugli, Alessandro] Univ Basel, Inst Pathol, Basel, Switzerland; [Karamitopoulou, Eva] Attikon Univ Hosp, Dept Pathol 2, Athens, Greece; [Piscuoglio, Salvatore] Univ Basel, Res Grp Human Genet, Dept Biomed, Basel, Switzerland; [Iezzi, Giandomenica; Muraro, Manuele Giuseppe; Spagnoli, Giulio] Univ Basel, Inst Surg Res & Hosp Management, Basel, Switzerland; [Baker, Kristi] Brigham & Womens Hosp, Dept Gastroenterol, Boston, MA 02115 USA	University of Basel; University Hospital Attikon; University of Basel; University of Basel; Harvard University; Brigham & Women's Hospital	Zlobec, I (corresponding author), Univ Basel, Inst Pathol, Basel, Switzerland.	izlobec@uhbs.ch	Piscuoglio, Salvatore/AAB-4959-2022; Tzankov, Alexandar/H-5656-2019; Terracciano, Luigi M./AAB-5335-2022; Tzankov, Alexandar/A-9155-2008	Piscuoglio, Salvatore/0000-0003-2686-2939; Tzankov, Alexandar/0000-0002-1100-3819; Terracciano, Luigi M./0000-0002-9393-9660; Muraro, Manuele Giuseppe/0000-0002-4590-1916; Zlobec, Inti/0000-0001-6741-3000; Baker, Kristi/0000-0002-2993-3889; Karamitopoulou-Diamantis, Eva/0000-0002-4833-1373; Iezzi, Giandomenica/0000-0001-5841-495X	Institute for Pathology, University Hospital of Basel	Institute for Pathology, University Hospital of Basel	The authors were funded by the Institute for Pathology, University Hospital of Basel, Research pool account. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro T, 2006, J CLIN ONCOL, V24, P5350, DOI 10.1200/JCO.2006.06.4766; Baker K, 2009, CANCER IMMUNOL IMMUN, V58, P135, DOI 10.1007/s00262-008-0534-1; Baker K, 2007, EUR J CANCER, V43, P624, DOI 10.1016/j.ejca.2006.11.012; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; CARROLL RP, 2010, J AM SOC NEPHROL; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; Compton C, 2006, PROGNOSTIC FACTORS C; Dadabayev AR, 2004, CANCER IMMUNOL IMMUN, V53, P978, DOI 10.1007/s00262-004-0548-2; de Kruijf EM, 2010, CLIN CANCER RES, V16, P1272, DOI 10.1158/1078-0432.CCR-09-1844; Dolcetti R, 1999, AM J PATHOL, V154, P1805, DOI 10.1016/S0002-9440(10)65436-3; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Forch P, 2001, APOPTOSIS, V6, P463, DOI 10.1023/A:1012441824719; FREY DM, 2009, INT J CANC; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Goethals L, 2006, J PATHOL, V208, P607, DOI 10.1002/path.1934; Izquierdo JM, 2007, J BIOL CHEM, V282, P1539, DOI 10.1074/jbc.C600198200; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Jenkins MA, 2007, GASTROENTEROLOGY, V133, P48, DOI 10.1053/j.gastro.2007.04.044; Mallett S, 2010, BRIT J CANCER, V102, P173, DOI 10.1038/sj.bjc.6605462; Mocellin S, 2003, INT J CANCER, V107, P317, DOI 10.1002/ijc.11369; O'Malley DP, 2007, AM J CLIN PATHOL, V127, P850, DOI 10.1309/A8FHDA0VVRJ05GJP; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Rubio CA, 1999, ANTICANCER RES, V19, P3221; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Santucci M, 2003, CANCER, V97, P610, DOI 10.1002/cncr.11107; Sasaki A, 2008, EJSO-EUR J SURG ONC, V34, P173, DOI 10.1016/j.ejso.2007.08.008; Shetye J, 1998, CLIN CANCER RES, V4, P1921; STEYERBERG EW, 2008, CLIN PREDICTION MODE, pCH17; SUZUKI H, 2009, CANC IMMUNOL IMMUNOT	33	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14282	10.1371/journal.pone.0014282	http://dx.doi.org/10.1371/journal.pone.0014282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21179245	gold, Green Published, Green Submitted			2022-12-25	WOS:000285181400008
J	Biswas, KH; Visweswariah, SS				Biswas, Kabir H.; Visweswariah, Sandhya S.			Distinct Allostery Induced in the Cyclic GMP-binding, Cyclic GMP-specific Phosphodiesterase (PDE5) by Cyclic GMP, Sildenafil, and Metal Ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CGMP-SPECIFIC PHOSPHODIESTERASE; CONFORMATIONAL-CHANGE; GAF DOMAIN; REGULATORY DOMAIN; CATALYTIC DOMAIN; INDUCED FIT; MECHANISM; INHIBITORS; EXPRESSION; DIMERIZATION	The activity of many proteins orchestrating different biological processes is regulated by allostery, where ligand binding at one site alters the function of another site. Allosteric changes can be brought about by either a change in the dynamics of a protein, or alteration in its mean structure. We have investigated the mechanisms of allostery induced by chemically distinct ligands in the cGMP-binding, cGMP-specific phosphodiesterase, PDE5. PDE5 is the target for catalytic site inhibitors, such as sildenafil, that are used for the treatment of erectile dysfunction and pulmonary hypertension. PDE5 is a multidomain protein and contains two N-terminal cGMP-specific phosphodiesterase, bacterial adenylyl cyclase, FhLA transcriptional regulator (GAF) domains, and a C-terminal catalytic domain. Cyclic GMP binding to the GAFa domain and sildenafil binding to the catalytic domain result in conformational changes, which to date have been studied either with individual domains or with purified enzyme. Employing intramolecular bioluminescence resonance energy transfer, which can monitor conformational changes both in vitro and in intact cells, we show that binding of cGMP and sildenafil to PDE5 results in distinct conformations of the protein. Metal ions bound to the catalytic site also allosterically modulated cGMP- and sildenafil-induced conformational changes. The sildenafil-induced conformational change was temperature-sensitive, whereas cGMP-induced conformational change was independent of temperature. This indicates that different allosteric ligands can regulate the conformation of a multidomain protein by distinct mechanisms. Importantly, this novel PDE5 sensor has general physiological and clinical relevance because it allows the identification of regulators that can modulate PDE5 conformation in vivo.	[Biswas, Kabir H.; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Sir CV Raman Ave, Bangalore 560041, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019; Biswas, Kabir H/AAG-9156-2019	Visweswariah, Sandhya/0000-0003-2786-7344; Biswas, Kabir H/0000-0001-9194-4127	Department of Biotechnology, Government of India; Indian Institute of Science; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Institute of Science; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Biotechnology, Government of India, and the Indian Institute of Science.; Recipient of a senior research fellowship from the Council of Scientific and Industrial Research, Government of India.	Bakre MM, 2000, EUR J BIOCHEM, V267, P179, DOI 10.1046/j.1432-1327.2000.00986.x; Bakre MM, 2000, J CELL BIOCHEM, V77, P159; Biswas KH, 2008, BIOCHEMISTRY-US, V47, P3534, DOI 10.1021/bi702025w; Blount MA, 2007, J PHARMACOL EXP THER, V323, P730, DOI 10.1124/jpet.107.126540; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Cann M, 2007, MOL MICROBIOL, V64, P461, DOI 10.1111/j.1365-2958.2007.05669.x; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Corbin J. D., 2003, HDB CELL SIGNALING, P465; Corbin JD, 2009, CELL SIGNAL, V21, P1768, DOI 10.1016/j.cellsig.2009.07.012; Corbin JD, 2000, EUR J BIOCHEM, V267, P2760, DOI 10.1046/j.1432-1327.2000.01297.x; Corbin JD, 2003, MOL PHARMACOL, V63, P1364, DOI 10.1124/mol.63.6.1364; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Dacres H, 2009, ANAL BIOCHEM, V385, P194, DOI 10.1016/j.ab.2008.10.040; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; Dolci S, 2006, BIOCHEM BIOPH RES CO, V341, P837, DOI 10.1016/j.bbrc.2006.01.035; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Francis SH, 2008, INT J IMPOT RES, V20, P333, DOI 10.1038/ijir.2008.4; Francis S. H., 2006, CYCLIC NUCL PHOSPHOD, P135; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; FRANCIS SH, 1994, J BIOL CHEM, V269, P22477; Francis SH, 2000, BIOCHEMISTRY-US, V39, P9591, DOI 10.1021/bi000392m; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Gierasch LM, 2009, NAT CHEM BIOL, V5, P774, DOI 10.1038/nchembio.241; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hilser VJ, 2010, SCIENCE, V327, P653, DOI 10.1126/science.1186121; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lin CS, 2004, INT J IMPOT RES, V16, pS8, DOI 10.1038/sj.ijir.3901207; Lin CS, 2000, BIOCHEM BIOPH RES CO, V268, P628, DOI 10.1006/bbrc.2000.2187; Lin CS, 2002, INT J IMPOT RES, V14, P15, DOI 10.1038/sj.ijir.3900802; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Matthiesen K, 2009, BIOCHEM J, V423, P401, DOI 10.1042/BJ20090982; Mullershausen F, 2003, J CELL BIOL, V160, P719, DOI 10.1083/jcb.200211041; Okada D, 2002, BIOCHEMISTRY-US, V41, P9672, DOI 10.1021/bi025727+; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Rybalkina IG, 2010, MOL PHARMACOL, V77, P670, DOI 10.1124/mol.109.062299; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Sopory S, 2004, CELL SIGNAL, V16, P681, DOI 10.1016/j.cellsig.2003.11.004; Sopory S, 2003, FEBS LETT, V539, P161, DOI 10.1016/S0014-5793(03)00219-9; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Touyz R. M., 2003, Molecular Aspects of Medicine, V24, P107, DOI 10.1016/S0098-2997(02)00094-8; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Turko IV, 1999, MOL PHARMACOL, V56, P124, DOI 10.1124/mol.56.1.124; Turko IV, 1998, BIOCHEMISTRY-US, V37, P4200, DOI 10.1021/bi972448r; Wang H, 2008, MOL PHARMACOL, V73, P104, DOI 10.1124/mol.107.040212; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wilson LS, 2008, P NATL ACAD SCI USA, V105, P13650, DOI 10.1073/pnas.0804738105; Wolf FI, 2008, CLIN SCI, V114, P27, DOI 10.1042/CS20070129; Yago MD, 2000, FRONT BIOSCI-LANDMRK, V5, pD602, DOI 10.2741/Yago; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	60	18	18	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8545	8554		10.1074/jbc.M110.193185	http://dx.doi.org/10.1074/jbc.M110.193185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193396	hybrid, Green Published			2022-12-25	WOS:000288013300081
J	Liao, MJ; Zhang, Y; Kang, JH; Dufau, ML				Liao, Mingjuan; Zhang, Ying; Kang, Jung-Hoon; Dufau, Maria L.			Coactivator Function of Positive Cofactor 4 ( PC4) in Sp1-directed Luteinizing Hormone Receptor (LHR) Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE 1; SP1 SITES; REGULATE TRANSCRIPTION; PROLACTIN RECEPTOR; P53 FUNCTION; DNA-BINDING; PROMOTER; ACTIVATION; PROTEIN; EXPRESSION	The LHR has an essential role in sexual development and reproductive function, and its transcription is subjected to several modes of regulation. In this study, we investigated PC4 coactivator function in the control of LHR transcription. Knockdown of PC4 by siRNA inhibited the LHR basal promoter activity and trichostatin A (TSA)-induced gene transcriptional activation and expression in MCF-7 cells. While overexpression of PC4 alone had no effect on the LHR gene, it significantly enhanced Sp1-but not Sp3-mediated LHR transcriptional activity. PC4 directly interacts with Sp1 at the LHR promoter, and this interaction is negatively regulated by PC4 phosphorylation. The coactivator domain (22-91 aa) of PC4 and DNA binding domain of Sp1 are essential for PC4/Sp1 interaction. ChIP assay revealed significant occupancy of PC4 at the LHR promoter that increased upon TSA treatment. Disruption of PC4 expression significantly reduced TSA-induced recruitment of TFIIB and RNAP II, at the promoter. PC4 functions are beyond TSA-induced phosphatase release, PI3K-mediated Sp1 phosphorylation, and HDAC1/2/mSin3A co-repressor release indicating its role as linker coactivator of Sp1 and the transcriptional machinery. These findings demonstrated a critical aspect of LHR modulation whereby PC4 acts as a coactivator of Sp1 to contribute to the human of LHR transcription.	[Liao, Mingjuan; Zhang, Ying; Kang, Jung-Hoon; Dufau, Maria L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Endocrinol Sect, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dufau, ML (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Endocrinol Sect, Program Dev Endocrinol & Genet, NIH, Bldg 49,Rm 6A-36, Bethesda, MD 20892 USA.	dufaum@mail.nih.gov			National Institutes of Health through the Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER	National Institutes of Health through the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program through the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Banerjee S, 2004, MOL CELL BIOL, V24, P2052, DOI 10.1128/MCB.24.5.2052-2062.2004; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Conesa C, 2010, RNA BIOL, V7, P287, DOI 10.4161/rna.7.3.11491; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; DUFAU ML, 2007, CONT ENDOCRINOLOGY, P227; GE H, 1994, P NATL ACAD SCI USA, V91, P12691, DOI 10.1073/pnas.91.26.12691; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Geng Y, 1999, BIOCHEM BIOPH RES CO, V263, P366, DOI 10.1006/bbrc.1999.1374; Haile DT, 1999, J BIOL CHEM, V274, P2113, DOI 10.1074/jbc.274.4.2113; Holloway AF, 2000, J BIOL CHEM, V275, P21668, DOI 10.1074/jbc.M909058199; Hu ZZ, 1998, J BIOL CHEM, V273, P26225, DOI 10.1074/jbc.273.40.26225; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Kadam S, 2000, GENE DEV, V14, P2441, DOI 10.1101/gad.828000; KAISER K, 1995, EMBO J, V14, P3520, DOI 10.1002/j.1460-2075.1995.tb07358.x; Kannan F, 1999, MOL CELL BIOL, V19, P899; Kim SN, 2009, MOL CANCER RES, V7, P735, DOI 10.1158/1541-7786.MCR-08-0296; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Kumar BRP, 2001, J BIOL CHEM, V276, P16804, DOI 10.1074/jbc.M100934200; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Liao MJ, 2008, MOL ENDOCRINOL, V22, P1449, DOI 10.1210/me.2008-0035; Luo Y, 1998, MOL CELL BIOL, V18, P3803, DOI 10.1128/MCB.18.7.3803; Rosonina E, 2009, MOL CELL BIOL, V29, P2308, DOI 10.1128/MCB.01841-08; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Tsai-Morris CH, 1998, J CLIN ENDOCR METAB, V83, P288, DOI 10.1210/jc.83.1.288; TSAIMORRIS CH, 1994, J BIOL CHEM, V269, P15868; TSAIMORRIS CH, 1993, J BIOL CHEM, V268, P4447; UJHAZY P, 1994, INT J CANCER, V59, P83, DOI 10.1002/ijc.2910590117; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Zhang Y, 2005, MOL CELL BIOL, V25, P7929, DOI 10.1128/MCB.25.18.7929-7939.2005; Zhang Y, 2003, MOL CELL BIOL, V23, P6958, DOI 10.1128/MCB.23.19.6958-6972.2003; Zhang Y, 2002, J BIOL CHEM, V277, P33431, DOI 10.1074/jbc.M204417200; Zhang Y, 2000, J BIOL CHEM, V275, P2763, DOI 10.1074/jbc.275.4.2763; Zhang Y, 2001, MOL ENDOCRINOL, V15, P1891, DOI 10.1210/me.15.11.1891; Zhang Y, 2008, J BIOL CHEM, V283, P24039, DOI 10.1074/jbc.M801878200; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06; Zhong L, 2003, GENE, V320, P155, DOI 10.1016/S0378-1119(03)00823-0	42	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7681	7691		10.1074/jbc.M110.188532	http://dx.doi.org/10.1074/jbc.M110.188532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193408	Green Published, hybrid			2022-12-25	WOS:000287737300081
J	Annamalai, L; Westmoreland, SV; Domingues, HG; Walsh, DG; Gonzalez, G; O'Neil, SP				Annamalai, Lakshmanan; Westmoreland, Susan V.; Domingues, Heber G.; Walsh, Dennis G.; Gonzalez, Gilberto; O'Neil, Shawn P.			Myocarditis in CD8-Depleted SIV-Infected Rhesus Macaques after Short-Term Dual Therapy with Nucleoside and Nucleotide Reverse Transcriptase Inhibitors	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CORONARY-HEART-DISEASE; TUMOR-NECROSIS-FACTOR; ACTIVE ANTIRETROVIRAL THERAPY; LEFT-VENTRICULAR DYSFUNCTION; HIV-INFECTION; DILATED CARDIOMYOPATHY; PROTEASE INHIBITORS; CARDIOVASCULAR-DISEASE; CYTOKINE PRODUCTION	Background: Although highly active antiretroviral therapy (HAART) has dramatically reduced the morbidity and mortality associated with HIV infection, a number of antiretroviral toxicities have been described, including myocardial toxicity resulting from the use of nucleotide and nucleoside reverse transcriptase inhibitors (NRTIs). Current treatment guidelines recommend the use of HAART regimens containing two NRTIs for initial therapy of HIV-1 positive individuals; however, potential cardiotoxicity resulting from treatment with multiple NRTIs has not been addressed. Methodology/Principal Findings: We examined myocardial tissue from twelve CD8 lymphocyte-depleted adult rhesus macaques, including eight animals infected with simian immunodeficiency virus, four of which received combined antiretroviral therapy (CART) consisting of two NRTIs [(9-R-2-Phosphonomethoxypropyl Adenine) (PMPA) and (+/-)-beta-2',3'- dideoxy-5-fluoro-3'-thiacytidine (RCV)] for 28 days. Multifocal infiltrates of mononuclear inflammatory cells were present in the myocardium of all macaques that received CART, but not untreated SIV-positive animals or SIV-negative controls. Macrophages were the predominant inflammatory cells within lesions, as shown by immunoreactivity for the macrophage markers Iba1 and CD68. Heart specimens from monkeys that received CART had significantly lower virus burdens than untreated animals (p, 0.05), but significantly greater quantities of TNF-alpha mRNA than either SIV-positive untreated animals or uninfected controls (p, 0.05). Interferon-gamma (IFN-gamma), IL-1 beta and CXCL11 mRNA were upregulated in heart tissue from SIV-positive monkeys, independent of antiretroviral treatment, but CXCL9 mRNA was only upregulated in heart tissue from macaques that received CART. Conclusions/Significance: These results suggest that short-term treatment with multiple NRTIs may be associated with myocarditis, and demonstrate that the CD8-depleted SIV-positive rhesus monkey is a useful model for studying the cardiotoxic effects of combined antiretroviral therapy in the setting of immunodeficiency virus infection.	[Annamalai, Lakshmanan; Westmoreland, Susan V.; Domingues, Heber G.; Walsh, Dennis G.; O'Neil, Shawn P.] Harvard Univ, Sch Med, Div Comparat Pathol, New England Primate Res Ctr, Southborough, MA 01772 USA; [Gonzalez, Gilberto] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA	Harvard University; Harvard University; Massachusetts General Hospital	Annamalai, L (corresponding author), Oregon Natl Primate Res Ctr, Dept Anim Resources, Beaverton, OR USA.	susan_westmoreland@hms.harvard.edu			NIH NINDS; NIH, NCRR [RR000150, NS048831, NS05004]; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048831] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by grants from NIH NINDS and NCRR, including RR000150 (SPO), NS048831 (SPO) and NS05004 (RGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DW, 1988, J AM COLL CARDIOL, V11, P792, DOI 10.1016/0735-1097(88)90213-6; Barile M, 1998, GEN PHARMACOL, V31, P531, DOI 10.1016/S0306-3623(98)00041-X; BAROLDI G, 1988, J AM COLL CARDIOL, V12, P463, DOI 10.1016/0735-1097(88)90420-2; Bilate AMB, 2007, MICROBES INFECT, V9, P1104, DOI 10.1016/j.micinf.2007.05.014; Bolger AP, 2002, AM J CARDIOL, V90, P384, DOI 10.1016/S0002-9149(02)02494-3; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Calabrese F, 2004, MODERN PATHOL, V17, P1108, DOI 10.1038/modpathol.3800158; Clumeck N, 2000, BIOMED PHARMACOTHER, V54, P7, DOI 10.1016/S0753-3322(00)88634-5; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Fantoni M, 2001, ANN NY ACAD SCI, V946, P179, DOI 10.1111/j.1749-6632.2001.tb03912.x; Fiala Milan, 2004, Cardiovasc Toxicol, V4, P97, DOI 10.1385/CT:4:2:097; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GRODY WW, 1990, AM J CARDIOL, V66, P203, DOI 10.1016/0002-9149(90)90589-S; Habib FM, 1996, LANCET, V347, P1151, DOI 10.1016/S0140-6736(96)90610-8; HERSKOWITZ A, 1994, J AM COLL CARDIOL, V24, P1025, DOI 10.1016/0735-1097(94)90865-6; HERSKOWITZ A, 1992, ANN INTERN MED, V116, P311, DOI 10.7326/0003-4819-116-4-311; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; Klatt EC, 2003, ADV CARDIOL, V40, P23; Klein D, 2002, J ACQ IMMUN DEF SYND, V30, P471, DOI 10.1097/00126334-200208150-00002; LEWIS W, 1991, LAB INVEST, V65, P228; LEWIS W, 1994, CIRC RES, V74, P344, DOI 10.1161/01.RES.74.2.344; Loos T, 2006, LAB INVEST, V86, P902, DOI 10.1038/labinvest.3700453; Mallat Z, 2004, FASEB J, V18, P1752, DOI 10.1096/fj.04-2426fje; Mari D, 2002, CLIN REV ALLERG IMMU, V23, P325, DOI 10.1385/CRIAI:23:3:325; MATSUMORI A, 1994, CIRCULATION, V89, P955, DOI 10.1161/01.CIR.89.3.955; Meng QY, 2002, J ACQ IMMUN DEF SYND, V30, P306, DOI [10.1097/00126334-200207010-00006, 10.1097/01.QAI.0000017995.56638.F8]; Miller MD, 2001, NUCLEOS NUCLEOT NUCL, V20, P1025, DOI 10.1081/NCN-100002483; Mondal Debasis, 2004, Cardiovasc Toxicol, V4, P287, DOI 10.1385/CT:4:3:287; Monsuez JJ, 2007, INT J CARDIOL, V120, P150, DOI 10.1016/j.ijcard.2006.11.143; Mu H, 2007, WORLD J SURG, V31, P632, DOI 10.1007/s00268-006-0730-0; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; O'Neil SP, 2004, AM J PATHOL, V164, P1157, DOI 10.1016/S0002-9440(10)63204-X; Pugliese A, 2000, J INFECTION, V40, P282, DOI 10.1053/jinf.2000.0672; Reifenberg K, 2007, AM J PATHOL, V171, P463, DOI 10.2353/ajpath.2007.060906; REILLY JM, 1988, AM J CARDIOL, V62, P789, DOI 10.1016/0002-9149(88)91223-4; Ren ZG, 2002, LAB INVEST, V82, P245, DOI 10.1038/labinvest.3780418; Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673; Rogers JS, 2008, MAYO CLIN PROC, V83, P1275, DOI 10.4065/83.11.1275; Sani MU, 2008, WIEN KLIN WOCHENSCHR, V120, P77, DOI 10.1007/s00508-008-0935-3; Shannon RP, 2000, CIRCULATION, V101, P185, DOI 10.1161/01.CIR.101.2.185; Sklar P, 2003, NEW ENGL J MED, V349, P2065, DOI 10.1056/NEJMe038158; Srinivas RV, 1998, ANTIMICROB AGENTS CH, V42, P1484, DOI 10.1128/AAC.42.6.1484; Starc TJ, 2002, J PEDIATR-US, V141, P327, DOI 10.1067/mpd.2002.126301; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Vittecoq D, 2003, ADV CARDIOL, V40, P151; Wang MJ, 2006, CIRCULATION, V114, pI282, DOI 10.1161/CIRCULATIONAHA.105.001164; Westphal E, 2008, MOL MED, V14, P55, DOI 10.2119/2007-00058.Westphal; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; Woldbaek PR, 2003, CARDIOVASC RES, V59, P122, DOI 10.1016/S0008-6363(03)00339-0; Yearley JH, 2008, AIDS, V22, P585, DOI 10.1097/QAD.0b013e3282f57f61; Yearley JH, 2006, AIDS RES HUM RETROV, V22, P529, DOI 10.1089/aid.2006.22.529; Yearley JH, 2009, LAB INVEST, V89, P657, DOI 10.1038/labinvest.2009.29; Zareba Karolina M., 2003, Curr Infect Dis Rep, V5, P513, DOI 10.1007/s11908-003-0096-5	57	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14429	10.1371/journal.pone.0014429	http://dx.doi.org/10.1371/journal.pone.0014429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203448	Green Published, gold, Green Submitted			2022-12-25	WOS:000285579200010
J	Grant, MKO; Noetzel, MJ; De Lorme, KC; Jakubik, J; Dolezal, V; El-Fakahany, EE				Grant, Marianne K. O.; Noetzel, Meredith J.; De Lorme, Kayla C.; Jakubik, Jan; Dolezal, Vladimir; El-Fakahany, Esam E.			Pharmacological Evaluation of the Long-Term Effects of Xanomeline on the M-1 Muscarinic Acetylcholine Receptor	PLOS ONE			English	Article							AGONIST; PROTEIN; BINDING; DESENSITIZATION; SELECTIVITY; SUBTYPES; ACTIVATION; MECHANISMS; CELLS; M1	Xanomeline is a unique agonist of muscarinic receptors that possesses functional selectivity at the M-1 and M-4 receptor subtypes. It also exhibits wash-resistant binding to and activation of the receptor. In the present work we investigated the consequences of this type of binding of xanomeline on the binding characteristics and function of the M-1 muscarinic receptor. Pretreatment of CHO cells that stably express the M-1 receptor for 1 hr with increasing concentrations of xanomeline followed by washing and waiting for an additional 23 hr in control culture media transformed xanomeline-induced inhibition of [H-3] NMS binding from monophasic to biphasic. The high-affinity xanomeline binding site exhibited three orders of magnitude higher affinity than in the case of xanomeline added directly to the binding assay medium containing control cells. These effects were associated with a marked decrease in maximal radioligand binding and attenuation of agonist-induced increase in PI hydrolysis and were qualitatively similar to those caused by continuous incubation of cells with xanomeline for 24 hr. Attenuation of agonist-induced PI hydrolysis by persistently-bound xanomeline developed with a time course that parallels the return of receptor activation by prebound xanomeline towards basal levels. Additional data indicated that blockade of the receptor orthosteric site or the use of a non-functional receptor mutant reversed the long-term effects of xanomeline, but not its persistent binding at an allosteric site. Furthermore, the long-term effects of xanomeline on the receptor are mainly due to receptor down-regulation rather than internalization.	[Grant, Marianne K. O.; Noetzel, Meredith J.; De Lorme, Kayla C.; El-Fakahany, Esam E.] Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA; [El-Fakahany, Esam E.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [El-Fakahany, Esam E.] Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA; [Jakubik, Jan; Dolezal, Vladimir] Acad Sci Czech Republic, Inst Physiol, Dept Neurochem, Prague, Czech Republic	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Grant, MKO (corresponding author), Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA.	jakubik@biomed.cas.cz	Grant, Marianne/AAL-1396-2020; Dolezal, Vladimir/A-8732-2008; Jakubik, Jan/B-7461-2012	Dolezal, Vladimir/0000-0003-3412-256X; Jakubik, Jan/0000-0002-1737-1487; Grant, Marianne/0000-0002-2963-4686	National Institutes of Health [RO1-NS25743, T32DE007288]; Grant Agency of the Czech Republic [GACR 305/09/0681]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants RO1-NS25743 (EEE-F) and T32DE007288 (MJN) and by Grant Agency of the Czech Republic grant GACR 305/09/0681 (JJ and VD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bymaster FP, 1997, DRUG DEVELOP RES, V40, P158, DOI 10.1002/(SICI)1098-2299(199702)40:2<158::AID-DDR6>3.0.CO;2-K; Bymaster FP, 1998, BRAIN RES, V795, P179, DOI 10.1016/S0006-8993(98)00267-4; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; Christopoulos A, 1998, MOL PHARMACOL, V53, P1120; Christopoulos A, 1997, EUR J PHARMACOL, V334, pR3, DOI 10.1016/S0014-2999(97)01162-X; Christopoulos A, 1999, J PHARMACOL EXP THER, V289, P1220; Davis Christopher N., 2009, BMC Pharmacology, V9, P14, DOI 10.1186/1471-2210-9-14; De Lorme KC, 2007, J PHARMACOL EXP THER, V323, P868, DOI 10.1124/jpet.107.129940; De Lorme KC, 2006, NEUROSCI LETT, V410, P11, DOI 10.1016/j.neulet.2006.09.062; EHLERT FJ, 1985, MOL PHARMACOL, V28, P410; ELFAKAHANY EE, 1990, MEMBRANE BIOCHEM, V9, P9, DOI 10.3109/09687689009026820; FEIGENBAUM P, 1985, J PHARMACOL EXP THER, V233, P134; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ford DJ, 2002, J PHARMACOL EXP THER, V300, P810, DOI 10.1124/jpet.300.3.810; HU JR, 1991, J PHARMACOL EXP THER, V257, P938; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Jakubik J, 2004, J PHARMACOL EXP THER, V308, P105, DOI 10.1124/jpet.103.058594; Jakubik J, 2002, J PHARMACOL EXP THER, V301, P1033, DOI 10.1124/jpet.301.3.1033; Jakubik J, 2006, MOL PHARMACOL, V70, P656, DOI 10.1124/mol.106.023762; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; SHANNON HE, 1994, J PHARMACOL EXP THER, V269, P271; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Spalding TA, 1995, J PHARMACOL EXP THER, V275, P1274; WANG SZ, 1993, J PHARMACOL EXP THER, V266, P237; WESS J, 1993, LIFE SCI, V53, P1447, DOI 10.1016/0024-3205(93)90618-D; Wood MD, 1999, BRIT J PHARMACOL, V126, P1620, DOI 10.1038/sj.bjp.0702463; ZHU SZ, 1994, MOL PHARMACOL, V45, P517	30	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15722	10.1371/journal.pone.0015722	http://dx.doi.org/10.1371/journal.pone.0015722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203415	Green Published, gold, Green Submitted			2022-12-25	WOS:000285579200032
J	Lenoir, J; Gegout, JC; Guisan, A; Vittoz, P; Wohlgemuth, T; Zimmermann, NE; Dullinger, S; Pauli, H; Willner, W; Grytnes, JA; Virtanen, R; Svenning, JC				Lenoir, Jonathan; Gegout, Jean-Claude; Guisan, Antoine; Vittoz, Pascal; Wohlgemuth, Thomas; Zimmermann, Niklaus E.; Dullinger, Stefan; Pauli, Harald; Willner, Wolfgang; Grytnes, John-Arvid; Virtanen, Risto; Svenning, Jens-Christian			Cross-Scale Analysis of the Region Effect on Vascular Plant Species Diversity in Southern and Northern European Mountain Ranges	PLOS ONE			English	Article							DECIDUOUS FORESTS; BETA-DIVERSITY; INDICATOR VALUES; GLOBAL PATTERNS; DISTANCE DECAY; CLIMATE-CHANGE; RICHNESS; HISTORY; VEGETATION; ECOLOGY	Background: The divergent glacial histories of southern and northern Europe affect present-day species diversity at coarse-grained scales in these two regions, but do these effects also penetrate to the more fine-grained scales of local communities? Methodology/Principal Findings: We carried out a cross-scale analysis to address this question for vascular plants in two mountain regions, the Alps in southern Europe and the Scandes in northern Europe, using environmentally paired vegetation plots in the two regions (n = 403 in each region) to quantify four diversity components: (i) total number of species occurring in a region (total gamma-diversity), (ii) number of species that could occur in a target plot after environmental filtering (habitat-specific gamma-diversity), (iii) pair-wise species compositional turnover between plots (plot-to-plot beta-diversity) and (iv) number of species present per plot (plot alpha-diversity). We found strong region effects on total gamma-diversity, habitat-specific gamma-diversity and plot-to-plot beta-diversity, with a greater diversity in the Alps even towards distances smaller than 50 m between plots. In contrast, there was a slightly greater plot alpha-diversity in the Scandes, but with a tendency towards contrasting region effects on high and low soil-acidity plots. Conclusions/Significance: We conclude that there are strong regional differences between coarse-grained (landscape-to regional-scale) diversity components of the flora in the Alps and the Scandes mountain ranges, but that these differences do not necessarily penetrate to the finest-grained (plot-scale) diversity component, at least not on acidic soils. Our findings are consistent with the contrasting regional Quaternary histories, but we also consider alternative explanatory models. Notably, ecological sorting and habitat connectivity may play a role in the unexpected limited or reversed region effect on plot alpha-diversity, and may also affect the larger-scale diversity components. For instance, plot connectivity and/or selection for high dispersal ability may increase plot alpha-diversity and compensate for low total gamma-diversity.	[Lenoir, Jonathan; Svenning, Jens-Christian] Aarhus Univ, Dept Biol Sci, Ecoinformat & Biodivers Grp, Aarhus, Denmark; [Gegout, Jean-Claude] AgroParisTech, INRA, LERFoB, Unite Mixte Rech 1092, Nancy, France; [Gegout, Jean-Claude] Pontificia Univ Catolica Chile, Dept Ecol, CASEB, Santiago, Chile; [Guisan, Antoine; Vittoz, Pascal] Univ Lausanne, Fac Biol & Med, Dept Ecol & Evolut, Lausanne, Switzerland; [Vittoz, Pascal] Univ Lausanne, Fac Geosci & Environm, Lausanne, Switzerland; [Wohlgemuth, Thomas; Zimmermann, Niklaus E.] Swiss Fed Res Inst Forest Snow & Landscape Res WS, Birmensdorf, Switzerland; [Dullinger, Stefan; Willner, Wolfgang] Vienna Inst Nat Conservat & Analyses, Vienna, Austria; [Pauli, Harald] Univ Vienna, Dept Conservat Biol Vegetat & Landscape Ecol, Fac Ctr Biodivers, Austrian Acad Sci,Inst Mt Res Man & Environm IGF, Vienna, Austria; [Grytnes, John-Arvid] Univ Bergen, Dept Biol, Bergen, Norway; [Virtanen, Risto] Univ Oulu, Dept Biol, Oulu, Finland	Aarhus University; AgroParisTech; INRAE; Pontificia Universidad Catolica de Chile; University of Lausanne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Austrian Academy of Sciences; University of Vienna; University of Bergen; University of Oulu	Lenoir, J (corresponding author), Aarhus Univ, Dept Biol Sci, Ecoinformat & Biodivers Grp, Aarhus, Denmark.	lenoir.john@gmail.com	Lenoir, Jonathan/AAE-8441-2019; Willner, Wolfgang/AAA-4822-2019; Guisan, Antoine/A-1057-2011; Zimmermann, Niklaus E./A-4276-2008; Svenning, Jens-Christian/C-8977-2012; Grytnes, John-Arvid/L-6357-2013; Wohlgemuth, Thomas/E-6588-2016; Virtanen, Risto/G-1810-2010	Lenoir, Jonathan/0000-0003-0638-9582; Willner, Wolfgang/0000-0003-1591-8386; Guisan, Antoine/0000-0002-3998-4815; Zimmermann, Niklaus E./0000-0003-3099-9604; Svenning, Jens-Christian/0000-0002-3415-0862; Wohlgemuth, Thomas/0000-0002-4623-0894; Virtanen, Risto/0000-0002-8295-8217; Dullinger, Stefan/0000-0003-3919-0887; Pauli, Harald/0000-0002-9842-9934; Vittoz, Pascal/0000-0003-4218-4517; Gegout, Jean-Claude/0000-0002-5760-9920; Grytnes, John-Arvid/0000-0002-6365-9676	Danish Natural Science Research Council [272-07-0242]; European Commission [GOCE-CT-036866 ECOCHANGE]	Danish Natural Science Research Council(Danish Natural Science Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors gratefully acknowledge grants from the Danish Natural Science Research Council (grant #272-07-0242 to J-C.S.) and from the European Commission (grant #GOCE-CT-036866 ECOCHANGE to S. D., A. G., P. V., and N.E.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez N, 2009, ECOL LETT, V12, P632, DOI 10.1111/j.1461-0248.2009.01312.x; [Anonymous], 2001, PLANT STRATEGIES VEG; [Anonymous], 2003, ALPINE PLANT LIFE, DOI DOI 10.1007/978-3-642-18970-8; Baselga A, 2008, ECOGRAPHY, V31, P263, DOI 10.1111/j.0906-7590.2008.5335.x; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Bivand R., 2009, SPDEP SPATIAL DEPEND; BRISSE H, 1995, ANN BOT ROMA, V53, P177; Brochmann C, 2003, TAXON, V52, P417, DOI 10.2307/3647444; Brunet J, 1997, J VEG SCI, V8, P329, DOI 10.2307/3237321; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; De Caceres M, 2008, OECOLOGIA, V156, P657, DOI 10.1007/s00442-008-1017-y; DIEKMANN M, 1995, ECOGRAPHY, V18, P178, DOI 10.1111/j.1600-0587.1995.tb00339.x; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; Diekmann M, 1997, J VEG SCI, V8, P855, DOI 10.2307/3237030; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Dupre C, 1998, APPL VEG SCI, V1, DOI 10.2307/1479092; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P1, DOI DOI 10.15468/TPNGMA; European C., 2005, SOIL ATLAS EUROPE; Ewald J, 2003, FOLIA GEOBOT, V38, P357, DOI 10.1007/BF02803244; Ewald J, 2002, J VEG SCI, V13, P191, DOI 10.1111/j.1654-1103.2002.tb02039.x; Gegout JC, 2005, J VEG SCI, V16, P257, DOI 10.1111/j.1654-1103.2005.tb02363.x; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; GRUBB PJ, 1987, ORG COMMUNITIES PAST, P99; Grytnes JA, 2003, ECOGRAPHY, V26, P291, DOI 10.1034/j.1600-0587.2003.03358.x; Grytnes JA, 2003, PLANT ECOL, V169, P273, DOI 10.1023/A:1026099705238; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hennekens SM, 2001, J VEG SCI, V12, P589, DOI 10.2307/3237010; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Huntley B., 1983, ATLAS PRESENT POLLEN; IVERSEN J, 1958, SYSTEMATICS TODAY, P210; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Koerner W, 1997, J ECOL, V85, P351, DOI 10.2307/2960507; LATHAM RE, 1993, OIKOS, V67, P325, DOI 10.2307/3545479; Leathwick JR, 1998, ECOGRAPHY, V21, P235, DOI 10.1111/j.1600-0587.1998.tb00561.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Normand S, 2006, PLANT ECOL, V186, P161, DOI 10.1007/s11258-006-9120-9; Partel M, 2002, ECOLOGY, V83, P2361, DOI 10.1890/0012-9658(2002)083[2361:LPDPAE]2.0.CO;2; Partel M, 1996, OIKOS, V75, P111, DOI 10.2307/3546327; PAULI H, 1993, UNTERSUCHUNGEN PHYTO; PELLISSIER L, 2010, PLANT ECOL, DOI DOI 10.1007/S11258-11010-19794-X; Pennisi E, 2005, SCIENCE, V309, P90, DOI 10.1126/science.309.5731.90; Qian H, 1999, AM NAT, V154, P160, DOI 10.1086/303230; Qian H, 2008, J BIOGEOGR, V35, P1362, DOI 10.1111/j.1365-2699.2008.01901.x; Qian H, 2007, ECOGRAPHY, V30, P471, DOI 10.1111/j.0906-7590.2007.05025.x; Qian H, 2007, ECOLOGY, V88, P1440, DOI 10.1890/06-0916; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; *R DEV COR TEAM I, 2009, R LANG ENV STAT COMP; Ricklefs RE, 2004, ECOGRAPHY, V27, P129; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Stehlik I, 2002, MOL ECOL, V11, P2027, DOI 10.1046/j.1365-294X.2002.01595.x; Steiner A, 2002, GEOBOT HELVETICA, V74, P1; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Svenning JC, 2009, ECOGRAPHY, V32, P13, DOI 10.1111/j.1600-0587.2008.05732.x; THIMONIER A, 1992, FOREST ECOL MANAG, V55, P149, DOI 10.1016/0378-1127(92)90098-T; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Turner JRG, 2004, BASIC APPL ECOL, V5, P435, DOI 10.1016/j.baae.2004.08.004; Tutin T.G., 2001, FLORA EUROPAEA; Tyler G, 2003, FOLIA GEOBOT, V38, P419, DOI 10.1007/BF02803249; Vare H., 2003, ECOL STU AN, P133, DOI 10.1007/978-3-642-18967-8_5; VIRTANEN R, 1997, ACTA PHYTOGEOGR SUEC, V82, P1; Vittoz P, 2005, BOT HELV, V115, P33, DOI 10.1007/s00035-005-0707-x; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; WILLNER W, 2009, AUSTRIAN VEGETATION; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	76	40	43	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15734	10.1371/journal.pone.0015734	http://dx.doi.org/10.1371/journal.pone.0015734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203521	Green Published, gold			2022-12-25	WOS:000285578000050
J	Patel, VB; Singh, R; Connolly, C; Kasprowicz, V; Zumla, A; Ndungu, T; Dheda, K				Patel, Vinod B.; Singh, Ravesh; Connolly, Cathy; Kasprowicz, Victoria; Zumla, Allimudin; Ndungu, Thumbi; Dheda, Keertan			Comparison of a Clinical Prediction Rule and a LAM Antigen-Detection Assay for the Rapid Diagnosis of TBM in a High HIV Prevalence Setting	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; ACUTE BACTERIAL-MENINGITIS; TUBERCULOUS MENINGITIS; EXTRAPULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; URINARY LIPOARABINOMANNAN; MEDICAL-CENTER; ADULTS; INFECTION	Background/Objective: The diagnosis of tuberculous meningitis (TBM) in resource poor TB endemic environments is challenging. The accuracy of current tools for the rapid diagnosis of TBM is suboptimal. We sought to develop a clinical-prediction rule for the diagnosis of TBM in a high HIV prevalence setting, and to compare performance outcomes to conventional diagnostic modalities and a novel lipoarabinomannan (LAM) antigen detection test (Clearview-TB (R)) using cerebrospinal fluid (CSF). Methods: Patients with suspected TBM were classified as definite-TBM(CSF culture or PCR positive), probable-TBM and non-TBM. Results: Of the 150 patients, 84% were HIV-infected (median [IQR] CD4 count = 132 [54; 241] cells/mu l). There were 39, 55 and 54 patients in the definite, probable and non-TBM groups, respectively. The LAM sensitivity and specificity (95% CI) was 31% (17; 48) and 94% (85; 99), respectively (cut-point >= 0.18). By contrast, smear-microscopy was 100% specific but detected none of the definite-TBM cases. LAM positivity was associated with HIV co-infection and low CD4 T cell count (CD4<200 vs.>200 cells/mu l; p = 0.03). The sensitivity and specificity in those with a CD4<100 cells/mu l was 50% (27; 73) and 95% (74; 99), respectively. A clinical-prediction rule >= 6 derived from multivariate analysis had a sensitivity and specificity (95% CI) of 47% (31; 64) and 98% (90; 100), respectively. When LAM was combined with the clinical-prediction-rule, the sensitivity increased significantly (p<0.001) to 63% (47; 68) and specificity remained high at 93% (82; 98). Conclusions: Despite its modest sensitivity the LAM ELISA is an accurate rapid rule-in test for TBM that has incremental value over smear-microscopy. The rule-in value of LAM can be further increased by combination with a clinical-prediction rule, thus enhancing the rapid diagnosis of TBM in HIV-infected persons with advanced immunosuppression.	[Patel, Vinod B.] Univ KwaZulu Natal, Dept Neurol, Berea, South Africa; [Singh, Ravesh; Kasprowicz, Victoria; Ndungu, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Berea, South Africa; [Connolly, Cathy] MRC, Biostat Unit, Durban, South Africa; [Zumla, Allimudin; Dheda, Keertan] UCL, Ctr Infect Dis & Int Hlth, Dept Infect, London, England; [Dheda, Keertan] Univ Cape Town, Lung Infect & Immun Unit, Div Pulmonol, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Lung Inst, Dept Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; University of London; University College London; University of Cape Town; University of Cape Town; University of Cape Town	Patel, VB (corresponding author), Univ KwaZulu Natal, Dept Neurol, Berea, South Africa.	keertan.dheda@uct.ac.za		Ndung'u, Thumbi/0000-0003-2962-3992; Zumla, Professor Sir Alimuddin/0000-0002-5111-5735	Fogarty International Center, National Institutes of Health [D43TW00231]; South African Medical Research Council; European Union; South African National Research Foundation Research Chairs Initiative; SA MRC Career Development Award; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER	Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); South African National Research Foundation Research Chairs Initiative; SA MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Columbia University-Southern African Fogarty AIDS International Training and Research Program funded by the Fogarty International Center, National Institutes of Health (grant # D43TW00231; VP), a South African Medical Research Council (SA MRC) grant (VP and KD), the European Union Seventh Framework Programme (TBsusgent; VP and KD), the South African National Research Foundation Research Chairs Initiative (SARChI; TN and KD), a SA MRC Career Development Award (KD), and the European and Developing Countries Clinical Trials Partnership (TESA and TB-NEAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENGUER J, 1992, NEW ENGL J MED, V326, P668, DOI 10.1056/NEJM199203053261004; Bhigjee AI, 2007, INT J INFECT DIS, V11, P348, DOI 10.1016/j.ijid.2006.07.007; BRAUNWALD E, 2001, HARRISONSS PRINCIPLE, P1028; CDC, 2005, EXTR TUB CAS PERC SI; Chan ED, 2000, AM J RESP CRIT CARE, V161, P1713, DOI 10.1164/ajrccm.161.5.9908125; CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; DUBE MP, 1992, AM J MED, V93, P520, DOI 10.1016/0002-9343(92)90579-Z; Garcia-Monco JC, 1999, NEUROL CLIN, V17, P737, DOI 10.1016/S0733-8619(05)70164-X; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Hamasur B, 2001, J MICROBIOL METH, V45, P41, DOI 10.1016/S0167-7012(01)00239-1; JEREN T, 1982, ACTA CYTOL, V26, P678; Karstaedt AS, 1998, QJM-INT J MED, V91, P743, DOI 10.1093/qjmed/91.11.743; KASHYAP RS, 2009, INFECTION; KENNEDY DH, 1979, JAMA-J AM MED ASSOC, V241, P264, DOI 10.1001/jama.241.3.264; KILPATRICK ME, 1986, J HYG-CAMBRIDGE, V96, P231, DOI 10.1017/S0022172400066006; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lipovsky MM, 2000, J NEUROIMMUNOL, V111, P10, DOI 10.1016/S0165-5728(00)00354-4; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; Moghtaderi A, 2009, SCAND J INFECT DIS, V41, P188, DOI 10.1080/00365540902721384; Mutetwa R, 2009, INT J TUBERC LUNG D, V13, P1253; OGAWA SK, 1987, MEDICINE, V66, P317, DOI 10.1097/00005792-198707000-00004; Ozbay B, 2002, CLIN CHEST MED, V23, P351, DOI 10.1016/S0272-5231(02)00002-3; Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2; PATEL VB, AM J RESP CRIT CARE; Patel VB, 2010, AM J RESP CRIT CARE, V182, P569, DOI 10.1164/rccm.200912-1931OC; Patel VB, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-13; Patil SA, 1996, CLIN IMMUNOL IMMUNOP, V81, P35, DOI 10.1006/clin.1996.0154; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Phypers M, 2006, INT J TUBERC LUNG D, V10, P99; Porkert MT, 1997, AM J MED SCI, V313, P325, DOI 10.1097/00000441-199706000-00002; Quan C, 2006, J CLIN MICROBIOL, V44, P3160, DOI 10.1128/JCM.00333-06; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Simmons CP, 2006, J IMMUNOL, V176, P2007, DOI 10.4049/jimmunol.176.3.2007; Steingart KR, 2007, THORAX, V62, P911, DOI 10.1136/thx.2006.075754; STEWART SM, 1953, J CLIN PATHOL, V6, P241, DOI 10.1136/jcp.6.3.241; Sumi MG, 2002, CLIN DIAGN LAB IMMUN, V9, P344, DOI 10.1128/CDLI.9.2.344-347.2002; Sumi MG, 2000, ACTA NEUROL SCAND, V101, P61, DOI 10.1034/j.1600-0404.2000.00012.x; Tessema TA, 2001, SCAND J INFECT DIS, V33, P279, DOI 10.1080/003655401300077306; Thwaites G, 2000, J NEUROL NEUROSUR PS, V68, P289, DOI 10.1136/jnnp.68.3.289; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P378, DOI 10.1128/JCM.42.1.378-379.2004; Thwaites GE, 2002, LANCET, V360, P1287, DOI 10.1016/S0140-6736(02)11318-3; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; Verdon R, 1996, CLIN INFECT DIS, V22, P982, DOI 10.1093/clinids/22.6.982; Weinberg A, 2005, J INFECT DIS, V191, P234, DOI 10.1086/426402; World Health Organization, 2008, GLOB TUB CONTR SURV; Yechoor VK, 1996, ARCH INTERN MED, V156, P1710, DOI 10.1001/archinte.156.15.1710	51	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15664	10.1371/journal.pone.0015664	http://dx.doi.org/10.1371/journal.pone.0015664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203513	Green Published, gold, Green Submitted			2022-12-25	WOS:000285578000043
J	Chen, TJ; Wu, CC; Tang, MJ; Huang, JS; Su, FC				Chen, Ting-Jung; Wu, Chia-Ching; Tang, Ming-Jer; Huang, Jong-Shin; Su, Fong-Chin			Complexity of the Tensegrity Structure for Dynamic Energy and Force Distribution of Cytoskeleton during Cell Spreading	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; LIVING CELLS; ACTIN-FILAMENTS; MODEL; MICROTUBULES; MECHANICS; ARCHITECTURE; FIBROBLASTS; PRESTRESS; TRACTION	Cytoskeleton plays important roles in intracellular force equilibrium and extracellular force transmission from/to attaching substrate through focal adhesions (FAs). Numerical simulations of intracellular force distribution to describe dynamic cell behaviors are still limited. The tensegrity structure comprises tension-supporting cables and compression-supporting struts that represent the actin filament and microtubule respectively, and has many features consistent with living cells. To simulate the dynamics of intracellular force distribution and total stored energy during cell spreading, the present study employed different complexities of the tensegrity structures by using octahedron tensegrity (OT) and cuboctahedron tensegrity (COT). The spreading was simulated by assigning specific connection nodes for radial displacement and attachment to substrate to form FAs. The traction force on each FA was estimated by summarizing the force carried in sounding cytoskeletal elements. The OT structure consisted of 24 cables and 6 struts and had limitations soon after the beginning of spreading by declining energy stored in struts indicating the abolishment of compression in microtubules. The COT structure, double the amount of cables and struts than the OT structure, provided sufficient spreading area and expressed similar features with documented cell behaviors. The traction force pointed inward on peripheral FAs in the spread out COT structure. The complex structure in COT provided further investigation of various FA number during different spreading stages. Before the middle phase of spreading (half of maximum spreading area), cell attachment with 8 FAs obtained minimized cytoskeletal energy. The maximum number of 12 FAs in the COT structure was required to achieve further spreading. The stored energy in actin filaments increased as cells spread out, while the energy stored in microtubules increased at initial spreading, peaked in middle phase, and then declined as cells reached maximum spreading. The dynamic flows of energy in struts imply that microtubules contribute to structure stabilization.	[Chen, Ting-Jung; Su, Fong-Chin] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Wu, Chia-Ching] Natl Cheng Kung Univ, Dept Cell Biol & Anat, Tainan 70101, Taiwan; [Tang, Ming-Jer] Natl Cheng Kung Univ, Dept Physiol, Tainan 70101, Taiwan; [Huang, Jong-Shin] Natl Cheng Kung Univ, Dept Civil Engn, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Chen, TJ (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	joshccwu@mail.ncku.edu.tw; fcsu@mail.ncku.edu.tw	SU, FONG-CHIN/C-8094-2011	SU, FONG-CHIN/0000-0002-3870-4842; Tang, Ming-Jer/0000-0002-0883-4363	National Science Council, Taiwan [NSC97-2320-B-006-005, NSC97-2314-B-006-063, NSC98-2627-B-006-010]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The financial support of the National Science Council, Taiwan (NSC97- 2320-B-006-005, NSC97-2314-B-006-063, and NSC98-2627-B-006-010) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NSC website: http://web1.nsc.gov.tw/mp.aspx?mp = 7.	BOAL DH, 1997, PHYS CANADA      SEP, P228; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Canadas P, 2002, J THEOR BIOL, V218, P155, DOI 10.1006/jtbi.2002.3064; Canadas P, 2006, J BIOMECH ENG-T ASME, V128, P487, DOI 10.1115/1.2205867; Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2; Coughlin MF, 2003, BIOPHYS J, V84, P1328, DOI 10.1016/S0006-3495(03)74948-0; Coughlin MF, 1998, J BIOMECH ENG-T ASME, V120, P770, DOI 10.1115/1.2834892; Coughlin MF, 1997, J APPL MECH-T ASME, V64, P480, DOI 10.1115/1.2788918; Dupuis DE, 1997, J MUSCLE RES CELL M, V18, P17, DOI 10.1023/A:1018672631256; Gavara N, 2008, BIOPHYS J, V95, P464, DOI 10.1529/biophysj.107.124180; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; INGBER DE, 1994, INT REV CYTOL, V150, P173; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ingber DE, 2000, J APPL PHYSIOL, V89, P1663, DOI 10.1152/jappl.2000.89.4.1663; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Kenner H., 1976, GEODESIC MATH USE IT; KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962; Laurent VM, 2003, ANN BIOMED ENG, V31, P1263, DOI 10.1114/1.1616932; Luo YZ, 2008, J BIOMECH, V41, P2379, DOI 10.1016/j.jbiomech.2008.05.026; Maurin B, 2008, J BIOMECH, V41, P2036, DOI 10.1016/j.jbiomech.2008.03.011; McGarry J G, 2004, Eur Cell Mater, V7, P27; Munevar S, 2001, BIOPHYS J, V80, p276A; Nagayama K, 2008, AM J PHYSIOL-CELL PH, V295, pC1569, DOI 10.1152/ajpcell.00098.2008; Paul R, 2008, BIOPHYS J, V94, P1470, DOI 10.1529/biophysj.107.108688; Pugh A, 1976, INTRO TENSEGRITY; Roy S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061916; Satcher R, 1997, MICROCIRCULATION-LON, V4, P439, DOI 10.3109/10739689709146808; Stamenovic D, 2002, AM J PHYSIOL-CELL PH, V282, pC617, DOI 10.1152/ajpcell.00271.2001; Stamenovic D, 2000, J BIOMECH ENG-T ASME, V122, P39, DOI 10.1115/1.429631; Stamenovic D, 1999, J THEOR BIOL, V201, P63, DOI 10.1006/jtbi.1999.1014; Sultan C, 2004, ANN BIOMED ENG, V32, P520, DOI 10.1023/B:ABME.0000019171.26711.37; Thoumine O, 1999, EUR BIOPHYS J BIOPHY, V28, P222, DOI 10.1007/s002490050203; Tolic-Norrelykke IM, 2005, J BIOMECH, V38, P1405, DOI 10.1016/j.jbiomech.2004.06.027; Tuszynski JA, 2005, EUR PHYS J E, V17, P29, DOI 10.1140/epje/i2004-10102-5; Volokh KY, 2000, J BIOMECH, V33, P1543, DOI 10.1016/S0021-9290(00)00157-3; WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wendling Sylvie, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P45, DOI 10.1080/1025584021000059413; Wendling Sylvie, 2002, Comput Methods Biomech Biomed Engin, V5, P1, DOI 10.1080/10255840290032162	41	20	20	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14392	10.1371/journal.pone.0014392	http://dx.doi.org/10.1371/journal.pone.0014392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200440	Green Published, gold, Green Submitted			2022-12-25	WOS:000285576900007
J	Khouri, R; Novais, F; Santana, G; de Oliveira, CI; dos Santos, MAV; Barral, A; Barral-Netto, M; Van Weyenbergh, J				Khouri, Ricardo; Novais, Fernanda; Santana, Giselia; de Oliveira, Camila Indiani; Vannier dos Santos, Marcos Andre; Barral, Aldina; Barral-Netto, Manoel; Van Weyenbergh, Johan			DETC Induces Leishmania Parasite Killing in Human In Vitro and Murine In Vivo Models: A Promising Therapeutic Alternative in Leishmaniasis	PLOS ONE			English	Article							DIFFUSE CUTANEOUS LEISHMANIASIS; NITRIC-OXIDE SYNTHASE; ACETYL-L-CYSTEINE; FACTOR-KAPPA-B; SUPEROXIDE-DISMUTASE; IMMUNE-RESPONSE; MAJOR INFECTION; BALB/C MICE; DIETHYLDITHIOCARBAMATE; SURVIVAL	Background: Chemotherapy remains the primary tool for treatment and control of human leishmaniasis. However, currently available drugs present serious problems regarding side-effects, variable efficacy, and cost. Affordable and less toxic drugs are urgently needed for leishmaniasis. Methodology/Principal Findings: We demonstrate, by microscopy and viability assays, that superoxide dismutase inhibitor diethyldithiocarbamate (DETC) dose-dependently induces parasite killing (p<0.001) and is able to "sterilize'' Leishmania amazonensis infection at 2 mM in human macrophages in vitro. We also show that DETC-induced superoxide production (p < 0.001) and parasite destruction (p < 0.05) were reverted by the addition of the antioxidant N-acetylcysteine, indicating that DETC-induced killing occurs through oxidative damage. Furthermore, ultrastructural analysis by electron microscopy demonstrates a rapid and highly selective destruction of amastigotes in the phagosome upon DETC treatment, without any apparent damage to the host cell, including its mitochondria. In addition, DETC significantly induced parasite killing in Leishmania promastigotes in axenic culture. In murine macrophages infected with Leishmania braziliensis, DETC significantly induced in vitro superoxide production (p = 0.0049) and parasite killing (p = 0.0043). In vivo treatment with DETC in BALB/C mice infected with Leishmania braziliensis caused a significant decrease in lesion size (p<0.0001), paralleled by a 100-fold decrease (p = 0.0087) in parasite burden. Conclusions/Significance: Due to its strong leishmanicidal effect in human macrophages in vitro, its in vivo effectiveness in a murine model, and its previously demonstrated in vivo safety profile in HIV treatment, DETC treatment might be considered as a valuable therapeutic option in human leishmaniasis, including HIV/Leishmania co-infection.	[Khouri, Ricardo; Novais, Fernanda; Santana, Giselia; de Oliveira, Camila Indiani; Vannier dos Santos, Marcos Andre; Barral, Aldina; Barral-Netto, Manoel; Van Weyenbergh, Johan] Fundacao Oswaldo Cruz FIOCRUZ, LIMI, Ctr Pesquisa Goncalo Moniz, LIP,LBP, Salvador, BA, Brazil; [Barral, Aldina; Barral-Netto, Manoel; Van Weyenbergh, Johan] INCT, Inst Invest Immunol, Sao Paulo, Brazil	Fundacao Oswaldo Cruz	Khouri, R (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, LIMI, Ctr Pesquisa Goncalo Moniz, LIP,LBP, Salvador, BA, Brazil.	johan@bahia.fiocruz.br	Vannier-Santos, Marcos A/L-3649-2013; Van Weyenbergh, Johan/B-4187-2009; Vannier-Santos, Marcos/G-5517-2012; Khouri, Ricardo/M-3184-2018; Van Weyenbergh, Johan/Q-3829-2019; Barral-Netto, Manoel/B-3904-2009; Vannier-Santos, Marcos/AAG-5053-2021; Barral, Aldina/B-4191-2009; de Oliveira, Camila I/B-4358-2009	Van Weyenbergh, Johan/0000-0003-3234-8426; Khouri, Ricardo/0000-0001-5664-4436; Van Weyenbergh, Johan/0000-0003-3234-8426; Barral-Netto, Manoel/0000-0002-5823-7903; Vannier-Santos, Marcos/0000-0001-9241-2261; Barral, Aldina/0000-0002-7177-464X; de Oliveira, Camila I/0000-0002-7868-5164	CNPq; CAPES; European Union [E06D103200BR]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); European Union(European Commission)	This work was supported by CNPq (AB and MBN are CNPq senior investigators), CAPES and Alban Program, European Union Program of High Level Scholarship for Latin America, scholarship no. E06D103200BR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato VS, 2007, AM J TROP MED HYG, V77, P266, DOI 10.4269/ajtmh.2007.77.266; BARRAL A, 1995, INT J DERMATOL, V34, P474, DOI 10.1111/j.1365-4362.1995.tb00613.x; Blos M, 2003, EUR J IMMUNOL, V33, P1224, DOI 10.1002/eji.200323825; COCCO D, 1981, J BIOL CHEM, V256, P8983; Cruz KK, 2008, PARASITE IMMUNOL, V30, P171, DOI 10.1111/j.1365-3024.2007.01014.x; Cvek B, 2007, CURR PHARM DESIGN, V13, P3155, DOI 10.2174/138161207782110390; de Moura TR, 2005, INFECT IMMUN, V73, P5827, DOI 10.1128/IAI.73.9.5827-5834.2005; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893; Getachew F, 2007, MOL BIOCHEM PARASIT, V154, P62, DOI 10.1016/j.molbiopara.2007.04.007; Ghosh S, 2003, BIOCHEM J, V369, P447, DOI 10.1042/BJ20021684; Hothersall JS, 1997, BIOCHEM J, V322, P477, DOI 10.1042/bj3220477; HUBNER L, 1991, INT J IMMUNOPHARMACO, V13, P1067, DOI 10.1016/0192-0561(91)90157-3; Khouri R, 2009, J IMMUNOL, V182, P2525, DOI 10.4049/jimmunol.0802860; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; Llanos-Cuentas A, 2008, CLIN INFECT DIS, V46, P223, DOI 10.1086/524042; Marikovsky M, 2003, J IMMUNOL, V170, P2993, DOI 10.4049/jimmunol.170.6.2993; Menezes D, 2006, PARASITOL RES, V98, P99, DOI 10.1007/s00436-005-0010-1; Mikoyan VD, 1997, BBA-GEN SUBJECTS, V1336, P225, DOI 10.1016/S0304-4165(97)00032-9; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Modabber Farrokh, 2007, Kinetoplastid Biol Dis, V6, P3, DOI 10.1186/1475-9292-6-3; Monteiro MC, 2008, PARASITOL RES, V102, P801, DOI 10.1007/s00436-007-0827-x; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; Novais FO, 2009, J IMMUNOL, V183, P8088, DOI 10.4049/jimmunol.0803720; Obminska-Mrukowicz Bozena, 2005, J Vet Sci, V6, P25; REISINGER EC, 1990, LANCET, V335, P679, DOI 10.1016/0140-6736(90)90802-C; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Rocha-Vieira E, 2003, IMMUNOLOGY, V108, P401, DOI 10.1046/j.1365-2567.2003.01582.x; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Tuon FF, 2008, INT J DERMATOL, V47, P109, DOI 10.1111/j.1365-4632.2008.03417.x; Vannier-Santos MA, 2009, CURR DRUG TARGETS, V10, P246, DOI 10.2174/138945009787581168; Vannier-Santos MA, 1999, MICROBIOL-UK, V145, P3213, DOI 10.1099/00221287-145-11-3213; Vannier-Santos MA, 2008, MICROBIOL-SGM, V154, P3104, DOI 10.1099/mic.0.2007/013896-0; Vannier-Santos Marcos A., 2001, Biological Procedures Online, V3, P8, DOI 10.1251/bpo19; Zerpa O, 2007, BRIT J DERMATOL, V156, P1328, DOI 10.1111/j.1365-2133.2007.07872.x; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x	40	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14394	10.1371/journal.pone.0014394	http://dx.doi.org/10.1371/journal.pone.0014394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200432	Green Published, Green Submitted, gold			2022-12-25	WOS:000285576900009
J	Berthet, N; Deletoile, A; Passet, V; Kennedy, GC; Manuguerra, JC; Cole, ST; Brisse, S				Berthet, Nicolas; Deletoile, Alexis; Passet, Virginie; Kennedy, Giulia C.; Manuguerra, Jean-Claude; Cole, Stewart T.; Brisse, Sylvain			Reconstructed Ancestral Sequences Improve Pathogen Identification Using Resequencing DNA Microarrays	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; PROTEIN SEQUENCES; LIKELIHOOD; ENTEROBACTERIACEAE; CORONAVIRUS; VIRUSES	We describe the benefit of using reconstructed ancestral sequences (RAS) on resequencing microarrays for rapid pathogen identification, with Enterobacteriaceae rpoB sequences as a model. Our results demonstrate a sharp improvement of call rate and accuracy when using RASs as compared to extant sequences. This improvement was attributed to the lower sequence divergence of RASs, which also expanded the sequence space covered by the microarray. Extension of this novel microarray design strategy to viruses, antimicrobial resistance elements or toxins is straightforward.	[Berthet, Nicolas] Inst Pasteur, Epidemiol & Pathophysiol Oncogen Virus Unit, CNRS, URA3015, Paris, France; [Kennedy, Giulia C.] Affymetrix, Santa Clara, CA USA; [Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France; [Cole, Stewart T.] Ecole Polytech Fed Lausanne, Lab Microbial Pathogenesis, Global Hlth Inst, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Affymetrix; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Berthet, N (corresponding author), Inst Pasteur, Epidemiol & Pathophysiol Oncogen Virus Unit, CNRS, URA3015, Paris, France.	sylvain.brisse@pasteur.fr	Berthet, Nicolas/J-9373-2012; Brisse, Sylvain/M-8723-2013	Brisse, Sylvain/0000-0002-2516-2108	National Institute of Allergy and Infectious Diseases, National Institutes of Health [UCI AI062613]; Institut Pasteur [246]; Institut de Veille Sanitaire (Saint-Maurice, France); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC1AI062613] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institut Pasteur(European Commission); Institut de Veille Sanitaire (Saint-Maurice, France); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health [Grant No. UCI AI062613 to G.C.K.] and by Institut Pasteur [Grant PTR DEVA no246 to N.B.]. Platform Genotyping of Pathogens and Public Health receives financial support from Institut Pasteur and the Institut de Veille Sanitaire (Saint-Maurice, France). Affymetrix employs G.C.K. and contributed to data analysis. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthet N, 2008, MICROB BIOTECHNOL, V1, P79, DOI 10.1111/j.1751-7915.2007.00012.x; Berthet N, 2010, NAT BIOTECHNOL, V28, P25, DOI 10.1038/nbt0110-25; Blanchette Mathieu, 2008, V422, P171, DOI 10.1007/978-1-59745-581-7_11; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Charlebois RL, 2004, GENOME RES, V14, P2469, DOI 10.1101/gr.3024704; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dacheux L, 2010, J VIROL, V84, P9557, DOI 10.1128/JVI.00771-10; Deletoile A, 2009, J CLIN MICROBIOL, V47, P300, DOI 10.1128/JCM.01916-08; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Elias I, 2007, J COMPUT BIOL, V14, P216, DOI 10.1089/cmb.2006.0101; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Golding GB, 1998, MOL BIOL EVOL, V15, P355, DOI 10.1093/oxfordjournals.molbev.a025932; Hall BG, 2006, P NATL ACAD SCI USA, V103, P5431, DOI 10.1073/pnas.0508991103; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Landraud L, 2010, INFECT DIS, P1690; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; Leski TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006569; Lin B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000419; Lin BC, 2007, J CLIN MICROBIOL, V45, P443, DOI 10.1128/JCM.01870-06; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Metzgar D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008995; Naum M, 2008, J MOL EVOL, V66, P630, DOI 10.1007/s00239-008-9115-3; Paauw A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003018; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Quan PL, 2007, J CLIN MICROBIOL, V45, P2359, DOI 10.1128/JCM.00737-07; Salerno A, 2007, J BACTERIOL, V189, P7808, DOI 10.1128/JB.00796-07; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Wang Z, 2006, EMERG INFECT DIS, V12, P638, DOI 10.3201/eid1204.051441; Wang Z, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-577; Wilson WJ, 2002, MOL CELL PROBE, V16, P119, DOI 10.1006/mcpr.2001.0397; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067	36	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15243	10.1371/journal.pone.0015243	http://dx.doi.org/10.1371/journal.pone.0015243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187950	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200025
J	Ling, A; Cordaux, R				Ling, Alison; Cordaux, Richard			Insertion Sequence Inversions Mediated by Ectopic Recombination between Terminal Inverted Repeats	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; GENE CONVERSION; TRANSPOSABLE ELEMENTS; GENOME; EVOLUTION; RETROTRANSPOSONS; DIVERSITY; EVENTS	Transposable elements are widely distributed and diverse in both eukaryotes and prokaryotes, as exemplified by DNA transposons. As a result, they represent a considerable source of genomic variation, for example through ectopic (i.e. nonallelic homologous) recombination events between transposable element copies, resulting in genomic rearrangements. Ectopic recombination may also take place between homologous sequences located within transposable element sequences. DNA transposons are typically bounded by terminal inverted repeats (TIRs). Ectopic recombination between TIRs is expected to result in DNA transposon inversions. However, such inversions have barely been documented. In this study, we report natural inversions of the most common prokaryotic DNA transposons: insertion sequences (IS). We identified natural TIR-TIR recombination-mediated inversions in 9% of IS insertion loci investigated in Wolbachia bacteria, which suggests that recombination between IS TIRs may be a quite common, albeit largely overlooked, source of genomic diversity in bacteria. We suggest that inversions may impede IS survival and proliferation in the host genome by altering transpositional activity. They may also alter genomic instability by modulating the outcome of ectopic recombination events between IS copies in various orientations. This study represents the first report of TIR-TIR recombination within bacterial IS elements and it thereby uncovers a novel mechanism of structural variation for this class of prokaryotic transposable elements.	[Ling, Alison; Cordaux, Richard] Univ Poitiers, CNRS, UMR Ecol 6556, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Ling, A (corresponding author), Univ Poitiers, CNRS, UMR Ecol 6556, Poitiers, France.	richard.cordaux@univ-poitiers.fr			Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This research was funded by a Young Investigator ATIP award from the Centre National de la Recherche Scientifique (CNRS) to RC. AL was supported by a postdoctoral fellowship from the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Arends HM, 2002, J GEN VIROL, V83, P1573, DOI 10.1099/0022-1317-83-7-1573; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; Belshaw R, 2007, J VIROL, V81, P9437, DOI 10.1128/JVI.02216-06; Chandler M, 2002, MOBILE DNA, V2, P305; Cordaux R, 2008, MOL BIOL EVOL, V25, P1889, DOI 10.1093/molbev/msn134; Cordaux R, 2008, GENE, V409, P20, DOI 10.1016/j.gene.2007.10.035; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cordaux R, 2009, MOL BIOL EVOL, V26, P1679, DOI 10.1093/molbev/msp093; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Filee J, 2007, MICROBIOL MOL BIOL R, V71, P121, DOI 10.1128/MMBR.00031-06; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leclercq S, 2011, MOL BIOL EVOL, V28, P685, DOI 10.1093/molbev/msq238; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Martin DW, 1997, VIROLOGY, V232, P300, DOI 10.1006/viro.1997.8573; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pichon S, 2009, BIOCHEM BIOPH RES CO, V385, P557, DOI 10.1016/j.bbrc.2009.05.118; REZNIKOFF WS, 2002, MOBILE DNA, V2, P403; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; Salzberg SL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r23; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Siguier P, 2009, RES MICROBIOL, V160, P232, DOI 10.1016/j.resmic.2009.02.003; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; Vitte C, 2003, MOL BIOL EVOL, V20, P528, DOI 10.1093/molbev/msg055; WEBER PC, 1988, CELL, V54, P369, DOI 10.1016/0092-8674(88)90200-0; WEBER PC, 1988, J BACTERIOL, V170, P4972, DOI 10.1128/jb.170.10.4972-4975.1988; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954	36	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15654	10.1371/journal.pone.0015654	http://dx.doi.org/10.1371/journal.pone.0015654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187977	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200058
J	Poonia, B; Kijak, GH; Pauza, CD				Poonia, Bhawna; Kijak, Gustavo H.; Pauza, C. David			High Affinity Allele for the Gene of FCGR3A Is Risk Factor for HIV Infection and Progression	PLOS ONE			English	Article							FC-GAMMA-RIIA; VARIANT GENOTYPES; KAPOSIS-SARCOMA; POLYMORPHISMS; RECEPTORS; CELLS; EXPRESSION; CORRELATE; IGG	Background: We investigated the genetics of Fc receptors, which function as activating receptors on immune cells and help to control HIV through antibody-mediated cellular cytotoxicity. Thus, Fc receptors may be important for virus immunity but might also promote immune hyperactivation that would enhance infection. Methodology/Principal Findings: We measured abundance of low and high activity alleles in two Fc receptor genes, FCGR2A and FCGR3A, for persons with HIV disease, natural virus suppressors (HIV+, without disease) and healthy controls to show whether genotypes were associated with infection and disease. Individuals homozygous for the high activity allele of FCGR3A (158VV) were predominantly found among HIV progressors and this group was also skewed toward higher allele frequencies for the V158 variant. Both of the HIV positive groups (progressors and natural virus suppressors) had significantly higher frequencies of the V158 allele compared with uninfected controls. There were no apparent associations among FCGR2A alleles and HIV status. Conclusions/Significance: Our results indicate that high activity alleles of FCGR3A may be risk factors for HIV infection or progression and we need to understand how allelic variants affect the balance between virus control and immune activation.	[Kijak, Gustavo H.] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR)		bpoonia@ihv.umaryland.edu			PHS [AI068508]; NATIONAL CANCER INSTITUTE [R01CA142458] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by PHS grant AI068508 (C.D.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Brouwer KC, 2004, AIDS, V18, P1187, DOI 10.1097/00002030-200405210-00012; Fontenot D, 2009, P NATL ACAD SCI USA, V106, P16776, DOI 10.1073/pnas.0907347106; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; HUSSAIN LA, 1992, CLIN EXP IMMUNOL, V90, P530; HUSSAIN LA, 1991, AIDS, V5, P1089, DOI 10.1097/00002030-199109000-00004; Kim DH, 2006, BLOOD, V108, P2720, DOI 10.1182/blood-2006-01-009480; Lehrnbecher T, 2000, BLOOD, V95, P2386; Lehrnbecher T, 1999, BLOOD, V94, p431A; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Ozturk C, 2006, CLIN EXP MED, V6, P27, DOI 10.1007/s10238-006-0090-y; POVOLOTSKY J, 1991, J INFECT DIS, V163, P247, DOI 10.1093/infdis/163.2.247; Sajadi MM, 2007, AIDS, V21, P517; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Thabet MM, 2009, ANN RHEUM DIS, V68, P1775, DOI 10.1136/ard.2008.099309	16	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15562	10.1371/journal.pone.0015562	http://dx.doi.org/10.1371/journal.pone.0015562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187939	Green Published, Green Submitted			2022-12-25	WOS:000285575200041
J	Thomas, S; Popov, VL; Walker, DH				Thomas, Sunil; Popov, Vsevolod L.; Walker, David H.			Exit Mechanisms of the Intracellular Bacterium Ehrlichia	PLOS ONE			English	Article							HOST-CELLS; ANAPLASMA-PHAGOCYTOPHILUM; CHAFFEENSIS; INFECTION; PROTEIN; MYCOBACTERIA; REPLICATION; FILOPODIA; PARASITE; INVASION	Background: The obligately intracellular bacterium Ehrlichia chaffeensis that resides in mononuclear phagocytes is the causative agent of human monocytotropic ehrlichiosis. Ehrlichia muris and Ixodes ovatus Ehrlichia (IOE) are agents of mouse models of ehrlichiosis. The mechanism by which Ehrlichia are transported from an infected host cell to a non-infected cell has not been demonstrated. Methodology/Principal Findings: Using fluorescence microscopy and transmission and scanning electron microscopy, we demonstrated that Ehrlichia was transported through the filopodia of macrophages during early stages of infection. If host cells were not present in the vicinity of an Ehrlichia-infected cell, the leading edge of the filopodium formed a fan-shaped structure filled with the pathogen. Formation of filopodia in the host macrophages was inhibited by cytochalasin D and ehrlichial transport were prevented due to the absence of filopodia formation. At late stages of infection the host cell membrane was ruptured, and the bacteria were released. Conclusions/Significance: Ehrlichia are transported through the host cell filopodium during initial stages of infection, but are released by host cell membrane rupture during later stages of infection.	[Thomas, Sunil] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Thomas, S (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	dwalker@utmb.edu		Thomas, Sunil/0000-0003-4780-8851	National Institute of Allergy and Infectious Diseases [AI031431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031431, R21AI031431] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a grant from the National Institute of Allergy and Infectious Diseases (AI031431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blouin EF, 1998, J MED ENTOMOL, V35, P788, DOI 10.1093/jmedent/35.5.788; FINLAY BB, 1988, BIOCHIMIE, V70, P1089, DOI 10.1016/0300-9084(88)90271-4; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; HARTWIG JH, 1977, J CELL BIOL, V75, pA253; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Lasunskaia EB, 2006, J LEUKOCYTE BIOL, V80, P1480, DOI 10.1189/jlb.0106066; Li JSY, 2003, INFECT IMMUN, V71, P4229, DOI 10.1128/IAI.71.8.4229-4237.2003; MAEDA K, 1987, NEW ENGL J MED, V316, P853, DOI 10.1056/NEJM198704023161406; Maender Jennifer L, 2004, Dermatol Ther, V17, P499, DOI 10.1111/j.1396-0296.2004.04052.x; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Popov VL, 1998, J MED MICROBIOL, V47, P235, DOI 10.1099/00222615-47-3-235; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; Rikihisa Y, 2010, VET PARASITOL, V167, P155, DOI 10.1016/j.vetpar.2009.09.017; Rosania GR, 1996, CELL MOTIL CYTOSKEL, V34, P230, DOI 10.1002/(SICI)1097-0169(1996)34:3<230::AID-CM6>3.0.CO;2-D; Srivastava KD, 1998, J IMMUNOL, V161, P5039; Stevenson HL, 2006, INFECT IMMUN, V74, P4856, DOI 10.1128/IAI.00246-06; Thomas S, 2009, PARASITE IMMUNOL, V31, P296, DOI 10.1111/j.1365-3024.2009.01099.x; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Wood W, 2002, INT J BIOCHEM CELL B, V34, P726, DOI 10.1016/S1357-2725(01)00172-8	23	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15775	10.1371/journal.pone.0015775	http://dx.doi.org/10.1371/journal.pone.0015775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187937	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200069
J	Leder, K; Holland, EC; Michor, F				Leder, Kevin; Holland, Eric C.; Michor, Franziska			The Therapeutic Implications of Plasticity of the Cancer Stem Cell Phenotype	PLOS ONE			English	Article							MYELOID-LEUKEMIA; BREAST-CANCER; IDENTIFICATION; HETEROGENEITY; MODEL	The cancer stem cell hypothesis suggests that tumors contain a small population of cancer cells that have the ability to undergo symmetric self-renewing cell division. In tumors that follow this model, cancer stem cells produce various kinds of specified precursors that divide a limited number of times before terminally differentiating or undergoing apoptosis. As cells within the tumor mature, they become progressively more restricted in the cell types to which they can give rise. However, in some tumor types, the presence of certain extra-or intracellular signals can induce committed cancer progenitors to revert to a multipotential cancer stem cell state. In this paper, we design a novel mathematical model to investigate the dynamics of tumor progression in such situations, and study the implications of a reversible cancer stem cell phenotype for therapeutic interventions. We find that higher levels of dedifferentiation substantially reduce the effectiveness of therapy directed at cancer stem cells by leading to higher rates of resistance. We conclude that plasticity of the cancer stem cell phenotype is an important determinant of the prognosis of tumors. This model represents the first mathematical investigation of this tumor trait and contributes to a quantitative understanding of cancer.	[Leder, Kevin; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Leder, Kevin; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, Canc Biol & Genet Program, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Memorial Sloan Kettering Cancer Center	Leder, K (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	michor@jimmy.harvard.edu			National Cancer Institute [U54CA143798]; NATIONAL CANCER INSTITUTE [R01CA100688, U54CA143798] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Award Number U54CA143798 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Dingli D, 2007, CELL CYCLE, V6, P461, DOI 10.4161/cc.6.4.3853; Ganguly R, 2006, CELL PROLIFERAT, V39, P3, DOI 10.1111/j.1365-2184.2006.00369.x; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Haeno H, 2009, P NATL ACAD SCI USA, V106, P16616, DOI 10.1073/pnas.0908107106; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Michor F, 2008, J CLIN ONCOL, V26, P2854, DOI 10.1200/JCO.2007.15.2421; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; PIETRAS KOA, 2010, EXP CELL RES; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sharif A, 2007, ONCOGENE, V26, P2695, DOI 10.1038/sj.onc.1210071; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Turner C, 2009, CELL PROLIFERAT, V42, P529, DOI 10.1111/j.1365-2184.2009.00619.x; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang JCY, 1998, BLOOD, V91, P2406, DOI 10.1182/blood.V91.7.2406.2406_2406_2414; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999	26	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14366	10.1371/journal.pone.0014366	http://dx.doi.org/10.1371/journal.pone.0014366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179426	Green Published, Green Submitted, gold			2022-12-25	WOS:000285572900005
J	Nieves, W; Heang, J; Asakrah, S; Bentrup, KHZ; Roy, CJ; Morici, LA				Nieves, Wildaliz; Heang, Julie; Asakrah, Saja; Bentrup, Kerstin Hoener Zu; Roy, Chad J.; Morici, Lisa A.			Immunospecific Responses to Bacterial Elongation Factor Tu during Burkholderia Infection and Immunization	PLOS ONE			English	Article							IMMUNOPROTEOMIC IDENTIFICATION; CAPSULAR POLYSACCHARIDE; PSEUDOMONAS-AERUGINOSA; PSEUDOMALLEI INFECTION; MYCOPLASMA-PNEUMONIAE; VACCINE CANDIDATES; IMMUNE-RESPONSES; MURINE MODEL; PROTECTION; PROTEINS	Burkholderia pseudomallei is the etiological agent of melioidosis, a disease endemic in parts of Southeast Asia and Northern Australia. Currently there is no licensed vaccine against infection with this biological threat agent. In this study, we employed an immunoproteomic approach and identified bacterial Elongation factor-Tu (EF-Tu) as a potential vaccine antigen. EF-Tu is membrane-associated, secreted in outer membrane vesicles (OMVs), and immunogenic during Burkholderia infection in the murine model of melioidosis. Active immunization with EF-Tu induced antigen-specific antibody and cell-mediated immune responses in mice. Mucosal immunization with EF-Tu also reduced lung bacterial loads in mice challenged with aerosolized B. thailandensis. Our data support the utility of EF-Tu as a novel vaccine immunogen against bacterial infection.	[Nieves, Wildaliz; Heang, Julie; Asakrah, Saja; Bentrup, Kerstin Hoener Zu; Roy, Chad J.; Morici, Lisa A.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Roy, Chad J.] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA	Tulane University; Tulane University	Nieves, W (corresponding author), Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.	lmorici@tulane.edu	asakrah, saja/ABB-6947-2021; asakrah, saja/ABH-3939-2020	asakrah, saja/0000-0002-0037-2707; Roy, Chad/0000-0002-1710-6974	National Institute of Allergy and Infectious Diseases (NIAID)/NIH [U54 AI057156]; Louisiana Vaccine Center/South Louisiana Institute for Infectious Disease Research Cooperative Pilot; Tulane Research Enhancement Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Louisiana Vaccine Center/South Louisiana Institute for Infectious Disease Research Cooperative Pilot; Tulane Research Enhancement Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant Number U54 AI057156 from National Institute of Allergy and Infectious Diseases (NIAID)/NIH, a Louisiana Vaccine Center/South Louisiana Institute for Infectious Disease Research Cooperative Pilot Research grant to L.M., and a Tulane Research Enhancement Grant to L.M. and C.R. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the RCE Programs Office, NIAID, or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO A, MICROBES INFECT; Ariel N, 2003, INFECT IMMUN, V71, P4563, DOI 10.1128/IAI.71.8.4563-4579.2003; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Balasubramanian S, 2009, INFECT IMMUN, V77, P3533, DOI 10.1128/IAI.00081-09; Barel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-145; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; BECK BD, 1978, P NATL ACAD SCI USA, V75, P1250, DOI 10.1073/pnas.75.3.1250; Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357; Breitbach Katrin, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS89, DOI 10.1016/S0035-9203(08)70022-1; Bunk S, 2008, J IMMUNOL, V180, P5490, DOI 10.4049/jimmunol.180.8.5490; Chen YS, 2006, INFECT IMMUN, V74, P1699, DOI 10.1128/IAI.74.3.1699-1705.2006; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Delpino MV, 2007, VACCINE, V25, P6721, DOI 10.1016/j.vaccine.2007.07.002; Druar C, 2008, FEMS IMMUNOL MED MIC, V52, P78, DOI 10.1111/j.1574-695X.2007.00345.x; DuBois AB, 2007, VACCINE, V25, P4747, DOI 10.1016/j.vaccine.2007.03.048; Elvin SJ, 2006, INFECT IMMUN, V74, P1706, DOI 10.1128/IAI.74.3.1706-1711.2006; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Gat O, 2006, INFECT IMMUN, V74, P3987, DOI 10.1128/IAI.00174-06; Glynn A, 2005, VACCINE, V23, P1957, DOI 10.1016/j.vaccine.2004.10.025; Gupta MK, 2009, J PROTEOME RES, V8, P2319, DOI 10.1021/pr8009462; Haque A, 2006, J INFECT DIS, V193, P370, DOI 10.1086/498983; Haque A, 2006, J INFECT DIS, V194, P1241, DOI 10.1086/508217; Hara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006496; Harding SV, 2007, VACCINE, V25, P2664, DOI 10.1016/j.vaccine.2006.12.006; Harland DN, 2007, INFECT IMMUN, V75, P4173, DOI 10.1128/IAI.00404-07; Healey GD, 2005, INFECT IMMUN, V73, P5945, DOI 10.1128/IAI.73.9.5945-5951.2005; Jonak J, 2007, J CHROMATOGR B, V849, P141, DOI 10.1016/j.jchromb.2006.11.053; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Klinman DM, 2009, ADV DRUG DELIVER REV, V61, P248, DOI 10.1016/j.addr.2008.12.012; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Leelarasamee A, 2004, CURR OPIN INFECT DIS, V17, P131, DOI 10.1097/00001432-200404000-00011; Lopez JE, 2008, J IMMUNOL METHODS, V332, P129, DOI 10.1016/j.jim.2007.12.018; Mayer F, 2003, CELL BIOL INT, V27, P429, DOI 10.1016/S1065-6995(03)00035-0; Moe GR, 2002, INFECT IMMUN, V70, P6021, DOI 10.1128/IAI.70.11.6021-6031.2002; MORICI LA, MICROB PATHOG, V48, P9; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; NEWMAN M, 1995, IMMUNOLOGICAL FORMUL, P1; Owen SJ, 2009, J INFECT DIS, V199, P1761, DOI 10.1086/599210; Peacock SJ, 2006, CURR OPIN INFECT DIS, V19, P421, DOI 10.1097/01.qco.0000244046.31135.b3; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Savitt AG, 2009, CLIN VACCINE IMMUNOL, V16, P414, DOI 10.1128/CVI.00362-08; Stevens JM, 2005, J BACTERIOL, V187, P7857, DOI 10.1128/JB.187.22.7857-7862.2005; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Watanabe M, 2003, INFECT IMMUN, V71, P733, DOI 10.1128/IAI.71.2.733-738.2003; West T Eoin, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS119, DOI 10.1016/S0035-9203(08)70028-2; Wiersinga WJ, 2008, CELL MICROBIOL, V10, P81, DOI 10.1111/j.1462-5822.2007.01016.x; Wiersinga WJ, 2009, CURR OPIN INFECT DIS, V22, P102, DOI 10.1097/QCO.0b013e328322e727; Wongratanacheewin S, 2004, INFECT IMMUN, V72, P4494, DOI 10.1128/IAI.72.8.4494-4502.2004; YOKOSAWA H, 1973, J BIOL CHEM, V248, P375	51	58	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14361	10.1371/journal.pone.0014361	http://dx.doi.org/10.1371/journal.pone.0014361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179405	Green Published, Green Submitted, gold			2022-12-25	WOS:000285572900004
J	Vogler, C; Gschwind, L; Rothlisberger, B; Huber, A; Filges, I; Miny, P; Auschra, B; Stetak, A; Demougin, P; Vukojevic, V; Kolassa, IT; Elbert, T; de Quervain, DJF; Papassotiropoulos, A				Vogler, Christian; Gschwind, Leo; Roethlisberger, Benno; Huber, Andreas; Filges, Isabel; Miny, Peter; Auschra, Bianca; Stetak, Attila; Demougin, Philippe; Vukojevic, Vanja; Kolassa, Iris-Tatjana; Elbert, Thomas; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas			Microarray-Based Maps of Copy-Number Variant Regions in European and Sub-Saharan Populations	PLOS ONE			English	Article							HUMAN GENOME; SEGMENTAL DUPLICATIONS; EVOLUTIONARY HISTORY; STRUCTURAL VARIATION; ARRAY-CGH; DISEASE; HAPLOTYPE; GENE; SUSCEPTIBILITY	The genetic basis of phenotypic variation can be partially explained by the presence of copy-number variations (CNVs). Currently available methods for CNV assessment include high-density single-nucleotide polymorphism (SNP) microarrays that have become an indispensable tool in genome-wide association studies (GWAS). However, insufficient concordance rates between different CNV assessment methods call for cautious interpretation of results from CNV-based genetic association studies. Here we provide a cross-population, microarray-based map of copy-number variant regions (CNVRs) to enable reliable interpretation of CNV association findings. We used the Affymetrix Genome-Wide Human SNP Array 6.0 to scan the genomes of 1167 individuals from two ethnically distinct populations (Europe, N = 717; Rwanda, N = 450). Three different CNV-finding algorithms were tested and compared for sensitivity, specificity, and feasibility. Two algorithms were subsequently used to construct CNVR maps, which were also validated by processing subsamples with additional microarray platforms (Illumina 1M-Duo BeadChip, Nimblegen 385K aCGH array) and by comparing our data with publicly available information. Both algorithms detected a total of 42669 CNVs, 74% of which clustered in 385 CNVRs of a cross-population map. These CNVRs overlap with 862 annotated genes and account for approximately 3.3% of the haploid human genome. We created comprehensive cross-populational CNVR-maps. They represent an extendable framework that can leverage the detection of common CNVs and additionally assist in interpreting CNV-based association studies.	[Vogler, Christian; Gschwind, Leo; Auschra, Bianca; Stetak, Attila; Demougin, Philippe; Vukojevic, Vanja; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas] Univ Basel, Dept Psychol, Basel, Switzerland; [Vogler, Christian; Gschwind, Leo; Auschra, Bianca; Stetak, Attila; Demougin, Philippe; Vukojevic, Vanja; Papassotiropoulos, Andreas] Univ Basel, Dept Biozentrum, Basel, Switzerland; [Vogler, Christian; Gschwind, Leo; Auschra, Bianca; Stetak, Attila; Demougin, Philippe; Vukojevic, Vanja; de Quervain, Dominique J. -F.; Papassotiropoulos, Andreas] Univ Basel, Dept Med, Basel, Switzerland; [Roethlisberger, Benno; Huber, Andreas] Cantonal Hosp, Ctr Lab Med, Aarau, Switzerland; [Filges, Isabel; Miny, Peter] Univ Childrens Hosp, Dept Biomed, Basel, Switzerland; [Kolassa, Iris-Tatjana; Elbert, Thomas] Univ Konstanz, Dept Psychol, Constance, Germany	University of Basel; University of Basel; University of Basel; University of Konstanz	Vogler, C (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	christian.vogler@unibas.ch	Kolassa, Iris Tatjana/Y-3032-2018; Elbert, Thomas/C-8556-2009	Elbert, Thomas/0000-0003-1332-4939; de Quervain, Dominique/0000-0001-7131-2464; Papassotiropoulos, Andreas/0000-0002-2210-9651; Vogler, Christian/0000-0003-3922-109X; Vukojevic, Vanja/0000-0001-5303-9492	Swiss National Science Foundation (SNSF) [PP00B-106708]; Sinergia [CRSIKO_122691]; National Centre of Competence in Research (NCCR) Swiss Etiological Study of Adjustment and Mental Health (sesam); Swiss National Science Foundation (SNF) [51A240-104890]; University of Basel; F. Hoffmann-La Roche Corp.; European Union [242257]; European Science Foundation	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Sinergia; National Centre of Competence in Research (NCCR) Swiss Etiological Study of Adjustment and Mental Health (sesam)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); University of Basel; F. Hoffmann-La Roche Corp.(Hoffmann-La Roche); European Union(European Commission); European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported in part by the Swiss National Science Foundation (SNSF) grants PP00B-106708 (D. Q.) and Sinergia CRSIKO_122691 (D. Q. and A. P.). This work is part of the National Centre of Competence in Research (NCCR) Swiss Etiological Study of Adjustment and Mental Health (sesam), The Swiss National Science Foundation (SNF) (project no. 51A240-104890); the University of Basel, the F. Hoffmann-La Roche Corp. and the Freie Akademische Gesellschaft provided core support for the NCCR sesam. This work is also part of the 7th framework programme of the European Union (ADAMS, project number 242257, FP7-HEALTH-2009) and of the European Science Foundation grant, EUROStress (D. Q. and A. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Cahan P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn110; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Filges I, 2009, AM J MED GENET A, V149A, P237, DOI 10.1002/ajmg.a.32622; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goidts V, 2006, HUM GENET, V120, P270, DOI 10.1007/s00439-006-0217-y; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; HASTINGS PJ, 2009, NAT REV GENET; *INC BOZ, GOLD HEL CNAM SOFTW; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Onyut Lamaro P, 2009, Confl Health, V3, P6, DOI 10.1186/1752-1505-3-6; *R DEV COR TEAM, 2009, COMP RFFS; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Solomon NM, 2004, J MED GENET, V41, P669, DOI 10.1136/jmg.2003.016949; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Tishkoff SA, 2003, CURR OPIN GENET DEV, V13, P569, DOI 10.1016/j.gde.2003.10.010; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006	32	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15246	10.1371/journal.pone.0015246	http://dx.doi.org/10.1371/journal.pone.0015246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179565	gold, Green Published, Green Submitted			2022-12-25	WOS:000285381200019
J	Boogert, NJ; Bui, C; Howarth, K; Giraldeau, LA; Lefebvre, L				Boogert, Neeltje J.; Bui, Cavina; Howarth, Krista; Giraldeau, Luc-Alain; Lefebvre, Louis			Does Foraging Behaviour Affect Female Mate Preferences and Pair Formation in Captive Zebra Finches?	PLOS ONE			English	Article							TAENIOPYGIA-GUTTATA; DARWINS FINCHES; SEXUAL SELECTION; SYMPATRIC MORPHS; PLUMAGE COLOR; ZENAIDA DOVES; CHOICE; SPECIATION; MALES; BIRDS	Background: Successful foraging is essential for survival and reproductive success. In many bird species, foraging is a learned behaviour. To cope with environmental change and survive periods in which regular foods are scarce, the ability to solve novel foraging problems by learning new foraging techniques can be crucial. Although females have been shown to prefer more efficient foragers, the effect of males' foraging techniques on female mate choice has never been studied. We tested whether females would prefer males showing the same learned foraging technique as they had been exposed to as juveniles, or whether females would prefer males that showed a complementary foraging technique. Methodology/Principal Findings: We first trained juvenile male and female zebra finches (Taeniopygia guttata) to obtain a significant proportion of their food by one of two foraging techniques. We then tested whether females showed a preference for males with the same or the alternative technique. We found that neither a male's foraging technique nor his foraging performance affected the time females spent in his proximity in the mate-choice apparatus. We then released flocks of these finches into an aviary to investigate whether assortative pairing would be facilitated by birds taught the same technique exploiting the same habitat. Zebra finches trained as juveniles in a specific foraging technique maintained their foraging specialisation in the aviary as adults. However, pair formation and nest location were random with regard to foraging technique. Conclusions/Significance: Our findings show that zebra finches can be successfully trained to be foraging specialists. However, the robust negative results of the conditions tested here suggest that learned foraging specializations do not affect mate choice or pair formation in our experimental context.	[Boogert, Neeltje J.; Bui, Cavina; Howarth, Krista; Lefebvre, Louis] McGill Univ, Montreal, PQ, Canada; [Giraldeau, Luc-Alain] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	McGill University; University of Quebec; University of Quebec Montreal	Boogert, NJ (corresponding author), McGill Univ, Montreal, PQ, Canada.	njboogert@gmail.com			Natural Sciences and Engineering Research Council of Canada; McGill University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); McGill University	This research was funded by Natural Sciences and Engineering Research Council of Canada discovery grants to LL and L-AG. NJB was financially supported by a Dr. Richard H. Tomlinson Fellowship and a Dr. Milton Leong Fellowship from McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amy M, 2008, ANIM BEHAV, V76, P971, DOI 10.1016/j.anbehav.2008.03.023; Artzy-Randrup Y, 2006, P NATL ACAD SCI USA, V103, P11619, DOI 10.1073/pnas.0602339103; Baldwin JM, 1896, AM NAT, V30, P441, DOI DOI 10.1086/276408; Bateson P., 1988, P191; BEAUCHAMP G, 1991, ANIM BEHAV, V41, P247, DOI 10.1016/S0003-3472(05)80476-2; Beauchamp G, 1997, ETHOL ECOL EVOL, V9, P105, DOI 10.1080/08927014.1997.9522890; Belovsky GE, 1996, BEHAV ECOL, V7, P438, DOI 10.1093/beheco/7.4.438; Beltman JB, 2005, P ROY SOC B-BIOL SCI, V272, P1455, DOI 10.1098/rspb.2005.3104; Birkhead TR, 1998, BEHAV ECOL SOCIOBIOL, V44, P179, DOI 10.1007/s002650050530; Bitton PP, 2008, BEHAV ECOL SOCIOBIOL, V62, P1543, DOI 10.1007/s00265-008-0583-7; Boogert NJ, 2008, ANIM BEHAV, V76, P1735, DOI 10.1016/j.anbehav.2008.08.009; Boogert NJ, 2010, BEHAV PROCESS, V85, P135, DOI 10.1016/j.beproc.2010.06.020; Bortolottia GR, 2008, BEHAV PROCESS, V78, P100, DOI 10.1016/j.beproc.2008.01.007; Burger R, 2006, EVOLUTION, V60, P2185; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; Burley NT, 2006, EVOLUTION, V60, P1076; Candolin U, 2009, AM NAT, V173, P273, DOI 10.1086/595753; Carlier P, 1996, BEHAVIOUR, V133, P1197, DOI 10.1163/156853996X00369; Cezilly F, 1997, IBIS, V139, P331, DOI 10.1111/j.1474-919X.1997.tb04632.x; Christensen R, 2007, J ORNITHOL, V148, P463, DOI 10.1007/s10336-007-0173-x; CLAYTON NS, 1990, ANIM BEHAV, V39, P474, DOI 10.1016/S0003-3472(05)80411-7; CLAYTON NS, 1990, PHILOS T R SOC B, V330, P351, DOI 10.1098/rstb.1990.0205; Deerenberg C, 1999, ANIM BEHAV, V58, P173, DOI 10.1006/anbe.1999.1123; Doebeli M, 2007, P ROY SOC B-BIOL SCI, V274, P347, DOI 10.1098/rspb.2006.3725; Drullion D, 2008, BEHAV ECOL SOCIOBIOL, V63, P269, DOI 10.1007/s00265-008-0658-5; FISHER J., 1949, BRITISH BIRDS, V42, P347; FUTUYMA DJ, 1998, EVOLUTIONARY BIOL, P751; Gajdon GK, 2006, ANIM COGN, V9, P173, DOI 10.1007/s10071-006-0018-7; Gibbons ME, 2005, ANIM BEHAV, V69, P721, DOI 10.1016/j.anbehav.2004.06.021; GIRALDEAU LA, 1984, AM NAT, V124, P72, DOI 10.1086/284252; GRANT BR, 1989, AM NAT, V133, P377, DOI 10.1086/284924; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant PR, 2008, P ROY SOC B-BIOL SCI, V275, P661, DOI 10.1098/rspb.2007.0898; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Helfenstein F, 2003, ANIM BEHAV, V65, P1027, DOI 10.1006/anbe.2003.2129; Hill GE, 2002, P ROY SOC B-BIOL SCI, V269, P1119, DOI 10.1098/rspb.2002.1980; Hinde R. A., 1951, BR BIRDS, V44, P392; Holveck MJ, 2007, ANIM BEHAV, V74, P297, DOI 10.1016/j.anbehav.2006.08.016; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Huber SK, 2007, P R SOC B, V274, P1709, DOI 10.1098/rspb.2007.0224; Jawor JM, 2003, BEHAV ECOL, V14, P515, DOI 10.1093/beheco/arg041; Karino K, 2005, BEHAV ECOL SOCIOBIOL, V59, P1, DOI 10.1007/s00265-005-0001-3; Komdeur J, 2005, BEHAV ECOL, V16, P805, DOI 10.1093/beheco/ari059; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; LEMON WC, 1991, NATURE, V352, P153, DOI 10.1038/352153a0; LEMON WC, 1992, ANIM BEHAV, V44, P851, DOI 10.1016/S0003-3472(05)80581-0; Lescroel A, 2010, ECOLOGY, V91, P2044, DOI 10.1890/09-0766.1; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Ludwig SC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1601, DOI 10.1007/s00265-008-0589-1; MacDougall AK, 2003, NATURWISSENSCHAFTEN, V90, P464, DOI 10.1007/s00114-003-0459-7; Mayr E., 1963, ANIMAL SPECIES EVOLU, pxiv; MILLER AH, 1956, EVOLUTION, V10, P262, DOI 10.2307/2406011; Moravec ML, 2006, ETHOLOGY, V112, P1108, DOI 10.1111/j.1439-0310.2006.01267.x; Neubauer RL, 1999, EVOL ECOL, V13, P365, DOI 10.1023/A:1006708826432; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Podos J, 2010, PHILOS T R SOC B, V365, P1031, DOI 10.1098/rstb.2009.0289; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; R Core Team, 2022, R LANG ENV STAT COMP; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; Rutstein AN, 2007, ANIM BEHAV, V74, P1277, DOI 10.1016/j.anbehav.2007.02.022; SILCOX AP, 1982, ANIM BEHAV, V30, P1237, DOI 10.1016/S0003-3472(82)80216-9; Slater P.J.B., 1988, Advances in the Study of Behavior, V18, P1; Snowberg LK, 2009, J EVOLUTION BIOL, V22, P762, DOI 10.1111/j.1420-9101.2009.01699.x; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; ten Cate C, 1999, ADV STUD BEHAV, V28, P1; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; Van Oers K, 2008, ANIM BEHAV, V76, P555, DOI 10.1016/j.anbehav.2008.03.011; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Wiersma P, 2005, J EXP BIOL, V208, P4091, DOI 10.1242/jeb.01854; Witte K, 2003, ANIM BEHAV, V65, P195, DOI 10.1006/anbe.2002.2009; Witte K, 2006, BEHAVIOUR, V143, P969, DOI 10.1163/156853906778623626; Witte K, 2006, ETHOL ECOL EVOL, V18, P195, DOI 10.1080/08927014.2006.9522707; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Zann RA., 1996, ZEBRA FINCH SYNTHESI	75	4	4	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14340	10.1371/journal.pone.0014340	http://dx.doi.org/10.1371/journal.pone.0014340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179514	Green Published, gold, Green Submitted			2022-12-25	WOS:000285340000012
J	Toh, YC; Voldman, J				Toh, Yi-Chin; Voldman, Joel			Fluid shear stress primes mouse embryonic stem cells for differentiation in a self-renewing environment via heparan sulfate proteoglycans transduction	FASEB JOURNAL			English	Article						microfluid; HSPG; mESC	FIBROBLAST-GROWTH-FACTOR; SUSPENSION-CULTURE; ENDOTHELIAL-CELLS; EXPANSION; MECHANOTRANSDUCTION; BIOREACTORS; RECEPTOR; SYSTEM; FORCES; STATE	Shear stress is a ubiquitous environmental cue experienced by stem cells when they are being differentiated or expanded in perfusion cultures. However, its role in modulating self-renewing stem cell phenotypes is unclear, since shear is usually only studied in the context of cardiovascular differentiation. We used a multiplex microfluidic array, which overcomes the limitations of macroperfusion systems in shear application throughput and precision, to initiate a comprehensive, quantitative study of shear effects on self-renewing mouse embryonic stem cells (mESCs), where shear stresses varying by >1000 times (0.016-16 dyn/cm(2)) are applied simultaneously. When compared with static controls in the presence or absence of a saturated soluble environment (i.e., mESC-conditioned medium), we ascertained that flow-induced shear stress specifically up-regulates the epiblast marker Fgf5. Epiblast-state transition in mESCs involves heparan sulfate proteoglycans (HSPGs), which have also been shown to transduce shear stress in endothelial cells. By disrupting (with sulfation inhibitors and heparinase) and partially reconstituting (with heparin) HSPG function, we show that mESCs also mechanically sense shear stress via HSPGs to modulate Fgf5 expression. This study demonstrates that self-renewing mESCs possess the molecular machinery to sense shear stress and provides quantitative shear application benchmarks for future scalable stem cell culture systems.-Toh, Y.-C., Voldman, J. Fluid shear stress primes mouse embryonic stem cells for differentiation in a self-renewing environment via heparan sulfate proteoglycans transduction. FASEB J. 25, 1208-1217 (2011). www.fasebj.org	[Toh, Yi-Chin; Voldman, Joel] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Toh, Yi-Chin; Voldman, Joel] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Voldman, J (corresponding author), MIT, Dept Elect Engn & Comp Sci, Rm 36-824,77 Massachusetts Ave, Cambridge, MA 02139 USA.	voldman@mit.edu		Toh, Yi-Chin/0000-0002-4105-4852	U.S. National Institutes of Health [EB007278]; A*STAR; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007278] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank Katarina Blagovic for technical assistance and Lily Y. Kim for developing the initial concept and first version of a multi-flowrate device. Y.-C.T. contributed to conception and design, collection and assembly of data, data analysis and interpretation, and manuscript writing. J.V. contributed to conception and design, financial support, data analysis and interpretation, manuscript writing, and final approval of manuscript. This work was supported by U.S. National Institutes of Health grant EB007278 and an A*STAR International Fellowship.	Abranches E, 2007, BIOTECHNOL BIOENG, V96, P1211, DOI 10.1002/bit.21191; Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; BLAGOVIC K, 2008, P MICR TOT ANAL SYST, V1, P677; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chau L, 2009, LAB CHIP, V9, P1897, DOI 10.1039/b823180j; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Cool SM, 2006, J CELL BIOCHEM, V99, P1040, DOI 10.1002/jcb.20936; Cormier JT, 2006, TISSUE ENG, V12, P3233, DOI 10.1089/ten.2006.12.3233; Davey RE, 2006, STEM CELLS, V24, P2538, DOI 10.1634/stemcells.2006-0216; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Gutierrez E, 2008, LAB CHIP, V8, P1486, DOI 10.1039/b804795b; HUMPHRIES DE, 1988, BIOCHEM BIOPH RES CO, V154, P365, DOI 10.1016/0006-291X(88)90694-8; Kehoe DE, 2010, TISSUE ENG PT A, V16, P405, DOI [10.1089/ten.tea.2009.0454, 10.1089/ten.TEA.2009.0454]; Kim L, 2006, LAB CHIP, V6, P394, DOI 10.1039/b511718f; King JA, 2007, CURR OPIN CHEM BIOL, V11, P394, DOI 10.1016/j.cbpa.2007.05.034; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; LANGER R, 1982, SCIENCE, V217, P261, DOI 10.1126/science.7089564; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455; Mansergh FC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-5; Mochizuki S, 2003, AM J PHYSIOL-HEART C, V285, pH722, DOI 10.1152/ajpheart.00691.2002; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Schaff UY, 2007, LAB CHIP, V7, P448, DOI 10.1039/b617915k; Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100; Song JW, 2005, ANAL CHEM, V77, P3993, DOI 10.1021/ac050131o; Stolberg S, 2009, BIOTECHNOL PROGR, V25, P10, DOI 10.1002/btpr.124; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Walker GM, 2004, LAB CHIP, V4, P91, DOI 10.1039/b311214d; Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; zur Nieden NI, 2007, J BIOTECHNOL, V129, P421, DOI 10.1016/j.jbiotec.2007.01.006	38	88	90	0	38	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2011	25	4					1208	1217		10.1096/fj.10-168971	http://dx.doi.org/10.1096/fj.10-168971			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21183594	Green Published			2022-12-25	WOS:000288982800010
J	Cherney, MM; Lecaille, F; Kienitz, M; Nallaseth, FS; Li, ZQ; James, MNG; Bromme, D				Cherney, Maia M.; Lecaille, Fabien; Kienitz, Martin; Nallaseth, Ferez S.; Li, Zhenqiang; James, Michael N. G.; Broemme, Dieter			Structure-Activity Analysis of Cathepsin K/Chondroitin 4-Sulfate Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGENOLYTIC ACTIVITY; PROTEASE; CRYSTAL; EXPRESSION; SYSTEM	In the presence of oligomeric chondroitin 4-sulfate (C4-S), cathepsin K (catK) forms a specific complex that was shown to be the source of the major collagenolytic activity in bone osteoclasts. C4-S forms multiple contacts with amino acid residues on the backside of the catK molecule that help to facilitate complex formation. As cathepsin L does not exhibit a significant collagenase activity in the presence or in the absence of C4-S, we substituted the C4-S interacting residues in catK with those of cathepsin L. Variants revealed altered collagenolytic activities with the largest inhibitory effect shown by the hexavariant M5. None of the variants showed a reduction in their gelatinolytic and peptidolytic activities when compared with wild-type catK, indicating no structural alteration within their active sites. However, the crystal structure of the M5 variant in the presence of oligomeric C4-S revealed a different binding of chondroitin 4-sulfate. C4-S is not continuously ordered as it is in the wildtype catK.C4-S complex. The orientation and the direction of the hexasaccharide on the catK surface have changed, so that the hexasaccharide is positioned between two symmetry-related molecules. Only one M5 variant molecule of the dimer that is present in the asymmetric unit interacts with C4-S. These substitutions have changed the mode of catK binding to C4-S and, as a result, have likely affected the collagenolytic potential of the variant. The data presented here support our hypothesis that distinct catK/C4-S interactions are necessary for the collagenolytic activity of the enzyme.	[Cherney, Maia M.; Kienitz, Martin; James, Michael N. G.] Univ Alberta, Grp Prot Struct & Funct, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; [Lecaille, Fabien; Nallaseth, Ferez S.; Li, Zhenqiang; Broemme, Dieter] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	University of Alberta; Icahn School of Medicine at Mount Sinai	James, MNG (corresponding author), Univ British Columbia, Inst Life Sci, 2350 Hlth Sci Mall,Rm 4558, Vancouver, BC V6T 1Z3, Canada.	michael.james@ualberta.ca; dbromme@interchange.ubc.ca	Lecaille, Fabien/GRY-5313-2022	James, Michael/0000-0002-5978-4562; Lecaille, Fabien/0000-0003-1060-4222	Canada Research Chair; National Institutes of Health [AR 48669]; Canadian Institutes of Health Research [FRN 12831]; Alberta Heritage Foundation for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048669] Funding Source: NIH RePORTER	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by a Canada Research Chair Award (Protease in Diseases to D. B.), National Institutes of Health Grant AR 48669 (to D. B.), and Canadian Institutes of Health Research Grant FRN 12831 (to M. N. G. J.) and from the Alberta Heritage Foundation for Medical Research (to M. N. G. J.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BARRETT AJ, 1981, ACTA BIOL MED GER, V40, P1513; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; BROMME D, 1995, BIOL CHEM H-S, V376, P379, DOI 10.1515/bchm3.1995.376.6.379; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Hou WS, 1999, J CLIN INVEST, V103, P731, DOI 10.1172/JCI653; Hou WS, 2001, AM J PATHOL, V159, P2167, DOI 10.1016/S0002-9440(10)63068-4; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lecaille F, 2002, BIOCHEMISTRY-US, V41, P8447, DOI 10.1021/bi025638x; Li ZQ, 2008, J MOL BIOL, V383, P78, DOI 10.1016/j.jmb.2008.07.038; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Wilson S, 2009, AM J PATHOL, V175, P2053, DOI 10.2353/ajpath.2009.090211; Yamashita DS, 2006, J MED CHEM, V49, P1597, DOI 10.1021/jm050915u	27	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8988	8998		10.1074/jbc.M110.126706	http://dx.doi.org/10.1074/jbc.M110.126706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21193413	hybrid, Green Published			2022-12-25	WOS:000288247700030
J	Gruenig, MC; Lu, D; Won, SJ; Dulberger, CL; Manlick, AJ; Keck, JL; Cox, MM				Gruenig, Marielle C.; Lu, Duo; Won, Sang Joon; Dulberger, Charles L.; Manlick, Angela J.; Keck, James L.; Cox, Michael M.			Creating Directed Double-strand Breaks with the Ref Protein A NOVEL RecA-DEPENDENT NUCLEASE FROM BACTERIOPHAGE P1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL RECA PROTEIN; ESCHERICHIA-COLI-RECA; LEXA REPRESSOR; HOMOLOGOUS RECOMBINATION; ATP HYDROLYSIS; SOS INDUCTION; DNA; CLEAVAGE; MECHANISM; FILAMENT	The bacteriophage P1-encoded Ref protein enhances RecA-dependent recombination in vivo by an unknown mechanism. We demonstrate that Ref is a new type of enzyme; that is, a RecA-dependent nuclease. Ref binds to ss-and dsDNA but does not cleave any DNA substrate until RecA protein and ATP are added to form RecA nucleoprotein filaments. Ref cleaves only where RecA protein is bound. RecA functions as a co-nuclease in the Ref/RecA system. Ref nuclease activity can be limited to the targeted strands of short RecA-containing D-loops. The result is a uniquely programmable endonuclease activity, producing targeted double-strand breaks at any chosen DNA sequence in an oligonucleotide-directed fashion. We present evidence indicating that cleavage occurs in the RecA filament groove. The structure of the Ref protein has been determined to 1.4 angstrom resolution. The core structure, consisting of residues 77-186, consists of a central 2-stranded beta-hairpin that is sandwiched between several alpha-helicaland extended loop elements. The N-terminal 76 amino acid residues are disordered; this flexible region is required for optimal activity. The overall structure of Ref, including several putative active site histidine residues, defines a new subclass of HNH-family nucleases. We propose that enhancement of recombination by Ref reflects the introduction of directed, recombinogenic double-strand breaks.	[Gruenig, Marielle C.; Won, Sang Joon; Dulberger, Charles L.; Manlick, Angela J.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53575 USA; [Lu, Duo; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53575 USA.	cox@biochem.wisc.edu		Keck, James/0000-0002-5961-0220	National Institutes of Health [GM32335, GM068061]; William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068061, R01GM032335, U01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32335 (to M. M. C.) and GM068061 (NIGMS; to J. L. K.). This work was also supported by a William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship (to M. C. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAGDASARIAN M, 1992, MOL MICROBIOL, V6, P885, DOI 10.1111/j.1365-2958.1992.tb01539.x; BAILONE A, 1988, MOL GEN GENET, V214, P389, DOI 10.1007/BF00330471; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Churchill JJ, 2000, J MOL BIOL, V297, P537, DOI 10.1006/jmbi.2000.3590; Churchill JJ, 1999, GENE DEV, V13, P901, DOI 10.1101/gad.13.7.901; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; Drees JC, 2006, J BIOL CHEM, V281, P4708, DOI 10.1074/jbc.M513592200; Drees JC, 2004, J BIOL CHEM, V279, P52991, DOI 10.1074/jbc.M409050200; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank EG, 2000, J MOL BIOL, V297, P585, DOI 10.1006/jmbi.2000.3591; GarinotSchneider C, 1996, J MOL BIOL, V260, P731, DOI 10.1006/jmbi.1996.0433; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; Gruenig MC, 2008, MOL MICROBIOL, V69, P1165, DOI 10.1111/j.1365-2958.2008.06341.x; Harmon FG, 1996, J BIOL CHEM, V271, P23874, DOI 10.1074/jbc.271.39.23874; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; HUNT JB, 1984, J BIOL CHEM, V259, P4793; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; KIM B, 1993, CELL, V73, P1165, DOI 10.1016/0092-8674(93)90645-7; KOCH WH, 1992, MOL GEN GENET, V233, P443, DOI 10.1007/BF00265442; LAVERY PE, 1992, J BIOL CHEM, V267, P20648; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LU SD, 1989, J BACTERIOL, V171, P3427, DOI 10.1128/jb.171.6.3427-3432.1989; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2004, J BIOL CHEM, V279, P30037, DOI 10.1074/jbc.M403064200; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; Mate MJ, 2004, J BIOL CHEM, V279, P34763, DOI 10.1074/jbc.M403719200; McIlwraith MJ, 2001, J MOL BIOL, V305, P23, DOI 10.1006/jmbi.2000.4268; Mehta P, 2004, PROTEIN SCI, V13, P295, DOI 10.1110/ps.03115604; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Shigemori Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh004; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VanLoock MS, 2003, J MOL BIOL, V333, P345, DOI 10.1016/j.jmb.2003.08.053; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Walker GC, 2000, BACTERIAL STRESS RESPONSES, P131; WINDLE BE, 1986, P NATL ACAD SCI USA, V83, P3885, DOI 10.1073/pnas.83.11.3885; WINDLE BE, 1988, J BACTERIOL, V170, P4881, DOI 10.1128/jb.170.10.4881-4889.1988; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yarmolinsky MB, 2004, J BACTERIOL, V186, P7025, DOI 10.1128/JB.186.21.7025-7028.2004; YONG YQ, 1995, J BIOL CHEM, V270, P24509, DOI 10.1074/jbc.270.41.24509; YU X, 1993, J MOL BIOL, V231, P29, DOI 10.1006/jmbi.1993.1254; YU X, 1992, J MOL BIOL, V227, P334, DOI 10.1016/0022-2836(92)90702-L	59	12	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8240	8251		10.1074/jbc.M110.205088	http://dx.doi.org/10.1074/jbc.M110.205088			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193392	Green Published, hybrid			2022-12-25	WOS:000288013300054
J	Schieber, C; Howitt, J; Putz, U; White, JM; Parish, CL; Donnelly, PS; Tan, SS				Schieber, Christine; Howitt, Jason; Putz, Ulrich; White, Jonathan M.; Parish, Clare L.; Donnelly, Paul S.; Tan, Seong-Seng			Cellular Up-regulation of Nedd4 Family Interacting Protein 1 (Ndfip1) using Low Levels of Bioactive Cobalt Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-BASED THERAPEUTICS; AMYLOID-BETA-PEPTIDE; UBIQUITIN LIGASE; CYTOTOXICITY; ACTIVATION; MECHANISM; PROMOTES; COPPER; DAMAGE; DMT1	The delivery of metal ions using cell membrane-permeable metal complexes represents a method for activating cellular pathways. Here, we report the synthesis and characterization of new [Co-III(salen)(acac)] complexes capable of up-regulating the ubiquitin ligase adaptor protein Ndfip1. Ndfip1 is a neuroprotective protein that is up-regulated in the brain after injury and functions in combination with Nedd4 ligases to ubiquitinate harmful proteins for removal. We previously showed that Ndfip1 can be increased in human neurons using CoCl2 that is toxic at high concentration. Here we demonstrate a similar effect can be achieved by low concentrations of synthetic Co-III complexes that are non-toxic and designed to be activated following cellular entry. Activation is achieved by intracellular reduction of Co-III to Co-II leading to release of Co-II ions for Ndfip1 up-regulation. The cellular benefit of Ndfip1 up-regulation by Co-III complexes includes demonstrable protection against cell death in SH-SY5Y cells during stress. In vivo, focal delivery of Co-III complexes into the adult mouse brain was observed to up-regulate Ndfip1 in neurons. These results demonstrate that a cellular response pathway can be advantageously manipulated by chemical modification of metal complexes, and represents a significant step of harnessing low concentration metal complexes for therapeutic benefit.	[Schieber, Christine; White, Jonathan M.; Donnelly, Paul S.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Sch Chem, Parkville, Vic 3010, Australia; [Schieber, Christine; Howitt, Jason; Putz, Ulrich; Parish, Clare L.; Tan, Seong-Seng] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3010, Australia; [Schieber, Christine; Howitt, Jason; Putz, Ulrich; Parish, Clare L.; Tan, Seong-Seng] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Donnelly, PS (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Sch Chem, Victoria, Parkville, Vic 3010, Australia.	pauld@unimelb.edu.au; stan@florey.edu.au	Parish, Clare/A-3380-2014	Parish, Clare/0000-0001-8212-9884; Howitt, Jason/0000-0001-9922-7931	Victorian Neurotrauma Initiative of the TAC; National Health and Medical Research Council (NHMRC)	Victorian Neurotrauma Initiative of the TAC; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants under the Victorian Neurotrauma Initiative of the TAC, and the National Health and Medical Research Council (NH&MRC).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ait-Aissa S, 2000, TOXICOLOGY, V145, P147, DOI 10.1016/S0300-483X(00)00145-1; BAILES RH, 1947, J AM CHEM SOC, V69, P1886, DOI 10.1021/ja01200a013; Bigotto A., 1970, INORG CHIM ACTA REV, V4, P41; Bjorklund O, 2008, EUR J PHARMACOL, V596, P6, DOI 10.1016/j.ejphar.2008.08.002; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Choi JH, 2009, BIOCHEM J, V424, P285, DOI 10.1042/BJ20090371; COZENS RJ, 1972, AUST J CHEM, V25, P911, DOI 10.1071/CH9720911; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Donnelly PS, 2008, J BIOL CHEM, V283, P4568, DOI 10.1074/jbc.M705957200; Dreos R, 2003, INORG CHIM ACTA, V349, P239, DOI 10.1016/S0020-1693(03)00038-0; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Failes TW, 2007, CHEM-EUR J, V13, P2974, DOI 10.1002/chem.200601137; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; FUJII Y, 1970, B CHEM SOC JPN, V43, P1722, DOI 10.1246/bcsj.43.1722; Hall Matthew D., 2007, DALTON T, P3983; Hambley TW, 2007, SCIENCE, V318, P1392, DOI 10.1126/science.1150504; Hambley TW, 2007, DALTON T, P4929, DOI 10.1039/b706075k; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Howitt J, 2009, P NATL ACAD SCI USA, V106, P15489, DOI 10.1073/pnas.0904880106; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mund T, 2010, P NATL ACAD SCI USA, V107, P11429, DOI 10.1073/pnas.0911714107; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Picard V, 2000, J BIOL CHEM, V275, P35738, DOI 10.1074/jbc.M005387200; Putz U, 2008, J BIOL CHEM, V283, P32621, DOI 10.1074/jbc.M804120200; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Tan XL, 2008, NEUROSCI LETT, V441, P272, DOI 10.1016/j.neulet.2008.06.050; TEICHER BA, 1990, CANCER RES, V50, P6971; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; White AR, 2003, J NEUROSCI RES, V71, P889, DOI 10.1002/jnr.10537; Yamada S., 1966, COORDIN CHEM REV, V1, P415; Yamamoto N, 2008, J BIOL INORG CHEM, V13, P861, DOI 10.1007/s00775-008-0374-7; Zhang XA, 2007, J ALLOY COMPD, V432, P247, DOI 10.1016/j.jallcom.2006.05.107	33	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8555	8564		10.1074/jbc.M110.203448	http://dx.doi.org/10.1074/jbc.M110.203448			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21187286	Green Published, hybrid			2022-12-25	WOS:000288013300082
J	Wang, H; Nora, GJ; Ghodke, H; Opresko, PL				Wang, Hong; Nora, Gerald J.; Ghodke, Harshad; Opresko, Patricia L.			Single Molecule Studies of Physiologically Relevant Telomeric Tails Reveal POT1 Mechanism for Promoting G-quadruplex Unfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; BINDING PROTEIN; FISSION YEAST; DNA-DAMAGE; SEQUENCE; END; TETRAPLEX; K+; VISUALIZATION; PROTECTION	Human telomeres are composed of duplex TTAGGG repeats and a 3' single-stranded DNA tail. The telomeric DNA is protected and regulated by the shelterin proteins, including the protection of telomeres 1 (POT1) protein that binds telomeric single-stranded DNA. The single-stranded tail can fold into G-quadruplex (G4) DNA. Both POT1 and G4 DNA play important roles in regulating telomere length homeostasis. To date, most studies have focused on individual quadruplexes formed by four TTAGGG repeats. Telomeric tails in human cells have on average six times as many repeats, and no structural studies have examined POT1 binding in competition with G4 DNA folding. Using single molecule atomic force microscopy imaging, we observed that the majority of the telomeric tails of 16 repeats formed two quadruplexes even though four were possible. The result that physiological telomeric tails rarely form the maximum potential number of G4 units provides a structural basis for the coexistence of G4 and POT1 on the same DNA molecule, which is observed directly in the captured atomic force microscopy images. We further observed that POT1 is significantly more effective in disrupting quadruplex DNA on long telomeric tails than an antisense oligonucleotide, indicating a novel POT1 activity beyond simply preventing quadruplex folding.	[Wang, Hong] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Wang, Hong; Ghodke, Harshad] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Nora, Gerald J.; Opresko, Patricia L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Nora, Gerald J.; Ghodke, Harshad; Opresko, Patricia L.] Univ Pittsburgh, Mol Biophys & Struct Biol Grad Program, Pittsburgh, PA 15260 USA; [Nora, Gerald J.; Ghodke, Harshad; Opresko, Patricia L.] Carnegie Mellon Univ, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Wang, H (corresponding author), 5117 Ctr Ave,Ste 2-6, Pittsburgh, PA 15213 USA.	wangh4@upmc.edu; plo4@pitt.edu	Wang, Hong/F-3164-2014; Ghodke, Harshad/AAE-1599-2019	Wang, Hong/0000-0003-0165-3559; Ghodke, Harshad/0000-0002-6628-876X; Opresko, Patricia/0000-0002-6470-2189	National Institutes of Health [ES0515052, 1K99ES016758-01, F30AG032861]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES016758, R01ES015052, R00ES016758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG032861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants ES0515052 (to P. L. O.), 1K99ES016758-01 (to H. W.), and F30AG032861 (to G. J. N.). This work was also supported by the Ellison Medical Foundation (to P. L. O.).	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chang CC, 2007, NUCLEIC ACIDS RES, V35, P2846, DOI 10.1093/nar/gkm155; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P4927, DOI 10.1093/nar/gkm522; Hansma HG, 1996, NUCLEIC ACIDS RES, V24, P713, DOI 10.1093/nar/24.4.713; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Janicijevic A, 2003, J MICROSC-OXFORD, V212, P264, DOI 10.1111/j.1365-2818.2003.01254.x; Kan ZY, 2007, NUCLEIC ACIDS RES, V35, P3646, DOI 10.1093/nar/gkm203; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Lyubchenko YL, 1997, P NATL ACAD SCI USA, V94, P496, DOI 10.1073/pnas.94.2.496; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; MARSH TC, 1995, NUCLEIC ACIDS RES, V23, P696, DOI 10.1093/nar/23.4.696; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P6269, DOI 10.1093/nar/gkp679; Opresko PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004825; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Petraccone L, 2010, BIOPOLYMERS, V93, P533, DOI 10.1002/bip.21392; Petraccone L, 2008, J AM CHEM SOC, V130, P16530, DOI 10.1021/ja8075567; Price CM, 2006, NAT STRUCT MOL BIOL, V13, P673, DOI 10.1038/nsmb0806-673; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Renciuk D, 2009, NUCLEIC ACIDS RES, V37, P6625, DOI 10.1093/nar/gkp701; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Sowd G, 2008, NUCLEIC ACIDS RES, V36, P4242, DOI 10.1093/nar/gkn385; Sowd G, 2009, J BIOL CHEM, V284, P34682, DOI 10.1074/jbc.M109.049031; Tang J, 2008, NUCLEIC ACIDS RES, V36, P1200, DOI 10.1093/nar/gkm1137; Torigoe H, 2007, J BIOCHEM, V141, P57, DOI 10.1093/jb/mvm011; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Vorlickova M, 2005, NUCLEIC ACIDS RES, V33, P5851, DOI 10.1093/nar/gki898; Wang H., 2007, PROTEIN INTERACTIONS, P39; Wang QA, 2010, ANAL CHEM, V82, P9469, DOI 10.1021/ac102168m; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Xu Y, 2009, ANGEW CHEM INT EDIT, V48, P7833, DOI 10.1002/anie.200903858; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Yoshimura SH, 2004, GENES CELLS, V9, P205, DOI 10.1111/j.1356-9597.2004.00719.x; Yu HQ, 2006, J AM CHEM SOC, V128, P15461, DOI 10.1021/ja064536h; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhang ML, 2010, NAT STRUCT MOL BIOL, V17, P202, DOI 10.1038/nsmb.1760; Zhang XY, 2003, J BIOMOL STRUCT DYN, V20, P693, DOI 10.1080/07391102.2003.10506886	45	69	69	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7479	7489		10.1074/jbc.M110.205641	http://dx.doi.org/10.1074/jbc.M110.205641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21183684	Green Published, hybrid			2022-12-25	WOS:000287737300062
J	Ye, QQ; Li, ZC; Tian, JA; Xie, JX; Liu, LJ; Xie, ZJ				Ye, Qiqi; Li, Zhichuan; Tian, Jiang; Xie, Jeffrey X.; Liu, Lijun; Xie, Zijian			Identification of a Potential Receptor That Couples Ion Transport to Protein Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/K+-ATPASE; NA/K-ATPASE; TYROSINE KINASE; ALPHA-SUBUNIT; SIGNALING MICRODOMAIN; STRUCTURAL BASIS; SRC FAMILY; NA+,K+-ATPASE; BINDING; COMPLEX	In our previous studies, we have demonstrated that the Src-coupled alpha 1 Na/K-ATPase works as a receptor for cardiotonic steroids, such as ouabain, to regulate cellular protein kinase cascades. Here, we explore further the structural determinants of the interaction between the alpha 1 Na/K-ATPase and Src and demonstrate that the Src-coupled alpha 1 Na/K-ATPase allows the cell to decode the transmembrane transport activity of the Na/K-ATPase to turn on/off protein kinases. The alpha 1 Na/K-ATPase undergoes E1/E2 conformational transition during an ion pumping cycle. The amount of E1 and E2 Na/K-ATPase is regulated by extracellular K+ and intracellular Na+. Using purified enzyme preparations we find that the E1 Na/K-ATPase can bind both the Src SH2 and kinase domains simultaneously and keep Src in an inactive state. Conversely, the E1 to E2 transition releases the kinase domain and activates the associated Src. Moreover, we demonstrate that changes in E1/E2 Na/K-ATPase by either Na+ or K+ are capable of regulating Src and Src effectors in live cells. Together, the data suggest that the Src-coupled alpha 1 Na/K-ATPase may act as a Na+/K+ receptor, allowing salt to regulate cellular function through Src and Src effectors.	Univ Toledo, Coll Med, Dept Physiol, Toledo, OH 43614 USA; Univ Toledo, Coll Med, Dept Pharmacol, Toledo, OH 43614 USA; Univ Toledo, Coll Med, Dept Med, Toledo, OH 43614 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Mail Stop 1008,3000 Arlington Ave, Toledo, OH 43614 USA.	Zi-jian.Xie@utoledo.edu	Li, Zhichuan/Q-7379-2017		NHLBI [HL-36573]; NIGMS [GM-78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573 from NHLBI and GM-78565 from NIGMS.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; AKERA T, 1991, LIFE SCI, V48, P97, DOI 10.1016/0024-3205(91)90402-W; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Boerner RJ, 1996, BIOCHEMISTRY-US, V35, P9519, DOI 10.1021/bi960248u; BOWEN JW, 1987, AM J PHYSIOL, V252, pC179, DOI 10.1152/ajpcell.1987.252.2.C179; Cai HP, 2008, AM J PHYSIOL-CELL PH, V294, pC555, DOI 10.1152/ajpcell.00475.2007; CARILLI CT, 1982, J BIOL CHEM, V257, P5601; Chen Y, 2008, J BIOL CHEM, V283, P1128, DOI 10.1074/jbc.M708025200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; DAWSON DC, 1990, AM J PHYSIOL, V259, pC181, DOI 10.1152/ajpcell.1990.259.2.C181; Geys SA, 2009, BIOPHYS J, V96, P4561, DOI 10.1016/j.bpj.2009.03.002; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; HEGYVARY C, 1976, BIOCHIM BIOPHYS ACTA, V422, P365, DOI 10.1016/0005-2744(76)90148-0; HOFFMAN PG, 1971, J GEN PHYSIOL, V58, P438, DOI 10.1085/jgp.58.4.438; HUANG WH, 1990, BIOCHIM BIOPHYS ACTA, V1030, P65, DOI 10.1016/0005-2736(90)90239-K; JORDAN C, 1995, J BIOL CHEM, V270, P29971; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JORGENSEN PL, 1992, ACTA PHYSIOL SCAND, V146, P89; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; Kimura T, 2007, MOL BIOL CELL, V18, P4508, DOI 10.1091/mbc.E06-08-0711; KROGH A, 1946, PROC R SOC SER B-BIO, V133, P140, DOI 10.1098/rspb.1946.0008; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Lin DH, 2004, AM J PHYSIOL-RENAL, V286, pF881, DOI 10.1152/ajprenal.00301.2003; Liu GQ, 1996, FEBS LETT, V390, P323, DOI 10.1016/0014-5793(96)00687-4; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Liu LJ, 2007, MOL CELL BIOCHEM, V306, P231, DOI 10.1007/s11010-007-9574-7; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; MISSIAEN L, 1988, BIOCHEM J, V253, P827, DOI 10.1042/bj2530827; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; SCHULTZ SG, 1981, AM J PHYSIOL, V241, pF579, DOI 10.1152/ajprenal.1981.241.6.F579; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; TAYLOR JS, 1981, J BIOL CHEM, V256, P9793; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Wang WH, 2004, ANNU REV PHYSIOL, V66, P547, DOI 10.1146/annurev.physiol.66.032102.112025; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200; ZOLOTARJOVA N, 1995, J BIOL CHEM, V270, P3989, DOI 10.1074/jbc.270.8.3989	47	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6225	6232		10.1074/jbc.M110.202051	http://dx.doi.org/10.1074/jbc.M110.202051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21189264	hybrid, Green Published			2022-12-25	WOS:000287476400032
J	Hendrich, L; Pons, J; Ribera, I; Balke, M				Hendrich, Lars; Pons, Joan; Ribera, Ignacio; Balke, Michael			Mitochondrial Cox1 Sequence Data Reliably Uncover Patterns of Insect Diversity But Suffer from High Lineage-Idiosyncratic Error Rates	PLOS ONE			English	Article							DNA TAXONOMY; COLEOPTERA; EVOLUTION; IDENTIFICATION; SOUTHEASTERN; BIODIVERSITY; DELIMITATION; LEPIDOPTERA; POPULATIONS; DIVERGENCE	Background: The demand for scientific biodiversity data is increasing, but taxonomic expertise is often limited or not available. DNA sequencing is a potential remedy to overcome this taxonomic impediment. Mitochondrial DNA is most commonly used, e. g., for species identification ("DNA barcoding"). Here, we present the first study in arthropods based on a near-complete species sampling of a family-level taxon from the entire Australian region. We aimed to assess how reliably mtDNA data can capture species diversity when many sister species pairs are included. Then, we contrasted phylogenetic subsampling with the hitherto more commonly applied geographical subsampling, where sister species are not necessarily captured. Methodology/Principal Findings: We sequenced 800 bp cox1 for 1,439 individuals including 260 Australian species (78% species coverage). We used clustering with thresholds of 1 to 10% and general mixed Yule Coalescent (GMYC) analysis for the estimation of species richness. The performance metrics used were taxonomic accuracy and agreement between the morphological and molecular species richness estimation. Clustering (at the 3% level) and GMYC reliably estimated species diversity for single or multiple geographic regions, with an error for larger clades of lower than 10%, thus outperforming parataxonomy. However, the rates of error were higher for some individual genera, with values of up to 45% when very recent species formed nonmonophyletic clusters. Taxonomic accuracy was always lower, with error rates above 20% and a larger variation at the genus level (0 to 70%). Sorensen similarity indices calculated for morphospecies, 3% clusters and GMYC entities for different pairs of localities was consistent among methods and showed expected decrease over distance. Conclusion/Significance: Cox1 sequence data are a powerful tool for large-scale species richness estimation, with a great potential for use in ecology and beta-diversity studies and for setting conservation priorities. However, error rates can be high in individual lineages.	[Hendrich, Lars; Balke, Michael] Zool State Collect, Dept Entomol, Munich, Germany; [Hendrich, Lars; Balke, Michael] Univ Munich, GeoBioCtr, Munich, Germany; [Pons, Joan] Inst Mediterrani Estudis Avancats, Dept Biodiversitat & Conservacio, Esporles, Spain; [Ribera, Ignacio] Inst Evolutionary Biol, Barcelona, Spain	University of Munich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE)	Hendrich, L (corresponding author), Zool State Collect, Dept Entomol, Munich, Germany.	coleoptera-zsm@zsm.mwn.de	Pons, Joan/A-5124-2008; Ribera, Ignacio/K-2909-2017	Pons, Joan/0000-0002-4683-8840; Ribera, Ignacio/0000-0002-2791-7615	Deutsche Forschungsgemeinschaft [BA 2152/4-1, BA 2152/6-1, BA 2152/7-1, HE 5729/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (BA 2152/4-1, 6-1, 7-1, HE 5729/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balke M, 2007, ZOOL SCR, V36, P173, DOI 10.1111/j.1463-6409.2006.00265.x; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Caesar RM, 2006, DIVERS DISTRIB, V12, P483, DOI 10.1111/j.1366-9516.2006.00237.x; Chapple DG, 2005, MOL ECOL, V14, P1279, DOI 10.1111/j.1365-294X.2005.02463.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; Davison A, 2009, MOL ECOL RESOUR, V9, P1092, DOI 10.1111/j.1755-0998.2009.02559.x; DeSaille R, 2007, BIOESSAYS, V29, P1289, DOI 10.1002/bies.20667; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Dickinson JA, 2002, J SEDIMENT RES, V72, P288, DOI 10.1306/082701720288; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Frakes LA, 1987, FAUNA AUSTR A, P1; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Goloboff PA, 2004, CLADISTICS, V20, P84; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich Lars, 2009, Zootaxa, V2288, P1; Jousselin E, 2009, P ROY SOC B-BIOL SCI, V276, P187, DOI 10.1098/rspb.2008.0679; Kelly RP, 2007, MOL ECOL NOTES, V7, P177, DOI 10.1111/j.1471-8286.2006.01641.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Krell FT, 2004, BIODIVERS CONSERV, V13, P795, DOI 10.1023/B:BIOC.0000011727.53780.63; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Maddison WP, 2000, MACCLADE VERSION 4 0; MARKGRAF V, 1995, TRENDS ECOL EVOL, V10, P143, DOI 10.1016/S0169-5347(00)89023-0; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Monaghan MT, 2006, P ROY SOC B-BIOL SCI, V273, P887, DOI 10.1098/rspb.2005.3391; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Papadopoulou A, 2009, MOL PHYLOGENET EVOL, V53, P935, DOI 10.1016/j.ympev.2009.08.027; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pons J, 2010, MOL PHYLOGENET EVOL, V56, P796, DOI 10.1016/j.ympev.2010.02.007; Ribera I, 2008, CLADISTICS, V24, P563, DOI 10.1111/j.1096-0031.2007.00192.x; Ribera I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-29; Riedel A, 2010, ZOOL SCR, V39, P63, DOI 10.1111/j.1463-6409.2009.00404.x; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sorensen T, 1957, BIOL SKR, V5, P1, DOI DOI 10.1016/J.NEUROIMAGE.2006.09.051; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Symula R, 2008, MOL PHYLOGENET EVOL, V47, P569, DOI 10.1016/j.ympev.2008.01.011; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; TEMPLETON AR, 1992, GENETICS, V132, P619; Wahlberg N, 2003, SYST ENTOMOL, V28, P257, DOI 10.1046/j.1365-3113.2003.00212.x; Watts CHS, 2009, T ROY SOC SOUTH AUST, V133, P62, DOI 10.1080/03721426.2009.10887112; WATTS CHS, 1978, AUST J ZOOL, P1; Wheeler QD, 2004, PHILOS T R SOC B, V359, P571, DOI 10.1098/rstb.2003.1452; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	57	84	88	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14448	10.1371/journal.pone.0014448	http://dx.doi.org/10.1371/journal.pone.0014448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203427	gold, Green Published, Green Submitted			2022-12-25	WOS:000285792500020
J	Hovanessian, AG; Soundaramourty, C; El Khoury, D; Nondier, I; Svab, J; Krust, B				Hovanessian, Ara G.; Soundaramourty, Calaiselvy; El Khoury, Diala; Nondier, Isabelle; Svab, Josette; Krust, Bernard			Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization	PLOS ONE			English	Article							PENTAMERIC PSEUDOPEPTIDE HB-19; INHIBITS HIV-INFECTION; BCL-2 MESSENGER-RNA; BINDING-PROTEIN; HEAT-SHOCK; ENVELOPE GLYCOPROTEIN; SCAVENGER RECEPTORS; PERMISSIVE CELLS; DNA-REPLICATION; PLASMA-MEMBRANE	Background: Nucleolin is one of the major proteins of the nucleolus, but it is also expressed on the cell surface where is serves as a binding protein for variety of ligands implicated in tumorigenesis and angiogenesis. Emerging evidence suggests that the cell-surface expressed nucleolin is a strategic target for an effective and nontoxic cancer therapy. Methodology/Principal Findings: By monitoring the expression of nucleolin mRNA, and by measuring the level of nucleolin protein recovered from the surface and nucleus of cells, here we show that the presence of nucleolin at the cell surface is dependent on the constant induction of nucleolin mRNA. Indeed, inhibitors of RNA transcription or translation block expression of surface nucleolin while no apparent effect is observed on the level of nucleolin in the nucleus. The estimated half-life of surface nucleolin is less than one hour, whereas that of nuclear nucleolin is more than 8 hours. Nucleolin mRNA induction is reduced markedly in normal fibroblasts that reach confluence, while it occurs continuously even in post-confluent epithelial tumor cells consistent with their capacity to proliferate without contact inhibition. Interestingly, cold and heat shock induce nucleolin mRNA concomitantly to enhanced mRNA expression of the heat shock protein 70, thus suggesting that surface nucleolin induction also occurs in response to an environmental insult. At the cell surface, one of the main functions of nucleolin is to shuttle specific extracellular ligands by an active transport mechanism, which we show here to be calcium dependent. Conclusion/Significance: Our results demonstrate that the expression of surface nucleolin is an early metabolic event coupled with tumor cell proliferation and stress response. The fact that surface nucleolin is constantly and abundantly expressed on the surface of tumor cells, makes them a preferential target for the inhibitory action of anticancer agents that target surface nucleolin.	[Hovanessian, Ara G.; Soundaramourty, Calaiselvy; El Khoury, Diala; Nondier, Isabelle; Svab, Josette; Krust, Bernard] Univ Paris 05, CNRS, Unite Regulat Transcript Maladies Genet, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Hovanessian, AG (corresponding author), Univ Paris 05, CNRS, Unite Regulat Transcript Maladies Genet, Paris, France.	ara.hovanessian@parisdescartes.fr			French National Center for Scientific Research (CNRS), France	French National Center for Scientific Research (CNRS), France(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the French National Center for Scientific Research (CNRS), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alete DE, 2006, FEBS J, V273, P4668, DOI 10.1111/j.1742-4658.2006.05471.x; Barel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-145; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Callebaut C, 1996, VIROLOGY, V218, P181, DOI 10.1006/viro.1996.0178; Callebaut C, 1998, J BIOL CHEM, V273, P21988, DOI 10.1074/jbc.273.34.21988; Callebaut C, 2001, VIROLOGY, V281, P248, DOI 10.1006/viro.2000.0767; Callebaut C, 1997, J BIOL CHEM, V272, P7159, DOI 10.1074/jbc.272.11.7159; Carpentier M, 2005, BIOCHEMISTRY-US, V44, P5804, DOI 10.1021/bi047831s; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; Dumler I, 1999, CURR BIOL, V9, P1468, DOI 10.1016/S0960-9822(00)80116-5; El Khoury D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-325; Fahling M, 2005, BBA-GENE STRUCT EXPR, V1731, P32, DOI 10.1016/j.bbaexp.2005.08.005; Fogal V, 2009, ANGIOGENESIS, V12, P91, DOI 10.1007/s10456-009-9137-5; Folkman J, 2007, BLOOD, V110, P2786, DOI 10.1182/blood-2007-08-102178; Gattoni-Celli S, 2009, AM J HEMATOL, V84, P535, DOI 10.1002/ajh.21461; Gilchrist JSC, 2002, J CELL BIOCHEM, V85, P268, DOI 10.1002/jcb.10121; Ginisty H, 1999, J CELL SCI, V112, P761; Girvan AC, 2006, MOL CANCER THER, V5, P1790, DOI 10.1158/1535-7163.MCT-05-0361; Grinstein E, 2007, CELL SIGNAL, V19, P2428, DOI 10.1016/j.cellsig.2007.06.021; Harms G, 2001, BIOCHEM J, V360, P531, DOI 10.1042/0264-6021:3600531; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Huang Y, 2006, BLOOD, V107, P3564, DOI 10.1182/blood-2005-07-2961; Hwang J, 2007, J BIOL CHEM, V282, P18645, DOI 10.1074/jbc.M702035200; Iliakis G, 2004, INT J HYPERTHER, V20, P240, DOI 10.1080/02656730310001656379; Inder KL, 2009, J BIOL CHEM, V284, P28410, DOI 10.1074/jbc.M109.001537; Jacotot E, 1996, VIROLOGY, V223, P318, DOI 10.1006/viro.1996.0483; Jiang BM, 2010, FEBS J, V277, P642, DOI 10.1111/j.1742-4658.2009.07510.x; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; Kim K, 2005, MOL CELL BIOL, V25, P2463, DOI 10.1128/MCB.25.6.2463-2474.2005; Kim SK, 2003, DNA CELL BIOL, V22, P171, DOI 10.1089/104454903321655792; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; KLEINMAN HK, 1991, ARCH BIOCHEM BIOPHYS, V290, P320, DOI 10.1016/0003-9861(91)90547-V; KONISHI T, 1995, J BIOCHEM-TOKYO, V117, P1170, DOI 10.1093/oxfordjournals.jbchem.a124840; Krust B, 2001, P NATL ACAD SCI USA, V98, P14090, DOI 10.1073/pnas.221467298; Larrucea S, 1998, J BIOL CHEM, V273, P31718, DOI 10.1074/jbc.273.48.31718; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; LLeonart ME, 2010, BBA-REV CANCER, V1805, P43, DOI 10.1016/j.bbcan.2009.11.001; Losfeld ME, 2009, EXP CELL RES, V315, P357, DOI 10.1016/j.yexcr.2008.10.039; Melendez AJ, 2008, BIOSCIENCE REP, V28, P287, DOI 10.1042/BSR20080082; Nisole S, 2002, J BIOL CHEM, V277, P20877, DOI 10.1074/jbc.M110024200; Nisole S, 2002, EXP CELL RES, V276, P155, DOI 10.1006/excr.2002.5522; Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875; Nisole S, 2000, AIDS RES HUM RETROV, V16, P237, DOI 10.1089/088922200309331; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; OHMORI H, 1990, EXP CELL RES, V189, P227, DOI 10.1016/0014-4827(90)90240-B; Otake Y, 2005, MOL PHARMACOL, V67, P319, DOI 10.1124/mol.104.006080; OTAKE Y, 2010, NEOPLASIA, V109, P3069; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Perez-Pinera P, 2008, CURR OPIN HEMATOL, V15, P210, DOI 10.1097/MOH.0b013e3282fdc69e; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; REY MA, 1989, VIROLOGY, V173, P258, DOI 10.1016/0042-6822(89)90242-0; Reyes-Reyes EM, 2008, EXP CELL RES, V314, P2212, DOI 10.1016/j.yexcr.2008.03.016; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Said EA, 2002, J BIOL CHEM, V277, P37492, DOI 10.1074/jbc.M201194200; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Shi HB, 2007, BLOOD, V110, P2899, DOI 10.1182/blood-2007-01-064428; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; Sinclair JF, 2002, J BIOL CHEM, V277, P2876, DOI 10.1074/jbc.M110230200; Sorokina EA, 1999, J BIOL CHEM, V274, P27491, DOI 10.1074/jbc.274.39.27491; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Srivastava MD, 1999, FASEB J, V13, pA683; Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455; STORCK S, 2007, SUBCELL BIOCH, V41; Tate A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-197; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; Theriault JR, 2006, J IMMUNOL, V177, P8604, DOI 10.4049/jimmunol.177.12.8604; Turck N, 2006, J CELL PHYSIOL, V206, P545, DOI 10.1002/jcp.20501; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Westmark CJ, 2001, J BIOL CHEM, V276, P1119, DOI 10.1074/jbc.M009435200; Xu XH, 2001, J BIOL CHEM, V276, P43221, DOI 10.1074/jbc.M104446200; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251	80	145	146	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15787	10.1371/journal.pone.0015787	http://dx.doi.org/10.1371/journal.pone.0015787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203423	Green Submitted, gold, Green Published			2022-12-25	WOS:000285579200040
J	Ohshima, S; Ohashi-Suzuki, M; Miura, Y; Yabu, Y; Okada, N; Ohta, N; Suzuki, T				Ohshima, Shigeru; Ohashi-Suzuki, Mitsuko; Miura, Yutaka; Yabu, Yoshisada; Okada, Noriko; Ohta, Nobuo; Suzuki, Takashi			TbUNC119 and Its Binding Protein Complex Are Essential for Propagation, Motility, and Morphogenesis of Trypanosoma brucei Procyclic Form Cells	PLOS ONE			English	Article							FLAGELLAR MOTILITY; NERVOUS-SYSTEM; HRG4 UNC119; UNC-119; GENE; INVASION; ELEGANS; PARASITE; CLONING; DIFFERENTIATION	Flagellum-mediated motility of Trypanosoma brucei is considered to be essential for the parasite to complete stage development in the tsetse fly vector, while the mechanism by which flagellum-mediated motility is controlled are not fully understood. We thus compared T. brucei whole gene products (amino acid sequence) with Caenorhabditis elegans UNC (uncoordinated) proteins, in order to find uncharacterized motility-related T. brucei genes. Through in silico analysis, we found 88 gene products which were highly similar to C. elegans UNC proteins and categorized them as TbCEUN (T. brucei gene products which have high similarity to C. elegans UNC proteins). Approximately two thirds of the 88 TbCEUN gene products were kinesin-related molecules. A gene product highly similar to C. elegans UNC119 protein was designated as TbUNC119. RNAi-mediated depletion of TbUNC119 showed no apparent phenotype. However, knock-down analysis of both TbUNC119 and its binding protein (TbUNC119BP) which was found by yeast two-hybrid analysis showed characteristic phenotypes, including reduced motility, morphological change (extended cell shape), and cellular apoptosis. Based on the observed phenotypes, possible function of the TbUNC119 and TbUNC119BP is discussed.	[Ohshima, Shigeru] Nagoya City Univ, Grad Sch Med Sci, Dept Core Lab, Nagoya, Aichi, Japan; [Ohshima, Shigeru; Ohashi-Suzuki, Mitsuko; Ohta, Nobuo; Suzuki, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Parasitol, Nagoya, Aichi, Japan; [Ohshima, Shigeru; Ohashi-Suzuki, Mitsuko; Yabu, Yoshisada; Okada, Noriko; Suzuki, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Immunol, Nagoya, Aichi, Japan; [Ohashi-Suzuki, Mitsuko; Ohta, Nobuo; Suzuki, Takashi] Tokyo Med & Dent Univ, Grad Sch, Dept Int Hlth Dev, Div Publ Hlth, Tokyo, Japan; [Miura, Yutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Neurol, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University; Nagoya City University; Tokyo Medical & Dental University (TMDU); Nagoya City University	Ohshima, S (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Core Lab, Nagoya, Aichi, Japan.	0897vip@tmd.ac.jp			Ministry of Education, Science, Culture and Sports of Japan [19590434 (2007-9)]; Japan Initiative Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This study was supported in part by a Grant-in-Aid for Scientific Research (C), 19590434 (2007-9), from the Ministry of Education, Science, Culture and Sports of Japan. This study was also supported in part by the Japan Initiative Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alpadi K, 2008, J BIOL CHEM, V283, P26461, DOI 10.1074/jbc.M801625200; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; BRUN R, 1979, ACTA TROP, V36, P289; CAVALLI A, 2009, Trypanosoma Leishman, V52, P7339, DOI DOI 10.1021/JM9004835; Cen O, 2003, J BIOL CHEM, V278, P8837, DOI 10.1074/jbc.M208261200; Chung S, 2007, GENE, V389, P45, DOI 10.1016/j.gene.2006.09.032; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hendriks EF, 2001, EMBO J, V20, P6700, DOI 10.1093/emboj/20.23.6700; Higashide T, 1999, GENOMICS, V57, P446, DOI 10.1006/geno.1999.5791; Hill KL, 2003, EUKARYOT CELL, V2, P200, DOI 10.1128/EC.2.2.200-208.2003; Karim Z, 2010, CELL SIGNAL, V22, P128, DOI 10.1016/j.cellsig.2009.09.022; Knobel KM, 2001, DEVELOPMENT, V128, P4079; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Lu S, 2007, PARASITOLOGY, V134, P1639, DOI 10.1017/S0031182007003046; MADURO M, 1995, GENETICS, V141, P977; Maduro MF, 2000, J NEUROGENET, V13, P191, DOI 10.3109/01677060009084494; Manning AG, 2004, GENESIS, V40, P223, DOI 10.1002/gene.20089; Manson MD, 1998, J BACTERIOL, V180, P1009, DOI 10.1128/JB.180.5.1009-1022.1998; Materi W, 2005, GENESIS, V42, P104, DOI 10.1002/gene.20130; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Pinder JC, 1998, J CELL SCI, V111, P1831; Ralston KS, 2008, INT J PARASITOL, V38, P869, DOI 10.1016/j.ijpara.2008.03.003; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; Suzuki T, 2004, PARASITOL INT, V53, P235, DOI 10.1016/j.parint.2004.02.001; TETLEY L, 1985, J CELL SCI, V74, P1; Vepachedu R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005211; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Welburn SC, 2006, PARASITOLOGY, V132, pS7, DOI 10.1017/S0031182006000825	39	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15577	10.1371/journal.pone.0015577	http://dx.doi.org/10.1371/journal.pone.0015577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203515	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000035
J	Durk, RC; Singh, K; Cornelison, CA; Rai, DK; Matzek, KB; Leslie, MD; Schafer, E; Marchand, B; Adedeji, A; Michailidis, E; Dorst, CA; Moran, J; Pautler, C; Rodriguez, LL; McIntosh, MA; Rieder, E; Sarafianos, SG				Durk, Ryan C.; Singh, Kamalendra; Cornelison, Ceili A.; Rai, Devendra K.; Matzek, Kayla B.; Leslie, Maxwell D.; Schafer, Elizabeth; Marchand, Bruno; Adedeji, Adeyemi; Michailidis, Eleftherios; Dorst, Christopher A.; Moran, Jennifer; Pautler, Christie; Rodriguez, Luis L.; McIntosh, Mark A.; Rieder, Elizabeth; Sarafianos, Stefan G.			Inhibitors of Foot and Mouth Disease Virus Targeting a Novel Pocket of the RNA-Dependent RNA Polymerase	PLOS ONE			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; I KLENOW FRAGMENT; HEPATITIS-C; NS5B POLYMERASE; ACTIVE-SITE; NONNUCLEOSIDE INHIBITOR; DRUG-RESISTANCE; RIBAVIRIN; MECHANISMS; REPLICATION	Background: Foot-and-Mouth Disease Virus (FMDV) is a picornavirus that infects cloven-hoofed animals and leads to severe losses in livestock production. In the case of an FMD outbreak, emergency vaccination requires at least 7 days to trigger an effective immune response. There are currently no approved inhibitors for the treatment or prevention of FMDV infections. Methodology/Principal Findings: Using a luciferase-based assay we screened a library of compounds and identified seven novel inhibitors of 3Dpol, the RNA-dependent RNA polymerase of FMDV. The compounds inhibited specifically 3Dpol (IC(50)s from 2-17 mu M) and not other viral or bacterial polymerases. Enzyme kinetic studies on the inhibition mechanism by compounds 5D9 and 7F8 showed that they are non-competitive inhibitors with respect to NTP and nucleic acid substrates. Molecular modeling and docking studies into the 3Dpol structure revealed an inhibitor binding pocket proximal to, but distinct from the 3Dpol catalytic site. Residues surrounding this pocket are conserved among all 60 FMDV subtypes. Site directed mutagenesis of two residues located at either side of the pocket caused distinct resistance to the compounds, demonstrating that they indeed bind at this site. Several compounds inhibited viral replication with 5D9 suppressing virus production in FMDV-infected cells with EC50 = 12 mu M and EC90 = 20 mu M). Significance: We identified several non-competitive inhibitors of FMDV 3Dpol that target a novel binding pocket, which can be used for future structure-based drug design studies. Such studies can lead to the discovery of even more potent antivirals that could provide alternative or supplementary options to contain future outbreaks of FMD.	[Durk, Ryan C.; Singh, Kamalendra; Cornelison, Ceili A.; Rai, Devendra K.; Matzek, Kayla B.; Leslie, Maxwell D.; Marchand, Bruno; Adedeji, Adeyemi; Michailidis, Eleftherios; Dorst, Christopher A.; Moran, Jennifer; Pautler, Christie; Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65212 USA; [Schafer, Elizabeth; Rodriguez, Luis L.; Rieder, Elizabeth] ARS, Foreign Anim Dis Res Unit, USDA, Plum Isl Anim Dis Ctr, Greenport, NY USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA)	Durk, RC (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65212 USA.	sarafianoss@missouri.edu	Rai, Devendra/J-3857-2013; Rai, Devendra/AAX-3100-2020; Adedeji, Adeyemi/AAO-5703-2020; Adedeji, Adeyemi O/I-1327-2019	Rai, Devendra/0000-0001-9035-685X; Adedeji, Adeyemi/0000-0002-5153-1990; Sarafianos, Stefan G/0000-0002-5840-154X; Michailidis, Eleftherios/0000-0002-9907-4346	United States Department of Agriculture [ARS-58-1940-5-519]; National Institutes of Health [AI076119, AI079801, AI074389]; AmfAR Mathilde Kim Fellowship; Korea Food & Drug Administration; Ministry of Knowledge and Economy, Republic of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074389, R21AI079801, R33AI079801, R01AI076119] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AmfAR Mathilde Kim Fellowship; Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Ministry of Knowledge and Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States Department of Agriculture (ARS-58-1940-5-519 to SGS); Salary support was also provided by the National Institutes of Health (AI076119, AI079801, and AI074389); AmfAR Mathilde Kim Fellowship grant to BM; and from the Korea Food & Drug Administration and the Ministry of Knowledge and Economy, Bilateral International Collaborative R&D Program, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo R, 2008, J MOL BIOL, V382, P652, DOI 10.1016/j.jmb.2008.07.033; Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; BELSHAM GJ, 1993, PROG BIOPHYS MOL BIO, V60, P241, DOI 10.1016/0079-6107(93)90016-D; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; D'Abramo CM, 2006, J BIOL CHEM, V281, P24991, DOI 10.1074/jbc.M600474200; De Clercq E, 2005, ANTIVIR RES, V67, P56, DOI 10.1016/j.antiviral.2005.05.001; De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703; Deval J, 2007, ANTIMICROB AGENTS CH, V51, P2920, DOI 10.1128/AAC.00186-07; Ellingham M, 2006, RNA, V12, P1970, DOI 10.1261/rna.161006; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Ferrer-Orta C, 2010, J VIROL, V84, P6188, DOI 10.1128/JVI.02420-09; Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198; Giuliano C, 2005, XENOBIOTICA, V35, P1035, DOI 10.1080/00498250500356548; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Grubman MJ, 2005, BIOLOGICALS, V33, P227, DOI 10.1016/j.biologicals.2005.08.009; Lahser FC, 2004, ANAL BIOCHEM, V325, P247, DOI 10.1016/j.ab.2003.10.034; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Love RA, 2003, J VIROL, V77, P7575, DOI 10.1128/JVI.77.13.7575-7581.2003; Ma H, 2007, J BIOL CHEM, V282, P29812, DOI 10.1074/jbc.M705274200; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Menendez-Arias L, 2008, VIRUS RES, V134, P1, DOI 10.1016/j.virusres.2008.01.009; Menendez-Arias L, 2010, ANTIVIR RES, V85, P210, DOI 10.1016/j.antiviral.2009.07.006; Michailidis E, 2009, J BIOL CHEM, V284, P35681, DOI 10.1074/jbc.M109.036616; Nayak A, 2005, J VIROL, V79, P7698, DOI 10.1128/JVI.79.12.7698-7706.2005; Nesya G, 2007, ANTIVIR RES, V73, P161, DOI 10.1016/j.antiviral.2006.09.007; Pace P, 2004, BIOORG MED CHEM LETT, V14, P3257, DOI 10.1016/j.bmcl.2004.03.087; Pariente N, 2005, VIRUS RES, V107, P183, DOI 10.1016/j.virusres.2004.11.008; Parniak M A, 2000, Adv Pharmacol, V49, P67; Paton DJ, 2005, REV SCI TECH OIE, V24, P981, DOI 10.20506/rst.24.3.1632; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Powdrill MH, 2010, ANTIMICROB AGENTS CH, V54, P977, DOI 10.1128/AAC.01216-09; RYAN MD, 1989, VIROLOGY, V173, P35, DOI 10.1016/0042-6822(89)90219-5; SARAFIANOS SG, 1995, BIOCHEMISTRY-US, V34, P7207, DOI 10.1021/bi00021a036; Sarafianos SG, 1996, BIOCHEM J, V319, P619, DOI 10.1042/bj3190619; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Shehu-Xhilaga M, 2005, CURR MED CHEM, V12, P1705, DOI 10.2174/0929867054367211; Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06; Singh K, 2003, J BIOL CHEM, V278, P11289, DOI 10.1074/jbc.M211496200; Singh K, 2010, VIRUSES-BASEL, V2, P606, DOI 10.3390/v2020606; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; SMITH DW, 1991, NEW ENGL J MED, V325, P24, DOI 10.1056/NEJM199107043250105; Tuske S, 2000, J BIOL CHEM, V275, P23759, DOI 10.1074/jbc.M001804200; Vagnozzi A, 2007, J VIROL, V81, P11669, DOI 10.1128/JVI.00557-07; Vandyck K, 2009, J MED CHEM, V52, P4099, DOI 10.1021/jm9005548; Xia Q, 2007, PROTEIN SCI, V16, P1728, DOI 10.1110/ps.072829007; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	51	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15049	10.1371/journal.pone.0015049	http://dx.doi.org/10.1371/journal.pone.0015049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203539	Green Published, gold			2022-12-25	WOS:000285576900016
J	Charlson, ES; Chen, J; Custers-Allen, R; Bittinger, K; Li, HZ; Sinha, R; Hwang, J; Bushman, FD; Collman, RG				Charlson, Emily S.; Chen, Jun; Custers-Allen, Rebecca; Bittinger, Kyle; Li, Hongzhe; Sinha, Rohini; Hwang, Jennifer; Bushman, Frederic D.; Collman, Ronald G.			Disordered Microbial Communities in the Upper Respiratory Tract of Cigarette Smokers	PLOS ONE			English	Article							BACTERIAL INTERFERENCE; POTENTIAL PATHOGENS; SMOKING-CESSATION; HOUSE-DUST; DIVERSITY; NASOPHARYNX; SEQUENCES; RECOVERY; STRAINS; OTITIS	Cigarette smokers have an increased risk of infectious diseases involving the respiratory tract. Some effects of smoking on specific respiratory tract bacteria have been described, but the consequences for global airway microbial community composition have not been determined. Here, we used culture-independent high-density sequencing to analyze the microbiota from the right and left nasopharynx and oropharynx of 29 smoking and 33 nonsmoking healthy asymptomatic adults to assess microbial composition and effects of cigarette smoking. Bacterial communities were profiled using 454 pyrosequencing of 16S sequence tags (803,391 total reads), aligned to 16S rRNA databases, and communities compared using the UniFrac distance metric. A Random Forest machine-learning algorithm was used to predict smoking status and identify taxa that best distinguished between smokers and nonsmokers. Community composition was primarily determined by airway site, with individuals exhibiting minimal side-of-body or temporal variation. Within airway habitats, microbiota from smokers were significantly more diverse than nonsmokers and clustered separately. The distributions of several genera were systematically altered by smoking in both the oro- and nasopharynx, and there was an enrichment of anaerobic lineages associated with periodontal disease in the oropharynx. These results indicate that distinct regions of the human upper respiratory tract contain characteristic microbial communities that exhibit disordered patterns in cigarette smokers, both in individual components and global structure, which may contribute to the prevalence of respiratory tract complications in this population.	[Charlson, Emily S.; Custers-Allen, Rebecca; Bittinger, Kyle; Sinha, Rohini; Hwang, Jennifer; Bushman, Frederic D.; Collman, Ronald G.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Chen, Jun; Li, Hongzhe] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Charlson, Emily S.; Collman, Ronald G.] Univ Penn, Sch Med, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Charlson, ES (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu; collmanr@mail.med.upenn.edu	Bittinger, Kyle/ABG-2342-2020	Bushman, Frederic/0000-0003-4740-4056; Collman, Ronald/0000-0002-0508-3701	National Institutes of Health [U01 HL98957]; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Lung Human Microbiome Project Grant U01 HL98957 from the National Institutes of Health to R.G.C. and F.D.B. The authors also acknowledge the Penn Genome Frontiers Institute and a grant with the Pennsylvania Department of Health; the Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALY R, 1974, J INFECT DIS, V129, P720, DOI 10.1093/infdis/129.6.720; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; ARONSON MD, 1982, JAMA-J AM MED ASSOC, V248, P181, DOI 10.1001/jama.248.2.181; Brook I, 2005, CHEST, V127, P2072, DOI 10.1378/chest.127.6.2072; BROOK I, 1995, ARCH OTOLARYNGOL, V121, P1405; Brook I, 2005, OTOLARYNG HEAD NECK, V133, P139, DOI 10.1016/j.otohns.2005.03.012; Brook I, 2008, ANN OTO RHINOL LARYN, V117, P727, DOI 10.1177/000348940811701003; Brook I, 2007, ARCH OTOLARYNGOL, V133, P135, DOI 10.1001/archotol.133.2.135; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; CROWE CC, 1973, J INFECT DIS, V128, P527, DOI 10.1093/infdis/128.4.527; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Downes J, 2001, J MED MICROBIOL, V50, P947, DOI 10.1099/0022-1317-50-11-947; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P27, DOI 10.1111/j.1574-695X.1999.tb01713.x; ERTEL A, 1991, CHEST, V100, P628, DOI 10.1378/chest.100.3.628; Fullmer SC, 2009, J DENT RES, V88, P524, DOI 10.1177/0022034509338676; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Kaarakainen P, 2009, SCI TOTAL ENVIRON, V407, P4673, DOI 10.1016/j.scitotenv.2009.04.046; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mikkelsen L, 2000, ORAL MICROBIOL IMMUN, V15, P263, DOI 10.1034/j.1399-302x.2000.150409.x; Pakarinen J, 2008, ENVIRON MICROBIOL, V10, P3317, DOI 10.1111/j.1462-2920.2008.01723.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rasmussen TT, 2000, APMIS, V108, P663, DOI 10.1034/j.1600-0463.2000.d01-13.x; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Senn L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-9; Shchipkova AY, 2010, J DENT RES, V89, P1247, DOI 10.1177/0022034510377203; STANLEY PJ, 1986, THORAX, V41, P519, DOI 10.1136/thx.41.7.519; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; TURKELTAUB PC, 1991, ANN ALLERGY, V67, P147; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Winkelhoff AJ, 2001, J PERIODONTOL, V72, P666, DOI 10.1902/jop.2001.72.5.666; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wos-Oxley ML, 2010, ISME J, V4, P839, DOI 10.1038/ismej.2010.15; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yang J, 2010, J DAIRY SCI, V93, P3136, DOI 10.3168/jds.2009-2898; Zambon JJ, 1996, J PERIODONTOL, V67, P1050, DOI 10.1902/jop.1996.67.10s.1050; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	52	240	250	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15216	10.1371/journal.pone.0015216	http://dx.doi.org/10.1371/journal.pone.0015216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188149	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200022
J	Crewther, DP; Crewther, SG				Crewther, David P.; Crewther, Sheila G.			Different Temporal Structure for Form versus Surface Cortical Color Systems - Evidence from Chromatic Non-Linear VEP	PLOS ONE			English	Article							VISUAL-EVOKED-POTENTIALS; PRIMATE STRIATE CORTEX; FUNCTIONAL-ORGANIZATION; OCCIPITOTEMPORAL CORTEX; MACAQUE V1; MONKEY; V2; CONTRAST; COMPONENTS; NEURONS	Physiological studies of color processing have typically measured responses to spatially varying chromatic stimuli such as gratings, while psychophysical studies of color include color naming, color and light, as well as spatial and temporal chromatic sensitivities. This raises the question of whether we have one or several cortical color processing systems. Here we show from non-linear analysis of human visual evoked potentials (VEP) the presence of distinct and independent temporal signatures for form and surface color processing. Surface color stimuli produced most power in the second order Wiener kernel, indicative of a slowly recovering neural system, while chromatic form stimulation produced most power in the first order kernel (showing rapid recovery). We find end-spectral saturation-dependent signals, easily separable from achromatic signals for surface color stimuli. However physiological responses to form color stimuli, though varying somewhat with saturation, showed similar waveform components. Lastly, the spectral dependence of surface and form color VEP was different, with the surface color responses almost vanishing with yellow-grey isoluminant stimulation whereas the form color VEP shows robust recordable signals across all hues. Thus, surface and form colored stimuli engage different neural systems within cortex, pointing to the need to establish their relative contributions under the diverse chromatic stimulus conditions used in the literature.	[Crewther, David P.] Swinburne Univ Technol, Brain Sci Inst, Melbourne, Vic, Australia; [Crewther, Sheila G.] La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia	Swinburne University of Technology; La Trobe University	Crewther, DP (corresponding author), Swinburne Univ Technol, Brain Sci Inst, Melbourne, Vic, Australia.	dcrewther@swin.edu.au	Crewther, Sheila G/A-2165-2008					BAIZER JS, 1977, J NEUROPHYSIOL, V40, P1024, DOI 10.1152/jn.1977.40.5.1024; Beauchamp MS, 1999, CEREB CORTEX, V9, P257, DOI 10.1093/cercor/9.3.257; BERNINGER TA, 1989, BRIT J OPHTHALMOL, V73, P502, DOI 10.1136/bjo.73.7.502; BRADLEY A, 1992, APPL OPTICS, V31, P3657, DOI 10.1364/AO.31.003657; Cant JS, 2008, PERCEPTION, V37, P57, DOI 10.1068/p5727; Cant JS, 2007, CEREB CORTEX, V17, P713, DOI 10.1093/cercor/bhk022; Chatterjee S, 2003, NATURE, V426, P668, DOI 10.1038/nature02163; Conway BR, 2002, CEREB CORTEX, V12, P915, DOI 10.1093/cercor/12.9.915; Crewther DP, 2002, CLIN EXP OPHTHALMOL, V30, P231, DOI 10.1046/j.1442-9071.2002.00517.x; CROGNALE MA, 1993, J OPT SOC AM A, V10, P1818, DOI 10.1364/JOSAA.10.001818; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DOW B, 1990, SCIENCE VISION; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; Engel SA, 2005, NEURON, V45, P613, DOI 10.1016/j.neuron.2005.01.014; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; ESTEVEZ O, 1983, COLOUR VISION, P261; FIORENTINI A, 1991, NATO ADV SCI I A-LIF, V203, P139; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; GOURAS P, 1968, J PHYSIOL-LONDON, V199, P533, DOI 10.1113/jphysiol.1968.sp008667; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; Johnson EN, 2008, J NEUROSCI, V28, P8096, DOI 10.1523/JNEUROSCI.1404-08.2008; KAISER PK, 1996, HUMAN COLOR VISION W; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Klistorner A, 1997, VISION RES, V37, P2161, DOI 10.1016/S0042-6989(97)00003-5; Klistorner A, 1998, VISION RES, V38, P3979, DOI 10.1016/S0042-6989(97)00394-5; KULIKOWSKI J, 1989, ELECTROPHYSIOL CORRE; LENNIE P, 1990, J NEUROSCI, V10, P649; Lu HD, 2008, CEREB CORTEX, V18, P516, DOI 10.1093/cercor/bhm081; Lu HD, 2007, CEREB CORTEX, V17, P2675, DOI 10.1093/cercor/bhl177; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; PAULUS WM, 1984, ELECTROEN CLIN NEURO, V58, P107, DOI 10.1016/0013-4694(84)90023-3; PAULUS WM, 1986, PROC R SOC SER B-BIO, V227, P53, DOI 10.1098/rspb.1986.0009; RABIN J, 1994, VISION RES, V34, P2657, DOI 10.1016/0042-6989(94)90222-4; Roe AW, 1999, J NEUROPHYSIOL, V82, P2719, DOI 10.1152/jn.1999.82.5.2719; Roe AW, 2005, ANAT REC PART A, V287A, P1213, DOI 10.1002/ar.a.20248; ROE AW, 2006, J VIS, V6, P405; Self MW, 2005, CEREB CORTEX, V15, P1270, DOI 10.1093/cercor/bhi010; Sutter Erich, 2000, Documenta Ophthalmologica, V100, P49, DOI 10.1023/A:1002702917233; Ts'o DY, 2001, VISION RES, V41, P1333, DOI 10.1016/S0042-6989(01)00076-1; TSO DY, 1988, J NEUROSCI, V8, P1712; Usher M, 1998, NATURE, V394, P179, DOI 10.1038/28166; Wang Y, 2007, CEREB CORTEX, V17, P116, DOI 10.1093/cercor/bhj131; Xiao YP, 2007, NEUROIMAGE, V35, P771, DOI 10.1016/j.neuroimage.2006.11.059; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15266	10.1371/journal.pone.0015266	http://dx.doi.org/10.1371/journal.pone.0015266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187960	Green Published, gold			2022-12-25	WOS:000285575200028
J	Fischer, K; Dierks, A; Franke, K; Geister, TL; Liszka, M; Winter, S; Pflicke, C				Fischer, Klaus; Dierks, Anneke; Franke, Kristin; Geister, Thorin L.; Liszka, Magdalena; Winter, Sarah; Pflicke, Claudia			Environmental Effects on Temperature Stress Resistance in the Tropical Butterfly Bicyclus Anynana	PLOS ONE			English	Article							BENEFICIAL ACCLIMATION HYPOTHESIS; DROSOPHILA-MELANOGASTER; THERMAL TOLERANCE; CHILL-COMA; PHENOTYPIC PLASTICITY; HSP70 EXPRESSION; MATING SUCCESS; RECOVERY-TIME; HEAT-SHOCK; LIFE-SPAN	Background: The ability to withstand thermal stress is considered to be of crucial importance for individual fitness and species' survival. Thus, organisms need to employ effective mechanisms to ensure survival under stressful thermal conditions, among which phenotypic plasticity is considered a particularly quick and effective one. Methodology/Principal Findings: In a series of experiments we here investigate phenotypic adjustment in temperature stress resistance following environmental manipulations in the butterfly Bicyclus anynana. Cooler compared to warmer acclimation temperatures generally increased cold but decreased heat stress resistance and vice versa. In contrast, short-time hardening responses revealed more complex patterns, with, e.g., cold stress resistance being highest at intermediate hardening temperatures. Adult food stress had a negative effect on heat but not on cold stress resistance. Additionally, larval feeding treatment showed interactive effects with adult feeding for heat but not for cold stress resistance, indicating that nitrogenous larval resources may set an upper limit to performance under heat stress. In contrast to expectations, cold resistance slightly increased during the first eight days of adult life. Light cycle had marginal effects on temperature stress resistance only, with cold resistance tending to be higher during daytime and thus active periods. Conclusions/Significance: Our results highlight that temperature-induced plasticity provides an effective tool to quickly and strongly modulate temperature stress resistance, and that such responses are readily reversible. However, resistance traits are not only affected by ambient temperature, but also by, e.g., food availability and age, making their measurement challenging. The latter effects are largely underexplored and deserve more future attention. Owing to their magnitude, plastic responses in thermal tolerance should be incorporated into models trying to forecast effects of global change on extant biodiversity.	[Fischer, Klaus; Dierks, Anneke; Franke, Kristin; Winter, Sarah] Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany; [Geister, Thorin L.; Liszka, Magdalena; Pflicke, Claudia] Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Bayreuth	Fischer, K (corresponding author), Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany.	klaus.fischer@uni-greifswald.de			German Research Council (DFG) [Fi 846/1-2, 1-3, 1-4]	German Research Council (DFG)(German Research Foundation (DFG))	This work was funded by the German Research Council (DFG grants no. Fi 846/1-2, 1-3 and 1-4 to KFi). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LH, 2010, J INSECT PHYSIOL, V56, P336, DOI 10.1016/j.jinsphys.2009.11.006; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Ayrinhac A, 2004, FUNCT ECOL, V18, P700, DOI 10.1111/j.0269-8463.2004.00904.x; Bahrndorff S, 2009, FUNCT ECOL, V23, P340, DOI 10.1111/j.1365-2435.2008.01503.x; Bauerfeind SS, 2005, OIKOS, V111, P514, DOI 10.1111/j.0030-1299.2005.13888.x; Bauerfeind SS, 2009, EXP GERONTOL, V44, P805, DOI 10.1016/j.exger.2009.10.007; Bijlsma R, 2005, J EVOLUTION BIOL, V18, P744, DOI 10.1111/j.1420-9101.2005.00962.x; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1997, ENV STRESS ADAPTATIO, P105; Calosi P, 2008, BIOL LETTERS, V4, P99, DOI 10.1098/rsbl.2007.0408; Castaneda LE, 2005, J INSECT PHYSIOL, V51, P1346, DOI 10.1016/j.jinsphys.2005.08.005; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; David JR, 2003, FUNCT ECOL, V17, P425, DOI 10.1046/j.1365-2435.2003.00750.x; Deere JA, 2006, J INSECT PHYSIOL, V52, P693, DOI 10.1016/j.jinsphys.2006.03.009; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diffenbaugh NS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030000; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Fischer K, 2003, ECOLOGY, V84, P3138, DOI 10.1890/02-0733; Fischer K, 2001, ANIM BEHAV, V61, P723, DOI 10.1006/anbe.2000.1662; Fischer K, 2008, P ROY SOC B-BIOL SCI, V275, P1517, DOI 10.1098/rspb.2007.1455; Geister TL, 2007, BEHAV ECOL, V18, P658, DOI 10.1093/beheco/arm024; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; HOFFMANN AA, 1991, EVOL GEN ENVIR STRES; Jensen D, 2007, J INSECT PHYSIOL, V53, P179, DOI 10.1016/j.jinsphys.2006.11.008; Karl I, 2009, J EVOLUTION BIOL, V22, P172, DOI 10.1111/j.1420-9101.2008.01630.x; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Karl I, 2007, BIOL J LINN SOC, V91, P403, DOI 10.1111/j.1095-8312.2007.00806.x; Karl I, 2010, POPUL ECOL, V52, P307, DOI 10.1007/s10144-009-0191-z; Karl I, 2009, FUNCT ECOL, V23, P1132, DOI 10.1111/j.1365-2435.2009.01607.x; KARLSSON B, 1994, OIKOS, V69, P224, DOI 10.2307/3546142; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Kellermann VM, 2006, EVOLUTION, V60, P1104, DOI 10.1554/05-710.1; Kellett M, 2005, FUNCT ECOL, V19, P853, DOI 10.1111/j.1365-2435.2005.01025.x; Lalouette L, 2010, BIOL LETTERS, V6, P346, DOI 10.1098/rsbl.2009.0873; LARSEN TB, 1991, BUTTERFLIES KENYA OX; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; Loeschcke V, 2005, J THERM BIOL, V30, P255, DOI 10.1016/j.jtherbio.2004.12.005; Loeschcke V, 2007, AM NAT, V169, P175, DOI 10.1086/510632; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Macdonald SS, 2004, J INSECT PHYSIOL, V50, P695, DOI 10.1016/j.jinsphys.2004.05.004; Marais E, 2009, J INSECT PHYSIOL, V55, P336, DOI 10.1016/j.jinsphys.2008.11.016; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; McMillan DM, 2005, FUNCT ECOL, V19, P844, DOI 10.1111/j.1365-2435.2005.01031.x; Merckx T, 2006, FUNCT ECOL, V20, P436, DOI 10.1111/j.1365-2435.2006.01124.x; Overgaard J, 2005, J INSECT PHYSIOL, V51, P1173, DOI 10.1016/j.jinsphys.2005.06.007; Overgaard J, 2008, J INSECT PHYSIOL, V54, P619, DOI 10.1016/j.jinsphys.2007.12.011; Pappas C, 2007, COMP BIOCHEM PHYS A, V146, P355, DOI 10.1016/j.cbpa.2006.11.010; Pigliucci M., 2001, SYN ECO EVO; Pijpe J, 2008, AM NAT, V171, P81, DOI 10.1086/524200; Rajamohan A, 2008, J INSECT PHYSIOL, V54, P708, DOI 10.1016/j.jinsphys.2008.01.011; Rajamohan A, 2009, PHYSIOL ENTOMOL, V34, P217, DOI 10.1111/j.1365-3032.2009.00677.x; Rako L, 2006, J INSECT PHYSIOL, V52, P94, DOI 10.1016/j.jinsphys.2005.09.007; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sejerkilde M, 2003, J INSECT PHYSIOL, V49, P719, DOI 10.1016/S0022-1910(03)00095-7; Sinclair BJ, 2005, J THERM BIOL, V30, P557, DOI 10.1016/j.jtherbio.2005.07.002; Sinclair BJ, 2003, TRENDS ECOL EVOL, V18, P257, DOI 10.1016/S0169-5347(03)00014-4; Sorensen JG, 2002, ECOL LETT, V5, P16, DOI 10.1046/j.1461-0248.2002.00296.x; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Stjernholm F, 2006, FUNCT ECOL, V20, P442, DOI 10.1111/j.1365-2435.2006.01120.x; Terblanche JS, 2007, J INSECT PHYSIOL, V53, P455, DOI 10.1016/j.jinsphys.2007.01.006; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; van't Hof AE, 2005, MOL ECOL NOTES, V5, P169, DOI 10.1111/j.1471-8286.2004.00870.x; WILLMER P, 2000, ENV PHYSIOL ANIMAL O; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9; WINDIG JJ, 1994, ECOL ENTOMOL, V19, P285, DOI 10.1111/j.1365-2311.1994.tb00420.x; Woods HA, 2002, EVOLUTION, V56, P1863; ZEILSTRA I, 2003, PHYSIOL ENTOMOL, V30, P92	76	86	88	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15284	10.1371/journal.pone.0015284	http://dx.doi.org/10.1371/journal.pone.0015284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187968	Green Published, Green Submitted, gold			2022-12-25	WOS:000285575200031
J	Jin, JY; Zhou, L; Wang, Y; Li, Z; Zhao, JG; Zhang, QY; Gui, JF				Jin, Jun-Yan; Zhou, Li; Wang, Yang; Li, Zhi; Zhao, Jiu-Gang; Zhang, Qi-Ya; Gui, Jian-Fang			Antibacterial and Antiviral Roles of a Fish beta-Defensin Expressed Both in Pituitary and Testis	PLOS ONE			English	Article							NF-KAPPA-B; ANTIMICROBIAL PEPTIDE; DIFFERENTIAL EXPRESSION; SEX REVERSAL; HUMAN BETA-DEFENSIN-3; TRANSCRIPTION FACTOR; GENE CLUSTERS; IDENTIFICATION; DISCOVERY; INNATE	Defensins are a group of cationic peptides that exhibit broad-spectrum antimicrobial activity. In this study, we cloned and characterized a beta-defensin from pituitary cDNA library of a protogynous hermaphroditic orange- spotted grouper (Epinephelus coioides). Interestingly, the beta-defensin was shown to be dominantly expressed in pituitary and testis by RT-PCR and Western blot analysis, and its transcript level is significantly upregulated in reproduction organs from intersexual gonad to testis during the natural and artificial sex reversal. Promoter sequence and the responsible activity region analyses revealed the pituitary-specific POU1F1a transcription binding site and testis-specific SRY responsible site, and demonstrated that the pituitary-specific POU1F1a transcription binding site that locates between 2180 and 2208 bp is the major responsible region of grouper beta-defensin promoter activity. Immunofluorescence localization observed its pituicyte expression in pituitary and spermatogonic cell expression in testis. Moreover, both in vitro antibacterial activity assay of the recombinant beta-defensin and in vivo embryo microinjection of the beta-defensin mRNA were shown to be effective in killing Gram-negative bacteria. And, its antiviral role was also demonstrated in EPC cells transfected with the beta-defensin construct. Additionally, the antibacterial activity was sensitive to concentrations of Na+, K+, Ca2+ and Mg2+. The above intriguing findings strongly suggest that the fish beta-defensin might play significant roles in both innate immunity defense and reproduction endocrine regulation.	[Jin, Jun-Yan; Zhou, Li; Wang, Yang; Li, Zhi; Zhao, Jiu-Gang; Zhang, Qi-Ya; Gui, Jian-Fang] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Wuhan Ctr Dev Biol, Inst Hydrobiol,Grad Sch, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Jin, JY (corresponding author), Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Wuhan Ctr Dev Biol, Inst Hydrobiol,Grad Sch, Wuhan, Peoples R China.	jfgui@ihb.ac.cn			National Key Basic Research Program [2010CB126301]; National Natural Science Foundation of China [U0631007]; State Key Laboratory of Freshwater Ecology and Biotechnology [2008FBZ15, 085B181F01]; Institute of Hydrobiology, Chinese Academy of Sciences [075A011301, 085A011301]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); Institute of Hydrobiology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by National Key Basic Research Program (2010CB126301), National Natural Science Foundation of China (U0631007), Open Project of State Key Laboratory of Freshwater Ecology and Biotechnology (2008FBZ15, 085B181F01), and Innovation Project of Institute of Hydrobiology, Chinese Academy of Sciences (075A011301, 085A011301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Casadei E, 2009, MOL IMMUNOL, V46, P3358, DOI 10.1016/j.molimm.2009.07.018; de la Vega RCR, 2005, TRENDS GENET, V21, P330, DOI 10.1016/j.tig.2005.03.009; DIAMOND G, 1991, P NATL ACAD SCI USA, V88, P3952, DOI 10.1073/pnas.88.9.3952; Dong B, 2007, BIOCHEM J, V401, P57, DOI 10.1042/BJ20060570; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Falco A, 2008, MOL IMMUNOL, V45, P757, DOI 10.1016/j.molimm.2007.06.358; Frolich O, 2001, BIOL REPROD, V64, P1072, DOI 10.1095/biolreprod64.4.1072; Froy O, 2005, IUBMB LIFE, V57, P41, DOI 10.1080/15216540500088912; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hamil KG, 2000, ENDOCRINOLOGY, V141, P1245, DOI 10.1210/en.141.3.1245; Hao HN, 2001, J NEUROCHEM, V77, P1027, DOI 10.1046/j.1471-4159.2001.00305.x; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Howell MD, 2007, J ALLERGY CLIN IMMUN, V119, P1022, DOI 10.1016/j.jaci.2007.01.044; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; Huang YH, 2007, APOPTOSIS, V12, P1569, DOI 10.1007/s10495-007-0089-1; Ibrahim NM, 2001, BIOL REPROD, V65, P575, DOI 10.1095/biolreprod65.2.575; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Krishnakumari V, 2009, ANTIMICROB AGENTS CH, V53, P256, DOI 10.1128/AAC.00470-08; Li CJ, 2005, MOL CELL ENDOCRINOL, V233, P33, DOI 10.1016/j.mce.2005.01.010; Li P, 2001, SCIENCE, V291, P1783, DOI 10.1126/science.1056545; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Lynn DJ, 2004, IMMUNOGENETICS, V56, P170, DOI 10.1007/s00251-004-0675-0; MACLEOD RJ, 1991, P NATL ACAD SCI USA, V88, P552, DOI 10.1073/pnas.88.2.552; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; Nam BH, 2010, FISH SHELLFISH IMMUN, V28, P267, DOI 10.1016/j.fsi.2009.11.004; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; OSBORN RW, 1995, FEBS LETT, V368, P257, DOI 10.1016/0014-5793(95)00666-W; Palladino MA, 2003, BIOL REPROD, V68, P509, DOI 10.1095/biolreprod.102.008953; Patil AA, 2005, PHYSIOL GENOMICS, V23, P5, DOI 10.1152/physiolgenomics.00104.2005; Peng JX, 2009, J EXP ZOOL PART B, V312B, P855, DOI 10.1002/jez.b.21301; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Sang YM, 2006, MAMM GENOME, V17, P332, DOI 10.1007/s00335-005-0158-0; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Semple CA, 2006, MOL DIVERS, V10, P575, DOI 10.1007/s11030-006-9031-7; Soman SS, 2009, MOL IMMUNOL, V46, P2029, DOI 10.1016/j.molimm.2009.03.003; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; TOMINAGA T, 1990, J ENDOCRINOL, V125, P287, DOI 10.1677/joe.0.1250287; Tsutsumi-Ishii Y, 2002, J LEUKOCYTE BIOL, V71, P154; Van As P, 2000, GEN COMP ENDOCR, V120, P127, DOI 10.1006/gcen.2000.7529; Wang D, 2009, ANIM GENET, V40, P978, DOI 10.1111/j.1365-2052.2009.01941.x; Wang XL, 2005, GENE, V350, P99, DOI 10.1016/j.gene.2005.02.002; Wang Y, 2004, MOL CELL ENDOCRINOL, V220, P77, DOI 10.1016/j.mce.2004.03.007; Weinberg A, 2006, Adv Dent Res, V19, P42; Weltzien FA, 2003, COMP BIOCHEM PHYS A, V134, P315, DOI 10.1016/S1095-6433(02)00266-0; Wu N, 2009, BIOL REPROD, V81, P275, DOI 10.1095/biolreprod.108.074955; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yao B, 2007, J EXP ZOOL PART A, V307A, P207, DOI 10.1002/jez.361; Yeh SL, 2003, AQUACULTURE, V218, P729, DOI 10.1016/S0044-8486(02)00565-3; Yenugu S, 2004, ENDOCRINOLOGY, V145, P3165, DOI 10.1210/en.2003-1698; Yudin AI, 2003, BIOL REPROD, V69, P1118, DOI 10.1095/biolreprod.103.016105; Zhao JG, 2009, DEV COMP IMMUNOL, V33, P624, DOI 10.1016/j.dci.2008.11.006; Zhao Z, 2008, VIROLOGY, V372, P118, DOI 10.1016/j.virol.2007.10.028; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127; Zhou L, 2006, AQUACULTURE, V256, P129, DOI 10.1016/j.aquaculture.2006.01.022; Zhou L, 2010, FISH PHYSIOL BIOCHEM, V36, P181, DOI 10.1007/s10695-008-9219-0; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07; Zou J, 2007, MOL IMMUNOL, V44, P638, DOI 10.1016/j.molimm.2006.01.012	69	82	89	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e12883	10.1371/journal.pone.0012883	http://dx.doi.org/10.1371/journal.pone.0012883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188147	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200001
J	Ravva, SV; Sarreal, CZ; Mandrell, RE				Ravva, Subbarao V.; Sarreal, Chester Z.; Mandrell, Robert E.			Identification of Protozoa in Dairy Lagoon Wastewater that Consume Escherichia coli O157:H7 Preferentially	PLOS ONE			English	Article							ACANTHAMOEBA-POLYPHAGA; SALMONELLA-ENTERICA; BACTERIAL PATHOGENS; LEGIONELLA-PNEUMOPHILA; MYCOBACTERIUM-AVIUM; O157-H7 SURVIVAL; BEEF-CATTLE; LETTUCE; AMEBAS; GROWTH	Escherichia coli O157:H7 (EcO157), an agent of life threatening hemolytic-uremic syndrome, resides in ruminants and is released in feces at numbers as high as 10 million cells/gram. EcO157 could survive in manure for as long as 21 months, but we observed a 90% decrease in cells of an outbreak strain of EcO157 within half a day in wastewater from dairy lagoons. Although chemical, environmental and biological factors may be responsible for this decrease, we observed an 11-fold increase in native protozoa when wastewater was re-inoculated with 2X10(7) cells of EcO157/mL. These protozoa engulfed the green fluorescent protein labeled EcO157 within 2 hours after inoculation, but expelled vacuoles filled with live EcO157 cells within 3 days into surrounding wastewater, whereas other protozoa retained the EcO157-filled vacuoles for 7 days. EcO157 was not detected by confocal microscopy either inside or outside protozoa after 7 days. Mixed cultures of protozoa enriched from wastewater consumed EcO157 preferentially as compared to native aerobic bacteria, but failed to eliminate them when EcO157 cells declined to 10(4)/mL. We isolated three protozoa from mixed cultures and typed them by 18S sequencing as Vorticella microstoma, Platyophyra sp. and Colpoda aspera. While all three protozoa internalized EcO157, only Platyophyra and Colpoda acted as predators. Similar to mixed cultures, these protozoa failed to eliminate EcO157 from PBS containing no other supplemental nutrients or prey. However, spiking PBS with cereal grass medium as nutrients induced predation of EcO157 by Platyophyra sp. after 3 days or enhanced predation by Colpoda after 5 days. Therefore, attempts to enrich protozoa to decrease EcO157 from dairy lagoons, may correspond to an increase in protozoa similar to Vorticella and possibly facilitate transport of bacterial pathogens to food crops grown in proximity.				subbarao.ravva@ars.usda.gov	Mandrell, Robert E/O-9814-2018		U. S. Department of Agriculture, Agricultural Research Service [5325-32000-005, 5325-42000-044]	U. S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work was funded by the U. S. Department of Agriculture, Agricultural Research Service under Current Research Information System projects 5325-32000-005 and 5325-42000-044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER M, 1981, ANNU REV MICROBIOL, V35, P113, DOI 10.1146/annurev.mi.35.100181.000553; Amaral AL, 2008, ANAL BIOANAL CHEM, V391, P1321, DOI 10.1007/s00216-008-1845-y; Artz RRE, 2002, FEMS MICROBIOL LETT, V216, P117, DOI 10.1016/S0378-1097(02)01002-9; Barker J, 1999, FEMS MICROBIOL LETT, V173, P291, DOI 10.1111/j.1574-6968.1999.tb13516.x; BARKER J, 1994, MICROBIOL-UK, V140, P1253, DOI 10.1099/00221287-140-6-1253; Blodgett R., 2006, BACTERIOLOGICAL ANAL; Bouyer S, 2007, ENVIRON MICROBIOL, V9, P1341, DOI 10.1111/j.1462-2920.2006.01229.x; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P5285, DOI 10.1128/AEM.01073-08; Brandl MT, 2005, APPL ENVIRON MICROB, V71, P1562, DOI 10.1128/AEM.71.3.1562-1569.2005; Burow LC, 2005, LETT APPL MICROBIOL, V40, P117, DOI 10.1111/j.1472-765X.2004.01642.x; CASIDA LE, 1989, APPL ENVIRON MICROB, V55, P1857, DOI 10.1128/AEM.55.8.1857-1859.1989; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; Cody SH, 1999, ANN INTERN MED, V130, P202, DOI 10.7326/0003-4819-130-3-199902020-00005; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cooley MB, 2006, J FOOD PROTECT, V69, P2329, DOI 10.4315/0362-028X-69.10.2329; DeWaal CS, 2009, OUTBREAK ALERT 2009; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Franz E, 2005, APPL ENVIRON MICROB, V71, P6165, DOI 10.1128/AEM.71.10.6165-6174.2005; Garcia MT, 2008, J APPL MICROBIOL, V105, P837, DOI 10.1111/j.1365-2672.2008.03804.x; Gaze WH, 2003, MICROBIAL ECOL, V46, P358, DOI 10.1007/s00248-003-1001-3; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P1851; Gourabathini P, 2008, APPL ENVIRON MICROB, V74, P2518, DOI 10.1128/AEM.02709-07; Guan TY, 2003, J ENVIRON QUAL, V32, P383, DOI 10.2134/jeq2003.0383; Hancock DD, 1998, PREV VET MED, V35, P11, DOI 10.1016/S0167-5877(98)00050-6; Hristov AN, 2001, J ANIM SCI, V79, P515; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Huws SA, 2008, FEMS MICROBIOL LETT, V282, P258, DOI 10.1111/j.1574-6968.2008.01123.x; Huws SA, 2006, ENVIRON MICROBIOL, V8, P1130, DOI 10.1111/j.1462-2920.2006.00991.x; KING CH, 1988, APPL ENVIRON MICROB, V54, P3023, DOI 10.1128/AEM.54.12.3023-3033.1988; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; LeJeune JT, 2001, J DAIRY SCI, V84, P1856, DOI 10.3168/jds.S0022-0302(01)74626-7; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Mandrell R. E., 2009, MICROBIAL SAFETY FRE, P5; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; Rasmussen MA, 2005, INFECT IMMUN, V73, P4668, DOI 10.1128/IAI.73.8.4668-4675.2005; Ravva SV, 2006, J APPL MICROBIOL, V101, P891, DOI 10.1111/j.1365-2672.2006.02956.x; Ravva SV, 2007, APPL ENVIRON MICROB, V73, P2191, DOI 10.1128/AEM.02213-06; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Schlimme W, 1997, FEMS MICROBIOL ECOL, V23, P239, DOI 10.1016/S0168-6496(97)00028-7; Shin EC, 2004, J APPL MICROBIOL, V97, P378, DOI 10.1111/j.1365-2672.2004.02304.x; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; Strauch E, 2007, FUTURE MICROBIOL, V2, P63, DOI 10.2217/17460913.2.1.63; Tanji Y, 2004, APPL MICROBIOL BIOT, V64, P270, DOI 10.1007/s00253-003-1438-9; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; VANCE RD, 1972, J ANIM SCI, V35, P598; Wand H, 2007, WATER RES, V41, P159, DOI 10.1016/j.watres.2006.08.024; WATSON PJ, 1981, J GEN MICROBIOL, V122, P323; Wright ADG, 1997, J EUKARYOT MICROBIOL, V44, P61, DOI 10.1111/j.1550-7408.1997.tb05693.x	51	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15671	10.1371/journal.pone.0015671	http://dx.doi.org/10.1371/journal.pone.0015671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187934	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200060
J	Yu, KD; Huang, AJ; Shao, ZM				Yu, Ke-Da; Huang, A-Ji; Shao, Zhi-Ming			Tailoring Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A CYP2D6 Multiple-Genotype-Based Modeling Analysis and Validation	PLOS ONE			English	Article							CYTOCHROME-P450 2D6; AMERICAN-SOCIETY; TAMOXIFEN; WOMEN; GENE; POLYMORPHISMS; PHARMACOGENETICS; ASSOCIATION; METABOLISM; INHIBITORS	Purpose: Previous studies have suggested that postmenopausal women with breast cancer who present with wild-type CYP2D6 may actually have similar or superior recurrence-free survival outcomes when given tamoxifen in place of aromatase inhibitors (AIs). The present study established a CYP2D6 multiple-genotype-based model to determine the optimal endocrine therapy for patients harboring wild-type CYP2D6. Methods: We created a Markov model to determine whether tamoxifen or AIs maximized 5-year disease-free survival (DFS) for extensive metabolizer (EM) patients using annual hazard ratio (HR) data from the BIG 1-98 trial. We then replicated the model by evaluating 9-year event-free survival (EFS) using HR data from the ATAC trial. In addition, we employed two-way sensitivity analyses to explore the impact of HR of decreased-metabolizer (DM) and its frequency on survival by studying a range of estimates. Results: The 5-year DFS of tamoxifen-treated EM patients was 83.3%, which is similar to that of genotypically unselected patients who received an AI (83.7%). In the validation study, we further demonstrated that the 9-year EFS of tamoxifen-treated EM patients was 81.4%, which is higher than that of genotypically unselected patients receiving tamoxifen (78.4%) and similar to that of patients receiving an AI (83.2%). Two-way sensitivity analyses demonstrated the robustness of the results. Conclusions: Our modeling analyses indicate that, among EM patients, the DFS/EFS outcome of patients receiving tamoxifen is similar to that of patients receiving an AI. Further prospective clinical trials are needed to evaluate the value of the CYP2D6 genotype in the selection of endocrine therapy.	[Yu, Ke-Da] Fudan Univ, Dept Oncol, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China; Fudan Univ, Ctr Canc, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yu, KD (corresponding author), Fudan Univ, Dept Oncol, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			Youth Foundation of Shanghai Public Health Bureau; Youth Foundation of Shanghai Medical College; Municipal Hospitals [SHDC12010116]; National Natural Science Foundation of China [30971143, 30972936, 81001169]	Youth Foundation of Shanghai Public Health Bureau; Youth Foundation of Shanghai Medical College; Municipal Hospitals; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the 2009 Youth Foundation of Shanghai Public Health Bureau, the 2009 Youth Foundation of Shanghai Medical College, the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), and the National Natural Science Foundation of China (30971143, 30972936, 81001169). The funders played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; BIJL MJ, 2009, BREAST CANC IN PRESS; Bonanni B, 2006, J CLIN ONCOL, V24, P3708, DOI 10.1200/JCO.2006.06.8072; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Colomer R, 2008, CLIN CANCER RES, V14, P811, DOI 10.1158/1078-0432.CCR-07-1923; Cooke AL, 2008, J CLIN ONCOL, V26, P5227, DOI 10.1200/JCO.2007.15.7123; Desta Z, 2007, J CLIN ONCOL, V25, P5147, DOI 10.1200/JCO.2007.13.4957; Gaedigk A, 2008, CLIN PHARMACOL THER, V83, P234, DOI 10.1038/sj.clpt.6100406; Gjerde J, 2008, ANN ONCOL, V19, P56, DOI 10.1093/annonc/mdm434; Goetz MP, 2008, CLIN CANCER RES, V14, P5864, DOI 10.1158/1078-0432.CCR-08-0619; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Hemeryck A, 2002, CURR DRUG METAB, V3, P13, DOI 10.2174/1389200023338017; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Lim HS, 2007, J CLIN ONCOL, V25, P3837, DOI 10.1200/JCO.2007.11.4850; Lin NU, 2008, J CLIN ONCOL, V26, P798, DOI 10.1200/JCO.2007.15.0946; Locker GY, 2007, BREAST CANCER RES TR, V106, P229, DOI 10.1007/s10549-006-9483-6; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; Punglia RS, 2008, JNCI-J NATL CANCER I, V100, P642, DOI 10.1093/jnci/djn100; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Schroth W, 2009, JAMA-J AM MED ASSOC, V302, P1429, DOI 10.1001/jama.2009.1420; Seruga B, 2009, J CLIN ONCOL, V27, P840, DOI 10.1200/JCO.2008.19.5594; Skedgel C, 2007, BREAST CANCER RES TR, V101, P325, DOI 10.1007/s10549-006-9299-4; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; Wegman P, 2005, BREAST CANCER RES, V7, pR284, DOI 10.1186/bcr993; Wegman P, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1640; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15649	10.1371/journal.pone.0015649	http://dx.doi.org/10.1371/journal.pone.0015649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187922	gold, Green Submitted, Green Published			2022-12-25	WOS:000285575200055
J	Jagannathan, V; Kaur, P; Datta, S				Jagannathan, Vijayalakshmi; Kaur, Parvinder; Datta, Santanu			Polyphosphate Kinase from M. tuberculosis: An Interconnect between the Genetic and Biochemical Role	PLOS ONE			English	Article							ESCHERICHIA-COLI; INORGANIC POLYPHOSPHATE; MYCOBACTERIUM-TUBERCULOSIS; NONREPLICATING PERSISTENCE; METABOLISM; MECHANISM; SURVIVAL; PRODUCT; ASSAY	The enzyme Polyphosphate Kinase (PPK) catalyses the reversible transfer of the terminal gamma-Pi of ATP to form a long chain Polyphosphate (PolyP). Using an IPTG inducible mycobacterial vector, the vulnerability of this gene has been evaluated by antisense knockdown experiments in M. tuberculosis. Expression profiling studies point to the fact that down regulation of PPK caused cidality during the late phase in contrast to its bacteriostatic mode immediately following antisense expression. PPK thus seems to be a suitable anti-tubercular drug target. The enzyme which is a tetramer has been cloned in E. coli and purified to homogeneity. An enzyme assay suitable for High Throughput Screening was optimized by using the statistical Taguchi protocol and the kinetic parameters determined. The enzyme displayed a strong product inhibition by ADP. In order to accurately estimate the product inhibition, progress curve analysis of the enzyme reaction was monitored. The kinetic equation describing the progress curve was suitably modified by taking into account the product inhibition. The reversible nature of the enzyme indicated a possibility of a two way ATP <-> ADP switch operating in the bacteria as a response to its growth requirement.	[Jagannathan, Vijayalakshmi; Kaur, Parvinder; Datta, Santanu] AstraZeneca India Pvt Ltd, Bangalore, Karnataka, India	AstraZeneca	Jagannathan, V (corresponding author), AstraZeneca India Pvt Ltd, Bangalore, Karnataka, India.	santanu.datta@gmail.com			AstraZeneca	AstraZeneca(AstraZeneca)	The project as detailed in the article was funded in-house by AstraZeneca. The funders played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Berlett BS, 2000, ANAL BIOCHEM, V287, P329, DOI 10.1006/abio.2000.4876; COBB BD, 1994, NUCLEIC ACIDS RES, V22, P3801, DOI 10.1093/nar/22.18.3801; Cornish-Bowden A, 1999, FUNDAMENTALS ENZYME; CORPER H. J., 1933, AMER REV TUBERC, V28, P856; CROOKE E, 1994, J BIOL CHEM, V269, P6290; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; GRIFFIN JB, 1965, J BIOL CHEM, V240, P4427; Hu JM, 1999, J BACTERIOL, V181, P469, DOI 10.1128/JB.181.2.469-476.1999; Jonnalagadda SB, 2000, J CHEM EDUC, V77, P506, DOI 10.1021/ed077p506; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Kulaev IS, 2000, BIOCHEMISTRY-MOSCOW+, V65, P271; LEITAO JM, 1995, MAR ECOL PROG SER, V121, P279, DOI 10.3354/meps121279; Mullan A, 2002, ANAL BIOCHEM, V308, P294, DOI 10.1016/S0003-2697(02)00249-X; Nesmeyanova MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P309; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; ROBINSON NA, 1986, J BIOL CHEM, V261, P4481; Roy R. K., 2001, DESIGN EXPT USING TA; SUREKA K, 2009, MOL MICROBIOL, DOI DOI 10.1111/J.1365-2958.06925.X; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; TINOCO, 1995, PHYS CHEM PRINCIPLES; TINSLEY CR, 1993, INFECT IMMUN, V61, P3703, DOI 10.1128/IAI.61.9.3703-3710.1993; Tzeng CM, 2000, J BIOL CHEM, V275, P3977, DOI 10.1074/jbc.275.6.3977; WALLACE, 1961, AM REV RESPIR DIS, V83, P66; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139	31	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14336	10.1371/journal.pone.0014336	http://dx.doi.org/10.1371/journal.pone.0014336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179463	gold, Green Published, Green Submitted			2022-12-25	WOS:000285340000009
J	Smolders, J; Peelen, E; Thewissen, M; Tervaert, JWC; Menheere, P; Hupperts, R; Damoiseaux, J				Smolders, Joost; Peelen, Evelyn; Thewissen, Marielle; Tervaert, Jan Willem Cohen; Menheere, Paul; Hupperts, Raymond; Damoiseaux, Jan			Safety and T Cell Modulating Effects of High Dose Vitamin D-3 Supplementation in Multiple Sclerosis	PLOS ONE			English	Article							INTERFERON-BETA; FOXP3; ENCEPHALOMYELITIS; EXPRESSION; RECEPTOR; RISK	Background: A poor vitamin D status has been associated with a high disease activity of multiple sclerosis (MS). Recently, we described associations between vitamin D status and peripheral T cell characteristics in relapsing remitting MS (RRMS) patients. In the present study, we studied the effects of high dose vitamin D-3 supplementation on safety and T cell related outcome measures. Methodology/Principal Findings: Fifteen RRMS patients were supplemented with 20 000 IU/d vitamin D-3 for 12 weeks. Vitamin D and calcium metabolism were carefully monitored, and T cell characteristics were studied by flowcytometry. All patients finished the protocol without side-effects, hypercalcaemia, or hypercalciuria. The median vitamin D status increased from 50 nmol/L (31-175) at week 0 to 380 nmol/L (151-535) at week 12 (P<0.001). During the study, 1 patient experienced an exacerbation of MS and was censored from the T cell analysis. The proportions of (naive and memory) CD4(+) Tregs remained unaffected. Although Treg suppressive function improved in several subjects, this effect was not significant in the total cohort (P=0.143). An increased proportion of IL-10(+) CD4(+) T cells was found after supplementation (P=0.021). Additionally, a decrease of the ratio between IFN-gamma(+) and IL-4(+) CD4(+) T cells was observed (P=0.035). Conclusion/Significance: Twelve week supplementation of high dose vitamin D-3 in RRMS patients was well tolerated and did not induce decompensation of calcium metabolism. The skewing towards an anti-inflammatory cytokine profile supports the evidence on vitamin D as an immune-modulator, and may be used as outcome measure for upcoming randomized placebo-controlled trials.	[Smolders, Joost; Peelen, Evelyn; Tervaert, Jan Willem Cohen; Hupperts, Raymond] Maastricht Univ, Sch Mental Hlth & Neurosci, Med Ctr, Maastricht, Netherlands; [Smolders, Joost; Peelen, Evelyn; Thewissen, Marielle; Tervaert, Jan Willem Cohen; Damoiseaux, Jan] Maastricht Univ, Dept Internal Med, Med Ctr, Div Clin & Expt Immunol, Maastricht, Netherlands; [Smolders, Joost; Peelen, Evelyn; Hupperts, Raymond] Orbis Med Ctr, Acad MS Ctr Limburg, Sittard, Netherlands; [Menheere, Paul] Maastricht Univ, Dept Clin Chem, Med Ctr, Maastricht, Netherlands; [Tervaert, Jan Willem Cohen; Damoiseaux, Jan] Maastricht Univ, Clin Immunol Lab, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University; Orbis Medical Center; Maastricht University; Maastricht University	Smolders, J (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Med Ctr, Maastricht, Netherlands.	j.smolders@mumc.nl	Peelen, Evelyn/H-9955-2012; Thewissen, Marielle/G-3545-2014; Smolders, Joost/B-7658-2009; Damoiseaux, Jan/B-8993-2009; tervaert, jan willem cohen/AAB-1111-2019	Smolders, Joost/0000-0001-9766-8661; Damoiseaux, Jan/0000-0003-4007-6985; 				ABBAS AK, NATURE, V383, P787; Andreev E, 1999, J INTERN MED, V246, P247, DOI 10.1046/j.1365-2796.1999.00515.x; Ascherio A, 2008, SEMIN NEUROL, V28, P17, DOI 10.1055/s-2007-1019126; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Becklund BR, 2010, P NATL ACAD SCI USA, V107, P6418, DOI 10.1073/pnas.1001119107; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Doorenbos CRC, 2009, NAT REV NEPHROL, V5, P691, DOI 10.1038/nrneph.2009.185; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Haas J, 2009, J NEUROIMMUNOL, V216, P113, DOI 10.1016/j.jneuroim.2009.06.011; Hayes CE, 1997, P SOC EXP BIOL MED, V216, P21, DOI 10.3181/00379727-216-44153A; Kimball SM, 2007, AM J CLIN NUTR, V86, P645, DOI 10.1093/ajcn/86.3.645; Korporal M, 2008, ARCH NEUROL-CHICAGO, V65, P1434, DOI 10.1001/archneur.65.11.1434; Kurtzke JF, 1983, NEUROLOGY, V33, P14; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Maalouf J, 2008, J CLIN ENDOCR METAB, V93, P2693, DOI 10.1210/jc.2007-2530; Mahon BD, 2003, J NEUROIMMUNOL, V134, P128, DOI 10.1016/S0165-5728(02)00396-X; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; PSTON A, 2008, LANCET, V372, P1502; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; Smolders J, 2008, J NEUROIMMUNOL, V194, P7, DOI 10.1016/j.jneuroim.2007.11.014; Smolders J, 2010, J STEROID BIOCHEM, V121, P243, DOI 10.1016/j.jsbmb.2010.03.001; Smolders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006635; Soilu-Hanninen M, 2005, MULT SCLER J, V11, P266, DOI 10.1191/1352458505ms1157oa; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8; van Etten E, 2007, J STEROID BIOCHEM, V103, P546, DOI 10.1016/j.jsbmb.2006.12.094; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	34	138	138	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15235	10.1371/journal.pone.0015235	http://dx.doi.org/10.1371/journal.pone.0015235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179201	Green Submitted, gold, Green Published			2022-12-25	WOS:000285246900034
J	Birukou, I; Soman, J; Olson, JS				Birukou, Ivan; Soman, Jayashree; Olson, John S.			Blocking the Gate to Ligand Entry in Human Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURES; MOLECULAR-DYNAMICS SIMULATION; SPERM-WHALE MYOGLOBIN; R-STATE HEMOGLOBIN; CARBON-MONOXIDE; DISTAL HISTIDINE; MIGRATION PATHWAYS; STRUCTURAL DETERMINANTS; INTERNAL CAVITIES; BINDING PATHWAYS	His(E7) to Trp replacements in HbA lead to markedly biphasic bimolecular CO rebinding after laser photolysis. For isolated mutant subunits, the fraction of fast phase increases with increasing [CO], suggesting a competition between binding to an open conformation with an empty E7 channel and relaxation to blocked or closed, slowly reacting states. The rate of conformational relaxation of the open state is similar to 18,000 s(-1) in alpha subunits and similar to 10-fold faster in beta subunits, similar to 175,000 s(-1). Crystal structures were determined for tetrameric alpha(WT)beta(Trp-63) HbCO, alpha(Trp-58)beta(WT) deoxyHb, and Trp-64 deoxy-and CO-Mb as controls. In Trp-63(E7) beta CO, the indole side chain is located in the solvent interface, blocking entry into the E7 channel. Similar blocked Trp-64(E7) conformations are observed in the mutant Mb crystal structures. In Trp-58(E7) deoxy-alpha subunits, the indole side chain fills both the channel and the distal pocket, forming a completely closed state. The bimolecular rate constant for CO binding, k'(CO), to the open conformations of both mutant Hb subunits is similar to 80-90 mu M-1 s(-1), whereas k'(CO) for the completely closed states is 1000-fold slower, similar to 0.08 mu M-1 s(-1). A transient intermediate with k'(CO) approximate to 0.7 mu M-1 s(-1) is observed after photolysis of Trp-63(E7) beta CO subunits and indicates that the indole ring blocks the entrance to the E7 channel, as observed in the crystal structures of Trp(E7) deoxyMb and beta CO subunits. Thus, either blocking or completely filling the E7 channel dramatically slows bimolecular binding, providing strong evidence that the E7 channel is the major pathway (>= 90%) for ligand entry in human hemoglobin.	Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Rice Univ, WM Keck Ctr Computat Biol, Houston, TX 77005 USA	Rice University; Rice University	Olson, JS (corresponding author), 6100 Main St, Houston, TX 77005 USA.	olson@rice.edu		Olson, John/0000-0002-0760-5403	National Institutes of Health [GM035649, HL047020]; Robert A. Welch Foundation [C0612]; Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM035649 and HL047020. This work was also supported by Robert A. Welch Foundation Grant C0612 (to J. S. O.) and a Welch Foundation pre-doctoral fellowship (to I. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 1968, J CRYST GROWTH, DOI [rg/10.1016/00220248(68)900717, DOI 10.1016/0022-0248(68)90071-7]; Aranda R, 2006, ACTA CRYSTALLOGR D, V62, P776, DOI 10.1107/S0907444906017318; ArredondoPeter R, 1997, PLANT PHYSIOL, V115, P1259, DOI 10.1104/pp.115.3.1259; Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Blouin GC, 2010, BIOCHEMISTRY-US, V49, P4987, DOI 10.1021/bi1001745; Boechi L, 2008, PROTEINS, V73, P372, DOI 10.1002/prot.22072; Bossa C, 2005, BIOPHYS J, V89, P465, DOI 10.1529/biophysj.104.055020; Bossa C, 2004, BIOPHYS J, V86, P3855, DOI 10.1529/biophysj.103.037432; Brucker EA, 2000, ACTA CRYSTALLOGR D, V56, P812, DOI 10.1107/S0907444900006557; Brucker EA, 1996, J BIOL CHEM, V271, P25419, DOI 10.1074/jbc.271.41.25419; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunori M, 2004, J STRUCT BIOL, V147, P223, DOI 10.1016/j.jsb.2004.04.008; CARVER TE, 1992, J BIOL CHEM, V267, P14443; Cohen J, 2008, METHOD ENZYMOL, V437, P439, DOI 10.1016/S0076-6879(07)37022-5; Cohen J, 2007, BIOPHYS J, V93, P3591, DOI 10.1529/biophysj.107.108712; ELBER R, 1990, J AM CHEM SOC, V112, P9161, DOI 10.1021/ja00181a020; Elber R, 2008, J PHYS CHEM B, V112, P6147, DOI 10.1021/jp0769779; Elber R, 2010, CURR OPIN STRUC BIOL, V20, P162, DOI 10.1016/j.sbi.2010.01.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esquerra RM, 2010, PHYS CHEM CHEM PHYS, V12, P10270, DOI 10.1039/c003606b; Franzen S, 2002, P NATL ACAD SCI USA, V99, P16754, DOI 10.1073/pnas.252590999; Franzen S, 2002, J AM CHEM SOC, V124, P13271, DOI 10.1021/ja017708d; Goldbeck RA, 2006, P NATL ACAD SCI USA, V103, P1254, DOI 10.1073/pnas.0507840103; Goldbeck RA, 2009, J AM CHEM SOC, V131, P12265, DOI 10.1021/ja903409j; Golden SD, 2008, METHOD ENZYMOL, V437, P417, DOI 10.1016/S0076-6879(07)37021-3; Halder P, 2007, PROTEINS, V66, P172, DOI 10.1002/prot.21210; Hargrove MS, 2000, BIOPHYS J, V79, P2733, DOI 10.1016/S0006-3495(00)76512-X; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; Ionascu D, 2005, J AM CHEM SOC, V127, P16921, DOI 10.1021/ja054249y; Jenkins JD, 2009, ACTA CRYSTALLOGR D, V65, P41, DOI 10.1107/S0907444908037256; Knapp JE, 2009, STRUCTURE, V17, P1494, DOI 10.1016/j.str.2009.09.004; Kozlowski PM, 2001, J PORPHYR PHTHALOCYA, V5, P312, DOI 10.1002/jpp.318; LAI HH, 1995, PROTEINS, V22, P322, DOI 10.1002/prot.340220404; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; Marti MA, 2007, PROTEINS, V68, P480, DOI 10.1002/prot.21454; MATHEWS AJ, 1991, J BIOL CHEM, V266, P21631; MIMS MP, 1983, J BIOL CHEM, V258, P4219; MORIKIS D, 1989, BIOCHEMISTRY-US, V28, P4791, DOI 10.1021/bi00437a041; Mouawad L, 2005, BBA-GEN SUBJECTS, V1724, P385, DOI 10.1016/j.bbagen.2005.05.014; Nienhaus K, 2007, BIOCHEMISTRY-US, V46, P14018, DOI 10.1021/bi7016798; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Olson JS, 2003, METH MOLEC MED, V82, P65; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; Ruscio JZ, 2008, P NATL ACAD SCI USA, V105, P9204, DOI 10.1073/pnas.0710825105; Salter MD, 2008, J BIOL CHEM, V283, P35689, DOI 10.1074/jbc.M805727200; Savino C, 2009, BIOPOLYMERS, V91, P1097, DOI 10.1002/bip.21201; SCHOENBORN BP, 1965, NATURE, V207, P28, DOI 10.1038/207028a0; Schotte F, 2004, J STRUCT BIOL, V147, P235, DOI 10.1016/j.jsb.2004.06.009; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Smagghe BJ, 2009, BIOPOLYMERS, V91, P1083, DOI 10.1002/bip.21256; Sottini S, 2005, J AM CHEM SOC, V127, P17427, DOI 10.1021/ja056101k; Sottini S, 2005, J PHYS CHEM B, V109, P11411, DOI 10.1021/jp0514224; Spiro TG, 2001, ACCOUNTS CHEM RES, V34, P137, DOI 10.1021/ar000108j; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Tetreau C, 2004, BIOPHYS J, V86, P435, DOI 10.1016/S0006-3495(04)74120-X; TIAN WD, 1993, J MOL BIOL, V233, P155, DOI 10.1006/jmbi.1993.1491; Tian WD, 1996, BIOCHEMISTRY-US, V35, P3487, DOI 10.1021/bi952474u; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; Tomita A, 2009, P NATL ACAD SCI USA, V106, P2612, DOI 10.1073/pnas.0807774106; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Trevaskis B, 1997, P NATL ACAD SCI USA, V94, P12230, DOI 10.1073/pnas.94.22.12230; Unzai S, 1998, J BIOL CHEM, V273, P23150, DOI 10.1074/jbc.273.36.23150; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123; Zhang ZY, 2009, J PHYS CHEM B, V113, P10923, DOI 10.1021/jp9031805	81	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10515	10529		10.1074/jbc.M110.176271	http://dx.doi.org/10.1074/jbc.M110.176271			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21193395	Green Published, hybrid			2022-12-25	WOS:000288547000068
J	Kim, Y; Konno, H; Sugano, Y; Hisabori, T				Kim, Yusung; Konno, Hiroki; Sugano, Yasushi; Hisabori, Toru			Redox Regulation of Rotation of the Cyanobacterial F-1-ATPase Containing Thiol Regulation Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST ATP SYNTHASE; COUPLING FACTOR-I; GAMMA-SUBUNIT; EPSILON-SUBUNIT; F-1 MOTOR; CHLAMYDOMONAS-REINHARDTII; INVERSE REGULATION; ESCHERICHIA-COLI; CYSTEINE BRIDGE; CDNA SEQUENCE	F-1-ATP synthase (F-1-ATPase) is equipped with a special mechanism that prevents the wasteful reverse reaction, ATP hydrolysis, when there is insufficient proton motive force to drive ATP synthesis. Chloroplast F-1-ATPase is subject to redox regulation, whereby ATP hydrolysis activity is regulated by formation and reduction of the disulfide bond located on the gamma subunit. To understand the molecular mechanism of this redox regulation, we constructed a chimeric F-1 complex (alpha(3)beta(3)gamma(redox)) using cyanobacterial F-1, which mimics the regulatory properties of the chloroplast F-1-ATPase, allowing the study of its regulation at the single molecule level. The redox state of the gamma subunit did not affect the ATP binding rate to the catalytic site(s) and the torque for rotation. However, the long pauses caused by ADP inhibition were frequently observed in the oxidized state. In addition, the duration of continuous rotation was relatively shorter in the oxidized alpha(3)beta(3)gamma(redox) complex. These findings lead us to conclude that redox regulation of CF1-ATPase is achieved by controlling the probability of ADP inhibition via the gamma subunit inserted region, a sequence feature observed in both cyanobacterial and chloroplast ATPase gamma subunits, which is important for ADP inhibition (Sunamura, E., Konno, H., Imashimizu-Kobayashi, M., Sugano, Y., and Hisabori, T. (2010) Plant Cell Physiol. 51, 855-865).	[Kim, Yusung; Konno, Hiroki; Sugano, Yasushi; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	; Hisabori, Toru/E-5205-2014	Sugano, Yasushi/0000-0001-8463-5131; Hisabori, Toru/0000-0003-2046-0277	Ministry of Education, Culture, Sports, Science and Technology, Japan [18074002]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (No. 18074002, to T. H.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and in part by the Management Expenses Grants for National Universities Corporations from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Bald D, 2001, J BIOL CHEM, V276, P39505, DOI 10.1074/jbc.C100436200; Bald D, 2000, J BIOL CHEM, V275, P12757, DOI 10.1074/jbc.275.17.12757; DUNN SD, 1990, BIOCHEMISTRY-US, V29, P4335, DOI 10.1021/bi00470a011; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Hisabori T, 1999, FEBS LETT, V463, P35, DOI 10.1016/S0014-5793(99)01602-6; Konno H, 2000, BIOCHEM J, V352, P783, DOI 10.1042/0264-6021:3520783; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Krenn BE, 1997, BIOCHEM J, V323, P841, DOI 10.1042/bj3230841; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Meiss E, 2008, J BIOL CHEM, V283, P24594, DOI 10.1074/jbc.M802574200; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Motohashi K, 2006, J BIOL CHEM, V281, P35039, DOI 10.1074/jbc.M605938200; NALIN CM, 1984, J BIOL CHEM, V259, P7275; NELSON N, 1972, J BIOL CHEM, V247, P7657; Nowak KF, 2004, BIOCHEMISTRY-US, V43, P3273, DOI 10.1021/bi035820d; ROSS SA, 1995, J BIOL CHEM, V270, P9813, DOI 10.1074/jbc.270.17.9813; Schwarz O, 1997, J BIOL CHEM, V272, P16924, DOI 10.1074/jbc.272.27.16924; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; SMITH JB, 1977, BIOCHEMISTRY-US, V16, P306, DOI 10.1021/bi00621a023; Sunamura EI, 2010, PLANT CELL PHYSIOL, V51, P855, DOI 10.1093/pcp/pcq061; Ueoka-Nakanishi H, 2004, J BIOL CHEM, V279, P16272, DOI 10.1074/jbc.M400607200; WERNERGRUNE S, 1994, MOL GEN GENET, V244, P144; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; WOLOSIUK RA, 1977, NATURE, V266, P565, DOI 10.1038/266565a0; Wu G, 2008, PHOTOSYNTH RES, V97, P185, DOI 10.1007/s11120-008-9315-0; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; YU LM, 1988, J BIOL CHEM, V263, P19342	32	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9071	9078		10.1074/jbc.M110.200584	http://dx.doi.org/10.1074/jbc.M110.200584			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21193405	Green Published, hybrid			2022-12-25	WOS:000288247700038
J	Fukuda, Y; Aguilar-Bryan, L; Vaxillaire, M; Dechaume, A; Wang, Y; Dean, M; Moitra, K; Bryan, J; Schuetz, JD				Fukuda, Yu; Aguilar-Bryan, Lydia; Vaxillaire, Martine; Dechaume, Aurelie; Wang, Yao; Dean, Michael; Moitra, Karobi; Bryan, Joseph; Schuetz, John D.			Conserved Intramolecular Disulfide Bond Is Critical to Trafficking and Fate of ATP-binding Cassette (ABC) Transporters ABCB6 and Sulfonylurea Receptor 1 (SUR1)/ABCC8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; PLASMA-MEMBRANE; CYSTIC-FIBROSIS; N-GLYCOSYLATION; PROTEIN; CHANNELS; OLIGOSACCHARIDES; IDENTIFICATION	The ATP-binding cassette (ABC) transporter ABCB6 is a mitochondrial porphyrin transporter that activates porphyrin biosynthesis. ABCB6 lacks a canonical mitochondrial targeting sequence but reportedly traffics to other cellular compartments such as the plasma membrane. How ABCB6 reaches these destinations is unknown. In this study, we show that endogenous ABCB6 is glycosylated in multiple cell types, indicating trafficking through the endoplasmic reticulum (ER), and has only one atypical site for glycosylation (NXC) in its amino terminus. ABCB6 remained glycosylated when the highly conserved cysteine (Cys-8) was substituted with serine to make a consensus site, NXS. However, this substitution blocked ER exit and produced ABCB6 degradation, which was mostly reversed by the proteasomal inhibitor MG132. The amino terminus of ABCB6 has an additional highly conserved ER luminal cysteine (Cys-26). When Cys-26 was mutated alone or in combination with Cys-8, it also resulted in instability and ER retention. Further analysis revealed that these two cysteines form a disulfide bond. We discovered that other ABC transporters with an amino terminus in the ER had similarly configured conserved cysteines. This analysis led to the discovery of a disease-causing mutation in the sulfonylurea receptor 1 (SUR1)/ABCC8 from a patient with hyperinsulinemic hypoglycemia. The mutant allele only contains a mutation in a conserved amino-terminal cysteine, producing SUR1 that fails to reach the cell surface. These results suggest that for ABC transporters the propensity to form a disulfide bond in the ER defines a unique checkpoint that determines whether a protein is ER-retained.	[Fukuda, Yu; Wang, Yao; Schuetz, John D.] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Fukuda, Yu] Univ Tennessee, Hlth Sci Ctr, Coll Grad Hlth Sci, Interdisciplinary Program, Memphis, TN 38163 USA; [Aguilar-Bryan, Lydia; Bryan, Joseph] Pacific NW Res Inst, Seattle, WA 98122 USA; [Vaxillaire, Martine; Dechaume, Aurelie] CNRS, Inst Biol, UMR Unit 8090, F-59019 Lille, France; [Vaxillaire, Martine; Dechaume, Aurelie] Inst Pasteur, F-59019 Lille, France; [Dean, Michael; Moitra, Karobi] NCI, Expt Immunol Lab, NIH, Frederick, MD 21702 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schuetz, JD (corresponding author), St Jude Childrens Hosp, Dept Pharmaceut Sci, MS 313,262 Danny Thomas Pl, Memphis, TN 38105 USA.	John.Schuetz@stjude.org	Dean, Michael C/G-8172-2012; Fukuda, Yu/GLT-1434-2022; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; Fukuda, Yu/0000-0001-6182-540X	National Institutes of Health [ES058571, P30 CA21745, CA21865]; American Lebanese Syrian Associated Charities; Thrasher Foundation; NATIONAL CANCER INSTITUTE [ZIABC011301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Thrasher Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants ES058571, P30 CA21745, and CA21865. This work was also supported by the American Lebanese Syrian Associated Charities and by a grant from the Thrasher Foundation (to L. A.-B.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; ALBERINI CM, 1990, NATURE, V347, P485, DOI 10.1038/347485a0; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; Goldenberg NM, 2007, MOL BIOL CELL, V18, P4762, DOI 10.1091/mbc.E06-11-0991; GRINNELL BW, 1991, J BIOL CHEM, V266, P9778; Hernandez MV, 2010, MOL BIOL CELL, V21, P1387, DOI 10.1091/mbc.E09-10-0880; Isidoro C, 1996, J BIOL CHEM, V271, P26138, DOI 10.1074/jbc.271.42.26138; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krogh TN, 1997, EUR J BIOCHEM, V244, P334, DOI 10.1111/j.1432-1033.1997.00334.x; Lynch J, 2009, CANCER RES, V69, P5560, DOI 10.1158/0008-5472.CAN-09-0078; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; Negroiu G, 2000, J BIOL CHEM, V275, P32200, DOI 10.1074/jbc.M005186200; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; RIORDAN JR, 1989, SCIENCE, V245, P1066; Satomi Y, 2004, FEBS LETT, V576, P51, DOI 10.1016/j.febslet.2004.08.061; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Tusnady GE, 2006, FEBS LETT, V580, P1017, DOI 10.1016/j.febslet.2005.11.040; Vance BA, 1997, J BIOL CHEM, V272, P23117, DOI 10.1074/jbc.272.37.23117; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Westlake CJ, 2005, MOL BIOL CELL, V16, P2483, DOI 10.1091/mbc.E04-12-1113; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	41	29	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8481	8492		10.1074/jbc.M110.174516	http://dx.doi.org/10.1074/jbc.M110.174516			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21199866	Green Published, hybrid			2022-12-25	WOS:000288013300076
J	Hughes, KJ; Meares, GP; Hansen, PA; Corbett, JA				Hughes, Katherine J.; Meares, Gordon P.; Hansen, Polly A.; Corbett, John A.			FoxO1 and SIRT1 Regulate beta-Cell Responses to Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT ISLETS; INDUCED APOPTOSIS; DNA-DAMAGE; TRANSCRIPTION FACTORS; SYNTHASE EXPRESSION; INSULIN-SECRETION; INHIBITION; ACTIVATION; INTERLEUKIN-1-BETA; LANGERHANS	For many cell types, including pancreatic beta-cells, nitric oxide is a mediator of cell death; paradoxically, nitric oxide can also activate pathways that promote the repair of cellular damage. In this report, a role for FoxO1-dependent transcriptional activation and its regulation by SIRT1 in determining the cellular response to nitric oxide is provided. In response to nitric oxide, FoxO1 translocates from the cytoplasm to the nucleus and stimulates the expression of the DNA repair gene GADD45 alpha, resulting in FoxO1-dependent DNA repair. FoxO1-dependent gene expression appears to be regulated by the NAD(+)-dependent deacetylase SIRT1. In response to SIRT1 inhibitors, the FoxO1-dependent protective actions of nitric oxide (GADD45 alpha expression and DNA repair) are attenuated, and FoxO1 activates a proapoptotic program that includes PUMA (p53-up-regulated mediator of apoptosis) mRNA accumulation and caspase-3 cleavage. These findings support primary roles for FoxO1 and SIRT1 in regulating the cellular responses of beta-cells to nitric oxide.	[Hansen, Polly A.; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Meares, Gordon P.] Univ Alabama Birmingham, Comprehens Diabet Ctr, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA	Medical College of Wisconsin; Saint Louis University; University of Alabama System; University of Alabama Birmingham	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu	Meares, Gordon/AAJ-6716-2020	Meares, Gordon/0000-0002-0805-0155	National Institutes of Health [DK52194, AI-44458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044458, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52194 and AI-44458 (to J. A. C.).	Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Brune B, 2005, ANTIOXID REDOX SIGN, V7, P497, DOI 10.1089/ars.2005.7.497; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Calabrese V, 2009, ANTIOXID REDOX SIGN, V11, P2717, DOI 10.1089/ARS.2009.2721; CARRIER F, 1994, J BIOL CHEM, V269, P32672; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; CORBETT JA, 1992, DIABETES, V41, P552, DOI 10.2337/diabetes.41.4.552; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; DELANEY CA, 1993, FEBS LETT, V333, P291, DOI 10.1016/0014-5793(93)80673-I; Eizirik DL, 1996, MOL CELL ENDOCRINOL, V118, P71, DOI 10.1016/0303-7207(96)03768-9; Eizirik DL, 1996, DIABETOLOGIA, V39, P875; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Heitmeyer M. R, 2000, NITRIC OXIDE BIOL PA, P785; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hughes KJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1187, DOI 10.1152/ajpendo.00214.2009; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; McLaughlin LM, 2005, CANCER RES, V65, P6097, DOI 10.1158/0008-5472.CAN-04-4254; Meares GP, 2010, J BIOL CHEM, V285, P3191, DOI 10.1074/jbc.M109.047365; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; PALMER JP, 1989, DIABETES, V38, P1211, DOI 10.2337/diabetes.38.10.1211; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Rosales AL, 2004, FREE RADICAL RES, V38, P665, DOI 10.1080/10715760410001697609; Scarim AL, 2003, ENDOCRINOLOGY, V144, P3415, DOI 10.1210/en.2002-0112; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Scarim AL, 1998, ENDOCRINOLOGY, V139, P5050, DOI 10.1210/en.139.12.5050; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Storling J, 2005, DIABETOLOGIA, V48, P2039, DOI 10.1007/s00125-005-1912-2; Szabo C, 2005, PHARMACOL RES, V52, P60, DOI 10.1016/j.phrs.2005.02.015; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; White BH, 1997, J NEUROSCI, V17, P1582; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zhang J, 2003, BIOESSAYS, V25, P808, DOI 10.1002/bies.10317	57	47	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8338	8348		10.1074/jbc.M110.204768	http://dx.doi.org/10.1074/jbc.M110.204768			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21196578	Green Published, hybrid			2022-12-25	WOS:000288013300062
J	Liu, YT; Dan, QJ; Wang, JW; Feng, YG; Chen, L; Liang, JA; Li, QX; Lin, SC; Wang, ZX; Wu, JW				Liu, Yi-Tong; Dan, Qiong-Jie; Wang, Jiawei; Feng, Yingang; Chen, Lei; Liang, Juan; Li, Qinxi; Lin, Sheng-Cai; Wang, Zhi-Xin; Wu, Jia-Wei			Molecular Basis of Wnt Activation via the DIX Domain Protein Ccd1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE COILED-COIL-DIX1 CCD1; POSITIVE REGULATOR; SIGNALING PATHWAY; LRP6 PHOSPHORYLATION; CELL POLARITY; AXIN; RECRUITMENT; ASSEMBLIES; EXPRESSION; SOFTWARE	The Wnt signaling plays pivotal roles in embryogenesis and cancer, and the three DIX domain-containing proteins, Dvl, Axin, and Ccd1, play distinct roles in the initiation and regulation of canonical Wnt signaling. Overexpressed Dvl has a tendency to form large polymers in a cytoplasmic punctate pattern, whereas the biologically active Dvl in fact forms low molecular weight oligomers. The molecular basis for how the polymeric sizes of Dvl proteins are controlled upon Wnt signaling remains unclear. Here we show that Ccd1 up-regulates canonical Wnt signaling via acting synergistically with Dvl. We determined the crystal structures of wild type Ccd1-DIX and mutant Dvl1-DIX(Y17D), which pack into "head-to-tail" helical filaments. Structural analyses reveal two sites crucial for intra-filament homo-and hetero-interaction and a third site for inter-filament homo-assembly. Systematic mutagenesis studies identified critical residues from all three sites required for Dvl homo-oligomerization, puncta formation, and stimulation of Wnt signaling. Remarkably, Ccd1 forms a hetero-complex with Dvl through the "head" of Dvl-DIX and the "tail" of Ccd1-DIX, depolymerizes Dvl homo-assembly, and thereby controls the size of Dvl polymer. These data together suggest a molecular mechanism for Ccd1-mediated Wnt activation in that Ccd1 converts latent polymeric Dvl to a biologically active oligomer(s).	[Liu, Yi-Tong; Wang, Jiawei; Chen, Lei; Liang, Juan; Wang, Zhi-Xin; Wu, Jia-Wei] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Dan, Qiong-Jie; Feng, Yingang; Wang, Zhi-Xin] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Li, Qinxi; Lin, Sheng-Cai] Xiamen Univ, Sch Life Sci, MOE Key Lab Cell Biol & Tumor Cell Engn, Xiamen 361005, Fujian, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Xiamen University	Wu, JW (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	jiaweiwu@mail.tsinghua.edu.cn	Feng, Yingang/B-6304-2008; Lin, SC/G-4666-2010; Wang, Jiawei/D-1144-2010; wang, zhixin/GZH-2500-2022; Li, QX/G-4669-2010	Feng, Yingang/0000-0002-0879-1316; Wang, Jiawei/0000-0001-9893-8539; 	Ministry of Science and Technology of China [2007CB914400, 2011CB910803]; National Natural Science Foundation of China [31070643]; Tsinghua University [09THZ02235]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	This work was supported in part by Ministry of Science and Technology of China Grants 2007CB914400 and 2011CB910803, National Natural Science Foundation of China Grant 31070643, and Tsinghua University Grant 09THZ02235.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Ehebauer MT, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-70; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greco TL, 1996, MAMM GENOME, V7, P475, DOI 10.1007/s003359900144; Ikeuchi Y, 2009, J NEUROSCI, V29, P4312, DOI 10.1523/JNEUROSCI.0126-09.2009; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klingensmith J, 1996, MECH DEVELOP, V58, P15, DOI 10.1016/S0925-4773(96)00549-7; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu ZL, 2008, J BIOL CHEM, V283, P13132, DOI 10.1074/jbc.M710595200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sakanaka C, 1999, J BIOL CHEM, V274, P14090, DOI 10.1074/jbc.274.20.14090; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shiomi K, 2005, MOL BRAIN RES, V135, P169, DOI 10.1016/j.molbrainres.2004.12.002; Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Soma K, 2006, GENE EXPR PATTERNS, V6, P325, DOI 10.1016/j.modgep.2005.06.013; SUMIMOTO H, 2007, SCI STKE, pRE6, DOI DOI 10.1126/STKE.4012007RE6; Tsang M, 1996, DEV DYNAM, V207, P253, DOI 10.1002/(SICI)1097-0177(199611)207:3<253::AID-AJA2>3.0.CO;2-G; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wang L, 2010, CANCER SCI, V101, P700, DOI 10.1111/j.1349-7006.2009.01448.x; Wong CK, 2004, J BIOL CHEM, V279, P39366, DOI 10.1074/jbc.M404598200; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	44	33	37	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8597	8608		10.1074/jbc.M110.186742	http://dx.doi.org/10.1074/jbc.M110.186742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21189423	Green Published, hybrid			2022-12-25	WOS:000288013300086
J	Zhang, ZL; Xu, JJ; Sheng, ZT; Sui, YP; Palli, SR				Zhang, Zhaolin; Xu, Jingjing; Sheng, Zhentao; Sui, Yipeng; Palli, Subba R.			Steroid Receptor Co-activator Is Required for Juvenile Hormone Signal Transduction through a bHLH-PAS Transcription Factor, Methoprene Tolerant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; GENE-PRODUCT; DROSOPHILA-MELANOGASTER; TRIBOLIUM-CASTANEUM; MOLECULAR ACTIONS; DNA-BINDING; STATUS-QUO; METAMORPHOSIS; ECDYSONE; INSECT	Metamorphosis in insects is regulated by juvenile hormone (JH) and ecdysteroids. The mechanism of 20-hydroxyecdysone (20E), but not of JH action, is well understood. A basic helixloop-helix (bHLH)-Per-Arnt-Sim (PAS) family member, methoprene tolerant (Met), plays an important role in JH action. Microarray analysis and RNA interference (RNAi) were used to identify 69 genes that require Met for their hydroprene-regulated expression in the red flour beetle, Tribolium castaneum. Quantitative real time PCR analysis confirmed microarray data for 13 of the 16 hydroprene-response genes tested. The members of the bHLH-PAS family often function as heterodimers to regulate gene expression and Met is a member of this family. To determine whether other members of the bHLH-PAS family are required for the expression of JH-response genes, we employed RNAi to knockdown the expression of all 11 members of the bHLH-PAS family and studied the expression of JH-response genes in RNAi insects. These studies showed that besides Met, another member of this family, steroid receptor co-activator (SRC) is required for the expression of 15 JH-response genes tested. Moreover, studies in JH responsive Aag-2 cells revealed that Aedes aegypti homologues of both Met and SRC are required for the expression of the JH-response gene, kr-h1, and SRC is required for expression of ecdysone-response genes. These data suggest the steroid receptor co-activator plays key roles in both JH and 20E action suggesting that this may be an important molecule that mediates cross-talk between JH and 20E to prevent metamorphosis.	[Zhang, Zhaolin; Xu, Jingjing; Sheng, Zhentao; Sui, Yipeng; Palli, Subba R.] Univ Kentucky, Coll Agr, Dept Entomol, Lexington, KY 40546 USA	University of Kentucky	Palli, SR (corresponding author), Univ Kentucky, Coll Agr, Dept Entomol, Lexington, KY 40546 USA.	rpalli@uky.edu	sheng, Zhentao Sheng/E-8962-2017; PALLI, SUBBA REDDY/AAU-8289-2020; Xu, Jingjing/H-2267-2013; Zhang, Zhaolin/E-6183-2012	PALLI, SUBBA REDDY/0000-0002-0873-3247; Xu, Jingjing/0000-0003-1976-3721	National Institutes of Health [GM070559-06]; Kentucky Agricultural Experimental Station [11-08-014]; NCRR IDeA [INBRE-P20 RR016481, COBRE-P20RR018733]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481, P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Agricultural Experimental Station; NCRR IDeA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070559-06. This is contribution 11-08-014 from the Kentucky Agricultural Experimental Station.; We thank Dr. Nigel Cooper and Xiahong Li, University of Louisville, for help with microarray analysis. The University of Louisville microarray facility is supported by NCRR IDeA Awards INBRE-P20 RR016481 and COBRE-P20RR018733.	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Bitra K, 2009, ARCH INSECT BIOCHEM, V70, P90, DOI 10.1002/arch.20281; Bitra K, 2009, GENE, V448, P74, DOI 10.1016/j.gene.2009.08.003; Emmons RB, 1999, DEVELOPMENT, V126, P3937; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; GOODMAN WG, 2005, COMPREHENSIVE MOL IN, V3, P319; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hassan BA, 2000, GENE DEV, V14, P1852; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Parthasarathy R, 2007, MECH DEVELOP, V124, P23, DOI 10.1016/j.mod.2006.09.002; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; Parthasarathy R, 2009, MECH DEVELOP, V126, P563, DOI 10.1016/j.mod.2009.03.005; Pursley S, 2000, INSECT BIOCHEM MOLEC, V30, P839, DOI 10.1016/S0965-1748(00)00056-4; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Swanson HI, 2002, CHEM-BIOL INTERACT, V141, P63, DOI 10.1016/S0009-2797(02)00066-2; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wheeler DE, 2003, BIOESSAYS, V25, P994, DOI 10.1002/bies.10337; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; Wilson TG, 2006, GENETICS, V172, P253, DOI 10.1534/genetics.105.046631; Wu Y, 2006, MECH DEVELOP, V123, P530, DOI 10.1016/j.mod.2006.05.005; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079; Zhu JS, 2006, MOL CELL BIOL, V26, P9402, DOI 10.1128/MCB.01318-06	35	148	158	3	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8437	8447		10.1074/jbc.M110.191684	http://dx.doi.org/10.1074/jbc.M110.191684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21190938	Green Published, hybrid			2022-12-25	WOS:000288013300072
J	Lin, TL; Wang, QJH; Brown, P; Peacock, C; Merchant, AA; Brennan, S; Jones, E; McGovern, K; Watkins, DN; Sakamoto, KM; Matsui, W				Lin, Tara L.; Wang, Qiuju H.; Brown, Patrick; Peacock, Craig; Merchant, Akil A.; Brennan, Sarah; Jones, Evan; McGovern, Karen; Watkins, D. Neil; Sakamoto, Kathleen M.; Matsui, William			Self-Renewal of Acute Lymphocytic Leukemia Cells Is Limited by the Hedgehog Pathway Inhibitors Cyclopamine and IPI-926	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELLS; ALDEHYDE DEHYDROGENASE; HUMAN HOMOLOG; PROGENITORS; GROWTH; SURVIVAL; IDENTIFICATION; REQUIREMENT; COMPARTMENT	Conserved embryonic signaling pathways such as Hedgehog (Hh), Wingless and Notch have been implicated in the pathogenesis of several malignancies. Recent data suggests that Hh signaling plays a role in normal B-cell development, and we hypothesized that Hh signaling may be important in precursor B-cell acute lymphocytic leukemia (B-ALL). We found that the expression of Hh pathway components was common in human B-ALL cell lines and clinical samples. Moreover, pathway activity could be modulated by Hh ligand or several pathway inhibitors including cyclopamine and the novel SMOOTHENED (SMO) inhibitor IPI-926. The inhibition of pathway activity primarily impacted highly clonogenic B-ALL cells expressing aldehyde dehydrogenase (ALDH) by limiting their self-renewal potential both in vitro and in vivo. These data demonstrate that Hh pathway activation is common in B-ALL and represents a novel therapeutic target regulating self-renewal and persistence of the malignant clone.	[Lin, Tara L.] LSU Hlth Sci Ctr, Dept Internal Med, Sect Hematol & Oncol, New Orleans, LA USA; [Wang, Qiuju H.; Brown, Patrick; Peacock, Craig; Merchant, Akil A.; Brennan, Sarah; Jones, Evan; Watkins, D. Neil; Matsui, William] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [McGovern, Karen] Infin Pharmaceut, Cambridge, MA USA; [Sakamoto, Kathleen M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Gwynne Hazen Cherry Mem Labs,Jonsson Comprehens C, Los Angeles, CA 90095 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Johns Hopkins University; Johns Hopkins Medicine; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lin, TL (corresponding author), LSU Hlth Sci Ctr, Dept Internal Med, Sect Hematol & Oncol, New Orleans, LA USA.	tlin@lsuhsc.edu; matsuwi@jhmi.edu	Watkins, David N/I-6113-2013	Matsui, William/0000-0002-3088-0964; Sakamoto, Kathleen/0000-0003-0494-8838; Lin, Tara/0000-0002-0242-6449	American Society of Clinical Oncology Foundation; National Institutes of Health [T32HL086345, R01CA127574, P01CA15396]; Gabrielle's Angel Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Leukemia and Lymphoma Society; NIH [HL75826, HL83077]; St. Baldrick's Foundation; William Lawrence and Blanche Hughes Foundation; Abbott Laboratories; Genentech, Inc.; NATIONAL CANCER INSTITUTE [R01CA127574, P01CA015396] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086345, R01HL083077, R01HL075826] Funding Source: NIH RePORTER	American Society of Clinical Oncology Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation for Cancer Research; Sidney Kimmel Foundation for Cancer Research; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Foundation; William Lawrence and Blanche Hughes Foundation; Abbott Laboratories(Abbott Laboratories); Genentech, Inc.(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	T.L.L. was supported by grants from the American Society of Clinical Oncology Foundation and National Institutes of Health T32HL086345. W. M. is supported by the National Institutes of Health R01CA127574, P01CA15396, the Gabrielle's Angel Foundation for Cancer Research, the Sidney Kimmel Foundation for Cancer Research, and the Leukemia and Lymphoma Society. K.M.S. is supported by NIH grants HL75826, HL83077, St. Baldrick's Foundation, William Lawrence and Blanche Hughes Foundation, and a grant from Abbott Laboratories, and Genentech, Inc. W.M. and K.M.S. are Scholars of the Leukemia and Lymphoma Society. K.M. is an employee of Infinity Pharmaceuticals. K. M. and Infinity Pharmaceuticals were involved in the design of the in vivo studies and preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cobaleda C, 2000, BLOOD, V95, P1007, DOI 10.1182/blood.V95.3.1007.003k35_1007_1013; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Hotfilder M, 2005, CANCER RES, V65, P1442, DOI 10.1158/0008-5472.CAN-04-1356; Hotfilder M, 2002, BLOOD, V100, P640, DOI 10.1182/blood.V100.2.640; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Ji ZY, 2007, J BIOL CHEM, V282, P37370, DOI 10.1074/jbc.M703697200; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; KASTAN MB, 1990, BLOOD, V75, P1947; Kawahara T, 2009, ANTICANCER RES, V29, P4629; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Siggins SL, 2009, BLOOD, V114, P995, DOI 10.1182/blood-2009-03-208330; Singh RR, 2010, LEUKEMIA, V24, P1025, DOI 10.1038/leu.2010.35; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Tremblay MR, 2008, J MED CHEM, V51, P6646, DOI 10.1021/jm8008508; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Warzecha J, 2008, LEUKEMIA LYMPHOMA, V49, P2383, DOI 10.1080/10428190802510315; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	47	62	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15262	10.1371/journal.pone.0015262	http://dx.doi.org/10.1371/journal.pone.0015262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203400	Green Published, Green Submitted, gold			2022-12-25	WOS:000285792500027
J	Lourenco, R; Lopes, SS; Saude, L				Lourenco, Raquel; Lopes, Susana S.; Saude, Leonor			Left-Right Function of dmrt2 Genes Is Not Conserved between Zebrafish and Mouse	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; SEGMENTATION CLOCK; NODAL EXPRESSION; BILATERAL SYMMETRY; VERTEBRATE EMBRYOS; NOTCH; SOMITOGENESIS; DOMAIN; AXIS; ESTABLISHMENT	Background: Members of the Dmrt family, generally associated with sex determination, were shown to be involved in several other functions during embryonic development. Dmrt2 has been studied in the context of zebrafish development where, due to a duplication event, two paralog genes dmrt2a and dmrt2b are present. Both zebrafish dmrt2a/terra and dmrt2b are important to regulate left-right patterning in the lateral plate mesoderm. In addition, dmrt2a/terra is necessary for symmetric somite formation while dmrt2b regulates somite differentiation impacting on slow muscle development. One dmrt2 gene is also expressed in the mouse embryo, where it is necessary for somite differentiation but with an impact on axial skeleton development. However, nothing was known about its role during left-right patterning in the lateral plate mesoderm or in the symmetric synchronization of somite formation. Methodology/Principal Findings: Using a dmrt2 mutant mouse line, we show that this gene is not involved in symmetric somite formation and does not regulate the laterality pathway that controls left-right asymmetric organ positioning. We reveal that dmrt2a/terra is present in the zebrafish laterality organ, the Kupffer's vesicle, while its homologue is excluded from the mouse equivalent structure, the node. On the basis of evolutionary sub-functionalization and neo-functionalization theories we discuss this absence of functional conservation. Conclusions/Significance: Our results show that the role of dmrt2 gene is not conserved during zebrafish and mouse embryonic development.	[Lourenco, Raquel; Lopes, Susana S.; Saude, Leonor] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Lourenco, Raquel; Lopes, Susana S.; Saude, Leonor] Univ Lisbon, Fac Med, Inst Histol & Biol Desenvolvimento, P-1699 Lisbon, Portugal; [Lourenco, Raquel; Lopes, Susana S.; Saude, Leonor] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade de Lisboa; Universidade de Lisboa; Instituto Gulbenkian de Ciencia	Lourenco, R (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.	msaude@fm.ul.pt	Lopes, Susana/AAB-3820-2019; Saúde, Leonor/D-2720-2012	Saúde, Leonor/0000-0001-5933-8872; Lopes, Susana/0000-0002-6733-6356; Lourenco, Raquel/0000-0002-6176-3066	Fundacao para a Ciencia e a Technologia (FCT) [PTDC/SAU-OBD/71596/2006, PTDC/SAU-OBD/64628/2006]	Fundacao para a Ciencia e a Technologia (FCT)(Portuguese Foundation for Science and Technology)	Two Fundacao para a Ciencia e a Technologia (FCT) (http://alfa.fct.mctes.pt) grants PTDC/SAU-OBD/71596/2006 and PTDC/SAU-OBD/64628/2006 supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade Raquel P., 2007, Birth Defects Research, V81, P65, DOI 10.1002/bdrc.20094; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Brend T, 2009, SEMIN CELL DEV BIOL, V20, P472, DOI 10.1016/j.semcdb.2008.11.009; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Force A, 1999, GENETICS, V151, P1531; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Goldbeter A, 2008, J THEOR BIOL, V252, P574, DOI 10.1016/j.jtbi.2008.01.006; Gourronc F, 2007, DEV DYNAM, V236, P2131, DOI 10.1002/dvdy.21249; Hong CS, 2007, DEV BIOL, V310, P1, DOI 10.1016/j.ydbio.2007.07.035; Isaac A, 1997, SCIENCE, V275, P1301, DOI 10.1126/science.275.5304.1301; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Kim SS, 2003, GENE EXPR PATTERNS, V3, P77, DOI 10.1016/S1567-133X(02)00071-6; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007261; Lourenco R, 2010, SYMMETRY-BASEL, V2, P1033, DOI 10.3390/sym2021033; Meng AM, 1999, DEVELOPMENT, V126, P1259; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Minowada G, 1999, DEVELOPMENT, V126, P4465; Morales AV, 2007, EMBO REP, V8, P104, DOI 10.1038/sj.embor.7400867; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Saude L, 2005, NAT CELL BIOL, V7, P918, DOI 10.1038/ncb1294; Schilling TF, 1999, DEV BIOL, V210, P277, DOI 10.1006/dbio.1999.9214; Seo KW, 2006, DEV BIOL, V290, P200, DOI 10.1016/j.ydbio.2005.11.027; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Tabin CJ, 2006, CELL, V127, P27, DOI 10.1016/j.cell.2006.09.018; Takeuchi JK, 2007, P NATL ACAD SCI USA, V104, P846, DOI 10.1073/pnas.0608118104; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Volff JN, 2003, J MOL EVOL, V57, pS241, DOI 10.1007/s00239-003-0033-0; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Zhou X, 2008, BIOCHIMIE, V90, P878, DOI 10.1016/j.biochi.2008.02.021	41	24	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14438	10.1371/journal.pone.0014438	http://dx.doi.org/10.1371/journal.pone.0014438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203428	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500014
J	Thomassen, GOS; Weel-Sneve, R; Rowe, AD; Booth, JA; Lindvall, JM; Lagesen, K; Kristiansen, KI; Bjoras, M; Rognes, T				Thomassen, Gard O. S.; Weel-Sneve, Ragnhild; Rowe, Alexander D.; Booth, James A.; Lindvall, Jessica M.; Lagesen, Karin; Kristiansen, Knut I.; Bjoras, Magnar; Rognes, Torbjorn			Tiling Array Analysis of UV Treated Escherichia coli Predicts Novel Differentially Expressed Small Peptides	PLOS ONE			English	Article							OLIGONUCLEOTIDE ARRAYS; COMPARATIVE GENOMICS; NONCODING RNAS; BINDING-SITES; GENES; K-12; LEXA; RESOLUTION; DAMAGE; IDENTIFICATION	Background: Despite comprehensive investigation, the Escherichia coli SOS response system is not yet fully understood. We have applied custom designed whole genome tiling arrays to measure UV invoked transcriptional changes in E. coli. This study provides a more complete insight into the transcriptome and the UV irradiation response of this microorganism. Results: We detected a number of novel differentially expressed transcripts in addition to the expected SOS response genes (such as sulA, recN, uvrA, lexA, umuC and umuD) in the UV treated cells. Several of the differentially expressed transcripts might play important roles in regulation of the cellular response to UV damage. We have predicted 23 novel small peptides from our set of detected non-gene transcripts. Further, three of the predicted peptides were cloned into protein expression vectors to test the biological activity. All three constructs expressed the predicted peptides, in which two of them were highly toxic to the cell. Additionally, a remarkably high overlap with previously in-silico predicted non-coding RNAs (ncRNAs) was detected. Generally we detected a far higher transcriptional activity than the annotation suggests, and these findings correspond with previous transcription mappings from E. coli and other organisms. Conclusions: Here we demonstrate that the E. coli transcriptome consists of far more transcripts than the present annotation suggests, of which many transcripts seem important to the bacterial stress response. Sequence alignment of promoter regions suggest novel regulatory consensus sequences for some of the upregulated genes. Finally, several of the novel transcripts identified in this study encode putative small peptides, which are biologically active.	[Thomassen, Gard O. S.; Weel-Sneve, Ragnhild; Rowe, Alexander D.; Booth, James A.; Lagesen, Karin; Kristiansen, Knut I.; Bjoras, Magnar; Rognes, Torbjorn] Oslo Univ Hosp, Rikshosp, CMBN, Oslo, Norway; [Thomassen, Gard O. S.; Weel-Sneve, Ragnhild; Rowe, Alexander D.; Booth, James A.; Lagesen, Karin; Kristiansen, Knut I.; Bjoras, Magnar; Rognes, Torbjorn] Oslo Univ Hosp, Rikshosp, Dept Microbiol, Oslo, Norway; [Thomassen, Gard O. S.; Weel-Sneve, Ragnhild; Lagesen, Karin; Bjoras, Magnar] Univ Oslo, CMBN, Oslo, Norway; [Thomassen, Gard O. S.; Weel-Sneve, Ragnhild; Lagesen, Karin; Bjoras, Magnar] Univ Oslo, Dept Microbiol, Oslo, Norway; [Lindvall, Jessica M.; Rognes, Torbjorn] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Bjoras, Magnar] Univ Oslo, Inst Clin Biochem, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Thomassen, GOS (corresponding author), Oslo Univ Hosp, Rikshosp, CMBN, Oslo, Norway.	torognes@ifi.uio.no	Rognes, Torbjørn/A-9692-2008; Lindvall, Jessica M/A-1762-2013; Bjørås, Magnar/N-9286-2017	Rognes, Torbjørn/0000-0002-9329-9974; Thomassen, Gard Olav Sundby/0000-0002-6979-8474; Lagesen, Karin/0000-0003-1329-9032; Booth, James/0000-0001-9452-3424; Lindvall, Jessica/0000-0002-5042-8481	Research Council of Norway (FUGE), Oslo University Hospital, University of Oslo; European Union	Research Council of Norway (FUGE), Oslo University Hospital, University of Oslo(Research Council of Norway); European Union(European Commission)	The study was funded by the Research Council of Norway (FUGE), Oslo University Hospital, University of Oslo and the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; BERG OG, 1988, NUCLEIC ACIDS RES, V16, P5089, DOI 10.1093/nar/16.11.5089; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; Chen S, 2002, BIOSYSTEMS, V65, P157, DOI 10.1016/S0303-2647(02)00013-8; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Courcelle J, 2001, GENETICS, V158, P41; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; de Saizieu A, 1998, NAT BIOTECHNOL, V16, P45, DOI 10.1038/nbt0198-45; DEWITT SK, 1962, GENETICS, V47, P577; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Fischer D, 1998, J BACTERIOL, V180, P6203; FRIEDBERG EC, 2006, AM SOC MICROBIOL, P463; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gene Expression Omnibus, GENE EXPRESSION OMNI; GIBERT I, 1990, MOL GEN GENET, V220, P400, DOI 10.1007/BF00391745; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Hemm MR, 2010, J BACTERIOL, V192, P46, DOI 10.1128/JB.00872-09; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Jorgensen F, 1999, MICROBIOL-UK, V145, P835, DOI 10.1099/13500872-145-4-835; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Khil PP, 2002, MOL MICROBIOL, V44, P89, DOI 10.1046/j.1365-2958.2002.02878.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KRUEGER JH, 1983, J BACTERIOL, V153, P1368, DOI 10.1128/JB.153.3.1368-1378.1983; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; MOUNT DW, 1972, J BACTERIOL, V112, P886, DOI 10.1128/JB.112.2.886-893.1972; Norris V, 2007, MICROBIOL MOL BIOL R, V71, P230, DOI 10.1128/MMBR.00035-06; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Royce TE, 2007, BIOINFORMATICS, V23, P988, DOI 10.1093/bioinformatics/btm052; Saetrom P, 2005, NUCLEIC ACIDS RES, V33, P3263, DOI 10.1093/nar/gki644; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Thomassen GOS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005943; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Tjaden Brian, 2002, Bioinformatics, V18 Suppl 1, pS337; Vogel J, 2004, CURR BIOL, V14, P2271, DOI 10.1016/j.cub.2004.12.003; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; Weel-Sneve R, 2008, NUCLEIC ACIDS RES, V36, P6249, DOI 10.1093/nar/gkn633; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470	49	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15356	10.1371/journal.pone.0015356	http://dx.doi.org/10.1371/journal.pone.0015356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203457	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200019
J	Bernardi, E; Deflorian, G; Pezzinenti, F; Diaz, VM; Mione, M; Blasi, F				Bernardi, Elisa; Deflorian, Gianluca; Pezzinenti, Federica; Diaz, Victor M.; Mione, Marina; Blasi, Francesco			Characterization of the Regulatory Region of the Zebrafish Prep1.1 Gene: Analogies to the Promoter of the Human PREP1	PLOS ONE			English	Article							EXPRESSION; PROTEINS; PBX; TRANSCRIPTION; MOUSE; CELLS; HOX; RHOMBOMERE-4; SENSITIVITY; MECHANISM	Prep1 is a developmentally essential TALE class homeodomain transcription factor. In zebrafish and mouse, Prep1 is already ubiquitously expressed at the earliest stages of development, with important tissue-specific peculiarities. The Prep1 gene in mouse is developmentally essential and has haploinsufficient tumor suppressor activity [ 1]. We have determined the human Prep1 transcription start site (TSS) by primer extension analysis and identified, within 20 bp, the transcription start region (TSR) of the zebrafish Prep1.1 promoter. The functions of the zebrafish 59 upstream sequences were analyzed both by transient transfections in Hela Cells and by injection in zebrafish embryos. This analysis revealed a complex promoter with regulatory sequences extending up to -1.8, possibly -5.0 Kb, responsible for tissue specific expression. Moreover, the first intron contains a conserved tissue-specific enhancer both in zebrafish and in human cells. Finally, a two nucleotides mutation of an EGR-1 site, conserved in all species including human and zebrafish and located at a short distance from the TSS, destroyed the promoter activity of the -5.0 Kb promoter. A transgenic fish expressing GFP under the 21.8 Kb zebrafish promoter/enhancer co-expressed GFP and endogenous Prep1.1 during embryonic development. In the adult fish, GFP was expressed in hematopoietic regions like the kidney, in agreement with the essential function of Prep1 in mouse hematopoiesis. Sequence comparison showed conservation from man to fish of the sequences around the TSS, within the first intron enhancer. Moreover, about 40% of the sequences spread throughout the 5 Kbof the zebrafish promoter are concentrated in the -3 to -5 Kb of the human upstream region.	[Bernardi, Elisa; Deflorian, Gianluca; Pezzinenti, Federica; Mione, Marina; Blasi, Francesco] IFOM FIRC Inst Mol Oncol Fdn, Milan, Italy; [Diaz, Victor M.; Blasi, Francesco] Univ Vita Salute San Raffaele, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Vita-Salute San Raffaele University	Bernardi, E (corresponding author), IFOM FIRC Inst Mol Oncol Fdn, Milan, Italy.	blasi.francesco@hsr.it	Mione, Maria Caterina/I-3073-2013; Mione, Maria Caterina/ABG-9926-2021; Díaz, Víctor Manuel/F-5013-2016	Díaz, Víctor Manuel/0000-0001-8561-7576; Mione, Maria Caterina/0000-0002-9040-3705; Blasi, Francesco/0000-0001-9406-1784	AIRC (Italian Association for Cancer Research); Telethon Onlus; Italian Ministry of Health	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); Telethon Onlus(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy)	This work was funded by grants from AIRC (Italian Association for Cancer Research), Telethon Onlus and the Italian Ministry of Health, to FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Costagli A, 2002, J COMP NEUROL, V450, P73, DOI 10.1002/cne.10292; Deflorian G, 2004, DEVELOPMENT, V131, P613, DOI 10.1242/dev.00948; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; Fernandez-Diaz LC, 2010, DEVELOPMENT, V137, P3393, DOI 10.1242/dev.050567; Ferrai C, 2009, MOL BIOL CELL, V20, P3543, DOI 10.1091/mbc.E09-02-0114; Ferretti E, 2000, DEVELOPMENT, V127, P155; Ferretti E, 2005, MOL CELL BIOL, V25, P8541, DOI 10.1128/MCB.25.19.8541-8552.2005; Ferretti E, 1999, MECH DEVELOP, V83, P53, DOI 10.1016/S0925-4773(99)00031-3; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Manzanares M, 2001, DEVELOPMENT, V128, P3595; Micali N, 2010, NUCLEIC ACIDS RES, V38, P3595, DOI 10.1093/nar/gkq019; Micali N, 2009, MOL CELL BIOL, V29, P1143, DOI 10.1128/MCB.01273-08; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; OBARDI E, 2010, MOL ONCOLOGY, V4, P226; Oriente F, 2008, MOL CELL BIOL, V28, P5634, DOI 10.1128/MCB.00117-08; Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tumpel S, 2007, DEV BIOL, V302, P646, DOI 10.1016/j.ydbio.2006.10.029; Vaccari E, 2010, DEV BIOL, V343, P94, DOI 10.1016/j.ydbio.2010.04.016; Westerfield M, 2007, ZEBRAFISH BOOK	25	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15047	10.1371/journal.pone.0015047	http://dx.doi.org/10.1371/journal.pone.0015047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203543	Green Submitted, Green Published, gold			2022-12-25	WOS:000285578000019
J	Verthelyi, D; Wang, VV				Verthelyi, Daniela; Wang, Vivian			Trace Levels of Innate Immune Response Modulating Impurities (IIRMIs) Synergize to Break Tolerance to Therapeutic Proteins	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CPG OLIGODEOXYNUCLEOTIDES; BACTERIAL-DNA; GENE-EXPRESSION; DENDRITIC CELLS; LIPOPOLYSACCHARIDE; ACTIVATION; VACCINE; ANTIBODIES; ADJUVANTS	Therapeutic proteins such as monoclonal antibodies, replacement enzymes and toxins have significantly improved the therapeutic options for multiple diseases, including cancer and inflammatory diseases as well as enzyme deficiencies and inborn errors of metabolism. However, immune responses to these products are frequent and can seriously impact their safety and efficacy. Of the many factors that can impact protein immunogenicity, this study focuses on the role of innate immune response modulating impurities (IIRMIs) that could be present despite product purification and whether these impurities can synergize to facilitate an immunogenic response to therapeutic proteins. Using lipopolysaccharide (LPS) and CpG ODN as IIRMIs we showed that trace levels of these impurities synergized to induce IgM, IFN gamma, TNF alpha and IL-6 expression. In vivo, trace levels of these impurities synergized to increase antigen-specific IgG antibodies to ovalbumin. Further, whereas mice treated with human erythropoietin showed a transient increase in hematocrit, those that received human erythropoietin containing low levels of IIRMIs had reduced response to erythropoietin after the 1(st) dose and developed long-lasting anemia following subsequent doses. This suggests that the presence of IIRMIs facilitated a breach in tolerance to the endogenous mouse erythropoietin. Overall, these studies indicate that the risk of enhancing immunogenicity should be considered when establishing acceptance limits of IIRMIs for therapeutic proteins.	[Verthelyi, Daniela; Wang, Vivian] US FDA, Div Therapeut Prot, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Verthelyi, D (corresponding author), US FDA, Div Therapeut Prot, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	daniela.verthelyi@fda.hhs.gov						Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Casadevall N, 2002, NEPHROL DIAL TRANSPL, V17, P42, DOI 10.1093/ndt/17.suppl_5.42; Chen WH, 2010, INNATE IMMUN-LONDON, V16, P322, DOI 10.1177/1753425909346973; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Crampton SR, 2010, ANN NY ACAD SCI, V1183, P58, DOI 10.1111/j.1749-6632.2009.05123.x; Dasari P, 2005, CELL IMMUNOL, V236, P140, DOI 10.1016/j.cellimm.2005.08.020; Ellis RD, 2009, VACCINE, V27, P4104, DOI 10.1016/j.vaccine.2009.04.077; Gao JJ, 1999, J IMMUNOL, V163, P4095; Gao JJ, 2001, J IMMUNOL, V166, P6855, DOI 10.4049/jimmunol.166.11.6855; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Gouw SC, 2007, BLOOD, V109, P4693, DOI 10.1182/blood-2006-11-056317; Hume D A, 2001, BMC Immunol, V2, P11, DOI 10.1186/1471-2172-2-11; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kishnani PS, 2010, MOL GENET METAB, V99, P26, DOI 10.1016/j.ymgme.2009.08.003; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Kumar S, 2004, INFECT IMMUN, V72, P949, DOI 10.1128/IAI.72.2.949-957.2004; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macdougall IC, 2005, NEPHROL DIAL TRANSPL, V20, P9, DOI 10.1093/ndt/gfh1087; MAEDA H, 1992, INT J HEMATOL, V55, P111; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Marsland BJ, 2007, CURR OPIN IMMUNOL, V19, P611, DOI 10.1016/j.coi.2007.07.022; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; McCoy SL, 2004, J BIOL CHEM, V279, P17217, DOI 10.1074/jbc.M303837200; MORENO E, 1984, INFECT IMMUN, V46, P74, DOI 10.1128/IAI.46.1.74-80.1984; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Richard K, 2008, J IMMUNOL, V181, P1746, DOI 10.4049/jimmunol.181.3.1746; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Rosenberg A S, 2003, Dev Biol (Basel), V112, P15; Ryan MH, 2006, INT IMMUNOPHARMACOL, V6, P647, DOI 10.1016/j.intimp.2005.10.001; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Schellekens H, 2004, J NEUROL, V251, P4, DOI 10.1007/s00415-004-1202-9; Schellekens Huub, 2006, J Immunotoxicol, V3, P123, DOI 10.1080/15476910600845567; Schellekens H, 2008, BIOTECHNOL ANN REV, V14, P191, DOI 10.1016/S1387-2656(08)00007-0; Schenk J, 1969, J IMMUNOL, V114, P770; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Thawani N, 2006, EXP HEMATOL, V34, P1451, DOI 10.1016/j.exphem.2006.06.014; Verthelyi D, 2002, J IMMUNOL, V168, P1659, DOI 10.4049/jimmunol.168.4.1659; Verthelyi D, 2004, AIDS, V18, P1003, DOI 10.1097/00002030-200404300-00007; Verthelyi D, 2003, J IMMUNOL, V170, P4717, DOI 10.4049/jimmunol.170.9.4717; Verthelyi D, 2003, TRENDS IMMUNOL, V24, P519, DOI 10.1016/S1471-4906(03)00243-6; Wang JH, 2008, NAT BIOTECHNOL, V26, P901, DOI 10.1038/nbt.1484; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Weiner GJ, 1997, P NATL ACAD SCI USA, V94, P10833, DOI 10.1073/pnas.94.20.10833; WEN D, 1993, BLOOD, V82, P1507; *WHO, 1998, REQ US AN CELLS IN V, V878, P8; WOROBEC A, 2005, BIO PHARM INT, P22	55	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15252	10.1371/journal.pone.0015252	http://dx.doi.org/10.1371/journal.pone.0015252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203556	Green Submitted, Green Published, gold			2022-12-25	WOS:000285578000026
J	Ince, NF; Gupta, R; Arica, S; Tewfik, AH; Ashe, J; Pellizzer, G				Ince, Nuri F.; Gupta, Rahul; Arica, Sami; Tewfik, Ahmed H.; Ashe, James; Pellizzer, Giuseppe			High Accuracy Decoding of Movement Target Direction in Non-Human Primates Based on Common Spatial Patterns of Local Field Potentials	PLOS ONE			English	Article							PREMOTOR CORTEX; MOTOR CORTEX; CORTICAL CONTROL; DISCHARGE; SIGNALS; SYNCHRONIZATION; OSCILLATIONS; ORGANIZATION; INFERENCE; NEURONS	Background: The current development of brain-machine interface technology is limited, among other factors, by concerns about the long-term stability of single-and multi-unit neural signals. In addition, the understanding of the relation between potentially more stable neural signals, such as local field potentials, and motor behavior is still in its early stages. Methodology/Principal Findings: We tested the hypothesis that spatial correlation patterns of neural data can be used to decode movement target direction. In particular, we examined local field potentials (LFP), which are thought to be more stable over time than single unit activity (SUA). Using LFP recordings from chronically implanted electrodes in the dorsal premotor and primary motor cortex of non-human primates trained to make arm movements in different directions, we made the following observations: (i) it is possible to decode movement target direction with high fidelity from the spatial correlation patterns of neural activity in both primary motor (M1) and dorsal premotor cortex (PMd); (ii) the decoding accuracy of LFP was similar to the decoding accuracy obtained with the set of SUA recorded simultaneously; (iii) directional information varied with the LFP frequency sub-band, being greater in low (0.3-4 Hz) and high (48-200 Hz) frequency bands than in intermediate bands; (iv) the amount of directional information was similar in M1 and PMd; (v) reliable decoding was achieved well in advance of movement onset; and (vi) LFP were relatively stable over a period of one week. Conclusions/Significance: The results demonstrate that the spatial correlation patterns of LFP signals can be used to decode movement target direction. This finding suggests that parameters of movement, such as target direction, have a stable spatial distribution within primary motor and dorsal premotor cortex, which may be used for brain-machine interfaces.	[Ince, Nuri F.; Gupta, Rahul; Ashe, James; Pellizzer, Giuseppe] VA Hlth Care Syst, Brain Sci Ctr, Minneapolis, MN USA; [Ince, Nuri F.; Ashe, James; Pellizzer, Giuseppe] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Arica, Sami] Cukurova Univ, Dept Elect & Elect Engn, Adana, Turkey; [Tewfik, Ahmed H.] Univ Minnesota, Dept Elect & Comp Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Cukurova University; University of Minnesota System; University of Minnesota Twin Cities	Ince, NF (corresponding author), VA Hlth Care Syst, Brain Sci Ctr, Minneapolis, MN USA.	ashe@umn.edu; pelli001@umn.edu	Arica, Sami/A-6647-2018; Pellizzer, Giuseppe/B-7540-2017	Arica, Sami/0000-0002-3820-029X; Pellizzer, Giuseppe/0000-0002-9254-5555	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	This study was supported by Merit Review awards (JA; GP) from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2004, CURR OPIN NEUROBIOL, V14, P720, DOI 10.1016/j.conb.2004.10.005; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Bouckaert RR, 2004, LECT NOTES ARTIF INT, V3056, P3; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2004, NATURE, V431, P993, DOI 10.1038/nature03005; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Dickey AS, 2009, J NEUROPHYSIOL, V102, P1331, DOI 10.1152/jn.90920.2008; Dietterich TG, 1994, J ARTIF INTELL RES, V2, P263; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; FISHER NI, 1983, BIOMETRIKA, V70, P327, DOI 10.1093/biomet/70.2.327; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Georgopoulos AP, 2007, P NATL ACAD SCI USA, V104, P11068, DOI 10.1073/pnas.0611597104; Heldman DA, 2006, IEEE T NEUR SYS REH, V14, P180, DOI 10.1109/TNSRE.2006.875549; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HUBEL DH, 1963, J PHYSIOL-LONDON, V165, P559, DOI 10.1113/jphysiol.1963.sp007079; Ince NF, 2009, I IEEE EMBS C NEUR E, P284; KOLES Z J, 1990, Brain Topography, V2, P275, DOI 10.1007/BF01129656; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Nadeau C, 2003, MACH LEARN, V52, P239, DOI 10.1023/A:1024068626366; Naselaris T, 2005, J NEUROPHYSIOL, V93, P2318, DOI 10.1152/jn.00581.2004; Naselaris T, 2006, J NEUROPHYSIOL, V96, P3237, DOI 10.1152/jn.00488.2006; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; O'Leary JG, 2006, J NEUROPHYSIOL, V96, P1492, DOI 10.1152/jn.00106.2006; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pohlmeyer EA, 2007, J NEURAL ENG, V4, P369, DOI 10.1088/1741-2560/4/4/003; Porter R, 1993, CORTICOSPINAL FUNCTI; Proakis J. G., 1995, DIGIT SIGNAL PROCESS, V3rd; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Suner S, 2005, IEEE T NEUR SYS REH, V13, P524, DOI 10.1109/TNSRE.2005.857687; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; WEINRICH M, 1984, BRAIN, V107, P385, DOI 10.1093/brain/107.2.385; Zhao QB, 2008, IEEE IJCNN, P2656, DOI 10.1109/IJCNN.2008.4634170	44	64	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14384	10.1371/journal.pone.0014384	http://dx.doi.org/10.1371/journal.pone.0014384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200434	Green Published, Green Submitted, gold			2022-12-25	WOS:000285576900004
J	Avlund, M; Krishna, S; Semsey, S; Dodd, IB; Sneppen, K				Avlund, Mikkel; Krishna, Sandeep; Semsey, Szabolcs; Dodd, Ian B.; Sneppen, Kim			Minimal Gene Regulatory Circuits for a Lysis-Lysogeny Choice in the Presence of Noise	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; PHAGE-LAMBDA; ESCHERICHIA-COLI; KINETIC-ANALYSIS; DECISION-MAKING; SINGLE-CELL; EXPRESSION; TEMPERATE; REPRESSOR; INFECTION	Gene regulatory networks (GRNs) that make reliable decisions should have design features to cope with random fluctuations in the levels or activities of biological molecules. The phage lambda GRN makes a lysis-lysogeny decision informed by the number of phages infecting the cell. To analyse the design of decision making GRNs, we generated random in silico GRNs comprised of two or three transcriptional regulators and selected those able to perform a lambda-like decision in the presence of noise. Various two-protein networks analogous to the lambda CI-Cro GRN worked in noise-less conditions but failed when noise was introduced. Adding a lambda CII-like protein significantly improved robustness to noise. CII relieves the CI-like protein of its 'decider' function, allowing CI to be optimized as a decision 'maintainer'. CII's lysogenic decider function was improved by its instability and rapid removal once the decision was taken, preventing its interference with maintenance. A more reliable decision also resulted from simulated co-transcription of the genes for CII and the Cro-like protein, which correlates fluctuations in these opposing decider functions and makes their ratio less noisy. Thus, the lambda decision network contains design features for reducing and resisting noise.	[Avlund, Mikkel; Krishna, Sandeep; Semsey, Szabolcs; Sneppen, Kim] Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen, Denmark; [Krishna, Sandeep] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Dodd, Ian B.] Univ Adelaide, Adelaide, SA, Australia	University of Copenhagen; Niels Bohr Institute; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Adelaide	Avlund, M (corresponding author), Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	sneppen@nbi.dk	Semsey, Szabolcs/L-6329-2013	krishna, sandeep/0000-0002-0581-173X; Sneppen, Kim/0000-0001-9820-3567; Dodd, Ian/0000-0003-2969-6841; Semsey, Szabolcs/0000-0002-4522-5495	Japanese Ministry of Health Labor and Welfare; Takeda Science Foundation	Japanese Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by the Japanese Ministry of Health Labor and Welfare and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Arkin A, 1998, GENETICS, V149, P1633; Aurell E, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051914; Avlund M, 2009, J MOL BIOL, V394, P681, DOI 10.1016/j.jmb.2009.09.053; Avlund M, 2009, J VIROL, V83, P11416, DOI 10.1128/JVI.01057-09; Baek K, 2003, J MOL BIOL, V334, P363, DOI 10.1016/j.jmb.2003.09.037; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; BETTER M, 1983, VIROLOGY, V126, P168, DOI 10.1016/0042-6822(83)90469-5; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Degnan PH, 2007, MOL MICROBIOL, V64, P232, DOI 10.1111/j.1365-2958.2007.05650.x; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; DODD IB, 1990, J MOL BIOL, V214, P27, DOI 10.1016/0022-2836(90)90144-B; EISEN H, 1970, P NATL ACAD SCI USA, V66, P855, DOI 10.1073/pnas.66.3.855; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; GANN A, 1992, Current Biology, V2, P282, DOI 10.1016/0960-9822(92)90861-4; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; GOTTESMAN S, 1981, CELL, V24, P225, DOI 10.1016/0092-8674(81)90518-3; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Kapfhammer D, 2002, J BACTERIOL, V184, P6592, DOI 10.1128/JB.184.23.6592-6601.2002; Karlsson JL, 2006, J BACTERIOL, V188, P3923, DOI 10.1128/JB.01953-05; Kobiler O, 2005, P NATL ACAD SCI USA, V102, P4470, DOI 10.1073/pnas.0500670102; Kobiler O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000363; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; KOURILSKY P, 1974, BIOCHIMIE, V56, P1517; Kropinski AM, 2000, J BACTERIOL, V182, P6066, DOI 10.1128/JB.182.21.6066-6074.2000; Little JW, 1999, EMBO J, V18, P4299, DOI 10.1093/emboj/18.15.4299; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedersen M, 2008, J MOL BIOL, V384, P577, DOI 10.1016/j.jmb.2008.09.071; Ptashne M, 2004, GENETIC SWITCH PHAGE; RATTRAY A, 1984, J BACTERIOL, V159, P238, DOI 10.1128/JB.159.1.238-242.1984; REICHARDT LF, 1975, J MOL BIOL, V93, P289, DOI 10.1016/0022-2836(75)90133-3; Rokney A, 2008, MOL MICROBIOL, V68, P29, DOI 10.1111/j.1365-2958.2008.06119.x; Schubert RA, 2007, GENE DEV, V21, P2461, DOI 10.1101/gad.1584907; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; SHEAN CS, 1992, CELL, V70, P513, DOI 10.1016/0092-8674(92)90175-C; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Svenningsen SL, 2005, P NATL ACAD SCI USA, V102, P4465, DOI 10.1073/pnas.0409839102; Trusina A, 2005, PLOS COMPUT BIOL, V1, P599, DOI 10.1371/journal.pcbi.0010074; Von Dassow G, 2002, J EXP ZOOL, V294, P179, DOI 10.1002/jez.10144; Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034	47	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15037	10.1371/journal.pone.0015037	http://dx.doi.org/10.1371/journal.pone.0015037			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188148	Green Published, gold, Green Submitted			2022-12-25	WOS:000285575200013
J	Fleming, NI; Knower, KC; Lazarus, KA; Fuller, PJ; Simpson, ER; Clyne, CD				Fleming, Nicholas I.; Knower, Kevin C.; Lazarus, Kyren A.; Fuller, Peter J.; Simpson, Evan R.; Clyne, Colin D.			Aromatase Is a Direct Target of FOXL2: C134W in Granulosa Cell Tumors via a Single Highly Conserved Binding Site in the Ovarian Specific Promoter	PLOS ONE			English	Article							LIVER RECEPTOR HOMOLOG-1; TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION; GENE-TRANSCRIPTION; DNA-BINDING; MUTATIONAL ANALYSIS; PROXIMAL PROMOTER; CYP19 GENE; EXPRESSION; LINE	Background: Granulosa cell tumors (GCT) of the ovary often express aromatase and synthesize estrogen, which in turn may influence their progression. Recently a specific point mutation (C134W) in the FOXL2 protein was identified in >94% of adult-type GCT and it is likely to contribute to their development. A number of genes are known to be regulated by FOXL2, including aromatase/CYP19A1, but it is unclear which are direct targets and whether the C134W mutation alters their regulation. Recently, it has been reported that FOXL2 forms a complex with steroidogenic factor 1 (SF-1) which is a known regulator of aromatase in granulosa cells. Methodology/Principal Findings: In this work, the human GCT-derived cell lines KGN and COV434 were heterozygous and wildtype for the FOXL2: C134W mutation, respectively. KGN had abundant FOXL2 mRNA expression but it was not expressed in COV434. Expression of exogenous FOXL2: C134W in COV434 cells induced higher expression of a luciferase reporter for the ovarian specific aromatase promoter, promoter II (PII) (-516bp) than expression of wildtype FOXL2, but did not alter induction of a similar reporter for the steroidogenic acute regulatory protein (StAR) promoter (-1300bp). Coimmunoprecipitation confirmed that FOXL2 bound SF-1 and that it also bound its homologue, liver receptor homologue 1 (LRH-1), however, the C134W mutation did not alter these interactions or induce a selective binding of the proteins. A highly conserved putative binding site for FOXL2 was identified in PII. FOXL2 was demonstrated to bind the site by electrophoretic mobility shift assays (EMSA) and site-directed mutagenesis of this element blocked its differential induction by wildtype FOXL2 and FOXL2: C134W. Conclusions/Significance: These findings suggest that aromatase is a direct target of FOXL2: C134W in adult-type GCT via a single distinctive and highly conserved binding site in PII and therefore provide insight into the pathogenic mechanism of this mutation.	[Fleming, Nicholas I.; Knower, Kevin C.; Lazarus, Kyren A.; Fuller, Peter J.; Simpson, Evan R.; Clyne, Colin D.] Prince Henrys Inst Med Res, Clayton, Vic, Australia; [Fuller, Peter J.; Simpson, Evan R.; Clyne, Colin D.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Prince Henry's Institute of Medical Research; Monash University	Fleming, NI (corresponding author), Prince Henrys Inst Med Res, Clayton, Vic, Australia.	colin.clyne@princehenrys.org	Knower, Kevin/C-2869-2014	Fuller, Peter/0000-0002-0948-2072	National Health and Medical Research Council (NHMRC) of Australia; U.S. Department of Defense [W81XWH-08-BCRP-POSTDOC]; Prince Henry's Institute; Victorian Breast Cancer Research Consortium Inc.; Victorian Government; NHMRC [338516, 494802]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); U.S. Department of Defense(United States Department of Defense); Prince Henry's Institute; Victorian Breast Cancer Research Consortium Inc.; Victorian Government; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	PJF and ERS were supported by the National Health and Medical Research Council (NHMRC) (www.nhmrc.gov.au) of Australia through a Senior Principal Research Fellowships. CDC was supported by the NHMRC R.D. Wright Fellowship #338516. KCK was supported by a U.S. Department of Defense Postdoctoral Training Award (W81XWH-08-BCRP-POSTDOC). KAL was supported by a Prince Henry's Institute Vacation Scholarship (www.princehenrys.org). The work was supported by a NHMRC Program Grant #494802 and also a grant from the Victorian Breast Cancer Research Consortium Inc. (www.vbcrc.org.au). Prince Henry's Institute is also supported by the Victorian Government's Operational Infrastructure Support Program (www.vic.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VR, 1995, MOL CELL PROBE, V9, P453, DOI 10.1006/mcpr.1995.0069; Bates DL, 2008, J MOL BIOL, V381, P1292, DOI 10.1016/j.jmb.2008.06.072; Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Benayoun BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008789; Bentsi-Barnes IK, 2010, FERTIL STERIL, V94, P353, DOI 10.1016/j.fertnstert.2009.09.050; Bilandzic M, 2009, MOL ENDOCRINOL, V23, P539, DOI 10.1210/me.2008-0300; Bittinger S, 2009, INT J GYNECOL CANCER, V19, P339, DOI 10.1111/IGC.0b013e3181a1cdfd; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Bratus A, 2009, CYTOGENET GENOME RES, V126, P180, DOI 10.1159/000245918; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chu S, 2004, MOL ENDOCRINOL, V18, P1919, DOI 10.1210/me.2004-0021; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; Clyne CD, 2002, J BIOL CHEM, V277, P20591, DOI 10.1074/jbc.M201117200; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; Escudero JM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-4; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Jin TR, 2000, BREAST CANCER RES TR, V62, P151, DOI 10.1023/A:1006481228794; Kalfa N, 2008, J UROLOGY, V180, P1810, DOI 10.1016/j.juro.2008.03.097; Kalfa N, 2007, FERTIL STERIL, V87, P896, DOI 10.1016/j.fertnstert.2006.11.016; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim MS, 2010, J PATHOL, V221, P147, DOI 10.1002/path.2688; Kim SY, 2009, ENDOCRINOLOGY, V150, P5085, DOI 10.1210/en.2009-0313; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Lee K, 2005, BIOCHEM BIOPH RES CO, V336, P876, DOI 10.1016/j.bbrc.2005.08.184; Loffler KA, 2003, ENDOCRINOLOGY, V144, P3237, DOI 10.1210/en.2002-0095; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; Marongiu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009477; Michael MD, 1997, MOL CELL ENDOCRINOL, V134, P147, DOI 10.1016/S0303-7207(97)00178-0; MICHAEL MD, 1995, J BIOL CHEM, V270, P13561, DOI 10.1074/jbc.270.22.13561; Moniot B, 2000, MECH DEVELOP, V91, P323, DOI 10.1016/S0925-4773(99)00267-1; Murphy MW, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-58; Murphy TC, 2004, INVEST OPHTH VIS SCI, V45, P2531, DOI 10.1167/iovs.04-0167; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Onuma H, 2006, MOL ENDOCRINOL, V20, P2831, DOI 10.1210/me.2006-0085; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Park M, 2010, MOL ENDOCRINOL, V24, P1024, DOI 10.1210/me.2009-0375; Peng N, 2003, J CLIN ENDOCR METAB, V88, P6020, DOI 10.1210/jc.2003-030880; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stevens K, 2000, J BIOL CHEM, V275, P30471, DOI 10.1074/jbc.M004891200; Sugawara T, 1996, BIOCHEMISTRY-US, V35, P9052, DOI 10.1021/bi960057r; Tsai KL, 2006, J BIOL CHEM, V281, P17400, DOI 10.1074/jbc.M600478200; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Uhlenhaut NH, 2006, MOL GENET METAB, V88, P225, DOI 10.1016/j.ymgme.2006.03.005; VANDENBERGBAKKER CAM, 1993, INT J CANCER, V53, P613, DOI 10.1002/ijc.2910530415; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Woods DC, 2008, CANCER LETT, V260, P20, DOI 10.1016/j.canlet.2007.10.016; Zhang H, 2000, MOL HUM REPROD, V6, P146, DOI 10.1093/molehr/6.2.146	66	99	100	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14389	10.1371/journal.pone.0014389	http://dx.doi.org/10.1371/journal.pone.0014389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188138	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200011
J	Gonci, B; Nemeth, V; Balogh, E; Szabo, B; Denes, A; Kornyei, Z; Vicsek, T				Goenci, Balazs; Nemeth, Valeria; Balogh, Emeric; Szabo, Balint; Denes, Adam; Koernyei, Zsuzsanna; Vicsek, Tamas			Viral Epidemics in a Cell Culture: Novel High Resolution Data and Their Interpretation by a Percolation Theory Based Model	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PSEUDORABIES VIRUS; IN-VITRO; SPREAD; INFECTION; REPLICATION; SUSCEPTIBILITY; TRANSMISSION; INTERFERON; DISEASE	Because of its relevance to everyday life, the spreading of viral infections has been of central interest in a variety of scientific communities involved in fighting, preventing and theoretically interpreting epidemic processes. Recent large scale observations have resulted in major discoveries concerning the overall features of the spreading process in systems with highly mobile susceptible units, but virtually no data are available about observations of infection spreading for a very large number of immobile units. Here we present the first detailed quantitative documentation of percolation-type viral epidemics in a highly reproducible in vitro system consisting of tens of thousands of virtually motionless cells. We use a confluent astroglial monolayer in a Petri dish and induce productive infection in a limited number of cells with a genetically modified herpesvirus strain. This approach allows extreme high resolution tracking of the spatio-temporal development of the epidemic. We show that a simple model is capable of reproducing the basic features of our observations, i.e., the observed behaviour is likely to be applicable to many different kinds of systems. Statistical physics inspired approaches to our data, such as fractal dimension of the infected clusters as well as their size distribution, seem to fit into a percolation theory based interpretation. We suggest that our observations may be used to model epidemics in more complex systems, which are difficult to study in isolation.	[Goenci, Balazs; Nemeth, Valeria; Balogh, Emeric; Szabo, Balint; Vicsek, Tamas] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Balogh, Emeric] Univ Babes Bolyai, Dept Theoret Phys, R-3400 Cluj Napoca, Romania; [Balogh, Emeric] Univ Szeged, Dept Opt & Quantum Elect, Szeged, Hungary; [Denes, Adam; Koernyei, Zsuzsanna] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Denes, Adam] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Vicsek, Tamas] Hungarian Acad Sci, Stat & Biol Phys Res Grp, Budapest, Hungary	Eotvos Lorand University; Babes Bolyai University from Cluj; Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Manchester; Hungarian Academy of Sciences	Gonci, B (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary.	vicsek@hal.elte.hu	Balogh, Emeric/F-7629-2010	Balogh, Emeric/0000-0002-8253-7105	National Office of Research and Technology, Hungary; European Research Council [227878]	National Office of Research and Technology, Hungary(National Office for Research and Technology); European Research Council(European Research Council (ERC)European Commission)	National Office of Research and Technology, Hungary, http://www.nkth.gov.hu/english, Grant: NKTH ELTE CellCom RET http://cellkom.elte.hu/projects. html, European Research Council, http://erc.europa.eu/ Grant: EU ERC COLLMOT No: 227878 http://erc.europa.eu/index.cfm?fuseaction = page.display&topicID = 517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAINBARRAT A, 2008, DYNAM PROC COMPL NET; APPLEYARD G, 1971, J GEN VIROL, V13, P9, DOI 10.1099/0022-1317-13-1-9; Boldogkoi Z, 2002, MOL BRAIN RES, V109, P105, DOI 10.1016/S0169-328X(02)00546-6; Boldogkoi Z, 2004, PROG NEUROBIOL, V72, P417, DOI 10.1016/j.pneurobio.2004.03.010; BRAUER F, 2001, NATH MOD POP BIO EPI; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; CARD JP, 1993, J NEUROSCI, V13, P2515, DOI 10.1523/JNEUROSCI.13-06-02515.1993; Carrascosa AL, 1999, ARCH VIROL, V144, P1309, DOI 10.1007/s007050050589; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; DALEY DJ, 1999, EPIDEM MOD INTR CAMB; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; Duca KA, 2001, BIOTECHNOL PROGR, V17, P1156, DOI 10.1021/bp010115m; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fitting S, 2010, J PROTEOME RES, V9, P1795, DOI 10.1021/pr900926n; Garner JA, 2003, ADV DRUG DELIVER REV, V55, P1497, DOI 10.1016/j.addr.2003.07.006; Granzow H, 1997, J VIROL, V71, P2072, DOI 10.1128/JVI.71.3.2072-2082.1997; Haseltine EL, 2008, B MATH BIOL, V70, P1730, DOI 10.1007/s11538-008-9316-3; Heindl JE, 2010, INFECT IMMUN, V78, P193, DOI 10.1128/IAI.00252-09; HOSHEN J, 1976, PHYS REV B, V14, P3438, DOI 10.1103/PhysRevB.14.3438; Hua H, 2009, P NATL ACAD SCI USA, V106, P1318, DOI 10.1073/pnas.0811973106; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; KATSUMOTO T, 1981, J GEN VIROL, V52, P267, DOI 10.1099/0022-1317-52-2-267; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; KHELIFA R, 1982, J VIROL, V42, P402; Kornyei Z, 2005, GLIA, V49, P430, DOI 10.1002/glia.20123; LAI PC, 2009, SPAT EPID APPR DIS M; Lam V, 2005, BIOTECHNOL BIOENG, V90, P793, DOI 10.1002/bit.20467; Law M, 2002, J GEN VIROL, V83, P209, DOI 10.1099/0022-1317-83-1-209; Lee Y, 1996, NAT BIOTECHNOL, V14, P491, DOI 10.1038/nbt0496-491; Li DQ, 1999, CLIN CANCER RES, V5, P4175; MARQUIS H, 2006, CURR PROT MICROBIOL, P4; PFEIFFER DU, 2008, SPAT ANALYS EPIDEM O; PRICE RW, 1982, ARCH VIROL, V71, P127, DOI 10.1007/BF01314882; Rhodes CJ, 1998, J FRANKLIN I, V335B, P199, DOI 10.1016/S0016-0032(96)00096-8; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; STAUFFER D, 1991, INTR PERC THEORY LON; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; TEYSSEIRE N, 1992, RES MICROBIOL, V143, P821, DOI 10.1016/0923-2508(92)90069-Z; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; van der Meulen KM, 2002, VET MICROBIOL, V86, P157, DOI 10.1016/S0378-1135(01)00499-0; VICSEK T, 1992, FRACT GROWTH PHEN SI; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Way SS, 1998, INFECT IMMUN, V66, P1342, DOI 10.1128/IAI.66.4.1342-1348.1998; Zhu Y, 2007, J VIROL METHODS, V139, P100, DOI 10.1016/j.jviromet.2006.09.006	45	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15571	10.1371/journal.pone.0015571	http://dx.doi.org/10.1371/journal.pone.0015571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187920	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200043
J	Rajicic, N; Cuschieri, J; Finkelstein, DM; Miller-Graziano, CL; Hayden, D; Moldawer, LL; Moore, E; O'Keefe, G; Pelik, K; Warren, HS; Schoenfeld, DA				Rajicic, Natasa; Cuschieri, Joseph; Finkelstein, Dianne M.; Miller-Graziano, Carol L.; Hayden, Douglas; Moldawer, Lyle L.; Moore, Ernest; O'Keefe, Grant; Pelik, Kimberly; Warren, H. Shaw; Schoenfeld, David A.		Inflammation Host Response Injury	Identification and Interpretation of Longitudinal Gene Expression Changes in Trauma	PLOS ONE			English	Article							MULTIPLE; INFLAMMATION; NEUTROPHILS; PATTERNS	Rationale: The relationship between leukocyte gene expression and recovery of respiratory function after injury may provide information on the etiology of multiple organ dysfunction. Objectives: To find a list of genes for which expression after injury predicts respiratory recovery, and to identify which networks and pathways characterize these genes. Methods: Blood was sampled at 12 hours and at 1, 4, 7, 21 and 28 days from 147 patients who had been admitted to the hospital after blunt trauma. Leukocyte gene expression was measured using Affymetrix oligonucleotide arrays. A linear model, fit to each probe-set expression value, was used to impute the gene expression trajectory over the entire follow-up period. The proportional hazards model score test was used to calculate the statistical significance of each probe-set trajectory in predicting respiratory recovery. A list of genes was determined such that the expected proportion of false positive results was less than 10%. These genes were compared to the Gene Ontology for 'response to stimulus' and, using Ingenuity software, were mapped into networks and pathways. Measurements and Main Results: The median time to respiratory recovery was 6 days. There were 170 probe-sets representing 135 genes that were found to be related to respiratory recovery. These genes could be mapped to nine networks. Two known pathways that were activated were antigen processing and presentation and JAK-signaling. Conclusions: The examination of the relationship of gene expression over time with a patient's clinical course can provide information which may be useful in determining the mechanism of recovery or lack of recovery after severe injury.	[Rajicic, Natasa] Pfizer Inc, New York, NY 10017 USA; [Cuschieri, Joseph] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Finkelstein, Dianne M.; Hayden, Douglas; Pelik, Kimberly; Schoenfeld, David A.] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Miller-Graziano, Carol L.] Univ Rochester, Rochester, NY USA; [Moldawer, Lyle L.] Univ Florida, Shands Hosp, Gainesville, FL USA; [Moore, Ernest] Univ Colorado, Denver Hlth Med Ctr, Denver, CO 80202 USA; [O'Keefe, Grant] Univ Washington, Div Trauma & Gen Surg, Harborview, WA USA; [Warren, H. Shaw] Massachusetts Gen Hosp, Infect Dis Unit, Charlestown, MA USA	Pfizer; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; University of Rochester; State University System of Florida; University of Florida; Denver Health Medical Center; University of Colorado System; University of Colorado Denver; University of Washington; Harvard University; Massachusetts General Hospital	Rajicic, N (corresponding author), Pfizer Inc, New York, NY 10017 USA.	Natasa.Rajicic@pfizer.com	O'KEEFE, GRANT/GON-5797-2022	xiao, wenzhong/0000-0003-4944-6380; Moldawer, Lyle/0000-0002-9041-9838; West, Michaela A/0000-0002-6598-4114	National Institute of General Medical Sciences [U54 GM-62119-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062119] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a Large Scale Collaborative Research Grant from the National Institute of General Medical Sciences, U54 GM-62119-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BO, 1991, J APPL PHYSIOL, V71, P1862, DOI 10.1152/jappl.1991.71.5.1862; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; Biffl WL, 1999, SURGERY, V126, P198, DOI 10.1067/msy.1999.98738; BOTHA AJ, 1995, SURGERY, V118, P358, DOI 10.1016/S0039-6060(05)80345-9; Brownstein BH, 2006, PHYSIOL GENOMICS, V24, P298, DOI 10.1152/physiolgenomics.00213.2005; Ciesla DJ, 2005, ARCH SURG-CHICAGO, V140, P432, DOI 10.1001/archsurg.140.5.432; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; ERICKSON SE, 2009, CRIT CARE MED, V37, P1798; Frank EG, 2001, EMBO J, V20, P2914, DOI 10.1093/emboj/20.11.2914; Maier M, 2008, SHOCK, V30, P344, DOI 10.1097/SHK.0b013e3181673eb4; Meldrum DR, 1997, ANN SURG, V226, P587, DOI 10.1097/00000658-199711000-00003; Moore EE, 2005, SHOCK, V24, P71, DOI 10.1097/01.shk.0000191336.01036.fe; MOORE FA, 1995, SURG CLIN N AM, V75, P257, DOI 10.1016/S0039-6109(16)46587-4; Murphy TJ, 2004, J LEUKOCYTE BIOL, V75, P400, DOI 10.1189/jlb.0503233; Rajicic N, 2006, BIOINFORMATICS, V22, P2643, DOI 10.1093/bioinformatics/btl450; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Warren HS, 2009, MOL MED, V15, P220, DOI 10.2119/molmed.2009.00027; Zallen G, 1999, J TRAUMA, V46, P42, DOI 10.1097/00005373-199901000-00007; INFLAMMATION HOST RE; 2007, GENE SET ANAL TOOLKI	23	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14380	10.1371/journal.pone.0014380	http://dx.doi.org/10.1371/journal.pone.0014380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187951	Green Published, gold, Green Submitted			2022-12-25	WOS:000285575200007
J	Tsurumi, C; Esser, N; Firat, E; Gaedicke, S; Follo, M; Behe, M; Elsasser-Beile, U; Grosu, AL; Graeser, R; Niedermann, G				Tsurumi, Chizuko; Esser, Norbert; Firat, Elke; Gaedicke, Simone; Follo, Marie; Behe, Martin; Elsaesser-Beile, Ursula; Grosu, Anca-Ligia; Graeser, Ralph; Niedermann, Gabriele			Non-Invasive In Vivo Imaging of Tumor-Associated CD133/Prominin	PLOS ONE			English	Article							CANCER STEM-CELLS; PANCREATIC-CANCER; INITIATING CELLS; DNA-DAMAGE; CD133; ANTIBODIES; IDENTIFICATION; RADIOBIOLOGY; GLIOBLASTOMA; CHALLENGES	Background: Cancer stem cells are thought to play a pivotal role in tumor maintenance, metastasis, tumor therapy resistance and relapse. Hence, the development of methods for non-invasive in vivo detection of cancer stem cells is of great importance. Methodology/Principal Findings: Here, we describe successful in vivo detection of CD133/prominin, a cancer stem cell surface marker for a variety of tumor entities. The CD133-specific monoclonal antibody AC133.1 was used for quantitative fluorescence-based optical imaging of mouse xenograft models based on isogenic pairs of CD133 positive and negative cell lines. A first set consisted of wild-type U251 glioblastoma cells, which do not express CD133, and lentivirally transduced CD133-overexpressing U251 cells. A second set made use of HCT116 colon carcinoma cells, which uniformly express CD133 at levels comparable to primary glioblastoma stem cells, and a CD133-negative HCT116 derivative. Not surprisingly, visualization and quantification of CD133 in overexpressing U251 xenografts was successful; more importantly, however, significant differences were also found in matched HCT116 xenograft pairs, despite the lower CD133 expression levels. The binding of i.v.-injected AC133.1 antibodies to CD133 positive, but not negative, tumor cells isolated from xenografts was confirmed by flow cytometry. Conclusions/Significance: Taken together, our results show that non-invasive antibody-based in vivo imaging of tumor-associated CD133 is feasible and that CD133 antibody-based tumor targeting is efficient. This should facilitate developing clinically applicable cancer stem cell imaging methods and CD133 antibody-based therapeutics.	[Tsurumi, Chizuko; Firat, Elke; Gaedicke, Simone; Grosu, Anca-Ligia; Niedermann, Gabriele] Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany; [Follo, Marie] Univ Hosp Freiburg, Dept Internal Med 1, Freiburg, Germany; [Behe, Martin] Univ Hosp Freiburg, Dept Nucl Med, Freiburg, Germany; [Elsaesser-Beile, Ursula] Univ Hosp Freiburg, Dept Urol, Freiburg, Germany; [Esser, Norbert; Graeser, Ralph] ProQinase GmbH, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; ProQinase	Tsurumi, C (corresponding author), Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany.	gabriele.niedermann@uniklinik-freiburg.de	Behe, Martin/E-2941-2013	Follo, Marie/0000-0002-3090-7442	Clotten Foundation	Clotten Foundation	This work was supported by a grant from the Clotten Foundation. ProQuinase did not sponsor this study. The costs were equally shared between the University of Freiburg and ProQuinase. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt K, 2010, PROSTATE, V70, P1413, DOI 10.1002/pros.21176; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chiou SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002090; Deonarain MP, 2009, MABS-AUSTIN, V1, P12, DOI 10.4161/mabs.1.1.7347; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Firat E, 2010, INT J RADIAT BIOL, V86, P252, DOI 10.3109/09553000903419320; Hart LS, 2008, J CLIN ONCOL, V26, P2901, DOI 10.1200/JCO.2008.16.9573; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; KOSSODO S, 2009, MOL IMAGING BIOL; Lonardo E, 2010, MOL ONCOL, V4, P431, DOI 10.1016/j.molonc.2010.06.002; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Montet X, 2005, CANCER RES, V65, P6330, DOI 10.1158/0008-5472.CAN-05-0382; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Ogawa M, 2009, CANCER RES, V69, P1268, DOI 10.1158/0008-5472.CAN-08-3116; Okamoto OK, 2008, EXPERT REV MOL DIAGN, V8, P387, DOI 10.1586/14737159.8.4.387; Olafsen T, 2010, SEMIN NUCL MED, V40, P167, DOI 10.1053/j.semnuclmed.2009.12.005; Pajonk F, 2010, STEM CELLS, V28, P639, DOI 10.1002/stem.318; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Singh SK, 2003, CANCER RES, V63, P5821; Smith LM, 2008, BRIT J CANCER, V99, P100, DOI 10.1038/sj.bjc.6604437; Sureban SM, 2008, GASTROENTEROLOGY, V134, pA86; Tsurumi C, 2009, BIOCHEM BIOPH RES CO, V386, P563, DOI 10.1016/j.bbrc.2009.06.068; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Woodward WA, 2008, CANCER METAST REV, V27, P459, DOI 10.1007/s10555-008-9130-2; Woodward WA, 2009, SEMIN RADIAT ONCOL, V19, P87, DOI 10.1016/j.semradonc.2008.11.003; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	40	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15605	10.1371/journal.pone.0015605	http://dx.doi.org/10.1371/journal.pone.0015605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187924	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200047
J	Yu, CY; Mayba, O; Lee, JV; Tran, J; Harris, C; Speed, TP; Wang, JC				Yu, Chi-Yi; Mayba, Oleg; Lee, Joyce V.; Tran, Joanna; Harris, Charlie; Speed, Terence P.; Wang, Jen-Chywan			Genome-Wide Analysis of Glucocorticoid Receptor Binding Regions in Adipocytes Reveal Gene Network Involved in Triglyceride Homeostasis	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; INDUCED INSULIN-RESISTANCE; HUMAN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; GLUCOSE-TOLERANCE; 11-BETA-HSD1 INHIBITION; MAPK PHOSPHATASE-1; NUCLEAR FACTOR-3	Glucocorticoids play important roles in the regulation of distinct aspects of adipocyte biology. Excess glucocorticoids in adipocytes are associated with metabolic disorders, including central obesity, insulin resistance and dyslipidemia. To understand the mechanisms underlying the glucocorticoid action in adipocytes, we used chromatin immunoprecipitation sequencing to isolate genome-wide glucocorticoid receptor (GR) binding regions (GBRs) in 3T3-L1 adipocytes. Furthermore, gene expression analyses were used to identify genes that were regulated by glucocorticoids. Overall, 274 glucocorticoid-regulated genes contain or locate nearby GBR. We found that many GBRs were located in or nearby genes involved in triglyceride (TG) synthesis (Scd-1, 2, 3, GPAT3, GPAT4, Agpat2, Lpin1), lipolysis (Lipe, Mgll), lipid transport (Cd36, Lrp-1, Vldlr, Slc27a2) and storage (S3-12). Gene expression analysis showed that except for Scd-3, the other 13 genes were induced in mouse inguinal fat upon 4-day glucocorticoid treatment. Reporter gene assays showed that except Agpat2, the other 12 glucocorticoid-regulated genes contain at least one GBR that can mediate hormone response. In agreement with the fact that glucocorticoids activated genes in both TG biosynthetic and lipolytic pathways, we confirmed that 4-day glucocorticoid treatment increased TG synthesis and lipolysis concomitantly in inguinal fat. Notably, we found that 9 of these 12 genes were induced in transgenic mice that have constant elevated plasma glucocorticoid levels. These results suggested that a similar mechanism was used to regulate TG homeostasis during chronic glucocorticoid treatment. In summary, our studies have identified molecular components in a glucocorticoid-controlled gene network involved in the regulation of TG homeostasis in adipocytes. Understanding the regulation of this gene network should provide important insight for future therapeutic developments for metabolic diseases.	[Yu, Chi-Yi; Lee, Joyce V.; Tran, Joanna; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Mayba, Oleg; Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Harris, Charlie; Wang, Jen-Chywan] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94141 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yu, CY (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	walwang@berkeley.edu	Speed, Terence P/B-8085-2009; Wang, Jen-Chywan/AAX-4445-2020	Speed, Terence P/0000-0002-5403-7998; Wang, Jen-Chywan/0000-0001-6030-6886	National Institutes of Health (NIH) [DK083591, DK081680]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083591, K08DK081680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health (NIH) (DK083591 to JCW and DK081680 to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM T, 1993, J BIOL CHEM, V268, P15681; Bazuine M, 2004, MOL ENDOCRINOL, V18, P1697, DOI 10.1210/me.2003-0213; BERDANIER CD, 1989, FASEB J, V3, P2179, DOI 10.1096/fasebj.3.10.2666232; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Deblois G, 2008, MOL ENDOCRINOL, V22, P1999, DOI 10.1210/me.2007-0546; Di Pietro N, 2010, MOL ENDOCRINOL, V24, P370, DOI 10.1210/me.2009-0265; DINNEEN S, 1993, J CLIN INVEST, V92, P2283, DOI 10.1172/JCI116832; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dudoit S, 2003, BIOTECHNIQUES, P45; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ensler K, 2002, BBA-MOL CELL BIOL L, V1581, P36, DOI 10.1016/S1388-1981(02)00118-X; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Gounarides JS, 2008, ENDOCRINOLOGY, V149, P758, DOI 10.1210/en.2007-1214; Gravholt CH, 2002, OBES RES, V10, P774, DOI 10.1038/oby.2002.105; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Krapivner S, 2008, J CLIN ENDOCR METAB, V93, P1995, DOI 10.1210/jc.2007-1850; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li JP, 2003, P NATL ACAD SCI USA, V100, P9476, DOI 10.1073/pnas.1133426100; Liu X, 2001, Pac Symp Biocomput, P127; Lloyd DJ, 2009, DIABETES OBES METAB, V11, P688, DOI 10.1111/j.1463-1326.2009.01034.x; Lu B, 2005, BIOCHEM J, V385, P469, DOI 10.1042/BJ20041348; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI17845; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MAYOSMITH W, 1989, RADIOLOGY, V170, P515, DOI 10.1148/radiology.170.2.2911678; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nishizuka M, 2001, J BIOL CHEM, V276, P29625, DOI 10.1074/jbc.C100272200; Nuotio-Antar AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1517, DOI 10.1152/ajpendo.00522.2007; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Ragolia L, 2008, PROSTAG OTH LIPID M, V87, P34, DOI 10.1016/j.prostaglandins.2008.06.001; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; RIZZA RA, 1982, J CLIN ENDOCR METAB, V54, P131, DOI 10.1210/jcem-54-1-131; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; ROUX J, 1995, DNA CELL BIOL, V14, P385, DOI 10.1089/dna.1995.14.385; Sakaue H, 2004, J BIOL CHEM, V279, P39951, DOI 10.1074/jbc.M407353200; Sakoda H, 2000, DIABETES, V49, P1700, DOI 10.2337/diabetes.49.10.1700; Samra JS, 1998, J CLIN ENDOCR METAB, V83, P626, DOI 10.1210/jc.83.2.626; Seckl JR, 2004, TRENDS ENDOCRIN MET, V15, P418, DOI 10.1016/j.tem.2004.09.007; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; STEGER DJ, GENES DEV, V24, P1035; STENZELPOORE MP, 1992, ENDOCRINOLOGY, V130, P3378, DOI 10.1210/en.130.6.3378; Tomlinson JW, 2007, J CLIN ENDOCR METAB, V92, P857, DOI 10.1210/jc.2006-2325; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Walker BR, 2006, DIABETIC MED, V23, P1281, DOI 10.1111/j.1464-5491.2006.01998.x; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Wang JC, 1996, MOL ENDOCRINOL, V10, P794, DOI 10.1210/me.10.7.794; Wang YX, 2004, J NUTR, V134, P1032; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yamada K, 1999, J BIOL CHEM, V274, P5880, DOI 10.1074/jbc.274.9.5880; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang M, 2007, NAT CELL BIOL, V9, P970, DOI 10.1038/ncb1623; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200; Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200	69	121	123	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15188	10.1371/journal.pone.0015188	http://dx.doi.org/10.1371/journal.pone.0015188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187916	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200019
J	Chapin, H; Jantzen, K; Kelso, JAS; Steinberg, F; Large, E				Chapin, Heather; Jantzen, Kelly; Kelso, J. A. Scott; Steinberg, Fred; Large, Edward			Dynamic Emotional and Neural Responses to Music Depend on Performance Expression and Listener Experience	PLOS ONE			English	Article							BEAT PERCEPTION; BRAIN; MOTOR; TIME; PREMOTOR; RHYTHMS; CORTEX; SYNCHRONIZATION; VISUALIZATION; COMMUNICATION	Apart from its natural relevance to cognition, music provides a window into the intimate relationships between production, perception, experience, and emotion. Here, emotional responses and neural activity were observed as they evolved together with stimulus parameters over several minutes. Participants listened to a skilled music performance that included the natural fluctuations in timing and sound intensity that musicians use to evoke emotional responses. A mechanical performance of the same piece served as a control. Before and after fMRI scanning, participants reported real-time emotional responses on a 2-dimensional rating scale (arousal and valence) as they listened to each performance. During fMRI scanning, participants listened without reporting emotional responses. Limbic and paralimbic brain areas responded to the expressive dynamics of human music performance, and both emotion and reward related activations during music listening were dependent upon musical training. Moreover, dynamic changes in timing predicted ratings of emotional arousal, as well as real-time changes in neural activity. BOLD signal changes correlated with expressive timing fluctuations in cortical and subcortical motor areas consistent with pulse perception, and in a network consistent with the human mirror neuron system. These findings show that expressive music performance evokes emotion and reward related neural activations, and that music's affective impact on the brains of listeners is altered by musical training. Our observations are consistent with the idea that music performance evokes an emotional response through a form of empathy that is based, at least in part, on the perception of movement and on violations of pulse-based temporal expectancies.	[Chapin, Heather; Kelso, J. A. Scott; Large, Edward] Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA; [Jantzen, Kelly] Western Washington Univ, Dept Psychol, Bellingham, WA 98225 USA; [Kelso, J. A. Scott] Univ Ulster, Intelligent Syst Res Ctr, Derry, North Ireland; [Steinberg, Fred] Univ MRI Boca Raton, Boca Raton, FL USA	State University System of Florida; Florida Atlantic University; Western Washington University; Ulster University	Chapin, H (corresponding author), Florida Atlantic Univ, Ctr Complex Syst & Brain Sci, Boca Raton, FL 33431 USA.	large@ccs.fau.edu			National Science Foundation [BCS-0094229]; Fulbright visiting research chair; National Institute of Mental Health [T151063]; Pierre de Fermat Chair; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048229] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Fulbright visiting research chair; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pierre de Fermat Chair; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation career award BCS-0094229 and a Fulbright visiting research chair awarded to E. W. Large, and by National Institute of Mental Health grant T151063 and the Pierre de Fermat Chair to J.A.S. Kelso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; Becker Judith, 2004, DEEP LISTENERS MUSIC; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BESSON M, 1994, NEUROSCI LETT, V168, P101, DOI 10.1016/0304-3940(94)90426-X; Bhatara AK, 2010, MUSICAL EXPRES UNPUB; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P, 1972, EMOTION HUMAN FACE G; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Fujioka T, 2009, ANN NY ACAD SCI, V1169, P89, DOI 10.1111/j.1749-6632.2009.04779.x; Gabrielsson A., 1996, PSYCHOL MUSIC, V24, P68, DOI DOI 10.1177/0305735696241007; Gaser C, 2003, J NEUROSCI, V23, P9240; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2009, ANN NY ACAD SCI, V1169, P35, DOI 10.1111/j.1749-6632.2009.04553.x; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Hurley D, 2008, NY TIMES        0603; Huron D.B., 2006, SWEET ANTICIPATION M; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; Jones MR., 1981, PSYCHOMUSICOLOGY J R, V1, P34, DOI [DOI 10.1037/H0094282, 10.1037/h0094282]; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2008, PLOS ONE; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Large E. W., 1994, Connection Science, V6, P177, DOI 10.1080/09540099408915723; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Large EW, 2007, MIDI TOOLBOX MATLAB; Large EW, 1992, JUDGMENTS SIMI UNPUB; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Levitin DJ, 2003, NEUROIMAGE, V20, P2142, DOI 10.1016/j.neuroimage.2003.08.016; Lewis Michael, 2008, HDB EMOTIONS, V3rd; London J., 2004, HEARING TIME; MADSEN CK, 1990, B COUN RES MUSIC ED, P45; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Meyer L., 1956, EMOTION MEANING MUSI; Mitterschiffthaler MT, 2007, HUMAN BRAIN MAPPING; Molnar-Szakacs I, 2006, SOC COGN AFFECT NEUR, V1, P235, DOI 10.1093/scan/nsl029; Nair D. G., 2002, P 7 INT C MUS PERC C, P627; Neale J.M., 1986, SCI BEHAV INTRO METH; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; PALMER C, 1991, J ACOUST SOC AM, V90, P60, DOI 10.1121/1.401249; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Rankin SK, 2009, MUSIC PERCEPT, V26, P401, DOI 10.1525/MP.2009.26.5.401; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Royet JP, 2000, J NEUROSCI, V20, P7752; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V38, P311; Schmithorst VJ, 2002, NEUROSCI LETT, V321, P57, DOI 10.1016/S0304-3940(02)00054-X; Schubert E, 2004, MUSIC PERCEPT, V21, P561, DOI 10.1525/mp.2004.21.4.561; Schubert E, 1999, AUST J PSYCHOL, V51, P154, DOI 10.1080/00049539908255353; Schubert E, 1996, CONTINUOUS RESPONSE, P263; SCHUBERT E, 2001, MUSIC EMOTION THEORY, P393; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; Sloboda JA, 2001, MUSIC PERCEPT, V19, P87, DOI 10.1525/mp.2001.19.1.87; Sloboda JA., 2001, MUSIC EMOTION THEORY; Snyder JS, 2005, COGNITIVE BRAIN RES, V24, P117, DOI 10.1016/j.cogbrainres.2004.12.014; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; Talairach J., 1988, COPLANAR STEREOTAXIC; TODD NPM, 1992, J ACOUST SOC AM, V91, P3540, DOI 10.1121/1.402843; [No title captured]	82	93	96	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e13812	10.1371/journal.pone.0013812	http://dx.doi.org/10.1371/journal.pone.0013812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695OI	21179549	Green Submitted, gold, Green Published			2022-12-25	WOS:000285381200001
J	Dresing, P; Borkens, S; Kocur, M; Kropp, S; Scheu, S				Dresing, Philipp; Borkens, Stephanie; Kocur, Magdalena; Kropp, Sonja; Scheu, Stefanie			A Fluorescence Reporter Model Defines "Tip-DCs'' as the Cellular Source of Interferon beta in Murine Listeriosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; DENDRITIC CELLS; MONOCYTOGENES INFECTION; BACTERIAL-INFECTION; MICE LACKING; ENDOTOXIC-SHOCK; I INTERFERONS; IFN-GAMMA; MONOCYTES; MACROPHAGES	Production of type I interferons, consisting mainly of multiple IFN alpha subtypes and IFN beta, represents an essential part of the innate immune defense against invading pathogens. While in most situations, namely viral infections, this class of cytokines is indispensable for host survival they mediate a detrimental effect during infection with L. monocytogenes by rendering macrophages insensitive towards IFN gamma signalling which leads to a lethal bacterial pathology in mice. Due to a lack of suitable analytic tools the precise identity of the cell population responsible for type I IFN production remains ill-defined and so far these cells have been described to be macrophages. As in general IFN beta is the first type I interferon to be produced, we took advantage of an IFN beta fluorescence reporter-knockin mouse model in which YFP is expressed from a bicistronic mRNA linked by an IRES to the endogenous ifnb mRNA to assess the IFN beta production on a single cell level in situ. Our results showed highest frequencies and absolute numbers of IFN beta(+) cells in the spleen 24 h after infection with L. monocytogenes where they were located predominately in the white pulp within the foci of infection. Detailed FACS surface marker analyses, intracellular cytokine stainings and T cell proliferation assays revealed that the IFN beta(+) cells were a phenotypically and functionally further specialized subpopulation of TNF and iNOS producing DCs (Tip-DCs) which are known to be essential for the early containment of L. monocytogenes infection. We proved that the IFN beta(+) cells exhibited the hallmark characteristics of Tip-DCs as they produced iNOS and TNF and possessed T cell priming abilities. These results point to a yet unappreciated ambiguous role for a multi-effector, IFN beta producing subpopulation of Tip-DCs in controlling the balance between containment of L. monocytogenes infection and effects detrimental to the host driven by IFN beta.	[Dresing, Philipp] Univ Dusseldorf, Inst Med Microbiol, Dusseldorf, Germany; Univ Dusseldorf, Hosp Hyg, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Dresing, P (corresponding author), Univ Dusseldorf, Inst Med Microbiol, Dusseldorf, Germany.	stefanie.scheu@uni-duesseldorf.de	Scheu, Stefanie/H-3670-2019	Scheu, Stefanie/0000-0002-9707-8191	Deutsche Forschungsgemeinschaft [SCHE692/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHE692/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Moussawi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000722; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Freudenberg MA, 2002, J IMMUNOL, V169, P1665, DOI 10.4049/jimmunol.169.4.1665; Garifulin O, 2007, PLOS GENET, V3, P1587, DOI 10.1371/journal.pgen.0030152; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gregory SH, 1996, J IMMUNOL, V157, P2514; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HAVELL EA, 1989, J IMMUNOL, V143, P2894; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Jablonska J, 2007, INFECT IMMUN, V75, P462, DOI 10.1128/IAI.00443-06; Jia T, 2009, J IMMUNOL, V183, P1271, DOI 10.4049/jimmunol.0900460; Jin YX, 2001, INFECT IMMUN, V69, P1093, DOI 10.1128/IAI.69.2.1093-1100.2001; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Kursar M, 2002, J IMMUNOL, V168, P6382, DOI 10.4049/jimmunol.168.12.6382; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Muraille E, 2005, EUR J IMMUNOL, V35, P1463, DOI 10.1002/eji.200526024; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stockinger S, 2008, IMMUNOBIOLOGY, V213, P889, DOI 10.1016/j.imbio.2008.07.020; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004	48	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15567	10.1371/journal.pone.0015567	http://dx.doi.org/10.1371/journal.pone.0015567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179567	Green Submitted, Green Published, gold			2022-12-25	WOS:000285381200031
J	Cruz-Motta, JJ; Miloslavich, P; Palomo, G; Iken, K; Konar, B; Pohle, G; Trott, T; Benedetti-Cecchi, L; Herrera, C; Hernandez, A; Sardi, A; Bueno, A; Castillo, J; Klein, E; Guerra-Castro, E; Gobin, J; Gomez, DI; Riosmena-Rodriguez, R; Mead, A; Bigatti, G; Knowlton, A; Shirayama, Y				Jose Cruz-Motta, Juan; Miloslavich, Patricia; Palomo, Gabriela; Iken, Katrin; Konar, Brenda; Pohle, Gerhard; Trott, Tom; Benedetti-Cecchi, Lisandro; Herrera, Cesar; Hernandez, Alejandra; Sardi, Adriana; Bueno, Andrea; Castillo, Julio; Klein, Eduardo; Guerra-Castro, Edlin; Gobin, Judith; Isabel Gomez, Diana; Riosmena-Rodriguez, Rafael; Mead, Angela; Bigatti, Gregorio; Knowlton, Ann; Shirayama, Yoshihisa			Patterns of Spatial Variation of Assemblages Associated with Intertidal Rocky Shores: A Global Perspective	PLOS ONE			English	Article							SPECIES-DIVERSITY; LATITUDINAL GRADIENTS; MARINE BIODIVERSITY; COMMUNITY STRUCTURE; ZONATION PATTERNS; CLIMATE-CHANGE; HUMAN IMPACT; ABUNDANCE; ECOLOGY; INVERTEBRATES	Assemblages associated with intertidal rocky shores were examined for large scale distribution patterns with specific emphasis on identifying latitudinal trends of species richness and taxonomic distinctiveness. Seventy-two sites distributed around the globe were evaluated following the standardized sampling protocol of the Census of Marine Life NaGISA project (www.nagisa.coml.org). There were no clear patterns of standardized estimators of species richness along latitudinal gradients or among Large Marine Ecosystems (LMEs); however, a strong latitudinal gradient in taxonomic composition (i.e., proportion of different taxonomic groups in a given sample) was observed. Environmental variables related to natural influences were strongly related to the distribution patterns of the assemblages on the LME scale, particularly photoperiod, sea surface temperature (SST) and rainfall. In contrast, no environmental variables directly associated with human influences (with the exception of the inorganic pollution index) were related to assemblage patterns among LMEs. Correlations of the natural assemblages with either latitudinal gradients or environmental variables were equally strong suggesting that neither neutral models nor models based solely on environmental variables sufficiently explain spatial variation of these assemblages at a global scale. Despite the data shortcomings in this study (e. g., unbalanced sample distribution), we show the importance of generating biological global databases for the use in large-scale diversity comparisons of rocky intertidal assemblages to stimulate continued sampling and analyses.	[Jose Cruz-Motta, Juan; Miloslavich, Patricia; Klein, Eduardo] Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Miranda, Venezuela; [Palomo, Gabriela] Museo Argentino Ciencias Nat Bernardino Rivadavia, Lab Ecosistemas Costeros, Buenos Aires, DF, Argentina; [Iken, Katrin; Konar, Brenda; Knowlton, Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Pohle, Gerhard] Huntsman Marine Sci Ctr, St Andrews, NB, Canada; [Trott, Tom] Suffolk Univ, Boston, MA 02114 USA; [Benedetti-Cecchi, Lisandro] Univ Pisa, Dipartimento Biol, Pisa, Tuscany, Italy; [Jose Cruz-Motta, Juan; Miloslavich, Patricia; Herrera, Cesar; Hernandez, Alejandra; Sardi, Adriana; Bueno, Andrea; Castillo, Julio; Klein, Eduardo] Univ Simon Bolivar, Ctr Biodiversidad Marina, Caracas, Miranda, Venezuela; [Guerra-Castro, Edlin] Inst Venezolano Invest Cient, Ctr Ecol, Caracas, Miranda, Venezuela; [Gobin, Judith] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago; [Isabel Gomez, Diana] Inst Invest Marinas & Costeras Jose Benito Vives, Santa Marta, Magdalena, Colombia; [Riosmena-Rodriguez, Rafael] Univ Autonoma Baja California Sur, Programa Invest Bot Marina, La Paz, Mexico; [Mead, Angela] Univ Cape Town, ZA-7925 Cape Town, Western Cape, South Africa; [Bigatti, Gregorio] Ctr Estudios Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Shirayama, Yoshihisa] Kyoto Univ, Field Sci Educ & Res Ctr, Seto Marine Biol Lab, Wakayama, Japan	Simon Bolivar University; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University of Alaska System; University of Alaska Fairbanks; Suffolk University; University of Pisa; Simon Bolivar University; Venezuelan Institute Science Research; University West Indies Mona Jamaica; University West Indies Saint Augustine; Universidad Autonoma de Baja California; University of Cape Town; Kyoto University	Cruz-Motta, JJ (corresponding author), Univ Simon Bolivar, Dept Estudios Ambientales, Caracas, Miranda, Venezuela.	juancruz@usb.ve	Herrera, César/AAI-3001-2021; Trott, Thomas J/N-4660-2018; Guerra-Castro, Edlin/E-3639-2014; Benedetti-Cecchi, Lisandro/J-8225-2019	Herrera, César/0000-0003-0307-6724; Trott, Thomas J/0000-0002-1851-5243; Guerra-Castro, Edlin/0000-0003-3529-4507; Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Sardi, Adriana E./0000-0001-5323-2006; Klein, Eduardo/0000-0003-2935-7065; Bueno, Andrea/0000-0002-4205-5275; Palomo, Maria Gabriela/0000-0002-9102-1282; BIGATTI, GREGORIO/0000-0001-7053-6802; Cruz Motta, Juan Jose/0000-0001-6117-9014; Miloslavich, Patricia/0000-0001-5409-1401	Alfred P. Sloan Foundation; Chevron (Venezuela) through a LOCTI (Ley Organica de Ciencia, Tecnologia e Innovacion); Decanato de Investigaciones (Universidad Simon Bolivar, Caracas, Venezuela)	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Chevron (Venezuela) through a LOCTI (Ley Organica de Ciencia, Tecnologia e Innovacion); Decanato de Investigaciones (Universidad Simon Bolivar, Caracas, Venezuela)	Funding for this study was given by Alfred P. Sloan Foundation, Chevron (Venezuela) through a LOCTI (Ley Organica de Ciencia, Tecnologia e Innovacion) scheme and Decanato de Investigaciones (Universidad Simon Bolivar, Caracas, Venezuela). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BARREIRO R, 1993, MAR ENVIRON RES, V36, P39, DOI 10.1016/0141-1136(93)90088-H; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V215, P79, DOI 10.3354/meps215079; Benedetti-Cecchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012946; Blanchette CA, 2008, J BIOGEOGR, V35, P1593, DOI 10.1111/j.1365-2699.2008.01913.x; Bolton JJ, 2002, S AFR J MARINE SCI, V24, P9, DOI 10.2989/025776102784528402; BOLTON JJ, 1994, BOT MAR, V37, P241, DOI 10.1515/botm.1994.37.3.241; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; BUSTAMANTE RH, 1995, OECOLOGIA, V102, P189, DOI 10.1007/BF00333251; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Castilla JC, 1996, ENVIRON MONIT ASSESS, V40, P171, DOI 10.1007/BF00414390; Castilla JC, 2000, J EXP MAR BIOL ECOL, V250, P3, DOI 10.1016/S0022-0981(00)00177-5; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; Clark R, 1997, MARINE POLLUTION, V4; CLARKE A, 1992, TRENDS ECOL EVOL, V7, P286, DOI 10.1016/0169-5347(92)90222-W; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR, 1998, OECOLOGIA, V113, P278, DOI 10.1007/s004420050379; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cruz-Motta JJ, 2007, CIENC MAR, V33, P133, DOI 10.7773/cm.v33i2.1113; Fisher JAD, 2010, GLOBAL ECOL BIOGEOGR, V19, P1, DOI 10.1111/j.1466-8238.2009.00482.x; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Gaston K. J., 2004, BIODIVERSITY INTRO; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Genner MJ, 2010, GLOBAL CHANGE BIOL, V16, P517, DOI 10.1111/j.1365-2486.2009.02027.x; Gessner MO, 2004, OIKOS, V104, P419, DOI 10.1111/j.0030-1299.1999.13252.x; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Good TP, 2004, B MAR SCI, V74, P459; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; He F, 2005, FUNCT ECOL, V19, P187, DOI 10.1111/j.0269-8463.2005.00944.x; Heath MR, 2008, SCIENCE, V321, DOI 10.1126/science.1157390; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Holbrook SJ, 1997, ECOL APPL, V7, P1299; Hubbell Stephen P., 2001, V32, pi; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; IKEN K, 2010, PLOS ONE IN PRESS; Ingolfsson A, 2005, J BIOGEOGR, V32, P169, DOI 10.1111/j.1365-2699.2004.01150.x; KENDALL MA, 1993, J EXP MAR BIOL ECOL, V172, P157, DOI 10.1016/0022-0981(93)90095-6; Kerr Jeremy, 2001, Trends in Ecology and Evolution, V16, P424, DOI 10.1016/S0169-5347(01)02226-1; Konar B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013195; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Lindstrom SC, 1999, BOT MAR, V42, P265, DOI 10.1515/BOT.1999.030; Lopez MM, 2005, REV BIOL TROP, V53, P291; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Meeus JH., 1991, ASTRONOMICAL ALGORIT; Menconi M, 1999, J EXP MAR BIOL ECOL, V233, P1, DOI 10.1016/S0022-0981(98)00123-3; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Nisbet E, 2007, NATURE, V450, P789, DOI 10.1038/450789a; Nunez SG, 1999, CIENC MAR, V25, P629, DOI 10.7773/cm.v25i4.722; O'Connor NE, 2005, ECOLOGY, V86, P1783, DOI 10.1890/04-1172; Okuda T, 2004, POPUL ECOL, V46, P159, DOI 10.1007/s10144-004-0185-9; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Reise K, 1998, HELGOLANDER MEERESUN, V52, P219, DOI 10.1007/BF02908898; Rigby PR, 2007, SAMPLING BIODIVERSIT; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; Robles C, 2002, ECOLOGY, V83, P1521, DOI 10.1890/0012-9658(2002)083[1521:HACDOA]2.0.CO;2; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Sagarin RD, 2002, J BIOGEOGR, V29, P985, DOI 10.1046/j.1365-2699.2002.00705.x; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; Santelices Bernabe, 1998, Diversity and Distributions, V4, P71, DOI 10.1046/j.1472-4642.1998.00005.x; Sherman K, 2007, NMFSNE208 NOAA US DE; Sink KJ, 2005, AFR J MAR SCI, V27, P81, DOI 10.2989/18142320509504070; SOUTHWARD AJ, 1978, J FISH RES BOARD CAN, V35, P682, DOI 10.1139/f78-120; Thompson RC, 2002, ENVIRON CONSERV, V29, P168, DOI 10.1017/S0376892902000115; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P51, DOI 10.1016/S0022-0981(00)00179-9; Walther GR, 2000, PHYTOCOENOLOGIA, V30, P409; Watson R.T., 2001, CLIMATE CHANGE 2001, P388; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Zacharias MA, 2001, J BIOGEOGR, V28, P471, DOI 10.1046/j.1365-2699.2001.00559.x	92	28	31	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14354	10.1371/journal.pone.0014354	http://dx.doi.org/10.1371/journal.pone.0014354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179546	Green Published, gold, Green Submitted			2022-12-25	WOS:000285381200008
J	Ward, LM; MacLean, SE; Kirschner, A				Ward, Lawrence M.; MacLean, Shannon E.; Kirschner, Aaron			Stochastic Resonance Modulates Neural Synchronization within and between Cortical Sources	PLOS ONE			English	Article							STEADY-STATE RESPONSES; POSTERIOR CINGULATE; PHASE SYNCHRONIZATION; BLIND SEPARATION; GAMMA; OSCILLATIONS; DYNAMICS; COMPONENTS; MECHANISM; AROUSAL	Neural synchronization is a mechanism whereby functionally specific brain regions establish transient networks for perception, cognition, and action. Direct addition of weak noise (fast random fluctuations) to various neural systems enhances synchronization through the mechanism of stochastic resonance (SR). Moreover, SR also occurs in human perception, cognition, and action. Perception, cognition, and action are closely correlated with, and may depend upon, synchronized oscillations within specialized brain networks. We tested the hypothesis that SR-mediated neural synchronization occurs within and between functionally relevant brain areas and thus could be responsible for behavioral SR. We measured the 40-Hz transient response of the human auditory cortex to brief pure tones. This response arises when the ongoing, random-phase, 40-Hz activity of a group of tuned neurons in the auditory cortex becomes synchronized in response to the onset of an above-threshold sound at its "preferred" frequency. We presented a stream of near-threshold standard sounds in various levels of added broadband noise and measured subjects' 40-Hz response to the standards in a deviant-detection paradigm using high-density EEG. We used independent component analysis and dipole fitting to locate neural sources of the 40-Hz response in bilateral auditory cortex, left posterior cingulate cortex and left superior frontal gyrus. We found that added noise enhanced the 40-Hz response in all these areas. Moreover, added noise also increased the synchronization between these regions in alpha and gamma frequency bands both during and after the 40-Hz response. Our results demonstrate neural SR in several functionally specific brain regions, including areas not traditionally thought to contribute to the auditory 40-Hz transient response. In addition, we demonstrated SR in the synchronization between these brain regions. Thus, both intra-and inter-regional synchronization of neural activity are facilitated by the addition of moderate amounts of random noise. Because the noise levels in the brain fluctuate with arousal system activity, particularly across sleep-wake cycles, optimal neural noise levels, and thus SR, could be involved in optimizing the formation of task-relevant brain networks at several scales under normal conditions.	[Ward, Lawrence M.; MacLean, Shannon E.; Kirschner, Aaron] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Ward, Lawrence M.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Ward, LM (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	lward@psych.ubc.ca		Ward, Lawrence/0000-0003-4431-5015	Natural Sciences and Engineering Research Council of Canada [A9958]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a Discovery Grant (A9958) from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) to LMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Bohorquez J, 2008, CLIN NEUROPHYSIOL, V119, P2598, DOI 10.1016/j.clinph.2008.08.002; CRICK F, 1990, COLD SH Q B, V55, P953; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Doesburg SM, 2009, BRAIN RES, V1303, P97, DOI 10.1016/j.brainres.2009.09.069; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Ermentrout GB, 2008, TRENDS NEUROSCI, V31, P428, DOI 10.1016/j.tins.2008.06.002; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GALAMBOS R, 1992, J ACOUST SOC AM, V92, P2683, DOI 10.1121/1.404383; GALAMBOS R, 1992, J ACOUST SOC AM, V92, P2691, DOI 10.1121/1.404384; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; GELDARD FA, 1972, HUMAN SENSES; GINGL Z, 1995, EUROPHYS LETT, V29, P191, DOI 10.1209/0295-5075/29/3/001; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Greenwood PE, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051110; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; JUNG P, 1995, PHYS REV LETT, V74, P2130, DOI 10.1103/PhysRevLett.74.2130; KILENY P, 1986, J SPEECH HEAR RES, V29, P20, DOI 10.1044/jshr.2901.20; Kitajo K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.218103; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40009; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lugo E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002860; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Manjarrez E, 2002, NEUROSCI LETT, V324, P213, DOI 10.1016/S0304-3940(02)00212-4; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Meinecke FC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.084102; Mori T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.218101; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; NICOLIS C, 1981, SOL PHYS, V74, P473, DOI 10.1007/BF00154530; Nielsen FA, 2005, NEUROIMAGE, V27, P520, DOI 10.1016/j.neuroimage.2005.04.034; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shalgi S, 2007, NEUROPSYCHOLOGIA, V45, P1878, DOI 10.1016/j.neuropsychologia.2006.11.023; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Srebro R, 1999, PHYS REV E, V59, P2566, DOI 10.1103/PhysRevE.59.2566; STAPELLS DR, 1984, EAR HEARING, V5, P105, DOI 10.1097/00003446-198403000-00009; STAPELLS DR, 1987, ELECTROEN CLIN NEURO, V67, P260, DOI 10.1016/0013-4694(87)90024-1; Stapells DR, 2005, SOUND FDN EARLY AMPL, P43; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Stone J.V., 2004, INDEPENDENT COMPONEN; Stufflebeam SM, 2000, NEUROREPORT, V11, P4081, DOI 10.1097/00001756-200012180-00034; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; Tanaka K, 2008, CLIN NEUROPHYSIOL, V119, P2104, DOI 10.1016/j.clinph.2008.05.007; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Ward LM, 2009, CONTEMP PHYS, V50, P563, DOI 10.1080/00107510902879246; Ward LM, 2005, AIP CONF PROC, V800, P245, DOI 10.1063/1.2138621; Ward LM, 2004, FLUCT NOISE LETT, V4, pL11, DOI 10.1142/S0219477504001616; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Zaks MA, 1999, PHYS REV LETT, V82, P4228, DOI 10.1103/PhysRevLett.82.4228	69	69	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14371	10.1371/journal.pone.0014371	http://dx.doi.org/10.1371/journal.pone.0014371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179552	gold, Green Submitted, Green Published			2022-12-25	WOS:000285381200014
J	Coenen, MJH; Enevold, C; Barrera, P; Schijvenaars, MMVAP; Toonen, EJM; Scheffer, H; Padyukov, L; Kastbom, A; Klareskog, L; Barton, A; Kievit, W; Rood, MJ; Jansen, TL; Swinkels, D; van Riel, PLCM; Franke, B; Bendtzen, K; Radstake, TRDJ				Coenen, Marieke J. H.; Enevold, Christian; Barrera, Pilar; Schijvenaars, Mascha M. V. A. P.; Toonen, Erik J. M.; Scheffer, Hans; Padyukov, Leonid; Kastbom, Alf; Klareskog, Lars; Barton, Anne; Kievit, Wietske; Rood, Maarten J.; Jansen, Tim L.; Swinkels, Dorine; van Riel, Piet L. C. M.; Franke, Barbara; Bendtzen, Klaus; Radstake, Timothy R. D. J.			Genetic Variants in Toll-Like Receptors Are Not Associated with Rheumatoid Arthritis Susceptibility or Anti-Tumour Necrosis Factor Treatment Outcome	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; GENOME-WIDE ASSOCIATION; DISEASE SEVERITY; TOLL-LIKE-RECEPTOR-4; POPULATION; EXPRESSION; RISK	Background: Several studies point to a role of Toll-like receptors (TLRs) in the development of rheumatoid arthritis (RA). We investigated if genetic variants in TLR genes are associated with RA and response to tumour necrosis factor blocking (anti-TNF) medication. Methodology and Principal Findings: 22 single nucleotide polymorphisms (SNPs) in seven TLR genes were genotyped in a Dutch cohort consisting of 378 RA patients and 294 controls. Significantly associated variants were investigated in replication cohorts from The Netherlands, United Kingdom and Sweden (2877 RA patients and 2025 controls). 182 of the Dutch patients were treated with anti-TNF medication. Using these patients and a replication cohort (269 Swedish patients) we analysed if genetic variants in TLR genes were associated with anti-TNF outcome. In the discovery phase of the study we found a significant association of SNPs rs2072493 in TLR5 and rs3853839 in TLR7 with RA disease susceptibility. Meta-analysis of discovery and replication cohorts did not confirm these findings. SNP rs2072493 in TLR5 was associated with anti-TNF outcome in the Dutch but not in the Swedish population. Conclusion: We conclude that genetic variants in TLRs do not play a major role in susceptibility for developing RA nor in anti-TNF treatment outcome in a Caucasian population.	[Coenen, Marieke J. H.; Schijvenaars, Mascha M. V. A. P.; Toonen, Erik J. M.; Scheffer, Hans; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, IGMD, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Enevold, Christian; Bendtzen, Klaus] Univ Copenhagen Hosp, Rigshosp, Inst Inflammat Res, Dept Rheumatol, DK-2100 Copenhagen, Denmark; [Barrera, Pilar; van Riel, Piet L. C. M.; Radstake, Timothy R. D. J.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Padyukov, Leonid; Klareskog, Lars] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Kastbom, Alf] Linkoping Univ, Dept Clin & Expt Med, Div Rheumatol, Linkoping, Sweden; [Barton, Anne] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester, Lancs, England; [Rood, Maarten J.] Ziekenhuis Gelderse Vallei, Dept Rheumatol, Ede, Netherlands; [Jansen, Tim L.] Med Ctr Leeuwarden, Dept Rheumatol, Leeuwarden, Netherlands; [Swinkels, Dorine] Radboud Univ Nijmegen, Clin Chem Lab, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Rigshospitalet; University of Copenhagen; Radboud University Nijmegen; Karolinska Institutet; Karolinska University Hospital; Linkoping University; University of Manchester; Gelderse Vallei Hospital; Medical Center Leeuwarden; Radboud University Nijmegen	Coenen, MJH (corresponding author), Radboud Univ Nijmegen, Med Ctr, IGMD, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	m.coenen@antrg.umcn.nl	Kastbom, Alf/F-6137-2011; Toonen, Erik/G-7337-2015; Kievit, Wietske/A-5666-2015; Jansen, T.L.Th.A./L-4407-2015; Scheffer, Hans/E-4644-2012; Swinkels, Dorine W./H-8098-2014; Coenen, Marieke/A-2159-2010; van Riel, P.L.C.M./H-8082-2014; Franke, Barbara/D-4836-2009; Schijvenaars, Mascha/P-8712-2015; Barton, Anne/N-2053-2014; Padyukov, Leonid/A-4890-2009	Kastbom, Alf/0000-0001-7187-1477; Scheffer, Hans/0000-0002-2986-0915; Swinkels, Dorine W./0000-0002-1040-9446; Coenen, Marieke/0000-0001-8796-2031; Franke, Barbara/0000-0003-4375-6572; Barton, Anne/0000-0003-3316-2527; Enevold, Christian/0000-0002-2748-1997; Padyukov, Leonid/0000-0003-2950-5670; Jansen, Tim L/0000-0003-3026-3154; Klareskog, Lars/0000-0001-9601-6186; Toonen, Erik/0000-0001-9039-635X	Danish Biotechnology program; Lundbeck Foundation; Netherlands Organisation for Scientific Research [916.76.020]	Danish Biotechnology program; Lundbeck Foundation(Lundbeckfonden); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by The Danish Biotechnology program (C. Enevold) and The Lundbeck Foundation (C. Enevold) and a personal grant to M. Coenen from the Netherlands Organisation for Scientific Research (grant 916.76.020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Coenen MJH, 2009, GENES IMMUN, V10, P101, DOI 10.1038/gene.2008.77; De Rycke L, 2005, ARTHRITIS RHEUM-US, V52, P2146, DOI 10.1002/art.21155; Enevold C, 2010, J RHEUMATOL, V37, P905, DOI 10.3899/jrheum.090775; Etem EO, 2011, RHEUMATOL INT, V31, P1369, DOI 10.1007/s00296-010-1472-8; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Jaen O, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2589; Kang ES, 2007, RHEUMATOL INT, V27, P887, DOI 10.1007/s00296-007-0311-z; Kastbom A, 2007, ARTHRITIS RHEUM, V56, P448, DOI 10.1002/art.22390; Kilding R, 2003, CLIN EXP RHEUMATOL, V21, P340; Kuuliala K, 2006, ANN RHEUM DIS, V65, P1241, DOI 10.1136/ard.2006.055137; Lee EY, 2006, INT J IMMUNOGENET, V33, P211, DOI 10.1111/j.1744-313X.2006.00599.x; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radstake TRDJ, 2004, ARTHRITIS RHEUM, V50, P999, DOI 10.1002/art.20114; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Sanchez E, 2004, TISSUE ANTIGENS, V63, P54, DOI 10.1111/j.1399-0039.2004.00162.x; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P1328, DOI 10.1136/ard.2007.083337; Taylor JD, 2001, BIOTECHNIQUES, V30, P661, DOI 10.2144/01303dd04; Toonen EJM, 2008, ANN RHEUM DIS, V67, P1174, DOI 10.1136/ard.2008.088138; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; Welsing PMJ, 2004, J RHEUMATOL, V31, P14; Ye F, 2001, HUM MUTAT, V17, P305, DOI 10.1002/humu.28	27	22	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14326	10.1371/journal.pone.0014326	http://dx.doi.org/10.1371/journal.pone.0014326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179534	Green Published, gold, Green Submitted			2022-12-25	WOS:000285340000005
J	Junaid, M; Lapins, M; Eklund, M; Spjuth, O; Wikberg, JES				Junaid, Muhammad; Lapins, Maris; Eklund, Martin; Spjuth, Ola; Wikberg, Jarl E. S.			Proteochemometric Modeling of the Susceptibility of Mutated Variants of the HIV-1 Virus to Reverse Transcriptase Inhibitors	PLOS ONE			English	Article							ORGANIC-COMPOUNDS; DESIGN; THERAPIES; SET	Background: Reverse transcriptase is a major drug target in highly active antiretroviral therapy (HAART) against HIV, which typically comprises two nucleoside/nucleotide analog reverse transcriptase (RT) inhibitors (NRTIs) in combination with a non-nucleoside RT inhibitor or a protease inhibitor. Unfortunately, HIV is capable of escaping the therapy by mutating into drug-resistant variants. Computational models that correlate HIV drug susceptibilities to the virus genotype and to drug molecular properties might facilitate selection of improved combination treatment regimens. Methodology/Principal Findings: We applied our earlier developed proteochemometric modeling technology to analyze HIV mutant susceptibility to the eight clinically approved NRTIs. The data set used covered 728 virus variants genotyped for 240 sequence residues of the DNA polymerase domain of the RT; 165 of these residues contained mutations; totally the data-set covered susceptibility data for 4,495 inhibitor-RT combinations. Inhibitors and RT sequences were represented numerically by 3D-structural and physicochemical property descriptors, respectively. The two sets of descriptors and their derived cross-terms were correlated to the susceptibility data by partial least-squares projections to latent structures. The model identified more than ten frequently occurring mutations, each conferring more than two-fold loss of susceptibility for one or several NRTIs. The most deleterious mutations were K65R, Q151M, M184V/I, and T215Y/F, each of them decreasing susceptibility to most of the NRTIs. The predictive ability of the model was estimated by cross-validation and by external predictions for new HIV variants; both procedures showed very high correlation between the predicted and actual susceptibility values (Q(2) = 0.89 and Q(ext)(2) = 0.86). The model is available at www.hivdrc.org as a free web service for the prediction of the susceptibility to any of the clinically used NRTIs for any HIV-1 mutant variant. Conclusions/Significance: Our results give directions how to develop approaches for selection of genome-based optimum combination therapy for patients harboring mutated HIV variants.	[Junaid, Muhammad; Lapins, Maris; Eklund, Martin; Spjuth, Ola; Wikberg, Jarl E. S.] Uppsala Univ, Dept Pharmaceut Pharmacol, Uppsala, Sweden	Uppsala University	Junaid, M (corresponding author), Uppsala Univ, Dept Pharmaceut Pharmacol, Uppsala, Sweden.	Jarl.Wikberg@farmbio.uu.se	Spjuth, Ola/Q-2638-2019	Spjuth, Ola/0000-0002-8083-2864; Lapins, Maris/0000-0002-0122-6680	Uppsala University [KoF 07]; Stiftelsen Lakare mot AIDS Forskningsfond; Wiberg's foundation	Uppsala University; Stiftelsen Lakare mot AIDS Forskningsfond; Wiberg's foundation	Support was received from Uppsala University (KoF 07), Stiftelsen Lakare mot AIDS Forskningsfond and Wiberg's foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2009, J INFECT DIS, V199, P999, DOI 10.1086/597305; [Anonymous], [No title captured]; Beerenwinkel N, 2005, BIOINFORMATICS, V21, P3943, DOI 10.1093/bioinformatics/bti654; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cozzi-Lepri A, 2005, ANTIVIR THER, V10, P791; De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703; Eriksson L, 1996, CHEMOMETR INTELL LAB, V34, P1, DOI 10.1016/0169-7439(96)00023-8; Eriksson L., 2001, MULTI MEGAVARIATE DA; Gao F, 2004, J VIROL, V78, P2426, DOI 10.1128/JVI.78.5.2426-2433.2004; GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817; GOODY RS, 1991, FEBS LETT, V291, P1, DOI 10.1016/0014-5793(91)81089-Q; JINGSHAN R, 2005, TRENDS PHARMACOL SCI, V26, P4; Kjer J, 2008, HIV MED, V9, P642, DOI 10.1111/j.1468-1293.2008.00612.x; KONTIJEVSKIS A, 2007, PLOS COMPUT BIOL; Lapins M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-181; Lapinsh M, 2001, BBA-GEN SUBJECTS, V1525, P180, DOI 10.1016/S0304-4165(00)00187-2; Lapinsh M, 2005, BIOINFORMATICS, V21, P4289, DOI 10.1093/bioinformatics/bti703; Lapinsh M, 2005, MOL PHARMACOL, V67, P50, DOI 10.1124/mol.104.002857; Lapinsh M, 2003, J MED CHEM, V46, P2572, DOI 10.1021/jm020945m; Lapinsh M, 2002, MOL PHARMACOL, V61, P1465, DOI 10.1124/mol.61.6.1465; Mandrika I, 2007, PROTEIN ENG DES SEL, V20, P301, DOI 10.1093/protein/gzm022; Parniak M A, 2000, Adv Pharmacol, V49, P67; Prusis P, 2001, BBA-PROTEIN STRUCT M, V1544, P350, DOI 10.1016/S0167-4838(00)00249-1; Rhee SY, 2006, P NATL ACAD SCI USA, V103, P17355, DOI 10.1073/pnas.0607274103; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rosen-Zvi M, 2008, BIOINFORMATICS, V24, pI399, DOI 10.1093/bioinformatics/btn141; Saigo H, 2007, BIOINFORMATICS, V23, P2455, DOI 10.1093/bioinformatics/btm353; Sandberg M, 1998, J MED CHEM, V41, P2481, DOI 10.1021/jm9700575; Strombergsson H, 2006, PROTEINS, V63, P24, DOI 10.1002/prot.20777; Todeschini R., 2008, HDB MOL DESCRIPTORS; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; *UNAIDS, AIDS EP UPD 2009; Wagener J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-279; Wang K, 2004, ANTIVIR THER, V9, P703; Wikberg J. E. S., 2004, CHEMOGENOMICS DRUG D, P289, DOI DOI 10.1002/3527603948.CH10; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; RELEASE NOTES HIVDB	40	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14353	10.1371/journal.pone.0014353	http://dx.doi.org/10.1371/journal.pone.0014353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179544	Green Published, gold, Green Submitted			2022-12-25	WOS:000285340000015
J	Moore, TJ; Glenmullen, J; Furberg, CD				Moore, Thomas J.; Glenmullen, Joseph; Furberg, Curt D.			Prescription Drugs Associated with Reports of Violence Towards Others	PLOS ONE			English	Article							SUICIDAL ADVERSE EVENTS	Context: Violence towards others is a seldom-studied adverse drug event and an atypical one because the risk of injury extends to others. Objective: To identify the primary suspects in adverse drug event reports describing thoughts or acts of violence towards others, and assess the strength of the association. Methodology: From the Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) data, we extracted all serious adverse event reports for drugs with 200 or more cases received from 2004 through September 2009. We identified any case report indicating homicide, homicidal ideation, physical assault, physical abuse or violence related symptoms. Main Outcome Measures: Disproportionality in reporting was defined as a) 5 or more violence case reports, b) at least twice the number of reports expected given the volume of overall reports for that drug, c) a chi 2 statistic indicating the violence cases were unlikely to have occurred by chance (p < 0.01). Results: We identified 1527 cases of violence disproportionally reported for 31 drugs. Primary suspect drugs included varenicline (an aid to smoking cessation), 11 antidepressants, 6 sedative/hypnotics and 3 drugs for attention deficit hyperactivity disorder. The evidence of an association was weaker and mixed for antipsychotic drugs and absent for all but 1 anticonvulsant/mood stabilizer. Two or fewer violence cases were reported for 435/484 (84.7%) of all evaluable drugs suggesting that an association with this adverse event is unlikely for these drugs. Conclusions: Acts of violence towards others are a genuine and serious adverse drug event associated with a relatively small group of drugs. Varenicline, which increases the availability of dopamine, and antidepressants with serotonergic effects were the most strongly and consistently implicated drugs. Prospective studies to evaluate systematically this side effect are needed to establish the incidence, confirm differences among drugs and identify additional common features.	[Moore, Thomas J.] Inst Safe Medicat Practices, Alexandria, VA USA; [Glenmullen, Joseph] Harvard Univ, Sch Med, Cambridge Hosp, Dept Psychiat, Cambridge, MA 02138 USA; [Furberg, Curt D.] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA	Harvard University; Cambridge Health Alliance; Cambridge Hospital; Wake Forest University; Wake Forest Baptist Medical Center	Moore, TJ (corresponding author), Inst Safe Medicat Practices, Alexandria, VA USA.	tmoore@ismp.org		Moore, Thomas/0000-0003-0994-836X				*ASTRAZENECA PHARM, 2010, SEROQUEL QUET FUM TA; Brown J.H., 2001, GOODMAN GILMANS PHAR, V10th ed., P10; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; *GLAXOSMITHKLINE, 2009, PAXIL PAR HYDR TABL; *JAZZ PHARM, 2009, XYREM SOD OX SOL PAC; *MEDDRA MAINT SUPP, 2009, INTR GUID MEDDRA VER; *MERCK CO I, 2010, SINGULAIR MONT SOD T; MOORE T, 2008, QUARTERWATCH 2008 QU; Moore TJ, 2010, ANN PHARMACOTHER, V44, P1389, DOI 10.1345/aph.1P172; Moore TJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4964; MOORE TJ, 2010, QUARTERWATCH 2009 QU; MOORE TJ, 2008, STRONG SIGNAL SEEN N; Mosholder AD, 2006, J CHILD ADOL PSYCHOP, V16, P25, DOI 10.1089/cap.2006.16.25; Mosholder AD, 2006, J CHILD ADOL PSYCHOP, V16, P33, DOI 10.1089/cap.2006.16.33; National Library of Medicine, 2010, UN MED LANG SYST UML; *PFIZ INC, 2008, ZOLOFT SERTR HYDR TA; Pfizer Inc, 2010, CHANTIX VAR TARTR TA; *SAN ADV US, 2009, AMBIEN ZOLP TARTR TA; U. S. Food and Drug Administration, 2007, NEW WARN PROP ANT; United States Food and Drug Administration, 2010, ADV EV REP SYST AERS; 2008, PRESCRIRE INT, V17, P199	22	51	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15337	10.1371/journal.pone.0015337	http://dx.doi.org/10.1371/journal.pone.0015337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179515	Green Submitted, Green Published, gold			2022-12-25	WOS:000285340000021
J	Tanase, CA				Tanase, Carmen-Alexandra			Histidine Domain-Protein Tyrosine Phosphatase Interacts with Grb2 and GrpL	PLOS ONE			English	Article							HD-PTP; ADAPTER; RECEPTOR; KINASE; GADS; RAS; LAT; EXPRESSION; SUBSTRATE; MIGRATION	Background: Histidine domain-protein tyrosine phosphatase (HD-PTP) plays a key role in vesicle trafficking and biogenesis. Although it is a large protein with at least five distinct structural domains, only a few of its interactors are presently known, and the significance of these interactions is largely obscure. Methodology and Results: In this study we performed a yeast two-hybrid screening using a human colon cDNA library and found that Grb2 and GrpL are binding partners of HD-PTP. Co-immunoprecipitation, pull-down and immunocytochemistry experiments confirmed the interactions. We also discovered that the central proline-rich and histidine-rich domain of HD-PTP is responsible for these interactions. Significance: The interaction of HD-PTP with two adapters of the Grb2 family, essential for numerous signaling pathways, suggests that HD-PTP might be important for signaling through a plethora of receptors. 2	Inst Biochem, Dept Enzymol, Bucharest, Romania	Romanian Academy of Sciences; Institute of Biochemistry, Bucharest	Tanase, CA (corresponding author), Inst Biochem, Dept Enzymol, Bucharest, Romania.	ctanase@biochim.ro	Tanase, Carmen/D-2293-2009; Tanase, Carmen/ABD-7943-2020		Romanian Council for Research and Higher Education [3182]; European Commission [MIRG 022374]	Romanian Council for Research and Higher Education(Consiliul National al Cercetarii Stiintifice (CNCS)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the Romanian Council for Research and Higher Education (grant number 3182) and by a Marie Curie International Reintegration Grant (MIRG 022374) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Asada H, 1999, J EXP MED, V189, P1383, DOI 10.1084/jem.189.9.1383; Balagopalan L, 2009, IMMUNOL REV, V232, P84, DOI 10.1111/j.1600-065X.2009.00840.x; Cao LG, 1998, J BIOL CHEM, V273, P21077, DOI 10.1074/jbc.273.33.21077; Castiglioni S, 2007, BIOCHEM BIOPH RES CO, V364, P534, DOI 10.1016/j.bbrc.2007.10.022; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Geisler C, 2004, CRIT REV IMMUNOL, V24, P67; Gingras MC, 2009, INT J DEV BIOL, V53, P1069, DOI 10.1387/ijdb.082820mg; Gingras MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005105; Gotoh N, 2008, CANCER SCI, V99, P1319, DOI 10.1111/j.1349-7006.2008.00840.x; Harkiolaki M, 2009, STRUCTURE, V17, P809, DOI 10.1016/j.str.2009.03.017; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Ichioka F, 2007, ARCH BIOCHEM BIOPHYS, V457, P142, DOI 10.1016/j.abb.2006.11.008; Jang IK, 2009, IMMUNOL REV, V232, P150, DOI 10.1111/j.1600-065X.2009.00842.x; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Johmura S, 2003, IMMUNITY, V18, P777, DOI 10.1016/S1074-7613(03)00139-0; Joneson T, 1997, J MOL MED-JMM, V75, P587, DOI 10.1007/s001090050143; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Katoh M, 2006, INT J ONCOL, V29, P163; Mariotti M, 2009, INT J BIOCHEM CELL B, V41, P687, DOI 10.1016/j.biocel.2008.08.005; Mariotti M, 2009, CANCER LETT, V273, P155, DOI 10.1016/j.canlet.2008.08.017; Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; REIF K, 1994, J BIOL CHEM, V269, P14081; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Stasyk T, 2007, MOL CELL PROTEOMICS, V6, P908, DOI 10.1074/mcp.M600463-MCP200; Stork B, 2004, IMMUNITY, V21, P681, DOI 10.1016/j.immuni.2004.09.007; Tanase Carmen-Alexandra, 2008, Romanian Journal of Biochemistry, V45, P169; Toyooka S, 2000, BIOCHEM BIOPH RES CO, V278, P671, DOI 10.1006/bbrc.2000.3870; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Yamazaki T, 2002, J CELL SCI, V115, P1791; Yankee TM, 2005, EUR J IMMUNOL, V35, P1184, DOI 10.1002/eji.200425507; Yankee TM, 2004, J IMMUNOL, V173, P1711, DOI 10.4049/jimmunol.173.3.1711; Yoder J, 2001, SCIENCE, V291, P1987, DOI 10.1126/science.1057176; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	37	9	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14339	10.1371/journal.pone.0014339	http://dx.doi.org/10.1371/journal.pone.0014339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179510	gold, Green Published, Green Submitted			2022-12-25	WOS:000285340000011
J	Bazazi, S; Ioannou, CC; Simpson, SJ; Sword, GA; Torney, CJ; Lorch, PD; Couzin, ID				Bazazi, Sepideh; Ioannou, Christos C.; Simpson, Stephen J.; Sword, Gregory A.; Torney, Colin J.; Lorch, Patrick D.; Couzin, Iain D.			The Social Context of Cannibalism in Migratory Bands of the Mormon Cricket	PLOS ONE			English	Article							PUBLIC INFORMATION; SELF-ORGANIZATION; FACILITATION; MOVEMENT; BEHAVIOR	Cannibalism has been shown to be important to the collective motion of mass migratory bands of insects, such as locusts and Mormon crickets. These mobile groups consist of millions of individuals and are highly destructive to vegetation. Individuals move in response to attacks from approaching conspecifics and bite those ahead, resulting in further movement and encounters with others. Despite the importance of cannibalism, the way in which individuals make attack decisions and how the social context affects these cannibalistic interactions is unknown. This can be understood by examining the decisions made by individuals in response to others. We performed a field investigation which shows that adult Mormon crickets were more likely to approach and attack a stationary cricket that was side-on to the flow than either head- or abdomen-on, suggesting that individuals could reduce their risk of an attack by aligning with neighbours. We found strong social effects on cannibalistic behaviour: encounters lasted longer, were more likely to result in an attack, and attacks were more likely to be successful if other individuals were present around a stationary individual. This local aggregation appears to be driven by positive feedback whereby the presence of individuals attracts others, which can lead to further crowding. This work improves our understanding of the local social dynamics driving migratory band formation, maintenance and movement at the population level.	[Bazazi, Sepideh] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Bazazi, Sepideh; Ioannou, Christos C.; Torney, Colin J.; Couzin, Iain D.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Simpson, Stephen J.; Sword, Gregory A.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Lorch, Patrick D.] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	University of Oxford; Princeton University; University of Sydney; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Bazazi, S (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	sbazazi@gmail.com	Couzin, Iain D./Q-6862-2018; Torney, Colin/C-6082-2015	Couzin, Iain D./0000-0001-8556-4558; Torney, Colin/0000-0003-1673-7835; Ioannou, Christos/0000-0002-9739-889X; Sword, Gregory/0000-0003-2094-2436; Simpson, Stephen J./0000-0003-0256-7687	Natural Environment Research Council; Princeton University; Searle Scholars Program [08-SPP-201]; National Science Foundation [PHY-0848755]; Office of Naval Research [N00014-09-1-1074]; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; Engineering and Physical Sciences Research Council; Australian Research Council Federation and Laureate Fellowships; Australian Research Council; Division Of Physics [0848755] Funding Source: National Science Foundation	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Princeton University(Princeton University); Searle Scholars Program; National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Australian Research Council Federation and Laureate Fellowships(Australian Research Council); Australian Research Council(Australian Research Council); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by Natural Environment Research Council (S.B.), Princeton University, Searle Scholars Program (08-SPP-201 to I.D.C), National Science Foundation (PHY-0848755 to I.D.C.), Office of Naval Research (N00014-09-1-1074 to I.D.C., C.C.I. and C.J.T.) a Defense Advanced Research Projects Agency Grant No. HR0011-05-1-0057 to Princeton University, the Engineering and Physical Sciences Research Council (I.D.C., S.J.S.), the Australian Research Council Federation and Laureate Fellowships (S.J.S.) and the Australian Research Council Discovery Scheme (S.J.S., G.A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; [Anonymous], 2020, ECONOMIST 0326; Baude M, 2008, ANIM BEHAV, V76, P1863, DOI 10.1016/j.anbehav.2008.08.010; BAZAZI S, 2010, P ROYAL SOC LONDON B; Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Bonnie KE, 2007, ANIM BEHAV, V74, P171, DOI 10.1016/j.anbehav.2006.12.009; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; BUHL J, BEHAV ECOLO IN PRESS; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Chittka L, 2005, CURR BIOL, V15, pR869, DOI 10.1016/j.cub.2005.10.018; Collett TS, 2002, CURR BIOL, V12, pR615, DOI 10.1016/S0960-9822(02)01132-6; Collins LM, 2007, J R SOC INTERFACE, V4, P65, DOI 10.1098/rsif.2006.0157; Coolen I, 2005, CURR BIOL, V15, P1931, DOI 10.1016/j.cub.2005.09.015; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; COWAN FT, 1929, TECH B USDA, V0161, P00001; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Danchin E., 2008, BEHAV ECOLOGY; DECASTRO JM, 1990, PHYSIOL BEHAV, V47, P1129, DOI 10.1016/0031-9384(90)90363-9; Elgar M., 1992, CANNIBALISM ECOLOGY, V1st; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Gwynne DT, 2001, CORNELL S ARTHR BIOL; Heyes G., 1996, SOCIAL LEARNING ANIM; Krause J, 2002, LIVING GROUPS; KURTA A, 1982, BIOTROPICA, V14, P132, DOI 10.2307/2387742; LAIDRE M, 2009, P ROYAL SOC LONDON B, V10; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lorch PD, 2005, ECOL ENTOMOL, V30, P548, DOI 10.1111/j.0307-6946.2005.00725.x; MacVean C.M., 1987, P116; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Simpson SJ, 2006, P NATL ACAD SCI USA, V103, P4152, DOI 10.1073/pnas.0508915103; Srygley RB, 2009, ECOL ENTOMOL, V34, P663, DOI 10.1111/j.1365-2311.2009.01117.x; SWEETING MP, 1985, J ANIM SCI, V60, P369, DOI 10.2527/jas1985.602369x; Sword GA, 2005, ANIM BEHAV, V69, P437, DOI 10.1016/j.anbehav.2004.04.016; Sword GA, 2005, NATURE, V433, P703, DOI 10.1038/433703a; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; WAKELAND CLAUDE, 1959, U S DEPT AGRIC TECH BULL, V1202, P1; Webster Sandra J., 2001, Animal Cognition, V4, P69, DOI 10.1007/s100710100108	44	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15118	10.1371/journal.pone.0015118	http://dx.doi.org/10.1371/journal.pone.0015118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179402	Green Published, gold, Green Submitted			2022-12-25	WOS:000285292500014
J	Blythe, MJ; Kao, D; Malla, S; Rowsell, J; Wilson, R; Evans, D; Jowett, J; Hall, A; Lemay, V; Lam, S; Aboobaker, AA				Blythe, Martin J.; Kao, Damian; Malla, Sunir; Rowsell, Joanna; Wilson, Ray; Evans, Deborah; Jowett, Jamie; Hall, Amy; Lemay, Virginie; Lam, Sabrina; Aboobaker, A. Aziz			A Dual Platform Approach to Transcript Discovery for the Planarian Schmidtea Mediterranea to Establish RNAseq for Stem Cell and Regeneration Biology	PLOS ONE			English	Article							FUNCTIONAL GENOMICS; MESSENGER-RNA; SELF-RENEWAL; GENE; PROTEIN; EXPRESSION; POLARITY; DATABASE; SEQ; MAINTENANCE	The use of planarians as a model system is expanding and the mechanisms that control planarian regeneration are being elucidated. The planarian Schmidtea mediterranea in particular has become a species of choice. Currently the planarian research community has access to this whole genome sequencing project and over 70,000 expressed sequence tags. However, the establishment of massively parallel sequencing technologies has provided the opportunity to define genetic content, and in particular transcriptomes, in unprecedented detail. Here we apply this approach to the planarian model system. We have sequenced, mapped and assembled 581,365 long and 507,719,814 short reads from RNA of intact and mixed stages of the first 7 days of planarian regeneration. We used an iterative mapping approach to identify and define de novo splice sites with short reads and increase confidence in our transcript predictions. We more than double the number of transcripts currently defined by publicly available ESTs, resulting in a collection of 25,053 transcripts described by combining platforms. We also demonstrate the utility of this collection for an RNAseq approach to identify potential transcripts that are enriched in neoblast stem cells and their progeny by comparing transcriptome wide expression levels between irradiated and intact planarians. Our experiments have defined an extensive planarian transcriptome that can be used as a template for RNAseq and can also help to annotate the S. mediterranea genome. We anticipate that suites of other 'omic approaches will also be facilitated by building on this comprehensive data set including RNAseq across many planarian regenerative stages, scenarios, tissues and phenotypes generated by RNAi.	[Blythe, Martin J.; Malla, Sunir; Rowsell, Joanna; Wilson, Ray; Aboobaker, A. Aziz] Univ Nottingham, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2RD, England; [Kao, Damian; Evans, Deborah; Jowett, Jamie; Hall, Amy; Lemay, Virginie; Lam, Sabrina; Aboobaker, A. Aziz] Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Evolutionary Dev Biol Lab, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Blythe, MJ (corresponding author), Univ Nottingham, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2RD, England.	Aziz.Aboobaker@nottingham.ac.uk		Moreton, Joanna/0000-0003-3193-1812; Aboobaker, Aziz/0000-0003-4902-5797	BBSRC; MRC; Biotechnology and Biological Sciences Research Council [BB/E01030X/1] Funding Source: researchfish; Medical Research Council [G0601133] Funding Source: researchfish; BBSRC [BB/E01030X/1] Funding Source: UKRI; MRC [G0601133] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by project grants from the BBSRC and MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000505; Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; CHANDEBOIS R, 1965, CR HEBD ACAD SCI, V260, P4834; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; Felix DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000915; Fernandez-Taboada E, 2010, DEVELOPMENT, V137, P1055, DOI 10.1242/dev.042564; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181; Kobayashi C, 2007, DEV BIOL, V306, P714, DOI 10.1016/j.ydbio.2007.04.010; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Molina MD, 2007, DEV BIOL, V311, P79, DOI 10.1016/j.ydbio.2007.08.019; Mollet IG, 2010, NUCLEIC ACIDS RES, V38, P4740, DOI 10.1093/nar/gkq197; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Orii H, 2005, DEV GENES EVOL, V215, P143, DOI 10.1007/s00427-004-0460-y; Oviedo NJ, 2007, DEVELOPMENT, V134, P3121, DOI 10.1242/dev.006635; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rossi L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r62; Salo E, 2006, BIOESSAYS, V28, P546, DOI 10.1002/bies.20416; Salvetti A, 2000, DEV DYNAM, V218, P603, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1016>3.0.CO;2-C; Salvetti A, 2005, DEVELOPMENT, V132, P1863, DOI 10.1242/dev.01785; Scimone ML, 2010, DEVELOPMENT, V137, P1231, DOI 10.1242/dev.042051; Solana J, 2009, DEV BIOL, V328, P410, DOI 10.1016/j.ydbio.2009.01.043; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang YY, 2007, P NATL ACAD SCI USA, V104, P5901, DOI 10.1073/pnas.0609708104; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102	62	53	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15617	10.1371/journal.pone.0015617	http://dx.doi.org/10.1371/journal.pone.0015617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179477	Green Submitted, gold, Green Published			2022-12-25	WOS:000285292500030
J	Hegeman, MA; Hennus, MP; van Meurs, M; Cobelens, PM; Kavelaars, A; Jansen, NJ; Schultz, MJ; van Vught, AJ; Molema, G; Heijnen, CJ				Hegeman, Maria A.; Hennus, Marije P.; van Meurs, Matijs; Cobelens, Pieter M.; Kavelaars, Annemieke; Jansen, Nicolaas J.; Schultz, Marcus J.; van Vught, Adrianus J.; Molema, Grietje; Heijnen, Cobi J.			Angiopoietin-1 Treatment Reduces Inflammation but Does Not Prevent Ventilator-Induced Lung Injury	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; MECHANICAL VENTILATION; MURINE MODEL; IN-VIVO; PERMEABILITY; PULMONARY; RATS; ACTIVATION; EXPRESSION; RESPONSES	Background: Loss of integrity of the epithelial and endothelial barriers is thought to be a prominent feature of ventilator-induced lung injury (VILI). Based on its function in vascular integrity, we hypothesize that the angiopoietin (Ang)-Tie2 system plays a role in the development of VILI. The present study was designed to examine the effects of mechanical ventilation on the Ang-Tie2 system in lung tissue. Moreover, we evaluated whether treatment with Ang-1, a Tie2 receptor agonist, protects against inflammation, vascular leakage and impaired gas exchange induced by mechanical ventilation. Methods: Mice were anesthetized, tracheotomized and mechanically ventilated for 5 hours with either an inspiratory pressure of 10 cmH(2)O ('low' tidal volume similar to 7.5 ml/kg; LVT) or 18 cmH(2)O ('high' tidal volume similar to 15 ml/kg; HVT). At initiation of HVT-ventilation, recombinant human Ang-1 was intravenously administered (1 or 4 mu g per animal). Non-ventilated mice served as controls. Results: HVT-ventilation influenced the Ang-Tie2 system in lungs of healthy mice since Ang-1, Ang-2 and Tie2 mRNA were decreased. Treatment with Ang-1 increased Akt-phosphorylation indicating Tie2 signaling. Ang-1 treatment reduced infiltration of granulocytes and expression of keratinocyte-derived chemokine (KC), macrophage inflammatory protein (MIP)-2, monocyte chemotactic protein (MCP)-1 and interleukin (IL)-1 beta caused by HVT-ventilation. Importantly, Ang-1 treatment did not prevent vascular leakage and impaired gas exchange in HVT-ventilated mice despite inhibition of inflammation, vascular endothelial growth factor (VEGF) and Ang-2 expression. Conclusions: Ang-1 treatment downregulates pulmonary inflammation, VEGF and Ang-2 expression but does not protect against vascular leakage and impaired gas exchange induced by HVT-ventilation.	[Hegeman, Maria A.; Cobelens, Pieter M.; Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Hegeman, Maria A.; Hennus, Marije P.; Jansen, Nicolaas J.; van Vught, Adrianus J.] Univ Med Ctr Utrecht, Dept Pediat Intens Care, Utrecht, Netherlands; [van Meurs, Matijs] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands; [van Meurs, Matijs; Molema, Grietje] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Med Biol, Groningen, Netherlands; [Cobelens, Pieter M.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Hegeman, MA (corresponding author), Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands.	c.heijnen@umcutrecht.nl	Hennus, Marije/D-1643-2014; Schultz, Marcus J/K-6147-2012; Schultz, Marcus/AAB-6379-2021	Schultz, Marcus/0000-0003-3969-7792; Molema, Grietje/0000-0002-4147-6676; Hennus, Marije/0000-0003-1508-0456	Catharijne Foundation, The Netherlands	Catharijne Foundation, The Netherlands(Netherlands Government)	This study was financially supported by the Catharijne Foundation, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Copland IB, 2004, AM J RESP CRIT CARE, V169, P739, DOI 10.1164/rccm.200310-1417OC; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; DREYFUSS D, 1985, AM REV RESPIR DIS, V132, P880; EGAN EA, 1982, J APPL PHYSIOL, V53, P121, DOI 10.1152/jappl.1982.53.1.121; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Haitsma JJ, 2003, CLIN PHYSIOL FUNCT I, V23, P349, DOI 10.1046/j.1475-0961.2003.00518.x; Hamanaka K, 2007, AM J PHYSIOL-LUNG C, V293, pL923, DOI 10.1152/ajplung.00221.2007; Hegeman MA, 2009, CRIT CARE, V13, DOI 10.1186/cc8168; Huang YQ, 2008, CRIT CARE MED, V36, P262, DOI 10.1097/01.CCM.0000297955.02633.A4; Karmpaliotis D, 2002, AM J PHYSIOL-LUNG C, V283, pL585, DOI 10.1152/ajplung.00048.2002; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Kuebler WM, 2003, AM J RESP CRIT CARE, V168, P1391, DOI 10.1164/rccm.200304-562OC; Lee KS, 2005, MOL PHARMACOL, V68, P1281, DOI 10.1124/mol.105.016055; Lemieux C, 2005, BLOOD, V105, P1523, DOI 10.1182/blood-2004-09-3531; McCarter SD, 2007, AM J RESP CRIT CARE, V175, P1014, DOI 10.1164/rccm.200609-1370OC; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nijboer CHA, 2007, J CEREBR BLOOD F MET, V27, P282, DOI 10.1038/sj.jcbfm.9600342; Nin N, 2008, INTENS CARE MED, V34, P948, DOI 10.1007/s00134-007-0959-6; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; PARKER JC, 1993, CRIT CARE MED, V21, P131, DOI 10.1097/00003246-199301000-00024; PARKER JC, 1984, J APPL PHYSIOL, V57, P1809, DOI 10.1152/jappl.1984.57.6.1809; Pugin J, 2003, CRIT CARE MED, V31, pS200, DOI 10.1097/01.CCM.0000057844.31307.ED; Simoes DCM, 2008, AM J RESP CRIT CARE, V177, P1314, DOI 10.1164/rccm.200708-1141OC; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Uhlig U, 2004, AM J RESP CRIT CARE, V169, P201, DOI 10.1164/rccm.200303-343OC; van der Heijden M, 2009, EXPERT OPIN THER TAR, V13, P39, DOI 10.1517/14728220802626256 ; van Meurs M, 2009, CRIT CARE, V13, DOI 10.1186/cc7153; Vreugdenhil HA, 2004, EUR RESPIR J, V23, P122, DOI 10.1183/09031936.03.00035003; Weppler A, 2008, EXP LUNG RES, V34, P425, DOI 10.1080/01902140802130105; Wilson MR, 2005, AM J PHYSIOL-LUNG C, V288, pL599, DOI 10.1152/ajplung.00304.2004; Wilson MR, 2003, J APPL PHYSIOL, V95, P1385, DOI 10.1152/japplphysiol.00213.2003; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; Wolthuis EK, 2009, SHOCK, V31, P262, DOI 10.1097/SHK.0b013e31817d42dd; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688	43	28	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15653	10.1371/journal.pone.0015653	http://dx.doi.org/10.1371/journal.pone.0015653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179479	Green Published, Green Submitted, gold			2022-12-25	WOS:000285292500033
J	Crawford, DC; Brown-Gentry, K; Rieder, MJ				Crawford, Dana C.; Brown-Gentry, Kristin; Rieder, Mark J.			VKORC1 Common Variation and Bone Mineral Density in the Third National Health and Nutrition Examination Survey	PLOS ONE			English	Article							K EPOXIDE REDUCTASE; SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; VITAMIN-K; OSTEOPOROSIS OUTCOMES; POSTMENOPAUSAL WOMEN; GENOTYPE-PHENOTYPE; GENDER SPECIFICITY; FEMORAL-NECK; US ADULTS	Osteoporosis, defined by low bone mineral density (BMD), is common among postmenopausal women. The distribution of BMD varies across populations and is shaped by both environmental and genetic factors. Because the candidate gene vitamin K epoxide reductase complex subunit 1 (VKORC1) generates vitamin K quinone, a cofactor for the gamma-carboxylation of bone-related proteins such as osteocalcin, we hypothesized that VKORC1 genetic variants may be associated with BMD and osteoporosis in the general population. To test this hypothesis, we genotyped six VKORC1 SNPs in 7,159 individuals from the Third National Health and Nutrition Examination Survey (NHANES III). NHANES III is a nationally representative sample linked to health and lifestyle variables including BMD, which was measured using dual energy x-ray absorptiometry (DEXA) on four regions of the proximal femur. In adjusted models stratified by race/ethnicity and sex, SNPs rs9923231 and rs9934438 were associated with increased BMD (p = 0.039 and 0.024, respectively) while rs8050894 was associated with decreased BMD (p = 0.016) among non-Hispanic black males (n = 619). VKORC1 rs2884737 was associated with decreased BMD among Mexican-American males (n = 795; p = 0.004). We then tested for associations between VKORC1 SNPs and osteoporosis, but the results did not mirror the associations observed between VKORC1 and BMD, possibly due to small numbers of cases. This is the first report of VKORC1 common genetic variation associated with BMD, and one of the few reports available that investigate the genetics of BMD and osteoporosis in diverse populations.	[Crawford, Dana C.; Brown-Gentry, Kristin] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Rieder, Mark J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Vanderbilt University; Vanderbilt University; University of Washington; University of Washington Seattle	Crawford, DC (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA.	crawford@chgr.mc.vanderbilt.edu	Crawford, Dana/C-1054-2012; Crawford, Dana/O-5578-2019	Crawford, Dana/0000-0002-6437-6248	NIH [NS053646, U01 HL065962]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053646] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by NIH grants NS053646 (MJR) and U01 HL065962. The funders (NIH) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NAT GENET, V41, P1199; Arden NK, 1996, J BONE MINER RES, V11, P530; Binkley N, 2007, J BONE MINER RES, V22, P695, DOI 10.1359/JBMR.070208; Brown LB, 2004, GENET EPIDEMIOL, V27, P153, DOI 10.1002/gepi.20009; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; CDC, 2002, FED REGISTER, V67, P51585; Centers for Disease Control and Prevention, 2006, FED REG, V71, P2248; Centers for Disease Control and Prevention, 2004, PLAN OP 3 NAT HLTH N; Centers for Disease Control and Prevention, 2007, FED REG, V72, P59094; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Crawford DC, 2007, PHARMACOGENOMICS, V8, P487, DOI 10.2217/14622416.8.5.487; Crosier MD, 2009, J NUTR SCI VITAMINOL, V55, P112, DOI 10.3177/jnsv.55.112; Duncan EL, 2003, J BONE MINER RES, V18, P1531, DOI 10.1359/jbmr.2003.18.8.1531; Guo Y, 2010, J BONE MINER RES, V25, P1042, DOI 10.1359/jbmr.091040; Howie BN, 2006, HUM GENET, V120, P58, DOI 10.1007/s00439-006-0182-5; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Iwamoto J, 2009, NUTR RES, V29, P221, DOI 10.1016/j.nutres.2009.03.012; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; KRALL EA, 1993, J BONE MINER RES, V8, P1; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Limdi NA, 2008, PHARMACOGENOMICS, V9, P1445, DOI 10.2217/14622416.9.10.1445; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Lohr LS, 1999, SAMPLING DESIGN ANAL; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Looker AC, 2010, J BONE MINER RES, V25, P64, DOI 10.1359/jbmr.090706; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Ng MYM, 2006, ANN HUM GENET, V70, P428, DOI 10.1111/j.1469-1809.2005.00242.x; Nimptsch K, 2009, BRIT J NUTR, V101, P1812, DOI 10.1017/S0007114508131750; Orwoll ES, 2001, J BONE MINER RES, V16, P1962, DOI 10.1359/jbmr.2001.16.11.1962; Peacock M, 2009, BONE, V45, P218, DOI 10.1016/j.bone.2009.04.236; Pearson DA, 2007, NUTR CLIN PRACT, V22, P517, DOI 10.1177/0115426507022005517; Ralston SH, 2006, PLOS MED, V3, P515, DOI 10.1371/journal.pmed.0030090; Rice TK, 2008, ADV GENET, V60, P293, DOI 10.1016/S0065-2660(07)00412-9; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Robitaille J, 2008, AM J PREV MED, V35, P47, DOI 10.1016/j.amepre.2008.03.027; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Sato Y, 1997, STROKE, V28, P2390, DOI 10.1161/01.STR.28.12.2390; Sato Y, 1999, AM J PHYS MED REHAB, V78, P317, DOI 10.1097/00002060-199907000-00005; Snelling AM, 2001, J WOMEN HEALTH GEN-B, V10, P57, DOI 10.1089/152460901750067124; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Videman T, 2007, J BONE MINER RES, V22, P1455, DOI 10.1359/JBMR.070606; Wang DX, 2008, BLOOD, V112, P1013, DOI 10.1182/blood-2008-03-144899; Wang XJ, 2007, J BONE MINER RES, V22, P527, DOI 10.1359/JBMR.070106; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; 2008, FED REG, V73, P51487	54	18	19	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15088	10.1371/journal.pone.0015088	http://dx.doi.org/10.1371/journal.pone.0015088			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179439	Green Submitted, Green Published, gold			2022-12-25	WOS:000285246900028
J	Saminathan, R; Bai, J; Sadrolodabaee, L; Karthik, GM; Singh, O; Subramaniyan, K; Ching, CB; Chen, WN; Chowbay, B				Saminathan, Ramasamy; Bai, Jing; Sadrolodabaee, Laleh; Karthik, Govindasamy Muralidharan; Singh, Onkar; Subramaniyan, Koilan; Ching, Chi Bun; Chen, Wei Ning; Chowbay, Balram			VKORC1 Pharmacogenetics and Pharmacoproteomics in Patients on Warfarin Anticoagulant Therapy: Transthyretin Precursor as a Potential Biomarker	PLOS ONE			English	Article							LC-MS/MS ANALYSIS; CYTOCHROME P4502C9; DOSE REQUIREMENTS; PROTEIN PROFILE; ASIAN PATIENTS; S-ENANTIOMERS; R-ENANTIOMERS; POLYMORPHISMS; CYP2C9; CELLS	Background: Recognizing specific protein changes in response to drug administration in humans has the potential for the development of personalized medicine. Such changes can be identified by pharmacoproteomics approach based on proteomic technologies. It can also be helpful in matching a particular target-based therapy to a particular marker in a subgroup of patients, in addition to the profile of genetic polymorphism. Warfarin is a commonly prescribed oral anticoagulant in patients with prosthetic valve disease, venous thromboembolism and stroke. Methods and Finding: We used a combined pharmacogenetics and iTRAQ-coupled LC-MS/MS pharmacoproteomics approach to analyze plasma protein profiles of 53 patients, and identified significantly upregulated level of transthyretin precursor in patients receiving low dose of warfarin but not in those on high dose of warfarin. In addition, real-time RT-PCR, western blotting, human IL-6 ELISA assay were done for the results validation. Conclusion: This combined pharmacogenomics and pharmacoproteomics approach may be applied for other target-based therapies, in matching a particular marker in a subgroup of patients, in addition to the profile of genetic polymorphism.	[Saminathan, Ramasamy; Karthik, Govindasamy Muralidharan; Singh, Onkar; Subramaniyan, Koilan; Chowbay, Balram] Natl Canc Ctr, Div Med Sci, Humphrey Oei Inst Canc Res, Lab Clin Pharmacol, Singapore, Singapore; [Bai, Jing; Sadrolodabaee, Laleh; Ching, Chi Bun; Chen, Wei Ning] Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Saminathan, R (corresponding author), Natl Canc Ctr, Div Med Sci, Humphrey Oei Inst Canc Res, Lab Clin Pharmacol, Singapore, Singapore.	WNChen@ntu.edu.sg; ctebal@nccs.com.sg	bai, jing/R-1506-2016	, Yang/0000-0002-6620-8897	National Medical Research Council [NMRC/EDG/0033/2008 and NMRCB1011]; SGH Research Fund [96/03]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SGH Research Fund	This work was supported by the National Medical Research Council grants (NMRC/EDG/0033/2008 and NMRCB1011) and the SGH Research Fund 96/03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absher RK, 2002, ANN PHARMACOTHER, V36, P1512, DOI 10.1345/aph.1C025; Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Anand SS, 1999, JAMA-J AM MED ASSOC, V282, P2058, DOI 10.1001/jama.282.21.2058; BARTALENA L, 1992, MOL ENDOCRINOL, V6, P935, DOI 10.1210/me.6.6.935; Beyth Rebecca J, 2002, Curr Hematol Rep, V1, P41; BRECKENRIDGE A, 1974, CLIN PHARMACOL THER, V15, P424; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Citarella F, 1997, BLOOD, V90, P1501, DOI 10.1182/blood.V90.4.1501.1501_1501_1507; FELDTRASMUSSEN U, 2007, THYROID HORMONE TRAN; Gan GG, 2003, INT J HEMATOL, V78, P84, DOI 10.1007/BF02983247; Kamali F, 2004, CLIN PHARMACOL THER, V75, P204, DOI 10.1016/j.clpt.2003.10.001; KAMALI F, ANN REV MED, P63; Kater AP, 2002, CLIN DIAGN LAB IMMUN, V9, P1396, DOI 10.1128/CDLI.9.6.1396-1397.2002; KUROHARA M, 2008, KOBE J MED SCI, V51, pE1; Lal S, 2008, BRIT J CLIN PHARMACO, V65, P260, DOI 10.1111/j.1365-2125.2007.03053.x; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Limdi NA, 2008, PHARMACOTHERAPY, V28, P1084, DOI 10.1592/phco.28.9.1084; Liu LY, 2007, CANCER SCI, V98, P1617, DOI 10.1111/j.1349-7006.2007.00576.x; Maclean PS, 2003, J THROMB HAEMOST, V1, P1838, DOI 10.1046/j.1538-7836.2003.t01-1-00372.x; Palha JA, 2002, CLIN CHEM LAB MED, V40, P1292, DOI 10.1515/CCLM.2002.223; Purkey HE, 2001, P NATL ACAD SCI USA, V98, P5566, DOI 10.1073/pnas.091431798; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Sandanaraj E, 2009, DRUG METAB PHARMACOK, V24, P365, DOI 10.2133/dmpk.24.365; Scordo MG, 2002, CLIN PHARMACOL THER, V72, P702, DOI 10.1067/mcp.2002.129321; Scordo MG, 2001, BRIT J CLIN PHARMACO, V52, P447, DOI 10.1046/j.0306-5251.2001.01460.x; SMITH P, 1990, NEW ENGL J MED, V323, P147, DOI 10.1056/NEJM199007193230302; Sui JJ, 2008, MOL CELL PROTEOMICS, V7, P1007, DOI 10.1074/mcp.M700485-MCP200; Sui JJ, 2007, J PROTEOME RES, V6, P1643, DOI 10.1021/pr0605926; Takahashi H, 2001, CLIN PHARMACOKINET, V40, P587, DOI 10.2165/00003088-200140080-00003; Taube J, 2000, BLOOD, V96, P1816, DOI 10.1182/blood.V96.5.1816.h8001816_1816_1819; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009; Yoon YR, 2001, BRIT J CLIN PHARMACO, V51, P277, DOI 10.1046/j.1365-2125.2001.00340.x; Zhang JH, 2008, PROTEOMICS, V8, P1595, DOI 10.1002/pmic.200700556; Zhao F, 2004, CLIN PHARMACOL THER, V76, P210, DOI 10.1016/j.clpt.2004.05.005	36	19	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15064	10.1371/journal.pone.0015064	http://dx.doi.org/10.1371/journal.pone.0015064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179214	Green Submitted, gold, Green Published			2022-12-25	WOS:000285246900027
J	Schauwecker, PE				Schauwecker, P. Elyse			Galanin Receptor 1 Deletion Exacerbates Hippocampal Neuronal Loss after Systemic Kainate Administration in Mice	PLOS ONE			English	Article							EXCITATORY AMINO-ACIDS; TEMPORAL-LOBE EPILEPSY; KAINIC ACID; CELL-DEATH; NEURODEGENERATIVE DISEASE; KINDLING EPILEPTOGENESIS; GENETIC DISSECTION; STATUS EPILEPTICUS; TYPE-2 RECEPTORS; SEIZURE ACTIVITY	Background: Galanin is a neuropeptide with a wide distribution in the central and peripheral nervous systems and whose physiological effects are mediated through three G protein-coupled receptor subtypes, GalR1, GalR2, and GalR3. Several lines of evidence indicate that galanin, as well as activation of the GalR1 receptor, is a potent and effective modulator of neuronal excitability in the hippocampus. Methodology/Principal Findings: In order to test more formally the potential influence of GalR1 on seizure-induced excitotoxic cell death, we conducted functional complementation tests in which transgenic mice that exhibit decreased expression of the GalR1 candidate mRNA underwent kainate-induced status epilepticus to determine if the quantitative trait of susceptibility to seizure-induced cell death is determined by the activity of GalR1. In the present study, we report that reduction of GalR1 mRNA via null mutation or injection of the GalR1 antagonist, galantide, prior to kainate-induced status epilepticus induces hippocampal damage in a mouse strain known to be highly resistant to kainate-induced neuronal injury. Wild-type and GalR1 knockout mice were subjected to systemic kainate administration. Seven days later, Nissl and NeuN immune-staining demonstrated that hippocampal cell death was significantly increased in GalR1 knockout strains and in animals injected with the GalR1 antagonist. Compared to GalR1-expressing mice, GalR1-deficient mice had significantly larger hippocampal lesions after status epilepticus. Conclusions/Significance: Our results suggest that a reduction of GalR1 expression in the C57BL/6J mouse strain renders them susceptible to excitotoxic injury following systemic kainate administration. From these results, GalR1 protein emerges as a new molecular target that may have a potential therapeutic value in modulating seizure-induced cell death.	Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University of Southern California	Schauwecker, PE (corresponding author), Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA.	schauwec@usc.edu			National Institutes of Health [NS38696]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS38696 to Paula Elyse Schauwecker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli T, 2002, J NEUROSCI RES, V70, P766, DOI 10.1002/jnr.10415; Babb T L, 1986, Adv Neurol, V44, P949; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BENARI Y, 1990, EUR J NEUROSCI, V2, P62, DOI 10.1111/j.1460-9568.1990.tb00381.x; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; BENARI Y, 1984, DEV BRAIN RES, V14, P284, DOI 10.1016/0165-3806(84)90314-6; Berkovic SF, 2006, TRENDS NEUROSCI, V29, P391, DOI 10.1016/j.tins.2006.05.009; Blumcke I, 2000, EPILEPSIA, V41, pS174, DOI 10.1111/j.1528-1157.2000.tb01577.x; Branchek TA, 2000, TRENDS PHARMACOL SCI, V21, P109, DOI 10.1016/S0165-6147(00)01446-2; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; COYLE JT, 1983, J NEUROCHEM, V41, P1; Crawley JN, 1996, LIFE SCI, V58, P2185, DOI 10.1016/0024-3205(96)00093-8; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Elliott-Hunt CR, 2007, J NEUROCHEM, V100, P780, DOI 10.1111/j.1471-4159.2006.04239.x; Elliott-Hunt CR, 2004, P NATL ACAD SCI USA, V101, P5105, DOI 10.1073/pnas.0304823101; Engel J Jr, 1989, Acta Neurochir Suppl (Wien), V46, P3; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Haberman RP, 2003, NAT MED, V9, P1076, DOI 10.1038/nm901; Holmes FE, 2000, P NATL ACAD SCI USA, V97, P11563, DOI 10.1073/pnas.210221897; Hwang IK, 2004, BRAIN RES, V1023, P193, DOI 10.1016/j.brainres.2004.07.023; Iismaa T P, 1999, Results Probl Cell Differ, V26, P257; Jacoby AS, 2002, MOL BRAIN RES, V107, P195, DOI 10.1016/S0169-328X(02)00451-5; Jayakar SS, 2004, INT J NEUROSCI, V114, P695, DOI 10.1080/00207450490430453; Jungnickel SRF, 2005, NEUROSCIENCE, V131, P407, DOI 10.1016/j.neuroscience.2004.11.023; Kalra SP, 1998, ANN NY ACAD SCI, V863, P236, DOI 10.1111/j.1749-6632.1998.tb10698.x; Kokaia M, 2001, P NATL ACAD SCI USA, V98, P14006, DOI 10.1073/pnas.231496298; Kong S, 2008, GENES BRAIN BEHAV, V7, P587, DOI 10.1111/j.1601-183X.2008.00395.x; Lang R, 2007, PHARMACOL THERAPEUT, V115, P177, DOI 10.1016/j.pharmthera.2007.05.009; Leibowitz SF, 2005, NEUROPEPTIDES, V39, P327, DOI 10.1016/j.npep.2004.12.022; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu HX, 2002, TRENDS PHARMACOL SCI, V23, P468, DOI 10.1016/S0165-6147(02)02074-6; Lorenzana A, 2007, EUR J NEUROSCI, V25, P1998, DOI 10.1111/j.1460-9568.2007.05443.x; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Lu Xiaoying, 2007, CNS & Neurological Disorders-Drug Targets, V6, P183, DOI 10.2174/187152707780619335; Mahoney SA, 2003, J NEUROSCI, V23, P416, DOI 10.1523/JNEUROSCI.23-02-00416.2003; Mattson MP, 1996, ADV NEUROL, V71, P1; Mazarati A, 2005, NEUROPEPTIDES, V39, P277, DOI 10.1016/j.npep.2004.12.003; Mazarati A, 2004, NEUROSCIENCE, V128, P431, DOI 10.1016/j.neuroscience.2004.06.052; Mazarati AM, 2000, J NEUROSCI, V20, P6276, DOI 10.1523/JNEUROSCI.20-16-06276.2000; Mazarati A, 2006, J PHARMACOL EXP THER, V318, P700, DOI 10.1124/jpet.106.104703; McLin JP, 2006, EUR J NEUROSCI, V24, P2191, DOI 10.1111/j.1460-9568.2006.05111.x; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NADLER JV, 1983, METHOD ENZYMOL, V103, P393; NADLER JV, 1980, BRAIN RES, V195, P47; NADLER JV, 1980, J COMP NEUROL, V192, P333, DOI 10.1002/cne.901920209; O'Meara G, 2000, P NATL ACAD SCI USA, V97, P11569, DOI 10.1073/pnas.210254597; Ogren SO, 2006, CNS DRUGS, V20, P633; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; Pirondi S, 2005, J NEUROCHEM, V95, P821, DOI 10.1111/j.1471-4159.2005.03437.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Rozen S, 2000, Methods Mol Biol, V132, P365; Santos JB, 2003, EPILEPSIA, V44, P995, DOI 10.1046/j.1528-1157.2003.66302.x; Schauwecker PE, 2000, EXP NEUROL, V161, P139, DOI 10.1006/exnr.1999.7251; Schauwecker PE, 2004, J COMP NEUROL, V477, P96, DOI 10.1002/cne.20245; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Sidman Richard L., 1971, ATLAS MOUSE BRAIN SP; Silva AP, 2003, NEUROPHARMACOLOGY, V44, P282, DOI 10.1016/S0028-3908(02)00382-9; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Tan NCK, 2006, CURR OPIN NEUROL, V19, P157, DOI 10.1097/01.wco.0000218232.66054.46; Upton N, 2003, CURR OPIN PHARMACOL, V3, P19, DOI 10.1016/S1471-4892(02)00010-3; Wiesenfeld-Hallin Z, 2001, EUR J PHARMACOL, V429, P49, DOI 10.1016/S0014-2999(01)01305-X; WOLF HK, 1993, J NEUROPATH EXP NEUR, V52, P499, DOI 10.1097/00005072-199309000-00008	69	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15657	10.1371/journal.pone.0015657	http://dx.doi.org/10.1371/journal.pone.0015657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179451	Green Published, gold, Green Submitted			2022-12-25	WOS:000285246900051
J	Schultz, O; Oberhauser, F; Saech, J; Rubbert-Roth, A; Hahn, M; Krone, W; Laudes, M				Schultz, Olaf; Oberhauser, Frank; Saech, Jasemine; Rubbert-Roth, Andrea; Hahn, Moritz; Krone, Wilhelm; Laudes, Matthias			Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ADIPOSE-TISSUE; ARTHRITIS; RECEPTOR; TOCILIZUMAB; EXPRESSION; RESISTANCE; IL-6; APOLIPOPROTEIN(A); METAANALYSIS	Background: Interleukin-6 (IL-6) is a pro-inflammatory cytokine that has been found to be increased in type 2 diabetic subjects. However, it still remains unclear if these elevated IL-6 levels are co-incidental or if this cytokine is causally related to the development of insulin resistance and type 2 diabetes in humans. Therefore, in the present study we examined insulin sensitivity, serum adipokine levels and lipid parameters in human subjects before and after treatment with the IL-6 receptor antibody Tocilizumab. Methodology/Principal Findings: 11 non-diabetic patients with rheumatoid disease were included in the study. HOMA-IR was calculated and serum levels for leptin, adiponectin, triglycerides, LDL-cholesterol, HDL-cholesterol and lipoprotein (a) (Lp (a)) were measured before as well as one and three months after Tocilizumab treatment. The HOMA index for insulin resistance decreased significantly. While leptin concentrations were not altered by inhibition of IL-6 signalling, adiponectin concentrations significantly increased. Thus the leptin to adiponectin ratio, a novel marker for insulin resistance, exhibited a significant decrease. Serum triglycerides, LDL-cholesterol and HDL-cholesterol tended to be increased whereas Lp (a) levels significantly decreased. Conclusions/Significance: Inhibition of IL-6 signalling improves insulin sensitivity in humans with immunological disease suggesting that elevated IL-6 levels in type 2 diabetic subjects might be causally involved in the pathogenesis of insulin resistance. Furthermore, our data indicate that inhibition of IL-6 signalling decreases Lp (a) serum levels, which might reduce the cardiovascular risk of human subjects.	[Schultz, Olaf; Oberhauser, Frank; Krone, Wilhelm; Laudes, Matthias] Univ Cologne, Dept Internal Med 2, Cologne, Germany; [Schultz, Olaf; Oberhauser, Frank; Krone, Wilhelm; Laudes, Matthias] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Saech, Jasemine; Rubbert-Roth, Andrea] Univ Cologne, Dept Internal Med 1, Cologne, Germany; [Hahn, Moritz] Univ Cologne, Inst Med Stat Informat & Epidemiol, Cologne, Germany; [Krone, Wilhelm] Univ Cologne, CECAD Cluster Excellence Cellular Stress Response, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Schultz, O (corresponding author), Univ Cologne, Dept Internal Med 2, Cologne, Germany.	matthias.laudes@uk-koeln.de	Laudes, Matthias/C-8885-2011		Chugai/Roche Pharmaceuticals	Chugai/Roche Pharmaceuticals(Roche Holding)	This study was supported by a grant from Chugai/Roche Pharmaceuticals to Matthias Laudes. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Dangas G, 1998, J AM COLL CARDIOL, V32, P2035, DOI 10.1016/S0735-1097(98)00469-0; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Glund S, 2008, ACTA PHYSIOL, V192, P37, DOI 10.1111/j.1748-1716.2007.01779.x; Golden SH, 2009, J CLIN ENDOCR METAB, V94, P1853, DOI 10.1210/jc.2008-2291; Hamid YH, 2005, DIABETOLOGIA, V48, P251, DOI 10.1007/s00125-004-1623-0; Huth C, 2006, DIABETES, V55, P2915, DOI 10.2337/db06-0600; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Katagiri H, 2007, CIRC RES, V101, P27, DOI 10.1161/CIRCRESAHA.107.151621; Kawashiri SY, 2009, RHEUMATOL INT; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lawn RM, 1996, CLIN GENET, V49, P167; Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Mertens M, 2009, J RHEUMATOL, V36, P1118, DOI 10.3899/jrheum.090074; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; OGATA A, 2010, ANN RHEUM DIS; Oldfield V, 2009, BIODRUGS, V23, P125, DOI 10.2165/00063030-200923020-00005; Patel AM, 2010, EXPERT REV CLIN IMMU, V6, P855, DOI 10.1586/ECI.10.69; Rieusset J, 2004, DIABETES, V53, P2232, DOI 10.2337/diabetes.53.9.2232; Rosenvinge A, 2007, SCAND J RHEUMATOL, V36, P91, DOI 10.1080/03009740601179605; SANGRAR W, 1995, BIOCHEMISTRY-US, V34, P5151, DOI 10.1021/bi00015a028; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; Siddiqui MAA, 2005, DRUGS, V65, P2179, DOI 10.2165/00003495-200565150-00014; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Takahashi M, 1996, HORM METAB RES, V28, P751, DOI 10.1055/s-2007-979893; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Voulgari PV, 2006, EXPERT OPIN BIOL TH, V6, P1349, DOI 10.1517/14712598.6.12.1349; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wiens A, 2009, SCAND J IMMUNOL, V70, P337, DOI 10.1111/j.1365-3083.2009.02296.x; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yamagishi S, 2006, MINI-REV MED CHEM, V6, P313, DOI 10.2174/138955706776073501; Yun KA, 2004, SCAND J CLIN LAB INV, V64, P223, DOI 10.1080/00365510410005749	44	155	167	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14328	10.1371/journal.pone.0014328	http://dx.doi.org/10.1371/journal.pone.0014328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179199	Green Submitted, Green Published, gold			2022-12-25	WOS:000285246900024
J	Manz, B; Gotz, V; Wunderlich, K; Eisel, J; Kirchmair, J; Stech, J; Stech, O; Chase, G; Frank, R; Schwemmle, M				Maenz, Benjamin; Goetz, Veronika; Wunderlich, Kerstin; Eisel, Jessica; Kirchmair, Johannes; Stech, Juergen; Stech, Olga; Chase, Geoffrey; Frank, Ronald; Schwemmle, Martin			Disruption of the Viral Polymerase Complex Assembly as a Novel Approach to Attenuate Influenza A Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; PANDEMIC INFLUENZA; H5N1 VIRUS; SUBUNIT; VACCINE; HEMAGGLUTININ; INTERFERON; ADAPTATION; TROPISM; BINDING	To develop a novel attenuation strategy applicable to all influenza A viruses, we targeted the highly conserved protein-protein interaction of the viral polymerase subunits PA and PB1. We postulated that impaired binding between PA and PB1 would negatively affect trimeric polymerase complex formation, leading to reduced viral replication efficiency in vivo. As proof of concept, we introduced single or multiple amino acid substitutions into the protein-protein-binding domains of either PB1 or PA, or both, to decrease binding affinity and polymerase activity substantially. As expected, upon generation of recombinant influenza A viruses (SC35M strain) containing these mutations, many pseudo-revertants appeared that partially restored PA-PB1 binding and polymerase activity. These polymerase assembly mutants displayed drastic attenuation in cell culture and mice. The attenuation of the polymerase assembly mutants was maintained in IFN alpha/beta receptor knock-out mice. As exemplified using a H5N1 polymerase assembly mutant, this attenuation strategy can be also applied to other highly pathogenic influenza A virus strains. Thus, we provide proof of principle that targeted mutation of the highly conserved interaction domains of PA and PB1 represents a novel strategy to attenuate influenza A viruses.	[Maenz, Benjamin; Goetz, Veronika; Wunderlich, Kerstin; Eisel, Jessica; Chase, Geoffrey; Schwemmle, Martin] Univ Freiburg, Dept Virol, D-79104 Freiburg, Germany; [Kirchmair, Johannes] Univ Innsbruck, Dept Pharmaceut Chem, A-6020 Innsbruck, Austria; [Stech, Juergen; Stech, Olga] Friedrich Loeffler Inst, D-17493 Greifswald, Germany; [Frank, Ronald] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	University of Freiburg; University of Innsbruck; Friedrich Loeffler Institute; Helmholtz Association; Helmholtz-Center for Infection Research	Schwemmle, M (corresponding author), Hermann Herder Str 11, D-79104 Freiburg, Germany.	martin.schwemmle@uniklinik-freiburg.de	Kirchmair, Johannes/J-1559-2012	Kirchmair, Johannes/0000-0003-2667-5877; Stech, Juergen/0000-0002-3187-702X	Deutsche Forschungsgemeinschaft (DFG); Bundesministerium fur Bildung und Forschung (BMBF, FluResearchNet); Excellence Initiative of the German Research Foundation (Spe-mann Graduate School) [GSC-4]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF, FluResearchNet)(Federal Ministry of Education & Research (BMBF)); Excellence Initiative of the German Research Foundation (Spe-mann Graduate School)	This study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Bundesministerium fur Bildung und Forschung (BMBF, FluResearchNet). This study was also supported by a grant from the Excellence Initiative of the German Research Foundation (GSC-4, Spe-mann Graduate School) (to K. W.).	Ambrose CS, 2008, INFLUENZA OTHER RESP, V2, P193, DOI 10.1111/j.1750-2659.2008.00056.x; Brownlee GG, 2002, J VIROL, V76, P7103, DOI 10.1128/JVI.76.14.7103-7113.2002; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Liu HX, 2010, MOL PHARMACEUT, V7, P75, DOI 10.1021/mp900131p; MAASSAB HF, 1967, NATURE, V213, P612, DOI 10.1038/213612a0; Manz B, 2010, J VIROL, V84, P8316, DOI 10.1128/JVI.00850-10; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; MUSTER T, 1991, P NATL ACAD SCI USA, V88, P5177, DOI 10.1073/pnas.88.12.5177; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Perales B, 1997, J VIROL, V71, P1381, DOI 10.1128/JVI.71.2.1381-1385.1997; PEREZ DR, 1995, J VIROL, V69, P6932; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Stech J, 2005, NAT MED, V11, P683, DOI 10.1038/nm1256; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Tumpey TM, 2009, ANNU REV MICROBIOL, V63, P79, DOI 10.1146/annurev.micro.091208.073359; Wunderlich K, 2010, J BIOL CHEM, V285, P16704, DOI 10.1074/jbc.M110.102533; Wunderlich K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007517	28	31	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8414	8424		10.1074/jbc.M110.205534	http://dx.doi.org/10.1074/jbc.M110.205534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21183679	Green Published, hybrid			2022-12-25	WOS:000288013300070
J	Brockmeyer, C; Paster, W; Pepper, D; Tan, CP; Trudgian, DC; McGowan, S; Fu, G; Gascoigne, NRJ; Acuto, O; Salek, M				Brockmeyer, Claudia; Paster, Wolfgang; Pepper, David; Tan, Choon P.; Trudgian, David C.; McGowan, Simon; Fu, Guo; Gascoigne, Nicholas R. J.; Acuto, Oreste; Salek, Mogjiborahman			T Cell Receptor (TCR)-induced Tyrosine Phosphorylation Dynamics Identifies THEMIS as a New TCR Signalosome Component	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAGE COMMITMENT; THYMOCYTE DEVELOPMENT; SIGNALING NETWORKS; HNRNP K; PROTEIN; FAMILY; ACTIVATION; SELECTION; EXPRESSION; KINASES	Stimulation of the T cell antigen receptor (TCR) induces formation of a phosphorylation-dependent signaling network via multiprotein complexes, whose compositions and dynamics are incompletely understood. Using stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics, we investigated the kinetics of signal propagation after TCR-induced protein tyrosine phosphorylation. We confidently assigned 77 proteins (of 758 identified) as a direct or indirect consequence of tyrosine phosphorylation that proceeds in successive "signaling waves" revealing the temporal pace at which tyrosine kinases activate cellular functions. The first wave includes thymocyte-expressed molecule involved in selection (THEMIS), a protein recently implicated in thymocyte development but whose signaling role is unclear. We found that tyrosine phosphorylation of THEMIS depends on the presence of the scaffold proteins Linker for activation of T cells (LAT) and SH2 domain-containing lymphocyte protein of 76 kDa (SLP-76). THEMIS associates with LAT, presumably via the adapter growth factor receptor-bound protein 2 (Grb2) and with phospholipase C gamma 1 (PLC-gamma 1). RNAi-mediated THEMIS knock-down inhibited TCR-induced IL-2 gene expression due to reduced ERK and nuclear factor of activated T cells (NFAT)/activator protein 1 (AP-1) signaling, whereas JNK, p38, or nuclear factor kappa B (NF-kappa B) activation were unaffected. Our study reveals the dynamics of TCR-dependent signaling networks and suggests a specific role for THEMIS in early TCR signalosome function.	[Brockmeyer, Claudia; Paster, Wolfgang; Pepper, David; Tan, Choon P.; Acuto, Oreste; Salek, Mogjiborahman] Univ Oxford, Sir William Dunn Sch Pathol, Cell Signalling Lab T, Oxford OX1 3RE, England; [Trudgian, David C.] Univ Oxford, Sir William Dunn Sch Pathol, Prote Facil, Oxford OX1 3RE, England; [McGowan, Simon] Univ Oxford, John Radcliffe Hosp, Computat Biol Res Grp, Oxford OX3 9DS, England; [Fu, Guo; Gascoigne, Nicholas R. J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Oxford; University of Oxford; University of Oxford; Scripps Research Institute	Acuto, O (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Cell Signalling Lab T, S Parks Rd, Oxford OX1 3RE, England.	oreste.acuto@path.ox.ac.uk; mogjib.salek@path.ox.ac.uk	Trudgian, David/D-4785-2012	Trudgian, David/0000-0002-7084-6787; McGowan, Simon/0000-0001-9720-1914; Salek, Mogjiborahman/0000-0002-6664-4752; Paster, Wolfgang/0000-0002-5537-2886	Wellcome Trust [GR076558MA]; EU-FP7 [201106]; Lincoln College, University of Oxford; Austrian Science Fund (FWF)	Wellcome Trust(Wellcome TrustEuropean Commission); EU-FP7(European Commission); Lincoln College, University of Oxford; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Wellcome Trust Grant GR076558MA and EU-FP7 "Sybilla" Grant 201106 (to O. A.).; Supported in part by a Sloane Robinson Graduate Award from Lincoln College, University of Oxford.; Supported by the Erwin Schrodinger Fellowship from the Austrian Science Fund (FWF).	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Adachi S, 2002, CELL IMMUNOL, V215, P45, DOI 10.1016/S0008-8749(02)00012-6; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Busa R, 2010, NUCLEIC ACIDS RES, V38, P3005, DOI 10.1093/nar/gkq004; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Elias JE, 2004, NAT BIOTECHNOL, V22, P214, DOI 10.1038/nbt930; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Fusaki N, 1997, J BIOL CHEM, V272, P6214, DOI 10.1074/jbc.272.10.6214; Gao J, 2003, J PROTEOME RES, V2, P643, DOI 10.1021/pr034038x; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Hu QZ, 2005, J MASS SPECTROM, V40, P430, DOI 10.1002/jms.856; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Kaye J, 2000, IMMUNOL RES, V21, P71, DOI 10.1385/IR:21:2-3:71; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Liu HB, 2010, P NATL ACAD SCI USA, V107, P10166, DOI 10.1073/pnas.0909112107; Lucas JA, 2007, J IMMUNOL, V179, P7561, DOI 10.4049/jimmunol.179.11.7561; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Makarov A, 2000, ANAL CHEM, V72, P1156, DOI 10.1021/ac991131p; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Naarmann IS, 2008, J BIOL CHEM, V283, P18461, DOI 10.1074/jbc.M710328200; Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Singer A, 2004, ADV IMMUNOL, V83, P91; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Wilkinson B, 2001, CELL IMMUNOL, V211, P86, DOI 10.1006/cimm.2001.1827; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yamada M, 2002, MOL CELL BIOL, V22, P8648, DOI 10.1128/MCB.22.24.8648-8658.2002; Yokoyama N, 2005, BIOCHEMISTRY-US, V44, P8841, DOI 10.1021/bi0500832; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x	66	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7535	7547		10.1074/jbc.M110.201236	http://dx.doi.org/10.1074/jbc.M110.201236			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189249	Green Published, hybrid			2022-12-25	WOS:000287737300067
J	Guadall, A; Orriols, M; Rodriguez-Calvo, R; Calvayrac, O; Crespo, J; Aledo, R; Martinez-Gonzalez, J; Rodriguez, C				Guadall, Anna; Orriols, Mar; Rodriguez-Calvo, Ricardo; Calvayrac, Olivier; Crespo, Javier; Aledo, Rosa; Martinez-Gonzalez, Jose; Rodriguez, Cristina			Fibulin-5 Is Up-regulated by Hypoxia in Endothelial Cells through a Hypoxia-inducible Factor-1 (HIF-1 alpha)-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ELASTIC FIBER FORMATION; LYSYL OXIDASE LOX; ALPHA-5 INTEGRIN; BINDING-PROTEIN; DOWN-REGULATION; FACTOR 1-ALPHA; TUMOR-GROWTH; CUTIS LAXA; TGF-BETA	Hypoxia modulates gene expression and affects multiple aspects of endothelial cell biology. Fibulin-5 (FBLN5) is an extracellular matrix protein essential for elastic fiber assembly and vasculogenesis that participates in vascular remodeling and controls endothelial cell adhesion, motility, and proliferation. In this context, we aimed to analyze FBLN5 regulation by hypoxia in endothelial cells. Hypoxia (1% O-2) increased FBLN5 mRNA levels in endothelial cells in a time-dependent manner. Maximal induction (similar to 2.5-fold) was achieved after 24 h of hypoxia. This effect paralleled an increase in both intracellular and extracellular FBLN5 protein levels. The increase in FBLN5 mRNA levels observed in hypoxic cells was blocked by inhibitors of the PI3K/Akt/mTOR pathway (LY294002 and rapamycin) and mimicked by dimethyl oxal glycine, which prevents proline hydroxylase-mediated degradation of HIF-1 alpha. Silencing of HIF-1 alpha completely prevented hypoxia-induced FBLN5 up-regulation. Accordingly, both hypoxia and HIF-1 alpha overexpression increased FBLN5 transcriptional activity. Serial promoter deletion and mutagenesis studies revealed the involvement of a putative hypoxia response element (HRE) located at -78 bp. In fact, EMSA and ChIP assays demonstrated increased HIF-1 binding to this site in hypoxic cells. Interestingly, the rate of endothelial cells undergoing apoptosis in cultures exposed to hypoxia increased in FBLN5 knockdown cells, suggesting that hypoxia-induced FBLN5 expression contributes to preserve cell survival. These results provide evidence that HIF-1 signaling underlies the increase of FBLN5 expression elicited by hypoxia in endothelial cells and suggest that FBLN5 induction could be involved in the adaptive survival response of endothelial cells to hypoxia.	[Guadall, Anna; Orriols, Mar; Rodriguez-Calvo, Ricardo; Calvayrac, Olivier; Crespo, Javier; Aledo, Rosa; Martinez-Gonzalez, Jose; Rodriguez, Cristina] Hosp Santa Creu & Sant Pau, Ctr Invest Cardiovasc, CSIC, Inst Catala Ciencies Cardiovasc,Inst Invest Biome, Barcelona 08025, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Rodriguez, C (corresponding author), Hosp Santa Creu & St Pau Pabellon 11, Ctr Invest Cardiovasc, CSIC, Inst Catala Ciencies Cardiovasc, St Antoni Maria Claret 167, Barcelona 08025, Spain.	crodriguezs@csic-iccc.org	Rodriguez-Calvo, Ricardo/AAB-4054-2019; Calvayrac, Olivier/A-7145-2016; Guadall, Anna/AAG-1691-2019; Guadall, Anna/I-1709-2014; Rodriguez, Cristina/D-3099-2011; Rodriguez-Calvo, Ricardo/R-6645-2018	Rodriguez-Calvo, Ricardo/0000-0001-7513-0983; Calvayrac, Olivier/0000-0002-0908-8323; Guadall, Anna/0000-0002-7821-8582; Guadall, Anna/0000-0002-7821-8582; Rodriguez, Cristina/0000-0002-6472-5647; Rodriguez-Calvo, Ricardo/0000-0001-7513-0983; Martinez-Gonzalez, Jose/0000-0002-3894-7166	Ministerio de Ciencia e Innovacion-Instituto de Salud Carlos III [PS09/01797, SAF2009-11949, RD06/0014/0027]; Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias	Ministerio de Ciencia e Innovacion-Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported in part by Grants PS09/01797 and SAF2009-11949 and Red Tematica de Investigacion Cardiovascular (RD06/0014/0027) from the Ministerio de Ciencia e Innovacion-Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias).; Supported by a fellowship from Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias.; Supported by the Ministerio de Ciencia e Innovacion (Juan de la Cierva program).	Abedin SA, 2009, CARCINOGENESIS, V30, P449, DOI 10.1093/carcin/bgp005; Albig Allan R, 2005, Future Oncol, V1, P23, DOI 10.1517/14796694.1.1.23; Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Albig AR, 2004, DNA CELL BIOL, V23, P367, DOI 10.1089/104454904323145254; Alvarez-Tejado M, 2001, J BIOL CHEM, V276, P22368, DOI 10.1074/jbc.M011688200; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Gonzalez-Diez M, 2008, THROMB HAEMOSTASIS, V100, P119, DOI 10.1160/TH07-11-0675; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jean JC, 2002, AM J PHYSIOL-LUNG C, V282, pL75, DOI 10.1152/ajplung.2002.282.1.L75; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; Kuang PP, 2006, AM J PHYSIOL-CELL PH, V291, pC1412, DOI 10.1152/ajpcell.00087.2006; Kuang PP, 2003, AM J PHYSIOL-LUNG C, V285, pL1147, DOI 10.1152/ajplung.00098.2003; Lee MJ, 2004, J AM COLL SURGEONS, V199, P403, DOI 10.1016/j.jamcollsurg.2004.04.021; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; Luo YX, 2006, MOL PHARMACOL, V69, P1953, DOI 10.1124/mol.105.017905; Madge LA, 2000, J BIOL CHEM, V275, P15458, DOI 10.1074/jbc.M001237200; Martinez-Gonzalez J, 2004, ATHEROSCLEROSIS, V174, P305, DOI 10.1016/j.atherosclerosis.2004.01.037; Martinez-Gonzalez J, 2008, J NUTR, V138, P443, DOI 10.1093/jn/138.3.443; Martorell L, 2007, J THROMB HAEMOST, V5, P1766, DOI 10.1111/j.1538-7836.2007.02627.x; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB; Nonaka R, 2009, CLIN BIOCHEM, V42, P713, DOI 10.1016/j.clinbiochem.2008.12.020; Orbe J, 2009, ARTERIOSCL THROM VAS, V29, P2109, DOI 10.1161/ATVBAHA.109.194589; Preis M, 2006, BIOCHEM BIOPH RES CO, V348, P1024, DOI 10.1016/j.bbrc.2006.07.156; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Raposo B, 2004, ATHEROSCLEROSIS, V177, P1, DOI 10.1016/j.atherosclerosis.2004.06.015; Rius J, 2006, ATHEROSCLEROSIS, V184, P276, DOI 10.1016/j.atherosclerosis.2005.04.008; Rodriguez C, 2008, ATHEROSCLEROSIS, V196, P558, DOI 10.1016/j.atherosclerosis.2007.06.002; Rodriguez C, 2003, CARDIOVASC RES, V58, P178, DOI 10.1016/S0008-6363(02)00856-8; Rodriguez C, 2009, CARDIOVASC RES, V83, P595, DOI 10.1093/cvr/cvp136; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; Ryu MH, 2010, BIOCHEM BIOPH RES CO, V393, P11, DOI 10.1016/j.bbrc.2010.01.060; Safran M, 2003, J CLIN INVEST, V111, P779, DOI 10.1172/JCI200318181; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Schluterman MK, 2010, DIS MODEL MECH, V3, P333, DOI 10.1242/dmm.003707; Semenza GL, 2000, J CLIN INVEST, V106, P809, DOI 10.1172/JCI11223; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Soderberg MW, 2009, MOL HUM REPROD, V15, P251, DOI 10.1093/molehr/gap011; Spencer JA, 2005, P NATL ACAD SCI USA, V102, P2946, DOI 10.1073/pnas.0500058102; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Sullivan KM, 2007, LAB INVEST, V87, P818, DOI 10.1038/labinvest.3700594; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Walton HL, 2000, J CELL BIOCHEM, V78, P674, DOI 10.1002/1097-4644(20000915)78:4<674::AID-JCB16>3.0.CO;2-G; Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629; Zhou SM, 2010, BIOCHEM BIOPH RES CO, V398, P247, DOI 10.1016/j.bbrc.2010.06.068	62	51	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7093	7103		10.1074/jbc.M110.162917	http://dx.doi.org/10.1074/jbc.M110.162917			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193390	Green Published, hybrid			2022-12-25	WOS:000287737300026
J	Yang, MT; Chang, CH; Wang, JM; Wu, TK; Wang, YK; Chang, CY; Li, TT				Yang, Ming-Te; Chang, Cheng-Hsiang; Wang, Jiou Ming; Wu, Tung Kung; Wang, Yu-Kuo; Chang, Chin-Yuan; Li, TienHsiung Thomas			Crystal Structure and Inhibition Studies of Transglutaminase from Streptomyces mobaraense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CROSS-LINKING; MICROBIAL TRANSGLUTAMINASE; STREPTOVERTICILLIUM-MOBARAENSE; SUBSTRATE SPECIFICITIES; GUINEA-PIG; PURIFICATION; PEPTIDES; ENZYMES	The crystal structure of the microbial transglutaminase (MTGase) zymogen from Streptomyces mobaraense has been determined at 1.9-angstrom resolution using the molecular replacement method based on the crystal structure of the mature MTGase. The overall structure of this zymogen is similar to that of the mature form, consisting of a single disk-like domain with a deep active cleft at the edge of the molecule. A major portion of the prosequence (45 additional amino acid residues at the N terminus of the mature transglutaminase) folds into an L-shaped structure, consisting of an extended N-terminal segment linked with a one-turn short helix and a long alpha-helix. Two key residues in the short helix of the prosequence, Tyr-12 and Tyr-16, are located on top of the catalytic triad (Cys-110, Asp-301, and His-320) to block access of the substrate acyl donors and acceptors. Biochemical characterization of the mature MTGase, using N-alpha-benzyloxycarbonyl-L-glutaminylglycine as a substrate, revealed apparent K-m and k(cat)/K-m values of 52.66 mM and 40.42 mM(-1) min(-1), respectively. Inhibition studies using the partial prosequence SYAETYR and homologous sequence SQAETYR showed a noncompetitive inhibition mechanism with IC50 values of 0.75 and 0.65 mM, respectively, but no cross-linking product formation. Nevertheless, the prosequence homologous oligopeptide SQAETQR, with Tyr-12 and Tyr-16 each replaced with Gln, exhibited inhibitory activity with the formation of the SQAETQR-monodansylcadaverine fluorophore cross-linking product (SQAETQR-C-DNS). MALDI-TOF tandem MS analysis of SQAETQR-C-DNS revealed molecular masses corresponding to those of (N)SQAETQ(C)-C-DNS and C-DNS-(N)QR(C) sequences, suggesting the incorporation of C-DNS onto the C-terminal Gln residue of the prosequence homologous oligopeptide. These results support the putative functional roles of both Tyr residues in substrate binding and inhibition.	[Wang, Jiou Ming; Li, TienHsiung Thomas] Natl Chung Hsing Univ, Grad Inst Biochem, Taichung 40227, Taiwan; [Yang, Ming-Te] Natl Chung Hsing Univ, Grad Inst Mol Biol, Taichung 40227, Taiwan; [Chang, Cheng-Hsiang; Wu, Tung Kung; Wang, Yu-Kuo; Chang, Chin-Yuan] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30010, Taiwan	National Chung Hsing University; National Chung Hsing University; National Yang Ming Chiao Tung University	Li, TT (corresponding author), Natl Chung Hsing Univ, Grad Inst Biochem, Taichung 40227, Taiwan.	lithomas@dragon.nchu.edu.tw	Chang, Chin-Yuan/AAM-5863-2021; Yang, Ming-Te/B-5626-2017	Chang, Chin-Yuan/0000-0001-7314-3967; Yang, Ming-Te/0000-0002-7644-0964	Institute of Biochemistry, National Chung Hsing University; Ministry of Education; National Chiao Tung University; National Science Council of the Republic of China [NSC 99-2113-M-009-004-MY2]	Institute of Biochemistry, National Chung Hsing University; Ministry of Education; National Chiao Tung University; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by intramural funding from the Institute of Biochemistry, National Chung Hsing University, and by the Ministry of Education Aiming for Top University Plan, the National Chiao Tung University, and National Science Council of the Republic of China Contract NSC 99-2113-M-009-004-MY2.	AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Ahvazi B, 2002, EMBO J, V21, P2055, DOI 10.1093/emboj/21.9.2055; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; CHUNG SI, 1972, P NATL ACAD SCI USA, V69, P303, DOI 10.1073/pnas.69.2.303; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; FOLK JE, 1966, J BIOL CHEM, V241, P5518; Hemung BO, 2008, J AGR FOOD CHEM, V56, P7510, DOI 10.1021/jf800856g; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kashiwagi T, 2002, J BIOL CHEM, V277, P44252, DOI 10.1074/jbc.M203933200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LORAND L, 1987, BIOCHEMISTRY-US, V26, P308, DOI 10.1021/bi00375a043; Melino G, 1998, Results Probl Cell Differ, V24, P175; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohtsuka T, 2001, J FOOD SCI, V66, P25, DOI 10.1111/j.1365-2621.2001.tb15576.x; Ohtsuka T, 2000, BIOSCI BIOTECH BIOCH, V64, P2608, DOI 10.1271/bbb.64.2608; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; Pasternack R, 1997, ANAL BIOCHEM, V249, P54, DOI 10.1006/abio.1997.2139; Serafini-Fracassini D, 2008, ANN BOT-LONDON, V102, P145, DOI 10.1093/aob/mcn075; Shimba N, 2002, J AGR FOOD CHEM, V50, P1330, DOI 10.1021/jf010995k; Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5; Zhu Y, 2008, TRENDS BIOTECHNOL, V26, P559, DOI 10.1016/j.tibtech.2008.06.006	21	37	43	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7301	7307		10.1074/jbc.M110.203315	http://dx.doi.org/10.1074/jbc.M110.203315			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193394	hybrid, Green Published			2022-12-25	WOS:000287737300046
J	Chopra, P; Lee, J; Kang, J; Lee, S				Chopra, Pankaj; Lee, Jinseung; Kang, Jaewoo; Lee, Sunwon			Improving Cancer Classification Accuracy Using Gene Pairs	PLOS ONE			English	Article							MICROARRAY DATA; EXPRESSION; TUMOR; PREDICTION; DIAGNOSIS; SELECTION; PATTERNS	Recent studies suggest that the deregulation of pathways, rather than individual genes, may be critical in triggering carcinogenesis. The pathway deregulation is often caused by the simultaneous deregulation of more than one gene in the pathway. This suggests that robust gene pair combinations may exploit the underlying bio-molecular reactions that are relevant to the pathway deregulation and thus they could provide better biomarkers for cancer, as compared to individual genes. In order to validate this hypothesis, in this paper, we used gene pair combinations, called doublets, as input to the cancer classification algorithms, instead of the original expression values, and we showed that the classification accuracy was consistently improved across different datasets and classification algorithms. We validated the proposed approach using nine cancer datasets and five classification algorithms including Prediction Analysis for Microarrays (PAM), C4.5 Decision Trees (DT), Naive Bayesian (NB), Support Vector Machine (SVM), and k-Nearest Neighbor (k-NN).	[Chopra, Pankaj] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Lee, Jinseung; Kang, Jaewoo; Lee, Sunwon] Korea Univ, Coll Informat & Commun, Dept Comp Sci & Engn, Seoul, South Korea; [Kang, Jaewoo] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea	Emory University; Korea University; Korea University; Korea University Medicine (KU Medicine)	Chopra, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	kangj@korea.ac.kr			Korean government (MEST) [2010-0015713, 2009-0086140, R01-2008-000-20564-0]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Second Brain Korea 21 Project Grant, a Microsoft Research Asia Grant, a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2010-0015713, 2009-0086140), and a Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (MEST) (R01-2008-000-20564-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Chopra P, 2009, WASH DC US P IEEE IN; Chopra P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-92; Dettling M, 2003, BIOINFORMATICS, V19, P1061, DOI 10.1093/bioinformatics/btf867; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Geman D., 2004, STAT APPL GENET MOL, V3, P1, DOI [10.2202/1544-6115.1071, DOI 10.2202/1544-6115.1071]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon GJ, 2002, CANCER RES, V62, P4963; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hall M, 2009, SIGKDD EXPLORATIONS, P2; Kang JW, 2005, LECT NOTES COMPUT SC, V3615, P105; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lin KM, 2009, INT J DATA MIN BIOIN, V3, P3, DOI 10.1504/IJDMB.2009.023881; Liu J, 2008, BIOINFORMATICS, V24, pI86, DOI 10.1093/bioinformatics/btn145; Mramor M, 2007, BIOINFORMATICS, V23, P2147, DOI 10.1093/bioinformatics/btm312; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Quinlan J. R., 1993, C4 5 PROGRAM MACHINE; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ripley B. D., 1996, PATTERN RECOGNITION; Rogers MF, 2009, BIOINFORMATICS, V25, P1173, DOI 10.1093/bioinformatics/btp122; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Welsh JB, 2001, CANCER RES, V61, P5974; Yoon S, 2010, SOFT COMPUT, V14, P151, DOI 10.1007/s00500-009-0437-x; Zhou XHJ, 2005, NAT BIOTECHNOL, V23, P238, DOI 10.1038/nbt1058	31	66	66	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14305	10.1371/journal.pone.0014305	http://dx.doi.org/10.1371/journal.pone.0014305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200431	gold, Green Published, Green Submitted			2022-12-25	WOS:000285576900002
J	Galpaz, N; Reymond, M				Galpaz, Navot; Reymond, Matthieu			Natural Variation in Arabidopsis thaliana Revealed a Genetic Network Controlling Germination Under Salt Stress	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SEED-GERMINATION; CROSS-TALK; TOLERANCE; POPULATIONS; ADAPTATION; DROUGHT; SHAPE; COLD; QTLS	Plant responses to environmental stresses are polygenic and complex traits. In this study quantitative genetics using natural variation in Arabidopsis thaliana was used to investigate the genetic architecture of plant responses to salt stress. Eighty seven A. thaliana accessions were screened and showed a large variation for root development and seed germination under 125 and 200 mM NaCl, respectively. Twenty two quantitative trait loci for these traits have been detected by phenotyping two recombinants inbred line populations, Sha x Col and Sha x Ler. Four QTLs controlling germination under salt were detected in the Sha x Col population. Interestingly, only one allelic combination at these four QTLs inhibits germination under salt stress, implying strong epistatic interactions between them. In this interacting context, we confirmed the effect of one QTL by phenotyping selected heterozygous inbred families. We also showed that this QTL is involved in the control of germination under other stress conditions such as KCl, mannitol, cold, glucose and ABA. Our data highlights the presence of a genetic network which consists of four interacting QTLs and controls germination under limiting environmental conditions.	[Galpaz, Navot; Reymond, Matthieu] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Reymond, Matthieu] INRA Ctr Versailles Grignon, INRA AgroParisTech, UMR1318, Inst Jean Pierre Bourgin, Versailles, France	Max Planck Society; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Galpaz, N (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany.	matthieu.reymond@versailles.inra.fr			ARABRAS [ERAPG-003-03]; Max Planck Society; Minerva Fellowship Program; Alexander Von Humboldt Research Fellowship	ARABRAS; Max Planck Society(Max Planck SocietyFoundation CELLEX); Minerva Fellowship Program; Alexander Von Humboldt Research Fellowship(Alexander von Humboldt Foundation)	Funding was provided by the ARABRAS program (ERAPG-003-03) and by the Max Planck Society. N.G. acknowledges support from the Minerva Fellowship Program and Alexander Von Humboldt Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Clerkx EJM, 2004, PLANT PHYSIOL, V135, P432, DOI 10.1104/pp.103.036814; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Foolad Majid R, 2007, Int J Plant Genomics, V2007, P97386, DOI [10.1155/2007/64358, 10.1155/2007/97386]; Foolad MR, 1999, PLANT BREEDING, V118, P167, DOI 10.1046/j.1439-0523.1999.118002167.x; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; Jang JY, 2008, J INTEGR PLANT BIOL, V50, P593, DOI 10.1111/j.1744-7909.2008.00650.x; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; JOHNSON DW, 1992, THEOR APPL GENET, V83, P833, DOI 10.1007/BF00226705; Joosen RVL, 2010, PLANT J, V62, P148, DOI 10.1111/j.1365-313X.2009.04116.x; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; LEE BH, 2010, COLD SPRING HARB PRO; Lefebvre V, 2009, INT J MOL SCI, V10, P3547, DOI 10.3390/ijms10083547; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Quesada V, 2002, PLANT PHYSIOL, V130, P951, DOI 10.1104/pp.006536; Ren ZH, 2010, P NATL ACAD SCI USA, V107, P5669, DOI 10.1073/pnas.0910798107; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Rowe HC, 2008, GENETICS, V180, P2237, DOI 10.1534/genetics.108.091439; Rus A, 2001, P NATL ACAD SCI USA, V98, P14150, DOI 10.1073/pnas.241501798; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	41	35	35	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15198	10.1371/journal.pone.0015198	http://dx.doi.org/10.1371/journal.pone.0015198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188145	Green Published, gold			2022-12-25	WOS:000285575200021
J	Han, HE; Sellamuthu, S; Shin, BH; Lee, YJ; Song, S; Seo, JS; Baek, IS; Bae, J; Kim, H; Yoo, YJ; Jung, YK; Song, WK; Han, PL; Park, WJ				Han, Hye-Eun; Sellamuthu, Saravanan; Shin, Bae Hyun; Lee, Yong Jae; Song, Sungmin; Seo, Ji-Seon; Baek, In-Sun; Bae, Jeomil; Kim, Hannah; Yoo, Yung Joon; Jung, Yong-Keun; Song, Woo Keun; Han, Pyung-Lim; Park, Woo Jin			The Nuclear Inclusion a (NIa) Protease of Turnip Mosaic Virus (TuMV) Cleaves Amyloid-beta	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; PLAQUE-FORMATION; IN-VITRO; COGNITIVE DEFICITS; PRECURSOR PROTEIN; DOWN-SYNDROME; ACCUMULATION; NEPRILYSIN	Background: The nuclear inclusion a (NIa) protease of turnip mosaic virus (TuMV) is responsible for the processing of the viral polyprotein into functional proteins. NIa was previously shown to possess a relatively strict substrate specificity with a preference for Val-Xaa-His-Gln down arrow, with the scissile bond located after Gln. The presence of the same consensus sequence, Val(12)-His-His-Gln(15), near the presumptive alpha-secretase cleavage site of the amyloid-beta (A beta) peptide led us to hypothesize that NIa could possess activity against A beta. Methodology/Principal Findings: Western blotting results showed that oligomeric as well as monomeric forms of A beta can be degraded by NIa in vitro. The specific cleavage of A beta was further confirmed by mass spectrometry analysis. NIa was shown to exist predominantly in the cytoplasm as observed by immunofluorescence microscopy. The overexpression of NIa in B103 neuroblastoma cells resulted in a significant reduction in cell death caused by both intracellularly generated and exogenously added A beta. Moreover, lentiviral-mediated expression of NIa in APP(sw)/PS1 transgenic mice significantly reduced the levels of A beta and plaques in the brain. Conclusions/Significance: These results indicate that the degradation of A beta in the cytoplasm could be a novel strategy to control the levels of A beta, plaque formation, and the associated cell death.	[Han, Hye-Eun; Sellamuthu, Saravanan; Shin, Bae Hyun; Lee, Yong Jae; Bae, Jeomil; Yoo, Yung Joon; Song, Woo Keun; Park, Woo Jin] GIST, Dept Life Sci, Kwangju, South Korea; [Song, Sungmin; Jung, Yong-Keun] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Seo, Ji-Seon; Baek, In-Sun; Kim, Hannah; Han, Pyung-Lim] Ewha Womans Univ, Div Nano Sci, Seoul, South Korea; [Seo, Ji-Seon; Baek, In-Sun; Kim, Hannah; Han, Pyung-Lim] Ewha Womans Univ, Brain Dis Res Inst, Seoul, South Korea	Gwangju Institute of Science & Technology (GIST); Seoul National University (SNU); Ewha Womans University; Ewha Womans University	Han, HE (corresponding author), GIST, Dept Life Sci, Kwangju, South Korea.	wjpark@gist.ac.kr	Seo, Ji-Seon/AAM-5949-2020	Han, Pyung-Lim/0000-0002-1735-6746; Jung, Yong-Keun/0000-0002-9686-3120; Bae, Jeomil/0000-0001-9374-6802	National Research Foundation of Korea [2009-0085747]; Korean government (MEST) [M6-0605-00-0001]; Gwangju Institute of Science and Technology (GIST)	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Gwangju Institute of Science and Technology (GIST)	This work was supported by a grant from the National Research Foundation of Korea (No. 2009-0085747), a grant from the Global Research Laboratory Program (M6-0605-00-0001) funded by the Korean government (MEST), and a grant from the "Systems biology infrastructure establishment grant'' provided by Gwangju Institute of Science and Technology (GIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Burns MP, 2009, HUM MOL GENET, V18, P3206, DOI 10.1093/hmg/ddp258; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Grant Susan M., 2000, Journal of Alzheimer's Disease, V2, P207; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kang H, 2001, J GEN VIROL, V82, P3115, DOI 10.1099/0022-1317-82-12-3115; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; KIM DH, 1995, VIROLOGY, V213, P517, DOI 10.1006/viro.1995.0024; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee EK, 2006, BIOCHEM BIOPH RES CO, V344, P471, DOI 10.1016/j.bbrc.2006.03.166; Lee KW, 2009, J NEUROCHEM, V108, P165, DOI 10.1111/j.1471-4159.2008.05769.x; LEHEL C, 1994, J BIOL CHEM, V269, P4761; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Marr RA, 2003, J NEUROSCI, V23, P1992; MARTIN BL, 1995, J BIOL CHEM, V270, P26727, DOI 10.1074/jbc.270.45.26727; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Mori C, 2002, AMYLOID, V9, P88, DOI 10.3109/13506120208995241; Mouri A, 2006, BEHAV BRAIN RES, V168, P83, DOI 10.1016/j.bbr.2005.10.014; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Rodriguez-Navarro JA, 2008, HUM MOL GENET, V17, P3128, DOI 10.1093/hmg/ddn210; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Song SM, 2004, TRENDS MOL MED, V10, P565, DOI 10.1016/j.molmed.2004.09.005; Song SM, 2008, J CELL BIOL, V182, P675, DOI 10.1083/jcb.200711066; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XL, 2007, FREE RADICAL BIO MED, V43, P1569, DOI 10.1016/j.freeradbiomed.2007.09.007; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	46	11	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15645	10.1371/journal.pone.0015645	http://dx.doi.org/10.1371/journal.pone.0015645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187975	Green Submitted, gold, Green Published			2022-12-25	WOS:000285575200054
J	Li, DJ; Yue, YP; Duan, DS				Li, Dejia; Yue, Yongping; Duan, Dongsheng			Marginal Level Dystrophin Expression Improves Clinical Outcome in a Strain of Dystrophin/Utrophin Double Knockout Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; TRANSGENIC MDX MICE; GLYCOPROTEIN COMPLEX; FULL-LENGTH; DEFICIENT MICE; MUSCLE-FIBERS; LIFE-SPAN; UTROPHIN; SKELETAL; MODEL	Inactivation of all utrophin isoforms in dystrophin-deficient mdx mice results in a strain of utrophin knockout mdx (uko/mdx) mice. Uko/mdx mice display severe clinical symptoms and die prematurely as in Duchenne muscular dystrophy (DMD) patients. Here we tested the hypothesis that marginal level dystrophin expression may improve the clinical outcome of uko/mdx mice. It is well established that mdx3cv (3cv) mice express a near-full length dystrophin protein at similar to 5% of the normal level. We crossed utrophin-null mutation to the 3cv background. The resulting uko/3cv mice expressed the same level of dystrophin as 3cv mice but utrophin expression was completely eliminated. Surprisingly, uko/3cv mice showed a much milder phenotype. Compared to uko/mdx mice, uko/3cv mice had significantly higher body weight and stronger specific muscle force. Most importantly, uko/3cv outlived uko/mdx mice by several folds. Our results suggest that a threshold level dystrophin expression may provide vital clinical support in a severely affected DMD mouse model. This finding may hold clinical implications in developing novel DMD therapies.	[Li, Dejia; Yue, Yongping; Duan, Dongsheng] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Li, DJ (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA.	duand@missouri.edu		Duan, Dongsheng/0000-0003-4109-1132	National Institutes of Health [AR-49419]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (AR-49419, DD) and the Muscular Dystrophy Association (DD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake DJ, 1996, BRAIN PATHOL, V6, P37, DOI 10.1111/j.1750-3639.1996.tb00781.x; Bostick B, 2010, MUSCLE NERVE, V42, P600, DOI 10.1002/mus.21763; BRAMBATI B, 1980, LANCET, V2, P969; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; COX GA, 1993, NAT GENET, V4, P87, DOI 10.1038/ng0593-87; COX GA, 1994, NAT GENET, V8, P333, DOI 10.1038/ng1294-333; Cozzi F, 2001, ACTA NEUROPATHOL, V101, P469; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Dinopoulos A, 2010, NEUROMUSCULAR DISORD, V20, P61, DOI 10.1016/j.nmd.2009.08.008; Fukada S, 2010, AM J PATHOL, V176, P2414, DOI 10.2353/ajpath.2010.090887; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; GREENBERG DS, 1994, NAT GENET, V8, P340, DOI 10.1038/ng1294-340; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Hernandez-Gonzalez EO, 2005, J CELL SCI, V118, P137, DOI 10.1242/jcs.01584; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; HOFFMAN EP, 1992, NEUROLOGY, V42, P967, DOI 10.1212/WNL.42.5.967; Judge LM, 2006, J CELL SCI, V119, P1537, DOI 10.1242/jcs.02857; Kunkel LM, 2005, AM J HUM GENET, V76, P205, DOI 10.1086/428143; Lai Y, 2005, NAT BIOTECHNOL, V23, P1435, DOI 10.1038/nbt1153; Li DJ, 2008, AM J PATHOL, V172, P1332, DOI 10.2353/ajpath.2008.071042; Li DJ, 2009, HUM MOL GENET, V18, P1209, DOI 10.1093/hmg/ddp015; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; Merrick D, 2009, DIS MODEL MECH, V2, P374, DOI 10.1242/dmm.001008; Mitrpant Chalermchai, 2009, Curr Mol Pharmacol, V2, P110; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Rafael JA, 2000, MAMM GENOME, V11, P725, DOI 10.1007/s003350010149; Rafael JA, 1999, MUSCLE NERVE, V22, P517, DOI 10.1002/(SICI)1097-4598(199904)22:4<517::AID-MUS14>3.0.CO;2-6; Rafael JA, 1996, J CELL BIOL, V134, P93, DOI 10.1083/jcb.134.1.93; SHIN JH, 2010, FENOTYP MDX MDX3CV M; THANH LT, 1995, AM J HUM GENET, V56, P725; Verma M, 2010, HUM MOL GENET, V19, P4145, DOI 10.1093/hmg/ddq334; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; WELLS DJ, 1995, HUM MOL GENET, V4, P1245, DOI 10.1093/hmg/4.8.1245; Yue YP, 2006, MOL THER, V14, P79, DOI 10.1016/j.ymthe.2006.01.007	36	31	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15286	10.1371/journal.pone.0015286	http://dx.doi.org/10.1371/journal.pone.0015286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187970	Green Published, gold, Green Submitted			2022-12-25	WOS:000285575200032
J	Prager, EM; Brielmaier, J; Bergstrom, HC; McGuire, J; Johnson, LR				Prager, Eric M.; Brielmaier, Jennifer; Bergstrom, Hadley C.; McGuire, Jennifer; Johnson, Luke R.			Localization of Mineralocorticoid Receptors at Mammalian Synapses	PLOS ONE			English	Article							LONG-TERM-MEMORY; GLUCOCORTICOID-RECEPTOR; CHRONIC STRESS; AMYGDALOID COMPLEX; RAT HIPPOCAMPUS; FEAR; CORTICOSTERONE; MODULATION; BRAIN; ACTIVATION	In the brain, membrane associated nongenomic steroid receptors can induce fast-acting responses to ion conductance and second messenger systems of neurons. Emerging data suggest that membrane associated glucocorticoid and mineralocorticoid receptors may directly regulate synaptic excitability during times of stress when adrenal hormones are elevated. As the key neuron signaling interface, the synapse is involved in learning and memory, including traumatic memories during times of stress. The lateral amygdala is a key site for synaptic plasticity underlying conditioned fear, which can both trigger and be coincident with the stress response. A large body of electrophysiological data shows rapid regulation of neuronal excitability by steroid hormone receptors. Despite the importance of these receptors, to date, only the glucocorticoid receptor has been anatomically localized to the membrane. We investigated the subcellular sites of mineralocorticoid receptors in the lateral amygdala of the Sprague-Dawley rat. Immunoblot analysis revealed the presence of mineralocorticoid receptors in the amygdala. Using electron microscopy, we found mineralocorticoid receptors expressed at both nuclear including: glutamatergic and GABAergic neurons and extra nuclear sites including: presynaptic terminals, neuronal dendrites, and dendritic spines. Importantly we also observed mineralocorticoid receptors at postsynaptic membrane densities of excitatory synapses. These data provide direct anatomical evidence supporting the concept that, at some synapses, synaptic transmission is regulated by mineralocorticoid receptors. Thus part of the stress signaling response in the brain is a direct modulation of the synapse itself by adrenal steroids.	[Prager, Eric M.; Johnson, Luke R.] Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA; [Brielmaier, Jennifer; Bergstrom, Hadley C.; McGuire, Jennifer; Johnson, Luke R.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Johnson, Luke R.] Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Prager, EM (corresponding author), Uniformed Serv Univ Hlth Sci, Program Neurosci, Bethesda, MD 20814 USA.	Luke.Johnson@usuhs.mil	Prager, Eric/O-1567-2015; Bergstrom, Hadley/S-1178-2019	Prager, Eric/0000-0002-3810-0985; Johnson PhD, Luke R/0000-0002-5088-1788; McGuire, Jennifer/0000-0003-3058-5241; Bergstrom, Hadley/0000-0003-3677-1619	Uniformed Services University [208867]	Uniformed Services University	This work was supported by Uniformed Services University grant 208867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIZA JL, 1988, NEURON, V1, P887, DOI 10.1016/0896-6273(88)90136-5; BARSEGYAN A, 2010, P NATL ACAD SCI US; Basu J, 2004, CURR SCI INDIA, V87, P212; Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Brunner R, 2006, ANN NY ACAD SCI, V1071, P434, DOI 10.1196/annals.1364.037; Conboy L, 2010, NEUROPSYCHOPHARMACOL, V35, P674, DOI 10.1038/npp.2009.172; Conrad CD, 2004, NEUROBIOL LEARN MEM, V81, P185, DOI 10.1016/j.nlm.2004.01.002; Cordero MI, 2002, STRESS, V5, P71, DOI 10.1080/102538902900124404; Cordero MI, 2003, BRAIN RES, V970, P242, DOI 10.1016/S0006-8993(03)02352-7; Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x; Datson NA, 2008, EUR J PHARMACOL, V583, P272, DOI 10.1016/j.ejphar.2007.11.070; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; de Kloet ER, 2008, FRONT NEUROENDOCRIN, V29, P268, DOI 10.1016/j.yfrne.2007.10.002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; de Kloet ER, 2000, KIDNEY INT, V57, P1329, DOI 10.1046/j.1523-1755.2000.00971.x; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Donley MP, 2005, BEHAV BRAIN RES, V164, P197, DOI 10.1016/j.bbr.2005.06.020; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Farb CR, 1997, SYNAPSE, V27, P106, DOI 10.1002/(SICI)1098-2396(199710)27:2<106::AID-SYN2>3.3.CO;2-F; Ferguson D, 2008, HIPPOCAMPUS, V18, P1103, DOI 10.1002/hipo.20467; FFRENCHMULLEN JMH, 1995, J NEUROSCI, V15, P903; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; GRAY EG, 1959, J ANAT, V93, P420; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Hlavacova N, 2008, HORM BEHAV, V54, P90, DOI 10.1016/j.yhbeh.2008.02.004; Joels M, 2008, TRENDS NEUROSCI, V31, P1, DOI 10.1016/j.tins.2007.10.005; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Johnson LR, 2005, NEUROSCIENCE, V136, P289, DOI 10.1016/j.neuroscience.2005.06.050; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kohda K, 2007, NEUROSCIENCE, V148, P22, DOI 10.1016/j.neuroscience.2007.05.041; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Levin ER, 2008, AM J PHYSIOL-REG I, V295, pR1425, DOI 10.1152/ajpregu.90605.2008; LIPOSITS Z, 1993, J NEUROSCI RES, V35, P14, DOI 10.1002/jnr.490350103; Liu L, 2007, NEUROSCI LETT, V420, P245, DOI 10.1016/j.neulet.2007.05.003; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Lou SJ, 1998, BIOCHEM BIOPH RES CO, V244, P403, DOI 10.1006/bbrc.1998.8280; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Lupien SJ, 1999, BEHAV NEUROSCI, V113, P420, DOI 10.1037/0735-7044.113.3.420; Marino M, 2006, IUBMB LIFE, V58, P716, DOI 10.1080/15216540601019485; Maroun M, 2008, NEUROPSYCHOPHARMACOL, V33, P394, DOI 10.1038/sj.npp.1301401; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mitra R, 2009, BEHAV BRAIN RES, V205, P535, DOI 10.1016/j.bbr.2009.08.014; Mitra R, 2009, BIOL PSYCHIAT, V66, P686, DOI 10.1016/j.biopsych.2009.04.016; Morsink MC, 2006, J NEUROCHEM, V99, P1282, DOI 10.1111/j.1471-4159.2006.04187.x; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Nishimura T, 2000, CELL STRUCT FUNCT, V25, P161, DOI 10.1247/csf.25.161; Olijslagers JE, 2008, EUR J NEUROSCI, V27, P2542, DOI 10.1111/j.1460-9568.2008.06220.x; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pare D, 1998, TRENDS NEUROSCI, V21, P240, DOI 10.1016/S0166-2236(98)01240-5; PARE D, 1993, NEUROSCIENCE, V57, P1061, DOI 10.1016/0306-4522(93)90049-L; Patel PD, 2000, J PSYCHIATR RES, V34, P383, DOI 10.1016/S0022-3956(00)00035-2; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Peters A., 1991, FINE STRUCTURE NERVO; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; Prager EM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286re5; Pugh CR, 1997, BEHAV NEUROSCI, V111, P503, DOI 10.1037/0735-7044.111.3.503; Rashidy-Pour A, 2004, BEHAV BRAIN RES, V154, P193, DOI 10.1016/j.bbr.2004.02.007; Rau V, 2005, NEUROSCI BIOBEHAV R, V29, P1207, DOI 10.1016/j.neubiorev.2005.04.010; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Rodrigues SM, 2009, BIOL PSYCHIAT, V65, P441, DOI 10.1016/j.biopsych.2008.09.003; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roozendaal B, 2010, J NEUROSCI, V30, P5037, DOI 10.1523/JNEUROSCI.5717-09.2010; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sheng ZJ, 2003, NEUROSCI RES, V46, P205, DOI 10.1016/S0168-0102(03)00056-7; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; Smith Y, 1998, J COMP NEUROL, V391, P164, DOI 10.1002/(SICI)1096-9861(19980209)391:2<164::AID-CNE2>3.0.CO;2-0; Takahashi T, 2002, J NEUROCHEM, V83, P1441, DOI 10.1046/j.1471-4159.2002.01251.x; Tasker JG, 2006, OBESITY, V14, P259; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; VISCARDI RM, 1993, STEROIDS, V58, P357, DOI 10.1016/0039-128X(93)90038-O; Vyas A, 2006, NEUROSCIENCE, V143, P387, DOI 10.1016/j.neuroscience.2006.08.003; Vyas A, 2004, BEHAV NEUROSCI, V118, P1450, DOI 10.1037/0735-7044.118.6.1450; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	84	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14344	10.1371/journal.pone.0014344	http://dx.doi.org/10.1371/journal.pone.0014344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179518	Green Submitted, Green Published, gold			2022-12-25	WOS:000285340000013
J	Puri, IK; Li, LW				Puri, Ishwar K.; Li, Liwu			Mathematical Modeling for the Pathogenesis of Alzheimer's Disease	PLOS ONE			English	Article							SENILE PLAQUES; MICROGLIA; INFLAMMATION; DEPOSITION	Despite extensive research, the pathogenesis of neurodegenerative Alzheimer's disease ( AD) still eludes our comprehension. This is largely due to complex and dynamic cross-talks that occur among multiple cell types throughout the aging process. We present a mathematical model that helps define critical components of AD pathogenesis based on differential rate equations that represent the known cross-talks involving microglia, astroglia, neurons, and amyloid-beta (A beta). We demonstrate that the inflammatory activation of microglia serves as a key node for progressive neurodegeneration. Our analysis reveals that targeting microglia may hold potential promise in the prevention and treatment of AD.	[Puri, Ishwar K.] Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA; [Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Puri, IK (corresponding author), Virginia Polytech Inst & State Univ, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA.	ikpuri@vt.edu; lwli@vt.edu	Puri, Ishwar/B-8734-2008	Puri, Ishwar/0000-0002-8713-4188; Li, Liwu/0000-0001-8870-5299; Puri, Ishwar/0000-0002-6638-5762	Virginia Tech	Virginia Tech	Internal funding from Virginia Tech supported this work. Virginia Tech had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Cuello AC, 2010, NEURODEGENER DIS, V7, P96, DOI 10.1159/000285514; Dudal S, 2004, NEUROBIOL AGING, V25, P861, DOI 10.1016/j.neurobiolaging.2003.08.008; Edelstein-Keshet L, 2002, J THEOR BIOL, V216, P301, DOI 10.1006/jtbi.2002.2540; Edelstein-Keshet L., 2005, MATH MODELS BIOL SOC; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Ganguly R, 2006, CELL PROLIFERAT, V39, P3, DOI 10.1111/j.1365-2184.2006.00369.x; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lee CC, 2007, BIOPHYS J, V92, P3448, DOI 10.1529/biophysj.106.098608; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Luca M, 2003, B MATH BIOL, V65, P693, DOI 10.1016/S0092-8240(03)00030-2; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; Pang Y, 2010, NEUROSCIENCE, V166, P464, DOI 10.1016/j.neuroscience.2009.12.040; Park Keun W, 2008, Curr Aging Sci, V1, P192; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630	23	34	34	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15176	10.1371/journal.pone.0015176	http://dx.doi.org/10.1371/journal.pone.0015176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179474	Green Submitted, Green Published, gold			2022-12-25	WOS:000285292500015
J	Zhang, RN; Mehla, R; Chauhan, A				Zhang, Ruonan; Mehla, Rajeev; Chauhan, Ashok			Perturbation of Host Nuclear Membrane Component RanBP2 Impairs the Nuclear Import of Human Immunodeficiency Virus-1 Preintegration Complex (DNA)	PLOS ONE			English	Article							HIV-1 MATRIX PROTEIN; PORE COMPLEX; LOCALIZATION SIGNAL; NONDIVIDING CELLS; MESSENGER-RNA; NUCLEOCYTOPLASMIC TRANSPORT; TYPE-1; INFECTION; INTEGRASE; EXPORT	HIV-1 is a RNA virus that requires an intermediate DNA phase via reverse transcription (RT) step in order to establish productive infection in the host cell. The nascent viral DNA synthesized via RT step and the preformed viral proteins are assembled into pre-integration complex (PIC) in the cell cytoplasm. To integrate the viral DNA into the host genome, the PIC must cross cell nuclear membrane through the nuclear pore complex (NPC). RanBP2, also known as Nup358, is a major component of the cytoplasmic filaments that emanates from the nuclear pore complex and has been implicated in various nucleo-cytoplasmic transport pathways including those for HIV Rev-protein. We sought to investigate the role of RanBP2 in HIV-1 replication. In our investigations, we found that RanBP2 depletion via RNAi resulted in profound inhibition of HIV-1 infection and played a pivotal role in the nuclear entry of HIV DNA. More precisely, there was a profound decline in 2-LTR DNA copies (marker for nuclear entry of HIV DNA) and an unchanged level of viral reverse transcription in RanBP2-ablated HIV-infected cells compared to RanBP3-depleted or non-specific siRNA controls. We further demonstrated that the function of Rev was unaffected in RanBP2-depleted latently HIV infected cells (reactivated). We also serendipitously found that RanBP2 depletion inhibited the global ectopic gene expression. In conclusion, RanBP2 is a host factor that is involved in the nuclear import of HIV-1 PIC (DNA), but is not critical to the nuclear export of the viral mRNAs or nucleo-cytoplasmic shuttling of Rev. RanBP2 could be a potential target for efficient inhibition of HIV.	[Zhang, Ruonan; Mehla, Rajeev; Chauhan, Ashok] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Zhang, RN (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Ashok.Chauhan@uscmed.sc.edu			National Institute of Neurological Disorders (NINDS), National Institutes of Health [RO1 NS 050064]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050064] Funding Source: NIH RePORTER	National Institute of Neurological Disorders (NINDS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported with federal funds from National Institute of Neurological Disorders (NINDS), National Institutes of Health grant RO1 NS 050064 (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Agostini I, 2000, EXP CELL RES, V259, P398, DOI 10.1006/excr.2000.4992; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Armon-Omer A, 2004, J MOL BIOL, V336, P1117, DOI 10.1016/j.jmb.2003.11.057; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Chauhan A, 2003, J BIOL CHEM, V278, P13512, DOI 10.1074/jbc.M209381200; Chauhan A, 2007, FASEB J, V21, P777, DOI 10.1096/fj.06-7054com; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Clarke PR, 2008, DEV CELL, V14, P316, DOI 10.1016/j.devcel.2008.02.005; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; De Rijck J, 2007, BIOESSAYS, V29, P441, DOI 10.1002/bies.20561; Depienne C, 2000, EXP CELL RES, V260, P387, DOI 10.1006/excr.2000.5016; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Ebina H, 2004, MICROBES INFECT, V6, P715, DOI 10.1016/j.micinf.2004.04.002; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; Fouchier RAM, 1999, ADV VIRUS RES, V52, P275, DOI 10.1016/S0065-3527(08)60302-4; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gallay P, 1996, J VIROL, V70, P1027, DOI 10.1128/JVI.70.2.1027-1032.1996; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Goff SP, 2001, J GENE MED, V3, P517, DOI 10.1002/1521-2254(200111)3:6<517::AID-JGM234>3.0.CO;2-E; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; HU C, 2010, J VIROL         0915; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011; Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kootstra NA, 1999, VIROLOGY, V253, P170, DOI 10.1006/viro.1998.9482; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Luban J, 2008, CURR BIOL, V18, pR710, DOI 10.1016/j.cub.2008.07.037; Maco Bohumil, 2006, V322, P273; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Mannioui A, 2005, VIROLOGY, V339, P21, DOI 10.1016/j.virol.2005.05.023; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Meyer BE, 1996, J VIROL, V70, P2350, DOI 10.1128/JVI.70.4.2350-2359.1996; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Riviere L, 2010, J VIROL, V84, P729, DOI 10.1128/JVI.01952-09; SADAIE MR, 1988, SCIENCE, V239, P910, DOI 10.1126/science.3277284; Stevenson M, 2000, NAT MED, V6, P626, DOI 10.1038/76191; Strebel Klaus, 2003, AIDS, V17 Suppl 4, pS25, DOI 10.1097/00002030-200317004-00003; Suzuki Y, 2003, VIRUS GENES, V27, P177, DOI 10.1023/A:1025732728195; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Truant R, 1999, MOL CELL BIOL, V19, P1210; Vijaykumar TS, 2008, VIROLOGY, V381, P1, DOI 10.1016/j.virol.2008.07.039; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yamashita M, 2005, PLOS PATHOG, V1, P170, DOI 10.1371/journal.ppat.0010018; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	69	68	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15620	10.1371/journal.pone.0015620	http://dx.doi.org/10.1371/journal.pone.0015620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179483	Green Submitted, Green Published, gold			2022-12-25	WOS:000285292500032
J	Mayers, JR; Fyfe, I; Schuh, AL; Chapman, ER; Edwardson, JM; Audhya, A				Mayers, Jonathan R.; Fyfe, Ian; Schuh, Amber L.; Chapman, Edwin R.; Edwardson, J. Michael; Audhya, Anjon			ESCRT-0 Assembles as a Heterotetrameric Complex on Membranes and Binds Multiple Ubiquitinylated Cargoes Simultaneously	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; UBIQUITINATED PROTEINS; MULTIVESICULAR BODIES; INTERACTING MOTIF; SORTING COMPLEX; MASTER MOLECULE; EARLY ENDOSOMES; HRS; DEGRADATION; DOMAINS	The ESCRT machinery consists of multiple protein complexes that collectively participate in the biogenesis of multivesicular endosomes (MVEs). The ESCRT-0 complex is composed of two subunits, Hrs and STAM, both of which can engage ubiquitinylated substrates destined for lysosomal degradation. Here, we conduct a comprehensive analysis of ESCRT-0:ubiquitin interactions using isothermal titration calorimetry and define the affinity of each ubiquitin-binding domain (UBD) within the intact ESCRT-0 complex. Our data demonstrate that ubiquitin binding is non-cooperative between the ESCRT-0 UBDs. Additionally, our findings show that the affinity of the Hrs double ubiquitin interacting motif (DUIM) for ubiquitin is more than 2-fold greater than that of UBDs found in STAM, suggesting that Hrs functions as the major ubiquitin-binding protein in ESCRT-0. In vivo, Hrs and STAM localize to endosomal membranes. To study recombinant ESCRT-0 assembly on lipid bilayers, we used atomic force microscopy. Our data show that ESCRT-0 forms mostly heterodimers and heterotetramers of Hrs and STAM when analyzed in the presence of membranes. Consistent with these findings, hydrodynamic analysis of endogenous ESCRT-0 indicates that it exists largely as a heterotetrameric complex of its two subunits. Based on these data, we present a revised model for ESCRT-0 function in cargo recruitment and concentration at the endosome.	[Mayers, Jonathan R.; Schuh, Amber L.; Audhya, Anjon] Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA; [Chapman, Edwin R.] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; [Fyfe, Ian; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Cambridge	Audhya, A (corresponding author), Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA.	audhya@wisc.edu		Chapman, Edwin/0000-0001-9787-8140; Fyfe, Ian/0000-0002-9362-0254	National Institutes of Health [1R01GM088151-01A1, MH061876]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by Grants 1R01GM088151-01A1 (to A. A.) and MH061876 (to E. R. C.) from the National Institutes of Health.	Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Audhya A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000956; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Chanut-Delalande H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010245; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Dam TK, 2008, J BIOL CHEM, V283, P31366, DOI 10.1074/jbc.M806473200; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hong YH, 2009, FEBS LETT, V583, P287, DOI 10.1016/j.febslet.2008.12.034; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kobayashi H, 2005, J BIOL CHEM, V280, P10468, DOI 10.1074/jbc.M409969200; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Mizuno E, 2004, J BIOCHEM, V135, P385, DOI 10.1093/jb/mvh046; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Shields SB, 2009, J CELL BIOL, V185, P213, DOI 10.1083/jcb.200811130; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Takata H, 2000, GENES CELLS, V5, P57, DOI 10.1046/j.1365-2443.2000.00303.x; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849	40	51	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9636	9645		10.1074/jbc.M110.185363	http://dx.doi.org/10.1074/jbc.M110.185363			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21193406	Green Published, hybrid			2022-12-25	WOS:000288247700088
J	Walsh, R; Blumenberg, M				Walsh, Rebecca; Blumenberg, Miroslav			Specific and Shared Targets of Ephrin A Signaling in Epidermal Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; CULTURED KERATINOCYTES; EXPRESSION; GENES; DIFFERENTIATION; TUMOR; PROTEINS; LIGANDS; EPHA2; AP-1	Both ephrins (EFNs) and their receptors (Ephs) are membrane-bound, restricting their interactions to the sites of direct cell-to-cell interfaces. They are widely expressed, often co-expressed, and regulate developmental processes, cell adhesion, motility, survival, proliferation, and differentiation. Both tumor suppressor and oncogene activities are ascribed to EFNs and Ephs in various contexts. A major conundrum regarding the EFN/Eph system concerns their large number and functional redundancy given the promiscuous cross-activation of ligands and receptors and the overlapping intracellular signaling pathways. To address this issue, we treated human epidermal keratinocytes with five EFNAs individually and defined the transcriptional responses in the cells. We found that a large set of genes is coregulated by all EFNAs. However, although the responses to EFNA3, EFNA4, and EFNA5 are identical, the responses to EFNA1 and EFNA2 are characteristic and distinctive. All EFNAs induce epidermal differentiation markers and suppress cell adhesion genes, especially integrins. Ontological analysis showed that all EFNAs induce cornification and keratin genes while suppressing wound healing-associated, signaling, receptor, and extracellular matrix-associated genes. Transcriptional targets of AP1 are selectively suppressed by EFNAs. EFNA1 and EFNA2, but not the EFNA3, EFNA4, EFNA5 cluster, regulate the members of the ubiquitin-associated proteolysis genes. EFNA1 specifically induces collagen production. Our results demonstrate that the EFN-Eph interactions in the epidermis, although promiscuous, are not redundant but specific. This suggests that different members of the EFN/Eph system have specific, clearly demarcated functions.	[Blumenberg, Miroslav] NYU, Sch Med, Dept Dermatol, Inst Canc, New York, NY 10016 USA; NYU, Sch Med, Dept Biochem, Inst Canc, New York, NY 10016 USA	New York University; New York University	Blumenberg, M (corresponding author), NYU, Sch Med, Dept Dermatol, Inst Canc, 550 1st Ave, New York, NY 10016 USA.	Miroslav.Blumenberg@nyumc.org		Blumenberg, Miroslav/0000-0002-8672-7774	R.O. Perelman Department of Dermatology, NYU Langone Medical Center	R.O. Perelman Department of Dermatology, NYU Langone Medical Center	This work was supported by the R.O. Perelman Department of Dermatology, NYU Langone Medical Center.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; [Anonymous], 1997, Cell, V90, P403; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Bernerd Francoise, 1993, Gene Expression, V3, P187; BOYD AW, 2001, SCI STKE, pRE20; Brantley-Sieders D, 2004, CURR PHARM DESIGN, V10, P3431, DOI 10.2174/1381612043383160; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Cahan P, 2005, GENE, V360, P78, DOI 10.1016/j.gene.2005.07.008; COOPER D, 1986, J BIOL CHEM, V261, P4646; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Evans IR, 2007, J CELL SCI, V120, P289, DOI 10.1242/jcs.03333; Finelt N, 2005, CYTOKINE, V31, P305, DOI 10.1016/j.cyto.2005.05.005; Freywald A, 2003, J BIOL CHEM, V278, P10150, DOI 10.1074/jbc.M208179200; Gazel A, 2003, J INVEST DERMATOL, V121, P1459, DOI 10.1111/j.1523-1747.2003.12611.x; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Genander M, 2010, STEM CELLS, V28, P1196, DOI 10.1002/stem.442; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hafner C, 2006, MODERN PATHOL, V19, P1369, DOI 10.1038/modpathol.3800660; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Lai KO, 2004, J BIOL CHEM, V279, P13383, DOI 10.1074/jbc.M313356200; Lee DD, 2010, METHODS MOL BIOL, V585, P193, DOI 10.1007/978-1-60761-380-0_15; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; Lin S, 2010, MOL BIOL CELL, V21, P3902, DOI 10.1091/mbc.E10-03-0242; LINDBERG K, 1990, DIFFERENTIATION, V45, P230, DOI 10.1111/j.1432-0436.1990.tb00477.x; LU B, 1994, J BIOL CHEM, V269, P7443; Ma SH, 1997, GENE EXPRESSION, V6, P361; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Molenda M, 2006, MOL IMMUNOL, V43, P1933, DOI 10.1016/j.molimm.2005.12.003; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Welter JF, 1995, ONCOGENE, V11, P2681; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; Zhang GQ, 2008, CANCER RES, V68, P1691, DOI 10.1158/0008-5472.CAN-07-2372; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700	53	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9419	9428		10.1074/jbc.M110.197087	http://dx.doi.org/10.1074/jbc.M110.197087			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21193391	hybrid, Green Published			2022-12-25	WOS:000288247700070
J	Brandenburger, T; Strehler, EE; Filoteo, AG; Caride, AJ; Aumuller, G; Post, H; Schwarz, A; Wilhelm, B				Brandenburger, Timo; Strehler, Emanuel E.; Filoteo, Adelaida G.; Caride, Ariel J.; Aumueller, Gerhard; Post, Heidi; Schwarz, Anja; Wilhelm, Beate			Switch of PMCA4 Splice Variants in Bovine Epididymis Results in Altered Isoform Expression during Functional Sperm Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE CA2+-ATPASE; RAT COAGULATING GLAND; CALCIUM-PUMP ISOFORMS; CA2+ PUMP; MESSENGER-RNAS; MALE-FERTILITY; CALMODULIN-BINDING; KNOCKOUT MICE; MOUSE SPERM; RT-PCR	Ca2+ and Ca2+-dependent signals are essential for sperm maturation and fertilization. In mouse sperm the plasma membrane Ca2+-ATPase (PMCA) isoform 4 plays a crucial role in Ca2+ transport. The two major splice variants of PMCA4 are PMCA4a and PMCA4b. PMCA4a differs from PMCA4b in the mechanism of calmodulin binding and activation. PMCA4a shows a much higher basal activity and is more effective than PMCA4b in returning Ca2+ to resting levels. Knock-out mice carrying a PMCA4-null mutation are infertile because their sperm cannot achieve a hyperactivated state of motility. As sperm reach functional maturity during their transit through the epididymis, the expression of PMCA4a and 4b was assessed in bull testis and epididymis. Quantitative PCR revealed that PMCA4b is the major splice variant in testis, caput, and corpus epididymidis. In contrast, PMCA4a is the major splice variant in cauda epididymidis, whereas sperm are transcriptionally silent. Immunohistochemical staining using a new antibody against bovine PMCA4a located the PMCA4a to the apical membrane of the epithelium of cauda epididymidis, whereas testis, caput, and corpus epididymidis were negative. Western blotting of testis, epididymis, and sperm isolated from caput and cauda epididymidis showed a much higher level of PMCA4a in cauda epididymidis and sperm from cauda epididymidis compared with testis membranes and sperm from caput epididymidis. These findings suggest that PMCA4a is transferred to bovine sperm membranes in cauda epididymidis. This isoform switch may facilitate a higher calcium turnover in sperm necessary to traverse the female genital tract.	[Brandenburger, Timo; Aumueller, Gerhard; Post, Heidi; Schwarz, Anja; Wilhelm, Beate] Univ Marburg, Dept Anat & Cell Biol, D-35037 Marburg, Germany; [Brandenburger, Timo] Univ Hosp Dusseldorf, Dept Anesthesiol, D-40225 Dusseldorf, Germany; [Strehler, Emanuel E.; Filoteo, Adelaida G.; Caride, Ariel J.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Philipps University Marburg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Mayo Clinic	Brandenburger, T (corresponding author), Moorenstr 5, D-40225 Dusseldorf, Germany.	timo.brandenburger@med.uni-duesseldorf.de	Brandenburger, Timo/AAJ-9090-2021; Schwarz, Anja/AAG-2530-2021	, Anja/0000-0001-9567-0717	National Institutes of Health [NS51769]; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS51769 (to E. E. S.). This work was also supported by the Deutsche Forschungsgemeinschaft Graduiertenkolleg 533 Giessen-Marburg Project A1 (to T. B., G. A., and B. W.).	BABCOCK DF, 1987, J BIOL CHEM, V262, P15041; BEGIN S, 1995, MOL REPROD DEV, V41, P249, DOI 10.1002/mrd.1080410216; BOUE F, 1994, BIOL REPROD, V51, P577, DOI 10.1095/biolreprod51.4.577; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDT P, 1992, J NEUROCHEM, V59, P1566, DOI 10.1111/j.1471-4159.1992.tb08476.x; BRANDT P, 1992, J BIOL CHEM, V267, P4376; Caride AJ, 1999, J BIOL CHEM, V274, P35227, DOI 10.1074/jbc.274.49.35227; Caride AJ, 2007, J BIOL CHEM, V282, P25640, DOI 10.1074/jbc.M701129200; Cooper T. G., 1999, EPIDIDYMIS; Cooper TG, 1996, ANDROLOGIA, V28, P57; COOPER TG, 1995, ADV EXP MED BIOL, V377, P87; DEJAEGERE S, 1993, BIOCHIM BIOPHYS ACTA, V1173, P188, DOI 10.1016/0167-4781(93)90180-L; ENYEDI A, 1993, J BIOL CHEM, V268, P10621; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; FRIEDMAN PA, 1995, PHYSIOL REV, V75, P429, DOI 10.1152/physrev.1995.75.3.429; Haendler B, 1999, J CELL PHYSIOL, V178, P371, DOI 10.1002/(SICI)1097-4652(199903)178:3<371::AID-JCP11>3.0.CO;2-N; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; HOWARD A, 1993, AM J PHYSIOL, V265, pG917, DOI 10.1152/ajpgi.1993.265.5.G917; JONES R, 1989, OXFORD REV REPROD B, V11, P285; Jones R, 1998, J REPROD FERTIL, P73; KEETON TP, 1995, BIOCHEM J, V306, P779, DOI 10.1042/bj3060779; KEETON TP, 1993, J BIOL CHEM, V268, P2740; Kirchhoff C, 1996, MOL HUM REPROD, V2, P177, DOI 10.1093/molehr/2.3.177; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Lalancette C, 2008, J CELL BIOCHEM, V104, P1570, DOI 10.1002/jcb.21756; Larsson Dennis, 2002, Journal of Biomedicine & Biotechnology, V2, P117, DOI 10.1155/S1110724302205045; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; Lessard C, 2000, J ANDROL, V21, P700; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Penheiter AR, 2003, BIOCHEMISTRY-US, V42, P12115, DOI 10.1021/bi027098+; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Post H, 2010, INT J ANDROL, V33, P775, DOI 10.1111/j.1365-2605.2009.01022.x; Post H, 2002, PROSTATE, V52, P159, DOI 10.1002/pros.10109; Prasad V, 2007, ANN NY ACAD SCI, V1099, P276, DOI 10.1196/annals.1387.029; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Sanchez-Luengo S, 2004, J ANDROL, V25, P234; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; SIKDAR R, 1991, MOL CELL BIOCHEM, V103, P121; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; STREHLER EE, 1990, J BIOL CHEM, V265, P2835; Strehler EE, 2004, CURR MOL MED, V4, P323, DOI 10.2174/1566524043360735; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Sullivan DA, 2003, J RHEUMATOL, V30, P2413; Sullivan R, 2005, BLOOD CELL MOL DIS, V35, P1, DOI 10.1016/j.bcmd.2005.03.005; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Wilhelm B, 1999, EUR J CELL BIOL, V78, P256, DOI 10.1016/S0171-9335(99)80059-4; Wilhelm B, 2008, HISTOCHEM CELL BIOL, V129, P331, DOI 10.1007/s00418-007-0362-y; Withers S, 2006, MOL CELL ENDOCRINOL, V250, P93, DOI 10.1016/j.mce.2005.12.028; ZACHARIAS DA, 1994, BIOTECHNIQUES, V17, P652	52	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7938	7946		10.1074/jbc.M110.142836	http://dx.doi.org/10.1074/jbc.M110.142836			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21187283	hybrid, Green Published			2022-12-25	WOS:000288013300024
J	Cheong, MC; Na, K; Kim, H; Jeong, SK; Joo, HJ; Chitwood, DJ; Paik, YK				Cheong, Mi Cheong; Na, Keun; Kim, Heekyeong; Jeong, Seul-Ki; Joo, Hyoe-Jin; Chitwood, David J.; Paik, Young-Ki			A Potential Biochemical Mechanism Underlying the Influence of Sterol Deprivation Stress on Caenorhabditis elegans Longevity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; DAUER FORMATION; OXIDATIVE STRESS; LIFE-SPAN; ANESTHETIC SENSITIVITY; SIGNALING PATHWAY; GENE-EXPRESSION; WILD-TYPE; CHOLESTEROL; NEMATODE	To investigate the biochemical mechanism underlying the effect of sterol deprivation on longevity in Caenorhabditis elegans, we treated parent worms (P0) with 25-azacoprostane (Aza), which inhibits sitosterol-to-cholesterol conversion, and measured mean lifespan (MLS) in F2 worms. At 25 mu M (similar to EC50), Aza reduced total body sterol by 82.5%, confirming sterol depletion. Aza (25 mu M) treatment of wild-type (N2) C. elegans grown in sitosterol (5 mu g/ml) reduced MLS by 35%. Similar results were obtained for the stress-related mutants daf-16(mu86) and gas-1(fc21). Unexpectedly, Aza had essentially no effect on MLS in the stress-resistant daf-2(e1370) or mitochondrial complex II mutant mev-1(kn1) strains, indicating that Aza may target both insulin/IGF-1 signaling (IIS) and mitochondrial complex II. Aza increased reactive oxygen species (ROS) levels 2.7-fold in N2 worms, but did not affect ROS production by mev-1(kn1), suggesting a direct link between Aza treatment and mitochondrial ROS production. Moreover, expression of the stress-response transcription factor SKN-1 was decreased in amphid neurons by Aza and that of DAF-28 was increased when DAF-6 was involved, contributing to lifespan reduction.	[Cheong, Mi Cheong; Na, Keun; Kim, Heekyeong; Jeong, Seul-Ki; Joo, Hyoe-Jin; Paik, Young-Ki] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Dept Biomed Sci,WCU Program Grad Sch, Seoul 120749, South Korea; [Cheong, Mi Cheong; Na, Keun; Kim, Heekyeong; Jeong, Seul-Ki; Joo, Hyoe-Jin; Paik, Young-Ki] Yonsei Univ, Yonsei Proteome Res Ctr, Seoul 120749, South Korea; [Chitwood, David J.] ARS, Nematol Lab, USDA, Beltsville, MD 20705 USA	Yonsei University; Yonsei University; United States Department of Agriculture (USDA)	Paik, YK (corresponding author), 134 Shinchon Dong, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr		Cheong, Mi Cheong/0000-0002-7604-6203	Ministry of Health and Welfare of Republic of Korea [A030003]; Ministry of Education, Science, and Technology [R31-2008-000-10086-0]	Ministry of Health and Welfare of Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported, in part, by the Korea Health 21 R&D project, Ministry of Health and Welfare of Republic of Korea Grant A030003 (to Y.K.-P.), and the WCU (World Class University) program through the National Research Foundation of Korea, funded by Ministry of Education, Science, and Technology Grant R31-2008-000-10086-0.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Chitwood DJ, 1999, CRIT REV BIOCHEM MOL, V34, P273, DOI 10.1080/10409239991209309; CHITWOOD DJ, 1984, LIPIDS, V19, P500, DOI 10.1007/BF02534482; CHITWOOD DJ, 1991, LIPIDS, V26, P619, DOI 10.1007/BF02536426; Choi BK, 2003, MOL CELL PROTEOMICS, V2, P1086, DOI 10.1074/mcp.M300036-MCP200; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; FRIEDMAN DB, 1988, J GERONTOL, V43, pB102, DOI 10.1093/geronj/43.4.B102; Garza RM, 2005, NATURE, V435, P37, DOI 10.1038/435037a; Gems David, 2009, SEB Exp Biol Ser, V62, P31; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gerisch G, 2007, CELL ADHES MIGR, V1, P145, DOI 10.4161/cam.1.3.4662; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; GOTTLIEB S, 1994, GENETICS, V137, P107; Gutierrez-Zepeda A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-54; Hannich JT, 2009, DEV CELL, V16, P833, DOI 10.1016/j.devcel.2009.04.012; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Hartman PS, 2001, MECH AGEING DEV, V122, P1187, DOI 10.1016/S0047-6374(01)00259-7; Hartwig K, 2009, GENES NUTR, V4, P59, DOI 10.1007/s12263-009-0113-x; Held JM, 2006, AGING CELL, V5, P283, DOI 10.1111/j.1474-9726.2006.00218.x; HIEB WF, 1968, SCIENCE, V160, P778, DOI 10.1126/science.160.3829.778; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Horner MA, 2009, GENE DEV, V23, P2711, DOI 10.1101/gad.1833609; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Ichimiya H, 2002, MITOCHONDRION, V2, P191, DOI 10.1016/S1567-7249(02)00069-7; Ishii N, 2000, FREE RADICAL RES, V33, P857, DOI 10.1080/10715760000301371; Kayser EB, 2004, MECH AGEING DEV, V125, P455, DOI 10.1016/j.mad.2004.04.002; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kobayashi D, 2002, ANTIMICROB AGENTS CH, V46, P3113, DOI 10.1128/AAC.46.10.3113-3117.2002; Kondo M, 2005, MECH AGEING DEV, V126, P637, DOI 10.1016/j.mad.2004.11.011; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee EY, 2005, BIOCHEM BIOPH RES CO, V328, P929, DOI 10.1016/j.bbrc.2005.01.050; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Li J, 2004, DEVELOPMENT, V131, P5741, DOI 10.1242/dev.01408; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lopez-Revuelta A, 2005, BBA-MOL CELL BIOL L, V1734, P74, DOI 10.1016/j.bbalip.2005.02.004; LOZANO R, 1984, COMP BIOCHEM PHYS C, V79, P21, DOI 10.1016/0742-8413(84)90156-7; Malone EA, 1996, GENETICS, V143, P1193; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Matyash V, 2004, PLOS BIOL, V2, P1561, DOI 10.1371/journal.pbio.0020280; Matyash V, 2001, MOL BIOL CELL, V12, P1725, DOI 10.1091/mbc.12.6.1725; Merris M, 2004, J LIPID RES, V45, P2044, DOI 10.1194/jlr.M400100-JLR200; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Oh WS, 2009, PLOS ONE, V4, pA22, DOI 10.1371/journal.pone.0007593; Patel DS, 2008, DEVELOPMENT, V135, P2239, DOI 10.1242/dev.016972; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; ROTHSTEIN M, 1968, COMP BIOCHEM PHYSIOL, V27, P309, DOI 10.1016/0010-406X(68)90773-1; Roux C, 2000, AM J CLIN NUTR, V71, p1270S, DOI 10.1093/ajcn/71.5.1270s; Sedensky MM, 2006, EXP GERONTOL, V41, P957, DOI 10.1016/j.exger.2006.06.056; Shim YH, 2002, MOL REPROD DEV, V61, P358, DOI 10.1002/mrd.10099; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Vanfleteren JR, 1996, J EXP ZOOL, V274, P93, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;93::AID-JEZ2&gt;3.0.CO;2-8; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473	65	8	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7248	7256		10.1074/jbc.M110.189183	http://dx.doi.org/10.1074/jbc.M110.189183			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21186286	Green Published, hybrid			2022-12-25	WOS:000287737300041
J	Joo, HY; Jones, A; Yang, CY; Zhai, L; Smith, AD; Zhang, Z; Chandrasekharan, MB; Sun, ZW; Renfrow, MB; Wang, YM; Chang, CB; Wang, HB				Joo, Heui-Yun; Jones, Amada; Yang, Chunying; Zhai, Ling; Smith, Archer D.; Zhang, Zhuo; Chandrasekharan, Mahesh B.; Sun, Zu-wen; Renfrow, Matthew B.; Wang, Yanming; Chang, Chenbei; Wang, Hengbin			Regulation of Histone H2A and H2B Deubiquitination and Xenopus Development by USP12 and USP46	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; MASS-SPECTROMETRY; PROTEIN IDENTIFICATION; STATISTICAL-MODEL; H3K4 METHYLATION; GENE-EXPRESSION; CHROMATIN; UBIQUITINATION; UBIQUITYLATION; TRANSCRIPTION	Post-translational histone modifications play important roles in regulating gene expression programs, which in turn determine cell fate and lineage commitment during development. One such modification is histone ubiquitination, which primarily targets histone H2A and H2B. Although ubiquitination of H2A and H2B has been generally linked to gene silencing and gene activation, respectively, the functions of histone ubiquitination during eukaryote development are not well understood. Here, we identified USP12 and USP46 as histone H2A and H2B deubiquitinases that regulate Xenopus development. USP12 and USP46 prefer nucleosomal substrates and deubiquitinate both histone H2A and H2B in vitro and in vivo. WDR48, a WD40 repeat-containing protein, interacts with USP12 and USP46 and is required for the histone deubiquitination activity. Overexpression of either gene leads to gastrulation defects without affecting mesodermal cell fate, whereas knockdown of USP12 in Xenopus embryos results in reduction of a subset of mesodermal genes at gastrula stages. Immunohistochemical staining and chromatin immunoprecipitation assays revealed that USP12 regulates histone deubiquitination in the mesoderm and at specific gene promoters during Xenopus development. Taken together, this study identifies USP12 and USP46 as histone deubiquitinases for H2A and H2B and reveals that USP12 regulates Xenopus development during gastrula stages.	[Smith, Archer D.; Renfrow, Matthew B.] Univ Alabama, Dept Biochem & Mol Genet, Biomed FT ICR MS Lab, Birmingham, AL 35294 USA; [Chandrasekharan, Mahesh B.; Sun, Zu-wen] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Wang, Yanming] Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Chang, Chenbei] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Alabama System; University of Alabama Birmingham	Wang, HB (corresponding author), Kaul Human Genet Bldg 402A,720 20th St S, Birmingham, AL 35294 USA.	hbwang@uab.edu	Yang, Chunying/C-2888-2011; Chandrasekharan, Mahesh/AAF-4793-2020	Wang, Yanming/0000-0002-0710-043X; Renfrow, Matthew B./0000-0002-4193-7305; Wang, Hengbin/0000-0003-2414-0609; Chandrasekharan, Mahesh/0000-0002-9956-8354	NCI, National Institutes of Health [CA13148-35]; National Institutes of Health [GM083029, GM081489]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA109355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081489, R01GM083029] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA13148-35 from NCI (University of Alabama at Birmingham Comprehensive Cancer Center Collaborative Programmatic Development Grant Program to H. W. and C. C.).; Supported by National Institutes of Health Grant GM083029.; Supported by National Institutes of Health Grant GM081489. A Sidney Kimmel Scholar. To whom correspondence should be addressed: Kaul Human Genetics Bldg. 402A, 720 20th St. South, Birmingham, AL 35294. Tel.: 205-934-5286; Fax: 205-934-0758; E-mail: hbwang@uab.edu.	Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Chang CB, 1997, DEVELOPMENT, V124, P827; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Espinosa JM, 2008, GENE DEV, V22, P2743, DOI 10.1101/gad.1732108; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hirst M, 2009, INT J BIOCHEM CELL B, V41, P136, DOI 10.1016/j.biocel.2008.09.011; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Jason LJM, 2002, BIOESSAYS, V24, P166, DOI 10.1002/bies.10038; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Ko M, 2008, MUTAT RES-FUND MOL M, V647, P59, DOI 10.1016/j.mrfmmm.2008.08.004; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Osley Mary Ann, 2006, Briefings in Functional Genomics & Proteomics, V5, P179, DOI 10.1093/bfgp/ell022; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Zhang XY, 2008, CELL CYCLE, V7, P1522, DOI 10.4161/cc.7.11.5962; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	55	79	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7190	7201		10.1074/jbc.M110.158311	http://dx.doi.org/10.1074/jbc.M110.158311			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21183687	hybrid, Green Published			2022-12-25	WOS:000287737300036
J	Peng, C; Cho, YY; Zhu, F; Zhang, JH; Wen, WH; Xu, YM; Yao, K; Ma, WY; Bode, AM; Dong, ZG				Peng, Cong; Cho, Yong-Yeon; Zhu, Feng; Zhang, Jishuai; Wen, Weihong; Xu, Yanming; Yao, Ke; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang			Phosphorylation of Caspase-8 (Thr-263) by Ribosomal S6 Kinase 2 (RSK2) Mediates Caspase-8 Ubiquitination and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LIGASE; CELL-SURVIVAL; HISTONE H3; APOPTOSIS; ACTIVATION; PATHWAY; GROWTH; TRANSFORMATION; DEGRADATION; REQUIREMENT	The ribosomal S6 kinase 2 (RSK2) is a member of the p90 ribosomal S6 kinase (p90RSK) family of proteins and plays a critical role in proliferation, cell cycle, and cell transformation. Here, we report that RSK2 phosphorylates caspase-8, and Thr-263 was identified as a novel caspase-8 phosphorylation site. In addition, we showed that EGF induces caspase-8 ubiquitination and degradation through the proteasome pathway, and phosphorylation of Thr-263 is associated with caspase-8 stability. Finally, RSK2 blocks Fas-induced apoptosis through its phosphorylation of caspase-8. These data provide a direct link between RSK2 and caspase-8 and identify a novel molecular mechanism for caspase-8 modulation by RSK2.	[Peng, Cong; Cho, Yong-Yeon; Zhu, Feng; Zhang, Jishuai; Wen, Weihong; Xu, Yanming; Yao, Ke; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/C-1303-2010; 温, 家琦/GYV-3177-2022; Cho, Yong-Yeon/AAD-4263-2020; peng, cong/A-9454-2012	Zhu, Feng/0000-0003-1172-0102; Cho, Yong-Yeon/0000-0003-1107-2651	Hormel Foundation; National Institutes of Health [CA077646, CA111536, CA120388, CA027502, ES016548]; NATIONAL CANCER INSTITUTE [R01CA120388, R01CA077646, P01CA027502, R01CA111536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by The Hormel Foundation and by National Institutes of Health Grants CA077646, CA111536, CA120388, CA027502, and ES016548.	Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2007, J BIOL CHEM, V282, P8380, DOI 10.1074/jbc.M611322200; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Huang HK, 2000, J BIOL CHEM, V275, P26661; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Mahadevan Louis C, 2004, Novartis Found Symp, V259, P102; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Peng C, 2010, FASEB J, V24, P3490, DOI 10.1096/fj.09-151290; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; Vaidyanathan H, 2003, J BIOL CHEM, V278, P32367, DOI 10.1074/jbc.M303988200; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	27	35	38	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6946	6954		10.1074/jbc.M110.172338	http://dx.doi.org/10.1074/jbc.M110.172338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21183680	Green Published, hybrid			2022-12-25	WOS:000287737300010
J	Tochowicz, A; Goettig, P; Evans, R; Visse, R; Shitomi, Y; Palmisano, R; Ito, N; Richter, K; Maskos, K; Franke, D; Svergun, D; Nagase, H; Bode, W; Itoh, Y				Tochowicz, Anna; Goettig, Peter; Evans, Richard; Visse, Robert; Shitomi, Yasuyuki; Palmisano, Ralf; Ito, Noriko; Richter, Klaus; Maskos, Klaus; Franke, Daniel; Svergun, Dmitri; Nagase, Hideaki; Bode, Wolfram; Itoh, Yoshifumi			The Dimer Interface of the Membrane Type 1 Matrix Metalloproteinase Hemopexin Domain CRYSTAL STRUCTURE AND BIOLOGICAL FUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCATTERING DATA-ANALYSIS; C-TERMINAL DOMAIN; CELL-MIGRATION; GELATINASE-A; PROMMP-2 ACTIVATION; TUMOR-CELLS; MT1-MMP; SURFACE; INVASION; COLLAGENASE	Homodimerization is an essential step for membrane type 1 matrix metalloproteinase (MT1-MMP) to activate proMMP-2 and to degrade collagen on the cell surface. To uncover the molecular basis of the hemopexin (Hpx) domain-driven dimerization of MT1-MMP, a crystal structure of the Hpx domain was solved at 1.7 angstrom resolution. Two interactions were identified as potential biological dimer interfaces in the crystal structure, and mutagenesis studies revealed that the biological dimer possesses a symmetrical interaction where blades II and III of molecule A interact with blades III and II of molecule B. The mutations of amino acids involved in the interaction weakened the dimer interaction of Hpx domains in solution, and incorporation of these mutations into the full-length enzyme significantly inhibited dimer-dependent functions on the cell surface, including proMMP-2 activation, collagen degradation, and invasion into the three-dimensional collagen matrix, whereas dimer-independent functions, including gelatin film degradation and two-dimensional cell migration, were not affected. These results shed light on the structural basis of MT1-MMP dimerization that is crucial to promote cellular invasion.	[Evans, Richard; Visse, Robert; Shitomi, Yasuyuki; Palmisano, Ralf; Ito, Noriko; Nagase, Hideaki; Itoh, Yoshifumi] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst, Dept Matrix Biol,Rheumatol Div, London W6 8LH, England; [Maskos, Klaus; Bode, Wolfram] Max Planck Inst Biochem, Arbeitsgrp Proteinaseforsch, D-82152 Martinsried, Germany; [Richter, Klaus] Tech Univ Munich, Inst Organ Chem & Biochem, D-85747 Munich, Germany; [Franke, Daniel; Svergun, Dmitri] DESY, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany	Imperial College London; University of Oxford; Max Planck Society; Technical University of Munich; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Itoh, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst, Dept Matrix Biol,Rheumatol Div, 65 Aspenlea Rd, London W6 8LH, England.	y.itoh@imperial.ac.uk	Goettig, Peter/R-7996-2017; Richter, Klaus/A-2673-2010; Goettig, Peter/K-4508-2019	Goettig, Peter/0000-0002-2430-1970; Richter, Klaus/0000-0002-8952-9642; Goettig, Peter/0000-0002-2430-1970; Svergun, Dmitri/0000-0003-0830-5696; Itoh, Yoshifumi/0000-0002-2128-2823; Palmisano, Ralf/0000-0003-4283-2115	National Institutes of Health [AR40994]; Cancer Research UK Project [C1507/A2670]; Arthritis Research UK (formerly Arthritis Research Campaign); Kennedy Institute of Rheumatology; Wellcome Trust [075473]; European Union [QLK3-CT-2002-02136, LSH-2002-2.2, LSHG-2006-018830]; Medical Research Council [G0802007] Funding Source: researchfish; MRC [G0802007] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK Project(Cancer Research UK); Arthritis Research UK (formerly Arthritis Research Campaign)(Versus Arthritis); Kennedy Institute of Rheumatology; Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR40994. This work was also supported by Cancer Research UK Project Grant C1507/A2670, an Arthritis Research UK (formerly Arthritis Research Campaign) core grant for the Kennedy Institute of Rheumatology, Wellcome Trust Programme Grant 075473, and European Union Projects QLK3-CT-2002-02136 (MMP profiling), LSH-2002-2.2 (cancer degradome), and LSHG-2006-018830 (CAMP).	ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Gohlke U, 1996, FEBS LETT, V378, P126, DOI 10.1016/0014-5793(95)01435-7; Gomis-Ruth F. X., 2004, HDB METALLOPROTEINS, P631; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; Ingvarsen S, 2008, BIOL CHEM, V389, P943, DOI 10.1515/BC.2008.097; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2008, J BIOL CHEM, V283, P13053, DOI 10.1074/jbc.M709327200; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Li YY, 2004, CANCER RES, V64, P7058, DOI 10.1158/0008-5472.CAN-04-1038; LIBSON AM, 1995, NAT STRUCT BIOL, V2, P938, DOI 10.1038/nsb1195-938; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Miller MC, 2009, ARTHRITIS RHEUM-US, V60, P686, DOI 10.1002/art.24331; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SWAMY M, 2006, SCI STKE, pPL14; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200	51	47	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7587	7600		10.1074/jbc.M110.178434	http://dx.doi.org/10.1074/jbc.M110.178434			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193411	Green Published, hybrid			2022-12-25	WOS:000287737300072
J	Moulay, G; Boutin, S; Masurier, C; Scherman, D; Kichler, A				Moulay, Gilles; Boutin, Sylvie; Masurier, Carole; Scherman, Daniel; Kichler, Antoine			Polymers for Improving the In Vivo Transduction Efficiency of AAV2 Vectors	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; HEPARAN-SULFATE PROTEOGLYCAN; GENE-TRANSFER; SYSTEMIC DELIVERY; POINT MUTATIONS; VIRAL VECTORS; EXPRESSION; TROPISM; MUSCLE; ADENOVIRUS	Background: Adeno-associated virus has attracted great attention as vehicle for body-wide gene delivery. However, for the successful treatment of a disease such as Duchenne muscular dystrophy infusion of very large amounts of vectors is required. This not only raises questions about the technical feasibility of the large scale production but also about the overall safety of the approach. One way to overcome these problems would be to find strategies able to increase the in vivo efficiency. Methodology: Here, we investigated whether polymers can act as adjuvants to increase the in vivo efficiency of AAV2. Our strategy consisted in the pre-injection of polymers before intravenous administration of mice with AAV2 encoding a murine secreted alkaline phosphatase (mSeAP). The transgene expression, vector biodistribution and tissue transduction were studied by quantification of the mSeAP protein and real time PCR. The injection of polyinosinic acid and polylysine resulted in an increase of plasmatic mSeAP of 2- and 12-fold, respectively. Interestingly, polyinosinic acid pre-injection significantly reduced the neutralizing antibody titer raised against AAV2. Conclusions: Our results show that the pre-injection of polymers can improve the overall transduction efficiency of systemically administered AAV2 and reduce the humoral response against the capsid proteins.	[Moulay, Gilles; Boutin, Sylvie; Masurier, Carole; Kichler, Antoine] Genethon, Res Dept, Evry, France; [Scherman, Daniel; Kichler, Antoine] Univ Paris 05, CNRS, U1022, UMR 8151,INSERM, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Moulay, G (corresponding author), Genethon, Res Dept, Evry, France.	akich@genethon.fr		Scherman, Daniel/0000-0003-1207-1298; Kichler, Antoine/0000-0003-0593-2424; MOULAY, Gilles/0000-0002-4913-9893	Association Francaise contre les Myopathies	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was funded by the Association Francaise contre les Myopathies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD LJ, 1979, P NATL ACAD SCI USA, V76, P3246, DOI 10.1073/pnas.76.7.3246; Bartlett JS, 2000, J VIROL, V74, P2777, DOI 10.1128/JVI.74.6.2777-2785.2000; Baskar JF, 1996, J VIROL, V70, P3207, DOI 10.1128/JVI.70.5.3207-3214.1996; Boucas J, 2009, J GENE MED, V11, P1103, DOI 10.1002/jgm.1392; Carlisle RC, 2008, J GENE MED, V10, P400, DOI 10.1002/jgm.1161; Cecchini S, 2008, GENE THER, V15, P823, DOI 10.1038/gt.2008.61; Douar AM, 2001, J VIROL, V75, P1824, DOI 10.1128/JVI.75.4.1824-1833.2001; Fein DE, 2009, MOL THER, V17, P2078, DOI 10.1038/mt.2009.173; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Haisma HJ, 2008, J GEN VIROL, V89, P1097, DOI 10.1099/vir.0.83495-0; Henderson JP, 2001, BIOCHEMISTRY-US, V40, P2052, DOI 10.1021/bi002015f; KAY MA, 1992, P NATL ACAD SCI USA, V89, P89, DOI 10.1073/pnas.89.1.89; Lee GK, 2005, BIOTECHNOL BIOENG, V92, P24, DOI 10.1002/bit.20562; MARKUSIC DM, 2010, MOL THER; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Perabo L, 2006, J VIROL, V80, P7265, DOI 10.1128/JVI.00076-06; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Walters RW, 2000, J VIROL, V74, P535, DOI 10.1128/JVI.74.1.535-540.2000; Wang MP, 2001, GENE, V279, P99, DOI 10.1016/S0378-1119(01)00754-5; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yang L, 2009, P NATL ACAD SCI USA, V106, P3946, DOI 10.1073/pnas.0813207106; Yang YW, 2001, PHARMACEUT RES, V18, P922, DOI 10.1023/A:1010923924844; Yeung SN, 1999, GENE THER, V6, P1536, DOI 10.1038/sj.gt.3300980; Yu CY, 2009, GENE THER, V16, P953, DOI 10.1038/gt.2009.59; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zhu T, 2005, CIRCULATION, V112, P2650, DOI 10.1161/CIRCULATIONAHA.105.565598	29	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15576	10.1371/journal.pone.0015576	http://dx.doi.org/10.1371/journal.pone.0015576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203395	Green Published, Green Submitted, gold			2022-12-25	WOS:000285792500031
J	Petersen, K; Qiu, JL; Lutje, J; Fiil, BK; Hansen, S; Mundy, J; Petersen, M				Petersen, Klaus; Qiu, Jin-Long; Lutje, Juri; Fiil, Berthe Katrine; Hansen, Sidsel; Mundy, John; Petersen, Morten			Arabidopsis MKS1 Is Involved in Basal Immunity and Requires an Intact N-terminal Domain for Proper Function	PLOS ONE			English	Article							PROTEIN-KINASES; BINDING PROTEIN; SALICYLIC-ACID; DOCKING-SITE; EDS1; SPECIFICITY; RESISTANCE; REGULATOR; PATHWAYS	Background: Innate immune signaling pathways in animals and plants are regulated by mitogen-activated protein kinase (MAPK) cascades. MAP kinase 4 (MPK4) functions downstream of innate immune receptors via a nuclear substrate MKS1 to regulate the activity of the WRKY33 transcription factor, which in turn controls the production of anti-microbial phytoalexins. Methodology/Principal Findings: We investigate the role of MKS1 in basal resistance and the importance of its N- and C-terminal domains for MKS1 function. We used the information that mks1 loss-of-function partially suppresses the mpk4 loss-of-function phenotype, and that transgenic expression of functional MKS1 in mpk4/mks1 double mutants reverted the mpk4 dwarf phenotype. Transformation of mks1/mpk4 with mutant versions of MKS1 constructs showed that a single amino acid substitution in a putative MAP kinase docking domain, MKS1-L32A, or a truncated MKS1 version unable to interact with WRKY33, were deficient in reverting the double mutant to the mpk4 phenotype. These results demonstrate functional requirement in MKS1 for the interaction with MPK4 and WRKY33. In addition, nuclear localization of MKS1 was shown to depend on an intact N-terminal domain. Furthermore, loss-of-function mks1 mutants exhibited increased susceptibility to strains of Pseudomonas syringae and Hyaloperonospora arabidopsidis, indicating that MKS1 plays a role in basal defense responses. Conclusions: Taken together, our results indicate that MKS1 function and subcellular location requires an intact N-terminus important for both MPK4 and WRKY33 interactions.	[Petersen, Klaus; Qiu, Jin-Long; Lutje, Juri; Fiil, Berthe Katrine; Hansen, Sidsel; Mundy, John; Petersen, Morten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Petersen, K (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	shutko@bio.ku.dk	Petersen, Morten/J-5023-2014; mundy, john/A-2361-2013	Petersen, Morten/0000-0002-3035-5991; mundy, john/0000-0001-7490-4588; Fiil, Berthe Katrine/0000-0002-9499-4848; Qiu, Jin-Long/0000-0001-8054-2552	Danish Research Councils [23020101, 23030076, 272050367, 272060049]	Danish Research Councils(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Research Councils to MP (23020101) and JM (23030076, 272050367 and 272060049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bi DL, 2010, PLANT PHYSIOL, V153, P1771, DOI 10.1104/pp.110.158501; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; Caspersen MB, 2007, BBA-PROTEINS PROTEOM, V1774, P1156, DOI 10.1016/j.bbapap.2007.07.002; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Morikawa K, 2002, FEBS LETT, V514, P300, DOI 10.1016/S0014-5793(02)02388-8; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Narusaka M, 2008, J GEN PLANT PATHOL, V74, P345, DOI 10.1007/s10327-008-0117-1; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Perruc E, 2004, PLANT J, V38, P410, DOI 10.1111/j.1365-313X.2004.02062.x; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Xie YD, 2010, PLANT CELL ENVIRON, V33, P828, DOI 10.1111/j.1365-3040.2009.02109.x; Yang SH, 1999, MOL CELL BIOL, V19, P4028	26	52	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14364	10.1371/journal.pone.0014364	http://dx.doi.org/10.1371/journal.pone.0014364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203436	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500002
J	Garske, T; Ghani, AC				Garske, Tini; Ghani, Azra C.			Uncertainty in the Tail of the Variant Creutzfeldt-Jakob Disease Epidemic in the UK	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; BLOOD-TRANSFUSION; VCJD EPIDEMIC; PROJECTIONS; INFECTIVITY; RISK; CJD	Despite low case numbers the variant Creutzfeldt-Jakob disease epidemic poses many challenges for public health planning due to remaining uncertainties in disease biology and transmission routes. We develop a stochastic model for variant CJD transmission, taking into account the known transmission routes (food and red-cell transfusion) to assess the remaining uncertainty in the epidemic. We use Bayesian methods to obtain scenarios consistent with current data. Our results show a potentially long but uncertain tail in the epidemic, with a peak annual incidence of around 11 cases, but the 95% credibility interval between 1 and 65 cases. These cases are predicted to be due to past food-borne transmissions occurring in previously mostly unaffected genotypes and to transmissions via blood transfusion in all genotypes. However, we also show that the latter are unlikely to be identifiable as transfusion-associated cases by case-linking. Regardless of the numbers of future cases, even in the absence of any further control measures, we do not find any self-sustaining epidemics.	[Garske, Tini; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Med Res Council, Ctr Outbreak Anal & Modelling, London, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Garske, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Med Res Council, Ctr Outbreak Anal & Modelling, London, England.	t.garske@imperial.ac.uk	Ghani, Azra/B-8560-2009	Ghani, Azra/0000-0002-0007-4910	Medical Research Council Centre	Medical Research Council Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Centre funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 1999, LANCET, V353, P1673, DOI 10.1016/S0140-6736(99)01342-2; CARLIN BP, 2000, C&H TEXT STAT SCI, P1; Chohan G, 2010, TRANSFUSION, V50, P1003, DOI 10.1111/j.1537-2995.2010.02614.x; Clarke P, 2005, J R SOC INTERFACE, V2, P19, DOI 10.1098/rsif.2004.0017; Clarke P, 2007, J R SOC INTERFACE, V4, P675, DOI 10.1098/rsif.2007.0216; Clewley JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1442; Collins SJ, 2004, LANCET, V363, P51, DOI 10.1016/S0140-6736(03)15171-9; Cooper J D, 2002, J Cancer Epidemiol Prev, V7, P49, DOI 10.1080/147666502321082719; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; *DEFRA, 2010, BOV SPONG ENC BSE; Dietz K, 2007, EMERG INFECT DIS, V13, P89, DOI 10.3201/eid1301.060396; Dobra SA, 2006, TRANSFUS CLIN BIOL, V13, P307, DOI 10.1016/j.tracli.2006.11.007; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Garske T, 2006, J R SOC INTERFACE, V3, P757, DOI 10.1098/rsif.2006.0142; Ghani AC, 2003, STAT METHODS MED RES, V12, P191, DOI 10.1191/0962280203sm327ra; Ghani AC, 1998, P ROY SOC B-BIOL SCI, V265, P2443, DOI 10.1098/rspb.1998.0596; GHANI AC, 2003, BMC INFECT DIS, V3; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Heath CA, 2010, ANN NEUROL, V67, P761, DOI 10.1002/ana.21987; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; *HPA, 2007, HLTH PROT REP; Kaski D, 2009, LANCET, V374, P2128, DOI 10.1016/S0140-6736(09)61568-3; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; *NAT CJD SURV UN, 2010, CJD STAT; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; *SEAC, 2008, POS STAT PREV SUBCL; St Rose SG, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-5; Turner ML, 2009, BRIT J HAEMATOL, V144, P14, DOI 10.1111/j.1365-2141.2008.07376.x; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; Wallis JP, 2004, TRANSFUSION, V44, P1025, DOI 10.1111/j.1537-2995.2004.03400.x; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Yan ZX, 2004, INFECT CONT HOSP EP, V25, P280, DOI 10.1086/502392	35	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15626	10.1371/journal.pone.0015626	http://dx.doi.org/10.1371/journal.pone.0015626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203419	Green Submitted, Green Published, gold			2022-12-25	WOS:000285579200027
J	Wakida, NM; Botvinick, EL; Lin, J; Berns, MW				Wakida, Nicole M.; Botvinick, Elliot L.; Lin, Justin; Berns, Michael W.			An Intact Centrosome Is Required for the Maintenance of Polarization during Directional Cell Migration	PLOS ONE			English	Article							MOTILE CELLS; CYCLE PROGRESSION; MICROTUBULES; FIBROBLASTS; LASER; ADHESIONS; POLARITY	Background: Establishing and maintaining polarization is critical during cell migration. It is known that the centrosome contains numerous proteins whose roles of organizing the microtubule network range include nucleation, stabilization and severing. It is not known whether the centrosome is necessary to maintain polarization. Due to its role as the microtubule organizing center, we hypothesize that the centrosome is necessary to maintain polarization in a migrating cell. Although there have been implications of its role in cell migration, there is no direct study of the centrosome's role in maintaining polarization. In this study we ablate the centrosome by intracellular laser irradiation to understand the role of the centrosome in two vastly different cell types, human osteosarcoma (U2OS) and rat kangaroo kidney epithelial cells (PtK). The PtK cell line has been extensively used as a model for cytoskeletal dynamics during cell migration. The U2OS cell line serves as a model for a complex, single migrating cell. Methodology/Principal Findings: In this study we use femtosecond near-infrared laser irradiation to remove the centrosome in migrating U2OS and PtK2 cells. Immunofluorescence staining for centrosomal markers verified successful irradiation with 94% success. A loss of cell polarization is observed between 30 and 90 minutes following removal of the centrosome. Changes in cell shape are correlated with modifications in microtubule and actin organization. Changes in cell morphology and microtubule organization were quantified revealing significant depolarization resulting from centrosome irradiation. Conclusions/Significance: This study demonstrates that the centrosome is necessary for the maintenance of polarization during directed cell migration in two widely different cell types. Removal of the centrosome from a polarized cell results in the reorganization of the microtubule network into a symmetric non-polarized phenotype. These results demonstrate that the centrosome plays a critical role in the maintenance of cytoskeletal asymmetry during cell migration.	[Wakida, Nicole M.; Botvinick, Elliot L.; Berns, Michael W.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92623 USA; [Botvinick, Elliot L.; Lin, Justin; Berns, Michael W.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Wakida, NM (corresponding author), Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92623 USA.	mwberns@uci.edu		Berns, Michael/0000-0002-9640-2885	Air Force Office of Scientific Research; National Institutes of Health, National Center for Research Resources [P41RR001192]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by grants from the Air Force Office of Scientific Research and from the National Institutes of Health, National Center for Research Resources, grant # P41RR001192. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHTBUEHLER G, 1979, EXP CELL RES, V120, P111, DOI 10.1016/0014-4827(79)90542-1; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Botvinick EL, 2004, BIOPHYS J, V87, P4203, DOI 10.1529/biophysj.104.049528; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; Grigoriev I, 2006, CELL MOTIL CYTOSKEL, V63, P29, DOI 10.1002/cm.20107; Khodjakov A, 1997, CELL MOTIL CYTOSKEL, V38, P311, DOI 10.1002/(SICI)1097-0169(1997)38:4<311::AID-CM1>3.3.CO;2-M; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; KOONCE MP, 1984, J CELL BIOL, V98, P1999, DOI 10.1083/jcb.98.6.1999; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; SCHUTZE K, 1991, P NATL ACAD SCI USA, V88, P8367, DOI 10.1073/pnas.88.19.8367; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Wakida NM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2718920; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Xu JS, 2007, P NATL ACAD SCI USA, V104, P9296, DOI 10.1073/pnas.0703153104; Yvon AMC, 2002, MOL BIOL CELL, V13, P1871, DOI 10.1091/mbc.01-11-0539	25	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15462	10.1371/journal.pone.0015462	http://dx.doi.org/10.1371/journal.pone.0015462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203421	Green Submitted, gold, Green Published			2022-12-25	WOS:000285579200022
J	Gong, C; Yao, HR; Liu, QA; Chen, JQ; Shi, JW; Su, FX; Song, EW				Gong, Chang; Yao, Herui; Liu, Qiang; Chen, Jingqi; Shi, Junwei; Su, Fengxi; Song, Erwei			Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; SIDE POPULATION; RESISTANCE; THERAPEUTICS; CULTURE; NOTCH	Purpose: Evidence is lacking whether the number of breast tumor-initiating cells (BT-ICs) directly correlates with the sensitivity of breast tumors to chemotherapy. Here, we evaluated the association between proportion of BT-ICs and chemoresistance of the tumors. Methods: Immunohistochemical staining(IHC) was used to examine the expression of aldehyde dehydrogenase 1 (ALDH1) and proliferating cell nuclear antigen, and TUNEL was used to detect the apoptosis index. The significance of various variables in patient survival was analyzed using a Cox proportional hazards model. The percentage of BT-ICs in breast cancer cell lines and primary breast tumors was determined by ALDH1 enzymatic assay, CD44(+)/CD24(-) phenotype and mammosphere formation assay. Results: ALDH1 expression determined by IHC in primary breast cancers was associated with poor clinical response to neoadjuvant chemotherapy and reduced survival in breast cancer patients. Breast tumors that contained higher proportion of BT-ICs with CD44(+)/CD24(-) phenotype, ALDH1 enzymatic activity and sphere forming capacity were more resistant to neoadjuvant chemotherapy. Chemoresistant cell lines AdrR/MCF-7 and SK-3rd, had increased number of cells with sphere forming capacity, CD44(+)/CD24(-) phenotype and side-population. Regardless the proportion of T-ICs, FACS-sorted CD44(+)/CD24(-) cells that derived from primary tumors or breast cancer lines were about 10-60 fold more resistant to chemotherapy relative to the non-CD44(+)/CD24(-) cells and their parental cells. Furthermore, our data demonstrated that MDR1 (multidrug resistance 1) and ABCG2 (ATP-binding cassette sub-family G member 2) were upregulated in CD44(+)/CD24(-) cells. Treatment with lapatinib or salinomycin reduced the proportion of BT-ICs by nearly 50 fold, and thus enhanced the sensitivity of breast cancer cells to chemotherapy by around 30 fold. Conclusions: These data suggest that the proportion of BT-ICs is associated with chemotherapeutic resistance of breast cancer. It highlights the importance of targeting T-ICs, rather than eliminating the bulk of rapidly dividing and terminally differentiated cells, in novel anti-cancer strategies.	[Gong, Chang; Yao, Herui; Liu, Qiang; Chen, Jingqi; Shi, Junwei; Su, Fengxi; Song, Erwei] Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Qiang] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Song, Erwei] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Harvard University; Dana-Farber Cancer Institute; Sun Yat Sen University	Gong, C (corresponding author), Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	songerwei02@yahoo.com.cn	Liu, Qiang/HHZ-3181-2022	Liu, Qiang/0000-0002-5451-4862	National Natural Science Foundation of China [30772550, 30801376, 30830110, 30831160515, 30921140312, 30973505]; Research Fund for the Doctoral Program of Higher Education (RFDP) [20070558248]; Sun Yat-Sen Excellent Medicine Youth Project [F002008010]; Ministry of Science and Technology of China [2010CB912800, 2009CB521706, 2005CB724605]; Science Foundation of Guangdong Province [8251008901000011, 2009B030801005]; foundation of Guangzhou Science and Technology Bureau [2009Y-C011-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Sun Yat-Sen Excellent Medicine Youth Project; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); foundation of Guangzhou Science and Technology Bureau	This work was supported by grants from the National Natural Science Foundation of China (30772550, 30801376, 30830110, 30831160515, 30921140312, 30973505), The Research Fund for the Doctoral Program of Higher Education (RFDP) (20070558248), Sun Yat-Sen Excellent Medicine Youth Project (F002008010), 973 (2010CB912800, 2009CB521706, 2005CB724605) Projects from Ministry of Science and Technology of China, Science Foundation of Guangdong Province (8251008901000011, 2009B030801005) and foundation of Guangzhou Science and Technology Bureau (2009Y-C011-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McClelland RA, 2001, ENDOCRINOLOGY, V142, P2776, DOI 10.1210/en.142.7.2776; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Senderowicz AM, 2003, CANCER CHEMOTH PHARM, V52, pS61, DOI 10.1007/s00280-003-0624-x; Shi W, 2006, J MAMMARY GLAND BIOL, V11, P41, DOI 10.1007/s10911-006-9011-7; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Xiao Z, 2005, ONCOGENE, V24, P1403, DOI 10.1038/sj.onc.1208309; Yin LQ, 2008, CANCER RES, V68, P800, DOI 10.1158/0008-5472.CAN-07-2545; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	28	51	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15630	10.1371/journal.pone.0015630	http://dx.doi.org/10.1371/journal.pone.0015630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187973	Green Published, Green Submitted, gold			2022-12-25	WOS:000285575200051
J	Ma, LS; Bradu, A; Podoleanu, AG; Bloor, JW				Ma, Lisha; Bradu, Adrian; Podoleanu, Adrian Gh.; Bloor, James W.			Arrhythmia Caused by a Drosophila Tropomyosin Mutation Is Revealed Using a Novel Optical Coherence Tomography Instrument	PLOS ONE			English	Article							DILATED CARDIOMYOPATHY; HEART DEVELOPMENT; MELANOGASTER HEART; POTASSIUM CHANNEL; TARGETED ABLATION; LARVAL HEART; GENES; FAILURE; DEVELOP; TINMAN	Background: Dilated cardiomyopathy (DCM) is a severe cardiac condition that causes high mortality. Many genes have been confirmed to be involved in this disease. An ideal system with which to uncover disease mechanisms would be one that can measure the changes in a wide range of cardiac activities associated with mutations in specific, diversely functional cardiac genes. Such a system needs a genetically manipulable model organism that allows in vivo measurement of cardiac phenotypes and a detecting instrument capable of recording multiple phenotype parameters. Methodology and Principal Findings: With a simple heart, a transparent body surface at larval stages and available genetic tools we chose Drosophila melanogaster as our model organism and developed for it a dual en-face/Doppler optical coherence tomography (OCT) instrument capable of recording multiple aspects of heart activity, including heart contraction cycle dynamics, ostia dynamics, heartbeat rate and rhythm, speed of heart wall movement and light reflectivity of cardiomyocytes in situ. We applied this OCT instrument to a model of Tropomyosin-associated DCM established in adult Drosophila. We show that DCM pre-exists in the larval stage and is accompanied by an arrhythmia previously unidentified in this model. We also detect reduced mobility and light reflectivity of cardiomyocytes in mutants. Conclusion: These results demonstrate the capability of our OCT instrument to characterize in detail cardiac activity in genetic models for heart disease in Drosophila.	[Ma, Lisha; Bloor, James W.] Univ Kent, Sch Biosci, Cell & Dev Biol Grp, Canterbury, Kent, England; [Bradu, Adrian; Podoleanu, Adrian Gh.] Univ Kent, Sch Phys Sci, Appl Opt Grp, Canterbury, Kent, England	University of Kent; University of Kent	Ma, LS (corresponding author), Bournemouth Univ, Sch Appl Sci, Talbot Campus, Poole BH12 5BB, Dorset, England.	lma@bournemouth.ac.uk	Podoleanu, Adrian/F-7094-2012; Bradu, Adrian/D-2312-2011	Podoleanu, Adrian/0000-0002-4899-9656; Bradu, Adrian/0000-0002-6890-1599	United Kingdom Biotechnology and Biological Sciences Research Council [BBSRC-BB/E002870/1]; European Research Council [249889]; BBSRC [BB/E002870/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E002870/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been supported by United Kingdom Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/science/initiatives/tdri.html) grant BBSRC-BB/E002870/1. Adrian Bradu and Adrian Podoleanu have also been supported by the European Research Council ( http://erc.europa.eu/) grant 249889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; BODMER R, 1993, DEVELOPMENT, V118, P719; Bradu A, 2009, J BIOPHOTONICS, V2, P380, DOI 10.1002/jbio.200910021; Choma MA, 2006, CIRCULATION, V114, pE35, DOI 10.1161/CIRCULATIONAHA.105.593541; Cooper AS, 2009, J VIS EXP, V32; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Dasari S, 2006, J COMP PHYSIOL B, V176, P349, DOI 10.1007/s00360-005-0058-3; Davis AM, 2008, J OPT SOC AM A, V25, P3134, DOI 10.1364/JOSAA.25.003134; Desai-Shah M., 2010, OPEN PHYSL J, V3, P16; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Hedman A, 2004, J MOL CELL CARDIOL, V36, P607, DOI 10.1016/j.yjmcc.2004.01.012; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Izatt SD, 2005, P SOC PHOTO-OPT INS, V5701, P122, DOI 10.1117/12.596122; Jenkins MW, 2006, OPT EXPRESS, V14, P736, DOI 10.1364/OPEX.14.000736; Lalevee N, 2006, CURR BIOL, V16, P1502, DOI 10.1016/j.cub.2006.05.064; Liang XQ, 2009, CIRCULATION, V120, P568, DOI 10.1161/CIRCULATIONAHA.109.864686; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Monier B, 2005, DEVELOPMENT, V132, P5283, DOI 10.1242/dev.02091; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; PIRCHER M, 2007, P SOC PHOTO-OPT INS, pT4290; Podoleanu AG, 2005, BRIT J RADIOL, V78, P976, DOI 10.1259/bjr/55735832; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Rizki T.M., 1978, P397; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Slama L, 2005, J INSECT PHYSIOL, V51, P489, DOI 10.1016/j.jinsphys.2004.11.016; Vogler Georg, 2009, J Vis Exp, DOI 10.3791/1425; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Wu MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004045	36	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14348	10.1371/journal.pone.0014348	http://dx.doi.org/10.1371/journal.pone.0014348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179409	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000285572900001
J	Bagdure, D; Curtis, DJ; Dobyns, E; Glode, MP; Dominguez, SR				Bagdure, Dayanand; Curtis, Donna J.; Dobyns, Emily; Glode, Mary P.; Dominguez, Samuel R.			Hospitalized Children with 2009 Pandemic Influenza A (H1N1): Comparison to Seasonal Influenza and Risk Factors for Admission to the ICU	PLOS ONE			English	Article								Background: Limited data are available describing the clinical presentation and risk factors for admission to the intensive care unit for children with 2009 H1N1 infection. Methods: We conducted a retrospective chart review of all hospitalized children with 2009 influenza A (H1N1) and 2008-09 seasonal influenza at The Children's Hospital, Denver, Colorado. Results: Of the 307 children identified with 2009 H1N1 infections, the median age was 6 years, 61% were male, and 66% had underlying medical conditions. Eighty children (26%) were admitted to the ICU. Thirty-two (40%) of the ICU patients required intubation and 17 (53%) of the intubated patients developed acute respiratory distress syndrome (ARDS). Four patients required extracorporeal membrane oxygenation. Eight (3%) of the hospitalized children died. Admission to the ICU was significantly associated with older age and underlying neurological condition. Compared to the 90 children admitted during the 2008-09 season, children admitted with 2009 H1N1 influenza were significantly older, had a shorter length of hospitalization, more use of antivirals, and a higher incidence of ARDS. Conclusions: Compared to the 2008-09 season, hospitalized children with 2009 H1N1 influenza were much older and had more severe respiratory disease. Among children hospitalized with 2009 H1N1 influenza, risk factors for admission to the ICU included older age and having an underlying neurological condition. Children under the age of 2 hospitalized with 2009 H1N1 influenza were significantly less likely to require ICU care compared to older hospitalized children.	[Bagdure, Dayanand; Dobyns, Emily] Univ Colorado Sch Med, Childrens Hosp, Dept Pediat Crit Care, Aurora, CO USA; [Curtis, Donna J.; Glode, Mary P.; Dominguez, Samuel R.] Univ Colorado Sch Med, Childrens Hosp, Dept Pediat Infect Dis, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bagdure, D (corresponding author), Univ Colorado Sch Med, Childrens Hosp, Dept Pediat Crit Care, Aurora, CO USA.	samuel.dominguez@ucdenver.edu		CURTIS, DONNA/0000-0003-4657-4299	NIH/NCRR (National Center for Research Resources) Colorado CTSI (Clinical and Translational Science Institute) [1UL1 RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	NIH/NCRR (National Center for Research Resources) Colorado CTSI (Clinical and Translational Science Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by NIH/NCRR (National Center for Research Resources) Colorado CTSI (Clinical and Translational Science Institute) Grant Number 1UL1 RR025780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; COSTELLO BE, 2010, ANN EMERG MED; *ENV CDOHA, 2008, COL CHILD HLTH SURV; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Lister P, 2009, LANCET, V374, P605, DOI [10.1016/S0140-6736(09)61512-9, 10.1016/S0140-6736(09)61513-0]; Lockman JL, 2010, PEDIATR CRIT CARE ME, V11, P173, DOI 10.1097/PCC.0b013e3181ccedae; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P395, DOI 10.1097/01.inf.0000214988.81379.71; Silva LFF, 2009, AM J RESP CRIT CARE, V179	12	58	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15173	10.1371/journal.pone.0015173	http://dx.doi.org/10.1371/journal.pone.0015173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179517	gold, Green Published, Green Submitted			2022-12-25	WOS:000285340000018
J	Muller, D; Jagla, T; Bodart, LM; Jahrling, N; Dodt, HU; Jagla, K; Frasch, M				Mueller, Dominik; Jagla, Teresa; Bodart, Ludivine Mihaila; Jaehrling, Nina; Dodt, Hans-Ulrich; Jagla, Krzysztof; Frasch, Manfred			Regulation and Functions of the lms Homeobox Gene during Development of Embryonic Lateral Transverse Muscles and Direct Flight Muscles in Drosophila	PLOS ONE			English	Article							CELL FATES; PATTERN DIVERSIFICATION; THORACIC MUSCLES; HOMEOTIC GENES; KEY ROLE; EXPRESSION; DIFFERENTIATION; SPECIFICATION; MYOGENESIS; LADYBIRD	Background: Patterning and differentiation of developing musculatures require elaborate networks of transcriptional regulation. In Drosophila, significant progress has been made into identifying the regulators of muscle development and defining their interactive networks. One major family of transcription factors involved in these processes consists of homeodomain proteins. In flies, several members of this family serve as muscle identity genes to specify the fates of individual muscles, or groups thereof, during embryonic and/or adult muscle development. Herein, we report on the expression and function of a new Drosophila homeobox gene during both embryonic and adult muscle development. Methodology/Principal Findings: The newly described homeobox gene, termed lateral muscles scarcer (lms), which has yet uncharacterized orthologs in other invertebrates and primitive chordates but not in vertebrates, is expressed exclusively in subsets of developing muscle tissues. In embryos, lms is expressed specifically in the four lateral transverse (LT) muscles and their founder cells in each hemisegment, whereas in larval wing imaginal discs, it is expressed in myoblasts that develop into direct flight muscles (DFMs), which are important for proper wing positioning. We have analyzed the regulatory inputs of various other muscle identity genes with overlapping or complementary expression patterns towards the cell type specific regulation of lms expression. Further we demonstrate that lms null mutants exhibit reduced numbers of embryonic LT muscles, and null mutant adults feature held-out-wing phenotypes. We provide a detailed description of the pattern and morphology of the direct flight muscles in the wild type and lms mutant flies by using the recently-developed ultramicroscopy and show that, in the mutants, all DFMs are present and present normal morphologies. Conclusions/Significance: We have identified the homeobox gene lms as a new muscle identity gene and show that it interacts with various previously-characterized muscle identity genes to regulate normal formation of embryonic lateral transverse muscles. In addition, the direct flight muscles in the adults require lms for reliably exerting their functions in controlling wing postures.	[Mueller, Dominik; Frasch, Manfred] Univ Erlangen Nurnberg, Dept Biol, Div Dev Biol, Erlangen, Germany; [Mueller, Dominik; Bodart, Ludivine Mihaila; Frasch, Manfred] Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY USA; [Jagla, Teresa; Jagla, Krzysztof] Clermont Univ, CNRS, UMR6247, INSERM,U931, Clermont Ferrand, France; [Jaehrling, Nina; Dodt, Hans-Ulrich] Vienna Univ Technol, Dept Bioelect, Inst Solid State Elect FKE, A-1040 Vienna, Austria; [Jaehrling, Nina; Dodt, Hans-Ulrich] Med Univ Vienna, Sect Bioelect, Ctr Brain Res, Vienna, Austria; [Jaehrling, Nina] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-2900 Oldenburg, Germany	University of Erlangen Nuremberg; Icahn School of Medicine at Mount Sinai; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Technische Universitat Wien; Medical University of Vienna; Carl von Ossietzky Universitat Oldenburg	Muller, D (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Div Dev Biol, Erlangen, Germany.	mfrasch@biologie.uni-erlangen.de	Frasch, Manfred/H-7002-2013; Jagla, Krzysztof/E-4144-2016	Frasch, Manfred/0000-0003-1373-9798; Jagla, Krzysztof/0000-0003-4965-8818; Teresa, Jagla/0000-0002-9277-6089	National Institutes of Health [HD30832]; Hertie-Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hertie-Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	National Institutes of Health (HD30832) to MF (http://www.nichd.nih.gov), Hertie-Foundation to HUD (http://www.ghst.de/en/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Balagopalan L, 2001, DEV BIOL, V231, P374, DOI 10.1006/dbio.2001.0162; BATE M, 1991, DEVELOPMENT, V113, P79; BATE M, 1993, DEV DROSOPHILA MELAN, P1023; Becker K, 2008, J BIOPHOTONICS, V1, P36, DOI 10.1002/jbio.200710011; Beckett K, 2006, INT REV NEUROBIOL, V75, P55, DOI 10.1016/S0074-7742(06)75003-6; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Bernard F, 2006, DEV BIOL, V295, P164, DOI 10.1016/j.ydbio.2006.03.022; Bernard F, 2003, DEV BIOL, V260, P391, DOI 10.1016/S0012-1606(03)00255-0; BOURGOUIN C, 1992, NEURON, V9, P549, DOI 10.1016/0896-6273(92)90192-G; BRAND AH, 1993, DEVELOPMENT, V118, P401; Capovilla M, 2001, DEVELOPMENT, V128, P1221; Crozatier M, 1999, DEVELOPMENT, V126, P1495; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; DOHRMANN C, 1990, GENE DEV, V4, P2098, DOI 10.1101/gad.4.12a.2098; Duan H, 2007, DEVELOPMENT, V134, P3985, DOI 10.1242/dev.008821; DUTTA D, 2005, DROSOPHILA MUSCLE DE; Enriquez J, 2010, DEVELOPMENT, V137, P457, DOI 10.1242/dev.045286; FERNANDES J, 1991, DEVELOPMENT, V113, P67; FERNANDES J, 1994, CURR BIOL, V4, P957, DOI 10.1016/S0960-9822(00)00219-0; Fujioka M, 2005, CIRC RES, V97, P1108, DOI 10.1161/01.RES.0000191546.08532.B2; Ghazi A, 2000, DEVELOPMENT, V127, P5309; Hartmann C, 1997, EMBO J, V16, P5299, DOI 10.1093/emboj/16.17.5299; HOOPER JE, 1986, EMBO J, V5, P2321, DOI 10.1002/j.1460-2075.1986.tb04500.x; Isshiki T, 1997, DEVELOPMENT, V124, P3099; Jahrling N, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/neuro.06.001.2010; Jagla K, 1997, DEVELOPMENT, V124, P3471; Jagla T, 1998, DEVELOPMENT, V125, P3699; Junion G, 2007, GENE DEV, V21, P3163, DOI 10.1101/gad.437307; Kehl BT, 1998, DEVELOPMENT, V125, P1217; KING DG, 1983, J EXP BIOL, V105, P231; Knirr S, 1999, DEVELOPMENT, V126, P4525; Kozopas KM, 2002, DEV BIOL, V243, P312, DOI 10.1006/dbio.2002.0572; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LAWRENCE PA, 1982, CELL, V29, P493, DOI 10.1016/0092-8674(82)90166-0; Liotta D, 2007, CURR BIOL, V17, P1409, DOI 10.1016/j.cub.2007.07.039; Maqbool T, 2007, J MUSCLE RES CELL M, V28, P397, DOI 10.1007/s10974-008-9133-1; Maqbool T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000122; MICHELSON AM, 1994, DEVELOPMENT, V120, P755; Miller A., 1950, BIOL DROSOPHILA, P420; MIYAN JA, 1985, PHILOS T ROY SOC B, V311, P271, DOI 10.1098/rstb.1985.0154; Muller D, 2005, GENETICS, V171, P1137, DOI 10.1534/genetics.105.044453; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Nose A, 1998, DEVELOPMENT, V125, P215; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Rivlin PK, 2001, DEV GENES EVOL, V211, P55, DOI 10.1007/s004270000126; Roy S, 1999, BIOESSAYS, V21, P486, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;486::AID-BIES5&gt;3.0.CO;2-M; Roy S, 1997, DEVELOPMENT, V124, P3333; Roy S, 1998, J CELL BIOL, V141, P1135, DOI 10.1083/jcb.141.5.1135; ROY S, 2005, DROSOPHILA MUSCLE DE; RuizGomez M, 1997, DEVELOPMENT, V124, P3407; Russell S, 2000, MOL GEN GENET, V263, P690, DOI 10.1007/s004380051218; Satou Y, 2008, DEV GENES EVOL, V218, P715, DOI 10.1007/s00427-008-0219-y; Smith ST, 1996, DEVELOPMENT, V122, P3141; Soler C, 2004, DEVELOPMENT, V131, P6041, DOI 10.1242/dev.01527; Sudarsan V, 2001, DEV CELL, V1, P829, DOI 10.1016/S1534-5807(01)00089-2; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Zhong YF, 2008, EVOL DEV, V10, P516, DOI 10.1111/j.1525-142X.2008.00266.x; Zikova M, 2003, P NATL ACAD SCI USA, V100, P12189, DOI 10.1073/pnas.2133156100	60	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14323	10.1371/journal.pone.0014323	http://dx.doi.org/10.1371/journal.pone.0014323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179520	Green Published, Green Submitted, gold			2022-12-25	WOS:000285340000003
J	Hertting, O; Holm, A; Luthje, P; Brauner, H; Dyrdak, R; Jonasson, AF; Wiklund, P; Chromek, M; Brauner, A				Hertting, Olof; Holm, Asa; Luthje, Petra; Brauner, Hanna; Dyrdak, Robert; Jonasson, Aino Fianu; Wiklund, Peter; Chromek, Milan; Brauner, Annelie			Vitamin D Induction of the Human Antimicrobial Peptide Cathelicidin in the Urinary Bladder	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; D DEFICIENCY; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE; EPITHELIAL-CELLS; EXPRESSION; TUBERCULOSIS; POPULATION; RESPONSES; IMMUNITY; HEALTH	The urinary tract is frequently being exposed to potential pathogens and rapid defence mechanisms are therefore needed. Cathelicidin, a human antimicrobial peptide is expressed and secreted by bladder epithelial cells and protects the urinary tract from infection. Here we show that vitamin D can induce cathelicidin in the urinary bladder. We analyzed bladder tissue from postmenopausal women for expression of cathelicidin, before and after a three-month period of supplementation with 25-hydroxyvitamin D(3) (25D(3)). Cell culture experiments were performed to elucidate the mechanisms for cathelicidin induction. We observed that, vitamin D per se did not up-regulate cathelicidin in serum or in bladder tissue of the women in this study. However, when the bladder biopsies were infected with uropathogenic E. coli (UPEC), a significant increase in cathelicidin expression was observed after 25D(3) supplementation. This observation was confirmed in human bladder cell lines, even though here, cathelicidin induction occurred irrespectively of infection. Vitamin D treated bladder cells exerted an increased antibacterial effect against UPEC and colocalization to cathelicidin indicated the relevance of this peptide. In the light of the rapidly growing problem of resistance to common urinary tract antibiotics, we suggest that vitamin D may be a potential complement in the prevention of UTI.	[Hertting, Olof; Holm, Asa; Luthje, Petra; Dyrdak, Robert; Chromek, Milan; Brauner, Annelie] Karolinska Inst, Div Clin Microbiol, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hertting, Olof; Chromek, Milan] Karolinska Univ Hosp, Astrid Lindgrens Childrens Hosp, Stockholm, Sweden; [Jonasson, Aino Fianu] Karolinska Inst, Dept Clin Sci, Unit Obstet & Gynecol, Stockholm, Sweden; [Wiklund, Peter] Karolinska Inst, Dept Urol, Div Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Hertting, O (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Annelie.Brauner@ki.se	Chromek, Milan/AAD-9116-2022; Chromek, Milan/ABE-7455-2020; Dyrdak, Robert/AAI-2718-2020; Hertting, Olof/ABB-9574-2020	Chromek, Milan/0000-0002-8941-057X; Dyrdak, Robert/0000-0001-8456-4898; Hertting, Olof/0000-0002-0813-7998; Wiklund, Peter/0000-0001-6497-4697	Swedish Research Council [56X-20356]; ALF Project; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF Project; Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Swedish Research Council (no. 56X-20356), ALF Project Funding, and the Karolinska Institutet. O.H. has a Karolinska Institutet funded postgraduate position. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Bergman P, 2005, CELL MICROBIOL, V7, P1009, DOI 10.1111/j.1462-5822.2005.00530.x; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chromek M, 2008, J MOL MED, V86, P37, DOI 10.1007/s00109-007-0256-4; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Crescioli C, 2005, J CLIN ENDOCR METAB, V90, P962, DOI 10.1210/jc.2004-1496; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; EBELING PR, 1992, J CLIN ENDOCR METAB, V75, P176, DOI 10.1210/jc.75.1.176; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Gombart AF, 2007, J STEROID BIOCHEM, V103, P552, DOI 10.1016/j.jsbmb.2006.12.095; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kimball SM, 2007, AM J CLIN NUTR, V86, P645, DOI 10.1093/ajcn/86.3.645; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Macdonald HM, 2010, BRIT J DERMATOL, V163, P434, DOI 10.1111/j.1365-2133.2010.09901.x; Mansson LE, 2007, CELL MICROBIOL, V9, P413, DOI 10.1111/j.1462-5822.2006.00799.x; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; McNally JD, 2009, PEDIATR PULM, V44, P981, DOI 10.1002/ppul.21089; Peric M, 2009, MOL IMMUNOL, V46, P3183, DOI 10.1016/j.molimm.2009.08.010; Roth DE, 2008, J INFECT DIS, V197, P676, DOI 10.1086/527488; Schuster I, 2011, BBA-PROTEINS PROTEOM, V1814, P186, DOI 10.1016/j.bbapap.2010.06.022; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weber G, 2005, J INVEST DERMATOL, V124, P1080, DOI 10.1111/j.0022-202X.2005.23687.x; White JH, 2010, J STEROID BIOCHEM, V121, P234, DOI 10.1016/j.jsbmb.2010.03.034; Williams B, 2008, PEDIATR INFECT DIS J, V27, P941, DOI 10.1097/INF.0b013e31817525df; Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.ORR; Yates AA, 1998, J AM DIET ASSOC, V98, P699, DOI 10.1016/S0002-8223(98)00160-6; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888	36	95	107	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15580	10.1371/journal.pone.0015580	http://dx.doi.org/10.1371/journal.pone.0015580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179490	Green Published, gold, Green Submitted			2022-12-25	WOS:000285292500027
J	Mirza, A; Mustafa, M; Talevich, E; Kannan, N				Mirza, Amar; Mustafa, Morad; Talevich, Eric; Kannan, Natarajan			Co-Conserved Features Associated with cis Regulation of ErbB Tyrosine Kinases	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; DEPENDENT PROTEIN-KINASE; FACTOR-RECEPTOR; CRYSTAL-STRUCTURE; TERMINAL TAIL; EGF RECEPTOR; STRUCTURAL BASIS; SELF-PHOSPHORYLATION; CATALYTIC SUBUNIT; DOMAIN	Background: The epidermal growth factor receptor kinases, or ErbB kinases, belong to a large sub-group of receptor tyrosine kinases (RTKs), which share a conserved catalytic core. The catalytic core of ErbB kinases have functionally diverged from other RTKs in that they are activated by a unique allosteric mechanism that involves specific interactions between the kinase core and the flanking Juxtamembrane (JM) and COOH-terminal tail (C-terminal tail). Although extensive studies on ErbB and related tyrosine kinases have provided important insights into the structural basis for ErbB kinase functional divergence, the sequence features that contribute to the unique regulation of ErbB kinases have not been systematically explored. Methodology/Principal Findings: In this study, we use a Bayesian approach to identify the selective sequence constraints that most distinguish ErbB kinases from other receptor tyrosine kinases. We find that strong ErbB kinase-specific constraints are imposed on residues that tether the JM and C-terminal tail to key functional regions of the kinase core. A conserved RIxKExE motif in the JM-kinase linker region and a glutamine in the inter-lobe linker are identified as two of the most distinguishing features of the ErbB family. While the RIxKExE motif tethers the C-terminal tail to the N-lobe of the kinase domain, the glutamine tethers the C-terminal tail to hinge regions critical for inter-lobe movement. Comparison of the active and inactive crystal structures of ErbB kinases indicates that the identified residues are conformationally malleable and can potentially contribute to the cis regulation of the kinase core by the JM and C-terminal tail. ErbB3, and EGFR orthologs in sponges and parasitic worms, diverge from some of the canonical ErbB features, providing insights into subfamily and lineage-specific functional specialization. Conclusion/Significance: Our analysis pinpoints key residues for mutational analysis, and provides new clues to cancer mutations that alter the canonical modes of ErbB kinase regulation.	[Mirza, Amar; Mustafa, Morad; Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Talevich, Eric; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Mirza, A (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	kannan@bmb.uga.edu		Talevich, Eric/0000-0002-8106-0720; Mustafa, Morad/0000-0001-9442-9665	American Cancer Society [RSG-10-188-01-TBE]; Georgia Cancer Coalition (GCC); University of Georgia	American Cancer Society(American Cancer Society); Georgia Cancer Coalition (GCC); University of Georgia	This study was supported by funds to NK from the American Cancer Society (RSG-10-188-01-TBE), Georgia Cancer Coalition (GCC) and University of Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio866; Chen YR, 2006, ONCOGENE, V25, P1205, DOI 10.1038/sj.onc.1209159; Cheng HC, 2010, CLIN EXP PHARMACOL P, V37, P93, DOI 10.1111/j.1440-1681.2009.05237.x; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Feinmesser RL, 1999, J BIOL CHEM, V274, P16168, DOI 10.1074/jbc.274.23.16168; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lamers MBAC, 1999, J MOL BIOL, V285, P713, DOI 10.1006/jmbi.1998.2369; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Landau M, 2008, BBA-REV CANCER, V1785, P12, DOI 10.1016/j.bbcan.2007.08.001; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Neuwald AF, 2003, GENOME RES, V13, P673, DOI 10.1101/gr.862303; Neuwald AF, 2007, TRENDS BIOCHEM SCI, V32, P487, DOI 10.1016/j.tibs.2007.08.009; Neuwald AF, 2009, BIOINFORMATICS, V25, P1869, DOI 10.1093/bioinformatics/btp342; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Papakyriakou A, 2009, PROTEINS, V76, P375, DOI 10.1002/prot.22353; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Romano RA, 2009, PROTEIN SCI, V18, P1486, DOI 10.1002/pro.146; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Schaefer G, 1999, J BIOL CHEM, V274, P859, DOI 10.1074/jbc.274.2.859; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; Shewchuk LM, 2000, STRUCTURE, V8, P1105, DOI 10.1016/S0969-2126(00)00516-5; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Walker F, 1998, GROWTH FACTORS, V16, P53, DOI 10.3109/08977199809017491; WALTON GM, 1990, J BIOL CHEM, V265, P1750; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Wu J, 2005, PROTEIN SCI, V14, P2871, DOI 10.1110/ps.051715205; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xia L, 2002, J BIOL CHEM, V277, P30716, DOI 10.1074/jbc.M202823200; Xu GZ, 2008, BIOORG MED CHEM LETT, V18, P4615, DOI 10.1016/j.bmcl.2008.07.020; Xu GZ, 2008, BIOORG MED CHEM LETT, V18, P3495, DOI 10.1016/j.bmcl.2008.05.024; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; Yang KS, 2010, J BIOL CHEM, V285, P24014, DOI 10.1074/jbc.M110.103317; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	67	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14310	10.1371/journal.pone.0014310	http://dx.doi.org/10.1371/journal.pone.0014310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179209	Green Published, Green Submitted, gold			2022-12-25	WOS:000285246900016
J	Wang, WQ; Huang, J; Chen, JJ				Wang, Wenqi; Huang, Jun; Chen, Junjie			Angiomotin-like Proteins Associate with and Negatively Regulate YAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PATHWAY; CELL CONTACT INHIBITION; ORGAN SIZE CONTROL; HIPPO PATHWAY; SIGNALING PATHWAY; BANTAM MICRORNA; GROWTH-CONTROL; COILED-COIL; DROSOPHILA; APOPTOSIS	In both Drosophila and mammalian systems, the Hippo pathway plays an important role in controlling organ size, mainly through its ability to regulate cell proliferation and apoptosis. The key component in the Hippo pathway is the Yes-associated protein YAP1, which localizes in nucleus, functions as a transcriptional coactivator, and regulates the expression of several proliferation-and apoptosis-related genes. The Hippo pathway negatively regulates YAP1 transcriptional activity by modulating its nuclear-cytoplasmic localization in a phosphorylation-dependent manner. Here, we describe the identification of several new PY motif-containing proteins, including angiomotin-like protein 1 (AMOTL1) and 2 (AMOTL2), as YAP1-associated proteins. We demonstrate that AMOTL1 and AMOTL2 can regulate YAP1 cytoplasm-to-nucleus translocation through direct protein-protein interaction, which can occur independent of YAP1 phosphorylation status. Moreover, down-regulation of AMOTL2 in MCF10A cells promotes epithelial-mesenchymal transition, a phenotype that is also observed in MCF10A cells with YAP1 overexpression. Together, these data support a new mechanism for YAP1 regulation, which is mediated via its direct interactions with angiomotin-like proteins.	[Huang, Jun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Wenqi; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	Zhejiang University; University of Texas System; UTMD Anderson Cancer Center	Huang, J (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	jhuang@zju.edu.cn; jchen8@mdanderson.org		Wang, Wenqi/0000-0003-4053-5088	Department of Defense (DOD) [W81XWH-09-1-0409, W81XWH-05-1-0470]; National Institutes of Health [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Department of Defense (DOD) Era of Hope research scholar award (W81XWH-09-1-0409) (to J. C.) and an Era of Hope Scholar award from the Department of Defense (W81XWH-05-1-0470) (to J. C.).; We thank all colleagues in the Chen laboratory for insightful discussion and technical assistance. The M. D. Anderson Cancer Center was supported by National Institutes of Health Grant CA016672.	Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Gagne V, 2009, CELL MOTIL CYTOSKEL, V66, P754, DOI 10.1002/cm.20405; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Ren FF, 2010, DEV BIOL, V337, P303, DOI 10.1016/j.ydbio.2009.10.046; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156	28	193	197	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4364	4370		10.1074/jbc.C110.205401	http://dx.doi.org/10.1074/jbc.C110.205401			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21187284	Green Published, hybrid			2022-12-25	WOS:000286975700036
J	Fan, YP; Chong, YS; Choolani, MA; Cregan, MD; Chan, JKY				Fan, Yiping; Chong, Yap Seng; Choolani, Mahesh A.; Cregan, Mark D.; Chan, Jerry K. Y.			Unravelling the Mystery of Stem/Progenitor Cells in Human Breast Milk	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; EPITHELIAL STEM-CELLS; IN-VITRO PROPAGATION; ADULT HUMAN BREAST; PROGENITOR CELLS; MAMMARY-GLAND; CANCER CELLS; HEMATOPOIETIC STEM; ENDOTHELIAL-CELLS; MOUSE ENDOMETRIUM	Background: Mammary stem cells have been extensively studied as a system to delineate the pathogenesis and treatment of breast cancer. However, research on mammary stem cells requires tissue biopsies which limit the quantity of samples available. We have previously identified putative mammary stem cells in human breast milk, and here, we further characterised the cellular component of human breast milk. Methodology/Principal Findings: We identified markers associated with haemopoietic, mesenchymal and neuro-epithelial lineages in the cellular component of human breast milk. We found 2.6+/-0.8% (mean+/-SEM) and 0.7+/-0.2% of the whole cell population (WCP) were found to be CD133+ and CD34+ respectively, 27.8+/-9.1% of the WCP to be positive for Stro-1 through flow-cytometry. Expressions of neuro-ectodermal stem cell markers such as nestin and cytokeratin 5 were found through reverse-transcription polymerase chain reaction (RT-PCR), and in 4.17+/-0.2% and 0.9+/-0.2% of the WCP on flow-cytometry. We also established the presence of a side-population (SP) (1.8+/-0.4% of WCP) as well as CD133+ cells (1.7+/-0.5% of the WCP). Characterisation of the sorted SP and non-SP, CD133+ and CD133-cells carried out showed enrichment of CD326 (EPCAM) in the SP cells (50.6+/-8.6 vs 18.1+/-6.0, P-value = 0.02). However, culture in a wide range of in vitro conditions revealed the atypical behaviour of stem/progenitor cells in human breast milk; in that if they are present, they do not respond to established culture protocols of stem/progenitor cells. Conclusions/Significance: The identification of primitive cell types within human breast milk may provide a non-invasive source of relevant mammary cells for a wide-range of applications; even the possibility of banking one's own stem cell for every breastfeeding woman.	[Fan, Yiping; Chong, Yap Seng; Choolani, Mahesh A.; Chan, Jerry K. Y.] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore, Singapore; [Cregan, Mark D.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia; [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore	National University of Singapore; University of Western Australia; KK Women's & Children's Hospital; National University of Singapore	Fan, YP (corresponding author), Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore, Singapore.	yiping@nus.edu.sg; jerrychan@nus.edu.sg		Chong, Yap Seng/0000-0002-7232-8473	National Healthcare Group, Singapore [SIG07057]; National University of Singapore; National Medical Research Council, Singapore [CSA/012/2009, CSA/007/2009]	National Healthcare Group, Singapore; National University of Singapore(National University of Singapore); National Medical Research Council, Singapore(National Medical Research Council, Singapore)	This work was funded by National Healthcare Group, Singapore (SIG07057) and also National University of Singapore through a research scholarship to Y. Fan. J. Chan and M. Choolani received support from the Clinician Scientist Award, National Medical Research Council, Singapore (CSA/012/2009 and CSA/007/2009). The funding bodies have supported the authors' research ideas, with no role in study design, data collection and analysis, decision to publish and preparation of manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; BROOKER BE, 1980, CELL TISSUE RES, V210, P321, DOI 10.1007/BF00237619; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chen CP, 2008, STEM CELLS, V26, P550, DOI 10.1634/stemcells.2007-0406; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Clayton H, 2004, EXP CELL RES, V297, P444, DOI 10.1016/j.yexcr.2004.03.029; CRAGO SS, 1979, CLIN EXP IMMUNOL, V38, P585; Cregan MD, 2007, CELL TISSUE RES, V329, P129, DOI 10.1007/s00441-007-0390-x; DEOME KB, 1959, CANCER RES, V19, P515; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; FINA L, 1990, BLOOD, V75, P2417; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; HARRIS J, 1991, J NEUROSCI RES, V30, P47, DOI 10.1002/jnr.490300107; Hida N, 2008, STEM CELLS, V26, P1695, DOI 10.1634/stemcells.2007-0826; HO FCS, 1979, ACTA PAEDIATR SCAND, V68, P389, DOI 10.1111/j.1651-2227.1979.tb05025.x; Kanof ME, 2001, CURR PROTOC IMMUNOL; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Musina RA, 2008, B EXP BIOL MED+, V145, P539, DOI 10.1007/s10517-008-0136-0; Petersen OW, 2001, BREAST CANCER RES, V3, P213; Piechaczek C, 2001, J BIOL REG HOMEOS AG, V15, P101; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Qi HL, 2003, P NATL ACAD SCI USA, V100, P3305, DOI 10.1073/pnas.0532693100; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Satish P, 2010, HUM CELL, V23, P6; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SMITH CW, 1968, PEDIATR RES, V2, P103, DOI 10.1203/00006450-196803000-00005; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; WATT SM, 1995, LEUKEMIA LYMPHOMA, V17, P229, DOI 10.3109/10428199509056827; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023; Zhang ZY, 2009, STEM CELLS	49	53	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14421	10.1371/journal.pone.0014421	http://dx.doi.org/10.1371/journal.pone.0014421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203434	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500006
J	Al-Moundhri, MS; Al-Nabhani, M; Tarantini, L; Baccarelli, A; Rusiecki, JA				Al-Moundhri, Mansour S.; Al-Nabhani, Maryam; Tarantini, Letizia; Baccarelli, Andrea; Rusiecki, Jennifer A.			The Prognostic Significance of Whole Blood Global and Specific DNA Methylation Levels in Gastric Adenocarcinoma	PLOS ONE			English	Article							GENE PROMOTER HYPERMETHYLATION; HELICOBACTER-PYLORI; MICROSATELLITE INSTABILITY; LINE-1 HYPOMETHYLATION; ABERRANT METHYLATION; E-CADHERIN; CANCER; TUMOR; RISK; AGE	Background: Epigenetics, particularly DNA methylation, has recently been elucidated as important in gastric cancer (GC) initiation and progression. We investigated the clinical and prognostic importance of whole blood global and site-specific DNA methylation in GC. Methods: Genomic DNA was extracted from the peripheral blood of 105 Omani GC patients at diagnosis. DNA methylation was quantified by pyrosequencing of global DNA and specific gene promoter regions at 5 CpG sites for CDH1, 7 CpG sites for p16, 4 CpG sites for p53, and 3 CpG sites for RUNX3. DNA methylation levels in patients were categorized into low, medium, and high tertiles. Associations between methylation level category and clinicopathological features were evaluated using chi(2) tests. Survival analyses were carried out using the Kaplan-Meier method and log rank test. A backward conditional Cox proportional hazards regression model was used to identify independent predictors of survival. Results: Older GC patients had increased methylation levels at specific CpG sites within the CDH1, p53, and RUNX-3 promoters. Male gender was significantly associated with reduced global and increased site-specific DNA methylation levels in CDH1, p16, and p53 promoters. Global DNA low methylation level was associated with better survival on univariate analysis. Patients with high and medium methylation vs. low methylation levels across p16 promoter CpG sites, site 2 in particular, had better survival. Multivariate analysis showed that global DNA hypermethylation was a significant independent predictor of worse survival (hazard ratio (HR) = 2.0, 95% CI: 1.1-3.8; p = 0.02) and high methylation mean values across p16 promoter sites 1-7 were associated with better survival with HR of 0.3 (95% CI, 0.1-0.8; p = 0.02) respectively. Conclusions: Analysis of global and site-specific DNA methylation in peripheral blood by pyrosequencing provides quantitative DNA methylation values that may serve as important prognostic indicators.	[Al-Moundhri, Mansour S.] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Med, Med Oncol Unit, Muscat, Oman; [Al-Nabhani, Maryam] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Genet, Muscat, Oman; [Tarantini, Letizia; Baccarelli, Andrea] Univ Milan, Milan, Italy; [Tarantini, Letizia; Baccarelli, Andrea] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Environm & Occupat Hlth, Ctr Mol & Genet Epidemiol, Milan, Italy; [Rusiecki, Jennifer A.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD USA	Sultan Qaboos University; Sultan Qaboos University; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Uniformed Services University of the Health Sciences - USA	Al-Moundhri, MS (corresponding author), Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Med, Med Oncol Unit, Muscat, Oman.	mansours@squ.edu.om		Baccarelli, Andrea/0000-0002-3436-0640; Rusiecki, Jennifer/0000-0003-3881-8695; Al-Moundhri, Mansour/0000-0003-3963-1232	Sultan Qaboos university	Sultan Qaboos university	Sultan Qaboos university Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ally MS, 2009, CANCER EPIDEM BIOMAR, V18, P922, DOI 10.1158/1055-9965.EPI-08-0703; An CH, 2005, CLIN CANCER RES, V11, P656; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Chan AOO, 2003, AM J PATHOL, V163, P370, DOI 10.1016/S0002-9440(10)63663-2; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Correa P, 2005, CANCER EPIDEM BIOMAR, V14, P1865, DOI 10.1158/1055-9965.EPI-05-0029; Correa P, 2005, J SURG ONCOL, V90, P134, DOI 10.1002/jso.20216; Correa Pelayo, 2004, IARC Sci Publ, P301; Cravo M, 1996, GUT, V39, P434, DOI 10.1136/gut.39.3.434; Dominguez G, 2003, MUTAT RES-FUND MOL M, V530, P9, DOI 10.1016/S0027-5107(03)00133-7; El-Omar EM, 2001, GASTROENTEROLOGY, V121, P1002, DOI 10.1016/S0016-5085(01)93000-8; Fang JY, 1997, J GASTROENTEROL, V32, P171, DOI 10.1007/BF02936363; Gonzalez C A, 2002, IARC Sci Publ, V156, P79; Gonzalez CA, 2003, INT J CANCER, V107, P629, DOI 10.1002/ijc.11426; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Graziano F, 2004, ANN ONCOL, V15, P489, DOI 10.1093/annonc/mdh108; Gupta A, 2003, CANCER RES, V63, P664; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Ichikawa D, 2004, ANTICANCER RES, V24, P2477; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Jang SJ, 2001, CANCER RES, V61, P7959; Kim DH, 2003, CANCER RES, V63, P3743; Ksiaa F, 2009, CLIN CHIM ACTA, V404, P128, DOI 10.1016/j.cca.2009.03.044; Lai JC, 2005, INT J CANCER, V117, P974, DOI 10.1002/ijc.21278; Lee TL, 2002, CLIN CANCER RES, V8, P1761; Leung WK, 2005, BRIT J CANCER, V92, P2190, DOI 10.1038/sj.bjc.6602636; Lin CH, 2001, CANCER RES, V61, P4238; Marsit CJ, 2008, CANCER-AM CANCER SOC, V113, P1566, DOI 10.1002/cncr.23770; Marsit CJ, 2007, CARCINOGENESIS, V28, P1745, DOI 10.1093/carcin/bgm116; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Nakajima T, 2001, INT J CANCER, V94, P208, DOI 10.1002/ijc.1454; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Rosty C, 2002, AM J PATHOL, V160, P45, DOI 10.1016/S0002-9440(10)64347-7; Sato N, 2003, CANCER RES, V63, P4158; SAUER J, 2010, BR J NUTR, P24; Shiozawa E, 2006, LEUKEMIA RES, V30, P859, DOI 10.1016/j.leukres.2005.11.004; Tamura G, 2004, HISTOL HISTOPATHOL, V19, P221, DOI 10.14670/HH-19.221; Tang XM, 2000, JNCI-J NATL CANCER I, V92, P1511, DOI 10.1093/jnci/92.18.1511; Widschwendter M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002656; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zazula M, 2006, DIAGN MOL PATHOL, V15, P24, DOI 10.1097/00019606-200603000-00004	43	26	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15585	10.1371/journal.pone.0015585	http://dx.doi.org/10.1371/journal.pone.0015585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203466	gold, Green Published, Green Submitted			2022-12-25	WOS:000285579200024
J	Coppieters, K; Martinic, MM; Kiosses, WB; Amirian, N; von Herrath, M				Coppieters, Ken; Martinic, Marianne M.; Kiosses, William B.; Amirian, Natalie; von Herrath, Matthias			A Novel Technique for the In Vivo Imaging of Autoimmune Diabetes Development in the Pancreas by Two-Photon Microscopy	PLOS ONE			English	Article							DENDRITIC CELLS; TRANSGENIC MICE; IMMUNE-SYSTEM; REAL-TIME; TOLERANCE; MOUSE; ACCELERATION; INDUCTION; INFECTION; ISLETS	Type 1 diabetes (T1D) is characterized by the immune-mediated destruction of beta cells in the pancreas. Little is known about the in vivo dynamic interactions between T cells and beta cells or the kinetic behavior of other immune cell subsets in the pancreatic islets. Utilizing multiphoton microscopy we have designed a technique that allows for the real-time visualization of diabetogenic T cells and dendritic cells in pancreatic islets in a live animal, including their interplay with beta cells and the vasculature. Using a custom designed stage, the pancreas was surgically exposed under live conditions so that imaging of islets under intact blood pressure and oxygen supply became possible. We demonstrate here that this approach allows for the tracking of diabetogenic leukocytes as well as vascularization phenotype of islets and accumulation of dendritic cells in islets during diabetes pathogenesis. This technique should be useful in mapping crucial kinetic events in T1D pathogenesis and in testing the impact of immune based interventions on T cell migration, extravasation and islet destruction.	[Coppieters, Ken; Martinic, Marianne M.; Amirian, Natalie; von Herrath, Matthias] Ctr La Jolla Inst Allergy & Immunol, Type Diabet 1, La Jolla, CA USA; [Kiosses, William B.] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA 92037 USA	Scripps Research Institute	Coppieters, K (corresponding author), Ctr La Jolla Inst Allergy & Immunol, Type Diabet 1, La Jolla, CA USA.	matthias@liai.org		Martinic, Marianne/0000-0003-4407-3423	Juvenile Diabetes Research Foundation [16-2007-370]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	Juvenile Diabetes Research Foundation Scholar Award #16-2007-370. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2010, DIABETES, V59, P1756, DOI 10.2337/db09-1400; Bertera S, 2003, BIOTECHNIQUES, V35, P718, DOI 10.2144/03354st01; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Bullen A, 2009, CURR TOP MICROBIOL, V334, P1, DOI 10.1007/978-3-540-93864-4_1; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Calderon B, 2008, P NATL ACAD SCI USA, V105, P6121, DOI 10.1073/pnas.0801973105; Coppieters K, 2008, DIABETOLOGIA, V51, P2145, DOI 10.1007/s00125-008-1181-y; Coppieters Ken T, 2009, Rev Diabet Stud, V6, P85, DOI 10.1900/RDS.2009.6.85; Deguine J, 2010, IMMUNITY, V33, P632, DOI 10.1016/j.immuni.2010.09.016; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; HARADA M, 1984, DIABETOLOGIA, V27, P604, DOI 10.1007/BF00276978; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Martinic MM, 2008, IMMUNOL REV, V221, P200, DOI 10.1111/j.1600-065X.2008.00581.x; Martinic MM, 2010, J AUTOIMMUN, V35, P404, DOI 10.1016/j.jaut.2010.08.006; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Nyman LR, 2008, J CLIN INVEST, V118, P3790, DOI 10.1172/JCI36209; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Seewaldt S, 2000, DIABETES, V49, P1801, DOI 10.2337/diabetes.49.11.1801; Serreze DV, 2000, DIABETES, V49, P708, DOI 10.2337/diabetes.49.5.708; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Villiger M, 2009, DIABETOLOGIA, V52, P1599, DOI 10.1007/s00125-009-1383-y; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; von Herrath M, 2009, NAT IMMUNOL, V10, P129, DOI 10.1038/ni0209-129; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x	33	38	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15732	10.1371/journal.pone.0015732	http://dx.doi.org/10.1371/journal.pone.0015732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203413	Green Submitted, Green Published, gold			2022-12-25	WOS:000285579200033
J	Voss, HU; Salgado-Commissariat, D; Helekar, SA				Voss, Henning U.; Salgado-Commissariat, Delanthi; Helekar, Santosh A.			Altered Auditory BOLD Response to Conspecific Birdsong in Zebra Finches with Stuttered Syllables	PLOS ONE			English	Article							WHITE-CROWNED SPARROW; GENE-EXPRESSION; BENGALESE FINCHES; CONTROL-SYSTEM; SONG; BRAIN; FOREBRAIN; NEURONS; SPEECH; ACTIVATION	How well a songbird learns a song appears to depend on the formation of a robust auditory template of its tutor's song. Using functional magnetic resonance neuroimaging we examine auditory responses in two groups of zebra finches that differ in the type of song they sing after being tutored by birds producing stuttering-like syllable repetitions in their songs. We find that birds that learn to produce the stuttered syntax show attenuated blood oxygenation level-dependent (BOLD) responses to tutor's song, and more pronounced responses to conspecific song primarily in the auditory area field L of the avian forebrain, when compared to birds that produce normal song. These findings are consistent with the presence of a sensory song template critical for song learning in auditory areas of the zebra finch forebrain. In addition, they suggest a relationship between an altered response related to familiarity and/or saliency of song stimuli and the production of variant songs with stuttered syllables.	[Voss, Henning U.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Voss, Henning U.] Weill Cornell Med Coll, Biomed Imaging Ctr, Citigrp, New York, NY USA; [Salgado-Commissariat, Delanthi; Helekar, Santosh A.] Methodist Hosp, Res Inst, Dept Neurol, Speech & Language Ctr, Houston, TX 77030 USA; [Helekar, Santosh A.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Cornell University; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine	Voss, HU (corresponding author), Weill Cornell Med Coll, Dept Radiol, New York, NY USA.	sahelekar@tmhs.org	Voss, Henning/C-2194-2009	Voss, Henning/0000-0003-2811-2074	M. R. Bauer Foundation; NIH [DC04778-01A1, MH073900-01]; Institute for Biomedical Imaging Sciences (IBIS), Houston, Texas; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH073900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004778] Funding Source: NIH RePORTER	M. R. Bauer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Biomedical Imaging Sciences (IBIS), Houston, Texas; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the M. R. Bauer Foundation, NIH Grant DC04778-01A1 (SAH), NIH Grant MH073900-01 (SAH), and the Institute for Biomedical Imaging Sciences (IBIS), Houston, Texas (HUV and SAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDILA A, 1986, BRAIN LANG, V27, P239, DOI 10.1016/0093-934X(86)90018-0; BIJLEVELD H, 1994, FOLIA PHONIATR LOGO, V46, P250, DOI 10.1159/000266323; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; BONKE BA, 1979, CELL TISSUE RES, V200, P101; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Chang SE, 2009, NEUROIMAGE, V46, P201, DOI 10.1016/j.neuroimage.2009.01.066; Cosyns M, 2010, J FLUENCY DISORD, V35, P235, DOI 10.1016/j.jfludis.2010.05.001; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Nil LF, 2008, BRAIN LANG, V107, P114, DOI 10.1016/j.bandl.2008.07.003; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Espino GG, 2003, NEUROSCIENCE, V122, P521, DOI 10.1016/S0306-4522(03)00549-9; Fox PT, 2000, BRAIN, V123, P1985, DOI 10.1093/brain/123.10.1985; Funabiki Y, 2003, J NEUROSCI, V23, P6928; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Helekar SA, 2003, BEHAV NEUROSCI, V117, P939, DOI 10.1037/0735-7044.117.5.939; Hosino T, 2000, NEUROREPORT, V11, P2091, DOI 10.1097/00001756-200007140-00007; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jin H, 1997, NEURON, V19, P1049, DOI 10.1016/S0896-6273(00)80396-7; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; LEBRUN Y, 1990, J FLUENCY DISORD, V15, P251, DOI 10.1016/0094-730X(90)90040-Y; Lee J.H., 2010, NATURE; Liotti M, 2010, BRAIN LANG, V115, P141, DOI 10.1016/j.bandl.2010.07.007; Logothetis NK, 2003, J NEUROSCI, V23, P3963; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; Maul KK, 2010, DEV NEUROBIOL, V70, P28, DOI 10.1002/dneu.20751; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Okanoya K, 1997, J NEUROBIOL, V33, P343; Periaswamy S, 2003, IEEE T MED IMAGING, V22, P865, DOI 10.1109/TMI.2003.815069; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Pinaud R, 2008, J NEUROPHYSIOL; Poirier C, 2008, NEUROIMAGE, V41, P1, DOI 10.1016/j.neuroimage.2008.01.069; Ribeiro S, 1998, NEURON, V21, P359, DOI 10.1016/S0896-6273(00)80545-0; ROSENFIELD DB, 1991, SPEECH MOTOR CONTROL; Soha JA, 2001, J COMP PSYCHOL, V115, P172, DOI 10.1037//0735-7036.115.2.172; Tabelow K, 2006, NEUROIMAGE, V33, P55, DOI 10.1016/j.neuroimage.2006.06.029; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Van Meir V, 2005, NEUROIMAGE, V25, P1242, DOI 10.1016/j.neuroimage.2004.12.058; VICARIO DS, 1993, J NEUROBIOL, V24, P488, DOI 10.1002/neu.480240407; Voss HU, 2007, P NATL ACAD SCI USA, V104, P10667, DOI 10.1073/pnas.0611515104; Voss HU, 2006, MAGN RESON IMAGING, V24, P231, DOI 10.1016/j.mri.2005.12.007; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; WILLIAMS H, 1985, SCIENCE, V229, P279, DOI 10.1126/science.4012321; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	53	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14415	10.1371/journal.pone.0014415	http://dx.doi.org/10.1371/journal.pone.0014415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203446	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200003
J	Lee, PS; Wilhelmson, ASK; Hubner, AP; Reynolds, SB; Gallacchi, DA; Chiou, TT; Kwiatkowski, DJ				Lee, Po-Shun; Wilhelmson, Anna S. K.; Hubner, Anton P.; Reynolds, Samuel B.; Gallacchi, Dana A.; Chiou, Terry T.; Kwiatkowski, David J.			mTORC1-S6K Activation by Endotoxin Contributes to Cytokine Up-Regulation and Early Lethality in Animals	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MAMMALIAN TARGET; TUBEROUS SCLEROSIS; MTOR; RAPAMYCIN; PATHWAY; INHIBITION; CANCER; TSC1; INFLAMMATION	Background: mTORC1 (mammalian target of rapamycin complex 1) activation has been demonstrated in response to endotoxin challenge, but the mechanism and significance are unclear. We investigated the effect of mTORC1 suppression in an animal model of endotoxemia and in a cellular model of endotoxin signaling. Methodology/Principal Findings: Mice were treated with the mTORC1 inhibitor rapamycin or vehicle prior to lethal endotoxin challenge. Mortality and cytokine levels were assessed. Cultured macrophage-like cells were challenged with endotoxin with or without inhibitors of various pathways known to be upstream of mTORC1. Activated pathways, including downstream S6K pathway, were assessed by immunoblots. We found that mTORC1-S6K suppression by rapamycin delayed mortality of mice challenged with lethal endotoxin, and was associated with dampened circulating levels of VEGF, IL-1 beta, IFN-gamma and IL-5. Furthermore, in vitro cellular studies demonstrated that LPS (lipopolysaccharide) activation of mTORC1-S6K still occurs in the presence of PI3K-Akt inhibition alone, but can be suppressed by concurrent inhibition of PI3K-Akt and MEKERK pathways. Conclusions/Significance: We conclude that cellular activation of mTORC1-S6K contributes to cytokine up-regulation and mortality in response to endotoxin, and may occur via multiple pathways.	[Lee, Po-Shun; Reynolds, Samuel B.; Gallacchi, Dana A.; Chiou, Terry T.; Kwiatkowski, David J.] Brigham & Womens Hosp, Translat Med Div, Boston, MA 02115 USA; [Lee, Po-Shun; Kwiatkowski, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Wilhelmson, Anna S. K.] Univ Gothenburg, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden; [Wilhelmson, Anna S. K.; Hubner, Anton P.] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Gothenburg; University of Gothenburg	Lee, PS (corresponding author), Brigham & Womens Hosp, Translat Med Div, 75 Francis St, Boston, MA 02115 USA.	plee@rics.bwh.harvard.edu	Wilhelmson, Anna S/HCI-9867-2022	Wilhelmson, Anna S/0000-0003-0640-0251	American Heart Association [0735620N]; National Institutes of Health/National Cancer Institute (NIH/NCI) [1P01CA120964]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by American Heart Association Scientist Development Grant 0735620N (PSL) and National Institutes of Health/National Cancer Institute (NIH/NCI) 1P01CA120964 (DJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; El-Hashemite N, 2003, CANCER RES, V63, P5173; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kimball SR, 2003, AM J PHYSIOL-ENDOC M, V285, pE637, DOI 10.1152/ajpendo.00340.2002; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lorne E, 2009, AM J RESP CELL MOL, V41, P237, DOI 10.1165/rcmb.2008-0290OC; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; Peschon JJ, 1998, J IMMUNOL, V160, P943; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Schmitz F, 2008, EUR J IMMUNOL, V38, P2981, DOI 10.1002/eji.200838761; Thickett DR, 2001, AM J RESP CRIT CARE, V164, P1601, DOI 10.1164/ajrccm.164.9.2011071; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	27	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14399	10.1371/journal.pone.0014399	http://dx.doi.org/10.1371/journal.pone.0014399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200439	gold, Green Published, Green Submitted			2022-12-25	WOS:000285576900013
J	Vento, MT; Zazzu, V; Loffreda, A; Cross, JR; Downward, J; Stoppelli, MP; Iaccarino, I				Vento, Maria Teresa; Zazzu, Valeria; Loffreda, Alessia; Cross, Justin R.; Downward, Julian; Stoppelli, Maria Patrizia; Iaccarino, Ingram			Praf2 Is a Novel Bcl-xL/Bcl-2 Interacting Protein with the Ability to Modulate Survival of Cancer Cells	PLOS ONE			English	Article							BCL-X-L; ANTI-APOPTOTIC ACTIVITY; ENDOPLASMIC-RETICULUM; MAMMALIAN OLIGOSACCHARYLTRANSFERASE; MITOCHONDRIAL-MEMBRANE; REGULATES APOPTOSIS; FAMILY PROTEINS; MEMBER-2 PRAF2; DOMAIN FAMILY; CYTOCHROME-C	Increased expression of Bcl-xL in cancer has been shown to confer resistance to a broad range of apoptotic stimuli and to modulate a number of other aspects of cellular physiology, including energy metabolism, cell cycle, autophagy, mitochondrial fission/fusion and cellular adhesion. However, only few of these activities have a mechanistic explanation. Here we used Tandem Affinity purification to identify novel Bcl-xL interacting proteins that could explain the pleiotropic effects of Bcl-xL overexpression. Among the several proteins co-purifying with Bcl-xL, we focused on Praf2, a protein with a predicted role in trafficking. The interaction of Praf2 with Bcl-xL was found to be dependent on the transmembrane domain of Bcl-xL. We found that Bcl-2 also interacts with Praf2 and that Bcl-xL and Bcl-2 can interact also with Arl6IP5, an homologue of Praf2. Interestingly, overexpression of Praf2 results in the translocation of Bax to mitochondria and the induction of apoptotic cell death. Praf2 dependent cell death is prevented by the co-transfection of Bcl-xL but not by its transmembrane domain deleted mutant. Accordingly, knock-down of Praf2 increases clonogenicity of U2OS cells following etoposide treatment by reducing cell death. In conclusion a screen for Bcl-xL-interacting membrane proteins let us identify a novel proapoptotic protein whose activity is strongly counteracted exclusively by membrane targeted Bcl-xL.	[Vento, Maria Teresa; Zazzu, Valeria; Loffreda, Alessia; Stoppelli, Maria Patrizia; Iaccarino, Ingram] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80125 Naples, Italy; [Cross, Justin R.; Downward, Julian] London Res Inst, Signal Transduct Lab, London, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Vento, MT (corresponding author), CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80125 Naples, Italy.	ingram@igb.cnr.it	Downward, Julian/A-3251-2012; Iaccarino, Ingram/B-9086-2015	Iaccarino, Ingram/0000-0001-7324-993X; Cross, Justin/0000-0002-6356-057X; Zazzu, Valeria/0000-0003-0528-8472; Downward, Julian/0000-0002-2331-4729; Loffreda, Alessia/0000-0003-4523-5666	Association for International Cancer Research [05-0416]; European Science Foundation (ESF), Eurocore Network on Membrane Architecture and Dynamics [LSHC-CT-2003-503297]	Association for International Cancer Research; European Science Foundation (ESF), Eurocore Network on Membrane Architecture and Dynamics(European Science Foundation (ESF))	This work was supported by the Association for International Cancer Research, Grant Ref.: 05-0416 (http://www.aicr.org.uk/index.stm), and the European Science Foundation (ESF), Eurocore Network on Membrane Architecture and Dynamics, Contract n.LSHC-CT-2003-503297, to M. P. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Amundson SA, 2000, CANCER RES, V60, P6101; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Cross JR, 2008, CELL DEATH DIFFER, V15, P997, DOI 10.1038/cdd.2008.14; Denis GV, 2003, J BIOL CHEM, V278, P5775, DOI 10.1074/jbc.M210202200; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dong Z, 2004, J BIOL CHEM, V279, P9215, DOI 10.1074/jbc.M312225200; Du YCN, 2007, PLOS BIOL, V5, P2255, DOI 10.1371/journal.pbio.0050276; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Fernandez Y, 2000, CELL DEATH DIFFER, V7, P350, DOI 10.1038/sj.cdd.4400662; Fo CS, 2006, GENE, V371, P154, DOI 10.1016/j.gene.2005.12.009; Geerts D, 2007, CLIN CANCER RES, V13, P6312, DOI 10.1158/1078-0432.CCR-07-0829; Geng JM, 2005, EUKARYOT CELL, V4, P1166, DOI 10.1128/EC.4.7.1166-1174.2005; Hajek P, 2007, J BIOL CHEM, V282, P5670, DOI 10.1074/jbc.M608168200; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Iaccarino I, 2003, CELL DEATH DIFFER, V10, P599, DOI 10.1038/sj.cdd.4401211; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; Kuo TH, 1998, ONCOGENE, V17, P1903, DOI 10.1038/sj.onc.1202110; Li C, 2002, P NATL ACAD SCI USA, V99, P9830, DOI 10.1073/pnas.152571899; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li LY, 2001, J BIOL CHEM, V276, P27354, DOI 10.1074/jbc.M103821200; Makishima T, 2000, J BIOCHEM-TOKYO, V128, P399, DOI 10.1093/oxfordjournals.jbchem.a022767; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Martin SS, 2004, ONCOGENE, V23, P4641, DOI 10.1038/sj.onc.1207595; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Priault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008755; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Ruggiero AM, 2008, J BIOL CHEM, V283, P6175, DOI 10.1074/jbc.M701008200; Schweneker M, 2005, FEBS LETT, V579, P1751, DOI 10.1016/j.febslet.2005.02.037; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Tagami S, 2000, ONCOGENE, V19, P5736, DOI 10.1038/sj.onc.1203948; Vander Heiden MG, 2002, J BIOL CHEM, V277, P44870, DOI 10.1074/jbc.M204888200; Wan QW, 2007, APOPTOSIS, V12, P319, DOI 10.1007/s10495-006-0574-y; Wang GL, 2008, EXP CELL RES, V314, P1626, DOI 10.1016/j.yexcr.2008.01.028; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhu L, 2007, CELL BIOL INT, V31, P825, DOI 10.1016/j.cellbi.2007.01.032	56	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15636	10.1371/journal.pone.0015636	http://dx.doi.org/10.1371/journal.pone.0015636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21203533	Green Submitted, gold, Green Published			2022-12-25	WOS:000285575200053
J	Whitehead, NP; Yeung, EW; Froehner, SC; Allen, DG				Whitehead, Nicholas P.; Yeung, Ella W.; Froehner, Stanley C.; Allen, David G.			Skeletal Muscle NADPH Oxidase Is Increased and Triggers Stretch-Induced Damage in the mdx Mouse	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; NAD(P)H OXIDASE; KAPPA-B; MICE; CELLS; PATHOPHYSIOLOGY; CAVEOLIN-3; EXPRESSION; SYSTEM	Recent studies have shown that oxidative stress contributes to the pathogenesis of muscle damage in dystrophic (mdx) mice. In this study we have investigated the role of NADPH oxidase as a source of the oxidative stress in these mice. The NADPH oxidase subunits gp91(phox), p67(phox) and rac 1 were increased 2-3 fold in tibilais anterior muscles from mdx mice compared to wild type. Importantly, this increase occurred in 19 day old mice, before the onset of muscle necrosis and inflammation, suggesting that NADPH oxidase is an important source of oxidative stress in mdx muscle. In muscles from 9 week old mdx mice, gp91(phox) and p67(phox) were increased 3-4 fold and NADPH oxidase superoxide production was 2 times greater than wild type. In single fibers from mdx muscle NADPH oxidase subunits were all located on or near the sarcolemma, except for p67(phox), which was expressed in the cytosol. Pharmacological inhibition of NADPH oxidase significantly reduced the intracellular Ca(2+) rise following stretched contractions in mdx single fibers, and also attenuated the loss of muscle force. These results suggest that NADPH oxidase is a major source of reactive oxygen species in dystrophic muscle and its enhanced activity has a stimulatory effect on stretch-induced Ca(2+) entry, a key mechanism for muscle damage and functional impairment.	[Whitehead, Nicholas P.; Allen, David G.] Univ Sydney, Discipline Physiol, Bosch Inst, Sydney, NSW 2006, Australia; [Whitehead, Nicholas P.; Froehner, Stanley C.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Yeung, Ella W.] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China	University of Sydney; University of Washington; University of Washington Seattle; Hong Kong Polytechnic University	Whitehead, NP (corresponding author), Univ Sydney, Discipline Physiol, Bosch Inst, Sydney, NSW 2006, Australia.	npwhite@u.washington.edu	Yeung, Ella/D-6672-2011	Allen, David/0000-0001-8605-1586; Yeung, Ella/0000-0002-6396-1146	National Health and Medical Research Council, Australia; National Institutes of Health (NIH); Parent Project Muscular Dystrophy (PPMD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033145] Funding Source: NIH RePORTER	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parent Project Muscular Dystrophy (PPMD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the National Health and Medical Research Council, Australia, and National Institutes of Health (NIH). NPW is the recipient of a Fellowship from Parent Project Muscular Dystrophy (PPMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Disatnik MH, 1998, J NEUROL SCI, V161, P77, DOI 10.1016/S0022-510X(98)00258-5; Dorchies OM, 2006, AM J PHYSIOL-CELL PH, V290, pC616, DOI 10.1152/ajpcell.00425.2005; Dudley RWR, 2006, AM J PHYSIOL-REG I, V291, pR704, DOI 10.1152/ajpregu.00031.2006; Evans NP, 2009, AM J PHYS MED REHAB, V88, P502, DOI 10.1097/PHM.0b013e3181a5a24f; Gauss KA, 2007, J LEUKOCYTE BIOL, V82, P729, DOI 10.1189/jlb.1206735; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Han WX, 2008, HYPERTENSION, V51, P481, DOI 10.1161/HYPERTENSIONAHA.107.103275; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Hnia K, 2007, AM J PATHOL, V170, P633, DOI 10.2353/ajpath.2007.060344; Huang J, 1995, BIOCHEMISTRY-US, V34, P16753, DOI 10.1021/bi00051a024; Javesghani D, 2002, AM J RESP CRIT CARE, V165, P412, DOI 10.1164/ajrccm.165.3.2103028; Jung C, 2008, CARDIOVASC RES, V77, P766, DOI 10.1093/cvr/cvm089; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Menazza S, 2010, HUM MOL GENET, V19, P4207, DOI 10.1093/hmg/ddq339; Messina S, 2006, AM J PATHOL, V168, P918, DOI 10.2353/ajpath.2006.050673; Mofarrahi M, 2008, ANTIOXID REDOX SIGN, V10, P559, DOI 10.1089/ars.2007.1792; Nguyen HX, 2003, J PHYSIOL-LONDON, V553, P833, DOI 10.1113/jphysiol.2003.051912; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PimoradyEsfahani A, 1997, MUSCLE NERVE, V20, P158, DOI 10.1002/(SICI)1097-4598(199702)20:2<158::AID-MUS4>3.0.CO;2-B; Rando TA, 2002, AM J PHYS MED REHAB, V81, pS175, DOI 10.1097/00002060-200211001-00018; Ravenscroft G, 2007, CELL MOTIL CYTOSKEL, V64, P727, DOI 10.1002/cm.20223; Shkryl VM, 2009, PFLUG ARCH EUR J PHY, V458, P915, DOI 10.1007/s00424-009-0670-2; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Touyz RM, 2003, ARTERIOSCL THROM VAS, V23, pA5; Tseng BS, 2002, J APPL PHYSIOL, V93, P537, DOI 10.1152/japplphysiol.00202.2002; Vaghy PL, 1998, FEBS LETT, V431, P125, DOI 10.1016/S0014-5793(98)00738-8; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Venema VJ, 1997, J BIOL CHEM, V272, P28187, DOI 10.1074/jbc.272.45.28187; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Whitehead N, 2006, NEUROMUSCULAR DISORD, V16, pS159; Whitehead NP, 2008, J PHYSIOL-LONDON, V586, P2003, DOI 10.1113/jphysiol.2007.148338; Williams IA, 2007, AM J PHYSIOL-HEART C, V293, pH1969, DOI 10.1152/ajpheart.00489.2007; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Zanou N, 2009, FEBS LETT, V583, P3600, DOI 10.1016/j.febslet.2009.10.033	39	128	131	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15354	10.1371/journal.pone.0015354	http://dx.doi.org/10.1371/journal.pone.0015354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187957	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200039
J	Chadwick, W; Zhou, Y; Park, SS; Wang, LY; Mitchell, N; Stone, MD; Becker, KG; Martin, B; Maudsley, S				Chadwick, Wayne; Zhou, Yu; Park, Sung-Soo; Wang, Liyun; Mitchell, Nicholas; Stone, Matthew D.; Becker, Kevin G.; Martin, Bronwen; Maudsley, Stuart			Minimal Peroxide Exposure of Neuronal Cells Induces Multifaceted Adaptive Responses	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CHROMATIN PROTEIN HMGB2; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; PREMATURE SENESCENCE; NEUROTROPHIC FACTOR; PROTHYMOSIN-ALPHA; MESSENGER-RNA; LIFE-SPAN; MITOCHONDRIAL RESPIRATION	Oxidative exposure of cells occurs naturally and may be associated with cellular damage and dysfunction. Protracted low level oxidative exposure can induce accumulated cell disruption, affecting multiple cellular functions. Accumulated oxidative exposure has also been proposed as one of the potential hallmarks of the physiological/pathophysiological aging process. We investigated the multifactorial effects of long-term minimal peroxide exposure upon SH-SY5Y neural cells to understand how they respond to the continued presence of oxidative stressors. We show that minimal protracted oxidative stresses induce complex molecular and physiological alterations in cell functionality. Upon chronic exposure to minimal doses of hydrogen peroxide, SH-SY5Y cells displayed a multifactorial response to the stressor. To fully appreciate the peroxide-mediated cellular effects, we assessed these adaptive effects at the genomic, proteomic and cellular signal processing level. Combined analyses of these multiple levels of investigation revealed a complex cellular adaptive response to the protracted peroxide exposure. This adaptive response involved changes in cytoskeletal structure, energy metabolic shifts towards glycolysis and selective alterations in transmembrane receptor activity. Our analyses of the global responses to chronic stressor exposure, at multiple biological levels, revealed a viable neural phenotype in-part reminiscent of aged or damaged neural tissue. Our paradigm indicates how cellular physiology can subtly change in different contexts and potentially aid the appreciation of stress response adaptations.	[Chadwick, Wayne; Zhou, Yu; Park, Sung-Soo; Wang, Liyun; Stone, Matthew D.; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Mitchell, Nicholas] St Bonaventure Univ, Dept Biol, St Bonaventure, NY 14778 USA; [Becker, Kevin G.] NIA, Gene Express & Genom Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Martin, Bronwen] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chadwick, W (corresponding author), NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA.	maudsleyst@mail.nih.gov	Mitchell, Nicholas/A-7066-2018; Zhou, Yu/M-7975-2014; Maudsley, Stuart/Q-4782-2019; Maudsley, Stuart/AAV-9929-2021	Mitchell, Nicholas/0000-0003-2088-5419; Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925; Becker, Kevin/0000-0002-6794-6656	National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000325, ZICAG000616, ZIAAG000318, ZIAAG000319] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institute on Aging. The funding authority had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian GS, 1996, J GERONTOL A-BIOL, V51, pB66, DOI 10.1093/gerona/51A.1.B66; Apprey V, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S119; Atamna H, 2007, MITOCHONDRION, V7, P297, DOI 10.1016/j.mito.2007.06.001; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Biessels GJ, 2005, BIOCHEM SOC T, V33, P1041, DOI 10.1042/BST0331041; BOHR VA, 1995, MUTAT RES-DNAGING G, V338, P25, DOI 10.1016/0921-8734(95)00008-T; Borras C, 2009, FEBS LETT, V583, P2287, DOI 10.1016/j.febslet.2009.06.019; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Brewer GJ, 2010, EXP GERONTOL, V45, P173, DOI 10.1016/j.exger.2009.11.007; Brooks PJ, 2008, DNA REPAIR, V7, P834, DOI 10.1016/j.dnarep.2008.01.017; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chen GH, 2004, PHYSIOL BEHAV, V82, P883, DOI 10.1016/j.physbeh.2004.07.008; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chiba T, 2007, MAMM GENOME, V18, P105, DOI 10.1007/s00335-006-0119-2; Cho DH, 2007, ONCOGENE, V26, P2809, DOI 10.1038/sj.onc.1210080; Cho DH, 2004, J BIOL CHEM, V279, P39942, DOI 10.1074/jbc.M405747200; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cummings Jeffrey L., 2000, Int J Neuropsychopharmacol, V3, P21, DOI 10.1017/S1461145700001917; Davidson L, 2004, J BIOL CHEM, V279, P11906, DOI 10.1074/jbc.M310784200; Davidson L, 2004, J BIOL CHEM, V279, P1980, DOI 10.1074/jbc.M309827200; De Santi S, 2001, NEUROBIOL AGING, V22, P529, DOI 10.1016/S0197-4580(01)00230-5; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Diener T, 2010, EXP GERONTOL, V45, P638, DOI 10.1016/j.exger.2010.03.002; DOSIL M, 1990, FEBS LETT, V269, P373, DOI 10.1016/0014-5793(90)81196-U; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Erickson RR, 2006, J GERONTOL A-BIOL, V61, P435, DOI 10.1093/gerona/61.5.435; Fatokun AA, 2008, FRONT BIOSCI-LANDMRK, V13, P3288, DOI 10.2741/2926; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; FRILLINGOS S, 1992, EXPERIENTIA, V48, P236, DOI 10.1007/BF01930463; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; FUJIWARA M, 1993, PHYTOTHER RES, V7, pS60, DOI 10.1002/ptr.2650070718; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Gannon J, 2008, INT J MOL MED, V22, P33; Gilca M, 2007, J POSTGRAD MED, V53, P207, DOI 10.4103/0022-3859.33869; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Gooney M, 2004, NEUROBIOL AGING, V25, P1323, DOI 10.1016/j.neurobiolaging.2004.01.003; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Honda K, 2004, ANN NY ACAD SCI, V1012, P179, DOI 10.1196/annals.1306.015; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Inumaru J, 2009, GENES CELLS, V14, P703, DOI 10.1111/j.1365-2443.2009.01303.x; Ip FCF, 2000, NEUROREPORT, V11, P457, DOI 10.1097/00001756-200002280-00006; Ishitani R, 1996, J PHARMACOL EXP THER, V278, P447; JAGUST WJ, 1991, J CEREBR BLOOD F MET, V11, P323, DOI 10.1038/jcbfm.1991.65; Jee HJ, 2009, BIOCHEM BIOPH RES CO, V383, P358, DOI 10.1016/j.bbrc.2009.04.017; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; JOHANSSON S, 1994, ACTA PHYSIOL SCAND, V151, P331, DOI 10.1111/j.1748-1716.1994.tb09752.x; Kamimura J, 2004, J HUM GENET, V49, P360, DOI 10.1007/s10038-004-0158-z; Kilts JD, 2002, J BIOL CHEM, V277, P31257, DOI 10.1074/jbc.M203640200; Kim CH, 1999, J NEUROSCI, V19, P4314; Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7; Kim JM, 2010, FREE RADICAL RES, V44, P454, DOI 10.3109/10715761003610737; Kim SY, 2010, BIOCHEM BIOPH RES CO, V391, P28, DOI 10.1016/j.bbrc.2009.10.154; Kojima N, 2007, NEUROSCI RES, V58, P1, DOI 10.1016/j.neures.2007.02.003; Lam PY, 2009, FREE RADICAL RES, V43, P431, DOI 10.1080/10715760902849813; LANDFIELD PW, 1987, NEUROBIOL AGING, V8, P346, DOI 10.1016/0197-4580(87)90074-1; LEVINE AS, 1986, J GERONTOL, V41, P20, DOI 10.1093/geronj/41.1.20; Li BJ, 2005, CELL CYCLE, V4, P246; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; Li MY, 2003, J CELL PHYSIOL, V197, P418, DOI 10.1002/jcp.10384; Li SC, 2010, J COGNITIVE NEUROSCI, V22, P2164, DOI 10.1162/jocn.2009.21374; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Linnane AW, 2007, BIOGERONTOLOGY, V8, P445, DOI 10.1007/s10522-007-9096-4; Liochev SI, 2003, FREE RADICAL BIO MED, V34, P1383, DOI 10.1016/S0891-5849(03)00153-9; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lopes GS, 2006, EXP GERONTOL, V41, P55, DOI 10.1016/j.exger.2005.10.004; MAJUMDAR APN, 1994, J GERONTOL, V49, pB110, DOI 10.1093/geronj/49.3.B110; MARIC D, 1991, ANN NY ACAD SCI, V621, P148; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; Martin Bronwen, 2007, IBS J Sci, V2, P35; MATOCHA MF, 1990, EXP GERONTOL, V25, P47, DOI 10.1016/0531-5565(90)90008-P; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Meltzer CC, 1998, NEUROPSYCHOPHARMACOL, V18, P407; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Mukaetova-Ladinska EB, 2008, DEMENT GERIATR COGN, V26, P32, DOI 10.1159/000141039; Murer MG, 1999, NEUROSCIENCE, V88, P1015, DOI 10.1016/S0306-4522(98)00219-X; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Nomura Y, 1999, NEUROBIOL AGING, V20, P111, DOI 10.1016/S0197-4580(99)00006-8; North KE, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S98; Ogunshola OO, 2009, CELL MOL LIFE SCI, V66, P3555, DOI 10.1007/s00018-009-0141-0; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Park SC, 2002, ANN NY ACAD SCI, V959, P45, DOI 10.1111/j.1749-6632.2002.tb02081.x; Petit-Taboue MC, 1998, NEUROIMAGE, V7, P176, DOI 10.1006/nimg.1997.0318; PICARD B, 1995, REPROD NUTR DEV, V35, P71, DOI 10.1051/rnd:19950105; Puzianowska-Kuznicka M, 2009, AGEING RES REV, V8, P160, DOI 10.1016/j.arr.2009.05.002; Quartu M, 1999, BRAIN RES BULL, V48, P375, DOI 10.1016/S0361-9230(99)00009-X; Rodriguez Sofia, 2010, Curr Aging Sci, V3, P81; Rollo CD, 2009, NEUROCHEM RES, V34, P601, DOI 10.1007/s11064-008-9858-7; Romanczyk TB, 2002, EUR J NEUROSCI, V15, P269, DOI 10.1046/j.0953-816x.2001.01858.x; Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Sarraj MA, 2007, REPRODUCTION, V133, P753, DOI 10.1530/rep.1.01184; Sato Y, 2005, NEUROSCI LETT, V382, P22, DOI 10.1016/j.neulet.2005.02.053; Schaaf MJM, 2001, BRAIN RES, V915, P227, DOI 10.1016/S0006-8993(01)02855-4; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; SESHADRI T, 1993, J BIOL CHEM, V268, P18474; Sharov VS, 2006, BIOCHEM J, V394, P605, DOI 10.1042/BJ20051214; Sheehan JP, 1997, J NEUROSCI, V17, P4612; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Silhol M, 2008, REJUV RES, V11, P1031, DOI 10.1089/rej.2008.0791; Smaili SS, 2008, METHOD ENZYMOL, V442, P27, DOI 10.1016/S0076-6879(08)01402-X; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stockl P, 2007, FREE RADICAL BIO MED, V43, P947, DOI 10.1016/j.freeradbiomed.2007.06.005; Stranahan AM, 2009, CURR MED CHEM, V16, P4668, DOI 10.2174/092986709789878292; Takahashi K, 2000, J BIOCHEM-TOKYO, V127, P73, DOI 10.1093/oxfordjournals.jbchem.a022586; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P16817, DOI 10.1073/pnas.0904414106; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P1181, DOI 10.1073/pnas.0806062106; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Terao A, 2004, NEUROSCI LETT, V355, P81, DOI 10.1016/j.neulet.2003.10.061; Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Toussaint O, 2002, INT J BIOCHEM CELL B, V34, P1415, DOI 10.1016/S1357-2725(02)00034-1; Uejima H, 1998, MOL CARCINOGEN, V22, P34, DOI 10.1002/(SICI)1098-2744(199805)22:1<34::AID-MC5>3.0.CO;2-L; UEJIMA H, 1995, GENE CHROMOSOME CANC, V14, P120, DOI 10.1002/gcc.2870140206; Valdez SR, 2007, SYNAPSE, V61, P124, DOI 10.1002/syn.20353; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; VanGuilder HD, 2010, J NEUROCHEM, V113, P1577, DOI 10.1111/j.1471-4159.2010.06719.x; VERKHRATSKY A, 1994, ANN NY ACAD SCI, V747, P365; Viner RI, 1999, BIOCHEMISTRY-US, V38, P12408, DOI 10.1021/bi9909445; Wang DT, 2010, J IMMUNOL, V184, P582, DOI 10.4049/jimmunol.0902352; Wang XL, 2008, BBA-MOL CELL RES, V1783, P1876, DOI 10.1016/j.bbamcr.2008.05.015; WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9; Weinmann A, 2005, INT J MOL MED, V16, P905; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; Wu D, 2010, HORM BEHAV, V58, P306, DOI 10.1016/j.yhbeh.2010.03.001; Xu K, 2010, ADV EXP MED BIOL, V662, P71, DOI 10.1007/978-1-4419-1241-1_9; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yamashita S, 2005, CANCER RES, V65, P2610, DOI 10.1158/0008-5472.CAN-04-2932; Yan LJ, 2008, MECH AGEING DEV, V129, P282, DOI 10.1016/j.mad.2008.01.006; Yang S, 2008, NEUROSCIENCE, V154, P1107, DOI 10.1016/j.neuroscience.2008.04.012; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015; Yue Z, 2008, NEUROSCI LETT, V439, P119, DOI 10.1016/j.neulet.2008.04.009; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x; ZHU W, 1994, MAMM GENOME, V5, P234, DOI 10.1007/BF00360552; Ziegenhorn AA, 2007, NEUROBIOL AGING, V28, P1436, DOI 10.1016/j.neurobiolaging.2006.06.011	156	51	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14352	10.1371/journal.pone.0014352	http://dx.doi.org/10.1371/journal.pone.0014352			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179406	gold, Green Submitted, Green Published			2022-12-25	WOS:000285572900002
J	Gonzalez-Voyer, A; Kolm, N				Gonzalez-Voyer, Alejandro; Kolm, Niclas			Sex, Ecology and the Brain: Evolutionary Correlates of Brain Structure Volumes in Tanganyikan Cichlids	PLOS ONE			English	Article							SIZE DIMORPHIC BRAINS; SPATIAL COGNITION; SPERM COMPETITION; SONG REPERTOIRE; PARENTAL CARE; PATTERNS; SELECTION; COMPLEXITY; MORPHOLOGY; BIRDS	Analyses of the macroevolutionary correlates of brain structure volumes allow pinpointing of selective pressures influencing specific structures. Here we use a multiple regression framework, including phylogenetic information, to analyze brain structure evolution in 43 Tanganyikan cichlid species. We analyzed the effect of ecological and sexually selected traits for species averages, the effect of ecological traits for each sex separately and the influence of sexual selection on structure dimorphism. Our results indicate that both ecological and sexually selected traits have influenced brain structure evolution. The patterns observed in males and females generally followed those observed at the species level. Interestingly, our results suggest that strong sexual selection is associated with reduced structure volumes, since all correlations between sexually selected traits and structure volumes were negative and the only statistically significant association between sexual selection and structure dimorphism was also negative. Finally, we previously found that monoparental female care was associated with increased brain size. However, here cerebellum and hypothalamus volumes, after controlling for brain size, associated negatively with female-only care. Thus, in accord with the mosaic model of brain evolution, brain structure volumes may not respond proportionately to changes in brain size. Indeed selection favoring larger brains can simultaneously lead to a reduction in relative structure volumes.	[Gonzalez-Voyer, Alejandro] CSIC, Estn Biol Donana, Dept Integrat Ecol, E-41080 Seville, Spain; [Gonzalez-Voyer, Alejandro; Kolm, Niclas] Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, Uppsala, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Uppsala University	Gonzalez-Voyer, A (corresponding author), CSIC, Estn Biol Donana, Dept Integrat Ecol, E-41080 Seville, Spain.	alejandro.gonzalez@ebd.csic.es	Gonzalez-Voyer, Alejandro/B-7322-2011	Kolm, Niclas/0000-0001-5791-336X	Wenner-Gren Foundations; Swedish Research Council [005-4920, 2009-5157]; Ministerio de Ciencia y Educacion, Spain	Wenner-Gren Foundations; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ministerio de Ciencia y Educacion, Spain	This work was funded through grants from the Wenner-Gren Foundations and the Swedish Research Council (005-4920 and 2009-5157) to N.K. A.G.-V. was supported by a Wenner-Gren Foundations postdoctoral stipend and a Juan de la Cierva post-doctoral fellowship from the Ministerio de Ciencia y Educacion, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Andersson Malte, 1994; Barton RA, 2007, J EVOLUTION BIOL, V20, P1504, DOI 10.1111/j.1420-9101.2007.01330.x; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Broglio C, 2003, FISH FISH, V4, P247, DOI 10.1046/j.1467-2979.2003.00128.x; Butler A.B., 2005, COMP VERTEBRATE NEUR, DOI DOI 10.1017/CBO9780511525636.010; Clabaut C, 2007, EVOLUTION, V61, P560, DOI 10.1111/j.1558-5646.2007.00045.x; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; de Winter W, 2001, NATURE, V409, P710, DOI 10.1038/35055547; Dechmann DKN, 2009, BIOL REV, V84, P161, DOI 10.1111/j.1469-185X.2008.00067.x; DEVOOGD TJ, 1993, P ROY SOC B-BIOL SCI, V254, P75, DOI 10.1098/rspb.1993.0129; Dunbar RIM, 2007, PHILOS T R SOC B, V362, P649, DOI 10.1098/rstb.2006.2001; Dunbar RIM, 1998, ETHOLOGY, V104, P695, DOI 10.1111/j.1439-0310.1998.tb00103.x; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FAIRBAIRN DJ, 2007, GENDER ROLES EVOLUTI, P1; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Freckleton RP, 2002, J ANIM ECOL, V71, P542, DOI 10.1046/j.1365-2656.2002.00618.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garamszegi LZ, 2005, BEHAV ECOL, V16, P335, DOI 10.1093/beheco/arh167; Garamszegi LZ, 2005, P ROY SOC B-BIOL SCI, V272, P159, DOI 10.1098/rspb.2004.2940; GASHAGAZA M M, 1991, Physiology and Ecology Japan, V28, P29; GITTLEMAN JL, 1994, P NATL ACAD SCI USA, V91, P5495, DOI 10.1073/pnas.91.12.5495; Gonzalez-Lagos C, 2010, J EVOLUTION BIOL, V23, P1064, DOI 10.1111/j.1420-9101.2010.01976.x; Gonzalez-Voyer A, 2008, EVOLUTION, V62, P2015, DOI 10.1111/j.1558-5646.2008.00426.x; Gonzalez-Voyer A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-238; Gonzalez-Voyer A, 2009, P ROY SOC B-BIOL SCI, V276, P161, DOI 10.1098/rspb.2008.0979; Guay PJ, 2008, AUST J ZOOL, V56, P311, DOI 10.1071/ZO08082; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Healy SD, 2005, TRENDS ECOL EVOL, V20, P17, DOI 10.1016/j.tree.2004.10.006; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; HUBER R, 1992, ENVIRON BIOL FISH, V33, P153, DOI 10.1007/BF00002561; Huber R, 1997, BRAIN BEHAV EVOLUT, V50, P167, DOI 10.1159/000113330; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; Ito H, 2007, BRAIN BEHAV EVOLUT, V69, P76, DOI 10.1159/000095196; Iwaniuk AN, 2004, P ROY SOC B-BIOL SCI, V271, pS148, DOI 10.1098/rsbl.2003.0127; Iwaniuk AN, 2003, CAN J ZOOL, V81, P1913, DOI 10.1139/Z03-190; Jacobs LF, 1996, TRENDS ECOL EVOL, V11, pA82; JACOBS LF, 1990, P NATL ACAD SCI USA, V87, P6349, DOI 10.1073/pnas.87.16.6349; Kolm N, 2009, J EVOLUTION BIOL, V22, P2524, DOI 10.1111/j.1420-9101.2009.01875.x; Konings A., 2005, BACK NATURE GUIDE TA, V2nd; Kornfield I, 2000, ANNU REV ECOL SYST, V31, P163, DOI 10.1146/annurev.ecolsys.31.1.163; Kotrschal K, 1998, REV FISH BIOL FISHER, V8, P373, DOI 10.1023/A:1008839605380; KOTRSCHAL K, 1988, J HIRNFORSCH, V29, P341; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Lefebvre L, 2002, BEHAVIOUR, V139, P939, DOI 10.1163/156853902320387918; Lemaitre JF, 2009, J EVOLUTION BIOL, V22, P2215, DOI 10.1111/j.1420-9101.2009.01837.x; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pitnick S, 2006, P ROY SOC B-BIOL SCI, V273, P719, DOI 10.1098/rspb.2005.3367; Pollen AA, 2007, BRAIN BEHAV EVOLUT, V70, P21, DOI 10.1159/000101067; Portavella M, 2005, EUR J NEUROSCI, V21, P2800, DOI 10.1111/j.1460-9568.2005.04114.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; REVELL LJ, 2010, METHODS ECOLOGY EVOL; Rodriguez F, 2002, J NEUROSCI, V22, P2894, DOI 10.1523/JNEUROSCI.22-07-02894.2002; RODRIGUEZ F, 2004, COGNITIVE EMOTIONAL, P365; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Safi K, 2005, P ROY SOC B-BIOL SCI, V272, P179, DOI 10.1098/rspb.2004.2924; Salas C, 2003, BRAIN BEHAV EVOLUT, V62, P72, DOI 10.1159/000072438; SALZBURGER W, 2005, BMC EVOLUTIONARY BIO; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; Shohet AJ, 2009, J FISH BIOL, V75, P1323, DOI 10.1111/j.1095-8649.2009.02366.x; Sokal RR, 1995, BIOMETRY; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sol D, 2007, P ROY SOC B-BIOL SCI, V274, P763, DOI 10.1098/rspb.2006.3765; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Szekely T, 1996, P ROY SOC B-BIOL SCI, V263, P607, DOI 10.1098/rspb.1996.0091; Team R. D. C., 2009, R LANGUAGE ENV STAT; Timmermans S, 2000, BRAIN BEHAV EVOLUT, V56, P196, DOI 10.1159/000047204; VANSTAADEN MJ, 1995, ZOOLOGY, V98, P165; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA	73	67	68	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14355	10.1371/journal.pone.0014355	http://dx.doi.org/10.1371/journal.pone.0014355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179407	Green Published, gold, Green Submitted			2022-12-25	WOS:000285572900003
J	Stafford, R; Hart, AG; Collins, L; Kirkhope, CL; Williams, RL; Rees, SG; Lloyd, JR; Goodenough, AE				Stafford, Richard; Hart, Adam G.; Collins, Laura; Kirkhope, Claire L.; Williams, Rachel L.; Rees, Samuel G.; Lloyd, Jane R.; Goodenough, Anne E.			Eu-Social Science: The Role of Internet Social Networks in the Collection of Bee Biodiversity Data	PLOS ONE			English	Article							PRESENCE-ONLY DATA; CITIZEN SCIENCE; TOOL; KNOWLEDGE	Background: Monitoring change in species diversity, community composition and phenology is vital to assess the impacts of anthropogenic activity and natural change. However, monitoring by trained scientists is time consuming and expensive. Methodology/Principal Findings: Using social networks, we assess whether it is possible to obtain accurate data on bee distribution across the UK from photographic records submitted by untrained members of the public, and if these data are in sufficient quantity for ecological studies. We used Flickr and Facebook as social networks and Flickr for the storage of photographs and associated data on date, time and location linked to them. Within six weeks, the number of pictures uploaded to the Flickr BeeID group exceeded 200. Geographic coverage was excellent; the distribution of photographs covered most of the British Isles, from the south coast of England to the Highlands of Scotland. However, only 59% of photographs were properly uploaded according to instructions, with vital information such as 'tags' or location information missing from the remainder. Nevertheless, this incorporation of information on location of photographs was much higher than general usage on Flickr (similar to 13%), indicating the need for dedicated projects to collect spatial ecological data. Furthermore, we found identification of bees is not possible from all photographs, especially those excluding lower abdomen detail. This suggests that giving details regarding specific anatomical features to include on photographs would be useful to maximise success. Conclusions/Significance: The study demonstrates the power of social network sites to generate public interest in a project and details the advantages of using a group within an existing popular social network site over a traditional (specifically-designed) web-based or paper-based submission process. Some advantages include the ability to network with other individuals or groups with similar interests, and thus increasing the size of the dataset and participation in the project.	[Stafford, Richard; Hart, Adam G.; Collins, Laura; Kirkhope, Claire L.; Williams, Rachel L.; Rees, Samuel G.; Lloyd, Jane R.; Goodenough, Anne E.] Univ Gloucestershire, Dept Nat & Social Sci, Cheltenham, Glos, England	University of Gloucestershire	Stafford, R (corresponding author), Univ Gloucestershire, Dept Nat & Social Sci, Cheltenham, Glos, England.	rstafford@glos.ac.uk	Goodenough, Anne/C-5220-2011; Stafford, Rick/B-1059-2013	Stafford, Rick/0000-0002-1964-5787; Goodenough, Anne/0000-0002-7662-6670				Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; BLOOMFIELD A, 2006, MARINE CONSERVATION; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Brooks SP, 2003, PHILOS T ROY SOC A, V361, P2681, DOI 10.1098/rsta.2003.1263; Brossard D, 2005, INT J SCI EDUC, V27, P1099, DOI 10.1080/09500690500069483; Cooper CB, 2007, ECOL SOC, V12; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Franklin J, 2009, MAPPING SPECIES DIST; *GOCC, 2009, GLOUC BIRD REP 2008; KIRKHOPE CL, 2010, P ISOCIETY 2010, P637; Kirkpatrick David, 2010, FACEBOOK EFFECT INSI; Kitchen-Wheeler AM, 2010, MAR BIOL RES, V6, P351, DOI 10.1080/17451000903233763; LLOYD JR, 2010, 30 ANN S SEA TURTL B; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Robinson ME, 2003, PAIN, V104, P259, DOI 10.1016/S0304-3959(03)00014-9; Rosenthal R., 1966, EXPT EFFECTS BEHAV R; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Staab S, 2005, IEEE INTELL SYST, V20, P80, DOI 10.1109/MIS.2005.16; Sutherland WJ, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P1, DOI 10.2277/ 0521606365; TWISSELL C, 2009, GLOUCESTERSHIRE NAT, V20, P26; Underwood, 1996, EXPT ECOLOGY THEIR L; WARD G, 2007, THESIS STANFORD U PA; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0; Zheng Pei, 2006, SMART PHONE NEXT GEN	25	45	48	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14381	10.1371/journal.pone.0014381	http://dx.doi.org/10.1371/journal.pone.0014381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179423	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000285572900012
J	Micewicz, ED; Cole, AL; Jung, CL; Luong, H; Phillips, ML; Pratikhya, P; Sharma, S; Waring, AJ; Cole, AM; Ruchala, P				Micewicz, Ewa D.; Cole, Amy L.; Jung, Chun-Ling; Luong, Hai; Phillips, Martin L.; Pratikhya, Pratikhya; Sharma, Shantanu; Waring, Alan J.; Cole, Alexander M.; Ruchala, Piotr			Grifonin-1: A Small HIV-1 Entry Inhibitor Derived from the Algal Lectin, Griffithsin	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIVIRAL PROTEIN GRIFFITHSIN; INACTIVATING PROTEIN; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; CARBOHYDRATE-BINDING; VIRAL PERSISTENCE; THETA-DEFENSIN; CYANOVIRIN-N; AMINO-ACIDS	Background: Griffithsin, a 121-residue protein isolated from a red algal Griffithsia sp., binds high mannose N-linked glycans of virus surface glycoproteins with extremely high affinity, a property that allows it to prevent the entry of primary isolates and laboratory strains of T-and M-tropic HIV-1. We used the sequence of a portion of griffithsin's sequence as a design template to create smaller peptides with antiviral and carbohydrate-binding properties. Methodology/Results: The new peptides derived from a trio of homologous beta-sheet repeats that comprise the motifs responsible for its biological activity. Our most active antiviral peptide, grifonin-1 (GRFN-1), had an EC50 of 190.8 +/- 11.0 nM in in vitro TZM-bl assays and an EC50 of 546.6 +/- 66.1 nM in p24(gag) antigen release assays. GRFN-1 showed considerable structural plasticity, assuming different conformations in solvents that differed in polarity and hydrophobicity. Higher concentrations of GRFN-1 formed oligomers, based on intermolecular beta-sheet interactions. Like its parent protein, GRFN-1 bound viral glycoproteins gp41 and gp120 via the N-linked glycans on their surface. Conclusion: Its substantial antiviral activity and low toxicity in vitro suggest that GRFN-1 and/or its derivatives may have therapeutic potential as topical and/or systemic agents directed against HIV-1.	[Micewicz, Ewa D.; Jung, Chun-Ling; Luong, Hai; Pratikhya, Pratikhya; Waring, Alan J.; Ruchala, Piotr] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Micewicz, Ewa D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA; [Cole, Amy L.; Cole, Alexander M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; [Phillips, Martin L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Sharma, Shantanu] CALTECH, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University System of Florida; University of Central Florida; University of California System; University of California Los Angeles; California Institute of Technology	Micewicz, ED (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	pruchala@mednet.ucla.edu		RUCHALA, PIOTR/0000-0002-5574-2779	Office of the David Geffen School of Medicine at University of California at Los Angeles; National Institutes of Health [AI-052017, AI082623]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052017, U19AI082623, R56AI052017] Funding Source: NIH RePORTER	Office of the David Geffen School of Medicine at University of California at Los Angeles; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported, in part, by funds from the Adams and Burnham endowments provided by the Dean's Office of the David Geffen School of Medicine at University of California at Los Angeles (PR) and by National Institutes of Health grants #AI-052017 and #AI082623 (to AMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Bokesch HR, 2004, FEBS LETT, V567, P287, DOI 10.1016/j.febslet.2004.04.085; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; BRUCH MD, 1991, PROTEINS, V10, P130, DOI 10.1002/prot.340100206; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AL, 2007, IMMUNOLOGY, V121, P140, DOI 10.1111/j.1365-2567.2006.02553.x; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Efimov AV, 2003, FEBS LETT, V554, P389, DOI 10.1016/S0014-5793(03)01189-X; Emau P, 2007, J MED PRIMATOL, V36, P244, DOI 10.1111/j.1600-0684.2007.00242.x; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Giomarelli B, 2006, PROTEIN EXPRES PURIF, V47, P194, DOI 10.1016/j.pep.2005.10.014; Haggerty CM, 2006, CURR OPIN HIV AIDS, V1, P62, DOI 10.1097/01.COH.0000191897.78309.70; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kiser JJ, 2008, CURR OPIN HIV AIDS, V3, P330, DOI 10.1097/COH.0b013e3282fbaa6b; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; LIU CC, 1988, J IMMUNOL METHODS, V114, P33; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Makinson A, 2009, CURR OPIN HIV AIDS, V4, P150, DOI 10.1097/COH.0b013e32832498d8; McCurdy S N, 1989, Pept Res, V2, P147; Miles AJ, 2003, SPECTROSC-INT J, V17, P653, DOI 10.1155/2003/379137; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mori T, 2001, ANTIMICROB AGENTS CH, V45, P664, DOI 10.1128/AAC.45.3.664-672.2001; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Owen SM, 2004, J PEPT RES, V63, P469, DOI 10.1111/j.1399-3011.2004.00155.x; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; TEMIN HM, 1993, NATURE, V362, P292, DOI 10.1038/362292a0; Vandekerckhove L, 2008, J ANTIMICROB CHEMOTH, V61, P1187, DOI 10.1093/jac/dkn130; Vandekerckhove L, 2009, J ANTIMICROB CHEMOTH, V63, P1087, DOI 10.1093/jac/dkp113; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770; Zeitlin L, 2009, P NATL ACAD SCI USA, V106, P6029, DOI 10.1073/pnas.0902239106; Ziolkowska NE, 2007, PROTEIN SCI, V16, P1485, DOI 10.1110/ps.072889407; Ziolkowska NE, 2007, PROTEINS, V67, P661, DOI 10.1002/prot.21336; Ziolkowska NE, 2006, ACTA BIOCHIM POL, V53, P617; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	52	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14360	10.1371/journal.pone.0014360	http://dx.doi.org/10.1371/journal.pone.0014360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179548	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000285381200010
J	Mendez, M; Rosenbaum, HC; Wells, RS; Stamper, A; Bordino, P				Mendez, Martin; Rosenbaum, Howard C.; Wells, Randall S.; Stamper, Andrew; Bordino, Pablo			Genetic Evidence Highlights Potential Impacts of By-Catch to Cetaceans	PLOS ONE			English	Article							PAIRWISE RELATEDNESS; CONSERVATION GENETICS; FRANCISCANA DOLPHINS; POPULATION-STRUCTURE; DIVERGENT SELECTION; MOLECULAR MARKERS; MARINE MAMMALS; PATTERNS; WHALES; FISHERIES	Incidental entanglement in fishing gear is arguably the most serious threat to many populations of small cetaceans, judging by the alarming number of captured animals. However, other aspects of this threat, such as the potential capture of mother-offspring pairs or reproductive pairs, could be equally or even more significant but have rarely been evaluated. Using a combination of demographic and genetic data we provide evidence that i) Franciscana dolphin pairs that are potentially reproductive and mother-offspring pairs form temporal bonds, and ii) are entangled simultaneously. Our results highlight potential demographic and genetic impacts of by-catch to cetacean populations: the joint entanglement of mother-offspring or reproductive pairs, compared to random individuals, might exacerbate the demographic consequences of by-catch, and the loss of groups of relatives means that significant components of genetic diversity could be lost together. Given the social nature of many odontocetes (toothed cetaceans), we suggest that these potential impacts could be rather general to the group and therefore by-catch could be more detrimental than previously considered.	[Mendez, Martin] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Mendez, Martin; Rosenbaum, Howard C.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Mendez, Martin; Bordino, Pablo] Fdn AquaMarina, Buenos Aires, DF, Argentina; [Rosenbaum, Howard C.] Wildlife Conservat Soc, Ocean Giants Program, Bronx, NY USA; [Bordino, Pablo] Wildlife Trust Alliance, New York, NY USA; [Wells, Randall S.; Bordino, Pablo] Mote Marine Lab, Chicago Zool Soc, Sarasota, FL 34236 USA; [Stamper, Andrew] Walt Disney World Resorts, Lake Buena Vista, FL USA	Columbia University; American Museum of Natural History (AMNH); Wildlife Conservation Society; Mote Marine Laboratory & Aquarium; Walt Disney Company	Mendez, M (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	mm1772@columbia.edu			Disney Worldwide Conservation Fund; Disney's Animal Programs and Environmental Initiatives; Chicago Zoological Society; Fundacion Vida Silvestre Argentina; World Wildlife Fund; Walt Disney World Resorts organization	Disney Worldwide Conservation Fund; Disney's Animal Programs and Environmental Initiatives; Chicago Zoological Society; Fundacion Vida Silvestre Argentina; World Wildlife Fund; Walt Disney World Resorts organization	This material is based upon work supported by Disney Worldwide Conservation Fund, Disney's Animal Programs and Environmental Initiatives, Chicago Zoological Society, Fundacion Vida Silvestre Argentina and the World Wildlife Fund. Walt Disney World Resorts organization only provided funding and support to Andrew Stamper. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors designed the study and the data collection strategy, collected all data and analyzed them. The authors prepared the manuscript, decided to publish it, and chose this outlet.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; Begon M., 1996, ECOLOGY; Bordino P, 2002, MAR MAMMAL SCI, V18, P833, DOI 10.1111/j.1748-7692.2002.tb01076.x; BORDINO P, 2004, 56 IWC M SORR IT; BORDINO P, 2008, SC53IA32 IWC; Crespo EA, 2010, MAR MAMMAL SCI, V26, P17, DOI 10.1111/j.1748-7692.2009.00313.x; DEMASTER DP, 1988, MAR MAMMAL SCI, V4, P297, DOI 10.1111/j.1748-7692.1988.tb00539.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Finkelstein M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002480; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; Gerber LR, 2004, BIOL CONSERV, V120, P121, DOI 10.1016/j.biocon.2004.01.029; Gotelli NJ, 2001, PRIMER ECOLOGY; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; HOELZEL AR, 1994, ANNU REV ECOL SYST, V25, P377; IUCN, 2014, IUCN RED LIST THREAT; Jaureguizar AJ, 2004, FISH RES, V66, P195, DOI 10.1016/S0165-7836(03)00200-5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Krutzen M, 2003, P ROY SOC B-BIOL SCI, V270, P497, DOI 10.1098/rspb.2002.2229; Lewison RL, 2009, ECOL APPL, V19, P920, DOI 10.1890/08-0623.1; Lynch M, 1999, GENETICS, V152, P1753; Mendez M, 2008, CONSERV GENET, V9, P419, DOI 10.1007/s10592-007-9354-7; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Milner JM, 2007, CONSERV BIOL, V21, P36, DOI 10.1111/j.1523-1739.2006.00591.x; Moore JE, 2008, ECOL APPL, V18, P1914, DOI 10.1890/07-0862.1; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosas Fernando C. Weber, 2002, Latin American Journal of Aquatic Mammals, V1, P161; Rosenbaum HC, 2002, J HERED, V93, P389, DOI 10.1093/jhered/93.6.389; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Secchi Eduardo R., 2001, Journal of Cetacean Research and Management, V3, P95; SLOOTEN E, 1991, CAN J ZOOL, V69, P1701, DOI 10.1139/z91-235; Valsecchi E., 2003, Journal of Cetacean Research and Management, V5, P69; Van de Casteele T, 2001, MOL ECOL, V10, P1539, DOI 10.1046/j.1365-294X.2001.01288.x; Wang JL, 2002, GENETICS, V160, P1203; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960	47	15	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15550	10.1371/journal.pone.0015550	http://dx.doi.org/10.1371/journal.pone.0015550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179542	gold, Green Published, Green Submitted			2022-12-25	WOS:000285340000026
J	Pillai, MM; Yang, XD; Balakrishnan, I; Bemis, L; Torok-Storb, B				Pillai, Manoj M.; Yang, Xiaodong; Balakrishnan, Ilango; Bemis, Lynne; Torok-Storb, Beverly			MiR-886-3p Down Regulates CXCL12 (SDF1) Expression in Human Marrow Stromal Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; MYELODYSPLASTIC SYNDROMES; MICRORNA TARGETS; SMALL RNAS; FACTOR-I; IDENTIFICATION; PATHWAYS; NICHE; MICROENVIRONMENT	Stromal Derived Factor 1 (SDF1 or CXCL12), is a chemokine known to be critical for the migration of cells in several tissue systems including the homing of the hematopoietic stem cell (HSC) to its niche in the bone marrow. A comparative analysis of miRNA expression profiles of two stromal cell lines, distinguishable by function and by CXCL12 expression (CXCL12(+) and CXCL12(-)), revealed that the CXCL12(-) cells expressed >40 fold more miR-886-3p than the CXCL12(+) cells. Screening studies showed that when miR-886-3p was transfected into the CXCL12(+) stromal cells, the expression of CXCL12 was down-regulated by as much as 85% when compared to appropriate controls, and results in the loss of CXCL12-directed chemotaxis. Similar reductions in CXCL12 were obtained with the transfection of miR-886-3p into primary stromal cell cultures. Additional studies showed that miR-886-3p specifically targeted the 3' untranslated region (UTR) of CXCL12 mRNA. These data suggest a role for miRNA in modulating the expression of CXCL12, a gene product with a critical role in hematopoietic regulation.	[Pillai, Manoj M.; Yang, Xiaodong; Balakrishnan, Ilango; Bemis, Lynne] Univ Colorado Denver, Dept Med, Div Med Oncol, Aurora, CO USA; [Torok-Storb, Beverly] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Fred Hutchinson Cancer Center	Pillai, MM (corresponding author), Univ Colorado Denver, Dept Med, Div Med Oncol, Aurora, CO USA.	Manoj.Pillai@UCDenver.edu	Yang, Xiaodong/B-9444-2014	Bemis, Lynne/0000-0001-9986-7154	National Institutes of Health [K08 DK073701, R01HL62923, P30DK56465]; University of Colorado Cancer Center [P30 CA046934]; Colorado Center for AIDS [P30 AI054907]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465, K08DK073701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Cancer Center; Colorado Center for AIDS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (grant K08 DK073701 to M. M. P. and grants R01HL62923 and P30DK56465 to B.T.-S.). The core facilities used in this manuscript were supported in part by the University of Colorado Cancer Center grant (P30 CA046934) and the Colorado Center for AIDS Research Grant (P30 AI054907). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cherla RP, 2001, J IMMUNOL, V166, P3067, DOI 10.4049/jimmunol.166.5.3067; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Dexter T M, 1984, Kroc Found Ser, V18, P57; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Fedyk ER, 2001, J IMMUNOL, V166, P5749, DOI 10.4049/jimmunol.166.9.5749; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Flores-Figueroa E, 2008, LEUKEMIA RES, V32, P1407, DOI 10.1016/j.leukres.2008.02.013; Garcia-Moruja C, 2005, J MOL BIOL, V348, P43, DOI 10.1016/j.jmb.2005.02.016; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li LH, 1998, IMMUNITY, V8, P43, DOI 10.1016/S1074-7613(00)80457-4; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakayama T, 2007, J NATL CANCER I, V99, P223, DOI 10.1093/jnci/djk031; Nakayama T, 2007, BLOOD, V109, P1363, DOI 10.1182/blood-2006-06-028217; Nandy C, 2009, J MOL BIOL, V388, P776, DOI 10.1016/j.jmb.2009.03.031; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Persson H, 2009, NAT CELL BIOL, V11, P1268, DOI 10.1038/ncb1972; Pillai MM, 2006, BLOOD, V107, P3520, DOI 10.1182/blood-2005-10-4285; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; SIMMONS PJ, 1991, BLOOD, V78, P55; Stadler PF, 2009, MOL BIOL EVOL, V26, P1975, DOI 10.1093/molbev/msp112; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tauro S, 2001, HAEMATOLOGICA, V86, P1038; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yue JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-8; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	48	50	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14304	10.1371/journal.pone.0014304	http://dx.doi.org/10.1371/journal.pone.0014304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179442	gold, Green Published, Green Submitted			2022-12-25	WOS:000285246900014
J	Lisboa, FA; Warren, J; Sulkowski, G; Aparicio, M; David, G; Zudaire, E; Dveksler, GS				Lisboa, Felipe A.; Warren, James; Sulkowski, Gisela; Aparicio, Marta; David, Guido; Zudaire, Enrique; Dveksler, Gabriela S.			Pregnancy-specific Glycoprotein 1 Induces Endothelial Tubulogenesis through Interaction with Cell Surface Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; HERPES-SIMPLEX-VIRUS; ALTERNATIVE ACTIVATION; TROPHOBLAST CELLS; GROWTH-FACTOR; EXPRESSION; ANGIOGENESIS; MONOCYTES; MUTANTS; BINDING	Pregnancy-specific beta 1 glycoproteins (PSGs) are the most abundant fetal proteins in the maternal bloodstream in late pregnancy. They are secreted by the syncytiotrophoblast and are detected around day 14 postfertilization. There are 11 human PSG genes, which encode a family of proteins exhibiting significant conservation at the amino acid level. We and others have proposed that PSGs have an immune modulatory function. In addition, we recently postulated that they are proangiogenic due to their ability to induce the secretion of VEGF-A and the formation of tubes by endothelial cells. The cellular receptor(s) for human PSGs remain unknown. Therefore, we conducted these studies to identify the receptor for PSG1, the highest expressed member of the family. We show that removal of cell surface glycosaminoglycans (GAGs) by enzymatic or chemical treatment of cells or competition with heparin completely inhibited binding of PSG1. In addition, PSG1 did not bind to cells lacking heparan or chondroitin sulfate on their surface, and binding was restored upon transfection with all four syndecans and glypican-1. Importantly, the presence of GAGs on the surface of endothelial cells was required for the ability of PSG1 to induce tube formation. This finding indicates that the PSG1-GAG interaction mediates at least some of the PSG1 proposed functions.	[Lisboa, Felipe A.; Warren, James; Sulkowski, Gisela; Dveksler, Gabriela S.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA; [Aparicio, Marta; Zudaire, Enrique] NCI, Angiogenesis Core Facil, Radiat Oncol Branch, NIH,Adv Technol Ctr, Bethesda, MD 20892 USA; [David, Guido] Katholieke Univ Leuven, Dept Mol & Dev Genet, Vlaams Inst Biotechnol, B-3000 Louvain, Belgium	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Flanders Institute for Biotechnology (VIB); KU Leuven	Dveksler, GS (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, Rm B3096,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	gdveksler@usuhs.mil			National Institutes of Health [R01HD035832]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD035832 (to G. S. D.).	Ball M, 2009, PLACENTA, V30, P649, DOI 10.1016/j.placenta.2009.05.001; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bobardt MD, 2004, J VIROL, V78, P6567, DOI 10.1128/JVI.78.12.6567-6584.2004; Camolotto S, 2010, PLACENTA, V31, P312, DOI 10.1016/j.placenta.2010.01.004; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; Chung JS, 2009, EUR J IMMUNOL, V39, P965, DOI 10.1002/eji.200838990; Crescimanno C, 1999, J PATHOL, V189, P600; den Dekker E, 2008, J IMMUNOL, V180, P3680, DOI 10.4049/jimmunol.180.6.3680; ESKO JD, 1986, J BIOL CHEM, V261, P5725; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Ha CT, 2008, AM J REPROD IMMUNOL, V59, P251, DOI 10.1111/j.1600-0897.2007.00573.x; Ha CT, 2010, BIOL REPROD, V83, P27, DOI 10.1095/biolreprod.109.082412; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Ishiguro K, 2000, DEV DYNAM, V219, P539, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1081>3.0.CO;2-K; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; IU ST, 1970, B EKSP BIOL MED, V69, P66; Jokimaa VIS, 2000, AM J OBSTET GYNECOL, V183, P1495, DOI 10.1067/mob.2000.107320; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; LIN TM, 1974, J CLIN INVEST, V54, P576, DOI 10.1172/JCI107794; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; McLellan AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-4; MERTENS G, 1992, J BIOL CHEM, V267, P20435; MINGUELL JJ, 1992, EXP CELL RES, V201, P200, DOI 10.1016/0014-4827(92)90364-E; Motran CC, 2003, EUR J IMMUNOL, V33, P3007, DOI 10.1002/eji.200323993; Motran CC, 2002, J LEUKOCYTE BIOL, V72, P512; NADER HB, 1987, P NATL ACAD SCI USA, V84, P3565, DOI 10.1073/pnas.84.11.3565; Noguer O, 2009, EXP CELL RES, V315, P795, DOI 10.1016/j.yexcr.2008.11.016; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; THOMPSON J, 1990, BIOCHEM BIOPH RES CO, V167, P848, DOI 10.1016/0006-291X(90)92103-7; TOWLER CM, 1977, BRIT J OBSTET GYNAEC, V84, P258, DOI 10.1111/j.1471-0528.1977.tb12573.x; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; Waterhouse R, 2002, J EXP MED, V195, P277, DOI 10.1084/jem.20011741; Wessells J, 2000, EUR J IMMUNOL, V30, P1830, DOI 10.1002/1521-4141(200007)30:7&lt;1830::AID-IMMU1830&gt;3.0.CO;2-M; Wu JA, 2008, BIOL REPROD, V79, P1054, DOI 10.1095/biolreprod.108.070268; Wulff C, 2003, REPRODUCTION, V126, P569, DOI 10.1530/rep.0.1260569; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200; Zhou GQ, 2001, BIOL REPROD, V64, P90, DOI 10.1095/biolreprod64.1.90	50	38	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7577	7586		10.1074/jbc.M110.161810	http://dx.doi.org/10.1074/jbc.M110.161810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193412	Green Published, hybrid			2022-12-25	WOS:000287737300071
J	Conrady, DG; Flagler, MJ; Friedmann, DR; Wielen, BDV; Kovall, RA; Weiss, AA; Herr, AB				Conrady, Deborah G.; Flagler, Michael J.; Friedmann, David R.; Wielen, Bradley D. Vander; Kovall, Rhett A.; Weiss, Alison A.; Herr, Andrew B.			Molecular Basis of Differential B-Pentamer Stability of Shiga Toxins 1 and 2	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; ESCHERICHIA-COLI O157-H7; SECONDARY STRUCTURE; SHIGELLA DIARRHEA; MASS-SPECTROMETRY; HYBRID TOXINS; SUBUNIT; BINDING; PATHOGENESIS; SEDIMENTATION	Escherichia coli strain O157:H7 is a major cause of food poisoning that can result in severe diarrhea and, in some cases, renal failure. The pathogenesis of E. coli O157: H7 is in large part due to the production of Shiga toxin (Stx), an AB5 toxin that consists of a ribosomal RNA-cleaving A-subunit surrounded by a pentamer of receptor-binding B subunits. There are two major isoforms, Stx1 and Stx2, which differ dramatically in potency despite having 57% sequence identity. Animal studies and epidemiological studies show Stx2 is associated with more severe disease. Although the molecular basis of this difference is unknown, data suggest it is associated with the B-subunit. Mass spectrometry studies have suggested differential B-pentamer stability between Stx1 and Stx2. We have examined the relative stability of the B-pentamers in solution. Analytical ultracentrifugation using purified B-subunits demonstrates that Stx2B, the more deadly isoform, shows decreased pentamer stability compared to Stx1B (EC50 = 2.3 mu M vs. EC50 = 0.043 mu M for Stx1B). X-ray crystal structures of Stx1B and Stx2B identified a glutamine in Stx2 (versus leucine in Stx1) within the otherwise strongly hydrophobic interface between B-subunits. Interchanging these residues switches the stability phenotype of the B-pentamers of Stx1 and Stx2, as demonstrated by analytical ultracentrifugation and circular dichroism. These studies demonstrate a profound difference in stability of the B-pentamers in Stx1 and Stx2, illustrate the mechanistic basis for this differential stability, and provide novel reagents to test the basis for differential pathogenicity of these toxins.	[Conrady, Deborah G.; Flagler, Michael J.; Friedmann, David R.; Wielen, Bradley D. Vander; Kovall, Rhett A.; Weiss, Alison A.; Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Conrady, DG (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	Rhett.Kovall@UC.edu; Alison.Weiss@UC.edu; Andrew.Herr@UC.edu	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399; Weiss, Alison/0000-0002-4726-8376	NIH-NIAID [ROI-AI064893, U01-AI075498]; State of Ohio; Midwest Center for Emerging Infectious Diseases at the University of Cincinnati; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064893, U01AI075498] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); State of Ohio; Midwest Center for Emerging Infectious Diseases at the University of Cincinnati; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH-NIAID ROI-AI064893 and U01-AI075498 (AAW), funds from the State of Ohio Eminent Scholar Program (ABH), and a pilot grant from the Midwest Center for Emerging Infectious Diseases at the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Asakura H, 2001, EPIDEMIOL INFECT, V127, P27, DOI 10.1017/S0950268801005635; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; Centers for Disease Control and Prevention, 2005, DIS LIST ENT E COLI; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Correia JJ, 2009, METHOD ENZYMOL, V467, P135, DOI 10.1016/S0076-6879(09)67006-3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DONOHUEROLFE A, 1984, J EXP MED, V160, P1767, DOI 10.1084/jem.160.6.1767; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILBERT GA, 1959, PROC R SOC LON SER-A, V250, P377, DOI 10.1098/rspa.1959.0070; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; HEAD SC, 1991, J BIOL CHEM, V266, P3617; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Kitova EN, 2009, BIOCHEMISTRY-US, V48, P5365, DOI 10.1021/bi9003155; Kitova EN, 2005, J AM SOC MASS SPECTR, V16, P1957, DOI 10.1016/j.jasms.2005.07.016; KLEANTHOUS H, 1990, ARCH DIS CHILD, V65, P722, DOI 10.1136/adc.65.7.722; Kulkarni AA, 2010, BIOCONJUGATE CHEM, V21, P1486, DOI 10.1021/bc100095w; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Ling H, 2000, STRUCTURE, V8, P253, DOI 10.1016/S0969-2126(00)00103-9; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Marcato P, 2003, INFECT IMMUN, V71, P6075, DOI 10.1128/IAI.71.10.6075-6078.2003; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; MERRITT EA, 1995, CURR OPIN STRUC BIOL, V5, P165, DOI 10.1016/0959-440X(95)80071-9; Miyake M, 2000, ANAL BIOCHEM, V281, P202, DOI 10.1006/abio.2000.4559; NELSON S, 1994, INT CONGR SER, V1072, P245; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pina DG, 2008, FEBS LETT, V582, P185, DOI 10.1016/j.febslet.2007.11.086; Pina DG, 2006, BIOCHIMIE, V88, P1199, DOI 10.1016/j.biochi.2006.03.010; Pina DG, 2003, BIOCHEMISTRY-US, V42, P9498, DOI 10.1021/bi034591s; Proulx F, 2001, PEDIATR RES, V50, P163, DOI 10.1203/00006450-200108000-00002; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Siegler RL, 1995, PEDIATR CLIN N AM, V42, P1505; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Tilden J, 1996, AM J PUBLIC HEALTH, V86, P1142, DOI 10.2105/AJPH.86.8_Pt_1.1142; Tomoda H, 2002, ANAL BIOCHEM, V311, P50, DOI 10.1016/S0003-2697(02)00380-9; WEINSTEIN DL, 1989, INFECT IMMUN, V57, P3743, DOI 10.1128/IAI.57.12.3743-3750.1989; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	51	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15153	10.1371/journal.pone.0015153	http://dx.doi.org/10.1371/journal.pone.0015153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203383	Green Submitted, Green Published, gold			2022-12-25	WOS:000285792500023
J	Kotchoni, SO; Jimenez-Lopez, JC; Gachomo, EW; Seufferheld, MJ				Kotchoni, Simeon O.; Jimenez-Lopez, Jose C.; Gachomo, Emma W.; Seufferheld, Manfredo J.			A New and Unified Nomenclature for Male Fertility Restorer (RF) Proteins in Higher Plants	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; PENTATRICOPEPTIDE REPEAT PROTEIN; T-CYTOPLASM; GENE SUPERFAMILY; SWISS-MODEL; MITOCHONDRIAL; RNA; ACCUMULATION; ENVIRONMENT; DATABASE	The male fertility restorer (RF) proteins belong to extended protein families associated with the cytoplasmic male sterility in higher plants. Up till now, there is no devised nomenclature for naming the RF proteins. The systematic sequencing of new plant species in recent years has uncovered the existence of several novel RF genes and their encoded proteins. Their naming has been simply arbitrary and could not be adequately handled in the context of comparative functional genomics. We propose in this study a unified nomenclature for the RF extended protein families across all plant species. This new and unified nomenclature relies upon previously developed nomenclature for the first ever characterized RF gene, RF2A/ALDH2B2, a member of ALDH gene superfamily, and adheres to the guidelines issued by the ALDH Genome Nomenclature Committees. The proposed nomenclature reveals that RF gene superfamily encodes currently members of 51 families. This unified nomenclature accommodates functional RF genes and pseudogenes, and offers the flexibility needed to incorporate additional RFs as they become available in future. In addition, we provide a phylogenetic relationship between the RF extended families and use computational protein modeling to demonstrate the high divergence of RF functional specializations through specific structural features of selected members of RF superfamily.	[Kotchoni, Simeon O.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Jimenez-Lopez, Jose C.] CSIC, EEZ, Dept Biochem Cell & Mol Biol Plants, Granada, Spain; [Gachomo, Emma W.] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Seufferheld, Manfredo J.] Univ Illinois UC, Dept Crop Sci, Urbana, IL USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Illinois System; University of Illinois Urbana-Champaign	Kotchoni, SO (corresponding author), Purdue Univ, Dept Agron, Lilly Hall, W Lafayette, IN 47907 USA.	skotchon@purdue.edu	Jimenez-Lopez, Jose C./H-5896-2011	Jimenez-Lopez, Jose C./0000-0002-1470-360X				Akagi H, 2004, THEOR APPL GENET, V108, P1449, DOI 10.1007/s00122-004-1591-2; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2004, CURR OPIN CHEM BIOL, V8, P76, DOI 10.1016/j.cbpa.2003.12.004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Chase CD, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P593, DOI 10.1007/978-1-4020-3166-3_22; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Cui XQ, 1996, SCIENCE, V272, P1334, DOI 10.1126/science.272.5266.1334; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DEWEY RE, 1987, P NATL ACAD SCI USA, V84, P5374, DOI 10.1073/pnas.84.15.5374; Dill CL, 1997, GENETICS, V147, P1367; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gonzalez-Melendi P, 2008, J EXP BOT, V59, P827, DOI 10.1093/jxb/erm365; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Kazama T, 2003, FEBS LETT, V544, P99, DOI 10.1016/S0014-5793(03)00480-0; KENNELL JC, 1987, MOL GEN GENET, V210, P399, DOI 10.1007/BF00327189; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kotchoni SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011516; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; LASER KD, 1972, BOT REV, V38, P425, DOI 10.1007/BF02860010; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu F, 2001, PLANT CELL, V13, P1063, DOI 10.1105/tpc.13.5.1063; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; PRING DR, 1989, ANNU REV PHYTOPATHOL, V27, P483; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Shi SL, 2010, PROTOPLASMA, V241, P37, DOI 10.1007/s00709-009-0100-5; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Skibbe David S., 2002, Plant Molecular Biology, V48, P751, DOI 10.1023/A:1014870429630; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; ULLSTRUP AJ, 1972, ANNU REV PHYTOPATHOL, V10, P37, DOI 10.1146/annurev.py.10.090172.000345; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Wise RP, 1996, GENETICS, V143, P1383; Wise RP, 1999, ADV AGRON, V65, P79, DOI 10.1016/S0065-2113(08)60911-6; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x	46	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15906	10.1371/journal.pone.0015906	http://dx.doi.org/10.1371/journal.pone.0015906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203394	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500042
J	Qureshi, A; Subathra, M; Grey, A; Schey, K; Del Poeta, M; Luberto, C				Qureshi, Asfia; Subathra, Marimuthu; Grey, Angus; Schey, Kevin; Del Poeta, Maurizio; Luberto, Chiara			Role of Sphingomyelin Synthase in Controlling the Antimicrobial Activity of Neutrophils against Cryptococcus neoformans	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE-D; TANDEM MASS-SPECTROMETRY; EARLY HOST-DEFENSE; QUANTITATIVE-ANALYSIS; CANDIDA-ALBICANS; BIOACTIVE SPHINGOLIPIDS; PHOSPHOLIPASE-C; IMMUNE-SYSTEM; IN-VITRO	The key host cellular pathway(s) necessary to control the infection caused by inhalation of the environmental fungal pathogen Cryptococcus neoformans are still largely unknown. Here we have identified that the sphingolipid pathway in neutrophils is required for them to exert their killing activity on the fungus. In particular, using both pharmacological and genetic approaches, we show that inhibition of sphingomyelin synthase (SMS) activity profoundly impairs the killing ability of neutrophils by preventing the extracellular release of an antifungal factor(s). We next found that inhibition of protein kinase D (PKD), which controls vesicular sorting and secretion and is regulated by diacylglycerol (DAG) produced by SMS, totally blocks the extracellular killing activity of neutrophils against C. neoformans. The expression of SMS genes, SMS activity and the levels of the lipids regulated by SMS (namely sphingomyelin (SM) and DAG) are up-regulated during neutrophil differentiation. Finally, tissue imaging of lungs infected with C. neoformans using matrix-assisted laser desorption-ionization mass spectrometry (MALDI-MS), revealed that specific SM species are associated with neutrophil infiltration at the site of the infection. This study establishes a key role for SMS in the regulation of the killing activity of neutrophils against C. neoformans through a DAG-PKD dependent mechanism, and provides, for the first time, new insights into the protective role of host sphingolipids against a fungal infection.	[Qureshi, Asfia; Subathra, Marimuthu; Del Poeta, Maurizio; Luberto, Chiara] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Grey, Angus; Schey, Kevin] Vanderbilt Univ, Dept Biochem, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Dept Microbiol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Dept Immunol, Charleston, SC 29425 USA; [Del Poeta, Maurizio] Med Univ S Carolina, Div Infect Dis, Charleston, SC 29425 USA	Medical University of South Carolina; Vanderbilt University; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Qureshi, A (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	delpoeta@musc.edu	Grey, Angus/O-3473-2019	Grey, Angus/0000-0002-1540-1080	Burroughs Wellcome Fund; National Institutes of Health (NIH) [AI56168, AI72142, AI78493]; National Center for Research Resources [RR17677, C06 RR015455]; National Science Foundation/EPSCoR [EPS-0132573]; American Cancer Society [IRG 97-219-08]; National Heart, Lung and Blood Institute Cardiovascular Proteomics Center [N01-HV-28282]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455, P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078493, R01AI056168, R01AI072142] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation/EPSCoR(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); National Heart, Lung and Blood Institute Cardiovascular Proteomics Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Burroughs Wellcome Fund, in part by Grants AI56168, AI72142, and AI78493 (to MDP) from the National Institutes of Health (NIH), in part by RR17677 Project 2 (to MDP) and Project 6 (to CL) from the Centers of Biomedical Research Excellence Program of the National Center for Research Resources, in part by the National Science Foundation/EPSCoR Grant EPS-0132573 to CL, in part by IRG 97-219-08 from the American Cancer Society (to CL), in part by National Heart, Lung and Blood Institute Cardiovascular Proteomics Center Contract N01-HV-28282, and in part by NIH C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOULOUMRE MS, 1993, ANTIMICROB AGENTS CH, V37, P2628, DOI 10.1128/AAC.37.12.2628; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Aratani Y, 2002, MED MYCOL, V40, P557, DOI 10.1080/mmy.40.6.557.563; Aratani Y, 2002, J INFECT DIS, V185, P1833, DOI 10.1086/340635; Aratani Y, 1999, INFECT IMMUN, V67, P1828; Aratani Y, 2006, J MED MICROBIOL, V55, P1291, DOI 10.1099/jmm.0.46620-0; Azoitei N, 2010, GUT, V59, P1316, DOI 10.1136/gut.2009.206813; Bielawska A, 2000, METHOD ENZYMOL, V311, P518; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Biswas MHU, 2010, CANCER RES, V70, P2095, DOI 10.1158/0008-5472.CAN-09-4155; Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001; Buschke A., 1895, DEUT MED WOCHENSCHR, V21, P14; Busse O., 1894, ZENTRALBL BAKTERIOL, V16, P175; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, P351; Chen LA, 2009, J BIOL CHEM, V284, P2459, DOI 10.1074/jbc.M801697200; Chretien F, 2002, J INFECT DIS, V186, P522, DOI 10.1086/341564; Culpitt SV, 2001, METH MOLEC MED, V56, P177, DOI 10.1385/1-59259-151-5:177; DIAMOND RD, 1972, J INFECT DIS, V125, P367, DOI 10.1093/infdis/125.4.367; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Fan WH, 2005, EUKARYOT CELL, V4, P1420, DOI 10.1128/EC.4.8.1420-1433.2005; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; FITZGERALD V, 1995, LIPIDS, V30, P805, DOI 10.1007/BF02533955; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Garcia J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.17; GOLDMAN D, 1994, INFECT IMMUN, V62, P4755, DOI 10.1128/IAI.62.11.4755-4761.1994; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Gutierrez MG, 2009, CELL MICROBIOL, V11, P406, DOI 10.1111/j.1462-5822.2008.01263.x; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hanada K, 2005, JPN J INFECT DIS, V58, P131; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heung LJ, 2006, INFECT IMMUN, V74, P28, DOI 10.1128/IAI.74.1.28-39.2006; HUFFNAGLE GB, 1991, INFECT IMMUN, V59, P1423, DOI 10.1128/IAI.59.4.1423-1433.1991; HUFFNAGLE GB, 1991, J EXP MED, V173, P793, DOI 10.1084/jem.173.4.793; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Jin JF, 2008, J BIOL CHEM, V283, P26509, DOI 10.1074/jbc.M801597200; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Levitz SM, 1999, INFECT IMMUN, V67, P885, DOI 10.1128/IAI.67.2.885-890.1999; Li ZQ, 2007, BBA-MOL CELL BIOL L, V1771, P1186, DOI 10.1016/j.bbalip.2007.05.007; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lin L, 2010, J INFECT DIS, V201, P1708, DOI 10.1086/652496; Liu DZ, 2007, BBA-MOL CELL RES, V1773, P869, DOI 10.1016/j.bbamcr.2007.03.018; Luberto C, 2003, J CLIN INVEST, V112, P1080, DOI 10.1172/JCI200318309; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Luberto C, 2000, J BIOL CHEM, V275, P14760, DOI 10.1074/jbc.275.19.14760; Ma HS, 2006, CURR BIOL, V16, P2156, DOI 10.1016/j.cub.2006.09.032; Mednick AJ, 2003, EUR J IMMUNOL, V33, P1744, DOI 10.1002/eji.200323626; Meng AM, 2004, EXP CELL RES, V292, P385, DOI 10.1016/j.yexcr.2003.10.001; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; MILLER MF, 1991, INFECT IMMUN, V59, P24, DOI 10.1128/IAI.59.1.24-28.1991; Miskolci V, 2003, ARCH BIOCHEM BIOPHYS, V417, P44, DOI 10.1016/S0003-9861(03)00336-9; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Ritter M, 2009, EXPERT OPIN PHARMACO, V10, P2433, DOI 10.1517/14656560903200642; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Sanfelice F, 1894, ANN IGIEN, V4, P463; Shao XP, 2005, J IMMUNOL, V175, P3244, DOI 10.4049/jimmunol.175.5.3244; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P805, DOI 10.1189/jlb.1109767; Spellberg BJ, 2005, J LEUKOCYTE BIOL, V78, P338, DOI 10.1189/jlb.0205072; Spellberg BJ, 2007, J LEUKOCYTE BIOL, V81, P632, DOI 10.1189/jlb.0906549; Spitsin SV, 1997, MOL MED, V3, P315, DOI 10.1007/BF03401810; Stano P, 2009, J IMMUNOL, V182, P84, DOI 10.4049/jimmunol.182.1.84; Sumara G, 2009, CELL, V136, P235, DOI 10.1016/j.cell.2008.11.018; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Valsecchi M, 2007, J LIPID RES, V48, P417, DOI 10.1194/jlr.M600344-JLR200; van der Luit AH, 2007, BIOCHEM J, V401, P541, DOI 10.1042/BJ20061178; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Villani M, 2008, BIOCHEM J, V414, P31, DOI 10.1042/BJ20071240; von Wicher G, 2008, CELL SIGNAL, V20, P925, DOI 10.1016/j.cellsig.2008.01.003; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wang YL, 2010, APPL BIOCHEM BIOTECH, V160, P213, DOI 10.1007/s12010-009-8566-3; Yamamoto H, 1997, BIOCHEM J, V325, P223, DOI 10.1042/bj3250223	77	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15587	10.1371/journal.pone.0015587	http://dx.doi.org/10.1371/journal.pone.0015587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203393	Green Published, Green Submitted, gold			2022-12-25	WOS:000285792500032
J	Castiglione, F; Paci, P				Castiglione, Filippo; Paci, Paola			Criticality of Timing for Anti-HIV Therapy Initiation	PLOS ONE			English	Article							INFECTION; MODELS; TIME	The time of initiation of antiretroviral therapy in HIV-1 infected patients has a determinant effect on the viral dynamics. The question is, how far can the therapy be delayed? Is sooner always better? We resort to clinical data and to microsimulations to forecast the dynamics of the viral load at therapy interruption after prolonged antiretroviral treatment. A computational model previously evaluated, produces results that are statistically adherent to clinical data. In addition, it allows a finer grain analysis of the impact of the therapy initiation point to the disease course. We find a swift increase of the viral density as a function of the time of initiation of the therapy measured when the therapy is stopped. In particular there is a critical time delay with respect to the infection instant beyond which the therapy does not affect the viral rebound. Initiation of the treatment is beneficial because it can down-regulate the immune activation, hence limiting viral replication and spread.	[Castiglione, Filippo; Paci, Paola] Natl Res Council Italy, Inst Comp Applicat Mauro Picone, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR)	Castiglione, F (corresponding author), Natl Res Council Italy, Inst Comp Applicat Mauro Picone, Rome, Italy.	paolapaci08@gmail.com	Castiglione, Filippo/B-1366-2010	Castiglione, Filippo/0000-0002-1442-3552				Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Bernaschi M, 2002, IMMUNOL CELL BIOL, V80, P307, DOI 10.1046/j.1440-1711.2002.01082.x; Bernaschi M, 2001, COMPUT BIOL MED, V31, P303, DOI 10.1016/S0010-4825(01)00011-7; Castiglione F, 2007, BIOINFORMATICS, V23, P3350, DOI 10.1093/bioinformatics/btm408; Castiglione F, 2004, AIDS RES HUM RETROV, V20, P1314, DOI 10.1089/aid.2004.20.1314; Castiglione F, 2007, BIOINFORMATICS, V23, P1371, DOI 10.1093/bioinformatics/btm044; CELADA F, 1992, IMMUNOL TODAY, V13, P56, DOI 10.1016/0167-5699(92)90135-T; Cox DR, 1974, THEORETICAL STAT; Department of Health and Human Services (DHHS), 2008, GUID US ANT AG HIV 1; FARMER JD, 1986, PHYSICA D, V22, pR7, DOI 10.1016/0167-2789(86)90227-7; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; GARDNER MB, 1989, FASEB J, V3, P2593, DOI 10.1096/fasebj.3.14.2556312; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Paci P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-172; Pappalardo F, 2006, CELL IMMUNOL, V244, P137, DOI 10.1016/j.cellimm.2007.03.002; Pappalardo F, 2005, BIOINFORMATICS, V21, P2891, DOI 10.1093/bioinformatics/bti426; Pappalardo F, 2009, BRIEF BIOINFORM, V10, P330, DOI 10.1093/bib/bbp014; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Steingrover R, 2008, AIDS, V22, P1583, DOI 10.1097/QAD.0b013e328305bd77; *UNAIDS, 2007, AIDS EP UPD	23	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15294	10.1371/journal.pone.0015294	http://dx.doi.org/10.1371/journal.pone.0015294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203461	gold, Green Published, Green Submitted			2022-12-25	WOS:000285579200016
J	Karschuk, N; Tepe, Y; Gerlach, S; Pape, W; Wenck, H; Schmucker, R; Wittern, KP; Schepky, A; Reuter, H				Karschuk, Nadine; Tepe, Yeliz; Gerlach, Silke; Pape, Wolfgang; Wenck, Horst; Schmucker, Robert; Wittern, Klaus-Peter; Schepky, Andreas; Reuter, Hendrik			A Novel In Vitro Method for the Detection and Characterization of Photosensitizers	PLOS ONE			English	Article							PHOTOALLERGIC CONTACT-DERMATITIS; LYMPH-NODE ASSAY; DENDRITIC CELLS; PHOTOCONTACT ALLERGY; PHOTOTOXICITY TEST; EXOGENOUS AGENTS; MUSK-AMBRETTE; PHASE-II; SENSITIZATION; VALIDATION	Photoactivation and binding of photoactive chemicals to proteins is a known prerequisite for the formation of immunogenic photoantigens and the induction of photoallergy. The intensive use of products and the availability of new chemicals, along with an increasing exposure to sun light contribute to the risk of photosensitizing adverse reactions. Dendritic cells (DC) play a pivotal role in the induction of allergic contact dermatitis. Human peripheral blood monocyte derived dendritic cells (PBMDC) were thus perceived as an obvious choice for the development of a novel in vitro photosensitization assay using the modulation of cell surface protein expression in response to photosensitizing agents. In this new protocol, known chemicals with photosensitizing, allergenic or non-allergenic potential were pre-incubated with PBMDCs prior to UVA irradiation (1 J/cm(2)). Following a 48 h incubation, the expression of the cell surface molecules CD86, HLA-DR and CD83 was measured by flow cytometry. All tested photosensitizers induced a significant and dose-dependent increase of CD86 expression after irradiation compared to non-irradiated controls. Moreover, the phototoxicity of the chemicals could also be determined. In contrast, (i) CD86 expression was not affected by the chosen irradiation conditions, (ii) increased CD86 expression induced by allergens was independent of irradiation and (iii) no PBMDC activation was observed with the non-allergenic control. The assay proposed here for the evaluation of the photoallergenic potential of chemicals includes the assessment of their allergenic, phototoxic and toxic potential in a single and robust test system and is filling a gap in the in vitro photoallergenicity test battery.	[Karschuk, Nadine; Tepe, Yeliz; Gerlach, Silke; Pape, Wolfgang; Wenck, Horst; Schmucker, Robert; Wittern, Klaus-Peter; Schepky, Andreas; Reuter, Hendrik] Beiersdorf AG, Res & Dev, Hamburg, Germany	Beiersdorf AG	Karschuk, N (corresponding author), Beiersdorf AG, Res & Dev, Hamburg, Germany.	Andreas.Schepky@beiersdorf.com						AEBY P, 2006, ALTEX S, V23, P226; Aiba S, 1997, EUR J IMMUNOL, V27, P3031, DOI 10.1002/eji.1830271141; Allen SK, 1997, BIOCHEM BIOPH RES CO, V235, P615, DOI 10.1006/bbrc.1997.6848; Basketter D, 2007, CUTAN OCUL TOXICOL, V26, P359, DOI 10.1080/15569520701622993; Bosca F, 1998, J PHOTOCH PHOTOBIO B, V43, P1, DOI 10.1016/S1011-1344(98)00062-1; BUEHLER EV, 1985, FOOD CHEM TOXICOL, V23, P689, DOI 10.1016/0278-6915(85)90158-9; Casati S, 2005, ATLA-ALTERN LAB ANIM, V33, P47, DOI 10.1177/026119290503300108; Coutant KD, 1999, TOXICOL SCI, V52, P189, DOI 10.1093/toxsci/52.2.189; Dearman RJ, 2001, CONTACT DERMATITIS, V44, P357, DOI 10.1034/j.1600-0536.2001.044006357.x; DELEO VA, 1992, ARCH DERMATOL, V128, P1513, DOI 10.1001/archderm.128.11.1513; Diaz RL, 2006, CONTACT DERMATITIS, V54, P239, DOI 10.1111/j.0105-1873.2006.00797.x; dos Santos GG, 2009, TOXICOL APPL PHARM, V236, P372, DOI 10.1016/j.taap.2009.02.004; Forte Giovanni, 2008, Inflammation & Allergy Drug Targets, V7, P145, DOI 10.2174/187152808785748146; GERBERICK GF, 1990, FOOD CHEM TOXICOL, V28, P361, DOI 10.1016/0278-6915(90)90110-9; Goossens A, 2004, PHOTODERMATOL PHOTO, V20, P121, DOI 10.1111/j.1600-0781.2004.00092.x; GOULD JW, 1995, J AM ACAD DERMATOL, V33, P551, DOI 10.1016/0190-9622(95)91271-1; Hino R, 2008, J DERMATOL SCI, V52, P140, DOI 10.1016/j.jdermsci.2008.06.002; Hoya M, 2009, TOXICOL IN VITRO, V23, P911, DOI 10.1016/j.tiv.2009.03.010; KATO S, 1985, TOXICOL APPL PHARM, V81, P295, DOI 10.1016/0041-008X(85)90166-8; KROON S, 1979, CONTACT DERMATITIS, V5, P337, DOI 10.1111/j.1600-0536.1979.tb04896.x; Lovell WW, 2000, ATLA-ALTERN LAB ANIM, V28, P707, DOI 10.1177/026119290002800506; Mang R., 2006, CONTACT DERMATITIS, P97; Mittelbrunn M, 2005, J INVEST DERMATOL, V125, P334, DOI 10.1111/j.0022-202X.2005.23824.x; Neumann NJ, 2005, J PHOTOCH PHOTOBIO B, V79, P25, DOI 10.1016/j.jphotobiol.2004.11.014; OECD (Organization for Economic Co-operation and Development), 2004, OECD GUID TEST CHEM, V432; Palmer RA, 2006, CONTACT DERMATITIS, P433; Pape WJW, 2001, ATLA-ALTERN LAB ANIM, V29, P145, DOI 10.1177/026119290102900208; PENDLINGTON RU, 1990, INT J COSMETIC SCI, V12, P91, DOI 10.1111/j.1467-2494.1990.tb00524.x; Placzek M, 2007, ACTA DERM-VENEREOL, V87, P312, DOI 10.2340/00015555-0251; Reuter H., 2010, TOXICOL IN VITRO; Rustemeyer T, 2004, CLIN EXP ALLERGY, V34, P1458, DOI 10.1111/j.1365-2222.2004.02045.x; Ryan CA, 2001, TOXICOL IN VITRO, V15, P43, DOI 10.1016/S0887-2333(00)00059-X; Sakaguchi H, 2009, CELL BIOL TOXICOL, V25, P109, DOI 10.1007/s10565-008-9059-9; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schauder S, 1996, CONTACT DERMATITIS, V35, P344, DOI 10.1111/j.1600-0536.1996.tb02415.x; Schnuch A, 2003, HAUTARZT, V54, P626, DOI 10.1007/s00105-003-0510-9; SCHOLES EW, 1992, J APPL TOXICOL, V12, P217, DOI 10.1002/jat.2550120312; Spielmann H, 1998, TOXICOL IN VITRO, V12, P305, DOI 10.1016/S0887-2333(98)00006-X; Spielmann H, 1995, Curr Probl Dermatol, V23, P256; Spielmann H, 2000, ATLA-ALTERN LAB ANIM, V28, P777, DOI 10.1177/026119290002800603; STEPHENS TJ, 1985, J TOXICOL-CUTAN OCUL, V4, P193, DOI 10.3109/15569528509033546; Timares L, 2008, PHOTOCHEM PHOTOBIOL, V84, P422, DOI 10.1111/j.1751-1097.2007.00284.x; Toebak MJ, 2009, CONTACT DERMATITIS, V60, P2, DOI 10.1111/j.1600-0536.2008.01443.x; Tokura Y, 1996, PHOTOCHEM PHOTOBIOL, V64, P838, DOI 10.1111/j.1751-1097.1996.tb01844.x; Tokura Y, 2000, J DERMATOL SCI, V23, pS6, DOI 10.1016/S0923-1811(99)00071-7; Tuschl H, 2000, TOXICOL IN VITRO, V14, P541, DOI 10.1016/S0887-2333(00)00051-5; WOJNAROWSKA F, 1986, BRIT J DERMATOL, V114, P667, DOI 10.1111/j.1365-2133.1986.tb04874.x	47	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15221	10.1371/journal.pone.0015221	http://dx.doi.org/10.1371/journal.pone.0015221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203464	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200014
J	Umbrasaite, J; Schweighofer, A; Kazanaviciute, V; Magyar, Z; Ayatollahi, Z; Unterwurzacher, V; Choopayak, C; Boniecka, J; Murray, JAH; Bogre, L; Meskiene, I				Umbrasaite, Julija; Schweighofer, Alois; Kazanaviciute, Vaiva; Magyar, Zoltan; Ayatollahi, Zahra; Unterwurzacher, Verena; Choopayak, Chonnanit; Boniecka, Justyna; Murray, James A. H.; Bogre, Laszlo; Meskiene, Irute			MAPK Phosphatase AP2C3 Induces Ectopic Proliferation of Epidermal Cells Leading to Stomata Development in Arabidopsis	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; EMERGING FUNCTIONS; SECRETORY PEPTIDE; HYPOCOTYL GROWTH; PROTEIN; ACID; DIFFERENTIATION; 2C	In plant post-embryonic epidermis mitogen-activated protein kinase (MAPK) signaling promotes differentiation of pavement cells and inhibits initiation of stomata. Stomata are cells specialized to modulate gas exchange and water loss. Arabidopsis MAPKs MPK3 and MPK6 are at the core of the signaling cascade; however, it is not well understood how the activity of these pleiotropic MAPKs is constrained spatially so that pavement cell differentiation is promoted only outside the stomata lineage. Here we identified a PP2C-type phosphatase termed AP2C3 (Arabidopsis protein phosphatase 2C) that is expressed distinctively during stomata development as well as interacts and inactivates MPK3, MPK4 and MPK6. AP2C3 co-localizes with MAPKs within the nucleus and this localization depends on its N-terminal extension. We show that other closely related phosphatases AP2C2 and AP2C4 are also MAPK phosphatases acting on MPK6, but have a distinct expression pattern from AP2C3. In accordance with this, only AP2C3 ectopic expression is able to stimulate cell proliferation leading to excess stomata development. This function of AP2C3 relies on the domains required for MAPK docking and intracellular localization. Concomitantly, the constitutive and inducible AP2C3 expression deregulates E2F-RB pathway, promotes the abundance and activity of CDKA, as well as changes of CDKB1;1 forms. We suggest that AP2C3 downregulates the MAPK signaling activity to help maintain the balance between differentiation of stomata and pavement cells.	[Umbrasaite, Julija; Schweighofer, Alois; Kazanaviciute, Vaiva; Ayatollahi, Zahra; Unterwurzacher, Verena; Choopayak, Chonnanit; Boniecka, Justyna; Meskiene, Irute] Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Vienna, Austria; [Schweighofer, Alois] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Kazanaviciute, Vaiva; Meskiene, Irute] Univ Vilnius, Inst Biotechnol, Vilnius, Lithuania; [Magyar, Zoltan; Bogre, Laszlo] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Magyar, Zoltan] Inst Plant Biol, Biol Res Ctr, Szeged, Hungary; [Murray, James A. H.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Max Planck Society; Vilnius University; University of London; Royal Holloway University London; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Cardiff University	Umbrasaite, J (corresponding author), Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Vienna, Austria.	irute.meskiene@univie.ac.at	Murray, James AH/D-3399-2009; Boniecka, Justyna/B-3160-2016	Murray, James AH/0000-0002-2282-3839; Schweighofer, Alois/0000-0002-8466-0924; Magyar, Zoltan/0000-0001-8376-7220; Ayatollahi, Zahra Sepideh/0000-0002-8022-1051; Unterwurzacher, Verena/0000-0002-5897-4620; Boniecka, Justyna/0000-0002-1753-9892	Austrian Exchange Service (OeAD); European Union (EU); Vienna University; Naresuan University; Austrian Erwin Schroedinger; Biotechnology and Biological Sciences Research Council [BBS/B/13268, BBS/B/13314]; Austrian Science Fund (FWF) [P16409, P19005, I255]; British Council; Lithuanian Science Fund; Austrian Science Fund (FWF) [I 255] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/F00964X/1, BBS/B/13268/2] Funding Source: researchfish; BBSRC [BB/F00964X/1] Funding Source: UKRI	Austrian Exchange Service (OeAD); European Union (EU)(CGIAREuropean Commission); Vienna University; Naresuan University; Austrian Erwin Schroedinger(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); British Council(The British Council in India); Lithuanian Science Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by fellowships from Austrian Exchange Service (OeAD) (for JU), European Union (EU) and Vienna University (for JU and ZA), Naresuan University (for CC), Austrian Erwin Schroedinger and EU Marie Curie fellowships for AS, and grants from the Biotechnology and Biological Sciences Research Council BBS/B/13268 and BBS/B/13314 to JAHM and LB respectively, and from Austrian Science Fund (FWF) Doctoral program "Molecular Mechanisms in Cell Signaling", P16409, P19005, I255, British Council and Lithuanian Science Fund to IM.	Abrash EB, 2009, DEV CELL, V16, P783, DOI 10.1016/j.devcel.2009.05.014; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bartels S, 2010, TRENDS PLANT SCI, V15, P322, DOI 10.1016/j.tplants.2010.04.003; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Borghi L, 2010, PLANT CELL, V22, P1792, DOI 10.1105/tpc.110.074591; Boudolf V, 2004, PLANT CELL, V16, P2683, DOI 10.1105/tpc.104.024398; Boudolf V, 2004, PLANT CELL, V16, P945, DOI 10.1105/tpc.021774; Boudolf V, 2001, J EXP BOT, V52, P1381, DOI 10.1093/jexbot/52.359.1381; Brock AK, 2010, PLANT PHYSIOL, V153, P1098, DOI 10.1104/pp.110.156109; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Casson S, 2008, NEW PHYTOL, V178, P9, DOI 10.1111/j.1469-8137.2007.02351.x; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Dai Y, 2006, PLANT CELL, V18, P308, DOI 10.1105/tpc.105.037846; De Veylder L, 2003, CURR OPIN PLANT BIOL, V6, P536, DOI 10.1016/j.pbi.2003.09.001; De Veylder L, 2002, EMBO J, V21, P1360, DOI 10.1093/emboj/21.6.1360; del Pozo JC, 2006, PLANT CELL, V18, P2224, DOI 10.1105/tpc.105.039651; Desvoyes B, 2006, PLANT PHYSIOL, V140, P67, DOI 10.1104/pp.105.071027; Ebel C, 2004, NATURE, V429, P776, DOI 10.1038/nature02637; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gray JE, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.149pe53; Gudesblat GE, 2009, PLANT SIGNAL BEHAV, V4, P1114, DOI 10.4161/psb.4.12.10062; Gudesblat GE, 2007, PLANT SIGNAL BEHAV, V2, P271, DOI 10.4161/psb.2.4.3896; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Holtorf S, 1995, PLANT MOL BIOL, V29, P637, DOI 10.1007/BF00041155; Hunt L, 2010, NEW PHYTOL, V186, P609, DOI 10.1111/j.1469-8137.2010.03200.x; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kang CY, 2009, PLANT CELL, V21, P2624, DOI 10.1105/tpc.109.069765; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kondo T, 2010, PLANT CELL PHYSIOL, V51, P1, DOI 10.1093/pcp/pcp180; Krysan PJ, 2002, PLANT CELL, V14, P1109, DOI 10.1105/tpc.001164; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; LAMPARD GR, 2009, PLANT CELL; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Lee JS, 2007, J BIOL CHEM, V282, P25020, DOI 10.1074/jbc.M701888200; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Leung J, 2006, PLANT SCI, V171, P596, DOI 10.1016/j.plantsci.2006.06.009; Lopez-Juez E, 2008, PLANT CELL, V20, P947, DOI 10.1105/tpc.107.057075; LOPEZJUEZ E, 1995, PLANT PHYSIOL, V107, P131, DOI 10.1104/pp.107.1.131; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Magyar Z, 2005, PLANT CELL, V17, P2527, DOI 10.1105/tpc.105.033761; Magyar Z, 1997, PLANT CELL, V9, P223, DOI 10.1105/tpc.9.2.223; Magyar Zoltan, 2008, V10, P89, DOI 10.1007/7089_2007_156; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Meskiene I, 1998, P NATL ACAD SCI USA, V95, P1938, DOI 10.1073/pnas.95.4.1938; Meskiene I, 2003, J BIOL CHEM, V278, P18945, DOI 10.1074/jbc.M300878200; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; NADEAU JA, 2008, STOMATAL DEV ARABIDO, P1; Nadeau JA, 2009, CURR OPIN PLANT BIOL, V12, P29, DOI 10.1016/j.pbi.2008.10.006; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Park JA, 2005, PLANT J, V42, P153, DOI 10.1111/j.1365-313X.2005.02361.x; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saez A, 2008, PLANT CELL, V20, P2972, DOI 10.1105/tpc.107.056705; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Schweighofer A, 2007, PLANT CELL, V19, P2213, DOI 10.1105/tpc.106.049585; Schweighofer Alois, 2009, V479, P247, DOI 10.1007/978-1-59745-289-2_16; Schweighofer Alois, 2008, V10, P277, DOI 10.1007/7089_2007_155; Serna L, 2009, BIOESSAYS, V31, P865, DOI 10.1002/bies.200800231; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Stals H, 2000, PLANT MOL BIOL, V43, P583, DOI 10.1023/A:1006409907831; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Takahashi Y, 2010, PLANT CELL PHYSIOL, V51, P1766, DOI 10.1093/pcp/pcq135; Tsuchisaka A, 2009, GENETICS, V183, P979, DOI 10.1534/genetics.109.107102; Ulm R, 2002, EMBO J, V21, P6483, DOI 10.1093/emboj/cdf646; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang ML, 1999, GENOME RES, V9, P325; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543	87	56	63	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15357	10.1371/journal.pone.0015357	http://dx.doi.org/10.1371/journal.pone.0015357			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203456	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000285579200020
J	Lin, CW; Yen, ST; Chang, HT; Chen, SJ; Lai, SL; Liu, YC; Chan, TH; Liao, WL; Lee, SJ				Lin, Chun-Wei; Yen, Shuo-Ting; Chang, Hui-Ting; Chen, Shiang-Jiuun; Lai, Shih-Lei; Liu, Yi-Ching; Chan, Tun-Hao; Liao, Wen-Lian; Lee, Shyh-Jye			Loss of Cofilin 1 Disturbs Actin Dynamics, Adhesion between Enveloping and Deep Cell Layers and Cell Movements during Gastrulation in Zebrafish	PLOS ONE			English	Article							FILAMENT TURNOVER; IN-VIVO; ARP2/3 COMPLEX; E-CADHERIN; F-ACTIN; ADF/COFILIN; CYTOSKELETON; POLARITY; DROSOPHILA; EXTENSION	During gastrulation, cohesive migration drives associated cell layers to the completion of epiboly in zebrafish. The association of different layers relies on E-cadherin based cellular junctions, whose stability can be affected by actin turnover. Here, we examined the effect of malfunctioning actin turnover on the epibolic movement by knocking down an actin depolymerizing factor, cofilin 1, using antisense morpholino oligos (MO). Knockdown of cfl1 interfered with epibolic movement of deep cell layer (DEL) but not in the enveloping layer (EVL) and the defect could be specifically rescued by overexpression of cfl1. It appeared that the uncoordinated movements of DEL and EVL were regulated by the differential expression of cfl1 in the DEL, but not EVL as shown by in situ hybridization. The dissociation of DEL and EVL was further evident by the loss of adhesion between layers by using transmission electronic and confocal microscopy analyses. cfl1 morphants also exhibited abnormal convergent extension, cellular migration and actin filaments, but not involution of hypoblast. The cfl1 MO-induced cell migration defect was found to be cell-autonomous in cell transplantation assays. These results suggest that proper actin turnover mediated by Cfl1 is essential for adhesion between DEL and EVL and cell movements during gastrulation in zebrafish.	[Lin, Chun-Wei; Chang, Hui-Ting; Lai, Shih-Lei; Liu, Yi-Ching; Chan, Tun-Hao; Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Yen, Shuo-Ting; Chen, Shiang-Jiuun; Lee, Shyh-Jye] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Liao, Wen-Lian] Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lin, CW (corresponding author), Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan.	jefflee@ntu.edu.tw	Lee, Shyh-Jye/C-6092-2008; Lai, Shih-Lei/O-1562-2018; Lai, Ben/AAD-1628-2019	Lee, Shyh-Jye/0000-0001-8452-9152; Lai, Shih-Lei/0000-0002-1409-4701; Yen, Shuo-Ting/0000-0003-4277-1965	National Science Council of Taiwan, R.O.C. [NSC94-2311-B-002-019]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by a grant (NSC94-2311-B-002-019) from the National Science Council of Taiwan, R.O.C. The NSC played no role in the study and the preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Babb SG, 2004, DEV DYNAM, V230, P263, DOI 10.1002/dvdy.20057; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Dedova IV, 2004, BIOPHYS CHEM, V110, P119, DOI 10.1016/j.bpc.2004.01.009; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Gee KR, 2001, BIOORG MED CHEM LETT, V11, P2181, DOI 10.1016/S0960-894X(01)00421-8; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Hable WE, 2005, CELL MOTIL CYTOSKEL, V61, P9, DOI 10.1002/cm.20059; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Huber F, 2008, BIOPHYS J, V95, P5508, DOI 10.1529/biophysj.108.134817; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Koppen M, 2006, DEVELOPMENT, V133, P2671, DOI 10.1242/dev.02439; Lachnit M, 2008, DEV BIOL, V315, P1, DOI 10.1016/j.ydbio.2007.10.008; Lai SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003439; Lai SL, 2005, MOL REPROD DEV, V71, P186, DOI 10.1002/mrd.20290; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McFarland KN, 2005, DEV DYNAM, V233, P390, DOI 10.1002/dvdy.20325; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roh-Johnson M, 2009, J CELL SCI, V122, P3983, DOI 10.1242/jcs.057562; Sawa M, 2003, J CELL SCI, V116, P1505, DOI 10.1242/jcs.00362; Sepich DS, 2000, GENESIS, V27, P159, DOI 10.1002/1526-968X(200008)27:4<159::AID-GENE50>3.0.CO;2-T; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Small J. Victor, 1994, Seminars in Cell Biology, V5, P157, DOI 10.1006/scel.1994.1020; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Tanaka K, 2005, ZOOL SCI, V22, P971, DOI 10.2108/zsj.22.971; THERIOT JA, 1994, ADV EXP MED BIOL, V358, P133; Theriot Julie A., 1994, Seminars in Cell Biology, V5, P193, DOI 10.1006/scel.1994.1024; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wang CH, 2008, J CELL SCI, V121, P2913, DOI 10.1242/jcs.023911; WARGA RM, 1990, DEVELOPMENT, V108, P569; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Yu D, 2005, SCI CHINA SER C, V48, P601, DOI 10.1360/062004-111; Yu D, 2010, EXP CELL RES, V316, P848, DOI 10.1016/j.yexcr.2009.11.018; Zalik SE, 1999, BIOCHEM CELL BIOL, V77, P527, DOI 10.1139/bcb-77-6-527	54	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15331	10.1371/journal.pone.0015331	http://dx.doi.org/10.1371/journal.pone.0015331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203473	gold, Green Published, Green Submitted			2022-12-25	WOS:000285578000030
J	Douard, G; Praud, K; Cloeckaert, A; Doublet, B				Douard, Gregory; Praud, Karine; Cloeckaert, Axel; Doublet, Benoit			The Salmonella Genomic Island 1 Is Specifically Mobilized In Trans by the IncA/C Multidrug Resistance Plasmid Family	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL PLASMIDS; TYPHIMURIUM DT104; CLINICAL ISOLATE; VARIANT SGI1-O; INCI1 PLASMID; ENTERICA; POULTRY; HUMANS; FRANCE	Background: The Salmonella genomic island 1 (SGI1) is a Salmonella enterica-derived integrative mobilizable element (IME) containing various complex multiple resistance integrons identified in several S. enterica serovars and in Proteus mirabilis. Previous studies have shown that SGI1 transfers horizontally by in trans mobilization in the presence of the IncA/C conjugative helper plasmid pR55. Methodology/Principal Findings: Here, we report the ability of different prevalent multidrug resistance (MDR) plasmids including extended-spectrum beta-lactamase (ESBL) gene-carrying plasmids to mobilize the multidrug resistance genomic island SGI1. Through conjugation experiments, none of the 24 conjugative plasmids tested of the IncFI, FII, HI2, I1, L/M, N, P incompatibility groups were able to mobilize SGI1 at a detectable level (transfer frequency <10(-9)). In our collection, ESBL gene-carrying plasmids were mainly from the IncHI2 and I1 groups and thus were unable to mobilize SGI1. However, the horizontal transfer of SGI1 was shown to be specifically mediated by conjugative helper plasmids of the broad-host-range IncA/C incompatibility group. Several conjugative IncA/C MDR plasmids as well as the sequenced IncA/C reference plasmid pRA1 of 143,963 bp were shown to mobilize in trans SGI1 from a S. enterica donor to the Escherichia coli recipient strain. Depending on the IncA/C plasmid used, the conjugative transfer of SGI1 occurred at frequencies ranging from 10(-3) to 10(-6) transconjugants per donor. Of particular concern, some large IncA/C MDR plasmids carrying the extended-spectrum cephalosporinase bla(CMY-2) gene were shown to mobilize in trans SGI1. Conclusions/Significance: The ability of the IncA/C MDR plasmid family to mobilize SGI1 could contribute to its spread by horizontal transfer among enteric pathogens. Moreover, the increasing prevalence of IncA/C plasmids in MDR S. enterica isolates worldwide has potential implications for the epidemic success of the antibiotic resistance genomic island SGI1 and its close derivatives.	[Douard, Gregory; Praud, Karine; Cloeckaert, Axel; Doublet, Benoit] INRA, UR1282, F-37380 Nouzilly, France	INRAE	Douard, G (corresponding author), INRA, UR1282, F-37380 Nouzilly, France.	Benoit.Doublet@tours.inra.fr		Doublet, Benoit/0000-0003-0531-0967	French National Institute of Agronomic Research; Ministere de l'Education Nationale et de la Recherche, France	French National Institute of Agronomic Research; Ministere de l'Education Nationale et de la Recherche, France	This research was supported by public funds from the French National Institute of Agronomic Research. GD was supported by a doctoral fellowship from the Ministere de l'Education Nationale et de la Recherche, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2007, J ANTIMICROB CHEMOTH, V59, P184, DOI 10.1093/jac/dkl471; AMABILECUEVAS CF, 1992, CELL, V70, P189, DOI 10.1016/0092-8674(92)90095-T; AOKI T, 1971, J GEN MICROBIOL, V65, P343, DOI 10.1099/00221287-65-3-343; Boyd D, 2002, ANTIMICROB AGENTS CH, V46, P1714, DOI 10.1128/AAC.46.6.1714-1722.2002; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P340, DOI 10.1128/AAC.00902-07; Call DR, 2010, ANTIMICROB AGENTS CH, V54, P590, DOI 10.1128/AAC.00055-09; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Carret G, 2003, INT J ANTIMICROB AG, V21, P364, DOI 10.1016/S0924-8579(03)00021-9; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; CHABBERT YA, 1972, J BACTERIOL, V112, P666, DOI 10.1128/JB.112.2.666-675.1972; Cloeckaert A, 2007, ANTIMICROB AGENTS CH, V51, P1872, DOI 10.1128/AAC.01514-06; Cloeckaert A, 2010, ANTIMICROB AGENTS CH, V54, P4484, DOI 10.1128/AAC.00460-10; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; DATTA N, 1971, J BACTERIOL, V108, P1244, DOI 10.1128/JB.108.3.1244-1249.1971; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Doublet B, 2003, EMERG INFECT DIS, V9, P585, DOI 10.3201/eid0905.020609; Doublet B, 2010, J ANTIMICROB CHEMOTH, V65, P2260, DOI 10.1093/jac/dkq283; Doublet B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002060; Fernandez AG, 2007, ANTIMICROB AGENTS CH, V51, P4177, DOI 10.1128/AAC.00603-07; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Lindsey RL, 2009, APPL ENVIRON MICROB, V75, P1908, DOI 10.1128/AEM.02228-08; Marcade G, 2009, J ANTIMICROB CHEMOTH, V63, P67, DOI 10.1093/jac/dkn428; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; Meunier D, 2010, J MED MICROBIOL, V59, P467, DOI 10.1099/jmm.0.016162-0; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Poole TL, 2009, FOODBORNE PATHOG DIS, V6, P1185, DOI 10.1089/fpd.2009.0316; ROUSSEL AF, 1978, J GEN MICROBIOL, V104, P269, DOI 10.1099/00221287-104-2-269; Su LH, 2008, FEMS IMMUNOL MED MIC, V52, P155, DOI 10.1111/j.1574-695X.2007.00360.x; Weill FX, 2004, J CLIN MICROBIOL, V42, P5767, DOI 10.1128/JCM.42.12.5767-5773.2004; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Welch TJ, 2009, ANTIMICROB AGENTS CH, V53, P845, DOI 10.1128/AAC.01312-08; WITCHITZ JL, 1971, ANN I PASTEUR PARIS, V121, P733	35	87	88	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15302	10.1371/journal.pone.0015302	http://dx.doi.org/10.1371/journal.pone.0015302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187963	Green Published, Green Submitted, gold			2022-12-25	WOS:000285575200035
J	Wang, CY; Wang, T; Zheng, W; Zhao, BL; Danscher, G; Chen, YH; Wang, ZY				Wang, Chun-Yan; Wang, Tao; Zheng, Wei; Zhao, Bao-Lu; Danscher, Gorm; Chen, Yu-Hua; Wang, Zhan-You			Zinc Overload Enhances APP Cleavage and A beta Deposition in the Alzheimer Mouse Brain	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; HISTOCHEMICALLY-REACTIVE ZINC; MILD COGNITIVE IMPAIRMENT; TRANSGENIC MICE; IN-VIVO; METAL HOMEOSTASIS; PLAQUE-FORMATION; DISEASE; COPPER; TOXICITY	Background: Abnormal zinc homeostasis is involved in beta-amyloid (A beta) plaque formation and, therefore, the zinc load is a contributing factor in Alzheimer's disease (AD). However, the involvement of zinc in amyloid precursor protein (APP) processing and Ab deposition has not been well established in AD animal models in vivo. Methodology/Principal Findings: In the present study, APP and presenilin 1 (PS1) double transgenic mice were treated with a high dose of zinc (20 mg/ml ZnSO4 in drinking water). This zinc treatment increased APP expression, enhanced amyloidogenic APP cleavage and A beta deposition, and impaired spatial learning and memory in the transgenic mice. We further examined the effects of zinc overload on APP processing in SHSY-5Y cells overexpressing human APPsw. The zinc enhancement of APP expression and cleavage was further confirmed in vitro. Conclusions/Significance: The present data indicate that excess zinc exposure could be a risk factor for AD pathological processes, and alteration of zinc homeostasis is a potential strategy for the prevention and treatment of AD.	[Wang, Chun-Yan; Wang, Tao; Zheng, Wei; Chen, Yu-Hua; Wang, Zhan-You] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Shenyang, Peoples R China; [Wang, Chun-Yan; Wang, Tao; Zheng, Wei; Chen, Yu-Hua; Wang, Zhan-You] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Zhao, Bao-Lu] Acad Sinica, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Danscher, Gorm] Univ Aarhus, Dept Anat & Neurobiol, Aarhus, Denmark	China Medical University; China Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Aarhus University	Wang, CY (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Shenyang, Peoples R China.	yhchen@mail.cmu.edu.cn; zhanyouw@hotmail.com		Wang, Zhan-You/0000-0003-0807-9916	Natural Science Foundation of China [30770680]; Program for New Century Excellent Talents in University [NCET-04-0288]; Universities of the Department of Education of Liaoning Province [20060948]; National Basic Research Program of China (973 Program) [2009CB930300]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Universities of the Department of Education of Liaoning Province; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The study was supported by the Natural Science Foundation of China (30770680), the Program for New Century Excellent Talents in University (NCET-04-0288), the Research Project for Universities of the Department of Education of Liaoning Province (20060948), and the National Basic Research Program of China (973 Program 2009CB930300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Atwood CS, 1999, MET IONS BIOL SYST, V36, P309; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Boom A, 2009, BBA-MOL CELL RES, V1793, P1058, DOI 10.1016/j.bbamcr.2008.11.011; Borchardt T, 2000, CELL MOL BIOL, V46, P785; BUSH AI, 1994, J BIOL CHEM, V269, P12152; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; BUSH AI, 1993, J BIOL CHEM, V268, P16109; Bush AI, 2002, NEUROBIOL AGING, V23, P1031, DOI 10.1016/S0197-4580(02)00120-3; Cardoso SM, 2005, NEUROTOX RES, V7, P273, DOI 10.1007/BF03033885; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; Cuajungco MP, 2003, BRAIN RES REV, V41, P44, DOI 10.1016/S0165-0173(02)00219-9; Cuajungco MP, 1996, NEUROREPORT, V7, P1301, DOI 10.1097/00001756-199605170-00017; Cuajungco MP, 1998, BRAIN RES, V799, P97, DOI 10.1016/S0006-8993(98)00482-X; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Dineley KE, 2005, MITOCHONDRION, V5, P55, DOI 10.1016/j.mito.2004.11.001; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Friedlich AL, 2004, J NEUROSCI, V24, P3453, DOI 10.1523/JNEUROSCI.0297-04.2004; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; Jenagaratnam L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005380.pub2; Kozin SA, 2001, BIOCHEM BIOPH RES CO, V285, P959, DOI 10.1006/bbrc.2001.5284; Lee JY, 1999, J NEUROSCI, V19, DOI 10.1523/jneurosci.19-11-j0002.1999; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lee JY, 2004, NEUROBIOL AGING, V25, P1315, DOI 10.1016/j.neurobiolaging.2004.01.005; Lovell MA, 2005, NEUROTOX RES, V7, P265, DOI 10.1007/BF03033884; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lovell MA, 1999, BRAIN RES, V823, P88, DOI 10.1016/S0006-8993(99)01114-2; Lovell MA, 2006, J NEUROPATH EXP NEUR, V65, P489, DOI 10.1097/01.jnen.0000229237.98124.91; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Maynard CJ, 2009, CELL MOL NEUROBIOL, V29, P757, DOI 10.1007/s10571-009-9401-7; Maynard CJ, 2005, INT J EXP PATHOL, V86, P147, DOI 10.1111/j.0959-9673.2005.00434.x; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Plonka PM, 2006, BRIT J DERMATOL, V155, P39, DOI 10.1111/j.1365-2133.2006.07376.x; Plonka PM, 2005, EXP DERMATOL, V14, P844, DOI 10.1111/j.1600-0625.2005.00365.x; Price Katherine A, 2007, Recent Pat CNS Drug Discov, V2, P180, DOI 10.2174/157488907782411774; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Smedman M, 1997, MOL CHEM NEUROPATHOL, V31, P13, DOI 10.1007/BF02815157; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; Stoltenberg M, 2007, NEUROSCIENCE, V150, P357, DOI 10.1016/j.neuroscience.2007.09.025; Stoltenberg M, 2005, HISTOCHEM CELL BIOL, V123, P605, DOI 10.1007/s00418-005-0787-0; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Tougu V, 2008, J NEUROCHEM, V104, P1249, DOI 10.1111/j.1471-4159.2007.05061.x; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Zhang J, 2006, NEUROSCIENCE, V143, P63, DOI 10.1016/j.neuroscience.2006.07.023; Zhang J, 2006, FASEB J, V20, P1212, DOI 10.1096/fj.05-5214fje; Zhang LH, 2008, BRAIN RES BULL, V77, P55, DOI 10.1016/j.brainresbull.2008.03.014; Zhang LH, 2010, NEUROBIOL AGING, V31, P74, DOI 10.1016/j.neurobiolaging.2008.02.018; Zheng W, 2010, J ALZHEIMERS DIS, V20, P323, DOI 10.3233/JAD-2010-1363; Zheng W, 2009, FASEB J, V23, P4207, DOI 10.1096/fj.09-135749	59	48	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15349	10.1371/journal.pone.0015349	http://dx.doi.org/10.1371/journal.pone.0015349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179415	Green Submitted, Green Published, gold			2022-12-25	WOS:000285572900018
J	George, I; Alcaix, S; Henry, L; Richard, JP; Cousillas, H; Hausberger, M				George, Isabelle; Alcaix, Sandrine; Henry, Laurence; Richard, Jean-Pierre; Cousillas, Hugo; Hausberger, Martine			Neural Correlates of Experience-Induced Deficits in Learned Vocal Communication	PLOS ONE			English	Article							STARLINGS STURNUS-VULGARIS; ZEBRA FINCH; EUROPEAN STARLINGS; AUDITORY FOREBRAIN; SONG DEVELOPMENT; GENE-EXPRESSION; SOCIAL-INTERACTION; CONSPECIFIC SONG; HUMAN SPEECH; ORGANIZATION	Songbirds are one of the few vertebrate groups (including humans) that evolved the ability to learn vocalizations. During song learning, social interactions with adult models are crucial and young songbirds raised without direct contacts with adults typically produce abnormal songs showing phonological and syntactical deficits. This raises the question of what functional representation of their vocalizations such deprived animals develop. Here we show that young starlings that we raised without any direct contact with adults not only failed to differentiate starlings' typical song classes in their vocalizations but also failed to develop differential neural responses to these songs. These deficits appear to be linked to a failure to acquire songs' functions and may provide a model for abnormal development of communicative skills, including speech.	[George, Isabelle; Alcaix, Sandrine; Henry, Laurence; Richard, Jean-Pierre; Cousillas, Hugo; Hausberger, Martine] Univ Rennes 1, CNRS, Ethol Anim & Humaine UMR6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	George, I (corresponding author), Univ Rennes 1, CNRS, Ethol Anim & Humaine UMR6552, Rennes, France.	Isabelle.George@univ-rennes1.fr	George, Isabelle/A-7770-2008	George, Isabelle/0000-0002-4842-4959	French CNRS (Centre national de la recherche scientifique); University of Rennes 1	French CNRS (Centre national de la recherche scientifique)(Centre National de la Recherche Scientifique (CNRS)); University of Rennes 1	This study has been funded by the French CNRS (Centre national de la recherche scientifique) and the University of Rennes 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRET-HAUSBERGER M, 1989, Bioacoustics, V2, P137; ADRETHAUSBERGER M, 1984, Z TIERPSYCHOL, V66, P309; ADRETHAUSBERGER M, 1982, BEHAV ECOL SOCIOBIOL, V11, P241, DOI 10.1007/BF00299300; ADRETHAUSBERGER M, 1984, IBIS, V126, P372, DOI 10.1111/j.1474-919X.1984.tb00258.x; ADRETHAUSBERGER M, 1990, ETHOLOGY, V84, P265; ADRETHAUSBERGER M, 1988, BEHAVIOUR, V107, P138, DOI 10.1163/156853988X00322; Amin N, 2004, J COMP PHYSIOL A, V190, P469, DOI 10.1007/s00359-004-0511-x; BAPTISTA LF, 1986, ANIM BEHAV, V34, P1359, DOI 10.1016/S0003-3472(86)80207-X; Bertin A, 2007, DEV PSYCHOBIOL, V49, P362, DOI 10.1002/dev.20223; Bertin A, 2009, J COMP PSYCHOL, V123, P195, DOI 10.1037/a0014050; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; BUCKINGHAM HW, 1979, J COMMUN DISORD, V12, P197, DOI 10.1016/0021-9924(79)90041-8; CARAMAZZA A, 1983, BRAIN LANG, V18, P128, DOI 10.1016/0093-934X(83)90011-1; CHAIKEN M, 1993, ANIM BEHAV, V46, P1079, DOI 10.1006/anbe.1993.1298; Chaiken M, 1997, J COMP PSYCHOL, V111, P379, DOI 10.1037/0735-7036.111.4.379; Chaiken M, 2007, CONDOR, V109, P968, DOI 10.1650/0010-5422(2007)109[968:SLAIIT]2.0.CO;2; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Clarke S, 2000, NEUROPSYCHOLOGIA, V38, P797, DOI 10.1016/S0028-3932(99)00141-4; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EENS M, 1991, BELG J ZOOL, V121, P257; EENS M, 1989, ARDEA, V77, P75; EENS M, 1991, BEHAVIOUR, V116, P210, DOI 10.1163/156853991X00049; EENS M, 1990, BIRD STUDY, V37, P48, DOI 10.1080/00063659009477038; Gentner TQ, 2004, ANN NY ACAD SCI, V1016, P282, DOI 10.1196/annals.1298.008; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; George I, 2005, NEUROSCIENCE, V136, P1, DOI 10.1016/j.neuroscience.2005.08.001; George I, 2003, J NEUROSCI METH, V125, P65, DOI 10.1016/S0165-0270(03)00025-6; George I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002203; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hattiangadi N, 2005, BRAIN LANG, V92, P12, DOI 10.1016/j.bandl.2004.05.003; Hausberger M, 2000, BEHAV BRAIN RES, V114, P89, DOI 10.1016/S0166-4328(00)00191-1; HAUSBERGER M, 1995, ETHOLOGY, V99, P193; HAUSBERGER M, 1991, BIRD BEHAV, V9, P81, DOI 10.3727/015613890791749127; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; HAUSBERGER M, 1981, BIOL BEHAV, V6, P79; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; Henry L., 1994, Bioacoustics, V5, P261; Henry L, 1998, REV ECOL-TERRE VIE, V53, P347; King AP, 2005, ETHOLOGY, V111, P101, DOI 10.1111/j.1439-0310.2004.01039.x; MELLO C, 1995, J NEUROSCI, V15, P6919; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Park KHJ, 2002, BEHAV BRAIN RES, V136, P185, DOI 10.1016/S0166-4328(02)00129-8; Poirier C, 2004, J COMP PSYCHOL, V118, P179, DOI 10.1037/0735-7036.118.2.179; Richard J-P, 1991, BIOACOUSTICS, V3, P45, DOI DOI 10.1080/09524622.1991.9753156; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Thompson JV, 2010, J NEUROPHYSIOL, V103, P1785, DOI 10.1152/jn.00885.2009; Vicario DS, 2004, ANN NY ACAD SCI, V1016, P246, DOI 10.1196/annals.1298.040; WILLIAMS H, 1990, ANIM BEHAV, V39, P745, DOI 10.1016/S0003-3472(05)80386-0	56	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14347	10.1371/journal.pone.0014347	http://dx.doi.org/10.1371/journal.pone.0014347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695OI	21179492	Green Published, Green Submitted, gold			2022-12-25	WOS:000285381200005
J	Agarwal, R; Khan, A; Gupta, D; Aggarwal, AN; Saxena, AK; Chakrabarti, A				Agarwal, Ritesh; Khan, Ajmal; Gupta, Dheeraj; Aggarwal, Ashutosh N.; Saxena, Akshay K.; Chakrabarti, Arunaloke			An Alternate Method of Classifying Allergic Bronchopulmonary Aspergillosis Based on High-Attenuation Mucus	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; CYSTIC-FIBROSIS; CT FINDINGS; CLINICAL-SIGNIFICANCE; FUNGAL SINUSITIS; PROGNOSTIC VALUE; NORTH-INDIA; SERUM IGE; DIAGNOSIS; HYPERSENSITIVITY	Background and Aim: Allergic bronchopulmonary aspergillosis (ABPA) is classified radiologically based on the findings of central bronchiectasis (CB) and other radiologic features (ORF). However, the long-term clinical significance of these classifications remains unknown. We hypothesized that the immunological activity and outcomes of ABPA could be predicted on HRCT chest finding of high-attenuation mucus (HAM), a marker of inflammatory activity. In this study, we evaluate the severity and clinical outcomes of ABPA with different radiological classifications. Methods: Patients were classified based on CT chest findings as: (a) serologic ABPA (ABPA-S) and ABPA-CB; (b) ABPA-S, ABPA-CB, and ABPA-CB-ORF; and, (c) ABPA-S, ABPA-CB and ABPA-CB-HAM. The clinical, spirometric and serological (total and A fumigatus specific IgE levels, eosinophil count) severity of the disease and clinical outcomes in various classifications were analyzed. Results: Of the 234 (123 males, 111 females; mean age, 34.1 years) patients, 55 (23.5%) had normal HRCT, 179 (76.5%) had CB, 49 (20.9%) had HAM, and 27 (11.5%) had ORF. All immunological markers were consistently higher in the HAM classification, while in other classifications these findings were inconsistent. On multivariate analysis, the factors predicting frequent relapses were presence of HAM (OR 7.38; 95% CI, 3.21-17.0) and CB (OR 3.93; 95% CI, 1.63-9.48) after adjusting for ORF. Conclusions: The classification scheme based on HAM most consistently predicts immunological severity in ABPA. Central bronchiectasis and HAM are independent predictors of recurrent relapses in ABPA. Hence, HAM should be employed in the radiological classification of ABPA.	[Agarwal, Ritesh; Khan, Ajmal; Gupta, Dheeraj; Aggarwal, Ashutosh N.] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India; [Saxena, Akshay K.] Postgrad Inst Med Educ & Res, Dept Radiodiag, Chandigarh 160012, India; [Chakrabarti, Arunaloke] Postgrad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Agarwal, R (corresponding author), Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India.	riteshpgi@gmail.com	Agarwal, Ritesh/A-3063-2009; KHAN, AJMAL/W-9962-2019	Agarwal, Ritesh/0000-0003-2547-7668; KHAN, AJMAL/0000-0002-4727-3554				Agarwal R, 2006, AM J ROENTGENOL, V186, P904, DOI 10.2214/AJR.05.0125; Agarwal R, 2009, INT J TUBERC LUNG D, V13, P936; AGARWAL R, 2010, INT J RESP IN PRESS; Agarwal R, 2006, CHEST, V130, P442, DOI 10.1378/chest.130.2.442; Agarwal R, 2007, CHEST, V132, P1183, DOI 10.1378/chest.07-0808; Agarwal R, 2011, MED MYCOL, V49, pS150, DOI 10.3109/13693786.2010.504752; Agarwal R, 2010, WORLD J RADIOL, V2, P41, DOI 10.4329/wjr.v2.i1.41; Agarwal R, 2010, MED MYCOL, V48, P988, DOI 10.3109/13693781003743148; Agarwal R, 2010, MYCOSES, V53, P138, DOI 10.1111/j.1439-0507.2008.01680.x; Agarwal R, 2010, RESP MED, V104, P204, DOI 10.1016/j.rmed.2009.09.005; Agarwal R, 2009, CHEST, V135, P805, DOI 10.1378/chest.08-2586; BULCKE JA, 1979, NEURORADIOLOGY, V17, P127; CAMPBELL MJ, 1964, AM REV RESPIR DIS, V89, P186; DILLON WP, 1990, RADIOLOGY, V174, P73, DOI 10.1148/radiology.174.1.2294574; Ghaye B, 2006, RADIOGRAPHICS, V26, P23, DOI 10.1148/rg.261055062; GOYAL R, 1992, J COMPUT ASSIST TOMO, V16, P649; GREENBERGER PA, 1984, J ALLERGY CLIN IMMUN, V74, P645, DOI 10.1016/0091-6749(84)90223-9; GREENBERGER PA, 1993, ANN ALLERGY, V70, P333; Hanak V, 2008, CHEST, V134, P133, DOI 10.1378/chest.07-3005; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; HANSELL DM, 1989, BRIT J RADIOL, V62, P1; HINSON KFW, 1952, THORAX, V7, P317, DOI 10.1136/thx.7.4.317; HOEHNE J, 1971, J LAB CLIN MED, V78, P1007; HOEHNE JH, 1973, CHEST, V63, P177, DOI 10.1378/chest.63.2.177; Karunaratne Nishantha, 2003, Australas Radiol, V47, P336, DOI 10.1046/j.1440-1673.2003.01192.x; KOPP W, 1985, RADIOLOGY, V156, P715, DOI 10.1148/radiology.156.3.4023231; Kumar R, 2003, CHEST, V124, P890, DOI 10.1378/chest.124.3.890; Logan PM, 1996, CAN ASSOC RADIOL J, V47, P374; Logan PM, 1996, IRISH J MED SCI, V165, P27, DOI 10.1007/BF02942797; LONGBOTTOM JL, 1964, J PATHOL BACTERIOL, V88, P141, DOI 10.1002/path.1700880119; MALO JL, 1979, CLIN ALLERGY, V9, P377, DOI 10.1111/j.1365-2222.1979.tb02496.x; Manning SC, 1997, LARYNGOSCOPE, V107, P170, DOI 10.1097/00005537-199702000-00007; McCarthy D S, 1971, Clin Allergy, V1, P415, DOI 10.1111/j.1365-2222.1971.tb00793.x; McCarthy DS, 1971, CLIN ALLERGY, V1, P261, DOI DOI 10.1111/J.1365-2222.1971.TB; Molinari M, 2004, Monaldi Arch Chest Dis, V61, P62; Morozov A, 2007, PEDIATR RADIOL, V37, P592, DOI 10.1007/s00247-007-0471-8; Mukherji SK, 1998, RADIOLOGY, V207, P417, DOI 10.1148/radiology.207.2.9577490; PATTERSON R, 1986, ARCH INTERN MED, V146, P916, DOI 10.1001/archinte.146.5.916; PATTERSON R, 1968, University of Michigan Medical Center Journal, V34, P8; Rajkumar DC, 2002, J ASTHMA, V39, P473, DOI 10.1081/JAS-120004905; REIFF DB, 1995, AM J ROENTGENOL, V165, P261, DOI 10.2214/ajr.165.2.7618537; ROSENBERG M, 1977, ANN INTERN MED, V86, P405, DOI 10.7326/0003-4819-86-4-405; Screaton NJ, 2005, CLIN RADIOL, V60, P96, DOI 10.1016/j.crad.2004.06.029; Shah A, 2003, FRONT BIOSCI, V8, pE138, DOI 10.2741/944; Shah A, 2008, ANN ALLERG ASTHMA IM, V101, P363, DOI 10.1016/S1081-1206(10)60311-0; SLAVIN RG, 1988, J ALLERGY CLIN IMMUN, V81, P718, DOI 10.1016/0091-6749(88)91044-5; SLAVIN RG, 1969, AM J MED, V47, P306, DOI 10.1016/0002-9343(69)90156-9; Tillie-Leblond I, 2005, ALLERGY, V60, P1004, DOI 10.1111/j.1398-9995.2005.00887.x; Vlahakis NE, 2001, MAYO CLIN PROC, V76, P930; WANG JLF, 1978, AM REV RESPIR DIS, V117, P917	50	73	77	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15346	10.1371/journal.pone.0015346	http://dx.doi.org/10.1371/journal.pone.0015346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179536	Green Submitted, Green Published, gold			2022-12-25	WOS:000285340000023
J	Derry, JMJ; Zhong, H; Molony, C; MacNeil, D; Guhathakurta, D; Zhang, B; Mudgett, J; Small, K; El Fertak, L; Guimond, A; Selloum, M; Zhao, WQ; Champy, MF; Monassier, L; Vogt, T; Cully, D; Kasarskis, A; Schadt, EE				Derry, Jonathan M. J.; Zhong, Hua; Molony, Cliona; MacNeil, Doug; Guhathakurta, Debraj; Zhang, Bin; Mudgett, John; Small, Kersten; El Fertak, Lahcen; Guimond, Alain; Selloum, Mohammed; Zhao, Wenqing; Champy, Marie France; Monassier, Laurent; Vogt, Tom; Cully, Doris; Kasarskis, Andrew; Schadt, Eric E.			Identification of Genes and Networks Driving Cardiovascular and Metabolic Phenotypes in a Mouse F2 Intercross	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BLOOD-PRESSURE LOCI; BODY-WEIGHT; FTO GENE; NERVOUS-SYSTEM; EXPRESSION; SUSCEPTIBILITY; MICE; QTL; REGULATOR	To identify the genes and pathways that underlie cardiovascular and metabolic phenotypes we performed an integrated analysis of a mouse C57BL/6J x A/J F-2 (B6AF2) cross by relating genome-wide gene expression data from adipose, kidney, and liver tissues to physiological endpoints measured in the population. We have identified a large number of trait QTLs including loci driving variation in cardiac function on chromosomes 2 and 6 and a hotspot for adiposity, energy metabolism, and glucose traits on chromosome 8. Integration of adipose gene expression data identified a core set of genes that drive the chromosome 8 adiposity QTL. This chromosome 8 trans eQTL signature contains genes associated with mitochondrial function and oxidative phosphorylation and maps to a subnetwork with conserved function in humans that was previously implicated in human obesity. In addition, human eSNPs corresponding to orthologous genes from the signature show enrichment for association to type II diabetes in the DIAGRAM cohort, supporting the idea that the chromosome 8 locus perturbs a molecular network that in humans senses variations in DNA and in turn affects metabolic disease risk. We functionally validate predictions from this approach by demonstrating metabolic phenotypes in knockout mice for three genes from the trans eQTL signature, Akr1b8, Emr1, and Rgs2. In addition we show that the transcriptional signatures for knockout of two of these genes, Akr1b8 and Rgs2, map to the F2 network modules associated with the chromosome 8 trans eQTL signature and that these modules are in turn very significantly correlated with adiposity in the F2 population. Overall this study demonstrates how integrating gene expression data with QTL analysis in a network-based framework can aid in the elucidation of the molecular drivers of disease that can be translated from mice to humans.	[Derry, Jonathan M. J.; Zhong, Hua; Molony, Cliona; Guhathakurta, Debraj; Zhang, Bin; Kasarskis, Andrew; Schadt, Eric E.] Rosetta Inpharmat LLC, Seattle, WA USA; [MacNeil, Doug; Mudgett, John; Small, Kersten; Zhao, Wenqing; Vogt, Tom; Cully, Doris] Merck & Co Inc, Basic Res, Rahway, NJ 07065 USA; [El Fertak, Lahcen; Guimond, Alain; Selloum, Mohammed; Champy, Marie France; Monassier, Laurent] Inst Clin Souris, Illkirch Graffenstaden, France	Merck & Company; Merck & Company	Derry, JMJ (corresponding author), Sage Bionetworks, Seattle, WA USA.	derry@sagebase.org	zhong, Judy/ABE-8314-2020	Zhong, Judy/0000-0002-2163-8447	Merck Co.	Merck Co.(Merck & Company)	These studies were all planned and funded by Merck & Co. Study design, data collection and analysis, and the preparation of the manuscript were conducted by current or former Merck employees as well as scientists from the Clinique de la Souris, Illkirch, France.	Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; DiPetrillo K, 2004, PHYSIOL GENOMICS, V17, P215, DOI 10.1152/physiolgenomics.00212.2003; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freson K, 2007, J HYPERTENS, V25, P117, DOI 10.1097/HJH.0b013e3280109c6c; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hamann J, 2007, EUR J IMMUNOL, V37, P2797, DOI 10.1002/eji.200737553; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; HEXIMER SP, 2007, SCI STKE, pPE2; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Hunter KW, 2008, ANNU REV GENET, V42, P131, DOI 10.1146/annurev.genet.42.110807.091659; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; KRUGLYAK L, 1995, GENETICS, V139, P1421; Kwakkenbos MJ, 2004, IMMUNOGENETICS, V55, P655, DOI 10.1007/s00251-003-0625-2; LEGRY V, 2009, METABOLISM; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Nishizuka M, 2001, J BIOL CHEM, V276, P29625, DOI 10.1074/jbc.C100272200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Petrash JM, 2004, CELL MOL LIFE SCI, V61, P737, DOI 10.1007/s00018-003-3402-3; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Riddle EL, 2006, HYPERTENSION, V47, P415, DOI 10.1161/01.HYP.0000200714.81990.61; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Sartori M, 2008, METABOLISM, V57, P421, DOI 10.1016/j.metabol.2007.10.021; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Smith SC, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2007.01.002; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; Stylianou IM, 2006, GENETICS, V174, P999, DOI 10.1534/genetics.106.059717; Sugiyama F, 2002, PHYSIOL GENOMICS, V10, P5, DOI 10.1152/physiolgenomics.00002.2002; Sugiyama F, 2001, GENOMICS, V71, P70, DOI 10.1006/geno.2000.6401; Suzuki M, 2002, CIRCULATION, V105, P1824, DOI 10.1161/01.CIR.0000014926.32463.89; Takeshita S, 2006, MAMM GENOME, V17, P927, DOI 10.1007/s00335-005-0130-z; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Wang XS, 2005, AM J HUM GENET, V77, P1, DOI 10.1086/431656; Woo DDL, 2003, PHYSIOL GENOMICS, V15, P236, DOI 10.1152/physiolgenomics.00027.2003; Wright FA, 1999, HYPERTENSION, V34, P625, DOI 10.1161/01.HYP.34.4.625; Wuschke S, 2007, INT J OBESITY, V31, P829, DOI 10.1038/sj.ijo.0803473; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang SM, 2003, OBES RES, V11, P828, DOI 10.1038/oby.2003.114; Zhu J, 2008, ADV GENET, V60, P603, DOI 10.1016/S0065-2660(07)00421-X; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	66	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14319	10.1371/journal.pone.0014319	http://dx.doi.org/10.1371/journal.pone.0014319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179467	Green Submitted, Green Published, gold			2022-12-25	WOS:000285292500004
J	Hervera, A; Negrete, R; Leanez, S; Martin-Campos, JM; Pol, O				Hervera, Arnau; Negrete, Roger; Leanez, Sergi; Martin-Campos, Jesus M.; Pol, Olga			The Spinal Cord Expression of Neuronal and Inducible Nitric Oxide Synthases and Their Contribution in the Maintenance of Neuropathic Pain in Mice	PLOS ONE			English	Article							THERMAL HYPERALGESIA; SCIATIC-NERVE; RAT; INJURY; MODEL; INOS; ANTAGONIST; INHIBITOR	Background: Nitric oxide generated by neuronal (NOS1), inducible (NOS2) or endothelial (NOS3) nitric oxide synthases contributes to pain processing, but the exact role of NOS1 and NOS2 in the maintenance of chronic peripheral neuropathic pain as well as the possible compensatory changes in their expression in the spinal cord of wild type (WT) and NOS knockout (KO) mice at 21 days after total sciatic nerve ligation remains unknown. Methodology/Principal Findings: The mechanical and thermal allodynia as well as thermal hyperalgesia induced by sciatic nerve injury was evaluated in WT, NOS1-KO and NOS2-KO mice from 1 to 21 days after surgery. The mRNA and protein levels of NOS1, NOS2 and NOS3 in the spinal cord of WT and KO mice, at 21 days after surgery, were also assessed. Sciatic nerve injury led to a neuropathic syndrome in WT mice, in contrast to the abolished mechanical allodynia and thermal hyperalgesia as well as the decreased or suppressed thermal allodynia observed in NOS1-KO and NOS2-KO animals, respectively. Sciatic nerve injury also increases the spinal cord expression of NOS1 and NOS2 isoforms, but not of NOS3, in WT and NOS1-KO mice respectively. Moreover, the presence of NOS2 is required to increase the spinal cord expression of NOS1 whereas an increased NOS1 expression might avoid the up-regulation of NOS2 in the spinal cord of nerve injured WT mice. Conclusions/Significance: These data suggest that the increased spinal cord expression of NOS1, regulated by NOS2, might be responsible for the maintenance of chronic peripheral neuropathic pain in mice and propose these enzymes as interesting therapeutic targets for their treatment.	[Hervera, Arnau; Negrete, Roger; Leanez, Sergi; Pol, Olga] Hosp Sta Creu & St Pau, Inst Recerca, Grp Neurofarmacol Mol, Barcelona, Spain; [Hervera, Arnau; Negrete, Roger; Leanez, Sergi; Pol, Olga] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Martin-Campos, Jesus M.] Hosp Sta Creu & St Pau, Inst Recerca, Grp Bioquim, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Hervera, A (corresponding author), Hosp Sta Creu & St Pau, Inst Recerca, Grp Neurofarmacol Mol, Barcelona, Spain.	opol@santpau.es	Martín-Campos, Jesús M./AAQ-5478-2021; Hervera, Arnau/C-9710-2011; Martín-Campos, Jesús Maria/AGJ-2586-2022; Leánez, Sergi/C-9709-2011; abad, Arnau Hervera/V-5435-2017; Pol, Olga/O-2146-2019; Pol, Olga/C-9194-2011	Martín-Campos, Jesús Maria/0000-0003-0414-037X; abad, Arnau Hervera/0000-0001-8362-369X; Pol, Olga/0000-0002-4621-8457; 	Fondo de Investigacian Sanitaria, Madrid [PS0900968]; Fundacio La Marato de TV3 Barcelona, Spain [070810]	Fondo de Investigacian Sanitaria, Madrid; Fundacio La Marato de TV3 Barcelona, Spain	This work was supported by Fondo de Investigacian Sanitaria, Madrid (http://www.isciii.es/htdocs/investigacion/Fondo_lineas.jsp) [Grant: PS0900968] and the Fundacio La Marato de TV3 Barcelona (http://www.fundaciomaratotv3.cat/) [Grant: 070810], Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boettger MK, 2007, EUR J PAIN, V11, P810, DOI 10.1016/j.ejpain.2006.12.008; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chu YC, 2005, PAIN, V119, P113, DOI 10.1016/j.pain.2005.09.024; Costa B, 2005, PAIN, V116, P52, DOI 10.1016/j.pain.2005.03.043; De Alba J, 2006, PAIN, V120, P170, DOI 10.1016/j.pain.2005.10.028; Guan Y, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-29; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; LaBuda CJ, 2006, EUR J PAIN, V10, P505, DOI 10.1016/j.ejpain.2005.07.004; Leanez S, 2009, EUR J PHARMACOL, V602, P41, DOI 10.1016/j.ejphar.2008.11.019; Levy D, 2000, EUR J NEUROSCI, V12, P2323, DOI 10.1046/j.1460-9568.2000.00129.x; Levy D, 1999, NEUROSCI LETT, V260, P207, DOI 10.1016/S0304-3940(98)00982-3; Levy D, 1998, EUR J NEUROSCI, V10, P1846, DOI 10.1046/j.1460-9568.1998.00186.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martucci C, 2008, PAIN, V137, P81, DOI 10.1016/j.pain.2007.08.017; MELLER ST, 1992, NEUROSCIENCE, V50, P7, DOI 10.1016/0306-4522(92)90377-E; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Pol O, 2007, CURR MED CHEM, V14, P1945; Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010; Tanabe M, 2009, NEUROPHARMACOLOGY, V56, P702, DOI 10.1016/j.neuropharm.2008.12.003; Tao F, 2004, NEUROSCIENCE, V128, P421, DOI 10.1016/j.neuroscience.2004.06.038; Tao F, 2003, NEUROSCIENCE, V120, P847, DOI 10.1016/S0306-4522(03)00362-2; Valsecchi AE, 2008, J NEUROCHEM, V107, P230, DOI 10.1111/j.1471-4159.2008.05614.x	23	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14321	10.1371/journal.pone.0014321	http://dx.doi.org/10.1371/journal.pone.0014321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179208	Green Published, Green Submitted, gold			2022-12-25	WOS:000285246900023
J	Nardinocchi, L; Pantisano, V; Puca, R; Porru, M; Aiello, A; Grasselli, A; Leonetti, C; Safran, M; Rechavi, G; Givol, D; Farsetti, A; D'Orazi, G				Nardinocchi, Lavinia; Pantisano, Valentina; Puca, Rosa; Porru, Manuela; Aiello, Aurora; Grasselli, Annalisa; Leonetti, Carlo; Safran, Michal; Rechavi, Gideon; Givol, David; Farsetti, Antonella; D'Orazi, Gabriella			Zinc Downregulates HIF-1 alpha and Inhibits Its Activity in Tumor Cells In Vitro and In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-I; HIF-ALPHA; HYPOXIA; ANGIOGENESIS; GENE; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; HIPK2; ERYTHROPOIETIN; TRANSFORMATION	Background: Hypoxia inducible factor-1 alpha (HIF-1 alpha) is responsible for the majority of HIF-1-induced gene expression changes under hypoxia and for the "angiogenic switch'' during tumor progression. HIF-1 alpha is often upregulated in tumors leading to more aggressive tumor growth and chemoresistance, therefore representing an important target for antitumor intervention. We previously reported that zinc downregulated HIF-1 alpha levels. Here, we evaluated the molecular mechanisms of zinc-induced HIF-1 alpha downregulation and whether zinc affected HIF-1 alpha also in vivo. Methodology/Principal Findings: Here we report that zinc downregulated HIF-1 alpha protein levels in human prostate cancer and glioblastoma cells under hypoxia, whether induced or constitutive. Investigations into the molecular mechanisms showed that zinc induced HIF-1 alpha proteasomal degradation that was prevented by treatment with proteasomal inhibitor MG132. HIF-1 alpha downregulation induced by zinc was ineffective in human RCC4 VHL-null renal carcinoma cell line; likewise, the HIF-1 alpha P402/P564A mutant was resistant to zinc treatment. Similarly to HIF-1 alpha, zinc downregulated also hypoxia-induced HIF-2 alpha whereas the HIF-1 beta subunit remained unchanged. Zinc inhibited HIF-1 alpha recruitment onto VEGF promoter and the zinc-induced suppression of HIF-1-dependent activation of VEGF correlated with reduction of glioblastoma and prostate cancer cell invasiveness in vitro. Finally, zinc administration downregulated HIF-1 alpha levels in vivo, by bioluminescence imaging, and suppressed intratumoral VEGF expression. Conclusions/Significance: These findings, by demonstrating that zinc induces HIF-1 alpha proteasomal degradation, indicate that zinc could be useful as an inhibitor of HIF-1 alpha in human tumors to repress important pathways involved in tumor progression, such as those induced by VEGF, MDR1, and Bcl2 target genes, and hopefully potentiate the anticancer therapies.	[Nardinocchi, Lavinia; Pantisano, Valentina; Puca, Rosa; Aiello, Aurora; Grasselli, Annalisa; Farsetti, Antonella; D'Orazi, Gabriella] Natl Canc Inst Regina Elena, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy; [Pantisano, Valentina] Catholic Univ, Chair Endocrinol, Rome, Italy; [Aiello, Aurora; Grasselli, Annalisa; Farsetti, Antonella] Inst Neurobiol & Mol Med, Natl Res Council, Rome, Italy; [Safran, Michal; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Safran, Michal; Rechavi, Gideon] Tel Aviv Univ, Sachler Sch Med, IL-69978 Tel Aviv, Israel; [Givol, David] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Puca, Rosa; D'Orazi, Gabriella] Univ G DAnnunzio, Sch Med, Dept Oncol & Expt Med, Chieti, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Chaim Sheba Medical Center; Tel Aviv University; Weizmann Institute of Science; G d'Annunzio University of Chieti-Pescara	Nardinocchi, L (corresponding author), Natl Canc Inst Regina Elena, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy.	gdorazi@unich.it	D'Orazi, Gabriella/T-2792-2019; Farsetti, Antonella/I-8710-2018; PORRU, MANUELA/K-4809-2018; Porru, Manuela/AAA-5510-2021; Leonetti, Carlo/B-2860-2018	D'Orazi, Gabriella/0000-0001-6876-9105; Farsetti, Antonella/0000-0002-8603-7925; PORRU, MANUELA/0000-0002-6614-9110; Porru, Manuela/0000-0002-6614-9110; Leonetti, Carlo/0000-0002-3526-7827; Aiello, Aurora/0000-0002-8303-1528	Italian Association for Cancer Research (AIRC); L'Oreal-Italia-UNESCO for Women in Science; Italian Foundation for Cancer Research (FIRC)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); L'Oreal-Italia-UNESCO for Women in Science; Italian Foundation for Cancer Research (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Italian Association for Cancer Research (AIRC) to GD, AF, and CL; LN is a recipient of a Fellowship from L'Oreal-Italia-UNESCO for Women in Science; RP is a recipient of a Fellowship from the Italian Foundation for Cancer Research (FIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyriou AA, 2009, ONCOLOGY-BASEL, V77, P1, DOI 10.1159/000218165; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Choi SM, 2006, J BIOL CHEM, V281, P34056, DOI 10.1074/jbc.M603913200; Di Stefana V, 2005, FEBS LETT, V579, P5473, DOI 10.1016/j.febslet.2005.09.008; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Grasselli A, 2008, CIRC RES, V103, P34, DOI 10.1161/CIRCRESAHA.107.169037; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KONDO K, 2002, CANCER CELL, V1, P337; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Li LM, 2005, CANCER RES, V65, P7249, DOI 10.1158/0008-5472.CAN-04-4426; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mazure NM, 1996, CANCER RES, V56, P3436; McCarty MF, 2010, MED HYPOTHESES, V74, P789, DOI 10.1016/j.mehy.2009.12.022; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Nanni S, 2002, J CLIN INVEST, V110, P219, DOI 10.1172/JCI200215552; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Nardinocchi L, 2010, CELL CYCLE, V9, P1270, DOI 10.4161/cc.9.7.11125; Nardinocchi L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006819; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Nardinocchi L, 2009, BBA-MOL CELL RES, V1793, P368, DOI 10.1016/j.bbamcr.2008.10.013; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Puca R, 2008, CANCER RES, V68, P3707, DOI 10.1158/0008-5472.CAN-07-6776; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sun X, 2001, GENE THER, V8, P638, DOI 10.1038/sj.gt.3301388; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhong XS, 2007, BIOCHEM BIOPH RES CO, V358, P92, DOI 10.1016/j.bbrc.2007.04.083	43	62	67	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15048	10.1371/journal.pone.0015048	http://dx.doi.org/10.1371/journal.pone.0015048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179202	Green Published, gold, Green Submitted			2022-12-25	WOS:000285246900026
J	Britt, RL; Chitteni-Pattu, S; Page, AN; Cox, MM				Britt, Rachel L.; Chitteni-Pattu, Sindhu; Page, Asher N.; Cox, Michael M.			RecA K72R Filament Formation Defects Reveal an Oligomeric RecA Species Involved in Filament Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DEPENDENT ATPASE ACTIVITY; ESCHERICHIA-COLI UVRB; DUPLEX DNA; NUCLEOSIDE TRIPHOSPHATE; STABLE COMPLEXES; IN-VIVO; PROTEIN; BINDING; HYDROLYSIS	Using an ensemble approach, we demonstrate that an oligomeric RecA species is required for the extension phase of RecA filament formation. The RecA K72R mutant protein can bind but not hydrolyze ATP or dATP. When mixed with other RecA variants, RecA K72R causes a drop in the rate of ATP hydrolysis and has been used to study disassembly of hydrolysis-proficient RecA protein filaments. RecA K72R filaments do not form in the presence of ATP but do so when dATP is provided. We demonstrate that in the presence of ATP, RecA K72R is defective for extension of RecA filaments on DNA. This defect is partially rescued when the mutant protein is mixed with sufficient levels of wild type RecA protein. Functional extension complexes form most readily when wild type RecA is in excess of RecA K72R. Thus, RecA K72R inhibits hydrolysis-proficient RecA proteins by interacting with them in solution and preventing the extension phase of filament assembly.	[Britt, Rachel L.; Chitteni-Pattu, Sindhu; Page, Asher N.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@biochem.wisc.edu			National Institutes of Health [GM32335]; William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335, U01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32335.; Supported in part by the William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship.	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bindslev N., 2008, DRUG ACCEPTOR INTERA; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Bork JM, 2001, J BIOL CHEM, V276, P45740, DOI 10.1074/jbc.M109247200; Brendel V, 1997, J MOL EVOL, V44, P528, DOI 10.1007/PL00006177; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Britt RL, 2010, J BIOL CHEM, V285, P3211, DOI 10.1074/jbc.M109.028951; Campbell MJ, 1999, J MOL BIOL, V286, P437, DOI 10.1006/jmbi.1998.2457; Campbell MJ, 1999, J MOL BIOL, V286, P417, DOI 10.1006/jmbi.1998.2456; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox JM, 2006, J BIOL CHEM, V281, P12968, DOI 10.1074/jbc.M513736200; Cox JM, 2005, PLOS BIOL, V3, P231, DOI 10.1371/journal.pbio.0030052; Cox Michael M., 2005, P369; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; COX MM, 1982, J BIOL CHEM, V257, P8523; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; DOMBROSKI AJ, 1988, J BIOL CHEM, V263, P18802; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; EGELMAN EH, 1986, J MOL BIOL, V191, P677, DOI 10.1016/0022-2836(86)90453-5; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gruenig MC, 2008, MOL MICROBIOL, V69, P1165, DOI 10.1111/j.1365-2958.2008.06341.x; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; HEUSER J, 1989, J MOL BIOL, V210, P473, DOI 10.1016/0022-2836(89)90124-1; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V84, P3127, DOI 10.1073/pnas.84.10.3127; LAVERY PE, 1992, J BIOL CHEM, V267, P20648; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MENETSKI JP, 1989, BIOCHEMISTRY-US, V28, P5871, DOI 10.1021/bi00440a025; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MENETSKI JP, 1987, J BIOL CHEM, V262, P2093; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; MYLES GM, 1991, BIOCHEMISTRY-US, V30, P3824, DOI 10.1021/bi00230a004; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; PUGH BF, 1987, J BIOL CHEM, V262, P1326; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Renzette N, 2008, MOL MICROBIOL, V67, P1347, DOI 10.1111/j.1365-2958.2008.06130.x; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SEELEY TW, 1990, J BIOL CHEM, V265, P7158; SEELEY TW, 1989, P NATL ACAD SCI USA, V86, P6577, DOI 10.1073/pnas.86.17.6577; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1997, J BIOL CHEM, V272, P11063; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shan Q, 1996, J MOL BIOL, V257, P756, DOI 10.1006/jmbi.1996.0200; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; TAKAHASHI M, 1989, J BIOL CHEM, V264, P288; THRESHER RJ, 1988, J MOL BIOL, V201, P101, DOI 10.1016/0022-2836(88)90442-1; van Loenhout MTJ, 2009, NUCLEIC ACIDS RES, V37, P4089, DOI 10.1093/nar/gkp326; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WITKIN EM, 1982, MOL GEN GENET, V185, P43, DOI 10.1007/BF00333788	65	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7830	7840		10.1074/jbc.M110.194407	http://dx.doi.org/10.1074/jbc.M110.194407			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193798	Green Published, hybrid			2022-12-25	WOS:000288013300014
J	Jrad-Lamine, A; Henry-Berger, J; Gourbeyre, P; Damon-Soubeyrand, C; Lenoir, A; Combaret, L; Saez, F; Kocer, A; Tone, S; Fuchs, D; Zhu, WT; Oefner, PJ; Munn, DH; Mellor, AL; Gharbi, N; Cadet, R; Aitken, RJ; Drevet, JR				Jrad-Lamine, Aicha; Henry-Berger, Joelle; Gourbeyre, Pascal; Damon-Soubeyrand, Christelle; Lenoir, Alain; Combaret, Lydie; Saez, Fabrice; Kocer, Ayhan; Tone, Shigenobu; Fuchs, Dietmar; Zhu, Wentao; Oefner, Peter J.; Munn, David H.; Mellor, Andrew L.; Gharbi, Najoua; Cadet, Remi; Aitken, R. John; Drevet, Joel R.			Deficient Tryptophan Catabolism along the Kynurenine Pathway Reveals That the Epididymis Is in a Unique Tolerogenic State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; DENDRITIC CELLS; DEPENDENT PROTEOLYSIS; UBIQUITIN-PROTEASOME; EXPRESSION; INHIBITION; IDO; DEGRADATION; SUPPRESSION; TOLERANCE	Indoleamine 2,3-dioxygenase (IDO) is the first and rate-limiting enzyme of tryptophan catabolism through the kynurenine pathway. Intriguingly, IDO is constitutively and highly expressed in the mammalian epididymis in contrast to most other tissues where IDO is induced by proinflammatory cytokines, such as interferons. To gain insight into the role of IDO in the physiology of the mammalian epididymis, we studied both wild type and Ido1(-/-)-deficient mice. In the caput epididymis of Ido1(-/-) animals, the lack of IDO activity was not compensated by other tryptophan-catabolizing enzymes and led to the loss of kynurenine production. The absence of IDO generated an inflammatory state in the caput epididymis as revealed by an increased accumulation of various inflammation markers. The absence of IDO also increased the tryptophan content of the caput epididymis and generated a parallel increase in caput epididymal protein content as a consequence of deficient proteasomal activity. Surprisingly, the lack of IDO expression had no noticeable impact on overall male fertility but did induce highly significant increases in both the number and the percentage of abnormal spermatozoa. These changes coincided with a significant decrease in white blood cell count in epididymal fluid compared with wild type mice. These data provide support for IDO playing a hitherto unsuspected role in sperm quality control in the epididymis involving the ubiquitination of defective spermatozoa and their subsequent removal.	[Jrad-Lamine, Aicha; Henry-Berger, Joelle; Damon-Soubeyrand, Christelle; Lenoir, Alain; Saez, Fabrice; Kocer, Ayhan; Cadet, Remi; Drevet, Joel R.] Clermont Univ, CNRS UMR 6247, INSERM U931, GReD, F-63171 Aubiere, France; [Gourbeyre, Pascal] INRA, Biopolymeres Interact Assemblages, F-44316 Nantes, France; [Combaret, Lydie] Univ Clermont Ferrand 2, Unite Nutr Humaine, F-63000 Clermont Ferrand, France; [Combaret, Lydie] CRNH Auvergne, UNH, UMR 1019, Inst Natl Rech Agron, F-63000 Clermont Ferrand, France; [Tone, Shigenobu] Kawasaki Med Sch, Dept Biochem, Okayama 7010192, Japan; [Fuchs, Dietmar] Innsbruck Med Univ, Bioctr, Div Biol Chem, A-6020 Innsbruck, Austria; [Zhu, Wentao; Oefner, Peter J.] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Munn, David H.; Mellor, Andrew L.] Med Coll Georgia, Immunotherapy Ctr, Augusta, GA 30912 USA; [Munn, David H.] Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; [Mellor, Andrew L.] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Gharbi, Najoua] Univ Tunis El Manar, Dept Biol, Fac Sci Tunis, Tunis 1060, Tunisia; [Aitken, R. John] Univ Newcastle, Sch Environm & Life Sci, Australian Res Council Ctr Excellence Biotechnol, Callaghan, NSW 2308, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Universite Clermont Auvergne (UCA); INRAE; Kawasaki Medical School; Medical University of Innsbruck; University of Regensburg; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); University of Newcastle	Drevet, JR (corresponding author), Clermont Univ, CNRS UMR 6247, INSERM U931, GReD, 24 Ave Landais,BP 80026, F-63171 Aubiere, France.	joel.drevet@univ-bpclermont.fr	Fuchs, Dietmar/AAL-8011-2021; Aitken, Robert John/AAY-8238-2020; Kocer, Ayhan/N-7927-2014; Zhu, Wentao/O-8964-2019; Drevet, Joël/W-2692-2019; Tone, Shigenobu/L-2694-2019	Fuchs, Dietmar/0000-0003-1627-9563; Aitken, Robert John/0000-0002-9152-156X; Zhu, Wentao/0000-0001-6371-7998; Drevet, Joël/0000-0003-3077-6558; Combaret, Lydie/0000-0001-6550-8700; Munn, David/0000-0002-7711-2858	French Ministry of Higher Education; CNRS; INSERM; BayGene; Australian Research Council	French Ministry of Higher Education; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); BayGene; Australian Research Council(Australian Research Council)	This work was supported by grants from the French Ministry of Higher Education, CNRS, and INSERM (to J. R. D.). This work was also supported by grants from BayGene (to P. J. O.) and the Australian Research Council (to R. J. A.).	Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Axner E, 2006, THERIOGENOLOGY, V66, P14, DOI 10.1016/j.theriogenology.2006.03.022; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Baska KM, 2008, J CELL PHYSIOL, V215, P684, DOI 10.1002/jcp.21349; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Beutelspacher SC, 2006, AM J TRANSPLANT, V6, P1320, DOI 10.1111/j.1600-6143.2006.01324.x; Britan A, 2006, CELL TISSUE RES, V324, P301, DOI 10.1007/s00441-005-0151-7; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Combaret L, 2005, J PHYSIOL-LONDON, V569, P489, DOI 10.1113/jphysiol.2005.098004; Deretic V, 2006, CURR OPIN IMMUNOL, V18, P375, DOI 10.1016/j.coi.2006.05.019; Dominguez K, 2009, SYST BIOL REPROD MED, V55, P193, DOI 10.3109/19396360903234052; Dufaure JP, 1996, CR ACAD SCI III-VIE, V319, P559; Favre D., 2010, TRANSL MED, V32, P32; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Hamel FG, 2003, METABOLISM, V52, P810, DOI 10.1016/S0026-0495(03)00094-5; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Itoh M, 2005, J REPROD IMMUNOL, V67, P57, DOI 10.1016/j.jri.2005.06.007; Jalili RB, 2007, IRAN J ALLERGY ASTHM, V6, P167; Jenny M, 2009, J NEUROIMMUNOL, V207, P75, DOI 10.1016/j.jneuroim.2008.12.004; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Jones R, 2004, BIOL REPROD, V71, P1405, DOI 10.1095/biolreprod.104.031252; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; King NJC, 2007, INT J BIOCHEM CELL B, V39, P2167, DOI 10.1016/j.biocel.2007.01.004; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; LEFRANCOIS AM, 1993, INT J ANDROL, V16, P147, DOI 10.1111/j.1365-2605.1993.tb01168.x; Levine SJ, 2005, AM J PHYSIOL-LUNG C, V289, pL233, DOI 10.1152/ajplung.00469.2004; Liu XQ, 2009, CHINESE MED J-PEKING, V122, P3072, DOI 10.3760/cma.j.issn.0366-6999.2009.24.030; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Rajapurohitam V, 2002, AM J PHYSIOL-ENDOC M, V282, pE739, DOI 10.1152/ajpendo.00511.2001; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; Takikawa O, 1999, ADV EXP MED BIOL, V467, P553; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Vazeille E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1181, DOI 10.1152/ajpendo.90532.2008; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Xu H, 2008, IMMUNOL LETT, V121, P1, DOI 10.1016/j.imlet.2008.08.008; YOSHIDA R, 1980, ARCH BIOCHEM BIOPHYS, V203, P343, DOI 10.1016/0003-9861(80)90185-X; Zhu BT, 2010, INT J MOL MED, V25, P831, DOI 10.3892/ijmm_00000411	48	42	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8030	8042		10.1074/jbc.M110.172114	http://dx.doi.org/10.1074/jbc.M110.172114			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21189261	hybrid, Green Published			2022-12-25	WOS:000288013300034
J	Kouchi, Z; Igarashi, T; Shibayama, N; Inanobe, S; Sakurai, K; Yamaguchi, H; Fukuda, T; Yanagi, S; Nakamura, Y; Fukami, K				Kouchi, Zen; Igarashi, Takahiro; Shibayama, Nami; Inanobe, Shunichi; Sakurai, Kazuyuki; Yamaguchi, Hideki; Fukuda, Toshifumi; Yanagi, Shigeru; Nakamura, Yoshikazu; Fukami, Kiyoko			Phospholipase C delta 3 Regulates RhoA/Rho Kinase Signaling and Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL NEURONAL MIGRATION; CEREBELLAR GRANULE CELLS; RHO-ASSOCIATED KINASE; ACROSOME REACTION; C-DELTA; POLARITY; PROTEIN; UBIQUITINATION; ESTABLISHMENT; REQUIREMENT	Phospholipase C delta 3 (PLC delta 3) is a key enzyme regulating phosphoinositide metabolism; however, its physiological function remains unknown. Because PLC delta 3 is highly enriched in the cerebellum and cerebral cortex, we examined the role of PLC delta 3 in neuronal migration and outgrowth. PLC delta 3 knockdown (KD) inhibits neurite formation of cerebellar granule cells, and application of PLC delta 3KD using in utero electroporation in the developing brain results in the retardation of the radial migration of neurons in the cerebral cortex. In addition, PLC delta 3KD inhibits axon and dendrite outgrowth in primary cortical neurons. PLC delta 3KD also suppresses neurite formation of Neuro2a neuroblastoma cells induced by serum withdrawal or treatment with retinoic acid. This inhibition is released by the reintroduction of wild-type PLC delta 3. Interestingly, the H393A mutant lacking phosphatidylinositol 4,5-bisphosphate hydrolyzing activity generates supernumerary protrusions, and a constitutively active mutant promotes extensive neurite outgrowth, indicating that PLC activity is important for normal neurite outgrowth. The introduction of dominant negative RhoA (RhoA-DN) or treatment with Y-27632, a Rho kinase-specific inhibitor, rescues the neurite extension in PLC delta 3KD Neuro2a cells. Similar effects were also detected in primary cortical neurons. Furthermore, the RhoA expression level was significantly decreased by serum withdrawal or retinoic acid in control cells, although this decrease was not observed in PLC delta 3KD cells. We also found that exogenous expression of PLC delta 3 down-regulated RhoA protein, and constitutively active PLC delta 3 promotes the RhoA down-regulation more significantly than PLC delta 3 upon differentiation. These results indicate that PLC delta 3 negatively regulates RhoA expression, inhibits RhoA/Rho kinase signaling, and thereby promotes neurite extension.	[Kouchi, Zen; Igarashi, Takahiro; Shibayama, Nami; Inanobe, Shunichi; Sakurai, Kazuyuki; Yamaguchi, Hideki; Nakamura, Yoshikazu; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Tokyo 1920392, Japan; [Yamaguchi, Hideki] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Fukuda, Toshifumi; Yanagi, Shigeru] Tokyo Univ Pharm & Life Sci, Lab Mol Biochem, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST); Tokyo University of Pharmacy & Life Sciences	Fukami, K (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, 1432-1 Horinouchi, Tokyo 1920392, Japan.	kfukami@ls.toyaku.ac.jp	Yanagi, Shigeru/AAU-9513-2020; Yamaguchi, Hideki/AAP-1767-2021	Yanagi, Shigeru/0000-0002-1392-8663; Yamaguchi, Hideki/0000-0003-2125-9655; Nakamura, Yoshikazu/0000-0001-8355-1091	Japan Ministry of Education, Culture, Sports, Science and Technology	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for young scientists (Category B to Z. K.) and for general scientific research (to K. F.) and a High-Tech Research Center Project for Private Universities matching the fund subsidy from the Japan Ministry of Education, Culture, Sports, Science and Technology.	Ahmed Z, 2009, MOL CELL NEUROSCI, V42, P128, DOI 10.1016/j.mcn.2009.06.005; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bryan B, 2005, FEBS LETT, V579, P1015, DOI 10.1016/j.febslet.2004.12.074; Choi JY, 2004, AM J PHYSIOL-CELL PH, V287, pC971, DOI 10.1152/ajpcell.00571.2003; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Fukami K, 2003, J CELL BIOL, V161, P79, DOI 10.1083/jcb.200210057; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Ichinohe M, 2007, BIOCHEM BIOPH RES CO, V356, P912, DOI 10.1016/j.bbrc.2007.03.082; Irino Y, 2004, BIOCHEM BIOPH RES CO, V320, P537, DOI 10.1016/j.bbrc.2004.05.206; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kouchi Z, 2005, J BIOL CHEM, V280, P21015, DOI 10.1074/jbc.M412123200; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Moon SY, 2003, J BIOL CHEM, V278, P4151, DOI 10.1074/jbc.M207789200; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; Nakamura Y, 2008, FASEB J, V22, P841, DOI 10.1096/fj.07-9239com; Nakanishi S, 2006, J PHYSIOL-LONDON, V575, P389, DOI 10.1113/jphysiol.2006.113340; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; Sato M, 2005, P NATL ACAD SCI USA, V102, P5874, DOI 10.1073/pnas.0501972102; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Xie Y, 2006, J BIOL CHEM, V281, P2605, DOI 10.1074/jbc.M512767200; Yagisawa H, 2006, BBA-MOL CELL BIOL L, V1761, P522, DOI 10.1016/j.bbalip.2006.02.016; Yamazaki M, 2002, J BIOL CHEM, V277, P17226, DOI 10.1074/jbc.M109795200; Zhang Z, 2006, CELL MOL BIOL LETT, V11, P12, DOI 10.2478/s11658-006-0002-x; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106	38	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8459	8471		10.1074/jbc.M110.171223	http://dx.doi.org/10.1074/jbc.M110.171223			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21187285	hybrid, Green Published			2022-12-25	WOS:000288013300074
J	Sharma, AK; Ye, LW; Baer, CE; Shanmugasundaram, K; Alber, T; Alper, SL; Rigby, AC				Sharma, Alok K.; Ye, Liwen; Baer, Christina E.; Shanmugasundaram, Kumaran; Alber, Tom; Alper, Seth L.; Rigby, Alan C.			Solution Structure of the Guanine Nucleotide-binding STAS Domain of SLC26-related SulP Protein Rv1739c from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; PUTATIVE SULFATE TRANSPORTER; ANION-EXCHANGER SLC26A6; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURES; MOTOR PROTEIN; IN-VIVO; NMR; MUTATIONS; SECRETION	The structure and intrinsic activities of conserved STAS domains of the ubiquitous SulP/SLC26 anion transporter superfamily have until recently remained unknown. Here we report the heteronuclear, multidimensional NMR spectroscopy solution structure of the STAS domain from the SulP/SLC26 putative anion transporter Rv1739c of Mycobacterium tuberculosis. The 0.87-angstrom root mean square deviation structure revealed a four-stranded beta-sheet with five interspersed alpha-helices, resembling the anti-sigma factor antagonist fold. Rv1739c STAS was shown to be a guanine nucleotide-binding protein, as revealed by nucleotide-dependent quench of intrinsic STAS fluorescence and photoaffinity labeling. NMR chemical shift perturbation analysis partnered with in silico docking calculations identified solvent-exposed STAS residues involved in nucleotide binding. Rv1739c STAS was not an in vitro substrate of mycobacterial kinases or anti-sigma factors. These results demonstrate that Rv1739c STAS binds guanine nucleotides at physiological concentrations and undergoes a ligand-induced conformational change but, unlike anti-sigma factor antagonists, may not mediate signals via phosphorylation.	[Sharma, Alok K.; Shanmugasundaram, Kumaran; Alper, Seth L.; Rigby, Alan C.] Beth Israel Deaconess Med Ctr, Div Mol & Vasc Med, Boston, MA 02215 USA; [Ye, Liwen; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Div Renal, Boston, MA 02215 USA; [Sharma, Alok K.; Ye, Liwen; Shanmugasundaram, Kumaran; Alper, Seth L.; Rigby, Alan C.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Sharma, Alok K.; Ye, Liwen; Shanmugasundaram, Kumaran; Alper, Seth L.; Rigby, Alan C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Baer, Christina E.; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of California System; University of California Berkeley	Alper, SL (corresponding author), 99 Brookline Ave,RN 380F, Boston, MA 02215 USA.	salper@bidmc.harvard.edu		Baer, Christina/0000-0002-8909-2583	National Institutes of Health [R01 DK43495, P30 DK34854, P01 AI68135]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK043495, R37DK043495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK43495 (to S. L. A.), P30 DK34854 (Harvard Digestive Diseases Center to S. L. A.), and P01 AI68135 (TB Structural Genomics Consortium to T. A.).	Alvarez BV, 2005, EMBO J, V24, P2499, DOI 10.1038/sj.emboj.7600736; Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Avila-Perez M, 2009, J BIOL CHEM, V284, P24958, DOI 10.1074/jbc.M109.033316; Babu M, 2010, STRUCTURE, V18, P1450, DOI 10.1016/j.str.2010.08.015; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bergbrede T, 2005, J STRUCT BIOL, V152, P235, DOI 10.1016/j.jsb.2005.10.001; Bergbrede T, 2009, J BIOL CHEM, V284, P2628, DOI 10.1074/jbc.M806003200; Buttani V, 2006, FEBS LETT, V580, P3818, DOI 10.1016/j.febslet.2006.06.007; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Clarkson J, 2003, BIOCHEM J, V372, P113, DOI 10.1042/BJ20021748; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dawson PA, 2010, J CLIN INVEST, V120, P706, DOI 10.1172/JCI31474; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Dorwart MR, 2008, J BIOL CHEM, V283, P8711, DOI 10.1074/jbc.M704328200; Etezady-Esfarjani T, 2006, MAGN RESON CHEM, V44, pS61, DOI 10.1002/mrc.1831; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hassan HA, 2007, AM J PHYSIOL-CELL PH, V292, pC1485, DOI 10.1152/ajpcell.00447.2006; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishiguro H, 2007, AM J PHYSIOL-GASTR L, V292, pG447, DOI 10.1152/ajpgi.00286.2006; Jiang ZR, 2006, NAT GENET, V38, P474, DOI 10.1038/ng1762; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kovacs H, 1998, P NATL ACAD SCI USA, V95, P5067, DOI 10.1073/pnas.95.9.5067; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Kuo S, 2008, J BACTERIOL, V190, P6625, DOI 10.1128/JB.00799-08; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Najafi SMA, 1996, J BACTERIOL, V178, P6632, DOI 10.1128/jb.178.22.6632-6634.1996; Niederweis M, 2008, MICROBIOL-SGM, V154, P679, DOI 10.1099/mic.0.2007/012872-0; Pasqualetto E, 2010, J MOL BIOL, V400, P448, DOI 10.1016/j.jmb.2010.05.013; Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101; Quin M, 2008, ACTA CRYSTALLOGR F, V64, P196, DOI 10.1107/S1744309108003849; RAO A, 1979, BIOCHEMISTRY-US, V18, P4505, DOI 10.1021/bi00588a008; Riordan JT, 2010, MICROBIOL-SGM, V156, P719, DOI 10.1099/mic.0.032631-0; Seavers PR, 2001, STRUCTURE, V9, P605, DOI 10.1016/S0969-2126(01)00623-2; Serrano P, 2010, ACTA CRYSTALLOGR F, V66, P1393, DOI 10.1107/S1744309110033658; Sharma AK, 2009, BIOMOL NMR ASSIGN, V3, P99, DOI 10.1007/s12104-009-9150-z; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Shelden MC, 2010, MOL MEMBR BIOL, V27, P11, DOI 10.3109/09687680903400120; Sherman T, 2005, AM J PHYSIOL-CELL PH, V289, pC341, DOI 10.1152/ajpcell.00071.2005; Shibagaki N, 2010, J BIOL CHEM, V285, P25094, DOI 10.1074/jbc.M110.126888; Tang YF, 2010, PHOTOCH PHOTOBIO SCI, V9, P47, DOI 10.1039/b9pp00075e; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Tuo BG, 2006, GASTROENTEROLOGY, V130, P349, DOI 10.1053/j.gastro.2005.10.017; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Wooff E, 2002, MOL MICROBIOL, V43, P653, DOI 10.1046/j.1365-2958.2002.02771.x; Xu J, 2009, J BIOL CHEM, V284, P29470, DOI 10.1074/jbc.M109.044396; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105; Zolotarev AS, 2008, COMP BIOCHEM PHYS A, V149, P255, DOI 10.1016/j.cbpa.2007.12.005	62	32	32	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8534	8544		10.1074/jbc.M110.165449	http://dx.doi.org/10.1074/jbc.M110.165449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21190940	Green Published, hybrid			2022-12-25	WOS:000288013300080
J	Dai, CS; Wen, XY; He, WC; Liu, YH				Dai, Chunsun; Wen, Xiaoyan; He, Weichun; Liu, Youhua			Inhibition of Proinflammatory RANTES Expression by TGF-beta 1 Is Mediated by Glycogen Synthase Kinase-3 beta-dependent beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GROWTH-FACTOR-BETA; CHEMOKINE RECEPTORS; RENAL INFLAMMATION; ACTIVATION; ALPHA; PROGRESSION; KINASE; FIBROBLASTS; INDUCTION	TGF-beta 1 is a pleiotropic cytokine with potent anti-inflammation property. However, the mechanisms underlying TGF-beta 1 suppression of inflammation remain largely unexplored. In this study, we demonstrated that TGF-beta 1 inhibited TNF-alpha-or IL-1-induced RANTES expression in human kidney tubular epithelial cells (HKC-8). To delineate the mechanism by which TGF-beta 1 inhibits RANTES expression, we examined the potential signal pathway activated by TGF-beta 1 in suppressing NF-kappa B signaling. TGF-beta 1 affected neither TNF-beta-induced I kappa B alpha phosphorylation and subsequent degradation, nor p65 NF-kappa B phosphorylation and its nuclear translocation. However, TGF-beta 1 could inhibit p65 and p50 binding to the kappa B site in human RANTES promoter as revealed by chromatin immunoprecipitation assay and protein-DNA binding assay. We found that TGF-beta 1 induced glycogen synthase kinase-3 beta (GSK-3 beta) phosphorylation on Ser-9 in HKC-8 cells, leading to its inactivation. Knockdown of GSK-3 beta mimicked TGF-beta 1 and inhibited RANTES induction, whereas overexpression of GSK-3 beta abolished the inhibitory effect of TGF-beta 1 and completely restored RANTES expression. Furthermore, TGF-beta 1 induced the dephosphorylation and activation of beta-catenin, a major downstream target of GSK-3 beta. Ectopic expression of constitutively active beta-catenin mimicked the TGF-beta 1 effect and completely suppressed RANTES expression induced by TNF-alpha. Interestingly, TGF-beta 1 induced a physical interaction between beta-catenin and p65 NF-kappa B, which prevented p65 binding to the kappa B site, sequestered its trans-activating activity, and repressed p65-mediated gene transcription. We conclude that TGF-beta 1 inhibition of proinflammatory RANTES expression is mediated by beta-catenin-triggered blockade of NF-kappa B signaling.	[Dai, Chunsun; Wen, Xiaoyan; He, Weichun; Liu, Youhua] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, YH (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, S-405 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	liuy@upmc.edu		Liu, Youhua/0000-0002-4740-805X	National Institutes of Health [DK061408, DK064005, DK071040]; American Heart Association [0865392D]; University of Pittsburgh Medical Center Health System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061408, R01DK064005, R01DK071040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Pittsburgh Medical Center Health System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061408, DK064005, and DK071040.; Supported by American Heart Association beginning Grant-in-aid 0865392D and the University of Pittsburgh Medical Center Health System Competitive Medical Research Fund.	Anders HJ, 2004, J AM SOC NEPHROL, V15, P1504, DOI 10.1097/01.ASN.0000130082.67775.60; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; BOIVIN GP, 1995, AM J PATHOL, V146, P276; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Cho ML, 2006, IMMUNOL LETT, V105, P159, DOI 10.1016/j.imlet.2006.02.003; Dai CS, 2006, J AM SOC NEPHROL, V17, P2164, DOI 10.1681/ASN.2006010033; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Du Q, 2009, CANCER RES, V69, P3764, DOI 10.1158/0008-5472.CAN-09-0014; Fan WQ, 2005, ENDOCRINOLOGY, V146, P85, DOI 10.1210/en.2004-1046; Ghafoori P, 2009, FASEB J, V23, P2226, DOI 10.1096/fj.08-124545; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Hao S, 2010, AM J PATHOL, V177, P1164, DOI 10.2353/ajpath.2010.091269; He WC, 2010, J BIOL CHEM, V285, P24665, DOI 10.1074/jbc.M109.091256; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ishinaga H, 2009, BIOCHEM J, V417, P583, DOI 10.1042/BJ20080781; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; KULKARNI AB, 1995, AM J PATHOL, V146, P264; Lan HY, 2008, FRONT BIOSCI-LANDMRK, V13, P4984, DOI 10.2741/3057; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu Y, 2010, STRUCT CHEM, V21, P21, DOI 10.1007/s11224-009-9519-8; Lu T, 2007, P NATL ACAD SCI USA, V104, P4365, DOI 10.1073/pnas.0700118104; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; PEREZ DL, 2001, J AM SOC NEPHROL, V12, P1369; Rangan G, 2009, FRONT BIOSCI-LANDMRK, V14, P3496, DOI 10.2741/3467; Ruster C, 2008, FRONT BIOSCI-LANDMRK, V13, P944, DOI 10.2741/2734; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tan RY, 2007, J AM SOC NEPHROL, V18, P2340, DOI 10.1681/ASN.2007010128; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Vielhauer Volker, 2009, Front Biosci (Schol Ed), V1, P1; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Xiao YQ, 2006, J IMMUNOL, V176, P1209, DOI 10.4049/jimmunol.176.2.1209; Yang JW, 2003, AM J PATHOL, V163, P621, DOI 10.1016/S0002-9440(10)63689-9; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3	40	25	26	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7052	7059		10.1074/jbc.M110.174821	http://dx.doi.org/10.1074/jbc.M110.174821			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189258	Green Published, hybrid			2022-12-25	WOS:000287737300022
J	Danielson, SR; Held, JM; Oo, M; Riley, R; Gibson, BW; Andersen, JK				Danielson, Steven R.; Held, Jason M.; Oo, May; Riley, Rebeccah; Gibson, Bradford W.; Andersen, Julie K.			Quantitative Mapping of Reversible Mitochondrial Complex I Cysteine Oxidation in a Parkinson Disease Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE DEPLETION; MASS-SPECTROMETRY; DIFFERENTIAL ALKYLATION; HEART-MITOCHONDRIA; INHIBITION; PROTEINS; ASSAYS; IDENTIFICATION; DEHYDROGENASE; NITROSATION	Differential cysteine oxidation within mitochondrial Complex I has been quantified in an in vivo oxidative stress model of Parkinson disease. We developed a strategy that incorporates rapid and efficient immunoaffinity purification of Complex I followed by differential alkylation and quantitative detection using sensitive mass spectrometry techniques. This method allowed us to quantify the reversible cysteine oxidation status of 34 distinct cysteine residues out of a total 130 present in murine Complex I. Six Complex I cysteine residues were found to display an increase in oxidation relative to controls in brains from mice undergoing in vivo glutathione depletion. Three of these residues were found to reside within iron-sulfur clusters of Complex I, suggesting that their redox state may affect electron transport function.	[Danielson, Steven R.; Held, Jason M.; Oo, May; Riley, Rebeccah; Gibson, Bradford W.; Andersen, Julie K.] Buck Inst Age Res, Novato, CA 94945 USA	Buck Institute for Research on Aging	Gibson, BW (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.	bgibson@buckinstitute.org; jandersen@buckinstitute.org		Andersen, Julie/0000-0003-1324-4875; Held, Jason/0000-0001-8024-2736	National Institutes of Health [P01AG025901, PL1AG032118, S10RR024615, S10RR0021222]; W. M. Keck Foundation; NATIONAL CANCER INSTITUTE [R21CA138308] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024615, S10RR021222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025901, PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AG025901(to J. K. A.), PL1AG032118(to B. W. G.), S10RR024615(to B. W. G.), and S10RR0021222 (to B. W. G.). This work was also supported by a grant from the W. M. Keck Foundation (to J. K. A. and B. W. G.).	Andersen JK, 1996, J NEUROCHEM, V67, P2164; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002; Chinta SJ, 2006, FREE RADICAL BIO MED, V40, P1557, DOI 10.1016/j.freeradbiomed.2005.12.023; Danielson SR, 2009, ANAL CHEM, V81, P7823, DOI 10.1021/ac901176t; Di Simplicio P, 2003, AMINO ACIDS, V25, P323, DOI 10.1007/s00726-003-0020-1; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; HEIKKILA RE, 1985, NEUROSCI LETT, V62, P389, DOI 10.1016/0304-3940(85)90580-4; Held JM, 2010, MOL CELL PROTEOMICS, V9, P1400, DOI 10.1074/mcp.M900643-MCP200; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hsu M, 2005, J NEUROCHEM, V92, P1091, DOI 10.1111/j.1471-4159.2004.02929.x; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; JENNER P, 1993, ACTA NEUROL SCAND, V87, P6; Jha N, 2000, J BIOL CHEM, V275, P26096, DOI 10.1074/jbc.M000120200; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Ladha JS, 2005, CELL DEATH DIFFER, V12, P1417, DOI 10.1038/sj.cdd.4401668; Lee MS, 1999, MASS SPECTROM REV, V18, P187, DOI 10.1002/(SICI)1098-2787(1999)18:3/4<187::AID-MAS2>3.0.CO;2-K; Nadanaciva S, 2007, TOXICOL APPL PHARM, V223, P277, DOI 10.1016/j.taap.2007.06.003; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Perdivara I, 2010, J AM SOC MASS SPECTR, V21, P1114, DOI 10.1016/j.jasms.2010.02.016; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PERRY TL, 1986, NEUROSCI LETT, V67, P269, DOI 10.1016/0304-3940(86)90320-4; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schilling B, 2006, BBA-MOL BASIS DIS, V1762, P213, DOI 10.1016/j.bbadis.2005.07.003; Schilling B, 2005, MOL CELL PROTEOMICS, V4, P84, DOI 10.1074/mcp.M400143-MCP200; Schilling B, 2004, INT J MASS SPECTROM, V236, P117, DOI 10.1016/j.ijms.2004.06.004; Sethuraman M, 2004, J PROTEOME RES, V3, P1228, DOI 10.1021/pr049887e; Taylor FR, 2006, ANAL BIOCHEM, V353, P204, DOI 10.1016/j.ab.2006.02.022; Tiller R, 1997, J CHROMATOGR A, V771, P119, DOI 10.1016/S0021-9673(97)00147-7; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009	37	46	47	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7601	7608		10.1074/jbc.M110.190108	http://dx.doi.org/10.1074/jbc.M110.190108			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21196577	Green Published, hybrid			2022-12-25	WOS:000287737300073
J	Kurita, T; Noda, Y; Takagi, T; Osumi, M; Yoda, K				Kurita, Tomokazu; Noda, Yoichi; Takagi, Tomoko; Osumi, Masako; Yoda, Koji			Kre6 Protein Essential for Yeast Cell Wall beta-1,6-Glucan Synthesis Accumulates at Sites of Polarized Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL ER INHERITANCE; BETA-GLUCAN SYNTHESIS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; SCHIZOSACCHAROMYCES-POMBE; ACTIN CYTOSKELETON; ELECTRON-MICROSCOPY; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; IN-VITRO	Saccharomyces cerevisiae Kre6 is a type II membrane protein with amino acid sequence homology with glycoside hydrolase and is essential for beta-1,6-glucan synthesis as revealed by the mutant phenotype, but its biochemical function is still unknown. The localization of Kre6, determined by epitope tagging, is a matter of debate. We raised anti-Kre6 rabbit antiserum and examined the localization of Kre6 and its tagged protein by immunofluorescence microscopy, subcellular fractionation in sucrose density gradients, and immunoelectron microscopy. Integration of the results indicates that the majority of Kre6 is in the endoplasmic reticulum; however, a small but significant portion is also present in the secretory vesicle-like compartments and plasma membrane. Kre6 in the latter compartments is observed as strong signals that accumulate at the sites of polarized growth by immunofluorescence. The truncated Kre6 without the N-terminal 230-amino acid cytoplasmic region did not show this polarized accumulation and had a severe defect in beta-1,6-glucan synthesis. This is the first evidence of a beta-1,6-glucan-related protein showing the polarized membrane localization that correlates with its biological function.	[Kurita, Tomokazu; Noda, Yoichi; Yoda, Koji] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Takagi, Tomoko; Osumi, Masako] Japan Womens Univ, Lab Electron Microscopy, Bio Imaging Ctr, Bunkyo Ku, Tokyo 1128681, Japan; [Osumi, Masako] Integrated Imaging Res Support, Chiyoda Ku, Tokyo 1020093, Japan	University of Tokyo; Japan Womens University	Yoda, K (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asdfg@mail.ecc.u-tokyo.ac.jp	Kurita, Tomokazu/E-6346-2012		Japan Society for the Promotion of Science; Noda Institute of Scientific Research; Grants-in-Aid for Scientific Research [21380058] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Noda Institute of Scientific Research(Noda Institute for Scientific Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (to Y.N. and K.Y.) and a grant from the Noda Institute of Scientific Research (to Y.N.).	Aimanianda V, 2009, J BIOL CHEM, V284, P13401, DOI 10.1074/jbc.M807667200; AMBERG DC, 2005, METHODS YEAST GENETI, P165; Arai S, 2008, CURR BIOL, V18, P987, DOI 10.1016/j.cub.2008.06.028; Ayscough KR, 1999, MOL BIOL CELL, V10, P1061, DOI 10.1091/mbc.10.4.1061; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; Epping EA, 2002, J BIOL CHEM, V277, P34860, DOI 10.1074/jbc.M202987200; Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030; Fehrenbacher KL, 2002, MOL BIOL CELL, V13, P854, DOI 10.1091/mbc.01-04-0184; Fujimoto K, 1997, HISTOCHEM CELL BIOL, V107, P87, DOI 10.1007/s004180050092; Gurunathan S, 2000, MOL BIOL CELL, V11, P3629, DOI 10.1091/mbc.11.10.3629; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Imai K, 2005, J BIOL CHEM, V280, P8275, DOI 10.1074/jbc.M409428200; Konomi M, 2003, YEAST, V20, P427, DOI 10.1002/yea.974; KONOMI M, 2000, PLANT MORPHOL, V12, P20; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levinson JN, 2002, YEAST, V19, P1243, DOI 10.1002/yea.908; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Li HJ, 2002, YEAST, V19, P1097, DOI 10.1002/yea.904; Montijn RC, 1999, J BACTERIOL, V181, P7414, DOI 10.1128/JB.181.24.7414-7420.1999; Nakamata K, 2007, J BIOL CHEM, V282, P34315, DOI 10.1074/jbc.M706486200; Page N, 2003, GENETICS, V163, P875; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; ROEMER T, 1994, J CELL BIOL, V127, P567, DOI 10.1083/jcb.127.2.567; ROEMER T, 1993, MOL CELL BIOL, V13, P4039, DOI 10.1128/MCB.13.7.4039; ROEMER T, 1991, P NATL ACAD SCI USA, V88, P11295, DOI 10.1073/pnas.88.24.11295; Sato K, 2007, MOL BIOL CELL, V18, P3472, DOI 10.1091/mbc.E07-03-0258; Sato K, 2009, MOL BIOL CELL, V20, P4444, DOI 10.1091/mbc.E09-03-0235; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Takagi T, 2003, J ELECTRON MICROSC, V52, P161, DOI 10.1093/jmicro/52.2.161; Takeuchi M, 2008, MOL BIOL CELL, V19, P3514, DOI 10.1091/mbc.E07-12-1289; Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; Vink E, 2004, YEAST, V21, P1121, DOI 10.1002/yea.1156	35	21	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7429	7438		10.1074/jbc.M110.174060	http://dx.doi.org/10.1074/jbc.M110.174060			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193403	Green Published, hybrid			2022-12-25	WOS:000287737300058
J	Head, BP; Peart, JN; Panneerselvam, M; Yokoyama, T; Pearn, ML; Niesman, IR; Bonds, JA; Schilling, JM; Miyanohara, A; Headrick, J; Ali, SS; Roth, DM; Patel, PM; Patel, HH				Head, Brian P.; Peart, Jason N.; Panneerselvam, Mathivadhani; Yokoyama, Takaakira; Pearn, Matthew L.; Niesman, Ingrid R.; Bonds, Jacqueline A.; Schilling, Jan M.; Miyanohara, Atsushi; Headrick, John; Ali, Sameh S.; Roth, David M.; Patel, Piyush M.; Patel, Hemal H.			Loss of Caveolin-1 Accelerates Neurodegeneration and Aging	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; RICH MEMBRANE DOMAINS; AGE-RELATED-CHANGES; SPINAL-CORD-INJURY; ALZHEIMERS-DISEASE; LIPID RAFTS; RAT-BRAIN; ISCHEMIC TOLERANCE; NEUROBLASTOMA-CELLS; NEUROTROPHIC FACTOR	Background: The aged brain exhibits a loss in gray matter and a decrease in spines and synaptic densities that may represent a sequela for neurodegenerative diseases such as Alzheimer's. Membrane/lipid rafts (MLR), discrete regions of the plasmalemma enriched in cholesterol, glycosphingolipids, and sphingomyelin, are essential for the development and stabilization of synapses. Caveolin-1 (Cav-1), a cholesterol binding protein organizes synaptic signaling components within MLR. It is unknown whether loss of synapses is dependent on an age-related loss of Cav-1 expression and whether this has implications for neurodegenerative diseases such as Alzheimer's disease. Methodology/Principal Findings: We analyzed brains from young (Yg, 3-6 months), middle age (Md, 12 months), aged (Ag, >18 months), and young Cav-1 KO mice and show that localization of PSD-95, NR2A, NR2B, TrkBR, AMPAR, and Cav-1 to MLR is decreased in aged hippocampi. Young Cav-1 KO mice showed signs of premature neuronal aging and degeneration. Hippocampi synaptosomes from Cav-1 KO mice showed reduced PSD-95, NR2A, NR2B, and Cav-1, an inability to be protected against cerebral ischemia-reperfusion injury compared to young WT mice, increased Ab, P-Tau, and astrogliosis, decreased cerebrovascular volume compared to young WT mice. As with aged hippocampi, Cav-1 KO brains showed significantly reduced synapses. Neuron-targeted re-expression of Cav-1 in Cav-1 KO neurons in vitro decreased Ab expression. Conclusions: Therefore, Cav-1 represents a novel control point for healthy neuronal aging and loss of Cav-1 represents a non-mutational model for Alzheimer's disease.	[Head, Brian P.; Panneerselvam, Mathivadhani; Yokoyama, Takaakira; Pearn, Matthew L.; Niesman, Ingrid R.; Bonds, Jacqueline A.; Schilling, Jan M.; Roth, David M.; Patel, Piyush M.; Patel, Hemal H.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Head, Brian P.; Schilling, Jan M.; Roth, David M.; Patel, Piyush M.; Patel, Hemal H.] VA San Diego Healthcare Syst, San Diego, CA USA; [Ali, Sameh S.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Peart, Jason N.; Headrick, John] Griffith Univ, Heart Fdn Res Ctr, Gold Coast, Qld, Australia; [Miyanohara, Atsushi] Univ Calif San Diego, Gene Therapy Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Griffith University; University of California System; University of California San Diego	Head, BP (corresponding author), Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA.	bhead@ucsd.edu	Patel, Hemal/C-7325-2019	Patel, Hemal/0000-0001-6722-9625; Ali, Sameh Saad/0000-0002-0339-6106; Niesman, Ingrid/0000-0001-9767-6629	Veteran Affairs; National Institutes of Health, Bethesda, MD, U.S.A.; National Institute on Aging Affairs [K25 AG026379]; UCSD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG026379] Funding Source: NIH RePORTER	Veteran Affairs; National Institutes of Health, Bethesda, MD, U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging Affairs; UCSD; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by Veteran Affairs Career Development Award-2 (B.P. Head), National Institutes of Health, Bethesda, MD, U.S.A., UCSD Start-up funds (H. H. Patel), and National Institute on Aging K25 AG026379 Affairs (S.Ali). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Bourasset F, 2009, NEUROPHARMACOLOGY, V56, P808, DOI 10.1016/j.neuropharm.2009.01.006; Bouwman J, 2004, NEUROSCIENCE, V126, P115, DOI 10.1016/j.neuroscience.2004.03.027; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Cecchi C, 2008, J CELL MOL MED, V12, P1990, DOI 10.1111/j.1582-4934.2008.00216.x; Cerezo-Guisado MI, 2007, BIOCHEM J, V401, P175, DOI 10.1042/BJ20060731; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; Elder GA, 2010, BRAIN STRUCT FUNCT, V214, P127, DOI 10.1007/s00429-009-0227-3; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; FERRER I, 2009, J BIOENERG BIOMEMBR; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Gabbita SP, 1997, FREE RADICAL BIO MED, V23, P191, DOI 10.1016/S0891-5849(97)00043-9; Gabbita SP, 1998, BBA-BIOMEMBRANES, V1372, P163, DOI 10.1016/S0005-2736(98)00040-6; Gaudreault SB, 2005, J NEUROCHEM, V92, P831, DOI 10.1111/j.1471-4159.2004.02917.x; Gidday JM, 1999, J CEREBR BLOOD F MET, V19, P331, DOI 10.1097/00004647-199903000-00011; Gioiosa L, 2008, BEHAV BRAIN RES, V188, P255, DOI 10.1016/j.bbr.2007.11.002; GONZALES RA, 1991, NEUROBIOL AGING, V12, P219, DOI 10.1016/0197-4580(91)90100-X; GRIDER MH, 2009, J NEUROSCI RES; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Harris B, 2009, BRAIN RES, V1296, P203, DOI 10.1016/j.brainres.2009.07.105; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Hattori C, 2006, J NEUROSCI RES, V84, P912, DOI 10.1002/jnr.20981; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hering H, 2003, J NEUROSCI, V23, P3262; HEURTEAUX C, 1995, P NATL ACAD SCI USA, V92, P4666, DOI 10.1073/pnas.92.10.4666; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; KANNAN M, 2008, NEUROBIOL AGING; Kerr DS, 2002, NEUROPHARMACOLOGY, V43, P357, DOI 10.1016/S0028-3908(02)00088-6; Kumar B, 2002, J NEUROSCI RES, V68, P627, DOI 10.1002/jnr.10241; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Magnusson KR, 2002, MOL BRAIN RES, V99, P40, DOI 10.1016/S0169-328X(01)00344-8; MATEOS MV, 2009, BIOCH BIOPHYS ACTA; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Monti B, 2004, NEUROCHEM INT, V44, P579, DOI 10.1016/j.neuint.2003.10.007; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nishio S, 2000, J NEUROSURG, V93, P845, DOI 10.3171/jns.2000.93.5.0845; Norris CM, 1998, J NEUROSCI, V18, P3171; Park DS, 2003, BIOCHEMISTRY-US, V42, P15124, DOI 10.1021/bi0356348; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peri A, 2008, J MOL ENDOCRINOL, V41, P251, DOI 10.1677/JME-08-0071; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Rubino A, 2000, TRENDS PHARMACOL SCI, V21, P225, DOI 10.1016/S0165-6147(00)01483-8; Samhan-Arias AK, 2009, MOL CELL NEUROSCI, V40, P14, DOI 10.1016/j.mcn.2008.08.013; Schaller BJ, 2007, EXP NEUROL, V205, P9, DOI 10.1016/j.expneurol.2006.01.017; Shapira S, 2002, BRAIN RES, V925, P148, DOI 10.1016/S0006-8993(01)03270-X; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Stefani M, 2009, CURR ALZHEIMER RES, V6, P15, DOI 10.2174/156720509787313899; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; TAMARU M, 1991, BRAIN RES, V542, P83, DOI 10.1016/0006-8993(91)91001-H; Thibault O, 1998, CELL CALCIUM, V24, P417, DOI 10.1016/S0143-4160(98)90064-1; Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010; Trushina E, 2006, BEHAV BRAIN RES, V172, P24, DOI 10.1016/j.bbr.2006.04.024; VANMIERLO T, 2009, J ALZHEIMERS DIS; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com; ZHAO H, 2009, NEUROCHEM RES; Zhu MJ, 2008, FREE RADICAL BIO MED, V45, P1493, DOI 10.1016/j.freeradbiomed.2008.08.027	83	120	124	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15697	10.1371/journal.pone.0015697	http://dx.doi.org/10.1371/journal.pone.0015697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203469	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200030
J	Pelczar, H; Woisard, A; Lemaitre, JM; Chachou, M; Andeol, Y				Pelczar, Helene; Woisard, Anne; Lemaitre, Jean Marc; Chachou, Mohamed; Andeol, Yannick			Evidence for an RNA Polymerization Activity in Axolotl and Xenopus Egg Extracts	PLOS ONE			English	Article							HEPATITIS-DELTA-VIRUS; DNA-REPLICATION; GENE-EXPRESSION; POLYMERASE-II; AMPHIBIAN OOCYTES; MESSENGER-RNAS; EXOGENOUS RNA; GLOBIN RNA; MAJOR LATE; IN-VITRO	We have previously reported a post-transcriptional RNA amplification observed in vivo following injection of in vitro synthesized transcripts into axolotl oocytes, unfertilized (UFE) or fertilized eggs. To further characterize this phenomenon, low speed extracts (LSE) from axolotl and Xenopus UFE were prepared and tested in an RNA polymerization assay. The major conclusions are: i) the amphibian extracts catalyze the incorporation of radioactive ribonucleotide in RNase but not DNase sensitive products showing that these products correspond to RNA; ii) the phenomenon is resistant to alpha-amanitin, an inhibitor of RNA polymerases II and III and to cordycepin (3'dAMP), but sensitive to cordycepin 5'-triphosphate, an RNA elongation inhibitor, which supports the existence of an RNA polymerase activity different from polymerases II and III; the detection of radiolabelled RNA comigrating at the same length as the exogenous transcript added to the extracts allowed us to show that iii) the RNA polymerization is not a 3' end labelling and that iv) the radiolabelled RNA is single rather than double stranded. In vitro cell-free systems derived from amphibian UFE therefore validate our previous in vivo results hypothesizing the existence of an evolutionary conserved enzymatic activity with the properties of an RNA dependent RNA polymerase (RdRp).	[Pelczar, Helene; Chachou, Mohamed; Andeol, Yannick] Univ Paris 06, UMR 7622, Paris, France; [Pelczar, Helene; Chachou, Mohamed; Andeol, Yannick] CNRS, UMR 7622, Paris, France; [Woisard, Anne] Univ Paris 06, Equipe Photobiol Mol, Paris, France; [Lemaitre, Jean Marc] INSERM, Inst Genom Fonct, U661, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Pelczar, H (corresponding author), Univ Paris 06, UMR 7622, Paris, France.	yannick.andeol@snv.jussieu.fr	LEMAITRE, Jean-Marc/I-4989-2016	LEMAITRE, Jean-Marc/0000-0002-6492-5219	Association pour la Recherche sur le Cancer [ARC 3387]	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by a grant from the Association pour la Recherche sur le Cancer (ARC 3387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOUZNI G, 1990, EMBO J, V9, P573, DOI 10.1002/j.1460-2075.1990.tb08145.x; Andeol Y, 1998, DIFFERENTIATION, V63, P69, DOI 10.1046/j.1432-0436.1998.6320069.x; Audic Y, 1997, MOL CELL BIOL, V17, P209, DOI 10.1128/MCB.17.1.209; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BALLANTYNE S, 1995, RNA, V1, P64; BARTON DJ, 1995, J VIROL, V69, P5516, DOI 10.1128/JVI.69.9.5516-5527.1995; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; CHAMBON P, 1975, ANNU REV BIOCHEM, V44, P613, DOI 10.1146/annurev.bi.44.070175.003145; Chang JH, 2008, J VIROL, V82, P1118, DOI 10.1128/JVI.01758-07; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; EDMONDS M, 1960, J BIOL CHEM, V235, P1142; FESENFELD G, 1992, NATURE, V355, P219; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GURDON JB, 1983, USE XENOPUS OOCYTES, P370; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; HUTCHISON CJ, 1987, EMBO J, V6, P3002; KING MW, 1986, MOL CELL BIOL, V6, P4499, DOI 10.1128/MCB.6.12.4499; Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/JVI.79.13.7951-7958.2005; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; MATSUI T, 1987, MOL CELL BIOL, V7, P1401, DOI 10.1128/MCB.7.4.1401; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Menut S, 1999, ADV MOLEC BIOL, P196; Modahl LE, 2000, MOL CELL BIOL, V20, P6030, DOI 10.1128/MCB.20.16.6030-6039.2000; Montreau N, 2004, NUCLEIC ACIDS RES, V32, P2957, DOI 10.1093/nar/gkh620; Montreau N, 2003, CR BIOL, V326, P1135, DOI 10.1016/j.crvi.2003.10.002; Moraleda G, 2001, J VIROL, V75, P10161, DOI 10.1128/JVI.75.21.10161-10169.2001; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nakano H, 2000, BIOCHEM BIOPH RES CO, V274, P434, DOI 10.1006/bbrc.2000.3178; Nishikura K, 2001, CELL, V107, P415, DOI 10.1016/S0092-8674(01)00581-5; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pelczar H, 2007, DEV GROWTH DIFFER, V49, P407, DOI 10.1111/j.1440-169x.2007.00934.x; PRIOLEAU MN, 1994, CELL, V77, P439, DOI 10.1016/0092-8674(94)90158-9; Sambrook J, 1989, MOL CLONING LABORATO; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Slomovic S, 2006, NUCLEIC ACIDS RES, V34, P2966, DOI 10.1093/nar/gkl357; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stein P, 2003, RNA, V9, P187, DOI 10.1261/rna.2860603; Vaur S, 2004, DEV BIOL, V267, P265, DOI 10.1016/j.ydbio.2003.12.002; VOLLOCH V, 1987, J CELL BIOL, V105, P137, DOI 10.1083/jcb.105.1.137; Volloch V, 1996, P NATL ACAD SCI USA, V93, P2476, DOI 10.1073/pnas.93.6.2476; Walter SA, 2000, MOL BIOL CELL, V11, P887, DOI 10.1091/mbc.11.3.887; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; WOLFFE AP, 1987, CELL, V355, P733; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9	58	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14411	10.1371/journal.pone.0014411	http://dx.doi.org/10.1371/journal.pone.0014411			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203452	Green Published, gold, Green Submitted			2022-12-25	WOS:000285579200002
J	Roy, V; Ghani, K; Caruso, M				Roy, Vincent; Ghani, Karim; Caruso, Manuel			A Dominant-Negative Approach That Prevents Diphthamide Formation Confers Resistance to Pseudomonas Exotoxin A and Diphtheria Toxin	PLOS ONE			English	Article							ADP-RIBOSYLATING TOXINS; ELONGATION FACTOR-II; SACCHAROMYCES-CEREVISIAE; TRANSLATION ELONGATION-FACTOR-2; POSTTRANSLATIONAL MODIFICATION; CORYNEBACTERIUM-DIPHTHERIAE; AERUGINOSA INFECTION; HYDROLYSIS PRODUCTS; GENE-THERAPY; HUMAN-CELLS	Diphtheria toxin (DT), Pseudomonas aeruginosa Exotoxin A (ETA) and cholix toxin from Vibrio cholerae share the same mechanism of toxicity; these enzymes ADP-rybosylate elongation factor-2 (EF-2) on a modified histidine residue called diphthamide, leading to a block in protein synthesis. Mutant Chinese hamster ovary cells that are defective in the formation of diphthamide have no distinct phenotype except their resistance to DT and ETA. These observations led us to predict that a strategy that prevents the formation of diphthamide to confer DT and ETA resistance is likely to be safe. It is well documented that Dph1 and Dph2 are involved in the first biochemical step of diphthamide formation and that these two proteins interact with each other. We hypothesized that we could block diphthamide formation with a dominant negative mutant of either Dph1 or Dph2. We report in this study the first cellular-targeted strategy that protects against DT and ETA toxicity. We have generated Dph2(C-), a dominant-negative mutant of Dph2, that could block very efficiently the formation of diphthamide. Cells expressing Dph2(C-) were 1000-fold more resistant to DT than parental cells, and a similar protection against Pseudomonas exotoxin A was also obtained. The targeting of a cellular component with this approach should have a reduced risk of generating resistance as it is commonly seen with antibiotic treatments.	[Roy, Vincent; Ghani, Karim; Caruso, Manuel] Univ Laval, Ctr Rech Canc, Hotel Dieu Quebec, CHU Quebec, Quebec City, PQ, Canada	Laval University	Roy, V (corresponding author), Univ Laval, Ctr Rech Canc, Hotel Dieu Quebec, CHU Quebec, Quebec City, PQ, Canada.	manuel.caruso@crhdq.ulaval.ca		Caruso, Manuel/0000-0002-7609-2015	Canadian Institute of Health Research (CIHR) [MOP-57833]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institute of Health Research (CIHR) (MOP-57833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar C, 2008, MOL MICROBIOL, V69, P1221, DOI 10.1111/j.1365-2958.2008.06350.x; BJORN MJ, 1977, INFECT IMMUN, V16, P362, DOI 10.1128/IAI.16.1.362-366.1977; BROWN BA, 1979, FEBS LETT, V103, P253, DOI 10.1016/0014-5793(79)81339-3; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Chen CM, 2005, CURR OPIN GENET DEV, V15, P49, DOI 10.1016/j.gde.2004.12.006; CHEN JYC, 1985, MOL CELL BIOL, V5, P3357, DOI 10.1128/MCB.5.12.3357; CHEN JYC, 1988, J BIOL CHEM, V263, P11692; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Danilova E, 2006, CLIN VACCINE IMMUNOL, V13, P627, DOI 10.1128/CVI.00026-06; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Densmore Charles L., 2006, Current Drug Delivery, V3, P55, DOI 10.2174/156720106775197547; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; El-Zaim HS, 1998, INFECT IMMUN, V66, P5551, DOI 10.1128/IAI.66.11.5551-5554.1998; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; FARIZO KM, 1993, CLIN INFECT DIS, V16, P59, DOI 10.1093/clinids/16.1.59; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Fichtner L, 2002, MOL MICROBIOL, V44, P865, DOI 10.1046/j.1365-2958.2002.02928.x; Fogle MR, 2002, J SURG RES, V106, P86, DOI 10.1006/jsre.2002.6433; Galazka A, 2000, J INFECT DIS, V181, pS2, DOI 10.1086/315533; Ghani K, 2007, GENE THER, V14, P1705, DOI 10.1038/sj.gt.3303039; Jacobsen F, 2005, GENE THER, V12, P1494, DOI 10.1038/sj.gt.3302568; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Liu SH, 2006, MOL CELL BIOL, V26, P3835, DOI 10.1128/MCB.26.10.3835-3841.2006; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Manafi A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-23; Matsumoto T, 1999, J MED MICROBIOL, V48, P765, DOI 10.1099/00222615-48-8-765; Matsumoto T, 1998, J MED MICROBIOL, V47, P303, DOI 10.1099/00222615-47-4-303; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; MATTHEAKIS LC, 1993, GENE, V132, P149, DOI 10.1016/0378-1119(93)90528-B; Mattos-Guaraldi AL, 2003, MEM I OSWALDO CRUZ, V98, P987, DOI 10.1590/S0074-02762003000800001; MIYAZAKI S, 1995, J MED MICROBIOL, V43, P169, DOI 10.1099/00222615-43-3-169; MOEHRING JM, 1980, P NATL ACAD SCI-BIOL, V77, P1010, DOI 10.1073/pnas.77.2.1010; MOEHRING TJ, 1984, MOL CELL BIOL, V4, P642, DOI 10.1128/MCB.4.4.642; Mohan RR, 2005, PROG RETIN EYE RES, V24, P537, DOI 10.1016/j.preteyeres.2005.04.001; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NICAS TI, 1985, CAN J MICROBIOL, V31, P387, DOI 10.1139/m85-074; OHMAN DE, 1980, J INFECT DIS, V142, P547, DOI 10.1093/infdis/142.4.547; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; PAPPENHEIMER AM, 1983, J BACTERIOL, V153, P1342, DOI 10.1128/JB.153.3.1342-1347.1983; PAVLOVSKIS OR, 1977, INFECT IMMUN, V18, P596, DOI 10.1128/IAI.18.3.596-602.1977; Pillar CM, 2002, INVEST OPHTH VIS SCI, V43, P1437; ROBINSON EA, 1974, J BIOL CHEM, V249, P5088; Roy V, 2005, GENE THER, V12, P169, DOI 10.1038/sj.gt.3302394; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Speranza FAB, 2010, BRAZ J MED BIOL RES, V43, P120, DOI 10.1590/S0100-879X2009007500032; VANNESS BG, 1980, J BIOL CHEM, V255, P710; VANNESS BG, 1980, J BIOL CHEM, V255, P717; Webb TR, 2008, J CELL SCI, V121, P3140, DOI 10.1242/jcs.035550; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007	54	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15753	10.1371/journal.pone.0015753	http://dx.doi.org/10.1371/journal.pone.0015753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203470	Green Submitted, Green Published, gold			2022-12-25	WOS:000285579200038
J	Dowling, AJ; Wilkinson, PA; Holden, MTG; Quail, MA; Bentley, SD; Reger, J; Waterfield, NR; Titball, RW; Ffrench-Constant, RH				Dowling, Andrea J.; Wilkinson, Paul A.; Holden, Matthew T. G.; Quail, Michael A.; Bentley, Stephen D.; Reger, Julia; Waterfield, Nicholas R.; Titball, Richard W.; Ffrench-Constant, Richard H.			Genome-Wide Analysis Reveals Loci Encoding Anti-Macrophage Factors in the Human Pathogen Burkholderia pseudomallei K96243	PLOS ONE			English	Article							PERTUSSIS FILAMENTOUS HEMAGGLUTININ; SYRINGAE PV. SYRINGAE; SECRETION SYSTEM; PHOSPHOLIPASE-D; CORYNEBACTERIUM-PSEUDOTUBERCULOSIS; VIRULENCE PLASMID; MACROPHAGE DEATH; PLANT PATHOGEN; MELIOIDOSIS; EXPRESSION	Burkholderia pseudomallei is an important human pathogen whose infection biology is still poorly understood. The bacterium is endemic to tropical regions, including South East Asia and Northern Australia, where it causes melioidosis, a serious disease associated with both high mortality and antibiotic resistance. B. pseudomallei is a Gram-negative facultative intracellular pathogen that is able to replicate in macrophages. However despite the critical nature of its interaction with macrophages, few anti-macrophage factors have been characterized to date. Here we perform a genome-wide gain of function screen of B. pseudomallei strain K96243 to identify loci encoding factors with anti-macrophage activity. We identify a total of 113 such loci scattered across both chromosomes, with positive gene clusters encoding transporters and secretion systems, enzymes/toxins, secondary metabolite, biofilm, adhesion and signal response related factors. Further phenotypic analysis of four of these regions shows that the encoded factors cause striking cellular phenotypes relevant to infection biology, including apoptosis, formation of actin 'tails' and multi-nucleation within treated macrophages. The detailed analysis of the remaining host of loci will facilitate genetic dissection of the interaction of this important pathogen with host macrophages and thus further elucidate this critical part of its infection cycle.	[Holden, Matthew T. G.; Quail, Michael A.; Bentley, Stephen D.] Wellcome Trust Sanger Inst, Cambridge, England; [Waterfield, Nicholas R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Titball, Richard W.] Univ Exeter, Sch Biosci, Exeter, Devon, England	Wellcome Trust Sanger Institute; University of Bath; University of Exeter		ajd211@exeter.ac.uk	Quail, michael/ABE-6131-2020; Holden, Matthew TG/K-6449-2014	Holden, Matthew TG/0000-0002-4958-2166; Waterfield, Nicholas/0000-0002-8044-7763; ffrench-Constant, Richard/0000-0001-5385-9888; Dowling, Andrea/0000-0003-0818-6092	BBSRC [BB/E021182/1, BB/E021328/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021182/1, BB/E021328/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abramson T, 2001, INFECT IMMUN, V69, P2650, DOI 10.1128/IAI.69.4.2650-2658.2001; Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Arjcharoen S, 2007, INFECT IMMUN, V75, P4298, DOI 10.1128/IAI.00285-07; Burtnick MN, 2008, INFECT IMMUN, V76, P2991, DOI 10.1128/IAI.00263-08; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Coleman CS, 2006, CELL PROLIFERAT, V39, P599, DOI 10.1111/j.1365-2184.2006.00402.x; Dance DAB, 2002, CURR OPIN INFECT DIS, V15, P127, DOI 10.1097/00001432-200204000-00005; Driskell LO, 2009, INFECT IMMUN, V77, P3244, DOI 10.1128/IAI.00395-09; Ffrench-Constant R, 2006, ADV APPL MICROBIOL, V58, P169, DOI 10.1016/S0065-2164(06)58005-5; GALYOV EE, ANN REV MICROBIOL; Groll M, 2008, NATURE, V452, P755, DOI 10.1038/nature06782; Haase A, 1997, J MED MICROBIOL, V46, P557, DOI 10.1099/00222615-46-7-557; Harland DN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-83; Hodgson ALM, 1999, VACCINE, V17, P802, DOI 10.1016/S0264-410X(98)00264-3; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; JacobDubuisson F, 1996, MOL MICROBIOL, V19, P65, DOI 10.1046/j.1365-2958.1996.349883.x; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Libby SJ, 2000, CELL MICROBIOL, V2, P49, DOI 10.1046/j.1462-5822.2000.00030.x; Matsuura M, 1996, FEMS MICROBIOL LETT, V137, P79, DOI 10.1111/j.1574-6968.1996.tb08086.x; McKean SC, 2007, MICROBIOL-SGM, V153, P2203, DOI 10.1099/mic.0.2007/005926-0; Muangsombut V, 2008, ARCH MICROBIOL, V190, P623, DOI 10.1007/s00203-008-0413-3; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Otto H, 2000, MOL MICROBIOL, V37, P1106, DOI 10.1046/j.1365-2958.2000.02064.x; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Sim SH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000178; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Tuanyok A, 2006, INFECT IMMUN, V74, P5465, DOI 10.1128/IAI.00737-06; Waspi U, 1998, MOL PLANT MICROBE IN, V11, P727, DOI 10.1094/MPMI.1998.11.8.727; Waterfield NR, 2003, FEMS MICROBIOL LETT, V229, P265, DOI 10.1016/S0378-1097(03)00846-2; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0	39	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15693	10.1371/journal.pone.0015693	http://dx.doi.org/10.1371/journal.pone.0015693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203527	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000047
J	Choi, YK; Nash, K; Byrne, BJ; Muzyczka, N; Song, SH				Choi, Young-Kook; Nash, Kevin; Byrne, Barry J.; Muzyczka, Nicholas; Song, Sihong			The Effect of DNA-Dependent Protein Kinase on Adeno-Associated Virus Replication	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; DOUBLE-STRAND BREAK; ADENO-ASSOCIATED VIRUS; SITE-SPECIFIC ENDONUCLEASE; DAMAGE-INDUCED APOPTOSIS; IN-VITRO REPLICATION; CATALYTIC SUBUNIT; REP PROTEIN; MUTATIONAL ANALYSIS; TERMINAL REPEATS	Background: DNA-dependent protein kinase (DNA-PK) is a DNA repair enzyme and plays an important role in determining the molecular fate of the rAAV genome. However, the effect this cellular enzyme on rAAV DNA replication remains elusive. Methodology/Principal Findings: In the present study, we characterized the roles of DNA-PK on recombinant adeno-associated virus DNA replication. Inhibition of DNA-PK by a DNA-PK inhibitor or siRNA targeting DNA-PKcs significantly decreased replication of AAV in MO59K and 293 cells. Southern blot analysis showed that replicated rAAV DNA formed head-to-head or tail-to-tail junctions. The head-to-tail junction was low or undetectable suggesting AAV-ITR self-priming is the major mechanism for rAAV DNA replication. In an in vitro replication assay, anti-Ku80 antibody strongly inhibited rAAV replication, while anti-Ku70 antibody moderately decreased rAAV replication. Similarly, when Ku heterodimer (Ku70/80) was depleted, less replicated rAAV DNA were detected. Finally, we showed that AAV-ITRs directly interacted with Ku proteins. Conclusion/Significance: Collectively, our results showed that that DNA-PK enhances rAAV replication through the interaction of Ku proteins and AAV-ITRs.	[Choi, Young-Kook; Song, Sihong] Univ Florida, Dept Pharmaceut, Gainesville, FL 32610 USA; [Nash, Kevin; Muzyczka, Nicholas] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Byrne, Barry J.] Univ Florida, Dept Pediat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Choi, YK (corresponding author), Univ Florida, Dept Pharmaceut, Gainesville, FL 32610 USA.	shsong@ufl.edu	Nash, Kevin R/B-4567-2009	Nash, Kevin R/0000-0002-8607-1832; Byrne, Barry J./0000-0002-7302-1756	National Institutes of Health [P01-DK58327, PO1 HL59412, PO1 HL51811]; Juvenile Diabetes Research Foundation (JDRF); Alpha One Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051811, P01HL059412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Alpha One Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants (P01-DK58327, PO1 HL59412, PO1 HL51811) to S.S., N.M. and B.B., and grants from Juvenile Diabetes Research Foundation (JDRF) and Alpha One Foundation to S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazard-Dany N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000340; Balague C, 1997, J VIROL, V71, P3299; BEATON A, 1989, J VIROL, V63, P4450, DOI 10.1128/JVI.63.10.4450-4454.1989; Berns KI, 1996, FIELDS VIROLOGY, P2173; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; BLIER PR, 1993, J BIOL CHEM, V268, P7594; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; Boulton S, 1996, CARCINOGENESIS, V17, P2285, DOI 10.1093/carcin/17.11.2285; Brister JR, 2000, J VIROL, V74, P7762, DOI 10.1128/JVI.74.17.7762-7771.2000; Brister JR, 1999, J VIROL, V73, P9325, DOI 10.1128/JVI.73.11.9325-9336.1999; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; CHANG C-T, 1989, Taiwan yixuehui zazhi, V88, P707; Chang Y N, 1990, Chin J Physiol, V33, P31; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Choi VW, 2006, J VIROL, V80, P10346, DOI 10.1128/JVI.00841-06; Conway JE, 1997, J VIROL, V71, P8780, DOI 10.1128/JVI.71.11.8780-8789.1997; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Davis MD, 2000, J VIROL, V74, P2936, DOI 10.1128/JVI.74.6.2936-2942.2000; Davis MD, 1999, J VIROL, V73, P2084, DOI 10.1128/JVI.73.3.2084-2093.1999; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Drouet J, 2005, J BIOL CHEM, V280, P7060, DOI 10.1074/jbc.M410746200; Duan DS, 2003, J VIROL, V77, P4751, DOI 10.1128/JVI.77.8.4751-4759.2003; Dubielzig R, 1999, J VIROL, V73, P8989, DOI 10.1128/JVI.73.11.8989-8998.1999; GRIFFITH AJ, 1992, J BIOL CHEM, V267, P331; Gullo C, 2006, BBA-REV CANCER, V1765, P223, DOI 10.1016/j.bbcan.2006.01.001; HERMONAT PL, 1984, J VIROL, V51, P329, DOI 10.1128/JVI.51.2.329-339.1984; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; Inagaki K, 2007, J VIROL, V81, P11304, DOI 10.1128/JVI.01225-07; Izzard RA, 1999, CANCER RES, V59, P2581; Jurvansuu J, 2005, J VIROL, V79, P569, DOI 10.1128/JVI.79.1.569-580.2005; Jurvansuu J, 2007, J MOL BIOL, V372, P397, DOI 10.1016/j.jmb.2007.06.077; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; LABOW MA, 1986, J VIROL, V60, P251, DOI 10.1128/JVI.60.1.251-258.1986; LAUGHLIN CA, 1986, J VIROL, V60, P515, DOI 10.1128/JVI.60.2.515-524.1986; LAUGHLIN CA, 1982, J VIROL, V41, P868, DOI 10.1128/JVI.41.3.868-876.1982; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MCCARTY DM, 1991, J VIROL, V65, P2936, DOI 10.1128/JVI.65.6.2936-2945.1991; MCCARTY DM, 1994, J VIROL, V68, P4988, DOI 10.1128/JVI.68.8.4988-4997.1994; MCLAUGHLIN SK, 1988, J VIROL, V62, P1963, DOI 10.1128/JVI.62.6.1963-1973.1988; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Nash K, 2008, J VIROL, V82, P1458, DOI 10.1128/JVI.01968-07; Nash K, 2007, J VIROL, V81, P5777, DOI 10.1128/JVI.02651-06; Nash K, 2009, J VIROL, V83, P454, DOI 10.1128/JVI.01939-08; Ni TH, 1998, J VIROL, V72, P2777, DOI 10.1128/JVI.72.4.2777-2787.1998; NI TH, 1994, J VIROL, V68, P1128, DOI 10.1128/JVI.68.2.1128-1138.1994; Parkinson J, 1999, J VIROL, V73, P650, DOI 10.1128/JVI.73.1.650-657.1999; Peng YL, 2002, CANCER RES, V62, P6400; Pereira DJ, 1997, J VIROL, V71, P1747, DOI 10.1128/JVI.71.3.1747-1756.1997; Pereira DJ, 1997, J VIROL, V71, P1079, DOI 10.1128/JVI.71.2.1079-1088.1997; Pereira DJ, 1997, J VIROL, V71, P4300, DOI 10.1128/JVI.71.6.4300-4309.1997; Philpott NJ, 2002, P NATL ACAD SCI USA, V99, P12381, DOI 10.1073/pnas.182430299; Price BD, 1996, CANCER RES, V56, P246; Ryan JH, 1996, J VIROL, V70, P1542, DOI 10.1128/JVI.70.3.1542-1553.1996; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; Schwartz RA, 2007, J VIROL, V81, P12936, DOI 10.1128/JVI.01523-07; Schwartz RA, 2009, J VIROL, V83, P6269, DOI 10.1128/JVI.00318-09; Shinohara ET, 2005, CANCER RES, V65, P4987, DOI 10.1158/0008-5472.CAN-04-4250; Singleton BK, 1999, MOL CELL BIOL, V19, P3267; Slanina H, 2006, J VIROL, V80, P5241, DOI 10.1128/JVI.02718-05; Song S, 1998, P NATL ACAD SCI USA, V95, P14384, DOI 10.1073/pnas.95.24.14384; Song SH, 2004, P NATL ACAD SCI USA, V101, P2112, DOI 10.1073/pnas.0307833100; Song SH, 2001, P NATL ACAD SCI USA, V98, P4084, DOI 10.1073/pnas.061014598; Stracker TH, 2004, J VIROL, V78, P441, DOI 10.1128/JVI.78.1.441-453.2004; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Toublanc E, 2004, J GENE MED, V6, P555, DOI 10.1002/jgm.542; TUTEJA N, 1994, EMBO J, V13, P4991, DOI 10.1002/j.1460-2075.1994.tb06826.x; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Walker SL, 1997, J VIROL, V71, P6996, DOI 10.1128/JVI.71.9.6996-7004.1997; Walker SL, 1997, J VIROL, V71, P2722, DOI 10.1128/JVI.71.4.2722-2730.1997; WARD P, 1994, J VIROL, V68, P6029, DOI 10.1128/JVI.68.9.6029-6037.1994; Ward P, 2001, J VIROL, V75, P10250, DOI 10.1128/JVI.75.21.10250-10258.2001; Ward P, 1996, J VIROL, V70, P4495, DOI 10.1128/JVI.70.7.4495-4501.1996; Ward P, 1998, J VIROL, V72, P420, DOI 10.1128/JVI.72.1.420-427.1998; Weger S, 1997, J VIROL, V71, P8437, DOI 10.1128/JVI.71.11.8437-8447.1997; WEINDLER FW, 1991, J VIROL, V65, P2476, DOI 10.1128/JVI.65.5.2476-2483.1991; WEITZMAN MD, 1994, P NATL ACAD SCI USA, V91, P5808, DOI 10.1073/pnas.91.13.5808; Woo RA, 2002, EMBO J, V21, P3000, DOI 10.1093/emboj/cdf307; Wu JW, 1999, J VIROL, V73, P8235, DOI 10.1128/JVI.73.10.8235-8244.1999; YALKINOGLU AO, 1988, CANCER RES, V48, P3123; Yamaguchi S, 2005, LEUKEMIA RES, V29, P307, DOI 10.1016/j.leukres.2004.07.003; Zentilin L, 2001, J VIROL, V75, P12279, DOI 10.1128/JVI.75.24.12279-12287.2001; Zhou XH, 1999, J VIROL, V73, P1580, DOI 10.1128/JVI.73.2.1580-1590.1999; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	87	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15073	10.1371/journal.pone.0015073	http://dx.doi.org/10.1371/journal.pone.0015073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188139	Green Published, gold			2022-12-25	WOS:000285575200014
J	Pennisi, A; Ling, W; Li, X; Khan, S; Wang, YP; Barlogie, B; Shaughnessy, JD; Yaccoby, S				Pennisi, Angela; Ling, Wen; Li, Xin; Khan, Sharmin; Wang, Yuping; Barlogie, Bart; Shaughnessy, John D., Jr.; Yaccoby, Shmuel			Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone	PLOS ONE			English	Article							MULTIPLE-MYELOMA; OXIDATIVE STRESS; BREAST-CANCER; MARROW MICROENVIRONMENT; OSTEOLYTIC LESIONS; BETA-CATENIN; PLASMA-CELLS; OSTEOBLAST; EXPRESSION; PROTEIN	Background: Induction of osteolytic bone lesions in multiple myeloma is caused by an uncoupling of osteoclastic bone resorption and osteoblastic bone formation. Current management of myeloma bone disease is limited to the use of antiresorptive agents such as bisphosphonates. Methodology/Principal Findings: We tested the effects of daily administered parathyroid hormone (PTH) on bone disease and myeloma growth, and we investigated molecular mechanisms by analyzing gene expression profiles of unique myeloma cell lines and primary myeloma cells engrafted in SCID-rab and SCID-hu mouse models. PTH resulted in increased bone mineral density of myelomatous bones and reduced tumor burden, which reflected the dependence of primary myeloma cells on the bone marrow microenvironment. Treatment with PTH also increased bone mineral density of uninvolved murine bones in myelomatous hosts and bone mineral density of implanted human bones in nonmyelomatous hosts. In myelomatous bone, PTH markedly increased the number of osteoblasts and bone-formation parameters, and the number of osteoclasts was unaffected or moderately reduced. Pretreatment with PTH before injecting myeloma cells increased bone mineral density of the implanted bone and delayed tumor progression. Human global gene expression profiling of myelomatous bones from SCID-hu mice treated with PTH or saline revealed activation of multiple distinct pathways involved in bone formation and coupling; involvement of Wnt signaling was prominent. Treatment with PTH also downregulated markers typically expressed by osteoclasts and myeloma cells, and altered expression of genes that control oxidative stress and inflammation. PTH receptors were not expressed by myeloma cells, and PTH had no effect on myeloma cell growth in vitro. Conclusions/Significance: We conclude that PTH-induced bone formation in myelomatous bones is mediated by activation of multiple signaling pathways involved in osteoblastogenesis and attenuated bone resorption and myeloma growth; mechanisms involve increased osteoblast production of anti-myeloma factors and minimized myeloma induction of inflammatory conditions.	[Pennisi, Angela; Ling, Wen; Li, Xin; Khan, Sharmin; Wang, Yuping; Barlogie, Bart; Shaughnessy, John D., Jr.; Yaccoby, Shmuel] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Pennisi, A (corresponding author), Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA.	yaccobyshmuel@uams.edu		Li, Xin/0000-0002-7414-5734	National Cancer Institute [CA-093897, CA-55819]; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA093897, P01CA055819] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA-093897 (SY) and CA-55819 (SY, BB, JS) from the National Cancer Institute, Senior and Translational Research Awards from the Multiple Myeloma Research Foundation (SY), and the authors' institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Abe M, 2004, BLOOD, V104, P2484, DOI 10.1182/blood-2003-11-3839; ALLAN EH, 2008, J BONE MINER RES; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Attal M, 2006, BLOOD, V108, P3289, DOI 10.1182/blood-2006-05-022962; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; BATAILLE R, 1991, J CLIN INVEST, V88, P62, DOI 10.1172/JCI115305; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bendre MS, 2002, CANCER RES, V62, P5571; Bilezikian JP, 2009, J BONE MINER RES, V24, P373, DOI [10.1359/JBMR.090105, 10.1359/jbmr.090105]; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Coleman RE, 2005, J CLIN ONCOL, V23, P4925, DOI 10.1200/JCO.2005.06.091; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; Edwards CM, 2008, BONE, V42, P1007, DOI 10.1016/j.bone.2008.01.027; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Giuliani N, 2006, BLOOD, V108, P3992, DOI 10.1182/blood-2006-05-026112; Graham S, 2009, EXPERT OPIN INV DRUG, V18, P1633, DOI 10.1517/13543780903241607; Guo J, 2010, CELL METAB, V11, P161, DOI 10.1016/j.cmet.2009.12.007; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Jeong BC, 2010, BONE, V46, P479, DOI 10.1016/j.bone.2009.09.019; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kulkarni NH, 2005, J CELL BIOCHEM, V95, P1178, DOI 10.1002/jcb.20506; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li X, 2008, BLOOD, V112, P159, DOI 10.1182/blood-2007-11-124164; Li X, 2007, BRIT J HAEMATOL, V138, P802, DOI 10.1111/j.1365-2141.2007.06742.x; Lindsay R, 2006, J BONE MINER RES, V21, P366, DOI 10.1359/JBMR.051109; Liu S, 2008, CANCER SCI, V99, P952, DOI 10.1111/j.1349-7006.2008.00787.x; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; Otsuki T, 2001, LEUKEMIA LYMPHOMA, V41, P397, DOI 10.3109/10428190109057995; Ozawa S, 2009, BIOMED RES-TOKYO, V30, P315, DOI 10.2220/biomedres.30.315; Park H, 2010, FEBS LETT, V584, P173, DOI 10.1016/j.febslet.2009.11.043; Pennisi A, 2009, BLOOD, V114, P1803, DOI 10.1182/blood-2009-01-201954; Pennisi A, 2009, AM J HEMATOL, V84, P6, DOI 10.1002/ajh.21310; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Qiang YW, 2008, BLOOD, V112, P374, DOI 10.1182/blood-2007-10-120253; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Roodman GD, 2004, BLOOD CELL MOL DIS, V32, P290, DOI 10.1016/j.bcmd.2004.01.001; Rosen LS, 2001, CANCER J, V7, P377; Sabbieti MG, 2009, J CELL PHYSIOL, V219, P143, DOI 10.1002/jcp.21661; Serra R, 1999, J CELL BIOL, V145, P783, DOI 10.1083/jcb.145.4.783; Sims NA, 2010, J BONE MINER RES, V25, P175, DOI 10.1002/jbmr.53; Stewart JP, 2006, J CELL BIOCHEM, V98, P1, DOI 10.1002/jcb.20774; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Weinstein RS, 2010, ENDOCRINOLOGY, V151, P2641, DOI 10.1210/en.2009-1488; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Yaccoby S, 2002, BRIT J HAEMATOL, V116, P278, DOI 10.1046/j.1365-2141.2002.03257.x; Yaccoby S, 1999, BLOOD, V94, P3576, DOI 10.1182/blood.V94.10.3576.422k01_3576_3582; Yaccoby S, 2006, HAEMATOL-HEMATOL J, V91, P192; Yaccoby S, 2005, CLIN CANCER RES, V11, P7599, DOI 10.1158/1078-0432.CCR-05-0523; Yaccoby S, 2004, CANCER RES, V64, P2016, DOI 10.1158/0008-5472.CAN-03-1131; Yaccoby S, 1998, BLOOD, V92, P2908, DOI 10.1182/blood.V92.8.2908.420a32_2908_2913; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yaccoby S, 2010, BRIT J HAEMATOL, V149, P311, DOI 10.1111/j.1365-2141.2010.08141.x; Yaccoby S, 2010, LEUKEMIA LYMPHOMA, V51, P213, DOI 10.3109/10428190903503438; Yamamoto T, 2007, BONE, V40, P354, DOI 10.1016/j.bone.2006.09.002; YAO GQ, 2010, J BONE MINER METAB; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513; Zangari M, 2005, BRIT J HAEMATOL, V131, P71, DOI 10.1111/j.1365-2141.2005.05733.x; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	74	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15233	10.1371/journal.pone.0015233	http://dx.doi.org/10.1371/journal.pone.0015233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188144	Green Published, gold, Green Submitted			2022-12-25	WOS:000285575200024
J	Bricard, G; Venkataswamy, MM; Yu, KOA; Im, JS; Ndonye, RM; Howell, AR; Veerapen, N; Illarionov, PA; Besra, GS; Li, QA; Chang, YT; Porcelli, SA				Bricard, Gabriel; Venkataswamy, Manjunatha M.; Yu, Karl O. A.; Im, Jin S.; Ndonye, Rachel M.; Howell, Amy R.; Veerapen, Natacha; Illarionov, Petr A.; Besra, Gurdyal S.; Li, Qian; Chang, Young-Tae; Porcelli, Steven A.			alpha-Galactosylceramide Analogs with Weak Agonist Activity for Human iNKT Cells Define New Candidate Anti-Inflammatory Agents	PLOS ONE			English	Article							KILLER T-CELLS; INVARIANT NKT CELLS; CD1D MOLECULES; TUMOR IMMUNOSURVEILLANCE; ANTITUMOR CYTOTOXICITY; CUTTING EDGE; NOD MICE; ACTIVATION; RECOGNITION; ANTIGENS	CD1d-restricted natural killer T cells with invariant T cell receptor alpha chains (iNKT cells) are a unique lymphocyte subset that responds to recognition of specific lipid and glycolipid antigens. They are conserved between mice and humans and exert various immunoregulatory functions through their rapid secretion of a variety of cytokines and secondary activation of dendritic cells, B cells and NK cells. In the current study, we analyzed the range of functional activation states of human iNKT cells using a library of novel analogs of alpha-galactosylceramide (alpha GalCer), the prototypical iNKT cell antigen. Measurement of cytokines secreted by human iNKT cell clones over a wide range of glycolipid concentrations revealed that iNKT cell ligands could be classified into functional groups, correlating with weak versus strong agonistic activity. The findings established a hierarchy for induction of different cytokines, with thresholds for secretion being consistently lowest for IL-13, higher for interferon-gamma (IFN gamma), and even higher for IL-4. These findings suggested that human iNKT cells can be intrinsically polarized to selective production of IL-13 by maintaining a low level of activation using weak agonists, whereas selective polarization to IL-4 production cannot be achieved through modulating the strength of the activating ligand. In addition, using a newly designed in vitro system to assess the ability of human iNKT cells to transactivate NK cells, we found that robust secondary induction of interferon-gamma secretion by NK cells was associated with strong but not weak agonist ligands of iNKT cells. These results indicate that polarization of human iNKT cell responses to Th2-like or anti-inflammatory effects may best be achieved through selective induction of IL-13 and suggest potential discrepancies with findings from mouse models that may be important in designing iNKT cell-based therapies in humans.	[Bricard, Gabriel; Venkataswamy, Manjunatha M.; Yu, Karl O. A.; Im, Jin S.; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Ndonye, Rachel M.; Howell, Amy R.] Univ Connecticut, Dept Chem, Storrs, CT USA; [Veerapen, Natacha; Illarionov, Petr A.; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Edgbaston, England; [Li, Qian; Chang, Young-Tae] Natl Univ Singapore, Dept Chem, Singapore Bioimaging Consortium, A STAR, Singapore 117548, Singapore	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Connecticut; University of Birmingham; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore	Bricard, G (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	steven.porcelli@einstein.yu.edu	Chang, Young-Tae/B-2780-2010; Yu, Karl/ABC-4547-2020	Chang, Young-Tae/0000-0002-1927-3688; Besra, Gurdyal/0000-0002-5605-0395; Howell, Amy/0000-0003-1958-6411	NIH/NIAID [AI45889]; National Institute of General Medical Sciences (NIGMS) [GM087136]; Einstein Center for AIDS Research [AI 051519]; Einstein Cancer Center [CA 13330]; Personal Research Chair; Royal Society; Lister Institute-Jenner Research Fellowship; Medical Research Council; Wellcome Trust [084923/B/08/Z]; MRC [G0400421] Funding Source: UKRI; Medical Research Council [G0400421] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045889, P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087136] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Einstein Center for AIDS Research; Einstein Cancer Center; Personal Research Chair; Royal Society(Royal Society of London); Lister Institute-Jenner Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant Support: This work was supported by NIH/NIAID grant AI45889 (to SAP) and National Institute of General Medical Sciences (NIGMS) grant GM087136 (to ARH). Core resources that facilitated flow cytometry were supported by the Einstein Center for AIDS Research (AI 051519) and the Einstein Cancer Center (CA 13330). GSB acknowledges support from a Personal Research Chair from Mr. James Bardrick, a Royal Society Wolfson Research Merit Award, a former Lister Institute-Jenner Research Fellowship, the Medical Research Council and The Wellcome Trust (084923/B/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; Bricard G, 2007, CELL MOL LIFE SCI, V64, P1824, DOI 10.1007/s00018-007-7007-0; Bricard G, 2009, J IMMUNOL, V182, P5140, DOI 10.4049/jimmunol.0711086; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brossay L, 1999, IMMUNOGENETICS, V50, P146, DOI 10.1007/s002510050590; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Carnaud C, 1999, J IMMUNOL, V163, P4647; Cernadas M, 2003, J IMMUNOL, V171, P4149, DOI 10.4049/jimmunol.171.8.4149; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Couedel C, 1998, EUR J IMMUNOL, V28, P4391, DOI 10.1002/(SICI)1521-4141(199812)28:12<4391::AID-IMMU4391>3.0.CO;2-2; de Lalla C, 2004, J IMMUNOL, V173, P1417, DOI 10.4049/jimmunol.173.2.1417; Forestier C, 2007, J IMMUNOL, V178, P1415, DOI 10.4049/jimmunol.178.3.1415; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Hegde S, 2009, J LEUKOCYTE BIOL, V86, P757, DOI 10.1189/jlb.0209059; Im JS, 2006, J IMMUNOL, V177, P5226, DOI 10.4049/jimmunol.177.8.5226; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Im JS, 2004, J BIOL CHEM, V279, P299, DOI 10.1074/jbc.M308803200; Ishihara S, 2000, J IMMUNOL, V165, P1659, DOI 10.4049/jimmunol.165.3.1659; Karni A, 2002, J NEUROIMMUNOL, V125, P134, DOI 10.1016/S0165-5728(02)00018-8; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Li Q, 2007, J COMB CHEM, V9, P1084, DOI 10.1021/cc070057i; Li XM, 2009, J IMMUNOL, V183, P4415, DOI 10.4049/jimmunol.0901021; Lind SM, 2009, EUR J IMMUNOL, V39, P2293, DOI 10.1002/eji.200839195; Lu X, 2006, CHEMBIOCHEM, V7, P1750, DOI 10.1002/cbic.200600197; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Metelitsa LS, 2001, J IMMUNOL, V167, P3114, DOI 10.4049/jimmunol.167.6.3114; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Mizuno M, 2004, J AUTOIMMUN, V23, P293, DOI 10.1016/j.jaut.2004.09.008; Moreno M, 2008, CLIN IMMUNOL, V129, P145, DOI 10.1016/j.clim.2008.07.004; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Motsinger A, 2003, J VIROL, V77, P8153, DOI 10.1128/JVI.77.14.8153-8158.2003; Ndonye RM, 2005, J ORG CHEM, V70, P10260, DOI 10.1021/jo051147h; Oki S, 2005, INT IMMUNOL, V17, P1619, DOI 10.1093/intimm/dxh342; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Osada T, 2005, INT IMMUNOL, V17, P1143, DOI 10.1093/intimm/dxh292; Pyz E, 2006, J IMMUNOL, V176, P7447, DOI 10.4049/jimmunol.176.12.7447; Roy KC, 2008, J IMMUNOL, V180, P2942, DOI 10.4049/jimmunol.180.5.2942; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Schmieg J, 2005, P NATL ACAD SCI USA, V102, P1127, DOI 10.1073/pnas.0408288102; Silk JD, 2008, J IMMUNOL, V180, P6452, DOI 10.4049/jimmunol.180.10.6452; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Swann JB, 2007, CURR TOP MICROBIOL, V314, P293; Terabe M, 2003, J EXP MED, V198, P1741, DOI 10.1084/jem.20022227; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Ueno Y, 2005, INFLAMM BOWEL DIS, V11, P35, DOI 10.1097/00054725-200501000-00005; Velazquez P, 2008, J IMMUNOL, V180, P2024, DOI 10.4049/jimmunol.180.4.2024; Venkataswamy MM, 2010, SEMIN IMMUNOL, V22, P68, DOI 10.1016/j.smim.2009.10.003; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Wang XH, 2008, BLOOD, V112, P4128, DOI 10.1182/blood-2008-05-157529; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zajonc DM, 2009, IMMUNOL REV, V230, P188, DOI 10.1111/j.1600-065X.2009.00802.x; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	58	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14374	10.1371/journal.pone.0014374	http://dx.doi.org/10.1371/journal.pone.0014374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179412	Green Published, Green Submitted, gold			2022-12-25	WOS:000285572900008
J	Du, WG; Ye, H; Zhao, B; Warner, DA; Shine, R				Du, Wei-Guo; Ye, Hua; Zhao, Bo; Warner, Daniel A.; Shine, Richard			Thermal Acclimation of Heart Rates in Reptilian Embryos	PLOS ONE			English	Article							NEST-SITE SELECTION; SNAPPING TURTLES; LIZARD EMBRYOS; OFFSPRING PHENOTYPES; CHELYDRA-SERPENTINA; ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; TEMPERATURE; INCUBATION; CONSUMPTION	In many reptiles, the thermal regimes experienced by eggs in natural nests vary as a function of ambient weather and location, and this variation has important impacts on patterns of embryonic development. Recent advances in non-invasive measurement of embryonic heart rates allow us to answer a long-standing puzzle in reptilian developmental biology: Do the metabolic and developmental rates of embryos acclimate to local incubation regimes, as occurs for metabolic acclimation by post-hatching reptiles? Based on a strong correlation between embryonic heart rate and oxygen consumption, we used heart rates as a measure of metabolic rate. We demonstrate acclimation of heart rates relative to temperature in embryos of one turtle, one snake and one lizard species that oviposit in relatively deep nests, but found no acclimation in another lizard species that uses shallow (and hence, highly thermally variable) nests. Embryonic thermal acclimation thus is widespread, but not ubiquitous, within reptiles.	[Du, Wei-Guo; Ye, Hua; Zhao, Bo] Hangzhou Normal Univ, Hangzhou Key Lab Anim Sci & Technol, Hangzhou, Peoples R China; [Du, Wei-Guo; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Warner, Daniel A.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Du, Wei-Guo] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China	Hangzhou Normal University; University of Sydney; Iowa State University; Chinese Academy of Sciences; Institute of Zoology, CAS	Du, WG (corresponding author), Hangzhou Normal Univ, Hangzhou Key Lab Anim Sci & Technol, Hangzhou, Peoples R China.	dwghz@126.com	Du, Wei-Guo/K-1071-2014	Warner, Daniel/0000-0001-7231-7785	Zhejiang Provincial Natural Science Foundation of China [G5080004]; University of Sydney; Australian Research Council	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); University of Sydney(University of Sydney); Australian Research Council(Australian Research Council)	This work was supported by grants from Zhejiang Provincial Natural Science Foundation of China (http://www.zjnsf.net/) (G5080004) and the University of Sydney to W.-G. Du and the Australian Research Council (http://www.arc.gov.au/) to R. Shine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Ralph A., 2008, P135; Aho E, 2001, J COMP PHYSIOL B, V171, P173, DOI 10.1007/s003600000171; Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P573, DOI 10.1086/501062; Angilletta MJ, 2000, ECOLOGY, V81, P2957, DOI 10.1890/0012-9658(2000)081[2957:TEOTEO]2.0.CO;2; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Ar A, 1999, COMP BIOCHEM PHYS A, V124, P491, DOI 10.1016/S1095-6433(99)00142-7; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Birchard GF, 1996, J COMP PHYSIOL B, V166, P461, DOI 10.1007/s003600050033; BIRCHARD GF, 1995, PHYSIOL ZOOL, V68, P799, DOI 10.1086/physzool.68.5.30163932; Blouin-Demers G, 2004, CAN J ZOOL, V82, P449, DOI 10.1139/Z04-014; BOBYN ML, 1994, CAN J ZOOL, V72, P28, DOI 10.1139/z94-005; CONGDON JD, 1987, HERPETOLOGICA, V43, P39; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; Du WG, 2008, COMP BIOCHEM PHYS A, V151, P102, DOI 10.1016/j.cbpa.2008.06.005; Du WG, 2009, J EXP BIOL, V212, P1302, DOI 10.1242/jeb.027425; Huey R.B., 1982, Biology of Reptilia, V12, P25; Huey R. B., 1996, ANIMALS TEMPERATURE, P205; KLINKHARDT MB, 1987, AQUACULTURE, V64, P219, DOI 10.1016/0044-8486(87)90327-9; Mirkovic T, 1998, PHYSIOL ZOOL, V71, P191, DOI 10.1086/515896; Nechaeva MV, 2007, COMP BIOCHEM PHYS A, V148, P599, DOI 10.1016/j.cbpa.2007.08.005; Olsson M, 1997, J EVOLUTION BIOL, V10, P369, DOI 10.1046/j.1420-9101.1997.10030369.x; Pearson JT, 1999, J COMP PHYSIOL B, V169, P256, DOI 10.1007/s003600050219; Radder R, 2006, BIOL LETTERS, V2, P415, DOI 10.1098/rsbl.2006.0495; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Shine R, 2003, BIOL J LINN SOC, V78, P325, DOI 10.1046/j.1095-8312.2003.00140.x; Shine R, 1996, ECOLOGY, V77, P1808, DOI 10.2307/2265785; Steyermark A., 2008, BIOL SNAPPING TURTLE; Tazawa H, 2005, AVIAN POULT BIOL REV, V16, P123, DOI 10.3184/147020605783437977; Thompson MB, 1998, COPEIA, P1016, DOI 10.2307/1447350; TSUJI JS, 1988, PHYSIOL ZOOL, V61, P241, DOI 10.1086/physzool.61.3.30161237; VLECK D, 1987, J APPL PHYSIOL, V62, P2103, DOI 10.1152/jappl.1987.62.5.2103; Wapstra E, 2010, J EVOLUTION BIOL, V23, P651, DOI 10.1111/j.1420-9101.2009.01924.x; Warner DA, 2002, HERPETOLOGICA, V58, P399, DOI 10.1655/0018-0831(2002)058[0399:NSIRTT]2.0.CO;2; Warner DA, 2007, OECOLOGIA, V154, P65, DOI 10.1007/s00442-007-0809-9; Whitehead P.J., 1987, P473; Zhao E, 1993, HERPETOLOGY CHINA, V10	36	40	41	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15308	10.1371/journal.pone.0015308	http://dx.doi.org/10.1371/journal.pone.0015308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179473	Green Published, gold, Green Submitted			2022-12-25	WOS:000285292500019
J	Michaud, V; Frappier, M; Dumas, MC; Turgeon, J				Michaud, Veronique; Frappier, Martin; Dumas, Marie-Christine; Turgeon, Jacques			Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism	PLOS ONE			English	Article							ARACHIDONIC-ACID METABOLISM; MOLECULAR-CLONING; GENE-EXPRESSION; CYTOCHROME-P450 ENZYMES; HEART-FAILURE; VERAPAMIL; INHIBITION; PATHWAY; CYP2J2; IDENTIFICATION	Background: Tissue-specific expression of CYP450s can regulate the intracellular concentration of drugs and explain inter-subject variability in drug action. The overall objective of our study was to determine in a large cohort of samples, mRNA levels and CYP450 activity expressed in the human heart. Methodology: CYP450 mRNA levels were determined by RTPCR in left ventricular samples (n = 68) of explanted hearts from patients with end-stage heart failure. Samples were obtained from ischemic and non-ischemic hearts. In some instances (n = 7), samples were available from both the left and right ventricles. A technique for the preparation of microsomes from human heart tissue was developed and CYP450-dependent activity was determined using verapamil enantiomers as probe-drug substrates. Principal Findings: Our results show that CYP2J2 mRNA was the most abundant isoform in all human heart left ventricular samples tested. Other CYP450 mRNAs of importance were CYP4A11, CYP2E1, CYP1A1 and CYP2C8 mRNAs while CYP2B6 and CYP2C9 mRNAs were present at low levels in only some of the hearts analyzed. CYP450 mRNAs did not differ between ischemic and non-ischemic hearts and appeared to be present at similar levels in the left and right ventricles. Incubation of verapamil with heart microsomes led to the formation of nine CYP450-dependent metabolites: a major finding was the observation that stereoselectivity was reversed compared to human liver microsomes, in which the R-enantiomer is metabolized to a greater extent. Conclusions: This study determined cardiac mRNA levels of various CYP450 isozymes involved in drug metabolism and demonstrated the prevalent expression of CYP2J2 mRNA. It revealed that cardiomyocytes can efficiently metabolize drugs and that cardiac CYP450s are highly relevant with regard to clearance of drugs in the heart. Our results support the claim that drug metabolism in the vicinity of a drug effector site can modulate drug effects.	[Michaud, Veronique] Univ Montreal, Ctr Hosp Univ Montreal, Univ Montreal Hosp Ctr CRCHUM, Res Ctr, Montreal, PQ, Canada; Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Michaud, V (corresponding author), Univ Montreal, Ctr Hosp Univ Montreal, Univ Montreal Hosp Ctr CRCHUM, Res Ctr, Montreal, PQ, Canada.	jacques.turgeon@umontreal.ca			Canadian Institutes of Health Research; Heart and Stroke Foundation of Quebec; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	Veronique Michaud is the recipient of a studentship from the Canadian Institutes of Health Research. Dr. Jacques Turgeon's laboratory is funded by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Quebec and the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboutabl ME, 2009, BRIT J PHARMACOL, V158, P1808, DOI 10.1111/j.1476-5381.2009.00461.x; ABRAHAM NG, 1987, J MOL CELL CARDIOL, V19, P73, DOI 10.1016/S0022-2828(87)80546-1; Busse D, 1995, N-S ARCH PHARMACOL, V353, P116; DeLozier TC, 2007, DRUG METAB DISPOS, V35, P682, DOI 10.1124/dmd.106.012823; Diczfalusy U, 2008, PHARMACOGENET GENOM, V18, P201, DOI 10.1097/FPC.0b013e3282f50ee9; Dubey RK, 2005, J CLIN ENDOCR METAB, V90, P247, DOI 10.1210/jc.2003-032154; Earley S, 2003, AM J PHYSIOL-HEART C, V285, pH127, DOI 10.1152/ajpheart.01052.2002; Elbekai RH, 2006, PHARMACOL THERAPEUT, V112, P564, DOI 10.1016/j.pharmthera.2005.05.011; Fischer D, 2007, EUR J HEART FAIL, V9, P770, DOI 10.1016/j.ejheart.2007.05.005; Fleming I, 2001, CIRC RES, V89, P753, DOI 10.1161/hh2101.099268; Granville DJ, 2004, P NATL ACAD SCI USA, V101, P1321, DOI 10.1073/pnas.0308185100; HUNT CM, 1992, BIOCHEM PHARMACOL, V44, P275, DOI 10.1016/0006-2952(92)90010-G; Hunter AL, 2005, VASC PHARMACOL, V43, P213, DOI 10.1016/j.vph.2005.07.005; KROEMER HK, 1993, N-S ARCH PHARMACOL, V348, P332; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Messina A, 2008, XENOBIOTICA, V38, P1453, DOI 10.1080/00498250802474437; Messina A, 2010, XENOBIOTICA, V40, P109, DOI 10.3109/00498250903410590; Michaelis UR, 2005, J CELL SCI, V118, P5489, DOI 10.1242/jcs.02674; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; RASCHACK M, 1976, N-S ARCH PHARMACOL, V294, P285, DOI 10.1007/BF00508397; Rendic S, 2002, DRUG METAB REV, V34, pIX; Satoh M, 2007, CIRCULATION, V115, P3197, DOI 10.1161/CIRCULATIONAHA.106.657981; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Shen LX, 2004, DRUG METAB DISPOS, V32, P186, DOI 10.1124/dmd.32.2.186; Sidorik L, 2005, CELL BIOL INT, V29, P51, DOI 10.1016/j.cellbi.2004.11.011; STEGEMAN JJ, 1982, MOL PHARMACOL, V21, P517; Theken KN, 2007, PHARMACOGENOMICS, V8, P1369, DOI 10.2217/14622416.8.10.1369; Thum T, 2000, BRIT J PHARMACOL, V130, P1745, DOI 10.1038/sj.bjp.0703465; Thum T, 2000, LANCET, V355, P979, DOI 10.1016/S0140-6736(00)99016-0; Thum T, 2002, FASEB J, V16, P1537, DOI 10.1096/fj.02-0138com; Tracy TS, 1999, BRIT J CLIN PHARMACO, V47, P545, DOI 10.1046/j.1365-2125.1999.00923.x; VOGELGESANG B, 1984, BRIT J CLIN PHARMACO, V18, P733, DOI 10.1111/j.1365-2125.1984.tb02536.x; Walles M, 2002, J CHROMATOGR A, V970, P117, DOI 10.1016/S0021-9673(02)00641-6; Wang YH, 2004, DRUG METAB DISPOS, V32, P259, DOI 10.1124/dmd.32.2.259; Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393; Wu S, 1996, J BIOL CHEM, V271, P3460; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551; Zordoky Beshay N. M., 2007, Journal of Pharmacological and Toxicological Methods, V56, P317, DOI 10.1016/j.vascn.2007.06.001	40	55	56	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15666	10.1371/journal.pone.0015666	http://dx.doi.org/10.1371/journal.pone.0015666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179487	Green Published, gold, Green Submitted			2022-12-25	WOS:000285292500034
J	Muinonen-Martin, AJ; Veltman, DM; Kalna, G; Insall, RH				Muinonen-Martin, Andrew J.; Veltman, Douwe M.; Kalna, Gabriela; Insall, Robert H.			An Improved Chamber for Direct Visualisation of Chemotaxis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL MOTILITY; FIBROBLAST MIGRATION; METASTASIS; GRADIENTS; ADHESION; INVASION; MV3	There has been a growing appreciation over the last decade that chemotaxis plays an important role in cancer migration, invasion and metastasis. Research into the field of cancer cell chemotaxis is still in its infancy and traditional investigative tools have been developed with other cell types and purposes in mind. Direct visualisation chambers are considered the gold standard for investigating the behaviour of cells migrating in a chemotactic gradient. We therefore drew up a list of key attributes that a chemotaxis chamber should have for investigating cancer cell chemotaxis. These include (1) compatibility with thin cover slips for optimal optical properties and to allow use of high numerical aperture (NA) oil immersion objectives; (2) gradients that are relatively stable for at least 24 hours due to the slow migration of cancer cells; (3) gradients of different steepnesses in a single experiment, with defined, consistent directions to avoid the need for complicated analysis; and (4) simple handling and disposability for use with medical samples. Here we describe and characterise the Insall chamber, a novel direct visualisation chamber. We use it to show GFP-lifeact transfected MV3 melanoma cells chemotaxing using a 60x high NA oil immersion objective, which cannot usually be done with other chemotaxis chambers. Linear gradients gave very efficient chemotaxis, contradicting earlier results suggesting that only polynomial gradients were effective. In conclusion, the chamber satisfies our design criteria, most importantly allowing high NA oil immersion microscopy to track chemotaxing cancer cells in detail over 24 hours.	[Muinonen-Martin, Andrew J.; Veltman, Douwe M.; Kalna, Gabriela; Insall, Robert H.] CRUK Beatson Inst Canc Res, Glasgow, Lanark, Scotland	Beatson Institute	Muinonen-Martin, AJ (corresponding author), CRUK Beatson Inst Canc Res, Glasgow, Lanark, Scotland.	a.muinonen-martin@beatson.gla.ac.uk	Veltman, Douwe M/D-6227-2011; Insall, Robert/G-5611-2011	Insall, Robert/0000-0003-4898-040X; Gilbey, Thomas/0000-0001-5677-3318	Cancer Research UK; DTI/Technology Strategy Board; OneNE Regional Development Agency	Cancer Research UK(Cancer Research UK); DTI/Technology Strategy Board; OneNE Regional Development Agency	Cancer Research UK Core Grant funded the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Epigem Limited and Phil Summersgill for the fabrication of the microfluidic devices. The fabrication work was carried out in the Fluence Microfluidics Application Centre supported by the DTI/Technology Strategy Board and the OneNE Regional Development Agency as part of the UK's MNT (Nanocentres) Network. We are very grateful to Margaret O'Prey and Tom Gilbey, Beatson Advanced Imaging Resource, for advice with technical aspects of imaging, and to Michael Carnell for assistance with Blender 3D rendering.	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Breckenridge MT, 2010, BIOMED MICRODEVICES, V12, P543, DOI 10.1007/s10544-010-9411-8; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Friedl P, 1997, CANCER RES, V57, P2061; GERISCH G, 1981, J CELL SCI, V52, P1; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; Maheshwari G, 1998, MICROSC RES TECHNIQ, V43, P358, DOI 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-D; Maheshwari G, 1999, BIOPHYS J, V76, P2814, DOI 10.1016/S0006-3495(99)77435-7; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; RHODES JM, 1982, J IMMUNOL METHODS, V49, P235, DOI 10.1016/0022-1759(82)90280-0; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; Stathopoulos GT, 2008, MOL CANCER RES, V6, P364, DOI 10.1158/1541-7786.MCR-07-0309; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; VANMUIJEN GNP, 1991, INT J CANCER, V48, P85; Wang WG, 2002, CANCER RES, V62, P6278; Ware MF, 1998, J CELL SCI, V111, P2423; Wells A, 2000, ADV CANCER RES, V78, P31; Zicha D, 1997, Methods Mol Biol, V75, P449; ZICHA D, 1991, J CELL SCI, V99, P769; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	26	76	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15309	10.1371/journal.pone.0015309	http://dx.doi.org/10.1371/journal.pone.0015309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179457	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000285292500020
J	Tham, M; Ramasamy, S; Gan, HT; Ramachandran, A; Poonepalli, A; Yu, YH; Ahmed, S				Tham, Muly; Ramasamy, Srinivas; Gan, Hui Theng; Ramachandran, Ashray; Poonepalli, Anuradha; Yu, Yuan Hong; Ahmed, Sohail			CSPG Is a Secreted Factor that Stimulates Neural Stem Cell Survival Possibly by Enhanced EGFR Signaling	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; HIPPOCAMPAL PROGENITOR; CAENORHABDITIS-ELEGANS; NEURITE OUTGROWTH; PROTEIN-KINASE; RADIAL GLIA; DIFFERENTIATION	Understanding how autocrine/paracrine factors regulate neural stem cell (NSC) survival and growth is fundamental to the utilization of these cells for therapeutic applications and as cellular models for the brain. In vitro, NSCs can be propagated along with neural progenitors (NPs) as neurospheres (nsphs). The nsph conditioned medium (nsph-CM) contains cell-secreted factors that can regulate NSC behavior. However, the identity and exact function of these factors within the nsph-CM has remained elusive. We analyzed the nsph-CM by mass spectrometry and identified DSD-1-proteoglycan, a chondroitin sulfate proteoglycan (CSPG), apolipoprotein E (ApoE) and cystatin C as components of the nsph-CM. Using clonal assays we show that CSPG and ApoE are responsible for the ability of the nsph-CM to stimulate nsph formation whereas cystatin C is not involved. Clonal nsphs generated in the presence of CSPG show more than four-fold increase in NSCs. Thus CSPG specifically enhances the survival of NSCs. CSPG also stimulates the survival of embryonic stem cell (ESC)-derived NSCs, and thus may be involved in the developmental transition of ESCs to NSCs. In addition to its role in NSC survival, CSPG maintains the three dimensional structure of nsphs. Lastly, CSPG's effects on NSC survival may be mediated by enhanced signaling via EGFR, JAK/STAT3 and PI3K/Akt pathways.	[Tham, Muly; Ramasamy, Srinivas; Gan, Hui Theng; Ramachandran, Ashray; Poonepalli, Anuradha; Yu, Yuan Hong; Ahmed, Sohail] Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Tham, M (corresponding author), Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Tham, Anh Vu Muly/0000-0001-5138-6503	Agency for Science, Technology and Research, Singapore	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by Agency for Science, Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama E, 2005, IMMUNOL LETT, V99, P80, DOI 10.1016/j.imlet.2005.01.005; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bauer S, 2009, ANN NY ACAD SCI, V1153, P48, DOI 10.1111/j.1749-6632.2009.03986.x; Bernhardt RR, 2000, DEV BIOL, V221, P206, DOI 10.1006/dbio.2000.9673; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Chang MY, 2003, NEUROREPORT, V14, P1191, DOI 10.1097/00001756-200307010-00001; Chung KY, 2000, DEVELOPMENT, V127, P2673; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gu WL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-128; Hayashi K, 2001, GLYCOCONJUGATE J, V18, P401, DOI 10.1023/A:1014864131288; Hayes AJ, 2008, J HISTOCHEM CYTOCHEM, V56, P125, DOI 10.1369/jhc.7A7320.2007; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Ichijo H, 2001, J NEUROSCI, V21, P9304, DOI 10.1523/JNEUROSCI.21-23-09304.2001; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Kabos P, 2004, BIOCHEM BIOPH RES CO, V318, P955, DOI 10.1016/j.bbrc.2004.04.114; Kaneko M, 2007, NEUROSCI LETT, V423, P62, DOI 10.1016/j.neulet.2007.06.038; Kato T, 2006, P NATL ACAD SCI USA, V103, P6019, DOI 10.1073/pnas.0509789103; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Kubota Y, 1999, DEV DYNAM, V214, P55, DOI 10.1002/(SICI)1097-0177(199901)214:1<55::AID-DVDY6>3.0.CO;2-E; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; Masuda T, 2004, MOL CELL NEUROSCI, V25, P217, DOI 10.1016/j.mcn.2003.10.005; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nakanishi K, 2006, J BIOL CHEM, V281, P24970, DOI 10.1074/jbc.M601498200; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Perissinotto D, 2000, DEVELOPMENT, V127, P2823; Properzi F, 2003, BIOCHEM SOC T, V31, P335, DOI 10.1042/BST0310335; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; SAJDERA S, 1969, J BIOL CHEM, V244, P77; SALTER J, 2007, USING SAS PERFORM ST; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; SIRKO S, 2010, STEM CELLS; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; von Holst A, 2006, J NEUROSCI, V26, P4082, DOI 10.1523/JNEUROSCI.0422-06.2006; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zhang JQ, 2006, NEUROREPORT, V17, P981, DOI 10.1097/01.wnr.0000227977.60271.ca; Zhou JH, 2010, J NEUROIMMUNOL, V223, P55, DOI 10.1016/j.jneuroim.2010.04.002	52	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15341	10.1371/journal.pone.0015341	http://dx.doi.org/10.1371/journal.pone.0015341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179491	Green Published, Green Submitted, gold			2022-12-25	WOS:000285292500023
J	Beer, C; Flicker, L; Horner, B; Bretland, N; Scherer, S; Lautenschlager, NT; Schaper, F; Almeida, OP				Beer, Christopher; Flicker, Leon; Horner, Barbara; Bretland, Nick; Scherer, Samuel; Lautenschlager, Nicola T.; Schaper, Frank; Almeida, Osvaldo P.			Factors Associated with Self and Informant Ratings of the Quality of Life of People with Dementia Living in Care Facilities: A Cross Sectional Study	PLOS ONE			English	Article							RESIDENTIAL CARE; QOL-AD	Background: There is no consensus regarding the optimal approach to assessment of the quality of life of people with dementia. We undertook the present study to describe and determine the factors associated with ratings of the quality of life of a cohort of people with dementia living in a residential care facility. Methodology/Principal Findings: 351 people with dementia living in residential care facilities, and their staff and family informants participated in this cross sectional observational study. Quality of life was measured using self (Quality of Life in Alzheimer's Disease [QoL-AD] scale), and informant (QoL-AD and Alzheimer's Disease Related QoL Scale) reports. 226 people (64%) with dementia (median MMSE 17; 12-21) were able to self rate the QoL-AD scale and these subjects' ratings were compared to ratings by staff and family. Both staff and family informant ratings of the QoL-AD underestimated self ratings (mean difference -7.8, 95% CI -8.8, -6.7 for staff rated QoL-AD; and mean difference -7.2, 95% CI -8.5, -6.0 for family rated QoL-AD). Self ratings of QoL were lower among people who were restrained, had fallen or had pain. Informant ratings of the QoL of the participants with dementia were consistently and significantly lower for people with severe cognitive impairment, who had fallen, had presence of neuropsychiatric symptoms, or where care giver distress was present. Documented restraint, reported pain and neuropsychiatric symptoms were independently associated with lower self rating of the QoL-AD in multivariate models. Cognitive impairment, case conferencing, hospitalizations and neuropsychiatric symptoms were found to be independently associated with staff rated ADRQL. Conclusions: The majority of people with dementia living in residential care facilities can rate their own QoL. Informant ratings underestimate self ratings of QoL of people with dementia, and appear to be associated with factors which are not associated with self ratings.	[Beer, Christopher; Flicker, Leon; Lautenschlager, Nicola T.; Almeida, Osvaldo P.] Med Res Ctr, WA Ctr Hlth & Ageing, Perth, WA, Australia; [Beer, Christopher; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Horner, Barbara] Curtin Univ Technol, Ctr Res Ageing, Perth, WA, Australia; [Bretland, Nick; Almeida, Osvaldo P.] Rowethorpe Med Ctr, Bentley, WA, Australia; [Scherer, Samuel] Royal Freemasons Homes Victoria, Prahran, Vic, Australia; [Lautenschlager, Nicola T.] Univ Melbourne, Dept Psychiat, Acad Unit Psychiat Old Age, St Vincents Hlth, Parkville, Vic 3052, Australia; [Schaper, Frank] Alzheimers Australia WA Ltd, Perth, WA, Australia; [Lautenschlager, Nicola T.] Univ Western Australia, Sch Psychiat & Neurosci, Crawley, WA, Australia	University of Western Australia; Curtin University; University of Melbourne; University of Western Australia	Beer, C (corresponding author), Med Res Ctr, WA Ctr Hlth & Ageing, Perth, WA, Australia.	Christopher.beer@uwa.edu.au	Almeida, Osvaldo P./A-4925-2008; Flicker, Leon/A-9039-2008; Flicker, Leon/AAE-1530-2022; Etherton-Beer, Christopher/B-2714-2014	Almeida, Osvaldo P./0000-0002-8689-6199; Flicker, Leon/0000-0002-3650-0475; Etherton-Beer, Christopher/0000-0001-5148-0188; Schaper, Frank/0000-0002-7687-1510; Lautenschlager, Nicola/0000-0003-4850-7794	National Institute of Allergy and Infectious Diseases [1R21 AI070033 (RCM), 5T32 AI065380-05 (JDS)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070033, T32AI065380] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Institutes of Health (NIH) Grant 1R21 AI070033 (RCM) and by NIH Grant 5T32 AI065380-05 (JDS) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer C, 2009, AGE AGEING, V38, P343, DOI 10.1093/ageing/afp018; Beer CD, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-63; Clare L, 2008, SOC SCI MED, V66, P2366, DOI 10.1016/j.socscimed.2008.01.045; Clare L, 2008, GERONTOLOGIST, V48, P711, DOI 10.1093/geront/48.6.711; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Edelman P, 2005, GERONTOLOGIST, V45, P27, DOI 10.1093/geront/45.suppl_1.27; GIBSON S, 2004, PRELIMINARY FIELD TE; Hoe J, 2006, BRIT J PSYCHIAT, V188, P460, DOI 10.1192/bjp.bp.104.007658; Hoe J, 2005, AGE AGEING, V34, P130, DOI 10.1093/ageing/afi030; KITWOOD T, 1993, INT J GERIATR PSYCH, V8, P541, DOI 10.1002/gps.930080702; Logsdon R.G., 1999, J MENTAL HLTH AGING, V5, P21, DOI DOI 10.1037/T03352-000; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; Molloy DW, 1997, INT PSYCHOGERIATR S, V9, P143; Rabins PV, 2000, INT PSYCHOGERIATR, V12, P47, DOI 10.1017/S104161020000675X; Rabins PV., 1999, J MENTAL HLTH AGING, V5, P33; Sloane PD, 2005, GERONTOLOGIST, V45, P37, DOI 10.1093/geront/45.suppl_1.37; Thorgrimsen L, 2003, ALZ DIS ASSOC DIS, V17, P201, DOI 10.1097/00002093-200310000-00002; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002; Winzelberg GS, 2005, GERONTOLOGIST, V45, P106, DOI 10.1093/geront/45.suppl_1.106; Woods B, 1999, INT J GERIATR PSYCH, V14, P97, DOI 10.1002/(SICI)1099-1166(199902)14:2<97::AID-GPS941>3.0.CO;2-X	21	85	85	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15621	10.1371/journal.pone.0015621	http://dx.doi.org/10.1371/journal.pone.0015621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	693SY	21179448	gold, Green Published			2022-12-25	WOS:000285246900048
J	Choi, YH; Park, CH; Kim, W; Ling, H; Kang, A; Chang, MW; Im, SK; Jeong, HW; Kong, YY; Kim, KT				Choi, Yoon Ha; Park, Choon-Ho; Kim, Wanil; Ling, Hua; Kang, Aram; Chang, Matthew Wook; Im, Sun-Kyoung; Jeong, Hyun-Woo; Kong, Young-Yun; Kim, Kyong-Tai			Vaccinia-Related Kinase 1 Is Required for the Maintenance of Undifferentiated Spermatogonia in Mouse Male Germ Cells	PLOS ONE			English	Article							HUMAN VACCINIA-RELATED-KINASE-1 VRK1; STEM-CELLS; SELF-RENEWAL; BINDING-SITE; PROLIFERATION; SPERMATOGENESIS; PHOSPHORYLATION; EXPRESSION; PROTEIN; DIFFERENTIATION	Vaccinia-related kinase 1 (VRK1) is a crucial protein kinase for mitotic regulation. VRK1 is known to play a role in germ cell development, and its deficiency results in sterility. Here we describe that VRK1 is essential for the maintenance of spermatogonial stem cells. To determine whether VRK1 plays a role in these cells, we assessed the population size of undifferentiated spermatogonia. Flow cytometry analyses showed that the number of undifferentiated spermatogonia was markedly reduced in VRK1-deficient testes. VRK1 was highly expressed in spermatogonial populations, and approximately 66% of undifferentiated spermatogonia that were sorted as an Ep-CAM(+)/c-kit(-)/alpha-6-integrin(+) population showed a positive signal for VRK1. Undifferentiated stem cells expressing Plzf and Oct4 but not c-kit also expressed VRK1, suggesting that VRK1 is an intrinsic factor for the maintenance of spermatogonial stem cells. Microarray analyses of the global testicular transcriptome and quantitative RT-PCR of VRK1-deficient testes revealed significantly reduced expression levels of undifferentiated spermatogonial marker genes in early postnatal mice. Together, these results suggest that VRK1 is required for the proliferation and differentiation of undifferentiated spermatogonia, which are essential for spermatogenic cell maintenance.	[Choi, Yoon Ha; Park, Choon-Ho; Kim, Wanil; Im, Sun-Kyoung; Jeong, Hyun-Woo; Kim, Kyong-Tai] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea; [Kim, Kyong-Tai] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Ling, Hua; Kang, Aram; Chang, Matthew Wook] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore; [Kong, Young-Yun] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Seoul National University (SNU)	Choi, YH (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea.	ktk@postech.ac.kr	Chang, Matthew Wook/G-6220-2010	Chang, Matthew Wook/0000-0001-6448-6319; Jeong, Hyun-Woo/0000-0002-6976-6739; KIM, KYONG-TAI/0000-0001-7292-2627; Ling, Hua/0000-0002-0680-6422	Anti-Aging and Well-Being Research Center; Ministry of Education, Science and Technology; National Research Foundation of Korea (NRF) [2010-0019706, 20100000755, 20100002146, R31-2008-000-10105-0]	Anti-Aging and Well-Being Research Center; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was supported by grants from the Core Research Program/Anti-Aging and Well-Being Research Center, the Brain Korea 21 program of the Ministry of Education, Science and Technology. This work was also supported by the grants (2010-0019706, 20100000755, and 20100002146) and WCU program (R31-2008-000-10105-0) funded by National Research Foundation of Korea (NRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Cullen CF, 2005, J CELL BIOL, V171, P593, DOI 10.1083/jcb.200508127; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; De Rooij DG, 2000, J ANDROL, V21, P776; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Ivanovska I, 2005, GENE DEV, V19, P2571, DOI 10.1101/gad.1348905; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Klerkx EPF, 2009, DEV BIOL, V335, P12, DOI 10.1016/j.ydbio.2009.08.007; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Ohta H, 2000, DEV GROWTH DIFFER, V42, P105; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Wiebe MS, 2010, BIOL REPROD, V82, P182, DOI 10.1095/biolreprod.109.079095; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; Zhao GQ, 1996, GENE DEV, V10, P1657, DOI 10.1101/gad.10.13.1657; Zhao GQ, 1998, DEVELOPMENT, V125, P1103; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	37	23	25	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15254	10.1371/journal.pone.0015254	http://dx.doi.org/10.1371/journal.pone.0015254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179456	gold, Green Submitted, Green Published			2022-12-25	WOS:000285246900039
J	Chowdhury, F; Li, YZ; Poh, YC; Yokohama-Tamaki, T; Wang, N; Tanaka, TS				Chowdhury, Farhan; Li, Yanzhen; Poh, Yeh-Chuin; Yokohama-Tamaki, Tamaki; Wang, Ning; Tanaka, Tetsuya S.			Soft Substrates Promote Homogeneous Self-Renewal of Embryonic Stem Cells via Downregulating Cell-Matrix Tractions	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; DIFFERENTIATION; STIFFNESS; NANOG; MECHANOTRANSDUCTION; HETEROGENEITY; PLURIPOTENCY; EQUILIBRIUM; PROTEINS; SURVIVAL	Maintaining undifferentiated mouse embryonic stem cell (mESC) culture has been a major challenge as mESCs cultured in Leukemia Inhibitory Factor (LIF) conditions exhibit spontaneous differentiation, fluctuating expression of pluripotency genes, and genes of specialized cells. Here we show that, in sharp contrast to the mESCs seeded on the conventional rigid substrates, the mESCs cultured on the soft substrates that match the intrinsic stiffness of the mESCs and in the absence of exogenous LIF for 5 days, surprisingly still generated homogeneous undifferentiated colonies, maintained high levels of Oct3/4, Nanog, and Alkaline Phosphatase (AP) activities, and formed embryoid bodies and teratomas efficiently. A different line of mESCs, cultured on the soft substrates without exogenous LIF, maintained the capacity of generating homogeneous undifferentiated colonies with relatively high levels of Oct3/4 and AP activities, up to at least 15 passages, suggesting that this soft substrate approach applies to long term culture of different mESC lines. mESC colonies on these soft substrates without LIF generated low cell-matrix tractions and low stiffness. Both tractions and stiffness of the colonies increased with substrate stiffness, accompanied by downregulation of Oct3/4 expression. Our findings demonstrate that mESC self-renewal and pluripotency can be maintained homogeneously on soft substrates via the biophysical mechanism of facilitating generation of low cell-matrix tractions.	[Chowdhury, Farhan; Poh, Yeh-Chuin; Wang, Ning] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Li, Yanzhen; Yokohama-Tamaki, Tamaki; Tanaka, Tetsuya S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Tanaka, Tetsuya S.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chowdhury, F (corresponding author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.	nwangrw@illinois.edu; ttanaka@illinois.edu	Wang, Ning/B-6966-2008; Chowdhury, Farhan/D-1496-2009	Chowdhury, Farhan/0000-0003-1527-2677; Tanaka, Tetsuya/0000-0002-0406-0217	NIH [GM072744]; United States Department of Agriculture Cooperative State Research, Education and Extension Service [ILLU-538-323]; University of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072744] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); University of Illinois; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM072744 (to N.W.), the United States Department of Agriculture Cooperative State Research, Education and Extension Service, Hatch project ILLU-538-323 (to T.S.T.), and by University of Illinois (to N.W. and T.S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AEX, 2009, CURR BIOL, V19, pR781, DOI 10.1016/j.cub.2009.06.054; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Chowdhury F, 2008, BIOPHYS J, V95, P5719, DOI 10.1529/biophysj.108.139832; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Duval D, 2000, FASEB J, V14, P1577, DOI 10.1096/fj.14.11.1577; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Evans ND, 2009, EUR CELLS MATER, V18, P1; FEINBERG AW, 2002, ORL FL 25 ANN M ADH; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Furusawa T, 2006, BIOL REPROD, V75, P555, DOI 10.1095/biolreprod.105.049502; GILBERT PM, 2010, SCIENCE         0715, DOI DOI 10.1126/SCIENCE.1191035; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kawahara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006343; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Li D, 2010, J CELL BIOL, V191, P631, DOI 10.1083/jcb.201006094; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Mijailovich SM, 2002, J APPL PHYSIOL, V93, P1429, DOI 10.1152/japplphysiol.00255.2002; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Nagaoka M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-60; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Poh YC, 2010, BIOPHYS J, V99, pL19, DOI 10.1016/j.bpj.2010.04.057; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tanaka TS, 2008, GENESIS, V46, P347, DOI 10.1002/dvg.20404; Tanaka TS, 2009, REPROD FERT DEVELOP, V21, P67, DOI 10.1071/RD08219; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.3.CO;2-6	61	236	243	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15655	10.1371/journal.pone.0015655	http://dx.doi.org/10.1371/journal.pone.0015655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179449	Green Submitted, Green Published, gold			2022-12-25	WOS:000285246900050
J	Broadhead, GK; Mun, HC; Avlani, VA; Jourdon, O; Church, WB; Christopoulos, A; Delbridge, L; Conigrave, AD				Broadhead, Geoffrey K.; Mun, Hee-chang; Avlani, Vimesh A.; Jourdon, Orane; Church, W. Bret; Christopoulos, Arthur; Delbridge, Leigh; Conigrave, Arthur D.			Allosteric Modulation of the Calcium-sensing Receptor by gamma-Glutamyl Peptides INHIBITION OF PTH SECRETION, SUPPRESSION OF INTRACELLULAR cAMP LEVELS, AND A COMMON MECHANISM OF ACTION WITH L-AMINO ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CA2+-SENSING RECEPTOR; PROTEIN-COUPLED RECEPTORS; PHYSIOLOGICAL SIGNIFICANCE; CALCIMIMETIC COMPOUND; SIGNAL-TRANSDUCTION; CA2+ OSCILLATIONS; RAT-BRAIN; GLUTATHIONE; DOMAIN; ACTIVATION	gamma-Glutamyl peptides were identified previously as novel positive allosteric modulators of Ca2+ (o)-dependent intracellular Ca2+ mobilization in HEK-293 cells that bind in the calcium-sensing receptor VFT domain. In the current study, we investigated whether gamma-glutamyl-tripeptides including gamma-Glu-Cys-Gly (glutathione) and its analogs S-methylglutathione and S-propylglutathione, or dipeptides including gamma-Glu-Ala and gamma-Glu-Cys are positive allosteric modulators of Ca2+ (o)-dependent Ca2+ (i) mobilization and PTH secretion from normal human parathyroid cells as well as Ca2+ (o)-dependent suppression of intracellular cAMP levels in calcium-sensing receptor (CaR)-expressing HEK-293 cells. In addition, we compared the effects of the potent gamma-glutamyl peptide S-methylglutathione, and the amino acid L-Phe on HEK-293 cells that stably expressed either the wild-type CaR or the double mutant T145A/S170T, which exhibits selectively impaired responses to L-amino acids. We find that gamma-glutamyl peptides are potent positive allosteric modulators of the CaR that promote Ca2+ (o)-dependent Ca2+ (i) mobilization, suppress intracellular cAMP levels and inhibit PTH secretion from normal human parathyroid cells. Furthermore, we find that the double mutant T145A/S170T exhibits markedly impaired Ca2+ (i) mobilization and cAMP suppression responses to S-methylglutathione as well as L-Phe indicating that gamma-glutamyl peptides and L-amino acids activate the CaR via a common mechanism.	[Broadhead, Geoffrey K.; Mun, Hee-chang; Avlani, Vimesh A.; Jourdon, Orane; Conigrave, Arthur D.] Univ Sydney, Sch Mol Biosci G08, Sydney, NSW 2006, Australia; [Church, W. Bret] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Delbridge, Leigh] Univ Sydney, Royal N Shore Hosp, Endocrine Surg Unit, St Leonards, NSW 2065, Australia	University of Sydney; University of Sydney; Monash University; Monash University; Royal North Shore Hospital; University of Sydney	Conigrave, AD (corresponding author), Univ Sydney, Sch Mol Biosci G08, Sydney, NSW 2006, Australia.	arthur.conigrave@sydney.edu.au	Christopoulos, Arthur/B-6207-2013; Church, William/H-6040-2013; Centeno, Patricia Pacios/O-8368-2016	Christopoulos, Arthur/0000-0003-4442-3294; Church, William/0000-0002-8033-5518; Conigrave, Arthur/0000-0002-7232-3891; Delbridge, leigh/0000-0001-8281-8831	NHMRC of Australia	NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the NHMRC of Australia for Fellowship and Project Grant funding (to A. C. and A. D. C.).	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Brennan SC, 2009, CURR PHARM BIOTECHNO, V10, P270, DOI 10.2174/138920109787847484; BROWN EM, 1976, ENDOCRINOLOGY, V99, P1582, DOI 10.1210/endo-99-6-1582; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Chang WH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159945; Conigrave AD, 2007, BIOCHEM SOC T, V35, P1195, DOI 10.1042/BST0351195; Conigrave AD, 2000, TRENDS PHARMACOL SCI, V21, P401, DOI 10.1016/S0165-6147(00)01546-7; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2006, TRENDS ENDOCRIN MET, V17, P398, DOI 10.1016/j.tem.2006.10.012; Conigrave AD, 2006, AM J PHYSIOL-GASTR L, V291, pG753, DOI 10.1152/ajpgi.00189.2006; Conigrave AD, 2010, PHARMACOL THERAPEUT, V127, P252, DOI 10.1016/j.pharmthera.2010.04.007; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Feng JY, 2010, P NATL ACAD SCI USA, V107, P17791, DOI 10.1073/pnas.1009078107; Ferry S, 2000, EUR J NEUROSCI, V12, P872, DOI 10.1046/j.1460-9568.2000.00980.x; Finney BA, 2008, J PHYSIOL-LONDON, V586, P6007, DOI 10.1113/jphysiol.2008.161687; Geibel JP, 2009, ANNU REV PHYSIOL, V71, P205, DOI 10.1146/annurev.physiol.010908.163128; Gerbino A, 2005, J CELL BIOL, V171, P303, DOI 10.1083/jcb.200507054; Hauache OM, 2000, ENDOCRINOLOGY, V141, P4156, DOI 10.1210/en.141.11.4156; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Janaky R, 1999, J NEUROCHEM, V73, P889, DOI 10.1046/j.1471-4159.1999.0730889.x; Jenei Z, 1998, NEUROCHEM RES, V23, P1085, DOI 10.1023/A:1020712203611; Khan MA, 2010, BRIT J PHARMACOL, V159, P1039, DOI 10.1111/j.1476-5381.2009.00603.x; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee HJ, 2007, BIOCHEM J, V404, P141, DOI 10.1042/BJ20061826; Lu WY, 1998, J PHYSIOL-LONDON, V512, P29, DOI 10.1111/j.1469-7793.1998.029bf.x; Mun HC, 2009, J CLIN ENDOCR METAB, V94, P3567, DOI 10.1210/jc.2008-2714; Mun HC, 2005, J BIOL CHEM, V280, P29067, DOI 10.1074/jbc.M500002200; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Ohsu T, 2010, J BIOL CHEM, V285, P1016, DOI 10.1074/jbc.M109.029165; Phillips CG, 2008, J NEUROSCI, V28, P12062, DOI 10.1523/JNEUROSCI.4134-08.2008; Pope SAS, 2008, NEUROCHEM RES, V33, P1410, DOI 10.1007/s11064-008-9602-3; QUINN SJ, 2003, ENDOCRIN UPDAT SER, V19, P203; Ray K, 2002, J BIOL CHEM, V277, P18908, DOI 10.1074/jbc.M202113200; Rey O, 2005, J BIOL CHEM, V280, P22875, DOI 10.1074/jbc.M503455200; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Varga V, 1997, NEUROCHEM RES, V22, P1165, DOI 10.1023/A:1027377605054; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Wang MH, 2006, BIOORGAN MED CHEM, V14, P2032, DOI 10.1016/j.bmc.2005.10.052; Ward DT, 2004, CELL CALCIUM, V35, P217, DOI 10.1016/j.ceca.2003.10.017; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; YANG CS, 1994, J CHROMATOGR B, V661, P231, DOI 10.1016/S0378-4347(94)80050-2; Young SH, 2002, AM J PHYSIOL-CELL PH, V282, pC1414, DOI 10.1152/ajpcell.00432.2001	46	68	71	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8786	8797		10.1074/jbc.M110.149724	http://dx.doi.org/10.1074/jbc.M110.149724			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21187282	Green Published, hybrid			2022-12-25	WOS:000288247700009
J	Rauner, C; Kohr, G				Rauner, Claudia; Koehr, Georg			Triheteromeric NR1/NR2A/NR2B Receptors Constitute the Major N-Methyl-D-aspartate Receptor Population in Adult Hippocampal Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC NMDA RECEPTORS; LONG-TERM POTENTIATION; SUBUNIT COMPOSITION; FUNCTIONAL-PROPERTIES; DIFFERENTIAL ROLES; NR2D SUBUNITS; MICE LACKING; RAT-BRAIN; IN-VITRO; LTP	NMDA receptors (NMDARs), fundamental to learning and memory and implicated in certain neurological disorders, are heterotetrameric complexes composed of two NR1 and two NR2 subunits. The function of synaptic NMDARs in postnatal principal forebrain neurons is typically attributed to diheteromeric NR1/NR2A and NR1/NR2B receptors, despite compelling evidence for triheteromeric NR1/NR2A/NR2B receptors. In synapses, the properties of triheteromeric NMDARs could thus far not be distinguished from those of mixtures of diheteromeric NMDARs. To find a signature of NR1/NR2A/NR2B receptors, we have employed two gene-targeted mouse lines, expressing either NR1/NR2A or NR1/NR2B receptors without NR1/NR2A/NR2B receptors, and compared their synaptic properties with those of wild type. In acute hippocampal slices of mutants older than 4 weeks we found a distinct voltage dependence of NMDA R-mediated excitatory postsynaptic current (NMDA EPSC) decay time for the two diheteromeric NMDARs. In wild-type mice, NMDA EPSCs unveiled the NR1/NR2A characteristic for this voltage-dependent deactivation exclusively, indicating that the contribution of NR1/NR2B receptors to evoked NMDA EPSCs is negligible in adult CA3-to-CA1 synapses. The presence of NR1/NR2A/NR2B receptors was obvious from properties that could not be explained by a mixture of diheteromeric NR1/NR2A and NR1/NR2B receptors or by the presence of NR1/NR2A receptors alone. The decay time for NMDA EPSCs in wild type was slower than that for NR1/NR2A receptors, and the sensitivity of NMDA EPSCs to NR2B-directed NMDAR antagonists was 50%. Thus, NR2B is prominent in adult hippocampal synapses as an integral part of NR1/NR2A/NR2B receptors.	[Rauner, Claudia; Koehr, Georg] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	Max Planck Society	Kohr, G (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.	kohr@mpimf-heidelberg.mpg.de						Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Berberich S, 2007, NEUROPHARMACOLOGY, V52, P77, DOI 10.1016/j.neuropharm.2006.07.016; Brickley SG, 2003, J NEUROSCI, V23, P4958; Brimecombe JC, 1997, P NATL ACAD SCI USA, V94, P11019, DOI 10.1073/pnas.94.20.11019; Brothwell SLC, 2008, J PHYSIOL-LONDON, V586, P739, DOI 10.1113/jphysiol.2007.144618; Chazot PL, 2002, NEUROPHARMACOLOGY, V42, P319, DOI 10.1016/S0028-3908(01)00191-5; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; Clarke RJ, 2008, J PHYSIOL-LONDON, V586, P5727, DOI 10.1113/jphysiol.2008.160622; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Costa BM, 2009, J PHARMACOL EXP THER, V331, P618, DOI 10.1124/jpet.109.156752; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; de Armentia ML, 2003, J NEUROSCI, V23, P6876; de Marchena J, 2008, J NEUROPHYSIOL, V100, P1936, DOI 10.1152/jn.90290.2008; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Harney SC, 2008, J NEUROSCI, V28, P11685, DOI 10.1523/JNEUROSCI.3035-08.2008; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kawakami R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001945; Kew JNC, 1998, J NEUROSCI, V18, P1935; Kew JNC, 1998, J PHYSIOL-LONDON, V512, P17, DOI 10.1111/j.1469-7793.1998.017bf.x; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kohr G, 2003, J NEUROSCI, V23, P10791; KONNERTH A, 1990, EXP BRAIN RES, V81, P209; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Kuner T, 1996, J NEUROSCI, V16, P3549; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lozovaya NA, 2004, J PHYSIOL-LONDON, V558, P451, DOI 10.1113/jphysiol.2004.063792; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Martina M, 2005, J PHYSIOL-LONDON, V563, P777, DOI 10.1113/jphysiol.2004.080655; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mott DD, 1998, NAT NEUROSCI, V1, P659, DOI 10.1038/3661; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tang TTT, 2010, J BIOL CHEM, V285, P20975, DOI 10.1074/jbc.M110.102210; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; WATANABE M, 1993, J COMP NEUROL, V338, P377, DOI 10.1002/cne.903380305; Wenzel A, 1997, J NEUROCHEM, V68, P469; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zhang W, 2008, NAT NEUROSCI, V11, P1373, DOI 10.1038/nn.2214; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	68	183	186	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7558	7566		10.1074/jbc.M110.182600	http://dx.doi.org/10.1074/jbc.M110.182600			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21190942	Green Published, hybrid			2022-12-25	WOS:000287737300069
J	Magarinos, M; Aburto, MR; Sanchez-Calderon, H; Munoz-Agudo, C; Rapp, UR; Varela-Nieto, I				Magarinos, Marta; Aburto, Maria R.; Sanchez-Calderon, Hortensia; Munoz-Agudo, Carmen; Rapp, Ulf R.; Varela-Nieto, Isabel			RAF Kinase Activity Regulates Neuroepithelial Cell Proliferation and Neuronal Progenitor Cell Differentiation during Early Inner Ear Development	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; B-RAF; SUBCELLULAR-LOCALIZATION; INDEPENDENT MECHANISM; TRANSCRIPTION FACTORS; SYSTEM DEVELOPMENT; CYCLE REGULATION; C-RAF-1 GENE; AXON GROWTH; MEK-ERK	Background: Early inner ear development requires the strict regulation of cell proliferation, survival, migration and differentiation, coordinated by the concerted action of extrinsic and intrinsic factors. Deregulation of these processes is associated with embryonic malformations and deafness. We have shown that insulin-like growth factor I (IGF-I) plays a key role in embryonic and postnatal otic development by triggering the activation of intracellular lipid and protein kinases. RAF kinases are serine/threonine kinases that regulate the highly conserved RAS-RAF-MEK-ERK signaling cascade involved in transducing the signals from extracellular growth factors to the nucleus. However, the regulation of RAF kinase activity by growth factors during development is complex and still not fully understood. Methodology/Principal Findings: By using a combination of qRT-PCR, Western blotting, immunohistochemistry and in situ hybridization, we show that C-RAF and B-RAF are expressed during the early development of the chicken inner ear in specific spatiotemporal patterns. Moreover, later in development B-RAF expression is associated to hair cells in the sensory patches. Experiments in ex vivo cultures of otic vesicle explants demonstrate that the influence of IGF-I on proliferation but not survival depends on RAF kinase activating the MEK-ERK phosphorylation cascade. With the specific RAF inhibitor Sorafenib, we show that blocking RAF activity in organotypic cultures increases apoptosis and diminishes the rate of cell proliferation in the otic epithelia, as well as severely impairing neurogenesis of the acoustic-vestibular ganglion (AVG) and neuron maturation. Conclusions/Significance: We conclude that RAF kinase activity is essential to establish the balance between cell proliferation and death in neuroepithelial otic precursors, and for otic neuron differentiation and axonal growth at the AVG.	[Magarinos, Marta; Aburto, Maria R.; Sanchez-Calderon, Hortensia; Munoz-Agudo, Carmen; Varela-Nieto, Isabel] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Magarinos, Marta] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Magarinos, Marta; Aburto, Maria R.; Sanchez-Calderon, Hortensia; Varela-Nieto, Isabel] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Unit 761, Madrid, Spain; [Rapp, Ulf R.] Max Planck Inst Biochem, Dept Mol Biol, D-8000 Munich, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Max Planck Society	Magarinos, M (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain.	mmagarinos@iib.uam.es	Rodriguez Aburto, Maria/ABG-7492-2021; SÁNCHEZ, MARTA MAGARIÑOS/ABG-7748-2020; Varela-Nieto, Isabel/G-5289-2015	SÁNCHEZ, MARTA MAGARIÑOS/0000-0003-4592-9377; Varela-Nieto, Isabel/0000-0003-3077-0500	Integrated Action [HA2004-0096]; Ministerio de Ciencia e Innovacion [SAF2008-00470]; Fundacion Mutua Madrilea; Consejo Superior de Investigaciones Cientificas-FSE I3	Integrated Action; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mutua Madrilea; Consejo Superior de Investigaciones Cientificas-FSE I3	This work was supported by the Integrated Action HA2004-0096 to IVN and URR, Ministerio de Ciencia e Innovacion (SAF2008-00470) and Fundacion Mutua Madrilea to IVN. Maria R. Aburto and Hortensia Sanchez-Calderon hold contracts from Consejo Superior de Investigaciones Cientificas-FSE I3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandro EU, 2008, J BIOL CHEM, V283, P2407, DOI 10.1074/jbc.M703612200; ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Camarero G, 2003, DEV BIOL, V262, P242, DOI 10.1016/S0012-1606(03)00387-7; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Camarero G, 2006, MOL CELL BIOL, V26, P7103, DOI 10.1128/MCB.00424-06; Carnahan J, 2010, MOL CANCER THER, V9, P2399, DOI 10.1158/1535-7163.MCT-10-0181; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Davies D, 2007, J COMP NEUROL, V502, P673, DOI 10.1002/cne.21302; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Espinosa AV, 2007, BRIT J CANCER, V96, P16, DOI 10.1038/sj.bjc.6603520; Frago LM, 2003, J CELL SCI, V116, P475, DOI 10.1242/jcs.00223; Frago LM, 1998, J CELL SCI, V111, P549; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; Galmiche A, 2007, BBA-MOL CELL RES, V1773, P1256, DOI 10.1016/j.bbamcr.2006.10.012; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hausott B, 2009, MOL CELL NEUROSCI, V42, P328, DOI 10.1016/j.mcn.2009.08.005; Jilaveanu LB, 2009, CLIN CANCER RES, V15, P5704, DOI 10.1158/1078-0432.CCR-09-0198; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Leon Y, 2004, APOPTOSIS, V9, P255, DOI 10.1023/B:APPT.0000025802.07676.a5; LEON Y, 1995, ENDOCRINOLOGY, V136, P3494, DOI 10.1210/en.136.8.3494; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Millimaki BB, 2010, DEV BIOL, V338, P262, DOI 10.1016/j.ydbio.2009.12.011; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Morice C, 1999, EUR J NEUROSCI, V11, P1995, DOI 10.1046/j.1460-9568.1999.00609.x; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; Pimentel B, 2000, J NEUROSCI, V20, P3254, DOI 10.1523/JNEUROSCI.20-09-03254.2000; Polzien L, 2010, ADV ENZYME REGUL, V50, P147, DOI 10.1016/j.advenzreg.2009.10.025; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Sanchez-Calderon H, 2007, INT J DEV BIOL, V51, P557, DOI 10.1387/ijdb.072373hs; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Sanz C, 1999, J CELL SCI, V112, P3967; Sanz C, 1999, ONCOGENE, V18, P429, DOI 10.1038/sj.onc.1202312; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Sienknecht UJ, 2009, J COMP NEUROL, V517, P751, DOI 10.1002/cne.22169; Troppmair J, 2003, BIOCHEM PHARMACOL, V66, P1341, DOI 10.1016/S0006-2952(03)00483-0; Tsukamoto H, 2008, EUR J IMMUNOL, V38, P518, DOI 10.1002/eji.200737430; Walenkamp MJE, 2006, HORM RES, V66, P221, DOI 10.1159/000095161; Wang S, 1998, MOL CELL BIOL, V18, P7487, DOI 10.1128/MCB.18.12.7487; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898	60	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14435	10.1371/journal.pone.0014435	http://dx.doi.org/10.1371/journal.pone.0014435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203386	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500012
J	Globisch, D; Munzel, M; Muller, M; Michalakis, S; Wagner, M; Koch, S; Bruckl, T; Biel, M; Carell, T				Globisch, Daniel; Muenzel, Martin; Mueller, Markus; Michalakis, Stylianos; Wagner, Mirko; Koch, Susanne; Brueckl, Tobias; Biel, Martin; Carell, Thomas			Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation Intermediates	PLOS ONE			English	Article							DNA METHYLATION; GLYCOSYLASE ACTIVITY; QUANTIFICATION; 5-METHYLCYTOSINE; CONVERSION; DEAMINATION; METABOLISM; NEURONS; REPAIR; DAMAGE	5-Hydroxymethylcytosine (hmC) was recently detected as the sixth base in mammalian tissue at so far controversial levels. The function of the modified base is currently unknown, but it is certain that the base is generated from 5-methylcytosine (mC). This fuels the hypothesis that it represents an intermediate of an active demethylation process, which could involve further oxidation of the hydroxymethyl group to a formyl or carboxyl group followed by either deformylation or decarboxylation. Here, we use an ultra-sensitive and accurate isotope based LC-MS method to precisely determine the levels of hmC in various mouse tissues and we searched for 5-formylcytosine (fC), 5-carboxylcytosine (caC), and 5-hydroxymethyluracil (hmU) as putative active demethylation intermediates. Our data suggest that an active oxidative mC demethylation pathway is unlikely to occur. Additionally, we show using HPLC-MS analysis and immunohistochemistry that hmC is present in all tissues and cell types with highest concentrations in neuronal cells of the CNS.	[Globisch, Daniel; Muenzel, Martin; Mueller, Markus; Wagner, Mirko; Brueckl, Tobias; Carell, Thomas] Univ Munich, Ctr Integrated Prot Sci CiPSM, Dept Chem, Munich, Germany; [Michalakis, Stylianos; Koch, Susanne; Biel, Martin] Univ Munich, Ctr Integrated Prot Sci CiPSM, Dept Pharm, Munich, Germany	University of Munich; University of Munich	Globisch, D (corresponding author), Univ Munich, Ctr Integrated Prot Sci CiPSM, Dept Chem, Marchioninistr 15, Munich, Germany.	Thomas.carell@cup.uni-muenchen.de	Michalakis, Stylianos/M-4677-2019; Carell, Thomas/G-4799-2012; Biel, Martin/G-1175-2014; Michalakis, Stylianos/W-2094-2018; Muenzel, Martin/B-3360-2011; Globisch, Daniel/C-7307-2011	Michalakis, Stylianos/0000-0001-5092-9238; Carell, Thomas/0000-0001-7898-2831; Biel, Martin/0000-0002-9974-3052; Michalakis, Stylianos/0000-0001-5092-9238; Globisch, Daniel/0000-0002-4526-5788; Koch, Susanne/0000-0001-9966-113X; Muenzel, Martin/0000-0002-4504-8281; Muller, Markus/0000-0002-3579-3317	excellence cluster CiPSM; SFBs [646, 749]; Fond der Chemischen Industrie; Bayer Schering Pharma AG	excellence cluster CiPSM; SFBs; Fond der Chemischen Industrie(Fonds der Chemischen Industrie); Bayer Schering Pharma AG(Bayer AG)	Funding was received from the following sources: the excellence cluster CiPSM, the SFBs 646 and 749, the Fond der Chemischen Industrie and Bayer Schering Pharma AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Bruckl T, 2009, ANGEW CHEM INT EDIT, V48, P7932, DOI 10.1002/anie.200902740; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; Cooke MS, 2008, CANCER EPIDEM BIOMAR, V17, P3, DOI 10.1158/1055-9965.EPI-07-0751; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Houk KN, 2001, CHEMBIOCHEM, V2, P113, DOI 10.1002/1439-7633(20010202)2:2<113::AID-CBIC113>3.3.CO;2-K; Hwang C. H., 1992, ARCH PHARMACAL RES, V15, P69, DOI DOI 10.1007/BF02973987; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Loenarz C, 2009, CHEM BIOL, V16, P580, DOI 10.1016/j.chembiol.2009.06.002; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; PALMATIER RD, 1970, J BIOL CHEM, V245, P6706; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Privat E, 1996, CHEM RES TOXICOL, V9, P745, DOI 10.1021/tx950182o; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rusmintratip V, 2000, P NATL ACAD SCI USA, V97, P14183, DOI 10.1073/pnas.97.26.14183; SHAFFER PM, 1975, J BACTERIOL, V121, P648, DOI 10.1128/JB.121.2.648-655.1975; Simmons JM, 2008, DALTON T, P5132, DOI 10.1039/b803512a; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Taghizadeh K, 2008, NAT PROTOC, V3, P1287, DOI 10.1038/nprot.2008.119; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Vanyushin BF, 1998, EUR J BIOCHEM, V256, P518, DOI 10.1046/j.1432-1327.1998.2560518.x; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yang YN, 2002, ANAL CHEM, V74, P5376, DOI 10.1021/ac020235o; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	34	621	649	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15367	10.1371/journal.pone.0015367	http://dx.doi.org/10.1371/journal.pone.0015367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203455	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200021
J	Kathrani, A; House, A; Catchpole, B; Murphy, A; German, A; Werling, D; Allenspach, K				Kathrani, Aarti; House, Arthur; Catchpole, Brian; Murphy, Angela; German, Alex; Werling, Dirk; Allenspach, Karin			Polymorphisms in the Tlr4 and Tlr5 Gene Are Significantly Associated with Inflammatory Bowel Disease in German Shepherd Dogs	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATION; TOLL-LIKE RECEPTOR-5; CROHNS-DISEASE; ULCERATIVE-COLITIS; EPITHELIAL BARRIER; SEQUENCE VARIANTS; ADAPTIVE IMMUNITY; LOCI CONTRIBUTE; SUSCEPTIBILITY	Inflammatory bowel disease (IBD) is considered to be the most common cause of vomiting and diarrhoea in dogs, and the German shepherd dog (GSD) is particularly susceptible. The exact aetiology of IBD is unknown, however associations have been identified between specific single-nucleotide polymorphisms (SNPs) in Toll-like receptors (TLRs) and human IBD. However, to date, no genetic studies have been undertaken in canine IBD. The aim of this study was to investigate whether polymorphisms in canine TLR 2, 4 and 5 genes are associated with IBD in GSDs. Mutational analysis of TLR2, TLR4 and TLR5 was performed in 10 unrelated GSDs with IBD. Four non-synonymous SNPs (T23C, G1039A, A1571T and G1807A) were identified in the TLR4 gene, and three non-synonymous SNPs (G22A, C100T and T1844C) were identified in the TLR5 gene. The non-synonymous SNPs identified in TLR4 and TLR5 were evaluated further in a case-control study using a SNaPSHOT multiplex reaction. Sequencing information from 55 unrelated GSDs with IBD were compared to a control group consisting of 61 unrelated GSDs. The G22A SNP in TLR5 was significantly associated with IBD in GSDs, whereas the remaining two SNPs were found to be significantly protective for IBD. Furthermore, the two SNPs in TLR4 (A1571T and G1807A) were in complete linkage disequilibrium, and were also significantly associated with IBD. The TLR5 risk haplotype (ACC) without the two associated TLR4 SNP alleles was significantly associated with IBD, however the presence of the two TLR4 SNP risk alleles without the TLR5 risk haplotype was not statistically associated with IBD. Our study suggests that the three TLR5 SNPs and two TLR4 SNPs; A1571T and G1807A could play a role in the pathogenesis of IBD in GSDs. Further studies are required to confirm the functional importance of these polymorphisms in the pathogenesis of this disease.	[Kathrani, Aarti; House, Arthur; Allenspach, Karin] Univ London, Dept Vet Clin Sci, Royal Vet Coll, Hatfield, Herts, England; [Catchpole, Brian; Werling, Dirk] Univ London, Dept Pathol & Infect Dis, Royal Vet Coll, Hatfield, Herts, England; [Murphy, Angela] Univ London, Dept Vet Basic Sci, Royal Vet Coll, Hatfield, Herts, England; [German, Alex] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of Liverpool	Kathrani, A (corresponding author), Univ London, Dept Vet Clin Sci, Royal Vet Coll, Hatfield, Herts, England.	akathrani@rvc.ac.uk	Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044; German, Alexander/0000-0002-3017-7988	Biotechnology and Biological Sciences Research Council (BBSRC); Pfizer; Petsavers	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer); Petsavers	This research was funded by Biotechnology and Biological Sciences Research Council (BBSRC), Pfizer and Petsavers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALLENSPACH K, 2010, VET MICROBIOL; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Austen B M, 1981, Biochem Soc Symp, P235; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Browning BL, 2007, AM J GASTROENTEROL, V102, P2504, DOI 10.1111/j.1572-0241.2007.01463.x; Burgener IA, 2008, J VET INTERN MED, V22, P553, DOI 10.1111/j.1939-1676.2008.0093.x; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Fritz JH, 2008, TRENDS IMMUNOL, V29, P41, DOI 10.1016/j.it.2007.10.002; FROLOVA L, 2007, J HISTOCHEM CYTOCHEM; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Groth M, 2008, HUM MUTAT, V29, P1247, DOI 10.1002/humu.20751; Guilford W. G., 1996, Strombeck's small animal gastroenterology, by W. G. Guilford et al., P451; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; House AK, 2009, TISSUE ANTIGENS, V73, P250, DOI 10.1111/j.1399-0039.2008.01190.x; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kennedy LJ, 1999, VET IMMUNOL IMMUNOP, V69, P101, DOI 10.1016/S0165-2427(99)00046-X; Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Magalhaes JG, 2007, SEMIN IMMUNOL, V19, P106, DOI 10.1016/j.smim.2006.12.006; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; McMahon LA, 2010, VET IMMUNOL IMMUNOP, V135, P158, DOI 10.1016/j.vetimm.2009.11.012; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogushi K, 2004, J BIOL CHEM, V279, P12213, DOI 10.1074/jbc.M307944200; Ortega-Cava CF, 2006, CLIN VACCINE IMMUNOL, V13, P132, DOI 10.1128/CVI.13.1.132-138.2006; Palazzo M, 2007, J IMMUNOL, V178, P4296, DOI 10.4049/jimmunol.178.7.4296; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Stanislawowski M, 2009, J PHYSIOL PHARMACOL, V60, P71; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Szebeni B, 2008, CLIN EXP IMMUNOL, V151, P34, DOI 10.1111/j.1365-2249.2007.03531.x; Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	48	89	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15740	10.1371/journal.pone.0015740	http://dx.doi.org/10.1371/journal.pone.0015740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203467	Green Submitted, Green Published, gold			2022-12-25	WOS:000285579200035
J	Livolsi, A; Niederhoffer, N; Dali-Youcef, N; Mokni, W; Olexa-Zorn, C; Gies, JP; Marcellin, L; Feldman, J; Bousquet, P				Livolsi, Angelo; Niederhoffer, Nathalie; Dali-Youcef, Nassim; Mokni, Walid; Olexa-Zorn, Catherine; Gies, Jean-Pierre; Marcellin, Luc; Feldman, Josiane; Bousquet, Pascal			Constitutive Overexpression of Muscarinic Receptors Leads to Vagal Hyperreactivity	PLOS ONE			English	Article							EXONIC SPLICING ENHANCERS; VASOVAGAL SYNCOPE; HUMAN HEART; ACETYLCHOLINE-RECEPTORS; MULTIPLE SUBTYPES; GENE-EXPRESSION; SUDDEN-DEATH; GUINEA-PIG; VARIABILITY; SPECIFICITY	Background: Alterations in muscarinic receptor expression and acetylcholinesterase (AchE) activity have been observed in tissues from Sudden Infant Death Syndrome (SIDS). Vagal overactivity has been proposed as a possible cause of SIDS as well as of vasovagal syncopes. The aim of the present study was to seek whether muscarinic receptor overexpression may be the underlying mechanism of vagal hyperreactivity. Rabbits with marked vagal pauses following injection of phenylephrine were selected and crossed to obtain a vagal hyperreactive strain. The density of cardiac muscarinic receptors and acetylcholinesterase (AchE) gene expression were assessed. Blood markers of the observed cardiac abnormalities were also sought. Methodology/Principal Findings: Cardiac muscarinic M(2) and M(3) receptors were overexpressed in hyperreactive rabbits compared to control animals (2.3-fold and 2.5-fold, respectively) and the severity of the phenylephrine-induced bradycardia was correlated with their densities. A similar overexpression of M(2) receptors was observed in peripheral mononuclear white blood cells, suggesting that cardiac M(2) receptor expression can be inferred with high confidence from measurements in blood cells. Sequencing of the coding fragment of the M(2) receptor gene revealed a single nucleotide mutation in 83% of hyperreactive animals, possibly contributing for the transcript overexpression. Significant increases in AchE expression and activity were also assessed (AchE mRNA amplification ratio of 3.6 versus normal rabbits). This phenomenon might represent a compensatory consequence of muscarinic receptors overexpression. Alterations in M(2) receptor and AchE expression occurred between the 5th and the 7th week of age, a critical period also characterized by a higher mortality rate of hyperreactive rabbits (52% in H rabbits versus 13% in normal rabbits) and preceeded the appearance of functional disorders. Conclusions/Significance: The results suggest that cardiac muscarinic receptor overexpression plays a critical role in the development of vagal hyperreactivity, whereas AchE hyperactivity appears as a compensatory consequence of it. Since similar vagal disorders were observed recently by us in SIDS, muscarinic receptor overexpression could become a marker of risk of vasovagal syncopes and SIDS.	[Livolsi, Angelo; Niederhoffer, Nathalie; Mokni, Walid; Olexa-Zorn, Catherine; Feldman, Josiane; Bousquet, Pascal] Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc EA 4438, Strasbourg, France; [Livolsi, Angelo; Mokni, Walid; Olexa-Zorn, Catherine; Bousquet, Pascal] Hop Univ Strasbourg, Strasbourg, France; [Mokni, Walid; Gies, Jean-Pierre; Bousquet, Pascal] Univ Strasbourg, CNRS, Lab Biophoton & Pharmacol, UMR 7213, Strasbourg, France; [Dali-Youcef, Nassim; Mokni, Walid; Bousquet, Pascal] Univ Strasbourg, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire Strasbourg IGB, Illkirch Graffenstaden, France; [Dali-Youcef, Nassim; Mokni, Walid; Bousquet, Pascal] Hop Univ, Lab Biochim Gen & Specialisee, Strasbourg, France; [Mokni, Walid; Bousquet, Pascal] Hop Univ, INSERM, Ctr Invest Clin, Strasbourg, France; [Marcellin, Luc] Hop Univ, Dept Anat Pathol, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg	Livolsi, A (corresponding author), Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc EA 4438, Strasbourg, France.	pascal.bousquet@unistra.fr	Niederhoffer, Nathalie/AAF-1343-2020; DALI-YOUCEF, Nassim/O-2549-2016	DALI-YOUCEF, Nassim/0000-0001-6958-1331	French Ministry of Research	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamia S, 2008, BLOOD, V112, P5111, DOI 10.1182/blood-2008-02-141770; Alexander SPH, 2004, BRIT J PHARMACOL, V141, pS1; Bechir M, 2003, CIRCULATION, V107, P1620, DOI 10.1161/01.CIR.0000056105.87040.2B; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Carvalho FA, 2004, J APPL TOXICOL, V24, P419, DOI 10.1002/jat.993; Chemnitius JM, 1997, GEN PHARMACOL, V28, P567, DOI 10.1016/S0306-3623(96)00287-X; Dalefield RR, 1999, GEN PHARMACOL, V32, P341, DOI 10.1016/S0306-3623(98)00229-8; Edner A, 2000, ACTA PAEDIATR, V89, P1326, DOI 10.1080/080352500300002516; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; ENGEL GL, 1978, ANN INTERN MED, V89, P403, DOI 10.7326/0003-4819-89-3-403; Ganzeboom KS, 2006, J CARDIOVASC ELECTR, V17, P1172, DOI 10.1111/j.1540-8167.2006.00595.x; Ganzeboom KS, 2003, AM J CARDIOL, V91, P1006, DOI 10.1016/S0002-9149(03)00127-9; GIES JP, 1989, J PHARMACOL EXP THER, V250, P309; HADDAD EB, 1991, AM J PHYSIOL, V261, pL327, DOI 10.1152/ajplung.1991.261.4.L327; Hellgren I, 2000, CELL MOL LIFE SCI, V57, P175, DOI 10.1007/s000180050507; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livolsi A, 2002, CIRCULATION, V106, P2301, DOI 10.1161/01.CIR.0000039155.49920.1F; Livolsi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009464; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Piccirillo G, 2004, CLIN SCI, V107, P55, DOI 10.1042/CS20030327; Shi H, 2004, J BIOL CHEM, V279, P21774, DOI 10.1074/jbc.C400100200; Shi H, 1999, MOL PHARMACOL, V55, P497; Shojaei-Brosseau T, 2003, ARCH DIS CHILD, V88, P88, DOI 10.1136/adc.88.1.88; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Vaddadi G, 2007, MED J AUSTRALIA, V187, P299, DOI 10.5694/j.1326-5377.2007.tb01248.x; Wang HZ, 2001, MOL PHARMACOL, V59, P1029, DOI 10.1124/mol.59.5.1029; Wang ZG, 2004, BRIT J PHARMACOL, V142, P395, DOI 10.1038/sj.bjp.0705787; WEI JW, 1978, EUR J PHARMACOL, V52, P235; Wilde AAM, 2007, CLIN AUTON RES, V17, P203, DOI 10.1007/s10286-007-0432-1; Willmy-Matthes P, 2003, N-S ARCH PHARMACOL, V368, P316, DOI 10.1007/s00210-003-0796-2	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15618	10.1371/journal.pone.0015618	http://dx.doi.org/10.1371/journal.pone.0015618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203511	Green Submitted, gold, Green Published			2022-12-25	WOS:000285578000038
J	Miao, AJ; Luo, ZP; Chen, CS; Chin, WC; Santschi, PH; Quigg, A				Miao, Ai-Jun; Luo, Zhiping; Chen, Chi-Shuo; Chin, Wei-Chun; Santschi, Peter H.; Quigg, Antonietta			Intracellular Uptake: A Possible Mechanism for Silver Engineered Nanoparticle Toxicity to a Freshwater Alga Ochromonas danica	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; CHELATING-AGENTS; NANOMATERIALS; DISSOLUTION; KINETICS; RISK	The behavior and toxicity of silver engineered nanoparticles (Ag-ENs) to the mixotrophic freshwater alga Ochromonas danica were examined in the present study to determine whether any other mechanisms are involved in their algal toxicity besides Ag(+) liberation outside the cells. Despite their good dispersability, the Ag-ENs were found to continuously aggregate and dissolve rapidly. When the initial nanoparticle concentration was lower than 10 mu M, the total dissolved Ag(+) concentration ([ Ag(+)] T) in the suspending media reached its maximum after 1 d and then decreased suggesting that Ag(+) release might be limited by the nanoparticle surface area under these conditions. Furthermore, Ag-EN dissolution extent remarkably increased in the presence of glutathione. In the Ag-EN toxicity experiment, glutathione was also used to eliminate the indirect effects of Ag(+) that was released. However, remarkable toxicity was still observed although the free Ag(+) concentration in the media was orders of magnitude lower than the non-observed effect concentration of Ag(+) itself. Such inhibitive effects were mitigated when more glutathione was added, but could never be completely eliminated. Most importantly, we demonstrate, for the first time, that Ag-ENs can be taken in and accumulated inside the algal cells, where they exerted their toxic effects. Therefore, nanoparticle internalization may be an alternative pathway through which algal growth can be influenced.	[Miao, Ai-Jun] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu Prov, Peoples R China; [Miao, Ai-Jun; Santschi, Peter H.; Quigg, Antonietta] Texas A&M Univ, Dept Marine Sci, Galveston, TX 77553 USA; [Miao, Ai-Jun; Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Luo, Zhiping] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX USA; [Chen, Chi-Shuo; Chin, Wei-Chun] Univ Calif Merced, Sch Engn, Merced, CA USA; [Santschi, Peter H.; Quigg, Antonietta] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	Nanjing University; Texas A&M University System; Texas A&M University System; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Merced; Texas A&M University System; Texas A&M University College Station	Miao, AJ (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu Prov, Peoples R China.	miaoaj@nju.edu.cn	Quigg, Antonietta S/A-9345-2010; Santschi, Peter H/D-5712-2012; Luo, Zhiping/C-4435-2014; Chin, Wei-Chun/A-6068-2008	Santschi, Peter H/0000-0001-8188-7691; Luo, Zhiping/0000-0002-8264-6424; Chin, Wei-Chun/0000-0003-4881-9085	Texas Institute of Oceanography; National Natural Science Foundation of China [41001338]; Natural Science Foundation of Jiangsu Province [BK2010371]; National Science Foundation [NSF-0351559, NSF-0210865, NSF-CBET-0933137, NSF-CBET-0932404]; National Oceanic and Atmospheric Administration [NAO5NOS4191064]	Texas Institute of Oceanography; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported, in parts, by the Texas Institute of Oceanography Postdoctoral Fellowship to Ai-Jun Miao, the National Natural Science Foundation of China (41001338) to Ai-Jun Miao, the Natural Science Foundation of Jiangsu Province (BK2010371) to Ai-Jun Miao, the National Science Foundation (NSF-0351559 and NSF-0210865) to Peter Santschi, (NSF-CBET-0933137) to Peter Santschi and Antonietta Quigg, (NSF-CBET-0932404) to Wei-Chun Chin and the National Oceanic and Atmospheric Administration (NAO5NOS4191064) to Antonietta Quigg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NWH, 1999, ENVIRON TOXICOL CHEM, V18, P2674, DOI 10.1002/etc.5620181204; ANDERSSON LO, 1972, J POLYM SCI A1, V10, P1963, DOI 10.1002/pol.1972.150100707; [Anonymous], 2010, PROJECT EMERGING NAN; Bell RA, 1999, ENVIRON TOXICOL CHEM, V18, P9, DOI [10.1897/1551-5028(1999)018&lt;0009:SCAGOS&gt;2.3.CO;2, 10.1002/etc.5620180103]; BELL RA, 1997, SILVER COMPLEXES ENV, P10; Borm P, 2006, TOXICOL SCI, V90, P23, DOI 10.1093/toxsci/kfj084; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; CHANG HC, 1983, J COLLOID INTERF SCI, V92, P479, DOI 10.1016/0021-9797(83)90169-8; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Fredd CN, 1998, J COLLOID INTERF SCI, V204, P187, DOI 10.1006/jcis.1998.5535; GREEN JB, 1977, J INORG NUCL CHEM, V39, P1023, DOI 10.1016/0022-1902(77)80257-1; Griffitt RJ, 2008, ENVIRON TOXICOL CHEM, V27, P1972, DOI 10.1897/08-002.1; Guillard R.R.L., 1975, CULTURE PHYTOPLANKTO; Han X, 2006, J COLLOID INTERF SCI, V303, P365, DOI 10.1016/j.jcis.2006.08.028; Johnston HJ, 2010, CRIT REV TOXICOL, V40, P328, DOI 10.3109/10408440903453074; Laban G, 2010, ECOTOXICOLOGY, V19, P185, DOI 10.1007/s10646-009-0404-4; Lee DY, 2005, AQUAT TOXICOL, V75, P127, DOI 10.1016/j.aquatox.2005.06.011; Li ZQ, 2010, ENVIRON SCI TECHNOL, V44, P3462, DOI 10.1021/es9031198; Lu WT, 2010, CHEM PHYS LETT, V487, P92, DOI 10.1016/j.cplett.2010.01.027; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6; MEYERS CN, 1921, J LAB CLIN MED, V6, P359; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Ratte HT, 1999, ENVIRON TOXICOL CHEM, V18, P89, DOI [10.1002/etc.5620180112, 10.1897/1551-5028(1999)018&lt;0089:BATOSC&gt;2.3.CO;2]; Rothhaupt KO, 1996, ECOLOGY, V77, P706, DOI 10.2307/2265495; SCHINDLER P, 1964, HELV CHIM ACTA, V47, P982, DOI 10.1002/hlca.19640470409; SCHINDLER P, 1965, HELV CHIM ACTA, V48, P1204, DOI 10.1002/hlca.19650480528; Stampoulis D, 2009, ENVIRON SCI TECHNOL, V43, P9473, DOI 10.1021/es901695c; Wen LS, 1997, ENVIRON SCI TECHNOL, V31, P723, DOI 10.1021/es9603057; Wiesner MR, 2009, ENVIRON SCI TECHNOL, V43, P6458, DOI 10.1021/es803621k; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914	33	144	150	7	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15196	10.1371/journal.pone.0015196	http://dx.doi.org/10.1371/journal.pone.0015196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203552	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000022
J	Taghizadeh, R; Noh, M; Huh, YH; Ciusani, E; Sigalotti, L; Maio, M; Arosio, B; Nicotra, MR; Natali, P; Sherley, JL; La Porta, CAM				Taghizadeh, Rouzbeh; Noh, Minsoo; Huh, Yang Hoon; Ciusani, Emilio; Sigalotti, Luca; Maio, Michele; Arosio, Beatrice; Nicotra, Maria R.; Natali, PierGiorgio; Sherley, James L.; La Porta, Caterina A. M.			CXCR6, a Newly Defined Biomarker of Tissue-Specific Stem Cell Asymmetric Self-Renewal, Identifies More Aggressive Human Melanoma Cancer Stem Cells	PLOS ONE			English	Article							CLASS-I; EXPRESSION; VARIANTS; DNA; DEHYDROGENASE; COSEGREGATION; RESISTANCE; RECEPTORS; ANTIGENS; ABCG2	Background: A fundamental problem in cancer research is identifying the cell type that is capable of sustaining neoplastic growth and its origin from normal tissue cells. Recent investigations of a variety of tumor types have shown that phenotypically identifiable and isolable subfractions of cells possess the tumor-forming ability. In the present paper, using two lineage-related human melanoma cell lines, primary melanoma line IGR39 and its metastatic derivative line IGR37, two main observations are reported. The first one is the first phenotypic evidence to support the origin of melanoma cancer stem cells (CSCs) from mutated tissue-specific stem cells; and the second one is the identification of a more aggressive subpopulation of CSCs in melanoma that are CXCR6+. Methods/Findings: We defined CXCR6 as a new biomarker for tissue-specific stem cell asymmetric self-renewal. Thus, the relationship between melanoma formation and ABCG2 and CXCR6 expression was investigated. Consistent with their non-metastatic character, unsorted IGR39 cells formed significantly smaller tumors than unsorted IGR37 cells. In addition, ABCG2+ cells produced tumors that had a 2-fold greater mass than tumors produced by unsorted cells or ABCG2-cells. CXCR6+ cells produced more aggressive tumors. CXCR6 identifies a more discrete subpopulation of cultured human melanoma cells with a more aggressive MCSC phenotype than cells selected on the basis of the ABCG2+ phenotype alone. Conclusions/Significance: The association of a more aggressive tumor phenotype with asymmetric self-renewal phenotype reveals a previously unrecognized aspect of tumor cell physiology. Namely, the retention of some tissue-specific stem cell attributes, like the ability to asymmetrically self-renew, impacts the natural history of human tumor development. Knowledge of this new aspect of tumor development and progression may provide new targets for cancer prevention and treatment.	[Taghizadeh, Rouzbeh; Huh, Yang Hoon; Sherley, James L.] Boston Biomed Res Inst, Adult Stem Cell Technol Ctr, Program Canc Biol, Watertown, MA USA; [Noh, Minsoo] Ajou Univ, Coll Pharm, Suwon 441749, South Korea; [Ciusani, Emilio] Ist Neurol Carlo Besta, Milan, Italy; [Sigalotti, Luca; Maio, Michele] Ist Ricovero Cura Carattere Sci, Ctr Riferimento Oncol, Dept Med Oncol, Canc Bioimmunotherapy Unit, Aviano, Italy; [Arosio, Beatrice] Univ Milan, Dept Internal Med, Milan, Italy; [Nicotra, Maria R.] CNR, Mol Biol & Pathol Inst, Rome, Italy; [Natali, PierGiorgio] Univ G dAnnunzio, CINBO Lab, Chieti, Italy; [La Porta, Caterina A. M.] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy	Boston Biomedical Research Institute; Ajou University; IRCCS Istituto Neurologico Besta; IRCCS Aviano (CRO); University of Milan; Consiglio Nazionale delle Ricerche (CNR); G d'Annunzio University of Chieti-Pescara; University of Milan		caterina.laporta@unimi.it	Ciusani, Emilio/J-9822-2016; Sigalotti, Luca/A-5893-2013; Sigalotti, Luca/AAC-2926-2020; Taghizadeh, Rouzbeh R./AAO-6669-2021; la porta, caterina/K-7345-2013	Ciusani, Emilio/0000-0002-7285-123X; Sigalotti, Luca/0000-0003-3362-5026; Sigalotti, Luca/0000-0002-1436-2358; Taghizadeh, Rouzbeh R./0000-0002-3437-7530; Arosio, Beatrice/0000-0002-0615-3580; la porta, caterina/0000-0002-3010-8966; coral, sandra/0000-0002-1308-3082; Maio, Michele/0000-0002-0323-6321; NOH, MINSOO/0000-0002-4020-5372	National Institues of Health [5DP1OD000805]; National Italian grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000805] Funding Source: NIH RePORTER	National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Italian grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Institues of Health Director's Pioneer Award #5DP1OD000805 and by National Italian grant COFIN 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Calabro L, 2005, J CELL PHYSIOL, V202, P474, DOI 10.1002/jcp.20133; Coral S, 1999, J IMMUNOTHER, V22, P16, DOI 10.1097/00002371-199901000-00003; Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; HANNES B, 2007, HUM PATHOL, V38, P768; Jager E, 1997, INT J CANCER, V71, P142, DOI 10.1002/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Kondo C, 2004, PHARM RES-DORDR, V21, P1895, DOI 10.1023/B:PHAM.0000045245.21637.d4; La Porta C, 2009, STEM CELL REV REP, V5, P61, DOI 10.1007/s12015-008-9048-7; La Porta CAM, 2009, CURR CANCER DRUG TAR, V9, P391, DOI 10.2174/156800909788166574; Lee HS, 2003, BIOTECHNOL BIOENG, V83, P760, DOI 10.1002/bit.10727; Liu Y, 1998, J CELL PHYSIOL, V177, P364, DOI 10.1002/(SICI)1097-4652(199811)177:2<364::AID-JCP18>3.0.CO;2-9; Liu YA, 1998, MOL BIOL CELL, V9, P15, DOI 10.1091/mbc.9.1.15; Loeffler Markus, 1997, P1, DOI 10.1016/B978-012563455-7/50002-7; Meijer J, 2008, CANCER RES, V68, P4701, DOI 10.1158/0008-5472.CAN-08-0482; Merok JR, 2002, CANCER RES, V62, P6791; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Nakagawa H, 2008, BIOCHEM J, V411, P623, DOI 10.1042/BJ20071229; Rambhatla L, 2005, CANCER RES, V65, P3155, DOI 10.1158/0008-5472.CAN-04-3161; Rambhatla L., 2001, J BIOMED BIOTECHNOL, V1, P28, DOI DOI 10.1155/S1110724301000079; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Seidl H, 2007, HUM PATHOL, V38, P768, DOI 10.1016/j.humpath.2006.11.013; Sherley James L., 2005, P21, DOI 10.1142/9781860949296_0002; Sigalotti L, 2002, BRIT J CANCER, V86, P979, DOI 10.1038/sj.bjc.6600174; Tamura A, 2006, MOL PHARMACOL, V70, P287, DOI 10.1124/mol.106.023556; Zamber CP, 2003, PHARMACOGENETICS, V13, P19, DOI 10.1097/00008571-200301000-00004	29	62	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15183	10.1371/journal.pone.0015183	http://dx.doi.org/10.1371/journal.pone.0015183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203549	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000021
J	Martin, CW; Valentine, MM; Valentine, JF				Martin, Charles W.; Valentine, Marla M.; Valentine, John F.			Competitive Interactions between Invasive Nile Tilapia and Native Fish: The Potential for Altered Trophic Exchange and Modification of Food Webs	PLOS ONE			English	Article							COASTAL MISSISSIPPI WATERSHEDS; OREOCHROMIS-NILOTICUS; SALINITY TOLERANCE; NONNATIVE ENVIRONMENTS; SPECIES INVASIONS; COLD TOLERANCE; INVASIBILITY; AQUACULTURE; COMMUNITY; EXTINCTION	Recent studies have highlighted both the positive and negative impacts of species invasions. Most of these studies have been conducted on either immobile invasive plants or sessile fauna found at the base of food webs. Fewer studies have examined the impacts of vagile invasive consumers on native competitors. This is an issue of some importance given the controlling influence that consumers have on lower order plants and animals. Here, we present results of laboratory experiments designed to assess the impacts of unintended aquaculture releases of the Nile tilapia (Oreochromis niloticus), in estuaries of the Gulf of Mexico, on the functionally similar redspotted sunfish (Lepomis miniatus). Laboratory choice tests showed that tilapia prefer the same structured habitat that native sunfish prefer. In subsequent interspecific competition experiments, agonistic tilapia displaced sunfish from their preferred structured habitats. When a piscivore (largemouth bass) was present in the tank with both species, the survival of sunfish decreased. Based on these findings, if left unchecked, we predict that the proliferation of tilapia (and perhaps other aggressive aquaculture fishes) will have important detrimental effects on the structure of native food webs in shallow, structured coastal habitats. While it is likely that the impacts of higher trophic level invasive competitors will vary among species, these results show that consequences of unintended releases of invasive higher order consumers can be important.	[Martin, Charles W.; Valentine, Marla M.; Valentine, John F.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Martin, Charles W.; Valentine, John F.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	Dauphin Island Sea Lab; University of South Alabama	Martin, CW (corresponding author), Dauphin Isl Sea Lab, Dauphin Isl, AL USA.	cwm301@jaguar1.usouthal.edu		Martin, Charles/0000-0001-9240-3824	Northern Gulf Institute; Dauphin Island Sea Lab; Department of Marine Sciences at the University of South Alabama	Northern Gulf Institute; Dauphin Island Sea Lab; Department of Marine Sciences at the University of South Alabama	Support for this project was provided through funding from the Northern Gulf Institute, Dauphin Island Sea Lab, and the Department of Marine Sciences at the University of South Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVELLA M, 1993, J FISH BIOL, V42, P243, DOI 10.1111/j.1095-8649.1993.tb00325.x; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Blanchet S, 2007, ECOL FRESHW FISH, V16, P133, DOI 10.1111/j.1600-0633.2006.00205.x; Bologna PAX, 2000, ESTUARIES, V23, P449, DOI 10.2307/1353138; Boschung HT, 2004, FISHES A SMITHSONIAN; Braaten B, 1983, ICES COASTAL MANAGEM, V26, P11; Buria L, 2007, FUND APPL LIMNOL, V168, P145, DOI 10.1127/1863-9135/2007/0168-0145; Capers RS, 2007, ECOLOGY, V88, P3135, DOI 10.1890/06-1911.1; Charo-Karisa H, 2005, AQUACULTURE, V249, P115, DOI 10.1016/j.aquaculture.2005.04.029; CHERVINSKI J, 1971, Bamidgeh, V23, P125; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cleland EE, 2004, ECOL LETT, V7, P947, DOI 10.1111/j.1461-0248.2004.00655.x; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; CONRY PJ, 1988, CONDOR, V90, P478, DOI 10.2307/1368576; Costa-Pierce BA, 2003, BIOL INVASIONS, V5, P71, DOI 10.1023/A:1024094606326; Courtenay Jr WR, 1991, BIOL POLLUTION CONTR, P35; Courtenay Jr WR, 1997, TILAPIA AQUACULTURE, V1, P18; Courtenay W.R. Jr, 1984, P41; COURTENAY WR, 1973, T AM FISH SOC, V102, P1, DOI 10.1577/1548-8659(1973)102<1:EAOIFW>2.0.CO;2; CRUTCHFIELD JU, 1995, AM FISH S S, V15, P452; Davis M. A., 2009, INVASION BIOL; Davis MA, 2003, BIOSCIENCE, V53, P481, DOI 10.1641/0006-3568(2003)053[0481:BGDCFI]2.0.CO;2; DEFUR PL, 1995, ESTUARIES, V18, P2, DOI 10.2307/1352278; DIAL R S, 1983, Florida Scientist, V46, P8; Dukes JS, 2004, REV CHIL HIST NAT, V77, P411; Duponchelle F, 1998, AQUAT LIVING RESOUR, V11, P137, DOI 10.1016/S0990-7440(98)80110-1; Edyvane K.S., 1999, Wetlands Ecology and Management, V7, P83, DOI 10.1023/A:1008481228129; El-Sayed AFM, 1999, AQUACULTURE, V179, P149, DOI 10.1016/S0044-8486(99)00159-3; Elton C. S., 1958, ECOLOGY INVASIONS AN; ESTES JA, 1978, ECOLOGY, V59, P822, DOI 10.2307/1938786; FAO Fisheries Department, 1997, FAO TECHN GUID RESP; FARMER GJ, 1969, J FISH RES BOARD CAN, V26, P2807, DOI 10.1139/f69-277; Faunce CH, 1999, WETLANDS, V19, P126, DOI 10.1007/BF03161741; Febry R, 1987, J EXP BIOL, V128, P60; Fodrie FJ, 2009, GLOBAL CHANGE BIOL; GOWEN RJ, 1987, OCEANOGR MAR BIOL, V25, P563; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Grosholz ED, 2000, ECOLOGY, V81, P1206, DOI 10.2307/177202; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hargreaves JA, 2000, TILAPIA AQUACULTURE, V2, P60; HAUSER WJ, 1977, CALIF FISH GAME, V63, P228; Heck KL, 2007, ESTUAR COAST, V30, P371, DOI 10.1007/BF02819384; Hofer Scott C., 2002, World Aquaculture, V33, P19; Howells RG, 1992, TEXAS PARKS WILDLIFE, V78; Jennings Dawn P., 1992, Northeast Gulf Science, V12, P111; Krakowiak PJ, 2008, J GREAT LAKES RES, V34, P675, DOI 10.3394/0380-1330-34.4.675; KREBS CJ, 1995, OECOLOGIA, V103, P481, DOI 10.1007/BF00328687; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lightner DV, 1997, REV SCI TECH OIE, V16, P146, DOI 10.20506/rst.16.1.1010; Liti D, 2005, AQUAC RES, V36, P746, DOI 10.1111/j.1365-2109.2005.01265.x; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; LOTAN RUTH, 1960, BAMIDGEH, V12, P96; Lowe MR, 2008, MS AL SEAGR BAYS BAY; LYDEARD C, 1995, CONSERV BIOL, V9, P800, DOI 10.1046/j.1523-1739.1995.09040800.x; Mack RN, 2000, ECOLOGICAL APPL, V10; Mair GC, 2000, P TIL 2001 INT TECHN, P136; Martin CW, 2011, ESTUAR COAST, V34, P364, DOI 10.1007/s12237-010-9274-5; McBay L. G., 1961, P 15 ANN C SE ASS GA, P208; McDonald JL, 2006, THESIS U SO MISSISSI; McVicar AH, 1997, ICES J MAR SCI, V54, P1093, DOI 10.1016/S1054-3139(97)80014-8; Miller SA, 2006, FRESHWATER BIOL, V51, P85, DOI 10.1111/j.1365-2427.2005.01477.x; Muir JF, 1998, J NW ATL FISH SCI, V23, P157; National Research Council, 1995, UND MAR BIOD; Naylor RL, 2001, SCIENCE, V294, P1655, DOI 10.1126/science.1064875; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Nico LG, 2010, USGS NONINDIGENOUS A; Nugon RW, 2003, THESIS SCH RENEWABLE; Nunan LM, 1998, AQUACULTURE, V160, P19, DOI 10.1016/S0044-8486(97)00222-6; OGUTUOHWAYO R, 1991, CAN J FISH AQUAT SCI, V48, P8, DOI 10.1139/f91-299; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Park K, 2007, J COASTAL RES, V23, P1332, DOI 10.2112/06-0686.1; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PERRY WG, 1972, PROG FISH CULT, V34, P229, DOI 10.1577/1548-8659(1972)34[229:COSMAT]2.0.CO;2; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Peterson MS, 2006, ENVIRON BIOL FISH, V76, P283, DOI 10.1007/s10641-006-9033-4; Peterson MS, 2005, WETLANDS, V25, P112, DOI 10.1672/0277-5212(2005)025[0112:TOONNT]2.0.CO;2; Peterson MS, 2004, COPEIA, P842; Peterson MS, 2002, 206 MISS DEP WILDL F; POPPER D, 1975, AQUACULTURE, V5, P213, DOI 10.1016/0044-8486(75)90101-5; POTTS WTW, 1967, J EXP BIOL, V47, P461; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Ricciardi A, 2004, TRENDS ECOL EVOL, V19, P619, DOI 10.1016/j.tree.2004.09.021; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Schiermeier Q, 2002, NATURE, V419, P662, DOI 10.1038/419662a; SELVIN HC, 1966, AM STAT, V20, P20, DOI 10.2307/2681493; Shafland Paul L., 1996, Reviews in Fisheries Science, V4, P101; Smith MD, 2004, OIKOS, V106, P253, DOI 10.1111/j.0030-1299.2004.13057.x; Springer V. G., 1963, Transactions of the American Fisheries Society, V92, P317, DOI 10.1577/1548-8659(1963)92[317:TACTHD]2.0.CO;2; Stickney RR, 2002, RESPONSIBLE MARINE AQUACULTURE, P205, DOI 10.1079/9780851996042.0205; TAYLOR JN, 1986, COPEIA, P903, DOI 10.2307/1445286; WATANABE WO, 1985, AQUACULTURE, V47, P353, DOI 10.1016/0044-8486(85)90220-0; WATANABE WO, 1985, AQUACULTURE, V48, P159, DOI 10.1016/0044-8486(85)90102-4; Wiles GJ, 2003, CONSERV BIOL, V17, P1350, DOI 10.1046/j.1523-1739.2003.01526.x; Williams MJ, 1997, AQUACULTURE SUSTAINA, P16; WILSON EO, 2006, CREATION APPEAL SAVE; ZALE AV, 1989, T AM FISH SOC, V118, P718, DOI 10.1577/1548-8659(1989)118<0718:EOSOCT>2.3.CO;2	99	78	89	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14395	10.1371/journal.pone.0014395	http://dx.doi.org/10.1371/journal.pone.0014395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200433	gold, Green Submitted, Green Published			2022-12-25	WOS:000285576900010
J	Costea, I; Mack, DR; Israel, D; Morgan, K; Krupoves, A; Seidman, E; Deslandres, C; Lambrette, P; Grimard, G; Levy, E; Amre, DK				Costea, Irina; Mack, David R.; Israel, David; Morgan, Kenneth; Krupoves, Alfreda; Seidman, Ernest; Deslandres, Colette; Lambrette, Philippe; Grimard, Guy; Levy, Emile; Amre, Devendra K.			Genes Involved in the Metabolism of Poly-Unsaturated Fatty-Acids (PUFA) and Risk for Crohn's Disease in Children & Young Adults	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; COLONIC-MUCOSA; EXPRESSION; LEUKOTRIENE-B4; VARIANTS; EPIDEMIOLOGY; EICOSANOIDS	Background and Objectives: Epidemiological evidence for the role of polyunsaturated fatty-acids (PUFA) in Crohn's disease (CD) is unclear, although the key metabolite leucotriene B4 (LTB4) is closely linked to the inflammatory process. We hypothesized that inherited variation in key PUFA metabolic enzymes may modify susceptibility for CD. Methods and Principal Results: A case-control design was implemented at three pediatric gastroenterology clinics in Canada. Children <= 20 yrs diagnosed with CD and controls were recruited. 19 single nucleotide polymorphisms (SNPs) across the ALOX5 (4) CYP4F3 (5) and CYP4F2 (10) genes, were genotyped. Associations between SNPs/haplotypes and CD were examined. A total of 431 cases and 507 controls were studied. The mean (+/-SD) age of the cases was 12.4 (+/-3.3) years. Most cases were male (56.4%), had ileo-colonic disease (L3+/-L4, 52.7%) and inflammatory behavior (B1+/-p, 87%) at diagnosis. One genotyped CYP4F3 SNP (rs2683037) not in Hardy-Weinberg Equilibrium was excluded. No associations with the remaining 4 CYP4F3 SNPs with CD were evident. However haplotype analysis revealed associations with a two-marker haplotype (TG) (rs3794987 & rs1290617) (p = 0.02; permuted p = 0.08). CYP4F2 SNPs, rs3093158 (OR (recessive) = 0.56, 95% CI = 0.35-0.89; p = 0.01), rs2074902 (OR (trend) = 1.26, 95% CI = 1.00-1.60; p = 0.05), and rs2108622 (OR (recessive) = 1.6, 95% CI = 1.00-2.57; p = 0.05) were significantly associated whereas rs1272 (OR (recessive) = 0.58, 95% CI = 0.30-1.13; p = 0.10) showed suggestions for associations with CD. A haplotype comprising these 4 SNPs was significantly associated (p = 0.007, permuted p = 0.02) with CD. Associations with SNP rs3780901 in the ALOX5 gene were borderline non-significant (OR (dominant) = 1.29, 95% CI = 0.99-1.67; p = 0.056). A haplotype comprising the 4 ALOX5 SNPs (TCAA, p = 0.036) was associated with CD, but did not withstand corrections for multiple comparisons (permuted p = 0.14). Conclusions: Inherited variation in enzymes involved in the synthesis/metabolism of LTB4 may be associated with CD. These findings implicate PUFA metabolism as a important pathway in the CD pathogenesis.	[Costea, Irina] Publ Hlth Agcy Canada, Montreal, PQ, Canada; [Costea, Irina; Krupoves, Alfreda; Deslandres, Colette; Lambrette, Philippe; Grimard, Guy; Levy, Emile; Amre, Devendra K.] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Mack, David R.] Childrens Hosp Eastern Ontario, Div Gastroenterol Hepatol & Nutr, Ottawa, ON K1H 8L1, Canada; [Israel, David] British Columbia Childrens Hosp, Dept Gastroenterol Hepatol & Nutr, Vancouver, BC, Canada; [Morgan, Kenneth] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Morgan, Kenneth; Seidman, Ernest] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Krupoves, Alfreda] Univ Montreal, Dept Prevent & Social Med, Montreal, PQ, Canada; [Seidman, Ernest] McGill Univ, Dept Med, Montreal, PQ, Canada; [Grimard, Guy] Univ Montreal, Dept Pediat, Div Orthoped, Montreal, PQ H3C 3J7, Canada; [Levy, Emile] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada	Public Health Agency of Canada; Universite de Montreal; University of Ottawa; Children's Hospital of Eastern Ontario; BC Childrens Hospital; University of British Columbia; McGill University; McGill University; Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal	Costea, I (corresponding author), Publ Hlth Agcy Canada, Montreal, PQ, Canada.	devendraamre@hotmail.com	AMRE, DEVENDRA K/D-4988-2015; Deslandres, Colette/AAO-5814-2021		Canadian Institutes of Health Research [MOP200603]; Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec; FRSQ; Sainte-Justine Hospital Foundation, Montreal; University of Montreal, Montreal	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec); Sainte-Justine Hospital Foundation, Montreal; University of Montreal, Montreal	The study was funded by the Canadian Institutes of Health Research (MOP200603). Dr. Amre is supported by a research salary award from the Fonds de la Recherche en Sante du Quebec (FRSQ), Quebec. Dr. Costea was supported by a doctoral award from the FRSQ. Dr. Krupoves is supported by a scholarship from the Sainte-Justine Hospital Foundation, Montreal and by a scholarship from the PhD Program of the University of Montreal, Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2010, ALIMENT PHARM THER, V31, P1186, DOI 10.1111/j.1365-2036.2010.04294.x; Amre DK, 2009, ALIMENT PHARM THER, V29, P1025, DOI 10.1111/j.1365-2036.2009.03953.x; Amre DK, 2008, AM J GASTROENTEROL, V103, P615, DOI 10.1111/j.1572-0241.2007.01661.x; Amre DK, 2007, AM J GASTROENTEROL, V102, P2016, DOI 10.1111/j.1572-0241.2007.01411.x; Amre DK, 2010, HUM GENET, V128, P131, DOI 10.1007/s00439-010-0835-2; Amre DK, 2009, AM J GASTROENTEROL, V104, P2824, DOI 10.1038/ajg.2009.430; Amre DK, 2009, INFLAMM BOWEL DIS, V15, P501, DOI 10.1002/ibd.20785; Amre DK, 2003, MED HYPOTHESES, V60, P344, DOI 10.1016/S0306-9877(02)00401-2; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Belluzzi A, 2000, AM J CLIN NUTR, V71, p339S, DOI 10.1093/ajcn/71.1.339s; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Curley CR, 2006, EUR J HUM GENET, V14, P1215, DOI 10.1038/sj.ejhg.5201687; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hashizume T, 2001, BIOCHEM BIOPH RES CO, V280, P1135, DOI 10.1006/bbrc.2000.4238; HAWTHORNE AB, 1992, GUT, V33, P513, DOI 10.1136/gut.33.4.513; Hendel J, 2002, INFLAMM RES, V51, P423, DOI 10.1007/PL00000324; IKEHATA A, 1993, PROSTAG LEUKOTR ESS, V49, P489, DOI 10.1016/0952-3278(93)90036-V; IKEHATA A, 1995, SCAND J GASTROENTERO, V30, P44, DOI 10.3109/00365529509093234; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jupp J, 2007, INFLAMM BOWEL DIS, V13, P537, DOI 10.1002/ibd.20094; Kikuta Y, 2002, PROSTAG OTH LIPID M, V68-9, P345, DOI 10.1016/S0090-6980(02)00039-4; Kim SG, 2004, GASTROENTEROLOGY, V126, pA260; KINSELLA JE, 1990, NUTRITION, V6, P24; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; LAURITSEN K, 1986, GASTROENTEROLOGY, V91, P837, DOI 10.1016/0016-5085(86)90684-0; LAURITSEN K, 1988, GASTROENTEROLOGY, V95, P11, DOI 10.1016/0016-5085(88)90284-3; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; LOBOS EA, 1987, DIGEST DIS SCI, V32, P1380, DOI 10.1007/BF01296664; Low JH, 2004, INFLAMM BOWEL DIS, V10, P173, DOI 10.1097/00054725-200405000-00001; Lowe AM, 2009, INFLAMM BOWEL DIS, V15, P429, DOI 10.1002/ibd.20756; MacLean CH, 2005, AM J CLIN NUTR, V82, P611, DOI 10.1093/ajcn/82.3.611; Mamula P, 2003, GASTROENTEROL CLIN N, V32, P967, DOI 10.1016/S0889-8553(03)00046-3; Massey D, 2007, GUT, V56, P1489, DOI 10.1136/gut.2007.127928; Murakami M, 2002, BIOCHEM BIOPH RES CO, V292, P689, DOI 10.1006/bbrc.2002.6716; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Sands BE, 2004, GASTROENTEROLOGY, V126, P1518, DOI 10.1053/j.gastro.2004.02.072; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Tello-Ruiz MK, 2006, EUR J HUM GENET, V14, P780, DOI 10.1038/sj.ejhg.5201612; van Heel DA, 2004, HUM MOL GENET, V13, P763, DOI 10.1093/hmg/ddh090; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081	45	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15672	10.1371/journal.pone.0015672	http://dx.doi.org/10.1371/journal.pone.0015672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187935	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200061
J	Fang, KM; Chen, JK; Hung, SC; Chen, MC; Wu, YT; Wu, TJ; Lin, HI; Chen, CH; Cheng, H; Yang, CS; Tzeng, SF				Fang, Kuan-Min; Chen, Jen-Kun; Hung, Shih-Chieh; Chen, Mei-Chun; Wu, Yi-Ting; Wu, Tsung-Jung; Lin, Hsin-I; Chen, Chia-Hua; Cheng, Henrich; Yang, Chung-Shi; Tzeng, Shun-Fen			Effects of Combinatorial Treatment with Pituitary Adenylate Cyclase Activating Peptide and Human Mesenchymal Stem Cells on Spinal Cord Tissue Repair	PLOS ONE			English	Article							MARROW STROMAL CELLS; LIPOPOLYSACCHARIDE-INDUCED NEUROTOXICITY; FUNCTIONAL RECOVERY; NERVOUS-SYSTEM; GLUTAMATE UPTAKE; AXONAL REGENERATION; REACTIVE ASTROCYTES; NEUROTROPHIC FACTOR; MICROGLIAL CELLS; GROWTH-FACTOR	The aim of this study is to understand if human mesenchymal stem cells (hMSCs) and neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) have synergistic protective effect that promotes functional recovery in rats with severe spinal cord injury (SCI). To evaluate the effect of delayed combinatorial therapy of PACAP and hMSCs on spinal cord tissue repair, we used the immortalized hMSCs that retain their potential of neuronal differentiation under the stimulation of neurogenic factors and possess the properties for the production of several growth factors beneficial for neural cell survival. The results indicated that delayed treatment with PACAP and hMSCs at day 7 post SCI increased the remaining neuronal fibers in the injured spinal cord, leading to better locomotor functional recovery in SCI rats when compared to treatment only with PACAP or hMSCs. Western blotting also showed that the levels of antioxidant enzymes, Mn-superoxide dismutase (MnSOD) and peroxiredoxin-1/6 (Prx-1 and Prx-6), were increased at the lesion center 1 week after the delayed treatment with the combinatorial therapy when compared to that observed in the vehicle-treated control. Furthermore, in vitro studies showed that co-culture with hMSCs in the presence of PACAP not only increased a subpopulation of microglia expressing galectin-3, but also enhanced the ability of astrocytes to uptake extracellular glutamate. In summary, our in vivo and in vitro studies reveal that delayed transplantation of hMSCs combined with PACAP provides trophic molecules to promote neuronal cell survival, which also foster beneficial microenvironment for endogenous glia to increase their neuroprotective effect on the repair of injured spinal cord tissue.	[Fang, Kuan-Min; Chen, Mei-Chun; Wu, Tsung-Jung; Lin, Hsin-I; Tzeng, Shun-Fen] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Chen, Jen-Kun; Wu, Yi-Ting; Chen, Chia-Hua; Yang, Chung-Shi] Natl Hlth Res Inst, Ctr Nanomed Res, Zhunan, Taiwan; [Cheng, Henrich] Taipei Vet Gen Hosp, Neural Regenerat Ctr, Taipei, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Dept Surg, Sch Med, Taipei 112, Taiwan; [Cheng, Henrich] Natl Yang Ming Univ, Dept Pharmacol, Sch Med, Taipei 112, Taiwan; [Yang, Chung-Shi] Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Puli, Taiwan	National Cheng Kung University; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Chi Nan University	Fang, KM (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan.	cyang@nhri.org.tw; stzeng@mail.ncku.edu.tw	Chen, Jen-Kun/C-6225-2011; Yang, Chung-Shi/E-3999-2010		Volkswagen Foundation within its Evolutionary Biology initiative [I/84 196]	Volkswagen Foundation within its Evolutionary Biology initiative	NC was supported by the Volkswagen Foundation within its Evolutionary Biology initiative, grant I/84 196. OK holds a Heisenberg Professorship of the German Science Foundation (DFG) (KR 2089/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bergles DE, 1998, J NEUROSCI, V18, P7709; Beschorner R, 2007, HISTOPATHOLOGY, V50, P897, DOI 10.1111/j.1365-2559.2007.02703.x; Bouhy D, 2006, FASEB J, V20, P1239, DOI 10.1096/fj.05-4382fje; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Chen WH, 2005, NEUROSCI LETT, V384, P117, DOI 10.1016/j.neulet.2005.04.070; Cheng H, 2002, J NEUROSCI RES, V69, P397, DOI 10.1002/jnr.10303; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Dezawa M, 2005, CURR MOL MED, V5, P723, DOI 10.2174/156652405774641070; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Grill R, 1997, J NEUROSCI, V17, P5560; Ha Yoon, 2005, Clin Neurosurg, V52, P341; Hattori Fumiyuki, 2007, V44, P357; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Horner PJ, 2000, J NEUROSCI, V20, P2218; Hsiao HY, 2007, GLIA, V55, P214, DOI 10.1002/glia.20453; Huang X, 2009, J NEUROL SCI, V277, P87, DOI 10.1016/j.jns.2008.10.022; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Kong LY, 1999, NEUROSCIENCE, V91, P493, DOI 10.1016/S0306-4522(98)00606-X; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Liu YP, 2008, J NEUROCHEM, V105, P137, DOI 10.1111/j.1471-4159.2007.05118.x; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mukaino M, 2010, EXP NEUROL, V224, P403, DOI 10.1016/j.expneurol.2010.04.020; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ono K, 2003, J NEUROSCI RES, V72, P503, DOI 10.1002/jnr.10588; PARK DH, 2010, STEM CELL REV; Park HW, 2010, GLIA, V58, P1118, DOI 10.1002/glia.20992; Phinney DG, 2005, CURR PHARM DESIGN, V11, P1255, DOI 10.2174/1381612053507495; REICHERT F, 1994, J NEUROSCI, V14, P3231; Reichert F, 1996, J NEUROIMMUNOL, V70, P153, DOI 10.1016/S0165-5728(96)00112-9; Reichert F, 1999, EXP NEUROL, V160, P508, DOI 10.1006/exnr.1999.7229; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Rossi SL, 2009, CURR OPIN BIOTECH, V20, P552, DOI 10.1016/j.copbio.2009.09.008; Rotshenker S, 2008, GLIA, V56, P1607, DOI 10.1002/glia.20713; Rotshenker S, 2009, J MOL NEUROSCI, V39, P99, DOI 10.1007/s12031-009-9186-7; Schinkothe T, 2008, STEM CELLS DEV, V17, P199, DOI 10.1089/scd.2007.0175; Schultz SS, 2005, CURR DRUG TARGETS, V6, P63, DOI 10.2174/1389450053345046; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tsai CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-64; Tzeng SF, 2004, NEUROSCI LETT, V367, P23, DOI 10.1016/j.neulet.2004.05.117; Vaudry D, 2000, PHARMACOL REV, V52, P269; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Walther M, 2000, J NEUROSCI RES, V61, P430, DOI 10.1002/1097-4547(20000815)61:4<430::AID-JNR9>3.0.CO;2-3; Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Waschek JA, 1998, P NATL ACAD SCI USA, V95, P9602, DOI 10.1073/pnas.95.16.9602; Watanabe J, 2007, PEPTIDES, V28, P1713, DOI 10.1016/j.peptides.2007.06.029; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yan YP, 2009, BRAIN RES, V1288, P116, DOI 10.1016/j.brainres.2009.06.073; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004	68	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15299	10.1371/journal.pone.0015299	http://dx.doi.org/10.1371/journal.pone.0015299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187959	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200034
J	Kim, MJ; Hwang, SH; Lim, JA; Froehner, SC; Adams, ME; Kim, HS				Kim, Min Jeong; Hwang, Sung Ho; Lim, Jeong A.; Froehner, Stanley C.; Adams, Marvin E.; Kim, Hye Sun			alpha-Syntrophin Modulates Myogenin Expression in Differentiating Myoblasts	PLOS ONE			English	Article							DYSTROPHIN-ASSOCIATED PROTEINS; DIACYLGLYCEROL KINASE-ZETA; NITRIC-OXIDE SYNTHASE; SKELETAL-MUSCLE; PDZ DOMAIN; NEUROMUSCULAR-JUNCTION; NUCLEAR-LOCALIZATION; GENE; CELLS; ALPHA-1-SYNTROPHIN	Background: alpha-syntrophin is a scaffolding protein linking signaling proteins to the sarcolemmal dystrophin complex in mature muscle. However, alpha-syntrophin is also expressed in differentiating myoblasts during the early stages of muscle differentiation. In this study, we examined the relationship between the expression of alpha-syntrophin and myogenin, a key muscle regulatory factor. Methods and Findings: The absence of alpha-syntrophin leads to reduced and delayed myogenin expression. This conclusion is based on experiments using muscle cells isolated from alpha-syntrophin null mice, muscle regeneration studies in alpha-syntrophin null mice, experiments in Sol8 cells (a cell line that expresses only low levels of alpha-syntrophin) and siRNA studies in differentiating C2 cells. In primary cultured myocytes isolated from alpha-syntrophin null mice, the level of myogenin was less than 50% that from wild type myocytes (p<0.005) 40 h after differentiation induction. In regenerating muscle, the expression of myogenin in the alpha-syntrophin null muscle was reduced to approximately 25% that of wild type muscle (p<0.005). Conversely, myogenin expression is enhanced in primary cultures of myoblasts isolated from a transgenic mouse over-expressing alpha-syntrophin and in Sol8 cells transfected with a vector to over-express alpha-syntrophin. Moreover, we find that myogenin mRNA is reduced in the absence of alpha-syntrophin and increased by alpha-syntrophin over-expression. Immunofluorescence microscopy shows that alpha-syntrophin is localized to the nuclei of differentiating myoblasts. Finally, immunoprecipitation experiments demonstrate that alpha-syntrophin associates with Mixed-Lineage Leukemia 5, a regulator of myogenin expression. Conclusions: We conclude that alpha-syntrophin plays an important role in regulating myogenesis by modulating myogenin expression.	[Kim, Min Jeong; Hwang, Sung Ho; Lim, Jeong A.; Kim, Hye Sun] Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea; [Froehner, Stanley C.; Adams, Marvin E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Ajou University; University of Washington; University of Washington Seattle	Kim, MJ (corresponding author), Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea.	marva@uw.edu; hsunkim@ajou.ac.kr			Korean Government (MOEHRD) [KRF-2008-531-E00004]; National Institutes of Health (NIH) [NS33145]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033145] Funding Source: NIH RePORTER	Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (KRF-2008-531-E00004) to HSK and by National Institutes of Health (NIH) grant NS33145 to SCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovici H, 2003, MOL BIOL CELL, V14, P4499, DOI 10.1091/mbc.E03-03-0190; Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Adams ME, 2004, J NEUROSCI, V24, P10302, DOI 10.1523/JNEUROSCI.3408-04.2004; ADAMS ME, 1995, J BIOL CHEM, V270, P25859, DOI 10.1074/jbc.270.43.25859; ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; Arnold HH, 1996, INT J DEV BIOL, V40, P345; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Chen ZJ, 2006, J BIOL CHEM, V281, P12414, DOI 10.1074/jbc.M508651200; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; DAUBAS P, 1988, NUCLEIC ACIDS RES, V16, P1251, DOI 10.1093/nar/16.4.1251; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FLORINI JR, 1991, MOL ENDOCRINOL, V5, P718, DOI 10.1210/mend-5-5-718; Gee SH, 1998, J NEUROSCI, V18, P128; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; Hasegawa M, 1999, J BIOL CHEM, V274, P12626, DOI 10.1074/jbc.274.18.12626; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hogan A, 2001, J BIOL CHEM, V276, P26526, DOI 10.1074/jbc.M104156200; Hosaka Y, 2002, J CELL BIOL, V158, P1097, DOI 10.1083/jcb.200204076; Kameya S, 1999, J BIOL CHEM, V274, P2193, DOI 10.1074/jbc.274.4.2193; Koo JH, 2007, BIOCHEM BIOPH RES CO, V363, P405, DOI 10.1016/j.bbrc.2007.08.186; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Luo S, 2005, J CELL BIOL, V169, P813, DOI 10.1083/jcb.200412008; Marchand E, 2001, CELL CALCIUM, V29, P85, DOI 10.1054/ceca.2000.0159; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PETERS MF, 1994, NEUROREPORT, V5, P1577, DOI 10.1097/00001756-199408150-00009; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; RICHLER C, 1970, DEV BIOL, V23, P1, DOI 10.1016/S0012-1606(70)80004-5; Roy K, 2002, J BIOL CHEM, V277, P33818, DOI 10.1074/jbc.M205159200; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	44	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15355	10.1371/journal.pone.0015355	http://dx.doi.org/10.1371/journal.pone.0015355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179410	Green Published, Green Submitted, gold			2022-12-25	WOS:000285572900020
J	Passerini, D; Beltramo, C; Coddeville, M; Quentin, Y; Ritzenthaler, P; Daveran-Mingot, ML; Le Bourgeois, P				Passerini, Delphine; Beltramo, Charlotte; Coddeville, Michele; Quentin, Yves; Ritzenthaler, Paul; Daveran-Mingot, Marie-Line; Le Bourgeois, Pascal			Genes but Not Genomes Reveal Bacterial Domestication of Lactococcus Lactis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; SUBSP LACTIS; SEQUENCE; DNA; CREMORIS; STRAINS; IDENTIFICATION; RESTRICTION; POPULATIONS; CHROMOSOME	Background: The population structure and diversity of Lactococcus lactis subsp. lactis, a major industrial bacterium involved in milk fermentation, was determined at both gene and genome level. Seventy-six lactococcal isolates of various origins were studied by different genotyping methods and thirty-six strains displaying unique macrorestriction fingerprints were analyzed by a new multilocus sequence typing (MLST) scheme. This gene-based analysis was compared to genomic characteristics determined by pulsed-field gel electrophoresis (PFGE). Methodology/Principal Findings: The MLST analysis revealed that L. lactis subsp. lactis is essentially clonal with infrequent intra-and intergenic recombination; also, despite its taxonomical classification as a subspecies, it displays a genetic diversity as substantial as that within several other bacterial species. Genome-based analysis revealed a genome size variability of 20%, a value typical of bacteria inhabiting different ecological niches, and that suggests a large pan-genome for this subspecies. However, the genomic characteristics (macrorestriction pattern, genome or chromosome size, plasmid content) did not correlate to the MLST-based phylogeny, with strains from the same sequence type (ST) differing by up to 230 kb in genome size. Conclusion/Significance: The gene-based phylogeny was not fully consistent with the traditional classification into dairy and non-dairy strains but supported a new classification based on ecological separation between "environmental" strains, the main contributors to the genetic diversity within the subspecies, and "domesticated" strains, subject to recent genetic bottlenecks. Comparison between gene-and genome-based analyses revealed little relationship between core and dispensable genome phylogenies, indicating that clonal diversification and phenotypic variability of the "domesticated" strains essentially arose through substantial genomic flux within the dispensable genome.	[Passerini, Delphine; Coddeville, Michele; Quentin, Yves; Ritzenthaler, Paul; Daveran-Mingot, Marie-Line; Le Bourgeois, Pascal] Univ Toulouse 3, Univ Toulouse, F-31062 Toulouse, France; [Passerini, Delphine; Coddeville, Michele; Quentin, Yves; Ritzenthaler, Paul; Daveran-Mingot, Marie-Line; Le Bourgeois, Pascal] CNRS, Lab Microbiol & Genet Mol, Toulouse, France; [Beltramo, Charlotte] SOREDAB SAS, La Tremblaye, La Boissiere Ec, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Passerini, D (corresponding author), Univ Toulouse 3, Univ Toulouse, F-31062 Toulouse, France.	marie-line.mingot@biotoul.fr; pascal.lebourgeois@biotoul.fr	Le Bourgeois, Pascal/G-6358-2010; Daveran-Mingot, Marie-Line/ABC-5525-2020	Le Bourgeois, Pascal/0000-0003-2039-1953; Daveran-Mingot, Marie-Line/0000-0001-6884-1840; Passerini, Delphine/0000-0002-5429-6260; Quentin, Yves/0000-0001-8248-0586	ANR-Agence Nationale de la Recherche - The French National Research Agency [ANR-05-PNRA-20]; Ministere de l'Enseignement Superieur et de la Recherche	ANR-Agence Nationale de la Recherche - The French National Research Agency(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was carried out with the financial support of the "ANR-Agence Nationale de la Recherche - The French National Research Agency" under the "Programme National de Recherche en Alimentation et nutrition humaine", project "ANR-05-PNRA-20, Genoferment". D. Passerini was supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bergthorsson U, 1998, MOL BIOL EVOL, V15, P6, DOI 10.1093/oxfordjournals.molbev.a025847; Bilhere E, 2009, APPL ENVIRON MICROB, V75, P1291, DOI 10.1128/AEM.02563-08; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Cai H, 2007, MICROBIOL-SGM, V153, P2655, DOI 10.1099/mic.0.2007/006452-0; Chaillou S, 2009, APPL ENVIRON MICROB, V75, P970, DOI 10.1128/AEM.01721-08; CHOPIN A, 1984, PLASMID, V11, P260, DOI 10.1016/0147-619X(84)90033-7; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/10635150118398; Cooper JE, 2006, MICROBIOL-SGM, V152, P1297, DOI 10.1099/mic.0.28620-0; Corroler D, 1998, APPL ENVIRON MICROB, V64, P4729; de las Rivas B, 2006, MICROBIOL-SGM, V152, P85, DOI 10.1099/mic.0.28482-0; Delorme C, 2010, APPL ENVIRON MICROB, V76, P451, DOI 10.1128/AEM.01018-09; DEVOS WM, 1990, J BIOL CHEM, V265, P22554; Diancourt L, 2007, APPL ENVIRON MICROB, V73, P6601, DOI 10.1128/AEM.01095-07; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dohm JC, 2006, J MOL EVOL, V63, P437, DOI 10.1007/s00239-005-0094-3; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; EFSTATHIOU JD, 1976, APPL ENVIRON MICROB, V32, P38, DOI 10.1128/AEM.32.1.38-44.1976; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FU YX, 1993, GENETICS, V133, P693; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; GODON JJ, 1992, APPL ENVIRON MICROB, V58, P4045, DOI 10.1128/AEM.58.12.4045-4047.1992; Guo H, 2005, APPL ENVIRON MICROB, V71, P7130, DOI 10.1128/AEM.71.11.7130-7138.2005; HAMMER BW, 1921, J DAIRY SCI, V4, P277; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Head NE, 2004, INFECT IMMUN, V72, P133, DOI 10.1128/IAI.72.1.133-144.2004; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Kelly W, 2002, MICROBIOL-SGM, V148, P3332, DOI 10.1099/00221287-148-11-3332; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KLIJN N, 1995, APPL ENVIRON MICROB, V61, P788, DOI 10.1128/AEM.61.2.788-792.1995; KOK J, 1991, BIOCHEM SOC T, V19, P670, DOI 10.1042/bst0190670; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kuo CH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-35; Lan RT, 2000, TRENDS MICROBIOL, V8, P396, DOI 10.1016/S0966-842X(00)01791-1; Le Bourgeois P, 2000, J BACTERIOL, V182, P2481, DOI 10.1128/JB.182.9.2481-2491.2000; LEBOURGEOIS P, 1992, J BACTERIOL, V174, P6752, DOI 10.1128/JB.174.21.6752-6762.1992; LEBOURGEOIS P, 1989, FEMS MICROBIOL LETT, V59, P65, DOI 10.1016/0378-1097(89)90460-6; LEBOURGEOIS P, 1995, J BACTERIOL, V177, P2840, DOI 10.1128/jb.177.10.2840-2850.1995; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mills S, 2006, FEMS MICROBIOL REV, V30, P243, DOI 10.1111/j.1574-6976.2005.00011.x; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; NEI M, 1990, GENETICS, V125, P873; NELSON RJ, 1994, APPL ENVIRON MICROB, V60, P3275, DOI 10.1128/AEM.60.9.3275-3283.1994; Nicolas P, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-141; Nomura M, 2006, J APPL MICROBIOL, V101, P396, DOI 10.1111/j.1365-2672.2006.02949.x; Rademaker JLW, 2007, APPL ENVIRON MICROB, V73, P7128, DOI 10.1128/AEM.01017-07; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Raynaud S, 2005, APPL ENVIRON MICROB, V71, P8016, DOI 10.1128/AEM.71.12.8016-8023.2005; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALAMA M, 1991, APPL ENVIRON MICROB, V57, P1313, DOI 10.1128/AEM.57.5.1313-1318.1991; SALAMA MS, 1993, APPL ENVIRON MICROB, V59, P3941, DOI 10.1128/AEM.59.11.3941-3945.1993; Schonhuber W, 2001, BMC Microbiol, V1, P20, DOI 10.1186/1471-2180-1-20; Siezen RJ, 2005, APPL ENVIRON MICROB, V71, P8371, DOI 10.1128/AEM.71.12.8371-8382.2005; Siezen RJ, 2010, J BACTERIOL, V192, P2649, DOI 10.1128/JB.00276-10; SINHA RP, 1991, CAN J MICROBIOL, V37, P488, DOI 10.1139/m91-082; Steidler L, 2006, ANN NY ACAD SCI, V1072, P176, DOI 10.1196/annals.1326.031; Tailliez P, 1998, SYST APPL MICROBIOL, V21, P530, DOI 10.1016/S0723-2020(98)80065-9; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANSKANEN EI, 1990, APPL ENVIRON MICROB, V56, P3105, DOI 10.1128/AEM.56.10.3105-3111.1990; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Teuber M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P205, DOI 10.1007/0-387-30744-3_7; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Turner KME, 2007, INT J ANTIMICROB AG, V29, P129, DOI 10.1016/j.ijantimicag.2006.11.002; Urbach E, 1997, APPL ENVIRON MICROB, V63, P694, DOI 10.1128/AEM.63.2.694-702.1997; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; Ward LJH, 2004, J APPL MICROBIOL, V96, P144, DOI 10.1046/j.1365-2672.2003.02134.x; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0	86	81	82	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15306	10.1371/journal.pone.0015306	http://dx.doi.org/10.1371/journal.pone.0015306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179431	Green Submitted, Green Published, gold			2022-12-25	WOS:000285572900017
J	Mazzola, V; Latorre, V; Petito, A; Gentili, N; Fazio, L; Popolizio, T; Blasi, G; Arciero, G; Bondolfi, G				Mazzola, Viridiana; Latorre, Valeria; Petito, Annamaria; Gentili, Nicoletta; Fazio, Leonardo; Popolizio, Teresa; Blasi, Giuseppe; Arciero, Giampiero; Bondolfi, Guido			Affective Response to a Loved One's Pain: Insula Activity as a Function of Individual Differences	PLOS ONE			English	Article							EMPATHIC NEURAL RESPONSES; MEDIAL PREFRONTAL CORTEX; OTHERS PAIN; INTEROCEPTIVE AWARENESS; PHYSIOLOGICAL CONDITION; THREATENING STIMULI; SOCIAL COGNITION; PARIETAL CORTEX; I FEEL; PERCEPTION	Individual variability in emotion processing may be associated with genetic variation as well as with psychological predispositions such as dispositional affect styles. Our previous fMRI study demonstrated that amygdala reactivity was independently predicted by affective-cognitive styles (phobic prone or eating disorders prone) and genotype of the serotonin transporter in a discrimination task of fearful facial expressions. Since the insula is associated with the subjective evaluation of bodily states and is involved in human feelings, we explored whether its activity could also vary in function of individual differences. In the present fMRI study, the association between dispositional affects and insula reactivity has been examined in two groups of healthy participants categorized according to affective-cognitive styles (phobic prone or eating disorders prone). Images of the faces of partners and strangers, in both painful and neutral situations, were used as visual stimuli. Interaction analyses indicate significantly different activations in the two groups in reaction to a loved one's pain: the phobic prone group exhibited greater activation in the left posterior insula. These results demonstrate that affective-cognitive style is associated with insula activity in pain empathy processing, suggesting a greater involvement of the insula in feelings for a certain cohort of people. In the mapping of individual differences, these results shed new light on variability in neural networks of emotion.	[Mazzola, Viridiana; Latorre, Valeria; Gentili, Nicoletta; Arciero, Giampiero] Ist Psicol Postrazionalista IPRA Rome, Rome, Italy; [Latorre, Valeria] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy; [Petito, Annamaria] Univ Foggia, Dept Med Sci, Inst Psychiat & Clin Psychol, Foggia, Italy; [Gentili, Nicoletta] SW London & St Georges NHS Trust, Natl Child & Deaf Family Serv, London, England; [Fazio, Leonardo; Blasi, Giuseppe] Univ Bari, Dept Neurol & Psychiat Sci, Sect Mental Disorders, Psychiat Neurosci Grp, Bari, Italy; [Popolizio, Teresa] IRCCSS Casa Sollievo della Sofferenza, Dept Neuroradiol, San Giovanni Rotondo, Italy; [Bondolfi, Guido] Hop Univ Geneve, Dept Psychiat, Geneva, Switzerland	Universita degli Studi di Bari Aldo Moro; University of Foggia; Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; University of Geneva	Mazzola, V (corresponding author), Ist Psicol Postrazionalista IPRA Rome, Rome, Italy.	neurolab@ipra.it	Blasi, Giuseppe/HHS-5404-2022; Fazio, Leonardo/J-4570-2012	Fazio, Leonardo/0000-0003-4000-974X; Blasi, Giuseppe/0000-0003-0878-1131				Ainsworth M., 1978, PATTERNS ATTACHMENT; Akitsuki Y, 2009, NEUROIMAGE, V47, P722, DOI 10.1016/j.neuroimage.2009.04.091; ARCIERO G, 1989, EPISTEMOLOGY ONTOLOG; Arciero G, 2004, COGNITION PSYCHOTERA, P261; Arciero G., 2000, CONSTRUCTIONS DISORD, P91, DOI [10.1037/10368-005, DOI 10.1037/10368-005]; Arciero G., 2009, SELFHOOD IDENTITY PE; Ashton-James C, 2007, SOC COGNITION, V25, P518, DOI 10.1521/soco.2007.25.4.518; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bertolino A, 2005, BIOL PSYCHIAT, V57, P1517, DOI 10.1016/j.biopsych.2005.02.031; Blasi G, 2009, BIOL PSYCHIAT, V66, P847, DOI 10.1016/j.biopsych.2009.06.017; BOWLBY J, 1973, ATTACHMENT LOSS LOSS; Bowlby J, 1973, ATTACHMENT LOSS SEPA; Bowlby J, 1982, ATTACHMENT LOSS ATTA, V1; Bretherton I, 1995, MONOGR SOC RES CHILD, V60, P310, DOI 10.2307/1166187; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Cameron OG, 2002, PSYCHOSOM MED, V64, P851, DOI 10.1097/01.PSY.0000038939.33335.32; Caprara GV, 1993, BIG 5 QUESTIONNAIRE; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chartrand TL, 2007, J EXP SOC PSYCHOL, V43, P719, DOI 10.1016/j.jesp.2006.08.003; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; COSTA PT, 1992, PERSONALITY INVENTOR; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2004, P NATL ACAD SCI USA, V101, P6333, DOI 10.1073/pnas.0401510101; Critchley HD, 2002, NEUROIMAGE, V16, P909, DOI 10.1006/nimg.2002.1147; Danziger N, 2006, BRAIN, V129, P2494, DOI 10.1093/brain/awl155; Davis M., 1996, EMPATHY SOCIAL PSYCH; Deichert NT, 2005, COGNITION EMOTION, V19, P941, DOI 10.1080/02699930541000075; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Draghi-Lorenz R, 2001, DEV REV, V21, P263, DOI 10.1006/drev.2000.0524; Ekman P., 2003, EMOTIONS REVEALED, V2; Ekman P., 1976, PICTURES FACIAL AFFE; Eysenck H.J, 1968, EYSENCK PERSONALITY; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Gu XS, 2010, J NEUROSCI, V30, P3739, DOI 10.1523/JNEUROSCI.4844-09.2010; Guidano V. F., 1987, COMPLEXITY SELF; Guidano V.F., 1991, SELF PROCESS POSTRAT; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Han SH, 2009, HUM BRAIN MAPP, V30, P3227, DOI 10.1002/hbm.20742; Hariri AR, 2009, ANNU REV NEUROSCI, V32, P225, DOI 10.1146/annurev.neuro.051508.135335; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Izard C. E., 1991, PSYCHOL EMOTIONS; Izard C.E., 1977, HUMAN EMOTIONS; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Katkin ES, 2001, PSYCHOL SCI, V12, P366, DOI 10.1111/1467-9280.00368; Levy R., 1973, TAHITIANS; Lewis Michael, 2008, HDB EMOTIONS, V3rd; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Lundstrom BN, 2003, NEUROIMAGE, V20, P1934, DOI 10.1016/j.neuroimage.2003.07.017; Magai C., 1996, HDB EMOTION ADULT DE; MAGAI C, 1995, ROLE EMOTION SOCIAL; Mayer AR, 2006, NEUROIMAGE, V30, P938, DOI 10.1016/j.neuroimage.2005.10.050; Merleau-Ponty Maurice, 2013, PHENOMENOLOGY PERCEP; Minio-Paluello I, 2009, BIOL PSYCHIAT, V65, P55, DOI 10.1016/j.biopsych.2008.08.006; Morrison I, 2007, CEREB CORTEX, V17, P2214, DOI 10.1093/cercor/bhl129; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Picardi A, 2003, PSYCHOTHER PSYCHOSOM, V72, P363, DOI 10.1159/000073037; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos O, 2007, HUM BRAIN MAPP, V28, P9, DOI 10.1002/hbm.20258; Porges, 1993, BODY PERCEPTION QUES; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Rainville P, 2006, INT J PSYCHOPHYSIOL, V61, P5, DOI 10.1016/j.ijpsycho.2005.10.024; ROSEN BC, 1976, J MARRIAGE FAM, V38, P605, DOI 10.2307/350681; ROSEN BC, 2001, MASKS MIRRORS GENERA; Rubino V, 2007, BRAIN RES BULL, V74, P250, DOI 10.1016/j.brainresbull.2007.06.019; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stapel DA, 2001, J PERS SOC PSYCHOL, V80, P766, DOI 10.1037//0022-3514.80.5.766; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; van Baaren RB, 2003, J PERS SOC PSYCHOL, V84, P1093, DOI 10.1037/0022-3514.84.5.1093; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905; WITKIN HA, 1977, PSYCHOL BULL, V84, P661, DOI 10.1037/0033-2909.84.4.661; Wong Y, 2007, SELF CONSCIOUS EMOTI, P223; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009; [No title captured]	104	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15268	10.1371/journal.pone.0015268	http://dx.doi.org/10.1371/journal.pone.0015268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	695OI	21179564	Green Published, Green Submitted, gold			2022-12-25	WOS:000285381200022
J	Westercamp, M; Bailey, RC; Bukusi, EA; Montandon, M; Kwena, Z; Cohen, CR				Westercamp, Matthew; Bailey, Robert C.; Bukusi, Elizabeth A.; Montandon, Michele; Kwena, Zachary; Cohen, Craig R.			Male Circumcision in the General Population of Kisumu, Kenya: Beliefs about Protection, Risk Behaviors, HIV, and STIs	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; NYANZA PROVINCE; PREVENTION; MEN; ACCEPTABILITY; INFECTIONS	Using a population-based survey we examined the behaviors, beliefs, and HIV/HSV-2 serostatus of men and women in the traditionally non-circumcising community of Kisumu, Kenya prior to establishment of voluntary medical male circumcision services. A total of 749 men and 906 women participated. Circumcision status was not associated with HIV/HSV-2 infection nor increased high risk sexual behaviors. In males, preference for being or becoming circumcised was associated with inconsistent condom use and increased lifetime number of sexual partners. Preference for circumcision was increased with understanding that circumcised men are less likely to become infected with HIV.	[Westercamp, Matthew; Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA; [Montandon, Michele; Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Bukusi, Elizabeth A.; Kwena, Zachary] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Kisumu, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco; Kenya Medical Research Institute	Westercamp, M (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA.	westrcmp@uic.edu			Doris Duke Charitable Foundation; Family AIDS Care and Educational Services (Kisumu); University of California (San Francisco); Kimberly Bale	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Family AIDS Care and Educational Services (Kisumu); University of California (San Francisco)(University of California System); Kimberly Bale	This study was supported by a Doris Duke Charitable Foundation Operations Research on AIDS Care and Treatment in Africa (ORACTA) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to acknowledge the support of Director, Kenya Medical Research Institute (Nairobi); Director, Center for Microbiology Research (Nairobi); staff of the ARTIS Project and the Family AIDS Care and Educational Services (Kisumu); and the University of California (San Francisco) - particularly Kimberly Bale.	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Bailey RC, 2002, AIDS CARE, V14, P27, DOI 10.1080/09540120220097919; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Central Bureau of Statistics [Kenya]. Ministry of Finance and Planning, 2002, KENY 1999 POP HOUS C; Cohen CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004573; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; WHO/UNAIDS Technical Consultation, 2007, MAL CIRC HIV PREV RE	14	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15552	10.1371/journal.pone.0015552	http://dx.doi.org/10.1371/journal.pone.0015552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179493	Green Published, gold			2022-12-25	WOS:000285381200030
J	Ben Amara, A; Ghigo, E; Le Priol, Y; Lepolard, C; Salcedo, SP; Lemichez, E; Bretelle, F; Capo, C; Mege, JL				Ben Amara, Amira; Ghigo, Eric; Le Priol, Yannick; Lepolard, Catherine; Salcedo, Suzana P.; Lemichez, Emmanuel; Bretelle, Florence; Capo, Christian; Mege, Jean-Louis			Coxiella burnetii, the Agent of Q Fever, Replicates within Trophoblasts and Induces a Unique Transcriptional Response	PLOS ONE			English	Article							EXPRESSION; ACTIVATION; MONOCYTES; INFECTION; PREGNANCY; PLACENTA; BRUCELLA; RECEPTOR; CELLS; DIFFERENTIATION	Q fever is a zoonosis caused by Coxiella burnetii, an obligate intracellular bacterium typically found in myeloid cells. The infection is a source of severe obstetrical complications in humans and cattle and can undergo chronic evolution in a minority of pregnant women. Because C. burnetii is found in the placentas of aborted fetuses, we investigated the possibility that it could infect trophoblasts. Here, we show that C. burnetii infected and replicated in BeWo trophoblasts within phagolysosomes. Using pangenomic microarrays, we found that C. burnetii induced a specific transcriptomic program. This program was associated with the modulation of inflammatory responses that were shared with inflammatory agonists, such as TNF, and more specific responses involving genes related to pregnancy development, including EGR-1 and NDGR1. In addition, C. burnetii stimulated gene networks organized around the IL-6 and IL-13 pathways, which both modulate STAT3. Taken together, these results revealed that trophoblasts represent a protective niche for C. burnetii. The activation program induced by C. burnetii in trophoblasts may allow bacterial replication but seems unable to interfere with the development of normal pregnancy. Such pathophysiologocal processes should require the activation of immune placental cells associated with trophoblasts.	[Ben Amara, Amira; Ghigo, Eric; Lepolard, Catherine; Bretelle, Florence; Capo, Christian; Mege, Jean-Louis] Univ Mediterranee, CNRS, IRD UMR 6236, Unite Rech Malad Infect Trop & Emergentes,IFR 48, Marseille, France; [Le Priol, Yannick] IMTSSA, Marseille, France; [Salcedo, Suzana P.] Univ Mediterranee, Ctr Immunol Marseille Luminy, UMR 6546, Marseille, France; [Lemichez, Emmanuel] Fac Med Nice, INSERM, Unite 895, Equipe 6,C3M, F-06034 Nice, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Ben Amara, A (corresponding author), Univ Mediterranee, CNRS, IRD UMR 6236, Unite Rech Malad Infect Trop & Emergentes,IFR 48, Marseille, France.	Jean-Louis.Mege@univmed.fr	salcedo, suzana/P-9830-2019; MEGE, JEAN-LOUIS/O-6063-2016; Salcedo, Suzana P/C-2853-2014; Lemichez, Emmanuel/G-3559-2013; catherine, lepolard/P-5653-2016; Eric, Ghigo/N-9427-2016	salcedo, suzana/0000-0001-5149-7756; Salcedo, Suzana P/0000-0001-5149-7756; Lemichez, Emmanuel/0000-0001-9080-7761; Bretelle, Florence/0000-0002-0909-3202; Le Priol, Yannick/0000-0002-5176-0857	Programme Hospitalier de Recherche Clinique	Programme Hospitalier de Recherche Clinique	The work was supported by the Programme Hospitalier de Recherche Clinique 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutagawa O, 2007, PLACENTA, V28, P920, DOI 10.1016/j.placenta.2007.03.005; Andrews AL, 2006, J ALLERGY CLIN IMMUN, V118, P858, DOI 10.1016/j.jaci.2006.06.041; Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bastonero S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005357; Benoit M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000066; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Benoit M, 2008, EUR J IMMUNOL, V38, P1065, DOI 10.1002/eji.200738067; BENTAL T, 1995, CLIN INFECT DIS, V21, P1318, DOI 10.1093/clinids/21.5.1318; Capo C, 1999, J IMMUNOL, V163, P6078; Carcopino X, 2007, CLIN INFECT DIS, V45, P548, DOI 10.1086/520661; Caron PL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-80; Catalano RD, 2005, P NATL ACAD SCI USA, V102, P8585, DOI 10.1073/pnas.0502343102; Chen CP, 2006, BJOG-INT J OBSTET GY, V113, P152, DOI 10.1111/j.1471-0528.2005.00843.x; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Daines MO, 2006, J IMMUNOL, V176, P7495, DOI 10.4049/jimmunol.176.12.7495; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; de la Torre E, 2009, J IMMUNOL, V182, P3735, DOI 10.4049/jimmunol.0800764; Dellacasagrande J, 2002, J IMMUNOL, V169, P6309, DOI 10.4049/jimmunol.169.11.6309; Ernst M, 2001, J EXP MED, V194, P189, DOI 10.1084/jem.194.2.189; Fitzgerald JS, 2008, HUM REPROD UPDATE, V14, P335, DOI 10.1093/humupd/dmn010; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Ghigo E, 2001, INFECT IMMUN, V69, P2345, DOI 10.1128/IAI.69.4.2345-2352.2001; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; Gorvel JP, 2008, MICROBES INFECT, V10, P1010, DOI 10.1016/j.micinf.2008.07.007; Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012; Jensen TK, 2007, APMIS, V115, P347, DOI 10.1111/j.1600-0463.2007.apm_591.x; Jiang K, 2007, PLACENTA, V28, P538, DOI 10.1016/j.placenta.2006.06.013; Jiang SJ, 2008, INFECT IMMUN, V76, P1558, DOI 10.1128/IAI.01331-07; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Kenzel S, 2009, INFECT IMMUN, V77, P2474, DOI 10.1128/IAI.01343-08; King A, 2000, PLACENTA, V21, pS113, DOI 10.1053/plac.1999.0526; LANG G, 1991, CAN J VET RES, V55, P139; LANGLEY JM, 1990, Q FEVER, V1, P201; Lee BN, 1997, J VIROL, V71, P3628, DOI 10.1128/JVI.71.5.3628-3635.1997; Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06; McArthur SJ, 2008, PRENATAL DIAG, V28, P434, DOI 10.1002/pd.1924; Meconi S, 2001, INFECT IMMUN, V69, P2520, DOI 10.1128/IAI.69.4.2520-2526.2001; Meghari S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040023; Meghari S, 2007, EUR J IMMUNOL, V37, P24, DOI 10.1002/eji.200636054; Miwa N, 2005, MOL HUM REPROD, V11, P865, DOI 10.1093/molehr/gah246; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Naroeni A, 2001, INFECT IMMUN, V69, P486, DOI 10.1128/IAI.69.1.486-493.2001; Neta AVC, 2008, INFECT IMMUN, V76, P1897, DOI 10.1128/IAI.01554-07; Parisi A, 2006, VET MICROBIOL, V118, P101, DOI 10.1016/j.vetmic.2006.06.023; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Pospechova K, 2009, MOL CELL ENDOCRINOL, V299, P178, DOI 10.1016/j.mce.2008.12.003; Rahaman SO, 2005, CANCER RES, V65, P2956, DOI 10.1158/0008-5472.CAN-04-3592; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Renaud SJ, 2009, PLACENTA, V30, P313, DOI 10.1016/j.placenta.2009.01.001; Sanchez J, 2006, J COMP PATHOL, V135, P108, DOI 10.1016/j.jcpa.2006.06.003; Stein A, 2000, J INFECT DIS, V181, P188, DOI 10.1086/315166; Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; VANMOLL P, 1993, J COMP PATHOL, V109, P295, DOI 10.1016/S0021-9975(08)80254-X; Ferro EAV, 2008, AM J PATHOL, V172, P50, DOI 10.2353/ajpath.2008.070432; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Xu B, 1999, BIOL REPROD, V61, P681, DOI 10.1095/biolreprod61.3.681	59	48	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15315	10.1371/journal.pone.0015315	http://dx.doi.org/10.1371/journal.pone.0015315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179488	Green Published, gold, Green Submitted			2022-12-25	WOS:000285292500022
J	Nijland, R; Hall, MJ; Burgess, JG				Nijland, Reindert; Hall, Michael J.; Burgess, J. Grant			Dispersal of Biofilms by Secreted, Matrix Degrading, Bacterial DNase	PLOS ONE			English	Article							BACILLUS-SUBTILIS; EXTRACELLULAR DNA; EXPRESSION; INHIBITOR; ACID	Microbial biofilms are composed of a hydrated matrix of biopolymers including polypeptides, polysaccharides and nucleic acids and act as a protective barrier and microenvironment for the inhabiting microbes. While studying marine biofilms, we observed that supernatant produced by a marine isolate of Bacillus licheniformis was capable of dispersing bacterial biofilms. We investigated the source of this activity and identified the active compound as an extracellular DNase (NucB). We have shown that this enzyme rapidly breaks up the biofilms of both Gram-positive and Gram-negative bacteria. We demonstrate that bacteria can use secreted nucleases as an elegant strategy to disperse established biofilms and to prevent de novo formation of biofilms of competitors. DNA therefore plays an important dynamic role as a reversible structural adhesin within the biofilm.	[Nijland, Reindert; Burgess, J. Grant] Newcastle Univ, Sch Marine Sci & Technol, Dove Marine Lab, N Shields, England; [Hall, Michael J.] Newcastle Univ, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Nijland, R (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	grant.burgess@ncl.ac.uk	Hall, Michael/N-2458-2019; Nijland, Reindert/B-8206-2008; Hall, Michael J/A-4126-2012	Hall, Michael/0000-0001-6475-9161; Nijland, Reindert/0000-0003-0049-3768; Hall, Michael J/0000-0001-6475-9161	European Community [PIEF-GA-2008-219592]; NERC [NE/G011206/1]	European Community(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a fellowship from the European Community's Seventh Framework Programme, under grant agreement PIEF-GA-2008-219592 to RN, and a NERC follow-on fund Pathfinder grant to RN, MJH and JGB (NE/G011206/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci M, 2006, J BACTERIOL, V188, P2325, DOI 10.1128/JB.188.7.2325-2335.2006; Ando T, 2006, J BIOCHEM, V139, P805, DOI 10.1093/jb/mvj091; Bongers RS, 2005, APPL ENVIRON MICROB, V71, P8818, DOI 10.1128/AEM.71.12.8818-8824.2005; Burgess JG, 1999, J BIOTECHNOL, V70, P27, DOI 10.1016/S0168-1656(99)00054-1; CATLIN BW, 1956, SCIENCE, V124, P441, DOI 10.1126/science.124.3219.441; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, J IND MICROBIOL, V15, P137, DOI 10.1007/BF01569816; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Fletcher Madilyn, 1994, Current Opinion in Biotechnology, V5, P302, DOI 10.1016/0958-1669(94)90033-7; HARTLEY RW, 1988, J MOL BIOL, V202, P913, DOI 10.1016/0022-2836(88)90568-2; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; LANDINI P, 2010, APPL MICROBIOL BIOTE; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lau PCY, 2009, BIOPHYS J, V96, P2935, DOI 10.1016/j.bpj.2008.12.3943; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Moorthy S, 2005, MOL MICROBIOL, V57, P1623, DOI 10.1111/j.1365-2958.2005.04797.x; MULCAHY H, ENV MICROBIOL, V12, P1621; Nagarajan V, 2009, FEMS MICROBIOL LETT, V295, P204, DOI 10.1111/j.1574-6968.2009.01595.x; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Sambrook J., 2002, MOL CLONING LAB MANU; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Suri R, 2005, BIODRUGS, V19, P135, DOI 10.2165/00063030-200519030-00001; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; UHLENHOPP EL, 1975, BIOPHYS J, V15, P233, DOI 10.1016/S0006-3495(75)85814-0; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P213; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yan LM, 2003, APPL ENVIRON MICROB, V69, P3719, DOI 10.1128/AEM.69.7.3719-3727.2003	30	110	121	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15668	10.1371/journal.pone.0015668	http://dx.doi.org/10.1371/journal.pone.0015668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179489	Green Published, gold, Green Submitted			2022-12-25	WOS:000285292500035
J	Correa-Costa, M; Semedo, P; Monteiro, APFS; Silva, RC; Pereira, RL; Goncalves, GM; Marques, GDM; Cenedeze, MA; Faleiros, ACG; Keller, AC; Shimizu, MHM; Seguro, AC; Reis, MA; Pacheco-Silva, A; Camara, NOS				Correa-Costa, Matheus; Semedo, Patricia; Monteiro, Ana Paula F. S.; Silva, Reinaldo C.; Pereira, Rafael L.; Goncalves, Giselle M.; Marcusso Marques, Georgia Daniela; Cenedeze, Marcos A.; Faleiros, Ana C. G.; Keller, Alexandre C.; Shimizu, Maria H. M.; Seguro, Antonio C.; Reis, Marlene A.; Pacheco-Silva, Alvaro; Camara, Niels O. S.			Induction of Heme Oxygenase-1 Can Halt and Even Reverse Renal Tubule-Interstitial Fibrosis	PLOS ONE			English	Article							RAT OBSTRUCTIVE NEPHROPATHY; URETERAL OBSTRUCTION; OXIDATIVE STRESS; TUBULOINTERSTITIAL FIBROSIS; MESENCHYMAL TRANSITION; CARBON-MONOXIDE; KIDNEY; INFLAMMATION; PROGRESSION; FIBROBLASTS	Background: The tubule-interstitial fibrosis is the hallmark of progressive renal disease and is strongly associated with inflammation of this compartment. Heme-oxygenase-1 (HO-1) is a cytoprotective molecule that has been shown to be beneficial in various models of renal injury. However, the role of HO-1 in reversing an established renal scar has not yet been addressed. Aim: We explored the ability of HO-1 to halt and reverse the establishment of fibrosis in an experimental model of chronic renal disease. Methods: Sprague-Dawley male rats were subjected to unilateral ureteral obstruction (UUO) and divided into two groups: non-treated and Hemin-treated. To study the prevention of fibrosis, animals were pre-treated with Hemin at days -2 and -1 prior to UUO. To investigate whether HO-1 could reverse established fibrosis, Hemin therapy was given at days 6 and 7 post-surgery. After 7 and/or 14 days, animals were sacrificed and blood, urine and kidney tissue samples were collected for analyses. Renal function was determined by assessing the serum creatinine, inulin clearance, proteinuria/creatininuria ratio and extent of albuminuria. Arterial blood pressure was measured and fibrosis was quantified by Picrosirius staining. Gene and protein expression of pro-inflammatory and pro-fibrotic molecules, as well as HO-1 were performed. Results: Pre-treatment with Hemin upregulated HO-1 expression and significantly reduced proteinuria, albuminuria, inflammation and pro-fibrotic protein and gene expressions in animals subjected to UUO. Interestingly, the delayed treatment with Hemin was also able to reduce renal dysfunction and to decrease the expression of pro-inflammatory molecules, all in association with significantly reduced levels of fibrosis-related molecules and collagen deposition. Finally, TGF-beta protein production was significantly lower in Hemin-treated animals. Conclusion: Treatment with Hemin was able both to prevent the progression of fibrosis and to reverse an established renal scar. Modulation of inflammation appears to be the major mechanism behind HO-1 cytoprotection.	[Correa-Costa, Matheus; Semedo, Patricia; Monteiro, Ana Paula F. S.; Silva, Reinaldo C.; Pereira, Rafael L.; Marcusso Marques, Georgia Daniela; Cenedeze, Marcos A.; Keller, Alexandre C.; Pacheco-Silva, Alvaro; Camara, Niels O. S.] Univ Fed Sao Paulo, Div Nephrol, Lab Clin & Expt Immunol, Sao Paulo, Brazil; [Correa-Costa, Matheus; Goncalves, Giselle M.; Camara, Niels O. S.] Univ Sao Paulo, Inst Biomed Sci 4, Dept Immunol, Lab Transplantat Immunobiol, Sao Paulo, Brazil; [Faleiros, Ana C. G.; Reis, Marlene A.] Univ Fed Triangulo Mineiro, Div Pathol, Uberaba, Brazil; [Shimizu, Maria H. M.; Seguro, Antonio C.] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal do Triangulo Mineiro; Universidade de Sao Paulo	Correa-Costa, M (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Lab Clin & Expt Immunol, Sao Paulo, Brazil.	niels@icb.usp.br	Shimizu, Maria/B-7887-2013; Silva, Reinaldo/C-6285-2013; Correa-Costa, Matheus/B-2006-2014; Keller, Alexandre C/E-4621-2012; Pacheco-Silva, Alvaro/K-3583-2013; Semedo-Kuriki, Patricia/D-2429-2010; camara, niels olsen saraiva/AAX-3269-2020; Camara, Niels OS/G-8336-2011	Keller, Alexandre C/0000-0002-7827-0292; camara, niels olsen saraiva/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248; Semedo-Kuriki, Patricia/0000-0002-2136-3308	Fundacao de Amparo Pesquisa do Estado de Sao Paulo-FAPESP [07/07139-3]; Coordenaco de Aperfeioamento de Pessoal de Nivel Superior-CAPES; Instituto Nacional de Ciencia e Tecnologia de Complexos Fluidos; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq	Fundacao de Amparo Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenaco de Aperfeioamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia de Complexos Fluidos; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo Pesquisa do Estado de Sao Paulo-FAPESP (07/07139-3), Coordenaco de Aperfeioamento de Pessoal de Nivel Superior-CAPES, Instituto Nacional de Ciencia e Tecnologia de Complexos Fluidos and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2009, AM J PHYSIOL-RENAL, V297, pF1137, DOI 10.1152/ajprenal.90449.2008; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BLANCOU P, METHODS MOL BIOL, V677, P247; BOMBARA MP, 1993, J LEUKOCYTE BIOL, V54, P399, DOI 10.1002/jlb.54.5.399; Burger D, 1998, ARTHRITIS RHEUM, V41, P1748, DOI 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.3.CO;2-V; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Desbuards N, 2009, NEPHRON EXP NEPHROL, V113, pE35, DOI 10.1159/000228081; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; EyssenHernandez R, 1996, FEBS LETT, V382, P229, DOI 10.1016/0014-5793(96)00127-5; Fioretto P, 1998, CURR OPIN NEPHROL HY, V7, P489, DOI 10.1097/00041552-199809000-00001; GAUDIO KM, 1980, AM J PHYSIOL, V238, pF205, DOI 10.1152/ajprenal.1980.238.3.F205; Giannico G, 2009, CLIN J AM SOC NEPHRO, V4, P1747, DOI 10.2215/CJN.01510209; Goncalves GM, 2006, KIDNEY INT, V70, P1742, DOI 10.1038/sj.ki.5001893; Goodman AI, 2007, KIDNEY INT, V72, P945, DOI 10.1038/sj.ki.5002447; Grimm PC, 2003, J AM SOC NEPHROL, V14, P1662, DOI 10.1097/01.ASN.0000066143.02832.5E; Hill-Kapturczak N, 2002, DNA CELL BIOL, V21, P307, DOI 10.1089/104454902753759726; Hwang M, 2006, EXP MOL PATHOL, V81, P48, DOI 10.1016/j.yexmp.2005.11.005; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Iwai T, 2008, UROLOGY, V72, P432, DOI 10.1016/j.urology.2007.11.123; Jarmi T, 2009, CURR HYPERTENS REP, V11, P56, DOI 10.1007/s11906-009-0011-z; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kie JH, 2008, J AM SOC NEPHROL, V19, P1681, DOI 10.1681/ASN.2007101099; Kim JH, 2006, J AM SOC NEPHROL, V17, P1373, DOI 10.1681/ASN.2005091001; Kirkby KA, 2006, AM J PHYSIOL-RENAL, V290, pF563, DOI 10.1152/ajprenal.00220.2005; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95; LENNON GM, 1993, BRIT J UROL, V72, P702, DOI 10.1111/j.1464-410X.1993.tb16251.x; Ma LJ, 2005, J AM SOC NEPHROL, V16, P966, DOI 10.1681/ASN.2004060492; Magnasco A, 2008, CELL TRANSPLANT, V17, P1157, DOI 10.3727/096368908787236567; Matsumoto H, 2006, MOL CELL BIOCHEM, V291, P21, DOI 10.1007/s11010-006-9190-y; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Meldrum KK, 2007, AM J PHYSIOL-REG I, V292, pR1456, DOI 10.1152/ajpregu.00620.2005; Miyajima A, 2003, J UROLOGY, V169, P1559, DOI 10.1097/01.ju.0000045686.21766.c1; Moriyama T, 2001, KIDNEY INT, V59, P2095, DOI 10.1046/j.1523-1755.2001.0590062095.x; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Noris M, 2003, KIDNEY INT, V64, P2253, DOI 10.1046/j.1523-1755.2003.00318.x; OPANASHUK LA, 1995, J NEUROSCI RES, V42, P623, DOI 10.1002/jnr.490420504; Rezzani R, 2005, J HISTOCHEM CYTOCHEM, V53, P105, DOI 10.1369/jhc.4A6456.2004; Ruggenenti P, 2001, LANCET, V357, P1601, DOI 10.1016/S0140-6736(00)04728-0; SHIBAHARA S, 1987, J BIOL CHEM, V262, P12889; SHIN DH, FREE RADIC BIOL MED, V48, P1051; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Strutz F, 2003, SPRINGER SEMIN IMMUN, V24, P459, DOI 10.1007/s00281-003-0123-5; Tashiro K, 2003, INT J MOL MED, V12, P587; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; VOGT BA, 1995, LAB INVEST, V72, P474; Wang L, 2008, AM J PHYSIOL-RENAL, V294, pF508, DOI 10.1152/ajprenal.00306.2007; Wang PHM, 2009, INT IMMUNOPHARMACOL, V9, P653, DOI 10.1016/j.intimp.2008.10.018; Xu YF, 2009, J NEPHROL, V22, P403; Yan JD, 2009, ACTA PHARMACOL SIN, V30, P994, DOI 10.1038/aps.2009.56	54	59	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14298	10.1371/journal.pone.0014298	http://dx.doi.org/10.1371/journal.pone.0014298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179206	gold, Green Published, Green Submitted			2022-12-25	WOS:000285246900011
J	Aflaki, E; Radovic, B; Chandak, PG; Kolb, D; Eisenberg, T; Ring, J; Fertschai, I; Uellen, A; Wolinski, H; Kohlwein, SD; Zechner, R; Levak-Frank, S; Sattler, W; Graier, WF; Malli, R; Madeo, F; Kratky, D				Aflaki, Elma; Radovic, Branislav; Chandak, Prakash G.; Kolb, Dagmar; Eisenberg, Tobias; Ring, Julia; Fertschai, Ismene; Uellen, Andreas; Wolinski, Heimo; Kohlwein, Sepp-Dieter; Zechner, Rudolf; Levak-Frank, Sanja; Sattler, Wolfgang; Graier, Wolfgang F.; Malli, Roland; Madeo, Frank; Kratky, Dagmar			Triacylglycerol Accumulation Activates the Mitochondrial Apoptosis Pathway in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; LOW-DENSITY-LIPOPROTEIN; LIPID STORAGE DISEASE; CYTOPLASMIC CHOLESTERYL ESTERS; CELL-DEATH; PATATIN DOMAIN; FOAM CELLS; MICE; RECEPTOR; METABOLISM	Programmed cell death of lipid-laden macrophages is a prominent feature of atherosclerotic lesions and mostly ascribed to accumulation of excess intracellular cholesterol. The present in vitro study investigated whether intracellular triacylglycerol (TG) accumulation could activate a similar apoptotic response in macrophages. To address this question, we utilized peritoneal macrophages isolated from mice lacking adipose triglyceride lipase (ATGL), the major enzyme responsible for TG hydrolysis in multiple tissues. In Atgl(-/-) macrophages, we observed elevated levels of cytosolic Ca2+ and reactive oxygen species, stimulated cytochrome c release, and nuclear localization of apoptosis-inducing factor. Fragmented mitochondria prior to cell death were indicative of the mitochondrial apoptosis pathway being triggered as a consequence of defective lipolysis. Other typical markers of apoptosis, such as externalization of phosphatidylserine in the plasma membrane, caspase 3 and poly(ADP-ribose) polymerase cleavage, were increased in Atgl(-/-) macrophages. An artificial increase of cellular TG levels by incubating wild-type macrophages with very low density lipoprotein closely mimicked the apoptotic phenotype observed in Atgl(-/-) macrophages. Results obtained during the present study define a novel pathway linking intracellular TG accumulation to mitochondrial dysfunction and programmed cell death in macrophages.	[Aflaki, Elma; Radovic, Branislav; Chandak, Prakash G.; Kolb, Dagmar; Fertschai, Ismene; Uellen, Andreas; Levak-Frank, Sanja; Sattler, Wolfgang; Graier, Wolfgang F.; Malli, Roland; Kratky, Dagmar] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Kolb, Dagmar; Eisenberg, Tobias; Ring, Julia; Wolinski, Heimo; Kohlwein, Sepp-Dieter; Zechner, Rudolf; Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	Medical University of Graz; University of Graz	Kratky, D (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Harrachgasse 21, A-8010 Graz, Austria.	dagmar.kratky@medunigraz.at	Graier, Wolfgang F./B-7052-2008; Eisenberg, Tobias/AAV-7806-2021; Kratky, Dagmar/ABF-5699-2021	Graier, Wolfgang F./0000-0003-1871-3298; Eisenberg, Tobias/0000-0003-3559-1130; Zechner, Rudolf/0000-0001-5483-1182; Ring, Julia/0000-0003-4991-9328; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Wolinski, Heimo/0000-0002-1583-6092; Malli, Roland/0000-0001-6327-8729; Kratky, Dagmar/0000-0003-1357-7573; Madeo, Frank/0000-0002-5070-1329	Medical University of Graz; Austrian Science Fund FWF [SFB-LIPOTOX F30, P19186]; Austrian Federal Ministry of Science and Research; Austrian Science Fund (FWF) [F 3002, Z 136, F 3007, F 3005, F 3004] Funding Source: researchfish	Medical University of Graz; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Medical University of Graz (Ph.D. Program "Molecular Medicine"), the Austrian Science Fund FWF (SFB-LIPOTOX F30 and P19186), and the Austrian Federal Ministry of Science and Research (GEN-AU project Genomics of Lipid-associated Disorders).	Akiyama M, 2007, MUSCLE NERVE, V36, P856, DOI 10.1002/mus.20869; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; HO YK, 1980, J LIPID RES, V21, P391; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kellner-Weibel G, 1998, ARTERIOSCL THROM VAS, V18, P423, DOI 10.1161/01.ATV.18.3.423; Kobayashi K, 2008, J CLIN ENDOCR METAB, V93, P2877, DOI 10.1210/jc.2007-2247; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lammers B, 2011, ARTERIOSCL THROM VAS, V31, P67, DOI 10.1161/ATVBAHA.110.215814; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; Lutgens E, 1999, CARDIOVASC RES, V41, P473, DOI 10.1016/S0008-6363(98)00311-3; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Thorp E, 2009, ARTERIOSCL THROM VAS, V29, P169, DOI 10.1161/ATVBAHA.108.176495; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Ullery-Ricewick JC, 2009, J LIPID RES, V50, P2014, DOI 10.1194/jlr.M800659-JLR200; Vander Heiden MG, 1999, MOL CELL, V3, P159; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; Yao PM, 2001, J BIOL CHEM, V276, P42468, DOI 10.1074/jbc.M101419200; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang KZ, 2003, NAT CELL BIOL, V5, P769, DOI 10.1038/ncb0903-769; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	41	54	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7418	7428		10.1074/jbc.M110.175703	http://dx.doi.org/10.1074/jbc.M110.175703			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21196579	Green Published, hybrid			2022-12-25	WOS:000287737300057
J	Mao, GH; Wang, RG; Guan, YF; Liu, YD; Zhang, SQ				Mao, Guohong; Wang, Ruigang; Guan, Yuefeng; Liu, Yidong; Zhang, Shuqun			Sulfurtransferases 1 and 2 Play Essential Roles in Embryo and Seed Development in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MERCAPTOPYRUVATE SULFURTRANSFERASE; CYANIDE DETOXIFICATION; ETHYLENE BIOSYNTHESIS; LEAFY COTYLEDON2; AUXIN GRADIENTS; EMBRYOGENESIS; SENESCENCE; GENES; EXPRESSION; RHODANESE	Sulfurtransferases (STRs) catalyze the transfer of a sulfur atom from a donor to a suitable acceptor molecule. The Arabidopsis thaliana genome encodes 20 putative STR proteins. The biological functions of most are unclear. We found that STR1 and STR2 play important roles in embryo/seed development. Mutation of STR1 alone resulted in a shrunken seed phenotype, although growth and development of vegetative and reproductive organs were not affected. The shrunken seed phenotype was associated with the delayed/arrested embryo development, in most cases, at the heart stage. The embryo defect of str1 mutant is not fully penetrant. Approximately 12.5% of embryos developed further and formed normal looking seeds. In severely shrunken seeds, no embryo could be identified after seed collection. Partially shrunken seeds that contained viable embryos could still germinate. However, cotyledons of the seedlings from such seeds were abnormal. An STR1-GUS fusion reporter revealed that the STR1 gene was universally expressed, with high levels of expression in specific tissues/organs including embryos. The incomplete penetrance of str1 embryo/seed phenotype is a result of functional STR2. Single str2 mutant had no phenotype. However, no str1(-/-)/str2(-/-) double mutant embryos were able to develop past the heart stage. Furthermore, STR2 is haplo-insufficient in str1 mutant background, and str1(-/-)/str2(+/-) embryos were 100% lethal. These data provide new insights into the biological functions of the ubiquitous sulfurtransferase in Arabidopsis embryogenesis and seed development.	[Zhang, Shuqun] Univ Missouri, Div Biochem, Bond Life Sci Ctr 371G, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Mao, Guohong; Guan, Yuefeng; Liu, Yidong; Zhang, Shuqun] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Wang, Ruigang] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot 010018, Inner Mongolia, Peoples R China	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Inner Mongolia Agricultural University	Zhang, SQ (corresponding author), Univ Missouri, Div Biochem, Bond Life Sci Ctr 371G, Interdisciplinary Plant Grp, Columbia, MO 65211 USA.	zhangsh@missouri.edu	Guan, Yuefeng/B-5733-2011; Zhang, Shuqun/X-6343-2019	Guan, Yuefeng/0000-0002-1436-3828	National Science Foundation [IOS-0743957]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS-0743957 (to S. Z.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bartels A, 2007, PLANT PHYSIOL BIOCH, V45, P178, DOI 10.1016/j.plaphy.2007.02.005; BAUD S, 2008, ARABIDOPSIS BOOK, P1; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; Bauer M, 2004, PLANT PHYSIOL, V135, P916, DOI 10.1104/pp.104.040121; Berger F, 2006, CURR OPIN PLANT BIOL, V9, P664, DOI 10.1016/j.pbi.2006.09.015; Berleth T, 1998, PLANT PHYSIOL BIOCH, V36, P69, DOI 10.1016/S0981-9428(98)80092-2; Billaut-Laden I, 2006, TOXICOL LETT, V165, P101, DOI 10.1016/j.toxlet.2006.02.002; BONOMI F, 1977, EUR J BIOCHEM, V72, P17, DOI 10.1111/j.1432-1033.1977.tb11219.x; Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; CAPRON A, 2008, ARABIDOPSIS BOOK, P1; CERLETTI P, 1986, TRENDS BIOCHEM SCI, V11, P369, DOI 10.1016/0968-0004(86)90206-9; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chung BC, 1997, J PLANT PHYSIOL, V151, P339, DOI 10.1016/S0176-1617(97)80262-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; DONADIO S, 1990, J BACTERIOL, V172, P350, DOI 10.1128/JB.172.1.350-360.1990; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; Grossmann K, 1996, PHYSIOL PLANTARUM, V97, P772, DOI 10.1111/j.1399-3054.1996.tb00543.x; Hatzfeld Y, 2000, FEBS LETT, V470, P147, DOI 10.1016/S0014-5793(00)01311-9; Iannetta PPM, 2006, PHYSIOL PLANTARUM, V127, P247, DOI 10.1111/j.1399-3054.2006.00656.x; Jenik PD, 2007, ANNU REV CELL DEV BI, V23, P207, DOI 10.1146/annurev.cellbio.22.011105.102609; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; Kamada H, 2005, PLANT BIOTECHNOL, V22, P253, DOI DOI 10.5511/plantbiotechnology.22.253; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Meyer T, 2003, PLANTA, V217, P1, DOI 10.1007/s00425-002-0964-5; Mezard C, 2006, BIOCHEM SOC T, V34, P531, DOI 10.1042/BST0340531; Michniewicz Marta, 2007, Arabidopsis Book, V5, pe0108, DOI 10.1199/tab.0108; Nagahara N, 2006, CURR MED CHEM, V13, P1219, DOI 10.2174/092986706776360914; Nagahara N, 1999, HISTOL HISTOPATHOL, V14, P1277, DOI 10.14670/HH-14.1277; Nakamura T, 2000, EUR J BIOCHEM, V267, P5621, DOI 10.1046/j.1432-1327.2000.01633.x; Olsen OA, 2001, ANNU REV PLANT PHYS, V52, P233, DOI 10.1146/annurev.arplant.52.1.233; Papenbrock J, 2000, EUR J BIOCHEM, V267, P5571, DOI 10.1046/j.1432-1327.2000.01623.x; Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005; Roeder S, 2009, PLANT MOL BIOL, V70, P535, DOI 10.1007/s11103-009-9490-1; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; SCHERES B, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0101; SCHWARTZ B, 1997, DEV SUSPENSOR DIFFER, P53; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Solomonson LP, 1981, CYANIDE BIOL, P11; Song SK, 2008, DEV CELL, V15, P98, DOI 10.1016/j.devcel.2008.05.008; Spencer MWB, 2007, PLANT PHYSIOL, V143, P924, DOI 10.1104/pp.106.087668; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Tzafrir I, 2003, NUCLEIC ACIDS RES, V31, P90, DOI 10.1093/nar/gkg028; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; VENNESLAND B, 1982, FED PROC, V41, P2639; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; WISLER JA, 1991, TOXICOL LETT, V56, P275, DOI 10.1016/0378-4274(91)90156-Z; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836; Zhao YD, 2003, SCIENCE, V301, P1107, DOI 10.1126/science.1084161	56	21	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7548	7557		10.1074/jbc.M110.182865	http://dx.doi.org/10.1074/jbc.M110.182865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189252	Green Published, hybrid			2022-12-25	WOS:000287737300068
J	Stitham, J; Arehart, E; Elderon, L; Gleim, SR; Douville, K; Kasza, Z; Fetalvero, K; MacKenzie, T; Robb, J; Martin, KA; Hwa, J				Stitham, Jeremiah; Arehart, Eric; Elderon, Larkin; Gleim, Scott R.; Douville, Karen; Kasza, Zsolt; Fetalvero, Kristina; MacKenzie, Todd; Robb, John; Martin, Kathleen A.; Hwa, John			Comprehensive Biochemical Analysis of Rare Prostacyclin Receptor Variants STUDY OF ASSOCIATION OF SIGNALING WITH CORONARY ARTERY OBSTRUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; NEPHROGENIC DIABETES-INSIPIDUS; VASCULAR SMOOTH-MUSCLE; CARDIOVASCULAR-DISEASE; RETINITIS-PIGMENTOSA; SYNTHETIC MUTATIONS; MICE LACKING; POLYMORPHISMS; GENE; RHODOPSIN	Currently, pharmacogenetic studies are at an impasse as the low prevalence (<2%) of most variants hinder their pharmacogenetic analysis with population sizes often inadequate for sufficiently powered studies. Grouping rare mutations by functional phenotype rather than mutation site can potentially increase sample size. Using human population-based studies (n = 1,761) to search for dysfunctional human prostacyclin receptor (hIP) variants, we recently discovered 18 non-synonymous mutations, all with frequencies less than 2% in our study cohort. Eight of the 18 had defects in binding, activation, and/or protein stability/folding. Mutations (M113T, L104R, and R279C) in three highly conserved positions demonstrated severe misfolding manifested by impaired binding and activation of cell surface receptors. To assess for association with coronary artery disease, we performed a case-control study comparing coronary angiographic results from patients with reduced cAMP production arising from the non-synonymous mutations (n = 23) with patients with non-synonymous mutations that had no reduction in cAMP (n = 17). Major coronary artery obstruction was significantly increased in the dysfunctional mutation group in comparison with the silent mutations. We then compared the 23 dysfunctional receptor patients with 69 age-and risk factor-matched controls (1:3). This verified the significantly increased coronary disease in the non-synonymous dysfunctional variant cohort. This study demonstrates the potential utility of in vitro functional characterization in predicting clinical phenotypes and represents the most comprehensive characterization of human prostacyclin receptor genetic variants to date.	[Fetalvero, Kristina; Martin, Kathleen A.; Hwa, John] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [MacKenzie, Todd; Robb, John; Hwa, John] Dartmouth Med Sch, Dept Med Cardiol, Hanover, NH 03755 USA; [Martin, Kathleen A.] Dartmouth Med Sch, Dept Vasc Surg, Hanover, NH 03755 USA; [Stitham, Jeremiah; Gleim, Scott R.; Martin, Kathleen A.; Hwa, John] Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06520 USA	Dartmouth College; Dartmouth College; Dartmouth College; Yale University	Hwa, J (corresponding author), Cardiovasc Res Ctr, 300 George St,759H, New Haven, CT 06511 USA.	john.hwa@yale.edu	Robb, John/AAI-9306-2021	Elderon, Larkin/0000-0002-9620-7756; Martin, Kathleen/0000-0002-1748-0034	National Institutes of Health, NHLBI [RO1 HL074190]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074190] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL074190 from the NHLBI (to J. H.). This work was also supported by grants from the American Heart Association (to J. H. and J. S.).	Abraham J, 2006, BBA-REV CANCER, V1766, P168, DOI 10.1016/j.bbcan.2006.10.003; [Anonymous], 2015, AM J CRIT CARE, V24, P156; Arehart E, 2007, CURR MED CHEM, V14, P2161; Arehart E, 2008, CIRC RES, V102, P986, DOI 10.1161/CIRCRESAHA.107.165936; Bengtsson K, 2001, CIRCULATION, V104, P187, DOI 10.1161/01.CIR.104.2.187; Berndt SI, 2007, INT J CANCER, V120, P1548, DOI 10.1002/ijc.22510; BOIE Y, 1994, J BIOL CHEM, V269, P12173; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Cravchik A, 1996, J BIOL CHEM, V271, P26013, DOI 10.1074/jbc.271.42.26013; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fetalvero KM, 2007, PROSTAG OTH LIPID M, V82, P109, DOI 10.1016/j.prostaglandins.2006.05.011; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Glynn RJ, 2007, CIRCULATION, V116, P1497, DOI 10.1161/CIRCULATIONAHA.107.716407; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hiratsuka M, 2001, MOL GENET METAB, V73, P298, DOI 10.1006/mgme.2001.3204; Hwa J, 1997, P NATL ACAD SCI USA, V94, P10571, DOI 10.1073/pnas.94.20.10571; Ibrahim S, 2010, ARTERIOSCL THROM VAS, V30, P1802, DOI 10.1161/ATVBAHA.110.208900; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kimchi-Sarfaty C, 2007, PHARMACOGENOMICS, V8, P29, DOI 10.2217/14622416.8.1.29; Liggett SB, 1998, J CLIN INVEST, V102, P1534, DOI 10.1172/JCI4059; Liu ISC, 1996, AM J MED GENET, V61, P277, DOI 10.1002/(SICI)1096-8628(19960122)61:3<277::AID-AJMG14>3.3.CO;2-5; Martin KA, 2004, AM J PHYSIOL-CELL PH, V286, pC507, DOI 10.1152/ajpcell.00201.2003; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; O'Keeffe MB, 2008, BBA-MOL CELL RES, V1783, P1914, DOI 10.1016/j.bbamcr.2008.04.010; OGAWA Y, 1995, GENOMICS, V27, P142, DOI 10.1006/geno.1995.1016; Oksche A, 1998, J MOL MED, V76, P326, DOI 10.1007/s001090050224; Patrignani P, 2008, PHARMACOGENET GENOM, V18, P611, DOI 10.1097/FPC.0b013e328301a774; Rana BK, 2001, ANNU REV PHARMACOL, V41, P593, DOI 10.1146/annurev.pharmtox.41.1.593; ROSENTHAL W, 1994, CELL MOL BIOL, V40, P429; ROSOLOWSKY M, 1993, AM J PHYSIOL, V264, pH327, DOI 10.1152/ajpheart.1993.264.2.H327; Saito S, 2003, J HUM GENET, V48, P461, DOI 10.1007/s10038-003-0062-y; Stitham J, 2007, BRIT J PHARMACOL, V152, P513, DOI 10.1038/sj.bjp.0707413; Stitham J, 2004, BIOCHEMISTRY-US, V43, P8974, DOI 10.1021/bi0496788; Stitham J, 2003, J BIOL CHEM, V278, P4250, DOI 10.1074/jbc.M207420200; Stitham J, 2002, MOL PHARMACOL, V61, P1202, DOI 10.1124/mol.61.5.1202; Stitham J, 2007, GENE, V396, P180, DOI 10.1016/j.gene.2007.03.016; Stitham J, 2007, PROSTAG OTH LIPID M, V82, P95, DOI 10.1016/j.prostaglandins.2006.05.010; Stitham J, 2006, J BIOL CHEM, V281, P37227, DOI 10.1074/jbc.M604042200; Stojanovic A, 2004, J BIOL CHEM, V279, P35932, DOI 10.1074/jbc.M403821200; Stojanovic A, 2003, J BIOL CHEM, V278, P39020, DOI 10.1074/jbc.M303625200; Stojanovic A, 2002, RECEPTOR CHANNEL, V8, P33, DOI 10.1080/10606820212137; Stoneking M, 2001, NATURE, V409, P821, DOI 10.1038/35057279; Tanaka H, 1998, J BIOL CHEM, V273, P11378, DOI 10.1074/jbc.273.18.11378; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; Trompet S, 2007, ANN NY ACAD SCI, V1100, P189, DOI 10.1196/annals.1395.018; Wise H, 1996, TRENDS PHARMACOL SCI, V17, P17, DOI 10.1016/0165-6147(96)81565-3; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058	50	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7060	7069		10.1074/jbc.M110.124933	http://dx.doi.org/10.1074/jbc.M110.124933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189259	Green Published, hybrid			2022-12-25	WOS:000287737300023
J	Fowler, CJ; Hammarsten, P; Bergh, A				Fowler, Christopher J.; Hammarsten, Peter; Bergh, Anders			Tumour Cannabinoid CB1 Receptor and Phosphorylated Epidermal Growth Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer	PLOS ONE			English	Article							INDUCED APOPTOSIS; CELLS; 2-ARACHIDONOYLGLYCEROL; INHIBITION; INVASION	Background: In cultured prostate cancer cells, down-regulation of epidermal growth factor receptor (EGFR) has been implicated in mediating the antiproliferative effect of the endogenous cannabinoid (CB) ligand anandamide. Using a well-characterised cohort of prostate cancer patients, we have previously reported that expression levels of phosphorylated EGFR (pEGFR-IR) and CB1 receptor (CB1IR) in tumour tissue at diagnosis are markers of disease-specific survival, but it is not known whether the two markers interact in terms of their influence on disease severity at diagnosis and disease outcome. Methodology/Principal Findings: Data from a cohort of 419 patients who were diagnosed with prostate cancer at transurethral resection for voiding difficulties was used. Scores for both tumour CB1IR and pEGFR-IR were available in the database. Of these, 235 had been followed by expectancy until the appearance of metastases. For patients scored for both parameters, Cox proportional-hazards regression analyses using optimal cut-off scores indicated that the two measures provided additional diagnostic information not only to each other, but to that provided by the tumour stage and the Gleason score. When the cases were divided into subgroups on the basis of these cut-off scores, the patients with both CB1IR and pEGFR-IR scores above their cut-off had a poorer disease-specific survival and showed a more severe pathology at diagnosis than patients with high pEGFR-IR scores but with CB1IR scores below the cut-off. Conclusions/Significance: These data indicate that a high tumour CB1 receptor expression at diagnosis augments the deleterious effects of a high pEGFR expression upon disease-specific survival.	[Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Hammarsten, Peter; Bergh, Anders] Umea Univ, Dept Med Biosci, Umea, Sweden	Umea University; Umea University	Fowler, CJ (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874	Swedish Science Council [12158]; Swedish Cancer Society [CAN 2007/712]; Medical Faculty, Umea University	Swedish Science Council; Swedish Cancer Society(Swedish Cancer Society); Medical Faculty, Umea University	The authors thank the Swedish Science Council (Grant no. 12158, medicine, C.J. Fowler); the Swedish Cancer Society (Grant no. CAN 2007/712, Anders Bergh); and the Research Funds of the Medical Faculty, Umea University (C.J. Fowler) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Alkaitis MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010891; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Chung SC, 2009, EUR J CANCER, V45, P174, DOI 10.1016/j.ejca.2008.10.010; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; De Miguel MP, 1999, CYTOKINE, V11, P722, DOI 10.1006/cyto.1998.0443; Egevad L, 2002, BJU INT, V89, P538, DOI 10.1046/j.1464-410X.2002.02669.x; Endsley MP, 2008, INT J CANCER, V123, P1318, DOI 10.1002/ijc.23674; Fowler CJ, 2010, CURR TOP MED CHEM, V10, P814; Freimuth N, 2010, J PHARMACOL EXP THER, V332, P336, DOI 10.1124/jpet.109.157735; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Lorente M, 2009, GLIA, V57, P1374, DOI 10.1002/glia.20856; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Melck D, 2000, ENDOCRINOLOGY, V141, P118, DOI 10.1210/en.141.1.118; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Mimeault M, 2003, PROSTATE, V56, P1, DOI 10.1002/pros.10190; Nithipatikom K, 2005, BIOCHEM BIOPH RES CO, V332, P1028, DOI 10.1016/j.bbrc.2005.05.049; Nithipatikom K, 2004, CANCER RES, V64, P8826, DOI 10.1158/0008-5472.CAN-04-3136; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pisanti S, 2009, BEST PRACT RES CL EN, V23, P117, DOI 10.1016/j.beem.2009.02.001; Sanchez MG, 2003, FEBS LETT, V555, P561, DOI 10.1016/S0014-5793(03)01349-8; Sarfaraz S, 2005, CANCER RES, V65, P1635, DOI 10.1158/0008-5472.CAN-04-3410; SARFARAZ S, 2008, CANCER RES, V68, P239; Sarfaraz S, 2006, J BIOL CHEM, V281, P39480, DOI 10.1074/jbc.M603495200; Thors L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012275; Velasco G, 2007, MOL NEUROBIOL, V36, P60, DOI 10.1007/s12035-007-0002-5; Wang DZ, 2008, CANCER RES, V68, P6468, DOI 10.1158/0008-5472.CAN-08-0896; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014; ZWEIG MH, 1993, CLIN CHEM, V39, P561	31	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15205	10.1371/journal.pone.0015205	http://dx.doi.org/10.1371/journal.pone.0015205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203460	gold, Green Submitted, Green Published			2022-12-25	WOS:000285579200013
J	Di Camillo, B; Sanavia, T; Iori, E; Bronte, V; Roncaglia, E; Maran, A; Avogaro, A; Toffolo, G; Cobelli, C				Di Camillo, Barbara; Sanavia, Tiziana; Iori, Elisabetta; Bronte, Vincenzo; Roncaglia, Enrica; Maran, Alberto; Avogaro, Angelo; Toffolo, Gianna; Cobelli, Claudio			The Transcriptional Response in Human Umbilical Vein Endothelial Cells Exposed to Insulin: A Dynamic Gene Expression Approach	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN SKELETAL-MUSCLE; STIMULATED PRODUCTION; METABOLIC SYNDROME; AKT; PHOSPHORYLATION; ACTIVATION; RESISTANCE; TISSUE; RISK	Background: In diabetes chronic hyperinsulinemia contributes to the instability of the atherosclerotic plaque and stimulates cellular proliferation through the activation of the MAP kinases, which in turn regulate cellular proliferation. However, it is not known whether insulin itself could increase the transcription of specific genes for cellular proliferation in the endothelium. Hence, the characterization of transcriptional modifications in endothelium is an important step for a better understanding of the mechanism of insulin action and the relationship between endothelial cell dysfunction and insulin resistance. Methodology and principal findings: The transcriptional response of endothelial cells in the 440 minutes following insulin stimulation was monitored using microarrays and compared to a control condition. About 1700 genes were selected as differentially expressed based on their treated minus control profile, thus allowing the detection of even small but systematic changes in gene expression. Genes were clustered in 7 groups according to their time expression profile and classified into 15 functional categories that can support the biological effects of insulin, based on Gene Ontology enrichment analysis. In terms of endothelial function, the most prominent processes affected were NADH dehydrogenase activity, N-terminal myristoylation domain binding, nitric-oxide synthase regulator activity and growth factor binding. Pathway-based enrichment analysis revealed "Electron Transport Chain" significantly enriched. Results were validated on genes belonging to "Electron Transport Chain" pathway, using quantitative RT-PCR. Conclusions: As far as we know, this is the first systematic study in the literature monitoring transcriptional response to insulin in endothelial cells, in a time series microarray experiment. Since chronic hyperinsulinemia contributes to the instability of the atherosclerotic plaque and stimulates cellular proliferation, some of the genes identified in the present work are potential novel candidates in diabetes complications related to endothelial dysfunction.	[Di Camillo, Barbara; Sanavia, Tiziana; Toffolo, Gianna; Cobelli, Claudio] Univ Padua, Dept Informat Engn, Padua, Italy; [Iori, Elisabetta; Maran, Alberto; Avogaro, Angelo] Univ Padua, Dept Clin & Expt Med, Div Metab Dis, Padua, Italy; [Bronte, Vincenzo] Ist Ricovero & Cura Carattere Sci, IOV, Padua, Italy; [Roncaglia, Enrica] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Roncaglia, Enrica] BioPharmaNet Inc, Emilia Romagna High Tech Network, Ferrara, Italy; [Avogaro, Angelo] VIMM, Padua, Italy	University of Padua; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Universita di Modena e Reggio Emilia; Veneto Institute Molecular Medicine	Di Camillo, B (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	cobelli@dei.unipd.it	Di Camillo, Barbara/L-3202-2013; Bronte, Vincenzo/K-7902-2016; Avogaro, Angelo/S-3808-2016; Sanavia, Tiziana/F-9446-2015	Di Camillo, Barbara/0000-0001-8415-4688; Bronte, Vincenzo/0000-0002-3741-5141; Sanavia, Tiziana/0000-0003-3288-0631; AVOGARO, ANGELO/0000-0002-1177-0516; MARAN, ALBERTO/0000-0002-7266-8486	PRIN; CARIPARO	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CARIPARO(Fondazione Cariparo)	This work was supported by PRIN 2005-2006 "Dynamic models of gene and protein expression in endothelial progenitor cells in evolution of diabetes" and CARIPARO 2008/2010 "Systems biology approaches to infer gene regulation from gene and protein time series data". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett EJ, 2009, DIABETOLOGIA, V52, P752, DOI 10.1007/s00125-009-1313-z; Boden G, 2008, AM J PHYSIOL-ENDOC M, V295, pE692, DOI 10.1152/ajpendo.90370.2008; Boo YC, 2006, FREE RADICAL BIO MED, V41, P144, DOI 10.1016/j.freeradbiomed.2006.03.024; CHENG Z, 2010, TRENDS ENDO IN PRESS; Consoli C, 2008, ARTERIOSCL THROM VAS, V28, pE7, DOI 10.1161/ATVBAHA.107.152264; dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5; Di Camillo B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S11; Di Camillo B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S10; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Fisslthaler B, 2003, NITRIC OXIDE-BIOL CH, V8, P253, DOI 10.1016/S1089-8603(03)00042-9; Fonseca VA, 2007, ENDOCRIN METAB CLIN, V36, P20, DOI 10.1016/S0889-8529(07)80009-0; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Hiden U, 2006, DIABETOLOGIA, V49, P123, DOI 10.1007/s00125-005-0054-x; Hirashima M, 2006, ENDOTHELIUM-J ENDOTH, V13, P137, DOI 10.1080/10623320600698078; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kashiwagi A, 1999, AM J PHYSIOL-ENDOC M, V277, pE976, DOI 10.1152/ajpendo.1999.277.6.E976; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; MATTHEWS VB, 2010, DIABETOLOGI IN PRESS; Montagnani M, 2002, MOL ENDOCRINOL, V16, P1931, DOI 10.1210/me.2002-0074; Moon CT, 2001, NEUROSURGERY, V48, P1328, DOI 10.1097/00006123-200106000-00030; Muniyappa R, 2008, ENDOCRIN METAB CLIN, V37, P685, DOI 10.1016/j.ecl.2008.06.001; POLLOCK JS, 1992, FEBS LETT, V309, P402, DOI 10.1016/0014-5793(92)80816-Y; Ritchie SA, 2010, BIOCHEM J, V426, P85, DOI 10.1042/BJ20091580; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Sata M, 2002, CIRC RES, V91, P273, DOI 10.1161/01.RES.0000031956.29928.62; SESSA WC, 1992, J BIOL CHEM, V267, P15274; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Tai SC, 2004, ARTERIOSCL THROM VAS, V24, P405, DOI 10.1161/01.ATV.0000109171.50229.33; Tanner FC, 2000, CIRCULATION, V101, P1982, DOI 10.1161/01.CIR.101.16.1982; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871	38	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14390	10.1371/journal.pone.0014390	http://dx.doi.org/10.1371/journal.pone.0014390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203503	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000006
J	Hohn, O; Strohschein, K; Brandt, AU; Seeher, S; Klein, S; Kurth, R; Paul, F; Meisel, C; Scheibenbogen, C; Bannert, N				Hohn, Oliver; Strohschein, Kristin; Brandt, Alexander U.; Seeher, Sandra; Klein, Sandra; Kurth, Reinhard; Paul, Friedemann; Meisel, Christian; Scheibenbogen, Carmen; Bannert, Norbert			No Evidence for XMRV in German CFS and MS Patients with Fatigue Despite the Ability of the Virus to Infect Human Blood Cells In Vitro	PLOS ONE			English	Article							PROSTATE CARCINOMA-CELLS; MULTIPLE-SCLEROSIS; GAMMARETROVIRUS XMRV; RETROVIRUS; CANCER; INTEGRATION; DEFINITION; DIAGNOSIS; TUMORS; SCALE	Background: Xenotropic murine leukemia virus-related virus (XMRV), a novel human retrovirus originally identified in prostate cancer tissues, has recently been associated with chronic fatigue syndrome (CFS), a disabling disease of unknown etiology affecting millions of people worldwide. However, several subsequent studies failed to detect the virus in patients suffering from these illnesses or in healthy subjects. Here we report the results of efforts to detect antibody responses and viral sequences in samples from a cohort of German CFS and relapsing remitting multiple sclerosis (MS) patients with fatigue symptoms. Methodology: Blood samples were taken from a cohort of 39 patients fulfilling the Fukuda/CDC criteria (CFS), from 112 patients with an established MS diagnosis and from 40 healthy donors. Fatigue severity in MS patients was assessed using the Fatigue Severity Scale (FSS). Validated Gag-and Env-ELISA assays were used to screen sera for XMRV antibodies. PHA-activated PBMC were cultured for seven days in the presence of IL-2 and DNA isolated from these cultures as well as from co-cultures of PBMC and highly permissive LNCaP cells was analyzed by nested PCR for the presence of the XMRV gag gene. In addition, PBMC cultures were exposed to 22Rv1-derived XMRV to assess infectivity and virus production. Conclusion: None of the screened sera from CFS and MS patients or healthy blood donors tested positive for XMRV specific antibodies and all PBMC (and PBMC plus LNCaP) cultures remained negative for XMRV sequences by nested PCR. These results argue against an association between XMRV infection and CFS and MS in Germany. However, we could confirm that PBMC cultures from healthy donors and from CFS patients can be experimentally infected by XMRV, resulting in the release of low levels of transmittable virus.	[Hohn, Oliver; Seeher, Sandra; Klein, Sandra; Bannert, Norbert] Robert Koch Inst, Ctr Biol Secur 4, D-1000 Berlin, Germany; [Strohschein, Kristin; Meisel, Christian; Scheibenbogen, Carmen] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Brandt, Alexander U.; Paul, Friedemann] Charite, NCRC, D-13353 Berlin, Germany; [Hohn, Oliver; Bannert, Norbert] Robert Koch Inst, Ctr Retrovirol, D-1000 Berlin, Germany	Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Hohn, O (corresponding author), Robert Koch Inst, Ctr Biol Secur 4, D-1000 Berlin, Germany.	bannertn@rki.de	Paul, Friedemann/ABF-9415-2020	Scheibenbogen, Carmen/0000-0002-8554-9638; Meisel, Christian/0000-0003-0222-991X; paul, friedemann/0000-0002-6378-0070	Fatigatio	Fatigatio	CS was supported by Fatigatio, the German patients self-help group for CFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony JM, 2010, BIOCH BIOPHYS ACTA; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Bakshi R, 2003, MULT SCLER J, V9, P219, DOI 10.1191/1352458503ms904oa; Behrendt R, 2009, J VIROL METHODS, V159, P40, DOI 10.1016/j.jviromet.2009.02.024; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; D'Arcy F, 2008, EUR UROL SUPPL, V7, P271, DOI 10.1016/S1569-9056(08)60798-8; DEFREITAS E, 1991, P NATL ACAD SCI USA, V88, P2922, DOI 10.1073/pnas.88.7.2922; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Maric R, 2010, J CLIN VIROL, V49, P227, DOI 10.1016/j.jcv.2010.08.003; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; PERRON H, 1991, LANCET, V337, P862, DOI 10.1016/0140-6736(91)92579-Q; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; SAITO M, 2010, INTERDISCIP PERSPECT; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Smith MM, 2005, MULT SCLER J, V11, P602, DOI 10.1191/1352458505ms1204oa; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Stieler K, 2010, VIROLOGY, V399, P23, DOI 10.1016/j.virol.2009.12.028; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Voisset C, 2008, MICROBIOL MOL BIOL R, V72, P157, DOI 10.1128/MMBR.00033-07; Yamashita M, 2006, VIROLOGY, V344, P88, DOI 10.1016/j.virol.2005.09.012	38	49	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15632	10.1371/journal.pone.0015632	http://dx.doi.org/10.1371/journal.pone.0015632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203514	Green Accepted, Green Published, gold			2022-12-25	WOS:000285578000041
J	D'Castro, L; Wenborn, A; Gros, N; Joiner, S; Cronier, S; Collinge, J; Wadsworth, JDF				D'Castro, Laura; Wenborn, Adam; Gros, Nathalie; Joiner, Susan; Cronier, Sabrina; Collinge, John; Wadsworth, Jonathan D. F.			Isolation of Proteinase K-Sensitive Prions Using Pronase E and Phosphotungstic Acid	PLOS ONE			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; SPONGIFORM ENCEPHALOPATHY; STRAIN VARIATION; TRANSGENIC MICE; MOLECULAR-BASIS; DISEASE; PROTEASE; SCRAPIE; PRPSC; THERMOLYSIN	Disease-related prion protein, PrP(Sc), is classically distinguished from its normal cellular precursor, PrP(C), by its detergent insolubility and partial resistance to proteolysis. Molecular diagnosis of prion disease typically relies upon detection of protease-resistant fragments of PrP(Sc) using proteinase K, however it is now apparent that the majority of disease-related PrP and indeed prion infectivity may be destroyed by this treatment. Here we report that digestion of RML prion-infected mouse brain with pronase E, followed by precipitation with sodium phosphotungstic acid, eliminates the large majority of brain proteins, including PrP(C), while preserving >70% of infectious prion titre. This procedure now allows characterization of proteinase K-sensitive prions and investigation of their clinical relevance in human and animal prion disease without being confounded by contaminating PrP	[D'Castro, Laura] Natl Hosp Neurol & Neurosurg, MRC Prion Unit, London WC1N 3BG, England; Natl Hosp Neurol & Neurosurg, Dept Neurodegenerat Dis, UCL Inst Neurol, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	D'Castro, L (corresponding author), Natl Hosp Neurol & Neurosurg, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	j.d.wadsworth@prion.ucl.ac.uk		Wadsworth, Jonathan/0000-0002-4797-2259	UK Medical Research Council; Medical Research Council [MC_U123160655] Funding Source: researchfish; MRC [MC_U123160655] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the UK Medical Research Council (http://www.mrc.ac.uk/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CHANDLER RL, 1961, LANCET, V1, P1378; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hill AF, 2006, BRAIN, V129, P676, DOI 10.1093/brain/awl013; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kuczius T, 2007, EUR J NEUROSCI, V25, P2649, DOI 10.1111/j.1460-9568.2007.05518.x; Kuczius T, 2009, MOL CELL NEUROSCI, V42, P226, DOI 10.1016/j.mcn.2009.07.004; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; Owen JP, 2007, MOL BIOTECHNOL, V35, P161, DOI 10.1007/BF02686111; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riesner D, 2003, BRIT MED BULL, V66, P21, DOI 10.1093/bmb/66.1.21; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, J VIROL, V79, P10796, DOI 10.1128/JVI.79.16.10796-10806.2005; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wadsworth JDF, 2007, BBA-MOL BASIS DIS, V1772, P598, DOI 10.1016/j.bbadis.2007.02.010; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200	44	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15679	10.1371/journal.pone.0015679	http://dx.doi.org/10.1371/journal.pone.0015679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187933	Green Published, Green Submitted, gold			2022-12-25	WOS:000285575200063
J	Hauser, PM; Burdet, FX; Cisse, OH; Keller, L; Taffe, P; Sanglard, D; Pagni, M				Hauser, Philippe M.; Burdet, Frederic X.; Cisse, Ousmane H.; Keller, Laurent; Taffe, Patrick; Sanglard, Dominique; Pagni, Marco			Comparative Genomics Suggests that the Fungal Pathogen Pneumocystis Is an Obligate Parasite Scavenging Amino Acids from Its Host's Lungs	PLOS ONE			English	Article							GENE PREDICTION; CARINII; METABOLISM; INSIGHTS; COEVOLUTION; SPECIFICITY; GENERATION; PNEUMONIA; PATHWAYS; PROTEASE	Pneumocystis jirovecii is a fungus causing severe pneumonia in immuno-compromised patients. Progress in understanding its pathogenicity and epidemiology has been hampered by the lack of a long-term in vitro culture method. Obligate parasitism of this pathogen has been suggested on the basis of various features but remains controversial. We analysed the 7.0 Mb draft genome sequence of the closely related species Pneumocystis carinii infecting rats, which is a well established experimental model of the disease. We predicted 8'085 (redundant) peptides and 14.9% of them were mapped onto the KEGG biochemical pathways. The proteome of the closely related yeast Schizosaccharomyces pombe was used as a control for the annotation procedure (4'974 genes, 14.1% mapped). About two thirds of the mapped peptides of each organism (65.7% and 73.2%, respectively) corresponded to crucial enzymes for the basal metabolism and standard cellular processes. However, the proportion of P. carinii genes relative to those of S. pombe was significantly smaller for the "amino acid metabolism'' category of pathways than for all other categories taken together (40 versus 114 against 278 versus 427, P<0.002). Importantly, we identified in P. carinii only 2 enzymes specifically dedicated to the synthesis of the 20 standard amino acids. By contrast all the 54 enzymes dedicated to this synthesis reported in the KEGG atlas for S. pombe were detected upon reannotation of S. pombe proteome (2 versus 54 against 278 versus 427, P<0.0001). This finding strongly suggests that species of the genus Pneumocystis are scavenging amino acids from their host's lung environment. Consequently, they would have no form able to live independently from another organism, and these parasites would be obligate in addition to being opportunistic. These findings have implications for the management of patients susceptible to P. jirovecii infection given that the only source of infection would be other humans.	[Hauser, Philippe M.; Burdet, Frederic X.; Cisse, Ousmane H.; Sanglard, Dominique] CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland; [Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Burdet, Frederic X.; Pagni, Marco] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland; [Taffe, Patrick] CHU Vaudois, Ctr Data, Swiss HIV Cohort Study, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Hauser, PM (corresponding author), CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland.	Philippe.Hauser@chuv.ch	keller, laurent/AAI-7175-2020; Cisse, Ousmane/X-6408-2019; Cissé, Ousmane/N-8780-2018; Taffé, Patrick/AAW-2701-2020; Sanglard, Dominique/K-6032-2017	Cisse, Ousmane/0000-0002-2990-2185; Cissé, Ousmane/0000-0002-2990-2185; Sanglard, Dominique/0000-0002-5244-4178; Hauser, Philippe/0000-0003-2834-7922; Pagni, Marco/0000-0001-9292-9463; keller, laurent/0000-0002-5046-9953; Taffe, Patrick/0000-0002-2049-6651	Swiss National Science Foundation (snf.ch) [310030-124998]	Swiss National Science Foundation (snf.ch)(Swiss National Science Foundation (SNSF))	This study was supported by Swiss National Science Foundation (snf.ch) grant 310030-124998. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambrose HE, 2004, MICROBIOL-SGM, V150, P293, DOI 10.1099/mic.0.26539-0; Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Atzori C, 2000, J INFECT DIS, V181, P1629, DOI 10.1086/315437; Basselin M, 2001, ARCH BIOCHEM BIOPHYS, V391, P90, DOI 10.1006/abbi.2001.2389; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Choi Min-Ho, 2000, Korean Journal of Parasitology, V38, P159, DOI 10.3347/kjp.2000.38.3.159; Corradi N, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1082; Cushion MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000423; Cushion MT, 2004, J EUKARYOT MICROBIOL, V51, P30, DOI 10.1111/j.1550-7408.2004.tb00158.x; Davis JL, 2008, CURR OPIN INFECT DIS, V21, P184, DOI 10.1097/QCO.0b013e3282f54fff; Demanche C, 2001, J CLIN MICROBIOL, V39, P2126, DOI 10.1128/JCM.39.6.2126-2133.2001; Ewann F, 2006, APPL ENVIRON MICROB, V72, P3993, DOI 10.1128/AEM.00684-06; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GIGLIOTTI F, 1993, INFECT IMMUN, V61, P2886, DOI 10.1128/IAI.61.7.2886-2890.1993; Hau J, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-2; JOFFRION TM, 2010, FEMS MICROB IN PRESS; Kaneshiro ES, 2004, LIPIDS, V39, P753, DOI 10.1007/s11745-004-1292-5; Keeling PJ, 2005, FOLIA PARASIT, V52, P8, DOI 10.14411/fp.2005.002; Keely SP, 2005, GENETICS, V170, P1589, DOI 10.1534/genetics.105.040733; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kutty G, 2008, J INFECT DIS, V198, P741, DOI 10.1086/590433; Nahimana A, 2000, J EUKARYOT MICROBIOL, V47, P368, DOI 10.1111/j.1550-7408.2000.tb00062.x; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Payne SH, 2006, EUKARYOT CELL, V5, P272, DOI 10.1128/EC.5.2.272-276.2006; Reichard U, 2008, MYCOSES, V51, P30, DOI 10.1111/j.1439-0507.2008.01584.x; Rodrigues MG, 2003, INT J SYST EVOL MICR, V53, P607, DOI 10.1099/ijs.0.02437-0; Sakharkar KR, 2004, INT J SYST EVOL MICR, V54, P1937, DOI 10.1099/ijs.0.63090-0; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Stringer JR, 1998, FEMS IMMUNOL MED MIC, V22, P15, DOI 10.1111/j.1574-695X.1998.tb01183.x; Sugiyama Junta, 1998, Mycoscience, V39, P487, DOI 10.1007/BF02460912; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; WAKEFIELD AE, 1995, BAILLIERE CLIN INF D, V2, P431; Wakefield AE, 1998, MED MYCOL, V36, P183	42	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15152	10.1371/journal.pone.0015152	http://dx.doi.org/10.1371/journal.pone.0015152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188143	Green Published, gold			2022-12-25	WOS:000285575200016
J	Mitea, C; Salentijn, EMJ; van Veelen, P; Goryunova, SV; van der Meer, IM; van den Broeck, HC; Mujico, JR; Monserrat, V; Gilissen, LJWJ; Drijfhout, JW; Dekking, L; Koning, F; Smulders, MJM				Mitea, Cristina; Salentijn, Elma M. J.; van Veelen, Peter; Goryunova, Svetlana V.; van der Meer, Ingrid M.; van den Broeck, Hetty C.; Mujico, Jorge R.; Monserrat, Veronica; Gilissen, Luud J. W. J.; Drijfhout, Jan Wouter; Dekking, Liesbeth; Koning, Frits; Smulders, Marinus J. M.			A Universal Approach to Eliminate Antigenic Properties of Alpha-Gliadin Peptides in Celiac Disease	PLOS ONE			English	Article							CEREAL TOXICITY; WHEAT; EPITOPES; MUTAGENESIS; PREVALENCE; VARIETIES; EXPLAINS; BINDING; CELLS; DNA	Celiac disease is caused by an uncontrolled immune response to gluten, a heterogeneous mixture of wheat storage proteins, including the alpha-gliadins. It has been shown that alpha-gliadins harbor several major epitopes involved in the disease pathogenesis. A major step towards elimination of gluten toxicity for celiac disease patients would thus be the elimination of such epitopes from alpha-gliadins. We have analyzed over 3,000 expressed alpha-gliadin sequences from 11 bread wheat cultivars to determine whether they encode for peptides potentially involved in celiac disease. All identified epitope variants were synthesized as peptides and tested for binding to the disease-associated HLA-DQ2 and HLA-DQ8 molecules and for recognition by patient-derived alpha-gliadin specific T cell clones. Several specific naturally occurring amino acid substitutions were identified for each of the alpha-gliadin derived peptides involved in celiac disease that eliminate the antigenic properties of the epitope variants. Finally, we provide proof of principle at the peptide level that through the systematic introduction of such naturally occurring variations alpha-gliadins genes can be generated that no longer encode antigenic peptides. This forms a crucial step in the development of strategies to modify gluten genes in wheat so that it becomes safe for celiac disease patients. It also provides the information to design and introduce safe gluten genes in other cereals, which would exhibit improved quality while remaining safe for consumption by celiac disease patients.	[Mitea, Cristina; van Veelen, Peter; Mujico, Jorge R.; Monserrat, Veronica; Drijfhout, Jan Wouter; Dekking, Liesbeth; Koning, Frits] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Salentijn, Elma M. J.; Goryunova, Svetlana V.; van der Meer, Ingrid M.; van den Broeck, Hetty C.; Gilissen, Luud J. W. J.; Smulders, Marinus J. M.] Wageningen UR, Wageningen, Netherlands; [Gilissen, Luud J. W. J.; Smulders, Marinus J. M.] Allergy Ctr Wageningen, Wageningen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mitea, C (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	f.koning@lumc.nl; rene.smulders@wur.nl	Goryunova, Svetlana/AAE-2743-2019; Drijfhout, Jan Wouter/ABA-6318-2021; gilisen, luud/F-5496-2017; Smulders, M.J.M./B-3654-2009	Drijfhout, Jan Wouter/0000-0003-4808-5296; Smulders, M.J.M./0000-0002-8549-6046; Mujico Fernandez, Jorge Raul/0000-0002-1235-9120; van Veelen, Peter/0000-0002-7898-9408; Koning, Frits/0000-0002-4007-5715	Celiac Disease Consortium; Dutch Government [BSIK03009]; Center for Medical Systems Biology (CMSB); The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO); The Netherlands Ministry of Agriculture, Nature, and Food Safety [KB-05-001-019]	Celiac Disease Consortium; Dutch Government; Center for Medical Systems Biology (CMSB); The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); The Netherlands Ministry of Agriculture, Nature, and Food Safety	This study was supported by the Celiac Disease Consortium, an Innovative Cluster approved by The Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK03009), by the Center for Medical Systems Biology (CMSB), a center of excellence approved by The Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO), and by The Netherlands Ministry of Agriculture, Nature, and Food Safety (project KB-05-001-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OD, 1997, THEOR APPL GENET, V95, P50, DOI 10.1007/s001220050531; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; de Pater S, 2009, PLANT BIOTECHNOL J, V7, P821, DOI 10.1111/j.1467-7652.2009.00446.x; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Kawaura K, 2005, PLANT PHYSIOL, V139, P1870, DOI 10.1104/pp.105.070722; Koning F, 2005, GASTROENTEROLOGY, V129, P1294, DOI 10.1053/j.gastro.2005.07.030; Li J, 2007, CURR OPIN PLANT BIOL, V10, P131, DOI 10.1016/j.pbi.2007.01.007; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Molberg O, 2005, GASTROENTEROLOGY, V128, P393, DOI 10.1053/j.gastro.2004.11.003; OKITA TW, 1985, J BIOL CHEM, V260, P8203; Qiao SW, 2005, J IMMUNOL, V175, P254, DOI 10.4049/jimmunol.175.1.254; Rewers M, 2005, GASTROENTEROLOGY, V128, pS47, DOI 10.1053/j.gastro.2005.02.030; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Spaenij-Dekking L, 2005, GASTROENTEROLOGY, V129, P797, DOI 10.1053/j.gastro.2005.06.017; Stepniak D, 2008, J IMMUNOL, V180, P3268, DOI 10.4049/jimmunol.180.5.3268; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Vader LW, 2003, GASTROENTEROLOGY, V125, P1105, DOI 10.1016/S0016-5085(03)01204-6; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; van de Wal Y, 1999, EUR J IMMUNOL, V29, P3133, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3133::AID-IMMU3133&gt;3.0.CO;2-G; van den Broeck H, 2010, MOL BIOSYST, V6, P2206, DOI 10.1039/c0mb00046a; van den Broeck HC, 2010, THEOR APPL GENET, V121, P1527, DOI 10.1007/s00122-010-1408-4; van Herpen TWJM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-1	31	57	69	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15637	10.1371/journal.pone.0015637	http://dx.doi.org/10.1371/journal.pone.0015637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179575	Green Published, gold			2022-12-25	WOS:000285381200034
J	Riederer, I; Sievert, W; Eissner, G; Molls, M; Multhoff, G				Riederer, Isabelle; Sievert, Wolfgang; Eissner, Guenther; Molls, Michael; Multhoff, Gabriele			Irradiation-Induced Up-Regulation of HLA-E on Macrovascular Endothelial Cells Confers Protection against Killing by Activated Natural Killer Cells	PLOS ONE			English	Article							TRANSENDOTHELIAL MIGRATION; CYTOLYTIC ACTIVITY; NK CELLS; E BINDS; ADHESION; NKG2D; CYTOTOXICITY; EXPRESSION; PEPTIDE; HSP70	Background: Apart from the platelet/endothelial cell adhesion molecule 1 (PECAM-1, CD31), endoglin (CD105) and a positive factor VIII-related antigen staining, human primary and immortalized macro-and microvascular endothelial cells (ECs) differ in their cell surface expression of activating and inhibitory ligands for natural killer (NK) cells. Here we comparatively study the effects of irradiation on the phenotype of ECs and their interaction with resting and activated NK cells. Methodology/Principal Findings: Primary macrovascular human umbilical vein endothelial cells (HUVECs) only express UL16 binding protein 2 (ULBP2) and the major histocompatibility complex (MHC) class I chain-related protein MIC-A (MIC-A) as activating signals for NK cells, whereas the corresponding immortalized EA. hy926 EC cell line additionally present ULBP3, membrane heat shock protein 70 (Hsp70), intercellular adhesion molecule ICAM-1 (CD54) and HLA-E. Apart from MIC-B, the immortalized human microvascular endothelial cell line HMEC, resembles the phenotype of EA. hy926. Surprisingly, primary HUVECs are more sensitive to Hsp70 peptide (TKD) plus IL-2 (TKD/IL-2)-activated NK cells than their immortalized EC counterpatrs. This finding is most likely due to the absence of the inhibitory ligand HLA-E, since the activating ligands are shared among the ECs. The co-culture of HUVECs with activated NK cells induces ICAM-1 (CD54) and HLA-E expression on the former which drops to the initial low levels (below 5%) when NK cells are removed. Sublethal irradiation of HUVECs induces similar but less pronounced effects on HUVECs. Along with these findings, irradiation also induces HLA-E expression on macrovascular ECs and this correlates with an increased resistance to killing by activated NK cells. Irradiation had no effect on HLA-E expression on microvascular ECs and the sensitivity of these cells to NK cells remained unaffected. Conclusion/Significance: These data emphasize that an irradiation-induced, transient up-regulation of HLA-E on macrovascular ECs might confer protection against NK cell-mediated vascular injury.	[Riederer, Isabelle; Sievert, Wolfgang; Molls, Michael; Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany; [Riederer, Isabelle; Sievert, Wolfgang; Molls, Michael; Multhoff, Gabriele] Helmholtz Zentrum Munchen, CCG Innate Immun Tumor Biol, Munich, Germany; [Eissner, Guenther] Klinikum Univ Munchen, Dept Cardiac Surg, Munich, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Riederer, I (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany.	gabriele.multhoff@lrz.tu-muenchen.de	Multhoff, Gabriele/AAW-9796-2021	Multhoff, Gabriele/0000-0002-2616-3137; Riederer, Isabelle/0000-0002-7856-8283	EU [FP7-211403]; DFG [SFB824/1]; BMBDF [01EZ0826]; BMBF Kompetenzverbund Strahlenforschung [03NUK007E]; multimmune GmbH	EU(European Commission); DFG(German Research Foundation (DFG)); BMBDF; BMBF Kompetenzverbund Strahlenforschung; multimmune GmbH	The funders are EU-CARDIORISK (FP7-211403), DFG (SFB824/1), BMBDF-MOBITUM (01EZ0826), BMBF Kompetenzverbund Strahlenforschung (03NUK007E) and multimmune GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external sources for this study.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Allavena P, 1996, NAT IMMUN, V15, P107; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Biassoni R, 2003, J CELL MOL MED, V7, P376, DOI 10.1111/j.1582-4934.2003.tb00240.x; Bielawska-Pohl A, 2005, J IMMUNOL, V174, P5573, DOI 10.4049/jimmunol.174.9.5573; Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; Braud V, 1997, EUR J IMMUNOL, V27, P1164, DOI 10.1002/eji.1830270517; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; CARLOS TM, 1994, BLOOD, V84, P2068; Chen WS, 2002, FASEB J, V16, pA214; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cordes N, 2007, INT J RADIAT BIOL, V83, P753, DOI 10.1080/09553000701639694; Ebert EC, 2008, IMMUNOLOGY, V124, P33, DOI 10.1111/j.1365-2567.2007.02656.x; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Gastpar R, 2004, J IMMUNOL, V172, P972, DOI 10.4049/jimmunol.172.2.972; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gifford SM, 2004, J ENDOCRINOL, V182, P485, DOI 10.1677/joe.0.1820485; Giron-Michel J, 2003, J EXP MED, V197, P763, DOI 10.1084/jem.20020150; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Gross C, 2003, CELL STRESS CHAPERON, V8, P348, DOI 10.1379/1466-1268(2003)008<0348:HSPRIA>2.0.CO;2; Gross C, 2003, J BIOL CHEM, V278, P41173, DOI 10.1074/jbc.M302644200; Gross C, 2003, BIOL CHEM, V384, P267, DOI 10.1515/BC.2003.030; Hayakawa Y, 2002, J IMMUNOL, V169, P5377, DOI 10.4049/jimmunol.169.10.5377; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; King AG, 2000, J IMMUNOL, V164, P3774, DOI 10.4049/jimmunol.164.7.3774; Krause SW, 2004, CLIN CANCER RES, V10, P3699, DOI 10.1158/1078-0432.CCR-03-0683; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lilienfeld BG, 2008, XENOTRANSPLANTATION, V15, P136, DOI 10.1111/j.1399-3089.2008.00453.x; Marin R, 2003, IMMUNOGENETICS, V54, P767, DOI 10.1007/s00251-002-0526-9; Multhoff G, 1997, J IMMUNOL, V158, P4341; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Parham P, 2004, IMMUNOL LETT, V92, P11, DOI 10.1016/j.imlet.2003.11.016; Pende D, 2002, CANCER RES, V62, P6178; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; ROBERTSON MJ, 1990, BLOOD, V76, P2421; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stangl S, 2008, CELL STRESS CHAPERON, V13, P221, DOI 10.1007/s12192-007-0008-y; Stangl S, 2006, J IMMUNOL, V176, P6270, DOI 10.4049/jimmunol.176.10.6270; Strasly M, 2001, J IMMUNOL, V166, P3890, DOI 10.4049/jimmunol.166.6.3890; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; ULBRECHT M, 1992, J IMMUNOL, V149, P2945; Videm V, 2008, SCAND J IMMUNOL, V67, P523, DOI 10.1111/j.1365-3083.2008.02029.x; Wallin RPA, 2003, EUR J IMMUNOL, V33, P2727, DOI 10.1002/eji.200324070; Weiss EH, 2009, TRANSPLANTATION, V87, P35, DOI 10.1097/TP.0b013e318191c784; Westgaard IH, 2003, J EXP MED, V197, P1551, DOI 10.1084/jem.20021253	56	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15339	10.1371/journal.pone.0015339	http://dx.doi.org/10.1371/journal.pone.0015339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179573	Green Published, gold, Green Submitted			2022-12-25	WOS:000285381200026
J	Wu, XS; Tschumper, RC; Gutierrez, A; Mihalcik, SA; Nowakowski, GS; Jelinek, DF				Wu, Xiaosheng; Tschumper, Renee C.; Gutierrez, Albert, Jr.; Mihalcik, Stephen A.; Nowakowski, Grzegorz S.; Jelinek, Diane F.			Selective Induction of DNA Repair Pathways in Human B Cells Activated by CD4(+) T Cells	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; SOMATIC HYPERMUTATION; EXPRESSION; LYMPHOMAS; CHROMATIN; CANCER; MICE; BCL6; AID; ATR	Greater than 75% of all hematologic malignancies derive from germinal center (GC) or post-GC B cells, suggesting that the GC reaction predisposes B cells to tumorigenesis. Because GC B cells acquire expression of the highly mutagenic enzyme activation-induced cytidine deaminase (AID), GC B cells may require additional DNA repair capacity. The goal of this study was to investigate whether normal human B cells acquire enhanced expression of DNA repair factors upon AID induction. We first demonstrated that several DNA mismatch repair, homologous recombination, base excision repair, and ATR signaling genes were overexpressed in GC B cells relative to naive and memory B cells, reflecting activation of a process we have termed somatic hyperrepair (SHR). Using an in vitro system, we next characterized activation signals required to induce AID expression and SHR. Although AID expression was induced by a variety of polyclonal activators, SHR induction strictly required signals provided by contact with activated CD4(+) T cells, and B cells activated in this manner displayed reduced levels of DNA damage-induced apoptosis. We further show the induction of SHR is independent of AID expression, as GC B cells from AID -/- mice retained heightened expression of SHR proteins. In consideration of the critical role that CD4(+) T cells play in inducing the SHR process, our data suggest a novel role for CD4(+) T cells in the tumor suppression of GC/post-GC B cells.	[Wu, Xiaosheng; Tschumper, Renee C.; Gutierrez, Albert, Jr.; Mihalcik, Stephen A.; Jelinek, Diane F.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Nowakowski, Grzegorz S.] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Wu, XS (corresponding author), Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA.	jelinek.diane@mayo.edu		Mihalcik, Stephen/0000-0003-2145-467X	National Institutes of Health [R01CA136591, P01CA062242]; NATIONAL CANCER INSTITUTE [P01CA062242, R01CA136591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health (R01CA136591 and P01CA062242 awarded to DFJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang DK, 2000, J BIOL CHEM, V275, P18424, DOI 10.1074/jbc.M001140200; Darce JR, 2007, J IMMUNOL, V179, P7276, DOI 10.4049/jimmunol.179.11.7276; de Yebenes VG, 2006, TRENDS MOL MED, V12, P432, DOI 10.1016/j.molmed.2006.07.001; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; Duval A, 2004, P NATL ACAD SCI USA, V101, P5002, DOI 10.1073/pnas.0400945101; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Horner M, SEER CANC STAT REV 1; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klemm L, 2009, CANCER CELL, V16, P232, DOI 10.1016/j.ccr.2009.07.030; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Li ZQ, 2004, GENE DEV, V18, P1, DOI 10.1101/gad.1161904; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Longo NS, 2009, BLOOD, V113, P3706, DOI 10.1182/blood-2008-10-183632; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Park K, 1998, J IMMUNOL, V161, P6128; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Perez-Duran P, 2007, CARCINOGENESIS, V28, P2427, DOI 10.1093/carcin/bgm201; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ranuncolo SA, 2008, BLOOD CELL MOL DIS, V41, P95, DOI 10.1016/j.bcmd.2008.02.003; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Schroering AG, 2008, DNA REPAIR, V7, P951, DOI 10.1016/j.dnarep.2008.03.023; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Wei K, 2002, TRENDS MOL MED, V8, P346, DOI 10.1016/S1471-4914(02)02359-6; Wu XS, 2005, NAT IMMUNOL, V6, P964, DOI 10.1038/ni1005-964; Wu XS, 2003, MOL CELL BIOL, V23, P3320, DOI 10.1128/MCB.23.9.3320-3328.2003; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15549	10.1371/journal.pone.0015549	http://dx.doi.org/10.1371/journal.pone.0015549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179576	Green Submitted, Green Published, gold			2022-12-25	WOS:000285381200028
J	Leibbrandt, A; Meier, C; Konig-Schuster, M; Weinmullner, R; Kalthoff, D; Pflugfelder, B; Graf, P; Frank-Gehrke, B; Beer, M; Fazekas, T; Unger, H; Prieschl-Grassauer, E; Grassauer, A				Leibbrandt, Andreas; Meier, Christiane; Koenig-Schuster, Marielle; Weinmuellner, Regina; Kalthoff, Donata; Pflugfelder, Bettina; Graf, Philipp; Frank-Gehrke, Britta; Beer, Martin; Fazekas, Tamas; Unger, Hermann; Prieschl-Grassauer, Eva; Grassauer, Andreas			Iota-Carrageenan Is a Potent Inhibitor of Influenza A Virus Infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SULFATED POLYSACCHARIDES; ANTIVIRAL ACTIVITY; DOUBLE-BLIND; H1N1 VIRUS; IN-VITRO; OSELTAMIVIR; NEURAMINIDASE; RESISTANCE; EFFICACY	The 2009 flu pandemic and the appearance of oseltamivir-resistant H1N1 influenza strains highlight the need for treatment alternatives. One such option is the creation of a protective physical barrier in the nasal cavity. In vitro tests demonstrated that iota-carrageenan is a potent inhibitor of influenza A virus infection, most importantly also of pandemic H1N1/2009 in vitro. Consequently, we tested a commercially available nasal spray containing iota-carrageenan in an influenza A mouse infection model. Treatment of mice infected with a lethal dose of influenza A PR8/34 H1N1 virus with iota-carrageenan starting up to 48 hours post infection resulted in a strong protection of mice similar to mice treated with oseltamivir. Since alternative treatment options for influenza are rare, we conclude that the nasal spray containing iota-carrageenan is an alternative to neuraminidase inhibitors and should be tested for prevention and treatment of influenza A in clinical trials in humans.	[Leibbrandt, Andreas; Meier, Christiane; Koenig-Schuster, Marielle; Weinmuellner, Regina; Pflugfelder, Bettina; Graf, Philipp; Frank-Gehrke, Britta; Prieschl-Grassauer, Eva; Grassauer, Andreas] Marinomed Biotechnol GmbH, Vienna, Austria; [Kalthoff, Donata; Beer, Martin] Bundesforsch Inst Tiergesundheit, Inst Diagnost Virol, Friedrich Loeffler Inst, Greifswald, Germany; [Fazekas, Tamas] St Anna Childrens Hosp, A-1090 Vienna, Austria; [Unger, Hermann] Vet Univ Vienna, Lab Trop Vet Med, A-1030 Vienna, Austria	Friedrich Loeffler Institute; Saint Anna Children's Hospital; University of Veterinary Medicine Vienna	Leibbrandt, A (corresponding author), Marinomed Biotechnol GmbH, Vienna, Austria.	andreas.leibbrandt@marinomed.com		Hoffmann, Donata/0000-0003-4552-031X	Austrian Research Promotion Agency (FFG) [813886, 818252, 824211]; Marinomed	Austrian Research Promotion Agency (FFG); Marinomed	This work was supported in part by the Austrian Research Promotion Agency (FFG) grant numbers 813886, 818252, and 824211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Marinomed Biotechnologie GmbH had a role in study design, data collection and analysis, decision to publish, preparation of the manuscript and is financing the processing charge of the manuscript.; The authors AL, AG, CM, MK, RW, BP, BF, PG, and EP are employed by Marinomed. Authors HU, EP and AG are co-founders of Marinomed. AG and EP are inventors of patent #WO2009027057 held by Marinomed Biotechnologie GmbH that relates to the content of the manuscript. Marinomed Biotechnologie GmbH is financing the processing charge of this manuscript. TF has previously served as principal investigator for a clinical investigator-initiated study that was co-financed by Marinomed. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Authors MB and DK declare no competing interests.	BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; Bantia S, 2001, ANTIMICROB AGENTS CH, V45, P1162, DOI 10.1128/AAC.45.4.1162-1167.2001; Barnard D, 2009, ANTIVIR RES, V82, pA32, DOI 10.1016/j.antiviral.2009.02.059; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Baz M, 2010, J INFECT DIS, V201, P740, DOI 10.1086/650464; Baz M, 2009, NEW ENGL J MED, V361, P2296, DOI 10.1056/NEJMc0910060; Benford D., 2008, WHO FOOD ADDITIVES S, V59, P65; Buck Christopher B., 2006, PLoS Pathogens, V2, DOI 10.1372/journal.ppat.0020069; Burch J, 2009, LANCET INFECT DIS, V9, P537, DOI 10.1016/S1473-3099(09)70199-9; Carlucci MJ, 2004, ANTIVIR RES, V64, P137, DOI 10.1016/j.antiviral.2004.07.001; Carlucci MJ, 1999, ANTIVIR RES, V43, P93, DOI 10.1016/S0166-3542(99)00038-8; Cohen SM, 2002, CRIT REV TOXICOL, V32, P413, DOI 10.1080/20024091064282; Damonte EB, 2004, CURR MED CHEM, V11, P2399, DOI 10.2174/0929867043364504; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; Eccles R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-108; Ghosh T, 2009, GLYCOBIOLOGY, V19, P2, DOI 10.1093/glycob/cwn092; GIROND S, 1991, RES VIROLOGY, V142, P261, DOI 10.1016/0923-2516(91)90011-Q; GONZALEZ ME, 1987, ANTIMICROB AGENTS CH, V31, P1388, DOI 10.1128/AAC.31.9.1388; Gooskens J, 2009, JAMA-J AM MED ASSOC, V301, P1042, DOI 10.1001/jama.2009.297; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; HAMASUNA R, 1994, J GEN VIROL, V75, P111, DOI 10.1099/0022-1317-75-1-111; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Hayden FG, 2006, J INFECT DIS, V194, pS119, DOI 10.1086/507552; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Hersh AL, 2009, AM J PUBLIC HEALTH, V99, pS362, DOI 10.2105/AJPH.2009.171462; Huang SJ, 2004, ELECTROPHORESIS, V25, P779, DOI 10.1002/elps.200305723; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jefferson T, 2006, Cochrane Database Syst Rev, pCD001169, DOI 10.1002/14651858.CD001265.pub2; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kalthoff D, 2010, EMERG INFECT DIS, V16, P703, DOI 10.3201/eid1604.091491; Khazeni N, 2009, ANN INTERN MED, V151, P464, DOI 10.7326/0003-4819-151-7-200910060-00143; Kilmarx PH, 2008, SEX TRANSM DIS, V35, P226, DOI 10.1097/OLQ.0b013e31815d6e0d; Matheson NJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002744.pub2; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Nelson MI, 2009, VIROLOGY, V388, P270, DOI 10.1016/j.virol.2009.03.026; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Perez-Andino J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005847; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; Pujol CA, 2006, PLANTA MED, V72, P121, DOI 10.1055/s-2005-373168; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; Sidwell RW, 1998, ANTIVIR RES, V37, P107, DOI 10.1016/S0166-3542(97)00065-X; Sidwell RW, 2000, ANTIVIR RES, V48, P1, DOI 10.1016/S0166-3542(00)00125-X; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; van de Velde F, 2002, TRENDS FOOD SCI TECH, V13, P73, DOI 10.1016/S0924-2244(02)00066-3; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; Witvrouw M, 1997, GEN PHARMACOL-VASC S, V29, P497, DOI 10.1016/S0306-3623(96)00563-0	61	104	113	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14320	10.1371/journal.pone.0014320	http://dx.doi.org/10.1371/journal.pone.0014320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179403	Green Published, Green Submitted, gold			2022-12-25	WOS:000285292500005
J	Sfreddo, C; Fuchs, SC; Merlo, AR; Fuchs, FD				Sfreddo, Carla; Fuchs, Sandra Costa; Merlo, Alvaro Roberto; Fuchs, Flavio Danni			Shift Work Is Not Associated with High Blood Pressure or Prevalence of Hypertension	PLOS ONE			English	Article							RECOVERY; WOMEN	Background: Working mostly at night has been suggested to be associated with upset of chronobiological rhythms and high blood pressure, but the evidence from epidemiological studies is weak. Methods: In a cross-sectional survey, we evaluated the association between shift work and blood pressure, pre-hypertension and hypertension. In total, 493 nurses, nurse technicians and assistants, were selected at random in a large general hospital setting. Hypertension was diagnosed by the mean of four automatic blood pressure readings >= 140/90 mmHg or use of blood pressure lowering agents, and pre-hypertension by systolic blood pressure >= 120-139 or diastolic blood pressure >= 80-89 mmHg. Risk factors for hypertension were evaluated by a standardized questionnaire and anthropometric measurements. The association between the shift of work and blood pressure, pre-hypertension and hypertension was explored using univariate and multivariate analyses that controlled for risk factors for hypertension by covariance analysis and modified Poisson regression. Results: The mean age of the participants was 34.3 +/- 69.4 years and 88.2% were women. Night shift workers were older, more frequently married or divorced, and less educated. The prevalence of hypertension in the whole sample was 16%, and 28% had pre-hypertension. Blood pressure (after adjustment for confounding) was not different in day and night shift workers. The prevalence of hypertension and pre-hypertension by shift work was not different in the univariate analysis and after adjustment for confounding (all risk ratios = 1.0). Conclusion: Night shift work did not increase blood pressure and was not associated with hypertension or pre-hypertension in nursing personnel working in a large general hospital.	[Sfreddo, Carla] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Porto Alegre, RS, Brazil; [Sfreddo, Carla] Univ Passo Fundo, Hosp Sao Vicente de Paulo, Passo Fundo, RS, Brazil; [Fuchs, Sandra Costa; Fuchs, Flavio Danni] Univ Fed Rio Grande do Sul, Postgrad Program Cardiol, Porto Alegre, RS, Brazil; [Merlo, Alvaro Roberto] Univ Fed Rio Grande do Sul, Postgrad Program Epidemiol, Porto Alegre, RS, Brazil; [Fuchs, Flavio Danni] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Passo Fundo; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Sfreddo, C (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Porto Alegre, RS, Brazil.	ffuchs@hcpa.ufrgs.br	Fuchs, Sandra C/T-2670-2019; Iats, Inct/K-2300-2013; Fuchs, Flávio D/L-5078-2016	fuchs, flavio/0000-0002-1191-0523	National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil; Fundo de Incentivo a Pesquisa (FIPE-HCPA), Brazil	National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa (FIPE-HCPA), Brazil	This study was supported by the National Institute of Science and Technology for Health Technology Assessment (IATS) - CNPq/Brazil and Fundo de Incentivo a Pesquisa (FIPE-HCPA), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barger LK, 2009, CURR NEUROL NEUROSCI, V9, P155, DOI 10.1007/s11910-009-0024-7; Hublin C, 2010, EUR J EPIDEMIOL, V25, P315, DOI 10.1007/s10654-010-9439-3; Lo SH, 2008, AM J HYPERTENS, V21, P759, DOI 10.1038/ajh.2008.186; Pickering Thomas G, 2006, J Clin Hypertens (Greenwich), V8, P819, DOI 10.1111/j.1524-6175.2006.05126.x; Stranges S, 2010, J HYPERTENS, V28, P896, DOI 10.1097/HJH.0b013e328335d076; Su TC, 2008, J OCCUP HEALTH, V50, P380, DOI 10.1539/joh.L7056; Suwazono Y, 2008, HYPERTENSION, V52, P581, DOI 10.1161/HYPERTENSIONAHA.108.114553; Yamasaki F, 1998, HYPERTENSION, V32, P417, DOI 10.1161/01.HYP.32.3.417	8	34	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15250	10.1371/journal.pone.0015250	http://dx.doi.org/10.1371/journal.pone.0015250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179460	Green Published, gold, Green Submitted			2022-12-25	WOS:000285292500017
J	Buermans, HPJ; van Wijk, B; Hulsker, MA; Smit, NCH; den Dunnen, JT; van Ommen, GB; Moorman, AF; van den Hoff, MJ; 't Hoen, PAC				Buermans, Henk P. J.; van Wijk, Bram; Hulsker, Margriet A.; Smit, Niels C. H.; den Dunnen, Johan T.; van Ommen, Gertjan B.; Moorman, Antoon F.; van den Hoff, Maurice J.; 't Hoen, Peter A. C.			Comprehensive Gene-Expression Survey Identifies Wif1 as a Modulator of Cardiomyocyte Differentiation	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; EMBRYONIC STEM-CELLS; EPICARDIAL PROGENITORS; SIGNALING PATHWAYS; CHICK-EMBRYO; HEART; TRANSCRIPTION; MYOCARDIUM; PATTERNS; LINEAGE	During chicken cardiac development the proepicardium (PE) forms the epicardium (Epi), which contributes to several non-myocardial lineages within the heart. In contrast to Epi-explant cultures, PE explants can differentiate into a cardiomyocyte phenotype. By temporal microarray expression profiles of PE-explant cultures and maturing Epi cells, we identified genes specifically associated with differentiation towards either of these lineages and genes that are associated with the Epi-lineage restriction. We found a central role for Wnt signaling in the determination of the different cell lineages. Immunofluorescent staining after recombinant-protein incubation in PE-explant cultures indicated that the early upregulated Wnt inhibitory factor-1 (Wif1), stimulates cardiomyocyte differentiation in a similar manner as Wnt stimulation. Concordingly, in the mouse pluripotent embryogenic carcinoma cell line p19cl6, early and late Wif1 exposure enhances and attenuates differentiation, respectively. In ovo exposure of the HH12 chicken embryonic heart to Wif1 increases the Tbx18-positive cardiac progenitor pool. These data indicate that Wif1 enhances cardiomyogenesis.	[Buermans, Henk P. J.; Hulsker, Margriet A.; Smit, Niels C. H.; den Dunnen, Johan T.; van Ommen, Gertjan B.; 't Hoen, Peter A. C.] Leiden Univ, Med Ctr, Leiden, Netherlands; [van Wijk, Bram; Moorman, Antoon F.; van den Hoff, Maurice J.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Buermans, HPJ (corresponding author), Leiden Univ, Med Ctr, Leiden, Netherlands.	h.buermans@lumc.nl	't Hoen, Peter/A-4857-2012; Hoen, Peter A 't/D-3950-2018; Smit, Cornelis/P-6036-2015; dunnen, johan den/ABH-4228-2020	Hoen, Peter A 't/0000-0003-4450-3112; dunnen, johan den/0000-0002-6304-1710; van den Hoff, Maurice/0000-0002-3837-8055	European Union [LSHM-CT-2205-018630]; Netherlands Heart Foundation [1996M002]	European Union(European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation)	This work is financially supported by the European Union FP6 program HeartRepair LSHM-CT-2205-018630 and the Netherlands Heart Foundation grant 1996M002 (B.v.W., M.J.v.d.H. and A.F.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afouda BA, 2008, DEVELOPMENT, V135, P3185, DOI 10.1242/dev.026443; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell GW, 2004, DEV DYNAM, V229, P677, DOI 10.1002/dvdy.10503; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrman LA, 1999, DEV BIOL, V207, P163, DOI 10.1006/dbio.1998.9167; Etzion S, 2002, CIRCULATION, V106, pI125, DOI 10.1161/01.cir.0000032888.55215.b8; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Jelier R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-291; Kruithof BPT, 2006, DEV BIOL, V295, P507, DOI 10.1016/j.ydbio.2006.03.033; Kwon C, 2008, CELL CYCLE, V7, P3815, DOI 10.4161/cc.7.24.7189; LANGFORD JK, 1990, ANN NY ACAD SCI, V588, P404, DOI 10.1111/j.1749-6632.1990.tb13246.x; Limana F, 2007, CIRC RES, V101, pE57; Liu J, 2005, ANGEW CHEM INT EDIT, V44, P1987, DOI 10.1002/anie.200462552; Manner J, 1999, ANAT RECORD, V255, P212; Moore JC, 2004, INT J DEV BIOL, V48, P47, DOI 10.1387/ijdb.15005574; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Peng CF, 2002, PHYSIOL GENOMICS, V9, P145, DOI 10.1152/physiolgenomics.00027.2002; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Robb L, 1998, DEV DYNAM, V213, P105, DOI 10.1002/(SICI)1097-0177(199809)213:1<105::AID-AJA10>3.0.CO;2-1; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Schlueter J, 2006, DEV BIOL, V295, P546, DOI 10.1016/j.ydbio.2006.03.036; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Somi S, 2006, J HISTOCHEM CYTOCHEM, V54, P649, DOI 10.1369/jhc.5A6846.2006; Soufan AT, 2003, PHYSIOL GENOMICS, V13, P187, DOI 10.1152/physiolgenomics.00182.2002; Soukas A, 2000, GENE DEV, V14, P963; 't Hoen PAC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng020; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van den Hoff MJB, 2001, DEV BIOL, V240, P61, DOI 10.1006/dbio.2001.0449; van Wijk B, 2007, CARDIOVASC RES, V74, P244, DOI 10.1016/j.cardiores.2006.11.022; van Wijk B, 2009, CIRC RES, V105, P431, DOI 10.1161/CIRCRESAHA.109.203083; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vinciotti V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-183; Vinciotti V, 2005, BIOINFORMATICS, V21, P492, DOI 10.1093/bioinformatics/bti022; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	52	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15504	10.1371/journal.pone.0015504	http://dx.doi.org/10.1371/journal.pone.0015504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179454	Green Published, Green Submitted, gold			2022-12-25	WOS:000285246900045
J	Hallerdei, J; Scheibe, RJ; Parkkila, S; Waheed, A; Sly, WS; Gros, G; Wetzel, P; Endeward, V				Hallerdei, Janine; Scheibe, Renate J.; Parkkila, Seppo; Waheed, Abdul; Sly, William S.; Gros, Gerolf; Wetzel, Petra; Endeward, Volker			T Tubules and Surface Membranes Provide Equally Effective Pathways of Carbonic Anhydrase-Facilitated Lactic Acid Transport in Skeletal Muscle	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; KNOCKOUT MICE; XIV; IV; DIFFUSION; MOUSE; IX; EXPRESSION; HEART; CO2	We have studied lactic acid transport in the fast mouse extensor digitorum longus muscles (EDL) by intracellular and cell surface pH microelectrodes. The role of membrane-bound carbonic anhydrases (CA) of EDL in lactic acid transport was investigated by measuring lactate flux in muscles from wildtype, CAIV-, CAIX- and CAXIV-single ko, CAIV-CAXIV double ko and CAIV-CAIX-CAXIV-triple ko mice. This was complemented by immunocytochemical studies of the subcellular localization of CAIV, CAIX and CAXIV in mouse EDL. We find that CAXIV and CAIX single ko EDL exhibit markedly but not maximally reduced lactate fluxes, whereas triple ko and double ko EDL show maximal or near-maximal inhibition of CA-dependent lactate flux. Interpretation of the flux measurements in the light of the immunocytochemical results leads to the following conclusions. CAXIV, which is homogeneously distributed across the surface membrane of EDL fibers, facilitates lactic acid transport across this membrane. CAIX, which is associated only with T tubular membranes, facilitates lactic acid transport across the T tubule membrane. The removal of lactic acid from the lumen of T tubuli towards the interstitial space involves a CO(2)-HCO(3)(-) diffusional shuttle that is maintained cooperatively by CAIX within the T tubule and, besides CAXIV, by the CAIV, which is strategically located at the opening of the T tubules. The data suggest that about half the CA-dependent muscular lactate flux occurs across the surface membrane, while the other half occurs across the membranes of the T tubuli.	[Hallerdei, Janine; Scheibe, Renate J.] Hannover Med Sch, Abt Physiol Chem, D-30623 Hannover, Germany; [Parkkila, Seppo] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Waheed, Abdul; Sly, William S.] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63103 USA	Hannover Medical School; Tampere University; Saint Louis University	Hallerdei, J (corresponding author), Hannover Med Sch, Abt Physiol Chem, D-30623 Hannover, Germany.	Gros.Gerolf@MH-Hannover.de; Endeward.Volker@MH-Hannover.de	Wahhed, Abdul/AAA-3099-2020; Gros, Gerolf/K-8421-2012	Parkkila, Seppo/0000-0001-7323-8536	Deutsche Forschungsgemeinschaft [WE 1962/4-1, WE 1962/4-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft WE 1962/4-1,2 (website: www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMERS M, 1972, J PHYSL, V225, P57; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Bonen A, 2000, AM J PHYSIOL-ENDOC M, V278, pE1067, DOI 10.1152/ajpendo.2000.278.6.E1067; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; Eisenberg BE, 1983, SKELETAL MUSCLE, P73; Endeward V, 2009, J PHYSIOL-LONDON, V587, P1153, DOI 10.1113/jphysiol.2008.165027; GROS G, 1974, J GEN PHYSIOL, V64, P356, DOI 10.1085/jgp.64.3.356; GROS G, 1976, J GEN PHYSIOL, V67, P773, DOI 10.1085/jgp.67.6.773; Gut MO, 2002, GASTROENTEROLOGY, V123, P1889, DOI 10.1053/gast.2002.37052; HALLERDEI J, 2009, THESIS U HANNOVER GE; Innocenti A, 2005, BIOORG MED CHEM LETT, V15, P573, DOI 10.1016/j.bmcl.2004.11.057; Innocenti A, 2009, BIOORG MED CHEM LETT, V19, P5825, DOI 10.1016/j.bmcl.2009.08.088; Juel C, 1997, PHYSIOL REV, V77, P321, DOI 10.1152/physrev.1997.77.2.321; JUNGE W, 1987, BIOCHIM BIOPHYS ACTA, V890, P1, DOI 10.1016/0005-2728(87)90061-2; Kaunisto K, 2002, KIDNEY INT, V61, P2111, DOI 10.1046/j.1523-1755.2002.00371.x; Papadopoulos S, 2001, P NATL ACAD SCI USA, V98, P5904, DOI 10.1073/pnas.101109798; Parkkila S, 2001, P NATL ACAD SCI USA, V98, P1918, DOI 10.1073/pnas.98.4.1918; PEACHEY LD, 1978, BIOPHYS J, V22, P145, DOI 10.1016/S0006-3495(78)85480-0; SAHLIN K, 1976, PFLUG ARCH EUR J PHY, V367, P143, DOI 10.1007/BF00585150; Scheibe RJ, 2008, AM J PHYSIOL-CELL PH, V294, pC402, DOI 10.1152/ajpcell.00228.2007; Scheibe RJ, 2006, J HISTOCHEM CYTOCHEM, V54, P1379, DOI 10.1369/jhc.6A7003.2006; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; Trastour C, 2007, INT J CANCER, V120, P1451, DOI 10.1002/ijc.22436; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vaughan-Jones RD, 2002, J PHYSIOL-LONDON, V541, P139, DOI 10.1113/jphysiol.2001.013267; WAHEED A, 1992, ARCH BIOCHEM BIOPHYS, V294, P550, DOI 10.1016/0003-9861(92)90724-B; Wetzel P, 2001, J PHYSIOL-LONDON, V531, P743, DOI 10.1111/j.1469-7793.2001.0743h.x; Wetzel P, 2007, AM J PHYSIOL-CELL PH, V293, pC358, DOI 10.1152/ajpcell.00057.2007	29	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15137	10.1371/journal.pone.0015137	http://dx.doi.org/10.1371/journal.pone.0015137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179203	Green Published, Green Submitted, gold			2022-12-25	WOS:000285246900030
J	Sulbaran, MZ; Di Lello, FA; Sulbaran, Y; Cosson, C; Loureiro, CL; Rangel, HR; Cantaloube, JF; Campos, RH; Moratorio, G; Cristina, J; Pujol, FH				Sulbaran, Maria Z.; Di Lello, Federico A.; Sulbaran, Yoneira; Cosson, Clarisa; Loureiro, Carmen L.; Rangel, Hector R.; Cantaloube, Jean F.; Campos, Rodolfo H.; Moratorio, Gonzalo; Cristina, Juan; Pujol, Flor H.			Genetic History of Hepatitis C Virus in Venezuela: High Diversity and Long Time of Evolution of HCV Genotype 2	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; UNITED-STATES; BLOOD-DONORS; POPULATION; PREVALENCE; INFECTION; RECOMBINATION; TRANSMISSION; SEQUENCES	Background: The subtype diversity of the hepatitis C virus (HCV) genotypes is unknown in Venezuela. Methodology/Principal Findings: Partial sequencing of the NS5B region was performed in 310 isolates circulating in patients from 1995 to 2007. In the samples collected between 2005 and 2007, HCV genotype 1 (G1) was the most common genotype (63%), composed as expected of mainly G1a and G1b. G2 was the second most common genotype (33%), being G2a almost absent and G2j the most frequent subtype. Sequence analysis of the core region confirmed the subtype assignment performed within the NS5b region in 63 isolates. The complete genome sequence of G2j was obtained. G2j has been described in France, Canada and Burkina Fasso, but it was not found in Martinique, where several subtypes of G2 circulate in the general population. Bayesian coalescence analysis indicated a most recent common ancestor (MRCA) of G2j around 1785, before the introduction of G1b (1869) and G1a (1922). While HCV G1a and G1b experienced a growth reduction since 1990, coincident with the time when blood testing was implemented in Venezuela, HCV G2j did not seem to reach growth equilibrium during this period. Conclusions/Significance: Assuming the introduction of G2j from Africa during the slave trade, the high frequency of G2j found in Venezuela could suggest: 1- the introduction of African ethnic groups different from the ones introduced to Martinique or 2- the occurrence of a founder effect. This study represents an in-depth analysis of the subtype diversity of HCV in Venezuela, which is still unexplored in the Americas and deserves further studies.	[Sulbaran, Maria Z.; Sulbaran, Yoneira; Cosson, Clarisa; Loureiro, Carmen L.; Rangel, Hector R.; Pujol, Flor H.] IVIC, CMBC, Lab Virol Mol, Caracas, Venezuela; [Di Lello, Federico A.; Campos, Rodolfo H.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina; [Cantaloube, Jean F.] Etab Francais Sang Alpes Mediterranee, Unite Emergence & Coevolut Virale, Marseille, France; [Moratorio, Gonzalo; Cristina, Juan] Univ Republica, Ctr Invest Nucl, Fac Ciencias, Dept Tecn Nucl Aplicadas, Montevideo, Uruguay; [Moratorio, Gonzalo] Inst Pasteur Montevideo, Unidad Biofis Prot, Montevideo, Uruguay	Venezuelan Institute Science Research; University of Buenos Aires; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Sulbaran, MZ (corresponding author), IVIC, CMBC, Lab Virol Mol, Caracas, Venezuela.	fhpujol@gmail.com	Rangel, Hector R/E-5575-2010; Pujol, Flor H/E-5687-2010	Rangel, Hector R/0000-0001-5937-9690; Di Lello, Federico Alejandro/0000-0001-9771-9705; Loureiro Marino, Carmen Luisa/0000-0003-3665-1107; Pujol, Flor H/0000-0001-6086-6883	Fondo Nacional de Ciencia y Tecnologia (FONACIT) [G-2005000394]; Ley Organica de Ciencia y Tecnologia (LOCTI), Venezuela; International Centre of Genetic Engineering and Biotechnology/Panamerican Health Organization/Red Latinoamericana de Ciencias Biologicas (ICGEB/PAHO/RELAB) [CRRLA/URU03-032]	Fondo Nacional de Ciencia y Tecnologia (FONACIT); Ley Organica de Ciencia y Tecnologia (LOCTI), Venezuela; International Centre of Genetic Engineering and Biotechnology/Panamerican Health Organization/Red Latinoamericana de Ciencias Biologicas (ICGEB/PAHO/RELAB)	This work was supported by Grant G-2005000394 from Fondo Nacional de Ciencia y Tecnologia (FONACIT), Ley Organica de Ciencia y Tecnologia (LOCTI) Fund 650, Venezuela, and from International Centre of Genetic Engineering and Biotechnology/Panamerican Health Organization/Red Latinoamericana de Ciencias Biologicas (ICGEB/PAHO/RELAB) through Project CRRLA/URU03-032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MS, 2001, ANN TROP MED PARASIT, V95, P187, DOI 10.1080/00034980120042944; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Alvarez-Valin F, 2000, GENETICS, V155, P1683; Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Campiotto S, 2005, BRAZ J MED BIOL RES, V38, P41, DOI 10.1590/S0100-879X2005000100007; Cantaloube JF, 2008, J MED VIROL, V80, P1732, DOI 10.1002/jmv.21285; Cantaloube JF, 2010, J MED VIROL, V82, P562, DOI 10.1002/jmv.21724; Cantaloube JF, 2005, J CLIN MICROBIOL, V43, P3624, DOI 10.1128/JCM.43.8.3624-3629.2005; Cavalheiro Norma de Paula, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P271, DOI 10.1590/S0036-46652007000500001; Chamberlain RW, 1997, J GEN VIROL, V78, P1341, DOI 10.1099/0022-1317-78-6-1341; CHAN SW, 1992, J GEN VIROL, V73, P1131, DOI 10.1099/0022-1317-73-5-1131; Chung YL, 2003, INT J CANCER, V107, P65, DOI 10.1002/ijc.11303; Comeron JM, 1995, J MOL EVOL, V41, P1152, DOI 10.1007/BF00173196; Cristina Juan, 2005, J Clin Virol, V34 Suppl 2, pS1; Fonseca José Carlos Ferraz da, 2004, Rev. Soc. Bras. Med. Trop., V37, P1, DOI 10.1590/S0037-86822004000700001; de Bruijne J, 2009, J CLIN MICROBIOL, V47, P3832, DOI 10.1128/JCM.01146-09; Dehesa-Violante Margarita, 2007, Rev Gastroenterol Mex, V72, P344; Di Lello F, 2008, J MED VIROL, V80, P619, DOI 10.1002/jmv.21112; Di Lello FA, 2009, J MED VIROL, V81, P1887, DOI 10.1002/jmv.21607; da Silva CM, 2007, MEM I OSWALDO CRUZ, V102, P867, DOI 10.1590/S0074-02762007005000122; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Echevarría José M., 2003, Cad. Saúde Pública, V19, P1583, DOI 10.1590/S0102-311X2003000600003; Eltis David, 2000, RISE SLAVERY AM; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Frederick T, 2009, AIDS PATIENT CARE ST, V23, P915, DOI 10.1089/apc.2009.0111; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Handler Jerome S., 2002, SLAVERY ABOLIT, V23, P25, DOI DOI 10.1080/714005224; Jeannel D, 1998, J MED VIROL, V55, P92, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt;92::AID-JMV2&gt;3.0.CO;2-I; Jukes TH, 1969, EVOLUTION PROTEIN MO; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Garcia-Montalvo BM, 2008, ANN HEPATOL, V7, P345; Markov PV, 2009, J GEN VIROL, V90, P2086, DOI 10.1099/vir.0.011569-0; Martial J, 2004, J CLIN MICROBIOL, V42, P784, DOI 10.1128/JCM.42.2.784-791.2004; Moratorio G, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-79; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Norder H, 1998, J CLIN MICROBIOL, V36, P3066, DOI 10.1128/JCM.36.10.3066-3069.1998; Plamondon M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000372; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pujol FH, 2007, J CLIN GASTROENTEROL, V41, P518, DOI 10.1097/01.mcg.0000248010.55149.ce; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Quarleri JF, 2000, J CLIN MICROBIOL, V38, P4560, DOI 10.1128/JCM.38.12.4560-4568.2000; Radkowski M, 2001, TRANSPLANTATION, V72, P833, DOI 10.1097/00007890-200109150-00016; Re V, 2003, MEDICINA-BUENOS AIRE, V63, P205; SALMINEN M, 1995, AIDS RES HUM RETROV, V11, pS119; Santos-Lopez G, 2008, J INFECTION, V56, P281, DOI 10.1016/j.jinf.2008.02.001; Silva Luciana, 1995, Arquivos de Gastroenterologia, V32, P168; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; Talarmin A, 1997, J MED VIROL, V52, P430, DOI 10.1002/(SICI)1096-9071(199708)52:4&lt;430::AID-JMV15&gt;3.0.CO;2-K; Tebit DM, 2007, AIDS REV, V9, P75; Thomas F, 2007, J MED VIROL, V79, P26, DOI 10.1002/jmv.20765; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000	63	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14315	10.1371/journal.pone.0014315	http://dx.doi.org/10.1371/journal.pone.0014315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179440	Green Published, Green Submitted, gold			2022-12-25	WOS:000285246900020
J	Som, A; Harder, C; Greber, B; Siatkowski, M; Paudel, Y; Warsow, G; Cap, C; Scholer, H; Fuellen, G				Som, Anup; Harder, Clemens; Greber, Boris; Siatkowski, Marcin; Paudel, Yogesh; Warsow, Gregor; Cap, Clemens; Schoeler, Hans; Fuellen, Georg			The PluriNetWork: An Electronic Representation of the Network Underlying Pluripotency in Mouse, and Its Applications	PLOS ONE			English	Article							STEM-CELLS; SELF-RENEWAL; REGULATORY NETWORKS; SYSTEMS BIOLOGY; GENE ONTOLOGY; DATABASE; DIFFERENTIATION; ANNOTATION; CIRCUITRY; UNIPROT	Background: Analysis of the mechanisms underlying pluripotency and reprogramming would benefit substantially from easy access to an electronic network of genes, proteins and mechanisms. Moreover, interpreting gene expression data needs to move beyond just the identification of the up-/downregulation of key genes and of overrepresented processes and pathways, towards clarifying the essential effects of the experiment in molecular terms. Methodology/Principal Findings: We have assembled a network of 574 molecular interactions, stimulations and inhibitions, based on a collection of research data from 177 publications until June 2010, involving 274 mouse genes/proteins, all in a standard electronic format, enabling analyses by readily available software such as Cytoscape and its plugins. The network includes the core circuit of Oct4 (Pou5f1), Sox2 and Nanog, its periphery (such as Stat3, Klf4, Esrrb, and c-Myc), connections to upstream signaling pathways (such as Activin, WNT, FGF, BMP, Insulin, Notch and LIF), and epigenetic regulators as well as some other relevant genes/proteins, such as proteins involved in nuclear import/export. We describe the general properties of the network, as well as a Gene Ontology analysis of the genes included. We use several expression data sets to condense the network to a set of network links that are affected in the course of an experiment, yielding hypotheses about the underlying mechanisms. Conclusions/Significance: We have initiated an electronic data repository that will be useful to understand pluripotency and to facilitate the interpretation of high-throughput data. To keep up with the growth of knowledge on the fundamental processes of pluripotency and reprogramming, we suggest to combine Wiki and social networking software towards a community curation system that is easy to use and flexible, and tailored to provide a benefit for the scientist, and to improve communication and exchange of research results. A PluriNetWork tutorial is available at http://www.ibima.med. uni-rostock. de/IBIMA/PluriNetWork/.	[Som, Anup; Harder, Clemens; Siatkowski, Marcin; Paudel, Yogesh; Warsow, Gregor; Fuellen, Georg] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Greber, Boris; Schoeler, Hans] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany; [Siatkowski, Marcin] German Ctr Neurodegenerat Dis, DZNE, Rostock, Germany; [Warsow, Gregor] Ernst Moritz Arndt Univ Greifswald, Inst Anat & Cell Biol, Greifswald, Germany; [Warsow, Gregor] Ernst Moritz Arndt Univ Greifswald, Dept Math & Informat, Greifswald, Germany; [Cap, Clemens] Univ Rostock, Dept Comp Sci, Rostock, Germany; [Schoeler, Hans] Univ Munster, Fac Med, Munster, Germany	University of Rostock; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Rostock; University of Munster	Som, A (corresponding author), Univ Rostock, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany.	fuellen@uni-rostock.de	Cap, Clemens Heinrich/J-6418-2016; , HS/AAB-4434-2019	Cap, Clemens Heinrich/0000-0003-3958-6136; , HS/0000-0003-2643-5136; Greber, Boris/0000-0002-9404-7293	DFG (Deutsche Forschungsgemeinschaft) [Schwerpunktprogramm 1356]; Pluripotency and Cellular Reprogramming [FU583/2-1]; BMBF (Bundesministerium fur Bildung und Forschung) [01GN0901, 01GN0805]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Pluripotency and Cellular Reprogramming; BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	Funding by the DFG (Deutsche Forschungsgemeinschaft) Schwerpunktprogramm 1356, Pluripotency and Cellular Reprogramming (FU583/2-1), and by the BMBF (Bundesministerium fur Bildung und Forschung) (01GN0901 & 01GN0805, Generation of pluri- and multipotent stem cells) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Bult CJ, 2010, NUCLEIC ACIDS RES, V38, pD586, DOI 10.1093/nar/gkp880; Bureeva S, 2009, METHODS MOL BIOL, V563, P75, DOI 10.1007/978-1-60761-175-2_5; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chakrabarty K, 2008, BIOL CHEM, V389, P791, DOI 10.1515/BC.2008.104; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen LG, 2010, STEM CELLS, V28, P57, DOI 10.1002/stem.251; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Do JT, 2009, TRENDS PHARMACOL SCI, V30, P296, DOI 10.1016/j.tips.2009.03.003; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Krupa Y, 2009, LECT NOTES ARTIF INT, V5881, P148, DOI 10.1007/978-3-642-10203-5_13; Kwan M, 2009, HUM-COMPUT INT-SPRIN, P287, DOI 10.1007/978-1-84800-356-9_11; Le Novere N, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S11; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Leinonen R, 2004, BIOINFORMATICS, V20, P3236, DOI 10.1093/bioinformatics/bth191; Lensch MW, 2006, STEM CELL REV, V2, P185, DOI 10.1007/s12015-006-0047-2; Liu XS, 2008, CELL RES, V18, P1177, DOI 10.1038/cr.2008.309; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; MACKALL M, 2006, OTT CAN LIN S, P83; Mazumdar J, 2009, J CELL MOL MED, V13, P4319, DOI 10.1111/j.1582-4934.2009.00963.x; MCGUINNESS D, 2006, MTW06 15 INT WWW C; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Mullen EM, 2007, PPAR RES, V2007, DOI 10.1155/2007/61563; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; ROTH U, 2006, ED SCOTL 15 INT WWW; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; SUN X, 2010, AGEING RES REV; Sun Y, 2006, CRIT REV EUKAR GENE, V16, P211, DOI 10.1615/CritRevEukarGeneExpr.v16.i3.20; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; VICTOR P, 2006, ED SCOTL 15 INT WWW; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; WARSOW G, 2010, BMC SYST BI IN PRESS; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Xu H, 2010, WILEY INTERDISCIPLIN	64	47	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e15165	10.1371/journal.pone.0015165	http://dx.doi.org/10.1371/journal.pone.0015165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21179244	Green Published, Green Submitted, gold			2022-12-25	WOS:000285181400019
J	Imamura, J; Suzuki, Y; Gonda, K; Roy, CN; Gatanaga, H; Ohuchi, N; Higuchi, H				Imamura, Junji; Suzuki, Yasuhiro; Gonda, Kohsuke; Roy, Chandra Nath; Gatanaga, Hiroyuki; Ohuchi, Noriaki; Higuchi, Hideo			Single Particle Tracking Confirms That Multivalent Tat Protein Transduction Domain-induced Heparan Sulfate Proteoglycan Cross-linkage Activates Rac1 for Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 TAT; QUANTUM DOTS; LIVING CELLS; VESICLE TRANSPORT; BINDING MECHANISM; MOLECULE TRACKING; PLASMA-MEMBRANE; FUSION PROTEINS; GROWTH-FACTOR	The mechanism by which HIV-1-Tat protein transduction domain (TatP) enters the cell remains unclear because of an insufficient understanding of the initial kinetics of peptide entry. Here, we report the successful visualization and tracking of TatP molecular kinetics on the cell surface with 7-nm spatial precision using quantum dots. Strong cell binding was only observed with a TatP valence of >= 8, whereas monovalent TatP binding was negligible. The requirement of the cell-surface heparan sulfate (HS) chains of HS proteoglycans (HSPGs) for TatP binding and intracellular transport was demonstrated by the enzymatic removal of HS and simultaneous observation of two individual particles. Multivalent TatP induces HSPG cross-linking, recruiting activated Rac1 to adjacent lipid rafts and thereby enhancing the recruitment of TatP/HSPG to actin-associated microdomains and its internalization by macropinocytosis. These findings clarify the initial binding mechanism of TatP to the cell surface and demonstrate the importance of TatP valence for strong surface binding and signal transduction. Our data also shed light on the ability of TatP to exploit the machinery of living cells, using HSPG signaling to activate Rac1 and alter TatP mobility and internalization. This work should guide the future design of TatP-based peptides as therapeutic nano-carriers with efficient transduction.	[Imamura, Junji; Suzuki, Yasuhiro; Roy, Chandra Nath] Tohoku Univ, Grad Sch Med, Dept Emerging Infect Dis, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Gonda, Kohsuke; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Dept Nanomed Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Gatanaga, Hiroyuki] Int Med Ctr Japan, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Ohuchi, Noriaki] Tohoku Univ, Dept Surg Oncol, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Higuchi, Hideo] Univ Tokyo, Dept Phys, Grad Sch Sci, Hongo Bunkyou Ku, Tokyo 1138654, Japan	Tohoku University; Tohoku University; National Center for Global Health & Medicine - Japan; Tohoku University; University of Tokyo	Suzuki, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Emerging Infect Dis, Aoba Ku, Seiryo Machi, Sendai, Miyagi 9808575, Japan.	suzukiy39@med.tohoku.ac.jp	Roy, Chandra Nath/X-5769-2019; Roy, Chandra Nath/E-8710-2010	Roy, Chandra Nath/0000-0001-6667-1550; 	Ministry of Health, Labor, and Welfare of Japan; Japanese Foundation for AIDS Prevention	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Foundation for AIDS Prevention	This work was supported by a grant-in-aid for AIDS research from the Ministry of Health, Labor, and Welfare of Japan and by the Japanese Foundation for AIDS Prevention (to Y. S.).	Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; BARTHOLOMEW JS, 1985, BIOCHEM J, V227, P429, DOI 10.1042/bj2270429; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Gonda K, 2010, J BIOL CHEM, V285, P2750, DOI 10.1074/jbc.M109.075374; Grande-Garcia A, 2005, BIOCHEM SOC T, V33, P609, DOI 10.1042/BST0330609; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Grimmer S, 2002, J CELL SCI, V115, P2953; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hikage M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/18/185103; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Mishra A, 2008, ANGEW CHEM INT EDIT, V47, P2986, DOI 10.1002/anie.200704444; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nguyen VT, 2003, EMBO J, V22, P4968, DOI 10.1093/emboj/cdg498; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SODROSKI J, 1985, SCIENCE, V229, P74, DOI 10.1126/science.2990041; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Tada H, 2007, CANCER RES, V67, P1138, DOI 10.1158/0008-5472.CAN-06-1185; Toschi E, 2006, MOL BIOL CELL, V17, P1985, DOI 10.1091/mbc.E05-08-0717; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Watanabe TM, 2007, BIOCHEM BIOPH RES CO, V359, P1, DOI 10.1016/j.bbrc.2007.04.168; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6; Ziegler A, 2003, BIOCHEMISTRY-US, V42, P9185, DOI 10.1021/bi0346805	49	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10581	10592		10.1074/jbc.M110.187450	http://dx.doi.org/10.1074/jbc.M110.187450			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21199870	Green Published, hybrid			2022-12-25	WOS:000288547000073
J	Yamashita, M; Somasundaram, A; Prakriya, M				Yamashita, Megumi; Somasundaram, Agila; Prakriya, Murali			Competitive Modulation of Ca2+ Release-activated Ca2+ Channel Gating by STIM1 and 2-Aminoethyldiphenyl Borate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST CA2+-DEPENDENT INACTIVATION; CRAC CHANNELS; 2-AMINOETHOXYDIPHENYL BORATE; CALCIUM-CHANNELS; PLASMA-MEMBRANE; ORAI CHANNELS; MOLECULAR DETERMINANTS; ENTRY; DOMAIN; CELLS	Activation of Ca2+ release-activated Ca2+ channels by depletion of intracellular Ca2+ stores involves physical interactions between the endoplasmic reticulum Ca2+ sensor, STIM1, and the channels composed of Orai subunits. Recent studies indicate that the Orai3 subtype, in addition to being store-operated, is also activated in a store-independent manner by 2-aminoethyldiphenyl borate (2-APB), a small molecule with complex pharmacology. However, it is unknown whether the store-dependent and -independent activation modes of Orai3 channels operate independently or whether there is cross-talk between these activation states. Here we report that in addition to causing direct activation, 2-APB also regulates store-operated gating of Orai3 channels, causing potentiation at low doses and inhibition at high doses. Inhibition of store-operated gating by 2-APB was accompanied by the suppression of several modes of Orai3 channel regulation that depend on STIM1, suggesting that high doses of 2-APB interrupt STIM1-Orai3 coupling. Conversely, STIM1-bound Orai3 (and Orai1) channels resisted direct gating by high doses of 2-APB. The rate of direct 2-APB activation of Orai3 channels increased linearly with the degree of STIM1-Orai3 uncoupling, suggesting that 2-APB has to first disengage STIM1 before it can directly gate Orai3 channels. Collectively, our results indicate that the store-dependent and -independent modes of Ca2+ release-activated Ca2+ channel activation are mutually exclusive: channels bound to STIM1 resist 2-APB gating, whereas 2-APB antagonizes STIM1 gating.	[Yamashita, Megumi; Somasundaram, Agila; Prakriya, Murali] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Prakriya, M (corresponding author), Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Sch Med, 303 E Chicago Ave,Ward 8-296, Chicago, IL 60611 USA.	m-prakriya@northwestern.edu		Prakriya, Murali/0000-0003-0781-4480; Yamashita, Megumi/0000-0003-0196-0428	National Institutes of Health [NS057499, GM082133]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057499, R56NS057499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS057499 and GM082133 (to M.P.).	BOLAND LM, 1993, J NEUROSCI, V13, P516; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Goto J, 2010, CELL CALCIUM, V47, P1, DOI 10.1016/j.ceca.2009.10.004; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Madl J, 2010, J BIOL CHEM, V285, P41135, DOI 10.1074/jbc.M110.177881; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	48	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9429	9442		10.1074/jbc.M110.189035	http://dx.doi.org/10.1074/jbc.M110.189035			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21193399	Green Published, hybrid			2022-12-25	WOS:000288247700071
J	Kinnunen, AI; Sormunen, R; Elamaa, H; Seppinen, L; Miller, RT; Ninomiya, Y; Janmey, PA; Pihlajaniemi, T				Kinnunen, Aino I.; Sormunen, Raija; Elamaa, Harri; Seppinen, Lotta; Miller, R. Tyler; Ninomiya, Yoshifumi; Janmey, Paul A.; Pihlajaniemi, Taina			Lack of Collagen XVIII Long Isoforms Affects Kidney Podocytes, whereas the Short Form Is Needed in the Proximal Tubular Basement Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; PRESSURE FROZEN SAMPLES; ENDOTHELIAL-CELLS; EXTRACELLULAR MATRICES; ENDOGENOUS INHIBITOR; KNOBLOCH-SYNDROME; TUMOR-GROWTH; TISSUE; ENDOSTATIN; EXPRESSION	Collagen XVIII is characterized by three variant N termini, an interrupted collagenous domain, and a C-terminal antiangiogenic domain known as endostatin. We studied here the roles of this collagen type and its variant isoforms in the mouse kidney. Collagen XVIII appeared to be in a polarized orientation in the tubular basement membranes (BMs), the endostatin domain embedded in the BM, and the N terminus residing at the BM-fibrillar matrix interface. In the case of the glomerular BM (GBM), collagen XVIII was expressed in different isoforms depending on the side of the GBM. The orientation appeared polarized here, too, both the endothelial promoter 1-derived short variant of collagen XVIII and the epithelial promoter 2-derived longer variants having their C-terminal endostatin domains embedded in the BM and the N termini at the respective BM-cell interfaces. In addition to loosening of the proximal tubular BM structure, the Col18a1(-/-) mice showed effacement of the glomerular podocyte foot processes, and microindentation studies showed changes in the mechanical properties of the glomeruli, the Col18a1(-/-) glomeruli being similar to 30% softer than the wild-type. Analysis of promoter-specific knockouts (Col18a1(P1/P1) and Col18a1(P2/P2)) indicated that tubular BM loosening is due to a lack of the shortest isoform, whereas the glomerular podocyte effacement was due to a lack of the longer isoforms. We suggest that lack of collagen XVIII may also have disparate effects on kidney function in man, but considering the mild physiological findings in the mutant mice, such effects may manifest themselves only late in life or require other compounding molecular changes.	[Kinnunen, Aino I.; Elamaa, Harri; Seppinen, Lotta; Pihlajaniemi, Taina] Univ Oulu, Dept Med Biochem & Mol Biol, Oulu Ctr Cell Matrix Res, Oulu 90014, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, Bioctr Oulu, Oulu 90014, Finland; [Miller, R. Tyler] Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Dept Med, Cleveland, OH 44106 USA; [Miller, R. Tyler] Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Dept Physiol, Cleveland, OH 44106 USA; [Miller, R. Tyler] Case Western Reserve Univ, Rammelkamp Ctr Res & Educ, Cleveland, OH 44106 USA; [Ninomiya, Yoshifumi] Okayama Univ, Dept Mol Biol & Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Janmey, Paul A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA	University of Oulu; University of Oulu; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Okayama University; University of Pennsylvania; Pennsylvania Medicine	Pihlajaniemi, T (corresponding author), Univ Oulu, Dept Med Biochem & Mol Biol, Oulu Ctr Cell Matrix Res, Aapistie 7, Oulu 90014, Finland.	taina.pihlajaniemi@oulu.fi		Pihlajaniemi, Taina/0000-0002-1664-9045	Research Council for Health of the Academy of Finland [115237]; Sigrid Juselius Foundation; Grants-in-Aid for Scientific Research [23390348] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083592] Funding Source: NIH RePORTER	Research Council for Health of the Academy of Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Research Council for Health of the Academy of Finland (Grant 115237) and the Sigrid Juselius Foundation.	Abrahamson DR, 2009, ORGANOGENESIS, V5, P275; Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; ABRAHAMSON DR, 1987, AM J PHYSIOL, V253, pF783, DOI 10.1152/ajprenal.1987.253.5.F783; ADLER S, 1992, AM J PATHOL, V141, P571; Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0; Cortes P, 1996, AM J PHYSIOL-RENAL, V270, pF356, DOI 10.1152/ajprenal.1996.270.2.F356; CYBULSKY AV, 1992, KIDNEY INT, V42, P1099, DOI 10.1038/ki.1992.393; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Elamaa H, 2005, AM J PATHOL, V166, P221, DOI 10.1016/S0002-9440(10)62246-8; Elamaa H, 2003, MATRIX BIOL, V22, P427, DOI 10.1016/S0945-053X(03)00073-8; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; Faye C, 2009, J BIOL CHEM, V284, P22029, DOI 10.1074/jbc.M109.002840; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gubler MC, 2008, NAT CLIN PRACT NEPHR, V4, P24, DOI 10.1038/ncpneph0671; Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404; Hamano Y, 2010, J AM SOC NEPHROL, V21, P1445, DOI 10.1681/ASN.2009050492; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Kawashima H, 2003, J BIOL CHEM, V278, P13069, DOI 10.1074/jbc.M212244200; Kojima K, 2004, J AM SOC NEPHROL, V15, P2079, DOI 10.1097/01.ASN.0000133531.43177.21; Kretzler M, 2002, MICROSC RES TECHNIQ, V57, P247, DOI 10.1002/jemt.10083; Kyriakides TR, 2009, J CELL COMMUN SIGNAL, V3, P215, DOI 10.1007/s12079-009-0077-z; Levental I, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194120; Marneros AG, 2004, EMBO J, V23, P89, DOI 10.1038/sj.emboj.7600014; Marneros AG, 2003, INVEST OPHTH VIS SCI, V44, P2367, DOI 10.1167/iovs.02-1180; McCarthy KJ, 1997, MICROSC RES TECHNIQ, V39, P233, DOI 10.1002/(SICI)1097-0029(19971101)39:3<233::AID-JEMT4>3.0.CO;2-L; McMillan JR, 2003, J HISTOCHEM CYTOCHEM, V51, P1299, DOI 10.1177/002215540305101007; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Quelard D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001878; Raats CJI, 2000, AM J PATHOL, V156, P1749, DOI 10.1016/S0002-9440(10)65046-8; Regele HM, 2000, J AM SOC NEPHROL, V11, P403, DOI 10.1681/ASN.V113403; Rehn M, 1996, GENOMICS, V32, P436, DOI 10.1006/geno.1996.0139; REHN M, 1995, J BIOL CHEM, V270, P4705, DOI 10.1074/jbc.270.9.4705; REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; SCHURER JW, 1978, J HISTOCHEM CYTOCHEM, V26, P688, DOI 10.1177/26.8.690407; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; Suzuki OT, 2002, AM J HUM GENET, V71, P1320, DOI 10.1086/344695; Tandon R, 2007, AM J PHYSIOL-RENAL, V292, pF701, DOI 10.1152/ajprenal.00246.2006; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; van Donselaar E, 2007, TRAFFIC, V8, P471, DOI 10.1111/j.1600-0854.2007.00552.x; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; Wickstrom SA, 2004, J BIOL CHEM, V279, P20178, DOI 10.1074/jbc.M312921200; Wickstrom SA, 2002, CANCER RES, V62, P5580; Ylikarppa R, 2003, FASEB J, V17, P2257, DOI 10.1096/fj.02-1001fje; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006	55	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7755	7764		10.1074/jbc.M110.166132	http://dx.doi.org/10.1074/jbc.M110.166132			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193414	Green Published, hybrid			2022-12-25	WOS:000288013300007
J	Rossi, M; Colecchia, D; Iavarone, C; Strambi, A; Piccioni, F; di Pianella, AV; Chiariello, M				Rossi, Matteo; Colecchia, David; Iavarone, Carlo; Strambi, Angela; Piccioni, Federica; di Pianella, Arturo Verrotti; Chiariello, Mario			Extracellular Signal-regulated Kinase 8 (ERK8) Controls Estrogen-related Receptor alpha (ERR alpha) Cellular Localization and Inhibits Its Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; ORPHAN NUCLEAR RECEPTORS; ACTIVATED PROTEIN-KINASES; STEROID-HORMONE RECEPTORS; C-JUN PROMOTER; LIVING CELLS; MITOCHONDRIAL BIOGENESIS; GLUCOCORTICOID-RECEPTOR; ANDROGEN RECEPTOR; DNA-SYNTHESIS	ERK8 (MAPK15) is a large MAP kinase already implicated in the regulation of the functions of different nuclear receptors and in cellular proliferation and transformation. Here, we identify ERR alpha as a novel ERK8-interacting protein. As a consequence of such interaction, ERK8 induces CRM1-dependent translocation of ERR alpha to the cytoplasm and inhibits its transcriptional activity. Also, we identify in ERK8 two LXXLL motifs, typical of agonist-bound nuclear receptor corepressors, as necessary features for this MAP kinase to interact with ERR alpha and to regulate its cellular localization and transcriptional activity. Ultimately, we demonstrate that ERK8 is able to counteract, in immortalized human mammary cells, ERR alpha activation induced by the EGF receptor pathway, often deregulated in breast cancer. Altogether, these results reveal a novel function for ERK8 as a bona fide ERR alpha corepressor, involved in control of its cellular localization by nuclear exclusion, and suggest a key role for this MAP kinase in the regulation of the biological activities of this nuclear receptor.	[Rossi, Matteo; Colecchia, David; Strambi, Angela; Chiariello, Mario] Ist Toscano Tumori, Core Res Lab, Signal Transduct Unit, I-53100 Siena, Italy; [Rossi, Matteo; Colecchia, David] Univ Siena, Naples, Italy; [Iavarone, Carlo; Chiariello, Mario] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Piccioni, Federica; di Pianella, Arturo Verrotti] CEINGE Biotecnol Avanzate, Naples, Italy; [di Pianella, Arturo Verrotti] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy; [Chiariello, Mario] CNR, Ist Fisiol Clin, Siena, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); CEINGE Biotecnologie Avanzate; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR)	Chiariello, M (corresponding author), Ist Toscano Tumori, Core Res Lab, Signal Transduct Unit, Via Fiorentina 1, I-53100 Siena, Italy.	mario.chiariello@ittumori.it	Colecchia, David/J-8361-2016; Colecchia, David/AAS-8110-2021; Chiariello, Mario/O-3642-2014	Colecchia, David/0000-0002-0364-8924; Chiariello, Mario/0000-0001-8434-5177	Regione Toscana; Italian Association for Cancer Research	Regione Toscana(Regione Toscana); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a "Start-up grant" from Regione Toscana and by a grant from the Italian Association for Cancer Research (to M.C.).	Abe MK, 2002, J BIOL CHEM, V277, P16733, DOI 10.1074/jbc.M112483200; Ariazi EA, 2002, CANCER RES, V62, P6510; Ariazi EA, 2007, MOL CANCER RES, V5, P71, DOI 10.1158/1541-7786.MCR-06-0227; Augereau P, 2006, J STEROID BIOCHEM, V102, P51, DOI 10.1016/j.jsbmb.2006.09.005; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Bartholome B, 2004, FASEB J, V18, P70, DOI 10.1096/fj.03-0328com; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bin Cho K, 2010, CANCER LETT, V293, P230, DOI 10.1016/j.canlet.2010.01.013; Black BE, 2001, CURR BIOL, V11, P1749, DOI 10.1016/S0960-9822(01)00537-1; Bogoyevitch MA, 2004, CELL SIGNAL, V16, P1345, DOI 10.1016/j.cellsig.2004.05.004; Bonnelye E, 1997, MOL ENDOCRINOL, V11, P905, DOI 10.1210/me.11.7.905; Boonyaratanakornkit V, 2004, ESSAYS BIOCHEM, V40, P105, DOI 10.1042/bse0400105; Castoria G, 1999, EMBO J, V18, P2500, DOI 10.1093/emboj/18.9.2500; Castoria G, 2004, MOL CELL BIOL, V24, P7643, DOI 10.1128/MCB.24.17.7643-7653.2004; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Cicek MS, 2005, CANCER EPIDEM BIOMAR, V14, P2173, DOI 10.1158/1055-9965.EPI-05-0215; DeFranco DB, 2002, MOL ENDOCRINOL, V16, P1449, DOI 10.1210/me.16.7.1449; Duellman SJ, 2010, BIOCHEM PHARMACOL, V80, P819, DOI 10.1016/j.bcp.2010.05.024; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fejes-Toth G, 1998, P NATL ACAD SCI USA, V95, P2973, DOI 10.1073/pnas.95.6.2973; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Groehler AL, 2010, J CELL BIOL, V190, P575, DOI 10.1083/jcb.201002124; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hatzoglou A, 2005, J CLIN ENDOCR METAB, V90, P893, DOI 10.1210/jc.2004-0801; Heard DJ, 2000, MOL ENDOCRINOL, V14, P382, DOI 10.1210/me.14.3.382; Henrich LM, 2003, MOL CELL BIOL, V23, P5979, DOI 10.1128/MCB.23.17.5979-5988.2003; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Johnston SD, 1997, MOL ENDOCRINOL, V11, P342, DOI 10.1210/me.11.3.342; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Klevernic IV, 2006, BIOCHEM J, V394, P365, DOI 10.1042/BJ20051288; Klevernic IV, 2009, FEBS LETT, V583, P680, DOI 10.1016/j.febslet.2009.01.011; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Kraus RJ, 2002, J BIOL CHEM, V277, P24826, DOI 10.1074/jbc.M202952200; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Lim CS, 1999, MOL ENDOCRINOL, V13, P366, DOI 10.1210/me.13.3.366; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; Lu DS, 2001, CANCER RES, V61, P6755; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; McKenna NJ, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.026; Nonclercq D, 2007, J MOL ENDOCRINOL, V39, P105, DOI 10.1677/JME-07-0040; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Rimawi MF, 2010, CANCER-AM CANCER SOC, V116, P1234, DOI 10.1002/cncr.24816; Saelzler MP, 2006, J BIOL CHEM, V281, P16821, DOI 10.1074/jbc.M512418200; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Scheller K, 2003, INT REV CYTOL, V222, P1; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sebastian T, 2004, MOL CELL BIOCHEM, V260, P91, DOI 10.1023/B:MCBI.0000026060.81570.35; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Terry K, 2010, GYNECOL ONCOL, V117, P255, DOI 10.1016/j.ygyno.2010.02.002; Teyssier C, 2008, NUCLEIC ACIDS RES, V36, P5350, DOI 10.1093/nar/gkn520; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Vanacker JM, 1998, CELL GROWTH DIFFER, V9, P1007; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; WEISZ A, 1988, MOL ENDOCRINOL, V2, P816, DOI 10.1210/mend-2-9-816; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Zheng W, 2004, CANCER EPIDEM BIOMAR, V13, P709	78	31	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8507	8522		10.1074/jbc.M110.179523	http://dx.doi.org/10.1074/jbc.M110.179523			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21190936	Green Published, hybrid			2022-12-25	WOS:000288013300078
J	Filomatori, CV; Iglesias, NG; Villordo, SM; Alvarez, DE; Gamarnik, AV				Filomatori, Claudia V.; Iglesias, Nestor G.; Villordo, Sergio M.; Alvarez, Diego E.; Gamarnik, Andrea V.			RNA Sequences and Structures Required for the Recruitment and Activity of the Dengue Virus Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST-NILE-VIRUS; MINUS-STRAND SYNTHESIS; LA PROTEIN BINDS; 3'-UNTRANSLATED REGION; FUNCTIONAL-ANALYSIS; CYCLIZATION SEQUENCES; UNTRANSLATED REGION; GENOME CYCLIZATION; NONCODING REGION; MOSQUITO-BORNE	Dengue virus RNA-dependent RNA polymerase specifically binds to the viral genome by interacting with a promoter element known as stem-loop A (SLA). Although a great deal has been learned in recent years about the function of this promoter in dengue virus-infected cells, the molecular details that explain how the SLA interacts with the polymerase to promote viral RNA synthesis remain poorly understood. Using RNA binding and polymerase activity assays, we defined two elements of the SLA that are involved in polymerase interaction and RNA synthesis. Mutations at the top of the SLA resulted in RNAs that retained the ability to bind the polymerase but impaired promoter-dependent RNA synthesis. These results indicate that protein binding to the SLA is not sufficient to induce polymerase activity and that specific nucleotides of the SLA are necessary to render an active polymerase-promoter complex for RNA synthesis. We also report that protein binding to the viral RNA induces conformational changes downstream of the promoter element. Furthermore, we found that structured RNA elements at the 3' end of the template repress dengue virus polymerase activity in the context of a fully active SLA promoter. Using assays to evaluate initiation of RNA synthesis at the viral 3'-UTR, we found that the RNA-RNA interaction mediated by 5'-3'-hybridization was able to release the silencing effect of the 3'-stem-loop structure. We propose that the long range RNA-RNA interactions in the viral genome play multiple roles during RNA synthesis. Together, we provide new molecular details about the promoter-dependent dengue virus RNA polymerase activity.	[Filomatori, Claudia V.; Iglesias, Nestor G.; Villordo, Sergio M.; Alvarez, Diego E.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1405 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Gamarnik, AV (corresponding author), Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Avenida Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.	agamarnik@leloir.org.ar	FILOMATORI, Claudia/W-9924-2019	Villordo, Sergio/0000-0003-4434-7930	Howard Hughes Medical Institute; L'Oreal-UNESCO-CONICET; CONICET	Howard Hughes Medical Institute(Howard Hughes Medical Institute); L'Oreal-UNESCO-CONICET; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Howard Hughes Medical Institute and L'Oreal-UNESCO-CONICET (to A. V. G.) and by CONICET fellowships (to C. V. F., N. G. I., S. M. V., and D. E. A.).	Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0; CAHOUR A, 1995, VIROLOGY, V207, P68, DOI 10.1006/viro.1995.1052; Corver J, 2003, J VIROL, V77, P2265, DOI 10.1128/JVI.77.3.2265-2270.2003; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040; Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Gamarnik A, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P55; Garcia-Montalvo BM, 2004, VIRUS RES, V102, P141, DOI 10.1016/j.virusres.2004.01.024; Gritsun TS, 2007, VIROLOGY, V366, P8, DOI 10.1016/j.virol.2007.04.011; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Khromykh AA, 2003, J VIROL, V77, P10623, DOI 10.1128/JVI.77.19.10623-10629.2003; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Kofler RM, 2006, J VIROL, V80, P4099, DOI 10.1128/JVI.80.8.4099-4113.2006; Leyssen P, 2002, VIROLOGY, V293, P125, DOI 10.1006/viro.2001.1241; Li XF, 2010, J GEN VIROL, V91, P1218, DOI 10.1099/vir.0.013854-0; Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003; Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08; Markoff L, 2003, ADV VIRUS RES, V59, P177, DOI 10.1016/S0065-3527(03)59006-6; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Olsthoorn RCL, 1999, EMBO J, V18, P4856, DOI 10.1093/emboj/18.17.4856; Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200; Pogany J, 2003, EMBO J, V22, P5602, DOI 10.1093/emboj/cdg523; Polacek C, 2009, J VIROL, V83, P1161, DOI 10.1128/JVI.01362-08; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Teramoto T, 2008, RNA, V14, P2645, DOI 10.1261/rna.1051208; Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0; Tilgner M, 2005, VIROLOGY, V331, P375, DOI 10.1016/j.virol.2004.07.022; Tilgner M, 2004, J VIROL, V78, P8159, DOI 10.1128/JVI.78.15.8159-8171.2004; TIRADO MGG, 1980, REV CUBA MED TROP, V32, P123; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yocupicio-Monroy M, 2007, VIROLOGY, V357, P29, DOI 10.1016/j.virol.2006.07.042; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016; Zhang GH, 2006, RNA, V12, P147, DOI 10.1261/rna.2166706; Zhang GH, 2004, J VIROL, V78, P7619, DOI 10.1128/JVI.78.14.7619-7633.2004	46	83	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6929	6939		10.1074/jbc.M110.162289	http://dx.doi.org/10.1074/jbc.M110.162289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21183683	hybrid, Green Published			2022-12-25	WOS:000287737300008
J	Seguin, A; Santos, R; Pain, D; Dancis, A; Camadro, JM; Lesuisse, E				Seguin, Alexandra; Santos, Renata; Pain, Debkumar; Dancis, Andrew; Camadro, Jean-Michel; Lesuisse, Emmanuel			Co-precipitation of Phosphate and Iron Limits Mitochondrial Phosphate Availability in Saccharomyces cerevisiae Lacking the Yeast Frataxin Homologue (YFH1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRIEDREICHS-ATAXIA; CLUSTER SYNTHESIS; OXIDATIVE STRESS; TRANSPORT; CARRIER; BIOGENESIS; CONVERSION; MEMBRANE; PROTEIN; STORAGE	Saccharomyces cerevisiae cells lacking the yeast frataxin homologue (Delta yfh1) accumulate iron in the mitochondria in the form of nanoparticles of ferric phosphate. The phosphate content of Delta yfh1 mitochondria was higher than that of wild-type mitochondria, but the proportion of mitochondrial phosphate that was soluble was much lower in Delta yfh1 cells. The rates of phosphate and iron uptake in vitro by isolated mitochondria were higher for Delta yfh1 than wild-type mitochondria, and a significant proportion of the phosphate and iron rapidly became insoluble in the mitochondrial matrix, suggesting co-precipitation of these species after oxidation of iron by oxygen. Increasing the amount of phosphate in the medium decreased the amount of iron accumulated by Delta yfh1 cells and improved their growth in an iron-dependent manner, and this effect was mostly transcriptional. Overexpressing the major mitochondrial phosphate carrier, MIR1, slightly increased the concentration of soluble mitochondrial phosphate and significantly improved various mitochondrial functions (cytochromes, [Fe-S] clusters, and respiration) in Delta yfh1 cells. We conclude that in Delta yfh1 cells, soluble phosphate is limiting, due to its co-precipitation with iron.	[Lesuisse, Emmanuel] Univ Paris Diderot, CNRS, Inst Jacques Monod, Lab Mitochondria Met & Oxidat Stress, F-75205 Paris 13, France; [Pain, Debkumar] Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Dancis, Andrew] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania	Lesuisse, E (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, Lab Mitochondria Met & Oxidat Stress, Batiment Buffon,15 Rue Helene Brion, F-75205 Paris 13, France.	lesuisse.emmanuel@ijm.univ-paris-diderot.fr		Camadro, Jean-Michel/0000-0002-8549-2707; Santos, Renata/0000-0002-3085-5128	NIA, National Institutes of Health [AG030504]; AFAF (Association Francaise Ataxie de Friedreich); Agence Nationale de la Recherche (ANR Maladies Rares) [ANR-06-MRAR-025-01]; NATIONAL INSTITUTE ON AGING [R01AG030504] Funding Source: NIH RePORTER	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AFAF (Association Francaise Ataxie de Friedreich); Agence Nationale de la Recherche (ANR Maladies Rares)(French National Research Agency (ANR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NIA, National Institutes of Health Grant AG030504 (to D. P.). This work was also supported by the AFAF (Association Francaise Ataxie de Friedreich), the "Agence Nationale de la Recherche" ("ANR Maladies Rares, ANR-06-MRAR-025-01") (to A. S., R. S., J.-M. C., and E. L.).	Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; Armstrong JS, 2010, FASEB J, V24, P2152, DOI 10.1096/fj.09-143222; Auchere F, 2008, HUM MOL GENET, V17, P2790, DOI 10.1093/hmg/ddn178; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Labbe P, 1969, Bull Soc Chim Biol (Paris), V51, P1642; LABBE P, 1971, ANAL BIOCHEM, V39, P322, DOI 10.1016/0003-2697(71)90421-0; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Li LT, 1997, J BIOL CHEM, V272, P28485, DOI 10.1074/jbc.272.45.28485; Martin H, 1998, ANAL BIOCHEM, V265, P123, DOI 10.1006/abio.1998.2863; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; MURAKAMI H, 1990, NATURE, V347, P488, DOI 10.1038/347488a0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Reddi AR, 2009, FREE RADICAL BIO MED, V46, P154, DOI 10.1016/j.freeradbiomed.2008.09.032; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Rosenfeld L, 2010, J BIOL INORG CHEM, V15, P1051, DOI 10.1007/s00775-010-0664-8; Santos MM, 2001, HUM MOL GENET, V10, P1935, DOI 10.1093/hmg/10.18.1935; Santos R, 2010, ANTIOXID REDOX SIGN, V13, P651, DOI 10.1089/ars.2009.3015; Schroers A, 1997, J BIOL CHEM, V272, P10558; Seguin A, 2010, BBA-MOL BASIS DIS, V1802, P531, DOI 10.1016/j.bbadis.2010.03.008; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Takabatake R, 2001, J BIOCHEM, V129, P827, DOI 10.1093/oxfordjournals.jbchem.a002926; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Zara V, 1996, MOL CELL BIOL, V16, P6524; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	37	16	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6071	6079		10.1074/jbc.M110.163253	http://dx.doi.org/10.1074/jbc.M110.163253			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21189251	Green Published, hybrid			2022-12-25	WOS:000287476400015
J	DeSilva, JM; Throckmorton, ZJ				DeSilva, Jeremy M.; Throckmorton, Zachary J.			Lucy's Flat Feet: The Relationship between the Ankle and Rearfoot Arching in Early Hominins	PLOS ONE			English	Article							HADAR FORMATION; FUNCTIONAL-MORPHOLOGY; FLEXIBLE FLATFOOT; LOCOMOTOR ANATOMY; FOOT; PREVALENCE; HOMO; FOOTPRINTS; EVOLUTION; PATTERNS	Background: In the Plio-Pleistocene, the hominin foot evolved from a grasping appendage to a stiff, propulsive lever. Central to this transition was the development of the longitudinal arch, a structure that helps store elastic energy and stiffen the foot during bipedal locomotion. Direct evidence for arch evolution, however, has been somewhat elusive given the failure of soft-tissue to fossilize. Paleoanthropologists have relied on footprints and bony correlates of arch development, though little consensus has emerged as to when the arch evolved. Methodology/Principal Findings: Here, we present evidence from radiographs of modern humans (n = 261) that the set of the distal tibia in the sagittal plane, henceforth referred to as the tibial arch angle, is related to rearfoot arching. Non-human primates have a posteriorly directed tibial arch angle, while most humans have an anteriorly directed tibial arch angle. Those humans with a posteriorly directed tibial arch angle (8%) have significantly lower talocalcaneal and talar declination angles, both measures of an asymptomatic flatfoot. Application of these results to the hominin fossil record reveals that a well developed rearfoot arch had evolved in Australopithecus afarensis. However, as in humans today, Australopithecus populations exhibited individual variation in foot morphology and arch development, and "Lucy" (A.L. 288-1), a 3.18 Myrold female Australopithecus, likely possessed asymptomatic flat feet. Additional distal tibiae from the Plio-Pleistocene show variation in tibial arch angles, including two early Homo tibiae that also have slightly posteriorly directed tibial arch angles. Conclusions/Significance: This study finds that the rearfoot arch was present in the genus Australopithecus. However, the female Australopithecus afarensis "Lucy" has an ankle morphology consistent with non-pathological flat-footedness. This study suggests that, as in humans today, there was variation in arch development in Plio-Pleistocene hominins.	[DeSilva, Jeremy M.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Throckmorton, Zachary J.] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA	Boston University; University of Wisconsin System; University of Wisconsin Madison	DeSilva, JM (corresponding author), Boston Univ, Dept Anthropol, Boston, MA 02215 USA.	jdesilva@bu.edu			Leakey Foundation	Leakey Foundation	This work was funded by the Leakey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Fattah M. M., 2006, Eastern Mediterranean Health Journal, V12, P211; Akcali O, 2000, FOOT ANKLE INT, V21, P772, DOI 10.1177/107110070002100910; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Berillon G., 2003, Human Evolution, V18, P113, DOI 10.1007/BF02436280; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; COOK DC, 1983, AM J PHYS ANTHROPOL, V60, P83, DOI 10.1002/ajpa.1330600113; Cowan D N, 1993, Arch Fam Med, V2, P773, DOI 10.1001/archfami.2.7.773; Curnoe D, 2006, J HUM EVOL, V50, P36, DOI 10.1016/j.jhevol.2005.07.008; Curnoe D, 2010, HOMO, V61, P151, DOI 10.1016/j.jchb.2010.04.002; DAVIS PR, 1964, NATURE, V201, P967, DOI 10.1038/201967a0; DAY MH, 1964, NATURE, V201, P969, DOI 10.1038/201969a0; Deloison Yvette, 2003, Biometrie Humaine et Anthropologie, V21, P189; DeSilva JM, 2010, AM J PHYS ANTHROPOL, V141, P245, DOI 10.1002/ajpa.21140; DeSilva JM, 2010, INT J OSTEO IN PRESS; Dunn JE, 2004, AM J EPIDEMIOL, V159, P491, DOI 10.1093/aje/kwh071; Feibel Craig S., 1995, Evolutionary Anthropology, V4, P149, DOI 10.1002/evan.1360040502; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; GRAUSZ HM, 1988, FOUND HUM B, P127; Harcourt-Smith W.E., 2002, THESIS U COLL LONDON; Harris Edwin J, 2010, Clin Podiatr Med Surg, V27, P1, DOI 10.1016/j.cpm.2009.09.002; HICKS JH, 1954, J ANAT, V88, P25; Hogan MT, 2002, FOOT ANKLE INT, V23, P43, DOI 10.1177/107110070202300108; Jennings MM, 2008, J FOOT ANKLE SURG, V47, P219, DOI 10.1053/j.jfas.2008.02.002; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; KENNEDY GE, 1983, AM J PHYS ANTHROPOL, V61, P429, DOI 10.1002/ajpa.1330610405; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Kidd RS, 1996, J HUM EVOL, V31, P269, DOI 10.1006/jhev.1996.0061; Kuman K, 2000, J HUM EVOL, V38, pA16; LAMY P, 1986, J HUM EVOL, V15, P31, DOI 10.1016/S0047-2484(86)80063-X; LATIMER B, 1987, AM J PHYS ANTHROPOL, V74, P155, DOI 10.1002/ajpa.1330740204; LATIMER B, 1990, AM J PHYS ANTHROPOL, V83, P13, DOI 10.1002/ajpa.1330830103; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; LOVEJOY CO, 1982, AM J PHYS ANTHROPOL, V57, P679, DOI 10.1002/ajpa.1330570411; Morag E, 1999, J BIOMECH, V32, P359, DOI 10.1016/S0021-9290(98)00188-2; Morton DJ, 1935, HUMAN FOOT; Pehlivan O, 2009, INT ORTHOP, V33, P447, DOI 10.1007/s00264-007-0508-5; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; Pickering R, 2010, J HUM EVOL, V59, P70, DOI 10.1016/j.jhevol.2010.03.014; Pickering TR, 2004, AM J PHYS ANTHROPOL, V125, P1, DOI 10.1002/ajpa.10278; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Preuschoft H., 1970, THE CHIMPANZEE, V3, P221; SARRAFIAN SK, 1987, FOOT ANKLE, V8, P4, DOI 10.1177/107110078700800103; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUSMAN RL, 1982, SCIENCE, V217, P931, DOI 10.1126/science.217.4563.931; SUSMAN RL, 1983, FOOT ANKLE, V3, P365, DOI 10.1177/107110078300300605; Teyhen DS, 2009, CLIN BIOMECH, V24, P391, DOI 10.1016/j.clinbiomech.2009.01.006; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; TRINKAUS E, 1984, AM J PHYS ANTHROPOL, V64, P137, DOI 10.1002/ajpa.1330640206; Tudor A, 2009, PEDIATRICS, V123, pe386, DOI 10.1542/peds.2008-2262; TUTTLE R, 1990, J ARCHAEOL SCI, V17, P347, DOI 10.1016/0305-4403(90)90028-4; Villemure I, 2009, J BIOMECH, V42, P1793, DOI 10.1016/j.jbiomech.2009.05.021; Walker A., 1993, NARIOKOTOME HOMO ERE; WALTER RC, 1994, GEOLOGY, V22, P6, DOI 10.1130/0091-7613(1994)022<0006:AOLATF>2.3.CO;2; WHITE TD, 1980, SCIENCE, V208, P175, DOI 10.1126/science.208.4440.175; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; Williams DS, 2001, CLIN BIOMECH, V16, P341, DOI 10.1016/S0268-0033(01)00005-5	57	33	33	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14432	10.1371/journal.pone.0014432	http://dx.doi.org/10.1371/journal.pone.0014432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	701CS	21203433	Green Published, gold			2022-12-25	WOS:000285792500009
J	Gies, E; Wilde, I; Winget, JM; Brack, M; Rotblat, B; Novoa, CA; Balgi, AD; Sorensen, PH; Roberge, M; Mayor, T				Gies, Esther; Wilde, Inga; Winget, Jason M.; Brack, Maria; Rotblat, Barak; Novoa, Carolina Arias; Balgi, Aruna D.; Sorensen, Poul H.; Roberge, Michel; Mayor, Thibault			Niclosamide Prevents the Formation of Large Ubiquitin-Containing Aggregates Caused by Proteasome Inhibition	PLOS ONE			English	Article							PROTEIN AGGREGATION; HUNTINGTONS-DISEASE; AUTOPHAGY PATHWAY; BODY FORMATION; DEGRADATION; SYSTEM; INCLUSIONS; CELLS; AGGRESOMES; BINDING	Background: Protein aggregation is a hallmark of many neurodegenerative diseases and has been linked to the failure to degrade misfolded and damaged proteins. In the cell, aberrant proteins are degraded by the ubiquitin proteasome system that mainly targets short-lived proteins, or by the lysosomes that mostly clear long-lived and poorly soluble proteins. Both systems are interconnected and, in some instances, autophagy can redirect proteasome substrates to the lysosomes. Principal Findings: To better understand the interplay between these two systems, we established a neuroblastoma cell population stably expressing the GFP-ubiquitin fusion protein. We show that inhibition of the proteasome leads to the formation of large ubiquitin-containing inclusions accompanied by lower solubility of the ubiquitin conjugates. Strikingly, the formation of the ubiquitin-containing aggregates does not require ectopic expression of disease-specific proteins. Moreover, formation of these focused inclusions caused by proteasome inhibition requires the lysine 63 (K63) of ubiquitin. We then assessed selected compounds that stimulate autophagy and found that the antihelmintic chemical niclosamide prevents large aggregate formation induced by proteasome inhibition, while the prototypical mTORC1 inhibitor rapamycin had no apparent effect. Niclosamide also precludes the accumulation of poly-ubiquitinated proteins and of p62 upon proteasome inhibition. Moreover, niclosamide induces a change in lysosome distribution in the cell that, in the absence of proteasome activity, may favor the uptake into lysosomes of ubiquitinated proteins before they form large aggregates. Conclusions: Our results indicate that proteasome inhibition provokes the formation of large ubiquitin containing aggregates in tissue culture cells, even in the absence of disease specific proteins. Furthermore our study suggests that the autophagy-inducing compound niclosamide may promote the selective clearance of ubiquitinated proteins in the absence of proteasome activity.	[Gies, Esther; Wilde, Inga; Winget, Jason M.; Brack, Maria; Novoa, Carolina Arias; Balgi, Aruna D.; Roberge, Michel; Mayor, Thibault] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Gies, Esther; Wilde, Inga; Winget, Jason M.; Brack, Maria; Novoa, Carolina Arias; Mayor, Thibault] Univ British Columbia, Ctr Highthroughput Biol, Vancouver, BC V5Z 1M9, Canada; [Rotblat, Barak; Sorensen, Poul H.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Rotblat, Barak; Sorensen, Poul H.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Gies, E (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	mayor@interchange.ubc.ca	Rotblat, Barak/H-5970-2019	Rotblat, Barak/0000-0003-2985-7115	Parkinson Society Canada; Canadian Institute of Health Research (CIHR); Canadian Breast Cancer Foundation	Parkinson Society Canada; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported by a Parkinson Society Canada New Investigator Award and a Canadian Institute of Health Research (CIHR) Pilot Project Grant to T.M. and a Canadian Breast Cancer Foundation Grant to M.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAND N, 1997, APPROACHES DESIGN SY, P239; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; BOTERO D, 1978, ANNU REV PHARMACOL, V18, P1; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Hands S, 2008, BBA-GENE REGUL MECH, V1779, P507, DOI 10.1016/j.bbagrm.2008.05.008; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; KAISER P, 2010, MOL CELL PROTEOMICS; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kolodziejska KE, 2005, P NATL ACAD SCI USA, V102, P4854, DOI 10.1073/pnas.0500485102; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kuusisto E, 2001, BIOCHEM BIOPH RES CO, V280, P223, DOI 10.1006/bbrc.2000.4107; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu C, 2007, J BIOL CHEM, V282, P14558, DOI 10.1074/jbc.M700422200; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; Mayor T, 2007, MOL CELL PROTEOMICS, V6, P1885, DOI 10.1074/mcp.M700264-MCP200; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Navab M, 2009, J LIPID RES, V50, P1538, DOI 10.1194/jlr.M800539-JLR200; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Outeiro Tiago Fleming, 2007, Semin Pediatr Neurol, V14, P15, DOI 10.1016/j.spen.2006.11.005; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Richter-Landsberg C, 2008, J MOL NEUROSCI, V35, P55, DOI 10.1007/s12031-007-9017-7; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Riedel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008753; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sin N, 1999, BIOORG MED CHEM LETT, V9, P2283, DOI 10.1016/S0960-894X(99)00376-5; Stenoien DL, 2002, NAT CELL BIOL, V4, P806, DOI 10.1038/ncb859; Sun F, 2006, NEUROTOXICOLOGY, V27, P807, DOI 10.1016/j.neuro.2006.06.006; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tan JM, 2007, AUTOPHAGY, V4; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zeng BY, 2006, ANN NEUROL, V60, P248, DOI 10.1002/ana.20932	62	17	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14410	10.1371/journal.pone.0014410	http://dx.doi.org/10.1371/journal.pone.0014410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203451	Green Published, gold, Green Submitted			2022-12-25	WOS:000285579200001
J	Longmate, JA; Larson, GP; Krontiris, TG; Sommer, SS				Longmate, Jeffrey A.; Larson, Garrett P.; Krontiris, Theodore G.; Sommer, Steve S.			Three Ways of Combining Genotyping and Resequencing in Case-Control Association Studies	PLOS ONE			English	Article							RARE VARIANTS; DOVAM-S; SUSCEPTIBILITY; MUTATIONS; POWER; STRATEGIES; DISEASES; CANCER; RISK	We describe three statistical results that we have found to be useful in case-control genetic association testing. All three involve combining the discovery of novel genetic variants, usually by sequencing, with genotyping methods that recognize previously discovered variants. We first consider expanding the list of known variants by concentrating variant-discovery in cases. Although the naive inclusion of cases-only sequencing data would create a bias, we show that some sequencing data may be retained, even if controls are not sequenced. Furthermore, for alleles of intermediate frequency, cases-only sequencing with bias-correction entails little if any loss of power, compared to dividing the same sequencing effort among cases and controls. Secondly, we investigate more strongly focused variant discovery to obtain a greater enrichment for disease-related variants. We show how case status, family history, and marker sharing enrich the discovery set by increments that are multiplicative with penetrance, enabling the preferential discovery of high-penetrance variants. A third result applies when sequencing is the primary means of counting alleles in both cases and controls, but a supplementary pooled genotyping sample is used to identify the variants that are very rare. We show that this raises no validity issues, and we evaluate a less expensive and more adaptive approach to judging rarity, based on group-specific variants. We demonstrate the important and unusual caveat that this method requires equal sample sizes for validity. These three results can be used to more efficiently detect the association of rare genetic variants with disease.	[Larson, Garrett P.; Krontiris, Theodore G.] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA USA; [Sommer, Steve S.] Medomics LLC, Azusa, CA USA	City of Hope		jlongmate@coh.org		Longmate, Jeffrey/0000-0002-0869-7928	National Cancer Institute [CA33572-26]; Beckman Research Institute at City of Hope; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Beckman Research Institute at City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Parts of this work were undertaken as Biostatistics Shared Resource support for multiple projects, funded by a Cancer Center Support Grant (CA33572-26) from the National Cancer Institute. The remainder was funded by the Beckman Research Institute at City of Hope. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Buzin CH, 2000, BIOTECHNIQUES, V28, P746, DOI 10.2144/00284rr04; Chen ZB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007220; Curtin K, 2009, ANN HUM GENET, V73, P54, DOI 10.1111/j.1469-1809.2008.00483.x; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; Larson GP, 1997, GENET TEST, V1, P165, DOI 10.1089/gte.1997.1.165; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Liu Q, 1999, BIOTECHNIQUES, V26, P932, DOI 10.2144/99265rr03; Longmate JA, 2001, AM J HUM GENET, V68, P1229, DOI 10.1086/320106; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCarthy MI, 2009, GENOME MED, V1, DOI 10.1186/gm66; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; PATIL GP, 1988, ENCY STATISTICAL SCI, V9, P565; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Slager SL, 2000, GENET EPIDEMIOL, V18, P143, DOI 10.1002/(SICI)1098-2272(200002)18:2<143::AID-GEPI4>3.0.CO;2-5; Sommer SS, 2003, CANCER GENET CYTOGEN, V145, P115, DOI 10.1016/S0165-4608(03)00119-5; Song WJ, 2008, BIOCHEM BIOPH RES CO, V367, P700, DOI 10.1016/j.bbrc.2007.12.117; TORNQVIST L, 1985, AM STAT, V39, P43, DOI 10.2307/2683905; Zeggini E, 2005, NAT GENET, V37, P1320, DOI 10.1038/ng1670; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14318	10.1371/journal.pone.0014318	http://dx.doi.org/10.1371/journal.pone.0014318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187953	Green Published, Green Submitted, gold			2022-12-25	WOS:000285575200005
J	Sebbane, F; Jarrett, C; Gardner, D; Long, D; Hinnebusch, BJ				Sebbane, Florent; Jarrett, Clayton; Gardner, Donald; Long, Daniel; Hinnebusch, B. Joseph			Role of the Yersinia pestis Yersiniabactin Iron Acquisition System in the Incidence of Flea-Borne Plague	PLOS ONE			English	Article							PASTEURELLA PESTIS; PIGMENTATION; TRANSMISSION; DELETION	Plague is a flea-borne zoonosis caused by the bacterium Yersinia pestis. Y. pestis mutants lacking the yersiniabactin (Ybt) siderophore-based iron transport system are avirulent when inoculated intradermally but fully virulent when inoculated intravenously in mice. Presumably, Ybt is required to provide sufficient iron at the peripheral injection site, suggesting that Ybt would be an essential virulence factor for flea-borne plague. Here, using a flea-to-mouse transmission model, we show that a Y. pestis strain lacking the Ybt system causes fatal plague at low incidence when transmitted by fleas. Bacteriology and histology analyses revealed that a Ybt-negative strain caused only primary septicemic plague and atypical bubonic plague instead of the typical bubonic form of disease. The results provide new evidence that primary septicemic plague is a distinct clinical entity and suggest that unusual forms of plague may be caused by atypical Y. pestis strains.	[Sebbane, Florent] Inst Pasteur, Ctr Infect & Immun Lille, Equipe Peste & Yersinia Pestis, F-59019 Lille, France; [Sebbane, Florent] INSERM, U1019, F-59045 Lille, France; [Sebbane, Florent] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Sebbane, Florent] Univ Lille Nord France, Lille, France; [Sebbane, Florent] Ctr Infect & Immun Lille, UDSL, Lille, France; [Jarrett, Clayton; Hinnebusch, B. Joseph] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MT USA; [Jarrett, Clayton; Gardner, Donald; Long, Daniel; Hinnebusch, B. Joseph] NIAID, Vet Pathol Sect, Rocky Mt Labs, NIH, Hamilton, MT USA	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sebbane, F (corresponding author), Inst Pasteur, Ctr Infect & Immun Lille, Equipe Peste & Yersinia Pestis, F-59019 Lille, France.	florent.sebbane@inserm.fr	Sebbane, Florent/D-4213-2009; Sebbane, Florent/ABA-2213-2020	Sebbane, Florent/0000-0003-3811-9691	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Institut National de la Sante et de la Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000919] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; and Institut National de la Sante et de la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearden SW, 1999, MOL MICROBIOL, V32, P403, DOI 10.1046/j.1365-2958.1999.01360.x; BRUBAKER RR, 1969, J BACTERIOL, V98, P1404, DOI 10.1128/JB.98.3.1404-1406.1969; Buchrieser C, 1998, J BACTERIOL, V180, P2321, DOI 10.1128/JB.180.9.2321-2329.1998; CHEN TH, 1961, J IMMUNOL, V87, P64; Eisen RJ, 2006, P NATL ACAD SCI USA, V103, P15380, DOI 10.1073/pnas.0606831103; Fetherston JD, 2010, INFECT IMMUN, V78, P2045, DOI 10.1128/IAI.01236-09; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; FONQUERNIE J., 1931, Bulletin de la Societe de Pathologie Exotique, V24, P446; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; ITEMAN I, 1993, INFECT IMMUN, V61, P2717, DOI 10.1128/IAI.61.6.2717-2722.1993; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; PERRY RD, 2004, YERSINIA MOL CELLULA, P257; Pollitzer R., 1954, PLAGUE; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Sebbane F, 2009, INFECT IMMUN, V77, P1222, DOI 10.1128/IAI.00950-08; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; WILLIAMS JE, 1978, AM J PUBLIC HEALTH, V68, P262, DOI 10.2105/AJPH.68.3.262	19	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14379	10.1371/journal.pone.0014379	http://dx.doi.org/10.1371/journal.pone.0014379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179420	Green Published, Green Submitted, gold			2022-12-25	WOS:000285572900011
J	Nakashima, T; Jinnin, M; Etoh, T; Fukushima, S; Masuguchi, S; Maruo, K; Inoue, Y; Ishihara, T; Ihn, H				Nakashima, Taiji; Jinnin, Masatoshi; Etoh, Tomomi; Fukushima, Satoshi; Masuguchi, Shinichi; Maruo, Keishi; Inoue, Yuji; Ishihara, Tsuyoshi; Ihn, Hironobu			Down-Regulation of mir-424 Contributes to the Abnormal Angiogenesis via MEK1 and Cyclin E1 in Senile Hemangioma: Its Implications to Therapy	PLOS ONE			English	Article							NONREPLICATING ENDOTHELIAL-CELLS; INTENSE PULSED-LIGHT; VASCULAR-LESIONS; EXPRESSION; MICRORNAS; KINASE; LASER; PROLIFERATION; MALFORMATIONS; CHILDREN	Background: Senile hemangioma, so-called cherry angioma, is known as the most common vascular anomalies specifically seen in the aged skin. The pathogenesis of its abnormal angiogenesis is still unclear. Methodology/Principal Findings: In this study, we found that senile hemangioma consisted of clusters of proliferated small vascular channels in upper dermis, indicating that this tumor is categorized as a vascular tumor. We then investigated the mechanism of endothelial proliferation in senile hemangioma, focusing on microRNA ( miRNA). miRNA PCR array analysis revealed the mir-424 level in senile hemangioma was lower than in other vascular anomalies. Protein expression of MEK1 and cyclin E1, the predicted target genes of mir-424, was increased in senile hemangioma compared to normal skin or other anomalies, but their mRNA levels were not. The inhibition of mir-424 in normal human dermal microvascular ECs (HDMECs) using specific inhibitor in vitro resulted in the increase of protein expression of MEK1 or cyclin E1, while mRNA levels were not affected by the inhibitor. Specific inhibitor of mir-424 also induced the cell proliferation of HDMECs significantly, while the cell number was decreased by the transfection of siRNA for MEK1 or cyclin E1. Conclusions/Significance: Taken together, decreased mir-424 expression and increased levels of MEK1 or cyclin E1 in senile hemangioma may cause abnormal cell proliferation in the tumor. Senile hemangioma may be the good model for cutaneous angiogenesis. Investigation of senile hemangioma and the regulatory mechanisms of angiogenesis by miRNA in the aged skin may lead to new treatments using miRNA by the transfection into senile hemangioma.	[Nakashima, Taiji; Jinnin, Masatoshi; Etoh, Tomomi; Fukushima, Satoshi; Masuguchi, Shinichi; Maruo, Keishi; Inoue, Yuji; Ishihara, Tsuyoshi; Ihn, Hironobu] Kumamoto Univ, Dept Dermatol & Plast Surg, Fac Life Sci, Kumamoto, Japan	Kumamoto University	Nakashima, T (corresponding author), Kumamoto Univ, Dept Dermatol & Plast Surg, Fac Life Sci, Kumamoto, Japan.	mjin@kumamoto-u.ac.jp		Fukushima, Satoshi/0000-0002-0622-7682	Rohto Award; JSID; Mitsubishi Pharma Research Foundation	Rohto Award; JSID; Mitsubishi Pharma Research Foundation	This study was supported in part by grants from Rohto Award, from JSID's Fellowship Shiseido Award, and from Mitsubishi Pharma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by grants from a commercial source (Rohto, Shiseido and Mitsubishi Pharma). The funders do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bernstein EF, 2009, GIORN ITAL DERMAT V, V144, P557; Boye E, 2001, J CLIN INVEST, V107, P745, DOI 10.1172/JCI11432; BRAVERMAN IM, 1983, J INVEST DERMATOL, V81, P489, DOI 10.1111/1523-1747.ep12522736; Brown LF, 1996, AM J PATHOL, V148, P1065; Bu Jingqiu, 2002, Zhonghua Kou Qiang Yi Xue Za Zhi, V37, P33; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chung JH, 2007, J DERMATOL, V34, P593, DOI 10.1111/j.1346-8138.2007.00341.x; Davidson-Moncada J, 2010, ANN NY ACAD SCI, V1183, P183, DOI 10.1111/j.1749-6632.2009.05121.x; DONSKY HJ, 1968, CAN MED ASSOC J, V99, P993; Val-Bernal JF, 2007, APMIS, V115, P1234, DOI 10.1111/j.1600-0643.2007.00756.x; Fodor L, 2006, ANN PLAS SURG, V56, P164, DOI 10.1097/01.sap.0000196579.14954.d6; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; FURER V, 2010, CLIN IMMUNO IN PRESS; Greulich H, 1998, J BIOL CHEM, V273, P13280, DOI 10.1074/jbc.273.21.13280; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; Jay H, 1998, LANCET, V351, P112, DOI 10.1016/S0140-6736(05)78149-6; Jinnin M, 2006, J CELL PHYSIOL, V206, P718, DOI 10.1002/jcp.20527; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Keenan SM, 2001, J BIOL CHEM, V276, P22404, DOI 10.1074/jbc.M100409200; KELLY RI, 1995, J AM ACAD DERMATOL, V33, P749, DOI 10.1016/0190-9622(95)91812-4; Kleinman ME, 2007, ARTERIOSCL THROM VAS, V27, P2664, DOI 10.1161/ATVBAHA.107.150284; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LISTON A, 2010, J CLIN IMMU IN PRESS; MAKINO T, 2010, BR J DERMAT IN PRESS; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Mazumder S, 2004, CURR CANCER DRUG TAR, V4, P65, DOI 10.2174/1568009043481669; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; MULLIKEN JB, VASCULAR ANOMALIES, P517; NEUMANN RA, 1990, CLIN EXP DERMATOL, V15, P115, DOI 10.1111/j.1365-2230.1990.tb02045.x; Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008; Paller AS, 2000, J INVEST DERM SYMP P, V5, P83, DOI 10.1046/j.1087-0024.2000.00011.x; Requena L, 1997, J AM ACAD DERMATOL, V37, P523, DOI 10.1016/S0190-9622(97)70169-5; Sheth S, 2008, SEMIN DIAGN PATHOL, V25, P1, DOI 10.1053/j.semdp.2007.10.001; TUDER RM, 1987, J INVEST DERMATOL, V89, P594, DOI 10.1111/1523-1747.ep12461306; Ugland H, 2008, MOL BIOL CELL, V19, P5082, DOI 10.1091/mbc.E08-01-0094; Webster G F, 2001, Clin Cornerstone, V4, P39, DOI 10.1016/S1098-3597(01)90006-7; Wolf IH, 2002, CLIN DERMATOL, V20, P273, DOI 10.1016/S0738-081X(02)00222-5; ZHENG CF, 1994, J BIOL CHEM, V269, P19947	40	92	94	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14334	10.1371/journal.pone.0014334	http://dx.doi.org/10.1371/journal.pone.0014334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179471	Green Published, gold, Green Submitted			2022-12-25	WOS:000285292500011
J	Bao, L; Xia, XF; Cui, Y				Bao, Lei; Xia, Xuefeng; Cui, Yan			Expression QTL Modules as Functional Components Underlying Higher-Order Phenotypes	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR NETWORKS; SYSTEMS GENETICS; PROTEIN; MOUSE; TRAIT; LOCI; ADIPOGENESIS; GENOMICS; MODEL	Systems genetics studies often involve the mapping of numerous regulatory relations between genetic loci and expression traits. These regulatory relations form a bipartite network consisting of genetic loci and expression phenotypes. Modular network organizations may arise from the pleiotropic and polygenic regulation of gene expression. Here we analyzed the expression QTL (eQTL) networks derived from expression genetic data of yeast and mouse liver and found 65 and 98 modules respectively. Computer simulation result showed that such modules rarely occurred in randomized networks with the same number of nodes and edges and same degree distribution. We also found significant within-module functional coherence. The analysis of genetic overlaps and the evidences from biomedical literature have linked some eQTL modules to physiological phenotypes. Functional coherence within the eQTL modules and genetic overlaps between the modules and physiological phenotypes suggests that eQTL modules may act as functional units underlying the higher-order phenotypes.	[Bao, Lei; Cui, Yan] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN USA; [Cui, Yan] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA; [Xia, Xuefeng] Tsinghua Univ, Inst Bioinformat, Beijing 100084, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Tsinghua University	Bao, L (corresponding author), Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA.	lebao@ucsd.edu; ycui2@uthsc.edu		Cui, Yan/0000-0002-7577-6845	NIH [NR009270, AI081050]; Department of Defense [W81XHW-05-01-0227]; American Heart Association [0830134N]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR009270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported in part by NIH grants NR009270, AI081050, a Department of Defense grant W81XHW-05-01-0227 and an American Heart Association grant 0830134N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Bao L, 2007, HUM MOL GENET, V16, P1381, DOI 10.1093/hmg/ddm089; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Greaves KA, 2003, METABOLISM, V52, P282, DOI 10.1053/meta.2003.50045; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Kudo T, 2009, XENOBIOTICA, V39, P889, DOI 10.3109/00498250903242592; Laudes M, 2008, J MOL MED, V86, P597, DOI 10.1007/s00109-008-0326-2; Li HQ, 2006, HUM MOL GENET, V15, P481, DOI 10.1093/hmg/ddi462; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Merezhinskaya N, 2009, HISTOL HISTOPATHOL, V24, P243, DOI 10.14670/HH-24.243; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mezey JG, 2000, GENETICS, V156, P305; Nogami S, 2007, PLOS GENET, V3, P305, DOI 10.1371/journal.pgen.0030031; Quigley D, 2009, NAT REV GENET, V10, P651, DOI 10.1038/nrg2617; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Robinson PN, 2004, BIOINFORMATICS, V20, P979, DOI 10.1093/bioinformatics/bth040; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Soni KG, 2004, J BIOL CHEM, V279, P40683, DOI 10.1074/jbc.M400541200; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; van Tits L, 2005, ARTERIOSCL THROM VAS, V25, P717, DOI 10.1161/01.ATV.0000157979.51673.2c; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015; Westfall Peter H, 2002, Methods Mol Biol, V184, P143; Zhang W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000642	36	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14313	10.1371/journal.pone.0014313	http://dx.doi.org/10.1371/journal.pone.0014313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179437	Green Published, gold, Green Submitted			2022-12-25	WOS:000285246900018
J	Vermeij, MJA; van Moorselaar, I; Engelhard, S; Hornlein, C; Vonk, SM; Visser, PM				Vermeij, Mark J. A.; van Moorselaar, Imke; Engelhard, Sarah; Hornlein, Christine; Vonk, Sophie M.; Visser, Petra M.			The Effects of Nutrient Enrichment and Herbivore Abundance on the Ability of Turf Algae to Overgrow Coral in the Caribbean	PLOS ONE			English	Article							PHASE-SHIFTS; SCLERACTINIAN CORALS; COMMUNITY STRUCTURE; REEFS; COMPETITION; MACROALGAE; SEDIMENT; STRESS; GROWTH; FLUOROMETRY	Turf algae are multispecies communities of small marine macrophytes that are becoming a dominant component of coral reef communities around the world. To assess the impact of turf algae on corals, we investigated the effects of increased nutrients (eutrophication) on the interaction between the Caribbean coral Montastraea annularis and turf algae at their growth boundary. We also assessed whether herbivores are capable of reducing the abundance of turf algae at coral-algae boundaries. We found that turf algae cause visible (overgrowth) and invisible negative effects (reduced fitness) on neighbouring corals. Corals can overgrow neighbouring turf algae very slowly (at a rate of 0.12 mm 3 wk(-1)) at ambient nutrient concentrations, but turf algae overgrew corals (at a rate of 0.34 mm 3 wk(-1)) when nutrients were experimentally increased. Exclusion of herbivores had no measurable effect on the rate turf algae overgrew corals. We also used PAM fluorometry (a common approach for measuring of a colony's "fitness") to detect the effects of turf algae on the photophysiology of neighboring corals. Turf algae always reduced the effective photochemical efficiency of neighbouring corals, regardless of nutrient and/or herbivore conditions. The findings that herbivores are not capable of controlling the abundance of turf algae and that nutrient enrichment gives turf algae an overall competitive advantage over corals together have serious implications for the health of Caribbean coral reef systems. At ambient nutrient levels, traditional conservation measures aimed at reversing coral-to-algae phase shifts by reducing algal abundance (i.e., increasing herbivore populations by establishing Marine Protected Areas or tightening fishing regulations) will not necessarily reduce the negative impact of turf algae on local coral communities. Because turf algae have become the most abundant benthic group on Curacao (and likely elsewhere in the Caribbean), new conservation strategies are required to mitigate their negative impact on coral communities.	[Vermeij, Mark J. A.; Visser, Petra M.] Carmabi Fdn, Willemstad, Curacao, Neth Antilles; [Vermeij, Mark J. A.; van Moorselaar, Imke; Engelhard, Sarah; Hornlein, Christine; Vonk, Sophie M.; Visser, Petra M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Amsterdam	Vermeij, MJA (corresponding author), Carmabi Fdn, Willemstad, Curacao, Neth Antilles.	m.vermeij@carmabi.org	Vermeij, Mark/AAR-6757-2020; Vermeij, Mark/B-2752-2013	Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527; Visser, Petra/0000-0003-3294-1908	University of Amsterdam; Government of the Netherlands Antilles; European Union [244161]	University of Amsterdam; Government of the Netherlands Antilles; European Union(European Commission)	Partial funding for this project was obtained from the University of Amsterdam's STUNT-Fund, the Government of the Netherlands Antilles and the European Union under the seventh framework program (Grant# 244161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Beer S, 1998, MAR BIOL, V131, P607, DOI 10.1007/s002270050352; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V112, P51, DOI 10.3354/meps112051; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2009, MAR ECOL PROG SER, V389, P71, DOI 10.3354/meps08142; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; Carricart-Ganivet JP, 2001, B MAR SCI, V68, P133; Chartrand KM, 2009, MAR BIOL, V156, P1691, DOI 10.1007/s00227-009-1204-3; Cheroske AG, 2000, J EXP MAR BIOL ECOL, V248, P1, DOI 10.1016/S0022-0981(00)00153-2; Costa OS, 2000, HYDROBIOLOGIA, V440, P307, DOI 10.1023/A:1004104118208; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; Fai PB, 2007, ENVIRON TOXICOL CHEM, V26, P1520, DOI 10.1897/06-394R1.1; Frade PR, 2008, CORAL REEFS, V27, P913, DOI 10.1007/s00338-008-0406-3; GLADFELTER EH, 1978, B MAR SCI, V28, P728; Gorgula SK, 2004, MAR BIOL, V145, P613, DOI 10.1007/s00227-004-1335-5; Haas A, 2010, CORAL REEFS, V29, P93, DOI 10.1007/s00338-009-0556-y; HATCHER BG, 1983, J EXP MAR BIOL ECOL, V69, P61, DOI 10.1016/0022-0981(83)90172-7; HAY ME, 1981, ECOLOGY, V62, P739, DOI 10.2307/1937742; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOKIEL PL, 1993, MAR ECOL PROG SER, V93, P175, DOI 10.3354/meps093175; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; Jones RJ, 1999, MAR POLLUT BULL, V38, P864, DOI 10.1016/S0025-326X(98)90160-6; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; Larned ST, 1998, MAR BIOL, V132, P409, DOI 10.1007/s002270050407; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; Littler MM, 2006, HARMFUL ALGAE, V5, P565, DOI 10.1016/j.hal.2005.11.003; Littler MM, 1997, CORAL REEFS, V16, P168; McClanahan TR, 2007, MAR POLLUT BULL, V54, P1947, DOI 10.1016/j.marpolbul.2007.09.023; McCook LJ, 2001, CORAL REEFS, V19, P419, DOI 10.1007/s003380000119; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Quan-Young LI, 2006, LIMNOL OCEANOGR, V51, P1159, DOI 10.4319/lo.2006.51.2.1159; ROGERS CS, 1997, P 8 INT COR REEF S P, V1, P555; Roy RE, 2004, REV BIOL TROP, V52, P869; Sandin SA, 2008, CARIBB J SCI, V44, P137; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; TILMAN D, 1997, SPATIAL ECOLOGY ROLE, P3; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; TITLYANOV EA, 2006, P 10 INT COR REEF S, P1931; Underwood A.J., 1986, P240; Van Veghel MLJ, 1994, THESIS U AMSTERDAM A; VANSTEVENINCK EDD, 1986, MAR ECOL PROG SER, V34, P87; Vermeij MJA, 2007, MAR ECOL PROG SER, V351, P91, DOI 10.3354/meps07085; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; VERMEIJ MJA, 2010, MAR ECOL, P1; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121	59	125	129	5	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14312	10.1371/journal.pone.0014312	http://dx.doi.org/10.1371/journal.pone.0014312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179215	Green Submitted, Green Published, gold			2022-12-25	WOS:000285246900017
J	Li, WW; Li, H; Sanders, PN; Mohler, PJ; Backs, J; Olson, EN; Anderson, ME; Grumbach, IM				Li, Weiwei; Li, Hui; Sanders, Philip N.; Mohler, Peter J.; Backs, Johannes; Olson, Eric N.; Anderson, Mark E.; Grumbach, Isabella M.			The Multifunctional Ca2+/Calmodulin-dependent Kinase II delta (CaMKII delta) Controls Neointima Formation after Carotid Ligation and Vascular Smooth Muscle Cell Proliferation through Cell Cycle Regulation by p21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; ANGIOTENSIN-II; CARDIAC-HYPERTROPHY; ISOFORM REGULATION; PRESSURE-OVERLOAD; DOWN-REGULATION; NIH 3T3-CELLS; C-JUN; ACTIVATION; PATHWAY	The multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) promotes vascular smooth muscle (VSMC) proliferation. However, the signaling pathways mediating CAMKII-dependent proliferative effects in vivo are poorly understood. This study tested the hypothesis that CaMKII delta mediates neointimal proliferation after carotid artery ligation by regulating expression and activity of cell cycle regulators, particularly at the G1/S checkpoint. Data herein indicate that 14 days after carotid ligation, C57Bl/6 mice developed a marked neointima with robust CaMKII protein expression. In particular, only the CaMKII isoform delta was increased as demonstrated by quantitative RT-PCR. Genetic deletion of CaMKII delta prevented injury-induced neointimal hyperplasia and cell proliferation in the intima and media. In ligated carotids of control mice, the proliferative cell cycle markers cdk2, cyclin E, and cyclin D1 were activated. In contrast, in CaMKII delta(-/-) mice, we detected a reduction in proliferative cell cycle regulators as well as an increase in the cell cycle inhibitor p21. This expression profile was confirmed in cultured CaMKII delta(-/-) VSMC, in which cdk2 and cdk4 activity was decreased. Toward understanding how CAMKII delta affects p53, a transcriptional regulator of p21, we examined p53 pathway components. Our data indicate that p53 is elevated in CAMKII delta(-/-) VSMC, whereas phosphorylation of the p53-specific E3 ligase, Mdm2, was decreased. In conclusion, CaMKII stimulates neointima proliferation after vascular injury by regulating cell proliferation through inhibition of p21 and induction of Mdm-2-mediated degradation of p53.	[Li, Weiwei; Li, Hui; Sanders, Philip N.; Mohler, Peter J.; Anderson, Mark E.; Grumbach, Isabella M.] Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Med, Iowa City, IA 52242 USA; [Grumbach, Isabella M.] Iowa City VA Med Ctr, Iowa City, IA 52242 USA; [Backs, Johannes] Univ Heidelberg, Dept Internal Med 3, D-69120 Heidelberg, Germany; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Ruprecht Karls University Heidelberg; University of Texas System; University of Texas Southwestern Medical Center Dallas	Grumbach, IM (corresponding author), Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Med, 2270-A CBRB,285 Newton Rd, Iowa City, IA 52242 USA.	isabella-grumbach@uiowa.edu		Grumbach, Isabella/0000-0002-2285-3157	National Institutes of Health [HL 079031, R01 HL 70250, R01 HL 084583, R01 HL 083422]; Pew Scholars Trust; American Heart Association; Office of Research and Development, Dept. of Veterans Affairs; Carver Trust Medical Research Initiative; University of Iowa Cardiovascular Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113001, R01HL084583, R01HL079031, R01HL070250, R01HL083422, R01HL096652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Trust; American Heart Association(American Heart Association); Office of Research and Development, Dept. of Veterans Affairs(US Department of Veterans Affairs); Carver Trust Medical Research Initiative; University of Iowa Cardiovascular Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 079031, and R01 HL 70250 (to M. E. A.); National Institutes of Health Grants R01 HL 084583 and R01 HL 083422, and Pew Scholars Trust (to P. J. M.). This work was also supported in part by funding from the following grants: an American Heart Association Scientist Development Grant, a VA Merit grant by the Office of Research and Development, Dept. of Veterans Affairs and a Carver Trust Medical Research Initiative Grant (to I. M. G.), and the University of Iowa Cardiovascular Center Interdisciplinary Research Fellowship (to W. L.).	Backs J, 2010, P NATL ACAD SCI USA, V107, P81, DOI 10.1073/pnas.0912658106; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Chen DH, 1997, J CLIN INVEST, V99, P2334, DOI 10.1172/JCI119414; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Gordon JW, 2009, J BIOL CHEM, V284, P19027, DOI 10.1074/jbc.M109.000539; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Kim I, 2000, J PHYSIOL-LONDON, V526, P367, DOI 10.1111/j.1469-7793.2000.00367.x; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Li F, 2005, AM J PHYSIOL-HEART C, V288, pH2306, DOI 10.1152/ajpheart.00571.2004; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Li N, 2009, J BIOL CHEM, V284, P3021, DOI 10.1074/jbc.M805483200; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Lu X, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000984; Ma SL, 2009, J BIOL CHEM, V284, P24773, DOI 10.1074/jbc.M109.028621; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; MORISHITA R, 1994, J CLIN INVEST, V93, P1458, DOI 10.1172/JCI117123; Morris TA, 1998, EXP CELL RES, V240, P218, DOI 10.1006/excr.1997.3925; Muthalif MM, 2002, HYPERTENSION, V39, P704, DOI 10.1161/hy0202.103823; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; Rousseau D, 1999, ONCOGENE, V18, P4313, DOI 10.1038/sj.onc.1202686; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Stabile E, 2003, CIRC RES, V93, P1059, DOI 10.1161/01.RES.0000105086.31909.1B; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Yuan KY, 2007, LAB INVEST, V87, P938, DOI 10.1038/labinvest.3700658; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; ZHOU ZHL, 1994, BIOCHEM J, V299, P489, DOI 10.1042/bj2990489	40	46	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7990	7999		10.1074/jbc.M110.163006	http://dx.doi.org/10.1074/jbc.M110.163006			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193397	Green Published, hybrid			2022-12-25	WOS:000288013300030
J	Donohue, E; Tovey, A; Vogl, AW; Arns, S; Sternberg, E; Young, RN; Roberge, M				Donohue, Elizabeth; Tovey, Andrew; Vogl, A. Wayne; Arns, Steve; Sternberg, Ethan; Young, Robert N.; Roberge, Michel			Inhibition of Autophagosome Formation by the Benzoporphyrin Derivative Verteporfin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT GLIOMA-CELLS; PROTEIN-DEGRADATION; CANCER-CELLS; NUTRIENT DEPRIVATION; MAMMALIAN-CELLS; TUMOR-CELLS; TUMORIGENESIS; TAMOXIFEN; THERAPY; TARGET	Autophagy enables cells to degrade and recycle cytoplasmic materials both as a housekeeping mechanism and in response to extracellular stress such as nutrient deprivation. Recent studies indicate that autophagy also functions as a protective mechanism in response to several cancer therapy agents, making it a prospective therapeutic target. Few pharmacological inhibitors suitable for testing the therapeutic potential of autophagy inhibition in vivo are known. An automated microscopy assay was used to screen > 3,500 drugs and pharmacological agents and identified one drug, verteporfin, as an inhibitor of autophagosome accumulation. Verteporfin is a benzoporphyrin derivative used in photodynamic therapy, but it inhibits autophagy without light activation. Verteporfin did not inhibit LC3/Atg8 processing or membrane recruitment in response to autophagic stimuli, but it inhibited drug-and starvation-induced autophagic degradation and the sequestration of cytoplasmic materials into autophagosomes. Transient exposure to verteporfin in starvation conditions reduced cell viability whereas cells in nutrient-rich medium were unaffected by drug treatment. Analysis of structural analogs indicated that the activity of verteporfin requires the presence of a substituted cyclohexadiene at ring A of the porphyrin core but that it can tolerate a number of large substituents at rings C and D. The existence of an autophagy inhibitor among FDA-approved drugs should facilitate the investigation of the therapeutic potential of autophagy inhibition in vivo.	[Donohue, Elizabeth; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Tovey, Andrew; Sternberg, Ethan] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada; [Vogl, A. Wayne] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Arns, Steve; Young, Robert N.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Simon Fraser University	Roberge, M (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	michelr@interchange.ubc.ca		Young, Robert/0000-0002-8235-6080	Canadian Breast Cancer Foundation	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported by the Canadian Breast Cancer Foundation.	Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Belzacq AS, 2001, CANCER RES, V61, P1260; Bilir A, 2001, PATHOBIOLOGY, V69, P120, DOI 10.1159/000048766; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; Chen B, 2005, INT J RADIAT ONCOL, V61, P1216, DOI 10.1016/j.ijrobp.2004.08.006; Curman D, 2001, J BIOL CHEM, V276, P17914, DOI 10.1074/jbc.M100728200; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Eskelinen EL, 2008, AUTOPHAGY, V4, P257, DOI 10.4161/auto.5179; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Granville D J, 2000, Curr Opin Drug Discov Devel, V3, P232; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Izuishi K, 2000, CANCER RES, V60, P6201; Jin SK, 2006, AUTOPHAGY, V2, P80, DOI 10.4161/auto.2.2.2460; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Kimura N, 2007, PATHOBIOLOGY, V74, P169, DOI 10.1159/000103376; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mari M, 2007, NAT CELL BIOL, V9, P1125, DOI 10.1038/ncb1007-1125; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Michels S, 2001, Semin Ophthalmol, V16, P201, DOI 10.1076/soph.16.4.201.10298; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Paglin S, 2001, CANCER RES, V61, P439; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; RICHTER AM, 1990, J PHOTOCH PHOTOBIO B, V5, P231, DOI 10.1016/1011-1344(90)80008-L; RICHTER AM, 1987, J NATL CANCER I, V79, P1327; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Schneider P, 1997, MICROSC RES TECHNIQ, V36, P253; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; TOVEY A, 1994, THESIS U BRIT COLUMB; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430	47	96	97	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7290	7300		10.1074/jbc.M110.139915	http://dx.doi.org/10.1074/jbc.M110.139915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193398	Green Published, hybrid			2022-12-25	WOS:000287737300045
J	Bulut, GB; Sulahian, R; Ma, Y; Chi, NW; Huang, LJS				Bulut, Gamze Betul; Sulahian, Rita; Ma, Yue; Chi, Nai-wen; Huang, Lily Jun-shen			Ubiquitination Regulates the Internalization, Endolysosomal Sorting, and Signaling of the Erythropoietin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE EXPRESSION; DEGRADATION; TRANSDUCTION; JAK2; ENDOCYTOSIS; ACTIVATION; MEMBRANE; REGION; DOMAIN	Ubiquitination is a common mechanism of down-regulation of mitogenic receptors. Here, we show that ubiquitination of the erythropoietin receptor (EpoR) at Lys(256) is necessary and sufficient for efficient Epo-induced receptor internalization, whereas ubiquitination at Lys(428) promotes trafficking of activated receptors to the lysosomes for degradation. Interestingly, EpoR that cannot be ubiquitinated has reduced mitogenic activities and ability to stimulate the STAT5, Ras/MAPK, and PI3K/AKT signaling pathways. We therefore propose that ubiquitination of the EpoR critically controls both receptor down-regulation and downstream signaling.	[Huang, Lily Jun-shen] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Chi, Nai-wen] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Huang, LJS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Lily.Huang@utsouthwestern.edu			National Institutes of Health [R01 HL089966]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL089966.	Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; dos Santos GMA, 2001, J BIOL CHEM, V276, P32635, DOI 10.1074/jbc.M103583200; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Hitchcock IS, 2008, BLOOD, V112, P2222, DOI 10.1182/blood-2008-01-134049; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kumar KGS, 2003, EMBO J, V22, P5480; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; NEUMANN D, 1993, J BIOL CHEM, V268, P13639; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Saur SJ, 2010, BLOOD, V115, P1254, DOI 10.1182/blood-2009-06-227033; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sulahian R, 2009, BLOOD, V113, P5287, DOI 10.1182/blood-2008-09-179572; Suzuki N, 2002, BLOOD, V100, P2279, DOI 10.1182/blood-2002-01-0124; Swaminathan G, 2008, J ENDOCRINOL, V196, pR1, DOI 10.1677/JOE-07-0554; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Teis D, 2003, CELL MOL LIFE SCI, V60, P2020, DOI 10.1007/s00018-003-3010-2; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tong W, 2006, J BIOL CHEM, V281, P38930, DOI 10.1074/jbc.M607524200; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Walz HA, 2010, J BIOL CHEM, V285, P14101, DOI 10.1074/jbc.M110.110536; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yen CH, 2000, J IMMUNOL, V165, P6372, DOI 10.4049/jimmunol.165.11.6372; Zang HS, 2001, EMBO J, V20, P3156, DOI 10.1093/emboj/20.12.3156	31	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6449	6457		10.1074/jbc.M110.186890	http://dx.doi.org/10.1074/jbc.M110.186890			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21183685	Green Published, hybrid			2022-12-25	WOS:000287476400055
J	Guo, C; Zhang, XY; Pfeifer, GP				Guo, Cai; Zhang, Xiaoying; Pfeifer, Gerd P.			The Tumor Suppressor RASSF1A Prevents Dephosphorylation of the Mammalian STE20-like Kinases MST1 and MST2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC INACTIVATION; CELL-PROLIFERATION; PROTEIN-KINASE; HIPPO PATHWAY; ORGAN SIZE; APOPTOSIS; PHOSPHORYLATION; ACTIVATION; INDUCTION; INTERACTS	The RASSF1A tumor suppressor protein interacts with the pro-apoptotic mammalian STE20-like kinases MST1 and MST2 and induces their autophosphorylation and activation, but the mechanism of how RASSF1A activates MST1/2 is unclear. Okadaic acid treatment and PP2A knockdown promoted MST1/2 phosphorylation. Data from dephosphorylation assays and reduced activation of MST1/2 seen after RASSF1A depletion suggest that dephosphorylation of MST1/2 on Thr-183 and Thr-180 by PP2A is prevented by RASSF1A, shifting the balance of MST1/2 to the activated autophosphorylated form. In addition to preventing dephosphorylation, RASSF1A also stabilized the MST2 protein. Through binding to MST1/2, RASSF1A supports maintenance of MST1/2 phosphorylation, promoting an active state of the MST kinases and favoring induction of apoptosis. This is one of the first examples of a tumor suppressor acting as an inhibitor of a specific dephosphorylation pathway.	[Guo, Cai; Zhang, Xiaoying; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Pfeifer, GP (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	gpfeifer@coh.org			University of California [17RT-0116]	University of California(University of California System)	This work was supported by University of California Tobacco-Related Disease Research Program Grant 17RT-0116.	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Avruch J, 2006, METHOD ENZYMOL, V407, P290, DOI 10.1016/S0076-6879(05)07025-4; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kilili GK, 2010, J BIOL CHEM, V285, P15076, DOI 10.1074/jbc.M109.078915; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lian JP, 2001, J IMMUNOL, V166, P6349, DOI 10.4049/jimmunol.166.10.6349; Liu L, 2008, ONCOGENE, V27, P6175, DOI 10.1038/onc.2008.220; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Matallanas D, 2008, CELL CYCLE, V7, P879, DOI 10.4161/cc.7.7.5630; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Pfeifer GP, 2010, CURR BIOL, V20, pR344, DOI 10.1016/j.cub.2010.02.019; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Rabizadeh S, 2004, J BIOL CHEM, V279, P29247, DOI 10.1074/jbc.M401699200; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Tommasi S, 2005, CANCER RES, V65, P92; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	44	80	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6253	6261		10.1074/jbc.M110.178210	http://dx.doi.org/10.1074/jbc.M110.178210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21199877	hybrid, Green Published			2022-12-25	WOS:000287476400035
J	Young, JA; Sermwittayawong, D; Kim, HJ; Nandu, S; An, N; Erdjument-Bromage, H; Tempst, P; Coscoy, L; Winoto, A				Young, Jennifer A.; Sermwittayawong, Decha; Kim, Hee-Jung; Nandu, Suruchi; An, Namsil; Erdjument-Bromage, Hediye; Tempst, Paul; Coscoy, Laurent; Winoto, Astar			Fas-associated Death Domain (FADD) and the E3 Ubiquitin-Protein Ligase TRIM21 Interact to Negatively Regulate Virus-induced Interferon Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-RECEPTOR; DOUBLE-STRANDED-RNA; AUTOANTIGEN RO52; INNATE IMMUNITY; CUTTING EDGE; CYTOKINE EXPRESSION; ANTIVIRAL RESPONSE; MASS-SPECTROMETRY; FAMILY PROTEINS; BETA PRODUCTION	The production of cytokines such as type I interferon (IFN) is an essential component of innate immunity. Insufficient amounts of cytokines lead to host sensitivity to infection, whereas abundant cytokine production can lead to inflammation. A tight regulation of cytokine production is, thus, essential for homeostasis of the immune system. IFN-alpha production during RNA virus infection is mediated by the master transcription factor IRF7, which is activated upon ubiquitination by TRAF6 and phosphorylation by IKK epsilon and TBK1 kinases. We found that Fas-associated death domain (FADD), first described as an apoptotic protein, is involved in regulating IFN-alpha production through a novel interaction with TRIM21. TRIM21 is a member of a large family of proteins that can impart ubiquitin modification onto its cellular targets. The interaction between FADD and TRIM21 enhances TRIM21 ubiquitin ligase activity, and together they cooperatively repress IFN-alpha activation in Sendai virus-infected cells. FADD and TRIM21 can directly ubiquitinate IRF7, affect its phosphorylation status, and interfere with the ubiquitin ligase activity of TRAF6. Conversely, a reduction of FADD and TRIM21 levels leads to higher IFN-alpha induction, IRF7 phosphorylation, and lower titers of RNA virus of infected cells. We conclude that FADD and TRIM21 together negatively regulate the late IFN-alpha pathway in response to viral infection.	[Young, Jennifer A.; Sermwittayawong, Decha; Kim, Hee-Jung; Nandu, Suruchi; An, Namsil; Coscoy, Laurent; Winoto, Astar] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Young, Jennifer A.; Sermwittayawong, Decha; Kim, Hee-Jung; Nandu, Suruchi; An, Namsil; Coscoy, Laurent; Winoto, Astar] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Mol Biol Programs, New York, NY 10065 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Memorial Sloan Kettering Cancer Center	Winoto, A (corresponding author), Univ Calif Berkeley, Canc Res Lab, 465 LSA, Berkeley, CA 94720 USA.	winoto@berkeley.edu	Sermwittayawong, Decha/AAX-1695-2020	Sermwittayawong, Decha/0000-0001-8941-3642; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	National Institutes of Health [PO1AI065831]; NCI Cancer Center Support Grant [P30 CA08748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grants PO1AI065831 (to L. C. and A. W.) and NCI Cancer Center Support Grant P30 CA08748.	Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Chelbi-Alix MK, 1998, J VIROL, V72, P1043, DOI 10.1128/JVI.72.2.1043-1051.1998; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Espinosa A, 2006, J IMMUNOL, V176, P6277, DOI 10.4049/jimmunol.176.10.6277; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Poole E, 2002, VIROLOGY, V303, P33, DOI 10.1006/viro.2002.1737; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Sandu C, 2006, CELL DEATH DIFFER, V13, P2052, DOI 10.1038/sj.cdd.4401966; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STETSON DB, 2006, J EXP MED, V203, pIL2; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Wada K, 2006, BIOCHEM BIOPH RES CO, V339, P415, DOI 10.1016/j.bbrc.2005.11.029; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277	58	48	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6521	6531		10.1074/jbc.M110.172288	http://dx.doi.org/10.1074/jbc.M110.172288			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21183682	Green Published, hybrid			2022-12-25	WOS:000287476400062
J	Berrocal-Lobo, M; Stone, S; Yang, X; Antico, J; Callis, J; Ramonell, KM; Somerville, S				Berrocal-Lobo, Marta; Stone, Sophia; Yang, Xin; Antico, Jay; Callis, Judy; Ramonell, Katrina M.; Somerville, Shauna			ATL9, a RING Zinc Finger Protein with E3 Ubiquitin Ligase Activity Implicated in Chitin- and NADPH Oxidase-Mediated Defense Responses	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; MILDEW DISEASE RESISTANCE; INNATE IMMUNE-RESPONSE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; PLANT-DEFENSE; SACCHAROMYCES-CEREVISIAE; CONSTITUTIVE EXPRESSION; BACTERIAL PATHOGENESIS; ENDOPLASMIC-RETICULUM	Pathogen associated molecular patterns (PAMPs) are signals detected by plants that activate basal defenses. One of these PAMPs is chitin, a carbohydrate present in the cell walls of fungi and in insect exoskeletons. Previous work has shown that chitin treatment of Arabidopsis thaliana induced defense-related genes in the absence of a pathogen and that the response was independent of the salicylic acid (SA), jasmonic acid (JA) and ethylene (ET) signaling pathways. One of these genes is ATL9 (=ATL2G), which encodes a RING zinc-finger like protein. In the current work we demonstrate that ATL9 has E3 ubiquitin ligase activity and is localized to the endoplasmic reticulum. The expression pattern of ATL9 is positively correlated with basal defense responses against Golovinomyces cichoracearum, a biotrophic fungal pathogen. The basal levels of expression and the induction of ATL9 by chitin, in wild type plants, depends on the activity of NADPH oxidases suggesting that chitin-mediated defense response is NADPH oxidase dependent. Although ATL9 expression is not induced by treatment with known defense hormones (SA, JA or ET), full expression in response to chitin is compromised slightly in mutants where ET-or SA-dependent signaling is suppressed. Microarray analysis of the atl9 mutant revealed candidate genes that appear to act downstream of ATL9 in chitin-mediated defenses. These results hint at the complexity of chitin-mediated signaling and the potential interplay between elicitor-mediated signaling, signaling via known defense pathways and the oxidative burst.	[Berrocal-Lobo, Marta; Somerville, Shauna] Carnegie Inst, Dept Plant Biol, Stanford, CA USA; [Yang, Xin; Antico, Jay; Ramonell, Katrina M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Stone, Sophia; Callis, Judy] Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Carnegie Institution for Science; University of Alabama System; University of Alabama Tuscaloosa; University of California System; University of California Davis	Berrocal-Lobo, M (corresponding author), Univ Politecn Madrid, UPM INIA, CBGP, Campus Montegancedo, Madrid, Spain.	kramonel@bama.ua.edu	Berrocal-Lobo, Marta/B-3482-2018	Berrocal-Lobo, Marta/0000-0002-4711-9338; Callis, Judy/0000-0002-0622-078X; Stone, Sophia/0000-0003-2140-6037	Carnegie Institution of Washington; Secretaria de Estado de Educacion y Universidades; Fondo Social Europeo, MECD/Fullbright (Spain); University of Alabama; National Institutes of Health [1-R15-GM073630-01]; U.S. Department of Agriculture [2007-01652]; National Science Foundation; Carnegie Institution; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM073630] Funding Source: NIH RePORTER	Carnegie Institution of Washington; Secretaria de Estado de Educacion y Universidades; Fondo Social Europeo, MECD/Fullbright (Spain)(European Social Fund (ESF)); University of Alabama; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Carnegie Institution; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Marta Berrocal-Lobo was supported by the Carnegie Institution of Washington and a postdoctoral fellowship from the Secretaria de Estado de Educacion y Universidades and Fondo Social Europeo, MECD/Fullbright (Spain). Katrina M. Ramonell was supported by the University of Alabama and by grants from the National Institutes of Health (grant no. 1-R15-GM073630-01) and the U.S. Department of Agriculture (grant no. 2007-01652 to K.M.R.). This work was supported in part by the National Science Foundation and the Carnegie Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Aguilar-Henonin L, 2006, CURR GENET, V50, P257, DOI 10.1007/s00294-006-0093-y; Albert P, 2005, PLANT CELL PHYSIOL, V46, pS122; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Bopopi JM, 2010, J EXP BOT, V61, P297, DOI 10.1093/jxb/erp305; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; DEBLAERE R, 1987, METHOD ENZYMOL, V153, P277; Delaure SL, 2008, PLANT SCI, V174, P375, DOI 10.1016/j.plantsci.2008.01.008; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez-Gomez L, 2004, MOL IMMUNOL, V41, P1055, DOI 10.1016/j.molimm.2004.06.008; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hammond-Kosack KE, 1998, PLANT CELL, V10, P1251, DOI 10.1105/tpc.10.8.1251; Hardtke CS, 2002, PLANT J, V30, P385, DOI 10.1046/j.1365-313X.2002.01298.x; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hondo D, 2007, MOL PLANT MICROBE IN, V20, P72, DOI 10.1094/MPMI-20-0072; Hong JK, 2007, PLANT MOL BIOL, V63, P571, DOI 10.1007/s11103-006-9110-2; Ingvardsen C, 2001, PHYSIOL PLANTARUM, V112, P451, DOI 10.1034/j.1399-3054.2001.1120401.x; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Katoh S, 2003, J BIOL CHEM, V278, P15341, DOI 10.1074/jbc.M210531200; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; KG KMR, 2007, GENE REGULATION SYST, V1, P167; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Liu Y, 2002, PLANT CELL, V14, P1483, DOI 10.1105/tpc.002493; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MartinezGarcia M, 1996, MOL GEN GENET, V252, P587, DOI 10.1007/s004380050266; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Michels J, 2005, INT J BIOCHEM CELL B, V37, P267, DOI 10.1016/j.biocel.2004.04.007; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Osbourn AE, 1996, PLANT CELL, V8, P1821, DOI 10.1105/tpc.8.10.1821; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Roden J, 2004, MOL PLANT MICROBE IN, V17, P633, DOI 10.1094/MPMI.2004.17.6.633; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rowland O, 2005, PLANT CELL, V17, P295, DOI 10.1105/tpc.104.026013; Salinas-Mondragon RE, 1999, PLANT MOL BIOL, V40, P579, DOI 10.1023/A:1006267201855; SCHIEFELBEIN JW, 1990, PLANT CELL, V2, P235, DOI 10.1105/tpc.2.3.235; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Serrano M, 2004, GENETICS, V167, P919, DOI 10.1534/genetics.104.028043; Serrano M, 2007, J BIOL CHEM, V282, P6803, DOI 10.1074/jbc.M608792200; Shirasu K, 2003, TRENDS PLANT SCI, V8, P252, DOI 10.1016/S1360-1385(03)00104-3; Solano R, 1998, CURR OPIN PLANT BIOL, V1, P393, DOI 10.1016/S1369-5266(98)80262-8; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Takai R, 2002, PLANT CELL PHYSIOL, V43, pS154; Takai R, 2002, PLANT J, V30, P447, DOI 10.1046/j.1365-313X.2002.01299.x; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; WALTHERLARSEN H, 1993, PLANT MOL BIOL, V21, P1097, DOI 10.1007/BF00023606; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wilson IW, 2001, GENETICS, V158, P1301; Xu WH, 2006, PLANT J, V45, P740, DOI 10.1111/j.1365-313X.2005.02638.x; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zimmerli L, 2004, PLANT J, V40, P633, DOI 10.1111/j.1365-313X.2004.02236.x; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	81	68	74	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							14426	10.1371/journal.pone.0014426	http://dx.doi.org/10.1371/journal.pone.0014426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203445	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200008
J	Agrillo, C; Piffer, L; Bisazza, A				Agrillo, Christian; Piffer, Laura; Bisazza, Angelo			Large Number Discrimination by Mosquitofish	PLOS ONE			English	Article							COTTON-TOP TAMARINS; NUMERICAL COMPETENCE; QUANTITY DISCRIMINATION; PERCEIVED NUMEROSITY; FEMALE MOSQUITOFISH; ANALOG MAGNITUDES; RHESUS-MONKEYS; INFANTS; REPRESENTATIONS; JUDGMENTS	0Background: Recent studies have demonstrated that fish display rudimentary numerical abilities similar to those observed in mammals and birds. The mechanisms underlying the discrimination of small quantities (, 4) were recently investigated while, to date, no study has examined the discrimination of large numerosities in fish. Methodology/Principal Findings: Subjects were trained to discriminate between two sets of small geometric figures using social reinforcement. In the first experiment mosquitofish were required to discriminate 4 from 8 objects with or without experimental control of the continuous variables that co-vary with number (area, space, density, total luminance). Results showed that fish can use the sole numerical information to compare quantities but that they preferentially use cumulative surface area as a proxy of the number when this information is available. A second experiment investigated the influence of the total number of elements to discriminate large quantities. Fish proved to be able to discriminate up to 100 vs. 200 objects, without showing any significant decrease in accuracy compared with the 4 vs. 8 discrimination. The third experiment investigated the influence of the ratio between the numerosities. Performance was found to decrease when decreasing the numerical distance. Fish were able to discriminate numbers when ratios were 1: 2 or 2: 3 but not when the ratio was 3: 4. The performance of a sample of undergraduate students, tested non-verbally using the same sets of stimuli, largely overlapped that of fish. Conclusions/Significance: Fish are able to use pure numerical information when discriminating between quantities larger than 4 units. As observed in human and non-human primates, the numerical system of fish appears to have virtually no upper limit while the numerical ratio has a clear effect on performance. These similarities further reinforce the view of a common origin of non-verbal numerical systems in all vertebrates.	[Agrillo, Christian; Piffer, Laura; Bisazza, Angelo] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Agrillo, C (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	christian.agrillo@unipd.it		Bisazza, Angelo/0000-0003-0209-7638; Agrillo, Christian/0000-0002-7391-8934	University of Padova to Angelo Bisazza	University of Padova to Angelo Bisazza	Research Grant "Progetto di Ateneo" from University of Padova to Angelo Bisazza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2007, ETHOL ECOL EVOL, V19, P145, DOI 10.1080/08927014.2007.9522574; Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2007, ANIM COGN, V10, P63, DOI 10.1007/s10071-006-0036-5; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; Al Ain S, 2009, ANIM COGN, V12, P145, DOI 10.1007/s10071-008-0178-8; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Beran MJ, 2008, PLOS BIOL, V6, P221, DOI 10.1371/journal.pbio.0060019; Beran MJ, 2008, AM J PRIMATOL, V70, P191, DOI 10.1002/ajp.20474; BISAZZA A, 1995, ETHOL ECOL EVOL, V7, P169, DOI 10.1080/08927014.1995.9522963; Bisazza A, 2010, ECOLOGY EVOLUTION PO; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Brannon EM, 2001, PSYCHOL SCI, V12, P238, DOI 10.1111/1467-9280.00342; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Buckingham JN, 2007, BEHAVIOUR, V144, P1333, DOI 10.1163/156853907782418196; Cantlon JF, 2007, PLOS BIOL, V5, P2912, DOI 10.1371/journal.pbio.0050328; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Chiandetti C, 2008, ANIM COGN, V11, P139, DOI 10.1007/s10071-007-0099-y; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Clearfield MW, 1999, PSYCHOL SCI, V10, P408, DOI 10.1111/1467-9280.00177; Dadda M, 2009, COGNITION, V112, P343, DOI 10.1016/j.cognition.2009.05.009; DAVIS H, 1988, BEHAV BRAIN SCI, V11, P561, DOI 10.1017/S0140525X00053437; DURGIN FH, 1995, J EXP PSYCHOL HUMAN, V21, P149, DOI 10.1037/0096-1523.21.1.149; Emmerton J, 2009, ANIM COGN, V12, P511, DOI 10.1007/s10071-009-0212-5; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Flombaum JI, 2005, COGNITION, V97, P315, DOI 10.1016/j.cognition.2004.09.004; Gomez-Laplaza LM, 2011, ANIM COGN, V14, P1, DOI 10.1007/s10071-010-0337-6; Gross HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004263; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P1441, DOI 10.1098/rspb.2003.2414; HOLLINGSWORTH WH, 1991, B PSYCHONOMIC SOC, V29, P448; Hope T, 2010, COGNITIVE SCI, V34, P406, DOI 10.1111/j.1551-6709.2009.01079.x; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Jordan KE, 2006, J EXP CHILD PSYCHOL, V95, P215, DOI 10.1016/j.jecp.2006.05.004; Kilian A, 2003, LEARN BEHAV, V31, P133; Koehler O., 1950, B ANIMAL BEHAVIOUR, V9, P41, DOI [10.1037/0033-2909.92.3.547, DOI 10.1037/0033-2909.92.3.547]; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Matsuzawa T, 2009, CURR OPIN NEUROBIOL, V19, P92, DOI 10.1016/j.conb.2009.04.007; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; Pisa P, 2009, J ETHOL, V27, P289, DOI 10.1007/s10164-008-0121-0; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Revkin SK, 2008, PSYCHOL SCI, V19, P607, DOI 10.1111/j.1467-9280.2008.02130.x; Rugani R, 2009, P ROY SOC B-BIOL SCI, V276, P2451, DOI 10.1098/rspb.2009.0044; Stevens JR, 2007, ANIM COGN, V10, P429, DOI 10.1007/s10071-007-0081-8; Suzuki K, 2000, J COMP PSYCHOL, V114, P73, DOI 10.1037//0735-7036.114.1.73; Tomonaga M, 2002, ANIM LEARN BEHAV, V30, P143, DOI 10.3758/BF03192916; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Uller C, 1999, COGNITIVE DEV, V14, P1, DOI 10.1016/S0885-2014(99)80016-1; Uller C, 2003, ANIM COGN, V6, P105, DOI 10.1007/s10071-003-0167-x; vanMarle K, 2009, COGNITION, V111, P302, DOI 10.1016/j.cognition.2009.01.011; Ward C, 2007, ANIM COGN, V10, P71, DOI 10.1007/s10071-006-0042-7; West RE, 2002, ANIM COGN, V5, P183, DOI 10.1007/s10071-002-0140-0; White DJ, 2009, PSYCHOL SCI, V20, P1140, DOI 10.1111/j.1467-9280.2009.02418.x; Xu F, 2007, BRIT J DEV PSYCHOL, V25, P103, DOI 10.1348/026151005X90704	59	64	64	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15232	10.1371/journal.pone.0015232	http://dx.doi.org/10.1371/journal.pone.0015232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698FG	21203508	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000024
J	Anafi, RC; Bates, JHT				Anafi, Ron C.; Bates, Jason H. T.			Balancing Robustness against the Dangers of Multiple Attractors in a Hopfield-Type Model of Biological Attractors	PLOS ONE			English	Article							NETWORKS; COMPLEX	Background: Many chronic human diseases are of unclear origin, and persist long beyond any known insult or instigating factor. These diseases may represent a structurally normal biologic network that has become trapped within the basin of an abnormal attractor. Methodology/Principal Findings: We used the Hopfield net as the archetypical example of a dynamic biological network. By progressively removing the links of fully connected Hopfield nets, we found that a designated attractor of the nets could still be supported until only slightly more than 1 link per node remained. As the number of links approached this minimum value, the rate of convergence to this attractor from an arbitrary starting state increased dramatically. Furthermore, with more than about twice the minimum of links, the net became increasingly able to support a second attractor. Conclusions/Significance: We speculate that homeostatic biological networks may have evolved to assume a degree of connectivity that balances robustness and agility against the dangers of becoming trapped in an abnormal attractor.	[Anafi, Ron C.] Univ Penn, Div Sleep Med, Philadelphia, PA 19104 USA; [Bates, Jason H. T.] Univ Vermont, Dept Med, Burlington, VT USA	University of Pennsylvania; University of Vermont	Anafi, RC (corresponding author), Univ Penn, Div Sleep Med, Philadelphia, PA 19104 USA.	jason.h.bates@uvm.edu			American Sleep Medicine Physician Scientist grant; NIH (NCRR COBRE) [RR15557HL87788]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015557] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL087788] Funding Source: NIH RePORTER	American Sleep Medicine Physician Scientist grant; NIH (NCRR COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge the financial support of an American Sleep Medicine Physician Scientist grant and the NIH (NCRR COBRE RR15557 and HL87788). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Bar-Yam Y, 2004, P NATL ACAD SCI USA, V101, P4341, DOI 10.1073/pnas.0400673101; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bray D, 2003, SCIENCE, V301, P1864, DOI 10.1126/science.1089118; Castillo IP, 2004, J PHYS A-MATH GEN, V37, P8789, DOI 10.1088/0305-4470/37/37/002; Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004; DERRIDA B, 1988, J PHYS A, V22, P2069; Detours V, 1996, J THEOR BIOL, V183, P409, DOI 10.1006/jtbi.1996.0231; Haykin S, NEURAL NETWORKS LEAR; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; KAUFFMAN S, 1971, J THEOR BIOL, V31, P429, DOI 10.1016/0022-5193(71)90020-8; Li X, 2007, J BIOMED INFORM, V40, P453, DOI 10.1016/j.jbi.2007.01.001; Macklem PT, 2008, J APPL PHYSIOL, V104, P1844, DOI 10.1152/japplphysiol.00942.2007; MORIN CM, 2005, PRINCIPLES PRACTICE; Oshima H, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036114; Paris L, 2008, MOL BIOL CELL, V19, P5409, DOI 10.1091/mbc.E08-05-0477; PERLIS ML, 2005, PRINCIPLES PRACTICE, P726; Prigogine I., 1984, ORDER OUT CHAOS; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ribeiro AS, 2007, J THEOR BIOL, V247, P743, DOI 10.1016/j.jtbi.2007.04.020; Segel LA, 1998, BIOPHYS CHEM, V72, P223, DOI 10.1016/S0301-4622(98)00136-7; Stauffer D, 2003, EUR PHYS J B, V32, P395, DOI 10.1140/epjb/e2003-00114-7; Sul JY, 2009, P NATL ACAD SCI USA, V106, P7624, DOI 10.1073/pnas.0902161106	24	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14413	10.1371/journal.pone.0014413	http://dx.doi.org/10.1371/journal.pone.0014413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203505	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000016
J	Haque, U; Hashizume, M; Glass, GE; Dewan, AM; Overgaard, HJ; Yamamoto, T				Haque, Ubydul; Hashizume, Masahiro; Glass, Gregory E.; Dewan, Ashraf M.; Overgaard, Hans J.; Yamamoto, Taro			The Role of Climate Variability in the Spread of Malaria in Bangladeshi Highlands	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; EL-NINO; REGRESSION-MODELS; RAINFALL; EPIDEMICS; ERITREA; DIPOLE	Background: Malaria is a major public health problem in Bangladesh, frequently occurring as epidemics since the 1990s. Many factors affect increases in malaria cases, including changes in land use, drug resistance, malaria control programs, socioeconomic issues, and climatic factors. No study has examined the relationship between malaria epidemics and climatic factors in Bangladesh. Here, we investigate the relationship between climatic parameters [rainfall, temperature, humidity, sea surface temperature (SST), El Nino-Southern Oscillation (ENSO), the normalized difference vegetation index (NDVI)], and malaria cases over the last 20 years in the malaria endemic district of Chittagong Hill Tracts (CHT). Methods and Principal Findings: Monthly malaria case data from January 1989 to December 2008, monthly rainfall, temperature, humidity sea surface temperature in the Bay of Bengal and ENSO index at the Nino Region 3 (NINO3) were used. A generalized linear negative binomial regression model was developed using the number of monthly malaria cases and each of the climatic parameters. After adjusting for potential mutual confounding between climatic factors there was no evidence for any association between the number of malaria cases and temperature, rainfall and humidity. Only a low NDVI was associated with an increase in the number of malaria cases. There was no evidence of an association between malaria cases and SST in the Bay of Bengal and NINO3. Conclusion and Significance: It seems counterintuitive that a low NDVI, an indicator of low vegetation greenness, is associated with increases in malaria cases, since the primary vectors in Bangladesh, such as An. dirus, are associated with forests. This relationship can be explained by the drying up of rivers and streams creating suitable breeding sites for the vector fauna. Bangladesh has very high vector species diversity and vectors suited to these habitats may be responsible for the observed results.	[Haque, Ubydul; Hashizume, Masahiro; Yamamoto, Taro] Nagasaki Univ, NEKKEN, Inst Trop Med, Dept Int Hlth, Nagasaki 852, Japan; [Haque, Ubydul; Hashizume, Masahiro; Yamamoto, Taro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Glass, Gregory E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Dewan, Ashraf M.] Univ Dhaka, Dept Geog & Environm, Dhaka 1000, Bangladesh; [Dewan, Ashraf M.] Curtin Univ Technol, Dept Spatial Sci, Perth, WA, Australia; [Overgaard, Hans J.] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway	Nagasaki University; Nagasaki University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Dhaka; Curtin University; Norwegian University of Life Sciences	Hashizume, M (corresponding author), Nagasaki Univ, NEKKEN, Inst Trop Med, Dept Int Hlth, Nagasaki 852, Japan.	hashizum@nagasaki-u.ac.jp	Dewan, Ashraf/O-2191-2015; Overgaard, Hans/AAE-9972-2020	Dewan, Ashraf/0000-0001-5594-5464; Hashizume, Masahiro/0000-0003-4720-1750	Global Center of Excellence program, Institute of Tropical Medicine, Nagasaki University, Japan; Johns Hopkins Malaria Research Institute	Global Center of Excellence program, Institute of Tropical Medicine, Nagasaki University, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Johns Hopkins Malaria Research Institute	The study was supported by the Global Center of Excellence program, Institute of Tropical Medicine, Nagasaki University, Japan. GG was supported by the Johns Hopkins Malaria Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeku TA, 2007, EMERG INFECT DIS, V13, P681, DOI 10.3201/eid1305.061333; Ahmed ASMS., 1996, MAUSAM, V47, P157, DOI DOI 10.54302/MAUSAM.V47I2.3713; Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; Alam M, 2009, MALARIA J, V9, P15; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P265; [Anonymous], WORLD MAL REP 2008; Barat LM, 2006, AM J TROP MED HYG, V74, P12, DOI 10.4269/ajtmh.2006.74.12; Bhattacharya S, 2006, CURR SCI INDIA, V90, P369; Bi P, 2005, VECTOR-BORNE ZOONOT, V5, P95, DOI 10.1089/vbz.2005.5.95; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2; Briet OJT, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-77; Bruce MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002775; Brumback BA, 2000, J AM STAT ASSOC, V95, P16; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Elias M., 1982, J PREV SOCIAL MED, V1, P20; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Gaudart J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-61; Gleiser RM, 1997, ANN TROP MED PARASIT, V91, P917, DOI 10.1080/00034989760301; Graves PM, 2008, TROP MED INT HEALTH, V13, P218, DOI 10.1111/j.1365-3156.2007.01993.x; Gupta R, 1996, J Assoc Physicians India, V44, P385; Haque U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006737; Hashizume M, 2009, P NATL ACAD SCI USA, V106, P1857, DOI 10.1073/pnas.0806544106; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; Kusumawathie PHD, 2006, ACTA TROP, V99, P30, DOI 10.1016/j.actatropica.2006.06.007; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; M&PDC, 2009, MOSQ VECT BANGL SURV; M&PDC, 2010, MAL COUNTR REP BANGL; Mantilla G, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-6; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Menno J, 1996, TROP MED INT HEALTH, V1, P86; Michel T, 2006, ENCY INFECT DIS MODE; Muirhead T, 1940, J MALAR I INDIA, V3, P265; Nihei N, 2002, JPN J INFECT DIS, V55, P160; Nkurunziza H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-114; Noedl H, 2003, AM J TROP MED HYG, V68, P140, DOI 10.4269/ajtmh.2003.68.140; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Rahman A, 2006, AM J TROP MED HYG, V74, P17, DOI 10.4269/ajtmh.2006.74.17; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; ROSENBERG R, 1982, AM J TROP MED HYG, V31, P192, DOI 10.4269/ajtmh.1982.31.192; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Salahuddin A, 2006, GLOBAL PLANET CHANGE, V53, P188, DOI 10.1016/j.gloplacha.2006.06.001; Singh N, 2002, ANN TROP MED PARASIT, V96, P349, DOI 10.1179/000349802125001113; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; Thomson MC, 2005, AM J TROP MED HYG, V73, P214, DOI 10.4269/ajtmh.2005.73.214; Tian LW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-110; Wiwanitkit V, 2006, J INFECTION, V52, P227, DOI 10.1016/j.jinf.2005.02.023; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100; Zhou GF, 2005, TRENDS PARASITOL, V21, P54, DOI 10.1016/j.pt.2004.11.002	55	47	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14341	10.1371/journal.pone.0014341	http://dx.doi.org/10.1371/journal.pone.0014341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179555	gold, Green Published			2022-12-25	WOS:000285381200002
J	Sheppard, SK; Dallas, JF; Wilson, DJ; Strachan, NJC; McCarthy, ND; Jolley, KA; Colles, FM; Rotariu, O; Ogden, ID; Forbes, KJ; Maiden, MCJ				Sheppard, Samuel K.; Dallas, John F.; Wilson, Daniel J.; Strachan, Norval J. C.; McCarthy, Noel D.; Jolley, Keith A.; Colles, Frances M.; Rotariu, Ovidiu; Ogden, Iain D.; Forbes, Ken J.; Maiden, Martin C. J.			Evolution of an Agriculture-Associated Disease Causing Campylobacter coli Clade: Evidence from National Surveillance Data in Scotland	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; ESCHERICHIA-COLI; RECOMBINATION; JEJUNI; DIVERSITY; INFECTION; GENOTYPES; MUTATION; STRAINS; POULTRY	The common zoonotic pathogen Campylobacter coli is an important cause of bacterial gastroenteritis worldwide but its evolution is incompletely understood. Using multilocus sequence type (MLST) data of 7 housekeeping genes from a national survey of Campylobacter in Scotland (2005/6), and a combined population genetic-phylogenetics approach, we investigated the evolutionary history of C. coli. Genealogical reconstruction of isolates from clinical infection, farm animals and the environment, revealed a three-clade genetic structure. The majority of farm animal, and all disease causing genotypes belonged to a single clade (clade 1) which had comparatively low synonymous sequence diversity, little deep branching genetic structure, and a higher number of shared alleles providing evidence of recent clonal decent. Calibration of the rate of molecular evolution, based on within-species genetic variation, estimated a more rapid rate of evolution than in traditional estimates. This placed the divergence of the clades at less than 2500 years ago, consistent with the introduction of an agricultural niche having had an effect upon the evolution of the C. coli clades. Attribution of clinical isolate genotypes to source, using an asymmetric island model, confirmed that strains from chicken and ruminants, and not pigs or turkeys, are the principal source of human C. coli infection. Taken together these analyses are consistent with an evolutionary scenario describing the emergence of agriculture-associated C. coli lineage that is an important human pathogen.	[Sheppard, Samuel K.; McCarthy, Noel D.; Jolley, Keith A.; Colles, Frances M.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Dallas, John F.; Ogden, Iain D.; Forbes, Ken J.] Univ Aberdeen, Dept Med Microbiol, Aberdeen, Scotland; [Strachan, Norval J. C.; Rotariu, Ovidiu] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Wilson, Daniel J.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 3PS, England	University of Oxford; University of Aberdeen; University of Aberdeen; University of Oxford	Sheppard, SK (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	samuel.sheppard@zoo.ox.ac.uk	Jolley, Keith/ABE-8587-2020; Strachan, Norval J/D-4744-2009; Wilson, Daniel J/AAE-8975-2019; Maiden, Martin/N-6805-2019; Maiden, Martin C J/C-5055-2014; McCarthy, Noel D/K-3314-2012	Jolley, Keith/0000-0002-0751-0287; Wilson, Daniel J/0000-0002-0940-3311; Maiden, Martin/0000-0001-6321-5138; Maiden, Martin C J/0000-0001-6321-5138; Sheppard, Samuel/0000-0001-6901-3203; Colles, Frances/0000-0002-3322-2991; McCarthy, Noel/0000-0003-1113-1017	Food Standards Agency of Scotland; DEFRA; Wellcome Trust	Food Standards Agency of Scotland; DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was funded by the Food Standards Agency of Scotland and DEFRA. SKS and MCJM are funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Buzby J C, 1997, World Health Stat Q, V50, P57; Coffey TJ, 2006, APPL ENVIRON MICROB, V72, P1420, DOI 10.1128/AEM.72.2.1420-1428.2006; Debruyne L, 2008, CAMPYLOBACTER, 3RD EDITION, P3; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Drummond AJ, 2002, GENETICS, V161, P1307; Duim B, 1999, APPL ENVIRON MICROB, V65, P2369; DYKHUIZEN DE, 1993, P NATL ACAD SCI USA, V90, P10163, DOI 10.1073/pnas.90.21.10163; Eggleston AK, 1997, CURR BIOL, V7, pR745, DOI 10.1016/S0960-9822(06)00394-0; EMBLEY TM, 1991, LETT APPL MICROBIOL, V13, P171, DOI 10.1111/j.1472-765X.1991.tb00600.x; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Fearnhead P, 2008, STAT COMPUT, V18, P151, DOI 10.1007/s11222-007-9045-8; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Friedman C.R., 2000, CAMPYLOBACTER, P121; Friedman CR, 2004, CLIN INFECT DIS, V38, pS285, DOI 10.1086/381598; Gillespie IA, 2002, EMERG INFECT DIS, V8, P937, DOI 10.3201/eid0809.010817; Gormley FJ, 2008, APPL ENVIRON MICROB, V74, P383, DOI 10.1128/AEM.01455-07; Holmes EC, 1999, MOL BIOL EVOL, V16, P741, DOI 10.1093/oxfordjournals.molbev.a026159; Humphrey TJ, 2005, ANTIMICROB AGENTS CH, V49, P690, DOI 10.1128/AAC.49.2.690-698.2005; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Kessel A S, 2001, Commun Dis Public Health, V4, P171; Khanna MR, 2006, LETT APPL MICROBIOL, V43, P84, DOI 10.1111/j.1472-765X.2006.01904.x; Kinana AD, 2007, RES MICROBIOL, V158, P138, DOI 10.1016/j.resmic.2006.11.009; Konkel ME, 2007, APPL ENVIRON MICROB, V73, P2297, DOI 10.1128/AEM.02193-06; Lenski RE, 2003, J MOL EVOL, V56, P498, DOI 10.1007/s00239-002-2423-0; Litrup E, 2007, J APPL MICROBIOL, V103, P210, DOI 10.1111/j.1365-2672.2006.03214.x; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; MCCORRISTON J, 1991, AM ANTHROPOL, V93, P46, DOI 10.1525/aa.1991.93.1.02a00030; McVean G, 2002, GENETICS, V160, P1231; Miller WG, 2006, MICROBIOL-SGM, V152, P245, DOI 10.1099/mic.0.28348-0; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; Nielsen R, 1998, GENETICS, V148, P929; Ochman H, 2003, MOL BIOL EVOL, V20, P2091, DOI 10.1093/molbev/msg229; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Olson CK, 2008, CAMPYLOBACTER, 3RD EDITION, P163; Pebody R G, 1997, Commun Dis Rep CDR Rev, V7, pR33; Perez-Losada M, 2007, INFECT GENET EVOL, V7, P271, DOI 10.1016/j.meegid.2006.11.003; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Rotariu O, 2009, APPL ENVIRON MICROB, V75, P6275, DOI 10.1128/AEM.00499-09; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; SOPWITH W, 2009, APPL ENV MICROBIOLOG; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Strachan NJC, 2009, J INFECT DIS, V199, P1205, DOI 10.1086/597417; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tam CC, 2003, J INFECTION, V47, P28, DOI 10.1016/S0163-4453(03)00042-2; Thakur S, 2005, J CLIN MICROBIOL, V43, P5705, DOI 10.1128/JCM.43.11.5705-5714.2005; van Bergen MAP, 2005, J CLIN MICROBIOL, V43, P5888, DOI 10.1128/JCM.43.12.5888-5898.2005; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706; Zhu PX, 2001, P NATL ACAD SCI USA, V98, P5234, DOI 10.1073/pnas.061386098; ZVELEBIL M, 1991, J WORLD PREHIST, V5, P233, DOI 10.1007/BF00974991	71	61	61	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15708	10.1371/journal.pone.0015708	http://dx.doi.org/10.1371/journal.pone.0015708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179537	Green Published, gold, Green Submitted			2022-12-25	WOS:000285340000030
J	Achame, EM; Baarends, WM; Gribnau, J; Grootegoed, JA				Achame, Eskeatnaf Mulugeta; Baarends, Willy M.; Gribnau, Joost; Grootegoed, J. Anton			Evaluating the Relationship between Spermatogenic Silencing of the X Chromosome and Evolution of the Y Chromosome in Chimpanzee and Human	PLOS ONE			English	Article							DOSAGE COMPENSATION; SPERM COMPETITION; SEX-CHROMOSOMES; UP-REGULATION; CHICKEN Z; MOUSE; GENE; INACTIVATION; EXPRESSION; MEIOSIS	Chimpanzees and humans are genetically very similar, with the striking exception of their Y chromosomes, which have diverged tremendously. The male-specific region (MSY), representing the greater part of the Y chromosome, is inherited from father to son in a clonal fashion, with natural selection acting on the MSY as a unit. Positive selection might involve the performance of the MSY in spermatogenesis. Chimpanzees have a highly polygamous mating behavior, so that sperm competition is thought to provide a strong selective force acting on the Y chromosome in the chimpanzee lineage. In consequence of evolution of the heterologous sex chromosomes in mammals, meiotic sex chromosome inactivation (MSCI) results in a transcriptionally silenced XY body in male meiotic prophase, and subsequently also in postmeiotic repression of the sex chromosomes in haploid spermatids. This has evolved to a situation where MSCI has become a prerequisite for spermatogenesis. Here, by analysis of microarray testicular expression data representing a small number of male chimpanzees and men, we obtained information indicating that meiotic and postmeiotic X chromosome silencing might be more effective in chimpanzee than in human spermatogenesis. From this, we suggest that the remarkable reorganization of the chimpanzee Y chromosome, compared to the human Y chromosome, might have an impact on its meiotic interactions with the X chromosome and thereby on X chromosome silencing in spermatogenesis. Further studies will be required to address comparative functional aspects of MSCI in chimpanzee, human, and other placental mammals.	[Achame, Eskeatnaf Mulugeta; Baarends, Willy M.; Gribnau, Joost; Grootegoed, J. Anton] Erasmus MC Univ Med Ctr, Dept Reprod & Dev, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Achame, EM (corresponding author), Erasmus MC Univ Med Ctr, Dept Reprod & Dev, Rotterdam, Netherlands.	j.a.grootegoed@erasmusmc.nl	Mulugeta, Eskeatnaf/AAZ-7471-2020; Mulugeta, Eskeatnaf/H-2640-2016	Mulugeta, Eskeatnaf/0000-0003-4045-4835; Mulugeta, Eskeatnaf/0000-0003-4045-4835	Netherlands Organization for Scientific Research (NWO); Erasmus University Rotterdam	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Erasmus University Rotterdam	The work was supported by The Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/nwohome.nsf/pages/SPPD_5R2QE7_Eng), in the form of career-development funding (Vidi and Vici) to WMB and JG. As candidate for the NWO Mosaic grant, EMA received a grant from Erasmus University Rotterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2007, AM J PHYS ANTHROPOL, V134, P274, DOI 10.1002/ajpa.20674; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; Barakat TS, 2010, EXP CELL RES, V316, P679, DOI 10.1016/j.yexcr.2010.01.015; Bellott DW, 2009, COLD SH Q B, V74, P345, DOI 10.1101/sqb.2009.74.048; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; CHANDLEY AC, 1984, CYTOGENET CELL GENET, V38, P241, DOI 10.1159/000132070; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; Ellis PJI, 2005, HUM MOL GENET, V14, P2705, DOI 10.1093/hmg/ddi304; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Goto H, 2009, J MOL EVOL, V68, P134, DOI 10.1007/s00239-008-9189-y; Grootegoed JA, 2000, BEST PRACT RES CL EN, V14, P331, DOI 10.1053/beem.2000.0083; HALE DW, 1994, CYTOGENET CELL GENET, V65, P278, DOI 10.1159/000133648; HANDEL MA, 1992, BIOESSAYS, V14, P817, DOI 10.1002/bies.950141205; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Itoh Y., 2007, J BIOL, V6; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; Krausz C, 2006, HUM MOL GENET, V15, P2673, DOI 10.1093/hmg/ddl198; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; Lu J, 2005, P NATL ACAD SCI USA, V102, P4063, DOI 10.1073/pnas.0500436102; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Malcom CM, 2003, MOL BIOL EVOL, V20, P1633, DOI 10.1093/molbev/msg178; Mank JE, 2009, HEREDITY, V102, P312, DOI 10.1038/hdy.2008.116; McCarrey JR, 2002, GENESIS, V34, P257, DOI 10.1002/gene.10163; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; McLachlan RI, 2010, J CLIN ENDOCR METAB, V95, P1013, DOI 10.1210/jc.2009-1925; Metzler-Guillemain C, 2000, CHROMOSOME RES, V8, P571, DOI 10.1023/A:1009277722579; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Namekawa SH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000493; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nascimento JM, 2008, J R SOC INTERFACE, V5, P297, DOI 10.1098/rsif.2007.1118; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; OHNO, 1967, SEX CHROMOSOMES SEX; PALMER S, 1995, NAT GENET, V10, P472, DOI 10.1038/ng0895-472; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Perry GH, 2007, MOL BIOL EVOL, V24, P853, DOI 10.1093/molbev/msm002; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Presgraves DC, 2009, TRENDS ECOL EVOL, V24, P533, DOI 10.1016/j.tree.2009.04.007; Rozen S, 2009, AM J HUM GENET, V85, P923, DOI 10.1016/j.ajhg.2009.11.011; Schimenti J, 2005, NAT GENET, V37, P11, DOI 10.1038/ng0105-11; Schoenmakers S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000466; Shiao MS, 2007, MOL BIOL EVOL, V24, P2242, DOI 10.1093/molbev/msm153; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; SPEED RM, 1990, HUM GENET, V84, P547; SPEED RM, 1986, CHROMOSOMA, V94, P115, DOI 10.1007/BF00286989; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; TRES LL, 1977, J CELL SCI, V25, P1; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Turner JMA, 2002, J CELL SCI, V115, P4097, DOI 10.1242/jcs.00111; Tyler-Smith C, 2009, NEW ENGL J MED, V360, P925, DOI 10.1056/NEJMe0900301; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Vogt PH, 2008, INT J ANDROL, V31, P383, DOI 10.1111/j.1365-2605.2008.00890.x; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Weinbauer GF, 2001, BIOL REPROD, V64, P120, DOI 10.1095/biolreprod64.1.120; Wistuba J, 2003, BIOL REPROD, V69, P582, DOI 10.1095/biolreprod.103.015925; Yang ZW, 1998, J CLIN ENDOCR METAB, V83, P1284; Yogev L, 2004, J ANDROL, V25, P110; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	74	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15598	10.1371/journal.pone.0015598	http://dx.doi.org/10.1371/journal.pone.0015598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179482	gold, Green Published, Green Submitted			2022-12-25	WOS:000285292500029
J	Mewborn, SK; Puckelwartz, MJ; Abuisneineh, F; Fahrenbach, JP; Zhang, YA; MacLeod, H; Dellefave, L; Pytel, P; Selig, S; Labno, CM; Reddy, K; Singh, H; McNally, E				Mewborn, Stephanie K.; Puckelwartz, Megan J.; Abuisneineh, Fida; Fahrenbach, John P.; Zhang, Yuan; MacLeod, Heather; Dellefave, Lisa; Pytel, Peter; Selig, Sara; Labno, Christine M.; Reddy, Karen; Singh, Harinder; McNally, Elizabeth			Altered Chromosomal Positioning, Compaction, and Gene Expression with a Lamin A/C Gene Mutation	PLOS ONE			English	Article							FAMILIAL DILATED CARDIOMYOPATHY; DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR LAMINA; CHROMATIN ORGANIZATION; TRANSCRIPTIONAL REGULATION; LMNA MUTATIONS; IN-VITRO; ENVELOPE; GENOME; EMERIN	Background: Lamins A and C, encoded by the LMNA gene, are filamentous proteins that form the core scaffold of the nuclear lamina. Dominant LMNA gene mutations cause multiple human diseases including cardiac and skeletal myopathies. The nuclear lamina is thought to regulate gene expression by its direct interaction with chromatin. LMNA gene mutations may mediate disease by disrupting normal gene expression. Methods/Findings: To investigate the hypothesis that mutant lamin A/C changes the lamina's ability to interact with chromatin, we studied gene misexpression resulting from the cardiomyopathic LMNA E161K mutation and correlated this with changes in chromosome positioning. We identified clusters of misexpressed genes and examined the nuclear positioning of two such genomic clusters, each harboring genes relevant to striated muscle disease including LMO7 and MBNL2. Both gene clusters were found to be more centrally positioned in LMNA-mutant nuclei. Additionally, these loci were less compacted. In LMNA mutant heart and fibroblasts, we found that chromosome 13 had a disproportionately high fraction of misexpressed genes. Using three-dimensional fluorescence in situ hybridization we found that the entire territory of chromosome 13 was displaced towards the center of the nucleus in LMNA mutant fibroblasts. Additional cardiomyopathic LMNA gene mutations were also shown to have abnormal positioning of chromosome 13, although in the opposite direction. Conclusions: These data support a model in which LMNA mutations perturb the intranuclear positioning and compaction of chromosomal domains and provide a mechanism by which gene expression may be altered.	[Mewborn, Stephanie K.; Puckelwartz, Megan J.; Abuisneineh, Fida; Fahrenbach, John P.; Zhang, Yuan; MacLeod, Heather; Dellefave, Lisa; Labno, Christine M.; McNally, Elizabeth] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Puckelwartz, Megan J.; McNally, Elizabeth] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Pytel, Peter] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Selig, Sara] Technion Israel Inst Technol, Mol Med Lab, Haifa, Israel; [Selig, Sara] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Reddy, Karen; Singh, Harinder] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Reddy, Karen; Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Selig, Sara] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel	University of Chicago; University of Chicago; University of Chicago; Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Howard Hughes Medical Institute; University of Chicago; University of Chicago; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Mewborn, SK (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	emcnally@uchicago.edu	McNally, Elizabeth/W-4909-2019	Reddy, Karen/0000-0003-4548-5999; fahrenbach, john/0000-0001-6785-9707; McNally, Elizabeth/0000-0002-1221-719X; Zhang, Yuan/0000-0003-0022-1201	Doris Duke Charitable Foundation; National Institutes of Health (NIH) [HL092443]; Howard Hughes Medical Institute (HHMI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092443] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Doris Duke Charitable Foundation, National Institutes of Health (NIH) HL092443 and Howard Hughes Medical Institute (HHMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Baker EA, 2005, MECH AGEING DEV, V126, P664, DOI 10.1016/j.mad.2004.12.002; Bisognin A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-68; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Charniot JC, 2006, EUR J HEART FAIL, V8, P249, DOI 10.1016/j.ejheart.2005.08.007; Correa Margarita, 2007, P R Health Sci J, V26, P229; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dillon N, 2008, DEV CELL, V15, P182, DOI 10.1016/j.devcel.2008.07.013; Dunham A, 2004, NATURE, V428, P522, DOI 10.1038/nature02379; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fields A P, 1995, Prog Cell Cycle Res, V1, P271; Filesi I, 2005, PHYSIOL GENOMICS, V23, P150, DOI 10.1152/physiolgenomics.00060.2005; Garg A, 2002, AM J MED, V112, P549, DOI 10.1016/S0002-9343(02)01070-7; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hao MQ, 2008, DEV DYNAM, V237, P403, DOI 10.1002/dvdy.21428; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Hegele RA, 2000, NAT MED, V6, P136, DOI 10.1038/72221; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; Holaska JM, 2006, HUM MOL GENET, V15, P3459, DOI 10.1093/hmg/ddl423; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018; Kalverda B, 2008, FEBS LETT, V582, P2017, DOI 10.1016/j.febslet.2008.04.015; Kandert S, 2009, EUR J CELL BIOL, V88, P593, DOI 10.1016/j.ejcb.2009.06.002; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Kurshakova MM, 2007, EMBO J, V26, P4956, DOI 10.1038/sj.emboj.7601901; MacLeod Heather M, 2003, BMC Med Genet, V4, P4, DOI 10.1186/1471-2350-4-4; Meaburn KJ, 2007, AGING CELL, V6, P139, DOI 10.1111/j.1474-9726.2007.00270.x; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Mislow JMK, 2002, J CELL SCI, V115, P61; Moir RD, 2000, J STRUCT BIOL, V129, P324, DOI 10.1006/jsbi.2000.4251; Otomo J, 2005, J CARDIOVASC ELECTR, V16, P137, DOI 10.1046/j.1540-8167.2004.40096.x; Parnaik VK, 2008, INT REV CEL MOL BIO, V266, P157, DOI 10.1016/S1937-6448(07)66004-3; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Perrot A, 2009, BASIC RES CARDIOL, V104, P90, DOI 10.1007/s00395-008-0748-6; Pethig K, 2005, CARDIOLOGY, V103, P57, DOI 10.1159/000082048; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Puckelwartz MJ, 2010, J MOL CELL CARDIOL, V48, P600, DOI 10.1016/j.yjmcc.2009.11.006; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Reddy KL, 2008, METHODS, V45, P242, DOI 10.1016/j.ymeth.2008.06.013; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Sebillon P, 2003, J MED GENET, V40, P560, DOI 10.1136/jmg.40.8.560; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Taimen P, 2009, P NATL ACAD SCI US; 2002, GENECHIP EXPRESSION	54	81	90	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14342	10.1371/journal.pone.0014342	http://dx.doi.org/10.1371/journal.pone.0014342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179469	Green Published, gold, Green Submitted			2022-12-25	WOS:000285292500013
J	Czabotar, PE; Lee, EF; Thompson, GV; Wardak, AZ; Fairlie, WD; Colman, PM				Czabotar, Peter E.; Lee, Erinna F.; Thompson, Geoff V.; Wardak, Ahmad Z.; Fairlie, W. Douglas; Colman, Peter M.			Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY-MEMBERS; CRYSTALLOGRAPHIC STRUCTURE DETERMINATION; PROGRAMMED CELL-DEATH; BH3-ONLY PROTEINS; MEMBRANE PERMEABILIZATION; X-RAY; CONFORMATIONAL-CHANGE; ANTIAPOPTOTIC BCL-2; ACTIVATION; BCL-X(L)	Pro-survival members of the Bcl-2 family of proteins restrain the pro-apoptotic activity of Bax, either directly through interactions with Bax or indirectly by sequestration of activator BH3-only proteins, or both. Mutations in Bax that promote apoptosis can provide insight into how Bax is regulated. Here, we describe crystal structures of the pro-survival proteins Mcl-1 and Bcl-x(L) in complex with a 34-mer peptide from Bax that encompasses its BH3 domain. These structures reveal canonical interactions between four signature hydrophobic amino acids from the BaxBH3 domain and the BH3-binding groove of the pro-survival proteins. In both structures, Met-74 from the Bax peptide engages with the BH3-binding groove in a fifth hydrophobic interaction. Various Bax Met-74 mutants disrupt interactions between Bax and all pro-survival proteins, but these Bax mutants retain pro-apoptotic activity. Bax/Bak-deficient mouse embryonic fibroblast cells reconstituted with several Bax Met-74 mutants are more sensitive to the BH3 mimetic compound ABT-737 as compared with cells expressing wild-type Bax. Furthermore, the cells expressing Bax Met-74 mutants are less viable in colony assays even in the absence of an external apoptotic stimulus. These results support a model in which direct restraint of Bax by pro-survival Bcl-2 proteins is a barrier to apoptosis.	[Czabotar, Peter E.; Lee, Erinna F.; Thompson, Geoff V.; Wardak, Ahmad Z.; Fairlie, W. Douglas; Colman, Peter M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Fairlie, W. Douglas; Colman, Peter M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Czabotar, PE (corresponding author), WEHI, 1G Royale Parade, Parkville, Vic 3052, Australia.	czabotar@wehi.edu.au; pcolman@wehi.edu.au	Lee, Erinna/N-1523-2015; Fairlie, Walter/M-8401-2015	Lee, Erinna/0000-0003-1255-9808; Fairlie, Walter/0000-0002-2498-1160; Czabotar, Peter/0000-0002-2594-496X	Australian Research Council; National Health and Medical Research Council (NHMRC) Australia [575561, 461221]; Leukemia and Lymphoma Society [SCOR 7015-02]; Cancer Council of Victoria [461239]; Leukaemia Foundation of Australia; Australian Cancer Research Foundation	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukaemia Foundation of Australia; Australian Cancer Research Foundation	This work was supported by a fellowship from the Australian Research Council (to P. E. C.), National Health and Medical Research Council (NHMRC) Australia Project Grant 575561 (to P. E. C.), Program Grant 461221 fellowships (to W. D. F. and P. M. C.), Leukemia and Lymphoma Society (SCOR 7015-02), Cancer Council of Victoria Grant-in-Aid 461239 (to W. D. F.), a Leukaemia Foundation of Australia Phillip Desbrow Postdoctoral Fellowship (to E. F. L.), and an Australian Cancer Research Foundation grant (to P. M. C.).	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Czabotar PE, 2010, CURR PHARM DESIGN, V16, P3132; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jabbour AM, 2006, J CELL SCI, V119, P2572, DOI 10.1242/jcs.02985; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Lee EF, 2009, J BIOL CHEM, V284, P31315, DOI 10.1074/jbc.M109.048009; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Meyerkord CL, 2008, ONCOGENE, V27, P7248, DOI 10.1038/onc.2008.336; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou H, 2007, ONCOGENE, V26, P7092, DOI 10.1038/sj.onc.1210517; Zwart P.H., 2005, CCP4 NEWSLETTER PROT, V43, P27	58	85	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7123	7131		10.1074/jbc.M110.161281	http://dx.doi.org/10.1074/jbc.M110.161281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21199865	Green Published, hybrid			2022-12-25	WOS:000287737300029
J	Lamanna, WC; Lawrence, R; Sarrazin, S; Esko, JD				Lamanna, William C.; Lawrence, Roger; Sarrazin, Stephane; Esko, Jeffrey D.			Secondary Storage of Dermatan Sulfate in Sanfilippo Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II-THROMBIN COMPLEX; INTRACELLULAR CALCIUM STORES; MASS-SPECTROMETRY; HUMAN-FIBROBLASTS; ENZYME ASSAY; MPS DISEASE; MUCOPOLYSACCHARIDOSIS; DISORDERS; AUTOPHAGY; GLYCOSAMINOGLYCANS	Mucopolysaccharidoses are a group of genetically inherited disorders that result from the defective activity of lysosomal enzymes involved in glycosaminoglycan catabolism, causing their intralysosomal accumulation. Sanfilippo disease describes a subset of mucopolysaccharidoses resulting from defects in heparan sulfate catabolism. Sanfilippo disorders cause severe neuropathology in affected children. The reason for such extensive central nervous system dysfunction is unresolved, but it may be associated with the secondary accumulation of metabolites such as gangliosides. In this article, we describe the accumulation of dermatan sulfate as a novel secondary metabolite in Sanfilippo. Based on chondroitinase ABC digestion, chondroitin/dermatan sulfate levels in fibroblasts from Sanfilippo patients were elevated 2-5-fold above wild-type dermal fibroblasts. Lysosomal turnover of chondroitin/dermatan sulfate in these cell lines was significantly impaired but could be normalized by reducing heparan sulfate storage using enzyme replacement therapy. Examination of chondroitin/dermatan sulfate catabolic enzymes showed that heparan sulfate and heparin can inhibit iduronate 2-sulfatase. Analysis of the chondroitin/dermatan sulfate fraction by chondroitinase ACII digestion showed dermatan sulfate storage, consistent with inhibition of iduronate 2-sulfatase. The discovery of a novel storage metabolite in Sanfilippo patients may have important implications for diagnosis and understanding disease pathology.	[Lamanna, William C.; Lawrence, Roger; Sarrazin, Stephane; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Esko, JD (corresponding author), 9500 Gilman Dr 0687,Rm 1055, La Jolla, CA 92093 USA.	jesko@ucsd.edu			NIDDK [F32DK85905]; NIGMS [GM077471]; National MPS Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK085905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077471] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National MPS Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant F32DK85905 from the NIDDK (to W. C. L.), Grant GM077471 from the NIGMS, and by a grant from the National MPS Society (to J. D. E.).	AKATSU C, 2010, GLYCOBIOLOG IN PRESS; Bai XM, 1997, J BIOL CHEM, V272, P23172, DOI 10.1074/jbc.272.37.23172; BAUMKOTTER J, 1983, BIOCHIM BIOPHYS ACTA, V761, P163, DOI 10.1016/0304-4165(83)90225-8; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; ESKO JD, 2001, CURR PROTOC MOL BIOL, V3; FRATANTONI JC, 1968, P NATL ACAD SCI USA, V60, P699, DOI 10.1073/pnas.60.2.699; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HARDY MR, 1989, METHOD ENZYMOL, V179, P76; HOPWOOD JJ, 1979, CLIN CHIM ACTA, V92, P257, DOI 10.1016/0009-8981(79)90121-9; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; KINT JA, 1973, SCIENCE, V181, P352, DOI 10.1126/science.181.4097.352; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Langford-Smith K, 2010, MOL GENET METAB, V99, P269, DOI 10.1016/j.ymgme.2009.10.175; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; LEABACK DH, 1961, BIOCHEM J, V78, pP22; LIE SO, 1972, P NATL ACAD SCI USA, V69, P2361, DOI 10.1073/pnas.69.9.2361; Liour SS, 2001, MOL GENET METAB, V72, P239, DOI 10.1006/mgme.2000.3139; Malstrom A, 1975, Biochem J, V151, P477; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nguyen HN, 2002, BRAIN RES, V924, P159, DOI 10.1016/S0006-8993(01)03229-2; Nielsen TC, 2008, GLYCOBIOLOGY, V18, P1119, DOI 10.1093/glycob/cwn097; Pelled D, 2003, J BIOL CHEM, V278, P29496, DOI 10.1074/jbc.M302964200; PETERS C, 1991, BIOCHEM J, V276, P499, DOI 10.1042/bj2760499; Randall DR, 2008, MOL GENET METAB, V94, P456, DOI 10.1016/j.ymgme.2008.05.001; Randall DR, 2006, MOL GENET METAB, V88, P235, DOI 10.1016/j.ymgme.2006.01.005; ROME LH, 1979, CELL, V17, P143, DOI 10.1016/0092-8674(79)90302-7; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; SIEGEL DA, 1994, J NEUROCHEM, V62, P1852; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Thomas G.H., METABOLIC MOL BASES, V3, P3507; Tomatsu S, 2010, MOL GENET METAB, V99, P124, DOI 10.1016/j.ymgme.2009.10.001; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; VANDIGGELEN OP, 1990, CLIN CHIM ACTA, V187, P131, DOI 10.1016/0009-8981(90)90339-T; Voznyi YV, 2001, J INHERIT METAB DIS, V24, P675, DOI 10.1023/A:1012763026526; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; Wei HF, 1998, J NEUROCHEM, V70, P2305	44	40	40	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6955	6962		10.1074/jbc.M110.192062	http://dx.doi.org/10.1074/jbc.M110.192062			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193389	hybrid, Green Published			2022-12-25	WOS:000287737300011
J	Cai, ML; Huang, Y; Craigie, R; Clore, GM				Cai, Mengli; Huang, Ying; Craigie, Robert; Clore, G. Marius			Structural Basis of the Association of HIV-1 Matrix Protein with DNA	PLOS ONE			English	Article							PARAMAGNETIC RELAXATION ENHANCEMENT; VIRUS TYPE-1 MATRIX; NUCLEAR-LOCALIZATION SIGNAL; DIPOLAR COUPLINGS; CRYSTAL-STRUCTURES; NONDIVIDING CELLS; MACROMOLECULES; INFECTION; BINDING; DOMAIN	HIV-1 matrix (MA) is a multifunctional protein that is synthesized as a polyprotein that is cleaved by protease during viral maturation. MA contains a cluster of basic residues whose role is controversial. Proposed functions include membrane anchoring, facilitating viral assembly, and directing nuclear import of the viral DNA. Since MA has been reported to be a component of the preintegration complex (PIC), we have used NMR to probe its interaction with other PIC components. We show that MA interacts with DNA and this is likely sufficient to account for its association with the PIC.	[Cai, Mengli; Clore, G. Marius] NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Huang, Ying; Craigie, Robert] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Cai, ML (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA.	robertc@mail.nih.gov; mariusc@mail.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027	NIDDK; NIH; Office of the Director of the NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029038, ZIADK029023, ZIADK036171] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director of the NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Program of NIDDK, NIH and by the AIDS Targeted Antiviral Program of the Office of the Director of the NIH (to G.M.C. and R.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hearps AC, 2008, BIOCHEMISTRY-US, V47, P2199, DOI 10.1021/bi701360j; Hearps AC, 2007, AIDS RES HUM RETROV, V23, P341, DOI 10.1089/aid.2006.0108; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2003, J AM CHEM SOC, V125, P6634, DOI 10.1021/ja034488q; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; Legler PM, 2004, J BIOL CHEM, V279, P39115, DOI 10.1074/jbc.M406764200; Mannioui A, 2005, VIROLOGY, V339, P21, DOI 10.1016/j.virol.2005.05.023; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; VONSCHWEDLER U, 1994, P NATL ACAD SCI USA, V91, P6992, DOI 10.1073/pnas.91.15.6992; Warrilow D, 2007, CURR HIV RES, V5, P293, DOI 10.2174/157016207780636579; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200	28	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15675	10.1371/journal.pone.0015675	http://dx.doi.org/10.1371/journal.pone.0015675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203471	Green Published, gold, Green Submitted			2022-12-25	WOS:000285579200028
J	Jensen, F; Woudwyk, M; Teles, A; Woidacki, K; Taran, F; Costa, S; Malfertheiner, SF; Zenclussen, AC				Jensen, Federico; Woudwyk, Mariana; Teles, Ana; Woidacki, Katja; Taran, Florin; Costa, Serban; Malfertheiner, Sara Fill; Zenclussen, Ana Claudia			Estradiol and Progesterone Regulate the Migration of Mast Cells from the Periphery to the Uterus and Induce Their Maturation and Degranulation	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; RAT UTERINE CERVIX; T-CELLS; EXTRACELLULAR-MATRIX; ESTRUS CYCLE; MOUSE UTERUS; EXPRESSION; TRYPTASE; METALLOPROTEINASES; IMPLANTATION	Background: Mast cells (MCs) have long been suspected as important players for implantation based on the fact that their degranulation causes the release of pivotal factors, e. g., histamine, MMPs, tryptase and VEGF, which are known to be involved in the attachment and posterior invasion of the embryo into the uterus. Moreover, MC degranulation correlates with angiogenesis during pregnancy. The number of MCs in the uterus has been shown to fluctuate during menstrual cycle in human and estrus cycle in rat and mouse indicating a hormonal influence on their recruitment from the periphery to the uterus. However, the mechanisms behind MC migration to the uterus are still unknown. Methodology/Principal Findings: We first utilized migration assays to show that MCs are able to migrate to the uterus and to the fetal-maternal interface upon up-regulation of the expression of chemokine receptors by hormonal changes. By using a model of ovariectomized animals, we provide clear evidences that also in vivo, estradiol and progesterone attract MC to the uterus and further provoke their maturation and degranulation. Conclusion/Significance: We propose that estradiol and progesterone modulate the migration of MCs from the periphery to the uterus and their degranulation, which may prepare the uterus for implantation.	[Jensen, Federico; Woudwyk, Mariana; Teles, Ana; Woidacki, Katja; Zenclussen, Ana Claudia] Otto Von Guericke Univ, Fac Med, Magdeburg, Germany; [Woudwyk, Mariana] Natl Univ La Plata, Sch Vet Sci, Lab Histol & Embryol, Buenos Aires, DF, Argentina; [Teles, Ana] Univ Coimbra, Ctr Neurosci & Cell Biol, Doctoral Program Expt Biol & Biomed, Coimbra, Portugal; [Taran, Florin; Costa, Serban; Malfertheiner, Sara Fill] Otto Von Guericke Univ, Univ Womens Clin, Magdeburg, Germany	Otto von Guericke University; National University of La Plata; Universidade de Coimbra; Otto von Guericke University	Jensen, F (corresponding author), Otto Von Guericke Univ, Fac Med, Magdeburg, Germany.	federico.jensen@med.ovgu.de; ana.zenclussen@med.ovgu.de	Zenclussen, Ana/AAE-8760-2020; Zenclussen, Ana C/G-2186-2013; Malfertheiner, Sara Fill/AAW-3419-2021; Taran, Florin-Andrei/GLV-3748-2022	Zenclussen, Ana/0000-0003-3544-4552; Zenclussen, Ana C/0000-0003-3544-4552; Malfertheiner, Sara Fill/0000-0002-4274-2526; 	Fritz-Thyssen Foundation [AZ. 10.08.2.179]; German Research Foundation [DFG ZE 526/6-1, SFB 854 TP7, DFG SPP 1394]	Fritz-Thyssen Foundation; German Research Foundation(German Research Foundation (DFG))	The present work was funded by grants from the Fritz-Thyssen Foundation (AZ. 10.08.2.179) and by the German Research Foundation (DFG ZE 526/6- 1 and SFB 854 TP7) to ACZ. ACZ, KW and FJ are members of the Priority Research Program "Mast cells-promoters of health and modulators of disease" from the German Research Foundation (DFG SPP 1394). ACZ is a member of the SFB 854 from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi-Mendonca D, 2002, PHARMACOLOGY, V64, P208, DOI 10.1159/000056173; Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Baram D, 2001, J IMMUNOL, V167, P4008, DOI 10.4049/jimmunol.167.7.4008; Batth BK, 2000, EUR J MORPHOL, V38, P17, DOI 10.1076/0924-3860(200002)38:01;1-#;FT017; Belot MP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1410, DOI 10.1152/ajpendo.00286.2006; Bischof P, 1995, Early Pregnancy, V1, P263; BISCHOF P, 1991, AM J OBSTET GYNECOL, V165, P1791, DOI 10.1016/0002-9378(91)90034-O; Bosquiazzo VL, 2007, REPRODUCTION, V133, P1045, DOI 10.1530/REP-06-0168; Brightling CE, 2003, CLIN EXP ALLERGY, V33, P550, DOI 10.1046/j.1365-2222.2003.01636.x; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; COCCHIARA R, 1986, HUM REPROD, V1, P445, DOI 10.1093/oxfordjournals.humrep.a136452; COCCHIARA R, 1992, HUM REPROD, V7, P1036, DOI 10.1093/oxfordjournals.humrep.a137790; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734; de Marco R, 2002, J ALLERGY CLIN IMMUN, V110, P228, DOI 10.1067/mai.2002.125600; Fang KC, 1996, J CLIN INVEST, V97, P1589, DOI 10.1172/JCI118583; FISHER SJ, 1989, J CELL BIOL, V109, P891, DOI 10.1083/jcb.109.2.891; FISHER SJ, 1985, J CELL BIOCHEM, V27, P31, DOI 10.1002/jcb.240270105; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; HARVEY EB, 1964, ANAT REC, V148, P507, DOI 10.1002/ar.1091480309; Hirota Y, 2006, J IMMUNOL, V177, P8813, DOI 10.4049/jimmunol.177.12.8813; JOHNSON DC, 1980, BIOL REPROD, V22, P1136, DOI 10.1093/biolreprod/22.5.1136; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Karaca T, 2009, VET RES COMMUN, V33, P545, DOI 10.1007/s11259-009-9203-x; KIELTY CM, 1993, BIOCHEM BIOPH RES CO, V191, P1230, DOI 10.1006/bbrc.1993.1349; Lambert KC, 2005, J IMMUNOL, V175, P5716, DOI 10.4049/jimmunol.175.9.5716; LEES M, 1994, EUR J BIOCHEM, V223, P171, DOI 10.1111/j.1432-1033.1994.tb18980.x; Liu ZT, 2004, MOL REPROD DEV, V68, P345, DOI 10.1002/mrd.20082; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; MANNINO DM, 2002, MMWR SURVEILL SUMM, V29, P1; Narita S, 2007, ENVIRON HEALTH PERSP, V115, P48, DOI 10.1289/ehp.9378; NELSON JF, 1981, BIOL REPROD, V24, P784, DOI 10.1095/biolreprod24.4.784; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Orsi NM, 2007, ANIM REPROD SCI, V100, P301, DOI 10.1016/j.anireprosci.2006.08.016; Ozen A, 2002, DEUT TIERARZTL WOCH, V109, P412; PADILLA L, 1990, CELL MOL BIOL, V36, P93; Schatz M, 2003, ANN ALLERG ASTHMA IM, V91, P553, DOI 10.1016/S1081-1206(10)61533-5; Schumacher A, 2009, J IMMUNOL, V182, P5488, DOI 10.4049/jimmunol.0803177; SHIMONOVITZ S, 1994, AM J OBSTET GYNECOL, V171, P832, DOI 10.1016/0002-9378(94)90107-4; STACK MS, 1994, J BIOL CHEM, V269, P9416; TSUJI A, 1994, BIOCHEM J, V298, P79, DOI 10.1042/bj2980079; Varayoud J, 2004, REPRODUCTION, V127, P379, DOI 10.1530/rep.1.00018; Vrieze A, 2003, J ALLERGY CLIN IMMUN, V112, P271, DOI 10.1067/mai.2003.1676; Wood GW, 1999, CYTOKINE, V11, P1038, DOI 10.1006/cyto.1999.0513; WORDINGER RJ, 1985, J REPROD FERTIL, V73, P451, DOI 10.1530/jrf.0.0730451; Zaitsu M, 2007, MOL IMMUNOL, V44, P1977, DOI 10.1016/j.molimm.2006.09.030; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4; Zhang J, 1998, BIOL REPROD, V59, P693, DOI 10.1095/biolreprod59.3.693; Zysow BR, 1997, ARTERIOSCL THROM VAS, V17, P1741, DOI 10.1161/01.ATV.17.9.1741	51	81	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14409	10.1371/journal.pone.0014409	http://dx.doi.org/10.1371/journal.pone.0014409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203555	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000014
J	Mundinano, J; Berguer, PM; Cabrera, G; Lorenzo, D; Nepomnaschy, I; Piazzon, I				Mundinano, Juliana; Berguer, Paula M.; Cabrera, Gabriel; Lorenzo, Daniela; Nepomnaschy, Irene; Piazzon, Isabel			Superantigens Increase the Survival of Mice Bearing T Cell Lymphomas by Inducing Apoptosis of Neoplastic Cells	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; MAMMARY-TUMOR VIRUS; IN-VIVO; BACTERIAL SUPERANTIGEN; FUSION PROTEIN; FAS LIGAND; ACTIVATION; IMMUNOTHERAPY; DEATH; STIMULATION	Superantigens bind to major histocompatibility complex class II molecules and interact with T cells expressing a particular T cell receptor V beta inducing a strong proliferation/deletion response of the superantigen-reactive T cells. However, there have been no attempts to investigate the ability of Sags to induce apoptosis in neoplastic T cells by signaling through the V beta region of their TCR. In the present study we show that bacterial and MMTV-encoded superantigens induce the apoptosis of AKR/J cognate lymphoma T cells both in vitro and in vivo. The Fas-Fas-L pathway was shown to be involved in the apoptosis of lymphoma T cells induced by bacterial superantigens. In vivo exposure to bacterial superantigens was able to improve the survival of lymphoma bearing mice. Moreover, the permanent expression of a retroviral encoded superantigen induced the complete remission of an aggressive lymphoma in a high percentage of mice. The possibility of a therapeutic use of superantigens in lymphoma/leukemia T cell malignancies is discussed.	[Mundinano, Juliana; Cabrera, Gabriel; Lorenzo, Daniela; Nepomnaschy, Irene; Piazzon, Isabel] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Div Med Expt, ILEX CONICET, Buenos Aires, DF, Argentina; [Berguer, Paula M.] Fundac Inst Leloir, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Mundinano, J (corresponding author), Acad Nacl Med Buenos Aires, Inst Invest Hematol, Div Med Expt, ILEX CONICET, Buenos Aires, DF, Argentina.	ipiazzon@hematologia.anm.edu.ar	Berguer, Paula/AAI-6353-2020		Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 506305]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 20080102494]; FUNDALEU; Fundacion A.J. Roemmers	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FUNDALEU; Fundacion A.J. Roemmers	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica PICT 506305, Consejo Nacional de Investigaciones Cientificas y Tecnicas PIP 20080102494, FUNDALEU, and Fundacion A.J. Roemmers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHAORBEA H, 1995, ANNU REV IMMUNOL, V13, P459, DOI 10.1146/annurev.iy.13.040195.002331; ALBER G, 1990, J IMMUNOL, V144, P4501; Arnold R, 2006, EUR J IMMUNOL, V36, P1654, DOI 10.1002/eji.200636197; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bittner JJ, 1936, SCIENCE, V84, P162, DOI 10.1126/science.84.2172.162; BRANDTCARLSON C, 1993, VIROLOGY, V193, P171, DOI 10.1006/viro.1993.1113; Brenner D, 2008, CRIT REV ONCOL HEMAT, V66, P52, DOI 10.1016/j.critrevonc.2008.01.002; Buggiano V, 1999, SCAND J IMMUNOL, V49, P269; Cabrera G, 2008, J VIROL, V82, P7422, DOI 10.1128/JVI.00102-08; CALLAHAN JE, 1990, J IMMUNOL, V144, P2473; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; CHOI YW, 1991, NATURE, V350, P203, DOI 10.1038/350203a0; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; ETTINGER R, 1995, J IMMUNOL, V154, P4302; Fernandez MM, 2006, MOL IMMUNOL, V43, P927, DOI 10.1016/j.molimm.2005.06.029; FLEMING SD, 1991, INFECT IMMUN, V59, P4049, DOI 10.1128/IAI.59.11.4049-4055.1991; Forsberg G, 2001, BRIT J CANCER, V85, P129, DOI 10.1054/bjoc.2001.1891; FRANKEL WN, 1991, NATURE, V349, P526, DOI 10.1038/349526a0; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Gidlof C, 1997, BLOOD, V89, P2089, DOI 10.1182/blood.V89.6.2089; Golovkina TV, 1997, J VIROL, V71, P3895, DOI 10.1128/JVI.71.5.3895-3903.1997; Gomez G, 2000, INT IMMUNOL, V12, P263, DOI 10.1093/intimm/12.3.263; GONZALO JA, 1993, J EXP MED, V177, P1239, DOI 10.1084/jem.177.5.1239; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Jackow CM, 1997, BLOOD, V89, P32, DOI 10.1182/blood.V89.1.32; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x; Kominsky SL, 2001, INT J CANCER, V94, P834, DOI 10.1002/ijc.1551; Linnemann T, 2004, BRIT J DERMATOL, V150, P1013, DOI 10.1111/j.1365-2133.2004.05970.x; Litton MJ, 1999, BRIT J CANCER, V81, P359, DOI 10.1038/sj.bjc.6690701; Lombardi G, 2005, J IMMUNOL, V174, P7022, DOI 10.4049/jimmunol.174.11.7022; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; MARRACK P, 1990, J EXP MED, V171, P455, DOI 10.1084/jem.171.2.455; METZGER R, 1993, SCAND J IMMUNOL, V37, P245, DOI 10.1111/j.1365-3083.1993.tb01762.x; NEWELL KA, 1991, P NATL ACAD SCI USA, V88, P1074, DOI 10.1073/pnas.88.3.1074; Ogata M, 1998, BRIT J HAEMATOL, V100, P490, DOI 10.1046/j.1365-2141.1998.00605.x; Perabo FG, 2005, INT J CANCER, V115, P591, DOI 10.1002/ijc.20941; Ragnarsson L, 2001, CANCER IMMUNOL IMMUN, V50, P382, DOI 10.1007/s002620100211; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; Renno T, 1999, J IMMUNOL, V162, P6312; Shurin G, 1997, NEUROENDOCRINOLOGY, V65, P18, DOI 10.1159/000127161; SIMPSON E, 1993, EUR J IMMUNOGENET, V20, P137; Sundberg EJ, 2002, CURR OPIN IMMUNOL, V14, P36, DOI 10.1016/S0952-7915(01)00296-5; Sundstedt A, 2009, INT IMMUNOPHARMACOL, V9, P1063, DOI 10.1016/j.intimp.2009.04.013; Terman DS, 2006, CLIN CHEST MED, V27, P321, DOI 10.1016/j.ccm.2006.01.001; TOKURA Y, 1992, J INVEST DERMATOL, V98, P33, DOI 10.1111/1523-1747.ep12494184; Tordsson JM, 2000, CANCER IMMUNOL IMMUN, V48, P691, DOI 10.1007/s002620050018; Ueno A, 2002, ANTICANCER RES, V22, P769; Vonderheid EC, 2005, J INVEST DERMATOL, V124, P651, DOI 10.1111/j.0022-202X.2004.23586.x; YAZDANBAKHSH K, 1993, J EXP MED, V178, P737, DOI 10.1084/jem.178.2.737	50	4	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15694	10.1371/journal.pone.0015694	http://dx.doi.org/10.1371/journal.pone.0015694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203530	Green Published, gold, Green Submitted			2022-12-25	WOS:000285578000048
J	Estey, T; Chen, Y; Carpenter, JF; Vasiliou, V				Estey, Tia; Chen, Ying; Carpenter, John F.; Vasiliou, Vasilis			Structural and Functional Modifications of Corneal Crystallin ALDH3A1 by UVB Light	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; ULTRAVIOLET-LIGHT; OXIDATIVE STRESS; CATALYTIC MECHANISM; ALPHA-CRYSTALLIN; CROSS-LINK; PROTEIN; TRYPTOPHAN; DITYROSINE; EXPRESSION	As one of the most abundantly expressed proteins in the mammalian corneal epithelium, aldehyde dehydrogenase 3A1 (ALDH3A1) plays critical and multifaceted roles in protecting the cornea from oxidative stress. Recent studies have demonstrated that one protective mechanism of ALDH3A1 is the direct absorption of UV-energy, which reduces damage to other corneal proteins such as glucose-6-phosphate dehydrogenase through a competition mechanism. UV-exposure, however, leads to the inactivation of ALDH3A1 in such cases. In the current study, we demonstrate that UV-light caused soluble, non-native aggregation of ALDH3A1 due to both covalent and non-covalent interactions, and that the formation of the aggregates was responsible for the loss of ALDH3A1 enzymatic activity. Spectroscopic studies revealed that as a result of aggregation, the secondary and tertiary structure of ALDH3A1 were perturbed. LysC peptide mapping using MALDI-TOF mass spectrometry shows that UV-induced damage to ALDH3A1 also includes chemical modifications to Trp, Met, and Cys residues. Surprisingly, the conserved active site Cys of ALDH3A1 does not appear to be affected by UV-exposure; this residue remained intact after exposure to UV-light that rendered the enzyme completely inactive. Collectively, our data suggest that the UV-induced inactivation of ALDH3A1 is a result of non-native aggregation and associated structural changes rather than specific damage to the active site Cys.	[Estey, Tia; Carpenter, John F.; Vasiliou, Vasilis] Univ Colorado Denver, Ctr Pharmaceut Biotechnol, Dept Pharmaceut Sci, Aurora, CO USA; [Chen, Ying; Vasiliou, Vasilis] Univ Colorado Denver, Mol Toxicol & Environm Hlth Sci Program, Dept Pharmaceut Sci, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Estey, T (corresponding author), Univ Colorado Denver, Ctr Pharmaceut Biotechnol, Dept Pharmaceut Sci, Aurora, CO USA.	vasiliou@ucdenver.edu		vasiliou, vasilis/0000-0003-2552-3118	NIH [R01 EY17963]; NATIONAL EYE INSTITUTE [R01EY017963] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research was supported by NIH grant R01 EY17963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEDINIA M, 1990, EXP EYE RES, V51, P419, DOI 10.1016/0014-4835(90)90154-M; ALEXANDER RJ, 1981, EXP EYE RES, V32, P205, DOI 10.1016/0014-4835(81)90009-9; Atherton SJ, 1999, PHOTOCHEM PHOTOBIOL, V70, P823, DOI 10.1111/j.1751-1097.1999.tb08289.x; Bhaskar B, 2003, J MOL BIOL, V328, P157, DOI 10.1016/S0022-2836(03)00179-7; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Davies MJ, 2001, J PHOTOCH PHOTOBIO B, V63, P114, DOI 10.1016/S1011-1344(01)00208-1; DOWNES JE, 1993, CORNEA, V12, P241, DOI 10.1097/00003226-199305000-00010; Estey T, 2007, J BIOL CHEM, V282, P4382, DOI 10.1074/jbc.M607546200; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; Estey T, 2009, J PHARM SCI-US, V98, P2994, DOI 10.1002/jps.21543; GUPTASARMA P, 1992, CURR EYE RES, V11, P1121, DOI 10.3109/02713689209015084; Hempel J, 1999, ADV EXP MED BIOL, V463, P53; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; HOTT JL, 1993, PHOTOCHEM PHOTOBIOL, V57, P312; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Kueltzo LA, 2003, J BIOL CHEM, V278, P2792, DOI 10.1074/jbc.M208383200; Lassen N, 2005, DRUG METAB DISPOS, V33, P649, DOI 10.1124/dmd.104.002964; Lassen N, 2007, J BIOL CHEM, V282, P25668, DOI 10.1074/jbc.M702076200; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; MACH H, 1994, ANAL BIOCHEM, V222, P323, DOI 10.1006/abio.1994.1499; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; Manzer R, 2003, CHEM-BIOL INTERACT, V143, P45, DOI 10.1016/S0009-2797(02)00171-0; MITCHELL J, 1995, CORNEA, V14, P266, DOI 10.1097/00003226-199505000-00007; Onorato JM, 1998, ANN NY ACAD SCI, V854, P277, DOI 10.1111/j.1749-6632.1998.tb09909.x; Osapay K, 2000, J BIOL CHEM, V275, P12017, DOI 10.1074/jbc.275.16.12017; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Pappa A, 2001, CHEM-BIOL INTERACT, V130, P181, DOI 10.1016/S0009-2797(00)00233-7; Piatigorsky J, 2000, J OCUL PHARMACOL TH, V16, P173, DOI 10.1089/jop.2000.16.173; Piatigorsky J, 1998, PROG RETIN EYE RES, V17, P145, DOI 10.1016/S1350-9462(97)00004-9; Requena JR, 2003, AMINO ACIDS, V25, P221, DOI 10.1007/s00726-003-0012-1; Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Stiuso P, 1999, EUR J BIOCHEM, V266, P1029, DOI 10.1046/j.1432-1327.1999.00944.x; VANKUIJK FJGM, 1991, ENVIRON HEALTH PERSP, V96, P177, DOI 10.2307/3431229; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; WALRANT P, 1974, PHOTOCHEM PHOTOBIOL, V19, P411, DOI 10.1111/j.1751-1097.1974.tb06533.x; ZIGMAN S, 1988, CURR EYE RES, V7, P531, DOI 10.3109/02713688809031808	44	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15218	10.1371/journal.pone.0015218	http://dx.doi.org/10.1371/journal.pone.0015218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203538	Green Published, Green Submitted, gold			2022-12-25	WOS:000285576900022
J	Alves, MMM; Osinga, J; Verheij, JBGM; Metzger, M; Eggen, BJL; Hofstra, RMW				Alves, Maria M. M.; Osinga, Jan; Verheij, Joke B. G. M.; Metzger, Marco; Eggen, Bart J. L.; Hofstra, Robert M. W.			Mutations in SCG10 Are Not Involved in Hirschsprung Disease	PLOS ONE			English	Article							RET; GENE; DYNAMICS; STATHMIN; GROWTH; CELL	Hirschsprung disease (HSCR) is a congenital malformation characterized by the absence of enteric neurons in the distal part of the colon. Several genes have been implicated in the development of this disease that together account for 20% of all cases, implying that other genes are involved. Since HSCR is frequently associated with other congenital malformations, the functional characterization of the proteins encoded by the genes involved in these syndromes can provide insights into the protein-network involved in HSCR development. Recently, we found that KBP, encoded by the gene involved in a HSCR-associated syndrome called Goldberg-Shprintzen syndrome, interacts with SCG10, a stathmin-like protein. To determine if SCG10 is involved in the etiology of HSCR, we determined SCG10 expression levels during development and screened 85 HSCR patients for SCG10 mutations. We showed that SCG10 expression increases during development but no germline mutation was found in any of these patients. In conclusion, this study shows that SCG10 is not directly implicated in HSCR development. However, an indirect involvement of SCG10 cannot be ruled out as this can be due to a secondary effect caused by its direct interactors.	[Alves, Maria M. M.; Osinga, Jan; Verheij, Joke B. G. M.; Hofstra, Robert M. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Metzger, Marco] Univ Leipzig, Translat Ctr Regenerat Med, Leipzig, Germany; [Eggen, Bart J. L.] Univ Groningen, Dept Neurosci, Sect Med Physiol, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; Leipzig University; University of Groningen	Alves, MMM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	r.m.w.hofstra@medgen.umcg.nl	Metzger, Marco/F-9706-2019; Alves, Maria/AAB-2054-2019	Hofstra, Robert/0000-0001-7498-3829	Graduate School of Medical Sciences (GUIDE); Jan Kornelis de Cock Stichting grant	Graduate School of Medical Sciences (GUIDE); Jan Kornelis de Cock Stichting grant	This work was supported by the Graduate School of Medical Sciences (GUIDE) and the Jan Kornelis de Cock Stichting grant to M.M.A.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MM, 2010, HUM MOL GENET, V19, P3642, DOI 10.1093/hmg/ddq280; Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; BADNER JA, 1990, AM J HUM GENET, V46, P568; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; CHAKRAVARTI A, 2001, METABOLIC MOL BASES, P6231; Doray B, 1998, HUM MOL GENET, V7, P1449, DOI 10.1093/hmg/7.9.1449; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hofstra RMW, 1999, AM J HUM GENET, V64, P304, DOI 10.1086/302184; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; Manna T, 2007, BIOCHEMISTRY-US, V46, P3543, DOI 10.1021/bi061819d; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Sancandi M, 2000, J PEDIATR SURG, V35, P139, DOI 10.1016/S0022-3468(00)80094-9	20	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15144	10.1371/journal.pone.0015144	http://dx.doi.org/10.1371/journal.pone.0015144			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187955	Green Published, Green Submitted, gold			2022-12-25	WOS:000285575200015
J	Cieslak, M; Pruvost, M; Benecke, N; Hofreiter, M; Morales, A; Reissmann, M; Ludwig, A				Cieslak, Michael; Pruvost, Melanie; Benecke, Norbert; Hofreiter, Michael; Morales, Arturo; Reissmann, Monika; Ludwig, Arne			Origin and History of Mitochondrial DNA Lineages in Domestic Horses	PLOS ONE			English	Article							ANCIENT DNA; MULTIPLEX AMPLIFICATION; EXTRACTION; SEQUENCES	Domestic horses represent a genetic paradox: although they have the greatest number of maternal lineages (mtDNA) of all domestic species, their paternal lineages are extremely homogeneous on the Y-chromosome. In order to address their huge mtDNA variation and the origin and history of maternal lineages in domestic horses, we analyzed 1961 partial d-loop sequences from 207 ancient remains and 1754 modern horses. The sample set ranged from Alaska and North East Siberia to the Iberian Peninsula and from the Late Pleistocene to modern times. We found a panmictic Late Pleistocene horse population ranging from Alaska to the Pyrenees. Later, during the Early Holocene and the Copper Age, more or less separated sub-populations are indicated for the Eurasian steppe region and Iberia. Our data suggest multiple domestications and introgressions of females especially during the Iron Age. Although all Eurasian regions contributed to the genetic pedigree of modern breeds, most haplotypes had their roots in Eastern Europe and Siberia. We found 87 ancient haplotypes (Pleistocene to Mediaeval Times); 56 of these haplotypes were also observed in domestic horses, although thus far only 39 haplotypes have been confirmed to survive in modern breeds. Thus, at least seventeen haplotypes of early domestic horses have become extinct during the last 5,500 years. It is concluded that the large diversity of mtDNA lineages is not a product of animal breeding but, in fact, represents ancestral variability.	[Cieslak, Michael; Pruvost, Melanie; Ludwig, Arne] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Pruvost, Melanie; Benecke, Norbert] German Archaeol Inst, Berlin, Germany; [Hofreiter, Michael] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Hofreiter, Michael] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Morales, Arturo] Univ Autonoma Madrid, Lab Archaeozool, Madrid, Spain; [Reissmann, Monika] Humboldt Univ, Dept Breeding Biol & Mol Genet, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Max Planck Society; University of York - UK; Autonomous University of Madrid; Humboldt University of Berlin	Cieslak, M (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	melpruvost@googlemail.com; ludwig@izw-berlin.de	Muñiz, Arturo Morales/ABG-7980-2020; Hofreiter, Michael/A-3996-2017	Muñiz, Arturo Morales/0000-0002-9933-6836; Pruvost, Melanie/0000-0001-7824-2155; Hofreiter, Michael/0000-0003-0441-4705; Cieslak, Michael/0000-0002-6111-658X	Deutsche Forschungsgemeinschaft [LU852-7/2-3]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was funded by grants provided by the Deutsche Forschungsgemeinschaft (LU852-7/2-3) and by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; ANTHONY DW, 1986, CURR ANTHROPOL, V27, P291, DOI 10.1086/203441; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Giuffra E, 2000, GENETICS, V154, P1785; Jansen T, 2002, P NATL ACAD SCI USA, V99, P10905, DOI 10.1073/pnas.152330099; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Lau AN, 2009, MOL BIOL EVOL, V26, P199, DOI 10.1093/molbev/msn239; LEI CZ, 2009, ANIMAL GENETICS, P933; Levine M., 1999, LATE PREHISTORIC EXP, P5; Levine MA, 2005, Domestic Horse: The Origins, Development and Management of Its Behaviour, P5; Ling YH, 2010, J HERED, V101, P639, DOI 10.1093/jhered/esq047; Lira J, 2010, MOL ECOL, V19, P64, DOI 10.1111/j.1365-294X.2009.04430.x; Ludwig A, 2009, SCIENCE, V324, P485, DOI 10.1126/science.1172750; MASHKOUR M, 2006, EQUIDS TIME SPACE OX; McGahern A, 2006, ANIM GENET, V37, P494, DOI 10.1111/j.1365-2052.2006.01495.x; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Pruvost M, 2008, PALAEOGEOGR PALAEOCL, V266, P211, DOI 10.1016/j.palaeo.2008.03.041; Rompler H, 2006, NAT PROTOC, V1, P720, DOI 10.1038/nprot.2006.84; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Sambraus H H, 1986, Tierarztl Prax, V14, P297; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Wallner B, 2004, J HERED, V95, P158, DOI 10.1093/jhered/esh020; WARING GH, 2002, HORSE BEHABIOUR BEHA; XU X, 1994, GENE, V148, P657	29	109	119	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15311	10.1371/journal.pone.0015311	http://dx.doi.org/10.1371/journal.pone.0015311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187961	Green Published, Green Submitted, gold			2022-12-25	WOS:000285575200036
J	Knapp, GS; Hu, JC				Knapp, Gwendowlyn S.; Hu, James C.			Specificity of the E-coli LysR-Type Transcriptional Regulators	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FAMILY; PROTEINS; ACTIVATOR; DOMAINS; OXYR; DNA; OLIGOMERIZATION; DEGRADATION	Background: Families of paralogous oligomeric proteins are common in biology. How the specificity of assembly evolves is a fundamental question of biology. The LysR-Type Transcriptional Regulators (LTTR) form perhaps the largest family of transcriptional regulators in bacteria. Because genomes often encode many LTTR family members, it is assumed that many distinct homooligomers are formed simultaneously in the same cell without interfering with each other's activities, suggesting specificity in the interactions. However, this assumption has not been systematically tested. Methodology/ Principal Findings: A negative-dominant assay with lambda cI repressor fusions was used to evaluate the assembly of the LTTRs in E. coli K-12. Thioredoxin (Trx)-LTTR fusions were used to challenge the homooligomeric interactions of lambda cI-LTTR fusions. Eight cI-LTTR fusions were challenged with twenty-eight Trx fusions. LTTRs could be divided into three classes based on their interactions with other LTTRs. Conclusions/Significance: Multimerization of LTTRs in E. coli K-12 is mostly specific. However, under the conditions of the assay, many LTTRs interact with more than one noncognate partner. The physiological significance and physical basis for these interactions are not known.	[Knapp, Gwendowlyn S.; Hu, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station		jimhu@tamu.edu	Knapp, Gwendowlyn/ABG-5852-2020	Hu, James/0000-0001-9016-2684	NIH [R01 GM63652]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063652] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH award R01 GM63652 to J.C.H., which ended in 2005. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Clark T, 2004, ACTA CRYSTALLOGR D, V60, P105, DOI 10.1107/S0907444903021589; Collier LS, 1998, J BACTERIOL, V180, P2493, DOI 10.1128/JB.180.9.2493-2501.1998; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; HENIKOFF S, 1988, P NATL ACAD SCI USA, V85, P6602, DOI 10.1073/pnas.85.18.6602; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Knapp GS, 2009, PROTEIN SCI, V18, P2307, DOI 10.1002/pro.241; Knapp GS, 2009, PROTEIN SCI, V18, P101, DOI 10.1002/pro.5; Kovacikova G, 1999, J BACTERIOL, V181, P4250, DOI 10.1128/JB.181.14.4250-4256.1999; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Marino-Ramirez L, 2004, J BACTERIOL, V186, P1311, DOI 10.1128/JB.186.5.1311-1319.2004; Marino-Ramirez Leonardo, 2003, Methods Mol Biol, V205, P235; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; ROMEROARROYO CE, 1995, J BACTERIOL, V177, P5891, DOI 10.1128/jb.177.20.5891-5898.1995; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Smirnova IA, 2004, J MOL BIOL, V340, P405, DOI 10.1016/j.jmb.2004.04.071; Stec E, 2006, J MOL BIOL, V364, P309, DOI 10.1016/j.jmb.2006.06.033; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tyrrell R, 1997, STRUCTURE, V5, P1017, DOI 10.1016/S0969-2126(97)00254-2; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Xiao GP, 2006, MICROBIOL-SGM, V152, P1679, DOI 10.1099/mic.0.28605-0; ZAGURSKY RJ, 1984, GENE, V27, P183, DOI 10.1016/0378-1119(84)90139-2; Zeng X, 1997, P NATL ACAD SCI USA, V94, P3673, DOI 10.1073/pnas.94.8.3673	28	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15189	10.1371/journal.pone.0015189	http://dx.doi.org/10.1371/journal.pone.0015189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187915	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200020
J	Blackiston, D; Shomrat, T; Nicolas, CL; Granata, C; Levin, M				Blackiston, Douglas; Shomrat, Tal; Nicolas, Cindy L.; Granata, Christopher; Levin, Michael			A Second-Generation Device for Automated Training and Quantitative Behavior Analyses of Molecularly-Tractable Model Organisms	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; XENOPUS-LAEVIS TADPOLES; ABSTINENCE-INDUCED WITHDRAWAL; LEAD INHIBITS ACQUISITION; CENTRAL-NERVOUS-SYSTEM; LEFT-RIGHT ASYMMETRY; LARVAL ZEBRAFISH; CAENORHABDITIS-ELEGANS; NEURAL-NETWORK; C-ELEGANS	A deep understanding of cognitive processes requires functional, quantitative analyses of the steps leading from genetics and the development of nervous system structure to behavior. Molecularly-tractable model systems such as Xenopus laevis and planaria offer an unprecedented opportunity to dissect the mechanisms determining the complex structure of the brain and CNS. A standardized platform that facilitated quantitative analysis of behavior would make a significant impact on evolutionary ethology, neuropharmacology, and cognitive science. While some animal tracking systems exist, the available systems do not allow automated training (feedback to individual subjects in real time, which is necessary for operant conditioning assays). The lack of standardization in the field, and the numerous technical challenges that face the development of a versatile system with the necessary capabilities, comprise a significant barrier keeping molecular developmental biology labs from integrating behavior analysis endpoints into their pharmacological and genetic perturbations. Here we report the development of a second-generation system that is a highly flexible, powerful machine vision and environmental control platform. In order to enable multidisciplinary studies aimed at understanding the roles of genes in brain function and behavior, and aid other laboratories that do not have the facilities to undergo complex engineering development, we describe the device and the problems that it overcomes. We also present sample data using frog tadpoles and flatworms to illustrate its use. Having solved significant engineering challenges in its construction, the resulting design is a relatively inexpensive instrument of wide relevance for several fields, and will accelerate interdisciplinary discovery in pharmacology, neurobiology, regenerative medicine, and cognitive science.	[Blackiston, Douglas; Shomrat, Tal; Nicolas, Cindy L.; Levin, Michael] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Blackiston, Douglas; Shomrat, Tal; Nicolas, Cindy L.; Levin, Michael] Tufts Univ, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA; [Blackiston, Douglas] Forsyth Inst, Dept Regenerat & Dev Biol, Boston, MA USA; [Granata, Christopher] Boston Engn Corp, Waltham, MA USA	Tufts University; Tufts University; Harvard University; Forsyth Institute	Blackiston, D (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	michael.levin@tufts.edu	Levin, Michael/A-5918-2011	Levin, Michael/0000-0001-7292-8084; Blackiston, Douglas/0000-0001-7231-0196	National Institutes of Health [T32-DE-007327]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	D.B. was supported by National Institutes of Health T32-DE-007327; M.L. and T.S. were supported by the G. Harold and Leila Y. Mathers Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Imari L, 2008, BEHAV BRAIN RES, V189, P216, DOI 10.1016/j.bbr.2007.12.007; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; ARBIB MA, 1985, FED PROC, V44, P2956; ARBIB MA, 1967, J THEOR BIOL, V14, P131, DOI 10.1016/0022-5193(67)90110-5; Arbib Michael, 1985, SEARCH PERSON PHILOS; Baier H, 2000, CURR OPIN NEUROBIOL, V10, P451, DOI 10.1016/S0959-4388(00)00116-1; Bang PI, 2002, J NEUROSCI METH, V118, P177, DOI 10.1016/S0165-0270(02)00118-8; Barnett MW, 2001, MECH DEVELOP, V102, P157, DOI 10.1016/S0925-4773(01)00304-5; Bass SLS, 2008, BEHAV BRAIN RES, V186, P107, DOI 10.1016/j.bbr.2007.07.037; Bensing BA, 2001, INFECT IMMUN, V69, P1373, DOI 10.1128/IAI.69.3.1373-1380.2001; Berghmans S, 2007, EPILEPSY RES, V75, P18, DOI 10.1016/j.eplepsyres.2007.03.015; Bert B, 2008, BEHAV BRAIN RES, V195, P78, DOI 10.1016/j.bbr.2008.02.028; BEST J, 1963, PROTOPSYCHOLOGY; BEST JB, 1962, J COMP PHYSIOL PSYCH, V55, P560, DOI 10.1037/h0044394; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; BLOCK RA, 1967, NATURE, V215, P1465, DOI 10.1038/2151465a0; Boisvert MJ, 2000, PHYSIOL BEHAV, V71, P147, DOI 10.1016/S0031-9384(00)00317-6; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Bretaud S, 2007, NEUROSCIENCE, V146, P1109, DOI 10.1016/j.neuroscience.2006.12.073; Brightwell JJ, 2008, NEUROBIOL LEARN MEM, V89, P27, DOI 10.1016/j.nlm.2007.09.004; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; BROWN HM, 1968, J GEN PHYSIOL, V51, P255, DOI 10.1085/jgp.51.2.255; Cahill GM, 1998, NEUROREPORT, V9, P3445, DOI 10.1097/00001756-199810260-00020; Cahill Gregory M, 2007, Methods Mol Biol, V362, P83; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; CAVEMAN A, 2000, J CELL SCI, V113, P3543; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Chen ZL, 2003, GENE, V306, P127, DOI 10.1016/S0378-1119(03)00431-1; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Colaiacovo MP, 2002, GENETICS, V162, P113; COPP NH, 1984, J EXP ZOOL, V230, P219, DOI 10.1002/jez.1402300207; Corning W. C., 1970, MOL APPROACHES LEARN, P107; CORNING WC, 1968, NATURE, V219, P1227, DOI 10.1038/2191227a0; CORNING WC, 1964, J PSYCHOL, V58, P131, DOI 10.1080/00223980.1964.9916729; CORNING WC, 1961, SCIENCE, V134, P1363, DOI 10.1126/science.134.3487.1363; CORNWELL P, 1961, WORM RUNNERS DIGEST, V3, P91; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; CRAM EJ, 2003, J CELL SCI; Creton R, 2009, BEHAV BRAIN RES, V203, P127, DOI 10.1016/j.bbr.2009.04.030; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; Darland T, 2001, P NATL ACAD SCI USA, V98, P11691, DOI 10.1073/pnas.191380698; de la Cruz CC, 1999, DEV BIOL, V216, P595, DOI 10.1006/dbio.1999.9528; Delcourt J, 2006, BEHAV RES METHODS, V38, P704, DOI 10.3758/BF03193904; den Hertog J, 2005, BIOSCIENCE REP, V25, P289, DOI 10.1007/s10540-005-2891-8; Eisenstein EM, 1997, BEHAV BRAIN RES, V82, P121, DOI 10.1016/S0166-4328(97)80982-5; ELEPFANDT A, 1985, NATURWISSENSCHAFTEN, V72, P492, DOI 10.1007/BF00441080; Elepfandt A, 2000, J EXP BIOL, V203, P3621; ELEPFANDT A, 1986, J COMP PHYSIOL A, V158, P235, DOI 10.1007/BF01338566; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Ermakova GV, 1999, DEVELOPMENT, V126, P4513; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fernandes Y, 2009, ALCOHOL CLIN EXP RES, V33, P601, DOI 10.1111/j.1530-0277.2008.00874.x; Fernandez de Miguel F., 1989, Boletin de Estudios Medicos y Biologicos Universidad Nacional Autonoma de Mexico, V37, P71; Fetcho JR, 1998, ANN NY ACAD SCI, V860, P333, DOI 10.1111/j.1749-6632.1998.tb09060.x; Fukumoto T, 2005, CURR BIOL, V15, P794, DOI 10.1016/j.cub.2005.03.044; Fusaoka E, 2006, GENES CELLS, V11, P541, DOI 10.1111/j.1365-2443.2006.00962.x; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2003, BEHAV GENET, V33, P461, DOI 10.1023/A:1025762314250; Gerlai R, 2006, PHARMACOL BIOCHEM BE, V85, P752, DOI 10.1016/j.pbb.2006.11.010; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; Giacomini NJ, 2006, NEUROTOXICOL TERATOL, V28, P245, DOI 10.1016/j.ntt.2006.01.013; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; Goldsmith P, 2001, NEUROREPORT, V12, pA73, DOI 10.1097/00001756-200109170-00001; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gonzalo A, 2007, ANIM BEHAV, V74, P447, DOI 10.1016/j.anbehav.2006.11.032; Goodnow RA, 2001, J CELL BIOCHEM, V84, P13, DOI 10.1002/jcb.10061; Granato M, 1996, DEVELOPMENT, V123, P399; HARTRY AL, 1964, SCIENCE, V146, P274, DOI 10.1126/science.146.3641.274; Hicks C, 2006, J NEUROBIOL, V66, P977, DOI 10.1002/neu.20290; HOFF K V, 1988, Society for Neuroscience Abstracts, V14, P692; HOFF KV, 1989, AM ZOOL, V29, pA43; HULSEY MG, 1991, PHYSIOL BEHAV, V50, P403, DOI 10.1016/0031-9384(91)90086-4; Humphries B., 1961, WORM RUNNERS DIGEST, V3; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; Jacobson A. L. A. M, 1962, CAROLINA TIPS, VXXV, P25; JACOBSON AL, 1967, J COMP PHYSIOL PSYCH, V64, P73, DOI 10.1037/h0024808; JACOBSON AL, 1966, NATURE, V209, P599, DOI 10.1038/209599a0; Jamieson D, 2000, J EXP BIOL, V203, P1857; JONES SM, 1994, J NEUROSCI, V14, P2789; Katayama T, 2001, BBA-GEN SUBJECTS, V1526, P183, DOI 10.1016/S0304-4165(01)00125-8; KATZ LC, 1981, ANIM BEHAV, V29, P20, DOI 10.1016/S0003-3472(81)80148-0; Key Brian, 2003, Methods in Cell Science, V25, P1; Koide K, 2001, J AM CHEM SOC, V123, P398, DOI 10.1021/ja0023377; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Koob GF, 2006, ADDICTION, V101, P23, DOI 10.1111/j.1360-0443.2006.01586.x; Kuriyama S, 2003, J EXP ZOOL PART A, V296A, P108, DOI 10.1002/jez.a.10247; Laurent MN, 1997, DEVELOPMENT, V124, P4905; LEE RM, 1963, SCIENCE, V139, P1048, DOI 10.1126/science.139.3559.1048; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; LUM AM, 1982, PHARMACOL BIOCHEM BE, V17, P363, DOI 10.1016/0091-3057(82)90093-4; MacNeil IA, 2001, J MOL MICROB BIOTECH, V3, P301; MacRae CA, 2002, COLD SPRING HARB SYM, V67, P301, DOI 10.1101/sqb.2002.67.301; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; MADRID JA, 1995, PHYSIOL BEHAV, V57, P129, DOI 10.1016/0031-9384(94)00214-P; Masino MA, 2005, J NEUROPHYSIOL, V93, P3177, DOI 10.1152/jn.01248.2004; Masse K, 2007, NATURE, V449, P1058, DOI 10.1038/nature06189; Mathis A, 2008, P ROY SOC B-BIOL SCI, V275, P2603, DOI 10.1098/rspb.2008.0754; MCCONNELL JV, 1960, AM J PSYCHOL, V73, P618, DOI 10.2307/1419955; MCCONNELL JV, 1965, WORM RUNNERS DIGEST; McElligott MB, 2005, BRAIN BEHAV EVOLUT, V66, P177, DOI 10.1159/000087158; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Miklosi A, 2001, BEHAV BRAIN RES, V122, P57, DOI 10.1016/S0166-4328(01)00167-X; Miklosi A, 1999, BEHAV BRAIN RES, V105, P199, DOI 10.1016/S0166-4328(99)00071-6; Miller G, 2006, SCIENCE, V314, P1674, DOI 10.1126/science.314.5806.1674; MILLER RR, 1977, J EXP PSYCHOL ANIM B, V3, P343, DOI 10.1037/0097-7403.3.4.343; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Moriya T, 1996, J EXP ZOOL, V276, P335, DOI 10.1002/(SICI)1097-010X(19961201)276:5<335::AID-JEZ4>3.0.CO;2-P; MURPHY J, 1963, WORM RUNNERS DIGEST, V5, P37; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Nascone N, 1997, DEV BIOL, V189, P68, DOI 10.1006/dbio.1997.8635; NEUMANN EK, 1992, BIOL CYBERN, V66, P485, DOI 10.1007/BF00204113; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Nichols CD, 2006, PHARMACOL THERAPEUT, V112, P677, DOI 10.1016/j.pharmthera.2006.05.012; Nielsen DM, 2002, J NEUROSCI METH, V115, P199, DOI 10.1016/S0165-0270(02)00020-1; Ninkovic J, 2006, METHODS, V39, P262, DOI 10.1016/j.ymeth.2005.12.007; Nishimura K, 2007, DEV NEUROBIOL, V67, P1059, DOI 10.1002/dneu.20377; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Nuttall ME, 2001, CELLS TISSUES ORGANS, V169, P265, DOI 10.1159/000047890; Orii H, 2003, DEV GENES EVOL, V213, P138, DOI 10.1007/s00427-003-0310-3; Orii H, 1999, DEV BIOL, V210, P456, DOI 10.1006/dbio.1999.9275; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; Oviedo NJ, 2009, SEMIN CELL DEV BIOL, V20, P557, DOI 10.1016/j.semcdb.2009.04.005; Pagan OR, 2009, EUR J PHARMACOL, V615, P118, DOI 10.1016/j.ejphar.2009.05.022; PAN Y, BEHAV BRAIN RES; Parng C, 2005, CURR OPIN DRUG DISC, V8, P100; PARNG C, 2006, J PHARM TOXICOL METH; PARNG C, 2006, NEUROTOXICOL TERATOL; Patino MAL, 2008, PHYSIOL BEHAV, V95, P36, DOI 10.1016/j.physbeh.2008.03.021; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Prentice SD, 2001, J ELECTROMYOGR KINES, V11, P19, DOI 10.1016/S1050-6411(00)00038-9; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Pronych SP, 1996, J EXP BIOL, V199, P2689; Pulak Rock, 2006, V351, P275; PUNZO F, 1991, J HERPETOL, V25, P214, DOI 10.2307/1564653; PUNZO F, 1976, Journal of the Bombay Natural History Society, V73, P270; Rawashdeh O, 2007, SCIENCE, V318, P1144, DOI 10.1126/science.1148564; Rawls SA, 2008, EUR J PHARMACOL, V584, P278, DOI 10.1016/j.ejphar.2008.02.018; Rawls SM, 2008, SYNAPSE, V62, P927, DOI 10.1002/syn.20571; Rawls SM, 2008, NEUROPEPTIDES, V42, P229, DOI 10.1016/j.npep.2008.03.005; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Renier C, 2007, PHARMACOGENET GENOM, V17, P237, DOI 10.1097/FPC.0b013e3280119d62; Rick JM, 2000, CURR BIOL, V10, P595, DOI 10.1016/S0960-9822(00)00495-4; Rilling M, 1996, AM PSYCHOL, V51, P589, DOI 10.1037/0003-066X.51.6.589; ROBERTS A, 1978, NATURE, V273, P774, DOI 10.1038/273774a0; Roe K., 1963, WORM RUNNERS DIGEST, V5, P16; Rosenthal, 1976, EXPT EFFECTS BEHAV R; Rowlands AL, 2008, EUR J PHARMACOL, V583, P170, DOI 10.1016/j.ejphar.2008.01.012; Russo A, 2005, PHYTOMEDICINE, V12, P305, DOI 10.1016/j.phymed.2003.12.008; Sacavage S, 2008, NEUROSCI LETT, V439, P84, DOI 10.1016/j.neulet.2008.04.086; SADAUSKAS KK, 1982, ZH VYSSH NERV DEYAT+, V32, P1176; SANBERG PR, 1985, NEUROBEH TOXICOL TER, V7, P87; Sarnat H. B., 1985, CANADIAN J NEUROLOGI; SCHAEFFER DJ, 1993, ECOTOX ENVIRON SAFE, V25, P1, DOI 10.1006/eesa.1993.1001; Sison M, 2006, LAB ANIMAL, V35, P33, DOI 10.1038/laban0506-33; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Spence R, 2007, ETHOLOGY, V113, P62, DOI 10.1111/j.1439-0310.2006.01295.x; Stephen AG, 2002, BIOCHEM BIOPH RES CO, V296, P1228, DOI 10.1016/S0006-291X(02)02063-6; Stephen W. S., 1963, WORM RUNNERS DIGEST, V5, P40; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749; STRICKLERSHAW S, 1991, NEUROTOXICOL TERATOL, V13, P167, DOI 10.1016/0892-0362(91)90007-J; STRICKLERSHAW S, 1990, ENVIRON TOXICOL CHEM, V9, P47, DOI 10.1002/etc.5620090107; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; THOMPSON R, 1955, J COMP PHYSIOL PSYCH, V48, P65, DOI 10.1037/h0041147; TIRAS KP, 1981, ZH VYSSH NERV DEYAT+, V31, P874; Ton C, 2005, HEARING RES, V208, P79, DOI 10.1016/j.heares.2005.05.005; TORELLO MW, 1983, PHARMACOL BIOCHEM BE, V19, P13, DOI 10.1016/0091-3057(83)90303-9; Tosh CR, 2006, AM NAT, V168, pE38, DOI 10.1086/505769; Tseng ASK, 2002, GENETICS, V162, P229; Turnell ER, 2003, BIOL BULL-US, V205, P225, DOI 10.2307/1543265; UNGAR G, 1974, LIFE SCI, V14, P595, DOI 10.1016/0024-3205(74)90394-4; Uretsky ME, 1996, PSYCHOL REP, V79, P763, DOI 10.2466/pr0.1996.79.3.763; Valentinuzzi VS, 1998, LEARN MEMORY, V5, P391; van Swinderen B, 2010, J NEUROSCI, V30, P1003, DOI 10.1523/JNEUROSCI.4516-09.2010; Vandenberg LN, 2010, DEVELOPMENT, V137, P1095, DOI 10.1242/dev.041798; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Viczian AS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000174; WASSERSUG R, 1971, ANIM BEHAV, V19, P386, DOI 10.1016/S0003-3472(71)80021-0; WELLS PATRICK H., 1967, P251; WELLS PH, 1963, WORM RUNNERS DIGEST, V5, P58; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1; Zhu LQ, 2007, PHYSIOL BEHAV, V91, P106, DOI 10.1016/j.physbeh.2007.01.023; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	187	32	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14370	10.1371/journal.pone.0014370	http://dx.doi.org/10.1371/journal.pone.0014370			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179424	Green Submitted, Green Published, gold			2022-12-25	WOS:000285572900007
J	Saithong, T; Painter, KJ; Millar, AJ				Saithong, Treenut; Painter, Kevin J.; Millar, Andrew J.			Consistent Robustness Analysis (CRA) Identifies Biologically Relevant Properties of Regulatory Network Models	PLOS ONE			English	Article							CIRCADIAN CLOCK; POSTTRANSCRIPTIONAL REGULATION; ARABIDOPSIS-THALIANA; SENSITIVITY-ANALYSIS; MOLECULAR-BASES; RHYTHMS; TOC1; CYANOBACTERIA; TRANSCRIPTION; CYCLE	Background: A number of studies have previously demonstrated that "goodness of fit'' is insufficient in reliably classifying the credibility of a biological model. Robustness and/or sensitivity analysis is commonly employed as a secondary method for evaluating the suitability of a particular model. The results of such analyses invariably depend on the particular parameter set tested, yet many parameter values for biological models are uncertain. Results: Here, we propose a novel robustness analysis that aims to determine the "common robustness'' of the model with multiple, biologically plausible parameter sets, rather than the local robustness for a particular parameter set. Our method is applied to two published models of the Arabidopsis circadian clock (the one-loop [1] and two-loop [2] models). The results reinforce current findings suggesting the greater reliability of the two-loop model and pinpoint the crucial role of TOC1 in the circadian network. Conclusions: Consistent Robustness Analysis can indicate both the relative plausibility of different models and also the critical components and processes controlling each model.	[Saithong, Treenut; Millar, Andrew J.] Univ Edinburgh, Inst Mol Plant Sci, Dept Biol Sci, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.] Heriot Watt Univ, Dept Math, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.] Heriot Watt Univ, Sch Math & Comp Sci, Maxwell Inst Math Sci, Edinburgh, Midlothian, Scotland; [Painter, Kevin J.; Millar, Andrew J.] Univ Edinburgh, Ctr Syst Biol Edinburgh, Edinburgh, Midlothian, Scotland; [Saithong, Treenut] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bangkok, Thailand	University of Edinburgh; Heriot Watt University; Heriot Watt University; University of Edinburgh; University of Edinburgh; King Mongkuts University of Technology Thonburi	Saithong, T (corresponding author), Univ Edinburgh, Inst Mol Plant Sci, Dept Biol Sci, Edinburgh, Midlothian, Scotland.	andrew.millar@ed.ac.uk	Millar, Andrew J/G-2423-2012; Painter, Kevin J/D-1055-2010; Saithong, Treenut/L-1395-2019	Millar, Andrew J/0000-0003-1756-3654; Painter, Kevin J/0000-0003-3273-6031; Saithong, Treenut/0000-0003-2888-6854	BBSRC [BB/D019621]; EPSRC [BB/D019621]; Royal Thai Government; BBSRC [BB/D019621/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Thai Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Centre for Systems Biology at Edinburgh is a Centre for Integrative Systems Biology supported by BBSRC and EPSRC through award BB/D019621. TS was supported by the postgraduate studentship from Higher Educational Strategic Scholarships for Frontier Research from the Royal Thai Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Bagheri N, 2007, BIOINFORMATICS, V23, P358, DOI 10.1093/bioinformatics/btl627; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BEERS KJ, 2006, NUMERICAL METHODS CH; Bell-Pedersen D, 2001, PHILOS T ROY SOC B, V356, P1697, DOI 10.1098/rstb.2001.0968; BORISUK MT, 1997, BIFURCATION ANAL MOD; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; BURNS JA, 1985, TRENDS BIOCHEM SCI, V10, P16, DOI 10.1016/0968-0004(85)90008-8; BURNS K, 1973, S SOC EXP BIOL, V27, P65; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Ding ZJ, 2007, GENETICS, V176, P1501, DOI 10.1534/genetics.107.072769; Doyle FJ, 2006, COMPUT CHEM ENG, V30, P1700, DOI 10.1016/j.compchemeng.2006.05.029; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Ferreira JS, 2006, LECT NOTES CONTR INF, V341, P279; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Hazen SP, 2005, P NATL ACAD SCI USA, V102, P10387, DOI 10.1073/pnas.0503029102; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Helfert S, 2001, BIOCHEM J, V357, P117, DOI 10.1042/0264-6021:3570117; Johnson CH, 1999, ANNU REV MICROBIOL, V53, P389, DOI 10.1146/annurev.micro.53.1.389; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kurata H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001103; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Lu J, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-11; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Millar AJ, 2004, J EXP BOT, V55, P277, DOI 10.1093/jxb/erh034; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Olivier BG, 2004, BIOINFORMATICS, V20, P2143, DOI 10.1093/bioinformatics/bth200; Poolman MG, 2000, J EXP BOT, V51, P319, DOI 10.1093/jexbot/51.suppl_1.319; Rand DA, 2004, J ROY SOC INTERFACE, V1, P119, DOI 10.1098/rsif.2004.0014; Roden LC, 2001, SEMIN CELL DEV BIOL, V12, P305, DOI 10.1006/scdb.2001.0258; SAITHONG T, 2004, THAI J BIOTECHNOLOGY, V5, P32; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Somers DE, 1998, DEVELOPMENT, V125, P485; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; TRANE C, 2008, ROBUSTNESS ANAL INTE; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; Tyson JJ, 2007, NATURE, V445, P823, DOI 10.1038/445823a; Ueda HR, 2006, MOL SYST BIOL, V2, DOI 10.1038/mbs4100105; Ueda HR, 2001, J THEOR BIOL, V210, P401, DOI 10.1006/jtbi.2000.2226; Wolf J, 2005, SYSTEMS BIOL, V2, P35, DOI 10.1049/sb:20045035; Zak DE, 2005, COMPUT CHEM ENG, V29, P663, DOI 10.1016/j.compchemeng.2004.08.021; ZEILINGER NM, 2006, MOL SYST BIOL, P1	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15589	10.1371/journal.pone.0015589	http://dx.doi.org/10.1371/journal.pone.0015589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179566	Green Published, gold, Green Submitted			2022-12-25	WOS:000285381200033
J	Kolyada, A; Lee, CJ; De Biasio, A; Beglova, N				Kolyada, Alexey; Lee, Chang-Jin; De Biasio, Alfredo; Beglova, Natalia			A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid Syndrome	PLOS ONE			English	Article							HUMAN BETA(2)-GLYCOPROTEIN I; PHOSPHOLIPID-BINDING; 5TH DOMAIN; LIPOPROTEIN RECEPTORS; LIGAND RECOGNITION; LOW-AFFINITY; ANTIBODIES; BETA-2-GLYCOPROTEIN-I; PLATELETS; AUTOANTIBODIES	Background: beta 2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an autoimmune disease characterized by thrombosis and recurrent pregnancy loss. Only the dimeric form of beta 2GPI generated by anti-beta 2GPI antibodies is pathologically important, in contrast to monomeric beta 2GPI which is abundant in plasma. Principal Findings: We created a dimeric inhibitor, A1-A1, to selectively target beta 2GPI in beta 2GPI/ antibody complexes. To make this inhibitor, we isolated the first ligand-binding module from ApoER2 (A1) and connected two A1 modules with a flexible linker. A1-A1 interferes with two pathologically important interactions in APS, the binding of beta 2GPI/ antibody complexes with anionic phospholipids and ApoER2. We compared the efficiency of A1-A1 to monomeric A1 for inhibition of the binding of beta 2GPI/ antibody complexes to anionic phospholipids. We tested the inhibition of beta 2GPI present in human serum, beta 2GPI purified from human plasma and the individual domain V of beta 2GPI. We demonstrated that when beta 2GPI/ antibody complexes are formed, A1-A1 is much more effective than A1 in inhibition of the binding of beta 2GPI to cardiolipin, regardless of the source of beta 2GPI. Similarly, A1-A1 strongly inhibits the binding of dimerized domain V of beta 2GPI to cardiolipin compared to the monomeric A1 inhibitor. In the absence of anti-beta 2GPI antibodies, both A1-A1 and A1 only weakly inhibit the binding of pathologically inactive monomeric beta 2GPI to cardiolipin. Conclusions: Our results suggest that the approach of using a dimeric inhibitor to block beta 2GPI in the pathological multivalent beta 2GPI/ antibody complexes holds significant promise. The novel inhibitor A1-A1 may be a starting point in the development of an effective therapeutic for antiphospholipid syndrome.	[Kolyada, Alexey] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kolyada, A (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	nbeglova@bidmc.harvard.edu		De Biasio, Alfredo/0000-0003-2139-2958	American Heart Association [0535027N]; American Society of Hematology; Offices of Biological and Environmental Research; Basic Energy Sciences of the US Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Society of Hematology; Offices of Biological and Environmental Research; Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was funded by the American Heart Association grant 0535027N and the American Society of Hematology Junior Faculty Scholar award to NB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Crystallographic data for this study were measured at beamline X29 of the National Synchrotron Light Source, which is supported principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and from the National Center for Research Resources of the National Institutes of Health. Coordinates and structure factors have been deposited to the Protein Data Bank with accession number 3OP8.	Abdul-Aziz D, 2005, BIOCHEMISTRY-US, V44, P5075, DOI 10.1021/bi047575j; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Atsumi T, 2005, AUTOIMMUNITY, V38, P377, DOI 10.1080/08916930500124312; BANCSI LFJMM, 1992, THROMB HAEMOSTASIS, V67, P649; Beglov D, 2009, PROTEINS, V77, P940, DOI 10.1002/prot.22519; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; Cockrell E, 2008, LUPUS, V17, P943, DOI 10.1177/0961203308095329; Cugno M, 2010, J AUTOIMMUN, V34, P105, DOI 10.1016/j.jaut.2009.07.004; de Laat HB, 2004, BLOOD, V104, P3598, DOI 10.1182/blood-2004-03-1107; De Lano WL., 2002, THEPYMOL MOL GRAPHIC; DELAAT B, 2009, J THROMB HAEMOST; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J; George D, 2009, PROG CARDIOVASC DIS, V52, P115, DOI 10.1016/j.pcad.2009.06.005; Giannakopoulos B, 2009, BLOOD, V113, P985, DOI 10.1182/blood-2007-12-129627; Giles IP, 2003, ARTHRITIS RHEUM-US, V48, P2111, DOI 10.1002/art.11101; Guerin J, 1999, AUTOIMMUNITY, V31, P109, DOI 10.3109/08916939908994054; Hammel M, 2002, J MOL BIOL, V321, P85, DOI 10.1016/S0022-2836(02)00621-6; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; HUNT J, 1994, J IMMUNOL, V152, P653; Ioannou Y, 2009, J THROMB HAEMOST, V7, P833, DOI 10.1111/j.1538-7836.2009.03316.x; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Koike T, 2007, J AUTOIMMUN, V28, P129, DOI 10.1016/j.jaut.2007.02.009; Lee CJ, 2010, STRUCTURE, V18, P366, DOI 10.1016/j.str.2009.12.013; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lim W, 2006, JAMA-J AM MED ASSOC, V295, P1050, DOI 10.1001/jama.295.9.1050; Lin F, 2006, LUPUS, V15, P87, DOI 10.1191/0961203306lu2270oa; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Lutters BCH, 2003, J BIOL CHEM, V278, P33831, DOI 10.1074/jbc.M212655200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNall-Knapp Rene Y, 2008, Curr Rheumatol Rep, V10, P62, DOI 10.1007/s11926-008-0011-z; MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120; Mehdi H, 2000, EUR J BIOCHEM, V267, P1770, DOI 10.1046/j.1432-1327.2000.01174.x; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; Pennings MTT, 2007, J THROMB HAEMOST, V5, P1538, DOI 10.1111/j.1538-7836.2007.02605.x; Pennings MTT, 2007, J THROMB HAEMOST, V5, P369, DOI 10.1111/j.1538-7836.2007.02310.x; Pennings MTT, 2006, J THROMB HAEMOST, V4, P1680, DOI 10.1111/j.1538-7836.2006.02036.x; Pierangeli SS, 2007, ANN RHEUM DIS, V66, P1327, DOI 10.1136/ard.2006.065037; Pierangeli SS, 2004, THROMB RES, V114, P467, DOI 10.1016/j.thromres.2004.06.031; Rand JH, 2010, LUPUS, V19, P460, DOI 10.1177/0961203310361485; Raschi E, 2008, LUPUS, V17, P937, DOI 10.1177/0961203308095140; Romay-Penabad Z, 2009, BLOOD, V114, P3074, DOI 10.1182/blood-2008-11-188698; ROUBEY RAS, 1995, J IMMUNOL, V154, P954; Sanghera DK, 1997, HUM MOL GENET, V6, P311, DOI 10.1093/hmg/6.2.311; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Sheng YH, 1996, J IMMUNOL, V157, P3744; Sheng YH, 1998, J IMMUNOL, V161, P2038; Shi T, 2006, ARTHRITIS RHEUM-US, V54, P2558, DOI 10.1002/art.21968; Takeuchi R, 2000, BLOOD, V96, P1594, DOI 10.1182/blood.V96.4.1594.h8001594_1594_1595; Tincani A, 1996, J IMMUNOL, V157, P5732; Urbanus RT, 2008, BLOOD REV, V22, P93, DOI 10.1016/j.blre.2007.09.001; URBANUS RT, 2008, J THROMB HAEMOST; van Lummel M, 2005, J BIOL CHEM, V280, P36729, DOI 10.1074/jbc.M504172200; van Os GMA, 2010, HAMOSTASEOLOGIE, V30, P139, DOI 10.1055/s-0037-1619044; Willems GM, 1996, BIOCHEMISTRY-US, V35, P13833, DOI 10.1021/bi960657q; Yasuda S, 2000, ATHEROSCLEROSIS, V152, P337, DOI 10.1016/S0021-9150(99)00496-7	61	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15345	10.1371/journal.pone.0015345	http://dx.doi.org/10.1371/journal.pone.0015345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179511	Green Submitted, Green Published, gold			2022-12-25	WOS:000285340000022
J	Banjo, OC; Nadler, R; Reiner, PB				Banjo, Opeyemi C.; Nadler, Roland; Reiner, Peter B.			Physician Attitudes towards Pharmacological Cognitive Enhancement: Safety Concerns Are Paramount	PLOS ONE			English	Article								The ethical dimensions of pharmacological cognitive enhancement have been widely discussed in academic circles and the popular media, but missing from the conversation have been the perspectives of physicians - key decision makers in the adoption of new technologies into medical practice. We queried primary care physicians in major urban centers in Canada and the United States with the aim of understanding their attitudes towards cognitive enhancement. Our primary hypothesis was that physicians would be more comfortable prescribing cognitive enhancers to older patients than to young adults. Physicians were presented with a hypothetical pharmaceutical cognitive enhancer that had been approved by the regulatory authorities for use in healthy adults, and was characterized as being safe, effective, and without significant adverse side effects. Respondents overwhelmingly reported increasing comfort with prescribing cognitive enhancers as the patient age increased from 25 to 65. When asked about their comfort with prescribing extant drugs that might be considered enhancements (sildenafil, modafinil, and methylphenidate) or our hypothetical cognitive enhancer to a normal, healthy 40 year old, physicians were more comfortable prescribing sildenafil than any of the other three agents. When queried as to the reasons they answered as they did, the most prominent concerns physicians expressed were issues of safety that were not offset by the benefit afforded the individual, even in the face of explicit safety claims. Moreover, many physicians indicated that they viewed safety claims with considerable skepticism. It has become routine for safety to be raised and summarily dismissed as an issue in the debate over pharmacological cognitive enhancement; the observation that physicians were so skeptical in the face of explicit safety claims suggests that such a conclusion may be premature. Thus, physician attitudes suggest that greater weight be placed upon the balance between safety and benefit in consideration of pharmacological cognitive enhancement.	[Banjo, Opeyemi C.; Nadler, Roland; Reiner, Peter B.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Banjo, OC (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	peter.reiner@ubc.ca		Nadler, Roland/0000-0002-9504-7527	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) (http://www.cihr.ca/e/193.html). (F08-04061: Normality, normalization and enhancement in the neurosciences: ethical, sociocultural and neuropsychiatric aspects of cognitive enhancement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom LS, 2008, SCAND J PUBLIC HEALT, V36, P532, DOI 10.1177/1403494807087558; Bostrom N, 2005, BIOETHICS, V19, P202, DOI 10.1111/j.1467-8519.2005.00437.x; BOSTROM N, ENHANCING H IN PRESS; *BRIT MED ASS, 2007, BOOST YOUR BRAINP ET; BROOKS D, 2008, NY TIMES        0502; BUSCH C, 2010, CONTENT ANAL; Bush SS, 2006, APPL NEUROPSYCHOL, V13, P125, DOI 10.1207/s15324826an1302_7; Cakic V, 2009, J MED ETHICS, V35, P611, DOI 10.1136/jme.2009.030882; Caplan A, 2004, PLOS MED, V1, P172, DOI 10.1371/journal.pmed.0010052; CASCIO J, 2009, ATLANTIC, V304, P94; Chatterjee A, 2004, NEUROLOGY, V63, P968, DOI 10.1212/01.WNL.0000138438.88589.7C; CHATTERJEE A, 2007, CAMB Q HEALTHC ETHIC, V2, P129; Crook T, 1986, DEV NEUROPSYCHOL, V2, P261, DOI 10.1080/87565648609540348; Daniels N, 2000, CAMB Q HEALTHC ETHIC, V9, P309, DOI 10.1017/S0963180100903037; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Flower R, 2004, TRENDS PHARMACOL SCI, V25, P182, DOI 10.1016/j.tips.2004.02.006; FREELON D, 2010, RECAL SOFTWARE; Fukuyama Francis, 2002, OUR POSTHUMAN FUTURE; GARREAU J, 2006, WASHINGTON POST 0611; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hughes JJ, 2007, FUTURES, V39, P942, DOI 10.1016/j.futures.2007.03.002; HUNT E, 1995, AM SCI, V83, P356; HYMAN SE, 2006, BIOSOCIETIES, V1, P103; KOIVISTO K, 1995, NEUROLOGY, V45, P741, DOI 10.1212/WNL.45.4.741; Larrabee G J, 1994, Int Psychogeriatr, V6, P95, DOI 10.1017/S1041610294001663; Larriviere D, 2009, NEUROLOGY, V73, P1406, DOI 10.1212/WNL.0b013e3181beecfe; Metzl JM, 2007, LANCET, V369, P697, DOI 10.1016/S0140-6736(07)60317-1; PERSSON I, 2008, J APPL PHILOS, V3, P162; Pieters T, 2009, NEUROETHICS-NETH, V2, P63, DOI 10.1007/s12152-009-9033-0; POITRAS G, 2008, J BUS ETHICS, V3, P313; Racine E, 2009, J MED ETHICS, V35, P469, DOI 10.1136/jme.2009.030460; Ravelingien A, 2009, NEUROETHICS-NETH, V2, P151, DOI 10.1007/s12152-009-9042-z; Reiner Peter B, 2010, Virtual Mentor, V12, P885, DOI 10.1001/virtualmentor.2010.12.11.msoc1-1011; Rose SPR, 2002, NAT REV NEUROSCI, V3, P975, DOI 10.1038/nrn984; Sarewitz D., 2006, POLICY IMPLICATIONS; Savulescu J, 2006, ANN NY ACAD SCI, V1093, P321, DOI 10.1196/annals.1382.021; SCHNEIDER S, 2008, PENN CTR GUIDE BIOET, P95; Schulz K, 2006, NATION, V282, P11; Scripko PD, 2010, J MED ETHICS, V36, P293, DOI 10.1136/jme.2009.032383; Synofzik M, 2009, NEUROETHICS-NETH, V2, P89, DOI 10.1007/s12152-008-9029-1; The President's Council on Bioethics, 2003, THER BIOT PURS HAPP; Turner D.C., 2006, BIOSOCIETIES, V1, P113, DOI DOI 10.1017/S1745855205040044; Whitehouse PJ, 1997, HASTINGS CENT REP, V27, P14, DOI 10.2307/3528662; Wiesing U, 2008, INT LIBR ETH LAW TEC, V2, P9; YOUNG M, 2008, N 1, V7, P209	46	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14322	10.1371/journal.pone.0014322	http://dx.doi.org/10.1371/journal.pone.0014322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	694JH	21179461	Green Submitted, Green Published, gold			2022-12-25	WOS:000285292500006
J	Mroz, P; Szokalska, A; Wu, MX; Hamblin, MR				Mroz, Pawel; Szokalska, Angelika; Wu, Mei X.; Hamblin, Michael R.			Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response	PLOS ONE			English	Article							CYTOLYTIC T-LYMPHOCYTES; COMPLEMENT ACTIVATION; ANTITUMOR IMMUNITY; COLON-TUMOR; IFN-GAMMA; GENE; RECOMBINANT; CELLS; INDUCTION; MICE	Background: The mechanism by which the immune system can effectively recognize and destroy tumors is dependent on recognition of tumor antigens. The molecular identity of a number of these antigens has recently been identified and several immunotherapies have explored them as targets. Photodynamic therapy (PDT) is an anti-cancer modality that uses a non-toxic photosensitizer and visible light to produce cytotoxic reactive oxygen species that destroy tumors. PDT has been shown to lead to local destruction of tumors as well as to induction of anti-tumor immune response. Methodology/Principal Findings: We used a pair of equally lethal BALB/c colon adenocarcinomas, CT26 wild-type (CT26WT) and CT26.CL25 that expressed a tumor antigen, beta-galactosidase (beta-gal), and we treated them with vascular PDT. All mice bearing antigen-positive, but not antigen-negative tumors were cured and resistant to rechallenge. T lymphocytes isolated from cured mice were able to specifically lyse antigen positive cells and recognize the epitope derived from beta-galactosidase antigen. PDT was capable of destroying distant, untreated, established, antigen-expressing tumors in 70% of the mice. The remaining 30% escaped destruction due to loss of expression of tumor antigen. The PDT anti-tumor effects were completely abrogated in the absence of the adaptive immune response. Conclusion: Understanding the role of antigen-expression in PDT immune response may allow application of PDT in metastatic as well as localized disease. To the best of our knowledge, this is the first time that PDT has been shown to lead to systemic, antigen-specific anti-tumor immunity.	[Mroz, Pawel; Szokalska, Angelika; Wu, Mei X.; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Mroz, Pawel; Wu, Mei X.; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Szokalska, Angelika] Med Univ Warsaw, Dept Immunol, Warsaw, Poland; [Wu, Mei X.; Hamblin, Michael R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Medical University of Warsaw; Harvard University; Massachusetts Institute of Technology (MIT)	Mroz, P (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	hamblin@helix.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019; Hamblin, Mike/AAB-2511-2022; Mroz, Pawel/P-1258-2019; Muchowicz, Angelika/J-7494-2012	Hamblin, Michael R/0000-0001-6431-4605; Muchowicz, Angelika/0000-0003-4707-1722; Mroz, Pawel/0000-0003-3838-4743	US NIH National Cancer Institute [RO1CA/AI838801, R01AI050875]; Genzyme-Partners Translational Research Grant; Foundation for Polish Science, International Union Against Cancer and European Structural Fund; NATIONAL CANCER INSTITUTE [R01CA083882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER	US NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genzyme-Partners Translational Research Grant; Foundation for Polish Science, International Union Against Cancer and European Structural Fund(Foundation for Polish Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by US NIH National Cancer Institute (grants RO1CA/AI838801 and R01AI050875 to MRH). P.M. was partly supported by Genzyme-Partners Translational Research Grant. A.S. was supported by the Foundation for Polish Science, International Union Against Cancer and European Structural Fund: "Mazowieckie Stypendium Doktoranckie." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER ABH, 1994, J EXP MED, V179, P1005, DOI 10.1084/jem.179.3.1005; Beatty GL, 2000, J IMMUNOL, V165, P5502, DOI 10.4049/jimmunol.165.10.5502; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Carroll MW, 1997, VACCINE, V15, P387, DOI 10.1016/S0264-410X(96)00195-8; Castano AP, 2008, P NATL ACAD SCI USA, V105, P5495, DOI 10.1073/pnas.0709256105; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Cecic I, 2006, PHOTOCHEM PHOTOBIOL, V82, P558, DOI 10.1562/2005-09-09-RA-681; Cecic I, 2006, J ENVIRON PATHOL TOX, V25, P189; Cecic I, 2005, CANCER LETT, V225, P215, DOI 10.1016/j.canlet.2004.11.059; Cecic I, 2002, CANCER LETT, V183, P43, DOI 10.1016/S0304-3835(02)00092-7; Cecic I, 2001, PHOTOCHEM PHOTOBIOL, V74, P712, DOI 10.1562/0031-8655(2001)074<0712:IOSNRI>2.0.CO;2; Cecic I, 2006, INT IMMUNOPHARMACOL, V6, P1259, DOI 10.1016/j.intimp.2006.03.008; Chen PW, 1996, J IMMUNOL, V156, P224; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; DALPORTO J, 1993, P NATL ACAD SCI USA, V90, P6671, DOI 10.1073/pnas.90.14.6671; Disis ML, 2002, J CLIN ONCOL, V20, P2624, DOI 10.1200/JCO.2002.06.171; Donohue KB, 2006, IMMUNOLOGY, V119, P63, DOI 10.1111/j.1365-2567.2006.02406.x; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Dougherty TJ, 2002, J CLIN LASER MED SUR, V20, P3, DOI 10.1089/104454702753474931; Dubey P, 1997, J EXP MED, V185, P695, DOI 10.1084/jem.185.4.695; GARRIDO F, CANC IMMUNOL IMMUNOT, V59, P1601; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; Golgher D, 2002, EUR J IMMUNOL, V32, P3267, DOI 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1; Gollnick SO, 2006, LASER SURG MED, V38, P509, DOI 10.1002/lsm.20362; Gollnick SO, 2003, BRIT J CANCER, V88, P1772, DOI 10.1038/sj.bjc.6600864; Hance KW, 2009, CLIN CANCER RES, V15, P2387, DOI 10.1158/1078-0432.CCR-08-1752; Hirohashi Y, 2009, CANCER SCI, V100, P798, DOI 10.1111/j.1349-7006.2009.01137.x; Huang AYC, 1996, P NATL ACAD SCI USA, V93, P9730, DOI 10.1073/pnas.93.18.9730; Huang Z, 2005, TECHNOL CANCER RES T, V4, P283, DOI 10.1177/153303460500400308; Irvine KR, 1996, J IMMUNOL, V156, P238; Jalili A, 2004, CLIN CANCER RES, V10, P4498, DOI 10.1158/1078-0432.CCR-04-0367; Kabingu E, 2009, CLIN CANCER RES, V15, P4460, DOI 10.1158/1078-0432.CCR-09-0400; Korbelik M, 2005, CANCER RES, V65, P1018; Korbelik M, 2007, BRIT J CANCER, V96, P67, DOI 10.1038/sj.bjc.6603508; Korbelik M, 1996, J Clin Laser Med Surg, V14, P329; Korbelik M, 2008, J PHOTOCH PHOTOBIO B, V93, P53, DOI 10.1016/j.jphotobiol.2008.04.005; Korbelik M, 2008, INT J CANCER, V122, P1411, DOI 10.1002/ijc.23248; Korbelik M, 2006, LASER SURG MED, V38, P500, DOI 10.1002/lsm.20337; KROSL G, 1995, BRIT J CANCER, V71, P549, DOI 10.1038/bjc.1995.108; Laheru D, 2005, NAT REV CANCER, V5, P459, DOI 10.1038/nrc1630; LETHE B, 1992, EUR J IMMUNOL, V22, P2283, DOI 10.1002/eji.1830220916; MANDELBOIM O, 1994, NATURE, V369, P67, DOI 10.1038/369067a0; Marshall JL, 2005, J CLIN ONCOL, V23, P720, DOI 10.1200/JCO.2005.10.206; McWilliams JA, 2008, VACCINE, V26, P1863, DOI 10.1016/j.vaccine.2008.01.052; MONACH PA, 1995, IMMUNITY, V2, P45, DOI 10.1016/1074-7613(95)90078-0; Mroz P, 2007, PHOTOCH PHOTOBIO SCI, V6, P1139, DOI 10.1039/b711141j; MULE JJ, 1992, J IMMUNOL, V148, P2622; NASTALA CL, 1994, J IMMUNOL, V153, P1697; Paglia P, 1996, J EXP MED, V183, P317, DOI 10.1084/jem.183.1.317; Parkinson-Lawrence EJ, 2005, CELL IMMUNOL, V236, P161, DOI 10.1016/j.cellimm.2005.08.024; Quesnel B, 2008, APMIS, V116, P685, DOI 10.1111/j.1600-0463.2008.01163.x; Restifo NP, 2002, SEMIN CANCER BIOL, V12, P81, DOI 10.1006/scbi.2001.0399; Robbins PF, 1996, J EXP MED, V183, P1185, DOI 10.1084/jem.183.3.1185; Stewart TJ, 2008, ONCOGENE, V27, P5894, DOI 10.1038/onc.2008.268; Stott B, 2007, CANCER IMMUNOL IMMUN, V56, P649, DOI 10.1007/s00262-006-0221-z; Takeda J, 2000, CELL IMMUNOL, V204, P11, DOI 10.1006/cimm.2000.1691; TRAVERSARI C, 1992, J EXP MED, V176, P1453, DOI 10.1084/jem.176.5.1453; van der Bruggen P, 2006, CURR OPIN IMMUNOL, V18, P98, DOI 10.1016/j.coi.2005.11.013; VANDENEYNDE B, 1991, J EXP MED, V173, P1373, DOI 10.1084/jem.173.6.1373; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; VandenEynde BJ, 1997, CURR OPIN IMMUNOL, V9, P684, DOI 10.1016/S0952-7915(97)80050-7; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Wang M, 1995, J IMMUNOTHER, V18, P139, DOI 10.1097/00002371-199510000-00001	65	98	103	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15194	10.1371/journal.pone.0015194	http://dx.doi.org/10.1371/journal.pone.0015194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179470	Green Published, gold, Green Submitted			2022-12-25	WOS:000285292500016
J	Piazza, P; McMurtrey, CP; Lelic, A; Cook, RL; Hess, R; Yablonsky, E; Borowski, L; Loeb, MB; Bramson, JL; Hildebrand, WH; Rinaldo, CR				Piazza, Paolo; McMurtrey, Curtis P.; Lelic, Alina; Cook, Robert L.; Hess, Rachel; Yablonsky, Eric; Borowski, Luann; Loeb, Mark B.; Bramson, Jonathan L.; Hildebrand, William H.; Rinaldo, Charles R.			Surface Phenotype and Functionality of WNV Specific T Cells Differ with Age and Disease Severity	PLOS ONE			English	Article							WEST-NILE-VIRUS; INFECTION; RESPONSES; IDENTIFICATION; EPITOPES; HUMANS	West Nile virus (WNV) infection can result in severe neuroinvasive disease, particularly in persons with advanced age. As rodent models demonstrate that T cells play an important role in limiting WNV infection, and strong T cell responses to WNV have been observed in humans, we postulated that inadequate antiviral T cell immunity was involved in neurologic sequelae and the more severe outcomes associated with age. We previously reported the discovery of six HLA-A*0201 restricted WNV peptide epitopes, with the dominant T cell targets in naturally infected individuals being SVG9 (Env) and SLF9 (NS4b). Here, memory phenotype and polyfunctional CD8(+) T cell responses to these dominant epitopes were assessed in 40 WNV seropositive patients displaying diverse clinical symptoms. The patients' PBMC were stained with HLA-I multimers loaded with the SVG9 and SLF9 epitopes and analyzed by multicolor flow cytometry. WNV-specific CD8(+) T cells were found in peripheral blood several months post infection. The number of WNV-specific T cells in older individuals was the same, if not greater, than in younger members of the cohort. WNV-specific T cells were predominantly monofunctional for CD107a, MIP-1 beta, TNF alpha, IL-2, or IFN gamma. When CD8(+) T cell responses were stratified by disease severity, an increased number of terminally differentiated, memory phenotype (CD45RA(+) CD27(-) CCR7(-) CD57(+)) T cells were detected in patients suffering from viral neuroinvasion. In conclusion, T cells of a terminally differentiated/cytolytic profile are associated with neuroinvasion and, regardless of age, monofunctional T cells persist following infection. These data provide the first indication that particular CD8(+) T cell phenotypes are associated with disease outcome following WNV infection.	[Piazza, Paolo; Yablonsky, Eric; Borowski, Luann; Rinaldo, Charles R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [McMurtrey, Curtis P.; Hildebrand, William H.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Lelic, Alina; Loeb, Mark B.; Bramson, Jonathan L.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Cook, Robert L.] Univ Florida, Hlth Sci Ctr, Dept Epidemiol & Biostat, Gainesville, FL USA; [Hess, Rachel] Ctr Res Hlth Care, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; State University System of Florida; University of Florida	Piazza, P (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	William-hildebrand@ouhsc.edu		Bramson, Jonathan/0000-0003-2874-6886; Piazza, Paolo/0000-0002-2173-1342	National Institutes of Health [HHSN266200400027C, 1U01AI082057-01, N01-AI-40066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082057, N01AI040066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (www.nih.gov) Contract HHSN266200400027C (to W.H.H.), National Institutes of Health grant 1U01AI082057-01 (to W.H.H.) and in part by National Institutes of Health Contract N01-AI-40066 (to J.L.B. and M.B.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; APPLER KK, PLOS ONE, V5; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Deng YP, 2004, J IMMUNOL, V172, P3437, DOI 10.4049/jimmunol.172.6.3437; Hoffmann TK, 2000, CYTOMETRY, V41, P321, DOI 10.1002/1097-0320(20001201)41:4<321::AID-CYTO11>3.0.CO;2-9; Khan N, 2004, J IMMUNOL, V173, P7481, DOI 10.4049/jimmunol.173.12.7481; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Lecuroux C, 2009, BLOOD, V113, P3209, DOI 10.1182/blood-2008-07-167601; McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Parsons R, 2008, J IMMUNOL, V181, P1563, DOI 10.4049/jimmunol.181.2.1563; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Sejvar JJ, 2007, CLIN INFECT DIS, V44, P1617, DOI 10.1086/518281; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Wang Y, 2006, J GEN VIROL, V87, P3599, DOI 10.1099/vir.0.81306-0	19	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15343	10.1371/journal.pone.0015343	http://dx.doi.org/10.1371/journal.pone.0015343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179445	Green Accepted, gold, Green Published			2022-12-25	WOS:000285246900044
J	Kamata, Y; Yamamoto, M; Kawakami, F; Tsuboi, R; Takeda, A; Ishihara, K; Hibino, T				Kamata, Yayoi; Yamamoto, Mami; Kawakami, Fumitaka; Tsuboi, Ryoji; Takeda, Atsushi; Ishihara, Kazuhiko; Hibino, Toshihiko			Bleomycin Hydrolase Is Regulated Biphasically in a Differentiation- and Cytokine-dependent Manner RELEVANCE TO ATOPIC DERMATITIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKIN-BARRIER FUNCTION; TRANSCRIPTIONAL REGULATION; ICHTHYOSIS VULGARIS; STRATUM-CORNEUM; GENE-EXPRESSION; FILAGGRIN; FAMILY; MZF1; SP1; LOCALIZATION	Loss-of-function mutation in the profilaggrin gene is a major risk factor for atopic dermatitis (AD). Previously, we showed that a neutral cysteine protease, bleomycin hydrolase (BH), has a role in generating natural moisturizing factors, and calpain I is an upstream protease in the filaggrin degradation pathway. Here, we investigated the transcriptional regulatory mechanisms of BH and the relevance of BH to AD. First, we cloned the 5'-flanking region of BH. Deletion analyses identified a critical region for BH promoter activity within -216 bp upstream. Electrophoretic mobility shift assay revealed that MZF-1, Sp-1, and interferon regulatory factor-1/2 could bind to this region in vitro. Moreover, site-directed mutagenesis of the MZF-1 and Sp-1 motifs markedly reduced BH promoter activity. These data indicate that BH expression is up-regulated via MZF-1 and Sp-1. Interestingly, a Th1 cytokine, IFN-gamma, significantly reduced the expression of BH. Analyses with site-directed mutagenesis and small interference RNA supported the suppressing effect of IFN-gamma on BH expression. On the other hand, a Th2 cytokine, IL-4, did not show any direct effect on BH expression. However, it down-regulated MZF-1 and Sp-1 in cultured keratinocytes, indicating that IL-4 could work as a suppressor in BH regulation. Lastly, we examined expression of BH in skins of patients with AD. BH activity and expression were markedly decreased in AD lesional skin, suggesting a defect of the filaggrin degradation pathway in AD. Our results suggest that BH transcription would be modulated during both differentiation and inflammation.	[Kamata, Yayoi; Yamamoto, Mami; Hibino, Toshihiko] Shiseido Res Ctr, Kanagawa 2388643, Japan; Kitasato Univ, Grad Sch Med Sci, Dept Biochem Regulat, Kanagawa 2520373, Japan; [Yamamoto, Mami; Tsuboi, Ryoji] Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, Tokyo 1608402, Japan; [Takeda, Atsushi] Sagami Womens Univ, Fac Nutr Sci, Biochem Lab, Kanagawa 2520383, Japan	Shiseido Company, Limited; Kitasato University; Tokyo Medical University	Hibino, T (corresponding author), Shiseido Res Ctr, Kanagawa 2388643, Japan.	toshihiko.hibino@to.shiseido.co.jp	Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172				Allam JP, 2006, CLIN EXP DERMATOL, V31, P89, DOI 10.1111/j.1365-2230.2005.01980.x; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Dong S, 2008, J INVEST DERMATOL, V128, P549, DOI 10.1038/sj.jid.5701048; Dong S, 2006, BIOCHEM J, V397, P449, DOI 10.1042/BJ20051939; Dong SJ, 2005, J INVEST DERMATOL, V124, P1026, DOI 10.1111/j.0022-202X.2005.23690.x; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Ferrando AA, 1997, J BIOL CHEM, V272, P33298, DOI 10.1074/jbc.272.52.33298; Ferrando AA, 1996, CANCER RES, V56, P1746; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kajiya A, 2006, PROTEIN PEPTIDE LETT, V13, P119, DOI 10.2174/092986606775101562; Kamata Y, 2007, J BIOCHEM, V141, P69, DOI 10.1093/jb/mvm005; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kim E, 2009, J IMMUNOL, V183, P7379, DOI 10.4049/jimmunol.0901489; Le Mee S, 2005, EXP CELL RES, V302, P129, DOI 10.1016/j.yexcr.2004.08.028; Lefterov IM, 2000, FASEB J, V14, P1837, DOI 10.1096/fj.99-0938com; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Nakamura Y, 2007, EXP DERMATOL, V16, P143, DOI 10.1111/j.1600-0625.2006.00528.x; Nomura T, 2008, J INVEST DERMATOL, V128, P1436, DOI 10.1038/sj.jid.5701205; Odanagi M, 2004, EXP DERMATOL, V13, P773, DOI 10.1111/j.0906-6705.2004.00219.x; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Schwartz DR, 1999, P NATL ACAD SCI USA, V96, P4680, DOI 10.1073/pnas.96.8.4680; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takahashi M, 2004, ARCH DERMATOL RES, V295, P448, DOI 10.1007/s00403-003-0448-x; Takeda A, 1996, J BIOCHEM-TOKYO, V119, P29; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; UMEZAWA H, 1974, Journal of Antibiotics (Tokyo), V27, P419; Verdier-Sevrain Sylvie, 2007, J Cosmet Dermatol, V6, P75, DOI 10.1111/j.1473-2165.2007.00300.x; Wang Y, 2007, CANCER RES, V67, P2535, DOI 10.1158/0008-5472.CAN-06-3530; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	42	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8204	8212		10.1074/jbc.M110.169292	http://dx.doi.org/10.1074/jbc.M110.169292			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21190945	Green Published, hybrid			2022-12-25	WOS:000288013300051
J	Pieulle, L; Stocker, P; Vinay, M; Nouailler, M; Vita, N; Brasseur, G; Garcin, E; Sebban-Kreuzer, C; Dolla, A				Pieulle, Laetitia; Stocker, Pierre; Vinay, Manon; Nouailler, Matthieu; Vita, Nicolas; Brasseur, Gael; Garcin, Edwige; Sebban-Kreuzer, Corinne; Dolla, Alain			Study of the Thiol/Disulfide Redox Systems of the Anaerobe Desulfovibrio vulgaris Points Out Pyruvate:Ferredoxin Oxidoreductase as a New Target for Thioredoxin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-FERREDOXIN OXIDOREDUCTASE; OXIDATIVE STRESS-RESPONSE; BACTEROIDES-FRAGILIS; ESCHERICHIA-COLI; SUPEROXIDE REDUCTASE; HYDROGEN-PEROXIDE; STRICT ANAEROBE; OXYGEN; HILDENBOROUGH; IDENTIFICATION	Sulfate reducers have developed a multifaceted adaptative strategy to survive against oxidative stresses. Along with this oxidative stress response, we recently characterized an elegant reversible disulfide bond-dependent protective mechanism in the pyruvate: ferredoxin oxidoreductase (PFOR) of various Desulfovibrio species. Here, we searched for thiol redox systems involved in this mechanism. Using thiol fluorescent labeling, we show that glutathione is not the major thiol/disulfide balance-controlling compound in four different Desulfovibrio species and that no other plentiful low molecular weight thiol can be detected. Enzymatic analyses of two thioredoxins (Trxs) and three thioredoxin reductases allow us to propose the existence of two independent Trx systems in Desulfovibrio vulgaris Hildenborough (DvH). The TR1/Trx1 system corresponds to the typical bacterial Trx system. We measured a TR1 apparent K-m value for Trx1 of 8.9 mu M. Moreover, our results showed that activity of TR1 was NADPH-dependent. The second system named TR3/Trx3 corresponds to an unconventional Trx system as TR3 used preferentially NADH (K-m for NADPH, 743 mu M; K-m for NADH, 5.6 mu M), and Trx3 was unable to reduce insulin. The K-m value of TR3 for Trx3 was 1.12 mu M. In vitro experiments demonstrated that the TR1/Trx1 system was the only one able to reactivate the oxygen-protected form of Desulfovibrio africanus PFOR. Moreover, ex vivo pulldown assays using the mutant Trx1(C33S) as bait allowed us to capture PFOR from the DvH extract. Altogether, these data demonstrate that PFOR is a new target for Trx1, which is probably involved in the protective switch mechanism of the enzyme.	[Pieulle, Laetitia; Vinay, Manon; Nouailler, Matthieu; Vita, Nicolas; Brasseur, Gael; Garcin, Edwige; Sebban-Kreuzer, Corinne; Dolla, Alain] CNRS UPR3243 IFR88, Lab Interact & Modulateurs Reponses, F-13402 Marseille 20, France; [Stocker, Pierre] FST Univ Paul Cezanne, Case 342, UMR6263, Equipe Biosci iSm2, F-13397 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Pieulle, L (corresponding author), CNRS UPR3243 IFR88, Lab Interact & Modulateurs Reponses, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	pieulle@ibsm.cnrs-mrs.fr		garcin, edwige b./0000-0002-0533-6940				Alkhalfioui F, 2007, J EXP BOT, V58, P969, DOI 10.1093/jxb/erl248; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Briukhanov A L, 2007, Prikl Biokhim Mikrobiol, V43, P635; Chabriere E, 1999, NAT STRUCT BIOL, V6, P182; Collet JF, 2003, J BIOL CHEM, V278, P45325, DOI 10.1074/jbc.M307818200; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; Dolla A, 2006, J BIOTECHNOL, V126, P87, DOI 10.1016/j.jbiotec.2006.03.041; Emerson JP, 2002, BIOCHEMISTRY-US, V41, P4348, DOI 10.1021/bi0119159; FAHEY RC, 1987, METHOD ENZYMOL, V143, P85; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Fareleira P, 2003, MICROBIOL-SGM, V149, P1513, DOI 10.1099/mic.0.26155-0; Foloppe N, 2004, STRUCTURE, V12, P289, DOI 10.1016/j.str.2004.01.009; Fournier M, 2003, J BACTERIOL, V185, P71, DOI 10.1128/JB.185.1.71-79.2003; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garczarek F, 2007, J STRUCT BIOL, V159, P9, DOI 10.1016/j.jsb.2007.01.020; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Hisabori T, 2005, J EXP BOT, V56, P1463, DOI 10.1093/jxb/eri170; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hummel CS, 2005, FEMS MICROBIOL LETT, V252, P229, DOI 10.1016/j.femsle.2005.09.004; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2008, MOL MICROBIOL, V68, P801, DOI 10.1111/j.1365-2958.2008.06213.x; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; Jeon SJ, 2002, EUR J BIOCHEM, V269, P5423, DOI 10.1046/j.1432-1033.2002.03231.x; JOHNSON TC, 1984, J BACTERIOL, V158, P1061, DOI 10.1128/JB.158.3.1061-1069.1984; Kawasaki S, 2005, APPL ENVIRON MICROB, V71, P8442, DOI 10.1128/AEM.71.12.8442-8450.2005; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Li XK, 2009, J BACTERIOL, V191, P4924, DOI 10.1128/JB.00197-09; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Motohashi Ken, 2009, V479, P117, DOI 10.1007/978-1-59745-289-2_8; Mukhopadhyay A, 2007, J BACTERIOL, V189, P5996, DOI 10.1128/JB.00368-07; Navarro F, 1996, PLANT PHYSIOL, V111, P1067, DOI 10.1104/pp.111.4.1067; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Niviere V, 2004, BIOCHEMISTRY-US, V43, P808, DOI 10.1021/bi035698i; Obiero J, 2010, J BACTERIOL, V192, P494, DOI 10.1128/JB.01046-09; ONDARZA RN, 1983, J MOL EVOL, V19, P371, DOI 10.1007/BF02101641; Pasternak C, 1997, MICROBIOL-UK, V143, P83, DOI 10.1099/00221287-143-1-83; Pereira PM, 2008, ARCH MICROBIOL, V189, P451, DOI 10.1007/s00203-007-0335-5; Pereira PM, 2008, ANTON LEEUW INT J G, V93, P347, DOI 10.1007/s10482-007-9212-0; PIEULLE L, 1995, BBA-PROTEIN STRUCT M, V1250, P49, DOI 10.1016/0167-4838(95)00029-T; Postgate J. R., 1984, SULFATE REDUCING BAC, P12; Potamitou A, 2002, J BIOL CHEM, V277, P18561, DOI 10.1074/jbc.M201225200; Reott MA, 2009, J BACTERIOL, V191, P3384, DOI 10.1128/JB.01665-08; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; Rocha ER, 2007, J BACTERIOL, V189, P8015, DOI 10.1128/JB.00714-07; Ruocco MR, 2004, BIOCHIMIE, V86, P883, DOI 10.1016/j.biochi.2004.10.008; Sambrook J., 1989, MOL CLONING, pA1; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; SENEZ JC, 1954, B SOC CHIM BIOL, V36, P541; Setterdahl AT, 2003, BIOCHEMISTRY-US, V42, P14877, DOI 10.1021/bi0302088; Smalley D, 2002, J BACTERIOL, V184, P895, DOI 10.1128/jb.184.4.895-903.2002; Strand KR, 2010, ARCH MICROBIOL, V192, P447, DOI 10.1007/s00203-010-0570-z; Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x; Tang Y, 2007, J BACTERIOL, V189, P940, DOI 10.1128/JB.00948-06; Vita N, 2008, BIOCHEMISTRY-US, V47, P957, DOI 10.1021/bi7014713; Yang XQ, 2010, J BACTERIOL, V192, P1370, DOI 10.1128/JB.01035-09; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1; Zhang WW, 2006, ANTON LEEUW INT J G, V90, P41, DOI 10.1007/s10482-006-9059-9; Zhou AF, 2010, ENVIRON MICROBIOL, V12, P2645, DOI 10.1111/j.1462-2920.2010.02234.x	66	19	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7812	7821		10.1074/jbc.M110.197988	http://dx.doi.org/10.1074/jbc.M110.197988			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21199874	Green Published, hybrid			2022-12-25	WOS:000288013300012
J	Devi, YS; Seibold, AM; Shehu, A; Maizels, E; Halperin, J; Le, J; Binart, N; Bao, L; Gibori, G				Devi, Y. Sangeeta; Seibold, Anita M.; Shehu, Aurora; Maizels, Evelyn; Halperin, Julia; Le, Jamie; Binart, Nadine; Bao, Lei; Gibori, Geula			Inhibition of MAPK by Prolactin Signaling through the Short Form of Its Receptor in the Ovary and Decidua INVOLVEMENT OF A NOVEL PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GRANULOSA-CELLS; UP-REGULATION; PRL RECEPTOR; EXPRESSION; KINASE; GENE; RAT; LONG; CLONING	Prolactin (PRL) is essential for normal reproduction and signals through two types of receptors, the short (PRL-RS) and long (PRL-RL) form. We have previously shown that transgenic mice expressing only PRL-RS (PRLR-/-RS) display abnormal follicular development and premature ovarian failure. Here, we report that MAPK, essential for normal follicular development, is critically inhibited by PRL in reproductive tissues of PRLR-/-RS mice. Consequently, the phosphorylation of MAPK downstream targets are also markedly inhibited by PRL without affecting immediate upstream kinases, suggesting involvement of MAPK specific phosphatase(s) in this inhibition. Similar results are obtained in a PRL-responsive ovary-derived cell line (GG-CL) that expresses only PRL-RS. However, we found the expression/activation of several known MAPK phosphatases not to be affected by PRL, suggesting a role of unidentified phosphatase(s). We detected a 27-kDa protein that binds to the intracellular domain of PRL-RS and identified it as dual specific phosphatase DUPD1. PRL does not induce expression of DUDP1 but represses its phosphorylation on Thr-155. We also show a physical association of this phosphatase with ERK1/2 and p38 MAPK. Using an in vitro phosphatase assay and overexpression studies, we established that DUPD1 is a MAPK phosphatase. Dual specific phosphatase inhibitors as well as siRNA to DUPD1, completely prevent PRL-mediated MAPK inhibition in ovarian cells. Our results strongly suggest that deactivation of MAPK by PRL/PRL-RS contributes to the severe ovarian defect in PRLR-/-RS mice and demonstrate the novel association of PRL-RS with DUPD1 and a role for this phosphatase in MAPK deactivation.	[Bao, Lei; Gibori, Geula] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Binart, Nadine] Univ Paris 11, INSERM, U693, Paris, France	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Gibori, G (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys, M-C 901, Chicago, IL 60612 USA.	ggibori@uic.edu	Binart, Nadine/F-2949-2013	Binart, Nadine/0000-0002-5606-3866; Halperin, Julia/0000-0003-1794-9776; Maizels, Evelyn/0000-0001-9072-1095	National Institutes of Health [HD11119, HD 12356, T32 HL007692]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012356, R01HD011119, R37HD011119] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HD11119 and HD 12356 (to G. G.) and T32 HL007692 (to J. L. and A. M. S.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bachelot A, 2007, REPRODUCTION, V133, P361, DOI 10.1530/REP-06-0299; Bao L, 2007, ENDOCRINOLOGY, V148, P2326, DOI 10.1210/en.2006-1643; Bao L, 2006, MOL ENDOCRINOL, V20, P3240, DOI 10.1210/me.2006-0296; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Berlanga JJ, 1997, MOL ENDOCRINOL, V11, P1449, DOI 10.1210/me.11.10.1449; Bignon C, 1997, J MOL ENDOCRINOL, V19, P109, DOI 10.1677/jme.0.0190109; Binart N, 2003, MOL ENDOCRINOL, V17, P1066, DOI 10.1210/me.2002-0181; BOUTIN JM, 1988, CELL, V53, P69, DOI 10.1016/0092-8674(88)90488-6; Chang WP, 1998, MOL CELL BIOL, V18, P896, DOI 10.1128/MCB.18.2.896; Chi HB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.141pe44; CLARKE DL, 1993, ENDOCRINOLOGY, V133, P224, DOI 10.1210/en.133.1.224; DAS R, 1995, MOL ENDOCRINOL, V9, P1750, DOI 10.1210/me.9.12.1750; DAVIS JA, 1989, MOL ENDOCRINOL, V3, P674, DOI 10.1210/mend-3-4-674; Devi YS, 2009, ENDOCRINOLOGY, V150, P3327, DOI 10.1210/en.2008-1719; Duan WR, 1996, J BIOL CHEM, V271, P15602, DOI 10.1074/jbc.271.26.15602; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Frasor J, 1999, J CLIN ENDOCR METAB, V84, P3344, DOI 10.1210/jc.84.9.3344; Friedberg I, 2007, FEBS LETT, V581, P2527, DOI 10.1016/j.febslet.2007.04.059; Gebauer G, 1999, J CELL BIOCHEM, V75, P547, DOI 10.1002/(SICI)1097-4644(19991215)75:4<547::AID-JCB1>3.3.CO;2-X; GU Y, 1992, ENDOCRINOLOGY, V131, P1321, DOI 10.1210/en.131.3.1321; Gu Y, 1996, ENDOCRINOLOGY, V137, P4878, DOI 10.1210/en.137.11.4878; Guo J, 2007, ANTICANCER RES, V27, P3067; Halperin J, 2008, MOL ENDOCRINOL, V22, P513, DOI 10.1210/me.2007-0399; Hu ZZ, 2001, J BIOL CHEM, V276, P41086, DOI 10.1074/jbc.M102109200; Huang KT, 2008, J MAMMARY GLAND BIOL, V13, P69, DOI 10.1007/s10911-008-9072-x; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Jabbour HN, 1998, J CLIN ENDOCR METAB, V83, P2545, DOI 10.1210/jc.83.7.2545; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; LESUEUR L, 1991, P NATL ACAD SCI USA, V88, P824, DOI 10.1073/pnas.88.3.824; Llovera M, 2000, EXP GERONTOL, V35, P41, DOI 10.1016/S0531-5565(99)00078-9; Nemoto K, 2004, PROSTATE, V58, P95, DOI 10.1002/pros.10292; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; ONEAL KD, 1994, J BIOL CHEM, V269, P26076; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Risk M, 2001, ENDOCRIN UPDAT, V12, P265; Russell DL, 1999, MOL ENDOCRINOL, V13, P2049, DOI 10.1210/me.13.12.2049; Shepherd EG, 2004, J BIOL CHEM, V279, P54023, DOI 10.1074/jbc.M408444200; Shoji T, 2007, J REPROD IMMUNOL, V75, P82, DOI 10.1016/j.jri.2007.05.002; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Sugino N, 1998, ENDOCRINOLOGY, V139, P1936, DOI 10.1210/en.139.4.1936; Tamura M, 2004, J REPROD DEVELOP, V50, P47, DOI 10.1262/jrd.50.47; Telleria CM, 1997, ENDOCRINOLOGY, V138, P4812, DOI 10.1210/en.138.11.4812; Thienel T, 2002, MOL HUM REPROD, V8, P465, DOI 10.1093/molehr/8.5.465; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wu W, 2005, CANCER RES, V65, P7509, DOI 10.1158/0008-5472.CAN-04-3350; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yoshino O, 2003, J CLIN ENDOCR METAB, V88, P2236, DOI 10.1210/jc.2002-021788; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	51	31	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7609	7618		10.1074/jbc.M110.166603	http://dx.doi.org/10.1074/jbc.M110.166603			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21199871	Green Published, hybrid			2022-12-25	WOS:000287737300074
J	Huambachano, O; Herrera, F; Rancourt, A; Satoh, MS				Huambachano, Orlando; Herrera, Fatima; Rancourt, Ann; Satoh, Masahiko S.			Double-stranded DNA Binding Domain of Poly(ADP-ribose) Polymerase-1 and Molecular Insight into the Regulation of Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER DOMAIN; CHROMATIN-STRUCTURE; ADP-RIBOSYLATION; LIGASE-III; POSTTRANSLATIONAL MODIFICATION; ENZYME ACTIVATION; LYSINE RESIDUES; IN-VITRO; PARP-1; TRANSCRIPTION	Poly(ADP-ribose) polymerase-1 (PARP-1) modifies various proteins, including itself, with ADP-ribose polymers (automodification). Polymer synthesis is triggered by binding of its zinc finger 1 (Zn1) and 2 (Zn2) to DNA breaks and is followed by inactivation through automodification. The multiple functional domains of PARP-1 appear to regulate activation and automodification-mediated inactivation of PARP-1. However, the roles of these domains in activation-inactivation processes are not well understood. Our results suggest that Zn1, Zn2, and a domain identified in this study, the double-stranded DNA binding (DsDB) domain, are involved in DNA break-dependent activation of PARP-1. We found that binding of the DsDB domain to double-stranded DNA and DNA break recognition by Zn1 and Zn2, whose actual binding targets are likely to be single-stranded DNA, lead to the activation of PARP-1. In turn, the displacement of single-and double-stranded DNA from Zn2 and the DsDB domain caused by ADP-ribose polymer synthesis results in the dissociation of PARP-1 from DNA breaks and thus its inactivation. We also found that the WGR domain is one of the domains involved in the RNA-dependent activation of PARP-1. Furthermore, because zinc finger 3 (Zn3) has the ability to bind to single-stranded RNA, it may have an indirect role in RNA-dependent activation. PARP-1 functional domains, which are involved in oligonucleic acid binding, therefore coordinately regulate PARP-1 activity depending on the status of the neighboring oligonucleic acids. Based on these results, we proposed a model for the regulation of PARP-1 activity.	[Huambachano, Orlando; Herrera, Fatima; Rancourt, Ann; Satoh, Masahiko S.] Univ Laval, Lab DNA Damage Responses & Bioimaging, Fac Med, Med Ctr CHUQ, Quebec City, PQ G1V 4G2, Canada	Laval University	Satoh, MS (corresponding author), 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	Masahiko.sato@crchul.ulaval.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research.	ADAMIETZ P, 1984, J BIOL CHEM, V259, P6841; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; ALTHAUS FR, 1987, ADP RIBOSYLATION PRO; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bauer PI, 2001, FEBS LETT, V506, P239, DOI 10.1016/S0014-5793(01)02919-2; BENJAMIN RC, 1980, J BIOL CHEM, V255, P502; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; D'Silva I, 1999, BBA-PROTEIN STRUCT M, V1430, P119, DOI 10.1016/S0167-4838(98)00278-7; DEMURCIA G, 1991, BIOESSAYS, V13, P455, DOI 10.1002/bies.950130905; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; FAKAN S, 1988, EXP CELL RES, V179, P517, DOI 10.1016/0014-4827(88)90289-3; Frizzell KM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2451; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Jorgensen TJ, 2009, J MOL RECOGNIT, V22, P446, DOI 10.1002/jmr.962; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; KAMESHITA I, 1984, J BIOL CHEM, V259, P4770; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Komori T, 2009, GENES CELLS, V14, P343, DOI 10.1111/j.1365-2443.2008.01273.x; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kulczyk AW, 2004, J MOL BIOL, V341, P723, DOI 10.1016/j.jmb.2004.06.035; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Messner S, 2010, NUCLEIC ACIDS RES, V38, P6350, DOI 10.1093/nar/gkq463; OGATA N, 1980, J BIOL CHEM, V255, P7616; Parent M, 2005, J BIOL CHEM, V280, P448, DOI 10.1074/jbc.M408435200; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; Pion E, 2003, BIOCHEMISTRY-US, V42, P12409, DOI 10.1021/bi0344432; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Rancourt A, 2009, DNA REPAIR, V8, P286, DOI 10.1016/j.dnarep.2008.11.018; SATOH MS, 1994, BIOCHEMISTRY-US, V33, P7099, DOI 10.1021/bi00189a012; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Soldatenkov VA, 2004, CURR DRUG TARGETS, V5, P357, DOI 10.2174/1389450043345498; TANUMA SI, 1985, ARCH BIOCHEM BIOPHYS, V237, P38, DOI 10.1016/0003-9861(85)90251-6; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; UEDA K, 1975, P NATL ACAD SCI USA, V72, P205, DOI 10.1073/pnas.72.1.205; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Yung TMC, 2004, J BIOL CHEM, V279, P39686, DOI 10.1074/jbc.M402729200; ZAHRADKA P, 1982, EUR J BIOCHEM, V127, P579; Zlatanova J, 2009, STRUCTURE, V17, P160, DOI 10.1016/j.str.2008.12.016	60	41	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7149	7160		10.1074/jbc.M110.175190	http://dx.doi.org/10.1074/jbc.M110.175190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21183686	Green Published, hybrid			2022-12-25	WOS:000287737300032
J	Singh, SK; Wilczynska, KM; Grzybowski, A; Yester, J; Osrah, B; Bryan, L; Wright, S; Griswold-Prenner, I; Kordula, T				Singh, Sandeep K.; Wilczynska, Katarzyna M.; Grzybowski, Adrian; Yester, Jessie; Osrah, Bahiya; Bryan, Lauren; Wright, Sarah; Griswold-Prenner, Irene; Kordula, Tomasz			The Unique Transcriptional Activation Domain of Nuclear Factor-I-X3 Is Critical to Specifically Induce Marker Gene Expression in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; NEURAL STEM-CELLS; FACTOR-I; DNA-REPLICATION; PRECURSOR CELLS; JC VIRUS; COMPLEX; BRAIN; BINDING; NFI	Transcription factors of the nuclear factor 1 (NFI) family regulate normal brain development in vertebrates. However, multiple splice variants of four NFI isoforms exist, and their biological functions have yet to be elucidated. Here, we cloned and analyzed human NFI-X3, a novel splice variant of the nfix gene, which contains a unique transcriptional activation (TA) domain completely conserved in primates. In contrast to previously cloned NFI-X1, overexpression of NFI-X3 potently activates NFI reporters, including glial fibrillary acidic protein (GFAP) reporter, in astrocytes and glioma cells. The GAL4 fusion protein containing the TA domain of NFI-X3 strongly activates the GAL4 reporter, whereas the TA domain of NFI-X1 is ineffective. The expression of NFI-X3 is dramatically up-regulated during the differentiation of neural progenitors to astrocytes and precedes the expression of astrocyte markers, such as GFAP and SPARCL1 (Secreted Protein, Acidic and Rich in Cysteines-like 1). Overexpression of NFI-X3 dramatically up-regulates GFAP and SPARCL1 expression in glioma cells, whereas the knockdown of NFI-X3 diminishes the expression of both GFAP and SPARCL1 in astrocytes. Although activation of astrocyte-specific genes involves DNA demethylation and subsequent increase of histone acetylation, NFI-X3 activates GFAP expression, in part, by inducing alterations in the nucleosome architecture that lead to the increased recruitment of RNA polymerase II.	[Singh, Sandeep K.; Wilczynska, Katarzyna M.; Grzybowski, Adrian; Yester, Jessie; Osrah, Bahiya; Bryan, Lauren; Kordula, Tomasz] Virginia Commonwealth Univ, Dept Biochem, Massey Canc Ctr, Richmond, VA 23298 USA; [Singh, Sandeep K.; Wilczynska, Katarzyna M.; Grzybowski, Adrian; Yester, Jessie; Osrah, Bahiya; Bryan, Lauren; Kordula, Tomasz] Virginia Commonwealth Univ, Dept Mol Biol, Massey Canc Ctr, Richmond, VA 23298 USA; [Grzybowski, Adrian] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Wright, Sarah; Griswold-Prenner, Irene] Elan Pharmaceut, San Francisco, CA 94080 USA	Virginia Commonwealth University; Virginia Commonwealth University; Jagiellonian University	Kordula, T (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	tkordula@vcu.edu	Grzybowski, Adrian/X-1558-2019	Grzybowski, Adrian/0000-0002-7340-9603	National Institutes of Health [R01NS044118, R21NS063283, F31NS060433]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS060433, R01NS044118, R21NS063283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS044118 and R21NS063283 (to T. K.).; Supported by National Institutes of Health Grant F31NS060433.	Al-Kandari W, 2007, J MOL BIOL, V369, P1175, DOI 10.1016/j.jmb.2007.04.033; ALLORE RJ, 1990, J BIOL CHEM, V265, P15537; ALTMANN H, 1994, P NATL ACAD SCI USA, V91, P3901, DOI 10.1073/pnas.91.9.3901; AMEMIYA K, 1992, J BIOL CHEM, V267, P14204; Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Barry G, 2008, J NEUROSCI, V28, P12328, DOI 10.1523/JNEUROSCI.4000-08.2008; BESNARD F, 1991, J BIOL CHEM, V266, P18877; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Cebolla B, 2006, J NEUROCHEM, V97, P1057, DOI 10.1111/j.1471-4159.2006.03804.x; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Chu HY, 2007, MOL CELL BIOL, V27, P3743, DOI 10.1128/MCB.01561-06; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Gevry N, 2009, METHODS MOL BIOL, V543, P281, DOI 10.1007/978-1-60327-015-1_19; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Gopalan SM, 2006, J BIOL CHEM, V281, P13126, DOI 10.1074/jbc.M601194200; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunder A, 2003, GENE, V304, P171, DOI 10.1016/S0378-1119(02)01204-0; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kordula T, 1998, J BIOL CHEM, V273, P4112, DOI 10.1074/jbc.273.7.4112; Krohn K, 1999, J NEUROCHEM, V72, P1353, DOI 10.1046/j.1471-4159.1999.721353.x; KRUSE U, 1994, J MOL BIOL, V238, P860, DOI 10.1006/jmbi.1994.1343; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; Michelhaugh SK, 2005, J NEUROCHEM, V95, P1342, DOI 10.1111/j.1471-4159.2005.03458.x; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Mudhasani R, 2002, MOL CELL BIOL, V22, P5019, DOI 10.1128/MCB.22.14.5019-5026.2002; Muller K, 2000, J BIOL CHEM, V275, P1645, DOI 10.1074/jbc.275.3.1645; NAGATA K, 1982, P NATL ACAD SCI-BIOL, V79, P6438, DOI 10.1073/pnas.79.21.6438; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; NEBL G, 1995, CELL MOL BIOL RES, V41, P85; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; Ouellet S, 2006, NUCLEIC ACIDS RES, V34, P6472, DOI 10.1093/nar/gkl861; Pekarik Vladimir, 2008, Journal of Biology (London), V7, DOI 10.1186/jbiol94; Plachez C, 2008, J COMP NEUROL, V508, P385, DOI 10.1002/cne.21645; Ravichandran V, 2006, J VIROL, V80, P10506, DOI 10.1128/JVI.01355-06; ROULET E, 1995, MOL CELL BIOL, V15, P5552; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; Schwartz ML, 1998, MOL BRAIN RES, V57, P21, DOI 10.1016/S0169-328X(98)00049-7; Shu TZ, 2003, J NEUROSCI, V23, P203; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; TAMURA T, 1988, NUCLEIC ACIDS RES, V16, P11441, DOI 10.1093/nar/16.24.11441; Vihma H, 2008, GENOMICS, V92, P279, DOI 10.1016/j.ygeno.2008.06.011; Wilczynska KM, 2009, STEM CELLS, V27, P1173, DOI 10.1002/stem.35; Zhao LH, 2005, ACTA BIOCH BIOPH SIN, V37, P440, DOI 10.1111/j.1745-7270.2005.00061.x	56	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7315	7326		10.1074/jbc.M110.152421	http://dx.doi.org/10.1074/jbc.M110.152421			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189253	Green Published, hybrid			2022-12-25	WOS:000287737300048
J	Lin, HX; Dai, T; Xiong, HP; Zhao, XH; Chen, XT; Yu, CP; Li, J; Wang, X; Song, LB				Lin, Huanxin; Dai, Ting; Xiong, Huaping; Zhao, Xiaohui; Chen, Xiuting; Yu, Chunping; Li, Jun; Wang, Xi; Song, Libing			Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a	PLOS ONE			English	Article							EXPRESSION; SURVIVAL; APOPTOSIS; GROWTH; BIM; INHIBITION; BIOGENESIS; MICRORNAS; MIR-182; LIGAND	FOXO transcription factors are key tumor suppressors in mammalian cells. Until now, suppression of FOXOs in cancer cells was thought to be mainly due to activation of multiple onco-kinases by a phosphorylation-ubiquitylation-mediated cascade. Therefore, it was speculated that inhibition of FOXO proteins would naturally occur through a multiple step post-translational process. However, whether cancer cells may downregulate FOXO protein via an alternative regulatory mechanism is unclear. In the current study, we report that expression of miR-96 was markedly upregulated in breast cancer cells and breast cancer tissues compared with normal breast epithelial cells (NBEC) and normal breast tissues. Ectopic expression of miR-96 induced the proliferation and anchorage-independent growth of breast cancer cells, while inhibition of miR-96 reduced this effect. Furthermore, upregulation of miR-96 in breast cancer cells resulted in modulation of their entry into the G1/S transitional phase, which was caused by downregulation of cyclin-dependent kinase (CDK) inhibitors, p27(Kip1) and p21(Cip1), and upregulation of the cell-cycle regulator cyclin D1. Moreover, we demonstrated that miR-96 downregulated FOXO3a expression by directly targeting the FOXO3a 3 '-untranslated region. Taken together, our results suggest that miR-96 may play an important role in promoting proliferation of human breast cancer cells and present a novel mechanism of miRNA-mediated direct suppression of FOXO3a expression in cancer cells.	[Lin, Huanxin; Zhao, Xiaohui; Chen, Xiuting; Yu, Chunping; Wang, Xi; Song, Libing] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Huanxin] Sun Yat Sen Univ, Dept Radiotherapy, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Dai, Ting; Li, Jun] Sun Yat Sen Univ, Dept Biochem, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Xiong, Huaping] Sun Yat Sen Univ, Dept Microbiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xi] Sun Yat Sen Univ, Dept Breast Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lin, HX (corresponding author), Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	wangxi0521@medmail.com.cn; songlb@sysucc.org.cn	Song, LB/AAL-1968-2020		Natural Science Foundation of China [81071780, 81030048, 30770836, 30771110, 30870963, 30831160517]; Program for New Century Excellent Talents in Universities [NCET-07-0877]; Science and Technology Department of Guangdong Province, China [2009B030801188, 8251008901000006, 2008A030201006]; Ministry of Education of China [(2008) 890, 200805580047]; Department of Health of Guangdong Province [A2009215]; Fundamental Research Funds [10ykzd03]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Science and Technology Department of Guangdong Province, China; Ministry of Education of China(Ministry of Education, China); Department of Health of Guangdong Province; Fundamental Research Funds	All grant information: The Natural Science Foundation of China (No. 81071780, 81030048, 30770836, 30771110, 30870963, 30831160517); Program for New Century Excellent Talents in Universities (No. NCET-07-0877); The Science and Technology Department of Guangdong Province, China (No. 2009B030801188, 8251008901000006, 2008A030201006); Ministry of Education of China [No.(2008) 890 and No. 200805580047]; Department of Health of Guangdong Province (No. A2009215); the Fundamental Research Funds for the Central Universities (No. 10ykzd03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Greene FL, 2002, AJCC CANC STAGING MA, P255; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Real PJ, 2005, CANCER RES, V65, P8151, DOI 10.1158/0008-5472.CAN-05-1134; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsai WB, 2008, NAT CELL BIOL, V10, P460, DOI 10.1038/ncb1709; Wang K, 2010, J BIOL CHEM, V285, P16958, DOI 10.1074/jbc.M109.093005; Yang JY, 2006, INT J ONCOL, V29, P643; Yang JY, 2010, CANCER RES, V70, P4709, DOI 10.1158/0008-5472.CAN-09-4524; YIYUZOU, 2008, BREAST CANCER RES, V10, pR21; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167	49	149	161	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15797	10.1371/journal.pone.0015797	http://dx.doi.org/10.1371/journal.pone.0015797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203424	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200042
J	Xu, Y; Fang, F; Zhang, JY; Josson, S; St Clair, WH; St Clair, DK				Xu, Yong; Fang, Fang; Zhang, Jiayou; Josson, Sajni; St Clair, William H.; St Clair, Daret K.			miR-17*Suppresses Tumorigenicity of Prostate Cancer by Inhibiting Mitochondrial Antioxidant Enzymes	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE GENE; MIR-17-92 CLUSTER; IDENTIFICATION; POLYCISTRON; BIOGENESIS; EXPRESSION; INDUCTION; MICRORNAS; REDUCTASE	Aberrant micro RNA (miRNA) expression has been implicated in the pathogenesis of cancer. Recent studies have shown that the miR-17-92 cluster is overexpressed in many types of cancer. The oncogenic function of mature miRNAs encoded by the miR-17-92 cluster has been identified from the 59 arm of six precursors. However, the function of the miRNAs produced from the 39 arm of these precursors remains unknown. The present study demonstrates that miR-17* is able to suppress critical primary mitochondrial antioxidant enzymes, such as manganese superoxide dismutase (MnSOD), glutathione peroxidase-2 (GPX2) and thioredoxin reductase-2 (TrxR2). Transfection of miR-17* into prostate cancer PC-3 cells significantly reduces levels of the three antioxidant proteins and activity of the luciferase reporter under the control of miR17* binding sequences located in the 3'-untranslated regions of the three target genes. Disulfiram (DSF), a dithiolcarbomate drug shown to have an anticancer effect, induces the level of mature miR-17* and cell death in PCa cells, which can be attenuated by transfection of antisense miR-17*. Increasing miR-17* level in PC-3 cells by a Tet-on based conditional expression system markedly suppresses its tumorigencity. These results suggest that miR-17* may suppress tumorigenicity of prostate cancer through inhibition of mitochondrial antioxidant enzymes.	[Xu, Yong; St Clair, Daret K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Fang, Fang; St Clair, William H.] Univ Kentucky, Dept Radiat Med, Lexington, KY USA; [Zhang, Jiayou] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Josson, Sajni] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	University of Kentucky; University of Kentucky; University of Kentucky; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Xu, Y (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA.	dstcl00@uky.edu			National Institutes of Health [CA115801, CA 049797]; NATIONAL CANCER INSTITUTE [R01CA049797, R01CA115801, R29CA049797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA115801 to William H. St. Clair and grant CA 049797 to Daret K. St. Clair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boggs RM, 2007, GENE, V404, P25, DOI 10.1016/j.gene.2007.08.015; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Ebi H, 2009, ONCOGENE, V28, P3371, DOI 10.1038/onc.2009.201; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Josson S, 2006, ONCOGENE, V25, P1554, DOI 10.1038/sj.onc.1209186; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Niki E, 2010, FREE RADICAL BIO MED, V49, P503, DOI 10.1016/j.freeradbiomed.2010.04.016; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; REYNOLDS AR, 2006, BR J PHARM S2, V2, P144; SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Xu Y, 2007, MOL CANCER THER, V6, P2048, DOI 10.1158/1535-7163.MCT-06-0700; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang XL, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/2/024204	32	57	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14356	10.1371/journal.pone.0014356	http://dx.doi.org/10.1371/journal.pone.0014356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203553	Green Published, gold, Green Submitted			2022-12-25	WOS:000285578000003
J	Brand, A; Smith, ES; Lewin, GR; Park, TJ				Brand, Antje; Smith, Ewan St. J.; Lewin, Gary R.; Park, Thomas J.			Functional Neurokinin and NMDA Receptor Activity in an Animal Naturally Lacking Substance P: The Naked Mole-Rat	PLOS ONE			English	Article							PROTEIN-KINASE-C; DORSAL-HORN NEURONS; NOCICEPTIVE RESPONSES; HYPERALGESIA; GLUTAMATE; NEUROPEPTIDES; POTENTIATION; CHANNELS; BLOCK; PAIN	Naked mole-rats are extremely unusual among mammals in that their cutaneous C-fibers lack the neuropeptide Substance P (SP). In other mammals, SP plays an important role in nociception: it is released from C-fibers onto spinal neurons where it facilitates NMDA receptor activity and causes sensitization that can last for minutes, hours or days. In the present study, we tested the effects of intrathecal application of: 1) SP, 2) an SP antagonist (GR-82334), and 3) an NMDA antagonist (APV) on heat-evoked foot withdrawal. In the naked mole-rat, at a high enough concentration, application of SP caused a large, immediate, and long-lasting sensitization of foot withdrawal latency that was transiently reversed by application of either antagonist. However, neither SP nor NMDA antagonists had an effect when administered alone to naive animals. In contrast, both antagonists induced an increase in basal withdrawal latency in mice. These results indicate that spinal neurons in naked mole-rats have functional SP and NMDA receptors, but that these receptors do not participate in heat-evoked foot withdrawal unless SP is experimentally introduced. We propose that the natural lack of SP in naked mole-rat C-fibers may have resulted during adaptation to living in a chronically high carbon dioxide, high ammonia environment that, in other mammals, would stimulate C-fibers and evoke nocifensive behavior.	[Brand, Antje; Park, Thomas J.] Univ Illinois, Dept Biol Sci, Lab Integrat Neurosci, Chicago, IL 60680 USA; [Smith, Ewan St. J.; Lewin, Gary R.] Max Delbruck Ctr Mol Med, Dept Neurosci, Berlin, Germany	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Brand, A (corresponding author), Univ Illinois, Dept Biol Sci, Lab Integrat Neurosci, Chicago, IL 60680 USA.	TPark@uic.edu	St. John Smith, Ewan/G-1776-2011; Lewin, Gary R/B-8028-2011	St. John Smith, Ewan/0000-0002-2699-1979; Lewin, Gary/0000-0002-2890-6352	National Science Foundation [0744979]; Alexander von Humboldt Foundation;  [Sonderforschungsbereich 665]	National Science Foundation(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); 	This work was supported by National Science Foundation grant 0744979, Sonderforschungsbereich 665, and the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SPH, 2009, BRIT J PHARMACOL, V158, pS1, DOI 10.1111/j.1476-5381.2009.00499.x; ANTON F, 1991, NEUROSCI LETT, V123, P208, DOI 10.1016/0304-3940(91)90932-J; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; CARPENTER SE, 1981, BRIT J PHARMACOL, V73, P755, DOI 10.1111/j.1476-5381.1981.tb16812.x; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Hua XY, 1999, NEUROSCIENCE, V89, P525, DOI 10.1016/S0306-4522(98)00488-6; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; LaVinka PC, 2009, J COMP PHYSIOL A, V195, P419, DOI 10.1007/s00359-009-0420-0; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; MALMBERG AB, 1992, SCIENCE, V257, P1276, DOI 10.1126/science.1381521; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MJELLEMJOLY N, 1991, NEUROSCI LETT, V133, P121, DOI 10.1016/0304-3940(91)90072-2; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Park TJ, 2003, J COMP NEUROL, V465, P104, DOI 10.1002/cne.10824; RUSIN KI, 1993, BRAIN RES BULL, V30, P329, DOI 10.1016/0361-9230(93)90261-9; RUSIN KI, 1992, J NEUROPHYSIOL, V68, P265, DOI 10.1152/jn.1992.68.1.265; SEKIZAWA S, 1994, RESP PHYSIOL, V96, P37, DOI 10.1016/0034-5687(94)90104-X; Seybold V S, 2009, Handb Exp Pharmacol, P451, DOI 10.1007/978-3-540-79090-7_13; SIMONE DA, 1987, BRAIN RES, V418, P201, DOI 10.1016/0006-8993(87)90982-6; Smith ES, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-29; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; Stanfa LC, 1999, NEUROSCIENCE, V93, P1391, DOI 10.1016/S0306-4522(99)00310-3; Suzuki R, 2001, PAIN, V91, P101, DOI 10.1016/S0304-3959(00)00423-1; Swanson L. W., 2003, BRAIN ARCHITECTURE U; Wajima Z, 2000, BRAIN RES, V877, P314, DOI 10.1016/S0006-8993(00)02714-1; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6; Yeomans DC, 1996, PAIN, V68, P133, DOI 10.1016/S0304-3959(96)03176-4	34	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15162	10.1371/journal.pone.0015162	http://dx.doi.org/10.1371/journal.pone.0015162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200438	Green Published, Green Accepted, gold			2022-12-25	WOS:000285576900017
J	Liu, ZQ; Han, J; Jia, LT; Maillet, JC; Bai, GA; Xu, L; Jia, ZP; Zheng, QH; Zhang, WD; Monette, R; Merali, Z; Zhu, Z; Wang, W; Ren, W; Zhang, X				Liu, Zhiqiang; Han, Jing; Jia, Lintao; Maillet, Jean-Christian; Bai, Guang; Xu, Lin; Jia, Zhengping; Zheng, Qiaohua; Zhang, Wandong; Monette, Robert; Merali, Zul; Zhu, Zhou; Wang, Wei; Ren, Wei; Zhang, Xia			Synaptic Neurotransmission Depression in Ventral Tegmental Dopamine Neurons and Cannabinoid-Associated Addictive Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTOR ENDOCYTOSIS; IN-VIVO; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; FEAR EXTINCTION; PLASTICITY; COCAINE; NMDA; AREA	Drug addiction is an association of compulsive drug use with long-term associative learning/memory. Multiple forms of learning/memory are primarily subserved by activity-or experience-dependent synaptic long-term potentiation (LTP) and long-term depression (LTD). Recent studies suggest LTP expression in locally activated glutamate synapses onto dopamine neurons (local Glu-DA synapses) of the midbrain ventral tegmental area (VTA) following a single or chronic exposure to many drugs of abuse, whereas a single exposure to cannabinoid did not significantly affect synaptic plasticity at these synapses. It is unknown whether chronic exposure of cannabis (marijuana or cannabinoids), the most commonly used illicit drug worldwide, induce LTP or LTD at these synapses. More importantly, whether such alterations in VTA synaptic plasticity causatively contribute to drug addictive behavior has not previously been addressed. Here we show in rats that chronic cannabinoid exposure activates VTA cannabinoid CB1 receptors to induce transient neurotransmission depression at VTA local Glu-DA synapses through activation of NMDA receptors and subsequent endocytosis of AMPA receptor GluR2 subunits. A GluR2-derived peptide blocks cannabinoid-induced VTA synaptic depression and conditioned place preference, i.e., learning to associate drug exposure with environmental cues. These data not only provide the first evidence, to our knowledge, that NMDA receptor-dependent synaptic depression at VTA dopamine circuitry requires GluR2 endocytosis, but also suggest an essential contribution of such synaptic depression to cannabinoid-associated addictive learning, in addition to pointing to novel pharmacological strategies for the treatment of cannabis addiction.	[Liu, Zhiqiang; Han, Jing; Ren, Wei; Zhang, Xia] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China; [Liu, Zhiqiang; Han, Jing; Jia, Lintao; Maillet, Jean-Christian; Zheng, Qiaohua; Merali, Zul; Zhang, Xia] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada; [Liu, Zhiqiang; Han, Jing; Jia, Lintao; Maillet, Jean-Christian; Zheng, Qiaohua; Merali, Zul; Zhang, Xia] Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada; [Liu, Zhiqiang; Han, Jing; Jia, Lintao; Maillet, Jean-Christian; Zheng, Qiaohua; Merali, Zul; Zhang, Xia] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Bai, Guang] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Program Neurosci, Baltimore, MD 21201 USA; [Xu, Lin] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming, Peoples R China; [Jia, Zhengping] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Zhang, Wandong; Monette, Robert] Natl Res Council Canada, Inst Biol Sci, Neurobiol Program, Ottawa, ON K1A 0R6, Canada; [Zhu, Zhou; Wang, Wei] Huazhong Univ Sci & Technol, Dept Neurol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Shaanxi Normal University; University of Ottawa; University of Ottawa; University of Ottawa; University System of Maryland; University of Maryland Baltimore; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Research Council Canada; Huazhong University of Science & Technology	Liu, ZQ (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China.	Xia.Zhang@rohcg.on.ca	Jia, zhengping/AAZ-4190-2021	Xu, Lin/0000-0002-2710-3507; Zhang, Wandong/0000-0001-6412-8124	Canadian Institutes of Health Research [MOP-62951]; National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA; Chinese Education Ministry	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA(NARSAD); Chinese Education Ministry(Ministry of Education, China)	This research was supported by a grant (MOP-62951) from Canadian Institutes of Health Research awarded to XZ who was a recipient of Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA, and Cheung Kong Scholar (Chang Jiang Scholar) from the Chinese Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Anwyl R, 2006, PROG NEUROBIOL, V78, P17, DOI 10.1016/j.pneurobio.2005.12.001; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Bedingfield JS, 1995, BRIT J PHARMACOL, V116, P3323, DOI 10.1111/j.1476-5381.1995.tb15142.x; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Bonci A, 1999, J NEUROSCI, V19, P3723; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; Cui SS, 2001, J NEUROSCI, V21, P9867, DOI 10.1523/JNEUROSCI.21-24-09867.2001; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dalton GL, 2008, NEUROPSYCHOPHARMACOL, V33, P2416, DOI 10.1038/sj.npp.1301642; De Vries TJ, 2001, NAT MED, V7, P1151, DOI 10.1038/nm1001-1151; Elkashef A, 2008, SUBST ABUS, V29, P17, DOI 10.1080/08897070802218166; FARB CR, 1995, J COMP NEUROL, V362, P86, DOI 10.1002/cne.903620106; Fattore L, 1999, BEHAV BRAIN RES, V104, P141, DOI 10.1016/S0166-4328(99)00059-5; Good CH, 2010, J NEUROSCI, V30, P7900, DOI 10.1523/JNEUROSCI.1507-10.2010; Gutlerner JL, 2002, NEURON, V36, P921, DOI 10.1016/S0896-6273(02)01051-6; Harris GC, 2004, NEUROSCIENCE, V129, P841, DOI 10.1016/j.neuroscience.2004.09.018; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Hill MN, 2004, EUR J NEUROSCI, V20, P859, DOI 10.1111/j.1460-9568.2004.03522.x; Hill MN, 2004, EUR J PHARMACOL, V499, P291, DOI 10.1016/j.ejphar.2004.06.069; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Leonoudakis D, 2008, J NEUROSCI, V28, P2119, DOI 10.1523/JNEUROSCI.5159-07.2008; Liu AG, 2004, J BIOL CHEM, V279, P17449, DOI 10.1074/jbc.M311267200; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lovinger David M., 2008, V184, P435; Lu J, 2003, NEUROSCIENCE, V121, P123, DOI 10.1016/S0306-4522(03)00421-4; Lupica CR, 2004, BRIT J PHARMACOL, V143, P227, DOI 10.1038/sj.bjp.0705931; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mao SC, 2009, MOL PHARMACOL, V76, P369, DOI 10.1124/mol.108.053728; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Mato S, 2005, J NEUROSCI, V25, P11619, DOI 10.1523/JNEUROSCI.2294-05.2005; McDonald AJ, 1996, NEUROSCI LETT, V208, P175, DOI 10.1016/0304-3940(96)12585-4; Melis M, 2004, J NEUROSCI, V24, P53, DOI 10.1523/JNEUROSCI.4503-03.2004; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nugent FS, 2008, NEUROPSYCHOPHARMACOL, V33, P1704, DOI 10.1038/sj.npp.1301561; Radley JJ, 2007, BRAIN RES, V1134, P87, DOI 10.1016/j.brainres.2006.11.045; Ro S, 2005, BIOTECHNIQUES, V38, P625, DOI 10.2144/05384RN01; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Vlachou S, 2003, BEHAV BRAIN RES, V141, P215, DOI 10.1016/S0166-4328(02)00370-4; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104	57	21	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15634	10.1371/journal.pone.0015634	http://dx.doi.org/10.1371/journal.pone.0015634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187978	Green Submitted, gold, Green Published			2022-12-25	WOS:000285575200052
J	Yang, CH; Chuang, LY; Shih, TM; Chang, HW				Yang, Cheng-Hong; Chuang, Li-Yeh; Shih, Tsung-Mu; Chang, Hsueh-Wei			hSAGEing: An Improved SAGE-Based Software for Identification of Human Tissue-Specific or Common Tumor Markers and Suppressors	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; SERIAL ANALYSIS; BREAST-CANCER; OVARIAN-CANCER; OVEREXPRESSION; SURVIVAL; TOOL; TRANSCRIPTS; CARCINOMA; CLUSTERIN	Background: SAGE (serial analysis of gene expression) is a powerful method of analyzing gene expression for the entire transcriptome. There are currently many well-developed SAGE tools. However, the cross-comparison of different tissues is seldom addressed, thus limiting the identification of common-and tissue-specific tumor markers. Methodology/Principal Findings: To improve the SAGE mining methods, we propose a novel function for cross-tissue comparison of SAGE data by combining the mathematical set theory and logic with a unique "multi-pool method" that analyzes multiple pools of pair-wise case controls individually. When all the settings are in "inclusion", the common SAGE tag sequences are mined. When one tissue type is in "inclusion" and the other types of tissues are not in "inclusion", the selected tissue-specific SAGE tag sequences are generated. They are displayed in tags-per-million (TPM) and fold values, as well as visually displayed in four kinds of scales in a color gradient pattern. In the fold visualization display, the top scores of the SAGE tag sequences are provided, along with cluster plots. A user-defined matrix file is designed for cross-tissue comparison by selecting libraries from publically available databases or user-defined libraries. Conclusions/Significance: The hSAGEing tool provides a combination of friendly cross-tissue analysis and an interface for comparing SAGE libraries for the first time. Some up-or down-regulated genes with tissue-specific or common tumor markers and suppressors are identified computationally. The tool is useful and convenient for in silico cancer transcriptomic studies and is freely available at http://bio.kuas.edu.tw/hSAGEing	[Yang, Cheng-Hong; Shih, Tsung-Mu] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Yang, Cheng-Hong] Toko Univ, Dept Network Syst, Chiayi, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chuang, Li-Yeh] I Shou Univ, Dept Chem Engn, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	National Kaohsiung University of Science & Technology; Kaohsiung Medical University; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Yang, CH (corresponding author), Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan.	chuang@isu.edu.tw; changhw@kmu.edu.tw	Chang, Hsueh-Wei/C-9654-2009; Yang, Cheng-Hong/K-2438-2019; Yang, Cheng-Hong/M-7984-2013; Chuang, Li-Yeh/E-5005-2011	Chang, Hsueh-Wei/0000-0003-0068-2366; Yang, Cheng-Hong/0000-0002-2741-0072; 	National Science Council in Taiwan [NSC97-2311-B-037-003-MY3, NSC97-2622-E-151-008-CC2, NSC96-2221-E-214-050-MY3, NSC96-2311-B037-002, NSC96-2622-E214-004-CC3, DOH99-TD-C-111-002, KMU-EM-98-1.4, KMU-EM-99-1.4]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work is partly supported by the National Science Council in Taiwan under grant NSC97-2311-B-037-003-MY3, NSC97-2622-E-151-008-CC2, NSC96-2221-E-214-050-MY3, NSC96-2311-B037-002, NSC96-2622-E214-004-CC3, the funds DOH99-TD-C-111-002, KMU-EM-98-1.4 and KMU-EM-99-1.4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldinger I, 2005, PANCREATOLOGY, V5, P370, DOI 10.1159/000086537; Bala P, 2005, GENE, V364, P123, DOI 10.1016/j.gene.2005.05.044; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Buckhaults P, 2003, CANCER RES, V63, P4144; Divina P, 2004, NUCLEIC ACIDS RES, V32, pD482, DOI 10.1093/nar/gkh058; Emerson JW, 2009, CANCER INFORM, V7, P29; Felix RS, 2009, CANCER LETT, V278, P41, DOI 10.1016/j.canlet.2008.12.022; Galante PAF, 2007, BIOINFORMATICS, V23, P903, DOI 10.1093/bioinformatics/btm023; Kim YC, 2006, FEBS LETT, V580, P6721, DOI 10.1016/j.febslet.2006.11.013; Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051; Lee S, 2005, RNA, V11, P939, DOI 10.1261/rna.7239605; Leyritz J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-378; Liang P, 2002, P NATL ACAD SCI USA, V99, P11547, DOI 10.1073/pnas.192436299; Lonergan KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009162; Luoh SW, 2004, ONCOGENE, V23, P1354, DOI 10.1038/sj.onc.1207251; Murray D, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-50; Nakayama K, 2006, P NATL ACAD SCI USA, V103, P18739, DOI 10.1073/pnas.0604083103; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; Prochasson P, 1999, EXP CELL RES, V248, P243, DOI 10.1006/excr.1999.4402; Robertson N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r6; STOLL RR, 1979, SET THEORY LOGIC; Tsukishiro S, 2005, GYNECOL ONCOL, V96, P516, DOI 10.1016/j.ygyno.2004.10.036; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wali A, 2005, LUNG CANCER, V48, P19, DOI 10.1016/j.lungcan.2004.10.011; Wang SM, 2007, TRENDS GENET, V23, P42, DOI 10.1016/j.tig.2006.11.001; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Xie D, 2005, CANCER-AM CANCER SOC, V103, P277, DOI 10.1002/cncr.20765; Yang CH, 2009, BIOINFORMATION, V3, P291, DOI 10.6026/97320630003291; Yang GFF, 2009, INT J GYNECOL CANCER, V19, P1342, DOI 10.1111/IGC.0b013e3181a83ed9; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083; Ye SQ, 2002, CELL RES, V12, P105, DOI 10.1038/sj.cr.7290116; Ye SQ, 2002, J BIOMED SCI, V9, P384, DOI 10.1159/000064547	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14369	10.1371/journal.pone.0014369	http://dx.doi.org/10.1371/journal.pone.0014369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179408	gold, Green Published, Green Submitted			2022-12-25	WOS:000285572900006
J	Braun, A; Dofiles, L; Rousselle, S; Guerrero, L; Gunther, J; Yednock, T; Stricker-Krongrad, A; Messersmith, E				Braun, Anne; Dofiles, Lilibeth; Rousselle, Serge; Guerrero, Luis; Gunther, Jane; Yednock, Ted; Stricker-Krongrad, Alain; Messersmith, Elizabeth			Effects of an Alpha-4 Integrin Inhibitor on Restenosis in a New Porcine Model Combining Endothelial Denudation and Stent Placement	PLOS ONE			English	Article							DRUG-ELUTING STENTS; NEOINTIMAL HYPERPLASIA; BALLOON-INJURY; BARE-METAL; CORONARY-ARTERIES; HYPERSENSITIVITY; IMPLANTATION; TRANILAST; GROWTH	Restenosis remains the main complication of balloon angioplasty and/or stent implantation. Preclinical testing of new pharmacologic agents preventing restenosis largely rely on porcine models, where restenosis is assessed after endothelial abrasion of the arterial wall or stent implantation. We combined endothelial cell denudation and implantation of stents to develop a new clinically relevant porcine model of restenosis, and used this model to determine the effects of an alpha 4 integrin inhibitor, ELN 457946, on restenosis. Balloon-angioplasty endothelial cell denudation and subsequent implantation of bare metal stents in the left anterior descending coronary, iliac, and left common carotid arteries was performed in domestic pigs, treated with vehicle or ELN 457946, once weekly via subcutaneous injections, for four weeks. After 1 month, histopathology and morphometric analyses of the arteries showed complete healing and robust, consistent restenotic response in stented arteries. Treatment with ELN 457946 resulted in a reduction in the neointimal response, with decreases in area percent stenosis between 12% in coronary arteries and 30% in peripheral vessels. This is the first description of a successful pig model combining endothelial cell denudation and bare metal stent implantation. This new double injury model may prove particularly useful to assess pharmacological effects of drug candidates on restenosis, in coronary and/or peripheral arteries. Furthermore, the ELN 457946 alpha 4 integrin inhibitor, administered subcutaneously, reduced inflammation and restenosis in stented coronary and peripheral arteries in pigs, therefore representing a promising systemic therapeutic approach in reducing restenosis in patients undergoing angioplasty and/or stent implantation.	[Braun, Anne; Guerrero, Luis; Stricker-Krongrad, Alain] Preclin Serv Massachusetts, Charles River Labs, Shrewsbury, MA USA; [Dofiles, Lilibeth; Gunther, Jane; Yednock, Ted; Messersmith, Elizabeth] Elan Pharmaceut Inc, San Francisco, CA USA; [Rousselle, Serge] Alizee Pathol LLC, Thurmont, MD USA		Braun, A (corresponding author), Preclin Serv Massachusetts, Charles River Labs, Shrewsbury, MA USA.	bostonegles@yahoo.com			Elan Pharmaceuticals	Elan Pharmaceuticals	This work was funded by Elan Pharmaceuticals. Elan Pharmaceuticals had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Barringhaus KG, 2004, J VASC RES, V41, P252, DOI 10.1159/000078646; Brito L, 2007, INT J NANOMED, V2, P143; Burke SE, 1999, J CARDIOVASC PHARM, V33, P829, DOI 10.1097/00005344-199906000-00001; Busnelli M, 2009, ATHEROSCLEROSIS, V207, P384, DOI 10.1016/j.atherosclerosis.2009.05.022; Charles R, 2000, CIRC RES, V87, P282, DOI 10.1161/01.RES.87.4.282; Chen YD, 2006, CHINESE MED J-PEKING, V119, P360, DOI 10.1097/00029330-200603010-00002; Danenberg HD, 2003, CIRCULATION, V108, P2798, DOI 10.1161/01.CIR.0000097002.69209.CD; Danenberg HD, 2003, J CARDIOVASC PHARM, V42, P671, DOI 10.1097/00005344-200311000-00014; Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x; Fitzgerald PJ, 2001, CIRCULATION, V103, P1828; GRINSTEAD WC, 1994, CORONARY ARTERY DIS, V5, P425, DOI 10.1097/00019501-199405000-00009; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huo YQ, 2000, CIRC RES, V87, P153, DOI 10.1161/01.RES.87.2.153; Ishiwata S, 2000, J AM COLL CARDIOL, V35, P1331, DOI 10.1016/S0735-1097(00)00528-3; KLING D, 1995, CIRC RES, V77, P1121, DOI 10.1161/01.RES.77.6.1121; Labinaz M, 2000, CAN J CARDIOL, V16, P187; Lee CW, 2008, CATHETER CARDIO INTE, V71, P594, DOI 10.1002/ccd.21399; Levitzki A, 2005, CARDIOVASC RES, V65, P581, DOI 10.1016/j.cardiores.2004.08.008; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nakazawa G, 2007, AM J CARDIOL, V100, p36M, DOI 10.1016/j.amjcard.2007.08.020; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Perkins LEL, 2010, VET PATHOL, V47, P58, DOI 10.1177/0300985809352978; Rodriguez AE, 2009, EXPERT OPIN EMERG DR, V14, P561, DOI 10.1517/14728210903203808; Schwartz RS, 2008, CIRC-CARDIOVASC INTE, V1, P143, DOI 10.1161/CIRCINTERVENTIONS.108.789974; Schwartz RS, 2004, J AM COLL CARDIOL, V44, P1373, DOI 10.1016/j.jacc.2004.04.060; Schwartz RS, 2002, CIRCULATION, V106, P1867, DOI 10.1161/01.CIR.0000033485.20594.6F; SCHWARTZ RS, 1994, ARTERIOSCLER THROMB, V14, P395, DOI 10.1161/01.ATV.14.3.395; Steinberg DH, 2009, AM J CARDIOL, V103, P491, DOI 10.1016/j.amjcard.2008.09.107; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Touchard AG, 2006, TOXICOL PATHOL, V34, P11, DOI 10.1080/01926230500499407; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Virmani R, 2003, HEART, V89, P133, DOI 10.1136/heart.89.2.133; Virmani R, 1999, CURR OPIN LIPIDOL, V10, P499, DOI 10.1097/00041433-199912000-00004; Ward MR, 2000, ATHEROSCLEROSIS, V151, P407, DOI 10.1016/S0021-9150(99)00407-4; Ward MR, 2002, ARTERIOSCL THROM VAS, V22, P940, DOI 10.1161/01.ATV.0000019405.84384.9C; Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B; WELT FGP, 1996, ARTERIOSCLER THROMB, V20, P2553	37	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14314	10.1371/journal.pone.0014314	http://dx.doi.org/10.1371/journal.pone.0014314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179441	gold, Green Published, Green Submitted			2022-12-25	WOS:000285246900019
J	Panneton, WM; Kumar, VB; Gan, Q; Burke, WJ; Galvin, JE				Panneton, W. Michael; Kumar, V. B.; Gan, Qi; Burke, William J.; Galvin, James E.			The Neurotoxicity of DOPAL: Behavioral and Stereological Evidence for Its Role in Parkinson Disease Pathogenesis	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NIGRA PARS COMPACTA; INDUCED ROTATIONAL BEHAVIOR; TOXIC DOPAMINE METABOLITE; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; TYROSINE-HYDROXYLASE; GENE-EXPRESSION; 6-OHDA LESIONS; BASAL GANGLIA	Background: The etiology of Parkinson disease (PD) has yet to be fully elucidated. We examined the consequences of injections of 3,4-dihydroxyphenylacetaldehyde (DOPAL), a toxic metabolite of dopamine, into the substantia nigra of rats on motor behavior and neuronal survival. Methods/Principal Findings: A total of 800 nl/rat of DOPAL (1 mu g/200 nl) was injected stereotaxically into the substantia nigra over three sites while control animals received similar injections of phosphate buffered saline. Rotational behavior of these rats was analyzed, optical density of striatal tyrosine hydroxylase was calculated, and unbiased stereological counts of the substantia nigra were made. The rats showed significant rotational asymmetry ipsilateral to the lesion, supporting disruption of dopaminergic nigrostriatal projections. Such disruption was verified since the density of striatal tyrosine hydroxylase decreased significantly (p<0.001) on the side ipsilateral to the DOPAL injections when compared to the non-injected side. Stereological counts of neurons stained for Nissl in pars compacta of the substantia nigra significantly decreased (p<0.001) from control values, while counts of those in pars reticulata were unchanged after DOPAL injections. Counts of neurons immunostained for tyrosine hydroxylase also showed a significant (p=0.032) loss of dopaminergic neurons. In spite of significant loss of dopaminergic neurons, DOPAL injections did not induce significant glial reaction in the substantia nigra. Conclusions: The present study provides the first in vivo quantification of substantia nigra pars compacta neuronal loss after injection of the endogenous toxin DOPAL. The results demonstrate that injections of DOPAL selectively kills SN DA neurons, suggests loss of striatal DA terminals, spares non-dopaminergic neurons of the pars reticulata, and triggers a behavioral phenotype (rotational asymmetry) consistent with other PD animal models. This study supports the "catecholaldehyde hypothesis'' as an important link for the etiology of sporadic PD.	[Panneton, W. Michael; Gan, Qi] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Kumar, V. B.] St Louis Univ, Sch Med, Dept Geriatr, St Louis, MO USA; [Burke, William J.] St Louis Univ, Sch Med, Dept Neurol, St Louis, MO USA; [Galvin, James E.] NYU, Dept Neurol, Ctr Excellence Brain Aging, Langone Med Ctr, New York, NY 10016 USA; [Galvin, James E.] NYU, Dept Psychiat, Ctr Excellence Brain Aging, Langone Med Ctr, New York, NY 10016 USA	Saint Louis University; Saint Louis University; Saint Louis University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Panneton, WM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	pannetwm@slu.edu	Galvin, James/AAM-7492-2021; Kumar, Vijaya/GSN-0719-2022		Saint Louis University School of Medicine	Saint Louis University School of Medicine	This work was supported by Saint Louis University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; Blandini F, 2001, FUNCT NEUROL, V16, P99; Blandini F, 1996, MOL NEUROBIOL, V12, P73, DOI 10.1007/BF02740748; Blandini F, 2001, NEUROL SCI, V22, P49, DOI 10.1007/s100720170041; Blandini Fabio, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS124, DOI 10.1016/j.parkreldis.2008.04.015; BLASCHKO H, 1952, PHARMACOL REV, V4, P415; Burke WJ, 2008, ACTA NEUROPATHOL, V115, P193, DOI 10.1007/s00401-007-0303-9; Burke WJ, 1997, BRAIN RES, V760, P290, DOI 10.1016/S0006-8993(97)00447-2; BURKE WJ, 1988, BIOCHEM PHARMACOL, V37, P1391, DOI 10.1016/0006-2952(88)90799-X; Burke WJ, 1998, BRAIN RES, V787, P328, DOI 10.1016/S0006-8993(97)01488-1; Burke WJ, 2004, NEUROTOXICOLOGY, V25, P101, DOI 10.1016/S0161-813X(03)00090-1; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; Burke WJ, 1999, ANAL BIOCHEM, V273, P111, DOI 10.1006/abio.1999.4196; CAHILL AL, 1981, J NEUROCHEM, V37, P1109, DOI 10.1111/j.1471-4159.1981.tb04660.x; CARMAN LS, 1991, BRAIN RES, V553, P275, DOI 10.1016/0006-8993(91)90835-J; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen JJ, 2006, AM J HEALTH-SYST PH, V63, P915, DOI 10.2146/ajhp050395; Emborg ME, 2004, J NEUROSCI METH, V139, P121, DOI 10.1016/j.jneumeth.2004.08.004; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Fahn S, 1997, CNS DRUGS, V8, P376, DOI 10.2165/00023210-199708050-00004; Fleming Sheila M, 2005, NeuroRx, V2, P495, DOI 10.1602/neurorx.2.3.495; Galter D, 2003, NEUROBIOL DIS, V14, P637, DOI 10.1016/j.nbd.2003.09.001; Galvin JE, 2006, ACTA NEUROPATHOL, V112, P115, DOI 10.1007/s00401-006-0096-2; GLICK SD, 1986, PHYSIOL BEHAV, V38, P67, DOI 10.1016/0031-9384(86)90133-2; Goldstein D, 2009, WORLD C PD REL UNPUB; Gonzalez D, 2006, ACTA MED OKAYAMA, V60, P319; Henderson JM, 2005, BEHAV BRAIN RES, V162, P222, DOI 10.1016/j.bbr.2005.03.017; Henderson JM, 2005, BEHAV BRAIN RES, V160, P267, DOI 10.1016/j.bbr.2004.12.008; Henderson JM, 2003, BEHAV BRAIN RES, V139, P105, DOI 10.1016/S0166-4328(02)00087-6; Konitsiotis S, 1998, BEHAV BRAIN RES, V92, P77, DOI 10.1016/S0166-4328(97)00127-7; Konitsiotis S, 2006, BEHAV BRAIN RES, V170, P337, DOI 10.1016/j.bbr.2006.02.030; Kristal BS, 2001, FREE RADICAL BIO MED, V30, P924, DOI 10.1016/S0891-5849(01)00484-1; Lamensdorf I, 2000, BRAIN RES, V868, P191, DOI 10.1016/S0006-8993(00)02309-X; Lamensdorf I, 2000, J NEUROSCI RES, V60, P552, DOI 10.1002/(SICI)1097-4547(20000515)60:4<552::AID-JNR14>3.0.CO;2-U; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Leshan RL, 2010, J NEUROSCI, V30, P5713, DOI 10.1523/JNEUROSCI.1001-10.2010; Li SW, 2001, MOL BRAIN RES, V93, P1, DOI 10.1016/S0169-328X(01)00120-6; Li SW, 1998, BIOORG CHEM, V26, P45, DOI 10.1006/bioo.1998.1087; Mandel S, 2005, ANN NY ACAD SCI, V1053, P356, DOI 10.1196/annals.1344.031; MATTAMMAL MB, 1993, J CHROMATOGR-BIOMED, V614, P205, DOI 10.1016/0378-4347(93)80310-Z; McCormack AL, 2006, NEUROSCIENCE, V141, P929, DOI 10.1016/j.neuroscience.2006.03.069; McPherson RJ, 2000, SYNAPSE, V36, P194, DOI 10.1002/(SICI)1098-2396(20000601)36:3<194::AID-SYN4>3.3.CO;2-4; MOKRY J, 1995, PHYSIOL RES, V44, P143; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Pioli EY, 2008, NEUROSCIENCE, V153, P1213, DOI 10.1016/j.neuroscience.2008.01.084; Pioli EY, 2004, BRAIN RES, V1022, P251, DOI 10.1016/j.brainres.2004.07.014; Plaitakis A, 2000, J NEUROL, V247, P25, DOI 10.1007/PL00007757; Rees JN, 2009, CHEM RES TOXICOL, V22, P1256, DOI 10.1021/tx9000557; Reichmann H, 2000, J NEUROL, V247, P63; Rodrigues RWP, 2001, INT J NEUROSCI, V109, P91, DOI 10.3109/00207450108986528; SAKAI K, 1994, BRAIN RES, V633, P144, DOI 10.1016/0006-8993(94)91533-4; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Terzioglu M, 2008, FEBS J, V275, P1384, DOI 10.1111/j.1742-4658.2008.06302.x; Thiel CM, 2001, NEUROPSYCHOBIOLOGY, V43, P192, DOI 10.1159/000054889; THOMAS J, 1994, EXP NEUROL, V126, P159, DOI 10.1006/exnr.1994.1054; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Weber M, 2004, NEUROSCI LETT, V358, P17, DOI 10.1016/j.neulet.2003.12.053; Werner CJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-8; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Willis G L, 1993, Int J Neurosci, V71, P135, DOI 10.3109/00207459309000599; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004	72	83	87	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15251	10.1371/journal.pone.0015251	http://dx.doi.org/10.1371/journal.pone.0015251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179455	gold, Green Published, Green Submitted			2022-12-25	WOS:000285246900038
J	Takikita, S; Schreiner, C; Baum, R; Xie, T; Ralston, E; Plotz, PH; Raben, N				Takikita, Shoichi; Schreiner, Cynthia; Baum, Rebecca; Xie, Tao; Ralston, Evelyn; Plotz, Paul H.; Raben, Nina			Fiber Type Conversion by PGC-1 alpha Activates Lysosomal and Autophagosomal Biogenesis in Both Unaffected and Pompe Skeletal Muscle	PLOS ONE			English	Article							ACID ALPHA-GLUCOSIDASE; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ENZYME REPLACEMENT THERAPY; ALGLUCOSIDASE ALPHA; GLYCOGEN AUTOPHAGY; PGC-1 COACTIVATORS; SIGNALING PATHWAYS; NATURAL COURSE; CELL-DEATH; DISEASE	PGC-1 alpha is a transcriptional co-activator that plays a central role in the regulation of energy metabolism. Our interest in this protein was driven by its ability to promote muscle remodeling. Conversion from fast glycolytic to slow oxidative fibers seemed a promising therapeutic approach in Pompe disease, a severe myopathy caused by deficiency of the lysosomal enzyme acid alpha-glucosidase (GAA) which is responsible for the degradation of glycogen. The recently approved enzyme replacement therapy (ERT) has only a partial effect in skeletal muscle. In our Pompe mouse model (KO), the poor muscle response is seen in fast but not in slow muscle and is associated with massive accumulation of autophagic debris and ineffective autophagy. In an attempt to turn the therapy-resistant fibers into fibers amenable to therapy, we made transgenic KO mice expressing PGC-1 alpha in muscle (tgKO). The successful switch from fast to slow fibers prevented the formation of autophagic buildup in the converted fibers, but PGC-1 alpha failed to improve the clearance of glycogen by ERT. This outcome is likely explained by an unexpected dramatic increase in muscle glycogen load to levels much closer to those observed in patients, in particular infants, with the disease. We have also found a remarkable rise in the number of lysosomes and autophagosomes in the tgKO compared to the KO. These data point to the role of PGC-1 alpha in muscle glucose metabolism and its possible role as a master regulator for organelle biogenesis - not only for mitochondria but also for lysosomes and autophagosomes. These findings may have implications for therapy of lysosomal diseases and other disorders with altered autophagy.	[Takikita, Shoichi; Schreiner, Cynthia; Baum, Rebecca; Xie, Tao; Plotz, Paul H.; Raben, Nina] NIAMSD, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA; [Ralston, Evelyn] NIAMSD, Light Imaging Sect, Off Sci & Technol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Takikita, S (corresponding author), NIAMSD, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA.	rabenn@mail.nih.gov			National Institute of Arthritis and Musculoskeleta and Skin Diseases of the National Institutes of Health; NIH; Genzyme Corporation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041099, ZICAR041186, ZIAAR041132] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeleta and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme Corporation(Sanofi-AventisGenzyme Corporation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. Dr. Takikita was supported in part by a Cooperative Research and Development Agreement (CRADA) between the NIH and Genzyme Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Douillard-Guilloux G, 2008, HUM MOL GENET, V17, P3876, DOI 10.1093/hmg/ddn290; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fukuda T, 2007, CURR NEUROL NEUROSCI, V7, P71, DOI 10.1007/s11910-007-0024-4; Fukuda T, 2006, MOL THER, V14, P831, DOI 10.1016/j.ymthe.2006.08.009; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hawes ML, 2007, MOL GENET METAB, V91, P343, DOI 10.1016/j.ymgme.2007.04.018; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hickson-Bick DLM, 2008, J MOL CELL CARDIOL, V44, P411, DOI 10.1016/j.yjmcc.2007.10.013; Hirschhorn R., 2000, METABOLIC MOL BASES, P3389; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Kondomerkos DJ, 2005, HISTOL HISTOPATHOL, V20, P689, DOI 10.14670/HH-20.689; Kotoulas OB, 2004, MICROSC RES TECHNIQ, V64, P10, DOI 10.1002/jemt.20046; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; Raben N, 2005, MOL THER, V11, P48, DOI 10.1016/j.ymthe.2004.09.017; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; Raben N, 2010, AUTOPHAGY IN PRESS, V6; Raben N, 2010, MOL GENET M IN PRESS, V6; Raben N, 2007, AUTOPHAGY, V3, P546, DOI 10.4161/auto.4591; Raben N, 2009, METHOD ENZYMOL, V453, P417, DOI 10.1016/S0076-6879(08)04021-4; Raben N, 2009, AUTOPHAGY, V5, P111, DOI 10.4161/auto.5.1.7293; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ralston E, 2001, J NEUROSCI, V21, P875, DOI 10.1523/JNEUROSCI.21-03-00875.2001; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; SCHIAFFINO S, 1972, J CELL BIOL, V52, P41, DOI 10.1083/jcb.52.1.41; Schiaffino S, 2008, AUTOPHAGY, V4; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Strothotte S, 2010, J NEUROL, V257, P91, DOI 10.1007/s00415-009-5275-3; TAMAKI H, 1994, J HISTOCHEM CYTOCHEM, V42, P1285, DOI 10.1177/42.9.8064136; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; van den Hout HMP, 2003, PEDIATRICS, V112, P332, DOI 10.1542/peds.112.2.332; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Winkel LPF, 2005, J NEUROL, V252, P875, DOI 10.1007/s00415-005-0922-9; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Zhou J, 2009, INT J BIOCHEM CELL B, V41, P2334, DOI 10.1016/j.biocel.2009.06.007; Zhu Y, 2005, BIOCH J	58	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15239	10.1371/journal.pone.0015239	http://dx.doi.org/10.1371/journal.pone.0015239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179212	Green Published, gold, Green Submitted			2022-12-25	WOS:000285246900035
J	Palkowitsch, L; Marienfeld, U; Brunner, C; Eitelhuber, A; Krappmann, D; Marienfeld, RB				Palkowitsch, Lysann; Marienfeld, Uta; Brunner, Cornelia; Eitelhuber, Andrea; Krappmann, Daniel; Marienfeld, Ralf B.			The Ca2+-dependent Phosphatase Calcineurin Controls the Formation of the Carma1-Bcl10-Malt1 Complex during T Cell Receptor-induced NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PKC-THETA; PHOSPHORYLATION; CARMA1; LYMPHOCYTES; BCL10; UBIQUITINATION; DEGRADATION; INTERFERES; CALMODULIN	T cell receptor (TCR) ligation induces increased diacylglycerol and Ca2+ levels in T cells, and both secondary messengers are crucial for TCR-induced nuclear factor of activated T cells (NF-AT) and NF-kappa B signaling pathways. One prominent calcium-dependent enzyme involved in the regulation of NF-AT and NF-kappa B signaling pathways is the protein phosphatase calcineurin. However, in contrast to NF-AT, which is directly dephosphorylated by calcineurin, the molecular basis of the calcium-calcineurin dependence of the TCR-induced NF-kappa B activity remains largely unknown. Here, we demonstrate that calcineurin regulates TCR-induced NF-kappa B activity by controlling the formation of a protein complex composed of Carma1, Bcl10, and Malt1 (CBM complex). For instance, increased calcium levels induced by ionomycin or thapsigargin augmented the phorbol 12-myristate 13-acetate-induced formation of the CBM complex and activation of NF-kappa B, whereas removal of calcium by the calcium chelator EGTA-acetoxymethyl ester (AM) attenuated both processes. Furthermore, inhibition of the calcium-dependent phosphatase calcineurin with the immunosuppressive agent cyclosporin A (CsA) or FK506 as well as siRNA-mediated knockdown of calcineurin A strongly affected the PMA + ionomycin- or anti-CD3 + CD28-induced CBM complex assembly. Mechanistically, the positive effect of calcineurin on the CBM complex formation seems to be linked to a dephosphorylation of Bcl10. For instance, Bcl10 was found to be hyperphosphorylated in Jurkat T cells upon treatment with CsA or EGTA-AM, and calcineurin dephosphorylated Bcl10 in vivo and in vitro. Furthermore, we show here that calcineurin A interacts with the CBM complex. In summary, the evidence provided here argues for a previously unanticipated role of calcineurin in CBM complex formation as a molecular basis of the inhibitory function of CsA or FK506 on TCR-induced NF-kappa B activity.	[Marienfeld, Ralf B.] Univ Ulm, Inst Pathol, D-89081 Ulm, Germany; [Palkowitsch, Lysann; Marienfeld, Uta; Brunner, Cornelia; Marienfeld, Ralf B.] Univ Ulm, Inst Physiol Chem, D-89081 Ulm, Germany; [Eitelhuber, Andrea; Krappmann, Daniel] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Toxicol, D-85764 Neuherberg, Germany	Ulm University; Ulm University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Marienfeld, RB (corresponding author), Univ Ulm, Inst Pathol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	ralf.marienfeld@uni-ulm.de	Brunner, Cornelia/L-1291-2013; Brunner, Cornelia/H-8893-2018; Krappmann, Daniel/ABF-4038-2021; Krappmann, Daniel/AAT-4354-2021	Brunner, Cornelia/0000-0002-6456-5508; Krappmann, Daniel/0000-0001-7640-3234; Krappmann, Daniel/0000-0001-7640-3234	Ministry of Science and Culture of the State of Baden-Wurttemberg; Deutsche Forschungsgemeinschaft [MA 2367/3-2]	Ministry of Science and Culture of the State of Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Junior professor program grant of the Ministry of Science and Culture of the State of Baden-Wurttemberg (to M. W. K.) and by Deutsche Forschungsgemeinschaft Grant MA 2367/3-2 (to R. M.).	Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Brenner D, 2009, P NATL ACAD SCI USA, V106, P14508, DOI 10.1073/pnas.0900457106; Edin S, 2010, MOL IMMUNOL, V47, P2057, DOI 10.1016/j.molimm.2010.04.005; HINZ M, 2007, SCI STKE, pPE19; Hughes K, 2001, J BIOL CHEM, V276, P36008, DOI 10.1074/jbc.M106125200; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Ishiguro K, 2007, MOL IMMUNOL, V44, P2095, DOI 10.1016/j.molimm.2006.09.012; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Marienfeld R, 1997, EUR J IMMUNOL, V27, P1601, DOI 10.1002/eji.1830270703; Moreno-Garcia ME, 2010, MOL CELL BIOL, V30, P922, DOI 10.1128/MCB.01129-09; Moreno-Garcia ME, 2009, J IMMUNOL, V183, P7362, DOI 10.4049/jimmunol.0902438; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Thome M, 2007, TRENDS IMMUNOL, V28, P281, DOI 10.1016/j.it.2007.04.004; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Welteke V, 2009, EMBO REP, V10, P642, DOI 10.1038/embor.2009.64; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Zeng H, 2007, MOL CELL BIOL, V27, P5235, DOI 10.1128/MCB.01645-06	28	81	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7522	7534		10.1074/jbc.M110.155895	http://dx.doi.org/10.1074/jbc.M110.155895			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21199863	Green Published, hybrid			2022-12-25	WOS:000287737300066
J	Zevian, S; Winterwood, NE; Stipp, CS				Zevian, Shannin; Winterwood, Nicole E.; Stipp, Christopher S.			Structure-Function Analysis of Tetraspanin CD151 Reveals Distinct Requirements for Tumor Cell Behaviors Mediated by alpha 3 beta 1 versus alpha 6 beta 4 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMININ-BINDING INTEGRINS; SUPERFAMILY MEMBER CD151; MICE LACKING; IN-VIVO; HEPATOCELLULAR-CARCINOMA; MONOCLONAL-ANTIBODIES; CLINICAL-SIGNIFICANCE; EPITHELIAL-CELLS; EXPRESSION; PALMITOYLATION	The basement membrane protein laminin-332 (laminin-5) mediates both stable cell adhesion and rapid cell migration and thus has the potential to either restrain or promote tumor cell metastasis. The major cellular receptors for laminin-332 are integrin alpha 3 beta 1, which mediates rapid tumor cell migration, and integrin alpha 6 beta 4, which often mediates stable cell attachment. Tetraspanin protein CD151 interacts directly with both alpha 3 beta 1 and alpha 6 beta 4 integrins and with other tetraspanins, thereby promoting alpha 3 beta 1 and alpha 6 beta 4 association with tetraspanin-enriched microdomains on the cell surface. To explore the possibility of selectively modulating tumor cell responses to laminin-332, we re-expressed a series of CD151 mutants in epidermoid carcinoma cells with near total, RNAi-mediated silencing of endogenous CD151. The interactions of CD151 with its integrin partners or its interactions with other tetraspanins were selectively disrupted by specific mutations in the CD151 large extracellular loop (EC2 domain) or in intracellular CD151 palmitoylation sites, respectively. CD151-integrin association and CD151-tetraspanin association were both important for alpha 3 beta 1 integrin-dependent initial adhesion and rapid migration on laminin-332. Remarkably, however, only CD151-integrin association was required for stable, alpha 6 beta 4 integrin-dependent cell attachment on laminin-332. In addition, we found that a QRD amino acid motif in the CD151 EC2 domain, which had been thought to be crucial for CD151-integrin interaction, is not essential for CD151-integrin association or for the ability of CD151 to promote several different integrin functions. These new data suggest potential strategies for selectively modulating migratory cell responses to laminin-332, while leaving stable cell attachment on laminin-332 intact.	[Zevian, Shannin; Winterwood, Nicole E.; Stipp, Christopher S.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Stipp, Christopher S.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Stipp, CS (corresponding author), 210 E Iowa Ave,BBE 236, Iowa City, IA 52242 USA.	christopher-stipp@uiowa.edu			National Institutes of Health [CA136664]; American Cancer Society [RSG-07-043-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA136664] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136664. This work was also supported by American Cancer Society Research Scholar Award RSG-07-043-01-CSM.	Ang J, 2004, CANCER EPIDEM BIOMAR, V13, P1717; Baleato RM, 2008, AM J PATHOL, V173, P927, DOI 10.2353/ajpath.2008.071149; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Chometon G, 2006, EXP CELL RES, V312, P983, DOI 10.1016/j.yexcr.2005.12.034; Cowin AJ, 2006, J INVEST DERMATOL, V126, P680, DOI 10.1038/sj.jid.5700142; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; FUKUDOME K, 1992, J VIROL, V66, P1394, DOI 10.1128/JVI.66.3.1394-1401.1992; Geary SM, 2008, EXP CELL RES, V314, P2165, DOI 10.1016/j.yexcr.2008.04.011; Hasegawa M, 2007, LAB INVEST, V87, P882, DOI 10.1038/labinvest.3700657; Hashida H, 2003, BRIT J CANCER, V89, P158, DOI 10.1038/sj.bjc.6601015; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Johnson JL, 2009, J CELL SCI, V122, P2263, DOI 10.1242/jcs.045997; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Lammerding J, 2003, P NATL ACAD SCI USA, V100, P7616, DOI 10.1073/pnas.1337546100; Lau LM, 2004, BLOOD, V104, P2368, DOI 10.1182/blood-2003-12-4430; LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Novitskaya V, 2010, CANCER RES, V70, P4698, DOI 10.1158/0008-5472.CAN-09-4330; Orlowski E, 2009, J THROMB HAEMOST, V7, P2074, DOI 10.1111/j.1538-7836.2009.03612.x; Ports MO, 2009, CANCER RES, V69, P5007, DOI 10.1158/0008-5472.CAN-09-0354; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rasband W., 2006, IMAGEJ; Raymond K, 2005, J CELL SCI, V118, P1045, DOI 10.1242/jcs.01689; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Sadej R, 2010, CANCER RES, V70, P6059, DOI 10.1158/0008-5472.CAN-09-3497; Sadej R, 2009, MOL CANCER RES, V7, P787, DOI 10.1158/1541-7786.MCR-08-0574; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Shi GM, 2010, HEPATOLOGY, V52, P183, DOI 10.1002/hep.23661; Sincock PM, 1999, J CELL SCI, V112, P833; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tokuhara T, 2001, CLIN CANCER RES, V7, P4109; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Yamada M, 2008, BIOCHEM J, V415, P417, DOI 10.1042/BJ20071625; Yamada M, 2008, FEBS J, V275, P3335, DOI 10.1111/j.1742-4658.2008.06481.x; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XWH, 2010, CANCER RES, V70, P2256, DOI 10.1158/0008-5472.CAN-09-4032; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031; Zuo HJ, 2010, ACTA PHARMACOL SIN, V31, P805, DOI 10.1038/aps.2010.65	50	40	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7496	7506		10.1074/jbc.M110.173583	http://dx.doi.org/10.1074/jbc.M110.173583			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193415	hybrid, Green Published			2022-12-25	WOS:000287737300064
J	Chen, CR; McLachlan, SM; Rapoport, B				Chen, Chun-Rong; McLachlan, Sandra M.; Rapoport, Basil			Evidence That the Thyroid-stimulating Hormone (TSH) Receptor Transmembrane Domain Influences Kinetics of TSH Binding to the Receptor Ectodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN THYROTROPIN RECEPTOR; EXTRACELLULAR DOMAIN; NEGATIVE COOPERATIVITY; LUTROPIN RECEPTOR; LIPID RAFTS; SIGNAL-TRANSDUCTION; INVERSE AGONIST; HINGE REGION; PROTEIN; ACTIVATION	Thyroid-stimulating hormone (TSH)-induced reduction in ligand binding affinity (negative cooperativity) requires TSH receptor (TSHR) homodimerization, the latter involving primarily the transmembrane domain (TMD) but with the extracellular domain (ECD) also contributing to this association. To test the role of the TMD in negative cooperativity, we studied the TSHR ECD tethered to the cell surface by a glycosylphosphatidylinositol (GPI) anchor that multimerizes despite the absence of the TMD. Using the infinite ligand dilution approach, we confirmed that TSH increased the rate of dissociation (k(off)) of prebound I-125-TSH from CHO cells expressing the TSH holoreceptor. Such negative cooperativity did not occur with TSHR ECD-GPI-expressing cells. However, even in the absence of added TSH, I-125-TSH dissociated much more rapidly from the TSHR ECD-GPI than from the TSH holoreceptor. This phenomenon, suggesting a lower TSH affinity for the former, was surprising because both the TSHR ECD and TSH holoreceptor contain the entire TSH-binding site, and the TSH binding affinities for both receptor forms should, theoretically, be identical. In ligand competition studies, we observed that the TSH binding affinity for the TSHR ECD-GPI was significantly lower than that for the TSH holoreceptor. Further evidence for a difference in ligand binding kinetics for the TSH holoreceptor and TSHR ECD-GPI was obtained upon comparison of the TSH K-d values for these two receptor forms at 4 degrees C versus room temperature. Our data provide the first evidence that the wild-type TSHR TMD influences ligand binding affinity for the ECD, possibly by altering the conformation of the closely associated hinge region that contributes to the TSH-binding site.	Cedars Sinai Res Inst, Thyroid Autoimmune Dis Unit, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rapoport, B (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,Suite B-131, Los Angeles, CA 90048 USA.	rapoportb@cshs.org			National Institutes of Health [DK19289]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK19289 (to B. R.).	Chazenbalk GD, 1996, ENDOCRINOLOGY, V137, P4586, DOI 10.1210/en.137.11.4586; Chazenbalk GD, 1999, ENDOCRINOLOGY, V140, P4516, DOI 10.1210/en.140.10.4516; Chen CR, 2007, ENDOCRINOLOGY, V148, P2375, DOI 10.1210/en.2006-1754; Costagliola S, 1998, FEBS LETT, V436, P427, DOI 10.1016/S0014-5793(98)01177-6; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Da Costa CR, 1998, J BIOL CHEM, V273, P11874, DOI 10.1074/jbc.273.19.11874; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Grace CRR, 2010, J BIOL CHEM, V285, P38580, DOI 10.1074/jbc.M110.121897; Graves PN, 1996, ENDOCRINOLOGY, V137, P3915, DOI 10.1210/en.137.9.3915; Guan RB, 2010, CELL SIGNAL, V22, P247, DOI 10.1016/j.cellsig.2009.09.023; Guan RB, 2009, J BIOL CHEM, V284, P7483, DOI 10.1074/jbc.M809150200; JI I, 1991, J BIOL CHEM, V266, P13076; JI IH, 1991, J BIOL CHEM, V266, P14953; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; KOSUGI S, 1991, J BIOL CHEM, V266, P19413; Latif R, 2007, ENDOCRINOLOGY, V148, P3164, DOI 10.1210/en.2006-1580; Latif R, 2003, ENDOCRINOLOGY, V144, P4725, DOI 10.1210/en.2003-0932; Latif R, 2001, J BIOL CHEM, V276, P45217, DOI 10.1074/jbc.M103727200; Latif R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009449; Latrofa F, 2004, THYROID, V14, P801, DOI 10.1089/1050725042451310; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1989, BIOCHEM BIOPH RES CO, V165, P1184, DOI 10.1016/0006-291X(89)92727-7; NAGAYAMA Y, 1992, ENDOCRINOLOGY, V131, P548, DOI 10.1210/en.131.2.548; NUNEZ MR, 2004, THYROID, V14, P991; Osuga Y, 1997, MOL ENDOCRINOL, V11, P1659, DOI 10.1210/me.11.11.1659; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; POWELLJONES CHJ, 1980, J BIOL CHEM, V255, P4001; POWELLJONES CHJ, 1979, P NATL ACAD SCI USA, V76, P705, DOI 10.1073/pnas.76.2.705; QUINTANA J, 1993, MOL ENDOCRINOL, V7, P767, DOI 10.1210/me.7.6.767; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; SALTIEL AR, 1982, MOL CELL ENDOCRINOL, V28, P299, DOI 10.1016/0303-7207(82)90128-9; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Siu FY, 2010, STRUCTURE, V18, P1067, DOI 10.1016/j.str.2010.08.004; Smits G, 2003, EMBO J, V22, P2692, DOI 10.1093/emboj/cdg260; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736	43	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6219	6224		10.1074/jbc.M110.211003	http://dx.doi.org/10.1074/jbc.M110.211003			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21190937	hybrid, Green Published			2022-12-25	WOS:000287476400031
J	Liu, CY; Lv, XB; Li, TT; Xu, YP; Zhou, X; Zhao, SM; Xiong, Y; Lei, QY; Guan, KL				Liu, Chen-Ying; Lv, Xianbo; Li, Tingting; Xu, Yanping; Zhou, Xin; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang			PP1 Cooperates with ASPP2 to Dephosphorylate and Activate TAZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; CELL-PROLIFERATION; SERINE/THREONINE PHOSPHATASES; NEGATIVE REGULATOR; PROTEIN; INTERACTS; TRANSCRIPTION; COACTIVATOR; INHIBITOR; TUMORIGENESIS	The Hippo pathway regulates organ size by controlling both cell proliferation and apoptosis. TAZ functions as a transcriptional co-activator downstream of the Hippo pathway and has been implicated in human cancer development. A key step in the Hippo-TAZ pathway is phosphorylation of TAZ by LATS kinase, which leads to TAZ inhibition by both cytoplasmic retention and degradation. However, the mechanism of TAZ dephosphorylation and the responsible phosphatase are unknown. Here, we identified PP1 as a bona fide TAZ phosphatase. PP1A dephosphorylates TAZ at Ser-89 and Ser-311, promotes TAZ nuclear translocation, and stabilizes TAZ by disrupting the binding to the SCF E3 ubiquitin ligase. Furthermore, ASPP2 facilitates the interaction between TAZ and PP1 to promote TAZ dephosphorylation. As a result, PP1 and ASPP2 increase TAZ-dependent gene expression. This study demonstrates that PP1A and ASPP2 play a critical role in promoting TAZ function by antagonizing the LATS kinase through TAZ dephosphorylation.	[Liu, Chen-Ying; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Key Lab Mol Med, Minist Educ, Dept Biochem & Mol Biol,Sch Med, Shanghai 200032, Peoples R China; [Liu, Chen-Ying; Lv, Xianbo; Li, Tingting; Xu, Yanping; Zhou, Xin; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Sch Life Sci, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Liu, Chen-Ying; Lv, Xianbo; Li, Tingting; Xu, Yanping; Zhou, Xin; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Mol & Cell Biol Lab, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego	Lei, QY (corresponding author), Fudan Univ, Key Lab Mol Med, Minist Educ, Dept Biochem & Mol Biol,Sch Med, Shanghai 200032, Peoples R China.	qlei@fudan.edu.cn; kuguan@ucsd.edu	Zhou, Xin/AAD-6937-2019; Guan, Kun-Liang/ADK-7088-2022; Lei, Qun-Ying/J-1390-2017	Lei, Qun-Ying/0000-0002-8547-8518; Liu, Chen-Ying/0000-0002-8930-6182	National Natural Science Foundation of China, NSFC [2009CB918401, 2011CB910600, 30600112, 30871255, 31071192]; 985 Program; Chinese Ministry of Education [NCET-09-0315]; National Institutes of Health [GM067113, CA132809]; Shanghai Key Project [09JC1402300]; Shanghai Leading Academic Discipline Project [B110]; NATIONAL CANCER INSTITUTE [R01CA132809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067113] Funding Source: NIH RePORTER	National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); 985 Program; Chinese Ministry of Education(Ministry of Education, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Key Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by 973 Program Grants 2009CB918401 and 2011CB910600, National Natural Science Foundation of China Grants NSFC grants 30600112, 30871255, and 31071192. This work was also supported by the 985 Program and New Century Talent from the Chinese Ministry of Education Grant NCET-09-0315, in whole or in part by National Institutes of Health Grants (to Y. X. and K.-L. G.: GM067113 and CA132809), by Shanghai Key Project Grant 09JC1402300, and by the Shanghai Leading Academic Discipline Project (Project Number B110).	Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen YZ, 2003, J NEUROCHEM, V85, P801, DOI 10.1046/j.1471-4159.2003.01727.x; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 2003, METHOD ENZYMOL, V366, P1; COHEN P, 2003, METHOD ENZYMOL, V366, pR15; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Hakuno F, 2007, J BIOL CHEM, V282, P37747, DOI 10.1074/jbc.M702472200; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Helps NR, 1995, FEBS LETT, V377, P295, DOI 10.1016/0014-5793(95)01347-4; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Nakaga H, 2000, CANCER RES, V60, P101; Naumovski L, 1996, MOL CELL BIOL, V16, P3884; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Slee EA, 2003, TOXICOL LETT, V139, P81, DOI 10.1016/S0378-4274(02)00421-6; SUGANUMA M, 1990, CANCER RES, V50, P3521; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	40	101	105	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5558	5566		10.1074/jbc.M110.194019	http://dx.doi.org/10.1074/jbc.M110.194019			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21189257	Green Published, hybrid			2022-12-25	WOS:000287230600065
J	Langlois, MJ; Bergeron, S; Bernatchez, G; Boudreau, F; Saucier, C; Perreault, N; Carrier, JC; Rivard, N				Langlois, Marie-Josee; Bergeron, Sebastien; Bernatchez, Gerald; Boudreau, Francois; Saucier, Caroline; Perreault, Nathalie; Carrier, Julie C.; Rivard, Nathalie			The PTEN Phosphatase Controls Intestinal Epithelial Cell Polarity and Barrier Function: Role in Colorectal Cancer Progression	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; MESENCHYMAL TRANSITION; COLON-CANCER; LIVER METASTASIS; MICROSATELLITE INSTABILITY; ADHERENS-JUNCTION; TIGHT-JUNCTION; GENE-MUTATIONS; KAPPA-B; EXPRESSION	Background: The PTEN phosphatase acts on phosphatidylinositol 3,4,5-triphosphates resulting from phosphatidylinositol 3-kinase (PI3K) activation. PTEN expression has been shown to be decreased in colorectal cancer. Little is known however as to the specific cellular role of PTEN in human intestinal epithelial cells. The aim of this study was to investigate the role of PTEN in human colorectal cancer cells. Methodology/Principal Findings: Caco-2/15, HCT116 and CT26 cells were infected with recombinant lentiviruses expressing a shRNA specifically designed to knock-down PTEN. The impact of PTEN downregulation was analyzed on cell polarization and differentiation, intercellular junction integrity (expression of cell-cell adhesion proteins, barrier function), migration (wound assay), invasion (matrigel-coated transwells) and on tumor and metastasis formation in mice. Electron microscopy analysis showed that lentiviral infection of PTEN shRNA significantly inhibited Caco-2/15 cell polarization, functional differentiation and brush border development. A strong reduction in claudin 1, 3, 4 and 8 was also observed as well as a decrease in transepithelial resistance. Loss of PTEN expression increased the spreading, migration and invasion capacities of colorectal cancer cells in vitro. PTEN downregulation also increased tumor size following subcutaneous injection of colorectal cancer cells in nude mice. Finally, loss of PTEN expression in HCT116 and CT26, but not in Caco-2/15, led to an increase in their metastatic potential following tail-vein injections in mice. Conclusions/Significance: Altogether, these results indicate that PTEN controls cellular polarity, establishment of cell-cell junctions, paracellular permeability, migration and tumorigenic/metastatic potential of human colorectal cancer cells.	[Langlois, Marie-Josee; Bergeron, Sebastien; Boudreau, Francois; Saucier, Caroline; Perreault, Nathalie; Rivard, Nathalie] Univ Sherbrooke, Canadian Inst Hlth Res Team Digest Epithelium, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada; [Bernatchez, Gerald; Carrier, Julie C.] Univ Sherbrooke, Canadian Inst Hlth Res Team Digest Epithelium, Dept Med, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke	Langlois, MJ (corresponding author), Univ Sherbrooke, Canadian Inst Hlth Res Team Digest Epithelium, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	nathalie.rivard@usherbrooke.ca	Saucier, Caroline/Q-9250-2019	Saucier, Caroline/0000-0001-7678-9886	Canadian Institutes of Health Research (CIHR) [CTP-82942, MT-14405]; Canadian Research Chair in Signaling and Digestive Physiopathology; Canadian Association of Gastroenterology/CIHR/CCFC; FRSQ	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Research Chair in Signaling and Digestive Physiopathology; Canadian Association of Gastroenterology/CIHR/CCFC(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec)	This research was supported by the Canadian Institutes of Health Research (CIHR: www.cihr-irsc.gc.ca) (CTP-82942) and MT-14405 (to N.R.). N.R. is a recipient of a Canadian Research Chair in Signaling and Digestive Physiopathology. J.C., C.S. and F.B. are scholars from the Fonds de la Recherche en Sante du Quebec. S.B. is a recipient of a post-doctoral fellowship from the Canadian Association of Gastroenterology/CIHR/CCFC. N.R., J.C., C.S., N.P., and F.B. are members of the FRSQ-funded "Centre de Recherche Clinique Etienne LeBel". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Boulanger J, 2005, J BIOL CHEM, V280, P18095, DOI 10.1074/jbc.M502184200; Bowen KA, 2009, ANTICANCER RES, V29, P4439; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Calzado MA, 2000, CLIN EXP IMMUNOL, V120, P317, DOI 10.1046/j.1365-2249.2000.01203.x; Colakoglu T, 2008, AM J SURG, V195, P719, DOI 10.1016/j.amjsurg.2007.05.061; Danielsen SA, 2008, HUM MUTAT, V29, pE252, DOI 10.1002/humu.20860; Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609; Dey N, 2008, CANCER RES, V68, P1862, DOI 10.1158/0008-5472.CAN-07-1182; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Garneau H, 2009, J CELL PHYSIOL, V221, P350, DOI 10.1002/jcp.21859; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Haier J, 2002, ONCOGENE, V21, P1450, DOI 10.1038/sj.onc.1205213; Hamada K, 2008, INT J ONCOL, V32, P153; HERMANEK P, 1995, WORLD J SURG, V19, P184, DOI 10.1007/BF00308624; Hu YL, 2007, ARCH BIOCHEM BIOPHYS, V467, P1, DOI 10.1016/j.abb.2007.07.027; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Ishizu K, 2007, BIOL PHARM BULL, V30, P1779, DOI 10.1248/bpb.30.1779; Jang KS, 2010, HISTOPATHOLOGY, V56, P229, DOI 10.1111/j.1365-2559.2009.03468.x; Jiang YA, 2003, WORLD J GASTROENTERO, V9, P491, DOI 10.3748/wjg.v9.i3.491; Kim S, 2002, GASTROENTEROLOGY, V123, P1163, DOI 10.1053/gast.2002.36043; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Kotelevets L, 2001, J CELL BIOL, V155, P1129, DOI 10.1083/jcb.200105109; Langlois MJ, 2009, FASEB J, V23, P1835, DOI 10.1096/fj.08-123125; Laprise P, 2002, J BIOL CHEM, V277, P8226, DOI 10.1074/jbc.M110235200; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Lemieux E, 2009, INT J CANCER, V125, P1575, DOI 10.1002/ijc.24485; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Li XH, 2009, ONCOL REP, V22, P757, DOI 10.3892/or_00000497; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Martin TA, 2009, BBA-BIOMEMBRANES, V1788, P872, DOI 10.1016/j.bbamem.2008.11.005; Martin-Belmonte F, 2007, CELL CYCLE, V6, P1957, DOI 10.4161/cc.6.16.4583; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Menard D, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, P755; Natalwala A, 2008, WORLD J GASTROENTERO, V14, P3792, DOI 10.3748/wjg.14.3792; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Oikonomou E, 2009, NEOPLASIA, V11, P1116, DOI 10.1593/neo.09514; Pallares J, 2005, MODERN PATHOL, V18, p198A; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rozen S, 2000, Methods Mol Biol, V132, P365; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Satake S, 2008, PATHOL INT, V58, P156, DOI 10.1111/j.1440-1827.2007.02204.x; Satohisa S, 2005, EXP CELL RES, V310, P66, DOI 10.1016/j.yexcr.2005.06.025; Sawai H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-56; Semba S, 2009, CANCER LETT, V274, P143, DOI 10.1016/j.canlet.2008.09.019; Shao J, 2007, CARCINOGENESIS, V28, P2476, DOI 10.1093/carcin/bgm186; Shin KH, 2001, CANCER LETT, V174, P189, DOI 10.1016/S0304-3835(01)00691-7; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Smakman N, 2005, BBA-REV CANCER, V1756, P103, DOI 10.1016/j.bbcan.2005.07.001; Tamura M, 1999, CANCER RES, V59, P442; Tetreault MP, 2005, EXP CELL RES, V306, P285, DOI 10.1016/j.yexcr.2005.02.019; Thant AA, 2008, ANTICANCER RES, V28, P3579; Tsanou E, 2008, ANTICANCER RES, V28, P3815; VACHON PH, 1992, GASTROENTEROLOGY, V103, P414, DOI 10.1016/0016-5085(92)90829-N; Voisin L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-337; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wang Z, 2004, BIOCHEM BIOPH RES CO, V322, P609, DOI 10.1016/j.bbrc.2004.07.166; Wang ZJ, 1998, AM J PATHOL, V153, P363, DOI 10.1016/S0002-9440(10)65579-4; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Weinstein R S, 1976, Adv Cancer Res, V23, P23, DOI 10.1016/S0065-230X(08)60543-6; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Yamada KM, 2001, J CELL SCI, V114, P2375; Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.E02-06-0350; Zhang BX, 2009, CANCER LETT, V277, P114, DOI 10.1016/j.canlet.2008.11.035; ZHONG W, AM J PHYSL GASTROINT, V299, pG643; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9; Zweibaum A, 1989, ADAPTATION DEV GASTR, P103	78	58	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15742	10.1371/journal.pone.0015742	http://dx.doi.org/10.1371/journal.pone.0015742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203412	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200036
J	Manavalan, B; Basith, S; Choi, YM; Lee, G; Choi, S				Manavalan, Balachandran; Basith, Shaherin; Choi, Yong-Min; Lee, Gwang; Choi, Sangdun			Structure-Function Relationship of Cytoplasmic and Nuclear I kappa B Proteins: An In Silico Analysis	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ANKYRIN REPEAT; DNA-BINDING; P50 HOMODIMERS; ZETA; BCL-3; SEQUENCE; COMPLEX; SERVER; MEMBER	Cytoplasmic I kappa B proteins are primary regulators that interact with NF-kappa B subunits in the cytoplasm of unstimulated cells. Upon stimulation, these IkB proteins are rapidly degraded, thus allowing NF-kB to translocate into the nucleus and activate the transcription of genes encoding various immune mediators. Subsequent to translocation, nuclear IkB proteins play an important role in the regulation of NF-kB transcriptional activity by acting either as activators or inhibitors. To date, molecular basis for the binding of I kappa B alpha, I kappa B beta and I kappa B zeta along with their partners is known; however, the activation and inhibition mechanism of the remaining I kappa B (I kappa BNS, I kappa Be and Bcl-3) proteins remains elusive. Moreover, even though I kappa B proteins are structurally similar, it is difficult to determine the exact specificities of I kappa B proteins towards their respective binding partners. The three-dimensional structures of I kappa BNS, I kappa B zeta and I kappa B epsilon were modeled. Subsequently, we used an explicit solvent method to perform detailed molecular dynamic simulations of these proteins along with their known crystal structures (I kappa B alpha, I kappa B beta and Bcl-3) in order to investigate the flexibility of the ankyrin repeat domains (ARDs). Furthermore, the refined models of IkBNS, IkBe and Bcl-3 were used for multiple protein-protein docking studies for the identification of I kappa BNS-p50/p50, I kappa B epsilon-p50/p65 and Bcl-3-p50/p50 complexes in order to study the structural basis of their activation and inhibition. The docking experiments revealed that I kappa B epsilon masked the nuclear localization signal (NLS) of the p50/p65 subunits, thereby preventing its translocation into the nucleus. For the Bcl-3-and I kappa BNS-p50/p50 complexes, the results show that Bcl-3 mediated transcription through its transactivation domain (TAD) while I kappa BNS inhibited transcription due to its lack of a TAD, which is consistent with biochemical studies. Additionally, the numbers of identified flexible residues were equal in number among all IkB proteins, although they were not conserved. This could be the primary reason for their binding partner specificities.	[Manavalan, Balachandran; Basith, Shaherin; Choi, Yong-Min; Lee, Gwang; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Lee, Gwang] Ajou Univ, Inst Med Sci, Sch Med, Suwon 441749, South Korea	Ajou University; Ajou University	Manavalan, B (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Manavalan, Balachandran/Q-8279-2019	Manavalan, Balachandran/0000-0003-0697-9419	Ministry of Education, Science and Technology [2010-0015356]; Korea Food and Drug Administration [10182KFDA992]; NRF of Korea [2009-0093826]; Ajou University	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); NRF of Korea; Ajou University	This work was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology (2010-0015356). This work was also partly supported by a grant (10182KFDA992) from the Korea Food and Drug Administration, the Priority Research Centers Program through the NRF of Korea (2009-0093826) and the Ajou University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AK, 2005, J PHARMACEUT BIOMED, V37, P351, DOI 10.1016/j.jpba.2004.10.036; Bundy DL, 1997, J BIOL CHEM, V272, P33132, DOI 10.1074/jbc.272.52.33132; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DA WL, 2002, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hariharan R, 2008, PROTEINS, V71, P1853, DOI 10.1002/prot.21869; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hertlein E, 2005, MOL CELL BIOL, V25, P4956, DOI 10.1128/MCB.25.12.4956-4968.2005; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Huxford T, 2002, J MOL BIOL, V324, P587, DOI 10.1016/S0022-2836(02)01149-X; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Li Z, 1997, MOL CELL BIOL, V17, P6184, DOI 10.1128/MCB.17.10.6184; Main ERG, 2003, CURR OPIN STRUC BIOL, V13, P482, DOI 10.1016/S0959-440X(03)00105-2; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Malek S, 1998, J BIOL CHEM, V273, P25427, DOI 10.1074/jbc.273.39.25427; MANAVALAN B, J MOL RECOG IN PRESS; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; McGuffin LJ, 2008, BIOINFORMATICS, V24, P586, DOI 10.1093/bioinformatics/btn014; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Sue SC, 2009, J MOL BIOL, V388, P824, DOI 10.1016/j.jmb.2009.03.048; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Touma M, 2007, J IMMUNOL, V179, P1681, DOI 10.4049/jimmunol.179.3.1681; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wu ZH, 2009, BIOCHEM BIOPH RES CO, V387, P348, DOI 10.1016/j.bbrc.2009.07.023; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2008, J BIOL CHEM, V283, P32404, DOI 10.1074/jbc.M802148200	56	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15782	10.1371/journal.pone.0015782	http://dx.doi.org/10.1371/journal.pone.0015782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203422	Green Published, gold, Green Submitted			2022-12-25	WOS:000285579200039
J	Donix, M; Petrowski, K; Jurjanz, L; Huebner, T; Herold, U; Baeumler, D; Amanatidis, EC; Poettrich, K; Smolka, MN; Holthoff, VA				Donix, Markus; Petrowski, Katja; Jurjanz, Luisa; Huebner, Thomas; Herold, Ulf; Baeumler, Damaris; Amanatidis, Eva C.; Poettrich, Katrin; Smolka, Michael N.; Holthoff, Vjera A.			Age and the Neural Network of Personal Familiarity	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORY; OLDER-ADULTS; SOCIAL COGNITION; SELF; RECOGNITION; RECOLLECTION; DEACTIVATION; REPRESENTATIONS; SYSTEMS; DEFICIT	Background: Accessing information that defines personally familiar context in real-world situations is essential for the social interactions and the independent functioning of an individual. Personal familiarity is associated with the availability of semantic and episodic information as well as the emotional meaningfulness surrounding a stimulus. These features are known to be associated with neural activity in distinct brain regions across different stimulus conditions (e. g., when perceiving faces, voices, places, objects), which may reflect a shared neural basis. Although perceiving context-rich personal familiarity may appear unchanged in aging on the behavioral level, it has not yet been studied whether this can be supported by neuroimaging data. Methodology/Principal Findings: We used functional magnetic resonance imaging to investigate the neural network associated with personal familiarity during the perception of personally familiar faces and places. Twelve young and twelve elderly cognitively healthy subjects participated in the study. Both age groups showed a similar activation pattern underlying personal familiarity, predominantly in anterior cingulate and posterior cingulate cortices, irrespective of the stimulus type. The young subjects, but not the elderly subjects demonstrated an additional anterior cingulate deactivation when perceiving unfamiliar stimuli. Conclusions/Significance: Although we found evidence for an age-dependent reduction in frontal cortical deactivation, our data show that there is a stimulus-independent neural network associated with personal familiarity of faces and places, which is less susceptible to aging-related changes.	[Donix, Markus; Jurjanz, Luisa; Huebner, Thomas; Baeumler, Damaris; Amanatidis, Eva C.; Poettrich, Katrin; Smolka, Michael N.; Holthoff, Vjera A.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Univ Clin Carl Gustav Carus, Dresden, Germany; [Donix, Markus; Petrowski, Katja; Herold, Ulf] Tech Univ Dresden, Dept Psychotherapy & Psychosomat Med, Univ Clin Carl Gustav Carus, Dresden, Germany; [Huebner, Thomas; Smolka, Michael N.] Tech Univ Dresden, Dept Psychol, Neuroimaging Ctr, Dresden, Germany; [Donix, Markus; Holthoff, Vjera A.] German Ctr Neurodegenerat Dis, DZNE, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Donix, M (corresponding author), Tech Univ Dresden, Dept Psychiat & Psychotherapy, Univ Clin Carl Gustav Carus, Dresden, Germany.	markus.donix@uniklinikum-dresden.de	Smolka, Michael/B-4865-2011	Smolka, Michael/0000-0001-5398-5569; Holthoff, Vjera/0000-0001-7803-1091	Hirnliga e.V.	Hirnliga e.V.	The study was funded by Hirnliga e.V. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Cabeza R, 1997, J NEUROSCI, V17, P391; Clough JS, 2010, SOC NEUROSCI, P1; Conway MA, 2004, SOC COGNITION, V22, P491, DOI 10.1521/soco.22.5.491.50768; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Donix M, 2010, ARCH CLIN NEUROPSYCH, V25, P383, DOI 10.1093/arclin/acq037; Epstein RA, 2007, J NEUROPHYSIOL, V97, P3670, DOI 10.1152/jn.00003.2007; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; Frith CD, 2008, PHILOS T R SOC B, V363, P2033, DOI 10.1098/rstb.2008.0005; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Healey MK, 2008, PROG BRAIN RES, V169, P353, DOI 10.1016/S0079-6123(07)00022-2; Jacoby LL, 1999, J EXP PSYCHOL LEARN, V25, P3, DOI 10.1037/0278-7393.25.1.3; Keightley ML, 2006, PSYCHOL AGING, V21, P558, DOI 10.1037/0882-7974.21.3.558; Kensinger EA, 2009, MEMORY, V17, P208, DOI 10.1080/09658210802221425; Kosaka H, 2003, NEUROIMAGE, V20, P1734, DOI 10.1016/S1053-8119(03)00447-6; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Martinelli P, 2009, PSYCHOL NEUROPSYCHIA, V7, P151, DOI 10.1684/pnv.2009.0178; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Miller SL, 2008, P NATL ACAD SCI USA, V105, P2181, DOI 10.1073/pnas.0706818105; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037/0278-7393.26.5.1170; Naveh-Benjamin M, 2007, PSYCHOL AGING, V22, P202, DOI 10.1037/0882-7974.22.1.202; Persson J, 2007, J COGNITIVE NEUROSCI, V19, P1021, DOI 10.1162/jocn.2007.19.6.1021; Piolino P, 2006, PSYCHOL AGING, V21, P510, DOI 10.1037/0882-7974.21.3.510; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Rhodes MG, 2008, PSYCHOL AGING, V23, P239, DOI 10.1037/0882-7974.23.2.239; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Sugiura M, 2005, J COGNITIVE NEUROSCI, V17, P183, DOI 10.1162/0898929053124956; SUGIURA M, 2010, J COGN NEUR IN PRESS; Sugiura M, 2009, J COGNITIVE NEUROSCI, V21, P1855, DOI 10.1162/jocn.2008.21150; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	44	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15790	10.1371/journal.pone.0015790	http://dx.doi.org/10.1371/journal.pone.0015790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698FG	21203474	Green Published, gold			2022-12-25	WOS:000285578000053
J	Levkovitz, L; Yosef, N; Gershengorn, MC; Ruppin, E; Sharan, R; Oron, Y				Levkovitz, Liron; Yosef, Nir; Gershengorn, Marvin C.; Ruppin, Eytan; Sharan, Roded; Oron, Yoram			A Novel HMM-Based Method for Detecting Enriched Transcription Factor Binding Sites Reveals RUNX3 as a Potential Target in Pancreatic Cancer Biology	PLOS ONE			English	Article							GENE-EXPRESSION; GROWTH; METASTASIS; INHIBITION; DISCOVERY	Background: Pancreatic adenocarcinoma (PAC) is one of the most intractable malignancies. In order to search for potential new therapeutic targets, we relied on computational methods aimed at identifying transcription factor binding sites (TFBSs) over-represented in the promoter regions of genes differentially expressed in PAC. Though many computational methods have been implemented to accomplish this, none has gained overall acceptance or produced proven novel targets in PAC. To this end we have developed DEMON, a novel method for motif detection. Methodology: DEMON relies on a hidden Markov model to score the appearance of sequence motifs, taking into account all potential sites in a promoter of potentially varying binding affinities. We demonstrate DEMON's accuracy on simulated and real data sets. Applying DEMON to PAC-related data sets identifies the RUNX family as highly enriched in PAC-related genes. Using a novel experimental paradigm to distinguish between normal and PAC cells, we find that RUNX3 mRNA (but not RUNX1 or RUNX2 mRNAs) exhibits time-dependent increases in normal but not in PAC cells. These increases are accompanied by changes in mRNA levels of putative RUNX gene targets. Conclusions: The integrated application of DEMON and a novel differentiation system led to the identification of a single family member, RUNX3, which together with four of its putative targets showed a robust response to a differentiation stimulus in healthy cells, whereas this regulatory mechanism was absent in PAC cells, emphasizing RUNX3 as a promising target for further studies.	[Levkovitz, Liron; Ruppin, Eytan; Oron, Yoram] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Levkovitz, Liron; Yosef, Nir; Ruppin, Eytan; Sharan, Roded] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Gershengorn, Marvin C.] NIDDK, Clin Endocrinol Branch, NIH, Bethesda, MD USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Levkovitz, L (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	roded@post.tau.ac.il; medfair@post.tau.ac.il	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940	Era-Net pathogenomics; Israel Cancer Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK011007] Funding Source: NIH RePORTER	Era-Net pathogenomics; Israel Cancer Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an Era-Net pathogenomics grant to ER and RS, and Israel Cancer Association grant to ER, RS and YO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brandt R, 2004, PANCREATOLOGY, V4, P587, DOI 10.1159/000082241; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Chang LW, 2006, GENOME RES, V16, P405, DOI 10.1101/gr.4303406; Durbin R., 1998, BIOL SEQUENCE ANAL P; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100; Hart SM, 2002, HAEMATOLOGICA, V87, P1307; Huang CH, 2007, BIOCHEM PHARMACOL, V73, P990, DOI 10.1016/j.bcp.2006.12.013; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Li J, 2004, J CLIN PATHOL, V57, P294, DOI 10.1136/jcp.2003.013011; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Naxerova K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r108; *NCI NIH SEER, NCI NIH SEER STAT FA; Nomoto S, 2008, BRIT J CANCER, V98, P1690, DOI 10.1038/sj.bjc.6604333; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Peng ZH, 2008, INT J ONCOL, V33, P979, DOI 10.3892/ijo_00000085; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Puig-Kroger A, 2006, J CELL BIOCHEM, V98, P744, DOI 10.1002/jcb.20813; Real FX, 2003, GASTROENTEROLOGY, V124, P1958, DOI 10.1016/S0016-5085(03)00389-5; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; Tan SH, 2007, ONCOL REP, V18, P1225; *UCSC, UCSC GEN BROWS DAT; Von Hoff DD, 2005, PANCREATIC CANC; Wada M, 2004, ONCOGENE, V23, P2401, DOI 10.1038/sj.onc.1207395; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Woolf E, 2007, DEV BIOL, V303, P703, DOI 10.1016/j.ydbio.2006.12.005; Zhong JA, 2006, NEURON, V49, P325, DOI 10.1016/j.neuron.2006.01.013	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14423	10.1371/journal.pone.0014423	http://dx.doi.org/10.1371/journal.pone.0014423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203558	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000018
J	Moutsatsou, P; Papoutsi, Z; Kassi, E; Heldring, N; Zhao, CY; Tsiapara, A; Melliou, E; Chrousos, GP; Chinou, I; Karshikoff, A; Nilsson, L; Dahlman-Wright, K				Moutsatsou, Paraskevi; Papoutsi, Zoi; Kassi, Eva; Heldring, Nina; Zhao, Chunyan; Tsiapara, Anna; Melliou, Eleni; Chrousos, George P.; Chinou, Ioanna; Karshikoff, Andrey; Nilsson, Lennart; Dahlman-Wright, Karin			Fatty Acids Derived from Royal Jelly Are Modulators of Estrogen Receptor Functions	PLOS ONE			English	Article							GENE-EXPRESSION; IN-VITRO; ALPHA; MECHANISMS; BINDING; BETA; IDENTIFICATION; PROLIFERATION; SEQUENCE; DYNAMICS	Royal jelly (RJ) excreted by honeybees and used as a nutritional and medicinal agent has estrogen-like effects, yet the compounds mediating these effects remain unidentified. The possible effects of three RJ fatty acids (FAs) (10-hydroxy-2-decenoic-10H2DA, 3,10-dihydroxydecanoic-3,10DDA, sebacic acid-SA) on estrogen signaling was investigated in various cellular systems. In MCF-7 cells, FAs, in absence of estradiol (E-2), modulated the estrogen receptor (ER) recruitment to the pS2 promoter and pS2 mRNA levels via only ER beta but not ER alpha, while in presence of E-2 FAs modulated both ER beta and ER alpha. Moreover, in presence of FAs, the E-2-induced recruitment of the EAB1 co-activator peptide to ER alpha is masked and the E-2-induced estrogen response element (ERE)-mediated transactivation is inhibited. In HeLa cells, in absence of E-2, FAs inhibited the ERE-mediated transactivation by ER beta but not ER alpha, while in presence of E-2, FAs inhibited ERE-activity by both ERb and ER alpha. Molecular modeling revealed favorable binding of FAs to ER alpha at the co-activator-binding site, while binding assays showed that FAs did not bind to the ligand-binding pocket of ER alpha or ER beta. In KS483 osteoblasts, FAs, like E-2, induced mineralization via an ER-dependent way. Our data propose a possible molecular mechanism for the estrogenic activities of RJ's components which, although structurally entirely different from E-2, mediate estrogen signaling, at least in part, by modulating the recruitment of ER alpha, ER beta and co-activators to target genes.	[Moutsatsou, Paraskevi; Papoutsi, Zoi; Kassi, Eva; Tsiapara, Anna] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece; [Papoutsi, Zoi; Heldring, Nina; Zhao, Chunyan; Karshikoff, Andrey; Nilsson, Lennart; Dahlman-Wright, Karin] Karolinska Inst, Novum, Dept Biosci & Med Nutr, Huddinge, Sweden; [Melliou, Eleni; Chinou, Ioanna] Univ Athens, Fac Pharm, Div Pharmacognosy & Nat Prod, GR-11527 Athens, Greece; [Chrousos, George P.] Univ Athens, Aghia Sophia Childrens Hosp, Sch Med, Dept Pediat 1, GR-11527 Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Karolinska Institutet; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Moutsatsou, P (corresponding author), Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece.	pmoutsatsou@med.uoa.gr	Karshikoff, Andrey D/C-4387-2016; Kassi, Eva N/G-1278-2011; Nilsson, Lennart/B-7208-2009	Kassi, Eva N/0000-0001-7491-2297; Nilsson, Lennart/0000-0002-5067-6397	Greek General Secretariat of Research and Technology; Bodossaki Foundation; Gaea Products SA; Aktina SA; Yiotis SA; Pierre Fabre Hellas; Bee Culturing Co "Attiki" Alex Pittas; Korres SA [EPAN-TP27, PENED-70-3-6340, PAVE-70-3-8966]; Swedish Research Council [08-0573, 621-2006-4470]; Marie Curie Outgoing International Fellowships [MOIF-CT-2006-040428]	Greek General Secretariat of Research and Technology(Greek Ministry of Development-GSRT); Bodossaki Foundation; Gaea Products SA; Aktina SA; Yiotis SA; Pierre Fabre Hellas; Bee Culturing Co "Attiki" Alex Pittas; Korres SA; Swedish Research Council(Swedish Research CouncilEuropean Commission); Marie Curie Outgoing International Fellowships	This research was supported by the Greek General Secretariat of Research and Technology, Bodossaki Foundation, Gaea Products SA, Aktina SA, Yiotis SA, Pierre Fabre Hellas, Bee Culturing Co "Attiki" Alex Pittas, Korres SA (EPAN-TP27, PENED-70-3-6340, PAVE-70-3-8966), the Swedish Research Council (08-0573, 621-2006-4470) and Marie Curie Outgoing International Fellowships (MOIF-CT-2006-040428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; Antinelli JF, 2002, J AGR FOOD CHEM, V50, P2227, DOI 10.1021/jf0112466; ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P1233, DOI 10.1002/jbm.820291010; Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; Berrada M, 2002, INT J RADIAT ONCOL, V54, P1550, DOI 10.1016/S0360-3016(02)03740-9; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Burendahl S, 2009, PROTEINS, V77, P842, DOI 10.1002/prot.22503; Dang ZC, 2002, J BONE MINER RES, V17, P394, DOI 10.1359/jbmr.2002.17.3.394; Davis T, 2000, CLIN CANCER RES, V6, P4334; DEFAZIO A, 1992, J BIOL CHEM, V267, P18008; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Feller SE, 2002, J AM CHEM SOC, V124, P318, DOI 10.1021/ja0118340; Fiegel J, 2004, J CONTROL RELEASE, V96, P411, DOI 10.1016/j.jconrel.2004.02.018; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Heldring N, 2004, MOL CELL BIOL, V24, P3445, DOI 10.1128/MCB.24.8.3445-3459.2004; Henley DV, 2009, ENVIRON HEALTH PERSP, V117, P1702, DOI 10.1289/ehp.0900800; Jansen MS, 2004, P NATL ACAD SCI USA, V101, P7199, DOI 10.1073/pnas.0402014101; Kipper MJ, 2006, J BIOMED MATER RES A, V76A, P798, DOI 10.1002/jbm.a.30545; Kridli RT, 2003, SMALL RUMINANT RES, V49, P25, DOI 10.1016/S0921-4488(03)00057-9; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; LERCKER G, 1981, LIPIDS, V16, P912, DOI 10.1007/BF02534997; Liu Y, 2008, P NATL ACAD SCI USA, V105, P2604, DOI 10.1073/pnas.0712085105; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malaisse WJ, 2000, BRIT J NUTR, V84, P733; Melliou E, 2005, J AGR FOOD CHEM, V53, P8987, DOI 10.1021/jf051550p; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Mishima S, 2005, J ETHNOPHARMACOL, V101, P215, DOI 10.1016/j.jep.2005.04.012; Mueller SO, 2002, J CHROMATOGR B, V777, P155, DOI 10.1016/S1570-0232(02)00282-9; Narita Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2508, DOI 10.1271/bbb.60240; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Omoto Y, 2001, BIOCHEM BIOPH RES CO, V285, P340, DOI 10.1006/bbrc.2001.5158; Papoutsi Z, 2006, J STEROID BIOCHEM, V98, P63, DOI 10.1016/j.jsbmb.2005.07.005; Papoutsi Z, 2009, J MOL ENDOCRINOL, V43, P65, DOI 10.1677/JME-08-0177; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Suzuki KM, 2008, EVID-BASED COMPL ALT, V5, P295, DOI 10.1093/ecam/nem036; Thurmond DC, 1998, J BIOL CHEM, V273, P15373, DOI 10.1074/jbc.273.25.15373; TOWNSEND GF, 1959, NATURE, V183, P1270, DOI 10.1038/1831270a0; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vivar OI, 2010, ENDOCRINOLOGY, V151, P1662, DOI 10.1210/en.2009-1028; Warnmark A, 2002, J BIOL CHEM, V277, P21862, DOI 10.1074/jbc.M200764200; Yamashita T, 1996, BONE, V19, P429, DOI 10.1016/S8756-3282(96)00255-4; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505; Zhou JH, 2007, J AOAC INT, V90, P244	50	51	55	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15594	10.1371/journal.pone.0015594	http://dx.doi.org/10.1371/journal.pone.0015594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203528	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000037
J	Teferedegne, B; Murata, H; Quinones, M; Peden, K; Lewis, AM				Teferedegne, Belete; Murata, Haruhiko; Quinones, Mariam; Peden, Keith; Lewis, Andrew M., Jr.			Patterns of microRNA Expression in Non-Human Primate Cells Correlate with Neoplastic Development In Vitro	PLOS ONE			English	Article							DOWN-REGULATION; BREAST-CANCER; TUMOR INVASION; NKG2D; TRANSFORMATION; PROGRESSION; SIGNATURE; REVEALS; GENE; PROLIFERATION	MicroRNAs (miRNAs) are small noncoding RNAs that negatively regulate gene expression post-transcriptionally. They play a critical role in developmental and physiological processes and have been implicated in the pathogenesis of several diseases including cancer. To identify miRNA signatures associated with different stages of neoplastic development, we examined the expression profile of 776 primate miRNAs in VERO cells (a neoplastically transformed cell line being used for the manufacture of viral vaccines), progenitor primary African green monkey kidney (pAGMK) cells, and VERO cell derivatives: spontaneously immortalized, non-tumorigenic, low-passage VERO cells (10-87 LP); tumorigenic, high-passage VERO cells (10-87 HP); and a cell line (10-87 T) derived from a 10-87 HP cell tumor xenograft in athymic nude mice. When compared with pAGMK cells, the majority of miRNAs were expressed at lower levels in 10-87 LP, 10-87 HP, and 10-87 T cells. We identified 10 up-regulated miRNAs whose level of expression correlated with VERO cell evolution from a non-tumorigenic phenotype to a tumorigenic phenotype. The overexpression of miR-376a and the polycistronic cluster of miR-376a, miR-376b and miR-376c conferred phenotypic changes to the non-tumorigenic 10-87 LP cells that mimic the tumorigenic 10-87 HP cells. Thirty percent of miRNAs that were components of the identified miRNAs in our spontaneously transformed AGMK cell model are also dysregulated in a variety of human tumors. These results may prove to be relevant to the biology of neoplastic development. In addition, one or more of these miRNAs could be biomarkers for the expression of a tumorigenic phenotype.	[Teferedegne, Belete; Murata, Haruhiko; Lewis, Andrew M., Jr.] US FDA, Lab DNA Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Peden, Keith] US FDA, Lab Retrovirus Res, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Quinones, Mariam] NIH, Bioinformat & Computat Biosci Branch, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA	Teferedegne, B (corresponding author), US FDA, Lab DNA Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	andrew.lewis@fda.hhs.gov		Quinones, Mariam/0000-0002-8520-5114	Division of Microbiology and Infectious Diseases (DMID); National Institute of Allergy and Infectious Diseases (NIAID) through Biologics Evaluation and Research (CBER); Food and Drug Administration (FDA)	Division of Microbiology and Infectious Diseases (DMID); National Institute of Allergy and Infectious Diseases (NIAID) through Biologics Evaluation and Research (CBER)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Food and Drug Administration (FDA)(United States Department of Health & Human Services)	This work is partially supported by a contract from the Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID) through an interagency agreement with Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chow TFF, 2010, CLIN BIOCHEM, V43, P150, DOI 10.1016/j.clinbiochem.2009.07.020; Cowland JB, 2007, APMIS, V115, P1090, DOI 10.1111/j.1600-0463.2007.apm_775.xml.x; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; DAVIS JM, 2002, BASIC CELL CULTURE P; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Furesz J, 1989, Dev Biol Stand, V70, P233; Gao CF, 2005, P NATL ACAD SCI USA, V102, P10528, DOI 10.1073/pnas.0504367102; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Hooth MJ, 1998, AM J PATHOL, V153, P1913, DOI 10.1016/S0002-9440(10)65705-7; HOPPS HE, 1963, J IMMUNOL, V91, P416; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; LEVENBOOK IS, 1984, J BIOL STAND, V12, P391, DOI 10.1016/S0092-1157(84)80063-3; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Manohar M, 2008, BIOLOGICALS, V36, P65, DOI 10.1016/j.biologicals.2007.06.002; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Rubin H, 2005, P NATL ACAD SCI USA, V102, P9276, DOI 10.1073/pnas.0503688102; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Slaby O, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-90; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Stern-Ginossar N, 2009, IMMUNOLOGY, V128, P1, DOI 10.1111/j.1365-2567.2009.03147.x; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; SWANSON SK, 1988, J BIOL STAND, V16, P311, DOI 10.1016/0092-1157(88)90019-4; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tsutsui T, 1997, MOL CARCINOGEN, V18, P7, DOI 10.1002/(SICI)1098-2744(199701)18:1<7::AID-MC2>3.0.CO;2-F; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weber B, 2007, CELL CYCLE, V6, P1001, DOI 10.4161/cc.6.9.4209; Wu XY, 2006, CANCER RES, V66, P9527, DOI 10.1158/0008-5472.CAN-05-4470; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yasumura Y., 1963, NIHON RINSHO, V21, P1201; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	78	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14416	10.1371/journal.pone.0014416	http://dx.doi.org/10.1371/journal.pone.0014416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203544	Green Published, gold, Green Submitted			2022-12-25	WOS:000285578000017
J	Hellman, U; Malm, L; Ma, LP; Larsson, G; Morner, S; Fu, M; Engstrom-Laurent, A; Waldenstrom, A				Hellman, Urban; Malm, Linus; Ma, Li-Ping; Larsson, Goran; Morner, Stellan; Fu, Michael; Engstrom-Laurent, Anna; Waldenstrom, Anders			Growth Factor PDGF-BB Stimulates Cultured Cardiomyocytes to Synthesize the Extracellular Matrix Component Hyaluronan	PLOS ONE			English	Article							FALSE DISCOVERY RATE; CELL-LINE; EXPRESSION; SYNTHASES; ANGIOGENESIS; FIBROBLASTS; DEGRADATION; FRAGMENTS; RECEPTOR	Background: Hyaluronan (HA) is a glycosaminoglycan located in the interstitial space which is essential for both structural and cell regulatory functions in connective tissue. We have previously shown that HA synthesis is up-regulated in a rat model of experimental cardiac hypertrophy and that cardiac tissue utilizes two different HA synthases in the hypertrophic process. Cardiomyocytes and fibroblasts are two major cell types in heart tissue. The fibroblasts are known to produce HA, but it has been unclear if cardiomyocytes share the same feature, and whether or not the different HA synthases are activated in the different cell types. Methodology/Principal Findings: This study shows, for the first time that cardiomyocytes can produce HA. Cardiomyocytes (HL-1) and fibroblasts (NIH 3T3) were cultivated in absence or presence of the growth factors FGF2, PDGF-BB and TGFB2. HA concentration was quantified by ELISA, and the size of HA was estimated using dynamic light scattering. Cardiomyocytes synthesized HA but only when stimulated by PDGF-BB, whereas fibroblasts synthesized HA without addition of growth factors as well as when stimulated by any of the three growth factors. When fibroblasts were stimulated by the growth factors, reverse dose dependence was observed, where the highest dose induced the least amount of HA. With the exception of TGFB2, a trend of reverse dose dependence of HA size was also observed. Conclusions/Significance: Co-cultivation of cardiomyocytes and fibroblasts (80%/20%) increased HA concentration far more that can be explained by HA synthesis by the two cell types separately, revealing a crosstalk between cardiomyocytes and fibroblasts that induces HA synthesis. We conclude that dynamic changes of the myocardium, such as in cardiac hypertrophy, do not depend on the cardiomyocyte alone, but are achieved when both cardiomyocytes and fibroblasts are present.	[Hellman, Urban; Morner, Stellan; Engstrom-Laurent, Anna; Waldenstrom, Anders] Umea Univ, Dept Publ Hlth & Clin Med Med, Umea, Sweden; [Hellman, Urban] Umea Univ, Umea Univ Hosp, Dept Med Biosci Med & Clin Genet, Ctr Heart, Umea, Sweden; [Malm, Linus; Larsson, Goran] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Ma, Li-Ping] Second Mil Med Univ, Dept Cardiol, Changhai Hosp, Shanghai, Peoples R China; [Ma, Li-Ping; Fu, Michael] Gothenburg Univ, Inst Med, Sahlgrenska Acad, Wallenberg Lab,Dept Mol & Clin Med, Gothenburg, Sweden	Umea University; Umea University; Umea University; Naval Medical University; University of Gothenburg	Hellman, U (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med Med, Umea, Sweden.	urban.hellman@medbio.umu.se	Hellman, Urban/L-7820-2019	Hellman, Urban/0000-0002-3822-0725; Waldenstrom, Anders/0000-0002-5304-0802	Swedish Heart Lung Foundation; Swedish Research Council; Heart Foundation of Northern Sweden; Northern County Councils Cooperation Committee	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart Foundation of Northern Sweden; Northern County Councils Cooperation Committee	This research received financial support from the Swedish Heart Lung Foundation, the Swedish Research Council, the Heart Foundation of Northern Sweden and the Northern County Councils Cooperation Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Craig EA, 2010, EXP CELL RES; David-Raoudi M, 2008, WOUND REPAIR REGEN, V16, P274, DOI 10.1111/j.1524-475X.2007.00342.x; EngstromLaurent A, 1997, J INTERN MED, V242, P57, DOI 10.1046/j.1365-2796.1997.00174.x; FEINBERG RN, 1983, SCIENCE, V220, P1177, DOI 10.1126/science.6857242; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; Hellman U, 2010, GENOMICS; Hellman U, 2008, CELL TISSUE RES, V332, P49, DOI 10.1007/s00441-007-0562-8; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; KNUDSON W, 1989, CIBA F SYMP, V143, P150; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Miller JC, 1993, STAT ANAL CHEM, P62; Olutoye OO, 1997, J PEDIATR SURG, V32, P1037, DOI 10.1016/S0022-3468(97)90394-8; Paiva P, 2005, GYNECOL ONCOL, V98, P193, DOI 10.1016/j.ygyno.2005.02.031; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Takano S, 2007, J BIOCHEM, V141, P345, DOI 10.1093/jb/mvm039; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; WALDENSTROM A, 1991, J CLIN INVEST, V88, P1622, DOI 10.1172/JCI115475; WEISSMANN B, 1954, J BIOL CHEM, V208, P417; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340	34	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14393	10.1371/journal.pone.0014393	http://dx.doi.org/10.1371/journal.pone.0014393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200430	Green Published, Green Submitted, gold			2022-12-25	WOS:000285576900008
J	Ghosh, S; Heffernan, J				Ghosh, Suma; Heffernan, Jane			Influenza Pandemic Waves under Various Mitigation Strategies with 2009 H1N1 as a Case Study	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; OSELTAMIVIR; TRANSMISSION; VACCINATION; DYNAMICS; STRAIN; VIRUS; MODEL	A significant feature of influenza pandemics is multiple waves of morbidity and mortality over a few months or years. The size of these successive waves depends on intervention strategies including antivirals and vaccination, as well as the effects of immunity gained from previous infection. However, the global vaccine manufacturing capacity is limited. Also, antiviral stockpiles are costly and thus, are limited to very few countries. The combined effect of antivirals and vaccination in successive waves of a pandemic has not been quantified. The effect of acquired immunity from vaccination and previous infection has also not been characterized. In times of a pandemic threat countries must consider the effects of a limited vaccine, limited antiviral use and the effects of prior immunity so as to adopt a pandemic strategy that will best aid the population. We developed a mathematical model describing the first and second waves of an influenza pandemic including drug therapy, vaccination and acquired immunity. The first wave model includes the use of antiviral drugs under different treatment profiles. In the second wave model the effects of antivirals, vaccination and immunity gained from the first wave are considered. The models are used to characterize the severity of infection in a population under different drug therapy and vaccination strategies, as well as school closure, so that public health policies regarding future influenza pandemics are better informed.	[Ghosh, Suma; Heffernan, Jane] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Ghosh, Suma; Heffernan, Jane] York Univ, Ctr Dis Modelling, Toronto, ON M3J 2R7, Canada	York University - Canada; York University - Canada	Ghosh, S (corresponding author), York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada.	suma.ghosh1@gmail.com; jmheffer@yorku.ca			Natural Sciences and Engineering Research Council of Canada, Mathematics of Information Technology and Complex Systems; Ontario Early Researcher Award	Natural Sciences and Engineering Research Council of Canada, Mathematics of Information Technology and Complex Systems(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	SG and JH are grateful to Natural Sciences and Engineering Research Council of Canada, Mathematics of Information Technology and Complex Systems, and JH is also grateful to Ontario Early Researcher Award for the support to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander ME, 2008, B MATH BIOL, V70, P382, DOI 10.1007/s11538-007-9257-2; ANDERSON R M, 1991; Andreasen V, 2003, J MATH BIOL, V46, P504, DOI 10.1007/s00285-002-0186-2; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Boelle PY, 2009, EURO SURVEILL, V14; Boni MF, 2004, THEOR POPUL BIOL, V65, P179, DOI 10.1016/j.tpb.2003.10.002; Democratis J, 2006, J ANTIMICROB CHEMOTH, V58, P911, DOI 10.1093/jac/dkl376; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Duvvuri VRSK, 2010, INFLUENZA OTHER RESP, V4, P249, DOI 10.1111/j.1750-2659.2010.00161.x; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Heffernan JM, 2008, THEOR POPUL BIOL, V73, P134, DOI 10.1016/j.tpb.2007.10.003; Heffernan JM, 2009, P ROY SOC B-BIOL SCI, V276, P2071, DOI 10.1098/rspb.2009.0057; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Linde A, 2001, ANTIVIR RES, V51, P81, DOI 10.1016/S0166-3542(01)00129-2; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Miller MA, 2008, J INFECT DIS, V198, P305, DOI 10.1086/589716; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Moghadas SM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-73; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Simonsen L, 2005, THREAT PANDEMIC INFL, P89, DOI DOI 10.2105/AJPH.2007.119933; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x	43	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14307	10.1371/journal.pone.0014307	http://dx.doi.org/10.1371/journal.pone.0014307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187938	gold, Green Submitted, Green Published			2022-12-25	WOS:000285575200004
J	Liu, C; Guan, J; Kang, YX; Xiu, HM; Chen, Y; Deng, B; Liu, KS				Liu, Chao; Guan, Jing; Kang, Yunxiao; Xiu, Heming; Chen, Ying; Deng, Bao; Liu, Kunshen			Inhibition of Dehydration-Induced Water Intake by Glucocorticoids Is Associated with Activation of Hypothalamic Natriuretic Peptide Receptor-A in Rat	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; BRAIN; DEXAMETHASONE; PREDNISONE; EXPRESSION; LOCALIZATION; HYPERTENSION; POLYPEPTIDE; METABOLISM; INCREASES	Atrial natriuretic peptide (ANP) provides a potent defense mechanism against volume overload in mammals. Its primary receptor, natriuretic peptide receptor-A (NPR-A), is localized mostly in the kidney, but also is found in hypothalamic areas involved in body fluid volume regulation. Acute glucocorticoid administration produces potent diuresis and natriuresis, possibly by acting in the renal natriuretic peptide system. However, chronic glucocorticoid administration attenuates renal water and sodium excretion. The precise mechanism underlying this paradoxical phenomenon is unclear. We assume that chronic glucocorticoid administration may activate natriuretic peptide system in hypothalamus, and cause volume depletion by inhibiting dehydration-induced water intake. Volume depletion, in turn, compromises renal water excretion. To test this postulation, we determined the effect of dexamethasone on dehydration-induced water intake and assessed the expression of NPR-A in the hypothalamus. The rats were deprived of water for 24 hours to have dehydrated status. Prior to free access to water, the water-deprived rats were pretreated with dexamethasone or vehicle. Urinary volume and water intake were monitored. We found that dexamethasone pretreatment not only produced potent diuresis, but dramatically inhibited the dehydration-induced water intake. Western blotting analysis showed the expression of NPR-A in the hypothalamus was dramatically upregulated by dexamethasone. Consequently, cyclic guanosine monophosphate (the second messenger for the ANP) content in the hypothalamus was remarkably increased. The inhibitory effect of dexamethasone on water intake presented in a time-and dose-dependent manner, which emerged at least after 18-hour dexamethasone pretreatment. This effect was glucocorticoid receptor (GR) mediated and was abolished by GR antagonist RU486. These results indicated a possible physiologic role for glucocorticoids in the hypothalamic control of water intake and revealed that the glucocorticoids can act centrally, as well as peripherally, to assist in the normalization of extracellular fluid volume.	[Liu, Chao; Chen, Ying; Deng, Bao; Liu, Kunshen] Hebei Med Univ, Ctr Heart, Hosp 1, Shijiazhuang, Peoples R China; [Guan, Jing] Hebei Gen Hosp, Stomatol Div, Shijiazhuang, Peoples R China; [Kang, Yunxiao] Hebei Med Univ, Dept Neurobiol, Shijiazhuang, Peoples R China; [Xiu, Heming] Hebei Med Univ, Cent Lab, Hosp 1, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Liu, C (corresponding author), Hebei Med Univ, Ctr Heart, Hosp 1, Shijiazhuang, Peoples R China.	ksliud@sohu.com	Liu, Chao/A-7533-2008; Liu, Kunshen/A-7699-2008	Liu, Chao/0000-0002-5323-6733; chen, ying/0000-0001-8490-5672	Nature Cardiovascular Drug Institute	Nature Cardiovascular Drug Institute	Nature Cardiovascular Drug Institute sponsored the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JA, 1999, EUR J PHARMACOL, V370, P271, DOI 10.1016/S0014-2999(99)00121-1; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; ANTUNESRODRIGUES J, 1985, P NATL ACAD SCI USA, V82, P8720, DOI 10.1073/pnas.82.24.8720; ANTUNESRODRIGUES J, 1986, ENDOCRINOLOGY, V118, P1726, DOI 10.1210/endo-118-4-1726; CHROUSOS GP, 1988, KIDNEY INT, V34, pS18; DANANBERG J, 1992, AM J PHYSIOL, V263, pH1377, DOI 10.1152/ajpheart.1992.263.5.H1377; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; De Wardener HE, 2001, PHYSIOL REV, V81, P1599, DOI 10.1152/physrev.2001.81.4.1599; GARCIA R, 1985, BIOCHEM BIOPH RES CO, V131, P806, DOI 10.1016/0006-291X(85)91311-7; GARDNER DG, 1986, BIOCHEM BIOPH RES CO, V139, P1047, DOI 10.1016/S0006-291X(86)80283-2; GARDNER DG, 1988, J CLIN INVEST, V82, P1275, DOI 10.1172/JCI113726; GEIGER H, 1991, NEUROENDOCRINOLOGY, V53, P63, DOI 10.1159/000125698; Goy MF, 2001, BIOCHEM J, V358, P379, DOI 10.1042/0264-6021:3580379; Heiss JD, 1996, J CLIN INVEST, V98, P1400, DOI 10.1172/JCI118927; Jahng JW, 2008, EUR J PHARMACOL, V581, P64, DOI 10.1016/j.ejphar.2007.11.029; KATSUURA G, 1986, EUR J PHARMACOL, V121, P285, DOI 10.1016/0014-2999(86)90502-9; LACZI F, 1991, NEUROPEPTIDES, V19, P183, DOI 10.1016/0143-4179(91)90117-2; LAUE L, 1988, J STEROID BIOCHEM, V29, P591, DOI 10.1016/0022-4731(88)90156-2; LIU C, 2010, POTENT DIURETIC EFFE; Liu C, 2007, CAN J CARDIOL, V23, P865, DOI 10.1016/S0828-282X(07)70840-1; Liu C, 2006, J CARDIOVASC PHARM, V48, P173, DOI 10.1097/01.fjc.0000245242.57088.5b; MANTYH CR, 1987, BRAIN RES, V412, P329, DOI 10.1016/0006-8993(87)91140-1; MICKERSON JN, 1959, BMJ-BRIT MED J, V1, P876, DOI 10.1136/bmj.1.5126.876; Oliveira MHA, 1997, BRAZ J MED BIOL RES, V30, P465, DOI 10.1590/S0100-879X1997000400006; Paxinos G., 1997, RAT BRAININ STEREOTA, V3; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P10043, DOI 10.1073/pnas.87.24.10043; Ryan MC, 1997, PEPTIDES, V18, P495, DOI 10.1016/S0196-9781(96)00329-4; SIMPSON CW, 1974, PHARMACOL BIOCHEM BE, V2, P19, DOI 10.1016/0091-3057(74)90130-0; TARJAN E, 1988, REGUL PEPTIDES, V23, P63, DOI 10.1016/0167-0115(88)90422-3; Thunhorst RL, 2007, AM J PHYSIOL-REG I, V293, pR1444, DOI 10.1152/ajpregu.00294.2007; Turner SW, 1996, HYPERTENSION, V27, P184, DOI 10.1161/01.HYP.27.2.184; Wallerath T, 1999, P NATL ACAD SCI USA, V96, P13357, DOI 10.1073/pnas.96.23.13357; WALLS EK, 1977, PHYSIOL BEHAV, V19, P171, DOI 10.1016/0031-9384(77)90177-9; Whitworth JA, 2000, HYPERTENSION, V36, P912, DOI 10.1161/01.HYP.36.5.912; Woodard GE, 2003, NEUROSCI RES, V47, P421, DOI 10.1016/j.neures.2003.08.002; Zhang HM, 2008, INT HEART J, V49, P587, DOI 10.1536/ihj.49.587	37	19	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15607	10.1371/journal.pone.0015607	http://dx.doi.org/10.1371/journal.pone.0015607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187974	Green Published, gold, Green Submitted			2022-12-25	WOS:000285575200049
J	Yao, JQ; Hennessey, T; Flynt, A; Lai, E; Beal, MF; Lin, MT				Yao, Jiaqi; Hennessey, Tom; Flynt, Alex; Lai, Eric; Beal, M. Flint; Lin, Michael T.			MicroRNA-Related Cofilin Abnormality in Alzheimer's Disease	PLOS ONE			English	Article							ACTIN DYNAMICS; HIRANO BODIES; EXPRESSION; BETA; ADF/COFILIN; PROTEIN; NEURODEGENERATION	Rod-like structures composed of actin and the actin-binding protein cofilin are found in Alzheimer's disease (AD) patients. However, the mechanisms underlying formation of these structures and their pathological consequences are still largely unknown. We found that microRNAs 103 and 107 repress translation of cofilin, and that reduced levels of miR-103 or miR-107 are associated with elevated cofilin protein levels and formation of rod-like structures in a transgenic mouse model of AD. These results suggest that microRNAs may play an important role in cytoskeletal pathology in AD.	[Yao, Jiaqi; Hennessey, Tom; Beal, M. Flint; Lin, Michael T.] Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Flynt, Alex; Lai, Eric] Mem Sloan Kettering Canc Ctr, Dept Dev Biol, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center	Yao, JQ (corresponding author), Weill Cornell Med Coll, Dept Neurol, New York, NY USA.	mtl2002@med.cornell.edu	Lai, Eric C/A-3412-2008		American Health Assistance Foundation [A2009606]; National Institutes of Health [R01 AG20729, R01 GM083300]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020729] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the American Health Assistance Foundation (A2009606 to JY) and the National Institutes of Health (R01 AG20729 to MTL and R01 GM083300 to ECL). The authors thank the donors of Alzheimer's Disease Research (ADR), a program of the American Health Assistance Foundation, for support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Davis RC, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1122; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Guo H., 2010, NATURE, V466, P835; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; HIRANO A, 1994, NEUROPATH APPL NEURO, V20, P3, DOI 10.1111/j.1365-2990.1994.tb00951.x; Hsu WC, 2008, J NEURAL TRANSM, V115, P1537, DOI 10.1007/s00702-008-0117-5; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; MACIVER SK, 1995, NEUROREPORT, V6, P1985, DOI 10.1097/00001756-199510010-00008; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Minamide LS, 2010, J BIOL CHEM, V285, P5450, DOI 10.1074/jbc.M109.063768; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773	26	55	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15546	10.1371/journal.pone.0015546	http://dx.doi.org/10.1371/journal.pone.0015546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179570	gold, Green Published, Green Submitted			2022-12-25	WOS:000285381200027
J	Bernal, AB; Vickers, MH; Hampton, MB; Poynton, RA; Sloboda, DM				Bernal, Angelica B.; Vickers, Mark H.; Hampton, Mark B.; Poynton, Rebecca A.; Sloboda, Deborah M.			Maternal Undernutrition Significantly Impacts Ovarian Follicle Number and Increases Ovarian Oxidative Stress in Adult Rat Offspring	PLOS ONE			English	Article							CATCH-UP GROWTH; HIGH-FAT DIET; DEVELOPMENTAL ORIGINS; DIFFERENTIATION FACTOR-9; REPRODUCTIVE FUNCTION; PEROXIREDOXIN-III; IN-UTERO; LEPTIN; PUBERTY; ONSET	Background: We have shown recently that maternal undernutrition (UN) advanced female pubertal onset in a manner that is dependent upon the timing of UN. The long-term consequence of this accelerated puberty on ovarian function is unknown. Recent findings suggest that oxidative stress may be one mechanism whereby early life events impact on later physiological functioning. Therefore, using an established rodent model of maternal UN at critical windows of development, we examined maternal UN-induced changes in offspring ovarian function and determined whether these changes were underpinned by ovarian oxidative stress. Methodology/Principal Findings: Our study is the first to show that maternal UN significantly reduced primordial and secondary follicle number in offspring in a manner that was dependent upon the timing of maternal UN. Specifically, a reduction in these early stage follicles was observed in offspring born to mothers undernourished throughout both pregnancy and lactation. Additionally, antral follicle number was reduced in offspring born to all mothers that were UN regardless of whether the period of UN was restricted to pregnancy or lactation or both. These reductions were associated with decreased mRNA levels of genes critical for follicle maturation and ovulation. Increased ovarian protein carbonyls were observed in offspring born to mothers UN during pregnancy and/or lactation and this was associated with peroxiredoxin 3 hyperoxidation and reduced mRNA levels; suggesting compromised antioxidant defence. This was not observed in offspring of mothers UN during lactation alone. Conclusions: We propose that maternal UN, particularly at a time-point that includes pregnancy, results in reduced offspring ovarian follicle numbers and mRNA levels of regulatory genes and may be mediated by increased ovarian oxidative stress coupled with a decreased ability to repair the resultant oxidative damage. Together these data are suggestive of maternal UN potentially contributing to premature ovarian ageing in offspring.	[Bernal, Angelica B.; Vickers, Mark H.; Sloboda, Deborah M.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Bernal, Angelica B.; Vickers, Mark H.; Sloboda, Deborah M.] Natl Res Ctr Growth & Dev, Auckland, New Zealand; [Hampton, Mark B.; Poynton, Rebecca A.] Univ Otago, Dept Pathol, Free Rad Res Grp, Christchurch, New Zealand	University of Auckland; University of Auckland; University of Otago	Bernal, AB (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	d.sloboda@auckland.ac.nz	Dalton-O'Reilly, Jessica/AAM-8569-2021; Hampton, Mark B/A-8490-2008	Hampton, Mark B/0000-0002-7349-3729; Vickers, Mark/0000-0003-4876-9356	National Research Centre for Growth and Development	National Research Centre for Growth and Development	The current study was funded by the National Research Centre for Growth and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Ahima RS, 1997, J CLIN INVEST, V99, P391, DOI 10.1172/JCI119172; Barkan D, 1999, ENDOCRINOLOGY, V140, P1731, DOI 10.1210/en.140.4.1731; Barkan D, 2004, FASEB J, V18, P133, DOI 10.1096/fj.04-2271fje; BILLIG H, 1993, ENDOCRINOLOGY, V133, P2204, DOI 10.1210/en.133.5.2204; Bluher Susann, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P458, DOI 10.1097/MED.0b013e3282f1cfdc; Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Cheung CC, 1997, ENDOCRINOLOGY, V138, P855, DOI 10.1210/en.138.2.855; Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339; Connor KL, 2010, J DEV ORIG HLTH DIS, V1, P245, DOI 10.1017/S2040174410000346; Couillard C, 2005, J CLIN ENDOCR METAB, V90, P6454, DOI 10.1210/jc.2004-2438; Cox AG, 2010, METHOD ENZYMOL, V474, P51, DOI 10.1016/S0076-6879(10)74004-0; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Faria TD, 2010, NUTRITION, V26, P1000, DOI 10.1016/j.nut.2009.09.026; Faria TD, 2004, J NUTR BIOCHEM, V15, P123, DOI 10.1016/j.jnutbio.2003.08.011; FARIA TD, 2010, NUTRITION IN PRESS; Gardner DS, 2009, PHILOS T R SOC B, V364, P3419, DOI 10.1098/rstb.2009.0121; Gluckman PD, 2005, BIOL NEONATE, V87, P127, DOI 10.1159/000082311; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Hilakivi-Clarke L, 1999, NUTRITION, V15, P392, DOI 10.1016/S0899-9007(99)00029-5; HIRSHFIELD AN, 1978, BIOL REPROD, V19, P597, DOI 10.1095/biolreprod19.3.597; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Jozwik M, 1999, MOL HUM REPROD, V5, P409, DOI 10.1093/molehr/5.5.409; Kaipia A, 1997, ANNU REV PHYSIOL, V59, P349, DOI 10.1146/annurev.physiol.59.1.349; Keisler D.H., 2016, J ANIM SCI, V74, P1, DOI [10.2527/1996.74suppl_31x, DOI 10.2527/1996.74SUPPL_31X]; Kiess W, 1998, EUR J ENDOCRINOL, V138, P26, DOI 10.1530/eje.0.1380026; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Leonhardt M, 2003, BIOL REPROD, V68, P390, DOI 10.1095/biolreprod.102.003269; Loui A, 2010, J TRACE ELEM MED BIO, V24, P111, DOI 10.1016/j.jtemb.2009.11.004; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002; Nilsson EE, 2002, BIOL REPROD, V67, P1018, DOI 10.1095/biolreprod.101.002527; Orisaka M, 2006, MOL ENDOCRINOL, V20, P2456, DOI 10.1210/me.2005-0357; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ozanne SE, 2005, MECH AGEING DEV, V126, P852, DOI 10.1016/j.mad.2005.03.005; PASZKOWSKI T, 1995, CLIN CHIM ACTA, V236, P173, DOI 10.1016/0009-8981(95)98130-9; Picton HM, 2001, THERIOGENOLOGY, V55, P1193, DOI 10.1016/S0093-691X(01)00478-2; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rae MT, 2002, ANIM REPROD SCI, V72, P63, DOI 10.1016/S0378-4320(02)00068-4; Ricci AG, 2006, REPRODUCTION, V132, P771, DOI 10.1530/rep.1.01164; Roman EA, 2005, MOL CELL ENDOCRINOL, V242, P33, DOI 10.1016/j.mce.2005.07.007; Rosenfeld CS, 2001, REPRODUCTION, V122, P215, DOI 10.1530/rep.0.1220215; Simmons RA, 2006, FREE RADICAL BIO MED, V40, P917, DOI 10.1016/j.freeradbiomed.2005.12.018; Sloboda DM, 2007, J CLIN ENDOCR METAB, V92, P46, DOI 10.1210/jc.2006-1378; Sloboda DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006744; Spicer LJ, 2001, DOMEST ANIM ENDOCRIN, V21, P251, DOI 10.1016/S0739-7240(01)00120-5; Spicer LJ, 2000, ENDOCRINE, V12, P53, DOI 10.1385/ENDO:12:1:53; Suzuki T, 1999, FERTIL STERIL, V72, P720, DOI 10.1016/S0015-0282(99)00332-5; TARIN JJ, 1995, HUM REPROD, V10, P1563, DOI 10.1093/HUMREP/10.6.1563; Tarin JJ, 1996, MOL HUM REPROD, V2, P717, DOI 10.1093/molehr/2.10.717; Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796; TARRYADKINS JL, 2010, FASEB J; Theys N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006110; Tilly J L, 1996, Rev Reprod, V1, P162, DOI 10.1530/revreprod/1.3.162; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vincent HK, 2007, DIABETES OBES METAB, V9, P813, DOI 10.1111/j.1463-1326.2007.00692.x; Vitt UA, 2000, ENDOCRINOLOGY, V141, P3814, DOI 10.1210/en.141.10.3814; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273	66	106	108	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15558	10.1371/journal.pone.0015558	http://dx.doi.org/10.1371/journal.pone.0015558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179452	Green Published, Green Submitted, gold			2022-12-25	WOS:000285246900046
J	Dillon, PF; Root-Bernstein, R; Robinson, NE; Abraham, WM; Berney, C				Dillon, Patrick F.; Root-Bernstein, Robert; Robinson, N. Edward; Abraham, William M.; Berney, Catherine			Receptor-Mediated Enhancement of Beta Adrenergic Drug Activity by Ascorbate In Vitro and In Vivo	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; LATE BRONCHIAL RESPONSES; AIRWAY HYPERRESPONSIVENESS; ACID; DESENSITIZATION; BINDING; KINASE; INTERNALIZATION; NOREPINEPHRINE; STIMULATION	Rationale: Previous in vitro research demonstrated that ascorbate enhances potency and duration of activity of agonists binding to alpha 1 adrenergic and histamine receptors. Objectives: Extending this work to beta 2 adrenergic systems in vitro and in vivo. Methods: Ultraviolet spectroscopy was used to study ascorbate binding to adrenergic receptor preparations and peptides. Force transduction studies on acetylcholine-contracted trachealis preparations from pigs and guinea pigs measured the effect of ascorbate on relaxation due to submaximal doses of beta adrenergic agonists. The effect of inhaled albuterol with and without ascorbate was tested on horses with heaves and sheep with carbachol-induced bronchoconstriction. Measurements: Binding constants for ascorbate binding to beta adrenergic receptor were derived from concentration-dependent spectral shifts. Dose- dependence curves were obtained for the relaxation of pre-contracted trachealis preparations due to beta agonists in the presence and absence of varied ascorbate. Tachyphylaxis and fade were also measured. Dose response curves were determined for the effect of albuterol plus-and-minus ascorbate on airway resistance in horses and sheep. Main Results: Ascorbate binds to the beta 2 adrenergic receptor at physiological concentrations. The receptor recycles dehydroascorbate. Physiological and supra-physiological concentrations of ascorbate enhance submaximal epinephrine and isoproterenol relaxation of trachealis, producing a 3-10-fold increase in sensitivity, preventing tachyphylaxis, and reversing fade. In vivo, ascorbate improves albuterol's effect on heaves and produces a 10-fold enhancement of albuterol activity in "asthmatic'' sheep. Conclusions: Ascorbate enhances beta-adrenergic activity via a novel receptor-mediated mechanism; increases potency and duration of beta adrenergic agonists effective in asthma and COPD; prevents tachyphylaxis; and reverses fade. These novel effects are probably caused by a novel mechanism involving phosphorylation of aminergic receptors and have clinical and drug-development applications.	[Dillon, Patrick F.; Root-Bernstein, Robert] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Robinson, N. Edward; Berney, Catherine] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Abraham, William M.] Mt Sinai Med Ctr, Dept Res, Miami Beach, FL 33140 USA	Michigan State University; Michigan State University; Mount Sinai Medical Center	Dillon, PF (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	rootbern@msu.edu			Acorn Technologies, Inc.	Acorn Technologies, Inc.	The research was partially funded by Acorn Technologies, Inc. and partially by Maurine Bernstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders have no financial interests in the research.	Abraham WM, 1999, AM J RESP CRIT CARE, V159, P1205, DOI 10.1164/ajrccm.159.4.9806002; Abraham WM, 2000, AM J RESP CRIT CARE, V162, P603, DOI 10.1164/ajrccm.162.2.9911061; ABRAHAM WM, 1994, J CLIN INVEST, V93, P776, DOI 10.1172/JCI117032; Altman P.I., 1961, BLOOD OTHER BODY FLU; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Clark RB, 2002, METHOD ENZYMOL, V343, P506; Cooper PR, 2008, J ALLERGY CLIN IMMUN, V122, P734, DOI 10.1016/j.jaci.2008.07.040; DERKSEN FJ, 1980, AM J VET RES, V41, P1756; Derksen FJ, 1999, AM J VET RES, V60, P689; Derksen FJ, 1996, EQUINE VET J, V28, P306, DOI 10.1111/j.2042-3306.1996.tb03094.x; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Dillon PF, 2006, AM J PHYSIOL-CELL PH, V291, pC977, DOI 10.1152/ajpcell.00613.2005; Dillon PF, 2000, BIOPHYS J, V79, P370, DOI 10.1016/S0006-3495(00)76298-9; Dillon PF, 2004, AM J PHYSIOL-HEART C, V286, pH2353, DOI 10.1152/ajpheart.00968.2003; ERJEFALT I, 1991, AM REV RESPIR DIS, V144, P788, DOI 10.1164/ajrccm/144.4.788; Greiff L, 1998, THORAX, V53, P1010, DOI 10.1136/thx.53.12.1010; Grossmann M, 2001, HYPERTENSION, V37, P949, DOI 10.1161/01.HYP.37.3.949; HOUSTON JB, 1976, RES COMMUN CHEM PATH, V14, P643; KIMURA K, 1994, J NEUROCHEM, V63, P2093; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; LANZARA R, 2005, INT J PHARMACEUT, V1, P122; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Lin R, 2008, PULM PHARMACOL THER, V21, P115, DOI 10.1016/j.pupt.2007.06.003; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; Lundblad LKA, 2007, AM J RESP CRIT CARE, V175, P768, DOI 10.1164/rccm.200610-1410OC; Mak S, 2001, CIRCULATION, V103, P826, DOI 10.1161/01.CIR.103.6.826; MAXWELL LC, 1983, MICROVASC RES, V26, P81, DOI 10.1016/0026-2862(83)90057-2; May JM, 2001, BBA-GEN SUBJECTS, V1528, P159, DOI 10.1016/S0304-4165(01)00188-X; McDonald JH., 2008, HDB BIOL STAT; Monahan KD, 2004, AM J PHYSIOL-HEART C, V286, pH2113, DOI 10.1152/ajpheart.01054.2003; Moore RH, 2007, AM J RESP CELL MOL, V36, P254, DOI 10.1165/rcmb.2006-0158OC; PARRA L, 1995, EUR J PHARMACOL, V277, P99, DOI 10.1016/0014-2999(95)00067-U; Penn RB, 2008, N-S ARCH PHARMACOL, V378, P149, DOI 10.1007/s00210-008-0263-1; Ren JH, 2005, AUTON NEUROSCI-BASIC, V117, P67, DOI 10.1016/j.autneu.2004.10.007; Robinson NE, 1999, VET J, V157, P160, DOI 10.1053/tvjl.1998.0281; Robinson NE, 1996, BRIT VET J, V152, P283, DOI 10.1016/S0007-1935(96)80101-1; Root-Bernstein R, 2002, DRUG DEVELOP RES, V57, P58, DOI 10.1002/ddr.10110; Root-Bernstein R, 2008, DRUG DEVELOP RES, V69, P242, DOI 10.1002/ddr.20250; RootBernstein RS, 1997, J THEOR BIOL, V188, P447, DOI 10.1006/jtbi.1997.0476; ROTH NS, 1991, P NATL ACAD SCI USA, V88, P6201, DOI 10.1073/pnas.88.14.6201; Rubenstein LA, 1998, J MOL STRUC-THEOCHEM, V430, P57, DOI 10.1016/S0166-1280(98)90217-2; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRASSER RH, 1986, P NATL ACAD SCI USA, V83, P6362, DOI 10.1073/pnas.83.17.6362; SVEDMYR N, 1990, AM REV RESPIR DIS, V141, pS31; van der Vliet A, 1999, AM J PHYSIOL-LUNG C, V276, pL289, DOI 10.1152/ajplung.1999.276.2.L289; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Venegas JG, 2005, RESP PHYSIOL NEUROBI, V148, P57, DOI 10.1016/j.resp.2005.05.023; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15130	10.1371/journal.pone.0015130	http://dx.doi.org/10.1371/journal.pone.0015130			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179213	Green Published, Green Submitted, gold			2022-12-25	WOS:000285246900029
J	Cao, XM; Pobezinskaya, YL; Morgan, MJ; Liu, ZG				Cao, Xiumei; Pobezinskaya, Yelena L.; Morgan, Michael J.; Liu, Zheng-gang			The role of TRADD in TRAIL-induced apoptosis and signaling	FASEB JOURNAL			English	Article						MEF; FADD; RIP1; DR5	NF-KAPPA-B; FADD-DEPENDENT APOPTOSIS; DEATH-DOMAIN KINASE; INDUCED ACTIVATION; RECEPTORS 1; PATHWAY; CASPASE-8; LIGAND; CELLS; RIP	Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily. TRAIL is promising for anticancer therapy because it induces apoptosis in cancer cells with little or no toxicity to normal cells; hence, TRAIL-receptor agonists are currently undergoing clinical trials for cancer treatment. However, many molecular signaling mechanisms in TRAIL signaling are not completely characterized. The functions of adaptor proteins, including TNF-receptor-associated death domain protein (TRADD) and receptor-interacting protein-1 (RIP1) in TRAIL signaling have been controversial. We demonstrate that while wild-type mouse embryonic fibroblasts (MEFs) are completely resistant to TRAIL-induced apoptosis, MEFs derived from Tradd(-/-) mice are hypersensitive to TRAIL (IC50 similar to 0.5 nM rmTRAIL, 24 h), an effect also seen in primary keratinocytes treated with TRAIL/CHX. Restoration of TRADD in Tradd(-/-) MEFs restores TRAIL resistance, indicating that TRADD plays a survival role in TRAIL signaling. We show that TRADD is recruited to the TRAIL-receptor complex, and RIP1 recruitment is mediated by TRADD. While early activation of the MAP kinase ERK is deficient in Tradd(-/-) cells, the main mechanism for enhanced TRAIL sensitivity is likely due to increased recruitment of FADD to the receptor complex, indicating that TRADD may limit FADD binding within the receptor complex and also mediate RIP1-dependent nonapoptotic signaling events, thus reducing caspase activation and subsequent apoptosis. These novel findings have potential implications for cancer therapy using TRAIL-receptor agonists.-Cao, X., Pobezinskaya, Y. L., Morgan, M. J., Liu, Z. The role of TRADD in TRAIL-induced apoptosis and signaling. FASEB J. 25, 1353-1358 (2011). www.fasebj.org	[Cao, Xiumei; Pobezinskaya, Yelena L.; Morgan, Michael J.; Liu, Zheng-gang] NCI, Cell & Canc Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Liu, ZG (corresponding author), NCI, Cell & Canc Biol Branch, Ctr Canc Res, 37 Convent Dr,Rm 1130, Bethesda, MD 20892 USA.	zgliu@helix.nih.gov			Center for Cancer Research, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIASC010376] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank S. Lipkowitz (U.S. NIH, Bethesda, MD, USA) for GST-rhTRAIL and Jianke Zhang (Thomas Jefferson University, Philadelphia, PA, USA) for the mouse FADD antibody. This work was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH.	Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Lacour S, 2003, ONCOGENE, V22, P1807, DOI 10.1038/sj.onc.1206127; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Soderstrom TS, 2002, J IMMUNOL, V169, P2851, DOI 10.4049/jimmunol.169.6.2851; Song JJ, 2008, CELL SIGNAL, V20, P892, DOI 10.1016/j.cellsig.2008.01.001; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Tang WH, 2009, CELL RES, V19, P758, DOI 10.1038/cr.2009.57; Tang WH, 2009, FEBS J, V276, P581, DOI 10.1111/j.1742-4658.2008.06809.x; Thomas LR, 2004, J BIOL CHEM, V279, P32780, DOI 10.1074/jbc.M401680200; Tran SEF, 2001, J BIOL CHEM, V276, P16484, DOI 10.1074/jbc.M010384200; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Verbrugge I, 2008, ONCOGENE, V27, P574, DOI 10.1038/sj.onc.1210696	23	32	35	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1353	1358		10.1096/fj.10-170480	http://dx.doi.org/10.1096/fj.10-170480			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21187341	Green Published			2022-12-25	WOS:000288982800024
J	Lie, PPY; Cheng, CY; Mruk, DD				Lie, Pearl P. Y.; Cheng, C. Yan; Mruk, Dolores D.			Interleukin-1 alpha is a regulator of the blood-testis barrier	FASEB JOURNAL			English	Article						Sertoli cell; actin; cytokine; spermatogenesis; seminiferous epithelial cycle	ANCHORING JUNCTION DYNAMICS; GERM CELL-INTERACTIONS; NECROSIS-FACTOR-ALPHA; SEMINIFEROUS EPITHELIUM; TISSUE INHIBITOR; SERTOLI; PROTEIN; TIGHT; METALLOPROTEASES-1; SPERMATOGENESIS	Throughout spermatogenesis, the Sertoli cell blood-testis barrier (BTB) is strictly regulated by cytokines, which mediate its timely restructuring, thereby allowing spermatocytes to enter the adluminal compartment of the seminiferous epithelium for development into spermatozoa. The aim herein was to investigate whether germ cells play a role in BTB restructuring via the action of interleukin-1 alpha (IL-1 alpha) since germ cells are known to control Sertoli cell production of this cytokine, and if yes, how these effects are mediated. When Sertoli cells were isolated from Sprague-Dawley rats and plated at high density, IL-1 alpha (100 pg/ml) was shown to "open" the Sertoli cell barrier when its integrity was assessed by transepithelial electrical resistance measurements. Further investigation of Sertoli cells treated with IL-1 alpha revealed striking changes in the cellular distribution of actin filaments when compared to untreated cells. These effects at the Sertoli cell barrier were mediated, in part, by epidermal growth factor receptor pathway substrate 8 (Eps8; an actin bundling and barbed-end capping protein) and actin-related protein 3 (Arp3; a component of the actin nucleation machinery). As important, an increase in the kinetics of occludin internalization but a decrease in its rate of degradation was noted following IL-1 alpha treatment. These results indicate that IL-1 alpha is a critical regulator of BTB dynamics.-Lie, P. P. Y., Cheng, C. Y., Mruk, D. D. Interleukin-1 alpha is a regulator of the blood-testis barrier. FASEB J. 25, 1244-1253 (2011). www.fasebj.org	[Lie, Pearl P. Y.; Cheng, C. Yan; Mruk, Dolores D.] Populat Council, Ctr Biomed Res, New York, NY 10065 USA	Population Council	Mruk, DD (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10065 USA.	mruk@popcbr.rockefeller.edu		Cheng, C Yan/0000-0003-3117-3791	National Institute of Child Health and Human Development, U.S. National Institutes of Health [R03 HD061401, R01 HD056034, R01 HD056034-02S1, U54 HD029990]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD029990, R01HD056034] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD061401] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the National Institute of Child Health and Human Development, U.S. National Institutes of Health (R03 HD061401 to D. D. M.; and R01 HD056034, R01 HD056034-02S1, and U54 HD029990 Project 5 to C.Y.C.) Population Council laboratories are located on the campus of The Rockefeller University. The authors are not affiliated with The Rockefeller University, and no support was received from The Rockefeller University.	Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Chung NPY, 2001, BIOL REPROD, V65, P1340, DOI 10.1095/biolreprod65.5.1340; Cudicini C, 1997, ENDOCRINOLOGY, V138, P2863, DOI 10.1210/en.138.7.2863; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; GALDIERI M, 1981, J ANDROL, V2, P249; HAUGEN TB, 1994, MOL CELL ENDOCRINOL, V105, pR19, DOI 10.1016/0303-7207(94)90177-5; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Kawaguchi Y, 2006, P NATL ACAD SCI USA, V103, P14501, DOI 10.1073/pnas.0603545103; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Li MWM, 2009, CYTOKINE GROWTH F R, V20, P329, DOI 10.1016/j.cytogfr.2009.07.007; Lie PPY, 2010, P NATL ACAD SCI USA, V107, P11411, DOI 10.1073/pnas.1001823107; Lie PPY, 2010, INT J BIOCHEM CELL B, V42, P975, DOI 10.1016/j.biocel.2010.02.010; Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573; MAIER JAM, 1994, MOL CELL BIOL, V14, P1845, DOI 10.1128/MCB.14.3.1845; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk DD, 2003, J ANDROL, V24, P510; Mruk DD, 2008, PHARMACOL REV, V60, P146, DOI 10.1124/pr.107.07105; Nehar D, 1998, BIOL REPROD, V59, P1425, DOI 10.1095/biolreprod59.6.1425; Papakonstanti EA, 2008, FEBS LETT, V582, P2120, DOI 10.1016/j.febslet.2008.02.064; PARVINEN M, 1982, ENDOCR REV, V3, P404, DOI 10.1210/edrv-3-4-404; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; RUSSELL L, 1977, AM J ANAT, V148, P313, DOI 10.1002/aja.1001480303; Sarkar O, 2008, BIOL REPROD, V78, P445, DOI 10.1095/biolreprod.107.064501; Siu MKY, 2005, J BIOL CHEM, V280, P25029, DOI 10.1074/jbc.M501049200; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Su LL, 2010, INT J BIOCHEM CELL B, V42, P1864, DOI 10.1016/j.biocel.2010.08.004; Svechnikov KV, 2001, MOL CELL ENDOCRINOL, V182, P193, DOI 10.1016/S0303-7207(01)00554-8; SYED V, 1995, ENDOCRINOLOGY, V136, P3070, DOI 10.1210/en.136.7.3070; Wahab-Wahlgren A, 2000, INT J ANDROL, V23, P360, DOI 10.1046/j.1365-2605.2000.t01-1-00253.x; Xia WL, 2006, J BIOL CHEM, V281, P16799, DOI 10.1074/jbc.M601618200; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; Xia WL, 2005, CYTOKINE GROWTH F R, V16, P469, DOI 10.1016/j.cytogfr.2005.05.007; Xia WL, 2005, DEV BIOL, V280, P321, DOI 10.1016/j.ydbio.2004.12.036; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Yan HHN, 2005, P NATL ACAD SCI USA, V102, P11722, DOI 10.1073/pnas.0503855102	42	35	36	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1244	1253		10.1096/fj.10-169995	http://dx.doi.org/10.1096/fj.10-169995			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21191089	Green Published			2022-12-25	WOS:000288982800013
J	Diez-Sampedro, A; Barcelona, S				Diez-Sampedro, Ana; Barcelona, Stephanie			Sugar Binding Residue Affects Apparent Na+ Affinity and Transport Stoichiometry in Mouse Sodium/Glucose Cotransporter Type 3B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-GALACTOSE MALABSORPTION; NA+/GLUCOSE COTRANSPORTER; CRYSTAL-STRUCTURE; SODIUM; MECHANISM; SUBSTRATE; RELEASE; CHARGE; FAMILY; SGLT3	SGLT1 is a sodium/glucose cotransporter that moves two Na+ ions with each glucose molecule per cycle. SGLT3 proteins belong to the same family and are described as glucose sensors rather than glucose transporters. Thus, human SGLT3 (hSGLT3) does not transport sugar, but extracellular glucose depolarizes the cell in which it is expressed. Mouse SGLT3b (mSGLT3b), although it transports sugar, has low apparent sugar affinity and partially uncoupled stoichiometry compared with SGLT1, suggesting that mSGLT3b is also a sugar sensor. The crystal structure of the Vibrio parahaemolyticus SGLT showed that residue Gln(428) interacts directly with the sugar. The corresponding amino acid in mammalian proteins, 457, is conserved in all SGLT1 proteins as glutamine. In SGLT3 proteins, glutamate is the most common residue at this position, although it is a glycine in mSGLT3b and a serine in rat SGLT3b. To test the contribution of this residue to the function of SGLT3 proteins, we constructed SGLT3b mutants that recapitulate residue 457 in SGLT1 and hSGLT3, glutamine and glutamate, respectively. The presence of glutamine at residue 457 increased the apparent Na+ and sugar affinities, whereas glutamate decreased the apparent Na+ affinity. Moreover, glutamate transported more cations per sugar molecule than the wild type protein. We propose a model where cations are released intracellularly without the release of sugar from an intermediate state. This model explains the uncoupled charge: sugar transport phenotype observed in wild type and G457E-mSGLT3b compared with SGLT1 and the sugar-activated cation transport without sugar transport that occurs in hSGLT3.	[Diez-Sampedro, Ana; Barcelona, Stephanie] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	University of Miami	Diez-Sampedro, A (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Rm 4054,Rosenstiel Bldg,1600 NW 10th Ave, Miami, FL 33136 USA.	adiezsampedro@med.miami.edu			Florida Biomedical Research Program	Florida Biomedical Research Program	This work was supported by the Florida Biomedical Research Program (to A.D.-S.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Aljure O, 2010, AM J PHYSIOL-CELL PH, V299, pC58, DOI 10.1152/ajpcell.00030.2010; Bianchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010241; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Diez-Sampedro A, 2001, J BIOL CHEM, V276, P49188, DOI 10.1074/jbc.M108286200; Diez-Sampedro A, 2001, AM J PHYSIOL-RENAL, V280, pF278, DOI 10.1152/ajprenal.2001.280.2.F278; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Lam JT, 1999, BBA-MOL BASIS DIS, V1453, P297, DOI 10.1016/S0925-4439(98)00109-4; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Liu TM, 2009, BIOPHYS J, V96, P748, DOI 10.1016/j.bpj.2008.09.045; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Loo DDF, 2006, J GEN PHYSIOL, V128, P701, DOI 10.1085/jgp.200609643; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; PANAYOTOVAHEIERMANN M, 1994, J BIOL CHEM, V269, P21016; PARENT L, 1992, J MEMBRANE BIOL, V125, P63; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Voss AA, 2007, MOL PHARMACOL, V71, P628, DOI 10.1124/mol.106.030288; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Wright EM, 2002, CELL BIOCHEM BIOPHYS, V36, P115, DOI 10.1385/CBB:36:2-3:115; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	23	6	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7975	7982		10.1074/jbc.M110.187880	http://dx.doi.org/10.1074/jbc.M110.187880			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21187287	Green Published, hybrid			2022-12-25	WOS:000288013300028
J	Lu, R; Yang, A; Jin, Y				Lu, Rui; Yang, Acong; Jin, Ying			Dual Functions of T-Box 3 (Tbx3) in the Control of Self-renewal and Extraembryonic Endoderm Differentiation in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULNAR-MAMMARY SYNDROME; PROTEIN-INTERACTION NETWORK; ES CELLS; TRANSCRIPTIONAL NETWORK; SIGNALING PATHWAYS; GENE-EXPRESSION; PLURIPOTENCY; LINEAGE; SOX2; ACTIVATION	Embryonic stem cells (ESCs) possess the capacity to proliferate indefinitely in an undifferentiated state and to differentiate into various cell types in an organism. However, the critical question of how self-renewal and differentiation are precisely regulated in ESCs is not entirely understood at present. Here, we report the essential role of Tbx3, a pluripotency-related transcription factor of the T-box gene family, for both the maintenance of self-renewal of mouse ESCs and for their differentiation into extraembryonic endoderm (ExEn). We show that Tbx3 is highly expressed in ExEn cells in addition to undifferentiated ESCs. Knockdown of Tbx3 expression using tetracycline-regulated Tbx3 siRNA resulted in the attenuation of ESC self-renewal ability and aberrant differentiation processes, including reduced ExEn differentiation but enhanced ectoderm and trophectoderm differentiation. Conversely, inducible forced expression of Tbx3 triggered ExEn lineage commitment. Mechanistically, Tbx3 directly activated the expression of Gata6, an essential regulator of ExEn. Interestingly, Tbx3 modulated H3K27me3 modification and the association of the PRC2 complex with the promoter region of Gata6. Taken together, the results of this study revealed a previously unappreciated role of a pluripotency factor in ExEn differentiation. Additionally, our data reveal that Tbx3 may function through direct binding and epigenetic modification of histones on the Gata6 promoter to maintain the ExEn differentiation potential of ESCs.	[Lu, Rui; Yang, Acong; Jin, Ying] CAS Shanghai Jiao Tong Univ Sch Med, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Yang, Acong; Jin, Ying] Shanghai Jiao Tong Univ Sch Med, Inst Med Sci, Shanghai Stem Cell Inst, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Jin, Y (corresponding author), 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn	Yang, Acong/B-2929-2012	Yang, Acong/0000-0002-1279-566X; , jin ying/0000-0003-0070-2048; Lu, Rui/0000-0003-1593-2612	National Natural Science Foundation [30730051, 30700116, 30911130361, 91019929]; National High Technology Research and Development Program of China [2009CB941103, 2007CB947904, 2007CB948004, 2010CB945200]; Shanghai Science and Technology Developmental Foundations [08dj1400502]; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Science and Technology Developmental Foundations; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation Grants 30730051, 30700116, 30911130361, and 91019929, National High Technology Research and Development Program of China Grants 2009CB941103, 2007CB947904, 2007CB948004, and 2010CB945200, and Shanghai Science and Technology Developmental Foundations Grant 08dj1400502. The work was also supported by the Shanghai Leading Academic Discipline Project (S30201).	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Coll M, 2002, STRUCTURE, V10, P343, DOI 10.1016/S0969-2126(02)00722-0; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hoogaars WMH, 2008, PIGM CELL MELANOMA R, V21, P379, DOI 10.1111/j.1755-148X.2008.00461.x; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Krawetz R, 2008, CELL SIGNAL, V20, P163, DOI 10.1016/j.cellsig.2007.10.011; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang BB, 2006, BIOCHEM BIOPH RES CO, V347, P1129, DOI 10.1016/j.bbrc.2006.07.020; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013	38	59	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8425	8436		10.1074/jbc.M110.202150	http://dx.doi.org/10.1074/jbc.M110.202150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21189255	Green Published, hybrid			2022-12-25	WOS:000288013300071
J	Mohammad, MM; Howard, KR; Movileanu, L				Mohammad, Mohammad M.; Howard, Khalil R.; Movileanu, Liviu			Redesign of a Plugged beta-Barrel Membrane Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI OUTER-MEMBRANE; FHUA TRANSPORT PROTEIN; SECONDARY STRUCTURE ANALYSES; PLANAR LIPID-BILAYERS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CIRCULAR-DICHROISM; FUNCTIONAL-CHARACTERIZATION; COBALAMIN TRANSPORTER; DYNAMICS SIMULATIONS	The redesign of biological nanopores is focused on bacterial outer membrane proteins and pore-forming toxins, because their robust beta-barrel structure makes them the best choice for developing stochastic biosensing elements. Using membrane protein engineering and single-channel electrical recordings, we explored the ferric hydroxamate uptake component A (FhuA), a monomeric 22-stranded beta-barrel protein from the outer membrane of Escherichia coli. FhuA has a luminal cross-section of 3.1 x 4.4 nm and is filled by a globular N-terminal cork domain. Various redesigned FhuA proteins were investigated, including single, double, and multiple deletions of the large extracellular loops and the cork domain. We identified four large extracellular loops that partially occlude the lumen when the cork domain is removed. The newly engineered protein, FhuA Delta C/Delta 4L, was the result of a removal of almost one-third of the total number of amino acids of the wild-type FhuA (WT-FhuA) protein. This extensive protein engineering encompassed the entire cork domain and four extracellular loops. Remarkably, FhuA Delta C/Delta 4L forms a functional open pore in planar lipid bilayers, with a measured unitary conductance of similar to 4.8 nanosiemens, which is much greater than the values recorded previously with other engineered FhuA protein channels. There are numerous advantages and prospects of using such an engineered outer membrane protein not only in fundamental studies of membrane protein folding and design, and the mechanisms of ion conductance and gating, but also in more applicative areas of stochastic single-molecule sensing of proteins and nucleic acids.	[Movileanu, Liviu] Syracuse Univ, Dept Phys, Syracuse, NY 13244 USA; [Howard, Khalil R.; Movileanu, Liviu] Syracuse Univ, Struct Biol Biochem & Biophys Program, Syracuse, NY 13244 USA; [Movileanu, Liviu] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA	Syracuse University; Syracuse University; Syracuse University	Movileanu, L (corresponding author), Syracuse Univ, Dept Phys, 201 Phys Bldg, Syracuse, NY 13244 USA.	lmovilea@physics.syr.edu			National Institutes of Health [R01 GM088403]; National Science Foundation [DMR-0706517, DMR-1006332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM088403 (to L. M.). This work was also supported by Grants DMR-0706517 and DMR-1006332 from the National Science Foundation (to L. M.).	Arora A, 2000, J BIOL CHEM, V275, P1594, DOI 10.1074/jbc.275.3.1594; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; BAYLEY H, 2004, NANOBIOTECHNOLOGY, P93; Berkane E, 2005, J Nanobiotechnology, V3, P3, DOI 10.1186/1477-3155-3-3; Bikwemu R, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454117; Biswas S, 2008, STRUCTURE, V16, P1027, DOI 10.1016/j.str.2008.04.009; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Bonhivers M, 1996, EMBO J, V15, P1850, DOI 10.1002/j.1460-2075.1996.tb00535.x; Bonhivers M, 2001, BIOCHEMISTRY-US, V40, P2606, DOI 10.1021/bi001725i; Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Braun M, 2002, EUR J BIOCHEM, V269, P4948, DOI 10.1046/j.1432-1033.2002.03195.x; BRAUN V, 1994, FEBS LETT, V346, P59, DOI 10.1016/0014-5793(94)00431-5; Braun V, 2009, J BACTERIOL, V191, P3431, DOI 10.1128/JB.00106-09; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cao Z, 2002, BIOCHIMIE, V84, P399, DOI 10.1016/S0300-9084(02)01455-4; Chen M, 2008, P NATL ACAD SCI USA, V105, P6272, DOI 10.1073/pnas.0711561105; Cherezov V, 2006, J MOL BIOL, V364, P716, DOI 10.1016/j.jmb.2006.09.022; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Chimerel C, 2008, EUR BIOPHYS J BIOPHY, V38, P121, DOI 10.1007/s00249-008-0366-0; Chow MKM, 2006, NUCLEIC ACIDS RES, V34, pD207, DOI 10.1093/nar/gkj080; COWAN SW, 1995, STRUCTURE, V3, P1041, DOI 10.1016/S0969-2126(01)00240-4; Destoumieux-Garzon D, 2005, BIOCHEM J, V389, P869, DOI 10.1042/BJ20042107; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Endriss F, 2004, J BACTERIOL, V186, P4818, DOI 10.1128/JB.186.14.4818-4823.2004; Endriss F, 2003, J BACTERIOL, V185, P4683, DOI 10.1128/JB.185.16.4683-4692.2003; Faraldo-Gomez JD, 2003, BIOPHYS J, V85, P1406, DOI 10.1016/S0006-3495(03)74573-1; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2001, STRUCTURE, V9, P707, DOI 10.1016/S0969-2126(01)00631-1; Goodrich CP, 2007, J PHYS CHEM B, V111, P3332, DOI 10.1021/jp071364h; HOFFMANN H, 1986, J BACTERIOL, V166, P404, DOI 10.1128/jb.166.2.404-411.1986; Howorka S, 2000, J AM CHEM SOC, V122, P2411, DOI 10.1021/ja993221h; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Huang YH, 2009, P NATL ACAD SCI USA, V106, P7403, DOI 10.1073/pnas.0902789106; Jung Y, 2006, J AM CHEM SOC, V128, P15332, DOI 10.1021/ja065827t; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; KILLMANN H, 1993, EMBO J, V12, P3007, DOI 10.1002/j.1460-2075.1993.tb05969.x; Killmann H, 1996, J BACTERIOL, V178, P6913, DOI 10.1128/jb.178.23.6913-6920.1996; Lambert O, 2000, P NATL ACAD SCI USA, V97, P7248, DOI 10.1073/pnas.130187297; Letellier L, 1999, RES MICROBIOL, V150, P499, DOI 10.1016/S0923-2508(99)00107-2; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Maglia G, 2008, P NATL ACAD SCI USA, V105, P19720, DOI 10.1073/pnas.0808296105; Mapingire OS, 2009, J BIOL CHEM, V284, P36324, DOI 10.1074/jbc.M109.055798; Mdzinarashvili T, 2006, EUR BIOPHYS J BIOPHY, V35, P231, DOI 10.1007/s00249-005-0029-3; Mohammad MM, 2008, EUR BIOPHYS J BIOPHY, V37, P913, DOI 10.1007/s00249-008-0309-9; Mohammad MM, 2008, J AM CHEM SOC, V130, P4081, DOI 10.1021/ja710787a; Mohammad MM, 2010, J PHYS CHEM B, V114, P8750, DOI 10.1021/jp101311s; Movileanu L, 2000, INT J PHARMACEUT, V205, P135, DOI 10.1016/S0378-5173(00)00503-2; Movileanu L, 2000, NAT BIOTECHNOL, V18, P1091, DOI 10.1038/80295; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Movileanu L, 2003, BIOPHYS J, V85, P897, DOI 10.1016/S0006-3495(03)74529-9; Movileanu L, 2001, P NATL ACAD SCI USA, V98, P10137, DOI 10.1073/pnas.181089798; Movileanu L, 2001, J GEN PHYSIOL, V117, P239, DOI 10.1085/jgp.117.3.239; Movileanu L, 2008, SOFT MATTER, V4, P925, DOI 10.1039/b719850g; Movileanu L, 2009, TRENDS BIOTECHNOL, V27, P333, DOI 10.1016/j.tibtech.2009.02.008; Nallani Madhavan, 2006, Biotechnology Journal, V1, P828, DOI 10.1002/biot.200600042; Nallani M, 2006, J BIOTECHNOL, V123, P50, DOI 10.1016/j.jbiotec.2005.10.025; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; Niedzwiecki DJ, 2010, J AM CHEM SOC, V132, P10816, DOI 10.1021/ja1026858; Onaca O, 2008, ANGEW CHEM INT EDIT, V47, P7029, DOI 10.1002/anie.200801076; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ramakrishnan M, 2005, BIOCHEMISTRY-US, V44, P3515, DOI 10.1021/bi047603y; Ramakrishnan M, 2004, BIOCHEMISTRY-US, V43, P11630, DOI 10.1021/bi048858e; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Subbarao GV, 2006, J MOL BIOL, V360, P750, DOI 10.1016/j.jmb.2006.05.045; Talaga DS, 2009, J AM CHEM SOC, V131, P9287, DOI 10.1021/ja901088b; Udho E, 2009, P NATL ACAD SCI USA, V106, P21990, DOI 10.1073/pnas.0910023106; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; Wendell D, 2009, NAT NANOTECHNOL, V4, P765, DOI [10.1038/NNANO.2009.259, 10.1038/nnano.2009.259]; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wolfe AJ, 2007, J AM CHEM SOC, V129, P14034, DOI 10.1021/ja0749340	76	55	56	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8000	8013		10.1074/jbc.M110.197723	http://dx.doi.org/10.1074/jbc.M110.197723			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21189254	Green Published, hybrid			2022-12-25	WOS:000288013300031
J	Chu-LaGraff, Q; Blanchette, C; O'Hern, P; Denefrio, C				Chu-LaGraff, Quynh; Blanchette, Cassandra; O'Hern, Patrick; Denefrio, Cassandra			The Batten Disease Palmitoyl Protein Thioesterase 1 Gene Regulates Neural Specification and Axon Connectivity during Drosophila Embryonic Development	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; NERVOUS-SYSTEM LINEAGES; MOLECULAR-CLONING; EXPRESSION; MELANOGASTER; MICE; CNS; NEUROECTODERM; PRECURSOR; ANTIBODY	Palmitoyl Protein Thioesterase 1 (PPT1) is an essential lysosomal protein in the mammalian nervous system whereby defects result in a fatal pediatric disease called Infantile Neuronal Ceroids Lipofuscinosis (INCL). Flies bearing mutations in the Drosophila ortholog Ppt1 exhibit phenotypes similar to the human disease: accumulation of autofluorescence deposits and shortened adult lifespan. Since INCL patients die as young children, early developmental neural defects due to the loss of PPT1 are postulated but have yet to be elucidated. Here we show that Drosophila Ppt1 is required during embryonic neural development. Ppt1 embryos display numerous neural defects ranging from abnormal cell fate specification in a number of identified precursor lineages in the CNS, missing and disorganized neurons, faulty motoneuronal axon trajectory, and discontinuous, misaligned, and incorrect midline crossings of the longitudinal axon bundles of the ventral nerve cord. Defects in the PNS include a decreased number of sensory neurons, disorganized chordotonal neural clusters, and abnormally shaped neurons with aberrant dendritic projections. These results indicate that Ppt1 is essential for proper neuronal cell fates and organization; and to establish the local environment for proper axon guidance and fasciculation. Ppt1 function is well conserved from humans to flies; thus the INCL pathologies may be due, in part, to the accumulation of various embryonic neural defects similar to that of Drosophila. These findings may be relevant for understanding the developmental origin of neural deficiencies in INCL.	[Chu-LaGraff, Quynh; Blanchette, Cassandra; O'Hern, Patrick; Denefrio, Cassandra] Union Coll, Dept Biol, Schenectady, NY 12308 USA	Union College	Chu-LaGraff, Q (corresponding author), Union Coll, Dept Biol, Schenectady, NY 12308 USA.	chulagrq@union.edu	Denefrio, Cassandra/AAV-2261-2021		NIH [NIH-R15 NS046334]; Merck-AAAS; Booth-Ferris; Batten Disease Research and Support Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS046334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck-AAAS(Merck & Company); Booth-Ferris; Batten Disease Research and Support Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH-R15 NS046334, Merck-AAAS Undergraduate Fellowship, Booth-Ferris Fellowship, and Batten Disease Research and Support Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahtiainen L, 2003, J COMP NEUROL, V455, P368, DOI 10.1002/cne.10492; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Broadus J, 1995, DEVELOPMENT, V121, P3989; Buff H, 2007, GENETICS, V176, P209, DOI 10.1534/genetics.106.067983; CAMP LA, 1993, J BIOL CHEM, V268, P22566; CAMP LA, 1994, J BIOL CHEM, V269, P23212; CHULAGRAFF Q, 1995, NEURON, V15, P1041, DOI 10.1016/0896-6273(95)90093-4; CHULAGRAFF Q, 1993, SCIENCE, V261, P1594, DOI 10.1126/science.8372355; Cooper JD, 2003, CURR OPIN NEUROL, V16, P121, DOI 10.1097/00019052-200304000-00001; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Glaser RL, 2003, GENE, V312, P271, DOI 10.1016/S0378-1119(03)00623-1; Goswami R, 2005, J NEUROSCI RES, V81, P208, DOI 10.1002/jnr.20549; GRENNINGLOH G, 1990, COLD SH Q B, V55, P327; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Heinonen O, 2000, MOL GENET METAB, V69, P123, DOI 10.1006/mgme.2000.2961; Hickey AJ, 2006, GENETICS, V172, P2379, DOI 10.1534/genetics.105.053306; Isosomppi J, 1999, DEV BRAIN RES, V118, P1, DOI 10.1016/S0165-3806(99)00115-7; Jalanko A, 2005, NEUROBIOL DIS, V18, P226, DOI 10.1016/j.nbd.2004.08.013; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Korey CA, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-30; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Lehtovirta M, 2001, HUM MOL GENET, V10, P69, DOI 10.1093/hmg/10.1.69; Little EB, 1998, CELL ADHES COMMUN, V6, P415, DOI 10.3109/15419069809109150; Mole S, 1999, EPILEPSIA, V40, P29, DOI 10.1111/j.1528-1157.1999.tb00896.x; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Soyombo AA, 1997, J BIOL CHEM, V272, P27456, DOI 10.1074/jbc.272.43.27456; Suopanki J, 1999, MOL GENET METAB, V66, P290, DOI 10.1006/mgme.1999.2839; UDOLPH G, 1993, DEVELOPMENT, V118, P765; ZIPURSKY SL, 1985, P NATL ACAD SCI USA, V82, P1855, DOI 10.1073/pnas.82.6.1855	34	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14402	10.1371/journal.pone.0014402	http://dx.doi.org/10.1371/journal.pone.0014402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203506	gold, Green Published, Green Submitted			2022-12-25	WOS:000285578000009
J	Glover, KA; Kanda, N; Haug, T; Pastene, LA; Oien, N; Goto, M; Seliussen, BB; Skaug, HJ				Glover, Kevin A.; Kanda, Naohisa; Haug, Tore; Pastene, Luis A.; Oien, Nils; Goto, Mutsuo; Seliussen, Bjorghild B.; Skaug, Hans J.			Migration of Antarctic Minke Whales to the Arctic	PLOS ONE			English	Article							ATLANTIC HUMPBACK WHALES; MULTILOCUS GENOTYPE DATA; BALAENOPTERA-ACUTOROSTRATA; POPULATION-STRUCTURE; NORTH-ATLANTIC; MEGAPTERA-NOVAEANGLIAE; MICROSATELLITE LOCI; BALEEN WHALES; FAROE-ISLANDS; INFERENCE	The Antarctic minke whale (Balaenoptera bonaerensis), and the common minke whale found in the North Atlantic (Balaenoptera acutorostrata acutorostrata), undertake synchronized seasonal migrations to feeding areas at their respective poles during spring, and to the tropics in the autumn where they overwinter. Differences in the timing of seasons between hemispheres prevent these species from mixing. Here, based upon analysis of mitochondrial and microsatellite DNA profiles, we report the observation of a single B. bonaerensis in 1996, and a hybrid with maternal contribution from B. bonaerensis in 2007, in the Arctic Northeast Atlantic. Paternal contribution was not conclusively resolved. This is the first documentation of B. bonaerensis north of the tropics, and, the first documentation of hybridization between minke whale species.	[Glover, Kevin A.; Oien, Nils; Seliussen, Bjorghild B.; Skaug, Hans J.] Inst Marine Res, N-5024 Bergen, Norway; [Kanda, Naohisa; Pastene, Luis A.; Goto, Mutsuo] Inst Cetacean Res, Tokyo, Japan; [Haug, Tore] Inst Marine Res, Tromso, Norway; [Skaug, Hans J.] Univ Bergen, Dept Math, N-5007 Bergen, Norway	Institute of Marine Research - Norway; Institute of Marine Research - Norway; University of Bergen	Glover, KA (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	Kevin.glover@imr.no		Breistein, Bjorghild/0000-0002-1805-7190	Institute of Marine Research	Institute of Marine Research	This research was funded by the Institute of Marine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als TD, 2006, EUR J HUM GENET, V14, P497, DOI 10.1038/sj.ejhg.5201578; ARNASON U, 1993, MOL BIOL EVOL, V10, P960; Berube M, 1998, MAR MAMMAL SCI, V14, P82, DOI 10.1111/j.1748-7692.1998.tb00692.x; Berube M, 2000, MOL ECOL, V9, P2181; Buchanan FC, 1996, MOL ECOL, V5, P571; BUCKLAND ST, 1989, REP INT WHAL COMMN, V11, P121; CHRISTENSEN I, 1990, MAR MAMMAL SCI, V6, P327, DOI 10.1111/j.1748-7692.1990.tb00362.x; Cornuet JM, 1999, GENETICS, V153, P1989; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Falush D, 2003, GENETICS, V164, P1567; Folkow L.P., 1991, REPORTS INT WHALING, V41, P531; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Horwood J., 1990, BIOL EXPLOITATION MI; Jorgensen TH, 2004, HUM GENET, V115, P19, DOI 10.1007/s00439-004-1117-7; Kalinowski ST, 2004, CAN J FISH AQUAT SCI, V61, P1075, DOI 10.1139/F04-060; KASAMATSU F, 1995, MAR ECOL PROG SER, V119, P1, DOI 10.3354/meps119001; Larsen AH, 1996, P ROY SOC B-BIOL SCI, V263, P1611, DOI 10.1098/rspb.1996.0236; MICHELL ED, 1991, REPORT INT WHALING C, V41, P455; Naess A, 1998, SARSIA, V83, P211; Narum SR, 2008, MOL ECOL, V17, P3464, DOI 10.1111/j.1365-294X.2008.03851.x; NEMOTO T, 1980, SCI REP WHALES RES, V32, P97; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Ohsum S., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P237; Omura H., 1975, Scientific Rep Whales Res Inst Tokyo, VNo. 27, P1; Palsboll Per J., 1998, P426; Palsboll PJ, 1997, MOL ECOL, V6, P893; PALSBOLL PJ, 1995, MAR ECOL PROG SER, V116, P1, DOI 10.3354/meps116001; Pastene L. A., 1994, REP INT WHAL COMMN, V44, P277; Pastene LA, 2007, MOL ECOL, V16, P1481, DOI 10.1111/j.1365-294X.2007.03244.x; Pastene LA, 2010, CONSERV GENET, V11, P1553, DOI 10.1007/s10592-009-9944-7; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pomilla C, 2005, BIOL LETTERS, V1, P476, DOI 10.1098/rsbl.2005.0351; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rice D. W., 1998, SOC MARINE MAMMALOGY, V4, P231; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Skaug HJ, 2004, CAN J FISH AQUAT SCI, V61, P870, DOI 10.1139/F04-020; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Waerebeek Koen, 1999, Journal of Cetacean Research and Management, V1, P223; Wada S., 1991, REP INT WHAL COMMN, V13, P203	41	34	39	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15197	10.1371/journal.pone.0015197	http://dx.doi.org/10.1371/journal.pone.0015197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203557	gold, Green Published, Green Submitted			2022-12-25	WOS:000285578000023
J	Fiorentini, A; Rosi, MC; Grossi, C; Luccarini, I; Casamenti, F				Fiorentini, Anna; Rosi, Maria Cristina; Grossi, Cristina; Luccarini, Ilaria; Casamenti, Fiorella			Lithium Improves Hippocampal Neurogenesis, Neuropathology and Cognitive Functions in APP Mutant Mice	PLOS ONE			English	Article							ADULT NEUROGENESIS; ALZHEIMERS-DISEASE; TRANSGENIC MICE; DENTATE GYRUS; NEWBORN NEURONS; BETA-CATENIN; MOUSE MODEL; DISRUPTION; STRATEGIES; REGULATORS	Background: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive deterioration of cognitive functions, extracellular beta-amyloid (Ab) plaques and intracellular neurofibrillary tangles within neocortex and hippocampus. Adult hippocampal neurogenesis plays an important role in learning and memory processes and its abnormal regulation might account for cognitive impairments associated with AD. Methodology/Principal Findings: The double transgenic (Tg) CRND8 mice (overexpressing the Swedish and Indiana mutations in the human amyloid precursor protein), aged 2 and 6 months, were used to examine in vivo the effects of 5 weeks lithium treatment. BrdU labelling showed a decreased neurogenesis in the subgranular zone of Tg mice compared to non-Tg mice. The decrease of hippocampal neurogenesis was accompanied by behavioural deficits and worsened with age and pathology severity. The differentiation into neurons and maturation of the proliferating cells were also markedly impaired in the Tg mice. Lithium treatment to 2-month-old Tg mice significantly stimulated the proliferation and neuron fate specification of newborn cells and fully counteracted the transgene-induced impairments of cognitive functions. The drug, by the inhibition of GSK-3 beta and subsequent activation of Wnt/ss-catenin signalling promoted hippocampal neurogenesis. Finally, the data show that the lithium's ability to stimulate neurogenesis and cognitive functions was lost in the aged Tg mice, thus indicating that the lithium-induced facilitation of neurogenesis and cognitive functions declines as brain Ab deposition and pathology increases. Conclusions: Lithium, when given on time, stimulates neurogenesis and counteracts AD-like pathology.	[Fiorentini, Anna; Rosi, Maria Cristina; Grossi, Cristina; Luccarini, Ilaria; Casamenti, Fiorella] Univ Florence, Dept Pharmacol, Florence, Italy	University of Florence	Fiorentini, A (corresponding author), Univ Florence, Dept Pharmacol, Florence, Italy.	fiorella.casamenti@unifi.it			Ministero dell'Istruzione, dell'Universita' e della Ricerca [PRIN2008R25HBW_01]; Universita' degli Studi di Firenze, Italy	Ministero dell'Istruzione, dell'Universita' e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Universita' degli Studi di Firenze, Italy	This work was supported by grants from Ministero dell'Istruzione, dell'Universita' e della Ricerca (PRIN2008R25HBW_01) and Universita' degli Studi di Firenze, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLUCCI A, 2006, NEUROBIOL DIS, V165, P1643; Bellucci A, 2007, NEUROBIOL DIS, V27, P328, DOI 10.1016/j.nbd.2007.06.008; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chuang TT, 2010, BBA-MOL BASIS DIS, V1802, P872, DOI 10.1016/j.bbadis.2009.12.008; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Grossi C, 2009, J ALZHEIMERS DIS, V17, P423, DOI 10.3233/JAD-2009-1063; Hampel H, 2009, J CLIN PSYCHIAT, V70, P922, DOI 10.4088/JCP.08m04606; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; He P, 2009, J NEUROSCI, V29, P6545, DOI 10.1523/JNEUROSCI.0421-09.2009; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jagasia R, 2006, TRENDS MOL MED, V12, P400, DOI 10.1016/j.molmed.2006.07.006; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lovestone S, 1997, LANCET, V350, P232, DOI 10.1016/S0140-6736(05)62221-0; NAKATSU SL, 1974, NATURE, V248, P334, DOI 10.1038/248334a0; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Noonan MA, 2008, J NEUROSCI, V28, P2516, DOI 10.1523/JNEUROSCI.4661-07.2008; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Rowe MK, 2007, NEUROSCI BIOBEHAV R, V31, P920, DOI 10.1016/j.neubiorev.2007.03.002; Schaeffer EL, 2009, PROG NEURO-PSYCHOPH, V33, P1087, DOI 10.1016/j.pnpbp.2009.06.024; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Tariot PN, 2009, J CLIN PSYCHIAT, V70, P919, DOI 10.4088/JCP.09com05331; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Toledo EM, 2010, MOL PSYCHIATR, V15, P272, DOI 10.1038/mp.2009.72; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; YAMAMOTO T, 1986, NEUROPATH APPL NEURO, V12, P3, DOI 10.1111/j.1365-2990.1986.tb00677.x; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	47	129	129	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14382	10.1371/journal.pone.0014382	http://dx.doi.org/10.1371/journal.pone.0014382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187954	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200008
J	Giri, PK; Tang, XH; Thangamani, S; Shenoy, RT; Ding, JL; Swaminathan, K; Sivaraman, J				Giri, Pankaj Kumar; Tang, Xuhua; Thangamani, Saravanan; Shenoy, Rajesh T.; Ding, Jeak Ling; Swaminathan, Kunchithapadam; Sivaraman, J.			Modifying the Substrate Specificity of Carcinoscorpius rotundicauda Serine Protease Inhibitor Domain 1 to Target Thrombin	PLOS ONE			English	Article							INNATE IMMUNITY; PROTEINASE-INHIBITORS; COMPLEX; SERPIN; DISCOVERY; SOFTWARE; HIRUDIN; DRUG	Protease inhibitors play a decisive role in maintaining homeostasis and eliciting antimicrobial activities. Invertebrates like the horseshoe crab have developed unique modalities with serine protease inhibitors to detect and respond to microbial and host proteases. Two isoforms of an immunomodulatory two-domain Kazal-like serine protease inhibitor, CrSPI-1 and CrSPI-2, have been recently identified in the hepatopancreas of the horseshoe crab, Carcinoscorpius rotundicauda. Full length and domain 2 of CrSPI-1 display powerful inhibitory activities against subtilisin. However, the structure and function of CrSPI-1 domain-1 (D1) remain unknown. Here, we report the crystal structure of CrSPI-1-D1 refined up to 2.0 angstrom resolution. Despite the close structural homology of CrSPI-1-D1 to rhodniin-D1 (a known thrombin inhibitor), the CrSPI-1-D1 does not inhibit thrombin. This prompted us to modify the selectivity of CrSPI-1-D1 specifically towards thrombin. We illustrate the use of structural information of CrSPI-1-D1 to modify this domain into a potent thrombin inhibitor with IC50 of 26.3 nM. In addition, these studies demonstrate that, besides the rigid conformation of the reactive site loop of the inhibitor, the sequence is the most important determinant of the specificity of the inhibitor. This study will lead to the significant application to modify a multi-domain inhibitor protein to target several proteases.	[Giri, Pankaj Kumar; Tang, Xuhua; Thangamani, Saravanan; Shenoy, Rajesh T.; Ding, Jeak Ling; Swaminathan, Kunchithapadam; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Giri, PK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsdjl@nus.edu.sg; dbsks@nus.edu.sg; dbsjayar@nus.edu.sg	Ding, Jeak/H-8057-2012; Shenoy, Rajesh/ABD-3976-2020; Thangamani, Saravanan/E-7371-2010; Sivaraman, J/H-8028-2012	Shenoy, Rajesh/0000-0002-5035-8321; Thangamani, Saravanan/0000-0002-4269-5993; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council of Singapore (BMRC); A*STAR Singapore [R154000362305]	Biomedical Research Council of Singapore (BMRC)(Agency for Science Technology & Research (A*STAR)); A*STAR Singapore(Agency for Science Technology & Research (A*STAR))	Biomedical Research Council of Singapore (BMRC) and A*STAR Singapore (R154000362305) provided financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PB, 2001, TRENDS IMMUNOL, V22, P47, DOI 10.1016/S1471-4906(00)01803-2; Barrette-Ng IH, 2003, J BIOL CHEM, V278, P31391, DOI 10.1074/jbc.M304562200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; De Simone G, 1999, BIOPOLYMERS, V51, P19, DOI 10.1002/(SICI)1097-0282(1999)51:1<19::AID-BIP4>3.0.CO;2-G; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; DING JL, 1993, BIOCHIM BIOPHYS ACTA, V1202, P149, DOI 10.1016/0167-4838(93)90076-4; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gurm HS, 2005, AM HEART J, V149, pS43, DOI 10.1016/j.ahj.2004.10.022; Hemmi H, 2005, BIOCHEMISTRY-US, V44, P9626, DOI 10.1021/bi0472806; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; IKEO K, 1995, J MOL EVOL, V40, P331, DOI 10.1007/BF00163238; Jiang N, 2009, J INNATE IMMUN, V1, P465, DOI 10.1159/000209224; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Leblond J, 2006, THROMB HAEMOSTASIS, V95, P243, DOI 10.1160/TH05-08-0561; Markwardt F, 2002, PATHOPHYSIOL HAEMO T, V32, P15, DOI 10.1159/000069104; MARKWARDT F, 1994, THROMB RES, V74, P1, DOI 10.1016/0049-3848(94)90032-9; Maynes JT, 2005, ACTA CRYSTALLOGR D, V61, P580, DOI 10.1107/S0907444905004889; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; OCHMAN H, 1988, GENETICS, V120, P621; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfau R, 2003, CURR OPIN DRUG DISC, V6, P437; Richer MJ, 2004, P NATL ACAD SCI USA, V101, P10560, DOI 10.1073/pnas.0401406101; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Salzet M, 2001, TRENDS IMMUNOL, V22, P285, DOI 10.1016/S1471-4906(01)01895-6; Steinmetzer T, 2001, EXPERT OPIN INV DRUG, V10, P845, DOI 10.1517/13543784.10.5.845; Stubbs MT, 1997, J BIOL CHEM, V272, P19931, DOI 10.1074/jbc.272.32.19931; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vacca JP, 2000, CURR OPIN CHEM BIOL, V4, P394, DOI 10.1016/S1367-5931(00)00112-5; VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x; Weitz JI, 2002, THROMB RES, V106, pV275, DOI 10.1016/S0049-3848(02)00093-2	36	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15258	10.1371/journal.pone.0015258	http://dx.doi.org/10.1371/journal.pone.0015258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188150	Green Published, gold, Green Submitted			2022-12-25	WOS:000285575200027
J	Wascher, CAF; Fraser, ON; Kotrschal, K				Wascher, Claudia A. F.; Fraser, Orlaith N.; Kotrschal, Kurt			Heart Rate during Conflicts Predicts Post-Conflict Stress-Related Behavior in Greylag Geese	PLOS ONE			English	Article							PASSIVE SOCIAL SUPPORT; DISPLACEMENT ACTIVITIES; ANSER-ANSER; RECONCILIATION; RESPONSES; CONSOLATION; VASOTOCIN; STARLINGS; FAMILIES; EMOTION	Background: Social stressors are known to be among the most potent stressors in group-living animals. This is not only manifested in individual physiology (heart rate, glucocorticoids), but also in how individuals behave directly after a conflict. Certain 'stress-related behaviors' such as autopreening, body shaking, scratching and vigilance have been suggested to indicate an individual's emotional state. Such behaviors may also alleviate stress, but the behavioral context and physiological basis of those behaviors is still poorly understood. Methodology/Principal Findings: We recorded beat-to-beat heart rates (HR) of 22 greylag geese in response to agonistic encounters using fully implanted sensor-transmitter packages. Additionally, for 143 major events we analyzed the behavior shown by our focal animals in the first two minutes after an interaction. Our results show that the HR during encounters and characteristics of the interaction predicted the frequency and duration of behaviors shown after a conflict. Conclusions/Significance: To our knowledge this is the first study to quantify the physiological and behavioral responses to single agonistic encounters and to link this to post conflict behavior. Our results demonstrate that 'stress-related behaviors' are flexibly modulated by the characteristics of the preceding aggressive interaction and reflect the individual's emotional strain, which is linked to autonomic arousal. We found no support for the stress-alleviating hypothesis, but we propose that stress-related behaviors may play a role in communication with other group members, particularly with pair-partners.	[Wascher, Claudia A. F.; Kotrschal, Kurt] Univ Vienna, Konrad Lorenz Forsch Stelle, Vienna, Austria; [Wascher, Claudia A. F.; Kotrschal, Kurt] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Wascher, Claudia A. F.; Fraser, Orlaith N.] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna	Wascher, CAF (corresponding author), Univ Vienna, Konrad Lorenz Forsch Stelle, Vienna, Austria.	claudia.wascher@klf.ac.at	Wascher, Claudia/L-4005-2015	Wascher, Claudia/0000-0003-4360-363X	Fonds zur Forderung der wissenschaftlichen Forschung [15766-B03, 21489-B17]; Austrian Science Fund (FWF) [P 21489] Funding Source: researchfish	Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by "Fonds zur Forderung der wissenschaftlichen Forschung'' projects 15766-B03 and 21489-B17 to K. Kotrschal (www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F, 2010, BIOL LETTERS, V6, P27, DOI 10.1098/rsbl.2009.0513; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Butovskaya ML, 2008, BEHAVIOUR, V145, P1557, DOI 10.1163/156853908786131342; Castles DL, 1998, ETHOLOGY, V104, P126; Castles DL, 1999, ANIM BEHAV, V58, P1207, DOI 10.1006/anbe.1999.1250; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Hemetsberger J, 2010, INTERACT STUD, V11, P380, DOI 10.1075/is.11.3.03hem; Johnstone RA, 2001, P NATL ACAD SCI USA, V98, P9177, DOI 10.1073/pnas.161058798; Kalueff AV, 2004, BRAIN RES PROTOC, V13, P151, DOI 10.1016/j.brainresprot.2004.04.002; Kotrschal K, 2010, ANIMAL BEHAV EVOLUTI, P121; Kutsukake N, 2001, Anim Cogn, V4, P259, DOI 10.1007/s10071-001-0119-2; Kutsukake N, 2006, ETHOLOGY, V112, P581, DOI 10.1111/j.1439-0310.2006.01200.x; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Major P, 1998, PHYSIOL BEHAV, V63, P381, DOI 10.1016/S0031-9384(97)00454-X; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; Nephew BC, 2003, HORM BEHAV, V44, P222, DOI 10.1016/j.yhbeh.2003.06.002; Nephew BC, 2003, GEN COMP ENDOCR, V133, P173, DOI 10.1016/S0016-6480(03)00165-5; Nephew BC, 2005, HORM BEHAV, V47, P280, DOI 10.1016/j.yhbeh.2004.11.007; Parr LA, 2005, CURR OPIN NEUROBIOL, V15, P716, DOI 10.1016/j.conb.2005.10.017; Peake Tom M., 2006, P13; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Prinzinger R, 2002, J ORNITHOL, V143, P456, DOI 10.1046/j.1439-0361.2002.02039.x; Riters LV, 1997, ANN NY ACAD SCI, V807, P478, DOI 10.1111/j.1749-6632.1997.tb51943.x; Scheiber IBR, 2005, BEHAVIOUR, V142, P1535, DOI 10.1163/156853905774831873; Scheiber IBR, 2005, ANN NY ACAD SCI, V1046, P154, DOI 10.1196/annals.1343.012; Scheiber IBR, 2009, ANIM BEHAV, V77, P1211, DOI 10.1016/j.anbehav.2009.01.026; Scheiber IBR, 2009, HORM BEHAV, V55, P133, DOI 10.1016/j.yhbeh.2008.09.006; Schino G, 1996, ANXIETY, V2, P186; Spoor JR, 2004, GROUP PROCESS INTERG, V7, P398, DOI 10.1177/1368430204046145; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; TINBERGEN N., 1952, QUART REV BIOL, V27, P1; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Troisi A, 2002, STRESS, V5, P46, DOI 10.1080/10253890290012378; WASCHER AFC, J COMP PSYC IN PRESS; Wascher CAF, 2008, P ROY SOC B-BIOL SCI, V275, P1653, DOI 10.1098/rspb.2008.0146; Wascher CAF, 2008, J COMP PSYCHOL, V122, P100, DOI 10.1037/0735-7036.122.1.100; Wascher CAF, 2009, ANIM BEHAV, V77, P955, DOI 10.1016/j.anbehav.2009.01.013; Weiss BM, 2004, ETHOLOGY, V110, P429, DOI 10.1111/j.1439-0310.2004.00979.x; [No title captured]	45	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15751	10.1371/journal.pone.0015751	http://dx.doi.org/10.1371/journal.pone.0015751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187927	Green Published, gold			2022-12-25	WOS:000285575200068
J	Wicklund, L; Leao, RN; Stromberg, AM; Mousavi, M; Hovatta, O; Nordberg, A; Marutle, A				Wicklund, Linn; Leao, Richardson N.; Stromberg, Anne-Marie; Mousavi, Malahat; Hovatta, Outi; Nordberg, Agneta; Marutle, Amelia			beta-Amyloid 1-42 Oligomers Impair Function of Human Embryonic Stem Cell-Derived Forebrain Cholinergic Neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; SUBVENTRICULAR ZONE; NICOTINIC RECEPTORS; SIGNALING PATHWAY; PROGENITOR CELLS; PRECURSOR CELLS; MOUSE-BRAIN; LINES	Cognitive impairment in Alzheimer's disease (AD) patients is associated with a decline in the levels of growth factors, impairment of axonal transport and marked degeneration of basal forebrain cholinergic neurons (BFCNs). Neurogenesis persists in the adult human brain, and the stimulation of regenerative processes in the CNS is an attractive prospect for neuroreplacement therapy in neurodegenerative diseases such as AD. Currently, it is still not clear how the pathophysiological environment in the AD brain affects stem cell biology. Previous studies investigating the effects of the beta-amyloid (A beta) peptide on neurogenesis have been inconclusive, since both neurogenic and neurotoxic effects on progenitor cell populations have been reported. In this study, we treated pluripotent human embryonic stem (hES) cells with nerve growth factor (NGF) as well as with fibrillar and oligomeric A beta(1-40) and A beta(1-42) (nM-mu M concentrations) and thereafter studied the differentiation in vitro during 28-35 days. The process applied real time quantitative PCR, immunocytochemistry as well as functional studies of intracellular calcium signaling. Treatment with NGF promoted the differentiation into functionally mature BFCNs. In comparison to untreated cells, oligomeric Ab(1-40) increased the number of functional neurons, whereas oligomeric A beta(1-42) suppressed the number of functional neurons. Interestingly, oligomeric Ab exposure did not influence the number of hES cell-derived neurons compared with untreated cells, while in contrast fibrillar A beta(1-40) and A beta(1-42) induced gliogenesis. These findings indicate that A beta(1-42) oligomers may impair the function of stem cell-derived neurons. We propose that it may be possible for future AD therapies to promote the maturation of functional stem cell-derived neurons by altering the brain microenvironment with trophic support and by targeting different aggregation forms of A beta.	[Wicklund, Linn; Mousavi, Malahat; Nordberg, Agneta; Marutle, Amelia] Karolinska Inst, Div Alzheimer Neurobiol, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Leao, Richardson N.] Karolinska Inst, Neuronal Oscillat Lab, Dept Neurosci, Stockholm, Sweden; [Stromberg, Anne-Marie; Hovatta, Outi] Karolinska Inst, Karolinska Univ Hosp Huddinge, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Nordberg, Agneta] Karolinska Univ Hosp Huddinge, Dept Geriatr Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Wicklund, L (corresponding author), Karolinska Inst, Div Alzheimer Neurobiol, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	amelia.marutle@ki.se	Leao, Richardson/AAX-4985-2020; nordberg, agneta/ABD-2479-2021	Leao, Richardson/0000-0001-8496-1965; Nordberg, Agneta/0000-0001-7345-5151	Swedish Research Council [05871, K2010-54X-15080-07-5]; Stockholm County Council-Karolinska Institute; Karolinska Institutet Strategic Neuroscience Program; Swedish Brain Foundation; Swedish Brain Power; Magnus Bergvalls Foundation; KI Foundations; Johnson Johnson; European Union; Foundation for Old Servants; Gun and Bertil Stohnes Foundation; Dementia Association; Alzheimer Foundation in Sweden; Lars Hierta Memorial Foundation; Olle Engkvist Byggmastare Foundation; International Human Frontier Science Program Organization	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council-Karolinska Institute(Karolinska Institutet); Karolinska Institutet Strategic Neuroscience Program; Swedish Brain Foundation; Swedish Brain Power; Magnus Bergvalls Foundation; KI Foundations; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); European Union(European Commission); Foundation for Old Servants; Gun and Bertil Stohnes Foundation; Dementia Association; Alzheimer Foundation in Sweden; Lars Hierta Memorial Foundation; Olle Engkvist Byggmastare Foundation; International Human Frontier Science Program Organization(Human Frontier Science Program)	This work was supported by the Swedish Research Council (project 05871 and K2010-54X-15080-07-5), Stockholm County Council-Karolinska Institute (ALF grants), the Karolinska Institutet Strategic Neuroscience Program, Swedish Brain Foundation, Swedish Brain Power, Magnus Bergvalls Foundation, KI Foundations, an academic grant from Johnson & Johnson administered through the Karolinska Institutet, the ESTOOLS consortium under the Sixth Research Framework Program of the European Union, the Foundation for Old Servants, Gun and Bertil Stohnes Foundation, The Dementia Association, Alzheimer Foundation in Sweden, The Lars Hierta Memorial Foundation and Olle Engkvist Byggmastare Foundation. RNL is supported by a long-term fellowship from the International Human Frontier Science Program Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bruno MA, 2009, J NEUROPATH EXP NEUR, V68, P857, DOI 10.1097/NEN.0b013e3181aed9e6; Calafiore M, 2006, NEUROBIOL AGING, V27, P606, DOI 10.1016/j.neurobiolaging.2005.03.019; Capsoni S, 2006, CELL MOL NEUROBIOL, V26, P619, DOI 10.1007/s10571-006-9112-2; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen Y, 2009, CELL DEATH DIFFER, V16, P386, DOI 10.1038/cdd.2008.94; Cuello AC, 2010, J MOL NEUROSCI, V40, P230, DOI 10.1007/s12031-009-9238-z; Eglen R. M., 2006, Autonomic & Autacoid Pharmacology, V26, P219, DOI 10.1111/j.1474-8673.2006.00368.x; ERIKSDOTTER JM, 1998, DEMENT GERIATR COGN, V9, P246, DOI DOI 10.1159/000017069; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; Heese K, 2006, NEUROSIGNALS, V15, P1, DOI 10.1159/000094383; Heo C, 2007, J NEUROCHEM, V102, P493, DOI 10.1111/j.1471-4159.2007.04499.x; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Inzunza J, 2005, STEM CELLS, V23, P544, DOI 10.1634/stemcells.2004-0201; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Madziar B, 2008, J NEUROCHEM, V107, P1284, DOI 10.1111/j.1471-4159.2008.05681.x; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; Muotri AR, 2005, P NATL ACAD SCI USA, V102, P18644, DOI 10.1073/pnas.0509315102; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Nilbratt M, 2010, J CELL MOL MED, V14, P1476, DOI 10.1111/j.1582-4934.2009.00916.x; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Paraoanu LE, 2007, LIFE SCI, V80, P2375, DOI 10.1016/j.lfs.2007.03.008; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Strom S, 2010, IN VITRO CELL DEV-AN, V46, P337, DOI 10.1007/s11626-010-9308-0; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Waldau B, 2008, CELL MOL LIFE SCI, V65, P2372, DOI 10.1007/s00018-008-8053-y; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yu WF, 2005, EXP NEUROL, V192, P215, DOI 10.1016/j.expneurol.2004.12.015	42	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15600	10.1371/journal.pone.0015600	http://dx.doi.org/10.1371/journal.pone.0015600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179413	Green Published, Green Submitted, gold			2022-12-25	WOS:000285572900023
J	Bjork, BC; Fujiwara, Y; Davis, SW; Qiu, HY; Saunders, TL; Sandy, P; Orkin, S; Camper, SA; Beier, DR				Bjork, Bryan C.; Fujiwara, Yuko; Davis, Shannon W.; Qiu, Haiyan; Saunders, Thomas L.; Sandy, Peter; Orkin, Stuart; Camper, Sally A.; Beier, David R.			A Transient Transgenic RNAi Strategy for Rapid Characterization of Gene Function during Embryonic Development	PLOS ONE			English	Article							BEAUTY TRANSPOSON SYSTEM; SLEEPING-BEAUTY; MAMMALIAN-CELLS; LENTIVIRAL VECTORS; STEM-CELLS; MICE; INTERFERENCE; EXPRESSION; MUTATIONS; MOUSE	RNA interference (RNAi) is a powerful strategy for studying the phenotypic consequences of reduced gene expression levels in model systems. To develop a method for the rapid characterization of the developmental consequences of gene dysregulation, we tested the use of RNAi for "transient transgenic" knockdown of mRNA in mouse embryos. These methods included lentiviral infection as well as transposition using the Sleeping Beauty (SB) and PiggyBac (PB) transposable element systems. This approach can be useful for phenotypic validation of putative mutant loci, as we demonstrate by confirming that knockdown of Prdm16 phenocopies the ENU-induced cleft palate (CP) mutant, csp1. This strategy is attractive as an alternative to gene targeting in embryonic stem cells, as it is simple and yields phenotypic information in a matter of weeks. Of the three methodologies tested, the PB transposon system produced high numbers of transgenic embryos with the expected phenotype, demonstrating its utility as a screening method.	[Bjork, Bryan C.; Qiu, Haiyan; Beier, David R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Fujiwara, Yuko; Orkin, Stuart] Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Div Hematol & Oncol, Boston, MA 02115 USA; [Davis, Shannon W.; Saunders, Thomas L.; Camper, Sally A.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Davis, Shannon W.; Saunders, Thomas L.; Camper, Sally A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Sandy, Peter] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT)	Bjork, BC (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA.	beier@receptor.med.harvard.edu		Saunders, Thom/0000-0003-2015-101X; Camper, Sally/0000-0001-8556-3379	University of Michigan Cancer Center (National Institutes of Health (NIH)) [CA46592]; University of Michigan Multipurpose Arthritis Center (NIH) [AR20557]; University of Michigan Center for Organogenesis; University of Michigan Gut Peptide Research Center (NIH) [DK34933]; University of Michigan Nathan Shock Center for the Biology of Aging (NIH) [P30AG013283]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000815]; NIH [R01HD34283, R37HD30428];  [F32HD045066];  [K12DE014528];  [RO1HD36404];  [R01MH081187]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036404, R01HD034283] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD045066, R37HD030428] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K12DE014528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	University of Michigan Cancer Center (National Institutes of Health (NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Multipurpose Arthritis Center (NIH)(University of Michigan SystemUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Center for Organogenesis(University of Michigan System); University of Michigan Gut Peptide Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Nathan Shock Center for the Biology of Aging (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Core support was provided by the University of Michigan Cancer Center (National Institutes of Health (NIH) grant CA46592), the University of Michigan Multipurpose Arthritis Center (NIH grant AR20557), the University of Michigan Center for Organogenesis, the University of Michigan Gut Peptide Research Center (NIH grant DK34933), the University of Michigan Nathan Shock Center for the Biology of Aging (NIH grant P30AG013283), and the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000815). SW Davis and SA Camper were supported by NIH grants R01HD34283 and R37HD30428. BC Bjork was supported by F32HD045066 and K12DE014528. BC Bjork, H Qiu, and DR Beier were supported by RO1HD36404 and R01MH081187. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2006, HUM MOL GENET, V15, pR75, DOI 10.1093/hmg/ddl061; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Geurts AM, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-30; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heggestad AD, 2004, BIOCHEM BIOPH RES CO, V316, P643, DOI 10.1016/j.bbrc.2004.02.090; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Ikeda R, 2007, MOL CELL BIOL, V27, P1665, DOI 10.1128/MCB.01500-06; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Kirilov M, 2007, TRANSGENIC RES, V16, P783, DOI 10.1007/s11248-007-9119-6; Makinen PI, 2006, J GENE MED, V8, P433, DOI 10.1002/jgm.860; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miskey C, 2005, CELL MOL LIFE SCI, V62, P629, DOI 10.1007/s00018-004-4232-7; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Nagy A., 2003, MANIPULATING MOUSE E; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Park CW, 2005, GENES CELLS, V10, P763, DOI 10.1111/j.1365-2443.2005.00875.x; Park F, 2007, PHYSIOL GENOMICS, V31, P159, DOI 10.1152/physiolgenomics.00069.2007; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sager JJ, 2010, BRAIN STRUCT FUNCT, V214, P285, DOI 10.1007/s00429-009-0237-1; Sandy P, 2005, BIOTECHNIQUES, V39, P215, DOI 10.2144/05392RV01; Singer O, 2006, NAT PROTOC, V1, P286, DOI 10.1038/nprot.2006.44; Wang N, 2007, J BIOMED SCI, V14, P767, DOI 10.1007/s11373-007-9189-8; Wilber A, 2006, MOL THER, V13, P625, DOI 10.1016/j.ymthe.2005.10.014; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yu Q, 2004, DEVELOPMENT, V131, P6211, DOI 10.1242/dev.01543; Yusa K, 2004, MOL CELL BIOL, V24, P4004, DOI 10.1128/MCB.24.9.4004-4018.2004; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219	42	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14375	10.1371/journal.pone.0014375	http://dx.doi.org/10.1371/journal.pone.0014375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179568	Green Published, Green Submitted, gold			2022-12-25	WOS:000285381200016
J	Reiner, JE; Kishore, RB; Levin, BC; Albanetti, T; Boire, N; Knipe, A; Helmerson, K; Deckman, KH				Reiner, Joseph E.; Kishore, Rani B.; Levin, Barbara C.; Albanetti, Thomas; Boire, Nicholas; Knipe, Ashley; Helmerson, Kristian; Deckman, Koren Holland			Detection of Heteroplasmic Mitochondrial DNA in Single Mitochondria	PLOS ONE			English	Article							STANDARD REFERENCE MATERIAL; MTDNA GENOME; CHROMOSOME; DISEASE; MANIPULATION; ORGANIZATION; ORGANELLES; MUTATIONS; SEQUENCE	Background: Mitochondrial DNA (mtDNA) genome mutations can lead to energy and respiratory-related disorders like myoclonic epilepsy with ragged red fiber disease (MERRF), mitochondrial myopathy, encephalopathy, lactic acidosis and stroke (MELAS) syndrome, and Leber's hereditary optic neuropathy (LHON). It is not well understood what effect the distribution of mutated mtDNA throughout the mitochondrial matrix has on the development of mitochondrial-based disorders. Insight into this complex sub-cellular heterogeneity may further our understanding of the development of mitochondria-related diseases. Methodology: This work describes a method for isolating individual mitochondria from single cells and performing molecular analysis on that single mitochondrion's DNA. An optical tweezer extracts a single mitochondrion from a lysed human HL-60 cell. Then a micron-sized femtopipette tip captures the mitochondrion for subsequent analysis. Multiple rounds of conventional DNA amplification and standard sequencing methods enable the detection of a heteroplasmic mixture in the mtDNA from a single mitochondrion. Significance: Molecular analysis of mtDNA from the individually extracted mitochondrion demonstrates that a heteroplasmy is present in single mitochondria at various ratios consistent with the 50/50 heteroplasmy ratio found in single cells that contain multiple mitochondria.	[Reiner, Joseph E.; Kishore, Rani B.; Helmerson, Kristian] NIST, Phys Measurement Lab, Gaithersburg, MD 20899 USA; [Levin, Barbara C.] NIST, Mat Measurement Lab, Gaithersburg, MD 20899 USA; [Albanetti, Thomas; Boire, Nicholas; Knipe, Ashley; Deckman, Koren Holland] Gettysburg Coll, Dept Chem, Gettysburg, PA 17325 USA	National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; Gettysburg College	Reiner, JE (corresponding author), NIST, Phys Measurement Lab, Gaithersburg, MD 20899 USA.	joseph.reiner@nist.gov	Helmerson, Kristian/E-3683-2013; Reiner, Joseph/B-7893-2013	Helmerson, Kristian/0000-0002-6387-0949; Reiner, Joseph/0000-0002-1056-8703				Agarwal A, 2007, ANAL CHEM, V79, P3589, DOI 10.1021/ac062049e; Agarwal R, 2005, OPT EXPRESS, V13, P8906, DOI 10.1364/OPEX.13.008906; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ASHKIN A, 1990, NATURE, V348, P346, DOI 10.1038/348346a0; BERNS MW, 1989, P NATL ACAD SCI USA, V86, P4539, DOI 10.1073/pnas.86.12.4539; Butler JM, 1998, TRENDS BIOTECHNOL, V16, P158, DOI 10.1016/S0167-7799(98)01173-1; Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen Y, 2007, ELECTROPHORESIS, V28, P2406, DOI 10.1002/elps.200600628; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Dahl HHM, 2001, AM J MED GENET, V106, P1, DOI 10.1002/ajmg.1427; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dufresne ER, 2001, REV SCI INSTRUM, V72, P1810, DOI 10.1063/1.1344176; Fuller KM, 2003, CURR OPIN BIOTECH, V14, P35, DOI 10.1016/S0958-1669(02)00008-3; Gertz EM, 2005, BLAST SCORING PARAME; Greaves LC, 2006, IUBMB LIFE, V58, P143, DOI 10.1080/15216540600686888; Jeffries GDM, 2007, NANO LETT, V7, P415, DOI 10.1021/nl0626784; Kuroiwa T, 1996, PROTOPLASMA, V194, P275, DOI 10.1007/BF01882033; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Levin BC, 2003, MITOCHONDRION, V2, P387, DOI 10.1016/S1567-7249(03)00010-2; Levin BC, 1999, GENOMICS, V55, P135, DOI 10.1006/geno.1998.5513; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Nambiar R, 2002, OPT LETT, V27, P836, DOI 10.1364/OL.27.000836; Niu H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000774; Pauzauskie PJ, 2006, NAT MATER, V5, P97, DOI 10.1038/nmat1563; Poe BG, 2010, ANAL BIOANAL CHEM, V397, P3397, DOI 10.1007/s00216-010-3751-3; Resnick A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316378; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Shelby JP, 2005, PHOTOCHEM PHOTOBIOL, V81, P994, DOI 10.1562/2005-02-02-RA-431R1.1; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Tang H, 2007, OPT EXPRESS, V15, P12708, DOI 10.1364/OE.15.012708; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VOROBJEV IA, 1993, BIOPHYS J, V64, P533, DOI 10.1016/S0006-3495(93)81398-5; Wang HW, 2004, J OPT A-PURE APPL OP, V6, P89, DOI 10.1088/1464-4258/6/1/016; Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113	38	20	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14359	10.1371/journal.pone.0014359	http://dx.doi.org/10.1371/journal.pone.0014359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179558	gold, Green Published			2022-12-25	WOS:000285381200009
J	Yi, Y; Ma, Y; Gao, F; Mao, XH; Peng, H; Feng, YJ; Fan, Z; Wang, GH; Guo, G; Yan, JH; Zeng, H; Zou, QM; Gao, GF				Yi, Yong; Ma, Ying; Gao, Feng; Mao, Xuhu; Peng, Hao; Feng, Youjun; Fan, Zheng; Wang, Guihua; Guo, Gang; Yan, Jinghua; Zeng, Hao; Zou, Quanming; Gao, George F.			Crystal Structure of EHEC Intimin: Insights into the Complementarity between EPEC and EHEC	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; TIR; RECEPTOR; O157-H7; CRYSTALLIZATION; RECOGNITION; ATTACHMENT; EVOLUTION; INFECTION; ADHESION	Enterohaemorrhagic E. coli (EHEC) O157:H7 is a primary food-borne bacterial pathogen capable of causing life-threatening human infections which poses a serious challenge to public health worldwide. Intimin, the bacterial outer-membrane protein, plays a key role in the initiating process of EHEC infection. This activity is dependent upon translocation of the intimin receptor (Tir), the intimin binding partner of the bacteria-encoded host cell surface protein. Intimin has attracted considerable attention due to its potential function as an antibacterial drug target. Here, we report the crystal structure of the Tir-binding domain of intimin (Int188) from E. coli O157: H7 at 2.8 angstrom resolution, together with a mutant (IntN916Y) at 2.6 angstrom. We also built the structural model of EHEC intimin-Tir complex and analyzed the key binding residues. It suggested that the binding pattern of intimin and Tir between EHEC and Enteropathogenic E. coli (EPEC) adopt a similar mode and they can complement with each other. Detailed structural comparison indicates that there are four major points of structural variations between EHEC and EPEC intimins: one in Domain I (Ig-like domain), the other three located in Domain II (C-type lectin-like domain). These variations result in different binding affinities. These findings provide structural insight into the binding pattern of intimin to Tir and the molecular mechanism of EHEC O157: H7.	[Yi, Yong; Ma, Ying; Mao, Xuhu; Guo, Gang; Zeng, Hao; Zou, Quanming] Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Clin Immunol, Chongqing, Peoples R China; [Ma, Ying; Peng, Hao; Feng, Youjun; Fan, Zheng; Wang, Guihua; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Yi, Yong] 306th Hosp PLA, Beijing, Peoples R China; [Feng, Youjun; Wang, Guihua] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Yi, Yong; Peng, Hao; Feng, Youjun; Fan, Zheng; Wang, Guihua; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Mol Microbiol, Beijing, Peoples R China; [Gao, Feng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Army Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences	Yi, Y (corresponding author), Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Clin Immunol, Chongqing, Peoples R China.	qmzou@mail.tmmu.com.cn; gaof@im.ac.cn	Gao, George Fu/ABD-5229-2021; Feng, Youjun/I-4134-2012		National Natural Science Foundation of China (NSFC) [30670167, 30770514]; China-Japan Joint Laboratory of Molecular Immunology and Molecular Microbiology; Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology)	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China-Japan Joint Laboratory of Molecular Immunology and Molecular Microbiology; Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from National Natural Science Foundation of China (NSFC) (30670167 and 30770514). The China-Japan Joint Laboratory of Molecular Immunology and Molecular Microbiology is, in part, supported by Japan MEXT (Ministry of Education, Culture, Sports, Science and Technology). GFG is a leading principal investigator of the NSFC Innovative Research Group (81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Bobie J, 1998, J CLIN MICROBIOL, V36, P662, DOI 10.1128/JCM.36.3.662-668.1998; Babol-Pokora Katarzyna, 2009, Arch Med Sadowej Kryminol, V59, P118; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batchelor M, 2000, EMBO J, V19, P2452, DOI 10.1093/emboj/19.11.2452; Bell C, 2002, INT J FOOD MICROBIOL, V78, P197, DOI 10.1016/S0168-1605(02)00188-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Celli J, 2000, CELL MICROBIOL, V2, P1, DOI 10.1046/j.1462-5822.2000.00033.x; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; HENDERSON S, AUST N Z J PSYCHIAT, V44, P1; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; Kenny B, 1999, MOL MICROBIOL, V31, P1229, DOI 10.1046/j.1365-2958.1999.01265.x; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; La Ragione RM, 2005, J MED MICROBIOL, V54, P485, DOI 10.1099/jmm.0.45897-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu H, 2002, MOL MICROBIOL, V45, P1557, DOI 10.1046/j.1365-2958.2002.03137.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mellmann A, 2005, CLIN INFECT DIS, V41, P785, DOI 10.1086/432722; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Oswald E, 2000, INFECT IMMUN, V68, P64, DOI [10.1128/IAI.68.1.64-71.2000, 10.1128/IAI.68.11.6402-6410.2000]; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Soderstrom A., 2005, EURO SURVEILL, V10; Spears KJ, 2006, FEMS MICROBIOL LETT, V255, P187, DOI 10.1111/j.1574-6968.2006.00119.x; Wang HX, 2004, ELECTROCHEM SOLID ST, V7, pA302, DOI 10.1149/1.1789831; Watanabe Y, 1999, EMERG INFECT DIS, V5, P424, DOI 10.3201/eid0503.990313; Welinder-Olsson C, 2005, SCAND J INFECT DIS, V37, P405, DOI 10.1080/00365540510038523; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; Zhou MH, 2004, ACTA CRYSTALLOGR D, V60, P1473, DOI 10.1107/S0907444904013587; 2009, CRYSTALCLEAR CRYSTAL	34	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15285	10.1371/journal.pone.0015285	http://dx.doi.org/10.1371/journal.pone.0015285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179574	Green Published, Green Submitted, gold			2022-12-25	WOS:000285381200023
J	Dauvillee, D; Delhaye, S; Gruyer, S; Slomianny, C; Moretz, SE; d'Hulst, C; Long, CA; Ball, SG; Tomavo, S				Dauvillee, David; Delhaye, Stephane; Gruyer, Sebastien; Slomianny, Christian; Moretz, Samuel E.; d'Hulst, Christophe; Long, Carole A.; Ball, Steven G.; Tomavo, Stanislas			Engineering the Chloroplast Targeted Malarial Vaccine Antigens in Chlamydomonas Starch Granules	PLOS ONE			English	Article							BLOOD-STAGE VACCINE; PLASMODIUM-FALCIPARUM; IN-VITRO; BIOSYNTHESIS; PARASITE; INVASION; AMYLOSE	Background: Malaria, an Anopheles-borne parasitic disease, remains a major global health problem causing illness and death that disproportionately affects developing countries. Despite the incidence of malaria, which remains one of the most severe infections of human populations, there is no licensed vaccine against this life-threatening disease. In this context, we decided to explore the expression of Plasmodium vaccine antigens fused to the granule bound starch synthase (GBSS), the major protein associated to the starch matrix in all starch-accumulating plants and algae such as Chlamydomonas reinhardtii. Methods and Findings: We describe the development of genetically engineered starch granules containing plasmodial vaccine candidate antigens produced in the unicellular green algae Chlamydomonas reinhardtii. We show that the C-terminal domains of proteins from the rodent Plasmodium species, Plasmodium berghei Apical Major Antigen AMA1, or Major Surface Protein MSP1 fused to the algal granule bound starch synthase (GBSS) are efficiently expressed and bound to the polysaccharide matrix. Mice were either immunized intraperitoneally with the engineered starch particles and Freund adjuvant, or fed with the engineered particles co-delivered with the mucosal adjuvant, and challenged intraperitoneally with a lethal inoculum of P. Berghei. Both experimental strategies led to a significantly reduced parasitemia with an extension of life span including complete cure for intraperitoneal delivery as assessed by negative blood thin smears. In the case of the starch bound P. falciparum GBSS-MSP1 fusion protein, the immune sera or purified immunoglobulin G of mice immunized with the corresponding starch strongly inhibited in vitro the intra-erythrocytic asexual development of the most human deadly plasmodial species. Conclusion: This novel system paves the way for the production of clinically relevant plasmodial antigens as algal starch-based particles designated herein as amylosomes, demonstrating that efficient production of edible vaccines can be genetically produced in Chlamydomonas.	[Dauvillee, David; Delhaye, Stephane; Gruyer, Sebastien; d'Hulst, Christophe; Ball, Steven G.; Tomavo, Stanislas] Univ Sci & Technol Lille, CNRS, UGSF, UMR 8576, Villeneuve Dascq, France; [Delhaye, Stephane; Tomavo, Stanislas] Univ Lille Nord France, Inst Pasteur Lille, INSERM, Ctr Infect & Immun Lille,CNRS,UMR 8204,U1019, Lille, France; [Slomianny, Christian] Univ Sci & Technol Lille, INSERM, U1003, Lab Physiol Cellulaire, Villeneuve Dascq, France; [Moretz, Samuel E.; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dauvillee, D (corresponding author), Univ Sci & Technol Lille, CNRS, UGSF, UMR 8576, Villeneuve Dascq, France.	Stan.Tomavo@pasteur-lille.fr	D'HULST, Christophe/B-2072-2012; D'Hulst, Christophe/AAX-2809-2020; Dauvillée, David/A-2174-2009; Slomianny, Christian/L-8285-2018	D'HULST, Christophe/0000-0002-5556-9099; D'Hulst, Christophe/0000-0002-5556-9099; Dauvillée, David/0000-0002-0751-9193; delhaye, stephane/0000-0001-9438-6730; Ball, Steven/0000-0003-1629-1650	Centre National de la Recherche Scientifique (CNRS); Institut Medicale de la Recherche Scientifique (INSERM); Institut Pasteur de Lille (IPL); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Medicale de la Recherche Scientifique (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur de Lille (IPL); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the Centre National de la Recherche Scientifique (CNRS), Institut Medicale de la Recherche Scientifique (INSERM) and the Institut Pasteur de Lille (IPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SG, 1998, TRENDS PLANT SCI, V3, P462, DOI 10.1016/S1360-1385(98)01342-9; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Bock R, 2010, TRENDS BIOTECHNOL, V28, P246, DOI 10.1016/j.tibtech.2010.01.006; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; DELRUE B, 1992, J BACTERIOL, V174, P3612, DOI 10.1128/JB.174.11.3612-3620.1992; Dzierszinski F, 2002, ANTIMICROB AGENTS CH, V46, P3197, DOI 10.1128/AAC.46.10.3197-3207.2002; Ellis RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008787; Gonzalez A, 2009, AM J TROP MED HYG, V81, P595, DOI 10.4269/ajtmh.2009.08-0637; Good MF, 2001, NAT REV IMMUNOL, V1, P117, DOI 10.1038/35100540; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; KINDLE K, 1990, GENETICS, V87, P1228; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Ral JP, 2006, PLANT PHYSIOL, V142, P305, DOI 10.1104/pp.106.081885; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Schroda M, 2002, PLANT J, V31, P445, DOI 10.1046/j.1365-313X.2002.01371.x; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093; van de Wal M, 1998, J BIOL CHEM, V273, P22232, DOI 10.1074/jbc.273.35.22232; VandenKoornhuyse N, 1996, J BIOL CHEM, V271, P16281, DOI 10.1074/jbc.271.27.16281; Warzecha H, 2003, J VIROL, V77, P8702, DOI 10.1128/JVI.77.16.8702-8711.2003; Wattebled F, 2002, EUR J BIOCHEM, V269, P3810, DOI 10.1046/j.1432-1033.2002.03072.x; World Health Organization, 2008, WORLD MAL REP	34	58	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15424	10.1371/journal.pone.0015424	http://dx.doi.org/10.1371/journal.pone.0015424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179538	Green Published, Green Submitted, gold			2022-12-25	WOS:000285340000025
J	Shegarfi, H; Naper, C; Rolstad, B; Inngjerdingen, M				Shegarfi, Hamid; Naper, Christian; Rolstad, Bent; Inngjerdingen, Marit			Listeria monocytogenes Infection Affects a Subset of Ly49-Expressing NK Cells in the Rat	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ENCODED TARGET LIGANDS; NECROSIS-FACTOR-ALPHA; MONOCLONAL-ANTIBODY; INTERFERON-GAMMA; IMMUNE-RESPONSES; 2 COMPLEMENTARY; LY49 RECEPTORS; GENE-COMPLEX; MICE	NK cells are protective against certain bacterial and viral infections, and their production of IFN-gamma is important for the early innate immune defence against L. monocytogenes. We have previously shown that depletion of NK cells in rats leads to increased bacterial burden upon L. monocytogenes infection, and that a subset of NK cells encompassing the majority of Ly49 receptors (Ly49s3(+) NK cells) contributed to this effect. In this study, we have further investigated how the Ly49s3(+) NK cell subset is affected by L. monocytogenes infection. We observed an increased percentage of Ly49s3(+) NK cells in the spleen and a reduction in the bone marrow within the first 48 hrs of L. monocytogenes infection. Concomitantly, we observed increased expression levels of the inflammatory chemokine receptors CCR5 and CXCR3 by Ly49s3(+) bone marrow NK cells, as compared to Ly49s3(-) NK cells, suggesting involvement of Ly49s3(+) NK cells in the early phase of infection. However, NK cell production of IFN-gamma was independent of Ly49 receptor expression. Furthermore, we observed increased expression levels of MHC class I molecules on both macrophages and NK cells during the first 48 hrs of infection, paralleled by a reduction in the surface expression of Ly49s3 on NK cells. In conclusion, L. monocytogenes infection modulates the tissue distribution of Ly49s3(+) NK cells, and induces increased MHC class I expression and hence reduced surface expression of Ly49 receptors on NK cells. These changes indicate that L. monocytogenes infection may have multiple effects on NK cells in vivo, and suggests the involvement of Ly49-expressing NK cells in the immune responses towards L. monocytogenes.	[Shegarfi, Hamid; Rolstad, Bent] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway; [Naper, Christian; Inngjerdingen, Marit] Univ Oslo, Rikshosp, Inst Immunol, N-0027 Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway	Shegarfi, H (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway.	marit.inngjerdingen@rr-research.no		Naper, Christian/0000-0002-2435-3615; Shegarfi, Hamid/0000-0002-5782-9026	Research Council of Norway; Norwegian Cancer Society	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from The Research Council of Norway (www.forskningsradet.no) and The Norwegian Cancer Society (www.kreftforeningen.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANCROFT GJ, 1991, IMMUNOL REV, V124, P5, DOI 10.1111/j.1600-065X.1991.tb00613.x; Bernardini G, 2008, BLOOD, V111, P3626, DOI 10.1182/blood-2007-08-106203; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Bubonja M, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/54202; CHAMBERS WH, 1989, J EXP MED, V169, P1373, DOI 10.1084/jem.169.4.1373; CHANG RJ, 1986, J IMMUNOL, V137, P2853; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; CZUPRYNSKI CJ, 1994, J IMMUNOL, V152, P1836; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Flesch IEA, 1998, INT IMMUNOL, V10, P757, DOI 10.1093/intimm/10.6.757; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; HUMANN J, 2010, J IMMUNOL; Ing R, 2009, INFECT IMMUN, V77, P770, DOI 10.1128/IAI.00994-08; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kase A, 1998, J IMMUNOL, V161, P6133; KING DP, 1983, J IMMUNOL, V131, P315; Kveberg L, 2006, IMMUNOGENETICS, V58, P905, DOI 10.1007/s00251-006-0154-x; Kveberg L, 2006, J IMMUNOL, V176, P4133, DOI 10.4049/jimmunol.176.7.4133; Kveberg L, 2010, J LEUKOCYTE BIOL, V88, P87, DOI 10.1189/jlb.0110039; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lapaque N, 2009, J IMMUNOL, V182, P4339, DOI 10.4049/jimmunol.0803329; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lobigs M, 2003, IMMUNOL CELL BIOL, V81, P217, DOI 10.1046/j.1440-1711.2003.01161.x; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; MCKNIGHT AJ, 1992, IMMUNOLOGY, V75, P286; Naper C, 2005, J IMMUNOL, V174, P2702, DOI 10.4049/jimmunol.174.5.2702; Naper C, 2002, J IMMUNOL, V169, P22, DOI 10.4049/jimmunol.169.1.22; Naper C, 2002, EUR J IMMUNOL, V32, P2031, DOI 10.1002/1521-4141(200207)32:7<2031::AID-IMMU2031>3.0.CO;2-H; Nylenna O, 2005, EUR J IMMUNOL, V35, P261, DOI 10.1002/eji.200425429; OlssonAlheim MY, 1997, J IMMUNOL, V159, P3189; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; RUITENBERG EJ, 1976, BRIT J EXP PATHOL, V57, P310; Salazar-Mather TP, 1998, J EXP MED, V187, P1, DOI 10.1084/jem.187.1.1; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Shegarfi H, 2009, SCAND J IMMUNOL, V70, P238, DOI 10.1111/j.1365-3083.2009.02292.x; TAUB DD, 1995, J IMMUNOL, V155, P3877; TRIPP CS, 1993, P NATL ACAD SCI USA, V90, P3725, DOI 10.1073/pnas.90.8.3725; Unanue ER, 1997, CURR OPIN IMMUNOL, V9, P35, DOI 10.1016/S0952-7915(97)80156-2; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Westgaard IH, 2004, J LEUKOCYTE BIOL, V76, P1200, DOI 10.1189/jlb.0903428; Zeng XY, 2003, INFECT IMMUN, V71, P1306, DOI 10.1128/IAI.71.3.1306-1315.2003; Zhong MX, 2004, INFECT IMMUN, V72, P1057, DOI 10.1128/IAI.72.2.1057-1064.2004	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15579	10.1371/journal.pone.0015579	http://dx.doi.org/10.1371/journal.pone.0015579			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179539	gold, Green Published, Green Submitted			2022-12-25	WOS:000285340000028
J	Nazir, A; Sammi, SR; Singh, P; Tripathi, RK				Nazir, Aamir; Sammi, Shreesh Raj; Singh, Pankaj; Tripathi, Raj Kamal			Trans-Cellular Introduction of HIV-1 Protein Nef Induces Pathogenic Response in Caenorhabditis elegans	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DOWN-REGULATION; MHC-I; COMPLEX; ACTIVATION; BINDING; FAMILY; CD4; LIPODYSTROPHY; TRANSCRIPTION	Background: Caenorhabditis elegans has emerged as a very powerful model for studying the host pathogen interactions. Despite the absence of a naturally occurring viral infection for C. elegans, the model is now being exploited experimentally to study the basic aspects of virus-host interplay. The data generated from recent studies suggests that the virus that infects mammalian cells does infect, replicate and accumulate in C. elegans. Methodology/Principal Findings: We took advantage of the easy-to-achieve protein introduction in C. elegans and employing the methodology, we administered HIV-1 protein Nef into live worms. Nef is known to be an important protein for exacerbating HIV-1 pathogenesis in host by enhancing viral replication. The deletion of nef from the viral genome has been reported to inhibit its replication in the host, thereby leading to delayed pathogenesis. Our studies, employing Nef introduction into C. elegans, led to creation of an in-vivo model that allowed us to study, whether or not, the protein induces effect in the whole organism. We observed a marked lipodystrophy, effect on neuromuscular function, impaired fertility and reduced longevity in the worms exposed to Nef. The observed effects resemble to those observed in Nef transgenic mice and most interestingly the effects also relate to some of the pathogenic aspects exhibited by human AIDS patients. Conclusions/Significance: Our studies underline the importance of this in vivo model for studying the interactions of Nef with host proteins, which could further be used for identifying possible inhibitors of such interactions.	[Nazir, Aamir; Sammi, Shreesh Raj] Cent Drug Res Inst, Div Toxicol, Lab Funct Genom & Mol Toxicol, CSIR, Lucknow 226001, Uttar Pradesh, India; [Singh, Pankaj; Tripathi, Raj Kamal] Cent Drug Res Inst, Div Toxicol, Lab Immunotoxicol, CSIR, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Nazir, A (corresponding author), Cent Drug Res Inst, Div Toxicol, Lab Funct Genom & Mol Toxicol, CSIR, Lucknow 226001, Uttar Pradesh, India.	anazir@cdri.res.in; rk_tripathi@cdri.res.in	Sammi, Shreesh Raj/AAA-1591-2019	Nazir, Aamir/0000-0002-2503-1335; Raj Sammi, Shreesh/0000-0003-4163-8628	Council of Scientific and Industrial Research Network Project [NWP 0034]; Department of Science and Technology [0050/2009]	Council of Scientific and Industrial Research Network Project(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India))	The study was supported by funds from Council of Scientific and Industrial Research Network Project (NWP 0034) and Department of Science and Technology (0050/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOPAIN K, 2006, J VIROL, V6, P3050; Arora VK, 2000, J VIROL, V74, P11081, DOI 10.1128/JVI.74.23.11081-11087.2000; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Atkins KM, 2008, J BIOL CHEM, V283, P11772, DOI 10.1074/jbc.M707572200; Balasubramanyam A, 2007, AM J PHYSIOL-ENDOC M, V292, pE40, DOI 10.1152/ajpendo.00163.2006; Baumeister R, 2002, TRENDS BIOTECHNOL, V20, P147, DOI 10.1016/S0167-7799(01)01925-4; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Betzi S, 2007, P NATL ACAD SCI USA, V104, P19256, DOI 10.1073/pnas.0707130104; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; BRENNER S, 1974, GENETICS, V77, P71; Brey CW, 2009, INT J BIOL SCI, V5, P622; Carr A, 2003, AIDS, V17, pS141, DOI 10.1097/00002030-200304001-00017; Coleman SH, 2005, J VIROL, V79, P2066, DOI 10.1128/JVI.79.4.2066-2078.2005; Delom F, 2007, BIOCHEM BIOPH RES CO, V352, P587, DOI 10.1016/j.bbrc.2006.11.046; Dhawan R, 1999, J TOXICOL ENV HEAL A, V58, P451, DOI 10.1080/009841099157179; Duerr Janet S, 2006, WormBook, P1; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Gorry PR, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-66; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Hanna Z, 1998, J VIROL, V72, P121, DOI 10.1128/JVI.72.1.121-132.1998; Hanna Z, 2006, VIROLOGY, V346, P40, DOI 10.1016/j.virol.2005.10.010; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Valdes-Ferrer SI, 2009, AIDS RES HUM RETROV, V25, P749, DOI 10.1089/aid.2008.0257; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KIRCHHOFF F, 2002, IMMUNITY, V16, P493; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lindwasser OW, 2008, J VIROL, V82, P1166, DOI 10.1128/JVI.01874-07; Liu WH, 2006, P NATL ACAD SCI USA, V103, P4174, DOI 10.1073/pnas.0506442103; Martinez E, 2001, LANCET, V357, P592, DOI 10.1016/S0140-6736(00)04056-3; NEILL EO, 2006, J VIROL, V80, P1311; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Pulkkinen K, 2004, J VIROL, V78, P12773, DOI 10.1128/JVI.78.23.12773-12780.2004; Raney A, 2005, J VIROL, V79, P12732, DOI 10.1128/JVI.79.20.12732-12741.2005; Rauch S, 2008, J VIROL, V82, P2918, DOI 10.1128/JVI.02185-07; Renkema GH, 1999, CURR BIOL, V9, P1407, DOI 10.1016/S0960-9822(00)80086-X; Ruan QL, 2009, J TOXICOL ENV HEAL A, V72, P746, DOI 10.1080/15287390902841532; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shaham S, 2006, P NATL ACAD SCI USA, V103, P3955, DOI 10.1073/pnas.0600779103; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Stiernagle T., 1999, C ELEGANS PRACTICAL, P51; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Ye HH, 2004, BIOCHEMISTRY-US, V43, P15775, DOI 10.1021/bi048712f; Zhang J, 2009, EXP CELL RES, V315, P2568, DOI 10.1016/j.yexcr.2009.04.025; Zheng YH, 2001, CURR BIOL, V11, P875, DOI 10.1016/S0960-9822(01)00237-8	53	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15312	10.1371/journal.pone.0015312	http://dx.doi.org/10.1371/journal.pone.0015312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179446	Green Published, Green Submitted, gold			2022-12-25	WOS:000285246900043
J	Spin, JM; Quertermous, T; Tsao, PS				Spin, Joshua M.; Quertermous, Thomas; Tsao, Philip S.			Chromatin Remodeling Pathways in Smooth Muscle Cell Differentiation, and Evidence for an Integral Role for p300	PLOS ONE			English	Article							CREB-BINDING PROTEIN; HISTONE ACETYLTRANSFERASE ACTIVITY; SERUM RESPONSE FACTOR; GENE-EXPRESSION; IN-VITRO; ALPHA-ACTIN; LYSINE 9; TRANSCRIPTION; ACETYLATION; METHYLATION	Background: Phenotypic alteration of vascular smooth muscle cells (SMC) in response to injury or inflammation is an essential component of vascular disease. Evidence suggests that this process is dependent on epigenetic regulatory processes. P300, a histone acetyltransferase (HAT), activates crucial muscle-specific promoters in terminal (non-SMC) myocyte differentiation, and may be essential to SMC modulation as well. Results: We performed a subanalysis examining transcriptional time-course microarray data obtained using the A404 model of SMC differentiation. Numerous chromatin remodeling genes (up to 62% of such genes on our array platform) showed significant regulation during differentiation. Members of several chromatin-remodeling families demonstrated involvement, including factors instrumental in histone modification, chromatin assembly-disassembly and DNA silencing, suggesting complex, multi-level systemic epigenetic regulation. Further, trichostatin A, a histone deacetylase inhibitor, accelerated expression of SMC differentiation markers in this model. Ontology analysis indicated a high degree of p300 involvement in SMC differentiation, with 60.7% of the known p300 interactome showing significant expression changes. Knockdown of p300 expression accelerated SMC differentiation in A404 cells and human SMCs, while inhibition of p300 HAT activity blunted SMC differentiation. The results suggest a central but complex role for p300 in SMC phenotypic modulation. Conclusions: Our results support the hypothesis that chromatin remodeling is important for SMC phenotypic switching, and detail wide-ranging involvement of several epigenetic modification families. Additionally, the transcriptional coactivator p300 may be partially degraded during SMC differentiation, leaving an activated subpopulation with increased HAT activity and SMC differentiation-gene specificity.	[Spin, Joshua M.; Quertermous, Thomas; Tsao, Philip S.] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Stanford University	Spin, JM (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	jspin@cvmed.stanford.edu		Spin, Joshua/0000-0002-4256-9161; Quertermous, Thomas/0000-0002-7645-9067	NIH [5K08 HL080567]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL080567] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by NIH grant 5K08 HL080567. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Brouillard F, 2003, J BIOL CHEM, V278, P39509, DOI 10.1074/jbc.M307123200; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dietze EC, 2003, BIOCHEM BIOPH RES CO, V302, P841, DOI 10.1016/S0006-291X(03)00266-3; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Goodman RH, 2000, GENE DEV, V14, P1553; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Marmorstein R, 2001, NAT REV MOL CELL BIO, V2, P422, DOI 10.1038/35073047; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Minucci S, 1997, P NATL ACAD SCI USA, V94, P11295, DOI 10.1073/pnas.94.21.11295; Okamoto H, 2006, J ATHEROSCLER THROMB, V13, P183, DOI 10.5551/jat.13.183; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Partanen M, 1999, INT J DEV BIOL, V43, P487; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Qiu P, 2006, BIOCHEM BIOPH RES CO, V348, P351, DOI 10.1016/j.bbrc.2006.07.009; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; Richon VM, 2004, METHOD ENZYMOL, V376, P199; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sagar V, 2004, BIOORGAN MED CHEM, V12, P3383, DOI 10.1016/j.bmc.2004.03.070; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Spin JM, 2004, PHYSIOL GENOMICS, V19, P292, DOI 10.1152/physiolgenomics.00148.2004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wada H, 2000, J BIOL CHEM, V275, P25330, DOI 10.1074/jbc.M000828200; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang SX, 2005, J BIOL CHEM, V280, P6204, DOI 10.1074/jbc.M409506200; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zheng YJ, 2005, J AM CHEM SOC, V127, P17182, DOI 10.1021/ja0558544; Zheng YJ, 2004, METHOD ENZYMOL, V376, P188	61	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14301	10.1371/journal.pone.0014301	http://dx.doi.org/10.1371/journal.pone.0014301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179216	gold, Green Submitted, Green Published			2022-12-25	WOS:000285246900013
J	Mandal, CC; Ghosh-Choudhury, N; Yoneda, T; Choudhury, GG; Ghosh-Choudhury, N				Mandal, Chandi Charan; Ghosh-Choudhury, Nayana; Yoneda, Toshi; Choudhury, Goutam Ghosh; Ghosh-Choudhury, Nandini			Simvastatin Prevents Skeletal Metastasis of Breast Cancer by an Antagonistic Interplay between p53 and CD44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-LINES; STEM-CELLS; LUNG METASTASIS; ANTICANCER AGENTS; BINDING PROTEIN; BONE METASTASES; MUTANT P53; EXPRESSION; GROWTH	Substantial data from clinical trials and epidemiological studies show promising results for use of statins in many cancers, including mammary carcinoma. Breast tumor primarily metastasizes to bone to form osteolytic lesions, causing severe pain and pathological fracture. Here, we report that simvastatin acts as an inhibitor of osteolysis in a mouse model of breast cancer skeletal metastasis of human mammary cancer cell MDA-MB-231, which expresses the mutant p53R280K. Simvastatin and lovastatin attenuated migration and invasion of MDA-MB- 231 and BT-20 breast tumor cells in culture. Acquisition of phenotype to express the cancer stem cell marker, CD44, leads to invasive potential of the tumor cells. Interestingly, statins significantly decreased the expression of CD44 protein via a transcriptional mechanism. shRNA-mediated down-regulation of CD44 markedly reduced the migration and invasion of breast cancer cells in culture. We identified that in the MDA-MB-231 cells, simvastatin elevated the levels of mutated p53R280K, which was remarkably active as a transcription factor. shRNA-derived inhibition of mutant p53R280K augmented the expression of CD44, leading to increased migration and invasion. Finally, we demonstrate an inverse correlation between expression of p53 and CD44 in the tumors of mice that received simvastatin. Our results reveal a unique function of statins, which foster enhanced expression of mutant p53R280K to prevent breast cancer cell metastasis to bone.	[Yoneda, Toshi; Choudhury, Goutam Ghosh; Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Mandal, Chandi Charan; Ghosh-Choudhury, Nayana; Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu; choudhury@uthscsa.edu		Mandal, Chandi/0000-0002-2292-6635	National Institutes of Health [RO1 AR52425, ROI DK50190]; Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AR52425 (to N.G.-C.) and ROI DK50190 (to G.G.C.) This work was also supported by Veterans Affairs merit review grants (to N.G.-C. and G.G.C.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bange J, 2002, CANCER RES, V62, P840; Barbour AP, 2003, CANCER RES, V63, P887; Beck P, 2003, J CLIN EPIDEMIOL, V56, P280, DOI 10.1016/S0895-4356(02)00614-5; Brazda V, 2006, BIOCHEM BIOPH RES CO, V351, P499, DOI 10.1016/j.bbrc.2006.10.065; Cauley JA, 2003, J WOMENS HEALTH, V12, P749, DOI 10.1089/154099903322447710; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chu MC, 2004, CANCER BIOL THER, V3, P568, DOI 10.4161/cbt.3.6.848; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Concin N, 2003, BREAST CANCER RES TR, V79, P37, DOI 10.1023/A:1023351717408; Damm S, 2010, J INVEST DERMATOL, V130, P1893, DOI 10.1038/jid.2010.45; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Edwards DR, 1998, NATURE, V394, P527, DOI 10.1038/28961; Evan GI, 2008, CANCER CELL, V14, P108, DOI 10.1016/j.ccr.2008.07.012; Fitzgerald KA, 1999, J IMMUNOL, V162, P4920; Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200; Ghosh-Choudhury N, 2006, J BIOL CHEM, V281, P20160, DOI 10.1074/jbc.M511071200; Ghosh-Choudhury N, 2010, CELL SIGNAL, V22, P749, DOI 10.1016/j.cellsig.2009.12.010; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gordon LA, 2003, INT J CANCER, V106, P8, DOI 10.1002/ijc.11172; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; HARVEY M, 1995, NAT GENET, V9, P305, DOI 10.1038/ng0395-305; Hayes DF, 2007, NEW ENGL J MED, V357, P1496, DOI 10.1056/NEJMoa071167; Hiraga T, 2001, CANCER RES, V61, P4418; HSIAO M, 1994, AM J PATHOL, V145, P702; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Mandal CC, 2009, ENDOCRINOLOGY, V150, P4989, DOI 10.1210/en.2009-0026; Mandal CC, 2010, CALCIFIED TISSUE INT, V87, P533, DOI 10.1007/s00223-010-9419-3; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Monti P, 2002, ONCOGENE, V21, P1641, DOI 10.1038/sj.onc.1205250; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakamura H, 2008, J BONE MINER METAB, V26, P642, DOI 10.1007/s00774-008-0857-1; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; OConnor PM, 1997, CANCER RES, V57, P4285; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Ouhtit A, 2007, AM J PATHOL, V171, P2033, DOI 10.2353/ajpath.2007.070535; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Rao S, 1999, P NATL ACAD SCI USA, V96, P7797, DOI 10.1073/pnas.96.14.7797; Recio JA, 2003, CANCER RES, V63, P1576; Ries L., 2005, SEER CANC STAT REV 1; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toy EP, 2005, CLIN EXP METASTAS, V22, P1, DOI 10.1007/s10585-005-0718-4; Ukomadu C, 2003, J BIOL CHEM, V278, P43586, DOI 10.1074/jbc.M307194200; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Weber GF, 2008, CANCER LETT, V270, P181, DOI 10.1016/j.canlet.2008.04.030; Weber GF, 2002, CANCER RES, V62, P2281; Weinberg RA, 2008, NAT CELL BIOL, V10, P1021, DOI 10.1038/ncb0908-1021; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Wu JH, 2004, CANCER RES, V64, P6461, DOI 10.1158/0008-5472.CAN-04-0866; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	71	88	91	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11314	11327		10.1074/jbc.M110.193714	http://dx.doi.org/10.1074/jbc.M110.193714			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21199873	Green Published, hybrid			2022-12-25	WOS:000288797100044
J	Santos-Aberturas, J; Vicente, CM; Guerra, SM; Payero, TD; Martin, JF; Aparicio, JF				Santos-Aberturas, Javier; Vicente, Claudia M.; Guerra, Susana M.; Payero, Tamara D.; Martin, Juan F.; Aparicio, Jesus F.			Molecular Control of Polyene Macrolide Biosynthesis DIRECT BINDING OF THE REGULATOR PimM TO EIGHT PROMOTERS OF PIMARICIN GENES AND IDENTIFICATION OF BINDING BOXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUORUM-SENSING REGULATOR; STREPTOMYCES-NATALENSIS; ANTIBIOTIC BIOSYNTHESIS; PIMARICIN BIOSYNTHESIS; GENE-CLUSTER; CHOLESTEROL OXIDASES; POSITIVE REGULATOR; TARGET PROMOTERS; SEQUENCE LOGOS; BINDING	Control of polyene macrolide production in Streptomyces natalensis is mediated by the transcriptional activator PimM. This regulator, which combines an N-terminal PAS domain with a C-terminal helix-turn-helix motif, is highly conserved among polyene biosynthetic gene clusters. PimM, truncated forms of the protein without the PAS domain (PimM(Delta PAS)), and forms containing just the DNA-binding domain (DBD) (PimM(DBD)) were overexpressed in Escherichia coli as GST-fused proteins. GST-PimM binds directly to eight promoters of the pimaricin cluster, as demonstrated by electrophoretic mobility shift assays. Assays with truncated forms of the protein revealed that the PAS domain does not mediate specificity or the distinct recognition of target genes, which rely on the DBD domain, but significantly reduces binding affinity up to 500-fold. Transcription start points were identified by 5'-rapid amplification of cDNA ends, and the binding regions of PimMDBD were investigated by DNase I protection studies. In all cases, binding took place covering the -35 hexamer box of each promoter, suggesting an interaction of PimM and RNA polymerase to cause transcription activation. Information content analysis of the 16 sequences protected in target promoters was used to deduce the structure of the PimM-binding site. This site displays dyad symmetry, spans 14 nucleotides, and adjusts to the consensus TVGGGAWWTCCCBA. Experimental validation of this binding site was performed by using synthetic DNA duplexes. Binding of PimM to the promoter region of one of the polyketide synthase genes from the Streptomyces nodosus amphotericin cluster containing the consensus binding site was also observed, thus proving the applicability of the findings reported here to other antifungal polyketides.	[Aparicio, Jesus F.] Inst Biotechnol INBIOTEC, Leon 24006, Spain; Univ Leon, Fac Biol, Area Microbiol, E-24071 Leon, Spain	Universidad de Leon	Aparicio, JF (corresponding author), Inst Biotechnol INBIOTEC, Avda Real 1, Leon 24006, Spain.	jesus.aparicio@unileon.es	Susana, Susana/L-9204-2015; Aparicio, Jesús F./K-8686-2014; Santos-Aberturas, Javier/AAE-8162-2021	Susana, Susana/0000-0003-2243-2376; Aparicio, Jesús F./0000-0003-4242-4701; Vicente, Claudia M./0000-0001-8205-6486	Spanish Ministerio de Ciencia e Innovacion [BIO2007-67585, BIO2010-19911]; Junta de Castilla y Leon Grupo de Excelencia [GR117]; Ministerio de Ciencia e Innovacion F.P.U. [AP2005-3644, AP2007-02055]; University of Leon; Junta de Castilla y Leon [E-24-2009-0053914]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon Grupo de Excelencia(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion F.P.U.(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Leon; Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Spanish Ministerio de Ciencia e Innovacion Grants BIO2007-67585 and BIO2010-19911 (to J. F. A.), Junta de Castilla y Leon Grupo de Excelencia GR117, Ministerio de Ciencia e Innovacion F.P.U. Fellowships AP2005-3644 (to J.S.-A.) and AP2007-02055 (to T. D. P.), a fellowship from the University of Leon (to S. M. G.), and Junta de Castilla y Leon Contract E-24-2009-0053914 (to C. M. V.).	Anton N, 2004, J BACTERIOL, V186, P2567, DOI 10.1128/JB.186.9.2567-2575.2004; Anton N, 2007, MICROBIOL-SGM, V153, P3174, DOI 10.1099/mic.0.2007/009126-0; Aparicio JF, 2008, MOL BIOSYST, V4, P804, DOI 10.1039/b717500k; Aparicio JF, 2004, CURR MED CHEM, V11, P1645; Aparicio JF, 2003, APPL MICROBIOL BIOT, V61, P179, DOI 10.1007/s00253-002-1183-5; Aparicio JF, 1999, J BIOL CHEM, V274, P10133, DOI 10.1074/jbc.274.15.10133; Bi CP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-76; Bibb M, 1996, MICROBIOL-SGM, V142, P1335, DOI 10.1099/13500872-142-6-1335; BOURN WR, 1995, NUCLEIC ACIDS RES, V23, P3696, DOI 10.1093/nar/23.18.3696; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Caffrey P, 2008, CURR TOP MED CHEM, V8, P639, DOI 10.2174/156802608784221479; Carmody M, 2004, GENE, V343, P107, DOI 10.1016/j.gene.2004.08.006; Chen S, 2003, CHEM BIOL, V10, P1065, DOI 10.1016/j.chembiol.2003.10.007; Ellison DW, 2000, J BACTERIOL, V182, P6592, DOI 10.1128/JB.182.23.6592-6597.2000; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Kells PM, 2010, CHEM BIOL, V17, P841, DOI 10.1016/j.chembiol.2010.05.026; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Martin JF, 2009, METHOD ENZYMOL, V459, P215, DOI 10.1016/S0076-6879(09)04610-2; Mendes MV, 2007, CHEM BIOL, V14, P279, DOI 10.1016/j.chembiol.2007.01.010; Mendes MV, 2007, METAB ENG, V9, P217, DOI 10.1016/j.ymben.2006.10.003; Mendes MV, 2005, BIOCHEM J, V386, P57, DOI 10.1042/BJ20040490; Mendes MV, 2001, CHEM BIOL, V8, P635, DOI 10.1016/S1074-5521(01)00033-3; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; RodriguezGarcia A, 1997, MOL MICROBIOL, V25, P219, DOI 10.1046/j.1365-2958.1997.4511815.x; Sambrook J, 2001, MOL CLONING LAB MANU; Schneider TD, 1997, J THEOR BIOL, V189, P427, DOI 10.1006/jtbi.1997.0540; Schneider TD, 1996, METHOD ENZYMOL, V274, P445; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; Sola-Landa A, 2005, MOL MICROBIOL, V56, P1373, DOI 10.1111/j.1365-2958.2005.04631.x; STEVENS AM, 1994, P NATL ACAD SCI USA, V91, P12619, DOI 10.1073/pnas.91.26.12619; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Vicente CM, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-33; Weingart CL, 2005, MOL MICROBIOL, V57, P452, DOI 10.1111/j.1365-2958.2005.04656.x; Welscher YMT, 2008, J BIOL CHEM, V283, P6393, DOI 10.1074/jbc.M707821200; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079	42	40	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9150	9161		10.1074/jbc.M110.182428	http://dx.doi.org/10.1074/jbc.M110.182428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21187288	Green Published, hybrid			2022-12-25	WOS:000288247700046
J	Bonnot, N; Gaillard, JM; Coulon, A; Galan, M; Cosson, JF; Delorme, D; Klein, F; Hewison, AJM				Bonnot, Nadege; Gaillard, Jean-Michel; Coulon, Aurelie; Galan, Maxime; Cosson, Jean-Francois; Delorme, Daniel; Klein, Francois; Hewison, A. J. Mark			No Difference between the Sexes in Fine-Scale Spatial Genetic Structure of Roe Deer	PLOS ONE			English	Article							FEMALE PHILOPATRY; BIASED DISPERSAL; MATING SYSTEM; RELATEDNESS; POPULATION; UNGULATE; ORGANIZATION; SOFTWARE; PATTERNS	Background: Data on spatial genetic patterns may provide information about the ecological and behavioural mechanisms underlying population structure. Indeed, social organization and dispersal patterns of species may be reflected by the pattern of genetic structure within a population. Methodology/Principal Findings: We investigated the fine-scale spatial genetic structure of a roe deer (Capreolus capreolus) population in Trois-Fontaines (France) using 12 microsatellite loci. The roe deer is weakly polygynous and highly sedentary, and can form matrilineal clans. We show that relatedness among individuals was negatively correlated with geographic distance, indicating that spatially proximate individuals are also genetically close. More unusually for a large mammalian herbivore, the link between relatedness and distance did not differ between the sexes, which is consistent with the lack of sex-biased dispersal and the weakly polygynous mating system of roe deer. Conclusions/Significance: Our results contrast with previous reports on highly polygynous species with male-biased dispersal, such as red deer, where local genetic structure was detected in females only. This divergence between species highlights the importance of socio-spatial organization in determining local genetic structure of vertebrate populations.	[Bonnot, Nadege; Hewison, A. J. Mark] INRA, Lab Comportement & Ecol Faune Sauvage, F-31326 Castanet Tolosan, France; [Gaillard, Jean-Michel] Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Coulon, Aurelie] CNRS, UMR 7179, Museum Natl Hist Nat, Brunoy, France; [Galan, Maxime; Cosson, Jean-Francois] INRA, Ctr Biol Gest Populat, Montferrier Sur Lez, France; [Delorme, Daniel; Klein, Francois] Ctr Natl Etud & Rech Appl Cervides Sangliers, Off Natl Chasse & Faune Sauvage, Bar Le Duc, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); INRAE; Institut de Recherche pour le Developpement (IRD)	Bonnot, N (corresponding author), INRA, Lab Comportement & Ecol Faune Sauvage, F-31326 Castanet Tolosan, France.	nbonnot@toulouse.inra.fr	Hewison, Aidan J Mark/AGJ-3300-2022; Galan, Maxime/AAB-9511-2019; Bonnot, Nadege/N-1762-2019	Hewison, Aidan J Mark/0000-0002-2276-4154; Galan, Maxime/0000-0001-6981-5732; Bonnot, Nadege/0000-0002-8717-231X; Cosson, Jean Francois/0000-0003-0863-5871	French National Institute for Agricultural Research	French National Institute for Agricultural Research	The study was funded by the French National Institute for Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apio A, 2010, J ZOOL, V280, P213, DOI 10.1111/j.1469-7998.2009.00654.x; Campbell V, 2006, CAN J ZOOL, V84, P1112, DOI 10.1139/Z06-099; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; Coltman DW, 2003, MOL ECOL, V12, P733, DOI 10.1046/j.1365-294X.2003.01762.x; Comer CE, 2005, J WILDLIFE MANAGE, V69, P332, DOI 10.2193/0022-541X(2005)069&lt;0332:FGSASO&gt;2.0.CO;2; Coulon A, 2006, P ROY SOC B-BIOL SCI, V273, P341, DOI 10.1098/rspb.2005.3329; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; Cullingham CI, 2011, EVOL APPL, V4, P116, DOI 10.1111/j.1752-4571.2010.00142.x; Cutrera AP, 2005, MOL ECOL, V14, P2511, DOI 10.1111/j.1365-294X.2005.02551.x; Da Silva A, 2009, EVOLUTION, V63, P403, DOI 10.1111/j.1558-5646.2008.00542.x; Frantz AC, 2008, EUR J WILDLIFE RES, V54, P44, DOI 10.1007/s10344-007-0107-1; Gaillard JM, 2008, P ROY SOC B-BIOL SCI, V275, P2025, DOI 10.1098/rspb.2008.0393; GAILLARD JM, 1993, J ANIM ECOL, V62, P778; Galan M, 2003, MOL ECOL NOTES, V3, P142, DOI 10.1046/j.1471-8286.2003.00384.x; Gauffre B, 2009, P R SOC B, V276, P3487, DOI 10.1098/rspb.2009.0881; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hardy OJ, 1999, HEREDITY, V83, P145, DOI 10.1046/j.1365-2540.1999.00558.x; Hazlitt SL, 2004, MOL ECOL, V13, P3621, DOI 10.1111/j.1365-294X.2004.02342.x; Hewison AJM, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P189; Kurt F, 1968, MAMMALIA DEPICTA, V3; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lynch M, 1999, GENETICS, V152, P1753; Miller BF, 2010, J MAMMAL, V91, P681, DOI 10.1644/09-MAMM-A-258.1; Nituch LA, 2008, ETHOLOGY, V114, P711, DOI 10.1111/j.1439-0310.2008.01522.x; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; Perez-Espona S, 2010, MOL ECOL, V19, P3101, DOI 10.1111/j.1365-294X.2010.04733.x; Pilot M, 2010, J EVOLUTION BIOL, V23, P20, DOI 10.1111/j.1420-9101.2009.01887.x; Poteaux C, 2009, J ZOOL, V278, P116, DOI 10.1111/j.1469-7998.2009.00553.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; R Core Team, 2022, R LANG ENV STAT COMP; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Stoen OG, 2005, BEHAV ECOL SOCIOBIOL, V59, P191, DOI 10.1007/s00265-005-0024-9; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanpe C, 2008, BEHAV ECOL, V19, P309, DOI 10.1093/beheco/arm132	40	24	24	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14436	10.1371/journal.pone.0014436	http://dx.doi.org/10.1371/journal.pone.0014436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203388	gold, Green Published, Green Submitted			2022-12-25	WOS:000285792500013
J	Valeri, A; Alonso-Ferrero, ME; Rio, P; Pujol, MR; Casado, JA; Perez, L; Jacome, A; Agirre, X; Calasanz, MJ; Hanenberg, H; Surralles, J; Prosper, F; Albella, B; Bueren, JA				Valeri, Antonio; Eugenia Alonso-Ferrero, Maria; Rio, Paula; Roser Pujol, Maria; Casado, Jose A.; Perez, Laura; Jacome, Ariana; Agirre, Xabier; Jose Calasanz, Maria; Hanenberg, Helmut; Surralles, Jordi; Prosper, Felipe; Albella, Beatriz; Bueren, Juan A.			Bcr/Abl Interferes with the Fanconi Anemia/BRCA Pathway: Implications in the Chromosomal Instability of Chronic Myeloid Leukemia Cells	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; STRAND BREAK REPAIR; BCR-ABL ONCOGENE; HEMATOPOIETIC-CELLS; DNA-REPAIR; PHOSPHATIDYLINOSITOL 3-KINASE; CENTROSOME AMPLIFICATION; PHILADELPHIA-CHROMOSOME; CYCLE CHECKPOINT; GENOTOXIC STRESS	Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by the expression of the BCR/ABL fusion oncogene. Although it is well known that CML cells are genetically unstable, the mechanisms accounting for this genomic instability are still poorly understood. Because the Fanconi anemia (FA) pathway is believed to control several mechanisms of DNA repair, we investigated whether this pathway was disrupted in CML cells. Our data show that CML cells have a defective capacity to generate FANCD2 nuclear foci, either in dividing cells or after DNA damage. Similarly, human cord blood CD34(+) cells transduced with BCR/ABL retroviral vectors showed impaired FANCD2 foci formation, whereas FANCD2 monoubiquitination in these cells was unaffected. Soon after the transduction of CD34+ cells with BCR/ABL retroviral vectors a high proportion of cells with supernumerary centrosomes was observed. Similarly, BCR/ABL induced a high proportion of chromosomal abnormalities, while mediated a cell survival advantage after exposure to DNA cross-linking agents. Significantly, both the impaired formation of FANCD2 nuclear foci, and also the predisposition of BCR/ABL cells to develop centrosomal and chromosomal aberrations were reverted by the ectopic expression of BRCA1. Taken together, our data show for the first time a disruption of the FA/BRCA pathway in BCR/ABL cells, suggesting that this defective pathway should play an important role in the genomic instability of CML by the co-occurrence of centrosomal amplification and DNA repair deficiencies.	[Valeri, Antonio; Eugenia Alonso-Ferrero, Maria; Rio, Paula; Casado, Jose A.; Perez, Laura; Jacome, Ariana; Albella, Beatriz; Bueren, Juan A.] Ctr Invest Energet Medioambientales & Tecnol CIEM, Madrid, Spain; [Valeri, Antonio; Eugenia Alonso-Ferrero, Maria; Rio, Paula; Casado, Jose A.; Perez, Laura; Jacome, Ariana; Albella, Beatriz; Bueren, Juan A.] CIBERER, Madrid, Spain; [Roser Pujol, Maria; Surralles, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain; [Roser Pujol, Maria; Surralles, Jordi] CIBERER, Barcelona, Spain; [Agirre, Xabier; Jose Calasanz, Maria; Prosper, Felipe] Univ Navarra Clin, Fdn Invest Med Aplicada CIMA, Pamplona, Spain; [Hanenberg, Helmut] Childrens Hosp, Dept Pediat Oncol Hematol & Immunol, Dusseldorf, Germany; [Hanenberg, Helmut] Riley Hosp Children, Dept Pediat, Wells Ctr Pediat Res, Indianapolis, IN USA	Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Navarra; James Whitcomb Riley Hospital Children	Valeri, A (corresponding author), Ctr Invest Energet Medioambientales & Tecnol CIEM, Madrid, Spain.	juan.bueren@ciemat.es	Surrallés, Jordi/AAE-7667-2020; Prosper, Felipe/H-6859-2017; Rio, Paula/G-8681-2015; Calasanz, MJ/R-5813-2016; Agirre, Xabier/ABE-4110-2020; Bueren, Juan/L-6112-2014; Casado, José Antonio/H-5077-2015	Prosper, Felipe/0000-0001-6115-8790; Rio, Paula/0000-0002-5424-5543; Calasanz, MJ/0000-0002-0374-3008; Bueren, Juan/0000-0002-3228-7013; Casado, José Antonio/0000-0003-2479-1508; Jacome de Azevedo, Ariana/0000-0002-2980-7399; Surralles, Jordi/0000-0002-4041-7519	European Program Life Sciences, Genomics and Biotechnology for Health [LSHB-CT-2004-5242]; Centro de Investigacion en Red de Enfermedades Raras (CIBERER); Comision Interministerial de Ciencia y Tecnologia [SAF2005-00058, SAF 2009-11936, SAF 2009-027]; Genoma Espana (FANCOGENE); NATIONAL CANCER INSTITUTE [R01CA155294] Funding Source: NIH RePORTER	European Program Life Sciences, Genomics and Biotechnology for Health; Centro de Investigacion en Red de Enfermedades Raras (CIBERER); Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Genoma Espana (FANCOGENE); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the European Program "Life Sciences, Genomics and Biotechnology for Health" (CONSERT; Ref LSHB-CT-2004-5242), Centro de Investigacion en Red de Enfermedades Raras (CIBERER), Comision Interministerial de Ciencia y Tecnologia (SAF2005-00058, SAF 2009-11936 and SAF 2009-027) and Genoma Espana (FANCOGENE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Altiok S, 1999, J BIOL CHEM, V274, P32274, DOI 10.1074/jbc.274.45.32274; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; BEDI A, 1995, BLOOD, V86, P1148, DOI 10.1182/blood.V86.3.1148.bloodjournal8631148; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Burke BA, 2010, LEUKEMIA; Cambier N, 1998, ONCOGENE, V16, P335, DOI 10.1038/sj.onc.1201490; Casado JA, 2007, J MED GENET, V44, P241, DOI 10.1136/jmg.2006.044719; Chalandon Y, 2002, BLOOD, V99, P3197, DOI 10.1182/blood.V99.9.3197; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Cramer K, 2008, CANCER RES, V68, P6884, DOI 10.1158/0008-5472.CAN-08-1101; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deutsch E, 2001, BLOOD, V97, P2084, DOI 10.1182/blood.V97.7.2084; Deutsch E, 2003, BLOOD, V101, P4583, DOI 10.1182/blood-2002-10-3011; Dierov J, 2009, LEUKEMIA, V23, P279, DOI 10.1038/leu.2008.308; Fernandes MS, 2009, BLOOD, V114, P1813, DOI 10.1182/blood-2008-07-172148; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Giehl M, 2005, LEUKEMIA, V19, P1192, DOI 10.1038/sj.leu.2403779; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hess CJ, 2008, CELL ONCOL, V30, P299, DOI 10.3233/CLO-2008-0426; Horita M, 2000, J EXP MED, V191, P977, DOI 10.1084/jem.191.6.977; Jacome A, 2006, HUM GENE THER, V17, P245, DOI 10.1089/hum.2006.17.245; Jose-Eneriz ES, 2008, BRIT J HAEMATOL, V142, P571, DOI 10.1111/j.1365-2141.2008.07221.x; Koptyra M, 2008, LEUKEMIA, V22, P1969, DOI 10.1038/leu.2008.78; Koptyra M, 2008, BLOOD, V112, P112; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Levitus M, 2006, CELL ONCOL, V28, P3; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Lyakhovich A, 2006, CANCER LETT, V232, P99, DOI 10.1016/j.canlet.2005.07.038; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Narayan G, 2004, CANCER RES, V64, P2994, DOI 10.1158/0008-5472.CAN-04-0245; Neshat MS, 2000, MOL CELL BIOL, V20, P1179, DOI 10.1128/MCB.20.4.1179-1186.2000; Nowicki MO, 2004, BLOOD, V104, P3746, DOI 10.1182/blood-2004-05-1941; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; SEYSCHAB H, 1995, BLOOD, V85, P2233, DOI 10.1182/blood.V85.8.2233.bloodjournal8582233; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Tischkowitz MD, 2004, LEUKEMIA, V18, P420, DOI 10.1038/sj.leu.2403280; Tonic I, 2010, J BIOL CHEM, V285, P23790, DOI 10.1074/jbc.M110.104372; Van der Heijden MS, 2004, AM J PATHOL, V165, P651, DOI 10.1016/S0002-9440(10)63329-9; Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zhao RC, 2001, BLOOD, V97, P2406, DOI 10.1182/blood.V97.8.2406	53	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15525	10.1371/journal.pone.0015525	http://dx.doi.org/10.1371/journal.pone.0015525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203397	gold, Green Published			2022-12-25	WOS:000285792500030
J	Chan, YC; Roos, C; Inoue-Murayama, M; Inoue, E; Shih, CC; Pei, KJC; Vigilant, L				Chan, Yi-Chiao; Roos, Christian; Inoue-Murayama, Miho; Inoue, Eiji; Shih, Chih-Chin; Pei, Kurtis Jai-Chyi; Vigilant, Linda			Mitochondrial Genome Sequences Effectively Reveal the Phylogeny of Hylobates Gibbons	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DIVERGENCE DATES; UPPER MIOCENE; DNA; BIOGEOGRAPHY; EVOLUTION; DIVERSIFICATION; SOFTWARE; HOMINID; ORIGIN	Background: Uniquely among hominoids, gibbons exist as multiple geographically contiguous taxa exhibiting distinctive behavioral, morphological, and karyotypic characteristics. However, our understanding of the evolutionary relationships of the various gibbons, especially among Hylobates species, is still limited because previous studies used limited taxon sampling or short mitochondrial DNA (mtDNA) sequences. Here we use mtDNA genome sequences to reconstruct gibbon phylogenetic relationships and reveal the pattern and timing of divergence events in gibbon evolutionary history. Methodology/Principal Findings: We sequenced the mitochondrial genomes of 51 individuals representing 11 species belonging to three genera (Hylobates, Nomascus and Symphalangus) using the high-throughput 454 sequencing system with the parallel tagged sequencing approach. Three phylogenetic analyses (maximum likelihood, Bayesian analysis and neighbor-joining) depicted the gibbon phylogenetic relationships congruently and with strong support values. Most notably, we recover a well-supported phylogeny of the Hylobates gibbons. The estimation of divergence times using Bayesian analysis with relaxed clock model suggests a much more rapid speciation process in Hylobates than in Nomascus. Conclusions/Significance: Use of more than 15 kb sequences of the mitochondrial genome provided more informative and robust data than previous studies of short mitochondrial segments (e. g., control region or cytochrome b) as shown by the reliable reconstruction of divergence patterns among Hylobates gibbons. Moreover, molecular dating of the mitogenomic divergence times implied that biogeographic change during the last five million years may be a factor promoting the speciation of Sundaland animals, including Hylobates species.	[Chan, Yi-Chiao; Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Roos, Christian] German Primate Ctr, Gene Bank Primates, Gottingen, Germany; [Roos, Christian] German Primate Ctr, Primate Genet Lab, Gottingen, Germany; [Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Inoue, Eiji] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Shih, Chih-Chin] Taipei Zoo, Anim Div, Taipei, Taiwan; [Pei, Kurtis Jai-Chyi] Natl Pingtung Univ Sci & Technol, Inst Wildlife Conservat, Pingtung, Taiwan	Max Planck Society; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Kyoto University; Kyoto University; National Pingtung University Science & Technology	Chan, YC (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	yichiao_chan@eva.mpg.de			Leakey Foundation; Deutscher Akademischer Austausch Dienst; Max Planck Society	Leakey Foundation; Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by a grant from the Leakey Foundation (L.V.), the fellowship of the Deutscher Akademischer Austausch Dienst (Y.-C.C.) and the Max Planck Society. Leakey Foundation website: http://www.leakeyfoundation.org/. Deutscher Akademischer Austausch Dienst (DAAD) website: http://www.daad.de/en/index.html. Max Planck Society website: http://www.mpg.de/english/portal/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004; ARNASON U, 1995, J MOL EVOL, V40, P78, DOI 10.1007/BF00166598; Benefit Brenda R., 2002, VVolume 33, P241; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Cerling TE, 1998, PHILOS T R SOC B, V353, P159, DOI 10.1098/rstb.1998.0198; Chatterjee HJ, 2006, INT J PRIMATOL, V27, P699, DOI 10.1007/s10764-006-9044-1; Delisle I, 2005, MOL PHYLOGENET EVOL, V37, P192, DOI 10.1016/j.ympev.2005.04.025; den Tex RJ, 2010, MOL PHYLOGENET EVOL, V55, P711, DOI 10.1016/j.ympev.2009.12.023; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fenn JD, 2008, MOL PHYLOGENET EVOL, V49, P59, DOI 10.1016/j.ympev.2008.07.004; Fortelius M, 2006, PALAEOGEOGR PALAEOCL, V238, P219, DOI 10.1016/j.palaeo.2006.03.042; Fulton TL, 2010, J BIOGEOGR, V37, P814, DOI 10.1111/j.1365-2699.2010.02271.x; Garza JC, 1992, MOL PHYLOGENET EVOL, V1, P202, DOI 10.1016/1055-7903(92)90016-A; Geissmann Thomas, 1995, IZN (International Zoo News), V42, P467; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; Groves CP, 2001, PRIMATE TAXONOMY; Hall LM, 1998, MOL PHYLOGENET EVOL, V10, P281, DOI 10.1006/mpev.1998.0539; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HAYASHI S, 1995, J MOL EVOL, V41, P359, DOI 10.1007/BF01215183; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kelley Jay, 2002, VVolume 33, P369; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebatard AE, 2008, P NATL ACAD SCI USA, V105, P3226, DOI 10.1073/pnas.0708015105; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Matsudaira K, 2010, MOL PHYLOGENET EVOL, V55, P454, DOI 10.1016/j.ympev.2010.01.032; Matsui A, 2009, GENE, V441, P53, DOI 10.1016/j.gene.2008.08.024; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mittermeier RA., 2005, HOTSPOTS REVISITED E; Miya M, 2001, MOL BIOL EVOL, V18, P1993, DOI 10.1093/oxfordjournals.molbev.a003741; Monda K, 2007, AM J PRIMATOL, V69, P1285, DOI 10.1002/ajp.20439; Mootnick A, 2005, INT J PRIMATOL, V26, P971, DOI 10.1007/s10764-005-5332-4; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Muller S, 2003, HUM GENET, V113, P493, DOI 10.1007/s00439-003-0997-2; Outlaw DC, 2008, J BIOGEOGR, V35, P739, DOI 10.1111/j.1365-2699.2007.01821.x; Quek SP, 2007, MOL ECOL, V16, P2045, DOI 10.1111/j.1365-294X.2007.03294.x; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; Roos Christian, 2007, Vietnamese Journal of Primatology, V1, P41; Schmitz J, 2005, J MOL EVOL, V61, P1, DOI 10.1007/s00239-004-0293-3; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takacs Z, 2005, MOL PHYLOGENET EVOL, V36, P456, DOI 10.1016/j.ympev.2005.03.032; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thalmann O, 2004, MOL ECOL, V13, P321, DOI 10.1046/j.1365-294X.2003.02070.x; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Whittaker DJ, 2007, MOL PHYLOGENET EVOL, V45, P620, DOI 10.1016/j.ympev.2007.08.009; Woodruff DS, 2009, J BIOGEOGR, V36, P803, DOI 10.1111/j.1365-2699.2008.02071.x; Young NM, 2004, J HUM EVOL, V46, P163, DOI 10.1016/j.jhevol.2003.11.002; Yu L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-198; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020	63	60	64	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14419	10.1371/journal.pone.0014419	http://dx.doi.org/10.1371/journal.pone.0014419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203450	Green Published, gold			2022-12-25	WOS:000285579200005
J	Gimenez, E; Pineda, B; Capel, J; Anton, MT; Atares, A; Perez-Martin, F; Garcia-Sogo, B; Angosto, T; Moreno, V; Lozano, R				Gimenez, Estela; Pineda, Benito; Capel, Juan; Teresa Anton, Maria; Atares, Alejandro; Perez-Martin, Fernando; Garcia-Sogo, Begona; Angosto, Trinidad; Moreno, Vicente; Lozano, Rafael			Functional Analysis of the Arlequin Mutant Corroborates the Essential Role of the ARLEQUIN/TAGL1 Gene during Reproductive Development of Tomato	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL ORGAN IDENTITY; FRUIT-DEVELOPMENT; ARABIDOPSIS-THALIANA; DIFFERENTIAL EXPRESSION; TRANSGENIC TOMATOES; FLOWER DEVELOPMENT; MOLECULAR-BIOLOGY; OVULE DEVELOPMENT; RIPENING MUTANT	Reproductive development of higher plants comprises successive events of organ differentiation and growth which finally lead to the formation of a mature fruit. However, most of the genetic and molecular mechanisms which coordinate such developmental events are yet to be identified and characterized. Arlequin (Alq), a semi-dominant T-DNA tomato mutant showed developmental changes affecting flower and fruit ripening. Sepals were converted into fleshy organs which ripened as normal fruit organs and fruits displayed altered ripening features. Molecular characterization of the tagged gene demonstrated that it corresponded to the previously reported TOMATO AGAMOUS-LIKE 1 (TAGL1) gene, the tomato ortholog of SHATTERPROOF MADS-box genes of Arabidopsis thaliana, and that the Alq mutation promoted a gain-of-function phenotype caused by the ectopic expression of TAGL1. Ectopic overexpression of TAGL1 resulted in homeotic alterations affecting floral organ identity that were similar to but stronger than those observed in Alq mutant plants. Interestingly, TAGL1 RNAi plants yielded tomato fruits which were unable to ripen. They displayed a yellow-orange color and stiffness appearance which are in accordance with reduced lycopene and ethylene levels, respectively. Moreover, pericarp cells of TAGL1 RNAi fruits showed altered cellular and structural properties which correlated to both decreased expression of genes regulating cell division and lignin biosynthesis. Over-expression of TAGL1 is able to rescue the non-ripening phenotype of rin and nor mutants, which is mediated by the transcriptional activation of several ripening genes. Our results demonstrated that TAGL1 participates in the genetic control of flower and fruit development of tomato plants. Furthermore, gene silencing and over-expression experiments demonstrated that the fruit ripening process requires the regulatory activity of TAGL1. Therefore, TAGL1 could act as a linking factor connecting successive stages of reproductive development, from flower development to fruit maturation, allowing this complex process to be carried out successfully.	[Gimenez, Estela; Capel, Juan; Lozano, Rafael] Univ Almeria, Dept Biol Aplicada, Politecn Super E, Almeria, Spain; [Pineda, Benito; Teresa Anton, Maria; Atares, Alejandro; Garcia-Sogo, Begona; Moreno, Vicente] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas UPV CSIC, E-46071 Valencia, Spain; [Perez-Martin, Fernando; Angosto, Trinidad] Univ Almeria, Dept Biol Vegetal & Ecol, Politecn Super E, Almeria, Spain	Universidad de Almeria; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Universidad de Almeria	Gimenez, E (corresponding author), Univ Almeria, Dept Biol Aplicada, Politecn Super E, Carretera Sacramento S-N, Almeria, Spain.	rlozano@ual.es	Pineda, Benito/ABD-5149-2020; Huerta, Alejandro Atares/M-6870-2019; Huerta, Alejandro Atares/G-9943-2015; Angosto, Trinidad/M-4451-2014; Caminero, Estela Gimenez/H-9198-2015; Capel, Juan/M-3772-2018; Lozano, Rafael/M-2813-2014; Ferrero, Vicente Moreno/C-6613-2016; Lozano, Rafael/AAD-6545-2020	Pineda, Benito/0000-0001-9176-701X; Huerta, Alejandro Atares/0000-0003-1728-5471; Huerta, Alejandro Atares/0000-0003-1728-5471; Angosto, Trinidad/0000-0003-0294-9255; Caminero, Estela Gimenez/0000-0002-7403-5279; Capel, Juan/0000-0002-4327-0604; Lozano, Rafael/0000-0001-5458-2075; Ferrero, Vicente Moreno/0000-0002-0345-7300; Lozano, Rafael/0000-0001-5458-2075; Garcia Sogo, Begona/0000-0001-8819-6711	Spanish Ministry of Science and Innovation [AGL2009-13388, BIO2009-11484]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Spanish Ministry of Science and Innovation (grants AGL2009-13388 and BIO2009-11484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1991, PLANT PHYSIOL, V95, P269, DOI 10.1104/pp.95.1.269; Adams-Phillips L, 2004, TRENDS PLANT SCI, V9, P331, DOI 10.1016/j.tplants.2004.05.004; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Andrews J, 2002, J EXP BOT, V53, P2393, DOI 10.1093/jxb/erf109; Bargel H, 2005, J EXP BOT, V56, P1049, DOI 10.1093/jxb/eri098; BAULCOMBE DC, 1986, NATURE, V321, P446, DOI 10.1038/321446a0; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Brukhin V, 2003, SEX PLANT REPROD, V15, P311, DOI 10.1007/s00497-003-0167-7; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; Dinneny JR, 2005, DEVELOPMENT, V132, P4687, DOI 10.1242/dev.02062; Ellul P, 2003, THEOR APPL GENET, V106, P231, DOI 10.1007/s00122-002-0928-y; Emmanuel E, 2002, CURR OPIN PLANT BIOL, V5, P112, DOI 10.1016/S1369-5266(02)00237-6; Eriksson EM, 2004, PLANT PHYSIOL, V136, P4184, DOI 10.1104/pp.104.045765; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Fornale S, 2006, PLANT MOL BIOL, V62, P809, DOI 10.1007/s11103-006-9058-2; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; FRAY RG, 1993, PLANT MOL BIOL, V22, P589, DOI 10.1007/BF00047400; Gidoni D, 2003, PLANT MOL BIOL, V51, P83, DOI 10.1023/A:1020718520618; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Gonzalez N, 2007, PLANT J, V51, P642, DOI 10.1111/j.1365-313X.2007.03167.x; GUSTAFSONBROWN C, 1994, CELL, V76, P131, DOI 10.1016/0092-8674(94)90178-3; HALL LN, 1993, PLANT J, V3, P121, DOI 10.1111/j.1365-313X.1993.tb00015.x; Hileman LC, 2006, MOL BIOL EVOL, V23, P2245, DOI 10.1093/molbev/msl095; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Itkin M, 2009, PLANT J, V60, P1081, DOI 10.1111/j.1365-313X.2009.04064.x; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Joubes J, 2000, PLANTA, V211, P430, DOI 10.1007/s004250000306; Joubes J, 1999, PLANT PHYSIOL, V121, P857, DOI 10.1104/pp.121.3.857; Kim CM, 2004, PLANT J, V39, P252, DOI 10.1111/j.1365-313X.2004.02116.x; KLANN EM, 1993, PLANT PHYSIOL, V103, P863, DOI 10.1104/pp.103.3.863; Knapp S, 2002, J EXP BOT, V53, P2001, DOI 10.1093/jxb/erf068; Kramer EM, 1998, GENETICS, V149, P765; Lashbrook CC, 1998, PLANT J, V15, P243, DOI 10.1046/j.1365-313X.1998.00202.x; Leseberg CH, 2008, J EXP BOT, V59, P2253, DOI 10.1093/jxb/ern094; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; LINCOLN JE, 1988, PLANT PHYSIOL, V88, P370, DOI 10.1104/pp.88.2.370; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Lozano R, 1998, PLANT PHYSIOL, V117, P91, DOI 10.1104/pp.117.1.91; Lozano R, 2009, INT J DEV BIOL, V53, P1635, DOI 10.1387/ijdb.072440rl; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Moore S, 2002, J EXP BOT, V53, P2023, DOI 10.1093/jxb/erf057; Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295; Ng M, 2000, CURR OPIN PLANT BIOL, V3, P47, DOI 10.1016/S1369-5266(99)00036-9; NICKLAS KJ, 1992, PLAN BIOMECHANICS EN; Orfila C, 2001, PLANT PHYSIOL, V126, P210, DOI 10.1104/pp.126.1.210; Pineda B, 2010, PLANT CELL PHYSIOL, V51, P435, DOI 10.1093/pcp/pcq009; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; Quiroga M, 2000, PLANT PHYSIOL, V122, P1119, DOI 10.1104/pp.122.4.1119; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x; Saladie M, 2007, PLANT PHYSIOL, V144, P1012, DOI 10.1104/pp.107.097477; Seymour GB, 2002, J EXP BOT, V53, P2065, DOI 10.1093/jxb/erf087; Seymour G, 2008, CURR OPIN PLANT BIOL, V11, P58, DOI 10.1016/j.pbi.2007.09.003; SHACKEL KA, 1991, PLANT PHYSIOL, V97, P814, DOI 10.1104/pp.97.2.814; SMITH CJS, 1988, NATURE, V334, P724, DOI 10.1038/334724a0; Soto-Zamora G, 2005, LWT-FOOD SCI TECHNOL, V38, P657, DOI 10.1016/j.lwt.2004.08.005; Spence J, 1996, J MICROSC-OXFORD, V181, P195, DOI 10.1046/j.1365-2818.1996.111391.x; Tadiello A, 2009, J EXP BOT, V60, P651, DOI 10.1093/jxb/ern313; Tani E, 2007, TREE PHYSIOL, V27, P649, DOI 10.1093/treephys/27.5.649; Tani Helen, 2004, Functional & Integrative Genomics, V4, P258, DOI 10.1007/s10142-004-0112-3; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Thompson AJ, 1999, PLANT PHYSIOL, V120, P383, DOI 10.1104/pp.120.2.383; Thompson DS, 1998, PLANT CELL ENVIRON, V21, P589, DOI 10.1046/j.1365-3040.1998.00308.x; Tieman DM, 1999, PLANT PHYSIOL, V120, P165, DOI 10.1104/pp.120.1.165; Tieman DV, 2000, P NATL ACAD SCI USA, V97, P5663, DOI 10.1073/pnas.090550597; TIGCHELAAR EC, 1978, HORTSCIENCE, V13, P508; van der Rest B, 2006, J EXP BOT, V57, P1399, DOI 10.1093/jxb/erj120; Victoria BM, 2003, PLANT MOL BIOL, V52, P801, DOI 10.1023/A:1025001402838; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Vrebalov J, 2009, PLANT CELL, V21, P3041, DOI 10.1105/tpc.109.066936; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; WHITMORE FW, 1978, PHYTOCHEMISTRY, V17, P421, DOI 10.1016/S0031-9422(00)89329-2; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807	86	83	88	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14427	10.1371/journal.pone.0014427	http://dx.doi.org/10.1371/journal.pone.0014427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203447	gold, Green Published, Green Submitted			2022-12-25	WOS:000285579200009
J	Kuchimaru, T; Kadonosono, T; Tanaka, S; Ushiki, T; Hiraoka, M; Kizaka-Kondoh, S				Kuchimaru, Takahiro; Kadonosono, Tetsuya; Tanaka, Shotaro; Ushiki, Takashi; Hiraoka, Masahiro; Kizaka-Kondoh, Shinae			In Vivo Imaging of HIF-Active Tumors by an Oxygen-Dependent Degradation Protein Probe with an Interchangeable Labeling System	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; SUPPRESSOR PROTEIN; CANCER; EXPRESSION; CELLS; HIF-1-ALPHA; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; TRANSDUCTION; MECHANISM; DELIVERY	Hypoxia-inducible factor (HIF) functions as a master transcriptional regulator for adaptation to hypoxia by inducing adaptive changes in gene expression for regulation of proliferation, angiogenesis, apoptosis and energy metabolism. Cancers with high expression of the alpha subunit of HIF (HIF alpha) are often malignant and treatment-resistant. Therefore, the development of a molecular probe that can detect HIF activity has great potential value for monitoring tumor hypoxia. HIF prolyl hydroxylases (HPHDs) act as oxygen sensors that regulate the fate of HIF alpha protein through its oxygen-dependent degradation (ODD) domain. We constructed a recombinant protein PTD-ODD-HaloTag (POH) that is under the same ODD regulation as HIF alpha and contains protein transduction domain (PTD) and an interchangeable labeling system. Administration of near-infrared fluorescently labeled POH (POH-N) to mouse models of cancers allowed successful monitoring of HIF-active regions. Immunohistochemical analysis for intratumoral localization of POH probe revealed its specificity to HIF-active cells. Furthermore, lack of the PTD domain or a point mutation in the ODD domain abrogated the specificity of POH-N to HIF-active cells. Overall results indicate that POH is a practical probe specific to HIF-active cell in cancers and suggest its large potential for imaging and targeting of HIF-related diseases.	[Kuchimaru, Takahiro; Kadonosono, Tetsuya; Kizaka-Kondoh, Shinae] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Tanaka, Shotaro] Tokyo Womens Med Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Ushiki, Takashi] Niigata Univ, Dept Hematol, Grad Sch Med & Dent Sci, Niigata, Japan; [Hiraoka, Masahiro] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Kyoto, Japan	Tokyo Institute of Technology; Tokyo Women's Medical University; Niigata University; Kyoto University	Kuchimaru, T (corresponding author), Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan.	skondoh@bio.titech.ac.jp	Kadonosono, Tetsuya/D-4651-2019; Kuchimaru, Takahiro/B-9269-2015; Kondoh, Shinae/AAF-8745-2020; Kondoh, Shinae/C-6937-2015	Kuchimaru, Takahiro/0000-0002-5355-3165; Kondoh, Shinae/0000-0003-3085-5782; Kondoh, Shinae/0000-0003-3085-5782				ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Contag CH, 2007, ANNU REV PATHOL-MECH, V2, P277, DOI 10.1146/annurev.pathol.2.010506.091930; Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006; Fels DR, 2005, TRENDS BIOCHEM SCI, V30, P426, DOI 10.1016/j.tibs.2005.06.009; Fujibayashi Y, 1999, NUCL MED BIOL, V26, P117, DOI 10.1016/S0969-8051(98)00049-3; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Harada H, 2002, CANCER RES, V62, P2013; Harada H, 2007, BIOCHEM BIOPH RES CO, V360, P791, DOI 10.1016/j.bbrc.2007.06.149; Harada H, 2005, MOL IMAGING, V4, P182; Harada H, 2006, FEBS LETT, V580, P5718, DOI 10.1016/j.febslet.2006.09.025; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; HWANG DR, 1989, APPL RADIAT ISOTOPES, V40, P117, DOI 10.1016/0883-2889(89)90186-X; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kizaka-Kondoh S, 2009, CLIN CANCER RES, V15, P3433, DOI 10.1158/1078-0432.CCR-08-2267; Kosaka N, 2009, BIOCONJUGATE CHEM, V20, P1367, DOI 10.1021/bc9001344; Lehmann S, 2009, P NATL ACAD SCI USA, V106, P14004, DOI 10.1073/pnas.0901194106; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Moroz E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005077; Piert M, 2005, J NUCL MED, V46, P106; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Shah Khalid, 2005, NeuroRx, V2, P215, DOI 10.1007/BF03206667; Sobhanifar S, 2005, CANCER RES, V65, P7259, DOI 10.1158/0008-5472.CAN-04-4480; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; VAUPEL P, 1989, CANCER RES, V49, P6449; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501	35	27	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15736	10.1371/journal.pone.0015736	http://dx.doi.org/10.1371/journal.pone.0015736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203417	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200034
J	van Dijk, SJ; Feskens, EJM; Heidema, AG; Bos, MB; van de Rest, O; Geleijnse, JM; de Groot, LCPGM; Muller, M; Afman, LA				van Dijk, Susan J.; Feskens, Edith J. M.; Heidema, A. Geert; Bos, Marieke B.; van de Rest, Ondine; Geleijnse, Johanna M.; de Groot, Lisette C. P. G. M.; Mueller, Michael; Afman, Lydia A.			Plasma Protein Profiling Reveals Protein Clusters Related to BMI and Insulin Levels in Middle-Aged Overweight Subjects	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; COMPLEMENT C3; MULTIMARKER APPROACH; ADIPOSE-TISSUE; SERUM-LEVELS; OLDER MEN; INFLAMMATION; RESISTANCE; RISK	Background: Biomarkers that allow detection of the onset of disease are of high interest since early detection would allow intervening with lifestyle and nutritional changes before the disease is manifested and pharmacological therapy is required. Our study aimed to improve the phenotypic characterization of overweight but apparently healthy subjects and to identify new candidate profiles for early biomarkers of obesity-related diseases such as cardiovascular disease and type 2 diabetes. Methodology/Principal Findings: In a population of 56 healthy, middle-aged overweight subjects Body Mass Index (BMI), fasting concentration of 124 plasma proteins and insulin were determined. The plasma proteins are implicated in chronic diseases, inflammation, endothelial function and metabolic signaling. Random Forest was applied to select proteins associated with BMI and plasma insulin. Subsequently, the selected proteins were analyzed by clustering methods to identify protein clusters associated with BMI and plasma insulin. Similar analyses were performed for a second population of 20 healthy, overweight older subjects to verify associations found in population I. In both populations similar clusters of proteins associated with BMI or insulin were identified. Leptin and a number of pro-inflammatory proteins, previously identified as possible biomarkers for obesity-related disease, e. g. Complement 3, C Reactive Protein, Serum Amyloid P, Vascular Endothelial Growth Factor clustered together and were positively associated with BMI and insulin. IL-3 and IL-13 clustered together with Apolipoprotein A1 and were inversely associated with BMI and might be potential new biomarkers. Conclusion/Significance: We identified clusters of plasma proteins associated with BMI and insulin in healthy populations. These clusters included previously reported biomarkers for obesity-related disease and potential new biomarkers such as IL-3 and IL-13. These plasma protein clusters could have potential applications for improved phenotypic characterization of volunteers in nutritional intervention studies or as biomarkers in the early detection of obesity-linked disease development and progression.	[van Dijk, Susan J.; Feskens, Edith J. M.; Heidema, A. Geert; Bos, Marieke B.; van de Rest, Ondine; Geleijnse, Johanna M.; de Groot, Lisette C. P. G. M.; Mueller, Michael; Afman, Lydia A.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Mueller, Michael] Netherlands Nutrigenom Ctr, TI Food & Nutr, Wageningen, Netherlands	Wageningen University & Research; Top Institute Food & Nutrition	van Dijk, SJ (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	lydia.afman@wur.nl	Muller, Michael/B-5795-2008; Muller, Michael/M-5724-2019; Feskens, Edith/ABI-1446-2020; van Dijk, Susan/H-8910-2013; Geleijnse, Johanna Marianna M/B-5749-2012; Feskens, Edith JM/A-3757-2012	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Feskens, Edith/0000-0001-5819-2488; van Dijk, Susan/0000-0001-7019-0418; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; de Groot, Lisette/0000-0003-2778-2789	Dutch Diabetes Research Foundation [20060052]; Netherlands Heart Foundation [2003B068]; Netherlands Genomics Initiative	Dutch Diabetes Research Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Genomics Initiative	This study was supported by the Dutch Diabetes Research Foundation (20060052), the Netherlands Heart Foundation (2003B068), and the Netherlands Genomics Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Barrett JH, 2008, STAT APPL GENET MOL, V7; Bastard JP, 2000, DIABETES-METAB RES, V16, P192, DOI 10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.3.CO;2-7; BOS MB, 2009, NUTR METAB CARDIOVAS; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carter AM, 2009, ATHEROSCLEROSIS, V203, P538, DOI 10.1016/j.atherosclerosis.2008.07.007; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Chang IH, 2009, J UROLOGY, V181, P567, DOI 10.1016/j.juro.2008.10.030; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; Fenton JI, 2009, DIABETES OBES METAB, V11, P343, DOI 10.1111/j.1463-1326.2008.00974.x; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Haffner SM, 2003, DIABETES RES CLIN PR, V61, pS9, DOI 10.1016/S0168-8227(03)00122-0; Heidema AG, 2007, GENET EPIDEMIOL, V31, P910, DOI 10.1002/gepi.20251; Heidema AG, 2009, J PROTEOME RES, V8, P2640, DOI 10.1021/pr8006182; HUYNH T, 2008, J MACHINE LEARNING R, V4, P60; Ikonomidis I, 2005, EUR HEART J, V26, P1618, DOI 10.1093/eurheartj/ehi192; Ikonomidis I, 2008, ATHEROSCLEROSIS, V199, P3, DOI 10.1016/j.atherosclerosis.2008.02.019; Ikonomidis I, 2009, DIS MARKERS, V26, P273, DOI [10.1155/2009/135423, 10.3233/DMA-2009-0633]; Jenny NS, 2007, ARTERIOSCL THROM VAS, V27, P352, DOI 10.1161/01.ATV.0000254150.97741.fe; Keshishian H, 2009, MOL CELL PROTEOMICS, V8, P2339, DOI 10.1074/mcp.M900140-MCP200; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Kyzer S, 1999, OBES SURG, V9, P229, DOI 10.1381/096089299765553089; Rodenburg W, 2008, PHYSIOL GENOMICS, V33, P78, DOI 10.1152/physiolgenomics.00167.2007; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Singh U, 2009, CLIN CHEM, V55, P361, DOI 10.1373/clinchem.2008.109207; Szeplaki G, 2004, ATHEROSCLEROSIS, V177, P383, DOI 10.1016/j.atherosclerosis.2004.07.022; Tracy RP, 1999, CURR OPIN LIPIDOL, V10, P435, DOI 10.1097/00041433-199910000-00008; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; van de Rest O, 2008, AM J CLIN NUTR, V88, P706, DOI 10.1093/ajcn/88.3.706; Vasudevan AR, 2006, J CLIN ENDOCR METAB, V91, P256, DOI 10.1210/jc.2005-1280; VERMEULEN A, 1990, MATURITAS, V12, P121, DOI 10.1016/0378-5122(90)90090-S; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Warnberg J, 2006, AM J CLIN NUTR, V84, P505; Yang Y, 2006, INT J OBESITY, V30, P439, DOI 10.1038/sj.ijo.0803173; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	41	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14422	10.1371/journal.pone.0014422	http://dx.doi.org/10.1371/journal.pone.0014422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203453	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200007
J	Anne, J				Anne, Joel			C-Terminal Moiety of Tudor Contains Its In Vivo Activity in Drosophila	PLOS ONE			English	Article							POLE PLASM; GERM PLASM; METHYLTRANSFERASE CAPSULEEN; ARGININE RESIDUES; SM PROTEINS; MELANOGASTER; DOMAIN; LOCALIZATION; GENE; METHYLATION	Background: In early Drosophila embryos, the germ plasm is localized to the posterior pole region and is partitioned into the germline progenitors, known as pole cells. Germ plasm, or pole plasm, contains the polar granules which form during oogenesis and are required for germline development. Components of these granules are also present in the perinuclear region of the nurse cells, the nuage. One such component is Tudor (Tud) which is a large protein containing multiple Tudor domains. It was previously reported that specific Tudor domains are required for germ cell formation and Tud localization. Methodology/Principal Findings: In order to better understand the function of Tud the distribution and functional activity of fragments of Tud were analyzed. These fragments were fused to GFP and the fusion proteins were synthesized during oogenesis. Non-overlapping fragments of Tud were found to be able to localize to both the nuage and pole plasm. By introducing these fragments into a tud mutant background and testing their ability to rescue the tud phenotype, I determined that the C-terminal moiety contains the functional activity of Tud. Dividing this fragment into two parts reduces its localization in pole plasm and abolishes its activity. Conclusions/Significance: I conclude that the C-terminal moiety of Tud contains all the information necessary for its localization in the nuage and pole plasm and its pole cell-forming activity. The present results challenge published data and may help refining the functional features of Tud.	[Anne, Joel] Deutsch Krebsforschungszentrum, Dept Dev Genet, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Anne, J (corresponding author), Univ Bern, Inst Biol Cellulaire, Bern, Switzerland.	joel.anne@izb.unibe.ch			DKFZ	DKFZ(Helmholtz Association)	This work was funded by the DKFZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikura R, 2001, MECH DEVELOP, V107, P97, DOI 10.1016/S0925-4773(01)00455-5; Amikura R, 2005, MECH DEVELOP, V122, P1087, DOI 10.1016/j.mod.2005.06.003; Anne J, 2005, DEVELOPMENT, V132, P2167, DOI 10.1242/dev.01809; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; BARDSLEY A, 1993, DEVELOPMENT, V119, P207; BEAMS HW, 1974, INT REV CYTOL, V39, P413, DOI 10.1016/S0074-7696(08)60944-4; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Callebaut I, 1997, BIOCHEM J, V321, P125, DOI 10.1042/bj3210125; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; EDDY EM, 1975, INT REV CYTOL, V43, P229; GOLUMBESKI GS, 1991, GENE DEV, V5, P2060, DOI 10.1101/gad.5.11.2060; HAY B, 1988, DEVELOPMENT, V103, P625; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kirino Y, 2010, RNA, V16, P70, DOI 10.1261/rna.1869710; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; MAHOWALD AP, 1962, J EXP ZOOL, V151, P201, DOI 10.1002/jez.1401510302; Mahowald AP, 2001, INT REV CYTOL, V203, P187; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Nishida KM, 2009, EMBO J, V28, P3820, DOI 10.1038/emboj.2009.365; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; RONGO C, 1995, DEVELOPMENT, V121, P2737; Sano H, 2002, MECH DEVELOP, V112, P129, DOI 10.1016/S0925-4773(01)00654-2; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Talbot K, 1998, HUM MOL GENET, V7, P2149, DOI 10.1093/hmg/7.13.2149; Thomson T, 2004, GENESIS, V40, P164, DOI 10.1002/gene.20079; Vanzo NF, 2002, DEVELOPMENT, V129, P3705	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e14378	10.1371/journal.pone.0014378	http://dx.doi.org/10.1371/journal.pone.0014378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179416	gold, Green Published, Green Submitted			2022-12-25	WOS:000285572900010
J	Marim, FM; Silveira, TN; Lima, DS; Zamboni, DS				Marim, Fernanda M.; Silveira, Tatiana N.; Lima, Djalma S., Jr.; Zamboni, Dario S.			A Method for Generation of Bone Marrow-Derived Macrophages from Cryopreserved Mouse Bone Marrow Cells	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA; HUMAN MONOCYTES; RECOGNITION	The broad use of transgenic and gene-targeted mice has established bone marrow-derived macrophages (BMDM) as important mammalian host cells for investigation of the macrophages biology. Over the last decade, extensive research has been done to determine how to freeze and store viable hematopoietic human cells; however, there is no information regarding generation of BMDM from frozen murine bone marrow (BM) cells. Here, we establish a highly efficient protocol to freeze murine BM cells and further generate BMDM. Cryopreserved murine BM cells maintain their potential for BMDM differentiation for more than 6 years. We compared BMDM obtained from fresh and frozen BM cells and found that both are similarly able to trigger the expression of CD80 and CD86 in response to LPS or infection with the intracellular bacteria Legionella pneumophila. Additionally, BMDM obtained from fresh or frozen BM cells equally restrict or support the intracellular multiplication of pathogens such as L. pneumophila and the protozoan parasite Leishmania (L.) amazonensis. Although further investigation are required to support the use of the method for generation of dendritic cells, preliminary experiments indicate that bone marrow-derived dendritic cells can also be generated from cryopreserved BM cells. Overall, the method described and validated herein represents a technical advance as it allows ready and easy generation of BMDM from a stock of frozen BM cells.	[Marim, Fernanda M.; Silveira, Tatiana N.; Lima, Djalma S., Jr.; Zamboni, Dario S.] Univ Sao Paulo FMRP USP, Sch Med Ribeirao Preto, Dept Cell Biol, Ribeirao Preto, Brazil	Universidade de Sao Paulo	Marim, FM (corresponding author), Univ Sao Paulo FMRP USP, Sch Med Ribeirao Preto, Dept Cell Biol, Ribeirao Preto, Brazil.	dszamboni@fmrp.usp.br	Lima-Junior, Djalma/H-4833-2013; Silveira, Tatiana/A-8924-2013; Zamboni, Dario S/D-3024-2012	Lima-Junior, Djalma/0000-0002-2092-8047; Silveira, Tatiana/0000-0001-5883-8621; Zamboni, Dario S/0000-0002-7856-7512	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV/CNPq); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/52867-4]; TNS; DSLJ; FAPESP [06/55084-0, 09/05054-6]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); TNS; DSLJ; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV/CNPq) and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant 06/52867-4). FMM is recipient of a master fellowship from CNPq; TNS and DSLJ are supported by doctoral fellowships from FAPESP (06/55084-0 and 09/05054-6 respectively). DSZ is a Research Fellow from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint B, 1999, BONE MARROW TRANSPL, V23, P613, DOI 10.1038/sj.bmt.1701623; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Berz D, 2007, AM J HEMATOL, V82, P463, DOI 10.1002/ajh.20707; Carregaro V, 2008, J LEUKOCYTE BIOL, V84, P104, DOI 10.1189/jlb.1107797; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; Donnenberg AD, 2002, CYTOTHERAPY, V4, P157, DOI 10.1080/146532402317381866; ENGLEN MD, 1995, J IMMUNOL METHODS, V184, P281, DOI 10.1016/0022-1759(95)00136-X; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Hiebl B, 2008, CLIN HEMORHEOL MICRO, V39, P221, DOI 10.3233/CH-2008-1086; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Kram D, 2008, J IMMUNOL METHODS, V333, P79, DOI 10.1016/j.jim.2008.01.004; LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Morrissette Naomi, 1999, Trends in Cell Biology, V9, P199, DOI 10.1016/S0962-8924(99)01540-8; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003	20	208	209	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15263	10.1371/journal.pone.0015263	http://dx.doi.org/10.1371/journal.pone.0015263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179419	Green Published, gold, Green Submitted			2022-12-25	WOS:000285572900016
J	Gleicher, N; Weghofer, A; Lee, IH; Barad, DH				Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.			FMR1 Genotype with Autoimmunity-Associated Polycystic Ovary-Like Phenotype and Decreased Pregnancy Chance	PLOS ONE			English	Article							TRIPLE CGG REPEATS; REPRODUCTIVE FAILURE; RISK-FACTOR; GENE; PREMUTATION; AUTOANTIBODIES; RECEPTOR; HORMONE; RESERVE; FSH	The FMR1 gene partially appears to control ovarian reserve, with a specific ovarian sub-genotype statistically associated with a polycystic ovary (PCO) like phenotype. Some forms of PCO have been associated with autoimmunity. We, therefore, investigated in multiple regression analyses associations of ovary-specific FMR1 genotypes with autoimmunity and pregnancy chances (with in vitro fertilization, IVF) in 339 consecutive infertile women (455 IVF cycles), 75 with PCO-like phenotype, adjusted for age, race/ethnicity, medication dosage and number of oocytes retrieved. Patients included 183 (54.0%) with normal (norm) and 156 (46%) with heterozygous (het) FMR1 genotypes; 133 (39.2%) demonstrated laboratory evidence of autoimmunity: 51.1% of het-norm/low, 38.3% of norm and 24.2% het-norm/high genotype and sub-genotypes demonstrated autoimmunity (p = 0.003). Prevalence of autoimmunity increased further in PCO-like phenotype patients with het-norm/low genotype (83.3%), remained unchanged with norm (34.0%) and decreased in het-norm/high women (10.0%; P<0.0001). Pregnancy rates were significantly higher with norm (38.6%) than het-norm/low (22.2%, p = 0.001). FMR1 sub-genotype het-norm/low is strongly associated with autoimmunity and decreased pregnancy chances in IVF, reaffirming the importance of the distal long arm of the X chromosome (FMR1 maps at Xq27.3) for autoimmunity, ovarian function and, likely, pregnancy chance with IVF.	[Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.] CHR, New York, NY USA; [Gleicher, Norbert; Weghofer, Andrea; Lee, Irene H.; Barad, David H.] Fdn Reprod Med, New York, NY USA; [Gleicher, Norbert] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Weghofer, Andrea] Univ Vienna, Sch Med, Dept Obstet & Gynecol, Vienna, Austria; [Barad, David H.] Albert Einstein Coll Med, Dept Epidemiol & Social Med, New York, NY USA; [Barad, David H.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, New York, NY USA	Yale University; University of Vienna; Yeshiva University; Yeshiva University	Gleicher, N (corresponding author), CHR, New York, NY USA.	ngleicher@thechr.com; dbarad@thechr.com	Barad, David/AAF-4332-2021		Foundation for Reproductive Medicine; Center for Human Reproduction	Foundation for Reproductive Medicine; Center for Human Reproduction	This work was supported by the Foundation for Reproductive Medicine and by intramural funds from the Center for Human Reproduction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ASRM PRACT COMM, 1999, ANT ANT DO NOT AFF 4; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P781, DOI 10.1210/jc.2005-2153; BANNATYNE P, 1990, INT J GYNECOL PATHOL, V9, P191, DOI 10.1097/00004347-199007000-00001; Barad DH, 2007, OBSTET GYNECOL, V109, P1404, DOI 10.1097/01.AOG.0000264065.37661.a0; Barad DH, 2009, FERTIL STERIL, V91, P1553, DOI 10.1016/j.fertnstert.2008.09.069; BARAD DH, 2010, RBMONLINE IN PRESS; Barad DH, 2009, FERTIL STERIL, V92, pS105; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Bodega B, 2006, HUM REPROD, V21, P952, DOI 10.1093/humrep/dei432; Bretherick KL, 2005, HUM GENET, V117, P376, DOI 10.1007/s00439-005-1326-8; Coulam CB, 2000, FERTIL STERIL, V74, P631; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Fenichel P, 1999, LANCET, V353, P2210, DOI 10.1016/S0140-6736(99)00256-1; FRISCHMUTH KH, 2010, FERTIL STERIL, V93, P2291; Geva E, 1997, FERTIL STERIL, V67, P599, DOI 10.1016/S0015-0282(97)81351-9; GLEICHER N, 1993, AUTOIMMUNITY, V16, P115, DOI 10.3109/08916939308993318; Gleicher N, 1999, RHEUMATOLOGY, V38, P485, DOI 10.1093/rheumatology/38.6.485; Gleicher N, 2007, AUTOIMMUN REV, V7, P42, DOI 10.1016/j.autrev.2007.06.001; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P768, DOI 10.1016/j.rbmo.2010.02.020; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P485, DOI 10.1016/j.rbmo.2009.12.017; Gleicher N, 2009, REPROD BIOMED ONLINE, V19, P385, DOI 10.1016/S1472-6483(10)60173-3; Gleicher N, 2009, HUM REPROD, V24, P2395, DOI 10.1093/humrep/dep256; Gleicher N, 2009, ACTA OBSTET GYN SCAN, V88, P1024, DOI 10.1080/00016340903171058; Gleicher N, 2009, MENOPAUSE, V16, P760, DOI 10.1097/gme.0b013e318193c48b; Gleicher N, 2009, FERTIL STERIL, V91, P1707, DOI 10.1016/j.fertnstert.2008.01.099; Gleicher N, 2009, FERTIL STERIL, V91, P1700, DOI 10.1016/j.fertnstert.2008.01.098; Hill JA, 2000, FERTIL STERIL, V74, P439, DOI 10.1016/S0015-0282(00)00705-6; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Hornstein MD, 2000, FERTIL STERIL, V74, P635, DOI 10.1016/S0015-0282(00)01529-6; Hundscheid RDL, 2001, HUM REPROD, V16, P457, DOI 10.1093/humrep/16.3.457; KIM YJ, 2010, ARCH GYNECOL OBSTET; KUIVASAARIPIRIN.P, 2010, GYNECOL ENDOCRINOL; La Marca A, 2009, J CLIN ENDOCR METAB, V94, P3816, DOI 10.1210/jc.2009-0817; Larizza D, 2009, J AUTOIMMUN, V33, P25, DOI 10.1016/j.jaut.2009.03.002; LONDSDALE RN, 1991, HISTOPATHOLOGY, V19, P77; Marozzi A, 2000, HUM GENET, V107, P304, DOI 10.1007/s004390000364; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; OTT J, 2010, FERTIL STER IN PRESS; Persani L, 2009, J AUTOIMMUN, V33, P35, DOI 10.1016/j.jaut.2009.03.004; Pessach IM, 2009, J AUTOIMMUN, V33, P17, DOI 10.1016/j.jaut.2009.03.003; Segars JH, 2010, J CLIN ENDOCR METAB, V95, P2058, DOI 10.1210/jc.2010-0518; Singer T, 2009, FERTIL STERIL, V91, P2616, DOI 10.1016/j.fertnstert.2008.03.034; Singh RR, 1998, J CLIN INVEST, V102, P1841, DOI 10.1172/JCI3872; Sutmuller M, 1999, CLIN EXP IMMUNOL, V115, P275, DOI 10.1046/j.1365-2249.1999.00798.x; Urman B, 2004, REPROD BIOMED ONLINE, V8, P419, DOI 10.1016/S1472-6483(10)60926-1; VANGELDEREN CJ, 1993, J REPROD MED, V38, P381; Wall JR, 2010, ENDOKRYNOL POL, V61, P222; Welt CK, 2004, J CLIN ENDOCR METAB, V89, P4569, DOI 10.1210/jc.2004-0347; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004; ENTREZ GENE; 2004, HUM REPROD, V19, P41	54	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15303	10.1371/journal.pone.0015303	http://dx.doi.org/10.1371/journal.pone.0015303			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179569	Green Published, gold, Green Submitted			2022-12-25	WOS:000285381200025
J	Seong, KH; Akimaru, H; Dai, P; Nomura, T; Okada, M; Ishii, S				Seong, Ki-Hyeon; Akimaru, Hiroshi; Dai, Ping; Nomura, Teruaki; Okada, Masahiro; Ishii, Shunsuke			Inhibition of the Nuclear Import of Cubitus Interruptus by Roadkill in the Presence of Strong Hedgehog Signal	PLOS ONE			English	Article							PROTEIN-KINASE-A; KINESIN-RELATED PROTEIN; REQUIRES PHOSPHORYLATION; GENE-EXPRESSION; DROSOPHILA; TRANSCRIPTION; TRANSDUCTION; SUPPRESSOR; PATHWAY; DEGRADATION	Hedgehog (Hh) signalling plays an important role in various developmental processes by activating the Cubitus interruptus (Ci)/Glioblastoma (Gli) family of transcription factors. In the process of proper pattern formation, Ci activity is regulated by multiple mechanisms, including processing, trafficking, and degradation. However, it remains elusive how Ci distinctly recognizes the strong and moderate Hh signals. Roadkill (Rdx) induces Ci degradation in the anterior region of the Drosophila wing disc. Here, we report that Rdx inhibited Ci activity by two different mechanisms. In the region abutting the anterior/posterior boundary, which receives strong Hh signal, Rdx inhibited the nuclear import of Ci by releasing importin alpha 3 from Ci. In this region, Rdx negatively regulated the expression of transcription factor Knot/Collier. In farther anterior regions receiving moderate levels of Hh signal, Rdx induced Ci degradation, as reported previously. Thus, two different mechanisms by which Rdx negatively regulates Ci may play an important role in the fine-tuning of Hh responses.	[Seong, Ki-Hyeon; Akimaru, Hiroshi; Dai, Ping; Nomura, Teruaki; Okada, Masahiro; Ishii, Shunsuke] RIKEN Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki, Japan	RIKEN	Seong, KH (corresponding author), RIKEN Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki, Japan.	sishii@rtc.riken.jp	Ishii, Shunsuke/A-5271-2016	Ishii, Shunsuke/0000-0002-6530-2478; Seong, Ki-Hyeon/0000-0002-0606-8896	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23370079] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Dai P, 2003, DEV CELL, V4, P917, DOI 10.1016/S1534-5807(03)00158-8; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Dussillol-Godar F, 2006, DEV BIOL, V291, P53, DOI 10.1016/j.ydbio.2005.12.004; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; LEPAGE T, 1995, NATURE, V373, P711, DOI 10.1038/373711a0; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Methot N, 2000, DEVELOPMENT, V127, P4001; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Pignoni F, 1997, DEVELOPMENT, V124, P271; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Rabut G., 2005, LIVE CELL IMAGING LA, P101; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Sisson BE, 2006, DEV BIOL, V294, P258, DOI 10.1016/j.ydbio.2006.02.050; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Smelkinson MG, 2007, DEV CELL, V13, P481, DOI 10.1016/j.devcel.2007.09.006; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang GL, 2000, GENE DEV, V14, P2893, DOI 10.1101/gad.843900; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; XU T, 1993, DEVELOPMENT, V117, P1223; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	63	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15365	10.1371/journal.pone.0015365	http://dx.doi.org/10.1371/journal.pone.0015365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179535	Green Published, Green Submitted, gold			2022-12-25	WOS:000285340000024
J	Tamada, K; Tomonaga, S; Hatanaka, F; Nakai, N; Takao, K; Miyakawa, T; Nakatani, J; Takumi, T				Tamada, Kota; Tomonaga, Shozo; Hatanaka, Fumiyuki; Nakai, Nobuhiro; Takao, Keizo; Miyakawa, Tsuyoshi; Nakatani, Jin; Takumi, Toru			Decreased Exploratory Activity in a Mouse Model of 15q Duplication Syndrome; Implications for Disturbance of Serotonin Signaling	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; TRANSPORTER KNOCKOUT MICE; 5-HT TRANSPORTER; AUTISTIC DISORDER; CELL-CYCLE; RECEPTOR; BEHAVIOR; DOPAMINE; ANXIETY; BRAIN	Autism spectrum disorders (ASDs) have garnered significant attention as an important grouping of developmental brain disorders. Recent genomic studies have revealed that inherited or de novo copy number variations (CNVs) are significantly involved in the pathophysiology of ASDs. In a previous report from our laboratory, we generated mice with CNVs as a model of ASDs, with a duplicated mouse chromosome 7C that is orthologous to human chromosome 15q11-13. Behavioral analyses revealed paternally duplicated (patDp/+) mice displayed abnormal behaviors resembling the symptoms of ASDs. In the present study, we extended these findings by performing various behavioral tests with C57BL/6J patDp/+ mice, and comprehensively measuring brain monoamine levels with ex vivo high performance liquid chromatography. Compared with wild-type controls, patDp/+ mice exhibited decreased locomotor and exploratory activities in the open field test, Y-maze test, and fear-conditioning test. Furthermore, their decreased activity levels overcame increased appetite induced by 24 hours of food deprivation in the novelty suppressed feeding test. Serotonin levels in several brain regions of adult patDp/+ mice were lower than those of wild-type control, with no concurrent changes in brain levels of dopamine or norepinephrine. Moreover, analysis of monoamines in postnatal developmental stages demonstrated reduced brain levels of serotonin in young patDp/+ mice. These findings suggest that a disrupted brain serotonergic system, especially during postnatal development, may generate the phenotypes of patDp/+ mice.	[Tamada, Kota; Tomonaga, Shozo; Hatanaka, Fumiyuki; Nakai, Nobuhiro; Nakatani, Jin; Takumi, Toru] Osaka Biosci Inst, Suita, Osaka 565, Japan; [Tamada, Kota; Nakai, Nobuhiro] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Tamada, Kota; Hatanaka, Fumiyuki; Nakai, Nobuhiro; Takumi, Toru] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Kyoto, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med, Aichi, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Behav Patterns, Okazaki, Aichi 444, Japan; [Miyakawa, Tsuyoshi; Takumi, Toru] Japan Sci & Technol Agcy, Saitama, Japan	Kyoto University; Hiroshima University; Kyoto University; Fujita Health University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Tamada, K (corresponding author), Osaka Biosci Inst, Suita, Osaka 565, Japan.	takumi@hiroshima-u.ac.jp	Takao, Keizo/B-9527-2008; Tomonaga, Shozo/S-3307-2018; Miyakawa, Tsuyoshi/A-7741-2008	Takao, Keizo/0000-0002-4734-3583; Tomonaga, Shozo/0000-0003-0888-1407; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Nakai, Nobuhiro/0000-0002-7171-230X	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Integrative Brain Research (IBR-shien); Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Foundation for Growth Science; Sankyo Foundation of Life Science; Mitsubishi Pharma Research Foundation; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation; Uehara Memorial Foundation; Novartis Foundation (Japan) for the promotion of Science; Nippon Boehringer Ingelheim Co., Ltd; Grants-in-Aid for Scientific Research [22780240] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Integrative Brain Research (IBR-shien); Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Foundation for Growth Science; Sankyo Foundation of Life Science; Mitsubishi Pharma Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Novartis Foundation (Japan) for the promotion of Science(Novartis); Nippon Boehringer Ingelheim Co., Ltd(Boehringer Ingelheim); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	S.T. and J.N. were supported by a Japan Society for the Promotion of Science fellowship. This work was supported in part by a grant from the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Integrative Brain Research (IBR-shien), Core Research for Evolutional Science and Technology of Japan Science and Technology Agency, and by research grants from the Foundation for Growth Science, the Sankyo Foundation of Life Science, the Mitsubishi Pharma Research Foundation, the Takeda Science Foundation, the Astellas Foundation for Research on Metabolic Disorders, the Naito Foundation, the Uehara Memorial Foundation, the Novartis Foundation (Japan) for the promotion of Science, and Nippon Boehringer Ingelheim Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Ansorge MS, 2008, J NEUROSCI, V28, P199, DOI 10.1523/JNEUROSCI.3973-07.2008; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Caston J, 1998, BRAIN RES, V808, P232, DOI 10.1016/S0006-8993(98)00847-6; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Chugani DC, 1999, ANN NEUROL, V45, P287, DOI 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Cook EH, 1997, AM J HUM GENET, V60, P928; Crandall JE, 2007, J NEUROSCI, V27, P3813, DOI 10.1523/JNEUROSCI.5124-06.2007; Croonenberghs J, 2000, NEUROPSYCHOPHARMACOL, V22, P275, DOI 10.1016/S0893-133X(99)00131-1; Depienne C, 2009, BIOL PSYCHIAT, V66, P349, DOI 10.1016/j.biopsych.2009.01.025; Devlin B, 2005, MOL PSYCHIATR, V10, P1110, DOI 10.1038/sj.mp.4001724; Fabre V, 2000, EUR J NEUROSCI, V12, P2299, DOI 10.1046/j.1460-9568.2000.00126.x; Frederick AL, 2009, DEV NEUROSCI-BASEL, V31, P7, DOI 10.1159/000207490; Glickman G, 2010, NEUROSCI BIOBEHAV R, V34, P755, DOI 10.1016/j.neubiorev.2009.11.017; Hedlund PB, 2009, PSYCHOPHARMACOLOGY, V206, P345, DOI 10.1007/s00213-009-1626-0; Hollander E, 2005, NEUROPSYCHOPHARMACOL, V30, P582, DOI 10.1038/sj.npp.1300627; Holmes A, 2002, PSYCHOPHARMACOLOGY, V161, P160, DOI 10.1007/s00213-002-1024-3; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Holmes A, 2001, NEUROSCI BIOBEHAV R, V25, P261, DOI 10.1016/S0149-7634(01)00012-4; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Kalueff AV, 2007, GENES BRAIN BEHAV, V6, P389, DOI 10.1111/j.1601-183X.2006.00270.x; Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003; Kalueff AV, 2007, BRAIN RES, V1169, P87, DOI 10.1016/j.brainres.2007.07.009; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Liu RJ, 2000, BRAIN RES, V873, P34, DOI 10.1016/S0006-8993(00)02468-9; Matsuo N, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00029; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Nakajima R, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-7; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Nakatani Y, 2008, EUR J NEUROSCI, V27, P2466, DOI 10.1111/j.1460-9568.2008.06201.x; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Ohtani N, 2003, J NEUROSCI, V23, P2840; Okado N, 2001, BRAIN DEV-JPN, V23, pS11, DOI 10.1016/S0387-7604(01)00371-0; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Pierce K, 2001, BIOL PSYCHIAT, V49, P655, DOI 10.1016/S0006-3223(00)01008-8; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sharp T, 2007, TRENDS PHARMACOL SCI, V28, P629, DOI 10.1016/j.tips.2007.10.009; Sotty F, 2009, NEUROPHARMACOLOGY, V57, P18, DOI 10.1016/j.neuropharm.2009.03.016; Stanwood GD, 2007, J NEUROSCI, V27, P152, DOI 10.1523/JNEUROSCI.4591-06.2007; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; TAKAO K, 2006, J VIS EXP; Takumi T, 2010, BRAIN DEV-JPN, V32, P753, DOI 10.1016/j.braindev.2010.05.001; TODD RD, 1992, BIOL PSYCHIAT, V31, P794, DOI 10.1016/0006-3223(92)90311-M; Tsujimura A, 2008, FRONT BEHAV NEUROSCI, V2, DOI 10.3389/neuro.08.004.2008; UMEDA T, PLOS ONE IN PRESS; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012; Zhang L, 2005, CEREB CORTEX, V15, P74, DOI 10.1093/cercor/bhh110; Zhao S, 2006, NEUROSCIENCE, V140, P321, DOI 10.1016/j.neuroscience.2006.01.049	56	83	87	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e15126	10.1371/journal.pone.0015126	http://dx.doi.org/10.1371/journal.pone.0015126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179543	Green Published, Green Submitted, gold			2022-12-25	WOS:000285340000017
J	Schneider, MR; Dahlhoff, M; Horst, D; Hirschi, B; Trulzsch, K; Muller-Hocker, J; Vogelmann, R; Allgauer, M; Gerhard, M; Steininger, S; Wolf, E; Kolligs, FT				Schneider, Marlon R.; Dahlhoff, Maik; Horst, David; Hirschi, Benjamin; Truelzsch, Konrad; Mueller-Hoecker, Josef; Vogelmann, Roger; Allgaeuer, Michael; Gerhard, Markus; Steininger, Sylvia; Wolf, Eckhard; Kolligs, Frank T.			A Key Role for E-cadherin in Intestinal Homeostasis and Paneth Cell Maturation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; IN-VIVO; CROHNS-DISEASE; N-CADHERIN; STEM-CELLS; GASTROINTESTINAL-TRACT; JUNCTIONAL COMPLEX; SIGNALING PATHWAY; GENE-EXPRESSION; FGF RECEPTOR	Background: E-cadherin is a major component of adherens junctions. Impaired expression of E-cadherin in the small intestine and colon has been linked to a disturbed intestinal homeostasis and barrier function. Down-regulation of E-cadherin is associated with the pathogenesis of infections with enteropathogenic bacteria and Crohn's disease. Methods and Findings: To genetically clarify the function of E-cadherin in intestinal homeostasis and maintenance of the epithelial defense line, the Cdh1 gene was conditionally inactivated in the mouse intestinal epithelium. Inactivation of the Cdh1 gene in the small intestine and colon resulted in bloody diarrhea associated with enhanced apoptosis and cell shedding, causing life-threatening disease within 6 days. Loss of E-cadherin led cells migrate faster along the crypt-villus axis and perturbed cellular differentiation. Maturation and positioning of goblet cells and Paneth cells, the main cell lineage of the intestinal innate immune system, was severely disturbed. The expression of anti-bacterial cryptidins was reduced and mice showed a deficiency in clearing enteropathogenic bacteria from the intestinal lumen. Conclusion: These results highlight the central function of E-cadherin in the maintenance of two components of the intestinal epithelial defense: E-cadherin is required for the proper function of the intestinal epithelial lining by providing mechanical integrity and is a prerequisite for the proper maturation of Paneth and goblet cells.	[Schneider, Marlon R.; Dahlhoff, Maik; Wolf, Eckhard] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Munich, Germany; [Schneider, Marlon R.; Dahlhoff, Maik; Wolf, Eckhard] Univ Munich, Lab Funct Genome Anal LAFUGA, Gene Ctr, Munich, Germany; [Horst, David; Mueller-Hoecker, Josef] Univ Munich, Inst Pathol, D-8000 Munich, Germany; [Hirschi, Benjamin; Kolligs, Frank T.] Univ Munich, Klinikum Grosshadern, Dept Med 2, D-8000 Munich, Germany; [Truelzsch, Konrad] Univ Munich, Inst Microbiol, Max Von Pettenkofer Inst, Munich, Germany; [Vogelmann, Roger; Allgaeuer, Michael; Gerhard, Markus; Steininger, Sylvia] Tech Univ Munich, Dept Med 2, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; Technical University of Munich	Schneider, MR (corresponding author), Univ Munich, Inst Mol Anim Breeding & Biotechnol, Munich, Germany.	fkolligs@med.uni-muenchen.de	Gerhard, Markus/P-8996-2019; Dahlhoff, Maik/AGH-1182-2022; Gerhard, Markus/N-3387-2014	Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Wolf, Eckhard/0000-0002-0430-9510; Allgaeuer, Michael/0000-0003-4518-7887; Schneider, Marlon/0000-0002-9570-3491; Hirschi, Benjamin/0000-0002-1046-8307; Dahlhoff, Maik/0000-0001-9189-7631; Trulzsch, Konrad/0000-0002-1937-5043	Else Kroner-Fresenius-Stiftung [P50/08//A43/08]; University of Munich [865438-6]	Else Kroner-Fresenius-Stiftung; University of Munich	This work was supported by a grant from the Else Kroner-Fresenius-Stiftung (http://www.ekfs.de) to FTK and MRS (P50/08//A43/08) and a grant from the University of Munich (www.uni-muenchen.de) to FTK (865438-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2007, GASTROENTEROLOGY, V133, P1755, DOI 10.1053/j.gastro.2007.10.029; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; Chambers FG, 1997, INFECT IMMUN, V65, P3561, DOI 10.1128/IAI.65.9.3561-3570.1997; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fouquet S, 2004, J BIOL CHEM, V279, P43061, DOI 10.1074/jbc.M405095200; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jankowski JAZ, 1998, LAB INVEST, V78, P1155; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; KEIGHLEY MRB, 1982, GASTROENTEROLOGY, V83, P1271; Kottke MD, 2006, J CELL SCI, V119, P797, DOI 10.1242/jcs.02888; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Laukoetter MG, 2008, WORLD J GASTROENTERO, V14, P401, DOI 10.3748/wjg.14.401; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Loessner H, 2007, CELL MICROBIOL, V9, P1529, DOI 10.1111/j.1462-5822.2007.00890.x; Meddings J, 2008, GUT, V57, P438, DOI 10.1136/gut.2007.143172; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Oellerich MF, 2007, INFECT IMMUN, V75, P3802, DOI 10.1128/IAI.00419-07; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Smits R, 2000, GASTROENTEROLOGY, V119, P1045, DOI 10.1053/gast.2000.18162; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tinkle CL, 2004, P NATL ACAD SCI USA, V101, P552, DOI 10.1073/pnas.0307437100; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Young P, 2003, EMBO J, V22, P5723, DOI 10.1093/emboj/cdg560; Zbar AP, 2004, J GASTROENTEROL, V39, P413, DOI 10.1007/s00535-004-1335-8	54	129	131	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14325	10.1371/journal.pone.0014325	http://dx.doi.org/10.1371/journal.pone.0014325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179475	gold, Green Published, Green Submitted			2022-12-25	WOS:000285292500007
J	Cadet, JL; Brannock, C; Krasnova, IN; Ladenheim, B; Mccoy, MT; Chou, J; Lehrmann, E; Wood, WH; Becker, KG; Wang, Y				Cadet, Jean Lud; Brannock, Christie; Krasnova, Irina N.; Ladenheim, Bruce; McCoy, Michael T.; Chou, Jenny; Lehrmann, Elin; Wood, William H.; Becker, Kevin G.; Wang, Yun			Methamphetamine-Induced Dopamine- Independent Alterations in Striatal Gene Expression in the 6-Hydroxydopamine Hemiparkinsonian Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; FENFLURAMINE-INDUCED ACTIVATION; DA UPTAKE SITES; NEUROMEDIN-U; GROWTH-FACTOR; STRIATOPALLIDAL NEURONS; PARKINSONS-DISEASE; GLUTAMATE RELEASE; SUBSTANTIA-NIGRA	Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle are used extensively as a model of Parkinson's disease. The present experiments sought to identify genes that were affected in the dopamine (DA)-denervated striatum after 6-hydroxydopamine-induced destruction of the nigrostriatal dopaminergic pathway in the rat. We also examined whether a single injection of methamphetamine (METH) (2.5 mg/kg) known to cause changes in gene expression in the normally DA-innervated striatum could still influence striatal gene expression in the absence of DA. Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle resulted in METH-induced rotational behaviors ipsilateral to the lesioned side and total striatal DA depletion on the lesioned side. This injection also caused decrease in striatal serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels. DA depletion was associated with increases in 5-HIAA/5-HT ratios that were potentiated by the METH injection. Microarray analyses revealed changes (+/- 1.7-fold, p<0.025) in the expression of 67 genes on the lesioned side in comparison to the intact side of the saline-treated hemiparkinsonian animals. These include follistatin, neuromedin U, and tachykinin 2 which were up-regulated. METH administration caused increases in the expression of c-fos, Egr1, and Nor-1 on the intact side. On the DA-depleted side, METH administration also increased the expression of 61 genes including Pdgf-d and Cox-2. There were METH-induced changes in 16 genes that were common in the DA-innervated and DA-depleted sides. These include c-fos and Nor-1 which show greater changes on the normal DA side. Thus, the present study documents, for the first time, that METH mediated DA-independent changes in the levels of transcripts of several genes in the DA-denervated striatum. Our results also implicate 5-HT as a potential player in these METH-induced alterations in gene expression because the METH injection also caused significant increases in 5-HIAA/5-HT ratios on the DA-depleted side.	[Cadet, Jean Lud; Brannock, Christie; Krasnova, Irina N.; Ladenheim, Bruce; McCoy, Michael T.; Chou, Jenny; Wang, Yun] NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA; [Lehrmann, Elin; Wood, William H.; Becker, Kevin G.] NIDA, Gene Express & Genom Unit, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Cadet, JL (corresponding author), NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA.	jcadet@intra.nida.nih.gov		Lehrmann, Elin/0000-0002-9869-9475; Becker, Kevin/0000-0002-6794-6656	National Institute on Drug Abuse and National Institute of Aging, National Institutes of Health (NIH)/Department of Health and Human Services (DHHS); NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000174, ZIADA000461, ZIADA000429, ZIADA000552, ZIADA000576] Funding Source: NIH RePORTER	National Institute on Drug Abuse and National Institute of Aging, National Institutes of Health (NIH)/Department of Health and Human Services (DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was supported by Intramural Research Programs of National Institute on Drug Abuse and National Institute of Aging, National Institutes of Health (NIH)/Department of Health and Human Services (DHHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEKAWA T, 1994, BRAIN RES, V643, P276, DOI 10.1016/0006-8993(94)90033-7; Adams DH, 2005, MOL BRAIN RES, V133, P131, DOI 10.1016/j.molbrainres.2004.10.005; Adams DH, 2001, NEUROSCIENCE, V102, P843, DOI 10.1016/S0306-4522(00)00530-3; ALTAR CA, 1987, J NEUROCHEM, V48, P390, DOI 10.1111/j.1471-4159.1987.tb04106.x; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; ANGULO JA, 1991, MOL BRAIN RES, V11, P161, DOI 10.1016/0169-328X(91)90117-G; ANGULO JA, 1986, EUR J PHARMACOL, V130, P341, DOI 10.1016/0014-2999(86)90290-6; Azdad K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006908; BEAN AJ, 1989, J NEUROSCI, V9, P4430; Beauvais G, 2010, BRAIN RES, V1318, P1, DOI 10.1016/j.brainres.2009.12.083; BERGER K, 1991, BRAIN RES BULL, V26, P301, DOI 10.1016/0361-9230(91)90242-C; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Berke JD, 1998, J NEUROSCI, V18, P5301, DOI 10.1523/JNEUROSCI.18-14-05301.1998; Bernard DJ, 2001, RECENT PROG HORM RES, V56, P417, DOI 10.1210/rp.56.1.417; Bilezikjian LM, 2004, MOL CELL ENDOCRINOL, V225, P29, DOI 10.1016/j.mce.2004.02.010; Bilezikjian LM, 2001, CLIN EXP PHARMACOL P, V28, P244, DOI 10.1046/j.1440-1681.2001.03422.x; Bilezikjian LM, 2006, REPRODUCTION, V132, P207, DOI 10.1530/rep.1.01073; Bottner M, 2006, J NEUROENDOCRINOL, V18, P97, DOI 10.1111/j.1365-2826.2005.01384.x; Budhiraja S, 2009, FUND CLIN PHARMACOL, V23, P149, DOI 10.1111/j.1472-8206.2009.00667.x; BURGUNDER JM, 1989, NEUROSCIENCE, V32, P323, DOI 10.1016/0306-4522(89)90081-X; Bustamante D, 2002, J NEUROCHEM, V83, P645, DOI 10.1046/j.1471-4159.2002.01171.x; Cadet JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007812; CADET JL, 1992, BRAIN RES, V595, P316, DOI 10.1016/0006-8993(92)91066-N; CADET JL, 1992, MOL BRAIN RES, V12, P59, DOI 10.1016/0169-328X(92)90068-M; Cadet JL, 2001, SYNAPSE, V41, P40, DOI 10.1002/syn.1058; CAMERON VA, 1994, ENDOCRINOLOGY, V134, P799, DOI 10.1210/en.134.2.799; CAMPBELL K, 1992, P NATL ACAD SCI USA, V89, P10489, DOI 10.1073/pnas.89.21.10489; Cardoso F, 2009, NEUROL CLIN, V27, P719, DOI 10.1016/j.ncl.2009.04.001; CASTEL MN, 1994, EUR J NEUROSCI, V6, P646, DOI 10.1111/j.1460-9568.1994.tb00310.x; Centonze D, 2005, NEUROSCIENCE, V133, P831, DOI 10.1016/j.neuroscience.2005.03.006; Chritin M, 1996, EUR J NEUROSCI, V8, P2511, DOI 10.1111/j.1460-9568.1996.tb01545.x; CHRITIN M, 1993, MOL BRAIN RES, V19, P318, DOI 10.1016/0169-328X(93)90132-9; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; CONLON JM, 1988, J NEUROCHEM, V51, P988, DOI 10.1111/j.1471-4159.1988.tb01837.x; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DOMIN J, 1987, PEPTIDES, V8, P779, DOI 10.1016/0196-9781(87)90058-1; El Atifi-Borel M, 2009, NEUROBIOL DIS, V34, P340, DOI 10.1016/j.nbd.2009.02.002; Enge M, 2003, NEUROCHEM RES, V28, P271, DOI 10.1023/A:1022421001288; Fahn S, 2008, MOVEMENT DISORD, V23, pS497, DOI 10.1002/mds.22028; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Funa K, 1996, NEUROSCIENCE, V74, P825, DOI 10.1016/0306-4522(96)00152-2; Garcia-Arencibia M, 2008, NEUROSCI LETT, V438, P10, DOI 10.1016/j.neulet.2008.04.041; Gardier AM, 2000, J NEUROCHEM, V74, P1363, DOI 10.1046/j.1471-4159.2000.0741363.x; Gartlon J, 2004, PSYCHOPHARMACOLOGY, V177, P1, DOI 10.1007/s00213-004-1918-3; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1991, J NEUROSCI, V11, P1016; GRAHAM WC, 1990, BRAIN RES, V514, P93, DOI 10.1016/0006-8993(90)90439-I; Hanson GR, 1999, MOL BRAIN RES, V66, P111, DOI 10.1016/S0169-328X(99)00033-9; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Herrera-Marschitz M, 2010, PROG NEUROBIOL, V90, P176, DOI 10.1016/j.pneurobio.2009.01.005; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Ishida Y, 1998, BRAIN RES, V809, P107, DOI 10.1016/S0006-8993(98)00874-9; Jayanthi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006092; KARSTAEDT PJ, 1994, EXP NEUROL, V126, P25, DOI 10.1006/exnr.1994.1039; Kita T, 2000, NEUROPHARMACOLOGY, V39, P399, DOI 10.1016/S0028-3908(99)00175-6; Konradi C, 2004, NEUROBIOL DIS, V17, P219, DOI 10.1016/j.nbd.2004.07.005; Konradi C, 1996, J NEUROSCI, V16, P4231; Krasnova IN, 2008, GENES BRAIN BEHAV, V7, P193, DOI 10.1111/j.1601-183X.2007.00338.x; Krasnova IN, 2007, NEUROTOX RES, V11, P107, DOI 10.1007/BF03033390; Krasnova IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008790; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; KUCZENSKI R, 1995, J NEUROSCI, V15, P1308; LI SJ, 1990, MOL BRAIN RES, V8, P219, DOI 10.1016/0169-328X(90)90020-E; MALENDOWICZ LK, 1994, NEUROPEPTIDES, V26, P47, DOI 10.1016/0143-4179(94)90092-2; Meshul CK, 1999, NEUROSCIENCE, V88, P1, DOI 10.1016/S0306-4522(98)00189-4; Meurers BH, 2009, J NEUROSCI, V29, P6828, DOI 10.1523/JNEUROSCI.5310-08.2009; MINAMINO N, 1988, BIOCHEM BIOPH RES CO, V156, P355, DOI 10.1016/S0006-291X(88)80848-9; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; MORRIS BJ, 1989, J MOL NEUROSCI, V1, P9, DOI 10.1007/BF02896851; Mukerji SS, 2007, J CEREBR BLOOD F MET, V27, P1161, DOI 10.1038/sj.jcbfm.9600423; NASH JF, 1992, BRAIN RES, V581, P237, DOI 10.1016/0006-8993(92)90713-J; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; PAUL ML, 1992, J NEUROSCI, V12, P3729, DOI 10.1523/jneurosci.12-10-03729.1992; PAUL ML, 1995, NEUROSCIENCE, V66, P347, DOI 10.1016/0306-4522(94)00582-P; Paulsen RE, 1995, J MOL NEUROSCI, V6, P249, DOI 10.1007/BF02736784; Peier A, 2009, ENDOCRINOLOGY, V150, P3101, DOI 10.1210/en.2008-1772; Rouillard C, 1996, MOL BRAIN RES, V37, P105, DOI 10.1016/0169-328X(95)00284-Y; Shan LX, 2000, J BIOL CHEM, V275, P39482, DOI 10.1074/jbc.C000522200; Shimada A, 1996, ANN NY ACAD SCI, V801, P361, DOI 10.1111/j.1749-6632.1996.tb17456.x; Simola N, 2009, NEUROSCIENCE, V158, P1625, DOI 10.1016/j.neuroscience.2008.11.009; Sjoborg M, 1998, EXP BRAIN RES, V119, P245, DOI 10.1007/s002210050338; STEPHANS SE, 1994, SYNAPSE, V17, P203, DOI 10.1002/syn.890170310; Thomas DM, 2005, FASEB J, V19, P515, DOI 10.1096/fj.05-4873fje; Thomas DM, 2005, J PHARMACOL EXP THER, V313, P870, DOI 10.1124/jpet.104.080242; Thomas DM, 2004, J NEUROCHEM, V88, P380, DOI 10.1046/j.1471-4159.2003.02182.x; Touchon JC, 2005, EXP NEUROL, V193, P131, DOI 10.1016/j.expneurol.2004.11.023; Tretter YP, 1996, NEUROREPORT, V7, P1819, DOI 10.1097/00001756-199607290-00026; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; WANG JQ, 1995, J PHARMACOL EXP THER, V273, P909; Wang JQ, 1996, BRAIN RES BULL, V39, P349, DOI 10.1016/0361-9230(96)00002-0; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Yang H, 2006, LIFE SCI, V78, P1940, DOI 10.1016/j.lfs.2005.08.001; ZETTERSTROM T, 1983, J NEUROCHEM, V41, P1769, DOI 10.1111/j.1471-4159.1983.tb00893.x; ZETTERSTROM T, 1986, BRAIN RES, V376, P1, DOI 10.1016/0006-8993(86)90893-0; ZHANG WQ, 1988, BRAIN RES, V461, P335, DOI 10.1016/0006-8993(88)90264-8	99	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15643	10.1371/journal.pone.0015643	http://dx.doi.org/10.1371/journal.pone.0015643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179447	Green Submitted, gold, Green Published			2022-12-25	WOS:000285246900049
J	Panosian, TD; Nannemann, DP; Watkins, GR; Phelan, VV; McDonald, WH; Wadzinski, BE; Bachmann, BO; Iverson, TM				Panosian, Timothy D.; Nannemann, David P.; Watkins, Guy R.; Phelan, Vanessa V.; McDonald, W. Hayes; Wadzinski, Brian E.; Bachmann, Brian O.; Iverson, Tina M.			Bacillus cereus Phosphopentomutase Is an Alkaline Phosphatase Family Member That Exhibits an Altered Entry Point into the Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOGLYCERATE MUTASE; MUSCLE PHOSPHOGLUCOMUTASE; BETA-PHOSPHOGLUCOMUTASE; CRYSTAL-STRUCTURES; XANTHINE-OXIDASE; WHEAT-GERM; MECHANISM; IDENTIFICATION; PHOSPHOHEXOMUTASE; CRYSTALLOGRAPHY	Bacterial phosphopentomutases (PPMs) are alkaline phosphatase superfamily members that interconvert alpha-D-ribose 5-phosphate (ribose 5-phosphate) and alpha-D-ribose 1-phosphate (ribose 1-phosphate). We investigated the reaction mechanism of Bacillus cereus PPM using a combination of structural and biochemical studies. Four high resolution crystal structures of B. cereus PPM revealed the active site architecture, identified binding sites for the substrate ribose 5-phosphate and the activator alpha-D-glucose 1,6-bisphosphate (glucose 1,6-bisphosphate), and demonstrated that glucose 1,6-bisphosphate increased phosphorylation of the active site residue Thr-85. The phosphorylation of Thr-85 was confirmed by Western and mass spectroscopic analyses. Biochemical assays identified Mn2+-dependent enzyme turnover and demonstrated that glucose 1,6-bisphosphate treatment increases enzyme activity. These results suggest that protein phosphorylation activates the enzyme, which supports an intermolecular transferase mechanism. We confirmed intermolecular phosphoryl transfer using an isotope relay assay in which PPM reactions containing mixtures of ribose 5-[O-18(3)] phosphate and [U-C-13(5)] ribose 5-phosphate were analyzed by mass spectrometry. This intermolecular phosphoryl transfer is seemingly counter to what is anticipated from phosphomutases employing a general alkaline phosphatase reaction mechanism, which are reported to catalyze intramolecular phosphoryl transfer. However, the two mechanisms may be reconciled if substrate encounters the enzyme at a different point in the catalytic cycle.	[Bachmann, Brian O.] Vanderbilt Univ, Dept Chem, Stevenson Ctr 7300, Nashville, TN 37235 USA; [Panosian, Timothy D.; Watkins, Guy R.; Wadzinski, Brian E.; Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [McDonald, W. Hayes; Bachmann, Brian O.; Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Bachmann, BO (corresponding author), Vanderbilt Univ, Dept Chem, Stevenson Ctr 7300, Box 1583, Nashville, TN 37235 USA.	brian.bachmann@vanderbilt.edu; tina.iverson@vanderbilt.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X; Nannemann, David/0000-0002-4946-3263; Bachmann, Brian/0000-0001-5815-1176; Phelan, Vanessa/0000-0001-7156-9294	National Institutes of Health [GM079419, GM077189, GM051366, DK070787, T32 NS07491, T32 GM008320, T90 DA022873, T32 GM07628]; Vanderbilt Institute of Chemical Biology; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, NCRR; NIGMS;  [P30EY008126]; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051366, T32GM007628, R01GM077189, R01GM079419, T32GM008320, R01GM051366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Institute of Chemical Biology; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM079419 (to T. M. I.), GM077189 (to B. O. B.), GM051366 (to B. E. W.), DK070787 (to B. E. W.), T32 NS07491 (to T. D. P.), T32 GM008320 (to T. D. P.), T90 DA022873 (to D. P. N.), and T32 GM07628 (to G. R. W.). This work was also supported by a pilot award funded by the Vanderbilt Institute of Chemical Biology (to B. O. B.).; Use of the LS-CAT beamline at the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, NCRR, Biomedical Technology Program, and NIGMS. A portion of this work used facilities that were supported by Vanderbilt Core Grant in Vision Research P30EY008126. We thank Dr. H. Alex Brown and Dr. John Exton for critical reading of the manuscript.	Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ball EG, 1939, J BIOL CHEM, V128, P51; BREATHNACH R, 1977, BIOCHEMISTRY-US, V16, P3054, DOI 10.1021/bi00633a002; BRITTON HG, 1968, BIOCHEM J, V110, P161, DOI 10.1042/bj1100161; BRITTON HG, 1971, BIOCHEMISTRY-US, V10, P4522, DOI 10.1021/bi00800a028; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; DAI JB, 1992, J BIOL CHEM, V267, P6322; Dai JY, 2006, BIOCHEMISTRY-US, V45, P7818, DOI 10.1021/bi060136v; DEGROOT H, 1985, BIOCHEM J, V230, P255, DOI 10.1042/bj2300255; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; Galperin MY, 2001, PROTEINS, V45, P318, DOI 10.1002/prot.1152; GATEHOUSE JA, 1977, BIOCHEMISTRY-US, V16, P3045, DOI 10.1021/bi00633a001; HAMMER-JESPERSEN K, 1970, European Journal of Biochemistry, V17, P397, DOI 10.1111/j.1432-1033.1970.tb01179.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KEMP BE, 1980, FEBS LETT, V110, P308, DOI 10.1016/0014-5793(80)80099-8; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Maliekal P, 2007, J BIOL CHEM, V282, P31844, DOI 10.1074/jbc.M706818200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nannemann DP, 2010, PROTEIN ENG DES SEL, V23, P607, DOI 10.1093/protein/gzq033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Panosian TD, 2010, ACTA CRYSTALLOGR F, V66, P811, DOI 10.1107/S1744309110017549; QIAN N, 1994, J BACTERIOL, V176, P5304, DOI 10.1128/JB.176.17.5304-5311.1994; Rasband W., 2009, IMAGE J; RAY WJ, 1976, BIOCHEMISTRY-US, V15, P4018, DOI 10.1021/bi00663a016; RAY WJ, 1964, J BIOL CHEM, V239, P1228; Regni C, 2006, J BIOL CHEM, V281, P15564, DOI 10.1074/jbc.M600590200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scism RA, 2010, CHEMBIOCHEM, V11, P67, DOI 10.1002/cbic.200900620; Segal I. H., 1976, BIOCH CALCULATIONS S, P291; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Tozzi MG, 2006, FEBS J, V273, P1089, DOI 10.1111/j.1742-4658.2006.05155.x; Wang J, 2006, PROTEIN SCI, V15, P2395, DOI 10.1110/ps.062351506; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	49	23	24	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8043	8054		10.1074/jbc.M110.201350	http://dx.doi.org/10.1074/jbc.M110.201350			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193409	Green Published, hybrid			2022-12-25	WOS:000288013300035
J	Tamura, K; Ohbayashi, N; Ishibashi, K; Fukuda, M				Tamura, Kanako; Ohbayashi, Norihiko; Ishibashi, Koutaro; Fukuda, Mitsunori			Structure-Function Analysis of VPS9-Ankyrin-repeat Protein (Varp) in the Trafficking of Tyrosinase-related Protein 1 in Melanocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAB BINDING-SPECIFICITY; MELANOSOME TRANSPORT; MYOSIN-VA; CRITICAL DETERMINANT; EXCHANGE FACTOR; DOMAIN; SLAC2-A/MELANOPHILIN; GTPASES; ORGANELLE; EFFECTOR	Because Varp (VPS9-ankyrin-repeat protein)/Ankrd27 specifically binds two small GTPases, Rab32 and Rab38, which redundantly regulate the trafficking of melanogenic enzymes in mammalian epidermal melanocytes, it has recently been implicated in the regulation of trafficking of a melanogenic enzyme tyrosinase-related protein 1 (Tyrp1) to melanosomes. However, the functional interaction between Rab32/38 and Varp and the involvement of the VPS9 domain (i.e. Rab21-GEF domain) in Tyrp1 trafficking have never been elucidated. In this study, we succeeded in identifying critical residues of Rab32/38 and Varp that are critical for the formation of the Rab32/38.Varp complex by performing Ala-based site-directed mutagenesis, and we discovered that a conserved Val residue in the switch II region of Rab32(Val-92) and Rab38(Val-78) is required for Varp binding activity and that its point mutant, Rab38(V78A), does not support Tyrp1 trafficking in Rab32/38-deficient melanocytes. We also identified two critical residues for Rab32/38 binding in the Varp ANKR1 domain and demonstrated that their point mutants, Varp(Q509A) and Varp(Y550A), do not support peripheral melanosomal distribution of Tyrp1 in Varp-deficient cells. Interestingly, the VPS9 domain point mutants, Varp(D310A) and Varp(Y350A), did support Tyrp1 trafficking in Varp-deficient cells, and knockdown of Rab21 had no effect on Tyrp1 distribution. We also found evidence for the functional interaction between a vesicle SNARE VAMP7/TI-VAMP and Varp in Tyrp1 trafficking. These results collectively indicated that both the Rab32/38 binding activity and VAMP7 binding activity of Varp are essential for trafficking of Tyrp1 in melanocytes but that activation of Rab21 by the VPS9 domain is not necessary for Tyrp1 trafficking.	[Tamura, Kanako; Ohbayashi, Norihiko; Ishibashi, Koutaro; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Grad Sch Life Sci, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology of Japan; Kato Memorial Bioscience Foundation; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [20113006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Bioscience Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology of Japan (to N. O. and M. F.), by a grant from the Global COE Program (Basic and Translational Research Center for Global Brain Science) from the Ministry of Education, Culture, Sports, and Technology of Japan (to N. O. and M. F.), and by a grant from the Kato Memorial Bioscience Foundation (to M. F.).; Supported by the Japan Society for the Promotion of Science.	Ando H, 2004, J BIOL CHEM, V279, P15427, DOI 10.1074/jbc.M313701200; Ando H, 2009, INT J MOL SCI, V10, P4428, DOI 10.3390/ijms10104428; Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Itzen A, 2008, STRUCTURE, V16, P1437, DOI 10.1016/j.str.2008.09.002; James P, 1996, GENETICS, V144, P1425; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kageyama A, 2004, J BIOL CHEM, V279, P27774, DOI 10.1074/jbc.M401786200; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Loftus SK, 2002, P NATL ACAD SCI USA, V99, P4471, DOI 10.1073/pnas.072087599; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Park M, 2007, CURR BIOL, V17, P2030, DOI 10.1016/j.cub.2007.10.051; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Tomita Y, 2004, AM J MED GENET C, V131C, P75, DOI 10.1002/ajmg.c.30036; Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x; Wang F, 2008, BIOCHEM BIOPH RES CO, V372, P162, DOI 10.1016/j.bbrc.2008.05.017; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810	49	49	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7507	7521		10.1074/jbc.M110.191205	http://dx.doi.org/10.1074/jbc.M110.191205			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21187289	hybrid, Green Published			2022-12-25	WOS:000287737300065
J	Lai, JF; Zindl, CL; Duffy, LB; Atkinson, TP; Jung, YW; van Rooijen, N; Waites, KB; Krause, DC; Chaplin, DD				Lai, Jen-Feng; Zindl, Carlene L.; Duffy, Lynn B.; Atkinson, T. Prescott; Jung, Yong Woo; van Rooijen, Nico; Waites, Ken B.; Krause, Duncan C.; Chaplin, David D.			Critical Role of Macrophages and Their Activation via MyD88-NF kappa B Signaling in Lung Innate Immunity to Mycoplasma pneumoniae	PLOS ONE			English	Article							NF-KAPPA-B; TOLL-LIKE-RECEPTORS; RESPIRATORY MYCOPLASMOSIS; PULMONARY INFLAMMATION; ALVEOLAR MACROPHAGES; POTENT INHIBITORS; BRONCHIAL-ASTHMA; STRUCTURAL CLASS; DENDRITIC CELLS; MICE	Mycoplasma pneumoniae (Mp), a common cause of pneumonia, is associated with asthma; however, the mechanisms underlying this association remain unclear. We investigated the cellular immune response to Mp in mice. Intranasal inoculation with Mp elicited infiltration of the lungs with neutrophils, monocytes and macrophages. Systemic depletion of macrophages, but not neutrophils, resulted in impaired clearance of Mp from the lungs. Accumulation and activation of macrophages were decreased in the lungs of MyD88(-/-) mice and clearance of Mp was impaired, indicating that MyD88 is a key signaling protein in the anti-Mp response. MyD88-dependent signaling was also required for the Mp-induced activation of NFkB, which was essential for macrophages to eliminate the microbe in vitro. Thus, MyD88-NF kappa B signaling in macrophages is essential for clearance of Mp from the lungs.	[Lai, Jen-Feng; Zindl, Carlene L.; Chaplin, David D.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [Zindl, Carlene L.; Duffy, Lynn B.; Jung, Yong Woo; Waites, Ken B.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Atkinson, T. Prescott] Univ Alabama, Dept Pediat, Birmingham, AL USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Krause, Duncan C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Vrije Universiteit Amsterdam; University System of Georgia; University of Georgia	Lai, JF (corresponding author), Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA.	dchaplin@uab.edu	Van Rooijen, Nico/Z-1578-2019	Zindl, Carlene/0000-0003-4841-3552; Chaplin, David/0000-0002-1354-3069	National Institutes of Health [5P01HL073907, 5R21AI083873, 5R01AI23362]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051, R01AI023362, R21AI083873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of this research were supported by National Institutes of Health grants 5P01HL073907 (DDC), 5R21AI083873 (TPA and KBW) and 5R01AI23362 (DCK). The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; BASEMAN JB, 1982, J BACTERIOL, V151, P1514, DOI 10.1128/JB.151.3.1514-1522.1982; Biscardi S, 2004, CLIN INFECT DIS, V38, P1341, DOI 10.1086/392498; CARTNER SC, 1995, INFECT IMMUN, V63, P4138, DOI 10.1128/IAI.63.10.4138-4142.1995; Chu HW, 2005, J IMMUNOL, V174, P5713, DOI 10.4049/jimmunol.174.9.5713; Chu HW, 2004, J INFECT DIS, V189, P1119, DOI 10.1086/382050; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Dallo SF, 1996, INFECT IMMUN, V64, P2595, DOI 10.1128/IAI.64.7.2595-2601.1996; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fayon M, 1999, ACTA PAEDIATR, V88, P1216, DOI 10.1080/080352599750030310; Fonseca-Aten M, 2005, AM J RESP CELL MOL, V32, P201, DOI 10.1165/rcmb.2004-0197OC; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; GIL JC, 1993, ANN ALLERGY, V70, P23; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hasselbring BM, 2006, P NATL ACAD SCI USA, V103, P16478, DOI 10.1073/pnas.0608051103; Hickman-Davis J, 1999, P NATL ACAD SCI USA, V96, P4953, DOI 10.1073/pnas.96.9.4953; Hickman-Davis JM, 2007, AM J RESP CELL MOL, V36, P103, DOI 10.1165/rcmb.2006-0049OC; HickmanDavis JM, 1997, INFECT IMMUN, V65, P2278, DOI 10.1128/IAI.65.6.2278-2282.1997; Hofmann AM, 2009, CURR OPIN IMMUNOL, V21, P679, DOI 10.1016/j.coi.2009.09.007; Jung YW, 2009, EUR J IMMUNOL, V39, P2281, DOI 10.1002/eji.200838985; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Katz B, 2004, CLIN LAB MED, V24, P627, DOI 10.1016/j.cll.2004.05.005; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kormann MSD, 2008, J ALLERGY CLIN IMMUN, V122, P86, DOI 10.1016/j.jaci.2008.04.039; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; KRAUSE DC, 1982, INFECT IMMUN, V35, P809, DOI 10.1128/IAI.35.3.809-817.1982; Kuroda E, 2002, J IMMUNOL, V168, P5477, DOI 10.4049/jimmunol.168.11.5477; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Martin RJ, 2006, CLIN CHEST MED, V27, P87, DOI 10.1016/j.ccm.2005.10.004; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; O'Dea KP, 2009, J IMMUNOL, V182, P1155, DOI 10.4049/jimmunol.182.2.1155; O'Dea KP, 2005, AM J RESP CRIT CARE, V172, P1119, DOI 10.1164/rccm.200504-605OC; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Romero-Arroyo CE, 1999, J BACTERIOL, V181, P1079, DOI 10.1128/JB.181.4.1079-1087.1999; Salvatore CM, 2007, INFECT IMMUN, V75, P236, DOI 10.1128/IAI.01249-06; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SEGGEV JS, 1986, ANN ALLERGY, V57, P263; Shimizu T, 2008, INFECT IMMUN, V76, P270, DOI 10.1128/IAI.00955-07; SIMBERKOFF MS, 1971, J EXP MED, V134, P1417, DOI 10.1084/jem.134.6.1417; Sleiman PMA, 2010, CURR OPIN PEDIATR, V22, P307, DOI 10.1097/MOP.0b013e328339553d; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Sutherland ER, 2010, J ALLERGY CLIN IMMUN, V126, P747, DOI 10.1016/j.jaci.2010.07.024; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waldo RH, 2006, J BACTERIOL, V188, P569, DOI 10.1128/JB.188.2.569-575.2006; WIKTORJEDRZEJCZAK W, 1982, J EXP MED, V156, P1516, DOI 10.1084/jem.156.5.1516; WILLIAMSON J, 1992, EPIDEMIOL INFECT, V109, P519, DOI 10.1017/S0950268800050512; Wubbel L, 1998, J INFECT DIS, V178, P1526, DOI 10.1086/314439; Xu X, 2006, AM J RESP CRIT CARE, V173, P219, DOI 10.1164/rccm.200507-1034OC; Yanagisawa S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-50	67	51	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14417	10.1371/journal.pone.0014417	http://dx.doi.org/10.1371/journal.pone.0014417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203444	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200004
J	Proulx, MJ				Proulx, Michael J.			Size Matters: Large Objects Capture Attention in Visual Search	PLOS ONE			English	Article							INTERFERENCE; LUMINANCE; GUIDANCE; SALIENCE; FEATURES; CONTRAST	Can objects or events ever capture one's attention in a purely stimulus-driven manner? A recent review of the literature set out the criteria required to find stimulus-driven attentional capture independent of goal-directed influences, and concluded that no published study has satisfied that criteria. Here visual search experiments assessed whether an irrelevantly large object can capture attention. Capture of attention by this static visual feature was found. The results suggest that a large object can indeed capture attention in a stimulus-driven manner and independent of displaywide features of the task that might encourage a goal-directed bias for large items. It is concluded that these results are either consistent with the stimulus-driven criteria published previously or alternatively consistent with a flexible, goal-directed mechanism of saliency detection.	Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England	University of London; Queen Mary University London	Proulx, MJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England.	m.proulx@qmul.ac.uk	Proulx, Michael J/A-1045-2008	Proulx, Michael/0000-0003-4066-3645				BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; Burnham BP, 2007, PSYCHON B REV, V14, P392, DOI 10.3758/BF03194082; Chan LKH, 2009, J EXP PSYCHOL HUMAN, V35, P119, DOI 10.1037/0096-1523.35.1.119; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Gibson BS, 1998, J EXP PSYCHOL HUMAN, V24, P699, DOI 10.1037/0096-1523.24.3.699; Hubner R, 2001, PERCEPT PSYCHOPHYS, V63, P258, DOI 10.3758/BF03194467; Kumada T, 1999, PERCEPT PSYCHOPHYS, V61, P61, DOI 10.3758/BF03211949; Lamy D, 1999, PSYCHON B REV, V6, P93, DOI 10.3758/BF03210814; Leber AB, 2006, PSYCHON B REV, V13, P132, DOI 10.3758/BF03193824; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Proulx MJ, 2008, PSYCHOL RES-PSYCH FO, V72, P106, DOI 10.1007/s00426-006-0077-z; Proulx MJ, 2007, J NEUROSCI, V27, P13043, DOI 10.1523/JNEUROSCI.4378-07.2007; Proulx MJ, 2007, J EXP PSYCHOL HUMAN, V33, P48, DOI 10.1037/0096-1523.33.1.48; Rauschenberger R, 2003, PSYCHON B REV, V10, P814, DOI 10.3758/BF03196545; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zehetleitner M, 2009, ATTEN PERCEPT PSYCHO, V71, P1760, DOI 10.3758/APP.71.8.1760	20	39	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15293	10.1371/journal.pone.0015293	http://dx.doi.org/10.1371/journal.pone.0015293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698FO	21203454	gold, Green Published, Green Submitted			2022-12-25	WOS:000285579200015
J	Johnson, TJ; Thorsness, JL; Anderson, CP; Lynne, AM; Foley, SL; Han, J; Fricke, WF; McDermott, PF; White, DG; Khatri, M; Stell, AL; Flores, C; Singer, RS				Johnson, Timothy J.; Thorsness, Jessica L.; Anderson, Cole P.; Lynne, Aaron M.; Foley, Steven L.; Han, Jing; Fricke, W. Florian; McDermott, Patrick F.; White, David G.; Khatri, Mahesh; Stell, Adam L.; Flores, Cristian; Singer, Randall S.			Horizontal Gene Transfer of a ColV Plasmid Has Resulted in a Dominant Avian Clonal Type of Salmonella enterica Serovar Kentucky	PLOS ONE			English	Article							PATHOGENIC ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; DNA-SEQUENCE; VIRULENCE; PREVALENCE; CHICKENS; STRAINS; COLONIZATION; ASSOCIATION; MENINGITIS	Salmonella enterica continues to be a significant cause of foodborne gastrointestinal illness in humans. A wide variety of Salmonella serovars have been isolated from production birds and from retail poultry meat. Recently, though, S. enterica subsp. enterica serovar Kentucky has emerged as one of the prominent Salmonella serovars isolated from broiler chickens. Recent work suggests that its emergence apparently coincides with its acquisition of a ColV virulence plasmid. In the present study, we examined 902 Salmonella isolates belonging to 59 different serovars for the presence of this plasmid. Of the serovars examined, the ColV plasmid was found only among isolates belonging to the serovars Kentucky (72.9%), Typhimurium (15.0%) and Heidelberg (1.7%). We demonstrated that a single PFGE clonal type of S. Kentucky harbors this plasmid, and acquisition of this plasmid by S. Kentucky significantly increased its ability to colonize the chicken cecum and cause extraintestinal disease. Comparison of the completed sequences of three ColV plasmids from S. Kentucky isolated from different geographical locales, timepoints and sources revealed a nearly identical genetic structure with few single nucleotide changes or insertions/deletions. Overall, it appears that the ColV plasmid was recently acquired by a single clonal type S. Kentucky and confers to its host enhanced colonization and fitness capabilities. Thus, the potential for horizontal gene transfer of virulence and fitness factors to Salmonella from other enteric bacteria exists in poultry, representing a potential human health hazard.	[Johnson, Timothy J.; Thorsness, Jessica L.; Khatri, Mahesh; Stell, Adam L.; Flores, Cristian; Singer, Randall S.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Anderson, Cole P.; Lynne, Aaron M.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA; [Foley, Steven L.; Han, Jing] US FDA, Natl Ctr Toxicol Res, Div Microbiol, Jefferson, AR 72079 USA; [Fricke, W. Florian] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [McDermott, Patrick F.; White, David G.] US FDA, Ctr Vet Med, Res Off, Div Anim & Food Microbiol, Laurel, MD USA	University of Minnesota System; University of Minnesota Twin Cities; Texas State University System; Sam Houston State University; US Food & Drug Administration (FDA); University System of Maryland; University of Maryland Baltimore; US Food & Drug Administration (FDA)	Johnson, TJ (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	joh04207@umn.edu	McDermott, Patrick F./ABE-4374-2021	McDermott, Patrick F./0000-0003-1868-8096; Foley, Steven/0000-0003-3146-4548; Stell, Adam/0000-0001-6810-316X; Fricke, W. Florian/0000-0003-1586-0962; Johnson, Timothy/0000-0001-7556-9347; Anderson, Cole/0000-0002-4366-6166	Minnesota Agricultural Experiment Station [MINV-063-054]; Food Safety Research and Response Network [2005-35212-15287]	Minnesota Agricultural Experiment Station; Food Safety Research and Response Network	This project was funded by the Minnesota Agricultural Experiment Station, grant MINV-063-054 and by the Food Safety Research and Response Network, which is supported by the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service, grant number # 2005-35212-15287. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUERO ME, 1989, MED MICROBIOL IMMUN, V178, P211, DOI 10.1007/BF00202554; Berrang ME, 2009, J FOOD PROTECT, V72, P1610, DOI 10.4315/0362-028X-72.8.1610; BINNS MM, 1979, NATURE, V279, P778, DOI 10.1038/279778a0; Byrd JA, 1999, AVIAN DIS, V43, P39, DOI 10.2307/1592760; *CDC, 2008, SALM SURV ANN SUMM 2; *CDC, 2006, SALM SURV ANN SUMM 2; Collard JM, 2007, J ANTIMICROB CHEMOTH, V60, P190, DOI 10.1093/jac/dkm114; COOPER GE, 1986, J MED MICROBIOL, V22, P231, DOI 10.1099/00222615-22-3-231; Corder Gregory W, 2009, NONPARAMETRIC STAT N; Dieye Y, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-3; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Gutierrez M, 2009, FOODBORNE PATHOG DIS, V6, P111, DOI 10.1089/fpd.2008.0163; Joerger RD, 2009, FOODBORNE PATHOG DIS, V6, P503, DOI 10.1089/fpd.2008.0144; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2010, INFECT IMMUN, V78, P1931, DOI 10.1128/IAI.01174-09; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; JOHNSON TJ, 2009, VET MICROBIOL; Kariyawasam S, 2004, AVIAN DIS, V48, P287, DOI 10.1637/7093; LEONARD EK, 2010, EVALUATION PET RELAT; Lestari SI, 2009, J FOOD PROTECT, V72, P1165, DOI 10.4315/0362-028X-72.6.1165; Li X, 2007, POULTRY SCI, V86, P591, DOI 10.1093/ps/86.3.591; Lo-Ten-Foe JR, 2007, J HOSP INFECT, V67, P105, DOI 10.1016/j.jhin.2007.07.005; Majtan V, 2006, JPN J INFECT DIS, V59, P358; McCrea BA, 2006, J FOOD PROTECT, V69, P2908, DOI 10.4315/0362-028X-69.12.2908; Muhammad M, 2010, VET MICROBIOL, V140, P131, DOI 10.1016/j.vetmic.2009.07.009; *NARMS, 2008, 2006 VET IS FIN REP; *NARMS, 2008, 2006 NARMS ANN MEAT; Parveen S, 2007, J FOOD PROTECT, V70, P2466, DOI 10.4315/0362-028X-70.11.2466; Peighambari SM, 2002, AVIAN DIS, V46, P287, DOI 10.1637/0005-2086(2002)046[0287:SIAEOT]2.0.CO;2; Roy P, 2002, AVIAN DIS, V46, P17, DOI 10.1637/0005-2086(2002)046[0017:ROSIFP]2.0.CO;2; Santos FBO, 2007, J FOOD PROTECT, V70, P1328, DOI 10.4315/0362-028X-70.6.1328; Singer RS, 2009, J FOOD PROTECT, V72, P707, DOI 10.4315/0362-028X-72.4.707; Sivula CP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-182; Skyberg JA, 2006, INFECT IMMUN, V74, P6287, DOI 10.1128/IAI.00363-06; Skyberg JA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-24; SMITH HW, 1976, J GEN MICROBIOL, V92, P335; SMITH HW, 1980, J GEN MICROBIOL, V121, P387; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WATERS VL, 1991, MICROBIOL REV, V55, P437, DOI 10.1128/MMBR.55.3.437-450.1991; WOOLEY RE, 1994, AVIAN DIS, V38, P141, DOI 10.2307/1591847; Zhao S, 2006, FOODBORNE PATHOG DIS, V3, P106, DOI 10.1089/fpd.2006.3.106	46	79	80	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15524	10.1371/journal.pone.0015524	http://dx.doi.org/10.1371/journal.pone.0015524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203520	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000033
J	Miller, TW; Isenberg, JS; Shih, HB; Wang, YC; Roberts, DD				Miller, Thomas W.; Isenberg, Jeff S.; Shih, Hubert B.; Wang, Yichen; Roberts, David D.			Amyloid-beta Inhibits No-cGMP Signaling in a CD36-and CD47-Dependent Manner	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; ISCHEMIC TISSUE SURVIVAL; LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; ALZHEIMERS-DISEASE; PLATELET-AGGREGATION; CELL RESPONSES; SMOOTH-MUSCLE; MICROGLIAL PHAGOCYTOSIS; PRECURSOR PROTEIN	Amyloid-beta interacts with two cell surface receptors, CD36 and CD47, through which the matricellular protein thrombospondin-1 inhibits soluble guanylate cyclase activation. Here we examine whether amyloid-beta shares this inhibitory activity. Amyloid-beta inhibited both drug and nitric oxide-mediated activation of soluble guanylate cyclase in several cell types. Known cGMP-dependent functional responses to nitric oxide in platelets and vascular smooth muscle cells were correspondingly inhibited by amyloid-beta. Functional interaction of amyloid-beta with the scavenger receptor CD36 was indicated by inhibition of free fatty acid uptake via this receptor. Both soluble oligomer and fibrillar forms of amyloid-beta were active. In contrast, amyloid-beta did not compete with the known ligand SIRP alpha for binding to CD47. However, both receptors were necessary for amyloid-beta to inhibit cGMP accumulation. These data suggest that amyloid-beta interaction with CD36 induces a CD47-dependent signal that inhibits soluble guanylate cyclase activation. Combined with the pleiotropic effects of inhibiting free fatty acid transport via CD36, these data provides a molecular mechanism through which amyloid-beta can contribute to the nitric oxide signaling deficiencies associated with Alzheimer's disease.	[Miller, Thomas W.; Isenberg, Jeff S.; Shih, Hubert B.; Wang, Yichen; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Isenberg, Jeff S.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Shih, Hubert B.] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Miller, TW (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008; Miller, Thomas W/G-1215-2011	Roberts, David D./0000-0002-2481-2981; Miller, Thomas W/0000-0001-8645-2785	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research [CA128616]; Howard Hughes Medical Institute-NIH; NATIONAL CANCER INSTITUTE [K22CA128616, ZIASC009174] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute-NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research (D. D. R.), NIH grant CA128616 (J.S.I.) and by the Howard Hughes Medical Institute-NIH Research Scholars Program (H. B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; Baltrons MA, 2002, NEUROBIOL DIS, V10, P139, DOI 10.1006/nbdi.2002.0492; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Barazi HO, 2002, J BIOL CHEM, V277, P42859, DOI 10.1074/jbc.M206849200; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bon CLM, 2003, J NEUROSCI, V23, P1941; Castellani RJ, 2009, J ALZHEIMERS DIS, V18, P447, DOI 10.3233/JAD-2009-1151; Crawford F, 1998, FEBS LETT, V436, P445, DOI 10.1016/S0014-5793(98)01170-3; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Giokarini T, 1997, Ann N Y Acad Sci, V826, P475, DOI 10.1111/j.1749-6632.1997.tb48507.x; GRUETTER CA, 1981, J PHARMACOL EXP THER, V219, P181; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; IGNARRO LJ, 1986, J PHARMACOL EXP THER, V237, P893; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Isenberg JS, 2008, ANN SURG, V247, P860, DOI 10.1097/SLA.0b013e31816c4006; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; Isenberg JS, 2006, CARDIOVASC RES, V71, P785, DOI 10.1016/j.cardiores.2006.05.024; Isenberg JS, 2006, J BIOL CHEM, V281, P26069, DOI 10.1074/jbc.M605040200; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jeon YJ, 2008, NEUROREPORT, V19, P1661, DOI 10.1097/WNR.0b013e3283140f10; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Law A, 2002, NEUROSCIENCE, V112, P267, DOI 10.1016/S0306-4522(02)00082-9; Li QX, 1998, LAB INVEST, V78, P461; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; Lu YF, 1999, J NEUROSCI, V19, P10250; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; MELLION BT, 1981, BLOOD, V57, P946; Miller TW, 2010, BRIT J PHARMACOL, V159, P1542, DOI 10.1111/j.1476-5381.2009.00631.x; Niederhoffer N, 2009, INT J IMMUNOPATH PH, V22, P473, DOI 10.1177/039463200902200224; Niwa K, 2001, AM J PHYSIOL-HEART C, V281, pH2417, DOI 10.1152/ajpheart.2001.281.6.H2417; Paris D, 1999, EXP NEUROL, V157, P211, DOI 10.1006/exnr.1999.7055; Paris D, 2000, ANN NY ACAD SCI, V903, P446, DOI 10.1111/j.1749-6632.2000.tb06397.x; Persaud-Sawin DA, 2009, GLIA, V57, P320, DOI 10.1002/glia.20759; Piccio L, 2005, BLOOD, V105, P2421, DOI 10.1182/blood-2004-07-2823; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Price JM, 2001, NEUROL RES, V23, P506, DOI 10.1179/016164101101198758; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Puzzo D, 2006, REV NEUROSCIENCE, V17, P497; SCHINI V, 1988, EUR J CELL BIOL, V47, P53; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith CCT, 2001, BRAIN RES, V896, P161, DOI 10.1016/S0006-8993(01)02080-7; Smith CCT, 2007, CLIN SCI, V113, P427, DOI 10.1042/CS20070082; Tulasne D, 2001, BLOOD, V98, P3346, DOI 10.1182/blood.V98.12.3346; Van Broeck B, 2007, NEURODEGENER DIS, V4, P349, DOI 10.1159/000105156; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Wirtz-Brugger F, 2000, NEUROSCIENCE, V99, P737, DOI 10.1016/S0306-4522(00)00243-8; Wright S, 2007, NEUROBIOL AGING, V28, P226, DOI 10.1016/j.neurobiolaging.2005.12.002; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4; Zhu WF, 2005, J BIOL CHEM, V280, P29543, DOI 10.1074/jbc.M501238200	60	37	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15686	10.1371/journal.pone.0015686	http://dx.doi.org/10.1371/journal.pone.0015686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203512	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000285578000045
J	Ohigashi, I; Yamasaki, Y; Hirashima, T; Takahama, Y				Ohigashi, Izumi; Yamasaki, Yuki; Hirashima, Tsukasa; Takahama, Yousuke			Identification of the Transgenic Integration Site in Immunodeficient tg epsilon 26 Human CD3 epsilon Transgenic Mice	PLOS ONE			English	Article							KILLER-CELL DEVELOPMENT; T-LYMPHOCYTE; GENE; REARRANGEMENTS; INDUCTION; MUTANT; DEFECT; GLAND; BLOCK	A strain of human CD3 epsilon transgenic mice, tg epsilon 26, exhibits severe immunodeficiency associated with early arrest of T cell development. Complete loss of T cells is observed in homozygous tg epsilon 26 mice, but not in heterozygotes, suggesting that genomic disruption due to transgenic integration may contribute to the arrest of T cell development. Here we report the identification of the transgenic integration site in tge26 mice. We found that multiple copies of the human CD3 epsilon transgene are inserted between the Sstr5 and Metrn loci on chromosome 17, and that this is accompanied by duplication of the neighboring genomic region spanning 323 kb. However, none of the genes in this region were abrogated. These results suggest that the severe immunodeficiency seen in tg epsilon 26 mice is not due to gene disruption resulting from transgenic integration.	[Ohigashi, Izumi; Takahama, Yousuke] Univ Tokushima, Inst Genom Res, Div Expt Immunol, Tokushima 770, Japan; [Yamasaki, Yuki; Hirashima, Tsukasa] Otsuka Pharmaceut Co Ltd, Tokushima, Japan	Tokushima University; Otsuka Pharmaceutical	Ohigashi, I (corresponding author), Univ Tokushima, Inst Genom Res, Div Expt Immunol, Tokushima 770, Japan.	takahama@genome.tokushima-u.ac.jp	Takahama, Yousuke/A-5863-2010	Takahama, Yousuke/0000-0002-4992-9174	MEXT	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a MEXT Grant-in-Aid for Scientific Research in the Priority Area "Immunological Self" (Y. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Guimond MJ, 1996, AM J REPROD IMMUNOL, V35, P501; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Kanemoto N, 1998, MAMM GENOME, V9, P419, DOI 10.1007/s003359900789; LEVELT CN, 1995, EUR J IMMUNOL, V25, P1257, DOI 10.1002/eji.1830250519; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Roberts NA, 2009, EUR J IMMUNOL, V39, P2395, DOI 10.1002/eji.200939501; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Smiraglia DJ, 1997, GENOMICS, V45, P572, DOI 10.1006/geno.1997.4976; Tokoro Y, 1998, J IMMUNOL, V161, P4591; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; Vermeire L, 2009, INT J DEV BIOL, V53, P1045, DOI 10.1387/ijdb.092859lv; Wang BP, 1997, IMMUNOL REV, V157, P53, DOI 10.1111/j.1600-065X.1997.tb00973.x; Wang BP, 1996, INT IMMUNOL, V8, P939, DOI 10.1093/intimm/8.6.939; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; Watanabe TK, 2000, MAMM GENOME, V11, P300, DOI 10.1007/s003350010056; Wen XY, 1998, HUM MOL GENET, V7, P743, DOI 10.1093/hmg/7.4.743	21	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14391	10.1371/journal.pone.0014391	http://dx.doi.org/10.1371/journal.pone.0014391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203507	Green Published, gold, Green Submitted			2022-12-25	WOS:000285578000007
J	Bordner, AJ				Bordner, Andrew J.			Towards Universal Structure-Based Prediction of Class II MHC Epitopes for Diverse Allotypes	PLOS ONE			English	Article							HYDROGEN-BOND INTERACTIONS; NONBONDED INTERACTIONS; ENERGY PARAMETERS; PEPTIDE-BINDING; GEOMETRICAL PARAMETERS; PROTEIN HLA-DR1; T-CELLS; HLA-DR; SUSCEPTIBILITY; COMPLEX	The binding of peptide fragments of antigens to class II MHC proteins is a crucial step in initiating a helper T cell immune response. The discovery of these peptide epitopes is important for understanding the normal immune response and its misregulation in autoimmunity and allergies and also for vaccine design. In spite of their biomedical importance, the high diversity of class II MHC proteins combined with the large number of possible peptide sequences make comprehensive experimental determination of epitopes for all MHC allotypes infeasible. Computational methods can address this need by predicting epitopes for a particular MHC allotype. We present a structure-based method for predicting class II epitopes that combines molecular mechanics docking of a fully flexible peptide into the MHC binding cleft followed by binding affinity prediction using a machine learning classifier trained on interaction energy components calculated from the docking solution. Although the primary advantage of structure-based prediction methods over the commonly employed sequence-based methods is their applicability to essentially any MHC allotype, this has not yet been convincingly demonstrated. In order to test the transferability of the prediction method to different MHC proteins, we trained the scoring method on binding data for DRB1*0101 and used it to make predictions for multiple MHC allotypes with distinct peptide binding specificities including representatives from the other human class II MHC loci, HLA-DP and HLA-DQ, as well as for two murine allotypes. The results showed that the prediction method was able to achieve significant discrimination between epitope and non-epitope peptides for all MHC allotypes examined, based on AUC values in the range 0.632-0.821. We also discuss how accounting for peptide binding in multiple registers to class II MHC largely explains the systematically worse performance of prediction methods for class II MHC compared with those for class I MHC based on quantitative prediction performance estimates for peptide binding to class II MHC in a fixed register.				bordner.andrew@mayo.edu			Mayo Clinic	Mayo Clinic	This work was funded by the Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Anderton SM, 2002, NAT IMMUNOL, V3, P175, DOI 10.1038/ni756; BAISCH JM, 1990, NEW ENGL J MED, V322, P1836, DOI 10.1056/NEJM199006283222602; Betancourt MR, 1999, PROTEIN SCI, V8, P361; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; Bordner AJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-41; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cui J, 2006, IMMUNOGENETICS, V58, P607, DOI 10.1007/s00251-006-0117-2; Davies MN, 2003, MOL MED, V9, P220, DOI 10.2119/2003-00032.Sansom; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; Fairchild PJ, 1996, INT IMMUNOL, V8, P1035, DOI 10.1093/intimm/8.7.1035; Fernandez-Recio J, 2002, PROTEIN SCI, V11, P280, DOI 10.1110/ps.19202; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; Haselden BM, 1999, J EXP MED, V189, P1885, DOI 10.1084/jem.189.12.1885; Hattotuwagama CK, 2006, J CHEM INF MODEL, V46, P1491, DOI 10.1021/ci050380d; Larche M, 2006, CURR OPIN IMMUNOL, V18, P745, DOI 10.1016/j.coi.2006.09.013; Lata Sneh, 2007, V409, P201, DOI 10.1007/978-1-60327-118-9_14; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu Wen, 2007, V409, P283, DOI 10.1007/978-1-60327-118-9_20; Marcotte GV, 1998, J ALLERGY CLIN IMMUN, V101, P506, DOI 10.1016/S0091-6749(98)70358-6; MATSUKI K, 1992, LANCET, V339, P1052, DOI 10.1016/0140-6736(92)90571-J; Maverakis E, 2003, P NATL ACAD SCI USA, V100, P5342, DOI 10.1073/pnas.0936151100; McFarland BJ, 1999, BIOCHEMISTRY-US, V38, P16663, DOI 10.1021/bi991393l; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; MOMANY FA, 1975, J PHYS CHEM-US, V79, P2361, DOI 10.1021/j100589a006; Muller U, 1998, J ALLERGY CLIN IMMUN, V101, P747, DOI 10.1016/S0091-6749(98)70402-6; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Murugan Naveen, 2005, Immunome Res, V1, P6, DOI 10.1186/1745-7580-1-6; NEMETHY G, 1983, J PHYS CHEM-US, V87, P1883, DOI 10.1021/j100234a011; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Oldfield WLG, 2002, LANCET, V360, P47, DOI 10.1016/S0140-6736(02)09332-7; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Salomon J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-501; Schafroth HD, 2004, PROTEINS, V54, P534, DOI 10.1002/prot.10608; Seamons A, 2003, J EXP MED, V197, P1391, DOI 10.1084/jem.20022226; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; Simon A, 2002, MOL IMMUNOL, V38, P681, DOI 10.1016/S0161-5890(01)00103-1; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Tong JC, 2006, BIOINFORMATICS, V22, P1232, DOI 10.1093/bioinformatics/btl071; Tong Joo Chuan, 2006, Immunome Res, V2, P1, DOI 10.1186/1745-7580-2-1; von Garnier C, 2000, EUR J IMMUNOL, V30, P1638, DOI 10.1002/1521-4141(200006)30:6<1638::AID-IMMU1638>3.0.CO;2-R; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wilson N, 2001, IMMUNITY, V14, P513, DOI 10.1016/S1074-7613(01)00140-6; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049; Zhang C, 2004, PROTEIN SCI, V13, P400, DOI 10.1110/ps.03348304; Zhang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009272	57	21	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14383	10.1371/journal.pone.0014383	http://dx.doi.org/10.1371/journal.pone.0014383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187956	Green Published, gold, Green Submitted			2022-12-25	WOS:000285575200009
J	Holm, L; Haslund, ML; Robach, P; van Hall, G; Calbet, JAL; Saltin, B; Lundby, C				Holm, Lars; Haslund, Mads Lyhne; Robach, Paul; van Hall, Gerrit; Calbet, Jose A. L.; Saltin, Bengt; Lundby, Carsten			Skeletal Muscle Myofibrillar and Sarcoplasmic Protein Synthesis Rates Are Affected Differently by Altitude-Induced Hypoxia in Native Lowlanders	PLOS ONE			English	Article							DOWN-REGULATION; ADAPTATIONS; EXERCISE; DEMAND; ACCLIMATIZATION; INTERLEUKIN-6; MITOCHONDRIAL; MECHANISMS; EXPRESSION; TURNOVER	As a consequence to hypobaric hypoxic exposure skeletal muscle atrophy is often reported. The underlying mechanism has been suggested to involve a decrease in protein synthesis in order to conserve O-2. With the aim to challenge this hypothesis, we applied a primed, constant infusion of 1-C-13-leucine in nine healthy male subjects at sea level and subsequently at high-altitude (4559 m) after 7-9 days of acclimatization. Physical activity levels and food and energy intake were controlled prior to the two experimental conditions with the aim to standardize these confounding factors. Blood samples and expired breath samples were collected hourly during the 4 hour trial and vastus lateralis muscle biopsies obtained at 1 and 4 hours after tracer priming in the overnight fasted state. Myofibrillar protein synthesis rate was doubled; 0.041 +/- 0.018 at sea-level to 0.080 +/- 0.018%.hr(-1) (p<0.05) when acclimatized to high altitude. The sarcoplasmic protein synthesis rate was in contrast unaffected by altitude exposure; 0.052 +/- 0.019 at sea-level to 0.059 +/- 0.010%.hr(-1) (p>0.05). Trends to increments in whole body protein kinetics were seen: Degradation rate elevated from 2.51 +/- 0.21 at sea level to 2.73 +/- 0.13 mu mol.kg-(1).min(-1) (p = 0.05) at high altitude and synthesis rate similar; 2.24 +/- 0.20 at sea level and 2.43 +/- 0.13 mu mol.kg(-1).min(-1) (p>0.05) at altitude. We conclude that whole body amino acid flux is increased due to an elevated protein turnover rate. Resting skeletal muscle myocontractile protein synthesis rate was concomitantly elevated by high-altitude induced hypoxia, whereas the sarcoplasmic protein synthesis rate was unaffected by hypoxia. These changed responses may lead to divergent adaptation over the course of prolonged exposure.	[Holm, Lars] Univ Copenhagen, Dept Orthopaed Surg M, Copenhagen, Denmark; [Holm, Lars] Univ Copenhagen, Inst Sports Med, Bispebjerg Hosp, Copenhagen, Denmark; [Holm, Lars] Univ Copenhagen, Ctr Healthy Ageing, Fac Hlth Sci, Copenhagen, Denmark; [Haslund, Mads Lyhne; van Hall, Gerrit; Saltin, Bengt; Lundby, Carsten] Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark; [Robach, Paul] Ecole Natl Ski & Alpinisme, Chamonix Mt Blanc, France; [van Hall, Gerrit] Univ Copenhagen, Rigshosp, Metab Mass Spectrometry Facil, DK-2100 Copenhagen, Denmark; [van Hall, Gerrit] Univ Copenhagen, Dept Biomed Sci, Fac Hlth Sci, Copenhagen, Denmark; [Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Canary Islands, Spain	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Universidad de Las Palmas de Gran Canaria	Holm, L (corresponding author), Univ Copenhagen, Dept Orthopaed Surg M, Copenhagen, Denmark.	L.Holm.isotope@gmail.com	Holm, Lars/AAI-1320-2020; Calbet, Jose A L/H-6693-2015; Holm, Lars/G-8181-2017	Calbet, Jose A L/0000-0002-9215-6234; antunez, Ariel/0000-0002-2548-7885; Holm, Lars/0000-0002-4392-9616; van Hall, Gerrit/0000-0002-2519-8127	Novo Nordisk Fonden	Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was financially supported by the Novo Nordisk Fonden (www.novonordiskfonden.dk) to CL while working at the Copenhagen Muscle Research Center, Rigshospitalet, Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; Desplanches D, 1996, J APPL PHYSIOL, V81, P1946, DOI 10.1152/jappl.1996.81.5.1946; Green H, 2000, J APPL PHYSIOL, V88, P634, DOI 10.1152/jappl.2000.88.2.634; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Guillet C, 2004, EXP GERONTOL, V39, P745, DOI 10.1016/j.exger.2004.02.011; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Heerlein K, 2005, AM J RESP CELL MOL, V32, P44, DOI 10.1165/rcmb.2004-0202OC; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; HOPPELER H, 1990, INT J SPORTS MED, V11, pS3, DOI 10.1055/s-2007-1024846; HOPPELER H, 1990, EXPERIENTIA, V46, P1185, DOI 10.1007/BF01936933; HOWALD H, 1990, INT J SPORTS MED, V11, pS10, DOI 10.1055/s-2007-1024847; Imoberdorf R, 2006, MED SCI SPORT EXER, V38, P1082, DOI 10.1249/01.mss.0000222836.66391.35; KAYSER B, 1992, J APPL PHYSIOL, V73, P2425, DOI 10.1152/jappl.1992.73.6.2425; Klausen T, 1997, EUR J APPL PHYSIOL, V76, P480, DOI 10.1007/s004210050278; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; KRAGGERUD SM, 1995, ANTICANCER RES, V15, P683; Larsen JJ, 1997, J PHYSIOL-LONDON, V504, P241, DOI 10.1111/j.1469-7793.1997.241bf.x; Ljungqvist OH, 1997, AM J PHYSIOL-ENDOC M, V273, pE564, DOI 10.1152/ajpendo.1997.273.3.E564; Lundby C, 2004, J EXP BIOL, V207, P3865, DOI 10.1242/jeb.01225; Lundby C, 2008, J PHYSIOL-LONDON, V586, P123, DOI 10.1113/jphysiol.2007.146035; Lundby C, 2009, CELL MOL LIFE SCI, V66, P3615, DOI 10.1007/s00018-009-0146-8; MACDOUGALL JD, 1991, ACTA PHYSIOL SCAND, V142, P421, DOI 10.1111/j.1748-1716.1991.tb09176.x; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Mizuno M, 2008, HIGH ALT MED BIOL, V9, P311, DOI 10.1089/ham.2008.1009; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; PREEDY VR, 1989, BIOCHEM J, V257, P519, DOI 10.1042/bj2570519; PREEDY VR, 1985, BIOCHEM J, V228, P179, DOI 10.1042/bj2280179; Rennie M J, 1983, Prog Clin Biol Res, V136, P317; Robach P, 2007, BLOOD, V109, P4724, DOI 10.1182/blood-2006-08-040006; Toffolo G, 2003, AM J PHYSIOL-ENDOC M, V285, pE1142, DOI 10.1152/ajpendo.00106.2003; Van Hall G, 2002, AM J PHYSIOL-ENDOC M, V283, pE1203, DOI 10.1152/ajpendo.00134.2001; van Hall G, 1999, P NUTR SOC, V58, P979, DOI 10.1017/S0029665199001299; Vigano A, 2008, PROTEOMICS, V8, P4668, DOI 10.1002/pmic.200800232	34	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15606	10.1371/journal.pone.0015606	http://dx.doi.org/10.1371/journal.pone.0015606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187972	Green Published, gold			2022-12-25	WOS:000285575200048
J	Thangaraj, K; Naidu, BP; Crivellaro, F; Tamang, R; Upadhyay, S; Sharma, VK; Reddy, AG; Walimbe, SR; Chaubey, G; Kivisild, T; Singh, L				Thangaraj, Kumarasamy; Naidu, B. Prathap; Crivellaro, Federica; Tamang, Rakesh; Upadhyay, Shashank; Sharma, Varun Kumar; Reddy, Alla G.; Walimbe, S. R.; Chaubey, Gyaneshwer; Kivisild, Toomas; Singh, Lalji			The Influence of Natural Barriers in Shaping the Genetic Structure of Maharashtra Populations	PLOS ONE			English	Article							Y-CHROMOSOME; INDIAN POPULATION; MTDNA VARIATION; CASTE; SETTLEMENT; ORIGIN; SOUTH; ASIA; HISTORIES	Background: The geographical position of Maharashtra state makes it rather essential to study the dispersal of modern humans in South Asia. Several hypotheses have been proposed to explain the cultural, linguistic and geographical affinity of the populations living in Maharashtra state with other South Asian populations. The genetic origin of populations living in this state is poorly understood and hitherto been described at low molecular resolution level. Methodology/Principal Findings: To address this issue, we have analyzed the mitochondrial DNA (mtDNA) of 185 individuals and NRY (non-recombining region of Y chromosome) of 98 individuals belonging to two major tribal populations of Maharashtra, and compared their molecular variations with that of 54 South Asian contemporary populations of adjacent states. Inter and intra population comparisons reveal that the maternal gene pool of Maharashtra state populations is composed of mainly South Asian haplogroups with traces of east and west Eurasian haplogroups, while the paternal haplogroups comprise the South Asian as well as signature of near eastern specific haplogroup J2a. Conclusions/Significance: Our analysis suggests that Indian populations, including Maharashtra state, are largely derived from Paleolithic ancient settlers; however, a more recent (similar to 10 Ky older) detectable paternal gene flow from west Asia is well reflected in the present study. These findings reveal movement of populations to Maharashtra through the western coast rather than mainland where Western Ghats-Vindhya Mountains and Narmada-Tapti rivers might have acted as a natural barrier. Comparing the Maharastrian populations with other South Asian populations reveals that they have a closer affinity with the South Indian than with the Central Indian populations.	[Thangaraj, Kumarasamy; Naidu, B. Prathap; Tamang, Rakesh; Upadhyay, Shashank; Sharma, Varun Kumar; Reddy, Alla G.; Chaubey, Gyaneshwer; Singh, Lalji] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Crivellaro, Federica; Kivisild, Toomas] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge, England; [Walimbe, S. R.] Deccan Coll Postgrad & Res Inst, Dept Archaeol, Pune, Maharashtra, India; [Chaubey, Gyaneshwer; Kivisild, Toomas] Univ Tartu, Dept Evolutionary Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Chaubey, Gyaneshwer; Kivisild, Toomas] Estonian Bioctr, Tartu, Estonia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Cambridge; University of Tartu; Estonian Biocentre	Thangaraj, K (corresponding author), Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	thangs@ccmb.res.in; lalji@ccmb.res.in	Chaubey, Gyaneshwer/H-2753-2012; Chaubey, Gyaneshwer/AAC-6409-2019; Sharma, Varun Kumar/AAQ-5947-2020; Kivisild, Toomas/P-5889-2017	Chaubey, Gyaneshwer/0000-0003-2899-3852; Chaubey, Gyaneshwer/0000-0003-2899-3852; Kivisild, Toomas/0000-0002-6297-7808; Crivellaro, Federica/0000-0003-1656-8605; Upadhyay, Shashank/0000-0002-0560-196X; Thangaraj, Kumarasamy/0000-0002-0075-0106; Sharma, Varun Kumar/0000-0001-8575-6939	Council of Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR); UK-India Education and Research Initiative (UKIERI) [RG47772]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); UK-India Education and Research Initiative (UKIERI)	The work was funded by the Council of Scientific and Industrial Research (CSIR), Indian Council of Medical Research (ICMR) and UK-India Education and Research Initiative (UKIERI) grant RG47772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ayub Qasim, 2009, Briefings in Functional Genomics & Proteomics, V8, P395, DOI 10.1093/bfgp/elp015; Baig MM, 2004, ANN HUM GENET, V68, P453, DOI 10.1046/j.1529-8817.2004.00108.x; Barnabas S, 2006, ANN HUM GENET, V70, P42, DOI 10.1111/j.1529-8817.2005.00207.x; CHAUBEY G, MOL BIOL EVOL; CHAUBEY G, 2010, DEMOGRAPHIC HISTORY; Chaubey G, 2008, INT J HUM GENET, V8, P41, DOI 10.1080/09723757.2008.11886018; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; CHAUHAN P, 2010, EVOLUTION HISTORY PO, P64; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Cordaux R, 2004, CURR BIOL, V14, P231, DOI 10.1016/j.cub.2004.01.024; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foote R.B., 1876, MEM GEOL SURV INDIA, V12, P1; Forster P, 1996, AM J HUM GENET, V59, P935; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Korisettar R, 2007, VERTEBR PALEOBIOL PA, P69, DOI 10.1007/1-4020-5562-5_4; Kumar S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-230; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Rajkumar R, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-23; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; SINGH KS, 1997, PEOPLE INDIA OXFORD, P1266; Thangaraj K, 1999, ELECTROPHORESIS, V20, P1743, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1743::AID-ELPS1743>3.0.CO;2-V; Thangaraj K, 2005, HUM GENET, V116, P507, DOI 10.1007/s00439-005-1271-6; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thangaraj K, 2002, J ANDROL, V23, P815; Thanseem I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-42; Trivedi R, 2008, INT J HUM GENET, V8, P97, DOI 10.1080/09723757.2008.11886023; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	39	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15283	10.1371/journal.pone.0015283	http://dx.doi.org/10.1371/journal.pone.0015283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187967	gold, Green Submitted, Green Published			2022-12-25	WOS:000285575200030
J	Casey, R; Blumenkrantz, D; Millington, K; Montamat-Sicotte, D; Kon, OM; Wickremasinghe, M; Bremang, S; Magtoto, M; Sridhar, S; Connell, D; Lalvani, A				Casey, Rosalyn; Blumenkrantz, Deena; Millington, Kerry; Montamat-Sicotte, Damien; Kon, Onn Min; Wickremasinghe, Melissa; Bremang, Samuel; Magtoto, Murphy; Sridhar, Saranya; Connell, David; Lalvani, Ajit			Enumeration of Functional T-Cell Subsets by Fluorescence-Immunospot Defines Signatures of Pathogen Burden in Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; IFN-GAMMA; POLYFUNCTIONAL CD4(+); INFECTION; RESPONSES; MEMORY; DISEASE; VACCINE; ASSAY	Background: IFN-gamma and IL-2 cytokine-profiles define three functional T-cell subsets which may correlate with pathogen load in chronic intracellular infections. We therefore investigated the feasibility of the immunospot platform to rapidly enumerate T-cell subsets by single-cell IFN-gamma/IL-2 cytokine-profiling and establish whether immunospot-based T-cell signatures distinguish different clinical stages of human tuberculosis infection. Methods: We used fluorophore-labelled anti-IFN-gamma and anti-IL-2 antibodies with digital overlay of spatially-mapped colour-filtered images to enumerate dual and single cytokine-secreting M. tuberculosis antigen-specific T-cells in tuberculosis patients and in latent tuberculosis infection (LTBI). We validated results against established measures of cytokine-secreting T-cells. Results: Fluorescence-immunospot correlated closely with single-cytokine enzyme-linked-immunospot for IFN-gamma-secreting T-cells and IL-2-secreting T-cells and flow-cytometry-based detection of dual IFN-gamma/IL-2-secreting T-cells. The untreated tuberculosis signature was dominated by IFN-gamma-only-secreting T-cells which shifted consistently in longitudinally-followed patients during treatment to a signature dominated by dual IFN-gamma/IL-2-secreting T-cells in treated patients. The LTBI signature differed from active tuberculosis, with higher proportions of IL-2-only and IFN-gamma/IL-2-secreting T-cells and lower proportions of IFN-gamma-only-secreting T-cells. Conclusions: Fluorescence-immunospot is a quantitative, accurate measure of functional T-cell subsets; identification of cytokine-signatures of pathogen burden, distinct clinical stages of M. tuberculosis infection and long-term immune containment suggests application for treatment monitoring and vaccine evaluation.	[Casey, Rosalyn; Blumenkrantz, Deena; Millington, Kerry; Montamat-Sicotte, Damien; Bremang, Samuel; Magtoto, Murphy; Sridhar, Saranya; Connell, David; Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, TB Res Unit, London, England; [Kon, Onn Min; Wickremasinghe, Melissa] St Marys Hosp, Imperial Coll Healthcare NHS Trust, London, England	Imperial College London; Imperial College London	Casey, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, TB Res Unit, London, England.	a.lalvani@imperial.ac.uk		Connell, David/0000-0002-7008-8883; Kon, Onn Min/0000-0003-2647-4688; Lalvani, Ajit/0000-0002-2396-246X; Sridhar, Saranya/0000-0002-4267-3102	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust. AL is a Wellcome Trust Senior Research Fellow in Clinical Science and National Institute of Health Research Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Adetifa IM, 2010, PLOS ONE, V5; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; CACCAMO N, 2010, EUR J IMMUNOL; Chee CBE, 2010, EUR RESPIR J, V36, P355, DOI 10.1183/09031936.00151309; Ciuffreda D, 2008, EUR J IMMUNOL, V38, P2665, DOI 10.1002/eji.200838336; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Doherty TM, 2009, CLIN CHEST MED, V30, P783, DOI 10.1016/j.ccm.2009.08.008; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Gazagne A, 2003, J IMMUNOL METHODS, V283, P91, DOI 10.1016/j.jim.2003.08.013; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hinks TSC, 2009, INFECT IMMUN, V77, P5486, DOI 10.1128/IAI.01436-08; Huaman MC, 2009, VACCINE, V27, P5239, DOI 10.1016/j.vaccine.2009.06.066; Karulin AY, 2000, J IMMUNOL, V164, P1862, DOI 10.4049/jimmunol.164.4.1862; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lalvani A, 2008, EUR RESPIR J, V32, P1428, DOI 10.1183/09031936.00148308; Lalvani A, 2008, J INFECT DIS, V197, P941, DOI 10.1086/529049; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Lalvani A, 2010, BRIT MED BULL, V93, P69, DOI 10.1093/bmb/ldp039; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Okamoto Y, 1998, IMMUNOPHARMACOLOGY, V39, P107, DOI 10.1016/S0162-3109(98)00007-1; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Quast S, 2005, CELL IMMUNOL, V237, P28, DOI 10.1016/j.cellimm.2005.09.002; Rebhahn JA, 2008, COMPUT METH PROG BIO, V92, P54, DOI 10.1016/j.cmpb.2008.06.002; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Semmo N, 2007, WORLD J GASTROENTERO, V13, P4831, DOI 10.3748/wjg.v13.i36.4831; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Tena-Coki NG, 2010, AM J RESP CRIT CARE, V182, P120, DOI 10.1164/rccm.200912-1862OC; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; Wilkinson KA, 2009, AM J RESP CRIT CARE, V180, P674, DOI 10.1164/rccm.200904-0568OC; 2009, STMARYS HOSP TB SERV	46	64	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15619	10.1371/journal.pone.0015619	http://dx.doi.org/10.1371/journal.pone.0015619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179481	gold, Green Published, Green Submitted			2022-12-25	WOS:000285292500031
J	Mayes, AE; Murray, PG; Gunn, DA; Tomlin, CC; Catt, SD; Wen, YB; Zhou, LP; Wang, HQ; Catt, M; Granger, SP				Mayes, Andrew E.; Murray, Peter G.; Gunn, David A.; Tomlin, Cyrena C.; Catt, Sharon D.; Wen, Yi B.; Zhou, Li P.; Wang, Hong Q.; Catt, Michael; Granger, Stewart P.			Environmental and Lifestyle Factors Associated with Perceived Facial Age in Chinese Women	PLOS ONE			English	Article							EXTRINSIC FACTORS; AGING APPEARANCE; SKIN; HEALTH; DEFINITION; BIOMARKER; RISK; OLD	Perceived facial age has been proposed as a biomarker of ageing with 'looking young for one's age' linked to physical and cognitive functioning and to increased survival for Caucasians. We have investigated the environmental and lifestyle factors associated with perceived facial ageing in Chinese women. Facial photographs were collected from 250 Chinese women, aged 25-70 years in Shanghai, China. Perceived facial age was determined and related to chronological age for each participant. Lifestyle and health information was collected by questionnaire. Bivariate analyses (controlling for chronological age) identified and quantified lifestyle variables associated with perceived facial age. Independent predictors of perceived age were identified by multivariate modelling. Factors which significantly associated with looking younger for one's chronological age included greater years of education (p<0.001), fewer household members (p=0.027), menopausal status (p=0.020), frequency of visiting one's doctor (p=0.013), working indoors (p<0.001), spending less time in the sun (p=0.015), moderate levels of physical activity (p=0.004), higher frequency of teeth cleaning (p<0.001) and more frequent use of facial care products: cleanser (p<0.001); moisturiser (p=0.016) or night cream (p=0.016). Overall, 36.5% of the variation in the difference between perceived and chronological age could be explained by a combination of chronological age and 6 independent lifestyle variables. We have thus identified and quantified a number of factors associated with younger appearance in Chinese women. Presentation of these factors in the context of facial appearance could provide significant motivation for the adoption of a range of healthy behaviours at the level of both individuals and populations.	[Mayes, Andrew E.; Murray, Peter G.; Gunn, David A.; Tomlin, Cyrena C.; Catt, Sharon D.; Catt, Michael; Granger, Stewart P.] Unilever Discover, Sharnbrook, Beds, England; [Wen, Yi B.; Zhou, Li P.; Wang, Hong Q.] Unilever Discover, Shanghai, Peoples R China	Unilever; Unilever	Mayes, AE (corresponding author), Unilever Discover, Colworth Sci Pk, Sharnbrook, Beds, England.	Andrew.Mayes@unilever.com		Catt, Michael/0000-0003-0935-7973; Gunn, David/0000-0001-9866-3221	Unilever; Medical Research Council [G0900686] Funding Source: researchfish; MRC [G0900686] Funding Source: UKRI	Unilever(Unilever); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was fully funded by Unilever (http://www.unilever.com) and all study staff were employed by Unilever Research at the time of the study. Study staff were responsible for the design of the study, data collection and analysis, decision to publish, and preparation of the manuscript on behalf of Unilever.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Christensen K, 2004, EPIDEMIOLOGY, V15, P251, DOI 10.1097/01.ede.0000112211.11416.a6; Christensen Kaare, 2009, BMJ, V339, pb5262; Chung JH, 2003, PHOTODERMATOL PHOTO, V19, P109, DOI 10.1034/j.1600-0781.2003.00027.x; Cosgrove MC, 2007, AM J CLIN NUTR, V86, P1225, DOI 10.1093/ajcn/86.4.1225; Farage M. A., 2008, International Journal of Cosmetic Science, V30, P87, DOI 10.1111/j.1468-2494.2007.00415.x; Guinot C, 2002, ARCH DERMATOL, V138, P1454, DOI 10.1001/archderm.138.11.1454; Gunn DA, 2008, BIOGERONTOLOGY, V9, P357, DOI 10.1007/s10522-008-9141-y; Gunn DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008021; Hawkins Stacy S, 2004, Dermatol Ther, V17 Suppl 1, P63, DOI 10.1111/j.1396-0296.2004.04S1008.x; KADUNCE DP, 1991, ANN INTERN MED, V114, P840, DOI 10.7326/0003-4819-114-10-840; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Li CB, 2006, INT PSYCHOGERIATR, V18, P551, DOI 10.1017/S1041610205002966; MacArthur JD, MACARTHUR RES NETWOR; Mayes AE, 2010, J EUR ACAD DERMATOL, V24, P341, DOI 10.1111/j.1468-3083.2009.03418.x; Morita A, 2007, J DERMATOL SCI, V48, P169, DOI 10.1016/j.jdermsci.2007.06.015; Myint PK, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b349; Ng TP, 2009, AM J GERIAT PSYCHIAT, V17, P407, DOI 10.1097/JGP.0b013e31819a808e; Nkengne A, 2008, J EUR ACAD DERMATOL, V22, P982, DOI 10.1111/j.1468-3083.2008.02698.x; Pollack CE, 2007, AM J PREV MED, V33, P250, DOI 10.1016/j.amepre.2007.04.033; Purba MB, 2001, AGE AGEING, V30, P227, DOI 10.1093/ageing/30.3.227; Rexbye H, 2006, AGE AGEING, V35, P110, DOI 10.1093/ageing/afj031; Rexbye H., 2007, INT J AGEING LATER L, V2, P61, DOI [DOI 10.3384/IJAL.1652-8670.072161, 10.3384/ijal.1652-8670.072161]; Samson N., 2010, International Journal of Cosmetic Science, V32, P167, DOI 10.1111/j.1468-2494.2009.00535.x; Seeman TE, 2004, SOC SCI MED, V58, P1985, DOI 10.1016/S0277-9536(03)00402-7; Shekar SN, 2005, J INVEST DERMATOL, V125, P1119, DOI 10.1111/j.0022-202X.2005.23961.x; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Verdier-Sevrain S, 2006, EXP DERMATOL, V15, P83, DOI 10.1111/j.1600-0625.2005.00377.x; Wang YN, 2009, J ZHEJIANG UNIV-SC B, V10, P57, DOI 10.1631/jzus.B0820071; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; Wildt L, 1999, LANCET, V354, P224, DOI 10.1016/S0140-6736(99)01436-1; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Zhao P, 1998, ARCH ENVIRON HEALTH, V53, P405, DOI 10.1080/00039899809605728	35	36	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15270	10.1371/journal.pone.0015270	http://dx.doi.org/10.1371/journal.pone.0015270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	693SY	21179450	Green Submitted, Green Published, gold			2022-12-25	WOS:000285246900040
J	Bjorklund, CC; Ma, WC; Wang, ZQ; Davis, RE; Kuhn, DJ; Kornblau, SM; Wang, M; Shah, JJ; Orlowski, RZ				Bjorklund, Chad C.; Ma, Wencai; Wang, Zhi-Qiang; Davis, R. Eric; Kuhn, Deborah J.; Kornblau, Steven M.; Wang, Michael; Shah, Jatin J.; Orlowski, Robert Z.			Evidence of a Role for Activation of Wnt/beta-Catenin Signaling in the Resistance of Plasma Cells to Lenalidomide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REFRACTORY MULTIPLE-MYELOMA; MEDIATED DRUG-RESISTANCE; SYNTHASE KINASE 3; PLUS DEXAMETHASONE; COMBINATION THERAPY; THALIDOMIDE; PATHWAY; MECHANISM; ADHESION; WNT	Lenalidomide plays an important role in our chemotherapeutic armamentarium against multiple myeloma, in part by exerting direct anti-proliferative and pro-apoptotic effects. Unfortunately, long-term exposure leads to the development of drug resistance through unknown mechanisms, and we therefore sought to identify pathways that could be responsible for this phenotype. Chronic drug exposure produced myeloma cell lines that were tolerant of the direct effects of lenalidomide, with a degree of resistance of up to 2,500-fold. Gene expression profiling and pathway analysis identified dysregulation of the Wnt/beta-catenin pathway as a consistent change across four independent cell isolates, and a pair of primary plasma cell samples. Acute drug treatment also increased beta-catenin transcription by 3-fold or more, and both acute and chronic exposure resulted in enhanced accumulation of beta-catenin protein by up to 20-fold or more. This produced Wnt/beta-catenin pathway activation, as judged by increased activity of a lymphoid enhancer factor/T-cell factor promoter reporter, and enhanced accumulation of the downstream targets cyclin D1 and c-Myc. Components of the beta-catenin destruction complex were also impacted by lenalidomide, which suppressed casein kinase 1 alpha expression while augmenting glycogen synthase kinase 3 alpha/beta phosphorylation. Stimulation of Wnt/beta-catenin signaling with recombinant Wnt-3a, or by overexpression of beta-catenin, reduced the anti-proliferative activity of lenalidomide. Conversely, suppression of beta-catenin with small hairpin RNAs restored plasma cell sensitivity to lenalidomide. Together, these findings support the hypothesis that lenalidomide mediates activation of Wnt/beta-catenin signaling in plasma cells as a mechanism of inducible chemoresistance through effects at the transcriptional and post-translational levels.	[Bjorklund, Chad C.; Ma, Wencai; Wang, Zhi-Qiang; Davis, R. Eric; Kuhn, Deborah J.; Wang, Michael; Shah, Jatin J.; Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Kornblau, Steven M.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Kornblau, Steven M.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Orlowski, RZ (corresponding author), 1515 Holcombe Blvd,Unit 429, Houston, TX 77030 USA.	rorlowsk@mdanderson.org	Ma, Wencai/K-3684-2013; Bjorklund, Chad/G-3645-2013	Orlowski, Robert/0000-0002-5723-4129	Multiple Myeloma Research Foundation; National Institutes of Health, NCI [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation; National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Leukemia and Lymphoma Society Scholar in Clinical Research, supported by a Multiple Myeloma Research Foundation Senior Research Award.; All flow cytometry experiments were performed at The University of Texas M. D. Anderson Cancer Center Flow Cytometry and Cellular Imaging Center, supported by National Institutes of Health Grant CA16672 from the NCI.	Aguilera Oscar, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P13; Bandapalli OR, 2009, J PATHOL, V218, P370, DOI 10.1002/path.2539; Chanan-Khan AA, 2008, J CLIN ONCOL, V26, P1544, DOI 10.1200/JCO.2007.14.5367; Cimbora-Zovko T, 2007, EUR J PHARMACOL, V558, P27, DOI 10.1016/j.ejphar.2006.11.077; Colla S, 2007, BLOOD, V109, P4470, DOI 10.1182/blood-2006-11-056747; Dalton WS, 2003, CANCER TREAT REV, V29, P1, DOI 10.1016/S0305-7372(03)00078-1; De Toni F, 2006, ONCOGENE, V25, P3113, DOI 10.1038/sj.onc.1209346; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Escoubet-Lozach L, 2009, CANCER RES, V69, P7347, DOI 10.1158/0008-5472.CAN-08-4898; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Flahaut M, 2009, ONCOGENE, V28, P2245, DOI 10.1038/onc.2009.80; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Gandhi AK, 2006, LEUKEMIA RES, V30, P849, DOI 10.1016/j.leukres.2006.01.010; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; Hideshima T, 2000, BLOOD, V96, P2943, DOI 10.1182/blood.V96.9.2943; Kikuchi A, 2003, CANCER SCI, V94, P225, DOI 10.1111/j.1349-7006.2003.tb01424.x; Knobloch J, 2008, CELL CYCLE, V7, P1121, DOI 10.4161/cc.7.9.5793; Knobloch J, 2007, FASEB J, V21, P1410, DOI 10.1096/fj.06-7603com; Knobloch J, 2008, MOL PHARMACEUT, V5, P1138, DOI 10.1021/mp8001232; Kobune M, 2007, MOL CANCER THER, V6, P1774, DOI 10.1158/1535-7163.MCT-06-0684; Kumar G, 2009, CANCER CHEMOTH PHARM, V63, P1171, DOI 10.1007/s00280-008-0867-7; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mateos M.V., 2009, BLOOD, V114; MCCARTHY PL, 2009, BLOOD, V114; Noda T, 2009, BRIT J CANCER, V100, P1647, DOI 10.1038/sj.bjc.6605064; Palumbo A, 2009, BLOOD, P114; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Quach H, 2010, LEUKEMIA, V24, P22, DOI 10.1038/leu.2009.236; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Rajkumar SV, 2005, BLOOD, V106, P4050, DOI 10.1182/blood-2005-07-2817; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Richardson P, 2009, BLOOD, V114, P772, DOI 10.1182/blood-2008-12-196238; Richardson PG, 2005, ONCOLOGY-NY, V19, P1781; Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; Shah JJ, 2009, LEUKEMIA, V23, P1964, DOI 10.1038/leu.2009.173; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Suppiah R, 2006, CLIN LYMPHOMA MYELOM, V6, P301, DOI 10.3816/CLM.2006.n.004; Vallet S, 2008, LEUKEMIA LYMPHOMA, V49, P1238, DOI 10.1080/10428190802005191; Verhelle D, 2007, CANCER RES, V67, P746, DOI 10.1158/0008-5472.CAN-06-2317; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Yata K, 2003, INT J ONCOL, V22, P165	45	94	99	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11009	11020		10.1074/jbc.M110.180208	http://dx.doi.org/10.1074/jbc.M110.180208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21189262	hybrid, Green Published			2022-12-25	WOS:000288797100013
J	Rautenberg, M; Joo, HS; Otto, M; Peschel, A				Rautenberg, Maren; Joo, Hwang-Soo; Otto, Michael; Peschel, Andreas			Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence	FASEB JOURNAL			English	Article						pathogen-associated molecular patterns; coagulase-negative staphylococci; skin microbiota; neutrophil chemotaxis	LIPOXIN A(4) RECEPTOR; COAGULASE-NEGATIVE STAPHYLOCOCCI; ACTIVATES NEUTROPHILS; MOLECULAR-PATTERNS; IMMUNE EVASION; AUREUS; LUGDUNENSIS; EPIDERMIDIS; RECOGNITION; CHEMOTAXIS	The mechanisms used by the immune system to discriminate between pathogenic and commensal bacteria have remained largely unclear. Recently, we have shown that virulence of Staphylococcus aureus depends on secretion of phenol-soluble modulin (PSM) peptides that disrupt neutrophils at micromolar concentrations. Moreover, all S. aureus PSMs stimulate and attract neutrophils at nanomolar concentrations via interaction with the formyl-peptide receptor 2 (FPR2). Here, we demonstrate that FPR2 allows neutrophils to adjust their responses in relation to the aggressiveness of staphylococcal species, which differ largely in their capacity to infect or colonize humans and animals. PSM-related peptides were detected in all human and animal pathogenic staphylococci, but were absent from most commensal species. Three PSM beta-like peptides produced by the serious human pathogen Staphylococcus lugdunensis were identified as the previously described S. lugdunensis-synergistic hemolysins (SLUSHs). SLUSHs attracted and stimulated human leukocytes in a FPR2-dependent manner, indicating that FPR2 is a general receptor for all PSM-like peptide toxins. Remarkably, the release of PSMs correlated closely with the apparent capacity of staphylococcal species to cause invasive infections and with their ability to activate FPR2. These findings suggest that the innate immune system may be able to respond in different ways to pathogenic or innocuous staphylococci by monitoring the presence of PSMs via FPR2.-Rautenberg, M., Joo, H. S., Otto, M., Peschel, A. Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. FASEB J. 25, 1254-1263 (2011). www.fasebj.org	[Rautenberg, Maren; Peschel, Andreas] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Cellular & Mol Microbiol Div, D-72076 Tubingen, Germany; [Joo, Hwang-Soo; Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, US Natl Inst Hlth, Bethesda, MD 20892 USA	Eberhard Karls University of Tubingen; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Peschel, A (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Cellular & Mol Microbiol Div, Elfriede Aulhorn Str 6, D-72076 Tubingen, Germany.	motto@niaid.nih.gov; andreas.peschel@uni-tuebingen.de		Otto, Michael/0000-0002-2222-4115; JOO, HWANG-SOO/0000-0003-4668-3225	German Research Foundation [SFB685, GRK685, TR34]; German Ministry of Education and Research; Medical Faculty, University of Tubingen; National Institutes of Allergy and Infectious Diseases, U.S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Medical Faculty, University of Tubingen; National Institutes of Allergy and Infectious Diseases, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Nele Nikola for excellent technical help, Jos van Strijp (Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands) for CHIPS, Francois Boulay (Universite Joseph Fourier, Grenoble, France) for FPR1 and FPR2-transfected cell lines, and Bernhard Krismer (Interfaculty Institute of Microbiology and Infection Medicine, University of Tuebingen, Tuebingen, Germany) for staphylococcal strains. This research is supported by grants from the German Research Foundation (SFB685, GRK685, TR34), the German Ministry of Education and Research (SkinStaph Menage), and the IZKF program of the Medical Faculty, University of Tubingen, to A. P. and from the Intramural Program of the National Institutes of Allergy and Infectious Diseases, U.S. National Institutes of Health, to M.O.	Betten A, 2001, J CLIN INVEST, V108, P1221, DOI 10.1172/JCI200113430; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Donvito B, 1997, INFECT IMMUN, V65, P95, DOI 10.1128/IAI.65.1.95-100.1997; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Frank KL, 2008, CLIN MICROBIOL REV, V21, P111, DOI 10.1128/CMR.00036-07; FRENEY J, 1988, INT J SYST BACTERIOL, V38, P168, DOI 10.1099/00207713-38-2-168; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Mader D, 2010, MICROBES INFECT, V12, P415, DOI 10.1016/j.micinf.2010.01.014; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Perretti M, 2002, NAT MED, V8, P1296, DOI 10.1038/nm786; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Queck Shu Yeong, 2008, P227; Rasmussen TT, 2000, APMIS, V108, P663, DOI 10.1034/j.1600-0463.2000.d01-13.x; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Shin EH, 2006, BIOCHEM BIOPH RES CO, V341, P1317, DOI 10.1016/j.bbrc.2006.01.098; Shopsin B, 2008, J INFECT DIS, V198, P1171, DOI 10.1086/592051; Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Tiffany HL, 2001, J BIOL CHEM, V276, P23645, DOI 10.1074/jbc.M101031200; van der Mee-Marquet N, 2003, J CLIN MICROBIOL, V41, P1404, DOI 10.1128/JCM.41.4.1404-1409.2003; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; WATSON DC, 1988, BIOCHEM J, V252, P87, DOI 10.1042/bj2520087; Wenzel A, 2009, AUTOIMMUNITY, V42, P331, DOI 10.1080/08916930902828239; Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	44	77	83	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2011	25	4					1254	1263		10.1096/fj.10-175208	http://dx.doi.org/10.1096/fj.10-175208			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21183593	Green Published, Bronze			2022-12-25	WOS:000288982800014
J	Wang, KH; Li, P; Dong, YY; Cai, X; Hou, DX; Guo, JG; Yin, YA; Zhang, YJ; Li, J; Liang, HW; Yu, BW; Chen, JN; Zen, K; Zhang, JF; Zhang, CY; Chen, X				Wang, Kehui; Li, Peng; Dong, Yanye; Cai, Xing; Hou, Dongxia; Guo, Jigang; Yin, Yuan; Zhang, Yujing; Li, Jing; Liang, Hongwei; Yu, Bowen; Chen, Jiangning; Zen, Ke; Zhang, Junfeng; Zhang, Chen-Yu; Chen, Xi			A Microarray-based Approach Identifies ADP Ribosylation Factor-like Protein 2 as a Target of microRNA-16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; MESSENGER-RNA; COFACTOR-D; FAMILY; ARL2; EXPRESSION; BIOGENESIS; DYNAMICS; CLEAVAGE; GENES	microRNAs (miRNAs) are generally thought to negatively regulate the expression of their target genes by mRNA degradation or by translation repression. Here we show an efficient way to identify miRNA target genes by screening alterations in global mRNA levels following changes in miRNA levels. In this study, we used mRNA microarrays to measure global mRNA expression in three cell lines with increased or decreased levels of miR-16 and performed bioinformatics analysis based on multiple target prediction algorithms. For further investigation among the predicted miR-16 target genes, we selected genes that show an expression pattern opposite to that of miR-16. One of the candidate target genes that may interact with miR-16, ADP-ribosylation factor-like protein 2 (ARL2), was further investigated. First, ARL2 was deduced to be an ideal miR-16 target by computational predictions. Second, ARL2 mRNA and protein levels were significantly abolished by treatment with miR-16 precursors, whereas a miR-16 inhibitor increased ARL2 mRNA and protein levels. Third, a luciferase reporter assay confirmed that miR-16 directly recognizes the 3'-untranslated region (3'-UTR) of ARL2. Finally, we showed that miR-16 could regulate proliferation and induce a significant G0/G1 cell cycle arrest, which was due at least in part, to the down-regulation of ARL2. In summary, the present study suggests that integrating global mRNA profiling and bioinformatics tools may provide the basis for further investigation of the potential targets of a given miRNA. These results also illustrate a novel function of miR-16 targeting ARL2 in modulating proliferation and cell cycle progression.	[Wang, Kehui; Li, Peng; Dong, Yanye; Cai, Xing; Hou, Dongxia; Guo, Jigang; Yin, Yuan; Zhang, Yujing; Li, Jing; Liang, Hongwei; Yu, Bowen; Chen, Jiangning; Zen, Ke; Zhang, Junfeng; Zhang, Chen-Yu; Chen, Xi] Nanjing Univ, Jiangsu Diabet Ctr, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Zen, K (corresponding author), Nanjing Univ, Jiangsu Diabet Ctr, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China.	kzen@nju.edu.cn; jfzhang@nju.edu.cn; cyzhang@nju.edu.cn; xichensunny@gmail.com	殷, 媛/GSE-4523-2022; Yin, Yuan/AAG-1707-2020		National Natural Science Foundation of China [90813035, 81070653, 30890044, 30771036, 30772484, 30725008, 30890032, 31071232, 90608010]; National Basic Research Program of China (973 Program) [2006CB503908, 2006CB503909, 2007CB815701, 2007CB815703, 2007CB815705, 2007CB815804]; Chinese 863 program [2006AA02Z177, 2006AA10A121]; "111" Project; Chinese Academy of Science [GJHZ0701-6, KSCX2-YWN-023]; Natural Science Foundation of Jiangsu Province [BK2006714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese 863 program(National High Technology Research and Development Program of China); "111" Project(Ministry of Education, China - 111 Project); Chinese Academy of Science(Chinese Academy of Sciences); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by Grants from the National Natural Science Foundation of China (Nos. 90813035, 81070653, 30890044, 30771036, 30772484, 30725008, 30890032, 31071232, 90608010), National Basic Research Program of China (973 Program) (Nos. 2006CB503908, 2006CB503909, 2007CB815701, 2007CB815703, 2007CB815705, 2007CB815804), the Chinese 863 program (2006AA02Z177, 2006AA10A121), the "111" Project, the Chinese Academy of Science (GJHZ0701-6, KSCX2-YWN-023), and the Natural Science Foundation of Jiangsu Province (No. BK2006714).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Hoyt MA, 1997, GENETICS, V146, P849; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; KAHN RA, 1991, J BIOL CHEM, V266, P2606; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; McElver J, 2000, PLANT CELL, V12, P1379, DOI 10.1105/tpc.12.8.1379; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	30	25	25	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9468	9476		10.1074/jbc.M110.178335	http://dx.doi.org/10.1074/jbc.M110.178335			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21199864	Green Published, hybrid			2022-12-25	WOS:000288247700074
J	Kubota, T; Matsuoka, M; Xu, SX; Otsuki, N; Takeda, M; Kato, A; Ozato, K				Kubota, Toru; Matsuoka, Mayumi; Xu, Songxiao; Otsuki, Noriyuki; Takeda, Makoto; Kato, Atsushi; Ozato, Keiko			PIASy Inhibits Virus-induced and Interferon-stimulated Transcription through Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; STAT1-MEDIATED GENE ACTIVATION; TOLL-LIKE RECEPTORS; NEGATIVE REGULATION; SIGNALING PATHWAYS; INNATE IMMUNITY; RIG-I; NUCLEAR-BODIES; RNA HELICASE; SUMO	The protein inhibitor of activated STAT (PIAS) family proteins regulates innate immune responses by controlling transcription induced by Toll-like receptor, RIG-I-like receptor signaling, and JAK/STAT pathways. Here, we show that PIASy negatively regulates type I interferon (IFN) transcription. Virus infection led to enhanced type I IFN induction in PIASy null cells, and conversely PIASy overexpression reduced IFN transcription. A mutation in the LXXLL motif of the SAP domain abolished inhibition of IFN-stimulated gene expression but did not affect virus or Toll-like receptor/RIG-I-like receptor-stimulated IFN transcription, indicating that PIASy employs distinct mechanisms to inhibit virus-induced and IFN-stimulated transcription. SUMO E3 activity was not required for PIASy inhibition of IFN transcription; however, PIASy relied on the SUMO modification mechanism to inhibit IFN transcription, because the activity of the SUMO-interacting motif was required for inhibition, and knockdown of SUMO E2 enzyme UBC9 decreased inhibitory activity of PIASy. Our results demonstrate that PIASy negatively regulates both IFN transcription and IFN-stimulated gene expression through multiple mechanisms utilizing the function of different domains.	[Kubota, Toru; Otsuki, Noriyuki; Takeda, Makoto; Kato, Atsushi] Natl Inst Infect Dis, Dept Virol 3, Tokyo 2080011, Japan; [Matsuoka, Mayumi] Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo 2080011, Japan; [Xu, Songxiao; Ozato, Keiko] NICHD, Lab Mol Growth Regulat, Genom Differentiat Program, NIH, Bethesda, MD 20892 USA	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kubota, T (corresponding author), Natl Inst Infect Dis, Dept Virol 3, Tokyo 2080011, Japan.	kubota@nih.go.jp	Takeda, Makoto/J-2550-2018; Xu, Songxiao/L-5737-2019	Takeda, Makoto/0000-0002-8194-7727; 	NICHD; NIH; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22590424]	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in whole or in part, by National Institutes of Health grant from the Intramural Research Program of NICHD and Trans NIH Bio-defense Program. This work was also supported by Grant-in-aid 22590424 for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akaike T, 2000, FASEB J, V14, P1447, DOI 10.1096/fj.14.10.1447; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bin L, 2008, TRENDS PHARMACOL SCI, V29, P505, DOI 10.1016/j.tips.2008.07.008; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Glass CK, 2000, GENE DEV, V14, P121; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Liao JY, 2000, P NATL ACAD SCI USA, V97, P5267, DOI 10.1073/pnas.97.10.5267; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Moore CB, 2008, IMMUNITY, V28, P735, DOI 10.1016/j.immuni.2008.05.005; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sakai Y, 1999, FEBS LETT, V456, P221, DOI 10.1016/S0014-5793(99)00960-6; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wang J, 2009, MICROBES INFECT, V11, P321, DOI 10.1016/j.micinf.2008.12.011; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhang J, 2004, FEBS LETT, V570, P97, DOI 10.1016/j.febslet.2004.05.081; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	54	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8165	8175		10.1074/jbc.M110.195255	http://dx.doi.org/10.1074/jbc.M110.195255			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21199872	Green Published, hybrid			2022-12-25	WOS:000288013300047
J	Chen, CJ; Su, LH; Lin, TY; Huang, YC				Chen, Chih-Jung; Su, Lin-Hui; Lin, Tzou-Yien; Huang, Yhu-Chering			Molecular Analysis of Repeated Methicillin-Resistant Staphylococcus aureus Infections in Children	PLOS ONE			English	Article							STRAIN-RELATEDNESS; HOSPITALS; MEC; IDENTIFICATION; COLONIZATION; EPIDEMIOLOGY; SURVEILLANCE; CRITERIA; TAIWAN; MRSA	Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen that causes severe morbidity and mortality in hospitalized patients. It is unclear whether repeated MRSA infections in pediatric patients are caused by relapse of previous infecting strains or by acquiring new strains from extrinsic sources. The study aimed to define the genetic relatedness of MRSA isolates from children with repeated infections. Methodology/Principal Findings: Children with multiple MRSA infections during 2004-2006 were identified in a teaching hospital. Repeated infections were confirmed by chart review and the responsible isolates were genotyped and screened for Panton-Valentine leukocidin (PVL) genes. Two consecutive episodes comprised an infection pair, and strain relatedness was defined for each pair as indistinguishable, highly related, or distinct if the isolates were of the same subtype, the same genotype, or different genotype, respectively. A total of 114 episodes comprising 66 infection pairs were identified in 48 children. The interval of infection pairs ranged from 15 days to 346 days, with a median duration of 57.5 days. Genotypings classified all isolates into 7 genotypes and 31 subtypes. Of 66 pairs, 46 (69.7%), 13 (19.7%) and 7 (10.6%) pairs were caused by indistinguishable, highly related and distinct strains, respectively. Subsequent infections caused by indistinguishable strains were more common for PVL-positive strains (17/18, 94.4%) than for PVL-negative strains (29/48, 60.4%, P = 0.007). The strain relatedness was not affected by the durations of interval between infections. Conclusions/Significance: Most repeated MRSA infections in children are caused by indistinguishable strains even after a long period of interval, suggesting that persistent carriage and relapse of initial infecting strains were responsible for the majority of recurrent MRSA infections.	[Chen, Chih-Jung; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Chen, Chih-Jung; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Mem Hosp, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Chen, Chih-Jung; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Mem Hosp, Pediat Res Ctr, Tao Yuan, Taiwan; [Chen, Chih-Jung; Su, Lin-Hui; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Su, Lin-Hui] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chen, CJ (corresponding author), Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan.	ychuang@adm.cgmh.org.tw			Chang Gung Memorial Hospital [CMRPG 460111, CMRPG450123]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from Chang Gung Memorial Hospital (CMRPG 460111 and CMRPG450123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; Chen Chih-Jung, 2005, Journal of Microbiology Immunology and Infection, V38, P376; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Gonzalez BE, 2006, INFECT CONT HOSP EP, V27, P1051, DOI 10.1086/507923; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang SS, 2008, CLIN INFECT DIS, V46, P1241, DOI 10.1086/529381; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2004, J CLIN MICROBIOL, V42, P307, DOI 10.1128/JCM.42.1.307-310.2004; Huang YC, 2006, PEDIATRICS, V118, P469, DOI 10.1542/peds.2006-0254; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Kotilainen P, 2001, ARCH INTERN MED, V161, P859, DOI 10.1001/archinte.161.6.859; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Liao CH, 2010, CLIN MICROBIOL INFEC, V16, P463, DOI 10.1111/j.1469-0691.2009.02885.x; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Robicsek A, 2009, CLIN INFECT DIS, V48, P910, DOI 10.1086/597296; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wang JT, 2007, EMERG INFECT DIS, V13, P494, DOI 10.3201/eid1303.060247; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656	30	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14431	10.1371/journal.pone.0014431	http://dx.doi.org/10.1371/journal.pone.0014431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203439	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500008
J	Chotard, L; Skorobogata, O; Sylvain, MA; Shrivastava, S; Rocheleau, CE				Chotard, Laetitia; Skorobogata, Olga; Sylvain, Marc-Andre; Shrivastava, Sanhita; Rocheleau, Christian E.			TBC-2 Is Required for Embryonic Yolk Protein Storage and Larval Survival during L1 Diapause in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; RAB7; NEMATODE; VITELLOGENIN; DEGRADATION; LYSOSOMES; REGULATOR; PATHWAY; KINASE	C. elegans first stage (L1) larvae hatched in the absence of food, arrest development and enter an L1 diapause, whereby they can survive starvation for several weeks. The physiological and metabolic requirements for survival during L1 diapause are poorly understood. However, yolk, a cholesterol binding/transport protein, has been suggested to serve as an energy source. Here, we demonstrate that C. elegans TBC-2, a RAB-5 GTPase Activating Protein (GAP) involved in early-to-late endosome transition, is important for yolk protein storage during embryogenesis and for L1 survival during starvation. We found during embryogenesis, that a yolk:: green fluorescent protein fusion (YP170::GFP), disappeared much more quickly in tbc-2 mutant embryos as compared with wild-type control embryos. The premature disappearance of YP170:: GFP in tbc-2 mutants is likely due to premature degradation in the lysosomes as we found that YP170:: GFP showed increased colocalization with Lysotracker Red, a marker for acidic compartments. Furthermore, YP170:: GFP disappearance in tbc-2 mutants required RAB-7, a regulator of endosome to lysosome trafficking. Although tbc-2 is not essential in fed animals, we discovered that tbc-2 mutant L1 larvae have strongly reduced survival when hatched in the absence of food. We show that tbc-2 mutant larvae are not defective in maintaining L1 diapause and that mutants defective in yolk uptake, rme-1 and rme-6, also had strongly reduced L1 survival when hatched in the absence of food. Our findings demonstrate that TBC-2 is required for yolk protein storage during embryonic development and provide strong correlative data indicating that yolk constitutes an important energy source for larval survival during L1 diapause.	[Chotard, Laetitia; Skorobogata, Olga; Sylvain, Marc-Andre; Shrivastava, Sanhita; Rocheleau, Christian E.] McGill Univ, Royal Victoria Hosp, Dept Med, Div Endocrinol & Metab,Hlth Ctr,Res Inst, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital	Chotard, L (corresponding author), McGill Univ, Royal Victoria Hosp, Dept Med, Div Endocrinol & Metab,Hlth Ctr,Res Inst, Montreal, PQ H3A 1A1, Canada.	christian.rocheleau@mcgill.ca		Rocheleau, Christian/0000-0001-6738-5636	Canadian Institutes for Health Research (CIHR) [MOP-86719]; Canada Research Chair in Signaling and Development; le Fonds de la Recherche en Sante du Quebec (FRSQ); Natural Sciences and Engineering Research Council of Canada (NSERC); CIHR Frederick Banting and Charles Best Canada graduate scholarship; FRSQ	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Signaling and Development; le Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Frederick Banting and Charles Best Canada graduate scholarship(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec)	This study was supported by a Canadian Institutes for Health Research (CIHR) operating grant (MOP-86719) to C.E.R. C.E.R. was supported by a Canada Research Chair in Signaling and Development and is supported by le Fonds de la Recherche en Sante du Quebec (FRSQ). S.S. was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) summer studentship award. O.S. is supported by a CIHR Frederick Banting and Charles Best Canada graduate scholarship and a FRSQ Master's training award. The Research Institute at the McGill University Health Centre is supported in part by the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Bossinger O, 1996, INT J DEV BIOL, V40, P431; BRENNER S, 1974, GENETICS, V77, P71; Britton C, 2002, MOL BIOCHEM PARASIT, V122, P21, DOI 10.1016/S0166-6851(02)00066-X; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chotard L, 2010, MOL BIOL CELL, V21, P2285, DOI 10.1091/mbc.E09-11-0947; Corsi AK, 2000, DEVELOPMENT, V127, P2041; FAGOTTO F, 1995, J CELL SCI, V108, P3645; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant B, 1999, MOL BIOL CELL, V10, p222A; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; Hong Y, 1998, DEVELOPMENT, V125, P3585; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Li WD, 2009, DEVELOPMENT, V136, P2445, DOI 10.1242/dev.035949; Matyash V, 2001, MOL BIOL CELL, V12, P1725, DOI 10.1091/mbc.12.6.1725; MERESSE S, 1995, J CELL SCI, V108, P3349; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Papini E, 1997, EMBO J, V16, P15, DOI 10.1093/emboj/16.1.15; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Schaheen L, 2006, DEV BIOL, V293, P382, DOI 10.1016/j.ydbio.2006.02.008; SPIETH J, 1991, J MOL EVOL, V32, P429, DOI 10.1007/BF02101283; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012	28	17	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15662	10.1371/journal.pone.0015662	http://dx.doi.org/10.1371/journal.pone.0015662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203392	gold, Green Submitted, Green Published			2022-12-25	WOS:000285792500035
J	Parhamifar, L; Sime, W; Yudina, Y; Vilhardt, F; Morgelin, M; Sjolander, A				Parhamifar, Ladan; Sime, Wondossen; Yudina, Yuliana; Vilhardt, Frederik; Morgelin, Matthias; Sjolander, Anita			Ligand-Induced Tyrosine Phosphorylation of Cysteinyl Leukotriene Receptor 1 Triggers Internalization and Signaling in Intestinal Epithelial Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CYSLT(1) RECEPTOR; COLORECTAL ADENOCARCINOMAS; RAB GTPASES; LIPID RAFTS; MAST-CELLS; ENDOCYTOSIS; TRAFFICKING; ACTIVATION; SURVIVAL	Background: Leukotriene D4 (LTD4) belongs to the bioactive lipid group known as eicosanoids and has implications in pathological processes such as inflammation and cancer. Leukotriene D4 exerts its effects mainly through two different G-protein-coupled receptors, CysLT(1) and CysLT(2). The high affinity LTD4 receptor CysLT(1)R exhibits tumor-promoting properties by triggering cell proliferation, survival, and migration in intestinal epithelial cells. In addition, increased expression and nuclear localization of CysLT(1)R correlates with a poorer prognosis for patients with colon cancer. Methodology/Principal Findings: Using a proximity ligation assay and immunoprecipitation, this study showed that endogenous CysLT(1)R formed heterodimers with its counter-receptor CysLT(2)R under basal conditions and that LTD4 triggers reduced dimerization of CysLTRs in intestinal epithelial cells. This effect was dependent upon a parallel LTD4-induced increase in CysLT(1)R tyrosine phosphorylation. Leukotriene D4 also led to elevated internalization of CysLT(1)Rs from the plasma membrane and a simultaneous increase at the nucleus. Using sucrose, a clathrin endocytic inhibitor, dominant-negative constructs, and siRNA against arrestin-3, we suggest that a clathrin-, arrestin-3, and Rab-5-dependent process mediated the internalization of CysLT(1)R. Altering the CysLT1R internalization process at either the clathrin or the arrestin-3 stage led to disruption of LTD4-induced Erk1/2 activation and up-regulation of COX-2 mRNA levels. Conclusions/Significance: Our data suggests that upon ligand activation, CysLT(1)R is tyrosine-phosphorylated and released from heterodimers with CysLT(2)R and, subsequently, internalizes from the plasma membrane to the nuclear membrane in a clathrin-, arrestin-3-, and Rab-5-dependent manner, thus, enabling Erk1/2 signaling and downstream transcription of the COX-2 gene.	[Parhamifar, Ladan; Sime, Wondossen; Yudina, Yuliana; Sjolander, Anita] Lund Univ, Skane Univ Hosp, Dept Lab Med, Clin Res Ctr, Malmo, Sweden; [Vilhardt, Frederik] Univ Copenhagen, Panum Inst, Inst Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Lund, Sweden	Lund University; Skane University Hospital; University of Copenhagen; Lund University	Parhamifar, L (corresponding author), Lund Univ, Skane Univ Hosp, Dept Lab Med, Clin Res Ctr, Malmo, Sweden.	anita.sjolander@med.lu.se	Parhamifar, Ladan/C-5145-2016; Vilhardt, Frederik/AAX-4766-2021	Parhamifar, Ladan/0000-0003-4374-5734; Vilhardt, Frederik/0000-0001-8604-7165	Swedish Cancer Foundation; Swedish Medical Research Council; Foundations at Malmo University Hospital; Ruth and Richard Julin Foundation; Gunnar Nilsson's Cancer Foundation; Osterlund Foundation; Royal Physiographic Society in Lund	Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Foundations at Malmo University Hospital; Ruth and Richard Julin Foundation; Gunnar Nilsson's Cancer Foundation; Osterlund Foundation; Royal Physiographic Society in Lund	This work was supported by grants to AS by the Swedish Cancer Foundation, the Swedish Medical Research Council, the Foundations at Malmo University Hospital, the Ruth and Richard Julin Foundation, Gunnar Nilsson's Cancer Foundation, and the Osterlund Foundation and to LP and WS from the Royal Physiographic Society in Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; BASCHONG W, 1985, HISTOCHEMISTRY, V83, P409, DOI 10.1007/BF00509201; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Capra V, 2005, J CELL SCI, V118, P5625, DOI 10.1242/jcs.02668; CARLEMALM E, 1985, J MICROSC-OXFORD, V140, P55, DOI 10.1111/j.1365-2818.1985.tb02660.x; Chen ZG, 2004, MOL PHARMACOL, V66, P377; Deshpande DA, 2007, FASEB J, V21, P2335, DOI 10.1096/fj.06-8060com; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Edwards SW, 2000, TRENDS PHARMACOL SCI, V21, P304, DOI 10.1016/S0165-6147(00)01513-3; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Lopez MAG, 2009, CELL SIGNAL, V21, P1748, DOI 10.1016/j.cellsig.2009.07.010; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; Goetzl EJ, 2007, FASEB J, V21, P638, DOI 10.1096/fj.06-6624hyp; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HENLE G, 1957, J IMMUNOL, V79, P54; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Insel PA, 2005, ANN NY ACAD SCI, V1047, P166, DOI 10.1196/annals.1341.015; Jiang Y, 2007, BLOOD, V110, P3263, DOI 10.1182/blood-2007-07-100453; Joos Guy F, 2008, Pol Arch Med Wewn, V118, P689; Lynch KR, 1999, NATURE, V399, P789; Magnusson C, 2007, CANCER RES, V67, P9190, DOI 10.1158/0008-5472.CAN-07-0771; Magnusson C, 2010, EUR J CANCER, V46, P826, DOI 10.1016/j.ejca.2009.12.022; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mezhybovska M, 2006, J BIOL CHEM, V281, P6776, DOI 10.1074/jbc.M509999200; Millar RP, 2010, MOL ENDOCRINOL, V24, P261, DOI 10.1210/me.2009-0473; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Naik S, 2005, J BIOL CHEM, V280, P8722, DOI 10.1074/jbc.M413014200; Nielsen CK, 2005, CANCER RES, V65, P732; Ohd JF, 2000, GASTROENTEROLOGY, V119, P1007, DOI 10.1053/gast.2000.18141; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Parhamifar L, 2005, CARCINOGENESIS, V26, P1988, DOI 10.1093/carcin/bgi159; Paruchuri S, 2006, ONCOGENE, V25, P6660, DOI 10.1038/sj.onc.1209666; Paruchuri S, 2005, J BIOL CHEM, V280, P13538, DOI 10.1074/jbc.M409811200; Paruchuri S, 2003, J BIOL CHEM, V278, P45577, DOI 10.1074/jbc.M302881200; Paruchuri S, 2002, J CELL SCI, V115, P1883; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Serhan CN, 1996, FASEB J, V10, P1147, DOI 10.1096/fasebj.10.10.8751717; Shmuel M, 2007, MOL BIOL CELL, V18, P1570, DOI 10.1091/mbc.E06-07-0618; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENSON WF, 1990, SCAND J GASTROENTERO, V25, P13, DOI 10.3109/00365529009091903; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Thompson Miles D., 2008, V448, P139, DOI 10.1007/978-1-59745-205-2_8; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Wikstrom K, 2003, BIOCHEM BIOPH RES CO, V302, P330, DOI 10.1016/S0006-291X(03)00187-6; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zhu T, 2006, CAN J PHYSIOL PHARM, V84, P377, DOI 10.1139/Y05-147	53	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14439	10.1371/journal.pone.0014439	http://dx.doi.org/10.1371/journal.pone.0014439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203429	Green Submitted, Green Published, gold			2022-12-25	WOS:000285792500015
J	Mukhopadhyay, P; Mukherjee, S; Ahsan, K; Bagchi, A; Pacher, P; Das, DK				Mukhopadhyay, Partha; Mukherjee, Subhendu; Ahsan, Kaimul; Bagchi, Angshuman; Pacher, Pal; Das, Dipak K.			Restoration of Altered MicroRNA Expression in the Ischemic Heart with Resveratrol	PLOS ONE			English	Article							SURVIVAL SIGNAL; NITRIC-OXIDE; CANCER; MECHANISM; STRESS; DIAGNOSIS	Background: Resveratrol, a constituent of red wine, is important for cardioprotection. MicroRNAs are known regulators for genes involved in resveratrol-mediated cardiac remodeling and the regulatory pathway involving microRNA has not been studied so far. Methods: We explored the cardioprotection by resveratrol in ischemia/reperfusion model of rat and determined cardiac functions. miRNA profile was determined from isolated RNA using quantitative Real-time PCR based array. Systemic analyses of miRNA array and theirs targets were determined using a number of computational approaches. Results: Cardioprotection by resveratrol and its derivative in ischemia/reperfusion [I/R] rat model was examined with miRNA expression profile. Unique expression pattern were found for each sample, particularly with resveratrol [pure compound] and longevinex [commercial resveratrol formulation] pretreated hearts. Longevinex and resveratrol pretreatment modulates the expression pattern of miRNAs close to the control level based on PCA analyses. Differential expression was observed in over 25 miRNAs, some of them, such as miR-21 were previously implicated in cardiac remodeling. The target genes for the differentially expressed miRNA include genes of various molecular function such as metal ion binding, sodium-potassium ion, transcription factors, which may play key role in reducing I/R injury. Conclusion: Rats pretreated with resveratrol for 3 weeks leads to significant cardioprotection against ischemia/reperfusion injury. A unique signature of miRNA profile is observed in control heart pretreated with resveratrol or longevinex. We have determined specific group of miRNA in heart that have altered during IR injuries. Most of those altered microRNA expressions modulated close to their basal level in resveratrol or longevinex treated I/R mice.	[Mukhopadhyay, Partha; Pacher, Pal] NIAAA, Lab Physiol Studies, NIH, Bethesda, MD USA; [Bagchi, Angshuman] Buck Inst Age Res, Novato, CA USA; [Mukherjee, Subhendu; Ahsan, Kaimul; Das, Dipak K.] Univ Connecticut, Sch Med, Cardiovasc Res Ctr, Farmington, CT USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Buck Institute for Research on Aging; University of Connecticut	Mukhopadhyay, P (corresponding author), NIAAA, Lab Physiol Studies, NIH, Bethesda, MD USA.	ddas@neuron.uchc.edu	., Angsuman Bagchi/U-4858-2019; Bagchi, Angshuman/AAP-1887-2021; MUKHOPADHYAY, PARTHA/G-3890-2010; Pacher, Pal/B-6378-2008; Mukherjee, Subhendu/N-6731-2016	MUKHOPADHYAY, PARTHA/0000-0002-1178-1274; Pacher, Pal/0000-0001-7036-8108; Mukherjee, Subhendu/0000-0002-4851-4428	NIH [HL 34360, HL 22559, HL 33889]; NIAAA/NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022559, R01HL033889, R01HL034360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAAA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by NIH HL 34360, HL 22559 and HL 33889 (to D. K. Das) and Intramural Research Program of the NIAAA/NIH (to P. Pacher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAUERSACHS J, 2010, J CARDIOVASC PHARM; Baxter Richard A, 2008, J Cosmet Dermatol, V7, P2, DOI 10.1111/j.1473-2165.2008.00354.x; Bertelli AAA, 2009, J CARDIOVASC PHARM, V54, P468, DOI 10.1097/FJC.0b013e3181bfaff3; Bhat KPL, 2002, ANN NY ACAD SCI, V957, P210, DOI 10.1111/j.1749-6632.2002.tb02918.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Cataluccia D, 2008, ANN NY ACAD SCI, V1123, P20, DOI 10.1196/annals.1420.004; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Das DK, 2004, BIOCHEMISTRY-MOSCOW+, V69, P10, DOI 10.1023/B:BIRY.0000016345.19027.54; DAS DK, 2010, HEART FAIL REV; Das S, 2006, J PHARMACOL EXP THER, V317, P980, DOI 10.1124/jpet.105.095133; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hattori R, 2002, AM J PHYSIOL-HEART C, V282, pH1988, DOI 10.1152/ajpheart.01012.2001; Imamura G, 2002, AM J PHYSIOL-HEART C, V282, pH1996, DOI 10.1152/ajpheart.01013.2001; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Kartha RV, 2010, J CARDIOVASC TRANSL, V3, P256, DOI 10.1007/s12265-010-9172-z; Lu YJ, 2009, CARDIOVASC RES, V84, P434, DOI 10.1093/cvr/cvp232; MUKHERJEE S, J EXP CLIN IN PRESS; Mukherjee S, 2009, FREE RADICAL BIO MED, V46, P573, DOI 10.1016/j.freeradbiomed.2008.11.005; MUKHERJI SRD, 2010, CAN J PHARM IN PRESS; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nana-Sinkam P, 2010, PHARMACOGENOMICS, V11, P667, DOI 10.2217/PGS.10.57; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Qurashi A, 2010, CURR PSYCHIAT REP, V12, P154, DOI 10.1007/s11920-010-0102-1; SAUNDERS LR, 2010, AGING ALBANY; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tili E, 2010, BIOCHEM PHARMACOL, V80, P2057, DOI 10.1016/j.bcp.2010.07.003; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009	38	73	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15705	10.1371/journal.pone.0015705	http://dx.doi.org/10.1371/journal.pone.0015705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203465	gold, Green Published, Green Submitted			2022-12-25	WOS:000285579200031
J	Yasuniwa, Y; Izumi, H; Wang, KY; Shimajiri, S; Sasaguri, Y; Kawai, K; Kasai, H; Shimada, T; Miyake, K; Kashiwagi, E; Hirano, G; Kidani, A; Akiyama, M; Han, B; Wu, Y; Ieiri, I; Higuchi, S; Kohno, K				Yasuniwa, Yoshihiro; Izumi, Hiroto; Wang, Ke-Yong; Shimajiri, Shohei; Sasaguri, Yasuyuki; Kawai, Kazuaki; Kasai, Hiroshi; Shimada, Takashi; Miyake, Koichi; Kashiwagi, Eiji; Hirano, Gen; Kidani, Akihiko; Akiyama, Masaki; Han, Bin; Wu, Ying; Ieiri, Ichiro; Higuchi, Shun; Kohno, Kimitoshi			Circadian Disruption Accelerates Tumor Growth and Angio/Stromagenesis through a Wnt Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER; CISPLATIN RESISTANCE; KELOID FIBROBLASTS; CELL LINES; NIGHT; MELATONIN; CLOCK; LIGHT; MICROENVIRONMENT	Epidemiologic studies show a high incidence of cancer in shift workers, suggesting a possible relationship between circadian rhythms and tumorigenesis. However, the precise molecular mechanism played by circadian rhythms in tumor progression is not known. To identify the possible mechanisms underlying tumor progression related to circadian rhythms, we set up nude mouse xenograft models. HeLa cells were injected in nude mice and nude mice were moved to two different cases, one case is exposed to a 24-hour light cycle (L/L), the other is a more "normal" 12-hour light/dark cycle (L/D). We found a significant increase in tumor volume in the L/L group compared with the L/D group. In addition, tumor microvessels and stroma were strongly increased in L/L mice. Although there was a hypervascularization in L/L tumors, there was no associated increase in the production of vascular endothelial cell growth factor (VEGF). DNA microarray analysis showed enhanced expression of WNT10A, and our subsequent study revealed that WNT10A stimulates the growth of both microvascular endothelial cells and fibroblasts in tumors from light-stressed mice, along with marked increases in angio/stromagenesis. Only the tumor stroma stained positive for WNT10A and WNT10A is also highly expressed in keloid dermal fibroblasts but not in normal dermal fibroblasts indicated that WNT10A may be a novel angio/stromagenic growth factor. These findings suggest that circadian disruption induces the progression of malignant tumors via a Wnt signaling pathway.	[Yasuniwa, Yoshihiro; Izumi, Hiroto; Kashiwagi, Eiji; Hirano, Gen; Kidani, Akihiko; Akiyama, Masaki; Han, Bin; Wu, Ying; Kohno, Kimitoshi] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Kitakyushu, Fukuoka 807, Japan; [Yasuniwa, Yoshihiro; Ieiri, Ichiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Fukuoka 812, Japan; [Wang, Ke-Yong; Shimajiri, Shohei; Sasaguri, Yasuyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Kitakyushu, Fukuoka 807, Japan; [Kawai, Kazuaki; Kasai, Hiroshi] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Dept Environm Oncol, Kitakyushu, Fukuoka 807, Japan; [Shimada, Takashi; Miyake, Koichi] Nihon Med Sch, Dept Biochem & Mol Biol, Tokyo, Japan; [Han, Bin] China Med Univ, Shengjing Hosp, Dept Urol, Shenyang, Peoples R China; [Wu, Ying; Higuchi, Shun] China Med Univ, Affiliated Hosp 1, Dept Oncol, Shenyang, Peoples R China	University of Occupational & Environmental Health - Japan; Kyushu University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Nippon Medical School; China Medical University; China Medical University	Yasuniwa, Y (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Kitakyushu, Fukuoka 807, Japan.	k-kohno@med.uoeh-u.ac.jp		wang, ke-yong/0000-0001-8295-1229	KAKENHI [17016075]; UOEH; Vehicle Racing Commemorative Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); UOEH(University of Occupational & Environmental Health - Japan); Vehicle Racing Commemorative Foundation	This work was supported by KAKENHI (17016075), UOEH Grants for Advanced Research and the Vehicle Racing Commemorative Foundation (to K. Kohno). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; BEILDECK ME, 2010, EXP CELL RE IN PRESS; Blankesteijn WM, 2000, AM J PATHOL, V157, P877, DOI 10.1016/S0002-9440(10)64601-9; Blask DE, 2005, CANCER RES, V65, P11174, DOI 10.1158/0008-5472.CAN-05-1945; Bohring A, 2009, AM J HUM GENET, V85, P97, DOI 10.1016/j.ajhg.2009.06.001; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Hansen J, 2006, CANCER CAUSE CONTROL, V17, P531, DOI 10.1007/s10552-005-9006-5; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Innominato PF, 2009, CANCER RES, V69, P4700, DOI 10.1158/0008-5472.CAN-08-4747; Itoh T, 2009, FEBS LETT, V583, P777, DOI 10.1016/j.febslet.2009.01.022; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Jung B, 2006, CANCER RES, V66, P9789, DOI 10.1158/0008-5472.CAN-06-1776; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kawai K, 2007, GENES ENVIRON, V29, P107, DOI DOI 10.3123/JEMSGE.29.107; Kidani A, 2009, INT J ONCOL, V35, P1435, DOI 10.3892/ijo_00000462; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Kirikoshi H, 2001, INT J ONCOL, V19, P533; KOHNO K, 1990, J BIOL CHEM, V265, P19690; Korkmaz A, 2009, BREAST CANCER RES TR, V115, P13, DOI 10.1007/s10549-008-0103-5; Levi F, 2006, CANCER CAUSE CONTROL, V17, P611, DOI 10.1007/s10552-005-9004-7; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Macheda ML, 2008, CURR CANCER DRUG TAR, V8, P454, DOI 10.2174/156800908785699324; MASCKAUCHA NTN, 2006, PHYSL BETHESDA, V21, P181; Miyamoto N, 2008, J BIOL CHEM, V283, P18218, DOI 10.1074/jbc.M802332200; NAKAGAWA M, 1993, J UROLOGY, V150, P1970, DOI 10.1016/S0022-5347(17)35948-7; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Nawaz S, 2009, EUR J HUM GENET, V17, P1600, DOI 10.1038/ejhg.2009.81; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Russell SB, 2010, J INVEST DERMATOL, V130, P2489, DOI 10.1038/jid.2010.162; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Smith JC, 2008, J INVEST DERMATOL, V128, P1298, DOI 10.1038/sj.jid.5701149; Vinogradova IA, 2009, AGING-US, V1, P855, DOI 10.18632/aging.100092; Wakasugi T, 2007, ONCOGENE, V26, P5194, DOI 10.1038/sj.onc.1210326; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834	41	48	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15330	10.1371/journal.pone.0015330	http://dx.doi.org/10.1371/journal.pone.0015330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203463	Green Published, gold, Green Submitted			2022-12-25	WOS:000285579200018
J	Blumenthal, A; Trujillo, C; Ehrt, S; Schnappinger, D				Blumenthal, Antje; Trujillo, Carolina; Ehrt, Sabine; Schnappinger, Dirk			Simultaneous Analysis of Multiple Mycobacterium tuberculosis Knockdown Mutants In Vitro and In Vivo	PLOS ONE			English	Article							INDUCIBLE GENE-EXPRESSION; CONDITIONAL EXPRESSION; ISOCITRATE LYASE-1; GROWTH; IDENTIFICATION; SMEGMATIS; SURVIVAL; REQUIREMENTS; REPLICATION; MUTAGENESIS	Mycobacterium tuberculosis (Mtb) represents one of the most persistent bacterial threats to human health and new drugs are needed to limit its impact. Conditional knockdown mutants can help validate new drug targets, but the analysis of individual mutants is laborious and time consuming. Here, we describe quantitative DNA tags (qTags) and their use to simultaneously analyze conditional Mtb knockdown mutants that allowed silencing the glyoxylate and methylcitrate cycles (via depletion of isocitrate lyase, ICL), the serine protease Rv3671c, and the core subunits of the mycobacterial proteasome, PrcB and PrcA. The impact of gene silencing in multi-strain cultures was determined by measuring the relative abundance of mutant-specific qTags with real-time PCR. This achieved accurate quantification over a broad range of qTag abundances and depletion of ICL, Rv3671c, or PrcBA resulted in the expected impairment of growth of Mtb with butyrate as the primary carbon source, survival during oxidative stress, acid stress and starvation. The impact of depleting ICL, Rv3671c, or PrcBA in multi-strain mouse infections was analyzed with two approaches. We first measured the relative abundance of mutant-specific qTags in total chromosomal DNA isolated from bacteria that were recovered from infected lungs on agar plates. We then developed a two-step amplification procedure, which allowed us to measure the abundances of individual mutants directly in infected lung tissue. Both strategies confirmed that inactivation of Rv3671c and PrcBA severely reduced persistence of Mtb in mice. The multi-strain infections furthermore suggested that silencing ICL not only prevented growth of Mtb during acute infections but also prevented survival of Mtb during chronic infections. Analyses of the ICL knockdown mutant in single-strain infections confirmed this and demonstrated that silencing of ICL during chronic infections impaired persistence of Mtb to the extent that the pathogen was cleared from the lungs of most mice.				dis2003@med.cornell.edu	Ehrt, Sabine/AAU-6449-2020; Blumenthal, Antje/A-3608-2011	Blumenthal, Antje/0000-0003-3673-7015	Bill and Melinda Gates Foundation [42848]; National Institutes of Health [AI063446]; Stony Wold-Herbert Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063446] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony Wold-Herbert Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Bill and Melinda Gates Foundation grant 42848 awarded to DS, and National Institutes of Health grant AI063446 awarded to SE. AB received support from the Stony Wold-Herbert Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; Carroll P, 2007, FEMS MICROBIOL LETT, V274, P73, DOI 10.1111/j.1574-6968.2007.00842.x; Cerda-Maira F, 2009, MICROBES INFECT, V11, P1150, DOI 10.1016/j.micinf.2009.08.003; Chalut C, 2006, P NATL ACAD SCI USA, V103, P8511, DOI 10.1073/pnas.0511129103; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Dolganov GM, 2001, GENOME RES, V11, P1473, DOI 10.1101/gr.191301; Dutton RJ, 2010, P NATL ACAD SCI USA, V107, P297, DOI 10.1073/pnas.0912952107; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gandotra S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001040; Garces A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000957; Gould TA, 2006, MOL MICROBIOL, V61, P940, DOI 10.1111/j.1365-2958.2006.05297.x; Greendyke R, 2002, MICROBIOL-SGM, V148, P3887, DOI 10.1099/00221287-148-12-3887; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hernandez-Abanto SM, 2006, ARCH MICROBIOL, V186, P459, DOI 10.1007/s00203-006-0160-2; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Hett EC, 2007, MOL MICROBIOL, V66, P658, DOI 10.1111/j.1365-2958.2007.05945.x; Hisert KB, 2004, INFECT IMMUN, V72, P5315, DOI 10.1128/IAI.72.9.5315-5321.2004; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kim DH, 2008, AM J RESP CRIT CARE, V178, P1075, DOI 10.1164/rccm.200801-132OC; KLOTZSCHE M, 2009, NUCL ACIDS RES; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; LoBue P, 2009, CURR OPIN INFECT DIS, V22, P167, DOI 10.1097/QCO.0b013e3283229fab; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mukherjee P, 2009, MOL MICROBIOL, V73, P103, DOI 10.1111/j.1365-2958.2009.06750.x; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rigel NW, 2009, J BIOL CHEM, V284, P9927, DOI 10.1074/jbc.M900325200; Rosas-Magallanes V, 2007, INFECT IMMUN, V75, P504, DOI 10.1128/IAI.00058-06; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; SERAFINI A, 2009, J BACTERIOL; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Sinha KM, 2007, J BIOL CHEM, V282, P15114, DOI 10.1074/jbc.M701167200; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Williams KJ, 2010, PLASMID, V64, P69, DOI 10.1016/j.plasmid.2010.04.003	56	48	48	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15667	10.1371/journal.pone.0015667	http://dx.doi.org/10.1371/journal.pone.0015667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203517	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000044
J	Hutnick, NA; Carnathan, DG; Dubey, SA; Cox, KS; Kierstead, L; Makadonas, G; Ratcliffe, SJ; Lasaro, MO; Robertson, MN; Casimiro, DR; Ertl, HCJ; Betts, MR				Hutnick, Natalie A.; Carnathan, Diane G.; Dubey, Sheri A.; Cox, Kara S.; Kierstead, Lisa; Makadonas, George; Ratcliffe, Sarah J.; Lasaro, Marcio O.; Robertson, Michael N.; Casimiro, Danilo R.; Ertl, Hildegund C. J.; Betts, Michael R.			Vaccination with Ad5 Vectors Expands Ad5-Specific CD8(+) T Cells without Altering Memory Phenotype or Functionality	PLOS ONE			English	Article							REPLICATION-DEFECTIVE ADENOVIRUS; HIV-1 VACCINE; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; HEALTHY-ADULTS; IN-VIVO; DNA; IMMUNOGENICITY; VIRUS; GENE	Background: Adenoviral (Ad) vaccine vectors represent both a vehicle to present a novel antigen to the immune system as well as restimulation of immune responses against the Ad vector itself. To what degree Ad-specific CD8(+) T cells are restimulated by Ad vector vaccination is unclear, although such knowledge would be important as vector-specific CD8(+) T cell expansion could potentially further limit Ad vaccine efficacy beyond Ad-specific neutralizing antibody alone. Methodology/Principal Findings: Here we addressed this issue by measuring human Adenovirus serotype 5 (Ad5)-specific CD8(+) T cells in recipients of the Merck Ad5 HIV-1 vaccine vector before, during, and after vaccination by multicolor flow cytometry. Ad5-specific CD8(+) T-cells were detectable in 95% of subjects prior to vaccination, and displayed primarily an effector-type functional profile and phenotype. Peripheral blood Ad5-specific CD8(+) T-cell numbers expanded after Ad5-HIV vaccination in all subjects, but differential expansion kinetics were noted in some baseline Ad5-neutralizing antibody (Ad5 nAb) seronegative subjects compared to baseline Ad5 nAb seropositive subjects. However, in neither group did vaccination alter polyfunctionality, mucosal targeting marker expression, or memory phenotype of Ad5-specific CD8(+) T-cells. Conclusions: These data indicate that repeat Ad5-vector administration in humans expands Ad5-specific CD8(+) T-cells without overtly affecting their functional capacity or phenotypic properties. This is a secondary analysis of samples collected during the 016 trial. Results of the Merck 016 trial safety and immunogenicity have been previously published in the journal of clinical infectious diseases [1].	[Hutnick, Natalie A.; Carnathan, Diane G.; Makadonas, George; Betts, Michael R.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Hutnick, Natalie A.; Carnathan, Diane G.; Makadonas, George; Betts, Michael R.] Univ Penn, Sch Med, Ctr AIDS Res, Philadelphia, PA 19104 USA; [Dubey, Sheri A.; Cox, Kara S.; Kierstead, Lisa; Robertson, Michael N.; Casimiro, Danilo R.] Merck Res Labs, West Point, PA USA; [Ratcliffe, Sarah J.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Lasaro, Marcio O.; Ertl, Hildegund C. J.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Merck & Company; University of Pennsylvania; The Wistar Institute	Hutnick, NA (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	betts@mail.med.upenn.edu	Ratcliffe, Sarah J/GYR-1110-2022	Ratcliffe, Sarah J/0000-0002-6644-8284	National Institutes of Health [IPCAVD U19AI074078]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI074078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health IPCAVD U19AI074078 to M. Betts and H. Ertl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Aste-Amezaga M, 2004, HUM GENE THER, V15, P293, DOI 10.1089/104303404322886147; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Calcedo R, 2009, J VIROL, V83, P2623, DOI 10.1128/JVI.02160-08; Casimiro DR, 2004, J VIROL, V78, P11434, DOI 10.1128/JVI.78.20.11434-11438.2004; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; Hensley SE, 2005, J IMMUNOL, V175, P6032, DOI 10.4049/jimmunol.175.9.6032; HUTNICK LK, J BIOL CHEM; HUTNICK NA, VACCINE, V28, P1932; Koup RA, 2009, J VIROL, V83, P6318, DOI 10.1128/JVI.00384-09; Krebs J W, 1998, J Public Health Manag Pract, V4, P56; Lasaro MO, 2005, MICROBES INFECT, V7, P1541, DOI 10.1016/j.micinf.2005.05.024; Leen AM, 2008, J VIROL, V82, P546, DOI 10.1128/JVI.01689-07; Magalhaes I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003790; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; O'Brien KL, 2009, NAT MED, V15, P873, DOI 10.1038/nm.1991; Prasad SA, 2001, J IMMUNOL, V166, P4809, DOI 10.4049/jimmunol.166.8.4809; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; SPERGEL JM, 1991, P NATL ACAD SCI USA, V88, P6472, DOI 10.1073/pnas.88.15.6472; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Steinwaerder DS, 2000, HUM GENE THER, V11, P1933, DOI 10.1089/10430340050129549; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Sumida SM, 2004, J VIROL, V78, P2666, DOI 10.1128/JVI.78.6.2666-2673.2004; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Xiang ZQ, 1996, VIROLOGY, V219, P220, DOI 10.1006/viro.1996.0239; Yang Y, 1996, GENE THER, V3, P137; Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003	33	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14385	10.1371/journal.pone.0014385	http://dx.doi.org/10.1371/journal.pone.0014385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203546	gold, Green Published, Green Submitted			2022-12-25	WOS:000285578000005
J	Tsai, JC; Yen, MR; Castillo, R; Leyton, DL; Henderson, IR; Saier, MH				Tsai, Jennifer C.; Yen, Ming-Ren; Castillo, Rostislav; Leyton, Denisse L.; Henderson, Ian R.; Saier, Milton H., Jr.			The Bacterial Intimins and Invasins: A Large and Novel Family of Secreted Proteins	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; GRAM-NEGATIVE BACTERIA; WEB-BASED PROGRAM; OUTER-MEMBRANE; CELL-ADHESION; STRUCTURE PREDICTION; TRANSLOCATOR DOMAIN; PASSENGER PROTEINS; VIRULENCE FACTORS; SIGNAL PEPTIDE	Background: Gram-negative bacteria have developed a limited repertoire of solutions for secreting proteins from the cytoplasmic compartment to the exterior of the cell. Amongst the spectrum of secreted proteins are the intimins and invasins (the Int/Inv family; TC# 1.B.54) which are characterized by an N-terminal beta-barrel domain and a C-terminal surface localized passenger domain. Despite the important role played by members of this family in diseases mediated by several species of the Enterobacteriaceae, there has been little appreciation for the distribution and diversity of these proteins amongst Gram-negative bacteria. Furthermore, there is little understanding of the molecular events governing secretion of these proteins to the extracellular milieu. Principal Findings: In silico approaches were used to analyze the domain organization and diversity of members of this secretion family. Proteins belonging to this family are predominantly associated with organisms from the gamma-proteobacteria. Whilst proteins from the Chlamydia, gamma-, beta-and epsilon-proteobacteria possess b-barrel domains and passenger domains of various sizes, Int/Inv proteins from the alpha-proteobacteria, cyanobacteria and chlorobi possess only the predicted b-barrel domains. Phylogenetic analyses revealed that with few exceptions these proteins cluster according to organismal type, indicating that divergence occurred contemporaneously with speciation, and that horizontal transfer was limited. Clustering patterns of the b-barrel domains correlate well with those of the full-length proteins although the passenger domains do so with much less consistency. The modular subdomain design of the passenger domains suggests that subdomain duplication and deletion have occurred with high frequency over evolutionary time. However, all repeated subdomains are found in tandem, suggesting that subdomain shuffling occurred rarely if at all. Topological predictions for the b-barrel domains are presented. Conclusion: Based on our in silico analyses we present a model for the biogenesis of these proteins. This study is the first of its kind to describe this unusual family of bacterial adhesins.	[Tsai, Jennifer C.; Yen, Ming-Ren; Castillo, Rostislav; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Leyton, Denisse L.; Henderson, Ian R.] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England	University of California System; University of California San Diego; University of Birmingham	Tsai, JC (corresponding author), Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA.	msaier@ucsd.edu	Leyton, Denisse L/A-6915-2015; Henderson, Ian/AAD-5369-2019	Leyton, Denisse L/0000-0003-4808-9289; Henderson, Ian/0000-0002-9954-4977	National Institutes of Health (NIH) [GM077402]; Medical Research Council [G0801209] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402] Funding Source: NIH RePORTER; MRC [G0801209] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NIH (GM077402) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TM, 2005, J BACTERIOL, V187, P522, DOI 10.1128/JB.187.2.522-533.2005; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Altschul SF, 2009, NUCLEIC ACIDS RES, V37, P815, DOI 10.1093/nar/gkn981; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Batchelor M, 2000, EMBO J, V19, P2452, DOI 10.1093/emboj/19.11.2452; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Gal-Mor O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000036; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jong WSP, 2008, BIOCHEM BIOPH RES CO, V368, P522, DOI 10.1016/j.bbrc.2008.01.122; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Kelly G, 1998, J BIOMOL NMR, V12, P189, DOI 10.1023/A:1008227103121; Kenny B, 1997, INFECT IMMUN, V65, P2528, DOI 10.1128/IAI.65.7.2528-2536.1997; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kim DSH, 2006, J BACTERIOL, V188, P5655, DOI 10.1128/JB.01596-05; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kostakioti M, 2006, INFECT IMMUN, V74, P4961, DOI 10.1128/IAI.00103-06; LEONG JM, 1991, INFECT IMMUN, V59, P3424, DOI 10.1128/IAI.59.10.3424-3433.1991; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loveless BJ, 1997, MOL MEMBR BIOL, V14, P113, DOI 10.3109/09687689709048171; Lund O., 2002, CASP5 C, pA102; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Newman CL, 2004, CRIT REV MICROBIOL, V30, P275, DOI 10.1080/10408410490499872; Niemann HH, 2004, MICROBES INFECT, V6, P101, DOI 10.1016/j.micinf.2003.11.001; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Ross NT, 2007, PROTEIN SCI, V16, P2677, DOI 10.1110/ps.073128607; Saier M. H, 1987, ENZYMES METABOLIC PA; SAIER MH, 1994, MICROBIOL REV, V58, P71, DOI 10.1128/MMBR.58.1.71-93.1994; Saier MH, 2006, J MEMBRANE BIOL, V214, P75, DOI 10.1007/s00232-006-0049-7; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sason H, 2009, MOL BIOL CELL, V20, P544, DOI 10.1091/mbc.E08-05-0516; Sinclair JF, 2006, INFECT IMMUN, V74, P1255, DOI 10.1128/IAI.74.2.1255-1265.2006; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Touze T, 2004, MOL MICROBIOL, V51, P73, DOI 10.1046/j.1365-2958.2003.03830.x; Watanabe M, 1997, BIOPHYS J, V72, P2094, DOI 10.1016/S0006-3495(97)78852-0; Wentzel A, 2001, J BACTERIOL, V183, P7273, DOI 10.1128/JB.183.24.7273-7284.2001; Yen MR, 2009, J MOL MICROB BIOTECH, V17, P163, DOI 10.1159/000239667; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; YU J, 1992, MOL MICROBIOL, V6, P411, DOI 10.1111/j.1365-2958.1992.tb01484.x; Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618; Zhai YF, 2002, J MOL MICROB BIOTECH, V4, P69; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P501; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P285	61	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14403	10.1371/journal.pone.0014403	http://dx.doi.org/10.1371/journal.pone.0014403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203509	gold, Green Submitted, Green Published			2022-12-25	WOS:000285578000010
J	Yu, KN; Minai-Tehrani, A; Chang, SH; Hwang, SK; Hong, SH; Kim, JE; Shin, JY; Park, SJ; Kim, JH; Kwon, JT; Jiang, HL; Kang, B; Kim, D; Chae, CH; Lee, KH; Yoon, TJ; Beck, GR; Cho, MH				Yu, Kyeong-Nam; Minai-Tehrani, Arash; Chang, Seung-Hee; Hwang, Soon-Kyung; Hong, Seong-Ho; Kim, Ji-Eun; Shin, Ji-Young; Park, Sung-Jin; Kim, Ji-Hye; Kwon, Jung-Taek; Jiang, Hu-Lin; Kang, Bitna; Kim, Duyeol; Chae, Chan-Hee; Lee, Kee-Ho; Yoon, Tae-Jong; Beck, George R., Jr.; Cho, Myung-Haing			Aerosol Delivery of Small Hairpin Osteopontin Blocks Pulmonary Metastasis of Breast Cancer in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-THERAPY; TUMOR PROGRESSION; LIVER METASTASIS; EXPRESSION; LUNG; PROTEIN; VECTORS; RNA; ANGIOGENESIS	Background: Metastasis to the lung may be the final step in the breast cancer-related morbidity. Conventional therapies such as chemotherapy and surgery are somewhat successful, however, metastasis-related breast cancer morbidity remains high. Thus, a novel approach to prevent breast tumor metastasis is needed. Methodology/Principal Finding: Aerosol of lentivirus-based small hairpin osteopontin was delivered into mice with breast cancer twice a week for 1 or 2 months using a nose-only inhalation system. The effects of small hairpin osteopontin on breast cancer metastasis to the lung were evaluated using near infrared imaging as well as diverse molecular techniques. Aerosol-delivered small hairpin osteopontin significantly decreased the expression level of osteopontin and altered the expression of several important metastasis-related proteins in our murine breast cancer model. Conclusion/Significance: Aerosol-delivered small hairpin osteopontin blocked breast cancer metastasis. Our results showed that noninvasive targeting of pulmonary osteopontin or other specific genes responsible for cancer metastasis could be used as an effective therapeutic regimen for the treatment of metastatic epithelial tumors.	[Yu, Kyeong-Nam; Minai-Tehrani, Arash; Chang, Seung-Hee; Hwang, Soon-Kyung; Hong, Seong-Ho; Kim, Ji-Eun; Shin, Ji-Young; Park, Sung-Jin; Kim, Ji-Hye; Kwon, Jung-Taek; Jiang, Hu-Lin; Kang, Bitna; Cho, Myung-Haing] Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea; [Kim, Ji-Eun; Kim, Ji-Hye; Cho, Myung-Haing] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Nano Fus Technol, Seoul, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Grad Grp Tumor Biol, Seoul, South Korea; [Kim, Duyeol; Chae, Chan-Hee] Seoul Natl Univ, Coll Vet Med, Pathol Lab, Seoul, South Korea; [Lee, Kee-Ho] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Mol Oncol Lab, Seoul, South Korea; [Yoon, Tae-Jong] CHA Univ, Dept Appl BioSci, Seoul, South Korea; [Beck, George R., Jr.] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Radiological & Medical Sciences; Pochon Cha University; Emory University	Yu, KN (corresponding author), Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea.	mchotox@snu.ac.kr	Cho, Myung-Haing/B-7362-2014; Beck, George/AAO-2117-2020	Cho, Myung-Haing/0000-0002-3993-2011; Kwon, Jung-Taek/0000-0002-3023-5463; Park, Sungjin/0000-0001-5801-5537	National Research Foundation [NRF-2010-0000784]; Ministry of Education, Science and Technology (MEST), Korea; 21C Frontier Functional Human Genome Project [FG03-0601-003-1-0-0]; Ministry of Science and Technology; NIH/NIAMS [AR056090]; NIH/NCI [CA136059]; Research Institute for Veterinary Science, Seoul National University; NATIONAL CANCER INSTITUTE [R03CA136059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056090] Funding Source: NIH RePORTER	National Research Foundation; Ministry of Education, Science and Technology (MEST), Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); 21C Frontier Functional Human Genome Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Research Institute for Veterinary Science, Seoul National University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Research Foundation (NRF-2010-0000784), Ministry of Education, Science and Technology (MEST), Korea. Kee-Ho Lee was supported by the 21C Frontier Functional Human Genome Project (FG03-0601-003-1-0-0) and by the National Nuclear R&D Program of the Ministry of Science and Technology. George R. Beck Jr was supported in part by grants from NIH/NIAMS (AR056090) and NIH/NCI (CA136059). Myung-Haing Cho was also partially supported by the Research Institute for Veterinary Science, Seoul National University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adwan H, 2004, INT J ONCOL, V24, P1235; Akar U, 2010, MOL CANCER THER, V9, P1180, DOI 10.1158/1535-7163.MCT-09-1025; BEHREND EI, 1994, CANCER RES, V54, P832; BEHREND EI, 1995, ANN NY ACAD SCI, V760, P299, DOI 10.1111/j.1749-6632.1995.tb44640.x; BROWN LF, 1994, AM J PATHOL, V145, P610; Chakraborty G, 2008, J CELL MOL MED, V12, P2305, DOI 10.1111/j.1582-4934.2008.00263.x; Dai JX, 2010, CANCER IMMUNOL IMMUN, V59, P355, DOI 10.1007/s00262-009-0754-z; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Denhardt DT, 1996, CRIT REV ONCOGENESIS, V7, P261, DOI 10.1615/CritRevOncog.v7.i3-4.70; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gao Yu-feng, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P227; Gautam A, 2001, MOL THER, V3, P551, DOI 10.1006/mthe.2001.0300; Goula D, 2000, GENE THER, V7, P499, DOI 10.1038/sj.gt.3301113; Hwang SK, 2007, GENE THER, V14, P1721, DOI 10.1038/sj.gt.3303042; Hwang SK, 2009, AM J RESP CRIT CARE, V179, P1131, DOI 10.1164/rccm.200810-1553OC; Jatoi I, 1999, J CLIN ONCOL, V17, P2334, DOI 10.1200/JCO.1999.17.8.2334; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; KELEG S, 2003, MOL CANCER, V22, P14; Kim HW, 2004, CANCER RES, V64, P7971, DOI 10.1158/0008-5472.CAN-04-1231; LEIDENG, 2009, BMC GASTROENTEROL, V9, P73; Leland P, 2000, MOL MED, V6, P165, DOI 10.1007/BF03402112; Lotze MT, 2002, CANCER GENE THER, V9, P692, DOI 10.1038/sj.cgt.7700493; Oates AJ, 1997, INVAS METAST, V17, P1; Ohno K, 2010, SURG TODAY, V40, P347, DOI 10.1007/s00595-009-4082-x; Paradis V, 1998, J CLIN PATHOL, V51, P798, DOI 10.1136/jcp.51.11.798; Ravi D, 1998, ORAL ONCOL, V34, P543, DOI 10.1016/S1368-8375(98)00054-2; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Roy R, 2006, EXP CELL RES, V312, P608, DOI 10.1016/j.yexcr.2005.11.022; SENGER DR, 1989, ANTICANCER RES, V9, P1291; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Shijubo N, 2000, CRIT REV ONCOGENESIS, V11, P135; Singh RP, 2006, J NATL CANCER I, V98, P846, DOI 10.1093/jnci/djj231; Singhal H, 1997, CLIN CANCER RES, V3, P605; Solomayer EF, 2000, BREAST CANCER RES TR, V59, P271, DOI 10.1023/A:1006308619659; Suzuki H, 2002, LUNG CANCER-J IASLC, V38, P137, DOI 10.1016/S0169-5002(02)00176-9; THAETE LG, 1989, CELL TISSUE RES, V256, P167; Tokunaga T, 1998, BRIT J CANCER, V77, P998, DOI 10.1038/bjc.1998.164; Toloza EM, 2006, J CELL BIOCHEM, V99, P1, DOI 10.1002/jcb.20851; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Veronesi U, 1999, JNCI-J NATL CANCER I, V91, P368, DOI 10.1093/jnci/91.4.368; Vinh-Hung V, 2004, BREAST CANCER RES, V6, pR680, DOI 10.1186/bcr934; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834; Yu P, 2010, J CANCER RES CLIN, V136, P1283, DOI 10.1007/s00432-010-0779-x; Yu PW, 2001, ONCOGENE, V20, P484, DOI 10.1038/sj.onc.1204113; Zamora-Avila DE, 2009, CANCER GENE THER, V16, P892, DOI 10.1038/cgt.2009.35	48	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15623	10.1371/journal.pone.0015623	http://dx.doi.org/10.1371/journal.pone.0015623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203518	Green Submitted, Green Published, gold			2022-12-25	WOS:000285578000039
J	Gallou-Kabani, C; Gabory, A; Tost, J; Karimi, M; Mayeur, S; Lesage, J; Boudadi, E; Gross, MS; Taurelle, J; Vige, A; Breton, C; Reusens, B; Remacle, C; Vieau, D; Ekstrom, TJ; Jais, JP; Junien, C				Gallou-Kabani, Catherine; Gabory, Anne; Tost, Joerg; Karimi, Mohsen; Mayeur, Sylvain; Lesage, Jean; Boudadi, Elsa; Gross, Marie-Sylvie; Taurelle, Julien; Vige, Alexandre; Breton, Christophe; Reusens, Brigitte; Remacle, Claude; Vieau, Didier; Ekstrom, Tomas J.; Jais, Jean-Philippe; Junien, Claudine			Sex- and Diet-Specific Changes of Imprinted Gene Expression and DNA Methylation in Mouse Placenta under a High-Fat Diet	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTERS; HUMAN CHORIONIC-GONADOTROPIN; FETAL-GROWTH; NUTRIENT TRANSPORT; TROPHOBLAST DIFFERENTIATION; MATERNAL UNDERNUTRITION; EPIGENETIC REGULATION; ADAPTIVE RESPONSES; BOVINE BLASTOCYSTS; MURINE PLACENTA	Background: Changes in imprinted gene dosage in the placenta may compromise the prenatal control of nutritional resources. Indeed monoallelic behaviour and sensitivity to changes in regional epigenetic state render imprinted genes both vulnerable and adaptable. Methods and Findings: We investigated whether a high-fat diet (HFD) during pregnancy modified the expression of imprinted genes and local and global DNA methylation patterns in the placenta. Pregnant mice were fed a HFD or a control diet (CD) during the first 15 days of gestation. We compared gene expression patterns in total placenta homogenates, for male and female offspring, by the RT-qPCR analysis of 20 imprinted genes. Sexual dimorphism and sensitivity to diet were observed for nine genes from four clusters on chromosomes 6, 7, 12 and 17. As assessed by in situ hybridization, these changes were not due to variation in the proportions of the placental layers. Bisulphite-sequencing analysis of 30 CpGs within the differentially methylated region (DMR) of the chromosome 17 cluster revealed sex-and diet-specific differential methylation of individual CpGs in two conspicuous subregions. Bioinformatic analysis suggested that these differentially methylated CpGs might lie within recognition elements or binding sites for transcription factors or factors involved in chromatin remodelling. Placental global DNA methylation, as assessed by the LUMA technique, was also sexually dimorphic on the CD, with lower methylation levels in male than in female placentae. The HFD led to global DNA hypomethylation only in female placenta. Bisulphite pyrosequencing showed that neither B1 nor LINE repetitive elements could account for these differences in DNA methylation. Conclusions: A HFD during gestation triggers sex-specific epigenetic alterations within CpG and throughout the genome, together with the deregulation of clusters of imprinted genes important in the control of many cellular, metabolic and physiological functions potentially involved in adaptation and/or evolution. These findings highlight the importance of studying both sexes in epidemiological protocols and dietary interventions.	[Gallou-Kabani, Catherine; Gabory, Anne; Boudadi, Elsa; Gross, Marie-Sylvie; Taurelle, Julien; Vige, Alexandre; Junien, Claudine] Univ Paris 05, Hop Necker Enfants Malades, AP HP, Fac Med,INSERM,U781, Paris, France; [Gabory, Anne; Junien, Claudine] INRA, Ctr Rech Jouy En Josas, UMR INRA ENV Maisons Alfort CNRS Biol Dev & Repro, UMR1198, F-78350 Jouy En Josas, France; [Tost, Joerg] Ctr Natl Genotypage, Inst Genom, CEA, Lab Epigenet, Evry, France; [Karimi, Mohsen; Ekstrom, Tomas J.] Karolinska Inst, Ctr Mol Med, Lab Med Epigenet, Dept Clin Neurosci, Stockholm, Sweden; [Mayeur, Sylvain; Lesage, Jean; Breton, Christophe; Vieau, Didier] Univ Sci & Technol Lille, Unite Environm Perinatal & Croissance, EA 4489, Villeneuve Dascq, France; [Reusens, Brigitte; Remacle, Claude] Catholic Univ Louvain, Cell Biol Lab, Inst Life Sci, B-3000 Louvain, Belgium; [Jais, Jean-Philippe] Univ Paris 05, SBIM, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Universite de Lille - ISITE; Universite de Lille; Universite Catholique Louvain; UDICE-French Research Universities; Universite Paris Cite	Gallou-Kabani, C (corresponding author), Univ Paris 05, Hop Necker Enfants Malades, AP HP, Fac Med,INSERM,U781, Paris, France.	claudine.junien@jouy.inra.fr	Ekström, Tomas/B-7764-2013; Tost, Joerg/H-7129-2019; lesage, jean/R-5019-2018	Tost, Joerg/0000-0002-2683-0817; lesage, jean/0000-0002-6329-1613; vieau, didier/0000-0002-3254-3662; Gabory, Anne/0000-0002-0059-7375	Nestle Foundation; Fondation pour la Recherche Medicale; Association Francaise d'Etudes et de Recherche sur l'Obesite; Fournier-Pharma; Swedish Cancer Society; INRA (Institut National de la Recherche Agronomique); INSERM (ATC-Nutrition, PRNH); Association Francaise des Diabetiques; Institut Benjamin Delessert; Fondation Coeur et Artrres (FCA); ANR-Agence Nationale de la Recherche (The French National Research Agency) [ANR-06-PNRA-022-01]; Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle [ISI IT-DIAB - 18/12/2008]	Nestle Foundation(Nestle SA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise d'Etudes et de Recherche sur l'Obesite; Fournier-Pharma; Swedish Cancer Society(Swedish Cancer Society); INRA (Institut National de la Recherche Agronomique); INSERM (ATC-Nutrition, PRNH)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francaise des Diabetiques; Institut Benjamin Delessert; Fondation Coeur et Artrres (FCA); ANR-Agence Nationale de la Recherche (The French National Research Agency)(French National Research Agency (ANR)); Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle	This work was supported by Nestle Foundation, the Fondation pour la Recherche Medicale and an Association Francaise d'Etudes et de Recherche sur l'Obesite studentship awarded to AV, a Fournier-Pharma studentship awarded to CGK, a grant from the Swedish Cancer Society awarded to TJE, and by grants from INRA (Institut National de la Recherche Agronomique), INSERM (ATC-Nutrition, PRNH), Association Francaise des Diabetiques, the Institut Benjamin Delessert, the Fondation Coeur et Artrres (FCA N degree 05-T4), the ANR-Agence Nationale de la Recherche (The French National Research Agency) under the Programme National de Recherche en Alimentation et nutrition humaine, project ANR-06-PNRA-022-01, and Contrat Cadre d'Aide au Projet d'Innovation Strategique Industrielle "IT-Diab" OSEO-ISI (ISI IT-DIAB - 18/12/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnouti Y, 2006, DRUG METAB DISPOS, V34, P477, DOI 10.1121/dmd.105.006932; Angiolini E, 2006, PLACENTA, V27, pS98, DOI 10.1016/j.placenta.2005.12.008; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; Asaka J, 2006, PHARM RES-DORDR, V23, P697, DOI 10.1007/s11095-006-9665-2; Ashworth CJ, 2009, PHILOS T R SOC B, V364, P3351, DOI 10.1098/rstb.2009.0184; Attig L, 2010, CURR OPIN CLIN NUTR, V13, P284, DOI 10.1097/MCO.0b013e328338aa61; Avila L, 2010, PLACENTA; Barker DJP, 2010, INT J DEV BIOL, V54, P525, DOI 10.1387/ijdb.082760db; BARKER DJP, 1992, EUR J CLIN NUTR, V46, pS3; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bottalico B, 2004, PLACENTA, V25, P518, DOI 10.1016/j.placenta.2003.10.017; Brideau CM, 2010, MOL CELL BIOL, V30, P3357, DOI 10.1128/MCB.01355-09; BROWN MJ, 1987, AM J OBSTET GYNECOL, V156, P716, DOI 10.1016/0002-9378(87)90085-8; Charalambous Marika, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P3, DOI 10.1097/MED.0b013e328013daa2; Charalambous M, 2010, DEV BIOL, V337, P1, DOI 10.1016/j.ydbio.2009.10.011; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Clifton VL, 2010, GROWTH HORM IGF RES, V20, P39, DOI 10.1016/j.ghir.2009.07.004; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; Cross JC, 2006, NUTR REV, V64, pS12, DOI 10.1301/nr.may.S12-S18; Cross JC, 2000, SEMIN CELL DEV BIOL, V11, P105, DOI 10.1006/scdb.2000.0156; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Ericsson A, 2007, J PHYSIOL-LONDON, V581, P1323, DOI 10.1113/jphysiol.2007.131185; Fauque P, 2010, HUM MOL GENET; Feil R, 2006, MUTAT RES-FUND MOL M, V600, P46, DOI 10.1016/j.mrfmmm.2006.05.029; Flajollet S, 2007, MOL CELL ENDOCRINOL, V270, P23, DOI 10.1016/j.mce.2007.02.004; Fortier AL, 2008, HUM MOL GENET; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Fryer Anthony A, 2009, Epigenetics, V4, P394; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gallou-Kabani C, 2007, AM J PHYSIOL-ENDOC M, V292, pE1095, DOI 10.1152/ajpendo.00390.2006; Gatford KL, 2010, PLACENTA, V31, pS60, DOI 10.1016/j.placenta.2009.12.015; Gebert C, 2009, GENOMICS, V94, P63, DOI 10.1016/j.ygeno.2009.03.004; Gheorghe CP, 2009, PLACENTA, V30, P411, DOI 10.1016/j.placenta.2009.03.002; Gheorghe C, 2006, J SOC GYNECOL INVEST, V13, P256, DOI 10.1016/j.jsgi.2006.02.007; Gheorghe CP, 2007, REPROD SCI, V14, P223, DOI 10.1177/1933719107302860; Gheorghe CP, 2010, INT J DEV BIOL, V54, P507, DOI 10.1387/ijdb.082770cg; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Grundemann D, 2000, HUM GENET, V106, P627, DOI 10.1007/s004390050035; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; Harlfinger S, 2005, N-S ARCH PHARMACOL, V372, P125, DOI 10.1007/s00210-005-0011-8; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hemberger M, 2007, CELL MOL LIFE SCI, V64, P2422, DOI 10.1007/s00018-007-7113-z; Hemberger M, 2001, TRENDS ENDOCRIN MET, V12, P162, DOI 10.1016/S1043-2760(01)00375-7; Hemberger M, 2010, EPIGENETICS-US, V5, P24, DOI 10.4161/epi.5.1.10589; Hernandez A, 2007, ENDOCRINOLOGY, V148, P3968, DOI 10.1210/en.2007-0029; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; Ishikawa H, 2003, BIOL REPROD, V69, P483, DOI 10.1095/biolreprod.102.012641; Janney CA, 1997, AM J CLIN NUTR, V66, P1116, DOI 10.1093/ajcn/66.5.1116; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jeong KS, 2005, BIOCHEM BIOPH RES CO, V335, P1211, DOI 10.1016/j.bbrc.2005.08.015; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kaneko-Ishino T, 2010, DEV GROWTH DIFFER, V52, P533, DOI 10.1111/j.1440-169X.2010.01194.x; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kokalj-Vokac N, 1998, CHROMOSOME RES, V6, P161, DOI 10.1023/A:1009299331871; Kulkarni A, 2010, DNA CELL BIOL; Kwong WY, 2006, REPRODUCTION, V132, P265, DOI 10.1530/rep.1.01038; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Lehavi O, 2005, FETAL DIAGN THER, V20, P235, DOI 10.1159/000083911; Lesage J, 2001, ENDOCRINOLOGY, V142, P1692, DOI 10.1210/en.142.5.1692; Liang CY, 2010, METABOLISM, V59, P943, DOI 10.1016/j.metabol.2009.10.015; Lim AL, 2010, SEMIN CELL DEV BIOL, V21, P201, DOI 10.1016/j.semcdb.2009.10.008; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; Mao J, 2010, P NATL ACAD SCI US; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McMinn J, 2006, PLACENTA, V27, P540, DOI 10.1016/j.placenta.2005.07.004; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; de Mello JCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010947; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Nathanielsz PW, 2007, OBSTET GYN CLIN N AM, V34, P201, DOI 10.1016/j.ogc.2007.03.006; Nelissen EC, 2010, HUM REPROD UPDATE; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nie WX, 2005, AM J PHYSIOL-GASTR L, V288, pG207, DOI 10.1152/ajpgi.00057.2004; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Ohgane J, 2004, GENES CELLS, V9, P253, DOI 10.1111/j.1356-9597.2004.00720.x; Pelis RM, 2007, J PHARMACOL EXP THER, V323, P555, DOI 10.1124/jpet.107.126748; Pembrey M., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P111; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; ROSSANT J, 1986, DEV BIOL, V117, P567, DOI 10.1016/0012-1606(86)90325-8; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Sibley CP, 2010, PLACENTA, V31, pS70, DOI 10.1016/j.placenta.2009.12.020; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2003, EMBO J, V22, P3696, DOI 10.1093/emboj/cdg341; Smith GCS, 2007, AM J PUBLIC HEALTH, V97, P157, DOI 10.2105/AJPH.2005.074294; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Steier JA, 2004, ACTA OBSTET GYN SCAN, V83, P170, DOI 10.1111/j.0001-6349.2004.00407.x; Tabano S, 2010, EPIGENETICS-US, V5, P313, DOI 10.4161/epi.5.4.11637; Theys N, 2010, J NUTR BIOC IN PRESS; Thornburg KL, 2010, PLACENTA, V31, pS54, DOI 10.1016/j.placenta.2010.01.002; Tost Jorg, 2007, V373, P89; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Urakami Y, 2000, FEBS LETT, V473, P173, DOI 10.1016/S0014-5793(00)01525-8; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Verhaagh S, 2001, MECH DEVELOP, V100, P127, DOI 10.1016/S0925-4773(00)00510-4; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Wagschal A, 2006, CYTOGENET GENOME RES, V113, P90, DOI 10.1159/000090819; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Weber M, 2005, PROG MOLEC, V38, P207; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wu Qing, 2006, Wei Sheng Yan Jiu, V35, P30; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	122	177	180	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e14398	10.1371/journal.pone.0014398	http://dx.doi.org/10.1371/journal.pone.0014398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21200436	Green Submitted, Green Published, gold			2022-12-25	WOS:000285576900012
J	Kurth, F; Belard, S; Mombo-Ngoma, G; Schuster, K; Adegnika, AA; Bouyou-Akotet, MK; Kremsner, PG; Ramharter, M				Kurth, Florian; Belard, Sabine; Mombo-Ngoma, Ghyslain; Schuster, Katharina; Adegnika, Ayola A.; Bouyou-Akotet, Marielle K.; Kremsner, Peter G.; Ramharter, Michael			Adolescence As Risk Factor for Adverse Pregnancy Outcome in Central Africa - A Cross-Sectional Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT	Background: Sub-Saharan Africa has the highest rates of maternal and neonatal mortality worldwide. Young maternal age at delivery has been proposed as risk factor for adverse pregnancy outcome, yet there is insufficient data from Sub-Saharan Africa. The present study aimed to investigate the influence of maternal adolescence on pregnancy outcomes in the Central African country Gabon. Methodology and Principal Findings: Data on maternal age, parity, birth weight, gestational age, maternal Plasmodium falciparum infection, use of bednets, and intake of intermittent preventive treatment of malaria in pregnancy were collected in a cross-sectional survey in 775 women giving birth in three mother-child health centers in Gabon. Adolescent women (<= 16 years of age) had a significantly increased risk to deliver a baby with low birth weight in univariable analysis (22.8%, 13/57, vs. 9.3%, 67/718, OR: 2.9, 95% CI: 1.5-5.6) and young maternal age showed a statistically significant association with the risk for low birth weight in multivariable regression analysis after correction for established risk factors (OR: 2.7; 95% CI: 1.1-6.5). In further analysis adolescent women were shown to attend significantly less antenatal care visits than adult mothers (3.3 +/- 1.9 versus 4.4 +/- 1.9 mean visits, p<0.01, n = 356) and this difference accounted at least for part of the excess risk for low birth weight in adolescents. Conclusion: Our data demonstrate the importance of adolescent age as risk factor for adverse pregnancy outcome. Antenatal care programs specifically tailored for the needs of adolescents may be necessary to improve the frequency of antenatal care visits and pregnancy outcomes in this risk group in Central Africa.	[Kurth, Florian; Belard, Sabine; Mombo-Ngoma, Ghyslain; Schuster, Katharina; Adegnika, Ayola A.; Kremsner, Peter G.; Ramharter, Michael] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Kurth, Florian] Univ Hosp Carl Gustav Carus, Dept Neonatol & Paediat Intens Care, Dresden, Germany; [Kurth, Florian; Belard, Sabine; Mombo-Ngoma, Ghyslain; Schuster, Katharina; Adegnika, Ayola A.; Kremsner, Peter G.; Ramharter, Michael] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Belard, Sabine; Schuster, Katharina] Univ Freiburg, Dept Paediat & Adolescent Med, Freiburg, Germany; [Mombo-Ngoma, Ghyslain; Bouyou-Akotet, Marielle K.] Univ Sci Sante, Dept Parasitol, Libreville, Gabon; [Adegnika, Ayola A.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Ramharter, Michael] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Eberhard Karls University of Tubingen; University of Freiburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Medical University of Vienna	Kurth, F (corresponding author), Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon.	michael.ramharter@meduniwien.ac.at	ADEGNIKA, Ayola Akim/AAK-7307-2020; Mombo-Ngoma, Ghyslain/I-4305-2019; Bélard, Sabine/J-9557-2019; Kurth, Florian/H-7427-2012; Ramharter, Michael/C-5273-2013	Mombo-Ngoma, Ghyslain/0000-0003-2658-8706; Bélard, Sabine/0000-0002-2008-418X; Kurth, Florian/0000-0002-3807-473X; Ramharter, Michael/0000-0002-9259-1885	independent Karl Landsteiner Gesellschaft, Austria	independent Karl Landsteiner Gesellschaft, Austria	This study was supported by a grant of the independent Karl Landsteiner Gesellschaft, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM I, 2007, LOW BODY MASS INDEX, DOI DOI 10.1093/TROPEJ/FMM110; ADEGNIKA, COMMUNICATION; Adegnika AA, 2006, AM J TROP MED HYG, V75, P798, DOI 10.4269/ajtmh.2006.75.798; CHAIBVA CN, 2009, MIDWIVERY       0224, DOI DOI 10.1016/J.MIDW.2009.01.001; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Elshibly EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-244; Feresu SA, 2004, PAEDIATR PERINAT EP, V18, P154, DOI 10.1111/j.1365-3016.2003.00539.x; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kurth F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-79; Milabyo Kyamusugulwa Patrick, 2006, Sante, V16, P103; Paranjothy S, 2009, ARCH DIS CHILD, V94, P239, DOI 10.1136/adc.2007.115915; Ramharter M, 2005, J INFECT DIS, V191, P1005, DOI 10.1086/427781; Ramharter M, 2004, AIDS, V18, P1847, DOI 10.1097/00002030-200409030-00015; Ramharter M, 2007, WIEN KLIN WOCHENSCHR, V119, P8, DOI 10.1007/s00508-007-0857-5; Ramharter M, 2007, AM J TROP MED HYG, V77, P418, DOI 10.4269/ajtmh.2007.77.418; Scholl T O, 1989, Paediatr Perinat Epidemiol, V3, P357, DOI 10.1111/j.1365-3016.1989.tb00524.x; United Nations, 2002, UN MILL DECL; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; World Health Organization, 2007, MAT MORT 2005 EST DE; World Health Organization, 2005, WORLD HLTH REP 2005	23	60	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14367	10.1371/journal.pone.0014367	http://dx.doi.org/10.1371/journal.pone.0014367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188301	Green Published, gold, Green Submitted			2022-12-25	WOS:000285575200006
J	Norgate, M; Southon, A; Greenough, M; Cater, M; Farlow, A; Batterham, P; Bush, AI; Subramaniam, VN; Burke, R; Camakaris, J				Norgate, Melanie; Southon, Adam; Greenough, Mark; Cater, Michael; Farlow, Ashley; Batterham, Philip; Bush, Ashley I.; Subramaniam, V. Nathan; Burke, Richard; Camakaris, James			Syntaxin 5 Is Required for Copper Homeostasis in Drosophila and Mammals	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MTF-1; PLASMA-MEMBRANE; TRANSPORTER; DISEASE; MENKES; MELANOGASTER; TRAFFICKING; EXPRESSION; WILSON; HCTR1	Copper is essential for aerobic life, but many aspects of its cellular uptake and distribution remain to be fully elucidated. A genome-wide screen for copper homeostasis genes in Drosophila melanogaster identified the SNARE gene Syntaxin 5 (Syx5) as playing an important role in copper regulation; flies heterozygous for a null mutation in Syx5 display increased tolerance to high dietary copper. The phenotype is shown here to be due to a decrease in copper accumulation, a mechanism also observed in both Drosophila and human cell lines. Studies in adult Drosophila tissue suggest that very low levels of Syx5 result in neuronal defects and lethality, and increased levels also generate neuronal defects. In contrast, mild suppression generates a phenotype typical of copper-deficiency in viable, fertile flies and is exacerbated by co-suppression of the copper uptake gene Ctr1A. Reduced copper uptake appears to be due to reduced levels at the plasma membrane of the copper uptake transporter, Ctr1. Thus Syx5 plays an essential role in copper homeostasis and is a candidate gene for copper-related disease in humans.	[Norgate, Melanie; Burke, Richard] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Southon, Adam; Greenough, Mark; Farlow, Ashley; Batterham, Philip; Camakaris, James] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Greenough, Mark; Cater, Michael; Bush, Ashley I.] Mental Hlth Res Inst Victoria, Parkville, Vic, Australia; [Subramaniam, V. Nathan] Queensland Inst Med Res, Membrane Transport Lab, Brisbane, Qld 4006, Australia	Monash University; University of Melbourne; QIMR Berghofer Medical Research Institute	Norgate, M (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	richard.burke@monash.edu	Greenough, Mark/AAK-1615-2021; Batterham, Philip/G-5914-2012; Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; Subramaniam, V. Nathan/A-1901-2010	Batterham, Philip/0000-0001-9840-9119; Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Subramaniam, V. Nathan/0000-0002-4583-7790; Greenough, Mark/0000-0001-6767-0584; Burke, Richard/0000-0003-0086-0767; Farlow, Ashley/0000-0003-3789-6456	International Copper Association [DP0451599]; Australian Research Council; Australian Institute of Nuclear Science and Engineering	International Copper Association; Australian Research Council(Australian Research Council); Australian Institute of Nuclear Science and Engineering	This work was supported by grants from the International Copper Association (grant DP0451599, www.copper.org), the Australian Research Council (www.arc.gov.au), and the Australian Institute of Nuclear Science and Engineering (www.ainse.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; BACH JP, J NEUROLOGICAL SCI, V291, P95; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; BINKS T, J BIOL INORGANIC CHE; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; DANKS DM, 1988, ANNU REV NUTR, V8, P235, DOI 10.1146/annurev.nu.08.070188.001315; DASCHER C, 1994, J BIOL CHEM, V269, P29363; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; Hamza I, 1999, P NATL ACAD SCI USA, V96, P13363, DOI 10.1073/pnas.96.23.13363; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Klomp AEM, 2003, BIOCHEM J, V370, P881, DOI 10.1042/BJ20021128; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; Maryon EB, 2007, BIOPHYS J, p358A; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Norgate M, 2006, MOL BIOL CELL, V17, P475, DOI 10.1091/mbc.E05-06-0492; NORGATE M, 2007, 5 INT BIOM S BIOM 20, P683; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Southon A, 2004, BIOCHEM J, V383, P303, DOI 10.1042/BJ20040745; Southon A, 2008, J EXP BIOL, V211, P709, DOI 10.1242/jeb.014159; Stein MP, 2002, TRENDS CELL BIOL, V12, P374, DOI 10.1016/S0962-8924(02)02331-0; Subramaniam VN, 1997, J BIOL CHEM, V272, P25441, DOI 10.1074/jbc.272.41.25441; Turski ML, 2007, J BIOL CHEM, V282, P24017, DOI 10.1074/jbc.M703792200; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Xu H, 2002, DEV BIOL, V251, P294, DOI 10.1006/dbio.2002.0830; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14303	10.1371/journal.pone.0014303	http://dx.doi.org/10.1371/journal.pone.0014303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188142	gold, Green Published			2022-12-25	WOS:000285575200003
J	Barnes, L; Tran, C; Sorg, O; Hotz, R; Grand, D; Carraux, P; Didierjean, L; Stamenkovic, I; Saurat, JH; Kaya, G				Barnes, Laurent; Tran, Christian; Sorg, Olivier; Hotz, Raymonde; Grand, Denise; Carraux, Pierre; Didierjean, Liliane; Stamenkovic, Ivan; Saurat, Jean-Hilaire; Kaya, Guerkan			Synergistic Effect of Hyaluronate Fragments in Retinaldehyde-Induced Skin Hyperplasia Which Is a Cd44-Dependent Phenomenon	PLOS ONE			English	Article							EPIDERMAL CD44 EXPRESSION; SCLEROSUS-ET-ATROPHICUS; GROWTH-FACTOR; MOUSE SKIN; TOPICAL RETINALDEHYDE; RETINOIC ACID; KERATINOCYTES; ADHESION; RECEPTOR; DERMATOPOROSIS	Background: CD44 is a polymorphic proteoglycan and functions as the principal cell-surface receptor for hyaluronate (HA). Heparin-binding epidermal growth factor (HB-EGF) activation of keratinocyte erbB receptors has been proposed to mediate retinoid-induced epidermal hyperplasia. We have recently shown that intermediate size HA fragments (HAFi) reverse skin atrophy by a CD44-dependent mechanism. Methodology and Principal Findings: Treatment of primary mouse keratinocyte cultures with retinaldehyde (RAL) resulted in the most significant increase in keratinocyte proliferation when compared with other retinoids, retinoic acid, retinol or retinoyl palmitate. RAL and HAFi showed a more significant increase in keratinocyte proliferation than RAL or HAFi alone. No proliferation with RAL was observed in CD44(-/-) keratinocytes. HA synthesis inhibitor, 4-methylumbelliferone inhibited the proliferative effect of RAL. HB-EGF, erbB1, and tissue inhibitor of MMP-3 blocking antibodies abrogated the RAL- or RAL- and HAFi-induced keratinocyte proliferation. Topical application of RAL or RAL and HAFi for 3 days caused a significant epidermal hyperplasia in the back skin of wild-type mice but not in CD44(-/-) mice. Topical RAL and HAFi increased epidermal CD44 expression, and the epidermal and dermal HA. RAL induced the expression of active HB-EGF and erbB1. However, treatment with RAL and HAFi showed a more significant increase in pro-HB-EGF when compared to RAL or HAFi treatments alone. We then topically applied RAL and HAFi twice a day to the forearm skin of elderly dermatoporosis patients. After 1 month of treatment, we observed a significant clinical improvement. Conclusions and Significance: Our results indicate that (i) RAL-induced in vitro and in vivo keratinocyte proliferation is a CD44-dependent phenomenon and requires the presence of HA, HB-EGF, erbB1 and MMPs, (ii) RAL and HAFi show a synergy in vitro and in vivo in mouse skin, and (iii) the combination of RAL and HAFi seems to have an important therapeutic effect in dermatoporosis.	[Barnes, Laurent; Tran, Christian; Sorg, Olivier; Hotz, Raymonde; Grand, Denise; Carraux, Pierre; Didierjean, Liliane; Saurat, Jean-Hilaire; Kaya, Guerkan] Univ Geneva, Dept Dermatol, Geneva, Switzerland; [Stamenkovic, Ivan] Univ Lausanne, Inst Pathol, Lausanne, Switzerland	University of Geneva; University of Lausanne	Barnes, L (corresponding author), Univ Geneva, Dept Dermatol, Geneva, Switzerland.	gkaya@hcuge.ch			University of Geneva; Genderm Research Program; Swiss National Science Foundation [310000-122322, 3100-65090-01]; Molecular Oncology National Centre for Competence in Research (NCCR)	University of Geneva; Genderm Research Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Molecular Oncology National Centre for Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	This work was supported by the University of Geneva Dermatology Fund, Genderm Research Program and Swiss National Science Foundation grant 310000-122322 to GK and JHS, and Swiss National Science Foundation grant 3100-65090-01 and the Molecular Oncology National Centre for Competence in Research (NCCR) to IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Calikoglu E, 2006, PHOTOCHEM PHOTOBIOL, V82, P1342, DOI 10.1562/2006-02-10-RA-801; Didierjean L, 1996, J INVEST DERMATOL, V107, P714, DOI 10.1111/1523-1747.ep12365603; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; HUDSON DL, 1995, J CELL SCI, V108, P1959; Kaya G, 2005, BRIT J DERMATOL, V152, P570, DOI 10.1111/j.1365-2133.2005.06396.x; Kaya G, 2005, J INVEST DERMATOL, V124, P284, DOI 10.1111/j.0022-202X.2004.23579.x; Kaya G, 2000, J INVEST DERMATOL, V115, P1054, DOI 10.1046/j.1523-1747.2000.00194.x; Kaya G, 1997, GENE DEV, V11, P996, DOI 10.1101/gad.11.8.996; Kaya G, 2008, ARCH DERMATOL, V144, P1303, DOI 10.1001/archderm.144.10.1303; Kaya G, 2006, PLOS MED, V3, P2291, DOI 10.1371/journal.pmed.0030493; Kaya G, 2007, DERMATOLOGY, V215, P284, DOI 10.1159/000107621; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; MIYAKE K, 1990, J EXP MED, V172, P69, DOI 10.1084/jem.172.1.69; Piepkorn M, 2003, ARCH DERMATOL RES, V295, P93, DOI 10.1007/s00403-003-0391-x; SAURAT JH, 1994, J INVEST DERMATOL, V103, P770, DOI 10.1111/1523-1747.ep12412861; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; Xian WJ, 1997, ONCOGENE, V14, P1435, DOI 10.1038/sj.onc.1200980; Xiao JH, 1999, EMBO J, V18, P1539, DOI 10.1093/emboj/18.6.1539; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702	22	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14372	10.1371/journal.pone.0014372	http://dx.doi.org/10.1371/journal.pone.0014372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179550	Green Submitted, Green Published, gold			2022-12-25	WOS:000285381200015
J	Holt, AG; Bissig, D; Mirza, N; Rajah, G; Berkowitz, B				Holt, Avril Genene; Bissig, David; Mirza, Najab; Rajah, Gary; Berkowitz, Bruce			Evidence of Key Tinnitus-Related Brain Regions Documented by a Unique Combination of Manganese-Enhanced MRI and Acoustic Startle Reflex Testing	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; RESONANCE-IMAGING MEMRI; GAZE-EVOKED TINNITUS; INFERIOR COLLICULUS; AUDITORY-CORTEX; ANIMAL-MODEL; RAT-BRAIN; BEHAVIORAL PARADIGM; CALCIUM-CHANNELS; SPIKE DISCHARGES	Animal models continue to improve our understanding of tinnitus pathogenesis and aid in development of new treatments. However, there are no diagnostic biomarkers for tinnitus-related pathophysiology for use in awake, freely moving animals. To address this disparity, two complementary methods were combined to examine reliable tinnitus models (rats repeatedly administered salicylate or exposed to a single noise event): inhibition of acoustic startle and manganese-enhanced MRI. Salicylate-induced tinnitus resulted in wide spread supernormal manganese uptake compared to noise-induced tinnitus. Neither model demonstrated significant differences in the auditory cortex. Only in the dorsal cortex of the inferior colliculus (DCIC) did both models exhibit supernormal uptake. Therefore, abnormal membrane depolarization in the DCIC appears to be important in tinnitus-mediated activity. Our results provide the foundation for future studies correlating the severity and longevity of tinnitus with hearing loss and neuronal activity in specific brain regions and tools for evaluating treatment efficacy across paradigms.	[Holt, Avril Genene; Bissig, David; Mirza, Najab; Rajah, Gary; Berkowitz, Bruce] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Berkowitz, Bruce] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA	Wayne State University; Wayne State University	Holt, AG (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.	agholt@med.wayne.edu		Holt, Avril Genene/0000-0001-6225-1700; Bissig, David/0000-0001-9664-5433	National Institutes of Health [DC007733, EY018109, P30]; Kresge Eye Institute; Wayne State University School of Medicine; NATIONAL EYE INSTITUTE [R21EY018109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC007733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kresge Eye Institute; Wayne State University School of Medicine; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	These studies were supported by the National Institutes of Health [DC007733 to AGH, EY018109 to BAB, P30 Grants (Anatomy and Cell Biology, Wayne State University and Kresge Hearing Research Institute, University of Michigan)], University Medical Student Grant to GR, an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute) and Wayne State University School of Medicine MD/PhD program for DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvestad S, 2007, NEUROIMAGE, V38, P57, DOI 10.1016/j.neuroimage.2007.07.027; ANDERSEN RA, 1980, J COMP NEUROL, V191, P479, DOI 10.1002/cne.901910310; Angenstein F, 2007, CEREB CORTEX, V17, P28, DOI 10.1093/cercer/bhj121; Aoki I, 2004, NMR BIOMED, V17, P569, DOI 10.1002/nbm.941; Bahmad Fayez M Jr, 2006, Int Tinnitus J, V12, P140; Bauer CA, 1999, OTOLARYNG HEAD NECK, V121, P457, DOI 10.1016/S0194-5998(99)70237-8; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Berkowitz BA, 2007, INVEST OPHTH VIS SCI, V48, P4733, DOI 10.1167/iovs.06-1516; Berkowitz BA, 2006, INVEST OPHTH VIS SCI, V47, P2668, DOI 10.1167/iovs.05-1588; Berkowitz BA, 2010, MOL VIS, V16, P1776; Bissig D, 2009, NEUROIMAGE, V44, P627, DOI 10.1016/j.neuroimage.2008.10.013; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; CACACE AT, 1994, HEARING RES, V81, P22, DOI 10.1016/0378-5955(94)90149-X; CACACE AT, 1994, AUDIOLOGY, V33, P291; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; CHEN GD, 1995, HEARING RES, V82, P158, DOI 10.1016/0378-5955(94)00174-O; Chuang KH, 2009, MAGN RESON IMAGING, V27, P594, DOI 10.1016/j.mri.2008.10.006; Chuang KH, 2006, MAGN RESON MED, V55, P604, DOI 10.1002/mrm.20797; Cross DJ, 2007, AM J NEURORADIOL, V28, P1865, DOI 10.3174/ajnr.A0693; Denk DM, 1997, ACTA OTO-LARYNGOL, V117, P825, DOI 10.3109/00016489709114208; DIAMOND IT, 1969, BRAIN RES, V15, P305, DOI 10.1016/0006-8993(69)90160-7; Dieler R, 2002, LARYNGO RHINO OTOL, V81, P196, DOI 10.1055/s-2002-25041; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; DRUGA R, 1984, PHYSIOL BOHEMOSLOV, V33, P31; Druga R, 1997, PHYSIOL RES, V46, P215; EVANS EF, 1973, EXP BRAIN RES, V17, P428; Fa ZQ, 2010, NEUROSCI LETT, V481, P110, DOI 10.1016/j.neulet.2010.06.063; Fagelson Marc A, 2007, Am J Audiol, V16, P107, DOI 10.1044/1059-0889(2007/015); FAYELUND H, 1985, ANAT EMBRYOL, V173, P53, DOI 10.1007/BF00707304; Francis HW, 2000, HEARING RES, V149, P91, DOI 10.1016/S0378-5955(00)00165-9; Gadjanski I, 2009, ANN NEUROL, V66, P81, DOI 10.1002/ana.21668; Guitton MJ, 2003, J NEUROSCI, V23, P3944; Heffner HE, 2005, BEHAV NEUROSCI, V119, P734, DOI 10.1037/0735-7044.119.3.734; Heffner HE, 2002, HEARING RES, V170, P83, DOI 10.1016/S0378-5955(02)00343-X; HIRSCH JA, 1988, J PHYSIOL-LONDON, V396, P535, DOI 10.1113/jphysiol.1988.sp016976; HOLT A, 2005, DIFFERENTIAL GENE EX, P329; Itoh K, 2008, NEUROSCIENCE, V154, P732, DOI 10.1016/j.neuroscience.2008.03.080; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; JASTREBOFF PJ, 1986, J ACOUST SOC AM, V80, P1384, DOI 10.1121/1.394391; JASTREBOFF PJ, 1994, AM J OTOL, V15, P19; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Kaltenbach JA, 2007, PROG BRAIN RES, V166, P89, DOI 10.1016/S0079-6123(07)66009-9; KAY IS, 1993, EUR ARCH OTO-RHINO-L, V250, P51; KOERBER KC, 1966, EXP NEUROL, V16, P119, DOI 10.1016/0014-4886(66)90091-4; Lee JH, 2005, MAGN RESON MED, V53, P640, DOI 10.1002/mrm.20368; Lew HL, 2007, J REHABIL RES DEV, V44, pVII; Liu YX, 2007, NEUROPHARMACOLOGY, V53, P870, DOI 10.1016/j.neuropharm.2007.08.015; Liu YX, 2005, HEARING RES, V205, P271, DOI 10.1016/j.heares.2005.03.028; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Ma WLD, 2006, HEARING RES, V212, P9, DOI 10.1016/j.heares.2005.10.003; Melcher JR, 2009, HEARING RES, V257, P63, DOI 10.1016/j.heares.2009.08.005; Moody D. B, 2004, TINNITUS THEORY MANA, P80; NORENA AJ, 2010, NEUROSCIENCE; Oertel D, 1991, Curr Opin Neurobiol, V1, P221, DOI 10.1016/0959-4388(91)90082-I; Paul AK, 2009, NEUROIMAGE, V44, P312, DOI 10.1016/j.neuroimage.2008.09.024; PFEIFFER RR, 1966, EXP BRAIN RES, V1, P220; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Salembier L, 2006, ACTA OTO-LARYNGOL, V126, P93, DOI 10.1080/03655230600895242; Snow J. B., 2004, TINNITUS THEORY MANA; Sun N, 2006, NEUROSCIENCE, V138, P77, DOI 10.1016/j.neuroscience.2005.10.034; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; SYKA J, 1988, AUDITORY PATHWAY STR; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Wenzel GI, 2010, EUR ARCH OTO-RHINO-L, V267, P691, DOI 10.1007/s00405-009-1126-1; Winer JA, 1998, J COMP NEUROL, V400, P147; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477; Yu X, 2008, NEUROIMAGE, V39, P223, DOI 10.1016/j.neuroimage.2007.08.029; Yu X, 2007, P NATL ACAD SCI USA, V104, P12193, DOI 10.1073/pnas.0700960104	74	61	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14260	10.1371/journal.pone.0014260	http://dx.doi.org/10.1371/journal.pone.0014260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179508	Green Published, gold, Green Submitted			2022-12-25	WOS:000285340000001
J	Lee, N; Iyer, SS; Mu, J; Weissman, JD; Ohali, A; Howcroft, TK; Lewis, BA; Singer, DS				Lee, Namhoon; Iyer, Shankar S.; Mu, Jie; Weissman, Jocelyn D.; Ohali, Anat; Howcroft, T. Kevin; Lewis, Brian A.; Singer, Dinah S.			Three Novel Downstream Promoter Elements Regulate MHC Class I Promoter Activity in Mammalian Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; CORE PROMOTER; GENE-EXPRESSION; BASAL PROMOTER; FUNCTIONAL-CHARACTERIZATION; REPRESSES TRANSCRIPTION; DNA-BINDING; TATA-BOX; C-JUN; DROSOPHILA	Background: MHC class I transcription is regulated by two distinct types of regulatory pathways: 1) tissue-specific pathways that establish constitutive levels of expression within a given tissue and 2) dynamically modulated pathways that increase or decrease expression within that tissue in response to hormonal or cytokine mediated stimuli. These sets of pathways target distinct upstream regulatory elements, have distinct basal transcription factor requirements, and utilize discrete sets of transcription start sites within an extended core promoter. Methodology/Principal Findings: We studied regulatory elements within the MHC class I promoter by cellular transfection and in vitro transcription assays in HeLa, HeLa/CIITA, and tsBN462 of various promoter constructs. We have identified three novel MHC class I regulatory elements (GLE, DPE-L1 and DPE-L2), located downstream of the major transcription start sites, that contribute to the regulation of both constitutive and activated MHC class I expression. These elements located at the 3' end of the core promoter preferentially regulate the multiple transcription start sites clustered at the 5' end of the core promoter. Conclusions/Significance: Three novel downstream elements (GLE, DPE-L1, DPE-L2), located between +1 and +32 bp, regulate both constitutive and activated MHC class I gene expression by selectively increasing usage of transcription start sites clustered at the 5' end of the core promoter upstream of +1 bp. Results indicate that the downstream elements preferentially regulate TAF1-dependent, relative to TAF1-independent, transcription.	[Lee, Namhoon; Iyer, Shankar S.; Mu, Jie; Weissman, Jocelyn D.; Ohali, Anat; Singer, Dinah S.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Lee, Namhoon] Johns Hopkins Univ, NIH, Bethesda, MD USA; [Iyer, Shankar S.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Howcroft, T. Kevin] NCI, Div Canc Biol, Bethesda, MD 20892 USA; [Lewis, Brian A.; Singer, Dinah S.] NCI, Metab Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; National Institutes of Health (NIH) - USA; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lee, N (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	Dinah.singer@nih.gov		Lewis, Brian/0000-0002-8321-0665	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC009279, ZIASC010375, ZIABC009285] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anish R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005103; Berk AJ, 1999, CURR OPIN CELL BIOL, V11, P330, DOI 10.1016/S0955-0674(99)80045-3; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; DAVID-WATINE B, 1990, IMMUNOL TODAY, V11, P286, DOI 10.1016/0167-5699(90)90114-O; FRELS WI, 1985, SCIENCE, V228, P577, DOI 10.1126/science.3885396; Gill G, 2001, ESSAYS BIOCHEM, V37, P33, DOI 10.1042/bse0370033; GIRDLESTONE J, 1995, IMMUNOBIOLOGY, V193, P229, DOI 10.1016/S0171-2985(11)80548-6; Girdlestone J, 1996, EUR J IMMUNOGENET, V23, P395; Gobin SJP, 1997, IMMUNITY, V6, P601, DOI 10.1016/S1074-7613(00)80348-9; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Howcroft TK, 1999, MOL CELL BIOL, V19, P4788; HOWCROFT TK, 1993, EMBO J, V12, P3163, DOI 10.1002/j.1460-2075.1993.tb05985.x; Howcroft TK, 2003, IMMUNOL RES, V27, P1, DOI 10.1385/IR:27:1:1; Howcroft TK, 2003, MOL CELL BIOL, V23, P3377, DOI 10.1128/MCB.23.10.3377-3391.2003; HOWCROFT TK, 1995, IMMUNITY, V3, P127; Ishiguro N, 1997, J BIOL CHEM, V272, P15993, DOI 10.1074/jbc.272.25.15993; IYER V, 1995, MOL CELL BIOL, V15, P7059; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kaufmann J, 1996, GENE DEV, V10, P873, DOI 10.1101/gad.10.7.873; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; LEBOUTEILLER P, 1994, CRIT REV IMMUNOL, V14, P89, DOI 10.1615/CritRevImmunol.v14.i2.10; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Lee MP, 2005, GENOME RES, V15, P1189, DOI 10.1101/gr.3873705; Lewis BA, 2000, P NATL ACAD SCI USA, V97, P7172, DOI 10.1073/pnas.120181197; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; MAGUIRE JE, 1992, MOL CELL BIOL, V12, P3078, DOI 10.1128/MCB.12.7.3078; Martin BK, 1997, IMMUNITY, V6, P591, DOI 10.1016/S1074-7613(00)80347-7; Nagarajan UM, 2000, J IMMUNOL, V164, P3666, DOI 10.4049/jimmunol.164.7.3666; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Raval A, 2003, J IMMUNOL, V170, P922, DOI 10.4049/jimmunol.170.2.922; Raval A, 2001, MOL CELL, V7, P105, DOI 10.1016/S1097-2765(01)00159-9; Reinberg D, 1998, COLD SPRING HARB SYM, V63, P83, DOI 10.1101/sqb.1998.63.83; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; SINGER DS, 1988, CURR TOP MICROBIOL, V137, P148; SINGER DS, 1982, P NATL ACAD SCI-BIOL, V79, P1403, DOI 10.1073/pnas.79.5.1403; Singer DS, 1997, CRIT REV IMMUNOL, V17, P463; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; Tokusumi Y, 2007, MOL CELL BIOL, V27, P1844, DOI 10.1128/MCB.01363-06; Weissman JDJ, 2000, J BIOL CHEM, V275, P10160, DOI 10.1074/jbc.275.14.10160; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Wong C, 1999, MOL CELL BIOL, V19, P1821; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103	54	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15278	10.1371/journal.pone.0015278	http://dx.doi.org/10.1371/journal.pone.0015278			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179443	Green Published, Green Submitted, gold			2022-12-25	WOS:000285246900041
J	Kohler, K; Xiong, SQ; Brzostek, J; Mehrabi, M; Eissmann, P; Harrison, A; Cordoba, SP; Oddos, S; Miloserdov, V; Gould, K; Burroughs, NJ; van der Merwe, PA; Davis, DM				Koehler, Karsten; Xiong, Shiqiu; Brzostek, Joanna; Mehrabi, Maryam; Eissmann, Philipp; Harrison, Alice; Cordoba, Shaun-Paul; Oddos, Stephane; Miloserdov, Vladimir; Gould, Keith; Burroughs, Nigel J.; van der Merwe, Philip Anton; Davis, Daniel M.			Matched Sizes of Activating and Inhibitory Receptor/Ligand Pairs Are Required for Optimal Signal Integration by Human Natural Killer Cells	PLOS ONE			English	Article							MHC CLASS-I; IMMUNOLOGICAL SYNAPSE; IMMUNE SYNAPSES; HLA-C; NK CELLS; T-CELLS; CRYSTAL-STRUCTURE; TARGET-CELLS; B-CELLS; LIGAND	It has been suggested that receptor-ligand complexes segregate or co-localise within immune synapses according to their size, and this is important for receptor signaling. Here, we set out to test the importance of receptor-ligand complex dimensions for immune surveillance of target cells by human Natural Killer (NK) cells. NK cell activation is regulated by integrating signals from activating receptors, such as NKG2D, and inhibitory receptors, such as KIR2DL1. Elongating the NKG2D ligand MICA reduced its ability to trigger NK cell activation. Conversely, elongation of KIR2DL1 ligand HLA-C reduced its ability to inhibit NK cells. Whereas normal-sized HLA-C was most effective at inhibiting activation by normal-length MICA, only elongated HLA-C could inhibit activation by elongated MICA. Moreover, HLA-C and MICA that were matched in size co-localised, whereas HLA-C and MICA that were different in size were segregated. These results demonstrate that receptor-ligand dimensions are important in NK cell recognition, and suggest that optimal integration of activating and inhibitory receptor signals requires the receptor-ligand complexes to have similar dimensions.	[Koehler, Karsten; Mehrabi, Maryam; Eissmann, Philipp; Oddos, Stephane; Davis, Daniel M.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England; [Xiong, Shiqiu; Harrison, Alice; Cordoba, Shaun-Paul; van der Merwe, Philip Anton] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Brzostek, Joanna; Gould, Keith] Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst, London, England; [Miloserdov, Vladimir; Burroughs, Nigel J.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England	Imperial College London; University of Oxford; Imperial College London; University of Warwick	Kohler, K (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	anton.vandermerwe@path.ox.ac.uk; d.davis@imperial.ac.uk	van der Merwe, P. Anton/F-8539-2011	Brzostek, Joanna/0000-0002-5621-2649; Mehrabi, Maryam/0000-0001-8809-2146; Gould, Keith/0000-0003-0913-5422; Davis, Daniel/0000-0002-9182-291X	Biotechnology and Biological Sciences Research Council [BB/D011663/1]; MRC [G0500563]; Wolfson Royal Society; Medical Research Council [G19/31, G0500563] Funding Source: researchfish; BBSRC [BB/D011663/1] Funding Source: UKRI; MRC [G19/31] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wolfson Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This work was funded by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk; BB/D011663/1) and the MRC (www.mrc.ac.uk; G0500563). DMD is supported by a Wolfson Royal Society Research Merit Award (royalsociety.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Barclay A. N, 1997, LEUKOCYTE ANTIGEN FA; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Billadeau DD, 2003, NAT IMMUNOL, V4, P557, DOI 10.1038/ni929; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Brzostek J, 2010, EUR J IMMUNOL, V40, P2050, DOI 10.1002/eji.201040335; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Burshtyn DN, 2000, CURR BIOL, V10, P777, DOI 10.1016/S0960-9822(00)00568-6; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Choudhuri K, 2009, J BIOL CHEM, V284, P26096, DOI 10.1074/jbc.M109.039966; Chuang SS, 2000, IMMUNOLOGY, V100, P378, DOI 10.1046/j.1365-2567.2000.00031.x; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Culley FJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000159; Davis DM, 2009, NAT REV IMMUNOL, V9, P543, DOI 10.1038/nri2602; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Faure M, 2003, J IMMUNOL, V170, P6107, DOI 10.4049/jimmunol.170.12.6107; Gleimer M, 2003, IMMUNITY, V19, P469, DOI 10.1016/S1074-7613(03)00272-3; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hidano S, 2008, INT IMMUNOL, V20, P345, DOI 10.1093/intimm/dxm150; HOGLUND P, 1991, J EXP MED, V174, P327, DOI 10.1084/jem.174.2.327; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Mandelboim O, 1997, P NATL ACAD SCI USA, V94, P4604, DOI 10.1073/pnas.94.9.4604; McCann FE, 2003, J IMMUNOL, V170, P2862, DOI 10.4049/jimmunol.170.6.2862; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sharma D, 2009, J IMMUNOL, V183, P4569, DOI 10.4049/jimmunol.0901734; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SHIMIZU Y, 1988, P NATL ACAD SCI USA, V85, P227, DOI 10.1073/pnas.85.1.227; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Standeven LJ, 2004, J IMMUNOL, V173, P5617, DOI 10.4049/jimmunol.173.9.5617; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Vyas YM, 2001, J IMMUNOL, V167, P4358, DOI 10.4049/jimmunol.167.8.4358; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145	61	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2010	5	11							e15374	10.1371/journal.pone.0015374	http://dx.doi.org/10.1371/journal.pone.0015374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675OD	21179506	Green Submitted, Green Published, gold			2022-12-25	WOS:000283839100020
J	Lee, Y; Chen, RM; Lee, HM; Lee, C				Lee, Yongjin; Chen, Rongmin; Lee, Hyeong-min; Lee, Choogon			Stoichiometric Relationship among Clock Proteins Determines Robustness of Circadian Rhythms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; MOLECULAR ANALYSIS; NEGATIVE FEEDBACK; CKI-EPSILON; TRANSCRIPTION; NEUROSPORA; PHOSPHORYLATION; MECHANISMS	The mammalian circadian oscillator is primarily driven by an essential negative feedback loop comprising a positive component, the CLOCK-BMAL1 complex, and a negative component, the PER-CRY complex. Numerous studies suggest that feedback inhibition of CLOCK-BMAL1 is mediated by time-dependent physical interaction with its direct target gene products PER and CRY, suggesting that the ratio between the negative and positive complexes must be important for the molecular oscillator and rhythm generation. We explored this idea by altering expression of clock components in fibroblasts derived from Per2(Luc) and Per mutant mice, a cell system extensively used to study in vivo clock mechanisms. Our data demonstrate that the stoichiometric relationship between clock components is critical for the robustness of circadian rhythms and provide insights into the mechanistic organization of the negative feedback loop. Our findings may explain why certain mutant mice or cells are arrhythmic, whereas others are rhythmic, and suggest that robustness of circadian rhythms can be increased even in wild-type cells by modulating the stoichiometry.	[Lee, Yongjin; Chen, Rongmin; Lee, Hyeong-min; Lee, Choogon] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32312 USA	State University System of Florida; Florida State University	Lee, C (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, 1115 W Call St, Tallahassee, FL 32306 USA.	choogon.lee@med.fsu.edu	Lee, HM/D-2777-2011; Lee, HM/ABC-2680-2020	Lee, HM/0000-0002-9381-3611; Lee, HM/0000-0002-9381-3611	National Institutes of Health [NS-053616]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-053616 (to C. L.).	Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cuninkova L, 2008, ANN NY ACAD SCI, V1129, P358, DOI 10.1196/annals.1417.005; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Duffield GE, 2009, CURR BIOL, V19, P297, DOI 10.1016/j.cub.2008.12.052; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hao HP, 1999, J NEUROSCI, V19, P987; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Kadener S, 2008, PLOS BIOL, V6, P965, DOI 10.1371/journal.pbio.0060119; Kim EY, 2006, P NATL ACAD SCI USA, V103, P6178, DOI 10.1073/pnas.0511215103; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu Y, 2006, EUKARYOT CELL, V5, P1184, DOI 10.1128/EC.00133-06; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; RUTILA JE, 1992, J NEUROGENET, V8, P101, DOI 10.3109/01677069209084155; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schibler U, 2005, EMBO REP, V6, pS9, DOI 10.1038/sj.embor.7400424; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406	59	59	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7033	7042		10.1074/jbc.M110.207217	http://dx.doi.org/10.1074/jbc.M110.207217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21199878	Green Published, hybrid			2022-12-25	WOS:000287737300020
J	Wang, LJ; Wang, J; Li, N; Ge, LA; Li, BL; Song, BL				Wang, Li-Juan; Wang, Jing; Li, Na; Ge, Liang; Li, Bo-Liang; Song, Bao-Liang			Molecular Characterization of the NPC1L1 Variants Identified from Cholesterol Low Absorbers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RECOMBINANT ADENOVIRUSES; GENETIC-VARIATION; ABSORPTION; EZETIMIBE; PROTEIN; METABOLISM; TRANSPORT; MEMBRANE; COMPLEX	Niemann-Pick C1-like 1 (NPC1L1) is an essential protein for dietary cholesterol absorption. Nonsynonymous (NS) variants of NPC1L1 in humans have been suggested to associate with cholesterol absorption variations. However, information concerning the characteristics and mechanism of these variants in cholesterol uptake is limited. In this study, we analyzed the cholesterol uptake ability of the 19 reported NS variants of NPC1L1 identified from cholesterol low absorbers. Among these variants, L110F, R306C, A395V, G402S, T413M, R693C, R1214H, and R1268H could partially mediate cellular cholesterol uptake and were categorized as partially dysfunctional variants. The other 11 variants including T61M, N132S, D398G, R417W, G434R, T499M, S620C, I647N, G672R, S881L, and R1108W could barely facilitate cholesterol uptake, and were classified into the severely dysfunctional group. The partially dysfunctional variants showed mild defects in one or multiple aspects of cholesterol-regulated recycling, subcellular localization, glycosylation, and protein stability. The severely dysfunctional ones displayed remarkable defects in all these aspects and were rapidly degraded through the ER-associated degradation (ERAD) pathway. In vivo analyses using adenovirus-mediated expression in mouse liver confirmed that the S881L variant failed to localize to liver canalicular membrane, and the mice showed defects in biliary cholesterol re-absorption, while the G402S variant appeared to be similar to wildtype NPC1L1 in mouse liver. This study suggests that the dysfunction of the 19 variants on cholesterol absorption is due to the impairment of recycling, subcellular localization, glycosylation, or stability of NPC1L1.	[Wang, Li-Juan; Wang, Jing; Li, Na; Ge, Liang; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	blsong@sibs.ac.cn		Song, Bao-Liang/0000-0002-6397-5935; Ge, Liang/0000-0002-7371-2039	Ministry of Science and Technology of China [2009CB919000, 2011CB910900]; National Natural Science Foundation of China [30925012, 90713025]; Shanghai Science and Technology Committee [10QH1402900]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by grants from the Ministry of Science and Technology of China (2009CB919000 and 2011CB910900), National Natural Science Foundation of China (30925012 and 90713025), and Shanghai Science and Technology Committee (10QH1402900).	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Bosner MS, 1999, J LIPID RES, V40, P302; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chen CW, 2009, J HUM GENET, V54, P242, DOI 10.1038/jhg.2009.18; Chu BB, 2009, J BIOL CHEM, V284, P22481, DOI 10.1074/jbc.M109.034355; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davis HR, 2007, J ATHEROSCLER THROMB, V14, P99, DOI 10.5551/jat.14.99; Davis HR, 2009, BBA-MOL CELL BIOL L, V1791, P679, DOI 10.1016/j.bbalip.2009.01.002; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; GRUNDY SM, 1983, ANNU REV NUTR, V3, P71, DOI 10.1146/annurev.nu.03.070183.000443; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hegele Robert A, 2005, Lipids Health Dis, V4, P16, DOI 10.1186/1476-511X-4-16; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maeda T, 2010, J ATHEROSCLER THROMB, V17, P356, DOI 10.5551/jat.2451; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Martin B, 2010, NUTR METAB CARDIOVAS, V20, P236, DOI 10.1016/j.numecd.2009.03.023; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Paulusma CC, 1999, BIOCHEM J, V338, P393, DOI 10.1042/0264-6021:3380393; Pisciotta L, 2007, ATHEROSCLEROSIS, V194, pE116, DOI 10.1016/j.atherosclerosis.2006.10.036; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; Polisecki E, 2010, J LIPID RES, V51, P1201, DOI 10.1194/jlr.P001172; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Severs N J, 1997, Subcell Biochem, V28, P477; Simon JS, 2005, GENOMICS, V86, P648, DOI 10.1016/j.ygeno.2005.08.007; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VARKI A, 2009, CURRENT PROTOCOLS PR, P57; Wang J, 2005, CLIN GENET, V67, P175, DOI 10.1111/j.1399-0004.2004.00388.x; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Yamanashi Y, 2009, PHARMACOGENET GENOM, V19, P884, DOI 10.1097/FPC.0b013e3283327925; Zhao H, 2008, LIPIDS, V43, P1155, DOI 10.1007/s11745-008-3241-y	42	50	57	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7397	7408		10.1074/jbc.M110.178368	http://dx.doi.org/10.1074/jbc.M110.178368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189420	Green Published, hybrid			2022-12-25	WOS:000287737300055
J	Fransen, F; Stenger, RM; Poelen, MCM; van Dijken, HH; Kuipers, B; Boog, CJP; van Putten, JPM; van Els, CACM; van der Ley, P				Fransen, Floris; Stenger, Rachel M.; Poelen, Martien C. M.; van Dijken, Harry H.; Kuipers, Betsy; Boog, Claire J. P.; van Putten, Jos P. M.; van Els, Cecile A. C. M.; van der Ley, Peter			Differential Effect of TLR2 and TLR4 on the Immune Response after Immunization with a Vaccine against Neisseria meningitidis or Bordetella pertussis	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-DEFICIENT MUTANT; TOLL-LIKE RECEPTOR-2; ACTIVATED PROTEIN-KINASE; DENDRITIC CELLS; ANTIBODY-RESPONSES; CONTROLLED-TRIAL; VESICLE VACCINE; I INTERFERONS; CUTTING EDGE; HOST-DEFENSE	Neisseria meningitidis and Bordetella pertussis are Gram-negative bacterial pathogens that can cause serious diseases in humans. N. meningitidis outer membrane vesicle (OMV) vaccines and whole cell pertussis vaccines have been successfully used in humans to control infections with these pathogens. The mechanisms behind their effectiveness are poorly defined. Here we investigated the role of Toll-like receptor (TLR) 2 and TLR4 in the induction of immune responses in mice after immunization with these vaccines. Innate and adaptive immune responses were compared between wild type mice and mice deficient in TLR2, TLR4, or TRIF. TRIF-deficient and TLR4-deficient mice showed impaired immunity after immunization. In contrast, immune responses were not lower in TLR2-/- mice but tended even to be higher after immunization. Together our data demonstrate that TLR4 activation contributes to the immunogenicity of the N. meningitidis OMV vaccine and the whole cell pertussis vaccine, but that TLR2 activation is not required.	[Fransen, Floris; Stenger, Rachel M.; Poelen, Martien C. M.; van Dijken, Harry H.; Kuipers, Betsy; Boog, Claire J. P.; van Els, Cecile A. C. M.; van der Ley, Peter] Netherlands Vaccine Inst, Lab Vaccine Res, Bilthoven, Netherlands; [Fransen, Floris; Boog, Claire J. P.; van Putten, Jos P. M.] Univ Utrecht, Dept Immunol & Infect Dis, Utrecht, Netherlands	Utrecht University	Fransen, F (corresponding author), Netherlands Vaccine Inst, Lab Vaccine Res, Bilthoven, Netherlands.	peter.van.der.ley@nvi-vaccin.nl		van Putten, Jos/0000-0002-4126-8172	Netherlands Vaccine Institute	Netherlands Vaccine Institute	This study was funded by the Netherlands Vaccine Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Banus S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-21; Cartwright K, 1999, VACCINE, V17, P2612, DOI 10.1016/S0264-410X(99)00044-4; Cervantes-Barragan L, 2009, EUR J IMMUNOL, V39, P126, DOI 10.1002/eji.200838185; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; de Kleijn ED, 2000, VACCINE, V18, P1456, DOI 10.1016/S0264-410X(99)00423-5; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Durand V, 2009, VACCINE, V27, P1912, DOI 10.1016/j.vaccine.2009.01.109; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Fransen F, 2007, INFECT IMMUN, V75, P5939, DOI 10.1128/IAI.00846-07; FREDRIKSEN J H, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P67; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Greco D, 1996, NEW ENGL J MED, V334, P341, DOI 10.1056/NEJM199602083340601; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Holdsworth SR, 1999, KIDNEY INT, V55, P1198, DOI 10.1046/j.1523-1755.1999.00369.x; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Ingalls RR, 2001, INFECT IMMUN, V69, P2230, DOI 10.1128/IAI.69.4.2230-2236.2001; Ingalls RR, 2000, J ENDOTOXIN RES, V6, P411, DOI 10.1177/09680519000060050301; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Latz E, 2004, J IMMUNOL, V172, P2431, DOI 10.4049/jimmunol.172.4.2431; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Luijkx TA, 2003, INFECT IMMUN, V71, P6367, DOI 10.1128/IAI.71.11.6367-6371.2003; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Mann PB, 2005, INFECT IMMUN, V73, P8144, DOI 10.1128/IAI.73.12.8144-8152.2005; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Maynard CL, 2008, IMMUNOL REV, V226, P219, DOI 10.1111/j.1600-065X.2008.00711.x; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; NICHOLSON A, 1979, SCIENCE, V205, P298, DOI 10.1126/science.451601; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Peeters CCAM, 1996, VACCINE, V14, P1009, DOI 10.1016/0264-410X(96)00001-1; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pridmore AC, 2001, J INFECT DIS, V183, P89, DOI 10.1086/317647; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Sieling PA, 2003, J IMMUNOL, V170, P194, DOI 10.4049/jimmunol.170.1.194; Smith PL, 2005, MOL IMMUNOL, V42, P869, DOI 10.1016/j.molimm.2004.11.008; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Steeghs L, 1999, INFECT IMMUN, V67, P4988, DOI 10.1128/IAI.67.10.4988-4993.1999; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004; Zughaier S, 2007, VACCINE, V25, P4401, DOI 10.1016/j.vaccine.2007.03.029	61	34	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15692	10.1371/journal.pone.0015692	http://dx.doi.org/10.1371/journal.pone.0015692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203418	Green Published, Green Submitted, gold			2022-12-25	WOS:000285579200029
J	Strata, F; Stoianov, IP; de Villers-Sidani, E; Bonham, B; Martone, T; Kenet, T; Chang, EF; Vincenti, V; Merzenich, MM				Strata, Fabrizio; Stoianov, Ivilin P.; de Villers-Sidani, Etienne; Bonham, Ben; Martone, Tiziana; Kenet, Tal; Chang, Edward F.; Vincenti, Vincenzo; Merzenich, Michael M.			Perinatal Asphyxia Affects Rat Auditory Processing: Implications for Auditory Perceptual Impairments in Neurodevelopmental Disorders	PLOS ONE			English	Article							CEREBRAL-PALSY; CORTEX NEURONS; BRAIN-STEM; AUTISM; INHIBITION; SYSTEM; BIRTH; ORGANIZATION; MONKEYS; CONSEQUENCES	Perinatal asphyxia, a naturally and commonly occurring risk factor in birthing, represents one of the major causes of neonatal encephalopathy with long term consequences for infants. Here, degraded spectral and temporal responses to sounds were recorded from neurons in the primary auditory cortex (A1) of adult rats exposed to asphyxia at birth. Response onset latencies and durations were increased. Response amplitudes were reduced. Tuning curves were broader. Degraded successive-stimulus masking inhibitory mechanisms were associated with a reduced capability of neurons to follow higher-rate repetitive stimuli. The architecture of peripheral inner ear sensory epithelium was preserved, suggesting that recorded abnormalities can be of central origin. Some implications of these findings for the genesis of language perception deficits or for impaired language expression recorded in developmental disorders, such as autism spectrum disorders, contributed to by perinatal asphyxia, are discussed.	[Strata, Fabrizio] Univ Parma, Physiol Sect, Dept Neurosci, I-43100 Parma, Italy; [Strata, Fabrizio; Merzenich, Michael M.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Coleman Mem Lab, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Stoianov, Ivilin P.] Univ Padua, Dept Gen Psychol, Padua, Italy; [de Villers-Sidani, Etienne] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Bonham, Ben] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Epstein Labs, San Francisco, CA 94143 USA; [Martone, Tiziana] Univ Turin, Div Otolaryngol, Dept Clin Physiopathol, Turin, Italy; [Kenet, Tal] Massachusetts Gen Hosp, Dept Neurol, Athinoula A Martinos Ctr Biomed Imaging MGH Marti, Charlestown, MA USA; [Chang, Edward F.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Vincenti, Vincenzo] Univ Parma, Dept Otolaryngol Head & Neck Surg, I-43100 Parma, Italy	University of Parma; University of California System; University of California San Francisco; University of Padua; McGill University; University of California System; University of California San Francisco; University of Turin; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; University of Parma	Strata, F (corresponding author), Univ Parma, Physiol Sect, Dept Neurosci, I-43100 Parma, Italy.	fab@phy.ucsf.edu	Stoianov, Ivilin/G-5904-2011; Stoianov, Ivilin/AAX-8528-2020; MARTONE, Tiziana/AAD-2706-2022	Stoianov, Ivilin/0000-0003-0642-259X; MARTONE, Tiziana/0000-0002-4019-6082	National Institutes of Health Conte Center [MH77970]; John C. and Edward Coleman Memorial Fund; Italian Ministry of University and Research; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER	National Institutes of Health Conte Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John C. and Edward Coleman Memorial Fund; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health Conte Center grant MH77970 (M.M.M.), the John C. and Edward Coleman Memorial Fund (M.M.M.), and the Italian Ministry of University and Research, PRIN 2009 (F.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; BERMAN D, 1971, EXP NEUROL, V31, P140, DOI 10.1016/0014-4886(71)90182-8; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Buonomano DV, 1998, J NEUROPHYSIOL, V80, P1765, DOI 10.1152/jn.1998.80.4.1765; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Coq JO, 2008, EXP NEUROL, V210, P95, DOI 10.1016/j.expneurol.2007.10.006; Dalman C, 2001, BRIT J PSYCHIAT, V179, P403, DOI 10.1192/bjp.179.5.403; de Villers-Sidani E, 2008, NAT NEUROSCI, V11, P957, DOI 10.1038/nn.2144; Dilenge ME, 2001, J CHILD NEUROL, V16, P781, DOI 10.1177/08830738010160110201; FARO MD, 1969, EXP NEUROL, V24, P38, DOI 10.1016/0014-4886(69)90004-1; HALL JG, 1964, ACTA OTO-LARYNGOL, V194, P191; KALTENBACH JA, 1993, HEARING RES, V67, P35, DOI 10.1016/0378-5955(93)90229-T; Khalfa S, 2004, HEARING RES, V198, P87, DOI 10.1016/j.heares.2004.07.006; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Kulesza RJ, 2008, BRAIN RES, V1200, P132, DOI 10.1016/j.brainres.2008.01.009; Magnusson AK, 2008, NEURON, V59, P125, DOI 10.1016/j.neuron.2008.05.011; MIRSKY AF, 1979, DEV PSYCHOBIOL, V12, P369, DOI 10.1002/dev.420120411; Myers R E, 1975, Adv Neurol, V10, P223; MYERS RE, 1975, BIOL NEONATE, V26, P21; MYERS RE, 1972, AM J OBSTET GYNECOL, V112, P246, DOI 10.1016/0002-9378(72)90124-X; NELKEN I, 1994, HEARING RES, V72, P223, DOI 10.1016/0378-5955(94)90221-6; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Oguni H, 2008, PEDIATR NEUROL, V38, P345, DOI 10.1016/j.pediatrneurol.2007.10.016; PETERSON BE, 1995, J NEUROSCI METH, V57, P133, DOI 10.1016/0165-0270(94)00103-N; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; Rosenhall U, 2003, EAR HEARING, V24, P206, DOI 10.1097/01.AUD.0000069326.11466.7E; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scholl B, 2008, J NEUROPHYSIOL, V100, P646, DOI 10.1152/jn.90406.2008; Schreiner C.E., 1994, AUDIT NEUROSCI, V1, P39; SCHREINER CE, 1981, NEURONAL MECH HEARIN, P191, DOI DOI 10.1007/978-1-4684-3908-320; SCHREINER CE, 2006, LISTENING SPEECH AUD, P129; Sechzer J A, 1971, Science, V172, P1221, DOI 10.1126/science.172.3989.1221; Simon EN, 2007, ARCH PEDIAT ADOL MED, V161, P1106, DOI 10.1001/archpedi.161.11.1106-a; Simon N, 1999, J AUTISM DEV DISORD, V29, P94; SMALL JG, 1975, BIOL PSYCHIAT, V10, P385; Strata F, 2005, P NATL ACAD SCI USA, V102, P19156, DOI 10.1073/pnas.0509520102; Strata F, 2004, NEUROSCIENCE, V129, P141, DOI 10.1016/j.neuroscience.2004.07.024; STRATA F, 2010, PEDIATRICS; Sutter ML, 1999, J NEUROPHYSIOL, V82, P2358, DOI 10.1152/jn.1999.82.5.2358; SYMMES D, 1966, EXP NEUROL, V16, P201, DOI 10.1016/0014-4886(66)90099-9; Szelag E, 2004, BRIT J PSYCHOL, V95, P269, DOI 10.1348/0007126041528167; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Teder-Salejarvi WA, 2005, COGNITIVE BRAIN RES, V23, P221, DOI 10.1016/j.cogbrainres.2004.10.021; Tharpe AM, 2006, EAR HEARING, V27, P430, DOI 10.1097/01.aud.0000224981.60575.d8; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; VOLKOV IO, 1992, EXP BRAIN RES, V91, P115; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WINDLE WF, 1969, SCI AM, V221, P77, DOI 10.1038/scientificamerican1069-76; Zhang H, 1998, J COMP PHYSIOL A, V182, P725, DOI 10.1007/s003590050217; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhou XM, 2008, P NATL ACAD SCI USA, V105, P4423, DOI 10.1073/pnas.0800009105	53	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15326	10.1371/journal.pone.0015326	http://dx.doi.org/10.1371/journal.pone.0015326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203459	gold, Green Published, Green Submitted			2022-12-25	WOS:000285579200017
J	Singh, R; Levitt, AL; Rajotte, EG; Holmes, EC; Ostiguy, N; Vanengelsdorp, D; Lipkin, WI; Depamphilis, CW; Toth, AL; Cox-Foster, DL				Singh, Rajwinder; Levitt, Abby L.; Rajotte, Edwin G.; Holmes, Edward C.; Ostiguy, Nancy; vanEngelsdorp, Dennis; Lipkin, W. Ian; Depamphilis, Claude W.; Toth, Amy L.; Cox-Foster, Diana L.			RNA Viruses in Hymenopteran Pollinators: Evidence of Inter-Taxa Virus Transmission via Pollen and Potential Impact on Non-Apis Hymenopteran Species	PLOS ONE			English	Article							KASHMIR-BEE-VIRUS; DEFORMED-WING-VIRUS; COLONY COLLAPSE DISORDER; RHOPALOSIPHUM-PADI VIRUS; LEAF MOTTLE VIRUS; QUEEN CELL VIRUS; HONEY-BEE; PARALYSIS VIRUS; SACBROOD VIRUS; VERTICAL-TRANSMISSION	Although overall pollinator populations have declined over the last couple of decades, the honey bee (Apis mellifera) malady, colony collapse disorder (CCD), has caused major concern in the agricultural community. Among honey bee pathogens, RNA viruses are emerging as a serious threat and are suspected as major contributors to CCD. Recent detection of these viral species in bumble bees suggests a possible wider environmental spread of these viruses with potential broader impact. It is therefore vital to study the ecology and epidemiology of these viruses in the hymenopteran pollinator community as a whole. We studied the viral distribution in honey bees, in their pollen loads, and in other non-Apis hymenopteran pollinators collected from flowering plants in Pennsylvania, New York, and Illinois in the United States. Viruses in the samples were detected using reverse transcriptase-PCR and confirmed by sequencing. For the first time, we report the molecular detection of picorna-like RNA viruses (deformed wing virus, sacbrood virus and black queen cell virus) in pollen pellets collected directly from forager bees. Pollen pellets from several uninfected forager bees were detected with virus, indicating that pollen itself may harbor viruses. The viruses in the pollen and honey stored in the hive were demonstrated to be infective, with the queen becoming infected and laying infected eggs after these virus-contaminated foods were given to virus-free colonies. These viruses were detected in eleven other non-Apis hymenopteran species, ranging from many solitary bees to bumble bees and wasps. This finding further expands the viral host range and implies a possible deeper impact on the health of our ecosystem. Phylogenetic analyses support that these viruses are disseminating freely among the pollinators via the flower pollen itself. Notably, in cases where honey bee apiaries affected by CCD harbored honey bees with Israeli Acute Paralysis virus (IAPV), nearby non-Apis hymenopteran pollinators also had IAPV, while those near apiaries without IAPV did not. In containment greenhouse experiments, IAPV moved from infected honey bees to bumble bees and from infected bumble bees to honey bees within a week, demonstrating that the viruses could be transmitted from one species to another. This study adds to our present understanding of virus epidemiology and may help explain bee disease patterns and pollinator population decline in general.	[Singh, Rajwinder; Levitt, Abby L.; Rajotte, Edwin G.; Ostiguy, Nancy; vanEngelsdorp, Dennis; Toth, Amy L.; Cox-Foster, Diana L.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Holmes, Edward C.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY USA; [Toth, Amy L.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Columbia University; University of Illinois System; University of Illinois Urbana-Champaign	Singh, R (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	dxc12@psu.edu	Lipkin, W. Ian/ABE-6216-2020; vanEngelsdorp, Dennis/E-7934-2010; Holmes, Edward/Y-2789-2019; Holmes, Edward/GVR-9499-2022; dePamphilis, Claude W/P-6652-2016; Toth, Amy L/A-9196-2011	Lipkin, W. Ian/0000-0002-8768-9386; Holmes, Edward/0000-0001-9596-3552; 	Pennsylvania Department of Agriculture [ME 446716]; Experiment Station, Pennsylvania State University; USAID [EPP-A-00-04-00016-00]; North American Pollinator Protection Campaign (NAPPC)	Pennsylvania Department of Agriculture; Experiment Station, Pennsylvania State University; USAID(United States Agency for International Development (USAID)); North American Pollinator Protection Campaign (NAPPC)	Funding for this study was provided by Pennsylvania Department of Agriculture (www.agriculture.state.pa.us) (grant ME 446716 awarded to DCF and NO), Hatch funds from the Experiment Station, Pennsylvania State University (research.cas.psu.edu) (awarded to ER and RS), Integrated Pest Management Collaborative Research Support Program (IPM CRSP) USAID Cooperative agreement No. EPP-A-00-04-00016-00 (www.oired.vt.edu/ipmcrsp) (awarded to ER), and a honey bee health improvement project grant from North American Pollinator Protection Campaign (NAPPC; www.nappc.org) awarded to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Allen M, 1996, BEE WORLD, V77, P141, DOI 10.1080/0005772X.1996.11099306; Amari K, 2007, PHYTOPATHOLOGY, V97, P892, DOI 10.1094/PHYTO-97-8-0892; ANDERSON DL, 1991, AM BEE J, V131, P767; Aparicio F, 1999, EUR J PLANT PATHOL, V105, P623, DOI 10.1023/A:1008783705183; Bailey L., 1975, Bee World, V56, P55; BAILEY L, 1964, J INSECT PATHOL, V6, P395; BAILEY L, 1969, ANN APPL BIOL, V63, P483, DOI 10.1111/j.1744-7348.1969.tb02844.x; BAILEY L, 1965, J INVERTEBR PATHOL, V7, P132, DOI 10.1016/0022-2011(65)90024-8; Baker AC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-10; Ball B.V., 1991, HONEYBEE PATHOLOGY, P193, DOI [https://doi.org/10.1007/BF00576582, DOI 10.1007/BF00576582]; Benjeddou M, 2001, APPL ENVIRON MICROB, V67, P2384, DOI 10.1128/AEM.67.5.2384-2387.2001; Bonning Bryony C., 2009, Virologica Sinica, V24, P415, DOI 10.1007/s12250-009-3044-1; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Boyapalle S, 2007, J INVERTEBR PATHOL, V94, P130, DOI 10.1016/j.jip.2006.09.010; BOYLANPETT W, 1991, PHYTOPATHOLOGY, V81, P1407, DOI 10.1094/Phyto-81-1407; Bristow PR, 1999, PHYTOPATHOLOGY, V89, P124, DOI 10.1094/PHYTO.1999.89.2.124; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Buchner R., 2000, PALDAT PALYNOLOGICAL; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; CHILDRESS AM, 1987, PHYTOPATHOLOGY, V77, P167, DOI 10.1094/Phyto-77-167; Christian PD, 1998, VIRUSES, P301; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Davis O.K., 2000, RO KAPPS POLLEN SPOR; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; GILDOW FE, 1990, J INVERTEBR PATHOL, V55, P245, DOI 10.1016/0022-2011(90)90060-J; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hung ACF, 2000, J APICULT RES, V39, P103, DOI 10.1080/00218839.2000.11101029; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Kapoor A, 2010, J VIROL, V84, P10322, DOI 10.1128/JVI.00601-10; KELLEY RD, 1986, PHYTOPATHOLOGY, V76, P317, DOI 10.1094/Phyto-76-317; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Mayo MA, 2002, ARCH VIROL, V147, P1271, DOI 10.1007/s007050200037; Meeus I, 2010, J INVERTEBR PATHOL, V105, P200, DOI 10.1016/j.jip.2010.06.012; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; *NAT RES COUNC, 2006, STAT POLL N AM; Nielsen SL, 2008, APIDOLOGIE, V39, P310, DOI 10.1051/apido:2008007; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PRISCO GD, 2010, J GEN VIROL IN PRESS; Quan M, 2009, J COMP PATHOL, V140, P225, DOI 10.1016/j.jcpa.2008.12.002; Ribiere M, 2007, APPL ENVIRON MICROB, V73, P7711, DOI 10.1128/AEM.01053-07; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruiz-Gonzalez MX, 2006, ECOL ENTOMOL, V31, P616, DOI 10.1111/j.1365-2311.2006.00823.x; Rzezutka A, 2004, FEMS MICROBIOL REV, V28, P441, DOI 10.1016/j.femsre.2004.02.001; Schmalhofer VR, 2001, OECOLOGIA, V129, P292, DOI 10.1007/s004420100726; Schwarz HH, 1997, INSECT SOC, V44, P303, DOI 10.1007/s000400050051; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; SLATKIN M, 1989, GENETICS, V123, P603; Swafford D. L., 2002, PAUP PHYLOGENETIC AN; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Welch A, 2009, APPL ENVIRON MICROB, V75, P7862, DOI 10.1128/AEM.01319-09; Whitton JL, 2005, NAT REV MICROBIOL, V3, P765, DOI 10.1038/nrmicro1284; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Winfree R, 2008, CURR BIOL, V18, pR968, DOI 10.1016/j.cub.2008.09.010; Yook HS, 1998, J FOOD PROTECT, V61, P217, DOI 10.4315/0362-028X-61.2.217; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0	78	270	282	3	149	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14357	10.1371/journal.pone.0014357	http://dx.doi.org/10.1371/journal.pone.0014357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203504	Green Published, gold			2022-12-25	WOS:000285578000004
J	Tran, E; Nielsen, JS; Wick, DA; Ng, AV; Johnson, LDS; Nesslinger, NJ; McMurtrie, E; Webb, JR; Nelson, BH				Tran, Eric; Nielsen, Julie S.; Wick, Darin A.; Ng, Alvin V.; Johnson, Lisa D. S.; Nesslinger, Nancy J.; McMurtrie, Elissa; Webb, John R.; Nelson, Brad H.			Polyfunctional T-Cell Responses Are Disrupted by the Ovarian Cancer Ascites Environment and Only Partially Restored by Clinically Relevant Cytokines	PLOS ONE			English	Article							GAMMA-INDUCING FACTOR; RECOMBINANT HUMAN INTERLEUKIN-21; IFN-GAMMA; INTERFERON-GAMMA; METASTATIC MELANOMA; PHASE-I; VACCINE; EXPRESSION; RECEPTOR; IL-12	Background: Host T-cell responses are associated with favorable outcomes in epithelial ovarian cancer (EOC), but it remains unclear how best to promote these responses in patients. Toward this goal, we evaluated a panel of clinically relevant cytokines for the ability to enhance multiple T-cell effector functions (polyfunctionality) in the native tumor environment. Methodology/Principal Findings: Experiments were performed with resident CD8+ and CD4+ T cells in bulk ascites cell preparations from high-grade serous EOC patients. T cells were stimulated with alpha-CD3 in the presence of 100% autologous ascites fluid with or without exogenous IL-2, IL-12, IL-18 or IL-21, alone or in combination. T-cell proliferation (Ki-67) and function (IFN-gamma, TNF-alpha, IL-2, CCL4, and CD107a expression) were assessed by multi-parameter flow cytometry. In parallel, 27 cytokines were measured in culture supernatants. While ascites fluid had variable effects on CD8+ and CD4+ T-cell proliferation, it inhibited T-cell function in most patient samples, with CD107a, IFN-gamma, and CCL4 showing the greatest inhibition. This was accompanied by reduced levels of IL-1 beta, IL-1ra, IL-9, IL-17, G-CSF, GM-CSF, Mip-1 alpha, PDGF-bb, and bFGF in culture supernatants. T-cell proliferation was enhanced by exogenous IL-2, but other T-cell functions were largely unaffected by single cytokines. The combination of IL-2 with cytokines engaging complementary signaling pathways, in particular IL-12 and IL-18, enhanced expression of IFN-gamma, TNF-alpha, and CCL4 in all patient samples by promoting polyfunctional T-cell responses. Despite this, other functional parameters generally remained inhibited. Conclusions/Significance: The EOC ascites environment disrupts multiple T-cell functions, and exogenous cytokines engaging diverse signaling pathways only partially reverse these effects. Our results may explain the limited efficacy of cytokine therapies for EOC to date. Full restoration of T-cell function will require activation of signaling pathways beyond those engaged by IL-2, IL-12, IL-18, and IL-21.	[Tran, Eric; Webb, John R.; Nelson, Brad H.] Univ Victoria, Dept Microbiol & Biochem, Victoria, BC, Canada; [Tran, Eric; Nielsen, Julie S.; Wick, Darin A.; Ng, Alvin V.; Johnson, Lisa D. S.; Nesslinger, Nancy J.; Webb, John R.; Nelson, Brad H.] British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada; [Nielsen, Julie S.; Nelson, Brad H.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [McMurtrie, Elissa] BC Canc Agcy, Victoria, BC, Canada	University of Victoria; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency	Tran, E (corresponding author), Univ Victoria, Dept Microbiol & Biochem, Victoria, BC, Canada.	bnelson@bccancer.bc.ca	Johnson, Lisa DS/E-4218-2013; Nelson, Brad H/K-2622-2014	Johnson, Lisa DS/0000-0002-2019-6560; Nelson, Brad/0000-0002-4445-5539	British Columbia Cancer Foundation; United States Department of Defense; Natural Sciences and Research Council of Canada	British Columbia Cancer Foundation; United States Department of Defense(United States Department of Defense); Natural Sciences and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the British Columbia Cancer Foundation, United States Department of Defense, and the Natural Sciences and Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 1997, J IMMUNOL, V159, P2125; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Badr G, 2008, J VIROL, V82, P10017, DOI 10.1128/JVI.01083-08; BAMIAS A, 2007, GYNECOL ONCOL; Bansal A, 2008, J VIROL, V82, P6458, DOI 10.1128/JVI.00068-08; Barnett B, 2005, AM J REPROD IMMUNOL, V54, P369, DOI 10.1111/j.1600-0897.2005.00330.x; BARTON DPJ, 1995, J SOC GYNECOL INVEST, V2, P762, DOI 10.1016/1071-5576(95)94692-N; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Carroll RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003289; Carson WE, 2000, BLOOD, V96, P1465, DOI 10.1182/blood.V96.4.1465.h8001465_1465_1473; Chu CS, 2008, EXPERT REV ANTICANC, V8, P243, DOI 10.1586/14737140.8.2.243; Cullen SP, 2010, CELL DEATH DIFFER, V17, P616, DOI 10.1038/cdd.2009.206; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Davis ID, 2007, CLIN CANCER RES, V13, P3630, DOI 10.1158/1078-0432.CCR-07-0410; Davis ID, 2009, CLIN CANCER RES, V15, P2123, DOI 10.1158/1078-0432.CCR-08-2663; DECESARE SL, 1995, GYNECOL ONCOL, V57, P86, DOI 10.1006/gyno.1995.1103; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Edwards RP, 1997, J CLIN ONCOL, V15, P3399, DOI 10.1200/JCO.1997.15.11.3399; Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gollob JA, 1999, J IMMUNOL, V162, P4472; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; HIRTE HW, 1992, CELL IMMUNOL, V142, P207, DOI 10.1016/0008-8749(92)90281-S; Hurteau JA, 2001, GYNECOL ONCOL, V82, P7, DOI 10.1006/gyno.2001.6255; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Imai N, 2009, CANCER SCI, V100, P1317, DOI 10.1111/j.1349-7006.2009.01179.x; Imai N, 2009, EUR J IMMUNOL, V39, P241, DOI 10.1002/eji.200838824; Iwai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002404; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; KRYCZEK I, 2009, BLOOD; Lenzi R, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-66; Lichterfeld M, 2004, BLOOD, V104, P487, DOI 10.1182/blood-2003-12-4341; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Nelson BH, 2008, IMMUNOL REV, V222, P101, DOI 10.1111/j.1600-065X.2008.00614.x; Okamoto I, 1999, J IMMUNOL, V162, P3202; Osaki T, 1998, J IMMUNOL, V160, P1742; Osaki T, 1999, GENE THER, V6, P808, DOI 10.1038/sj.gt.3300908; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; Perales MA, 2008, MOL THER, V16, P2022, DOI 10.1038/mt.2008.196; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Recchia F, 2005, INT J ONCOL, V27, P1039; Recchia F, 2010, GYNECOL ONCOL, V116, P202, DOI 10.1016/j.ygyno.2009.09.042; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; Robertson MJ, 2008, CLIN CANCER RES, V14, P3462, DOI 10.1158/1078-0432.CCR-07-4740; Robertson MJ, 2006, CLIN CANCER RES, V12, P4265, DOI 10.1158/1078-0432.CCR-06-0121; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Smeltz RB, 2001, J EXP MED, V194, P143, DOI 10.1084/jem.194.2.143; Tarhini AA, 2009, CANCER-AM CANCER SOC, V115, P859, DOI 10.1002/cncr.24100; Thompson JA, 2008, J CLIN ONCOL, V26, P2034, DOI 10.1200/JCO.2007.14.5193; Valor L, 2008, VACCINE, V26, P2738, DOI 10.1016/j.vaccine.2008.03.019; Vlad AM, 2010, CANCER IMMUNOL IMMUN, V59, P293, DOI 10.1007/s00262-009-0750-3; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Weiss JM, 2007, EXPERT OPIN BIOL TH, V7, P1705, DOI 10.1517/14712598.7.11.1705; Winstone N, 2009, EUR J IMMUNOL, V39, P975, DOI 10.1002/eji.200839167; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yang T, 2007, CLIN CANCER RES, V13, P7172, DOI 10.1158/1078-0432.CCR-07-1724; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	68	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15625	10.1371/journal.pone.0015625	http://dx.doi.org/10.1371/journal.pone.0015625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203522	Green Submitted, Green Published, gold			2022-12-25	WOS:000285578000040
J	Derenko, M; Malyarchuk, B; Grzybowski, T; Denisova, G; Rogalla, U; Perkova, M; Dambueva, I; Zakharov, I				Derenko, Miroslava; Malyarchuk, Boris; Grzybowski, Tomasz; Denisova, Galina; Rogalla, Urszula; Perkova, Maria; Dambueva, Irina; Zakharov, Ilia			Origin and Post-Glacial Dispersal of Mitochondrial DNA Haplogroups C and D in Northern Asia	PLOS ONE			English	Article							VOLGA-URAL REGION; GENOME VARIATION; GENETIC HISTORY; MTDNA VARIATION; MODERN HUMANS; EASTERN; DIVERSITY; PHYLOGENY; LINEAGES; SEQUENCE	More than a half of the northern Asian pool of human mitochondrial DNA (mtDNA) is fragmented into a number of subclades of haplogroups C and D, two of the most frequent haplogroups throughout northern, eastern, central Asia and America. While there has been considerable recent progress in studying mitochondrial variation in eastern Asia and America at the complete genome resolution, little comparable data is available for regions such as southern Siberia - the area where most of northern Asian haplogroups, including C and D, likely diversified. This gap in our knowledge causes a serious barrier for progress in understanding the demographic pre-history of northern Eurasia in general. Here we describe the phylogeography of haplogroups C and D in the populations of northern and eastern Asia. We have analyzed 770 samples from haplogroups C and D (174 and 596, respectively) at high resolution, including 182 novel complete mtDNA sequences representing haplogroups C and D (83 and 99, respectively). The present-day variation of haplogroups C and D suggests that these mtDNA clades expanded before the Last Glacial Maximum (LGM), with their oldest lineages being present in the eastern Asia. Unlike in eastern Asia, most of the northern Asian variants of haplogroups C and D began the expansion after the LGM, thus pointing to post-glacial re-colonization of northern Asia. Our results show that both haplogroups were involved in migrations, from eastern Asia and southern Siberia to eastern and northeastern Europe, likely during the middle Holocene.	[Derenko, Miroslava; Malyarchuk, Boris; Denisova, Galina; Perkova, Maria] Russian Acad Sci, Inst Biol Problems N, Magadan, Russia; [Grzybowski, Tomasz; Rogalla, Urszula] Nicholas Copernicus Univ, Ludwik Rydygier Coll Med, Dept Mol & Forens Genet, Inst Forens Med, Bydgoszcz, Poland; [Zakharov, Ilia] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Dambueva, Irina] Russian Acad Sci, Inst Gen & Expt Biol, Ulan Ude, Russia	Institute of Biological Problems of the North; Russian Academy of Sciences; Nicolaus Copernicus University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences	Derenko, M (corresponding author), Russian Acad Sci, Inst Biol Problems N, Magadan, Russia.	mderenko@mail.ru	Grzybowski, Tomasz/A-1676-2015; Malyarchuk, Boris/D-5783-2018; Derenko, Miroslava/J-1495-2018; Dambueva, Irina/K-3073-2018; Dambueva, Irina/AAZ-4313-2020; Rogalla, Urszula/E-3342-2014; Denisova, Galina/AAZ-4310-2020	Grzybowski, Tomasz/0000-0001-6228-6460; Malyarchuk, Boris/0000-0002-0304-0652; Derenko, Miroslava/0000-0002-1849-784X; Rogalla, Urszula/0000-0002-2778-9844; 	Presidium of Russian Academy of Sciences [09-I-P23-10]; Far-Eastern Branch of the Russian Academy of Sciences [09-III-A-06-220]	Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Far-Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences)	The study was supported by grants from the Presidium of Russian Academy of Sciences (09-I-P23-10), and the Far-Eastern Branch of the Russian Academy of Sciences (09-III-A-06-220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Derenko M. V., 1997, Molekulyarnaya Biologiya (Moscow), V31, P784; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Derenko MV, 2000, HUM BIOL, V72, P945; Derenko MV, 2009, THESIS I BIOL PROBLE; Egyed B, 2007, FORENSIC SCI INT-GEN, V1, P158, DOI 10.1016/j.fsigen.2007.03.001; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2007, EUR J HUM GENET, V15, P115, DOI 10.1038/sj.ejhg.5201712; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kushnerevich EI, 2008, THESIS NATL ACAD BEL, P21; LAUKHIN SA, 1993, DOKL AKAD NAUK+, V332, P352; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk B, 2004, HUM BIOL, V76, P877, DOI 10.1353/hub.2005.0021; Malyarchuk BA, 2006, ANN HUM GENET, V70, P195, DOI 10.1111/j.1529-8817.2005.00222.x; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; Malyarchuk BA, 2002, THESIS I BIOL PROBLE; Malyarchuk B, 2010, MOL BIOL EVOL, V27, P2220, DOI 10.1093/molbev/msq065; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Metspalu M, 2006, NUCL ACID M, V18, P181; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Nohira C, 2010, INT J LEGAL MED, V124, P7, DOI 10.1007/s00414-008-0308-5; Okladnikov AP, 1981, PALEOLITHIC CENTRAL; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Qin Z, 2010, AM J PHYS ANTHR; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schroeder KB, 2007, BIOL LETTERS, V3, P218, DOI 10.1098/rsbl.2006.0609; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Ueno H, 2009, MITOCHONDRION, V9, P385, DOI 10.1016/j.mito.2009.06.003; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VASILEV SA, 1993, CURR ANTHROPOL, V34, P82, DOI 10.1086/204141; Volodko NV, 2008, AM J HUM GENET, V82, P1084, DOI 10.1016/j.ajhg.2008.03.019	63	78	80	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15214	10.1371/journal.pone.0015214	http://dx.doi.org/10.1371/journal.pone.0015214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203537	Green Published, gold, Green Submitted			2022-12-25	WOS:000285576900021
J	Carrolo, M; Frias, MJ; Pinto, FR; Melo-Cristino, J; Ramirez, M				Carrolo, Margarida; Frias, Maria Joao; Pinto, Francisco Rodrigues; Melo-Cristino, Jose; Ramirez, Mario			Prophage Spontaneous Activation Promotes DNA Release Enhancing Biofilm Formation in Streptococcus pneumoniae	PLOS ONE			English	Article							EXTRACELLULAR DNA; BACTERIAL BIOFILMS; ENTEROCOCCUS-FAECALIS; PSEUDOALTEROMONAS-TUNICATA; MIDDLE-EAR; CELL-DEATH; BACTERIOPHAGE; AUTOLYSIN; PHAGES; CONTRIBUTES	Streptococcus pneumoniae (pneumococcus) is able to form biofilms in vivo and previous studies propose that pneumococcal biofilms play a relevant role both in colonization and infection. Additionally, pneumococci recovered from human infections are characterized by a high prevalence of lysogenic bacteriophages (phages) residing quiescently in their host chromosome. We investigated a possible link between lysogeny and biofilm formation. Considering that extracellular DNA (eDNA) is a key factor in the biofilm matrix, we reasoned that prophage spontaneous activation with the consequent bacterial host lysis could provide a source of eDNA, enhancing pneumococcal biofilm development. Monitoring biofilm growth of lysogenic and non-lysogenic pneumococcal strains indicated that phage-infected bacteria are more proficient at forming biofilms, that is their biofilms are characterized by a higher biomass and cell viability. The presence of phage particles throughout the lysogenic strains biofilm development implicated prophage spontaneous induction in this effect. Analysis of lysogens deficient for phage lysin and the bacterial major autolysin revealed that the absence of either lytic activity impaired biofilm development and the addition of DNA restored the ability of mutant strains to form robust biofilms. These findings establish that limited phage-mediated host lysis of a fraction of the bacterial population, due to spontaneous phage induction, constitutes an important source of eDNA for the S. pneumoniae biofilm matrix and that this localized release of eDNA favors biofilm formation by the remaining bacterial population.	[Carrolo, Margarida; Frias, Maria Joao; Melo-Cristino, Jose; Ramirez, Mario] Univ Lisbon, Inst Microbiol, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal; [Pinto, Francisco Rodrigues] Univ Lisbon, Ctr Quim & Bioquim, Fac Ciencias, Campo Grande, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Carrolo, M (corresponding author), Univ Lisbon, Inst Microbiol, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal.	ramirez@fm.ul.pt	Carrolo, Margarida/AAM-2938-2020; Ramirez, Mario/B-4993-2008; Carrolo, Margarida/C-4781-2009; Pinto, Francisco/A-7443-2008; Melo-Cristino, Jose A G/H-3726-2013	Ramirez, Mario/0000-0002-4084-6233; Pinto, Francisco/0000-0002-4217-0054; Melo-Cristino, Jose A G/0000-0001-8643-1722; Frias, Maria Joao/0000-0002-8060-1206; Carrolo, Margarida/0000-0002-6866-9515	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/35854/2007, SFRH/BD/38543/2007, PTDC/SAU-ESA/64888/2006, PIC/IC/83065/2007]; Fundacao Calouste Gulbenkian; GlaxoSmithKline	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian(European Commission); GlaxoSmithKline(GlaxoSmithKline)	M. C. and M.J.F. are supported by research grants from Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BD/35854/2007 and SFRH/BD/38543/2007 respectively). This work was partly supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/SAU-ESA/64888/2006 and PIC/IC/83065/2007), Fundacao Calouste Gulbenkian and an unrestricted grant from GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Ausubel F., 1999, CURRENT PROTOCOLS MO; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Bossi L, 2003, J BACTERIOL, V185, P6467, DOI 10.1128/JB.185.21.6467-6471.2003; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Desiere F, 2001, VIROLOGY, V288, P325, DOI 10.1006/viro.2001.1085; Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Frias MJ, 2009, J BACTERIOL, V191, P5428, DOI 10.1128/JB.00477-09; Guiton PS, 2009, INFECT IMMUN, V77, P3626, DOI 10.1128/IAI.00219-09; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Little JW, 2005, PHAGES THEIR ROLES B, V1st, P37; Livny J, 2004, MOL MICROBIOL, V51, P1691, DOI 10.1111/j.1365-2958.2003.03934.x; Lizcano A, 2010, MICROB PATHOGENESIS, V48, P124, DOI 10.1016/j.micpath.2010.01.002; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; LWOFF A, 1953, BACTERIOL REV, V17, P269, DOI 10.1128/MMBR.17.4.269-337.1953; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mai-Prochnow A, 2004, APPL ENVIRON MICROB, V70, P3232, DOI 10.1128/AEM.70.6.3232-3238.2004; Mai-Prochnow A, 2006, APPL ENVIRON MICROB, V72, P5414, DOI 10.1128/AEM.00546-06; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Moscoso M, 2004, MOL MICROBIOL, V54, P783, DOI 10.1111/j.1365-2958.2004.04305.x; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Moscoso M, 2009, INT MICROBIOL, V12, P77, DOI 10.2436/20.1501.01.84; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Ramirez M, 1999, J BACTERIOL, V181, P3618, DOI 10.1128/JB.181.12.3618-3625.1999; Reid SD, 2009, J INFECT DIS, V199, P786, DOI 10.1086/597042; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Severina E, 1999, J CLIN MICROBIOL, V37, P3308, DOI 10.1128/JCM.37.10.3308-3315.1999; Spoering AL, 2006, CURR OPIN MICROBIOL, V9, P133, DOI 10.1016/j.mib.2006.02.004; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Tapiainen T, 2010, APMIS, V118, P255, DOI 10.1111/j.1600-0463.2010.02587.x; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Thomas VC, 2009, MOL MICROBIOL, V72, P1022, DOI 10.1111/j.1365-2958.2009.06703.x; TOMASZ A, 1988, J BACTERIOL, V170, P5931, DOI 10.1128/jb.170.12.5931-5934.1988; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Williamson SJ, 2008, ISME J, V2, P1112, DOI 10.1038/ismej.2008.73	50	104	109	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15678	10.1371/journal.pone.0015678	http://dx.doi.org/10.1371/journal.pone.0015678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187931	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200062
J	Hayasaka, N; Larue, SI; Green, CB				Hayasaka, Naoto; Larue, Silvia I.; Green, Carla B.			Differential Contribution of Rod and Cone Circadian Clocks in Driving Retinal Melatonin Rhythms in Xenopus	PLOS ONE			English	Article							PERIPHERAL-TISSUES; LAEVIS; GENE; PHOTORECEPTORS; EXPRESSION	Background: Although an endogenous circadian clock located in the retinal photoreceptor layer governs various physiological events including melatonin rhythms in Xenopus laevis, it remains unknown which of the photoreceptors, rod and/or cone, is responsible for the circadian regulation of melatonin release. Methodology/Principal Findings: We selectively disrupted circadian clock function in either the rod or cone photoreceptor cells by generating transgenic Xenopus tadpoles expressing a dominant-negative CLOCK (XCL Delta Q) under the control of a rod or cone-specific promoter. Eyecup culture and continuous melatonin measurement revealed that circadian rhythms of melatonin release were abolished in a majority of the rod-specific XCL Delta Q transgenic tadpoles, although the percentage of arrhythmia was lower than that of transgenic tadpole eyes expressing XCL Delta Q in both rods and cones. In contrast, whereas a higher percentage of arrhythmia was observed in the eyes of the cone-specific XCL Delta Q transgenic tadpoles compare to wildtype counterparts, the rate was significantly lower than in rod-specific transgenics. The levels of the transgene expression were comparable between these two different types of transgenics. In addition, the average overall melatonin levels were not changed in the arrhythmic eyes, suggesting that CLOCK does not affect absolute levels of melatonin, only its temporal expression pattern. Conclusions/Significance: These results suggest that although the Xenopus retina is made up of approximately equal numbers of rods and cones, the circadian clocks in the rod cells play a dominant role in driving circadian melatonin rhythmicity in the Xenopus retina, although some contribution of the clock in cone cells cannot be excluded.	[Hayasaka, Naoto; Larue, Silvia I.; Green, Carla B.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Virginia	Hayasaka, N (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA.	hayasaka@med.kindai.ac.jp	Hayasaka, Naoto/C-9370-2011; Wilson, Matthew H/K-3193-2013		NIMH [MH61461]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061461] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from NIMH (MH61461) to CBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lopez C, 2004, BRAIN RES, V1024, P137, DOI 10.1016/j.brainres.2004.07.057; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BESHARSE JC, 1988, EXP EYE RES, V47, P609, DOI 10.1016/0014-4835(88)90098-X; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; CAHILL GM, 1990, J NEUROCHEM, V54, P716, DOI 10.1111/j.1471-4159.1990.tb01932.x; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; GREEN CB, 1995, VISUAL NEUROSCI, V12, P663, DOI 10.1017/S0952523800008956; Gustincich S, 2004, P NATL ACAD SCI USA, V101, P5069, DOI 10.1073/pnas.0400913101; Hayasaka N, 2005, METHOD ENZYMOL, V393, P205, DOI 10.1016/S0076-6879(05)93006-1; Hayasaka N, 2002, J NEUROSCI, V22, P1600, DOI 10.1523/JNEUROSCI.22-05-01600.2002; Hornstein EP, 2005, J NEUROSCI, V25, P11201, DOI 10.1523/JNEUROSCI.3416-05.2005; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; Krizaj D, 1998, J COMP NEUROL, V398, P529; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee HS, 2003, NAT NEUROSCI, V6, P111, DOI 10.1038/nn1006; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Ribelayga C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011020; ROLLAG MD, 1976, ENDOCRINOLOGY, V98, P482, DOI 10.1210/endo-98-2-482; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Steenhard BM, 2000, J NEUROSCI, V20, P8572; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tosini G, 2008, BIOESSAYS, V30, P624, DOI 10.1002/bies.20777; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Witkovsky P, 2003, J NEUROSCI, V23, P7670; Witkovsky P, 2000, MICROSC RES TECHNIQ, V50, P338, DOI 10.1002/1097-0029(20000901)50:5<338::AID-JEMT3>3.0.CO;2-I; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405; Zhu HS, 2000, MOL BRAIN RES, V75, P303, DOI 10.1016/S0169-328X(99)00309-5; Zhu HS, 2001, MOL VIS, V7, P210; Zhuang MH, 2000, MOL BRAIN RES, V82, P52, DOI 10.1016/S0169-328X(00)00177-7	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15599	10.1371/journal.pone.0015599	http://dx.doi.org/10.1371/journal.pone.0015599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187976	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200046
J	Sherwood, R; Pearson, J				Sherwood, Rachel; Pearson, Joel			Closing the Mind's Eye: Incoming Luminance Signals Disrupt Visual Imagery	PLOS ONE			English	Article							MENTAL-IMAGERY; WORKING-MEMORY; RETINOTOPIC ORGANIZATION; TERM-MEMORY; PERCEPTION; ATTENTION; VISION; BRAIN; PERFORMANCE; APPEARANCE	Mental imagery has been associated with many cognitive functions, both high and low-level. Despite recent scientific advances, the contextual and environmental conditions that most affect the mechanisms of visual imagery remain unclear. It has been previously shown that the greater the level of background luminance the weaker the effect of imagery on subsequent perception. However, in these experiments it was unclear whether the luminance was affecting imagery generation or storage of a memory trace. Here, we report that background luminance can attenuate both mental imagery generation and imagery storage during an unrelated cognitive task. However, imagery generation was more sensitive to the degree of luminance. In addition, we show that these findings were not due to differential dark adaptation. These results suggest that afferent visual signals can interfere with both the formation and priming-memory effects associated with visual imagery. It follows that background luminance may be a valuable tool for investigating imagery and its role in various cognitive and sensory processes.	[Sherwood, Rachel; Pearson, Joel] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Sherwood, R (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	Joel@pearsonlab.org		Pearson, Joel/0000-0003-3704-5037	The University of New South Wales; National Health and Medical Research Council (Australia) [457146]	The University of New South Wales; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by The University of New South Wales and a National Health and Medical Research Council (Australia) CJ Martin Fellowship 457146 to J.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERBACH E, 1961, AT&T TECH J, V40, P309, DOI 10.1002/j.1538-7305.1961.tb03987.x; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley AD, 2000, J EXP PSYCHOL GEN, V129, P126, DOI 10.1037//0096-3445.129.1.126; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Dean GM, 2008, EXP PSYCHOL, V55, P283, DOI 10.1027/1618-3169.55.4.283; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Ganis G., 2006, CASE MENTAL IMAGERY; Hecht S, 1937, J GEN PHYSIOL, V20, P831, DOI 10.1085/jgp.20.6.831; HEUER F, 1986, CAN J PSYCHOL, V40, P161, DOI 10.1037/h0080090; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Klein I, 2004, COGNITIVE BRAIN RES, V22, P26, DOI 10.1016/j.cogbrainres.2004.07.006; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; Pearson J, 2008, CURR BIOL, V18, P982, DOI 10.1016/j.cub.2008.05.048; Pelli D. G., 1997, SPATIAL VISION, V10; Perky CW, 1910, AM J PSYCHOL, V21, P422, DOI 10.2307/1413350; Pylyshyn Z, 2003, TRENDS COGN SCI, V7, P113, DOI 10.1016/S1364-6613(03)00003-2; PYLYSHYN ZW, 1973, PSYCHOL BULL, V80, P1, DOI 10.1037/h0034650; REISBERG D, 1987, CAN J PSYCHOL, V41, P521, DOI 10.1037/h0084167; Sack AT, 2005, SCIENCE, V308, P702, DOI 10.1126/science.1107784; Sacks O., 2003, NEW YORKER, V79, P48; Serruya G, 2009, J CLIN PSYCHOL, V65, P791, DOI 10.1002/jclp.20616; Slotnick SD, 2008, CURR BIOL, V18, pR603, DOI 10.1016/j.cub.2008.06.002; Slotnick SD, 2005, CEREB CORTEX, V15, P1570, DOI 10.1093/cercor/bhi035; Smyth MM, 1998, APPL COGNITIVE PSYCH, V12, P145, DOI 10.1002/(SICI)1099-0720(199804)12:2<145::AID-ACP505>3.0.CO;2-Z; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Tanaka Y, 1998, P NATL ACAD SCI USA, V95, P12729, DOI 10.1073/pnas.95.21.12729; Tartaglia EM, 2009, CURR BIOL, V19, P2081, DOI 10.1016/j.cub.2009.10.060; Wais PE, 2010, J NEUROSCI, V30, P8541, DOI 10.1523/JNEUROSCI.1478-10.2010; WOOLFOLK RL, 1985, COGNITIVE THER RES, V9, P335, DOI 10.1007/BF01183852	38	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15217	10.1371/journal.pone.0015217	http://dx.doi.org/10.1371/journal.pone.0015217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698EM	21187952	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200023
J	van der Velden, WJFM; Herbers, AHE; Feuth, T; Schaap, NPM; Donnelly, JP; Blijlevens, NMA				van der Velden, Walter J. F. M.; Herbers, Alexandra H. E.; Feuth, Ton; Schaap, Nicolaas P. M.; Donnelly, J. Peter; Blijlevens, Nicole M. A.			Intestinal Damage Determines the Inflammatory Response and Early Complications in Patients Receiving Conditioning for a Stem Cell Transplantation	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; MUCOSAL BARRIER INJURY; C-REACTIVE PROTEIN; MYELOABLATIVE THERAPY; VIRIDANS STREPTOCOCCI; CONSENSUS CONFERENCE; NEUTROPENIC PATIENTS; CANCER; BACTEREMIA	Background: Stem cell transplantation (SCT) is still complicated by the occurrence of fever and inflammatory complications attributed to neutropenia and subsequent infectious complications. The role of mucosal barrier injury (MBI) of the intestinal tract therein has received little attention. Methods: We performed a retrospective analysis in 163 SCT recipients of which data had been collected prospectively on intestinal damage (citrulline), inflammation (C-reactive protein), and neutrophil count. Six different conditioning regimens were studied; 5 myeloablative (MA) and 1 non-myeloablative (NMA). Linear mixed model multivariate and AUC analyses were used to define the role of intestinal damage in post-SCT inflammation. We also studied the relationship between the degree of intestinal damage and the occurrence of early post-SCT complications. Results: In the 5 MA regimen there was a striking pattern of inflammatory response that coincided with the occurrence of severe intestinal damage. This contrasted with a modest inflammatory response seen in the NMA regimen in which intestinal damage was limited. With linear mixed model analysis the degree of intestinal damage was shown the most important determinant of the inflammatory response, and both neutropenia and bacteremia had only a minor impact. AUC analysis revealed a strong correlation between citrulline and CRP (Pearson correlation r = 0.96). Intestinal damage was associated with the occurrence of bacteremia and acute lung injury, and influenced the kinetics of acute graft-versus-host disease. Conclusion: The degree of intestinal damage after myeloablative conditioning appeared to be the most important determined the inflammatory response following SCT, and was associated with inflammatory complications. Studies should explore ways to ameliorate cytotoxic therapy-induced intestinal damage in order to reduce complications associated with myeloablative conditioning therapy.	[van der Velden, Walter J. F. M.; Herbers, Alexandra H. E.; Schaap, Nicolaas P. M.; Donnelly, J. Peter; Blijlevens, Nicole M. A.] Radboud Univ Nijmegen, Dept Hematol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Feuth, Ton] Radboud Univ Nijmegen, Dept Epidemiol Biostat & Hlth Technol Assessment, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van der Velden, WJFM (corresponding author), Radboud Univ Nijmegen, Dept Hematol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	w.vandervelden@hemat.umcn.nl	Donnelly, J Peter/AAC-1041-2019; Schaap, Nicolaas/L-4625-2015; van der Velden, Walter/D-2216-2016; Blijlevens, N.M.A./H-8012-2014	Donnelly, J Peter/0000-0002-8521-335X; Schaap, Nicolaas/0000-0001-7696-4752; 				Abraham E, 2000, CRIT CARE MED, V28, P232, DOI 10.1097/00003246-200001000-00039; Andersen J, 2006, BONE MARROW TRANSPL, V37, P635, DOI 10.1038/sj.bmt.1705295; Bachanova V, 2009, BONE MARROW TRANSPL, V43, P237, DOI 10.1038/bmt.2008.313; Blijlevens NMA, 2005, BONE MARROW TRANSPL, V36, P703, DOI 10.1038/sj.bmt.1705118; Blijlevens NMA, 2005, BONE MARROW TRANSPL, V35, P707, DOI 10.1038/sj.bmt.1704863; Blijlevens NMA, 2004, BONE MARROW TRANSPL, V34, P193, DOI 10.1038/sj.bmt.1704563; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; Chakraverty R, 2006, J EXP MED, V203, P2021, DOI 10.1084/jem.20060376; Choi SW, 2008, BLOOD, V112, P1539, DOI 10.1182/blood-2008-02-138867; Cooke KR, 2000, J IMMUNOL, V165, P6612, DOI 10.4049/jimmunol.165.11.6612; Costa SF, 2006, AM J INFECT CONTROL, V34, P36, DOI 10.1016/j.ajic.2005.10.007; Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; DEPAUW BE, 1994, ANN INTERN MED, V120, P834, DOI 10.7326/0003-4819-120-10-199405150-00004; Diaconescu R, 2004, BLOOD, V104, P1550, DOI 10.1182/blood-2004-03-0804; DONNELLY JP, 1993, SCAND J INFECT DIS, V25, P43, DOI 10.1080/00365549309169668; ELTING LS, 1992, CLIN INFECT DIS, V14, P1201, DOI 10.1093/clinids/14.6.1201; Fassas ABT, 2005, LEUKEMIA LYMPHOMA, V46, P1159, DOI 10.1080/10428190500086121; Gorak E, 2005, BIOL BLOOD MARROW TR, V11, P542, DOI 10.1016/j.bbmt.2005.04.009; GUIOT HFL, 1990, INFECTION, V18, P131, DOI 10.1007/BF01642100; Herbers AH, 2010, ANN ONCOL, V21, P1706, DOI 10.1093/annonc/mdp596; Herbers AHE, 2008, BONE MARROW TRANSPL, V42, P345, DOI 10.1038/bmt.2008.170; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Johansson JE, 1997, BONE MARROW TRANSPL, V19, P921, DOI 10.1038/sj.bmt.1700765; Kim SY, 2008, AM J HEMATOL, V83, P784, DOI 10.1002/ajh.21227; Logan RM, 2007, CANCER TREAT REV, V33, P448, DOI 10.1016/j.ctrv.2007.03.001; Marron A, 2000, CLIN INFECT DIS, V31, P1126, DOI 10.1086/317460; Ong ZY, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-22; PIZZO PA, 1990, J INFECT DIS, V161, P397, DOI 10.1093/infdis/161.3.397; POUTSIAKA DD, 2010, BONE MARROW IN PRESS; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Ruescher TJ, 1998, CANCER-AM CANCER SOC, V82, P2275, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q; Schots R, 2003, LEUKEMIA, V17, P1150, DOI 10.1038/sj.leu.2402946; Schots R, 2002, BONE MARROW TRANSPL, V30, P441, DOI 10.1038/sj.bmt.1703672; Takatsuka H, 2000, BONE MARROW TRANSPL, V26, P419, DOI 10.1038/sj.bmt.1702517; Tsuji E, 2003, INT J CANCER, V107, P303, DOI 10.1002/ijc.11196; Turner BE, 2008, TRANSPLANTATION, V86, P968, DOI 10.1097/TP.0b013e3181874787; van der Velden WJFM, 2009, BONE MARROW TRANSPL, V43, P55, DOI 10.1038/bmt.2008.270	38	72	75	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15156	10.1371/journal.pone.0015156	http://dx.doi.org/10.1371/journal.pone.0015156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188146	Green Published, Green Submitted, gold			2022-12-25	WOS:000285575200017
J	Eldh, M; Ekstrom, K; Valadi, H; Sjostrand, M; Olsson, B; Jernas, M; Lotvall, J				Eldh, Maria; Ekstrom, Karin; Valadi, Hadi; Sjostrand, Margareta; Olsson, Bob; Jernas, Margareta; Lotvall, Jan			Exosomes Communicate Protective Messages during Oxidative Stress; Possible Role of Exosomal Shuttle RNA	PLOS ONE			English	Article							PC12 CELL TOLERANCE; COMPLEX CLASS-II; HYDROGEN-PEROXIDE; TRANSFERRIN RECEPTOR; PROTEIN OXIDATION; BIOGENESIS; APOPTOSIS; VESICLES; EXTERNALIZATION; ACCUMULATION	Background: Exosomes are small extracellular nanovesicles of endocytic origin that mediate different signals between cells, by surface interactions and by shuttling functional RNA from one cell to another. Exosomes are released by many cells including mast cells, dendritic cells, macrophages, epithelial cells and tumour cells. Exosomes differ compared to their donor cells, not only in size, but also in their RNA, protein and lipid composition. Methodology/Principal Findings: In this study, we show that exosomes, released by mouse mast cells exposed to oxidative stress, differ in their mRNA content. Also, we show that these exosomes can influence the response of other cells to oxidative stress by providing recipient cells with a resistance against oxidative stress, observed as an attenuated loss of cell viability. Furthermore, Affymetrix microarray analysis revealed that the exosomal mRNA content not only differs between exosomes and donor cells, but also between exosomes derived from cells grown under different conditions; oxidative stress and normal conditions. Finally, we also show that exposure to UV-light affects the biological functions associated with exosomes released under oxidative stress. Conclusions/Significance: These results argue that the exosomal shuttle of RNA is involved in cell-to-cell communication, by influencing the response of recipient cells to an external stress stimulus.	[Eldh, Maria; Ekstrom, Karin; Sjostrand, Margareta; Lotvall, Jan] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Krefting Res Ctr, Gothenburg, Sweden; [Valadi, Hadi] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Eldh, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med, Krefting Res Ctr, Gothenburg, Sweden.	jan.lotvall@gu.se	Eldh, Maria/AFO-1744-2022; Valadi, Hadi/ABH-9766-2020; Ekström, Karin/M-7501-2013	Valadi, Hadi/0000-0003-3482-2451; Ekström, Karin/0000-0001-7808-4572; Olsson, Bob/0000-0002-6368-6172; Eldh, Maria/0000-0003-2173-1796; Lotvall, Jan/0000-0001-9195-9249	Swedish Research Council; Herman Krefting Foundation against Asthma Allergy; VBG GROUP CENTRE for Asthma and Allergy Research at University of Gothenburg	Swedish Research Council(Swedish Research CouncilEuropean Commission); Herman Krefting Foundation against Asthma Allergy; VBG GROUP CENTRE for Asthma and Allergy Research at University of Gothenburg	This study was funded by the Swedish Research Council, Herman Krefting Foundation against Asthma Allergy, and the VBG GROUP CENTRE for Asthma and Allergy Research at University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2003, EUR RESPIR J, V22, P578, DOI 10.1183/09031936.03.00041703; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Admyre C, 2006, EUR J IMMUNOL, V36, P1772, DOI 10.1002/eji.200535615; Alonso-Fernandez A, 2009, THORAX, V64, P581, DOI 10.1136/thx.2008.100537; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen ZH, 2005, NEUROSCI LETT, V383, P256, DOI 10.1016/j.neulet.2005.04.022; Clayton A, 2005, BLOOD CELL MOL DIS, V34, P206, DOI 10.1016/j.bcmd.2005.03.003; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Fatokun AA, 2006, BONE, V39, P542, DOI 10.1016/j.bone.2006.02.062; GREENBERG JR, 1979, NUCLEIC ACIDS RES, V6, P715, DOI 10.1093/nar/6.2.715; Hernebring M, 2006, P NATL ACAD SCI USA, V103, P7700, DOI 10.1073/pnas.0510944103; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Nadeem A, 2003, J ALLERGY CLIN IMMUN, V111, P72, DOI 10.1067/mai.2003.17; Omata Y, 2008, FREE RADICAL BIO MED, V45, P1437, DOI 10.1016/j.freeradbiomed.2008.08.018; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Palomba L, 1999, BIOCHEM PHARMACOL, V58, P1743, DOI 10.1016/S0006-2952(99)00271-3; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; PONTA H, 1979, MOL GEN GENET, V175, P13, DOI 10.1007/BF00267850; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; SETLOW JK, 1964, BIOCHIM BIOPHYS ACTA, V87, P664, DOI 10.1016/0926-6550(64)90284-1; SPITZ DR, 1987, J CELL PHYSIOL, V131, P364, DOI 10.1002/jcp.1041310308; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; SZYPOWSKA A, 2010, ANTIOXID REDOX SIGNA; Takeda M, 1999, NEPHRON, V81, P234, DOI 10.1159/000045282; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; TIAN T, 2010, J CELL BIOCH; Tsukagoshi H, 2000, RESP MED, V94, P584, DOI 10.1053/rmed.2000.0785; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225; Wigginton KR, 2010, ENVIRON SCI TECHNOL, V44, P5437, DOI 10.1021/es100435a; Wijeratne SSK, 2005, J AGR FOOD CHEM, V53, P8768, DOI 10.1021/jf0512003; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wurtmann EJ, 2009, CRIT REV BIOCHEM MOL, V44, P34, DOI [10.1080/10409230802594043, 10.1080/10409230802594043 ]; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	51	318	339	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15353	10.1371/journal.pone.0015353	http://dx.doi.org/10.1371/journal.pone.0015353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179422	Green Published, Green Submitted, gold			2022-12-25	WOS:000285572900019
J	Er, F; Ederer, S; Nia, AM; Caglayan, E; Dahlem, KM; Semmo, N; Gassanov, N				Er, Fikret; Ederer, Stefan; Nia, Amir M.; Caglayan, Evren; Dahlem, Kristina M.; Semmo, Nasser; Gassanov, Natig			Accuracy of Doppler-Echocardiographic Mean Pulmonary Artery Pressure for Diagnosis of Pulmonary Hypertension	PLOS ONE			English	Article							INFERIOR VENA-CAVA; RIGHT HEART; AMERICAN-SOCIETY; EUROPEAN-ASSOCIATION; STANDARDS COMMITTEE; TASK-FORCE; GUIDELINES; RECOMMENDATIONS; QUANTIFICATION; CATHETERIZATION	Background: The validity of Doppler echocardiographic (DE) measurement of systolic pulmonary artery pressure (sPAP) has been questioned. Recent studies suggest that mean pulmonary artery pressure (mPAP) might reflect more accurately the invasive pressures. Methodology/Principal Findings: 241 patients were prospectively studied to evaluate the diagnostic accuracy of mPAP for the diagnosis of PH. Right heart catheterization (RHC) and DE were performed in 164 patients mainly for preoperative evaluation of heart valve dysfunction. The correlation between DE and RHC was better when mPAP (r = 0.93) and not sPAP (r = 0.81) was assessed. Bland-Altman analysis revealed a smaller variation of mPAP than sPAP. The following ROC analysis identified that a mPAP >= 25.5 mmHg is useful for the diagnosis of PH. This value was validated in an independent cohort of patients (n = 50) with the suspicion of chronic-thromboembolic pulmonary hypertension. The calculated diagnostic accuracy was 98%, based on excellent sensitivity of 98% and specificity of 100%. The corresponding positive and negative predictive values were 100%, respectively 88%. Conclusion: mPAP has been found to be highly accurate for the initial diagnosis of PH. A cut-off value of 25.5 mmHg might be helpful to avoid unnecessary RHC and select patients in whom RHC might be beneficial.	[Er, Fikret; Ederer, Stefan; Nia, Amir M.; Caglayan, Evren; Dahlem, Kristina M.; Gassanov, Natig] Univ Cologne, Dept Internal Med 3, Cologne, Germany; [Semmo, Nasser] Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany	University of Cologne; University of Freiburg	Er, F (corresponding author), Univ Cologne, Dept Internal Med 3, Cologne, Germany.	Fikret.Er@uk-koeln.de	Caglayan, Evren/ABB-8674-2020					Abbas AE, 2003, AM J CARDIOL, V92, P1373, DOI 10.1016/j.amjcard.2003.08.037; Aduen JF, 2009, J AM SOC ECHOCARDIOG, V22, P814, DOI 10.1016/j.echo.2009.04.007; ADUEN JF, 2010, CHEST; Arcasoy SM, 2003, AM J RESP CRIT CARE, V167, P735, DOI 10.1164/rccm.200210-1130OC; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Arora H, 2008, TEX HEART I J, V35, P38; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; BERGER M, 1985, J AM COLL CARDIOL, V6, P359, DOI 10.1016/S0735-1097(85)80172-8; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Brennan JM, 2007, J AM SOC ECHOCARDIOG, V20, P857, DOI 10.1016/j.echo.2007.01.005; Chemla D, 2004, CHEST, V126, P1313, DOI 10.1378/chest.126.4.1313; Chemla D, 2009, CHEST, V135, P760, DOI 10.1378/chest.08-0904; CURRIE PJ, 1985, J AM COLL CARDIOL, V6, P750, DOI 10.1016/S0735-1097(85)80477-0; D'Cruz IA, 1998, ECHOCARDIOGR-J CARD, V15, P759, DOI 10.1111/j.1540-8175.1998.tb00677.x; Fisher MR, 2007, EUR RESPIR J, V30, P914, DOI 10.1183/09031936.00033007; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Lai WW, 2008, INT J CARDIOVAS IMAG, V24, P691, DOI 10.1007/s10554-008-9314-4; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lindqvist P, 2008, EUR J ECHOCARDIOGR, V9, P225, DOI 10.1016/j.euje.2007.04.002; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; MORENO FL, 1984, AM J CARDIOL, V53, P579, DOI 10.1016/0002-9149(84)90034-1; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Swanson KL, 2008, MED SCI MONITOR, V14, pCR177; Syyed R, 2008, CHEST, V133, P633, DOI 10.1378/chest.07-1367; Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107; Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709	31	17	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15670	10.1371/journal.pone.0015670	http://dx.doi.org/10.1371/journal.pone.0015670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179417	Green Published, gold, Green Submitted			2022-12-25	WOS:000285572900025
J	Tone, SO; Dayanandan, B; Fournier, AE; Mandato, CA				Tone, Stephan Ong; Dayanandan, Bama; Fournier, Alyson E.; Mandato, Craig A.			GSK3 Regulates Mitotic Chromosomal Alignment through CRMP4	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; RESPONSE MEDIATOR PROTEINS; AXON OUTGROWTH INHIBITION; BI-ORIENTATION; MICROTUBULE DYNAMICS; SPINDLE ATTACHMENTS; CELL-DIVISION; GROWTH CONES; AURORA-A; PHOSPHORYLATION	Background: Glycogen Synthase Kinase 3 (GSK3) has been implicated in regulating chromosomal alignment and mitotic progression but the physiological substrates mediating these GSK3-dependent effects have not been identified. Collapsin Response Mediator Protein 4 (CRMP4) is a cytosolic phosphoprotein known to regulate cytoskeletal dynamics and is a known physiological substrate of GSK3. In this study, we investigate the role of CRMP4 during mitosis. Methodology and Principal Findings: Here we demonstrate that during mitosis CRMP4 phosphorylation is regulated in a GSK3-dependent manner. We show that CRMP4 localizes to spindle microtubules during mitosis and loss of CRMP4 disrupts chromosomal alignment and mitotic progression. The effect of CRMP4 on chromosomal alignment is dependent on phosphorylation by GSK3 identifying CRMP4 as a critical GSK3 substrate during mitotic progression. We also provide mechanistic data demonstrating that CRMP4 regulates spindle microtubules consistent with its known role in the regulation of the microtubule cytoskeleton. Conclusion and Significance: Our findings identify CRMP4 as a key physiological substrate of GSK3 in regulating chromosomal alignment and mitotic progression through its effect on spindle microtubules.	[Tone, Stephan Ong; Fournier, Alyson E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Dayanandan, Bama; Mandato, Craig A.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	McGill University; McGill University	Tone, SO (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	alyson.fournier@mcgill.ca; craig.mandato@mcgill.ca			Canadian Institutes of Health Research (CIHR) [MOPS68970, MOP64332]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR). C.A.M. is supported by a CIHR grant MOPS68970 and A.E.F. is supported by a CIHR grant MOP64332. S.O.T. is supported by a fellowship from CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Alabed YZ, 2007, J NEUROSCI, V27, P1702, DOI 10.1523/JNEUROSCI.5055-06.2007; Alabed YZ, 2010, J NEUROSCI, V30, P5635, DOI 10.1523/JNEUROSCI.6154-09.2010; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Byk T, 1998, EUR J BIOCHEM, V254, P14, DOI 10.1046/j.1432-1327.1998.2540014.x; Byk T, 1996, J NEUROSCI, V16, P688; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Decordier I, 2008, MUTAT RES-GEN TOX EN, V651, P30, DOI 10.1016/j.mrgentox.2007.10.016; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fumoto K, 2008, ONCOGENE, V27, P4478, DOI 10.1038/onc.2008.92; Gaetano C, 1997, J BIOL CHEM, V272, P12195, DOI 10.1074/jbc.272.18.12195; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Goold RG, 1999, J CELL SCI, V112, P3373; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Inatome R, 2000, J BIOL CHEM, V275, P27291; Jeffery JM, 2010, ONCOGENE, V29, P2649, DOI 10.1038/onc.2010.37; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; MINTURN JE, 1995, J COMP NEUROL, V355, P369, DOI 10.1002/cne.903550304; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; PAN S, 2009, LUNG CANC; PIZARRO JG, 2008, J CELL MOL MED; Quach TT, 2004, MOL CELL NEUROSCI, V25, P433, DOI 10.1016/j.mcn.2003.11.006; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.0.CO;2-0; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wang JZ, 1998, FEBS LETT, V436, P28, DOI 10.1016/S0014-5793(98)01090-4; Wang LH, 1996, J NEUROSCI, V16, P6197; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; YOSHIMURA T, 2005, RAS REGULATES NEURON, P7; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	53	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14345	10.1371/journal.pone.0014345	http://dx.doi.org/10.1371/journal.pone.0014345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179545	Green Published, Green Submitted, gold			2022-12-25	WOS:000285340000014
J	Gazave, E; Lapebie, P; Renard, E; Vacelet, J; Rocher, C; Ereskovsky, AV; Lavrov, DV; Borchiellini, C				Gazave, Eve; Lapebie, Pascal; Renard, Emmanuelle; Vacelet, Jean; Rocher, Caroline; Ereskovsky, Alexander V.; Lavrov, Dennis V.; Borchiellini, Carole			Molecular Phylogeny Restores the Supra-Generic Subdivision of Homoscleromorph Sponges (Porifera, Homoscleromorpha)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SECONDARY STRUCTURE; CALCAREOUS SPONGES; DEMOSPONGIAE; MITOCHONDRIAL; PROTEIN; MODEL; DNA; EVOLUTIONARY; SUBSTITUTION	Background: Homoscleromorpha is the fourth major sponge lineage, recently recognized to be distinct from the Demospongiae. It contains <100 described species of exclusively marine sponges that have been traditionally subdivided into 7 genera based on morphological characters. Because some of the morphological features of the homoscleromorphs are shared with eumetazoans and are absent in other sponges, the phylogenetic position of the group has been investigated in several recent studies. However, the phylogenetic relationships within the group remain unexplored by modern methods. Methodology/Principal Findings: Here we describe the first molecular phylogeny of Homoscleromorpha based on nuclear ( 18S and 28S rDNA) and complete mitochondrial DNA sequence data that focuses on inter-generic relationships. Our results revealed two robust clades within this group, one containing the spiculate species ( genera Plakina, Plakortis, Plakinastrella and Corticium) and the other containing aspiculate species ( genera Oscarella and Pseudocorticium), thus rejecting a close relationship between Pseudocorticium and Corticium. Among the spiculate species, we found affinities between the Plakortis and Plakinastrella genera, and between the Plakina and Corticium. The validity of these clades is furthermore supported by specific morphological characters, notably the type of spicules. Furthermore, the monophyly of the Corticium genus is supported while the monophyly of Plakina is not. Conclusions/Significance: As the result of our study we propose to restore the pre-1995 subdivision of Homoscleromorpha into two families: Plakinidae Schulze, 1880 for spiculate species and Oscarellidae Lendenfeld, 1887 for aspiculate species that had been rejected after the description of the genus Pseudocorticium. We also note that the two families of homoscleromorphs exhibit evolutionary stable, but have drastically distinct mitochondrial genome organizations that differ in gene content and gene order.	[Gazave, Eve; Lapebie, Pascal; Renard, Emmanuelle; Vacelet, Jean; Rocher, Caroline; Ereskovsky, Alexander V.; Borchiellini, Carole] Aix Marseille Univ, Ctr Oceanol Marseille, Marine Endoume Stn, CNRS,DIMAR,UMR 6540, Marseilles, France; [Ereskovsky, Alexander V.] St Petersburg State Univ, Dept Embryol, Fac Biol & Soils, St Petersburg, Russia; [Lavrov, Dennis V.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Saint Petersburg State University; Iowa State University	Gazave, E (corresponding author), Aix Marseille Univ, Ctr Oceanol Marseille, Marine Endoume Stn, CNRS,DIMAR,UMR 6540, Marseilles, France.	carole.borchiellini@univmed.fr	Gazave, Eve/F-2665-2010; Lavrov, Dennis/V-3699-2019; Ereskovsky, Alexander/B-3136-2013; Ereskovsky, Alexander/W-1504-2019	Lavrov, Dennis/0000-0002-2745-1704; Ereskovsky, Alexander/0000-0003-1079-7204; Lapebie, Pascal/0000-0003-4073-0633; Gazave, Eve/0000-0002-4647-6640	Centre National de Recherche Scientifique, Universite de la Mediterranee; National Science foundation [DEB-0828783]; Iowa State University; Russian Foundation of Basic Research [N 09-04-00337]; European Marie Curie Mobility program [MIF1-CT-2006-040065]	Centre National de Recherche Scientifique, Universite de la Mediterranee; National Science foundation(National Science Foundation (NSF)); Iowa State University; Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); European Marie Curie Mobility program(European Commission)	This work was supported by the Centre National de Recherche Scientifique, Universite de la Mediterranee, a DEB-0828783 grant from the National Science foundation, a foreign travel grant from Iowa State University, the program Russian Foundation of Basic Research N 09-04-00337 and European Marie Curie Mobility program (fellowship of A. Ereskovsky, MIF1-CT-2006-040065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Borchiellini C, 2001, J EVOLUTION BIOL, V14, P171, DOI 10.1046/j.1420-9101.2001.00244.x; Boury-Esnault N, 2003, INVERTEBR BIOL, V122, P187, DOI 10.1111/j.1744-7410.2003.tb00084.x; BOURYESNAULT N, 1995, OPHELIA, V43, P25, DOI 10.1080/00785326.1995.10430575; Bowerbank J.S., 1864, MONOGRAPH BRIT SPONG, V1; Burger G, 2007, NAT PROTOC, V2, P603, DOI 10.1038/nprot.2007.59; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CAVA AMS, 1992, MAR BIOL, V113, P299; DENDY A, 1905, REPORT SPONGES COLLE; DIAZ MC, 1994, P 4 INT POR C U AMST, P93; DIXON MT, 1993, MOL BIOL EVOL, V10, P256; Dohrmann M, 2008, SYST BIOL, V57, P388, DOI 10.1080/10635150802161088; Dohrmann M, 2006, MOL PHYLOGENET EVOL, V40, P830, DOI 10.1016/j.ympev.2006.04.016; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ereskovsky AV, 2009, BIOESSAYS, V31, P89, DOI 10.1002/bies.080058; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1571, DOI 10.1017/S0025315407058201; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gazave E, 2008, DEV GENES EVOL, V218, P479, DOI 10.1007/s00427-008-0242-z; Gazave E, 2010, MOL PHYLOGENET EVOL, V57, P35, DOI 10.1016/j.ympev.2010.05.028; Grothe F., 1989, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V106, P155; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall B.G., 2004, PHYLOGENETIC TREES M; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Hooper J.N.A., 2002, SYSTEMA PORIFERA GUI; Hudelot C, 2003, MOL PHYLOGENET EVOL, V28, P241, DOI 10.1016/S1055-7903(03)00061-7; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kornprobst JM, 2005, SUBSTANCES NATURELLE, V2, P246; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lapebie P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005823; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lavrov DV, 2008, MOL PHYLOGENET EVOL, V49, P111, DOI 10.1016/j.ympev.2008.05.014; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; LENDENFELD RV, 1886, P ZOOL SOC LOND, P558; Levi C., 1956, Archives de Zoologie Experimentale et Generale, V93, P1; Levi C., 1973, TRAITE ZOOLOGIE P GR, V3, P577; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Maldonado M, 1999, NATURE, V401, P785, DOI 10.1038/44560; Manuel M, 2003, SYST BIOL, V52, P311, DOI 10.1080/10635150390196966; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Morell V, 1996, SCIENCE, V273, P569, DOI 10.1126/science.273.5275.569; Muricy G, 1998, ZOOL J LINN SOC-LOND, V124, P169, DOI 10.1111/j.1096-3642.1998.tb00572.x; Muricy G, 1996, MAR ECOL PROG SER, V138, P181, DOI 10.3354/meps138181; Muricy G., 2002, SYSTEMA PORIFERA GUI, P71, DOI [10.1007/978-1-4615-0747-5_6, DOI 10.1007/978-1-4615-0747-5_6]; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Pearson W R, 1994, Methods Mol Biol, V25, P365; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reid R. E. H., 1970, Symp. zool. Soc. Lond., VNo. 25, P63; Sanderson Michael J., 1994, American Journal of Botany, V81, P183; Schmidt O., 1862, SPONGIEN ADRIATISCHE; Schmidt O., 1870, GRUNDZUGE SPONGIEN F; Schulze F.E., 1880, Z WISSENSCHAFTLICHE, V34, P407; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sollas WJ, 1885, ANN MAG NAT HIST, V16, DOI [10.1080/00222938509459901, DOI 10.1080/00222938509459901]; SPERLING EA, 2007, PORIFERAN PARAPHYLY, P355; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tillier ERM, 1998, GENETICS, V148, P1993; Topsent E., 1897, REV SUISSE ZOOL, V4, P421, DOI DOI 10.5962/BHL.PART.35507; Uriz MJ, 2006, CAN J ZOOL, V84, P322, DOI 10.1139/Z06-032; Uriz MJ, 2003, MICROSC RES TECHNIQ, V62, P279, DOI 10.1002/jemt.10395; VANSOEST RWM, 1984, BIJDR DIERKD, V54, P211, DOI 10.1163/26660644-05402007; VANSOEST RWM, 2008, WORLD PORIFERA DATAB; Vosmaer G.C.J., 1884, MITTEILUNGEN ZOOLOGI, V5, P483; Wang XJ, 2007, MOL BIOL EVOL, V24, P363, DOI 10.1093/molbev/msl167; Wang XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002723; WHEELER WC, 1988, MOL BIOL EVOL, V5, P90; WIEDENMAYER F, 1994, ABH, V116, P1; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	90	72	74	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14290	10.1371/journal.pone.0014290	http://dx.doi.org/10.1371/journal.pone.0014290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179486	Green Published, Green Submitted, gold			2022-12-25	WOS:000285292500001
J	Ravache, M; Weber, C; Merienne, K; Trottier, Y				Ravache, Myriam; Weber, Chantal; Merienne, Karine; Trottier, Yvon			Transcriptional Activation of REST by Sp1 in Huntington's Disease Models	PLOS ONE			English	Article							RESTRICTIVE SILENCER FACTOR; GENE-EXPRESSION CHANGES; NF-KAPPA-B; TRANSGENIC MICE; MOUSE MODEL; NEURONAL DIFFERENTIATION; BINDING-SITE; TARGET GENES; IN-VIVO; POLYGLUTAMINE	In Huntington's disease (HD), mutant huntingtin (mHtt) disrupts the normal transcriptional program of disease neurons by altering the function of several gene expression regulators such as Sp1. REST (Repressor Element-1 Silencing Transcription Factor), a key regulator of neuronal differentiation, is also aberrantly activated in HD by a mechanism that remains unclear. Here, we show that the level of REST mRNA is increased in HD mice and in NG108 cells differentiated into neuronal-like cells and expressing a toxic mHtt fragment. Using luciferase reporter gene assay, we delimited the REST promoter regions essential for mHtt-mediated REST upregulation and found that they contain Sp factor binding sites. We provide evidence that Sp1 and Sp3 bind REST promoter and interplay to fine-tune REST transcription. In undifferentiated NG108 cells, Sp1 and Sp3 have antagonistic effect, Sp1 acting as an activator and Sp3 as a repressor. Upon neuronal differentiation, we show that the amount and ratio of Sp1/Sp3 proteins decline, as does REST expression, and that the transcriptional role of Sp3 shifts toward a weak activator. Therefore, our results provide new molecular information to the transcriptional regulation of REST during neuronal differentiation. Importantly, specific knockdown of Sp1 abolishes REST upregulation in NG108 neuronal-like cells expressing mHtt. Our data together with earlier reports suggest that mHtt triggers a pathogenic cascade involving Sp1 activation, which leads to REST upregulation and repression of neuronal genes.	[Ravache, Myriam; Weber, Chantal; Merienne, Karine; Trottier, Yvon] Univ Strasbourg, CNRS, INSERM, IGBMC,U964,UMR 1704, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ravache, M (corresponding author), Univ Rennes 1, INSERM, UMR 991, Rennes, France.	Yvon.TROTTIER@igbmc.fr	Trottier, Yvon/H-8852-2016	Trottier, Yvon/0000-0001-7230-4810; Merienne, Karine/0000-0003-2549-2315	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Strasbourg (UdS); Federation pour la Recherche sur le Cerveau (FRC); Association Huntington France (AHF); Association pour la recherche sur le cancer (ARC)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg (UdS); Federation pour la Recherche sur le Cerveau (FRC); Association Huntington France (AHF); Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by funds from the Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Strasbourg (UdS); Federation pour la Recherche sur le Cerveau (FRC). M.R. was supported by a fellowship from Association Huntington France (AHF) and from Association pour la recherche sur le cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleymane G, 2006, HUM MOL GENET, V15, P691, DOI 10.1093/hmg/ddi483; Al-Sarraj A, 2005, J CELL BIOCHEM, V94, P153, DOI 10.1002/jcb.20305; Alpy F, 2003, ONCOGENE, V22, P3770, DOI 10.1038/sj.onc.1206500; Augood SJ, 1996, NEUROSCIENCE, V72, P1023, DOI 10.1016/0306-4522(95)00595-1; Augood SJ, 1997, ANN NEUROL, V42, P215, DOI 10.1002/ana.410420213; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Calderone A, 2003, J NEUROSCI, V23, P2112; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Chan EYW, 2002, HUM MOL GENET, V11, P1939, DOI 10.1093/hmg/11.17.1939; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Desplats PA, 2006, J NEUROCHEM, V96, P743, DOI 10.1111/j.1471-4159.2005.03588.x; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Feng ZH, 1999, MOL BRAIN RES, V69, P144, DOI 10.1016/S0169-328X(99)00099-6; Ferrante RJ, 2004, J NEUROSCI, V24, P10335, DOI 10.1523/JNEUROSCI.2599-04.2004; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Koenigsberger C, 2000, P NATL ACAD SCI USA, V97, P2291, DOI 10.1073/pnas.050578797; Kojima T, 2001, MOL BRAIN RES, V90, P174, DOI 10.1016/S0169-328X(01)00107-3; Lardenois A, 2006, NUCLEIC ACIDS RES, V34, pW578, DOI 10.1093/nar/gkl193; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Lietz M, 2003, EUR J BIOCHEM, V270, P2, DOI 10.1046/j.1432-1033.2003.03360.x; Lorincz MT, 2004, MOL CELL NEUROSCI, V26, P135, DOI 10.1016/j.mcn.2004.01.016; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Merienne K, 2003, J BIOL CHEM, V278, P16957, DOI 10.1074/jbc.M212049200; Merienne K, 2007, NEUROBIOL DIS, V25, P571, DOI 10.1016/j.nbd.2006.11.002; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Napolitano M, 2008, NEUROSCI LETT, V434, P241, DOI 10.1016/j.neulet.2007.09.056; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Palm K, 1998, J NEUROSCI, V18, P1280; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RICHFIELD EK, 1995, ANN NEUROL, V37, P335, DOI 10.1002/ana.410370309; Ryu H, 2003, J NEUROSCI, V23, P3597; Sadri-Vakili G, 2006, NAT CLIN PRACT NEURO, V2, P330, DOI 10.1038/ncpneuro0199; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Smith R, 2006, HUM MOL GENET, V15, P3119, DOI 10.1093/hmg/ddl252; Spencer EM, 2006, NEUROBIOL DIS, V24, P41, DOI 10.1016/j.nbd.2006.04.020; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Thomas EA, 2006, J NEUROSCI RES, V84, P1151, DOI 10.1002/jnr.21046; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Yefimova MG, 2010, NEUROBIOL DIS, V40, P311, DOI 10.1016/j.nbd.2010.06.005; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	61	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14311	10.1371/journal.pone.0014311	http://dx.doi.org/10.1371/journal.pone.0014311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179468	Green Submitted, gold, Green Published			2022-12-25	WOS:000285292500003
J	Pukelsheim, K; Stoeger, T; Kutschke, D; Ganguly, K; Wjst, M				Pukelsheim, Katrin; Stoeger, Tobias; Kutschke, David; Ganguly, Koustav; Wjst, Matthias			Cytokine Profiles in Asthma Families Depend on Age and Phenotype	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; COLONY-STIMULATING FACTOR; SERUM INTERFERON-GAMMA; T-CELLS; PROINFLAMMATORY CYTOKINES; LUNG-FUNCTION; INTERLEUKIN-8; INFLAMMATION; SEVERITY; CHILDREN	Background: Circulating cytokine patterns may be relevant for the diagnosis of asthma, for the discrimination of certain phenotypes, and prognostic factors for exacerbation of disease. Methodology/Principal Findings: In this study we investigated serum samples from 944 individuals of 218 asthma-affected families by a multiplex, microsphere based system detecting at high sensitivity eleven asthma associated mediators: eotaxin (CCL11), granulocyte macrophage stimulating factor (GM-CSF), interferon gamma (IFN gamma), interleukin-4 (IL-4), IL-5, IL-8, IL-10, IL-12 (p40), IL-13, IL-17 and tumor necrosis factor alpha (TNF alpha). Single cytokine levels were largely similar between asthmatic and healthy individuals when analysing asthma as single disease entity. Regulatory differences between parental and pediatric asthma were reflected by six of the eleven mediators analyzed (eotaxin, IL-4, IL-5, IL-10, IL-12, TNF alpha). IL-12 (p40) and IL-5 were the best predictor for extrinsic asthma in children with an increased odds ratio of 2.85 and 1.96 per log pg/ml increase (IL-12 (p40): 1.2-6.8, p = 0.019, and IL-5: 1.2-2.5, p = 0.025). Frequent asthma attacks in children are associated with elevated IL-5 serum levels (p = 0.013). Cytokine patterns seem to be individually balanced in both, healthy and diseased adults and children, with various cytokines correlating among each other (IL-17 and IFN gamma (r(s) = 0.67), IL-4 and IL-5 (r(s) = 0.55), IFN gamma and GM-CSF (r(s) = 0.54)). Conclusion/Significance: Our data support mainly an age-but also an asthma phenotype-dependent systemic immune regulation.	[Pukelsheim, Katrin; Stoeger, Tobias; Kutschke, David; Ganguly, Koustav; Wjst, Matthias] Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Munich, Germany; [Ganguly, Koustav] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pukelsheim, K (corresponding author), Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Munich, Germany.	m@wjst.de	Stöger, Tobias/M-9861-2014	Stöger, Tobias/0000-0002-2790-0389	BMBF [07ALE087]; Deutsche Forschungsgemeinschaft [DFG WI621/5-1, DFG FR1526/1]; National Genome Network [01GS0122]; HMGU (Helmholtz Center Munich, former GSF) [fA1/4r, FE 75051]; EU	BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Genome Network; HMGU (Helmholtz Center Munich, former GSF)(Helmholtz Association); EU(European Commission)	The asthma family study was funded by BMBF 07ALE087, Deutsche Forschungsgemeinschaft DFG WI621/5-1, DFG FR1526/1 and National Genome Network 01GS0122. K. P. and M. W. are funded by HMGU (Helmholtz Center Munich, former GSF (Gesellschaft fA1/4r Strahlenforschung) research center) FE 75051 and the EU Grant Europrevall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmuller Janine, 2005, BMC Pulm Med, V5, P1, DOI 10.1186/1471-2466-5-1; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; CORRIGAN CJ, 1990, AM REV RESPIR DIS, V141, P970, DOI 10.1164/ajrccm/141.4_Pt_1.; Dente FL, 2006, ANN ALLERG ASTHMA IM, V97, P312, DOI 10.1016/S1081-1206(10)60795-8; Friebe A, 2008, ARCH PATHOL LAB MED, V132, P1802, DOI 10.1043/1543-2165-132.11.1802; Halonen M, 2009, J IMMUNOL, V182, P3285, DOI 10.4049/jimmunol.0711996; Hollander C, 2007, RESP MED, V101, P1947, DOI 10.1016/j.rmed.2007.04.010; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; John M, 1998, AM J RESP CRIT CARE, V157, P256, DOI 10.1164/ajrccm.157.1.9703079; Krogulska A, 2009, J INVEST ALLERG CLIN, V19, P43; Kumar Rakesh K., 2006, Inflammation & Allergy Drug Targets, V5, P253, DOI 10.2174/187152806779010909; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Litonjua AA, 2003, ANN ALLERG ASTHMA IM, V90, P422, DOI 10.1016/S1081-1206(10)61827-3; Meyts I, 2006, J IMMUNOL, V177, P6460, DOI 10.4049/jimmunol.177.9.6460; Nakajima H, 2007, INT ARCH ALLERGY IMM, V142, P265, DOI 10.1159/000097357; Nakamura H, 1999, AM J RESP CRIT CARE, V160, P1952, DOI 10.1164/ajrccm.160.6.9811089; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Perez-Machado MA, 2004, ALLERGY, V59, P346, DOI 10.1046/j.1398-9995.2003.00328.x; Prokesova L, 2006, PEDIAT ALLERG IMM-UK, V17, P175, DOI 10.1111/j.1399-3038.2006.00395.x; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; SAHA SK, 2009, GRANULOCYTE MACROPHA; SAITO H, 1988, INT ARCH ALLER A IMM, V87, P286, DOI 10.1159/000234687; Shute JK, 1997, AM J RESP CRIT CARE, V155, P1877, DOI 10.1164/ajrccm.155.6.9196089; Silvestri M, 2006, CLIN EXP ALLERGY, V36, P1373, DOI 10.1111/j.1365-2222.2006.02502.x; Tateno H, 2004, RESP MED, V98, P782, DOI 10.1016/j.rmed.2004.01.005; ten Hacken NHT, 1998, EUR RESPIR J, V11, P312, DOI 10.1183/09031936.98.11020312; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Wjst M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-60; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Yamashita N, 2002, CELL IMMUNOL, V219, P92, DOI 10.1016/S0008-8749(02)00565-8	36	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14299	10.1371/journal.pone.0014299	http://dx.doi.org/10.1371/journal.pone.0014299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179211	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000285246900012
J	Justilien, V; Jameison, L; Der, CJ; Rossman, KL; Fields, AP				Justilien, Verline; Jameison, Lee; Der, Channing J.; Rossman, Kent L.; Fields, Alan P.			Oncogenic Activity of Ect2 Is Regulated through Protein Kinase C iota-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR; G2/M PHASE; CYTOKINESIS; ACTIVATION; TRANSFORMATION; DOMAINS; GTPASES; CANCER; LINKS; LUNG	The Rho GTPase guanine nucleotide exchange factor Ect2 is genetically and biochemically linked to the PKC iota oncogene in non-small cell lung cancer (NSCLC). Ect2 is overexpressed and mislocalized to the cytoplasm of NSCLC cells where it binds the oncogenic PKC iota-Par6 complex, leading to activation of the Rac1 small GTPase. Here, we identify a previously uncharacterized phosphorylation site on Ect2, threonine 328, that serves to regulate the oncogenic activity of Ect2 in NSCLC cells. PKC iota directly phosphorylates Ect2 at Thr-328 in vitro, and RNAi-mediated knockdown of either PKC iota or Par6 leads to a decrease in phospho-Thr-328 Ect2, indicating that PKC iota regulates Thr-328 Ect2 phosphorylation in NSCLC cells. Both wild-type Ect2 and a phosphomimetic T328D Ect2 mutant bind the PKC iota-Par6 complex, activate Rac1, and restore transformed growth and invasion when expressed in NSCLC cells made deficient in endogenous Ect2 by RNAi-mediated knockdown. In contrast, a phosphorylation-deficient T328A Ect2 mutant fails to bind the PKC iota-Par6 complex, activate Rac1, or restore transformation. Our data support a model in which PKC iota-mediated phosphorylation regulates Ect2 binding to the oncogenic PKC iota-Par6 complex thereby activating Rac1 activity and driving transformed growth and invasion.	[Justilien, Verline; Jameison, Lee; Fields, Alan P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA; [Der, Channing J.; Rossman, Kent L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA	Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill	Fields, AP (corresponding author), Mayo Clin, Coll Med, Dept Canc Biol, Griffin Canc Res Bldg,Rm 211,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	fields.alan@mayo.edu		Der, Channing/0000-0002-7751-2747	National Institutes of Health [R01 CA081436-13, R21 CA151250-01]; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA081436, R21CA151250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA081436-13 and R21 CA151250-01. This work was also supported by the V Foundation for Cancer Research (to A. P. F.).	Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Hara T, 2006, ONCOGENE, V25, P566, DOI 10.1038/sj.onc.1209078; Hirata D, 2009, CLIN CANCER RES, V15, P256, DOI 10.1158/1078-0432.CCR-08-1672; Jamieson L, 1999, J BIOL CHEM, V274, P3927, DOI 10.1074/jbc.274.7.3927; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kanada M, 2008, MOL BIOL CELL, V19, P8, DOI 10.1091/mbc.E07-04-0370; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Saito S, 2003, J CELL BIOCHEM, V90, P819, DOI 10.1002/jcb.10688; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sano M, 2006, ONCOL REP, V16, P1093; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Westwick JK, 1998, J BIOL CHEM, V273, P16739, DOI 10.1074/jbc.273.27.16739; Zhang J, 2004, J BIOL CHEM, V279, P22118, DOI 10.1074/jbc.M400774200	21	59	63	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8149	8157		10.1074/jbc.M110.196113	http://dx.doi.org/10.1074/jbc.M110.196113			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21189248	Green Published, hybrid			2022-12-25	WOS:000288013300045
J	Minard, LV; Williams, JS; Walker, AC; Schultz, MC				Minard, Laura V.; Williams, Jessica S.; Walker, Amelia C.; Schultz, Michael C.			Transcriptional Regulation by Asf1 NEW MECHANISTIC INSIGHTS FROM STUDIES OF THE DNA DAMAGE RESPONSE TO REPLICATION STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE CHAPERONE ASF1; SISTER-CHROMATID COHESION; H3 LYSINE-56 ACETYLATION; DEPOSITION PROTEIN ASF1; SACCHAROMYCES-CEREVISIAE; S-PHASE; CHECKPOINT PATHWAYS; REPLISOME INTEGRITY; STRUCTURAL BASIS; GENE DISRUPTION	Asf1 is a conserved histone H3/H4 chaperone. We find that Asf1 in budding yeast promotes an essential cellular response to replication stress caused by the ribonucleotide reductase inhibitor hydroxyurea. That is, Asf1 stimulates derepression of DNA damage response (DDR) genes during the S phase. Derepression of DDR genes strongly correlates with Asf1 binding to their promoters. Having identified the C terminus and histone-binding domains of Asf1 as molecular determinants of its constitutive and inducible association with chromatin, we tested whether Asf1 binding to DDR genes is mechanistically important for their derepression. Our results provide little support for this hypothesis. Rather, the contribution of Asf1 to DDR gene derepression depends on its ability to stimulate H3K56 acetylation by lysine acetyltransferase Rtt109. The precise regulation of H3K56 acetylation in the promoters of DDR genes is unexpected: DDR gene promoters are occupied by H3K56-acetylated nucleosomes under repressing conditions, and the steady state level of H3K56 promoter acetylation does not change upon derepression. We propose that replication-coupled deposition of Lys(56)-acetylated H3 poises the DDR genes in newly synthesized daughter duplexes for derepression during the S phase. In this model, the presence of a histone mark that destabilizes nucleosomes is compatible with suppression of transcription because in the uninduced state, DDR gene promoters are constitutively occupied by a potent repressor-corepressor complex.	[Minard, Laura V.; Williams, Jessica S.; Walker, Amelia C.; Schultz, Michael C.] Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada	University of Alberta	Schultz, MC (corresponding author), Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada.	michael.schultz@ualberta.ca			Canadian Institutes for Health Research; Alberta Heritage Foundation for Medical Research; Government of Alberta; Natural Science and Engineering Research Council of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Government of Alberta; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants (to M. C. S.) from the Canadian Institutes for Health Research and the Alberta Heritage Foundation for Medical Research.; Supported by a Queen Elizabeth II Scholarship from the Government of Alberta, a Master's Award from the Canadian Institutes for Health Research, and a scholarship from the Natural Science and Engineering Research Council of Canada.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; APARICIO O, 2004, CURRENT PROTOCOLS CE; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Basrai MA, 1999, MOL CELL BIOL, V19, P7041; Biddick R, 2009, YEAST, V26, P205, DOI 10.1002/yea.1660; Brachmann CB, 1998, YEAST, V14, P115; Celic I, 2008, GENETICS, V179, P1769, DOI 10.1534/genetics.108.088914; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/j.cub.2003.11.027; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dubacq C, 2006, MOL GENET GENOMICS, V275, P114, DOI 10.1007/s00438-005-0077-5; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Franco AA, 2005, GENE DEV, V19, P1365, DOI 10.1101/gad.1305005; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Li B, 2001, J BIOL CHEM, V276, P33788, DOI 10.1074/jbc.M104220200; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lin LJ, 2010, MOL CELL BIOL, V30, P1116, DOI 10.1128/MCB.01229-09; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; Parnas O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005497; Pondugula S, 2009, MOL CELL BIOL, V29, P4891, DOI 10.1128/MCB.00222-09; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sharma VM, 2007, MOL CELL BIOL, V27, P3199, DOI 10.1128/MCB.02311-06; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Sharp JA, 2005, GENETICS, V171, P885, DOI 10.1534/genetics.105.044719; Tamburini BA, 2006, GENETICS, V173, P599, DOI 10.1534/genetics.105.054783; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; TRECO DA, 1993, CURRENT PROTOCOLS MO, V2; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Wade SL, 2009, EMBO J, V28, P2919, DOI 10.1038/emboj.2009.229; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang Z, 2004, J BIOL CHEM, V279, P39240, DOI 10.1074/jbc.M407159200; Zhang Z, 2004, EMBO J, V23, P2246, DOI 10.1038/sj.emboj.7600227	59	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7082	7092		10.1074/jbc.M110.193813	http://dx.doi.org/10.1074/jbc.M110.193813			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21190944	Green Published, hybrid			2022-12-25	WOS:000287737300025
J	Zutz, A; Hoffmann, J; Hellmich, UA; Glaubitz, C; Ludwig, B; Brutschy, B; Tampe, R				Zutz, Ariane; Hoffmann, Jan; Hellmich, Ute A.; Glaubitz, Clemens; Ludwig, Bernd; Brutschy, Bernd; Tampe, Robert			Asymmetric ATP Hydrolysis Cycle of the Heterodimeric Multidrug ABC Transport Complex TmrAB from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; LASER MASS-SPECTROMETRY; P-GLYCOPROTEIN; LACTOCOCCUS-LACTIS; RESISTANCE PROTEIN-1; HOECHST-33342 TRANSPORT; STAPHYLOCOCCUS-AUREUS; SUBSTRATE-SPECIFICITY; MEMBRANE-PROTEINS; LMRA	ATP-binding cassette (ABC) systems translocate a wide range of solutes across cellular membranes. The thermophilic Gram-negative eubacterium Thermus thermophilus, a model organism for structural genomics and systems biology, discloses similar to 46 ABC proteins, which are largely uncharacterized. Here, we functionally analyzed the first two and only ABC half-transporters of the hyperthermophilic bacterium, TmrA and TmrB. The ABC system mediates uptake of the drug Hoechst 33342 in inside-out oriented vesicles that is inhibited by verapamil. TmrA and TmrB form a stable heterodimeric complex hydrolyzing ATP with a K-m of 0.9 mM and k(cat) of 9 s(-1) at 68 degrees C. Two nucleotides can be trapped in the heterodimeric ABC complex either by vanadate or by mutation inhibiting ATP hydrolysis. Nucleotide trapping requires permissive temperatures, at which a conformational ATP switch is possible. We further demonstrate that the canonic glutamate 523 of TmrA is essential for rapid conversion of the ATP/ATP-bound complex into its ADP/ATP state, whereas the corresponding aspartate in TmrB (Asp-500) has only a regulatory role. Notably, exchange of this single noncanonic residue into a catalytic glutamate cannot rescue the function of the E523Q/D500E complex, implicating a built-in asymmetry of the complex. However, slow ATP hydrolysis in the newly generated canonic site (D500E) strictly depends on the formation of a posthydrolysis state in the consensus site, indicating an allosteric coupling of both active sites.	[Zutz, Ariane; Ludwig, Bernd; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany; [Hoffmann, Jan; Brutschy, Bernd] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany; [Hellmich, Ute A.; Glaubitz, Clemens] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Glaubitz, Clemens; Ludwig, Bernd; Tampe, Robert] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60438 Frankfurt, Germany; [Glaubitz, Clemens; Ludwig, Bernd; Brutschy, Bernd; Tampe, Robert] Cluster Excellence Frankfurt, Macromol Complexes, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Tampe, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Tampé, Robert/H-2953-2015; Glaubitz, Clemens/D-5714-2011	Tampé, Robert/0000-0002-0403-2160; Glaubitz, Clemens/0000-0002-3554-6586; Hellmich, Ute/0000-0001-7162-285X	German Research Foundation [SFB807, TA157/7-1, AB149/1-1]; European Community	German Research Foundation(German Research Foundation (DFG)); European Community(European Commission)	This work was supported by German Research Foundation Grants (SFB807-Transport and Communication across Biological Membranes, TA157/7-1, and AB149/1-1) and funds from the European Community Seventh Framework Program as part of the European Drug Initiative on Channels and Transporters.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Beaudet L, 1998, BIOCHEMISTRY-US, V37, P9073, DOI 10.1021/bi972656j; Chen M, 2004, J BIOL CHEM, V279, P46073, DOI 10.1074/jbc.M404042200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Ecker GF, 2004, MOL PHARMACOL, V66, P1169, DOI 10.1124/mol.104.001420; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Gottesman M M, 1994, Cancer Treat Res, V73, P107; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hofacker M, 2007, J BIOL CHEM, V282, P3951, DOI 10.1074/jbc.M609899200; Hoffman J, 2010, PHYS CHEM CHEM PHYS, V12, P3480, DOI 10.1039/b924630d; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; Huang Y, 2006, CANCER LETT, V239, P168, DOI 10.1016/j.canlet.2005.07.032; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jenkinson HF, 1996, J DENT RES, V75, P736, DOI 10.1177/00220345960750020201; Johnson BJH, 2010, BIOCHEMISTRY-US, V49, P3403, DOI 10.1021/bi902064g; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; LOO TW, 1994, BIOCHEMISTRY-US, V33, P14049, DOI 10.1021/bi00251a013; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Lubelski J, 2004, J BIOL CHEM, V279, P34449, DOI 10.1074/jbc.M404072200; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Lubelski J, 2006, MOL MICROBIOL, V61, P771, DOI 10.1111/j.1365-2958.2006.05267.x; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; Matsuo T, 2008, J BACTERIOL, V190, P648, DOI 10.1128/JB.01513-07; Morgner N, 2006, AUST J CHEM, V59, P109, DOI 10.1071/CH05285; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Payen LF, 2003, J BIOL CHEM, V278, P38537, DOI 10.1074/jbc.M305786200; Poelarends GJ, 2002, J BIOL CHEM, V277, P42891, DOI 10.1074/jbc.M206508200; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Robey RW, 2001, CLIN CANCER RES, V7, P145; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Torres C, 2009, BBA-BIOMEMBRANES, V1788, P615, DOI 10.1016/j.bbamem.2008.12.012; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van Saparoea HBV, 2005, BIOCHEMISTRY-US, V44, P16931, DOI 10.1021/bi051497y; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zhang DW, 2006, J BIOL CHEM, V281, P4507, DOI 10.1074/jbc.M512277200	55	50	50	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7104	7115		10.1074/jbc.M110.201178	http://dx.doi.org/10.1074/jbc.M110.201178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21190941	Green Published, hybrid			2022-12-25	WOS:000287737300027
J	Espeseth, T; Sneve, MH; Rootwelt, H; Laeng, B				Espeseth, Thomas; Sneve, Markus Handal; Rootwelt, Helge; Laeng, Bruno			Nicotinic Receptor Gene CHRNA4 Interacts with Processing Load in Attention	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PREFRONTAL ACETYLCHOLINE-RELEASE; VISUAL-ATTENTION; WORKING-MEMORY; VISUOSPATIAL ATTENTION; SELECTIVE ATTENTION; INDIVIDUAL-DIFFERENCES; SPATIAL ATTENTION; PERCEPTUAL LOAD; HUMAN BRAIN	Background: Pharmacological studies suggest that cholinergic neurotransmission mediates increases in attentional effort in response to high processing load during attention demanding tasks [1]. Methodology/ Principal Findings: In the present study we tested whether individual variation in CHRNA4, a gene coding for a subcomponent in alpha 4b2 nicotinic receptors in the human brain, interacted with processing load in multiple-object tracking (MOT) and visual search (VS). We hypothesized that the impact of genotype would increase with greater processing load in the MOT task. Similarly, we predicted that genotype would influence performance under high but not low load in the VS task. Two hundred and two healthy persons (age range = 39-77, Mean = 57.5, SD = 9.4) performed the MOT task in which twelve identical circular objects moved about the display in an independent and unpredictable manner. Two to six objects were designated as targets and the remaining objects were distracters. The same observers also performed a visual search for a target letter (i.e. X or Z) presented together with five non-targets while ignoring centrally presented distracters (i.e. X, Z, or L). Targets differed from non-targets by a unique feature in the low load condition, whereas they shared features in the high load condition. CHRNA4 genotype interacted with processing load in both tasks. Homozygotes for the T allele (N = 62) had better tracking capacity in the MOT task and identified targets faster in the high load trials of the VS task. Conclusion: The results support the hypothesis that the cholinergic system modulates attentional effort, and that common genetic variation can be used to study the molecular biology of cognition.	[Espeseth, Thomas; Sneve, Markus Handal; Laeng, Bruno] Univ Oslo, Dept Psychol, Ctr Study Human Cognit, Oslo, Norway; [Rootwelt, Helge] Oslo Univ Hosp, Rikshosp, Dept Med Biochem, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway	Espeseth, T (corresponding author), Univ Oslo, Dept Psychol, Ctr Study Human Cognit, Oslo, Norway.	thomas.espeseth@psykologi.uio.no			Norwegian Research Council [177458/V50]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was supported by Norwegian Research Council grant 177458/V50 to Thomas Espeseth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2007, J VISION, V7, DOI 10.1167/7.13.14; Beck AT., 1996, BECK DEPRESSION INVE; Beck DM, 2005, J EXP PSYCHOL HUMAN, V31, P592, DOI 10.1037/0096-1523.31.3.592; Bellgrove MA, 2008, ANN NY ACAD SCI, V1129, P200, DOI 10.1196/annals.1417.013; Bentley P, 2004, NEURON, V41, P969, DOI 10.1016/S0896-6273(04)00145-X; Braff DL, 2004, PSYCHOPHARMACOLOGY, V174, P75, DOI 10.1007/s00213-004-1848-0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bundesen C, 2005, PSYCHOL REV, V112, P291, DOI 10.1037/0033-295X.112.2.291; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; COULL J, 2005, NEUROBIOLOGY ATTENTI; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; DARK VJ, 1985, J EXP PSYCHOL GEN, V114, P472, DOI 10.1037/0096-3445.114.4.472; Deco G, 2009, EUR J NEUROSCI, V30, P347, DOI 10.1111/j.1460-9568.2009.06833.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DINGLEDINE R, 1977, J PHYSIOL-LONDON, V271, P135, DOI 10.1113/jphysiol.1977.sp011994; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dukas R, 2009, VIENNA SER THEOR BIO, P147; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Espeseth T, 2007, NEUROSCIENCE, V147, P974, DOI 10.1016/j.neuroscience.2007.04.027; Evans DE, 2009, ADDICT BIOL, V14, P32, DOI 10.1111/j.1369-1600.2008.00130.x; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fan J, 2003, P NATL ACAD SCI USA, V100, P7406, DOI 10.1073/pnas.0732088100; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; FAN J, 2008, TOPICS INTEGRATIVE N; Feng Y, 2004, AM J HUM GENET, V75, P112, DOI 10.1086/422194; Flores CM, 1996, J NEUROSCI, V16, P7892; Forster S, 2007, PSYCHOL SCI, V18, P377, DOI 10.1111/j.1467-9280.2007.01908.x; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Furey ML, 2000, SCIENCE, V290, P2315, DOI 10.1126/science.290.5500.2315; Giessing C, 2006, NEUROSCIENCE, V137, P853, DOI 10.1016/j.neuroscience.2005.10.005; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Gioanni Y, 1999, EUR J NEUROSCI, V11, P18, DOI 10.1046/j.1460-9568.1999.00403.x; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Greenwood PM, 2009, P NATL ACAD SCI USA, V106, P3633, DOI 10.1073/pnas.0807891106; Greenwood PM, 2009, J COGNITIVE NEUROSCI, V21, P2139, DOI 10.1162/jocn.2008.21164; Greenwood PM, 2005, J COGNITIVE NEUROSCI, V17, P1611, DOI 10.1162/089892905774597281; HAMMOND EJ, 1987, NEUROLOGY, V37, P346, DOI 10.1212/WNL.37.2.346; Han ZY, 2000, EUR J NEUROSCI, V12, P3664, DOI 10.1046/j.1460-9568.2000.00262.x; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; HODA JC, 2007, SOC NEUR M NOV 3 7 S; Horowitz TS, 1998, NATURE, V394, P575, DOI 10.1038/29068; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Jacobsen LK, 2007, NEUROPSYCHOPHARMACOL, V32, P2453, DOI 10.1038/sj.npp.1301398; Jacobsen LK, 2006, NEUROPSYCHOPHARMACOL, V31, P1550, DOI 10.1038/sj.npp.1300981; KAHNEMAN D, 1983, J EXP PSYCHOL HUMAN, V9, P497, DOI 10.1037/0096-1523.9.4.497; Kahneman D., 1973, ATTENTION EFFORT; Kosslyn SM, 2002, AM PSYCHOL, V57, P341, DOI 10.1037//0003-066X.57.5.341; Kozak R, 2006, CEREB CORTEX, V16, P9, DOI 10.1093/cercor/bhi079; LABERGE D, 1990, J NEUROSCI, V10, P613; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 1997, PSYCHOL SCI, V8, P395, DOI 10.1111/j.1467-9280.1997.tb00432.x; Lawrence NS, 2002, NEURON, V36, P539, DOI 10.1016/S0896-6273(02)01004-8; Lena C, 1998, J PHYSIOL-PARIS, V92, P63, DOI 10.1016/S0928-4257(98)80140-X; Levin ED, 2007, BIOCHEM PHARMACOL, V74, P1182, DOI 10.1016/j.bcp.2007.07.019; Markett SA, 2010, J COGNITIVE NEUROSCI, V22, P1944, DOI 10.1162/jocn.2009.21354; Marutle A, 1999, J NEUROCHEM, V72, P1161, DOI 10.1046/j.1471-4159.2000.0721161.x; Meinke A, 2006, NEUROSCIENCE, V141, P201, DOI 10.1016/j.neuroscience.2006.03.072; MESULAM MM, 1995, ANN NY ACAD SCI, V757, P169, DOI 10.1111/j.1749-6632.1995.tb17472.x; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MESULAM MM, 1990, PROG BRAIN RES, V84, P231; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; MILLER J, 1991, PERCEPT PSYCHOPHYS, V49, P270, DOI 10.3758/BF03214311; MORAY N, 1967, ACTA PSYCHOL, V27, P84, DOI 10.1016/0001-6918(67)90048-0; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; NORDBERG A, 2006, BRAIN CHOLINERGIC SY, P181; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Parasuraman R, 2005, PSYCHOL SCI, V16, P200, DOI 10.1111/j.0956-7976.2005.00804.x; Parikh V, 2008, J NEUROSCI, V28, P3769, DOI 10.1523/JNEUROSCI.5251-07.2008; Parikh V, 2008, ANN NY ACAD SCI, V1129, P225, DOI 10.1196/annals.1417.021; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; PEAVLER WS, 1974, PSYCHOPHYSIOLOGY, V11, P559, DOI 10.1111/j.1469-8986.1974.tb01114.x; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; Phillips JM, 2000, PSYCHOPHARMACOLOGY, V150, P112, DOI 10.1007/s002130000437; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Schneider W., 2002, E PRIME VERSION 20 C; Scholl BJ, 2009, COMPUTATION, COGNITION, AND PYLYSHYN, P49; Steinlein OK, 2008, BIOCHEM PHARMACOL, V76, P1175, DOI 10.1016/j.bcp.2008.07.012; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Thiel CM, 2005, NEUROPSYCHOPHARMACOL, V30, P810, DOI 10.1038/sj.npp.1300633; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; UNDERWOOD BJ, 1975, AM PSYCHOL, V30, P128, DOI 10.1037/h0076759; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wechsler D., 1999, WECHSLER ABBREVIATED; Weiser M, 2004, AM J PSYCHIAT, V161, P1219, DOI 10.1176/appi.ajp.161.7.1219; Winterer G, 2007, HUM MOL GENET, V16, P2165, DOI 10.1093/hmg/ddm168; Winterer G, 2010, CURR OPIN PSYCHIATR, V23, P112, DOI 10.1097/YCO.0b013e3283366643; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P324, DOI 10.1007/s002130050352; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P135, DOI 10.1037/0096-1523.16.1.135; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	103	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14407	10.1371/journal.pone.0014407	http://dx.doi.org/10.1371/journal.pone.0014407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203548	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000013
J	Krug, AZ; Jablonski, D; Roy, K; Beu, AG				Krug, Andrew Z.; Jablonski, David; Roy, Kaustuv; Beu, Alan G.			Differential Extinction and the Contrasting Structure of Polar Marine Faunas	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; ARCTIC-OCEAN; EVOLUTIONARY DYNAMICS; NORTHERN ALASKA; BIODIVERSITY; PATTERNS; ANTARCTICA; BIVALVES; CLIMATE; EOCENE	Background: The low taxonomic diversity of polar marine faunas today reflects both the failure of clades to colonize or diversify in high latitudes and regional extinctions of once-present clades. However, simple models of polar evolution are made difficult by the strikingly different faunal compositions and community structures of the two poles. Methodology/Principal Findings: A comparison of early Cenozoic Arctic and Antarctic bivalve faunas with modern ones, within the framework of a molecular phylogeny, shows that while Arctic losses were randomly distributed across the tree, Antarctic losses were significantly concentrated in more derived families, resulting in communities dominated by basal lineages. Potential mechanisms for the phylogenetic structure to Antarctic extinctions include continental isolation, changes in primary productivity leading to turnover of both predators and prey, and the effect of glaciation on shelf habitats. Conclusions/Significance: These results show that phylogenetic consequences of past extinctions can vary substantially among regions and thus shape regional faunal structures, even when due to similar drivers, here global cooling, and provide the first phylogenetic support for the "retrograde" hypothesis of Antarctic faunal evolution.	[Krug, Andrew Z.; Jablonski, David] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Roy, Kaustuv] Univ Calif San Diego, Div Biol, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; [Beu, Alan G.] Inst Geol & Nucl Sci Ltd, Lower Hutt, New Zealand	University of Chicago; University of California System; University of California San Diego; GNS Science - New Zealand	Krug, AZ (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	akrug@uchicago.edu			NASA Astrobiology; National Science Foundation	NASA Astrobiology; National Science Foundation(National Science Foundation (NSF))	This research was supported by grants from NASA Astrobiology and the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson RB, 2001, AM ZOOL, V41, P27, DOI 10.1668/0003-1569(2001)041[0027:GCCATO]2.0.CO;2; Aronson RB, 1997, GEOLOGY, V25, P903, DOI 10.1130/0091-7613(1997)025<0903:RCSITL>2.3.CO;2; Aronson RB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004385; Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Barnes DKA, 2006, GLOBAL ECOL BIOGEOGR, V15, P121, DOI 10.1111/j.1466-822x.2006.00216.x; BERKE S, 2010, COMMUNICATION; Beu AG, 2009, PALAEOGEOGR PALAEOCL, V284, P191, DOI 10.1016/j.palaeo.2009.09.025; Bieler R, 2006, ZOOL J LINN SOC-LOND, V148, P223, DOI 10.1111/j.1096-3642.2006.00255.x; Brinkhuis H, 2006, NATURE, V441, P606, DOI 10.1038/nature04692; BROUWERS EM, 1993, PALAIOS, V8, P140, DOI 10.2307/3515168; Carr ME, 2006, DEEP-SEA RES PT II, V53, P741, DOI 10.1016/j.dsr2.2006.01.028; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; Clarke A, 2010, PHILOS T R SOC B, V365, P3655, DOI 10.1098/rstb.2010.0270; Clarke A, 2008, J EXP MAR BIOL ECOL, V366, P48, DOI 10.1016/j.jembe.2008.07.008; Dayton P.K., 1990, P631; DAYTON PK, 1994, AM ZOOL, V34, P90; Dierssen HM, 2010, P NATL ACAD SCI USA, V107, P17073, DOI 10.1073/pnas.0913800107; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FREDERIKSEN NO, 2000, 00493136 US GEOL SUR; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Golonka J, 2003, MAR PETROL GEOL, V20, P211, DOI 10.1016/S0264-8172(03)00043-6; HAIN S, 1992, POLAR BIOL, V12, P303; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Ivany LC, 2008, GEOL SOC AM BULL, V120, P659, DOI 10.1130/B26269.1; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Kembel S. W., 2010, PICANTE R TOOLS INTE; Krug AZ, 2009, ASTROBIOLOGY, V9, P113, DOI 10.1089/ast.2008.0253; Linse K, 2006, DEEP-SEA RES PT II, V53, P985, DOI 10.1016/j.dsr2.2006.05.003; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; MARINCOVICH L, 1993, J PALEONTOL, V67, P1; McClain CR, 2005, MAR ECOL PROG SER, V297, P181, DOI 10.3354/meps297181; Miller A.I, 2007, PRINCIPLES PALEONTOL; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Orme C. D. L., 2009, CAIC COMP ANAL USING; Page TJ, 2002, POLAR BIOL, V25, P818, DOI 10.1007/s00300-002-0414-7; Phillips RL, 2003, CRETACEOUS RES, V24, P499, DOI 10.1016/S0195-6671(03)00068-5; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Poulin E, 2002, TRENDS ECOL EVOL, V17, P218, DOI 10.1016/S0169-5347(02)02493-X; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; R Core Team, 2022, R LANG ENV STAT COMP; RAUP DM, 1991, ANAL PALEOBIOLOGY SH, V4, P207; Ricklefs Robert E., 1993, P350; Roy K, 2000, P NATL ACAD SCI USA, V97, P13150, DOI 10.1073/pnas.97.24.13150; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Roy K, 2009, SCIENCE, V325, P733, DOI 10.1126/science.1173073; Sastry A.N., 1979, P113; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stilwell JD, 2003, PALAEOGEOGR PALAEOCL, V195, P319, DOI 10.1016/S0031-0182(03)00364-X; Taylor JD, 2007, J MAR BIOL ASSOC UK, V87, P565, DOI 10.1017/S0025315407054409; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Valentine James W., 2009, P3; Vermeij G.J, 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zelaya DG, 2005, SCI MAR, V69, P113, DOI 10.3989/scimar.2005.69s2113	59	27	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15362	10.1371/journal.pone.0015362	http://dx.doi.org/10.1371/journal.pone.0015362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203524	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000031
J	Li, FX; Yang, ZL; Lu, Y; Wei, Y; Wang, JH; Yin, DZ; He, RQ				Li, Fangxu; Yang, Zhilai; Lu, Yang; Wei, Yan; Wang, Jinhui; Yin, Dazhong; He, Rongqiao			Malondialdehyde Suppresses Cerebral Function by Breaking Homeostasis between Excitation and Inhibition in Turtle Trachemys scripta	PLOS ONE			English	Article							LIPID-PEROXIDATION; SLEEP-DEPRIVATION; MAILLARD REACTION; OXIDATIVE STRESS; REACTIVE OXYGEN; IN-VITRO; BRAIN; MECHANISMS; DAMAGE; MALONALDEHYDE	The levels of malondialdehyde (MDA) are high in the brain during carbonyl stress, such as following daily activities and sleep deprivation. To examine our hypothesis that MDA is one of the major substances in the brain leading to fatigue, the influences of MDA on brain functions and neuronal encodings in red-eared turtle (Trachemys scripta) were studied. The intrathecal injections of MDA brought about sleep-like EEG and fatigue-like behaviors in a dose-dependent manner. These changes were found associated with the deterioration of encoding action potentials in cortical neurons. In addition, MDA increased the ratio of gamma-aminobutyric acid to glutamate in turtle's brain, as well as the sensitivity of GABAergic neurons to inputs compared to excitatory neurons. Therefore, MDA, as a metabolic product in the brain, may weaken cerebral function during carbonyl stress through breaking the homeostasis between excitatory and inhibitory neurons.	[Li, Fangxu; Yang, Zhilai; Lu, Yang; Wei, Yan; Wang, Jinhui; He, Rongqiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Li, Fangxu; Yin, Dazhong] Hunan Normal Univ, Coll Life Sci, Changsha, Hunan, Peoples R China; [He, Rongqiao] Chinese Acad Sci, Inst Psychol, Lab Mental Hlth, Beijing 100080, Peoples R China; [Lu, Yang] Univ Sci & Technol China, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Hunan Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, FX (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	dazhongyin@hotmail.com; herq@sun5.ibp.ac.cn			NSFC [30970695]; 973-Projects [2010CB912303, KSCX2-YW-R-119, KSCX2-YW-R-256, 863-2008AA02Z411]	NSFC(National Natural Science Foundation of China (NSFC)); 973-Projects(National Basic Research Program of China)	This work was supported by the NSFC 30970695, 973-Projects 2010CB912303, KSCX2-YW-R-119, KSCX2-YW-R-256 and 863-2008AA02Z411. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 1999, CEREB CORTEX, V9, P783, DOI 10.1093/cercor/9.8.783; ANDERSEN P, 1974, HDB ELECTROENCEPHALO; Annunziato L, 2002, NEUROBIOL AGING, V23, P819, DOI 10.1016/S0197-4580(02)00069-6; AYALAGUERRERO F, 1988, PHYSIOL BEHAV, V44, P333, DOI 10.1016/0031-9384(88)90034-0; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; BENTE D, 1979, PHARMAKOPSYCH NEURO, V12, P137, DOI 10.1055/s-0028-1094604; Bettendorff L, 1996, SLEEP, V19, P65, DOI 10.1093/sleep/19.1.65; Bo P, 2003, BRAIN RES PROTOC, V11, P155, DOI 10.1016/S1385-299X(03)00042-4; BUTLER AB, 1980, COMP NEUROLOGY TELEN, P344; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; CHIO KS, 1969, BIOCHEMISTRY-US, V8, P2821, DOI 10.1021/bi00835a019; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; ESTERBAUE H, 1990, MEMBRANE LIPID OXIDA, P16; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; FINCH CE, 1990, LONGEVITY SENESCENCE, P284; FLANIGAN WF, 1973, ELECTROEN CLIN NEURO, V34, P521, DOI 10.1016/0013-4694(73)90069-2; Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; Fraser SF, 2002, J APPL PHYSIOL, V93, P1650, DOI 10.1152/japplphysiol.01247.2001; Gonzalez J, 1999, AM J PHYSIOL-REG I, V277, pR86, DOI 10.1152/ajpregu.1999.277.1.R86; Griffiths HR, 1996, FEBS LETT, V388, P161, DOI 10.1016/0014-5793(96)00542-X; Guezennec CY, 1998, INT J SPORTS MED, V19, P323, DOI 10.1055/s-2007-971925; HALLIWELL B, 1999, FREE RADICAL BIO MED, P458; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; KIKUGAWA K, 1981, CHEM PHARM BULL, V29, P3003; KOSUGI H, 1994, BIOL PHARM BULL, V17, P1645; KRIJZER F, 1993, NEUROPSYCHOBIOLOGY, V28, P122, DOI 10.1159/000119015; KRUEGER JM, 1995, BEHAV BRAIN RES, V69, P177, DOI 10.1016/0166-4328(95)00015-L; Lee RS, 2001, J NEUROSCI, V21, P1757; Li FX, 2008, PROG BIOCHEM BIOPHYS, V35, P393; Li GL, 2005, NEUROENDOCRINOL LETT, V26, P61; Li L, 2005, NEUROENDOCRINOL LETT, V26, P799; LINDSLEY DB, 1950, ELECTROEN CLIN NEURO, V2, P483, DOI 10.1016/0013-4694(50)90086-1; Lutz PL, 2003, EXP GERONTOL, V38, P797, DOI 10.1016/S0531-5565(03)00111-6; LUTZ PL, 2003, BRAIN OXYGEN CAUSES, P11; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; MARNETT LJ, 1985, PROSTAGLANDINS, V30, P241, DOI 10.1016/0090-6980(85)90188-1; MONNIER VM, 1991, GERONTOLOGY, V37, P152; Nie CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000629; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; Piepponen TP, 2001, J CHROMATOGR B, V757, P277, DOI 10.1016/S0378-4347(01)00156-6; REINER A, 1993, COMP BIOCHEM PHYS A, V104, P735, DOI 10.1016/0300-9629(93)90149-X; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; TSAI LL, 1993, BRAIN RES, V602, P221, DOI 10.1016/0006-8993(93)90686-H; Venditti P, 1996, ARCH BIOCHEM BIOPHYS, V331, P63, DOI 10.1006/abbi.1996.0283; Wang Sheng-Xu, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P888; Yin DZ, 2005, EXP GERONTOL, V40, P455, DOI 10.1016/j.exger.2005.03.012; Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X; Yin DZ, 1995, GERONTOLOGY, V41, P159; Yoyama Y., 1995, ADV EUROL SCI, V39, P14	54	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15325	10.1371/journal.pone.0015325	http://dx.doi.org/10.1371/journal.pone.0015325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203547	Green Published, gold, Green Submitted			2022-12-25	WOS:000285578000028
J	Lindeman, LC; Reiner, AH; Mathavan, S; Alestrom, P; Collas, P				Lindeman, Leif C.; Reiner, Andrew H.; Mathavan, Sinnakaruppan; Alestroem, Peter; Collas, Philippe			Tiling Histone H3 Lysine 4 and 27 Methylation in Zebrafish Using High-Density Microarrays	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; DIFFERENTIATED CELLS; GENOME; CHROMATIN; PATTERNS; GENES; PLURIPOTENT; MARKS; POLYCOMB	Background: Uncovering epigenetic states by chromatin immunoprecipitation and microarray hybridization (ChIP-chip) has significantly contributed to the understanding of gene regulation at the genome-scale level. Many studies have been carried out in mice and humans; however limited high-resolution information exists to date for non-mammalian vertebrate species. Principal Findings: We report a 2.1-million feature high-resolution Nimblegen tiling microarray for ChIP-chip interrogations of epigenetic states in zebrafish (Danio rerio). The array covers 251 megabases of the genome at 92 base-pair resolution. It includes similar to 15 kb of upstream regulatory sequences encompassing all RefSeq promoters, and over 5 kb in the 59 end of coding regions. We identify with high reproducibility, in a fibroblast cell line, promoters enriched in H3K4me3, H3K27me3 or co-enriched in both modifications. ChIP-qPCR and sequential ChIP experiments validate the ChIP-chip data and support the co-enrichment of trimethylated H3K4 and H3K27 on a subset of genes. H3K4me3- and/or H3K27me3-enriched genes are associated with distinct transcriptional status and are linked to distinct functional categories. Conclusions: We have designed and validated for the scientific community a comprehensive high-resolution tiling microarray for investigations of epigenetic states in zebrafish, a widely used developmental and disease model organism.	[Lindeman, Leif C.; Reiner, Andrew H.; Collas, Philippe] Univ Oslo, Inst Basic Med Sci, Fac Med, Oslo, Norway; [Lindeman, Leif C.; Reiner, Andrew H.; Collas, Philippe] Univ Oslo, Norwegian Ctr Stem Cell Res, Oslo, Norway; [Mathavan, Sinnakaruppan] Genome Inst Singapore, Singapore, Singapore; [Alestroem, Peter] Norwegian Sch Vet Sci, BasAM, Oslo, Norway	University of Oslo; University of Oslo; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Norwegian University of Life Sciences	Lindeman, LC (corresponding author), Univ Oslo, Inst Basic Med Sci, Fac Med, Oslo, Norway.	philippe.collas@medisin.uio.no			Norwegian Research Council of Norway	Norwegian Research Council of Norway(Research Council of Norway)	This work was funded by grants from the Norwegian Research Council of Norway to PA and PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LG, 2007, BIOTECHNIQUES, V43, P791, DOI 10.2144/000112625; Akkers RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008820; Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; Dahl JA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r13; Delbarre E, 2010, MOL BIOL CELL, V21, P1872, DOI 10.1091/mbc.E09-09-0839; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Sorensen AL, 2010, MOL BIOL CELL, V21, P2066, DOI 10.1091/mbc.E10-01-0018; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	34	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15651	10.1371/journal.pone.0015651	http://dx.doi.org/10.1371/journal.pone.0015651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187971	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200057
J	Zanet, J; Freije, A; Ruiz, M; Coulon, V; Sanz, JR; Chiesa, J; Gandarillas, A				Zanet, Jennifer; Freije, Ana; Ruiz, Maria; Coulon, Vincent; Sanz, J. Ramon; Chiesa, Jean; Gandarillas, Alberto			A Mitosis Block Links Active Cell Cycle with Human Epidermal Differentiation and Results in Endoreplication	PLOS ONE			English	Article							STEM-CELLS; TRANSGENIC MICE; CHROMOSOME SEGREGATION; INVOLUCRIN SYNTHESIS; HUMAN KERATINOCYTES; EXPRESSION; MYC; ENDOREDUPLICATION; MOUSE; SKIN	How human self-renewal tissues co-ordinate proliferation with differentiation is unclear. Human epidermis undergoes continuous cell growth and differentiation and is permanently exposed to mutagenic hazard. Keratinocytes are thought to arrest cell growth and cell cycle prior to terminal differentiation. However, a growing body of evidence does not satisfy this model. For instance, it does not explain how skin maintains tissue structure in hyperproliferative benign lesions. We have developed and applied novel cell cycle techniques to human skin in situ and determined the dynamics of key cell cycle regulators of DNA replication or mitosis, such as cyclins E, A and B, or members of the anaphase promoting complex pathway: cdc14A, Ndc80/Hec1 and Aurora kinase B. The results show that actively cycling keratinocytes initiate terminal differentiation, arrest in mitosis, continue DNA replication in a special G2/M state, and become polyploid by mitotic slippage. They unambiguously demonstrate that cell cycle progression coexists with terminal differentiation, thus explaining how differentiating cells increase in size. Epidermal differentiating cells arrest in mitosis and a genotoxic-induced mitosis block rapidly pushes epidermal basal cells into differentiation and polyploidy. These observations unravel a novel mitosis-differentiation link that provides new insight into skin homeostasis and cancer. It might constitute a self-defence mechanism against oncogenic alterations such as Myc deregulation.	[Freije, Ana; Ruiz, Maria; Sanz, J. Ramon; Gandarillas, Alberto] Univ Cantabria, Cell Cycle Stem Cell Decis & Canc Lab, Res & Training Inst, Fdn Marques Valdecilla IFMAV FMDV,Mol Biol Dept, E-39005 Santander, Spain; [Zanet, Jennifer; Coulon, Vincent; Gandarillas, Alberto] INSERM, Lab Dermatol Mol, UPRES EA3754, Inst Univ Rech Clin,UMI, Montpellier, France; [Gandarillas, Alberto] INSERM, ADR Languedoc Roussillon, Montpellier, France; [Chiesa, Jean] CHU Nimes, Unite Fonct Cytogenet Antenatale & Oncol, Nimes, France; [Sanz, J. Ramon] HUMV, Serv Cirugia Plast, Santander, Spain	Universidad de Cantabria; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Nimes; Hospital Universitario Marques de Valdecilla (HUMV)	Zanet, J (corresponding author), INSERM, Lab Dermatol Mol, UPRES EA3754, Inst Univ Rech Clin,UMI, Montpellier, France.	gandarillasa@unican.es	Coulon, Vincent/B-2437-2009; Coulon, Vincent/AFF-7934-2022	Coulon, Vincent/0000-0002-3168-8755; Coulon, Vincent/0000-0002-3168-8755; RUIZ SOTO, MARIA/0000-0003-2672-1407	Association pour la Recherce sur le Cancer (ARC; France); La Ligue Nationale contre le Cancer and La Ligue de l'Herault (France); Societe Francaise de Dermatologie (France); Instituto de Salud Carlos III (ISCIII-Programa Regiones Emergentes; Spain); Fondo de Investigaciones Sanitarias (Spain) [ISCIII-FIS: PI080890]; French Council; ISCIII (Spain); Fundacion Marques de Valdecilla - Instituto de Formacion e Investigacion Marques de Valdecilla (FMDV-IFIMAV; Spain)	Association pour la Recherce sur le Cancer (ARC; France); La Ligue Nationale contre le Cancer and La Ligue de l'Herault (France); Societe Francaise de Dermatologie (France); Instituto de Salud Carlos III (ISCIII-Programa Regiones Emergentes; Spain)(Instituto de Salud Carlos III); Fondo de Investigaciones Sanitarias (Spain)(Instituto de Salud Carlos III); French Council; ISCIII (Spain)(Instituto de Salud Carlos III); Fundacion Marques de Valdecilla - Instituto de Formacion e Investigacion Marques de Valdecilla (FMDV-IFIMAV; Spain)	This work was funded by the Association pour la Recherce sur le Cancer (ARC; France), La Ligue Nationale contre le Cancer and La Ligue de l'Herault (France), Societe Francaise de Dermatologie (France), Instituto de Salud Carlos III (ISCIII-Programa Regiones Emergentes; Spain), and Fondo de Investigaciones Sanitarias (ISCIII-FIS: PI080890; Spain). JZ was the recipient of a fellowship from the French Council, AG and MR received fellowships from ISCIII (Spain), and AF received a fellowship from the Fundacion Marques de Valdecilla - Instituto de Formacion e Investigacion Marques de Valdecilla (FMDV-IFIMAV; Spain). AG also belongs to the INSERM (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalaf M, 1999, ONCOGENE, V18, P1419, DOI 10.1038/sj.onc.1202448; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; BATACSORGO Z, 1993, J EXP MED, V178, P1271, DOI 10.1084/jem.178.4.1271; CHIESA J, 1995, VISUALISATION NUCL A, P185; Dazard JE, 2000, ONCOGENE, V19, P3693, DOI 10.1038/sj.onc.1203695; de Marval PLM, 2001, AM J PATHOL, V159, P369, DOI 10.1016/S0002-9440(10)61703-8; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Dick FA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-26; DOVER R, 1987, J INVEST DERMATOL, V89, P349, DOI 10.1111/1523-1747.ep12471751; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Flores I, 2004, ONCOGENE, V23, P5923, DOI 10.1038/sj.onc.1207796; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1; Gandarillas A, 2000, ONCOGENE, V19, P3278, DOI 10.1038/sj.onc.1203630; Garcia P, 2000, ONCOGENE, V19, P1820, DOI 10.1038/sj.onc.1203494; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Harvat BL, 1998, J CELL SCI, V111, P1185; Hauser PJ, 1998, ONCOGENE, V17, P3083, DOI 10.1038/sj.onc.1202235; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; IBRAHIM J, 1985, ARCH ORAL BIOL, V30, P627, DOI 10.1016/0003-9969(85)90084-6; ISHIDA R, 1991, CANCER RES, V51, P4909; JACK EM, 1990, HEPATOLOGY, V11, P286, DOI 10.1002/hep.1840110220; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; KARALOVA E M, 1988, Byulleten' Eksperimental'noi Biologii i Meditsiny, V106, P604; KARTASOVA T, 1992, MOL CARCINOGEN, V6, P18, DOI 10.1002/mc.2940060105; Kasili R, 2010, GENETICS, V185, P257, DOI 10.1534/genetics.109.113274; KIRK D, 1980, CELL BIOL INT REP, V4, P83, DOI 10.1016/0309-1651(80)90013-2; Kondorosi E, 2000, CURR OPIN PLANT BIOL, V3, P488, DOI 10.1016/S1369-5266(00)00118-7; Larkins BA, 2001, J EXP BOT, V52, P183, DOI 10.1093/jexbot/52.355.183; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; MacAuley A, 1998, MOL BIOL CELL, V9, P795, DOI 10.1091/mbc.9.4.795; Macias E, 2008, CANCER RES, V68, P162, DOI 10.1158/0008-5472.CAN-07-2461; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mandrioli M, 2010, Q REV BIOL, V85, P159, DOI 10.1086/652341; Mantel C, 2008, CELL CYCLE, V7, P484, DOI 10.4161/cc.7.4.5316; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Mena AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013037; Mills AD, 2000, NAT CELL BIOL, V2, P244, DOI 10.1038/35008670; MULLER R, 1995, TRENDS GENET, V11, P173, DOI 10.1016/S0168-9525(00)89039-3; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; NAKATANI S, 1992, ARCH DERMATOL RES, V284, P349, DOI 10.1007/BF00372038; Paramio JM, 1999, MOL CELL BIOL, V19, P3086; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; PENNEYS NS, 1970, ARCH DERMATOL, V101, P323, DOI 10.1001/archderm.101.3.323; Pierce AM, 1998, P NATL ACAD SCI USA, V95, P8858, DOI 10.1073/pnas.95.15.8858; PINKUS H, 1966, ARCH DERMATOL, V94, P351, DOI 10.1001/archderm.94.3.351; Ravid K, 2002, J CELL PHYSIOL, V190, P7, DOI 10.1002/jcp.10035; REGNIER M, 1986, J INVEST DERMATOL, V87, P472, DOI 10.1111/1523-1747.ep12455517; Rheinwald JG., 1989, CELL GROWTH DIVISION, P81; Robles AI, 1996, P NATL ACAD SCI USA, V93, P7634, DOI 10.1073/pnas.93.15.7634; Rodriguez-Puebla ML, 2000, AM J PATHOL, V157, P1039, DOI 10.1016/S0002-9440(10)64616-0; Santos M, 2002, J BIOL CHEM, V277, P35371, DOI 10.1074/jbc.M205143200; SAUER K, 1995, GENE DEV, V9, P1327, DOI 10.1101/gad.9.11.1327; Schellmann S, 2005, INT J DEV BIOL, V49, P579, DOI 10.1387/ijdb.051983ss; Schindler K, 2009, BIOL REPROD, V80, P795, DOI 10.1095/biolreprod.108.074906; SUN TT, 1976, CELL, V9, P511, DOI 10.1016/0092-8674(76)90033-7; TOUNEKTI O, 1993, CANCER RES, V53, P5462; Traas J, 1998, CURR OPIN PLANT BIOL, V1, P498, DOI 10.1016/S1369-5266(98)80042-3; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; VAUGHAN FL, 1976, MOL CELL BIOCHEM, V12, P171, DOI 10.1007/BF01741715; Vinardell JM, 2003, PLANT CELL, V15, P2093, DOI 10.1105/tpc.014373; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; WATT FM, 1981, J CELL BIOL, V90, P738, DOI 10.1083/jcb.90.3.738; Zanet J, 2005, J CELL SCI, V118, P1693, DOI 10.1242/jcs.02298; Zimmet JM, 1997, MOL CELL BIOL, V17, P7248, DOI 10.1128/MCB.17.12.7248	74	74	75	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15701	10.1371/journal.pone.0015701	http://dx.doi.org/10.1371/journal.pone.0015701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187932	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200065
J	Basile, LFH; Lozano, MD; Alvarenga, MY; Pereira, JF; Machado, S; Velasques, B; Ribeiro, P; Piedade, R; Anghinah, R; Knyazev, G; Ramos, RT				Basile, Luis F. H.; Lozano, Mirna D.; Alvarenga, Milkes Y.; Pereira, Jose F., Jr.; Machado, Sergio; Velasques, Bruna; Ribeiro, Pedro; Piedade, Roberto; Anghinah, Renato; Knyazev, Gennady; Ramos, Renato T.			Minor and Unsystematic Cortical Topographic Changes of Attention Correlates between Modalities	PLOS ONE			English	Article							FUNCTIONAL MRI; BRAIN; GENERATION; CORTEX; TASKS; RECONSTRUCTIONS; OSCILLATIONS; VARIABILITY; RELIABILITY; POTENTIALS	In this study we analyzed the topography of induced cortical oscillations in 20 healthy individuals performing simple attention tasks. We were interested in qualitatively replicating our recent findings on the localization of attention-induced beta bands during a visual task [1], and verifying whether significant topographic changes would follow the change of attention to the auditory modality. We computed corrected latency averaging of each induced frequency bands, and modeled their generators by current density reconstruction with Lp-norm minimization. We quantified topographic similarity between conditions by an analysis of correlations, whereas the inter-modality significant differences in attention correlates were illustrated in each individual case. We replicated the qualitative result of highly idiosyncratic topography of attention-related activity to individuals, manifested both in the beta bands, and previously studied slow potential distributions [2]. Visual inspection of both scalp potentials and distribution of cortical currents showed minor changes in attention-related bands with respect to modality, as compared to the theta and delta bands, known to be major contributors to the sensory-related potentials. Quantitative results agreed with visual inspection, supporting to the conclusion that attention-related activity does not change much between modalities, and whatever individual changes do occur, they are not systematic in cortical localization across subjects. We discuss our results, combined with results from other studies that present individual data, with respect to the function of cortical association areas.	[Basile, Luis F. H.; Lozano, Mirna D.; Ramos, Renato T.] Univ Metodista Sao Paulo, Fac Saude, Psychophysiol Lab, Sao Paulo, Brazil; [Basile, Luis F. H.; Alvarenga, Milkes Y.; Pereira, Jose F., Jr.] Univ Sao Paulo, Sch Med, Div Neurosurg, Sao Paulo, Brazil; [Machado, Sergio; Velasques, Bruna; Ribeiro, Pedro; Piedade, Roberto] Univ Fed Rio de Janeiro, Dept Psychiat, Rio De Janeiro, Brazil; [Ramos, Renato T.] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil; [Anghinah, Renato] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil; [Alvarenga, Milkes Y.] Univ Sao Judas Tadeu, Sao Paulo, Brazil; [Knyazev, Gennady] Russian Acad Med Sci, Inst Physiol, Siberian Branch, Novosibirsk, Russia	Universidade Metodista de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Sao Judas Tadeu; Research Institute for Neurosciences & Medicine; Russian Academy of Medical Sciences; Russian Academy of Sciences	Basile, LFH (corresponding author), Univ Metodista Sao Paulo, Fac Saude, Psychophysiol Lab, Sao Paulo, Brazil.	lbasile@usp.br	Ramos, Renato T/G-1566-2013; Pereira Júnior, José Francisco/D-9804-2013; Knyazev, Gennady G/F-6095-2010; Machado, Sergio/M-9384-2013; Velasques, Bruna/D-3989-2012	Pereira Júnior, José Francisco/0000-0002-1185-8147; Knyazev, Gennady G/0000-0002-8628-4678; Machado, Sergio/0000-0001-8946-8467; 	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [07/50390-9]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grant 07/50390-9 from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbas H, 1992, Adv Neurol, V57, P91; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P91, DOI 10.1016/S0167-8760(00)00135-5; BASILE LFH, 1994, ELECTROEN CLIN NEURO, V90, P157, DOI 10.1016/0013-4694(94)90007-8; Basile LFH, 2004, BRAZ J MED BIOL RES, V37, P97, DOI 10.1590/S0100-879X2004000100014; Basile LFH, 2003, INT J PSYCHOPHYSIOL, V48, P55, DOI 10.1016/S0167-8760(03)00004-7; Basile LFH, 2002, INT J PSYCHOPHYSIOL, V45, P227, DOI 10.1016/S0167-8760(02)00014-4; Basile LFH, 1997, INT J PSYCHOPHYSIOL, V27, P29, DOI 10.1016/S0167-8760(97)00784-8; BASILE LFH, 1998, COCAINA CRACK ABUSO; Basile LFH, 2007, BIOL RES, V40, P451, DOI [10.4067/S0716-97602007000500007, /S0716-97602007000500007]; Basile LFH, 2007, INT J PSYCHOPHYSIOL, V65, P238, DOI 10.1016/j.ijpsycho.2007.05.001; Basile LFH, 2006, INT J PSYCHOPHYSIOL, V61, P149, DOI 10.1016/j.ijpsycho.2005.09.004; Brannen JH, 2001, AM J NEURORADIOL, V22, P1711; Buchner H, 1997, ELECTROEN CLIN NEURO, V102, P267, DOI 10.1016/S0013-4694(96)95698-9; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; Fell J, 2004, J COGNITIVE NEUROSCI, V16, P1595, DOI 10.1162/0898929042568514; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; Gruber WR, 2005, CEREB CORTEX, V15, P371, DOI 10.1093/cercor/bhh139; Hanslmayr S, 2007, CEREB CORTEX, V17, P1, DOI 10.1093/cercor/bhj129; Herholz K, 1996, NEUROIMAGE, V3, P185, DOI 10.1006/nimg.1996.0020; Hudson AJ, 2000, CAN J NEUROL SCI, V27, P2, DOI 10.1017/S0317167100051908; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Macko K A, 1985, Res Publ Assoc Res Nerv Ment Dis, V63, P73; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, NEUROIMAGE, V44, P265, DOI 10.1016/j.neuroimage.2008.08.019; Mazoyer, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Mechelli A, 2002, NEUROIMAGE, V17, P1459, DOI 10.1006/nimg.2002.1231; Noppeney U, 2004, J ANAT, V205, P433, DOI 10.1111/j.0021-8782.2004.00343.x; Otzenberger H, 2005, NEUROPSYCHOLOGY, V19, P484, DOI 10.1037/0894-4105.19.4.484; Pandya D. N., 1988, COMP PRIMATE BIOL, V4, P39; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Seghier ML, 2007, NEUROIMAGE, V36, P594, DOI 10.1016/j.neuroimage.2007.03.021; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Valencia M, 2006, J NEUROSCI METH, V154, P142, DOI 10.1016/j.jneumeth.2005.12.011; Wei XC, 2004, NEUROIMAGE, V21, P1000, DOI 10.1016/j.neuroimage.2003.10.039; [No title captured]	39	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15022	10.1371/journal.pone.0015022	http://dx.doi.org/10.1371/journal.pone.0015022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698DS	21179421	gold, Green Submitted, Green Published			2022-12-25	WOS:000285572900013
J	Saraiva, LM; da Silva, GSS; Galina, A; da-Silva, WS; Klein, WL; Ferreira, ST; De Felice, FG				Saraiva, Leonardo M.; Seixas da Silva, Gisele S.; Galina, Antonio; da-Silva, Wagner S.; Klein, William L.; Ferreira, Sergio T.; De Felice, Fernanda G.			Amyloid-beta Triggers the Release of Neuronal Hexokinase 1 from Mitochondria	PLOS ONE			English	Article							SOLUBLE-PROTEIN OLIGOMERS; A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TAU-HYPERPHOSPHORYLATION; GLUCOSE-METABOLISM; NEUROTOXICITY; HIPPOCAMPAL; DEPOSITION; MECHANISM	Brain accumulation of the amyloid-beta peptide (A beta) and oxidative stress underlie neuronal dysfunction and memory loss in Alzheimer's disease (AD). Hexokinase (HK), a key glycolytic enzyme, plays important pro-survival roles, reducing mitochondrial reactive oxygen species (ROS) generation and preventing apoptosis in neurons and other cell types. Brain isozyme HKI is mainly associated with mitochondria and HK release from mitochondria causes a significant decrease in enzyme activity and triggers oxidative damage. We here investigated the relationship between A beta-induced oxidative stress and HK activity. We found that A beta triggered HKI detachment from mitochondria decreasing HKI activity in cortical neurons. A beta oligomers further impair energy metabolism by decreasing neuronal ATP levels. A beta-induced HKI cellular redistribution was accompanied by excessive ROS generation and neuronal death. 2-deoxyglucose blocked A beta-induced oxidative stress and neuronal death. Results suggest that A beta-induced cellular redistribution and inactivation of neuronal HKI play important roles in oxidative stress and neurodegeneration in AD.	[Saraiva, Leonardo M.; Seixas da Silva, Gisele S.; Galina, Antonio; da-Silva, Wagner S.; Ferreira, Sergio T.; De Felice, Fernanda G.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil; [Klein, William L.; De Felice, Fernanda G.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Universidade Federal do Rio de Janeiro; Northwestern University	Saraiva, LM (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, Rio De Janeiro, Brazil.	felice@bioqmed.ufrj.br	Galina, Antonio/A-9292-2008; De Felice, Fernanda G/M-1074-2017; da Silva, Gisele S Seixas/J-7628-2017; Ferreira, Sergio/AAZ-1576-2020; da Silva, Wagner S/A-7835-2008	Ferreira, Sergio/0000-0001-7160-9866; da Silva, Wagner S/0000-0002-0001-0386	Human Frontier Science Program (HFSP); John Simon Guggenheim Memorial Foundation; Howard Hughes Medical Institute; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro/Brazil; Instituto Nacional de Neurociencia Translacional/Brazil; American Health Assistance Foundation; Alzheimer's Association; National Institutes of Health-National Institute on Aging [RO1-AG18877, RO1-AG22547]; NATIONAL INSTITUTE ON AGING [R01AG018877, R01AG022547] Funding Source: NIH RePORTER	Human Frontier Science Program (HFSP)(Human Frontier Science Program); John Simon Guggenheim Memorial Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro/Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Neurociencia Translacional/Brazil; American Health Assistance Foundation; Alzheimer's Association(Alzheimer's Association); National Institutes of Health-National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Human Frontier Science Program (HFSP) and The John Simon Guggenheim Memorial Foundation (FGF), Howard Hughes Medical Institute (STF), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro/Brazil and Instituto Nacional de Neurociencia Translacional/Brazil (FGF and STF). WLK is supported by grants from the American Health Assistance Foundation, Alzheimer's Association, National Institutes of Health-National Institute on Aging Grants RO1-AG18877 and RO1-AG22547. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Andersson CX, 2005, BIOCHEM J, V387, P377, DOI 10.1042/BJ20041387; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Baum L, 1996, MOL CHEM NEUROPATHOL, V29, P253, DOI 10.1007/BF02815006; Bigl M, 2003, J NEURAL TRANSM, V110, P77, DOI 10.1007/s00702-002-0772-x; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huang TJ, 2005, MOL CELL NEUROSCI, V28, P42, DOI 10.1016/j.mcn.2004.08.009; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Jolivet Renaud, 2009, Front Neuroenergetics, V1, P4, DOI 10.3389/neuro.14.004.2009; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mark RJ, 1997, J NEUROSCI, V17, P1046; Martins SM, 2006, J BIOL CHEM, V281, P26121, DOI 10.1074/jbc.M605367200; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Moreira PI, 2005, ANN NY ACAD SCI, V1043, P545, DOI 10.1196/annals.1333.062; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Paula-Lima AC, 2005, NEUROPHARMACOLOGY, V49, P1140, DOI 10.1016/j.neuropharm.2005.06.015; Pellerin L, 2005, MOL NEUROBIOL, V32, P59, DOI 10.1385/MN:32:1:059; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; ROSE IA, 1967, J BIOL CHEM, V242, P1635; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P418, DOI 10.1093/jnen/63.5.418; Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Shulman RG, 2004, TRENDS NEUROSCI, V27, P489, DOI 10.1016/j.tins.2004.06.005; Skaff DA, 2005, J BIOL CHEM, V280, P38403, DOI 10.1074/jbc.M506943200; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang Z, 2008, NEUROSCI LETT, V434, P6, DOI 10.1016/j.neulet.2008.01.057; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147	52	71	75	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15230	10.1371/journal.pone.0015230	http://dx.doi.org/10.1371/journal.pone.0015230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179577	Green Submitted, Green Published, gold			2022-12-25	WOS:000285381200018
J	Anne, J				Anne, Joel			Targeting and Anchoring Tudor in the Pole Plasm of the Drosophila Oocyte	PLOS ONE			English	Article							GERM-CELL FORMATION; VASA PROTEIN; METHYLTRANSFERASE CAPSULEEN; POSTERIOR LOCALIZATION; OSKAR TRANSLATION; COMPONENT; GRANULES; GENE; MELANOGASTER; POLARITY	Background: Germline formation is a highly regulated process in all organisms. In Drosophila embryos germ cells are specified by the pole plasm, a specialized cytoplasmic region containing polar granules. Components of these granules are also present in the perinuclear ring surrounding nurse cells, the nuage. Two such molecules are the Vasa and Tudor proteins. How Tudor localizes and is maintained in the pole plasm is, however, not known. Methodology/Principal Findings: Here, the process of Tudor localization in nuage and pole plasm was analyzed. The initial positioning of Tudor at the posterior pole of stage 9 oocytes was found to occur in the absence of a structurally detectable nuage. However, in mutants for genes encoding components of the nuage, including vasa, aubergine, maelstrom, and krimper, Tudor was detached from the posterior cortex in stage 10 oocytes, suggesting a prior passage in the nuage for its stability in the pole plasm. Further studies indicated that Valois, which was previously shown to bind in vitro to Tudor, mediates the localization of Tudor in the pole plasm by physically interacting with Oskar, the polar granule organizer. An association between Tudor and Vasa mediated by RNA was also detected in ovarian extracts. Conclusions/Significance: The present data challenge the view that the assembly of the polar granules occurs in a stepwise and hierarchical manner and, consequently, a revised model of polar granule assembly is proposed. In this model Oskar recruits two downstream components of the polar granules, Vasa and Tudor, independently from each other: Vasa directly interacts with Oskar while Valois mediates the recruitment of Tudor by interacting with Oskar and Tudor.	[Anne, Joel] Deutsch Krebsforschungszentrum, Dept Dev Genet, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Anne, J (corresponding author), Univ Bern, Inst Biol Cellulaire, Bern, Switzerland.	joel.anne@izb.unibe.ch			Deutsches Krebsforschungszentrum (DKFZ)	Deutsches Krebsforschungszentrum (DKFZ)(Helmholtz Association)	Research was funded by the Deutsches Krebsforschungszentrum (DKFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikura R, 2001, MECH DEVELOP, V107, P97, DOI 10.1016/S0925-4773(01)00455-5; Anne J, 2005, DEVELOPMENT, V132, P2167, DOI 10.1242/dev.01809; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; BARDSLEY A, 1993, DEVELOPMENT, V119, P207; BEAMS HW, 1974, INT REV CYTOL, V39, P413, DOI 10.1016/S0074-7696(08)60944-4; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Clegg NJ, 1997, DEVELOPMENT, V124, P4661; EDDY EM, 1975, INT REV CYTOL, V43, P229; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Findley SD, 2003, DEVELOPMENT, V130, P859, DOI 10.1242/dev.00310; Harris AN, 2001, DEVELOPMENT, V128, P2823; HAY B, 1988, DEVELOPMENT, V103, P625; HAY B, 1990, DEVELOPMENT, V109, P425; Jones JR, 2007, DEVELOPMENT, V134, P233, DOI 10.1242/dev.02729; JONGENS TA, 1992, CELL, V70, P569, DOI 10.1016/0092-8674(92)90427-E; KIM JS, 1993, PROTEIN SCI, V2, P348; Kirino Y, 2010, J BIOL CHEM, V285, P8148, DOI 10.1074/jbc.M109.089821; KOBAYASHI S, 1993, SCIENCE, V260, P1521, DOI 10.1126/science.7684857; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Mahowald AP, 2001, INT REV CYTOL, V203, P187; MAHOWALD AP, 1978, GENET BIOL DROSOPHIL, V2, P141; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; RONGO C, 1995, DEVELOPMENT, V121, P2737; Sano H, 2002, MECH DEVELOP, V112, P129, DOI 10.1016/S0925-4773(01)00654-2; Snee MJ, 2004, J CELL SCI, V117, P2109, DOI 10.1242/jcs.01059; Styhler S, 1998, DEVELOPMENT, V125, P1569; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Tearle R., 1987, DROSOPHILA INFORMATI, V66, P209; Thomson T, 2004, GENESIS, V40, P164, DOI 10.1002/gene.20079; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Wilson JE, 1996, DEVELOPMENT, V122, P1631	36	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14362	10.1371/journal.pone.0014362	http://dx.doi.org/10.1371/journal.pone.0014362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179512	gold, Green Submitted, Green Published			2022-12-25	WOS:000285340000016
J	Gendrin, C; Sarrazin, S; Bonnaffe, D; Jault, JM; Lortat-Jacob, H; Dessen, A				Gendrin, Claire; Sarrazin, Stephane; Bonnaffe, David; Jault, Jean-Michel; Lortat-Jacob, Hugues; Dessen, Andrea			Hijacking of the Pleiotropic Cytokine Interferon-gamma by the Type III Secretion System of Yersinia pestis	PLOS ONE			English	Article							ANTIGEN FUSION PEPTIDE; V-ANTIGEN; PSEUDOMONAS-AERUGINOSA; HEPARAN-SULFATE; HOST MEMBRANES; PORE FORMATION; TIP COMPLEX; IFN-GAMMA; BINDING; PROTEIN	Yersinia pestis, the causative agent of bubonic plague, employs its type III secretion system to inject toxins into target cells, a crucial step in infection establishment. LcrV is an essential component of the T3SS of Yersinia spp, and is able to associate at the tip of the secretion needle and take part in the translocation of anti-host effector proteins into the eukaryotic cell cytoplasm. Upon cell contact, LcrV is also released into the surrounding medium where it has been shown to block the normal inflammatory response, although details of this mechanism have remained elusive. In this work, we reveal a key aspect of the immunomodulatory function of LcrV by showing that it interacts directly and with nanomolar affinity with the inflammatory cytokine IFN gamma. In addition, we generate specific IFN gamma mutants that show decreased interaction capabilities towards LcrV, enabling us to map the interaction region to two basic C-terminal clusters of IFN gamma. Lastly, we show that the LcrV-IFN gamma interaction can be disrupted by a number of inhibitors, some of which display nanomolar affinity. This study thus not only identifies novel potential inhibitors that could be developed for the control of Yersinia-induced infection, but also highlights the diversity of the strategies used by Y. pestis to evade the immune system, with the hijacking of pleiotropic cytokines being a long-range mechanism that potentially plays a key role in the severity of plague.	[Gendrin, Claire; Sarrazin, Stephane; Jault, Jean-Michel; Lortat-Jacob, Hugues; Dessen, Andrea] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct,UMR 5075, Grenoble, France; [Bonnaffe, David] Univ Paris 11, Inst Chim Mol & Mat Orsay, Lab Chim Organ Multifonct, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Universite Paris Saclay	Gendrin, C (corresponding author), Univ Grenoble 1, CNRS, CEA, Inst Biol Struct,UMR 5075, Grenoble, France.	andrea.dessen@ibs.fr	jault, jean-michel/G-2086-2012	jault, jean-michel/0000-0003-1743-2777; Dessen, Andrea/0000-0001-6487-4020	Comissariat a l'Energie Atomique (CEA); Mizutani Foundation for Glycoscience; DGA [06.70.151.00.470.75.96]	Comissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission); Mizutani Foundation for Glycoscience; DGA	CG was the recipient of a postdoctoral fellowship from the Comissariat a l'Energie Atomique (CEA) and SS was supported by a grant from the Mizutani Foundation for Glycoscience. This work was supported by DGA grant number 06.70.151.00.470.75.96 (to AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov VM, 2007, J PROTEOME RES, V6, P2222, DOI 10.1021/pr070036r; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Broms JE, 2003, J INFECT DIS, V188, P239, DOI 10.1086/376452; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; BRUBAKER RR, 1991, CONTRIB TO MICROBIOL, V12, P127; Brubaker RR, 2003, INFECT IMMUN, V71, P3673, DOI 10.1128/IAI.71.7.3673-3681.2003; Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; DIVITA G, 1992, BIOCHEMISTRY-US, V31, P5791, DOI 10.1021/bi00140a015; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999; Fields KA, 1999, INFECT IMMUN, V67, P4801, DOI 10.1128/IAI.67.9.4801-4813.1999; Frank DW, 2002, J INFECT DIS, V186, P64, DOI 10.1086/341069; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Haelewyn J, 1995, BIOCHEM MOL BIOL INT, V37, P1163; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; Lee PC, 2010, MOL MICROBIOL, V75, P924, DOI 10.1111/j.1365-2958.2009.07027.x; LORTAT-JACOB H, 1991, J CLIN INVEST, V87, P878, DOI 10.1172/JCI115093; Lortat-Jacob H, 1996, J BIOL CHEM, V271, P16139, DOI 10.1074/jbc.271.27.16139; Lubineau A, 2004, CHEM-EUR J, V10, P4265, DOI 10.1002/chem.200306063; LUNDELL DJ, 1994, PHARMACOL THERAPEUT, V64, P1, DOI 10.1016/0163-7258(94)90031-0; MOTIN VL, 1994, INFECT IMMUN, V62, P4192, DOI 10.1128/IAI.62.10.4192-4201.1994; Motin VL, 1996, INFECT IMMUN, V64, P4313, DOI 10.1128/IAI.64.10.4313-4318.1996; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; NAKAJIMA R, 1995, INFECT IMMUN, V63, P3021, DOI 10.1128/IAI.63.8.3021-3029.1995; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Nanao M, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-21; Nedialkov YA, 1997, INFECT IMMUN, V65, P1196, DOI 10.1128/IAI.65.4.1196-1203.1997; Nilles ML, 1998, J BACTERIOL, V180, P3410, DOI 10.1128/JB.180.13.3410-3420.1998; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x; Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104; Ramamurthi KS, 2002, ANNU REV CELL DEV BI, V18, P107, DOI 10.1146/annurev.cellbio.18.012502.105912; Sadir R, 1998, J BIOL CHEM, V273, P10919, DOI 10.1074/jbc.273.18.10919; Sarrazin S, 2005, J BIOL CHEM, V280, P37558, DOI 10.1074/jbc.M507729200; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315; Sun P, 2008, J MOL BIOL, V377, P819, DOI 10.1016/j.jmb.2007.12.067; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; VanHaverbeke C, 2004, BIOCHEM J, V384, P93, DOI 10.1042/BJ20040757; WALTER MR, 1995, NATURE, V376, P230, DOI 10.1038/376230a0; Wilson M, 1998, INFECT IMMUN, V66, P2401, DOI 10.1128/IAI.66.6.2401-2409.1998; Yahr TL, 1997, J BACTERIOL, V179, P7165, DOI 10.1128/jb.179.22.7165-7168.1997	54	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15242	10.1371/journal.pone.0015242	http://dx.doi.org/10.1371/journal.pone.0015242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179438	Green Submitted, gold, Green Published			2022-12-25	WOS:000285246900036
J	Yano, T; Kassovska-Bratinova, S; Teh, JS; Winkler, J; Sullivan, K; Isaacs, A; Schechter, NM; Rubin, H				Yano, Takahiro; Kassovska-Bratinova, Sacha; Teh, J. Shin; Winkler, Jeffrey; Sullivan, Kevin; Isaacs, Andre; Schechter, Norman M.; Rubin, Harvey			Reduction of Clofazimine by Mycobacterial Type 2 NADH: Quinone Oxidoreductase A PATHWAY FOR THE GENERATION OF BACTERICIDAL LEVELS OF REACTIVE OXYGEN SPECIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAMETHYLPIPERIDINE-SUBSTITUTED PHENAZINES; MENAQUINONE OXIDOREDUCTASE; ANTIMICROBIAL ACTIVITIES; IN-VITRO; MITOCHONDRIA; TUBERCULOSIS; ANALOGS; METABOLISM; MECHANISMS; PARACOCCUS	The mechanism of action of clofazimine (CFZ), an antimycobacterial drug with a long history, is not well understood. The present study describes a redox cycling pathway that involves the enzymatic reduction of CFZ by NDH-2, the primary respiratory chain NADH: quinone oxidoreductase of mycobacteria and nonenzymatic oxidation of reduced CFZ by O-2 yielding CFZ and reactive oxygen species (ROS). This pathway was demonstrated using isolated membranes and purified recombinant NDH-2. The reduction and oxidation of CFZ was measured spectrally, and the production of ROS was measured using a coupled assay system with Amplex Red. Supporting the ROS-based killing mechanism, bacteria grown in the presence of antioxidants are more resistant to CFZ. CFZ-mediated increase in NADH oxidation and ROS production were not observed in membranes from three different Gram-negative bacteria but was observed in Staphylococcus aureus and Saccharomyces cerevisiae, which is consistent with the known antimicrobial specificity of CFZ. A more soluble analog of CFZ, KS6, was synthesized and was shown to have the same activities as CFZ. These studies describe a pathway for a continuous and high rate of reactive oxygen species production in Mycobacterium smegmatis treated with CFZ and a CFZ analog as well as evidence that cell death produced by these agents are related to the production of these radical species.	[Yano, Takahiro; Kassovska-Bratinova, Sacha; Teh, J. Shin; Rubin, Harvey] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Schechter, Norman M.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Schechter, Norman M.; Rubin, Harvey] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Winkler, Jeffrey; Sullivan, Kevin; Isaacs, Andre] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Rubin, H (corresponding author), 522 Johnson Pavil,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	rubinh@upenn.edu		Isaacs, Andre/0000-0002-7222-1668; Sullivan, Kevin/0000-0001-7455-2308	National Institutes of Health [R01-AI068942-02]; Global Alliance for New Tuberculosis Drug Development; Institute for the Translational Medicine and Therapeutics from the University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Alliance for New Tuberculosis Drug Development; Institute for the Translational Medicine and Therapeutics from the University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI068942-02. This work was also supported by grants from the Global Alliance for New Tuberculosis Drug Development and the Institute for the Translational Medicine and Therapeutics from the University of Pennsylvania.; We thank Khisi Mdluli, Zhenkun Ma, and Takushi Kaneko of the Global Alliance for New Tuberculosis Drug Development for intellectual and financial support of this work, whose interest in reinvestigating clofazimine as a tuberculosis drug played a large role in the initiation of this work. We also thank Val Bratinov, Jennifer Yano, and Yashashree Angadi for excellent technical support throughout this study.	Baker SC, 1998, MICROBIOL MOL BIOL R, V62, P1046, DOI 10.1128/MMBR.62.4.1046-1078.1998; BARRY VC, 1957, NATURE, V179, P1013, DOI 10.1038/1791013a0; Bopape MC, 2004, J ANTIMICROB CHEMOTH, V53, P971, DOI 10.1093/jac/dkh215; Cholo MC, 2006, J ANTIMICROB CHEMOTH, V57, P79, DOI 10.1093/jac/dki409; DEVRIES S, 1988, EUR J BIOCHEM, V176, P377; Durandt C, 2001, INT J ONCOL, V19, P579; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; FAHELELBOM KMS, 1993, PHARMACEUT RES, V10, P631, DOI 10.1023/A:1018978809545; FRANZBLAU SG, 1989, ANTIMICROB AGENTS CH, V33, P2004, DOI 10.1128/AAC.33.11.2004; Hoff DR, 2008, ANTIMICROB AGENTS CH, V52, P4137, DOI 10.1128/AAC.00196-08; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KOVACIC P, 1989, BIOELECTROCH BIOENER, V21, P269, DOI 10.1016/0302-4598(89)85006-8; KRAJEWSKA MM, 1993, INT J IMMUNOPHARMACO, V15, P99, DOI 10.1016/0192-0561(93)90086-E; Lai XZ, 2008, ACCOUNTS CHEM RES, V41, P1233, DOI 10.1021/ar700270t; Lenaerts AJ, 2008, TRENDS MICROBIOL, V16, P48, DOI 10.1016/j.tim.2007.12.002; MEISINGER C, 2006, METHOD MOL BIOL, V313, P33039; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; MORRISON NE, 1976, INT J LEPROSY, V44, P475; NIWA Y, 1984, J CLIN MICROBIOL, V20, P837, DOI 10.1128/JCM.20.5.837-842.1984; OConnor R, 1995, DRUG METAB REV, V27, P591, DOI 10.3109/03602539508994208; Oliva B, 2004, J ANTIMICROB CHEMOTH, V53, P435, DOI 10.1093/jac/dkh114; PON L, 1989, J CELL BIOL, V109, P2603, DOI 10.1083/jcb.109.6.2603; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Reddy VM, 1999, J ANTIMICROB CHEMOTH, V43, P615, DOI 10.1093/jac/43.5.615; Reddy VM, 1996, ANTIMICROB AGENTS CH, V40, P633, DOI 10.1128/AAC.40.3.633; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; RHODES PM, 1973, BIOCHEM PHARMACOL, V22, P1047, DOI 10.1016/0006-2952(73)90169-X; ROSNER JL, 1994, ANTIMICROB AGENTS CH, V38, P1829, DOI 10.1128/AAC.38.8.1829; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sanchez MR, 2000, CLIN DERMATOL, V18, P131, DOI 10.1016/S0738-081X(99)00103-0; Sano K, 2004, ANTIMICROB AGENTS CH, V48, P2132, DOI 10.1128/AAC.48.6.2132-2139.2004; Teh J. S., 2007, Infectious Disorders - Drug Targets, V7, P169; Timmins GS, 2006, MOL MICROBIOL, V62, P1220, DOI 10.1111/j.1365-2958.2006.05467.x; van Rensburg CEJ, 2000, CHEMOTHERAPY, V46, P43, DOI 10.1159/000007255; VANRENSBURG CEJ, 1982, ANTIMICROB AGENTS CH, V21, P693, DOI 10.1128/AAC.21.5.693; VANRENSBURG CEJ, 1992, ANTIMICROB AGENTS CH, V36, P2729, DOI 10.1128/AAC.36.12.2729; VANRENSBURG CEJ, 1993, CANCER RES, V53, P318; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yang LH, 2007, J AM CHEM SOC, V129, P12141, DOI 10.1021/ja072310o; Yano T, 2006, J BIOL CHEM, V281, P11456, DOI 10.1074/jbc.M508844200; Yano T, 2001, J BIOENERG BIOMEMBR, V33, P213, DOI 10.1023/A:1010782903144; ZEIS BM, 1986, INT J IMMUNOPHARMACO, V8, P731, DOI 10.1016/0192-0561(86)90009-3; ZEIS BM, 1987, ANTIMICROB AGENTS CH, V31, P789, DOI 10.1128/AAC.31.5.789	51	208	219	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10276	10287		10.1074/jbc.M110.200501	http://dx.doi.org/10.1074/jbc.M110.200501			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21193400	hybrid, Green Published			2022-12-25	WOS:000288547000045
J	Willis, KL; Langland, JO; Shisler, JL				Willis, Kristen L.; Langland, Jeffrey O.; Shisler, Joanna L.			Viral Double-stranded RNAs from Vaccinia Virus Early or Intermediate Gene Transcripts Possess PKR Activating Function, Resulting in NF-kappa B Activation, When the K1 Protein Is Absent or Mutated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HELA-CELLS; HOST-RANGE; KINASE PKR; INFECTED-CELLS; DNA VIRUSES; LIFE-CYCLE; INHIBITION; INTERFERON; TRANSLATION; TERMINATION	PKR is a potent antiviral molecule that can terminate infection by inhibiting protein synthesis and stimulating NF-kappa B activation and apoptosis. Originally, it was thought that only intermediate and late gene transcription produced double-stranded (ds) RNA to activate PKR during vaccinia virus (VACV) infection. The VACV E3 or K3 proteins squelch this effect by binding to either dsRNA or PKR. However, in the absence of the K1 protein, VACV infection activates PKR at very early times post-infection and despite the presence of E3 and K3. These data suggest that VACV infection induces PKR activation by a currently unknown mechanism. To determine this mechanism, cells were infected with K1L-containing or -deficient VACVs. By using conditions that limited the progression of the poxvirus replication cycle, we observed that early gene transcripts activated PKR in RK13 cells, identifying a new PKR-activating mechanism of poxvirus infection. Using a similar approach for HeLa cells, intermediate gene transcription was sufficient to activate PKR. RNA isolated from infected RK13 or HeLa cells maintained PKR-activating properties only when dsRNA was present. Moreover, viral dsRNA was directly detected in infected cells either by RT-PCR or immunofluorescent microscopy. Interestingly, dsRNA levels were higher in infected cells in which the K1 protein was nonfunctional. Only K1 proteins with PKR inhibitory function prevented downstream NF-kappa B activation. These results reveal a new PKR activation pathway during VACV infection, in which the K1 protein reduces dsRNA levels early in VACV infection to directly inhibit PKR and several of its downstream antiviral effects, thereby enhancing virus survival.	[Willis, Kristen L.; Shisler, Joanna L.] Univ Illinois, Coll Med, Dept Microbiol, Urbana, IL 61801 USA; [Langland, Jeffrey O.] SW Coll Naturopath Med, Dept Naturopath Res, Tempe, AZ 85282 USA; [Langland, Jeffrey O.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA	University of Illinois System; University of Illinois Urbana-Champaign; Arizona State University; Arizona State University-Tempe	Shisler, JL (corresponding author), B103 Chem & Life Sci Bldg,601 S Goodwin Ave, Urbana, IL 61801 USA.	jshisler@illinois.edu		Shisler, Joanna/0000-0003-4833-1557	NIAID [AI055530, T32 GM007283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007283] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI055530 from NIAID (to J. L. S.).; Supported by National Institutes of Health Training Grant T32 GM007283.	Backes S, 2010, J GEN VIROL, V91, P470, DOI 10.1099/vir.0.015347-0; BAYLISS CD, 1993, VIROLOGY, V194, P254, DOI 10.1006/viro.1993.1256; BEATTIE E, 1991, VIROLOGY, V183, P419, DOI 10.1016/0042-6822(91)90158-8; BEAUD G, 1980, VIROLOGY, V100, P10, DOI 10.1016/0042-6822(80)90547-4; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; BOONE RF, 1979, J VIROL, V30, P365, DOI 10.1128/JVI.30.1.365-374.1979; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Chang SJ, 2009, J VIROL, V83, P4140, DOI 10.1128/JVI.01835-08; Condit RC, 2002, BBA-GENE STRUCT EXPR, V1577, P325, DOI 10.1016/S0167-4781(02)00461-X; EARL PL, 1990, J VIROL, V64, P2448, DOI 10.1128/JVI.64.5.2448-2451.1990; ESTEBAN M, 1973, J GEN VIROL, V20, P111, DOI 10.1099/0022-1317-20-1-111; FRIEDMAN RM, 1972, FEBS LETT, V24, P273, DOI 10.1016/0014-5793(72)80371-5; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Gedey R, 2006, J VIROL, V80, P8676, DOI 10.1128/JVI.00935-06; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gil J, 2001, J GEN VIROL, V82, P3027, DOI 10.1099/0022-1317-82-12-3027; Hsiao JC, 2004, VIROLOGY, V329, P199, DOI 10.1016/j.virol.2004.07.032; Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; KERR IM, 1974, J VIROL, V13, P9, DOI 10.1128/JVI.13.1.9-21.1974; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; Li YC, 2010, J VIROL, V84, P3331, DOI 10.1128/JVI.02332-09; Ludwig H, 2006, J GEN VIROL, V87, P1145, DOI 10.1099/vir.0.81623-0; Ludwig H, 2005, J VIROL, V79, P2584, DOI 10.1128/JVI.79.4.2584-2596.2005; Lynch HE, 2009, VIROLOGY, V391, P177, DOI 10.1016/j.virol.2009.06.012; Martin S, 2009, VIROLOGY, V390, P298, DOI 10.1016/j.virol.2009.05.014; Meng XZ, 2006, VIROLOGY, V353, P220, DOI 10.1016/j.virol.2006.05.032; Moss B, 2007, FIELDS VIROLOGY; Myskiw C, 2009, J VIROL, V83, P6757, DOI 10.1128/JVI.02570-08; PERKUS ME, 1990, VIROLOGY, V179, P276, DOI 10.1016/0042-6822(90)90296-4; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; RamseyEwing AL, 1996, VIROLOGY, V222, P75, DOI 10.1006/viro.1996.0399; Raven JF, 2008, CELL CYCLE, V7, P1146, DOI 10.4161/cc.7.9.5811; Robertson HD, 1996, BIOCHIMIE, V78, P909, DOI 10.1016/S0300-9084(97)86712-0; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; Weaver JR, 2007, VIRUS RES, V130, P269, DOI 10.1016/j.virusres.2007.05.012; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Willis KL, 2009, VIROLOGY, V394, P73, DOI 10.1016/j.virol.2009.08.020; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07	42	36	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7765	7778		10.1074/jbc.M110.194704	http://dx.doi.org/10.1074/jbc.M110.194704			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21183678	Green Published, hybrid			2022-12-25	WOS:000288013300008
J	Kawai, Y; Garduno, L; Theodore, M; Yang, JQ; Arinze, IJ				Kawai, Yumiko; Garduno, LaKisha; Theodore, Melanie; Yang, Jianqi; Arinze, Ifeanyi J.			Acetylation-Deacetylation of the Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-related Factor 2) Regulates Its Transcriptional Activity and Nucleocytoplasmic Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; ADENOVIRAL ONCOPROTEIN E1A; SUBSTRATE ADAPTER PROTEIN; PROMOTES CELL-SURVIVAL; CREB-BINDING-PROTEIN; GENE-EXPRESSION; KAPPA-B; ACETYLTRANSFERASE ACTIVITY; NEUROBLASTOMA-CELLS; OXIDATIVE STRESS	Activation of Nrf2 by covalent modifications that release it from its inhibitor protein Keap1 has been extensively documented. In contrast, covalent modifications that may regulate its action after its release from Keap1 have received little attention. Here we show that CREB-binding protein induced acetylation of Nrf2, increased binding of Nrf2 to its cognate response element in a target gene promoter, and increased Nrf2-dependent transcription from target gene promoters. Heterologous sirtuin 1 (SIRT1) decreased acetylation of Nrf2 as well as Nrf2-dependent gene transcription, and its effects were overridden by dominant negative SIRT1 (SIRT1-H355A). The SIRT1-selective inhibitors EX-527 and nicotinamide stimulated Nrf2-dependent gene transcription, whereas resveratrol, a putative activator of SIRT1, was inhibitory, mimicking the effect of SIRT1. Mutating lysine to alanine or to arginine at Lys(588) and Lys(591) of Nrf2 resulted in decreased Nrf2-dependent gene transcription and abrogated the transcription-activating effect of CREB-binding protein. Furthermore, SIRT1 had no effect on transcription induced by these mutants, indicating that these sites are acetylation sites. Microscope imaging of GFP-Nrf2 in HepG2 cells as well as immunoblotting for Nrf2 showed that acetylation conditions resulted in increased nuclear localization of Nrf2, whereas deacetylation conditions enhanced its cytoplasmic rather than its nuclear localization. We posit that Nrf2 in the nucleus undergoes acetylation, resulting in binding, with basic-region leucine zipper protein(s), to the antioxidant response element and consequently in gene transcription, whereas deacetylation disengages it from the antioxidant response element, thereby resulting in transcriptional termination and subsequently in its nuclear export.	[Kawai, Yumiko; Garduno, LaKisha; Theodore, Melanie; Arinze, Ifeanyi J.] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Yang, Jianqi] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	Meharry Medical College; University of Iowa	Arinze, IJ (corresponding author), Meharry Med Coll, Dept Physiol, Rm 2105,Basic Sci Bldg, Nashville, TN 37208 USA.	iarinze@mmc.edu			National Institutes of Health [SO6-GM08037, SC1CA143985, U54NS041071, U54CA9140, U54RR026140, G12RR03032, 5T32HL007737]; Meharry Medical College Morphology Core Laboratory; Alpha Omega Alpha Carolyn L. Kuckein; Center of Excellence [HRSA D34HP00003]; NATIONAL CANCER INSTITUTE [SC1CA143985, T32CA009140] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003032, U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Meharry Medical College Morphology Core Laboratory; Alpha Omega Alpha Carolyn L. Kuckein; Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants SO6-GM08037 and SC1CA143985. This work was also supported by the Meharry Medical College Morphology Core Laboratory, which is supported in part by National Institutes of Health Grants U54NS041071, U54CA9140, U54RR026140, and G12RR03032. This work was presented in poster form at the Experimental Biology Meeting, April 18-22, 2009, New Orleans, LA (Garduno, L., Theodore, M., Kawai, Y., and Arinze, I.J. (2009) FASEB J.23, A495.13).; Supported in part by an Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship and by Center of Excellence Grant HRSA D34HP00003 to the School of Medicine, Meharry Medical College.; Supported by National Institutes of Health Training Grant 5T32HL007737.	Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Arinze IJ, 2005, J BIOL CHEM, V280, P9786, DOI 10.1074/jbc.M414006200; Arinze IJ, 2003, J BIOL CHEM, V278, P17785, DOI 10.1074/jbc.M209430200; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brown SL, 2008, CANCER RES, V68, P364, DOI 10.1158/0008-5472.CAN-07-2170; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Davis MG, 2000, BIOCHEM J, V346, P455, DOI 10.1042/0264-6021:3460455; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Flint J, 1997, ANNU REV GENET, V31, P177, DOI 10.1146/annurev.genet.31.1.177; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Forsberg EC, 1999, J BIOL CHEM, V274, P26850, DOI 10.1074/jbc.274.38.26850; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Goodman RH, 2000, GENE DEV, V14, P1553; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Isobe T, 2009, J BIOL CHEM, V284, P27766, DOI 10.1074/jbc.M109.006809; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kawai Y, 2006, CANCER RES, V66, P6563, DOI 10.1158/0008-5472.CAN-06-0814; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Li W, 2008, BBA-MOL CELL RES, V1783, P1847, DOI 10.1016/j.bbamcr.2008.05.024; Li WG, 2006, J BIOL CHEM, V281, P27251, DOI 10.1074/jbc.M602746200; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Li WG, 2005, J BIOL CHEM, V280, P28430, DOI 10.1074/jbc.M410601200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mai A, 2005, J MED CHEM, V48, P7789, DOI 10.1021/jm050100l; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Moehlenkamp JD, 1999, ARCH BIOCHEM BIOPHYS, V363, P98, DOI 10.1006/abbi.1998.1046; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Orino K, 1999, FEBS LETT, V461, P334, DOI 10.1016/S0014-5793(99)01443-X; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Perissi V, 1999, P NATL ACAD SCI USA, V96, P3652, DOI 10.1073/pnas.96.7.3652; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yang JQ, 2001, J BIOL CHEM, V276, P25742, DOI 10.1074/jbc.M102821200; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	79	227	239	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7629	7640		10.1074/jbc.M110.208173	http://dx.doi.org/10.1074/jbc.M110.208173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21196497	Green Published, hybrid			2022-12-25	WOS:000287737300076
J	Spears, E; Neufeld, KL				Spears, Erick; Neufeld, Kristi L.			Novel Double-negative Feedback Loop between Adenomatous Polyposis Coli and Musashi1 in Colon Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN MUSASHI-1; INTESTINAL STEM-CELLS; APC TUMOR-SUPPRESSOR; NUCLEAR EXPORT; MESSENGER-RNA; IN-VIVO; MARKER; CANCER; WNT; IDENTIFICATION	Loss of tumor suppressor adenomatous polyposis coli (APC) is thought to initiate the majority of all colorectal cancers. The predominant theory of colorectal carcinogenesis implicates stem cells as the initiating cells. However, relatively little is known about the function of APC in governing the homeostasis of normal intestinal stem cells. Here, we identify a novel double-negative feedback loop between APC and a translation inhibitor protein, Musashi1 (MSI1), in cultured human colonocytes. We show APC as a key factor in MSI1 regulation through Wnt signaling and identify APC mRNA as a novel target of translational inhibition by MSI1. We propose that APC/MSI1 interactions maintain homeostatic balance in the intestinal epithelium.	[Spears, Erick; Neufeld, Kristi L.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Neufeld, KL (corresponding author), 1200 Sunnyside Ave,Haworth Hall 7049, Lawrence, KS 66045 USA.	klneuf@ku.edu		Neufeld, Kristi/0000-0003-3653-9385	Kansas Masonic Cancer Research Institute; Kansas Institutional Development Award Network of Biomedical Research Excellence [NIH P20 RR016475]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	Kansas Masonic Cancer Research Institute; Kansas Institutional Development Award Network of Biomedical Research Excellence; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by funds from the Kansas Masonic Cancer Research Institute and the Kansas Institutional Development Award Network of Biomedical Research Excellence, NIH P20 RR016475.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Clarke AR, 2006, ONCOGENE, V25, P7512, DOI 10.1038/sj.onc.1210065; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fukui T, 2006, DIGEST DIS SCI, V51, P1260, DOI 10.1007/s10620-006-8046-3; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; Miyanoiri Y, 2003, J BIOL CHEM, V278, P41309, DOI 10.1074/jbc.M306210200; Neufeld KL, 2000, P NATL ACAD SCI USA, V97, P12085, DOI 10.1073/pnas.220401797; Neufeld KL, 2000, EMBO REP, V1, P519; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rezza A, 2010, J CELL SCI, V123, P3256, DOI 10.1242/jcs.065284; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sureban SM, 2008, GASTROENTEROLOGY, V134, pA86; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218	27	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4946	4950		10.1074/jbc.C110.205922	http://dx.doi.org/10.1074/jbc.C110.205922			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21199875	Green Published, hybrid			2022-12-25	WOS:000287230600002
J	Baroni, F; Torres, JJ; Varona, P				Baroni, Fabiano; Torres, Joaquin J.; Varona, Pablo			History-Dependent Excitability as a Single-Cell Substrate of Transient Memory for Information Discrimination	PLOS ONE			English	Article							GRADED PERSISTENT ACTIVITY; MEMBRANE-POTENTIAL FLUCTUATIONS; TERM SYNAPTIC PLASTICITY; NEURONS IN-VIVO; PREFRONTAL CORTEX; CORTICAL-NEURONS; WORKING-MEMORY; NETWORK STATES; TEMPORAL INFORMATION; NEURAL INFORMATION	Neurons react differently to incoming stimuli depending upon their previous history of stimulation. This property can be considered as a single-cell substrate for transient memory, or context-dependent information processing: depending upon the current context that the neuron "sees" through the subset of the network impinging on it in the immediate past, the same synaptic event can evoke a postsynaptic spike or just a subthreshold depolarization. We propose a formal definition of History-Dependent Excitability (HDE) as a measure of the propensity to firing in any moment in time, linking the subthreshold history-dependent dynamics with spike generation. This definition allows the quantitative assessment of the intrinsic memory for different single-neuron dynamics and input statistics. We illustrate the concept of HDE by considering two general dynamical mechanisms: the passive behavior of an Integrate and Fire (IF) neuron, and the inductive behavior of a Generalized Integrate and Fire (GIF) neuron with subthreshold damped oscillations. This framework allows us to characterize the sensitivity of different model neurons to the detailed temporal structure of incoming stimuli. While a neuron with intrinsic oscillations discriminates equally well between input trains with the same or different frequency, a passive neuron discriminates better between inputs with different frequencies. This suggests that passive neurons are better suited to rate-based computation, while neurons with subthreshold oscillations are advantageous in a temporal coding scheme. We also address the influence of intrinsic properties in single-cell processing as a function of input statistics, and show that intrinsic oscillations enhance discrimination sensitivity at high input rates. Finally, we discuss how the recognition of these cell-specific discrimination properties might further our understanding of neuronal network computations and their relationships to the distribution and functional connectivity of different neuronal types.	[Baroni, Fabiano; Varona, Pablo] Univ Autonoma Madrid, Escuela Politecn Super, Dept Ingn Informat, Grp Neurocomputac Biol, Madrid, Spain; [Torres, Joaquin J.] Univ Granada, Dept Electromagnetismo & Fis Mat, Granada, Spain; [Torres, Joaquin J.] Univ Granada, Inst Carlos Theoret & Computat Phys, Granada, Spain	Autonomous University of Madrid; University of Granada; University of Granada	Baroni, F (corresponding author), Univ Autonoma Madrid, Escuela Politecn Super, Dept Ingn Informat, Grp Neurocomputac Biol, Madrid, Spain.	fabiano.baroni@uam.es	Baroni, Fabiano/R-8180-2019; Torres, Joaquín J./AAE-6228-2019; Varona, Pablo/B-5583-2012; Torres, Joaquín J./C-1385-2012	Baroni, Fabiano/0000-0001-6047-8100; Varona, Pablo/0000-0002-1754-8991; Torres, Joaquín J./0000-0001-6175-9676	Spanish MICINN (Ministerio de Ciencia e Innovacion) [BFU2009-08473]; Spanish CAM (Comunidad Autonoma de Madrid) [S-SEM-0255-2006]; Spanish JA (Junta de Andalucia) [MICINN FIS2009-08451, FQM-01505]	Spanish MICINN (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish CAM (Comunidad Autonoma de Madrid)(Comunidad de Madrid); Spanish JA (Junta de Andalucia)(Junta de Andalucia)	FB and PV are supported by projects BFU2009-08473 financed by the Spanish MICINN (Ministerio de Ciencia e Innovacion) and S-SEM-0255-2006 by the Spanish CAM (Comunidad Autonoma de Madrid). JJT is supported by projects MICINN FIS2009-08451 and FQM-01505 financed by the Spanish JA (Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel HDI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.148104; Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Adrian ED, 1923, J PHYSIOL-LONDON, V58, P0209; Anderson RB, 2001, MEM COGNITION, V29, P1061, DOI 10.3758/BF03195767; Arnold L, 2003, SPRINGER MONOGRAPHS; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Baker SN, 2000, J NEUROPHYSIOL, V84, P1770, DOI 10.1152/jn.2000.84.4.1770; Baroni F, 2007, NEUROCOMPUTING, V70, P1611, DOI 10.1016/j.neucom.2006.10.042; Baroni F, 2010, J PHYSIOL-PARIS, V104, P91, DOI 10.1016/j.jphysparis.2009.11.007; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Buzsaki G., 2006, RHYTHMS BRAIN; Chelaru MI, 2008, P NATL ACAD SCI USA, V105, P16344, DOI 10.1073/pnas.0807744105; Cole KS, 1932, J GEN PHYSIOL, V15, P641, DOI 10.1085/jgp.15.6.641; Cole KS, 1941, J GEN PHYSIOL, V25, P29, DOI 10.1085/jgp.25.1.29; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; DEVALOIS RL, 1962, SCIENCE, V136, P986, DOI 10.1126/science.136.3520.986; Durstewitz D, 2008, EUR J NEUROSCI, V27, P217, DOI 10.1111/j.1460-9568.2007.05976.x; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Fontanini A, 2008, J NEUROPHYSIOL, V100, P1160, DOI 10.1152/jn.90592.2008; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Hill AV, 1936, PROC R SOC SER B-BIO, V119, P305, DOI 10.1098/rspb.1936.0012; Hooper SL, 1998, NAT NEUROSCI, V1, P720, DOI 10.1038/3721; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Johnson HA, 2007, J NEUROSCI, V27, P5915, DOI 10.1523/JNEUROSCI.0447-07.2007; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; Kavalali ET, 2007, J PHYSIOL-LONDON, V585, P669, DOI 10.1113/jphysiol.2007.137745; Kintos N, 2008, J COMPUT NEUROSCI, V24, P374, DOI 10.1007/s10827-007-0061-7; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kleppe IC, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041909; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; Latorre R, 2006, BIOL CYBERN, V95, P169, DOI 10.1007/s00422-006-0077-5; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Legenstein R, 2007, NEURAL NETWORKS, V20, P323, DOI 10.1016/j.neunet.2007.04.017; Li CG, 2006, PLOS COMPUT BIOL, V2, P925, DOI 10.1371/journal.pcbi.0020103; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Moreno R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.288101; Nadim F, 2008, J NEUROSCI, V28, P11806, DOI 10.1523/JNEUROSCI.3796-08.2008; Nayak TK, 2007, J MEMBRANE BIOL, V219, P19, DOI 10.1007/s00232-007-9058-4; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Pakdaman K, 2002, NEURAL COMPUT, V14, P781, DOI 10.1162/089976602317318956; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Proekt A, 2004, P NATL ACAD SCI USA, V101, P9447, DOI 10.1073/pnas.0402002101; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Rabinovich MI, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000072; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Rainer G, 1999, J NEUROSCI, V19, P5493; Richardson MJE, 2003, J NEUROPHYSIOL, V89, P2538, DOI 10.1152/jn.00955.2002; RIPLEY S. H., 1953, PHYSIOL COMPARATA ET OECOL, V3, P1; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Saideman SR, 2007, J NEUROSCI, V27, P6664, DOI 10.1523/JNEUROSCI.0315-07.2007; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Scheich H, 2005, COMPUTATIONAL NEUROS, P343; Schreiber S, 2004, J NEUROPHYSIOL, V92, P408, DOI 10.1152/jn.01116.2003; SEGUNDO JP, 1963, J EXP BIOL, V40, P643; Seung HS, 2000, J COMPUT NEUROSCI, V9, P171, DOI 10.1023/A:1008971908649; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shamir M, 2006, NEURAL COMPUT, V18, P1951, DOI 10.1162/neco.2006.18.8.1951; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; Sikstrom S, 2002, COGNITIVE PSYCHOL, V45, P95, DOI 10.1016/S0010-0285(02)00012-9; Soltesz I, 2005, DIVERSITY NEURONAL M; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Steriade M, 2004, NAT REV NEUROSCI, V5, P121, DOI 10.1038/nrn1325; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Szucs A, 2003, J NEUROPHYSIOL, V89, P1363, DOI 10.1152/jn.00732.2002; Takeda K, 2002, J NEUROPHYSIOL, V87, P567, DOI 10.1152/jn.00249.2001; Tateno T, 2004, CHAOS, V14, P511, DOI 10.1063/1.1756118; Teramae JN, 2005, J COMPUT NEUROSCI, V18, P105, DOI 10.1007/s10827-005-5474-6; THOMSON AM, 1994, TRENDS NEUROSCI, V17, P119, DOI 10.1016/0166-2236(94)90121-X; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P793, DOI 10.1017/S0140525X01000097; Turrigiano GG, 1996, J NEUROPHYSIOL, V75, P963, DOI 10.1152/jn.1996.75.2.963; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; White JA, 1998, J COMPUT NEUROSCI, V5, P5, DOI 10.1023/A:1008841325921; WIERSMA CAG, 1950, PHYS COMP OECOL, V2, P20; Winograd M, 2008, P NATL ACAD SCI USA, V105, P7298, DOI 10.1073/pnas.0800360105; Wolf DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001700; Wolfe J, 2010, CURR OPIN NEUROBIOL, V20, P306, DOI 10.1016/j.conb.2010.03.006; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhurov Y, 2006, J NEUROSCI, V26, P7056, DOI 10.1523/JNEUROSCI.5277-05.2006; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	109	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15023	10.1371/journal.pone.0015023	http://dx.doi.org/10.1371/journal.pone.0015023			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203387	Green Published, Green Submitted, gold			2022-12-25	WOS:000285792500021
J	Gonzalez-Roca, E; Garcia-Albeniz, X; Rodriguez-Mulero, S; Gomis, RR; Kornacker, K; Auer, H				Gonzalez-Roca, Eva; Garcia-Albeniz, Xabier; Rodriguez-Mulero, Silvia; Gomis, Roger R.; Kornacker, Karl; Auer, Herbert			Accurate Expression Profiling of Very Small Cell Populations	PLOS ONE			English	Article							SINGLE-CELL; GENE-EXPRESSION; MESSENGER-RNA; STEM-CELLS; AMPLIFICATION; CDNA; QUANTITIES; LEVEL	Background: Expression profiling, the measurement of all transcripts of a cell or tissue type, is currently the most comprehensive method to describe their physiological states. Given that accurate profiling methods currently available require RNA amounts found in thousands to millions of cells, many fields of biology working with specialized cell types cannot use these techniques because available cell numbers are limited. Currently available alternative methods for expression profiling from nanograms of RNA or from very small cell populations lack a broad validation of results to provide accurate information about the measured transcripts. Methods and Findings: We provide evidence that currently available methods for expression profiling of very small cell populations are prone to technical noise and therefore cannot be used efficiently as discovery tools. Furthermore, we present Pico Profiling, a new expression profiling method from as few as ten cells, and we show that this approach is as informative as standard techniques from thousands to millions of cells. The central component of Pico Profiling is Whole Transcriptome Amplification (WTA), which generates expression profiles that are highly comparable to those produced by others, at different times, by standard protocols or by Real-time PCR. We provide a complete workflow from RNA isolation to analysis of expression profiles. Conclusions: Pico Profiling, as presented here, allows generating an accurate expression profile from cell populations as small as ten cells.	[Gonzalez-Roca, Eva; Garcia-Albeniz, Xabier; Rodriguez-Mulero, Silvia; Gomis, Roger R.; Auer, Herbert] Inst Res Biomed, Barcelona, Spain; [Garcia-Albeniz, Xabier] Hosp Clin Barcelona, Barcelona, Spain; [Gomis, Roger R.] Inst Catala Recerca & Estudis Avancats, Barcelona, Spain; [Kornacker, Karl] Ohio State Univ, Div Sensory Biophys, Columbus, OH 43210 USA	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Hospital Clinic de Barcelona; ICREA; University System of Ohio; Ohio State University	Gonzalez-Roca, E (corresponding author), Inst Res Biomed, Barcelona, Spain.	herbert.auer@irbbarcelona.org	Rodriguez-Mulero, Silvia/J-9758-2014; Auer, Herbert/AAV-2332-2020; Gomis, Roger R/E-9788-2016	Rodriguez-Mulero, Silvia/0000-0001-5818-7304; Gomis, Roger R/0000-0001-6473-2858; Garcia-Albeniz, Xabier/0000-0002-9814-2343; Gonzalez-Roca, Eva/0000-0002-1126-0321	Foundation Banco Bilbao Vizcaya Argentaria (Fundacion BBVA); Foundation Genoma Espanya; Institut d'investigacions Biomediques August Pi i Sunyer (IDIBAPS)	Foundation Banco Bilbao Vizcaya Argentaria (Fundacion BBVA); Foundation Genoma Espanya; Institut d'investigacions Biomediques August Pi i Sunyer (IDIBAPS)	This work was supported by the Foundation Banco Bilbao Vizcaya Argentaria (Fundacion BBVA, www.fbbva.es) to RRG, by the Foundation Genoma Espanya (www.gen-es.org) to EG, SR and HA and by Institut d'investigacions Biomediques August Pi i Sunyer (IDIBAPS, www.idibaps.org) to XG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-111; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Clement-Ziza M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-246; Eklund AC, 2006, NAT BIOTECHNOL, V24, P1071, DOI 10.1038/nbt0906-1071; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Janes KA, 2010, NAT METHODS, V7, P311, DOI [10.1038/nmeth.1442, 10.1038/NMETH.1442]; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurn N, 2005, CLIN CHEM, V51, P1973, DOI 10.1373/clinchem.2005.053694; Nygaard V, 2006, NUCLEIC ACIDS RES, V34, P996, DOI 10.1093/nar/gkj499; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Pradervand S, 2008, BIOTECHNIQUES, V44, P759, DOI 10.2144/000112751; Sambrook J, 2001, MOL CLONING LAB MANU; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Subkhankulova T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r18; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tomlins SA, 2006, NEOPLASIA, V8, P153, DOI 10.1593/neo.05754; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Viale Agnes, 2007, J Biomol Tech, V18, P150; Wilson CL, 2004, BIOTECHNIQUES, V36, P498, DOI 10.2144/04363RN05; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844; Zhumabayeva B, 2001, BIOTECHNIQUES, V30, P158, DOI 10.2144/01301pf01	29	54	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14418	10.1371/journal.pone.0014418	http://dx.doi.org/10.1371/journal.pone.0014418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203435	Green Submitted, Green Published, gold			2022-12-25	WOS:000285792500005
J	Little, SA; Kembel, SW; Wilf, P				Little, Stefan A.; Kembel, Steven W.; Wilf, Peter			Paleotemperature Proxies from Leaf Fossils Reinterpreted in Light of Evolutionary History	PLOS ONE			English	Article							MARGIN ANALYSIS; TERRESTRIAL PALEOCLIMATE; COEXISTENCE APPROACH; NEOTROPICAL FORESTS; ANGIOSPERM LEAVES; TERTIARY FLORAS; SOUTH-AMERICA; EARLY EOCENE; CLIMATE; SHAPE	Present-day correlations between leaf physiognomic traits (shape and size) and climate are widely used to estimate paleoclimate using fossil floras. For example, leaf-margin analysis estimates paleotemperature using the modern relation of mean annual temperature (MAT) and the site-proportion of untoothed-leaf species (NT). This uniformitarian approach should provide accurate paleoclimate reconstructions under the core assumption that leaf-trait variation principally results from adaptive environmental convergence, and because variation is thus largely independent of phylogeny it should be constant through geologic time. Although much research acknowledges and investigates possible pitfalls in paleoclimate estimation based on leaf physiognomy, the core assumption has never been explicitly tested in a phylogenetic comparative framework. Combining an extant dataset of 21 leaf traits and temperature with a phylogenetic hypothesis for 569 species-site pairs at 17 sites, we found varying amounts of non-random phylogenetic signal in all traits. Phylogenetic vs. standard regressions generally support prevailing ideas that leaf-traits are adaptively responding to temperature, but wider confidence intervals, and shifts in slope and intercept, indicate an overall reduced ability to predict climate precisely due to the non-random phylogenetic signal. Notably, the modern-day relation of proportion of untoothed taxa with mean annual temperature (NT-MAT), central in paleotemperature inference, was greatly modified and reduced, indicating that the modern correlation primarily results from biogeographic history. Importantly, some tooth traits, such as number of teeth, had similar or steeper slopes after taking phylogeny into account, suggesting that leaf teeth display a pattern of exaptive evolution in higher latitudes. This study shows that the assumption of convergence required for precise, quantitative temperature estimates using present-day leaf traits is not supported by empirical evidence, and thus we have very low confidence in previously published, numerical paleotemperature estimates. However, interpreting qualitative changes in paleotemperature remains warranted, given certain conditions such as stratigraphically closely-spaced samples with floristic continuity.	[Little, Stefan A.; Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Little, Stefan A.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kembel, Steven W.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis; University of Oregon	Little, SA (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	dslittle@ucdavis.edu		Wilf, Peter/0000-0001-6813-1937; Kembel, Steven/0000-0001-5224-0952	David and Lucile Packard Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by the David and Lucile Packard Foundation to Peter Wilf, which funded Stefan Little's position at Pennsylvania State University 2006-2009 (http://www.packard.org/home.aspx, http://www.packard.org/fellowsDetails.aspx?RootCatID = 3&CategoryID = 70&ItemID = 2951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2008, GLOBAL PLANET CHANGE, V60, P523, DOI 10.1016/j.gloplacha.2007.07.001; Aizen MA, 2008, GLOBAL ECOL BIOGEOGR, V17, P164, DOI 10.1111/j.1466-8238.2007.00350.x; Backhaus A, 2010, NEW PHYTOL, V187, P251, DOI 10.1111/j.1469-8137.2010.03266.x; Bailey IW, 1916, AM J BOT, V3, P24, DOI 10.2307/2435109; Bailey IW, 1915, SCIENCE, V41, P831, DOI 10.1126/science.41.1066.831; Bensmihen S, 2008, HFSP J, V2, P110, DOI 10.2976/1.2836738; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham RJ, 1997, BIOTROPICA, V29, P384, DOI 10.1111/j.1744-7429.1997.tb00034.x; Burnham RJ, 2001, AM J BOT, V88, P1096, DOI 10.2307/2657093; Bylesjo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-82; CASCI T, 2010, NATURE REV GENETICS, V11, P594; CHALONER WG, 1990, J GEOL SOC LONDON, V147, P343, DOI 10.1144/gsjgs.147.2.0343; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Currano ED, 2010, ECOL MONOGR, V80, P547, DOI 10.1890/09-2138.1; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Dilcher DL., 1973, VEGETATION VEGETATIO, P39; Doyle JA, 2007, COUR FOR SEKENBG, V258, P21; Feild TS, 2005, PLANT CELL ENVIRON, V28, P1179, DOI 10.1111/j.1365-3040.2005.01354.x; Feild TS, 2005, NEW PHYTOL, V166, P383, DOI 10.1111/j.1469-8137.2005.01333.x; Feng XZ, 2009, PLANT CELL, V21, P2999, DOI 10.1105/tpc.109.069054; Fricke HC, 2004, AM J SCI, V304, P612, DOI 10.2475/ajs.304.7.612; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Green WA, 2006, PALAEONTOL ELECTRON, V9; Greenwood DR, 2007, COUR FOR SEKENBG, V258, P95; Greenwood DR, 2005, NEW PHYTOL, V166, P355, DOI 10.1111/j.1469-8137.2005.01380.x; Greenwood DR, 2004, PALAIOS, V19, P129, DOI 10.1669/0883-1351(2004)019<0129:PEULAI>2.0.CO;2; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; HICKEY LJ, 1975, ANN MO BOT GARD, V62, P538, DOI 10.2307/2395267; Hinojosa LF, 2006, J BIOGEOGR, V33, P331, DOI 10.1111/j.1365-2699.2005.01350.x; HINOJOSA LF, 2010, GLOBAL ECOL BIOGEOGR, DOI DOI 10.1111/J.1466-8238.2010.00595.X; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; Hunt R.J., 2003, GEOLOGICAL SOC AM SP, V369, P395, DOI DOI 10.1130/0-8137-2369-8.395; Jordan GJ, 1997, AUST J BOT, V45, P527, DOI 10.1071/BT96035; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Kowalski EA, 2002, PALAEOGEOGR PALAEOCL, V188, P141, DOI 10.1016/S0031-0182(02)00550-3; Krieger JD, 2007, PALAIOS, V22, P212, DOI 10.2110/palo.2005.p05-079r; Liang MM, 2003, PALAEOGEOGR PALAEOCL, V198, P279, DOI 10.1016/S0031-0182(03)00471-1; Albarran-Lara AL, 2010, INT J PLANT SCI, V171, P310, DOI 10.1086/650317; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Manchester SR, 1998, REV PALAEOBOT PALYNO, V102, P153, DOI 10.1016/S0034-6667(97)00056-0; McIver EE, 1999, ANN MO BOT GARD, V86, P523, DOI 10.2307/2666184; Miller IM, 2006, EARTH PLANET SC LETT, V245, P95, DOI 10.1016/j.epsl.2006.02.022; Mosbrugger V, 1997, PALAEOGEOGR PALAEOCL, V134, P61, DOI 10.1016/S0031-0182(96)00154-X; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peppe DJ, 2010, TECTONICS, V29, DOI 10.1029/2009TC002549; PEPPE DJ, 2010, NEW PHYTOL IN PRESS; Poole I, 2005, PALAEOGEOGR PALAEOCL, V222, P95, DOI 10.1016/j.palaeo.2005.03.011; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; R Development Core Team, 2009, R FDN STAT COMP; Royer DL, 2008, NEW PHYTOL, V179, P808, DOI 10.1111/j.1469-8137.2008.02496.x; Royer DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007653; Royer DL, 2009, AM J BOT, V96, P738, DOI 10.3732/ajb.0800282; Royer DL, 2006, INT J PLANT SCI, V167, P11, DOI 10.1086/497995; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Spicer RA, 2009, PALAEOGEOGR PALAEOCL, V283, P91, DOI 10.1016/j.palaeo.2009.09.009; Stranks L, 1997, PALAEOGEOGR PALAEOCL, V131, P15, DOI 10.1016/S0031-0182(96)00147-2; Uhl D, 2003, REV PALAEOBOT PALYNO, V126, P49, DOI 10.1016/S0034-6667(03)00058-7; Upchurch Jr G.R., 1993, EVOLUTION W INTERIOR, P243; Utescher T, 2000, PALAIOS, V15, P430, DOI 10.2307/3515514; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wilf P, 2000, GEOL SOC AM BULL, V112, P292, DOI 10.1130/0016-7606(2000)112<0292:LPEECC>2.3.CO;2; Wilf P, 2003, P NATL ACAD SCI USA, V100, P599, DOI 10.1073/pnas.0234701100; Wing S.L., 2000, WARM CLIMATES EARTH, P197; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; WING SL, 1993, PHILOS T ROY SOC B, V341, P243, DOI 10.1098/rstb.1993.0109; WING SL, 1987, ANN MO BOT GARD, V74, P748, DOI 10.2307/2399449; Wolfe J.A., 1993, US GEOLOGICAL SURVEY, V2040, P1; WOLFE JA, 1971, PALAEOGEOGR PALAEOCL, V9, P27, DOI 10.1016/0031-0182(71)90016-2; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0; WOLFE JA, 1987, PALAEOGEOGR PALAEOCL, V61, P33, DOI 10.1016/0031-0182(87)90040-X; WOLFE JA, 1987, PALEOBIOLOGY, V13, P215; WOLFE JA, 1995, ANNU REV EARTH PL SC, V23, P119, DOI 10.1146/annurev.earth.23.1.119; WOLFE JA, 1982, CLIMATE EARTH HIST, P154; Wolfe JA, 1979, US GEOLOGICAL SURVEY, V1106, P1, DOI DOI 10.3133/PP1106; WOLFE JA, 1966, US GEOLOGICAL SURV B, V398, P1; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; [No title captured]	86	85	87	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15161	10.1371/journal.pone.0015161	http://dx.doi.org/10.1371/journal.pone.0015161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203554	Green Submitted, gold, Green Published			2022-12-25	WOS:000285578000020
J	Kim, WT; Yun, SJ; Park, C; Kim, IY; Moon, SK; Kwon, TG; Choi, YH; Kim, WJ				Kim, Won Tae; Yun, Seok Joong; Park, Cheol; Kim, Isaac Yi; Moon, Sung-Kwon; Kwon, Tae Gyun; Choi, Yung Hyun; Kim, Wun-Jae			Identification of C16orf74 as a Marker of Progression in Primary Non-Muscle Invasive Bladder Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; PANCREATIC TRYPSINOGEN; TUMOR-MARKERS; CARCINOMA; GENE; EXPRESSION; MUTATIONS; HYPERMETHYLATION; METASTASIS; HYPOXIA	Purpose: Methylation-induced silencing of PRSS3 has been shown to be significantly associated with invasive bladder cancer, and expression of the C16orf74 gene locus has been shown to correlate positively with PRSS3. The aim of the current study was to evaluate the relationship between C16orf74 expression level and progression in non-muscle invasive bladder cancer (NMIBC). Materials and Methods: C16orf74 mRNA levels were examined by real-time reverse transcriptase polymerase chain reaction (RT-PCR) analysis of 193 tumor specimens from patients with primary NMIBC. Expression data were analyzed in terms of clinical and experimental parameters. Kaplan-Meier curves and multivariate Cox regression models, respectively, were used to determine progression-free survival and to identify independent predictive parameters of progression. Results: Analysis using Kaplan-Meier curves revealed prolonged progression-free survival of high-C16orf74-expressors as compared to low-expressors (p < 0.001). Multivariate Cox regression analysis revealed that low C16orf74 mRNA expression levels are a significant risk factor for disease progression in patients with primary NMIBC (HR: 10.042, CI: 2.699-37.360, p = 0.001). Conclusions: Decreased expression of C16orf74 correlates significantly with progression in primary NMIBC. C16orf74 expression level represents a potentially useful marker for predicting progression in primary NMIBC patients.	[Kim, Won Tae; Yun, Seok Joong; Park, Cheol; Kim, Wun-Jae] Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju, South Korea; [Kim, Isaac Yi] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Sect Urol Oncol, Canc Inst New Jersey, New Brunswick, NJ USA; [Moon, Sung-Kwon] Chungju Natl Univ, Dept Food & Biotechnol, Chungju, South Korea; [Kwon, Tae Gyun] Kyungpook Natl Univ, Sch Med, Dept Urol, Taegu, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Dept Biomat Control, Pusan, South Korea	Chungbuk National University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Kyungpook National University; Dong-Eui University	Kim, WT (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju, South Korea.	wjkim@chungbuk.ac.kr		KWON, TAE GYUN/0000-0002-4390-0952; Yun, Seok-Joong/0000-0001-7737-4746	Ministry of Education, Science and Technology [2010-0001730]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0001730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Birkhahn M, 2010, EUR UROL, V57, P12, DOI 10.1016/j.eururo.2009.09.013; Bland JM, 1996, BRIT MED J, V312, P1079; Chan MWY, 2003, INT J CANCER, V104, P611, DOI 10.1002/ijc.10971; Creighton J, 1999, LANCET, V354, P42, DOI 10.1016/S0140-6736(99)01814-0; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Ebbesen P, 2009, J ENZYM INHIB MED CH, V24, P1, DOI 10.1080/14756360902784425; Eguchi S, 2010, CANCER GENET CYTOGEN, V200, P16, DOI 10.1016/j.cancergencyto.2010.03.007; Greene Frederick L, 2002, Bull Am Coll Surg, V87, P13; Grinblatt JA, 1997, NEW ENGL J MED, V337, P1394; Habuchi T, 2005, UROLOGY, V66, P64, DOI 10.1016/j.urology.2005.08.065; Hall MC, 2007, J UROLOGY, V178, P2314, DOI 10.1016/j.juro.2007.09.003; HIRAHARA F, 1995, INT J CANCER, V63, P176, DOI 10.1002/ijc.2910630205; Hockla A, 2009, BREAST CANC IN PRESS; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; KOIVUNEN E, 1991, INT J CANCER, V47, P592, DOI 10.1002/ijc.2910470419; KOSHIKAWA N, 1992, CANCER RES, V52, P5046; Liou LS, 2006, UROLOGY, V67, P25, DOI 10.1016/j.urology.2006.01.034; Liu CY, 2008, MOL MED, V14, P575, DOI 10.2119/2008-00056.Liu; Marsit CJ, 2006, CARCINOGENESIS, V27, P112, DOI 10.1093/carcin/bgi172; Marsit CJ, 2005, MOL CARCINOGEN, V44, P146, DOI 10.1002/mc.20125; Messing EM, 2007, CAMPBELLWALSHS UROLO, P2417; Messing EM, 2002, CAMPBELLS UROLOGY, P2750; Minn A, 1998, GLIA, V22, P338, DOI 10.1002/(SICI)1098-1136(199804)22:4<338::AID-GLIA3>3.0.CO;2-#; OHTA T, 1994, BRIT J CANCER, V69, P152, DOI 10.1038/bjc.1994.25; Ross JS, 2000, CANCER CYTOPATHOL, V90, P75, DOI 10.1002/(SICI)1097-0142(20000425)90:2<75::AID-CNCR2>3.3.CO;2-N; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; TANI T, 1990, NUCLEIC ACIDS RES, V18, P1631, DOI 10.1093/nar/18.6.1631; Wang R, 2009, CANCER RES, V69, P3810, DOI 10.1158/0008-5472.CAN-08-4405; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Yamashita K, 2003, CANCER RES, V63, P6575; Zhou XF, 2006, NEOPLASIA, V8, P925, DOI 10.1593/neo.06430	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15260	10.1371/journal.pone.0015260	http://dx.doi.org/10.1371/journal.pone.0015260			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203532	Green Published, Green Submitted, gold			2022-12-25	WOS:000285576900025
J	Liu, JQ; Lee, TF; Bigam, DL; Cheung, PY				Liu, Jiang-Qin; Lee, Tze-Fun; Bigam, David L.; Cheung, Po-Yin			Effects of Post-Resuscitation Treatment with N-acetylcysteine on Cardiac Recovery in Hypoxic Newborn Piglets	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RANDOMIZED CONTROLLED-TRIAL; MYOCARDIAL-ISCHEMIA; PERINATAL ASPHYXIA; OXIDATIVE STRESS; 100-PERCENT OXYGEN; INDUCED APOPTOSIS; NEURONAL CELLS; TROPONIN-I; DYSFUNCTION	Aims: Although N-acetylcysteine (NAC) can decrease reactive oxygen species and improve myocardial recovery after ischemia/hypoxia in various acute animal models, little is known regarding its long-term effect in neonatal subjects. We investigated whether NAC provides prolonged protective effect on hemodynamics and oxidative stress using a surviving swine model of neonatal asphyxia. Methods and Results: Newborn piglets were anesthetized and acutely instrumented for measurement of systemic hemodynamics and oxygen transport. Animals were block-randomized into a sham-operated group (without hypoxiareoxygenation [H-R, n = 6]) and two H-R groups (2 h normocapnic alveolar hypoxia followed by 48 h reoxygenation, n = 8/group). All piglets were acidotic and in cardiogenic shock after hypoxia. At 5 min after reoxygenation, piglets were given either saline or NAC (intravenous 150 mg/kg bolus + 20 mg/kg/h infusion) via for 24 h in a blinded, randomized fashion. Both cardiac index and stroke volume of H-R controls remained lower than the pre-hypoxic values throughout recovery. Treating the piglets with NAC significantly improved cardiac index, stroke volume and systemic oxygen delivery to levels not different from those of sham-operated piglets. Accompanied with the hemodynamic improvement, NAC-treated piglets had significantly lower plasma cardiac troponin-I, myocardial lipid hydroperoxides, activated caspase-3 and lactate levels (vs. H-R controls). The change in cardiac index after H-R correlated with myocardial lipid hydroperoxides, caspase-3 and lactate levels (all p, 0.05). Conclusions: Post-resuscitation administration of NAC reduces myocardial oxidative stress and caused a prolonged improvement in cardiac function and in newborn piglets with H-R insults.	[Liu, Jiang-Qin; Lee, Tze-Fun; Cheung, Po-Yin] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Bigam, David L.; Cheung, Po-Yin] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta	Liu, JQ (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	poyin@ualberta.ca	Cheung, Po-Yin/C-2804-2013	Cheung, Po-Yin/0000-0002-7141-1523	Canadian Institutes of Health Research [MOP51306]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was supported by the operating grant (MOP51306) from the Canadian Institutes of Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, J PHARMACOL SCI, V106, P571, DOI 10.1254/jphs.FP0071664; Adamy C, 2007, J MOL CELL CARDIOL, V43, P344, DOI 10.1016/j.yjmcc.2007.06.010; Ahola T, 2003, J PEDIATR-US, V143, P713, DOI 10.1067/S0022-3476(03)00419-0; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Barberi I, 1999, EUR J PEDIATR, V158, P742, DOI 10.1007/s004310051192; Benrahmoune M, 2000, FREE RADICAL BIO MED, V29, P775, DOI 10.1016/S0891-5849(00)00380-4; Bolanos JP, 2010, IUBMB LIFE, V62, P14, DOI 10.1002/iub.280; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Carbonell LF, 2007, MED CHEM, V3, P29, DOI 10.2174/157340607779317580; Carter BS, 1998, J PEDIATR-US, V132, P619, DOI 10.1016/S0022-3476(98)70349-X; Cheung PY, 2000, J MOL CELL CARDIOL, V32, P1669, DOI 10.1006/jmcc.2000.1203; Clark SJ, 2006, EUR J PEDIATR, V165, P87, DOI 10.1007/s00431-005-0001-3; Conesa EL, 2001, AM J PHYSIOL-REG I, V281, pR730, DOI 10.1152/ajpregu.2001.281.3.R730; Cuzzocrea S, 2000, CARDIOVASC RES, V47, P537, DOI 10.1016/S0008-6363(00)00018-3; Duilio C, 2001, AM J PHYSIOL-HEART C, V280, pH2649, DOI 10.1152/ajpheart.2001.280.6.H2649; FERRARI G, 1995, J NEUROSCI, V15, P2857; Fiordaliso F, 2004, J MOL CELL CARDIOL, V37, P959, DOI 10.1016/j.yjmcc.2004.07.008; Foresti R, 2001, AM J PHYSIOL-HEART C, V281, pH1976, DOI 10.1152/ajpheart.2001.281.5.H1976; Gensini GF, 1998, CRIT CARE MED, V26, P1986, DOI 10.1097/00003246-199812000-00025; HARRISON PM, 1991, NEW ENGL J MED, V324, P1852, DOI 10.1056/NEJM199106273242604; Ho FY, 2006, BIOCHEM BIOPH RES CO, V345, P1131, DOI 10.1016/j.bbrc.2006.04.178; Hsu BG, 2006, LIFE SCI, V79, P2010, DOI 10.1016/j.lfs.2006.06.040; Hu CP, 2007, AM J PHYSIOL-HEART C, V293, pH1833, DOI 10.1152/ajpheart.00488.2007; Johnson ST, 2007, SHOCK, V28, P484, DOI 10.1097/shk.0b013e31804f775d; Kanik E, 2009, J MATERN-FETAL NEO M, V22, P239, DOI 10.1080/14767050802430834; Kin H, 2008, SHOCK, V29, P761, DOI 10.1097/SHK.0b013e31815cfd5a; Korge P, 2008, CIRC RES, V103, P873, DOI 10.1161/CIRCRESAHA.108.180869; Kyaw M, 2004, J PHARMACOL SCI, V95, P483, DOI 10.1254/jphs.SC0040061; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; LE CT, 1995, EUR HEART J, V16, P553, DOI 10.1093/oxfordjournals.eurheartj.a060950; Lee TF, 2008, INTENS CARE MED, V34, P190, DOI 10.1007/s00134-007-0880-z; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Liu J, 2007, J TROP PEDIATRICS, V53, P44, DOI 10.1093/tropej/fml053; MARTINANCEL A, 1995, J PEDIATR-US, V127, P786, DOI 10.1016/S0022-3476(95)70174-5; Noren H, 2003, AM J OBSTET GYNECOL, V188, P183, DOI 10.1067/mob.2003.109; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Prybytkowski E, 1996, ARCH BIOCHEM BIOPHYS, V325, P91; Qin FZ, 2003, AM J PHYSIOL-HEART C, V285, pH822, DOI 10.1152/ajpheart.00015.2003; Rajakumar PS, 2008, INDIAN J PEDIATR, V75, P1223, DOI 10.1007/s12098-008-0242-z; Rajan GP, 2004, J TRAUMA, V57, P801, DOI 10.1097/01.TA.0000135157.93649.72; Shah P, 2004, ARCH DIS CHILD-FETAL, V89, P152, DOI 10.1136/adc.2002.023093; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Song JQ, 2009, APOPTOSIS, V14, P1061, DOI 10.1007/s10495-009-0382-2; TALLEY AK, 1995, MOL CELL BIOL, V15, P2359; Timmers L, 2009, J AM COLL CARDIOL, V53, P501, DOI 10.1016/j.jacc.2008.10.033; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; WALTHER FJ, 1985, J PEDIATR-US, V107, P781, DOI 10.1016/S0022-3476(85)80417-0; Wei Y, 2009, PEDIATR CARDIOL, V30, P741, DOI 10.1007/s00246-009-9421-6; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhao ZQ, 2004, CURR OPIN PHARMACOL, V4, P159, DOI 10.1016/j.coph.2003.10.010	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15322	10.1371/journal.pone.0015322	http://dx.doi.org/10.1371/journal.pone.0015322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203535	gold, Green Published, Green Submitted			2022-12-25	WOS:000285576900028
J	Menendez, P; Kourmpetis, YAI; ter Braak, CJF; van Eeuwijk, FA				Menendez, Patricia; Kourmpetis, Yiannis A. I.; ter Braak, Cajo J. F.; van Eeuwijk, Fred A.			Gene Regulatory Networks from Multifactorial Perturbations Using Graphical Lasso: Application to the DREAM4 Challenge	PLOS ONE			English	Article							MODEL; SELECTION; LIKELIHOOD; REGRESSION; INFERENCE	A major challenge in the field of systems biology consists of predicting gene regulatory networks based on different training data. Within the DREAM4 initiative, we took part in the multifactorial sub-challenge that aimed to predict gene regulatory networks of size 100 from training data consisting of steady-state levels obtained after applying multifactorial perturbations to the original in silico network. Due to the static character of the challenge data, we tackled the problem via a sparse Gaussian Markov Random Field, which relates network topology with the covariance inverse generated by the gene measurements. As for the computations, we used the Graphical Lasso algorithm which provided a large range of candidate network topologies. The main task was to select the optimal network topology and for that, different model selection criteria were explored. The selected networks were compared with the golden standards and the results ranked using the scoring metrics applied in the challenge, giving a better insight in our submission and the way to improve it. Our approach provides an easy statistical and computational framework to infer gene regulatory networks that is suitable for large networks, even if the number of the observations (perturbations) is greater than the number of variables (genes).	[Menendez, Patricia; Kourmpetis, Yiannis A. I.] Wageningen Univ, Lab Bioinformat, Wageningen, Netherlands; [Menendez, Patricia; van Eeuwijk, Fred A.] Ctr BioSyst Genet, Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	Menendez, P (corresponding author), Wageningen Univ, Lab Bioinformat, Wageningen, Netherlands.	cajo.terbraak@wur.nl	Menéndez, Patricia/M-7719-2019; Bujan, Pablo Menendez/W-3736-2017; Menéndez, Patricia/D-8905-2013; Braak, Cajo J. F. ter/G-7006-2011	Menéndez, Patricia/0000-0003-0701-6315; Bujan, Pablo Menendez/0000-0001-9372-1007; Menéndez, Patricia/0000-0003-0701-6315; Braak, Cajo J. F. ter/0000-0002-0414-8745	Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research	Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This project was cofinanced by the Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Alon U, 2007, INTRO SYSTEMS BIOL D; Banerjee O, 2008, J MACH LEARN RES, V9, P485; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman J, 2007, ANN APPL STAT, V1, P302, DOI 10.1214/07-AOAS131; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; *GENENETWEAVER, GENENETWEAVER TOOL V; Goutte C, 2005, LECT NOTES COMPUT SC, V3408, P345; Kindermann R., 1980, MARKOV RANDOM FIELDS, DOI [10.1090/conm/001, DOI 10.1090/CONM/001]; Lauritzen S.L, 1996, GRAPHICAL MODELS; Manning C.D., 2000, FDN STAT NATURAL LAN; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Pan W, 2007, J MACH LEARN RES, V8, P1145; PROVOST F, 1998, P 15 INT C MACH LEAR, P445; RAGHAVAN VV, 1989, ACM T INFORM SYST, V7, P205, DOI 10.1145/65943.65945; Rue H, 2002, SCAND J STAT, V29, P31, DOI 10.1111/1467-9469.00058; Rue H., 2005, GAUSSIAN MARKOV RAND; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Stone M., 1978, Mathematische Operationsforschung und Statistik, Series Statistics, V9, P127, DOI 10.1080/02331887808801414; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Whittaker J., 1990, GRAPHICAL MODELS APP; Zou H, 2007, ANN STAT, V35, P2173, DOI 10.1214/009053607000000127; DREAM4 IN SILICO NET	27	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14147	10.1371/journal.pone.0014147	http://dx.doi.org/10.1371/journal.pone.0014147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21188141	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200002
J	Mignardot, JB; Olivier, I; Promayon, E; Nougier, V				Mignardot, Jean-Baptiste; Olivier, Isabelle; Promayon, Emmanuel; Nougier, Vincent			Obesity Impact on the Attentional Cost for Controlling Posture	PLOS ONE			English	Article							OLDER-ADULTS; BODY-WEIGHT; REDUCTION PROGRAM; SWAY MOVEMENTS; VOLUNTARY SWAY; REACTION-TIME; DUAL-TASK; DEMANDS; BALANCE; STABILITY	Background: This study investigated the effects of obesity on attentional resources allocated to postural control in seating and unipedal standing. Methods: Ten non obese adults (BMI = 22.4 +/- 1.3, age = 42.4 +/- 15.1) and 10 obese adult patients (BMI = 35.2 +/- 2.8, age = 46.2 +/- 19.6) maintained postural stability on a force platform in two postural tasks (seated and unipedal). The two postural tasks were performed (1) alone and (2) in a dual-task paradigm in combination with an auditory reaction time task (RT). Performing the RT task together with the postural one was supposed to require some attentional resources that allowed estimating the attentional cost of postural control. 4 trials were performed in each condition for a total of 16 trials. Findings: (1) Whereas seated non obese and obese patients exhibited similar centre of foot pressure oscillations (CoP), in the unipedal stance only obese patients strongly increased their CoP sway in comparison to controls. (2) Whatever the postural task, the additional RT task did not affect postural stability. (3) Seated, RT did not differ between the two groups. (4) RT strongly increased between the two postural conditions in the obese patients only, suggesting that body schema and the use of internal models was altered with obesity. Interpretation: Obese patients needed more attentional resources to control postural stability during unipedal stance than non obese participants. This was not the case in a more simple posture such as seating. To reduce the risk of fall as indicated by the critical values of CoP displacement, obese patients must dedicate a strong large part of their attentional resources to postural control, to the detriment of non-postural events. Obese patients were not able to easily perform multitasking as healthy adults do, reflecting weakened psycho-motor abilities.	[Mignardot, Jean-Baptiste; Olivier, Isabelle; Nougier, Vincent] UJF, CNRS, UMR 5525, Lab TIMC IMAG,Team SPM, La Tronche, France; [Mignardot, Jean-Baptiste; Promayon, Emmanuel] UJF, CNRS, UMR 5525, Lab TIMC IMAG,Team GMCAO, La Tronche, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA)	Mignardot, JB (corresponding author), UJF, CNRS, UMR 5525, Lab TIMC IMAG,Team SPM, La Tronche, France.	jean-baptiste.mignardot@imag.fr	Nougier, Vincent M/B-4993-2013; Olivier, Isabelle/M-6054-2014; Nougier, Vincent/AAG-5794-2021; Promayon, Emmanuel/M-6872-2014	Nougier, Vincent M/0000-0002-9917-0004; Promayon, Emmanuel/0000-0001-8934-6793	French ministry of education	French ministry of education	Doctoral grant from the French ministry of education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basdevant A, 2008, JOINT BONE SPINE, V75, P665, DOI 10.1016/j.jbspin.2008.06.007; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Berrigan F, 2006, INT J OBESITY, V30, P1750, DOI 10.1038/sj.ijo.0803342; Bisson E, 2007, CYBERPSYCHOL BEHAV, V10, P16, DOI 10.1089/cpb.2006.9997; Blaszczyk JW, 2009, J BIOMECH, V42, P1295, DOI 10.1016/j.jbiomech.2009.03.006; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Brown LA, 2002, ARCH PHYS MED REHAB, V83, P1732, DOI 10.1053/apmr.2002.36400; CLARKSON PM, 1978, EUR J APPL PHYSIOL O, V40, P17, DOI 10.1007/BF00420985; Cliff DP, 2011, MED SCI SPORT EXER, V43, P90, DOI 10.1249/MSS.0b013e3181e741e8; Close JCT, 2005, BEST PRACT RES CL RH, V19, P913, DOI 10.1016/j.berh.2005.06.002; Corbeil P, 2001, IEEE T NEUR SYS REH, V9, P126, DOI 10.1109/7333.928572; Gage WH, 2003, EXP BRAIN RES, V150, P385, DOI 10.1007/s00221-003-1468-7; Greve J, 2007, CLINICS, V62, P717, DOI 10.1590/S1807-59322007000600010; Handrigan GA, 2010, J BIOMECH, V43, P383, DOI 10.1016/j.jbiomech.2009.08.041; Hue O, 2007, GAIT POSTURE, V26, P32, DOI 10.1016/j.gaitpost.2006.07.005; *INT OB TASKFORCE, 2005, OB EUR; International Association for the Study of Obesity, AD OV OB EUR UN EU 2; Lajoie Y, 1999, SPINAL CORD, V37, P245, DOI 10.1038/sj.sc.3100810; Lajoie Y, 1996, EXP AGING RES, V22, P185, DOI 10.1080/03610739608254006; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Maffiuletti NA, 2005, J ENDOCRINOL INVEST, V28, P2, DOI 10.1007/BF03345521; Maffiuletti NA, 2007, EUR J APPL PHYSIOL, V101, P51, DOI 10.1007/s00421-007-0471-2; Mahboobin A, 2007, NEUROSCI LETT, V429, P147, DOI 10.1016/j.neulet.2007.10.004; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Marsh AP, 2000, GAIT POSTURE, V12, P105, DOI 10.1016/S0966-6362(00)00074-6; McGraw B, 2000, ARCH PHYS MED REHAB, V81, P484, DOI 10.1053/mr.2000.3782; Morasso PG, 1999, NEURAL NETWORKS, V12, P1173, DOI 10.1016/S0893-6080(99)00058-1; Morasso PG, 1999, HUM MOVEMENT SCI, V18, P759, DOI 10.1016/S0167-9457(99)00039-1; Olivier I, 2008, EXP BRAIN RES, V185, P341, DOI 10.1007/s00221-008-1271-6; Olivier I, 2007, NEUROREPORT, V18, P817, DOI 10.1097/WNR.0b013e3280e129e1; Personnier P, 2010, NEUROSCI LETT, V476, P146, DOI 10.1016/j.neulet.2010.04.017; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; Saimpont A, 2010, ARCH GERONTOL GERIAT, V51, pE41, DOI 10.1016/j.archger.2009.11.010; Sartorio A, 2001, J ENDOCRINOL INVEST, V24, P393, DOI 10.1007/BF03351039; Simoneau M, 1999, J AM GERIATR SOC, V47, P235, DOI 10.1111/j.1532-5415.1999.tb04584.x; Teasdale N, 2007, INT J OBESITY, V31, P153, DOI 10.1038/sj.ijo.0803360; Teasdale N, 2001, GAIT POSTURE, V14, P203, DOI 10.1016/S0966-6362(01)00134-5; Tucker MG, 2009, CLIN BIOMECH, V24, P597, DOI 10.1016/j.clinbiomech.2009.06.002; Tucker MG, 2008, HUM MOVEMENT SCI, V27, P728, DOI 10.1016/j.humov.2008.03.002; van Dieen JH, 2010, GAIT POSTURE, V31, P42, DOI 10.1016/j.gaitpost.2009.08.242; Vuillerme N, 2006, EXP BRAIN RES, V169, P232, DOI 10.1007/s00221-005-0142-7; Wang L, 2008, MED SCI MONITOR, V14, pCR129; Williams HG, 2008, OBESITY, V16, P1421, DOI 10.1038/oby.2008.214	44	49	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e14387	10.1371/journal.pone.0014387	http://dx.doi.org/10.1371/journal.pone.0014387			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	698EM	21187914	Green Published, Green Submitted, gold			2022-12-25	WOS:000285575200010
J	Shoji, JY; Kikuma, T; Arioka, M; Kitamoto, K				Shoji, Jun-ya; Kikuma, Takashi; Arioka, Manabu; Kitamoto, Katsuhiko			Macroautophagy-Mediated Degradation of Whole Nuclei in the Filamentous Fungus Aspergillus oryzae	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; AUTOPHAGY; DIFFERENTIATION; VISUALIZATION; MITOCHONDRIA; INFECTION; TRANSPORT; SYSTEMS; HYPHAE; YEAST	Filamentous fungi consist of continuum of multinucleate cells called hyphae, and proliferate by means of hyphal tip growth. Accordingly, research interest has been focusing on hyphal tip cells, but little is known about basal cells in colony interior that do not directly contribute to proliferation. Here, we show that autophagy mediates degradation of basal cell components in the filamentous fungus Aspergillus oryzae. In basal cells, enhanced green fluorescent protein (EGFP)-labeled peroxisomes, mitochondria, and even nuclei were taken up into vacuoles in an autophagy-dependent manner. During this process, crescents of autophagosome precursors matured into ring-like autophagosomes to encircle apparently whole nuclei. The ring-like autophagosomes then disappeared, followed by dispersal of the nuclear material throughout the vacuoles, suggesting the autophagy-mediated degradation of whole nuclei. We also demonstrated that colony growth in a nutrient-depleted medium was significantly inhibited in the absence of functional autophagy. This is a first report describing autophagy-mediated degradation of whole nuclei, as well as suggesting a novel strategy of filamentous fungi to degrade components of existing hyphae for use as nutrients to support mycelial growth in order to counteract starvation.				junya@fungalcell.org; akitamo@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford AE, 1998, ADV BOT RES, V28, P119; BITTNER GD, 1991, TRENDS NEUROSCI, V14, P188, DOI 10.1016/0166-2236(91)90104-3; Darrah PR, 2006, EUKARYOT CELL, V5, P1111, DOI 10.1128/EC.00026-06; DOWSON CG, 1989, NEW PHYTOL, V111, P501, DOI 10.1111/j.1469-8137.1989.tb00713.x; Escano CS, 2009, EUKARYOT CELL, V8, P296, DOI 10.1128/EC.00197-08; Farre JC, 2004, TRENDS CELL BIOL, V14, P515, DOI 10.1016/j.tcb.2004.07.014; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Kikuma T, 2006, EUKARYOT CELL, V5, P1328, DOI 10.1128/EC.00024-06; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Liu TB, 2010, AUTOPHAGY, V6, P74, DOI 10.4161/auto.6.1.10438; Lu E, 2001, CELL DEATH DIFFER, V8, P289, DOI 10.1038/sj.cdd.4400807; Lu JP, 2009, CURR GENET, V55, P461, DOI 10.1007/s00294-009-0259-5; Mabashi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1882, DOI 10.1271/bbb.60052; Maheshwari R, 2005, FEMS MICROBIOL LETT, V249, P7, DOI 10.1016/j.femsle.2005.06.031; Maruyama J, 2001, BIOSCI BIOTECH BIOCH, V65, P1504, DOI 10.1271/bbb.65.1504; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; Pinan-Lucarre R, 2003, MOL MICROBIOL, V47, P321, DOI 10.1046/j.1365-2958.2003.03208.x; Richie DL, 2007, EUKARYOT CELL, V6, P2437, DOI 10.1128/EC.00224-07; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Shoji JY, 2006, AUTOPHAGY, V2, P226, DOI 10.4161/auto.2695; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; Taylor MV, 2000, CURR BIOL, V10, pR646, DOI 10.1016/S0960-9822(00)00664-3; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479	26	66	69	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15650	10.1371/journal.pone.0015650	http://dx.doi.org/10.1371/journal.pone.0015650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187926	Green Published, gold, Green Submitted			2022-12-25	WOS:000285575200056
J	Zhang, ZJ; Chen, DM; Chen, Y; Liu, WB; Wang, L; Zhao, F; Yao, BD				Zhang, Zhijie; Chen, Dongmei; Chen, Yue; Liu, Wenbao; Wang, Lei; Zhao, Fei; Yao, Baodong			Spatio-Temporal Data Comparisons for Global Highly Pathogenic Avian Influenza (HPAI) H5N1 Outbreaks	PLOS ONE			English	Article							VIRUS-INFECTION; SURVEILLANCE; PATTERNS; MIGRATION; THAILAND; SYSTEMS; SPREAD; BIRDS; RISK; ASIA	Highly pathogenic avian influenza subtype H5N1 is a zoonotic disease and control of the disease is one of the highest priority in global health. Disease surveillance systems are valuable data sources for various researches and management projects, but the data quality has not been paid much attention in previous studies. Based on data from two commonly used databases (Office International des Epizooties (OIE) and Food and Agriculture Organization of the United Nations (FAO)) of global HPAI H5N1 outbreaks during the period of 2003-2009, we examined and compared their patterns of temporal, spatial and spatiotemporal distributions for the first time. OIE and FAO data showed similar trends in temporal and spatial distributions if they were considered separately. However, more advanced approaches detected a significant difference in joint spatio-temporal distribution. Because of incompleteness for both OIE and FAO data, an integrated dataset would provide a more complete picture of global HPAI H5N1 outbreaks. We also displayed a mismatching profile of global HPAI H5N1 outbreaks and found that the degree of mismatching was related to the epidemic severity. The ideas and approaches used here to assess spatiotemporal data on the same disease from different sources are useful for other similar studies.	[Zhang, Zhijie; Chen, Dongmei; Liu, Wenbao; Wang, Lei] Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada; [Zhang, Zhijie; Zhao, Fei; Yao, Baodong] Fudan Univ, Dept Epidemiol, Shanghai 200433, Peoples R China; [Chen, Yue] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	Queens University - Canada; Fudan University; University of Ottawa	Zhang, ZJ (corresponding author), Queens Univ, Dept Geog, Kingston, ON K7L 3N6, Canada.	epistat@gmail.com; chendm@queensu.ca		zhang, zhijie/0000-0002-1276-787X	Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada [PIV-005]	Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada	This research was supported by a grant from the Geomatics for Information Decision (GEOIDE), National Centre of Excellence, Canada (grant number PIV-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SSU, 2010, EPIDEMIOL INFECT, V138, P843, DOI 10.1017/S0950268810000178; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; BADDELEY AJ, 1993, J R STAT SOC C-APPL, V42, P641; *BIRDLIFE INT, 2006, IILEGAL IMPORTS PROB; Butler D, 2006, NATURE, V439, P6, DOI 10.1038/439006a; BUTLER D, 2006, NATURE GETS MASHED T; Capua I, 2009, POULTRY SCI, V88, P842, DOI 10.3382/ps.2008-00289; Cecchi G, 2008, GEOSPATIAL HEALTH, V3, P7, DOI 10.4081/gh.2008.227; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Farnsworth ML, 2010, PREV VET MED, V95, P175, DOI 10.1016/j.prevetmed.2010.03.012; Farnsworth ML, 2009, VET RES, V40, DOI 10.1051/vetres/2009003; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Hadorn DC, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-52; Henning J, 2009, VET RES, V40, DOI 10.1051/vetres:2008053; Kaiser J, 2006, SCIENCE, V312, P380, DOI 10.1126/science.312.5772.380; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Martin V, 2007, J WILDLIFE DIS, V43, pS71; MERTON AA, 2008, DISTR FREE COMP MULT; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Pittman M, 2007, J WILDLIFE DIS, V43, pS64; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; ROWLINGSON BS, 1993, COMPUT GEOSCI, V19, P627, DOI 10.1016/0098-3004(93)90099-Q; Rushton J, 2005, WORLD POULTRY SCI J, V61, P491, DOI 10.1079/WPS200570; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Stohr K, 2005, NEW ENGL J MED, V352, P405, DOI 10.1056/NEJMe048344; Tiensin T, 2009, J INFECT DIS, V199, P1735, DOI 10.1086/599207; Toma B., 1999, DICT VET EPIDEMIOLOG; Vallat B, 2006, REV SCI TECH OIE, V25, P163, DOI 10.20506/rst.25.1.1645; Zepeda C, 2005, PREV VET MED, V67, P125, DOI 10.1016/j.prevetmed.2004.11.005	32	24	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15314	10.1371/journal.pone.0015314	http://dx.doi.org/10.1371/journal.pone.0015314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187964	Green Published, Green Submitted, gold			2022-12-25	WOS:000285575200037
J	Lu, L; Zhou, XH; Wang, J; Zheng, SG; Horwitz, DA				Lu, Ling; Zhou, Xiaohui; Wang, Julie; Zheng, Song Guo; Horwitz, David A.			Characterization of Protective Human CD4(+)CD25(+) FOXP3(+) Regulatory T Cells Generated with IL-2, TGF-beta and Retinoic Acid	PLOS ONE			English	Article							HUMAN PERIPHERAL-BLOOD; VERSUS-HOST-DISEASE; MEDIATED SUPPRESSION; RECEPTOR EXPRESSION; EX-VIVO; CUTTING EDGE; IN-VIVO; CD4(+); STIMULATION; LYMPHOCYTES	Background: Protective CD4+CD25+ regulatory T cells bearing the Forkhead Foxp3 transcription factor can now be divided into three subsets: Endogenous thymus-derived cells, those induced in the periphery, and another subset induced ex-vivo with pharmacological amounts of IL-2 and TGF-beta. Unfortunately, endogenous CD4+CD25+ regulatory T cells are unstable and can be converted to effector cells by pro-inflammatory cytokines. Although protective Foxp3+CD4+ CD25+ cells resistant to proinflammatory cytokines have been generated in mice, in humans this result has been elusive. Our objective, therefore, was to induce human naive CD4+ cells to become stable, functional CD25+ Foxp3+ regulatory cells that were also resistant to the inhibitory effects of proinflammatory cytokines. Methodology/Principal Findings: The addition of the vitamin A metabolite, all-trans retinoic acid (atRA) to human naive CD4+ cells suboptimally activated with IL-2 and TGF-beta enhanced and stabilized FOXP3 expression, and accelerated their maturation to protective regulatory T cells. AtRA, by itself, accelerated conversion of naive to mature cells but did not induce FOXP3 or suppressive activity. The combination of atRA and TGF-beta enabled CD4+ CD45RA+ cells to express a phenotype and trafficking receptors similar to natural Tregs. AtRA/TGF-beta-induced CD4+ regs were anergic and low producers of IL-2. They had potent in vitro suppressive activity and protected immunodeficient mice from a human-anti-mouse GVHD as well as expanded endogenous Tregs. However, treatment of endogenous Tregs with IL-1 beta and IL-6 decreased FOXP3 expression and diminished their protective effects in vivo while atRA-induced iTregs were resistant to these inhibitory effects. Conclusions/Significance: We have developed a methodology that induces human CD4(+) cells to rapidly become stable, fully functional suppressor cells that are also resistant to proinflammatory cytokines. This methodology offers a practical novel strategy to treat human autoimmune diseases and prevent allograft rejection without the use of agents that kill cells or interfere with signaling pathways.	[Lu, Ling; Zhou, Xiaohui; Wang, Julie; Zheng, Song Guo; Horwitz, David A.] Univ So Calif, Keck Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90033 USA; [Lu, Ling] Nanjing Med Univ, Affiliated Hosp 1, Dept Liver Transplantat, Nanjing, Peoples R China; [Zhou, Xiaohui] Tonji Univ Med, Immune Tolerance Ctr, Shanghai E Hosp, Shanghai, Peoples R China	University of Southern California; Nanjing Medical University	Lu, L (corresponding author), Univ So Calif, Keck Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90033 USA.	szheng@usc.edu; dhorwitz@usc.edu	lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022					Aricha R, 2008, J IMMUNOL, V180, P2132, DOI 10.4049/jimmunol.180.4.2132; AUSTRUP F, 1995, EUR J IMMUNOL, V25, P1487, DOI 10.1002/eji.1830250602; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cosmi L, 2003, BLOOD, V102, P4107, DOI 10.1182/blood-2003-04-1320; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Godebu E, 2008, J IMMUNOL, V181, P1798, DOI 10.4049/jimmunol.181.3.1798; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hippen KL, 2008, BLOOD, V112, P2847, DOI 10.1182/blood-2008-01-132951; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Horwitz DA, 2008, EUR J IMMUNOL, V38, P912, DOI 10.1002/eji.200738109; Horwitz DA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2511; Iellem A, 2003, EUR J IMMUNOL, V33, P1488, DOI 10.1002/eji.200323658; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Lim HW, 2006, J IMMUNOL, V177, P840, DOI 10.4049/jimmunol.177.2.840; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Miyara M, 2009, J ALLERGY CLIN IMMUN, V123, P749, DOI 10.1016/j.jaci.2009.03.001; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Mutis T, 2006, CLIN CANCER RES, V12, P5520, DOI 10.1158/1078-0432.CCR-06-0035; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Oida T, 2006, J IMMUNOL, V177, P2331, DOI 10.4049/jimmunol.177.4.2331; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Rao PE, 2005, J IMMUNOL, V174, P1446, DOI 10.4049/jimmunol.174.3.1446; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Selvaraj RK, 2007, J IMMUNOL, V179, P1390, DOI 10.4049/jimmunol.179.2.1390-b; Selvaraj RK, 2008, J IMMUNOL, V180, P2830, DOI 10.4049/jimmunol.180.5.2830; Singh RP, 2007, J IMMUNOL, V178, P7649, DOI 10.4049/jimmunol.178.12.7649; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zheng SG, 2004, J IMMUNOL, V172, P1531, DOI 10.4049/jimmunol.172.3.1531; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598	54	95	103	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15150	10.1371/journal.pone.0015150	http://dx.doi.org/10.1371/journal.pone.0015150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179414	Green Submitted, gold, Green Published			2022-12-25	WOS:000285572900014
J	Olotu, A; Fegan, G; Williams, TN; Sasi, P; Ogada, E; Bauni, E; Wambua, J; Marsh, K; Borrmann, S; Bejon, P				Olotu, Ally; Fegan, Gregory; Williams, Thomas N.; Sasi, Philip; Ogada, Edna; Bauni, Evasius; Wambua, Juliana; Marsh, Kevin; Borrmann, Steffen; Bejon, Philip			Defining Clinical Malaria: The Specificity and Incidence of Endpoints from Active and Passive Surveillance of Children in Rural Kenya	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CASE DEFINITIONS; SOUTHERN TANZANIA; EFFICACY; VACCINE; TRANSMISSION; FEVER; AREA; MORBIDITY; MORTALITY	Background: Febrile malaria is the most common clinical manifestation of P. falciparum infection, and is often the primary endpoint in clinical trials and epidemiological studies. Subjective and objective fevers are both used to define the endpoint, but have not been carefully compared, and the relative incidence of clinical malaria by active and passive case detection is unknown. Methods: We analyzed data from cohorts under active and passive surveillance, including 19,462 presentations with fever and 5,551 blood tests for asymptomatic parasitaemia. A logistic regression model was used to calculate Malaria Attributable Fractions (MAFs) for various case definitions. Incidences of febrile malaria by active and passive surveillance were compared in a subset of children matched for age and location. Results: Active surveillance identified three times the incidence of clinical malaria as passive surveillance in a subset of children matched for age and location. Objective fever (temperature >= 37.5 degrees C) gave consistently higher MAFs than case definitions based on subjective fever. Conclusion: The endpoints from active and passive surveillance have high specificity, but the incidence of endpoints is lower on passive surveillance. Subjective fever had low specificity and should not be used in primary endpoint. Passive surveillance will reduce the power of clinical trials but may cost-effectively deliver acceptable sensitivity in studies of large populations.	[Olotu, Ally; Fegan, Gregory; Williams, Thomas N.; Ogada, Edna; Bauni, Evasius; Wambua, Juliana; Marsh, Kevin; Borrmann, Steffen; Bejon, Philip] Ctr Geog Med Res, Wellcome Trust Res Programme, Kenya Med Res Inst, Kilifi, Kenya; [Fegan, Gregory; Marsh, Kevin; Bejon, Philip] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Nuffield Dept Med, Oxford, England; [Sasi, Philip] Muhimbili Univ Hlth & Allied Sci, Dept Clin Pharmacol, Dar Es Salaam, Tanzania; [Borrmann, Steffen] Heidelberg Univ, Sch Med, Dept Infect Dis, Heidelberg, Germany	Kenya Medical Research Institute; University of Oxford; Muhimbili University of Health & Allied Sciences; Ruprecht Karls University Heidelberg	Olotu, A (corresponding author), Ctr Geog Med Res, Wellcome Trust Res Programme, Kenya Med Res Inst, Kilifi, Kenya.	Aolotu@kilifi.kemri-wellcome.org	Fegan, Greg W/O-8079-2018; Borrmann, Steffen/G-1838-2013	Fegan, Greg W/0000-0002-2663-2765; Borrmann, Steffen/0000-0001-9189-4393; Ogada, Edna/0000-0003-0181-2505	Biomedical Research Centre in Oxford; German Research Foundation (DFG) [SFB 544, A7]; Wellcome Trust	Biomedical Research Centre in Oxford; German Research Foundation (DFG)(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission)	Philip Bejon is supported by the Biomedical Research Centre in Oxford. Steffen Borrmann received funding from German Research Foundation (DFG)(Grant number SFB 544, A7) and Kevin Marsh is supported by Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysekera T, 1997, TROP MED INT HEALTH, V2, P1057, DOI 10.1046/j.1365-3156.1997.d01-183.x; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; DALESSANDRO U, 1995, LANCET, V346, P462, DOI 10.1016/S0140-6736(95)91321-1; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; Erhart A, 2007, T ROY SOC TROP MED H, V101, P216, DOI 10.1016/j.trstmh.2006.07.003; Franckel A, 2009, J BIOSOC SCI, V41, P1, DOI 10.1017/S0021932008002885; Kangwana BB, 2009, AM J TROP MED HYG, V80, P737, DOI 10.4269/ajtmh.2009.80.737; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; McGuinness D, 1998, T ROY SOC TROP MED H, V92, P527, DOI 10.1016/S0035-9203(98)90902-6; Molyneux CS, 2002, J BIOSOC SCI, V34, P109, DOI 10.1017/S0021932002001098; Moorthy VS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-23; Moorthy VS, 2009, VACCINE, V27, P624, DOI 10.1016/j.vaccine.2008.11.034; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; Nwanyanwu OC, 1997, ANN TROP MED PARASIT, V91, P359, DOI 10.1080/00034989760978; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Oum S, 2005, TROP MED INT HEALTH, V10, P689, DOI 10.1111/j.1365-3156.2005.01445.x; Rogers WO, 2006, J INFECT DIS, V193, P467, DOI 10.1086/499314; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sumba PO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-245; Teng CL, 2008, J TROP PEDIATRICS, V54, P70, DOI 10.1093/tropej/fmm077; Van den Ende J, 2005, TROP MED INT HEALTH, V10, P1207, DOI 10.1111/j.1365-3156.2005.01508.x	32	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15569	10.1371/journal.pone.0015569	http://dx.doi.org/10.1371/journal.pone.0015569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179571	gold, Green Published, Green Submitted			2022-12-25	WOS:000285381200032
J	Stevenson, CG; Beane, WS				Stevenson, Claire G.; Beane, Wendy Scott			A Low Percent Ethanol Method for Immobilizing Planarians	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SCHMIDTEA-MEDITERRANEA; GENE-EXPRESSION; MODEL SYSTEM; STEM-CELLS; REGENERATION; ORGANIZATION; MECHANISM; EVOLUTION; CILIA	Planarians have recently become a popular model system for the study of adult stem cells, regeneration and polarity. The system is attractive for both undergraduate and graduate research labs, since planarian colonies are low cost and easy to maintain. Also in situ hybridization, immunofluorescence and RNA-interference (RNAi) gene knockdown techniques have been developed for planarian studies. However, imaging of live worms (particularly at high magnifications) is difficult because animals are strongly photophobic; they quickly move away from light sources and out of frame. The current methods available to inhibit movement in planarians include RNAi injection and exposure to cold temperatures. The former is labor and time intensive, while the latter precludes the use of many fluorescent reporter dyes. Here, we report a simple, inexpensive and reversible method to immobilize planarians for live imaging. Our data show that a short 1 hour treatment with 3% ethanol (EtOH) is sufficient to inhibit both the fine and gross movements of Schmidtea mediterranea planarians, of the typical size used (4-6 mm), with full recovery of movement within 3-4 hours. Importantly, EtOH treatment did not interfere with regeneration, even after repeated exposure, nor lyse epithelial cells (as assayed by H&E staining). We demonstrate that a short exposure to a low concentration of EtOH is a quick and effective method of immobilizing planarians, one that is easily adaptable to planarians of all sizes and will increase the accessibility of live imaging assays to planarian researchers.	[Stevenson, Claire G.; Beane, Wendy Scott] Tufts Univ, Dept Biol, Tufts Ctr Regenerat & Dev Biol, Medford, MA 02155 USA	Tufts University	Stevenson, CG (corresponding author), Tufts Univ, Dept Biol, Tufts Ctr Regenerat & Dev Biol, Medford, MA 02155 USA.	wendy.beane@tufts.edu		Beane, Wendy/0000-0002-3762-1025	National Institutes of Health (NIH) [F32 GM083542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083542, F32GM083547] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) National Research Service Award grant F32 GM083542 (http://grants.nih.gov/training/nrsa.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; BAGUNA J, 1989, DEVELOPMENT, V107, P77; BEST JB, 1982, TERATOGEN CARCIN MUT, V2, P277, DOI 10.1002/1520-6866(1990)2:3/4<277::AID-TCM1770020309>3.0.CO;2-8; Castle WA, 1928, J EXP ZOOL, V51, P417, DOI 10.1002/jez.1400510402; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Cebria F, 2008, NEUROSCI RES, V61, P375, DOI 10.1016/j.neures.2008.04.005; Cebria F, 2007, DEV GENES EVOL, V217, P733, DOI 10.1007/s00427-007-0188-6; Chakrabarti A, 1998, CELL TISSUE RES, V293, P453, DOI 10.1007/s004410051137; DEITRICH RA, 1989, PHARMACOL REV, V41, P489; DICIAULA LLR, 1995, BIOTECH HISTOCHEM, V70, P119; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Hicks C, 2006, J NEUROBIOL, V66, P977, DOI 10.1002/neu.20290; HORI I, 1980, TISSUE CELL, V12, P513, DOI 10.1016/0040-8166(80)90040-3; Izuhara K, 2009, CURR MED CHEM, V16, P2867, DOI 10.2174/092986709788803196; LENTZ TL, 1967, J ULTRA MOL STRUCT R, V17, P114, DOI 10.1016/S0022-5320(67)80024-8; MACHEMER H, 1979, J PHYSIOL-LONDON, V296, P49, DOI 10.1113/jphysiol.1979.sp012990; MARTIN GG, 1978, ZOOMORPHOLOGIE, V91, P235, DOI 10.1007/BF00999813; McGee C, 1998, COMP BIOCHEM PHYS B, V119, P293, DOI 10.1016/S0305-0491(97)00328-3; Mitchell KAP, 2009, METHOD CELL BIOL, V94, P87, DOI 10.1016/S0091-679X(08)94004-8; MIYAZAWA K, 1987, TOXICON, V25, P975, DOI 10.1016/0041-0101(87)90160-7; Nishimura K, 2007, DEV NEUROBIOL, V67, P1059, DOI 10.1002/dneu.20377; Nogi T, 2005, DEV BIOL, V287, P314, DOI 10.1016/j.ydbio.2005.09.002; Nogi T, 2005, LATERALITY, V10, P193, DOI 10.1080/1357650054200001440; Nogi T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000464; Nori VS, 1997, J COMP PHYSIOL A, V180, P473, DOI 10.1007/s003590050064; Okamoto K, 2005, ZOOL SCI, V22, P535, DOI 10.2108/zsj.22.535; Oviedo NJ, 2007, DEVELOPMENT, V134, P3121, DOI 10.1242/dev.006635; Oviedo Nestor J, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5054; Oviedo NJ, 2010, DEV BIOL, V339, P188, DOI 10.1016/j.ydbio.2009.12.012; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Rompolas P, 2009, METHOD CELL BIOL, V93, P81, DOI 10.1016/S0091-679X(08)93004-1; Salo E, 2009, INT J DEV BIOL, V53, P1317, DOI 10.1387/ijdb.072414es; She WY, 2010, LARYNGOSCOPE, V120, P1470, DOI 10.1002/lary.20970; Stephens RE, 2008, ACS CHEM BIOL, V3, P84, DOI 10.1021/cb8000217; STEPHENS RE, 1992, J CELL SCI, V101, P837; Stevens NM, 1907, ARCH ENTWICKLUNG ORG, V24, P350, DOI 10.1007/BF02161840; Umesono Y, 2009, DEV GROWTH DIFFER, V51, P185, DOI 10.1111/j.1440-169X.2009.01099.x	41	21	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15310	10.1371/journal.pone.0015310	http://dx.doi.org/10.1371/journal.pone.0015310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179478	gold, Green Published, Green Submitted			2022-12-25	WOS:000285292500021
J	Guetta, D; Langou, K; Grunwald, D; Klein, G; Aubry, L				Guetta, Dorian; Langou, Karine; Grunwald, Didier; Klein, Gerard; Aubry, Laurence			FYVE-Dependent Endosomal Targeting of an Arrestin-Related Protein in Amoeba	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM AMEBAS; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; BETA-ARRESTIN; RECEPTOR TRAFFICKING; LOCALIZATION; ROLES; ENDOCYTOSIS; MEMBRANES; DOMAINS; PATHWAY	Background: Visual and beta-arrestins are scaffolding proteins involved in the regulation of receptor-dependent intracellular signaling and their trafficking. The arrestin superfamilly includes several arrestin domain-containing proteins and the structurally related protein Vps26. In Dictyostelium discoideum, the arrestin-domain containing proteins form a family of six members, namely AdcA to -F. In contrast to canonical arrestins, Dictyostelium Adc proteins show a more complex architecture, as they possess, in addition to the arrestin core, other domains, such as C2, FYVE, LIM, MIT and SAM, which potentially mediate selective interactions with either lipids or proteins. Methodology and Principal Findings: A detailed analysis of AdcA has been performed. AdcA extends on both sides of the arrestin core, in particular by a FYVE domain which mediates selective interactions with PI(3) P, as disclosed by intrinsic fluorescence measurements and lipid overlay assays. Localization studies showed an enrichment of tagged- and endogenous AdcA on the rim of early macropinosomes and phagosomes. This vesicular distribution relies on a functional FYVE domain. Our data also show that the arrestin core binds the ADP-ribosylation factor ArfA, the unique amoebal Arf member, in its GDP-bound conformation. Significance: This work describes one of the 6 arrestin domain-containing proteins of Dictyostelium, a novel and atypical member of the arrestin clan. It provides the basis for a better understanding of arrestin-related protein involvement in trafficking processes and for further studies on the expanding roles of arrestins in eukaryotes.	[Guetta, Dorian; Langou, Karine; Klein, Gerard; Aubry, Laurence] CEA, DSV, Lab Biochim & Biophys Syst Integres, iRTSV, Grenoble, France; [Grunwald, Didier] CEA, DSV, Lab Transduct Signal, iRTSV, Grenoble, France; [Grunwald, Didier] INSERM, LTS, EMI104, Grenoble, France; [Guetta, Dorian; Klein, Gerard; Aubry, Laurence] CNRS, LBBSI, UMR5092, Grenoble, France; [Guetta, Dorian; Grunwald, Didier; Klein, Gerard; Aubry, Laurence] Univ Grenoble 1, Grenoble, France	CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Guetta, D (corresponding author), CEA, DSV, Lab Biochim & Biophys Syst Integres, iRTSV, Grenoble, France.	laubry@cea.fr		guetta, dafne/0000-0002-7349-1109; Aubry, Laurence/0000-0001-7640-1706	Commissariat a l'Energie Atomique; Centre National de la Recherche Scientifique; Universite Joseph Fourier Grenoble I	Commissariat a l'Energie Atomique(French Atomic Energy Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier Grenoble I	This work was funded by the Commissariat a l'Energie Atomique, the Centre National de la Recherche Scientifique and the Universite Joseph Fourier Grenoble I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADESSI C, 1995, J CELL SCI, V108, P3331; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Aubry L, 2002, J BIOL CHEM, V277, P21947, DOI 10.1074/jbc.M201718200; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; AUBRY L, 1993, J CELL SCI, V105, P861; Aubry L, 1997, DICTYOSTELIUM MODEL, P65; Aubry Laurence, 2006, V346, P171; Aubry L, 2009, CURR GENOMICS, V10, P133, DOI 10.2174/138920209787847014; Bennett N, 2008, EXP CELL RES, V314, P2822, DOI 10.1016/j.yexcr.2008.06.019; BRENOT F, 1992, BIOCHIMIE, V74, P883, DOI 10.1016/0300-9084(92)90072-M; Chen PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008624; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Ellson CD, 2001, CURR BIOL, V11, P1631, DOI 10.1016/S0960-9822(01)00447-X; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gotthardt D, 2006, MOL CELL PROTEOMICS, V5, P2228, DOI 10.1074/mcp.M600113-MCP200; Graf R, 1999, BIOL CELL, V91, P471, DOI 10.1016/S0248-4900(99)80088-4; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Hacker U, 1997, J CELL SCI, V110, P105; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Journet A, 1999, J CELL SCI, V112, P3833; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Mattei S, 2005, DEV BIOL, V279, P99, DOI 10.1016/j.ydbio.2004.12.004; Mercanti V, 2006, J CELL SCI, V119, P4079, DOI 10.1242/jcs.03190; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mukherjee A, 2005, NAT CELL BIOL, V7, P1191, DOI 10.1038/ncb1327; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Popov S, 2009, J VIROL, V83, P7185, DOI 10.1128/JVI.00198-09; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Price HP, 2007, MOL BIOL CELL, V18, P864, DOI 10.1091/mbc.E06-08-0736; Raiborg C, 2001, J CELL SCI, V114, P2255; Rauchenberger R, 1997, CURR BIOL, V7, P215, DOI 10.1016/S0960-9822(97)70093-9; Ravanel K, 2001, EUR J CELL BIOL, V80, P754, DOI 10.1078/0171-9335-00215; Roman G, 2000, GENETICS, V155, P1281; Rupper AC, 2001, J CELL SCI, V114, P1283; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shinoda J, 2007, BIOCHEM BIOPH RES CO, V364, P258, DOI 10.1016/j.bbrc.2007.09.134; Sussman M., 1966, METHOD CELL PHYSIOL, V2, P397; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; WEINER OH, 1993, J CELL BIOL, V123, P23, DOI 10.1083/jcb.123.1.23; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; ZHOU KM, 1995, MOL CELL BIOL, V15, P5645	55	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15249	10.1371/journal.pone.0015249	http://dx.doi.org/10.1371/journal.pone.0015249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179207	Green Published, gold			2022-12-25	WOS:000285246900037
J	Parsons, CJ; Stefanovic, B; Seki, E; Aoyama, T; Latour, AM; Marzluff, WF; Rippe, RA; Brenner, DA				Parsons, Christopher J.; Stefanovic, Branko; Seki, Ekihiro; Aoyama, Tomonori; Latour, Anne M.; Marzluff, William F.; Rippe, Richard A.; Brenner, David A.			Mutation of the 5 '-Untranslated Region Stem-Loop Structure Inhibits alpha 1(I) Collagen Expression in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELL; MESSENGER-RNA; OSTEOGENESIS IMPERFECTA; GENE COL1A1; 1ST INTRON; POSTTRANSCRIPTIONAL REGULATION; TRANSLATION INITIATION; SPONTANEOUS FRACTURES; EXTRACELLULAR-MATRIX; DELETED GENE	Type I collagen is a heterotrimeric extracellular matrix protein consisting of two alpha 1(I) chains and one alpha 2(I) chain. During liver fibrosis, activated hepatic stellate cells (HSCs) are the major source of the type I collagen that accumulates in the damaged tissue. Expression of alpha 1(I) and alpha 2(I) collagen mRNA is increased 60-fold compared with quiescent stellate cells and is due predominantly to post-transcriptional message regulation. Specifically, a stem-loop structure in the 5'-untranslated region of alpha 1(I) collagen mRNA may regulate mRNA expression in activated HSCs through its interaction with stem-loop binding proteins. The stem-loop may also be necessary for efficient production and folding of the type I collagen heterotrimer. To assess the role of the stem-loop in type I collagen expression in vivo, we generated a knock-in mouse harboring a mutation that abolished the stem-loop structure. Heterozygous and homozygous knock-in mice exhibited a normal phenotype. However, steady-state levels of alpha 1(I) collagen mRNA decreased significantly in homozygous mutant MEFs as well as HSCs; intracellular and secreted type I collagen protein levels also decreased. Homozygous mutant mice developed less liver fibrosis. These results confirm an important role of the 5' stem-loop in regulating type I collagen mRNA and protein expression and provide a mouse model for further study of collagen-associated diseases.	[Seki, Ekihiro; Aoyama, Tomonori; Brenner, David A.] Univ Calif San Diego, Dept Med, Sch Med, La Jolla, CA 92093 USA; [Parsons, Christopher J.; Marzluff, William F.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Latour, Anne M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Rippe, Richard A.] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Med, Chapel Hill, NC 27599 USA; [Stefanovic, Branko] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; Florida State University	Brenner, DA (corresponding author), Univ Calif San Diego, Dept Med, Sch Med, 9500 Gilman Dr MC 0702, La Jolla, CA 92093 USA.	dbrenner@ucsd.edu	Seki, Ekihiro/K-2481-2016	Seki, Ekihiro/0000-0002-9472-6085; Brenner, David/0000-0003-2573-525X	National Institutes of Health [AA010459, DK065972, GM041804]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085252, R01DK065972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010459, R29AA010459, R01AA020172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA010459 and DK065972 (to R. A. R.) and GM041804 (to D. A. B.).	Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; BENSONCHANDA V, 1989, GENE, V78, P255, DOI 10.1016/0378-1119(89)90228-X; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P1139, DOI 10.1021/bi00274a023; Berro R, 2006, J VIROL, V80, P3189, DOI 10.1128/JVI.80.7.3189-3204.2006; Breault DT, 1997, J BIOL CHEM, V272, P31241, DOI 10.1074/jbc.272.50.31241; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; Bricker AL, 1999, J BACTERIOL, V181, P3587, DOI 10.1128/JB.181.11.3587-3590.1999; Cai Le, 2009, Expert Rev Gastroenterol Hepatol, V3, P1, DOI 10.1586/17474124.3.1.1; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; DALESSIO M, 1988, GENE, V67, P105, DOI 10.1016/0378-1119(88)90013-3; Doyle SA, 1998, J CELL BIOCHEM, V71, P233; Dubois GM, 2002, GENE, V294, P55, DOI 10.1016/S0378-1119(02)00770-9; ELEFTHERIADES EG, 1995, J MOL CELL CARDIOL, V27, P1459, DOI 10.1016/S0022-2828(95)90095-0; EXPOSITO JY, 1995, EUR J BIOCHEM, V234, P59, DOI 10.1111/j.1432-1033.1995.059_c.x; Forlino A, 1999, J BIOL CHEM, V274, P37923, DOI 10.1074/jbc.274.53.37923; Forlino A, 2000, MOL GENET METAB, V71, P225, DOI 10.1006/mgme.2000.3039; Fournier B, 2001, J BACTERIOL, V183, P2367, DOI 10.1128/JB.183.7.2367-2371.2001; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; FU XY, 1987, MOL CELL BIOL, V7, P738, DOI 10.1128/MCB.7.2.738; HELMINEN HJ, 1993, J CLIN INVEST, V92, P582, DOI 10.1172/JCI116625; Hensold JO, 1997, NUCLEIC ACIDS RES, V25, P2869, DOI 10.1093/nar/25.14.2869; HOGAN B, 1994, MANIPULATING MOUSE E, P1; Hormuzdi SG, 1999, MATRIX BIOL, V18, P287, DOI 10.1016/S0945-053X(99)00017-7; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; Kvist AP, 2001, AM J PATHOL, V159, P1581, DOI 10.1016/S0002-9440(10)62542-4; Lang A, 1999, ITAL J GASTROENTEROL, V31, P173; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Ledermann B, 2000, EXP PHYSIOL, V85, P603, DOI 10.1017/S0958067000021059; Lindquist JN, 2000, AM J PHYSIOL-GASTR L, V279, pG471, DOI 10.1152/ajpgi.2000.279.3.G471; Lindquist JN, 2004, J BIOL CHEM, V279, P23822, DOI 10.1074/jbc.M314060200; Lipshitz HD, 2000, CURR OPIN GENET DEV, V10, P476, DOI 10.1016/S0959-437X(00)00116-7; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; MILANI S, 1990, AM J PATHOL, V137, P59; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Niederreither K, 1995, MATRIX BIOL, V14, P705, DOI 10.1016/S0945-053X(05)80013-7; PEREIRA R, 1994, J CLIN INVEST, V93, P1765, DOI 10.1172/JCI117161; PEREIRA R, 1993, J CLIN INVEST, V91, P709, DOI 10.1172/JCI116252; Rahkonen O, 2004, CIRC RES, V94, P83, DOI 10.1161/01.RES.0000108263.74520.15; RIPPE RA, 1989, MOL CELL BIOL, V9, P2224, DOI 10.1128/MCB.9.5.2224; RIPPE RA, 1995, HEPATOLOGY, V22, P241, DOI 10.1016/0270-9139(95)90378-X; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Roughley P. J., 2003, European Cells & Materials, V5, P41; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Saunders C, 1999, MOL CELL, V3, P43, DOI 10.1016/S1097-2765(00)80173-2; Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sengupta P, 2005, J BIOL CHEM, V280, P21004, DOI 10.1074/jbc.M413191200; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; STACEY A, 1988, NATURE, V332, P131, DOI 10.1038/332131a0; Stefanovic B, 1999, MOL CELL BIOL, V19, P4334; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Stefanovic B, 2003, J BIOL CHEM, V278, P927, DOI 10.1074/jbc.M209175200; Stefanovic B, 2002, J BIOL CHEM, V277, P18229, DOI 10.1074/jbc.M108065200; Wang YC, 2000, J VIROL, V74, P10571, DOI 10.1128/JVI.74.22.10571-10580.2000; YAMADA Y, 1983, J BIOL CHEM, V258, P4914	60	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8609	8619		10.1074/jbc.M110.189118	http://dx.doi.org/10.1074/jbc.M110.189118			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193410	Green Published, hybrid			2022-12-25	WOS:000288013300087
J	Qiao, Q; Li, Y; Chen, Z; Wang, MZ; Reinberg, D; Xu, RM				Qiao, Qi; Li, Yan; Chen, Zhi; Wang, Mingzhu; Reinberg, Danny; Xu, Rui-Ming			The Structure of NSD1 Reveals an Autoregulatory Mechanism Underlying Histone H3K36 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING GENE; TRANSCRIPTIONAL ELONGATION; PRODUCT SPECIFICITY; SOTOS-SYNDROME; METHYLTRANSFERASE; PROTEIN; H3; SET2; NUP98; MMSET	The Sotos syndrome gene product, NSD1, is a SET domain histone methyltransferase that primarily dimethylates nucleosomal histone H3 lysine 36 (H3K36). To date, the intrinsic properties of NSD1 that determine its nucleosomal substrate selectivity and dimethyl H3K36 product specificity remain unknown. The 1.7 angstrom structure of the catalytic domain of NSD1 presented here shows that a regulatory loop adopts a conformation that prevents free access of H3K36 to the bound S-adenosyl-L-methionine. Molecular dynamics simulation and computational docking revealed that this normally inhibitory loop can adopt an active conformation, allowing H3K36 access to the active site, and that the nucleosome may stabilize the active conformation of the regulatory loop. Hence, our study reveals an autoregulatory mechanism of NSD1 and provides insight into the molecular mechanism of the nucleosomal substrate selectivity of this disease-related H3K36 methyltransferase.	[Qiao, Qi; Chen, Zhi; Wang, Mingzhu; Xu, Rui-Ming] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Li, Yan; Reinberg, Danny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Howard Hughes Medical Institute; New York University; New York University	Xu, RM (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	rmxu@sun5.ibp.ac.cn	xu, rui/GRX-5734-2022	Reinberg, Danny/0000-0003-4288-2016	National Institutes of Health [4R37G037120-24]; Chinese Ministry of Science and Technology [2009CB825501, 2010CB944903]; National Science Foundation of China [90919029, 3098801]; Novo Nordisk-Chinese Academy of Sciences Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Novo Nordisk-Chinese Academy of Sciences Foundation	This work was supported, in whole or in part, by National Institutes of Health Grant 4R37G037120-24 (to D. R.). This work was also supported by the Chinese Ministry of Science and Technology (Grants 2009CB825501 and 2010CB944903 to R.-M. X.), the National Science Foundation of China (Grants 90919029 and 3098801 to R.-M. X.), and the Novo Nordisk-Chinese Academy of Sciences Foundation.	An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Angrand PO, 2001, GENOMICS, V74, P79, DOI 10.1006/geno.2001.6524; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Douglas J, 2003, AM J HUM GENET, V72, P132, DOI 10.1086/345647; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Kang HB, 2009, FEBS LETT, V583, P1880, DOI 10.1016/j.febslet.2009.05.038; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Landry J, 2003, MOL CELL BIOL, V23, P5972, DOI 10.1128/MCB.23.17.5972-5978.2003; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Saugier-Veber P, 2007, HUM MUTAT, V28, P1098, DOI 10.1002/humu.20568; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	49	122	127	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8361	8368		10.1074/jbc.M110.204115	http://dx.doi.org/10.1074/jbc.M110.204115			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21196496	hybrid, Green Published			2022-12-25	WOS:000288013300064
J	Stawowczyk, M; Van Scoy, S; Kumar, KP; Reich, NC				Stawowczyk, Marcin; Van Scoy, Sarah; Kumar, K. Prasanna; Reich, Nancy C.			The Interferon Stimulated Gene 54 Promotes Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY FACTOR-3; ENDOPLASMIC-RETICULUM; ADENOVIRUS E4ORF6; INDUCIBLE PROTEIN; BCL-2 FAMILY; TARGET GENES; ALPHA; TRANSCRIPTION; ACTIVATION; P56	The ability of interferons (IFNs) to inhibit viral replication and cellular proliferation is well established, but the specific contribution of each IFN-stimulated gene (ISG) to these biological responses remains to be completely understood. In this report we demonstrate that ISG54, also known as IFN-induced protein with tetratricopeptide repeats 2 (IFIT2), is a mediator of apoptosis. Expression of ISG54, independent of IFN stimulation, elicits apoptotic cell death. Cell death and apoptosis were quantified by propidium iodide uptake and annexin-V staining, respectively. The activation of caspase-3, a key mediator of the execution phase of apoptosis, was clearly apparent in cells expressing ISG54. The anti-apoptotic B cell lymphoma-xl (Bcl-xl) protein inhibited the apoptotic effects of ISG54 as did the anti-apoptotic adenoviral E1B-19K protein. In addition, ISG54 was not able to promote cell death in the absence of pro-apoptotic Bcl family members, Bax and Bak. Analyses of binding partners of ISG54 revealed association with two homologous proteins, ISG56/IFIT1 and ISG60/IFIT3. In addition, ISG60 binding negatively regulates the apoptotic effects of ISG54. The results reveal a previously unidentified role of ISG54 in the induction of apoptosis via a mitochondrial pathway and shed new light on the mechanism by which IFN elicits anti-viral and anti-cancer effects.	[Stawowczyk, Marcin; Van Scoy, Sarah; Kumar, K. Prasanna; Reich, Nancy C.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Reich, NC (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Life Sci Bldg, Stony Brook, NY 11794 USA.	nreich@notes.cc.sunysb.edu			National Institutes of Health [R21AI067885]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AI067885 (to N. C. R.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Clemens MJ, 2003, J INTERF CYTOK RES, V23, P277, DOI 10.1089/107999003766628124; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; George CX, 2009, J INTERF CYTOK RES, V29, P477, DOI 10.1089/jir.2009.0065; Gomez D, 2003, J IMMUNOL, V170, P5373, DOI 10.4049/jimmunol.170.11.5373; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; GUTCH MJ, 1992, P NATL ACAD SCI USA, V89, P11411, DOI 10.1073/pnas.89.23.11411; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Jagus R, 1999, INT J BIOCHEM CELL B, V31, P123, DOI 10.1016/S1357-2725(98)00136-8; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; KOFLER R, 2006, MOL CANCER THER, V5, P1927; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; KOTANIDES H, 1995, J BIOL CHEM, V270, P19481, DOI 10.1074/jbc.270.33.19481; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kumar KP, 2000, MOL CELL BIOL, V20, P4159, DOI 10.1128/MCB.20.11.4159-4168.2000; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; LAFAGE M, 1992, GENOMICS, V13, P458, DOI 10.1016/0888-7543(92)90272-T; LEVY D, 1986, P NATL ACAD SCI USA, V83, P8929, DOI 10.1073/pnas.83.23.8929; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; Li W, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/15/155003; MartinezMoczygemba M, 1997, J BIOL CHEM, V272, P20070, DOI 10.1074/jbc.272.32.20070; Mawji IA, 2006, EXP BIOL MED, V231, P704; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Pokrovskaja K, 2005, J INTERF CYTOK RES, V25, P799, DOI 10.1089/jir.2005.25.799; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHAULIAN E, 1995, ONCOGENE, V10, P671; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; Terenzi F, 2005, VIROLOGY, V340, P116, DOI 10.1016/j.virol.2005.06.011; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241; Thyrell L, 2002, ONCOGENE, V21, P1251, DOI 10.1038/sj.onc.1205179; Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X; VALES LD, 1989, GENE DEV, V3, P49, DOI 10.1101/gad.3.1.49; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Weaver BK, 2001, FASEB J, V15, P501, DOI 10.1096/fj.00-0222com; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	79	117	123	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7257	7266		10.1074/jbc.M110.207068	http://dx.doi.org/10.1074/jbc.M110.207068			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21190939	Green Published, hybrid			2022-12-25	WOS:000287737300042
J	Brockington, M; Torelli, S; Sharp, PS; Liu, K; Cirak, S; Brown, SC; Wells, DJ; Muntoni, F				Brockington, Martin; Torelli, Silvia; Sharp, Paul S.; Liu, Ke; Cirak, Sebahattin; Brown, Susan C.; Wells, Dominic J.; Muntoni, Francesco			Transgenic Overexpression of LARGE Induces alpha-Dystroglycan Hyperglycosylation in Skeletal and Cardiac Muscle	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; HUMAN LARGE GENE; LAMININ-BINDING; PROTEIN GENE; DEFECTIVE GLYCOSYLATION; ABNORMAL GLYCOSYLATION; MENTAL-RETARDATION; LARGE FAMILY; O-GLYCAN	Background: LARGE is one of seven putative or demonstrated glycosyltransferase enzymes defective in a common group of muscular dystrophies with reduced glycosylation of alpha-dystroglycan. Overexpression of LARGE induces hyperglycosylation of alpha-dystroglycan in both wild type and in cells from dystroglycanopathy patients, irrespective of their primary gene defect, restoring functional glycosylation. Viral delivery of LARGE to skeletal muscle in animal models of dystroglycanopathy has identical effects in vivo, suggesting that the restoration of functional glycosylation could have therapeutic applications in these disorders. Pharmacological strategies to upregulate Large expression are also being explored. Methodology/Principal Findings: In order to asses the safety and efficacy of long term LARGE over-expression in vivo, we have generated four mouse lines expressing a human LARGE transgene. On observation, LARGE transgenic mice were indistinguishable from the wild type littermates. Tissue analysis from young mice of all four lines showed a variable pattern of transgene expression: highest in skeletal and cardiac muscles, and lower in brain, kidney and liver. Transgene expression in striated muscles correlated with alpha-dystroglycan hyperglycosylation, as determined by immunoreactivity to antibody IIH6 and increased laminin binding on an overlay assay. Other components of the dystroglycan complex and extracellular matrix ligands were normally expressed, and general muscle histology was indistinguishable from wild type controls. Further detailed muscle physiological analysis demonstrated a loss of force in response to eccentric exercise in the older, but not in the younger mice, suggesting this deficit developed over time. However this remained a subclinical feature as no pathology was observed in older mice in any muscles including the diaphragm, which is sensitive to mechanical load-induced damage. Conclusions/Significance: This work shows that potential therapies in the dystroglycanopathies based on LARGE upregulation and alpha-dystroglycan hyperglycosylation in muscle should be safe.	[Brockington, Martin; Torelli, Silvia; Cirak, Sebahattin; Muntoni, Francesco] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Brockington, Martin; Torelli, Silvia; Cirak, Sebahattin; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London, England; [Sharp, Paul S.; Liu, Ke; Wells, Dominic J.] Univ London Imperial Coll Sci Technol & Med, Dept Cellular & Mol Neurosci, London, England; [Brown, Susan C.; Wells, Dominic J.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Imperial College London; University of London; University of London Royal Veterinary College	Brockington, M (corresponding author), UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.	f.muntoni@ich.ucl.ac.uk	Cirak, Sebahattin/AAZ-6829-2020; Cirak, Sebahattin/AAX-9593-2020	Brown, Sue/0000-0001-8112-933X; Wells, Dominic/0000-0002-1425-6344	Institute of Child Health and Great Ormond Street Hospitals Biomedical Research Centre [BRC 08DN25]; Association Francaise contres les Myopathies [AFM 1399, AFM 13992, 14175]; Muscular Dystrophy Association of America [MDA 68721]; Wellcome Trust; Great Ormond Street Hospital Children's Charity; Medical Research Council [G0200171, G0601943] Funding Source: researchfish; MRC [G0601943, G0200171] Funding Source: UKRI	Institute of Child Health and Great Ormond Street Hospitals Biomedical Research Centre; Association Francaise contres les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association of America(Muscular Dystrophy Association); Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Hospital Children's Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Institute of Child Health and Great Ormond Street Hospitals Biomedical Research Centre (BRC 08DN25) to FM, Association Francaise contres les Myopathies (AFM 1399 to FM, AFM 13992 and 14175 to SCB) and Muscular Dystrophy Association of America (MDA 68721 to FM). MB was the recipient of a Wellcome Trust Value in People award. FM is supported by Great Ormond Street Hospital Children's Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200; Balci B, 2005, NEUROMUSCULAR DISORD, V15, P271, DOI 10.1016/j.nmd.2005.01.013; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Brown SC, 1999, J CELL SCI, V112, P209; Chiba A, 1997, J BIOL CHEM, V272, P2156; Clement E, 2008, ANN NEUROL, V64, P573, DOI 10.1002/ana.21482; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Endo Tamao, 2006, V347, P43; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; Fahim AT, 2009, THROMB RES, V123, P785, DOI 10.1016/j.thromres.2008.07.004; Fujimura K, 2005, BIOCHEM BIOPH RES CO, V329, P1162, DOI 10.1016/j.bbrc.2005.02.082; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2006, ANN NEUROL, V60, P603, DOI 10.1002/ana.21006; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Herbst R, 2009, NEUROMUSCULAR DISORD, V19, P366, DOI 10.1016/j.nmd.2009.02.011; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; Hoyte K, 2002, BRAIN RES MOL BRAIN, V109; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ikeguchi Y, 2004, BIOCHEM J, V381, P701, DOI 10.1042/BJ20040419; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Martin PT, 2006, NAT CLIN PRACT NEURO, V2, P222, DOI 10.1038/ncpneuro0155; Martin PT, 2003, GLYCOBIOLOGY, V13, p55R, DOI 10.1093/glycob/cwg076; Martin PT, 2003, GLYCOBIOLOGY, V13, p67R, DOI 10.1093/glycob/cwg077; Matsumura K, 1997, J BIOL CHEM, V272, P13904, DOI 10.1074/jbc.272.21.13904; Mercuri E, 2003, ANN NEUROL, V53, P537, DOI 10.1002/ana.10559; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Muntoni F, 2004, CURR OPIN NEUROL, V17, P205, DOI 10.1097/00019052-200404000-00020; Muntoni F, 2008, NEUROTHERAPEUTICS, V5, P627, DOI 10.1016/j.nurt.2008.08.005; Muntoni F, 2007, CURR OPIN NEUROL, V20, P590, DOI 10.1097/WCO.0b013e3282efc157; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Poppe M, 2004, ANN NEUROL, V56, P738, DOI 10.1002/ana.20283; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Wairkar YP, 2008, J NEUROSCI, V28, P3781, DOI 10.1523/JNEUROSCI.0478-08.2008; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	53	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14434	10.1371/journal.pone.0014434	http://dx.doi.org/10.1371/journal.pone.0014434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203384	Green Published, Green Accepted, gold			2022-12-25	WOS:000285792500011
J	Chan, SSK; Li, HJ; Hsueh, YC; Lee, DS; Chen, JH; Hwang, SM; Chen, CY; Shih, E; Hsieh, PCH				Chan, Sunny Sun-Kin; Li, Hui-Jing; Hsueh, Ying-Chang; Lee, Desy S.; Chen, Jyh-Hong; Hwang, Shiaw-Min; Chen, Chen-Yun; Shih, Emily; Hsieh, Patrick C. H.			Fibroblast Growth Factor-10 Promotes Cardiomyocyte Differentiation from Embryonic and Induced Pluripotent Stem Cells	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; PEPTIDE NANOFIBERS; HEART DEVELOPMENT; CARDIAC MYOCYTES; PRECURSOR CELLS; FGF FAMILY; MOUSE; THERAPY; SPECIFICATION; GENERATION	Background: The fibroblast growth factor (FGF) family is essential to normal heart development. Yet, its contribution to cardiomyocyte differentiation from stem cells has not been systemically studied. In this study, we examined the mechanisms and characters of cardiomyocyte differentiation from FGF family protein treated embryonic stem (ES) cells and induced pluripotent stem (iPS) cells. Methodology/Principal Findings: We used mouse ES cells stably transfected with a cardiac-specific a-myosin heavy chain (aMHC) promoter-driven enhanced green fluorescent protein (EGFP) and mouse iPS cells to investigate cardiomyocyte differentiation. During cardiomyocyte differentiation from mouse ES cells, FGF-3, -8, -10, -11, -13 and -15 showed an expression pattern similar to the mesodermal marker Brachyury and the cardiovascular progenitor marker Flk-1. Among them, FGF-10 induced cardiomyocyte differentiation in a time-and concentration-dependent manner. FGF-10 neutralizing antibody, small molecule FGF receptor antagonist PD173074 and FGF-10 and FGF receptor-2 short hairpin RNAs inhibited cardiomyocyte differentiation. FGF-10 also increased mouse iPS cell differentiation into cardiomyocyte lineage, and this effect was abolished by FGF-10 neutralizing antibody or PD173074. Following Gene Ontology analysis, microarray data indicated that genes involved in cardiac development were upregulated after FGF-10 treatment. In vivo, intramyocardial co-administration of FGF-10 and ES cells demonstrated that FGF-10 also promoted cardiomyocyte differentiation. Conclusion/Significance: FGF-10 induced cardiomyocyte differentiation from ES cells and iPS cells, which may have potential for translation into clinical applications.	[Chan, Sunny Sun-Kin; Li, Hui-Jing; Lee, Desy S.; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Inst Clin Med, Tainan, Taiwan; [Chan, Sunny Sun-Kin; Li, Hui-Jing; Lee, Desy S.; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Res Ctr Clin Med, Tainan, Taiwan; [Hsueh, Ying-Chang; Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Inst Basic Med, Tainan, Taiwan; [Chen, Jyh-Hong] Natl Cheng Kung Univ & Hosp, Dept Med, Tainan, Taiwan; [Hwang, Shiaw-Min] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu, Taiwan; [Chen, Chen-Yun; Hsieh, Patrick C. H.] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Chen, Chen-Yun; Hsieh, Patrick C. H.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shih, Emily] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; University of Washington; University of Washington Seattle	Chan, SSK (corresponding author), Natl Cheng Kung Univ & Hosp, Inst Clin Med, Tainan, Taiwan.	phsieh@mail.ncku.edu.tw	Li, Huijing/AAU-5279-2020; Shih, Emily/AAS-3943-2021	Shih, Emily/0000-0002-2426-513X	National Science Council [NSC 97IR082, NSC 96-2314-B-006-032]; National Health Research Institutes [NHRI EX97-9722SI]; National Cheng Kung University [97I006]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); National Cheng Kung University	This work was supported by grants from the National Science Council [NSC 97IR082, NSC 96-2314-B-006-032] (http://web1.nsc.gov.tw), the National Health Research Institutes [NHRI EX97-9722SI] (http://www.nhri.org.tw), and the National Cheng Kung University Landmark Project [97I006] (http://web.ncku.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Chan SSK, 2009, BIOCHEM BIOPH RES CO, V387, P723, DOI 10.1016/j.bbrc.2009.07.122; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Conway SJ, 1999, MECH DEVELOP, V81, P187, DOI 10.1016/S0925-4773(98)00235-4; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Dell'Era P, 2003, CIRC RES, V93, P414, DOI 10.1161/01.RES.0000089460.12061.E1; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; King T, 1998, MECH DEVELOP, V79, P29, DOI 10.1016/S0925-4773(98)00166-X; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Marguerie A, 2006, CARDIOVASC RES, V71, P50, DOI 10.1016/j.cardiores.2006.03.021; Martinez-Fernandez A, 2009, CIRC RES, V105, P648, DOI 10.1161/CIRCRESAHA.109.203109; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Nakashima Y, 2009, BIOCHEM BIOPH RES CO, V390, P821, DOI 10.1016/j.bbrc.2009.10.056; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Saga Y, 1999, DEVELOPMENT, V126, P3437; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	32	37	41	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14414	10.1371/journal.pone.0014414	http://dx.doi.org/10.1371/journal.pone.0014414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203390	Green Submitted, Green Published, gold			2022-12-25	WOS:000285792500004
J	Karyala, P; Namsa, ND; Chilakalapudi, DR				Karyala, Prashanthi; Namsa, Nima D.; Chilakalapudi, Durga Rao			Translational Up-Regulation and High-Level Protein Expression from Plasmid Vectors by mTOR Activation via Different Pathways in PC3 and 293T Cells	PLOS ONE			English	Article							P70 S6 KINASE; PHOSPHOLIPASE-D; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; ELONGATION-FACTOR-2 KINASE; PHOSPHOINOSITIDE 3-KINASE; GENE-PRODUCT; PHAS-I; PHOSPHORYLATION; GROWTH	Background: Though 293T cells are widely used for expression of proteins from transfected plasmid vectors, the molecular basis for the high-level expression is yet to be understood. We recently identified the prostate carcinoma cell line PC3 to be as efficient as 293T in protein expression. This study was undertaken to decipher the molecular basis of high-level expression in these two cell lines. Methodology/Principal Findings: In a survey of different cell lines for efficient expression of platelet-derived growth factor-B (PDGF-B), beta-galactosidase (beta-gal) and green fluorescent protein (GFP) from plasmid vectors, PC3 was found to express at 5-50-fold higher levels compared to the bone metastatic prostate carcinoma cell line PC3BM and many other cell lines. Further, the efficiency of transfection and level of expression of the reporters in PC3 were comparable to that in 293T. Comparative analyses revealed that the high level expression of the reporters in the two cell lines was due to increased translational efficiency. While phosphatidic acid (PA)-mediated activation of mTOR, as revealed by drastic reduction in reporter expression by n-butanol, primarily contributed to the high level expression in PC3, multiple pathways involving PA, PI3K/Akt and ERK1/2 appear to contribute to the abundant reporter expression in 293T. Thus the extent of translational upregulation attained through the concerted activation of mTOR by multiple pathways in 293T could be achieved through its activation primarily by the PA pathway in PC3. Conclusions/Significance: Our studies reveal that the high-level expression of proteins from plasmid vectors is effected by translational up-regulation through mTOR activation via different signaling pathways in the two cell lines and that PC3 is as efficient as 293T for recombinant protein expression. Further, PC3 offers an advantage in that the level of expression of the protein can be regulated by simple addition of n-butanol to the culture medium.	[Karyala, Prashanthi; Namsa, Nima D.; Chilakalapudi, Durga Rao] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Karyala, P (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	cdr@mcbl.iisc.ernet.in	Karyala, Prashanthi/AAP-5229-2020	Karyala, Prashanthi/0000-0002-1099-5262	Department of Biotechnology, Government of India, New Delhi [BT/PR2180/BRB/15/215/2000]; Department of Science and Technology, Government of India, New Delhi [SR/SO/BB-63/2004]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology (Grant BT/PR2180/BRB/15/215/2000) during 2001-2004 and Department of Science and Technology (Grant SR/SO/BB-63/2004) during 2005-2008, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; BARRETT TB, 1987, P NATL ACAD SCI USA, V84, P1099, DOI 10.1073/pnas.84.4.1099; BARRETT TB, 1984, P NATL ACAD SCI-BIOL, V81, P6772, DOI 10.1073/pnas.81.21.6772; Berven LA, 2000, IMMUNOL CELL BIOL, V78, P447, DOI 10.1046/j.1440-1711.2000.00928.x; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Cantrell DA, 2001, J CELL SCI, V114, P1439; Cazzolli R, 2006, IUBMB LIFE, V58, P457, DOI 10.1080/15216540600871142; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FOECKING MK, 1986, GENE, V45, P101, DOI 10.1016/0378-1119(86)90137-X; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GOUSTIN AS, 1985, CELL, V41, P301, DOI 10.1016/0092-8674(85)90083-2; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Houle MG, 1999, BBA-MOL CELL BIOL L, V1439, P135, DOI 10.1016/S1388-1981(99)00090-6; Hui L, 2005, J BIOL CHEM, V280, P35829, DOI 10.1074/jbc.M504192200; IGARASHI H, 1987, ONCOGENE, V1, P79; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kim CH, 1997, GENE, V199, P293, DOI 10.1016/S0378-1119(97)00384-3; Kumar V, 2000, EMBO J, V19, P1087, DOI 10.1093/emboj/19.5.1087; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MARTINET Y, 1986, NATURE, V319, P158, DOI 10.1038/319158a0; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Proud CG, 2004, BIOCHEM J, V403, P217; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; RAO CD, 1986, P NATL ACAD SCI USA, V83, P2392, DOI 10.1073/pnas.83.8.2392; RAO CD, 1988, MOL CELL BIOL, V8, P284, DOI 10.1128/MCB.8.1.284; ROBBINS KC, 1983, NATURE, V305, P605, DOI 10.1038/305605a0; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Sans MD, 2004, BIOCHEM BIOPH RES CO, V319, P144, DOI 10.1016/j.bbrc.2004.04.164; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schlaeger EJ, 1998, NEW DEV NEW APPL ANI, P105; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Stauber RH, 1998, BIOTECHNIQUES, V24, P462, DOI 10.2144/98243rr01; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wurm F, 1999, CURR OPIN BIOTECH, V10, P156, DOI 10.1016/S0958-1669(99)80027-5; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yang X, 2008, J Anim Sci, V86, pE36	69	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14408	10.1371/journal.pone.0014408	http://dx.doi.org/10.1371/journal.pone.0014408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203441	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500003
J	Lowe, CD; Montagnes, DJS; Martin, LE; Watts, PC				Lowe, Chris D.; Montagnes, David J. S.; Martin, Laura E.; Watts, Phillip C.			High Genetic Diversity and Fine-Scale Spatial Structure in the Marine Flagellate Oxyrrhis marina (Dinophyceae) Uncovered by Microsatellite Loci	PLOS ONE			English	Article							DINOFLAGELLATE COCHLODINIUM-POLYKRIKOIDES; NITZSCHIA-PUNGENS BACILLARIOPHYCEAE; ALEXANDRIUM-CATENELLA; POPULATION-STRUCTURE; MOLECULAR EVIDENCE; SPRING BLOOM; MARKERS; DISPERSAL; TIDE; DIFFERENTIATION	Free-living marine protists are often assumed to be broadly distributed and genetically homogeneous on large spatial scales. However, an increasing application of highly polymorphic genetic markers (e.g., microsatellites) has provided evidence for high genetic diversity and population structuring on small spatial scales in many free-living protists. Here we characterise a panel of new microsatellite markers for the common marine flagellate Oxyrrhis marina. Nine microsatellite loci were used to assess genotypic diversity at two spatial scales by genotyping 200 isolates of O. marina from 6 broad geographic regions around Great Britain and Ireland; in one region, a single 2 km shore line was sampled intensively to assess fine-scale genetic diversity. Microsatellite loci resolved between 1-6 and 7-23 distinct alleles per region in the least and most variable loci respectively, with corresponding variation in expected heterozygosities (H-e) of 0.00-0.30 and 0.81-0.93. Across the dataset, genotypic diversity was high with 183 genotypes detected from 200 isolates. Bayesian analysis of population structure supported two model populations. One population was distributed across all sampled regions; the other was confined to the intensively sampled shore, and thus two distinct populations co-occurred at this site. Whilst model-based analysis inferred a single UK-wide population, pairwise regional F-ST values indicated weak to moderate population sub-division (0.01-0.12), but no clear correlation between spatial and genetic distance was evident. Data presented in this study highlight extensive genetic diversity for O. marina; however, it remains a substantial challenge to uncover the mechanisms that drive genetic diversity in free-living microorganisms.	[Lowe, Chris D.; Montagnes, David J. S.; Martin, Laura E.; Watts, Phillip C.] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Lowe, CD (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England.	clowe@liv.ac.uk		Watts, Phillip/0000-0001-7755-187X	Natural Environment Research Council [NE/F005237/1]; NERC [NE/F005237/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a Natural Environment Research Council grant (NE/F005237/1) awarded to PCW, CDL and DJSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpermann TJ, 2006, MOL ECOL NOTES, V6, P1057, DOI 10.1111/j.1471-8286.2006.01432.x; Alpermann TJ, 2009, MOL ECOL, V18, P2122, DOI 10.1111/j.1365-294X.2009.04165.x; Begun AA., 2004, RUSS J MAR BIOL, V30, P51, DOI [10.1023/B:RUMB.0000020569.49887.7e, DOI 10.1023/B:RUMB.0000020569.49887.7E]; BLOOR P. A., 2001, MICROSATELLITE LIB E; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bolch CJS, 2007, HARMFUL ALGAE, V6, P465, DOI 10.1016/j.hal.2006.12.008; Buskey EJ, 1998, J PLANKTON RES, V20, P1553, DOI 10.1093/plankt/20.8.1553; Caron DA, 2009, J EUKARYOT MICROBIOL, V56, P105, DOI 10.1111/j.1550-7408.2008.00381.x; Casteleyn G, 2009, MAR BIOL, V156, P1149, DOI 10.1007/s00227-009-1157-6; Cho SY, 2009, MOL ECOL RESOUR, V9, P915, DOI 10.1111/j.1755-0998.2008.02474.x; Darling KF, 2007, P NATL ACAD SCI USA, V104, P5002, DOI 10.1073/pnas.0700520104; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans KM, 2005, J PHYCOL, V41, P506, DOI 10.1111/j.1529-8817.2005.00084.x; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Field D, 1996, P ROY SOC B-BIOL SCI, V263, P209, DOI 10.1098/rspb.1996.0033; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Foissner W, 2008, BIODIVERS CONSERV, V17, P235, DOI 10.1007/s10531-007-9248-5; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Gardner MG, 1999, J HERED, V90, P301, DOI 10.1093/jhered/90.2.301; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Iglesias-Rodriguez MD, 2006, HEREDITAS, V143, P99; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Iglesias-Rodriguez MD, 2002, MOL ECOL NOTES, V2, P495, DOI 10.1046/j.1471-8286.2002.00289.x; JONSSON PR, 1994, J EXP MAR BIOL ECOL, V175, P77, DOI 10.1016/0022-0981(94)90177-5; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lowe CD, 2005, J EUKARYOT MICROBIOL, V52, P250, DOI 10.1111/j.1550-7408.2005.00034.x; Lowe CD, 2011, J PLANKTON RES, V33, P555, DOI 10.1093/plankt/fbq110; Lowe CD, 2010, PROTIST, V161, P212, DOI 10.1016/j.protis.2009.11.003; MacLeod A, 2001, PHILOS T R SOC B, V356, P1035, DOI 10.1098/rstb.2001.0892; Masseret E, 2009, APPL ENVIRON MICROB, V75, P2037, DOI 10.1128/AEM.01686-08; McCauley LAR, 2009, J PHYCOL, V45, P454, DOI 10.1111/j.1529-8817.2009.00650.x; Montagnes DJS, 2011, J PLANKTON RES, V33, P615, DOI 10.1093/plankt/fbq111; MONTAGNES DJS, 2010, J PLANKTON IN PRESS; Montresor M, 2003, POLAR BIOL, V26, P186, DOI 10.1007/s00300-002-0473-9; Nagai S, 2007, MOL ECOL NOTES, V7, P993, DOI 10.1111/j.1471-8286.2007.01750.x; Nagai S, 2006, MOL ECOL NOTES, V6, P756, DOI 10.1111/j.1471-8286.2006.01331.x; Nagai S, 2006, MOL ECOL NOTES, V6, P120, DOI 10.1111/j.1471-8286.2005.01160.x; Nagai S, 2004, MOL ECOL NOTES, V4, P83, DOI 10.1046/j.1471-8286.2003.00576.x; Nagai S, 2009, MOL ECOL, V18, P2337, DOI 10.1111/j.1365-294X.2009.04193.x; Nagai S, 2007, J PHYCOL, V43, P43, DOI 10.1111/j.1529-8817.2006.00304.x; Nishitani G, 2007, MOL ECOL NOTES, V7, P827, DOI 10.1111/j.1471-8286.2007.01717.x; Nishitani G, 2009, CONSERV GENET, V10, P1561, DOI 10.1007/s10592-008-9793-9; Nishitani G, 2009, CONSERV GENET, V10, P713, DOI 10.1007/s10592-008-9628-8; Pawlowski J, 2007, MOL ECOL, V16, P4089, DOI 10.1111/j.1365-294X.2007.03465.x; PEREZUZ B, 1995, FEMS MICROBIOL ECOL, V16, P193, DOI 10.1016/0168-6496(94)00083-9; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Refseth UH, 1997, ELECTROPHORESIS, V18, P1519, DOI 10.1002/elps.1150180905; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rynearson TA, 2006, LIMNOL OCEANOGR, V51, P1249, DOI 10.4319/lo.2006.51.3.1249; Rynearson TA, 2005, MOL ECOL, V14, P1631, DOI 10.1111/j.1365-294X.2005.02526.x; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Sambrook J, 2001, MOL CLONING LAB MANU; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; WATTS PC, 2010, J PLANKTON IN PRESS; Watts PC, 2006, MAR BIOL, V149, P1093, DOI 10.1007/s00227-006-0288-2; Watts PC, 2010, ICES J MAR SCI, V67, P607, DOI 10.1093/icesjms/fsp274; Weetman D, 2006, MAR ECOL PROG SER, V317, P157, DOI 10.3354/meps317157; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weisse T, 2006, J PLANKTON RES, V28, P55, DOI 10.1093/plankt/fbi100; Weisse T, 2008, BIODIVERS CONSERV, V17, P243, DOI 10.1007/s10531-007-9249-4; WRIGHT S, 1951, ANN EUGENIC, V15, P323	71	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15557	10.1371/journal.pone.0015557	http://dx.doi.org/10.1371/journal.pone.0015557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203414	Green Submitted, Green Published, gold			2022-12-25	WOS:000285579200023
J	Zheng, W; Watts, LT; Holstein, DM; Prajapati, SI; Keller, C; Grass, EH; Walter, CA; Lechleiter, JD				Zheng, Wei; Watts, Lora Talley; Holstein, Deborah M.; Prajapati, Suresh I.; Keller, Charles; Grass, Eileen H.; Walter, Christi A.; Lechleiter, James D.			Purinergic Receptor Stimulation Reduces Cytotoxic Edema and Brain Infarcts in Mouse Induced by Photothrombosis by Energizing Glial Mitochondria	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; ENHANCES NEUROPROTECTION; ASTROCYTES; METABOLISM; RELEASE; CHLORIDE; STROKE; RAT; ACTIVATION; MECHANISM	Treatments to improve the neurological outcome of edema and cerebral ischemic stroke are severely limited. Here, we present the first in vivo single cell images of cortical mouse astrocytes documenting the impact of single vessel photothrombosis on cytotoxic edema and cerebral infarcts. The volume of astrocytes expressing green fluorescent protein (GFP) increased by over 600% within 3 hours of ischemia. The subsequent growth of cerebral infarcts was easily followed as the loss of GFP fluorescence as astrocytes lysed. Cytotoxic edema and the magnitude of ischemic lesions were significantly reduced by treatment with the purinergic ligand 2-methylthioladenosine 2' diphosphate (2-MeSADP), an agonist with high specificity for the purinergic receptor type 1 isoform (P2Y(1)R). At 24 hours, cytotoxic edema in astrocytes was still apparent at the penumbra and preceded the cell lysis that defined the infarct. Delayed 2MeSADP treatment, 24 hours after the initial thrombosis, also significantly reduced cytotoxic edema and the continued growth of the brain infarction. Pharmacological and genetic evidence are presented indicating that 2MeSADP protection is mediated by enhanced astrocyte mitochondrial metabolism via increased inositol trisphosphate (IP3)-dependent Ca2+ release. We suggest that mitochondria play a critical role in astrocyte energy metabolism in the penumbra of ischemic lesions, where low ATP levels are widely accepted to be responsible for cytotoxic edema. Enhancement of this energy source could have similar protective benefits for a wide range of brain injuries.	[Zheng, Wei; Watts, Lora Talley; Holstein, Deborah M.; Keller, Charles; Grass, Eileen H.; Walter, Christi A.; Lechleiter, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Prajapati, Suresh I.; Keller, Charles] Univ Texas Hlth Sci Ctr San Antonio, Greenhey Childrens Canc Res Inst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Zheng, W (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	lechleiter@uthscsa.edu	Watts, Lora Talley/A-2724-2012; ZHENG, WEI/B-9482-2012	Watts, Lora Talley/0000-0002-2337-1504; Keller, Charles/0000-0003-2505-7487; Zheng, Wei/0000-0003-3193-2655	National Institutes of Health [AG29461, AG19316]; NATIONAL INSTITUTE ON AGING [P01AG019316, R01AG029461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by National Institutes of Health AG29461 and AG19316 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cherniak C, 1990, J Cogn Neurosci, V2, P58, DOI 10.1162/jocn.1990.2.1.58; Chu XF, 2007, BRAIN RES, V1149, P157, DOI 10.1016/j.brainres.2007.02.061; Chvatal A, 2007, J ANAT, V210, P671, DOI 10.1111/j.1469-7580.2007.00724.x; Darby M, 2003, J NEUROPHYSIOL, V89, P1870, DOI 10.1152/jn.00510.2002; Dienel GA, 2005, GLIA, V50, P362, DOI 10.1002/glia.20157; Dietrich HH, 2009, J VASC RES, V46, P253, DOI 10.1159/000167273; Fisher M, 2004, STROKE, V35, P367, DOI 10.1161/01.STR.0000115296.67346.28; Fonnum F, 1997, GLIA, V21, P106; Fujita T, 2009, GLIA, V57, P244, DOI 10.1002/glia.20749; GACHET C, 1995, BRIT J HAEMATOL, V91, P434, DOI 10.1111/j.1365-2141.1995.tb05319.x; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; GRASS E, 2009, ECORI TARGETED UNPUB; Haberg A, 2006, NEUROCHEM INT, V48, P531, DOI 10.1016/j.neuint.2005.12.025; Hajnoczky G, 2000, J BIOENERG BIOMEMBR, V32, P15, DOI 10.1023/A:1005504210587; Heo JH, 2005, FREE RADICAL BIO MED, V39, P51, DOI 10.1016/j.freeradbiomed.2005.03.035; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Howard G, 2007, STROKE, V38, P2446, DOI 10.1161/STROKEAHA.106.478032; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Klohs J, 2008, STROKE, V39, P2845, DOI 10.1161/STROKEAHA.107.509844; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Leary MC, 2003, CEREBROVASC DIS, V16, P280, DOI 10.1159/000071128; Leis JA, 2005, GLIA, V50, P407, DOI 10.1002/glia.20145; LeMaistre JL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-209; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Meairs S, 2006, CEREBROVASC DIS, V22, P75, DOI 10.1159/000093098; Mongin AA, 2002, AM J PHYSIOL-CELL PH, V283, pC569, DOI 10.1152/ajpcell.00438.2001; Nakase T, 2003, CELL COMMUN ADHES, V10, P413, DOI 10.1080/714040461; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Pangrsic T, 2006, J NEUROCHEM, V99, P514, DOI 10.1111/j.1471-4159.2006.04042.x; PASANTESMORALES H, 1994, AM J PHYSIOL, V266, pC165, DOI 10.1152/ajpcell.1994.266.1.C165; PAUSER S, 1995, MAGN RESON IMAGING, V13, P269, DOI 10.1016/0730-725X(94)00109-G; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Siushansian R, 2001, J COMP NEUROL, V440, P387, DOI 10.1002/cne.1392; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Uckermann O, 2006, J NEUROSCI RES, V83, P538, DOI 10.1002/jnr.20760; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Watts Lora T., 2009, P569, DOI 10.1007/978-0-387-79492-1_23; Woitzik J, 2008, FRONT BIOSCI-LANDMRK, V13, P1500, DOI 10.2741/2776; Wu J, 2007, J NEUROSCI, V27, P6510, DOI 10.1523/JNEUROSCI.1256-07.2007; Wunder A, 2009, NEUROSCIENCE, V158, P1161, DOI 10.1016/j.neuroscience.2008.10.005; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016	52	56	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14401	10.1371/journal.pone.0014401	http://dx.doi.org/10.1371/journal.pone.0014401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203502	gold, Green Submitted, Green Published			2022-12-25	WOS:000285578000008
J	Ma, LA; Jensen, JS; Mancuso, M; Hamasuna, R; Jia, QY; McGowin, CL; Martin, DH				Ma, Liang; Jensen, Jorgen S.; Mancuso, Miriam; Hamasuna, Ryoichi; Jia, Qiuyao; McGowin, Chris L.; Martin, David H.			Genetic Variation in the Complete MgPa Operon and Its Repetitive Chromosomal Elements in Clinical Strains of Mycoplasma genitalium	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; FRAGMENT LENGTH POLYMORPHISM; REAL-TIME PCR; NONGONOCOCCAL URETHRITIS; AZITHROMYCIN TREATMENT; PNEUMONIAE; RECOMBINATION; SPECIMENS; SEQUENCES; PROTEIN	Mycoplasma genitalium has been increasingly recognized as an important microbe not only because of its significant association with human genital tract diseases but also because of its utility as a model for studying the minimum set of genes necessary to sustain life. Despite its small genome, 4.7% of the total genome sequence is devoted to making the MgPa adhesin operon and its nine chromosomal repetitive elements (termed MgPars). The MgPa operon, along with 9 MgPars, is believed to play an important role in pathogenesis of M. genitalium infection and has also served as the main target for development of diagnostic tools. However, genetic variation in the complete MgPa operon and MgPars among clinical strains of M. genitalium has not been addressed. In this study we examined the genetic variation in the complete MgPa operon (approximately 8.5 kb) and full or partial MgPar sequences (0.4-2.6 kb) in 15 geographically diverse strains of M. genitalium. Extensive variation was present in four repeat regions of the MgPa operon (with homology to MgPars) among and within strains while the non-repeat regions (without homology to MgPars) showed low-level variation among strains and no variation within strains. MgPars showed significant variation among strains but were highly homogeneous within strains, supporting gene conversion as the likely recombination mechanism. When applying our sequence data to evaluate published MgPa operon-based diagnostic PCR assays and genotyping systems, we found that 11 of 19 primers contain up to 19 variable nucleotides and that the target for one of two typing systems is located in a hypervariable repeat region, suggesting the likelihood of false results with some of these assays. This study not only provides new insights into the role of the MgPa operon in the pathogenesis of M. genitalium infection but has important implications for the development of diagnostic tools.	[Ma, Liang; Mancuso, Miriam; Jia, Qiuyao; McGowin, Chris L.; Martin, David H.] Louisiana State Univ, Infect Dis Sect, Dept Med, Hlth Sci Ctr, New Orleans, LA USA; [Jensen, Jorgen S.] Statens Serum Inst, Mycoplasma Lab, DK-2300 Copenhagen, Denmark; [Hamasuna, Ryoichi] Univ Occupat & Environm Hlth, Dept Urol, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Statens Serum Institut; University of Occupational & Environmental Health - Japan	Ma, LA (corresponding author), NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA.	LMa1@lsuhsc.edu	Jensen, Jørgen Skov/H-5159-2019; Jensen, Jørgen/I-2917-2012	Jensen, Jørgen Skov/0000-0002-7464-7435; Ma, Liang/0000-0002-6078-5730	Department of Defense [W81XWH-08-1-0676]; National Institutes of Health [5 U19 AI061972]; Louisiana Vaccine Center; Louisiana State of Regents [149752505J]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI061972] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Vaccine Center; Louisiana State of Regents; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Department of Defense (grant W81XWH-08-1-0676), the Gulf South Sexually Transmitted Infections/Topical Microbicide Cooperative Research Center grant from the National Institutes of Health (grant 5 U19 AI061972), and the Louisiana Vaccine Center and the South Louisiana Institute for Infectious Disease Research sponsored by the Louisiana State of Regents (grant 149752505J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgos R, 2006, J BACTERIOL, V188, P8627, DOI 10.1128/JB.00978-06; CADIEUX N, 1993, J GEN MICROBIOL, V139, P2431, DOI 10.1099/00221287-139-10-2431; DALLO SF, 1991, MICROB PATHOGENESIS, V10, P475, DOI 10.1016/0882-4010(91)90113-O; DEBARBEYRAC B, 1993, CLIN INFECT DIS, V17, pS83, DOI 10.1093/clinids/17.Supplement_1.S83; DEGUCHI T, 1995, EUR J CLIN MICROBIOL, V14, P629, DOI 10.1007/BF01690742; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hamasuna R, 2005, ANTIMICROB AGENTS CH, V49, P4993, DOI 10.1128/AAC.49.12.4993-4998.2005; Hamasuna R, 2007, J CLIN MICROBIOL, V45, P847, DOI 10.1128/JCM.02056-06; Hjorth SV, 2006, J CLIN MICROBIOL, V44, P2078, DOI 10.1128/JCM.00003-06; HU PC, 1987, INFECT IMMUN, V55, P1126, DOI 10.1128/IAI.55.5.1126-1131.1987; Iverson-Cabral SL, 2007, MOL MICROBIOL, V66, P55, DOI 10.1111/j.1365-2958.2007.05898.x; Iverson-Cabral SL, 2006, INFECT IMMUN, V74, P3715, DOI 10.1128/IAI.00239-06; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Jensen JS, 2006, DAN MED BULL, V53, P1; Jensen JS, 2009, CLIN INFECT DIS, V48, P1655, DOI 10.1086/599034; Jensen JS, 1996, J CLIN MICROBIOL, V34, P286, DOI 10.1128/JCM.34.2.286-291.1996; JENSEN JS, 1993, GENITOURIN MED, V69, P265; JENSEN JS, 1991, J CLIN MICROBIOL, V29, P46, DOI 10.1128/JCM.29.1.46-50.1991; Jensen JS, 2004, J CLIN MICROBIOL, V42, P683, DOI 10.1128/JCM.42.2.683-692.2004; Kokotovic B, 1999, J CLIN MICROBIOL, V37, P3300, DOI 10.1128/JCM.37.10.3300-3307.1999; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Ma L, 2004, J CLIN MICROBIOL, V42, P4876, DOI 10.1128/JCM.42.10.4876-4878.2004; Ma L, 2007, MOL MICROBIOL, V66, P220, DOI 10.1111/j.1365-2958.2007.05911.x; Ma L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-130; McGowin CL, 2010, INFECT IMMUN, V78, P726, DOI 10.1128/IAI.00840-09; Mena L, 2002, CLIN INFECT DIS, V35, P1167, DOI 10.1086/343829; MORRISONPLUMMER J, 1987, INFECT IMMUN, V55, P49, DOI 10.1128/IAI.55.1.49-56.1987; Musatovova O, 2006, J CLIN MICROBIOL, V44, P598, DOI 10.1128/JCM.44.2.598-603.2006; Musatovova O, 2009, J CLIN MICROBIOL, V47, P1469, DOI 10.1128/JCM.01602-08; PALMER HM, 1991, FEMS MICROBIOL LETT, V61, P199; PETERSON SN, 1995, P NATL ACAD SCI USA, V92, P11829, DOI 10.1073/pnas.92.25.11829; Svenstrup HF, 2006, CLIN VACCINE IMMUNOL, V13, P913, DOI 10.1128/CVI.00048-06; Totten PA, 2001, J INFECT DIS, V183, P269, DOI 10.1086/317942; TULLY JG, 1981, LANCET, V1, P1288	36	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15660	10.1371/journal.pone.0015660	http://dx.doi.org/10.1371/journal.pone.0015660			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187921	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200059
J	Patapati, KK; Glykos, NM				Patapati, Kalliopi K.; Glykos, Nicholas M.			Order through Disorder: Hyper-Mobile C-Terminal Residues Stabilize the Folded State of a Helical Peptide. A Molecular Dynamics Study	PLOS ONE			English	Article							FOLDING SIMULATIONS; ALPHA-LACTALBUMIN; PROTEINS; MECHANICS; MODELS	Conventional wisdom has it that the presence of disordered regions in the three-dimensional structures of polypeptides not only does not contribute significantly to the thermodynamic stability of their folded state, but, on the contrary, that the presence of disorder leads to a decrease of the corresponding proteins' stability. We have performed extensive 3.4 mu s long folding simulations (in explicit solvent and with full electrostatics) of an undecamer peptide of experimentally known helical structure, both with and without its disordered (four residue long) C-terminal tail. Our simulations clearly indicate that the presence of the apparently disordered (in structural terms) C-terminal tail, increases the thermodynamic stability of the peptide's folded (helical) state. These results show that at least for the case of relatively short peptides, the interplay between thermodynamic stability and the apparent structural stability can be rather subtle, with even disordered regions contributing significantly to the stability of the folded state. Our results have clear implications for the understanding of peptide energetics and the design of foldable peptides.	[Patapati, Kalliopi K.; Glykos, Nicholas M.] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece	Democritus University of Thrace	Patapati, KK (corresponding author), Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece.	glykos@mbg.duth.gr	Glykos, Nicholas/H-9179-2019	Glykos, Nicholas/0000-0003-3782-206X				Altis A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2746330; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Araki A, 2007, PROTEINS, V66, P860, DOI 10.1002/prot.21263; De Mori GMS, 2005, MINI-REV MED CHEM, V5, P353, DOI 10.2174/1389557053544038; Demarest SJ, 1999, BIOCHEMISTRY-US, V38, P7380, DOI 10.1021/bi990320z; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gnanakaran S, 2003, CURR OPIN STRUC BIOL, V13, P168, DOI 10.1016/S0959-440X(03)00040-X; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Jiang XW, 2010, J COMPUT CHEM, V31, P2502, DOI 10.1002/jcc.21544; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Khandogin J, 2007, P NATL ACAD SCI USA, V104, P16880, DOI 10.1073/pnas.0703832104; Koehl P, 2006, CURR OPIN STRUC BIOL, V16, P142, DOI 10.1016/j.sbi.2006.03.001; Lin ZX, 2010, J AM CHEM SOC, V132, P7276, DOI 10.1021/ja100879k; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matthes D, 2009, BIOPHYS J, V97, P599, DOI 10.1016/j.bpj.2009.04.061; Mitraki A, 2005, METH MOL B, V300, P125; Mittal J, 2010, BIOPHYS J, V99, pL26, DOI 10.1016/j.bpj.2010.05.005; Mohammed OF, 2009, ANGEW CHEM INT EDIT, V48, P5628, DOI 10.1002/anie.200900513; Montalvo G, 2010, J AM CHEM SOC, V132, P5616, DOI 10.1021/ja100459a; Morra G, 2008, CURR PROTEIN PEPT SC, V9, P181, DOI 10.2174/138920308783955234; Morrone JA, 2010, J CHEM THEORY COMPUT, V6, P1798, DOI 10.1021/ct100054k; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Osterhout JJ, 2005, PROTEIN PEPTIDE LETT, V12, P159, DOI 10.2174/0929866053005890; Permyakov EA, 2000, FEBS LETT, V473, P269, DOI 10.1016/S0014-5793(00)01546-5; Thorpe IF, 2008, J PHYS CHEM B, V112, P13079, DOI 10.1021/jp8015968; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003	33	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15290	10.1371/journal.pone.0015290	http://dx.doi.org/10.1371/journal.pone.0015290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187962	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200033
J	Pita-Thomas, W; Fernandez-Martos, C; Yunta, M; Maza, RM; Navarro-Ruiz, R; Lopez-Rodriguez, MJ; Reigada, D; Nieto-Sampedro, M; Nieto-Diaz, M				Pita-Thomas, Wolfgang; Fernandez-Martos, Carmen; Yunta, Monica; Maza, Rodrigo M.; Navarro-Ruiz, Rosa; Javier Lopez-Rodriguez, Marcos; Reigada, David; Nieto-Sampedro, Manuel; Nieto-Diaz, Manuel			Gene Expression of Axon Growth Promoting Factors in the Deer Antler	PLOS ONE			English	Article							DENSITY OLIGONUCLEOTIDE ARRAYS; EPITHELIUM-DERIVED FACTOR; NEURITE OUTGROWTH; NEUROTROPHIC FACTOR; RETINOIC ACID; CELL-ADHESION; SCHWANN-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; FIN REGENERATION; SENSORY NEURONS	The annual regeneration cycle of deer (Cervidae, Artiodactyla) antlers represents a unique model of epimorphic regeneration and rapid growth in adult mammals. Regenerating antlers are innervated by trigeminal sensory axons growing through the velvet, the modified form of skin that envelopes the antler, at elongation velocities that reach one centimetre per day in the common deer (Cervus elaphus). Several axon growth promoters like NT-3, NGF or IGF-1 have been described in the antler. To increase the knowledge on the axon growth environment, we have combined different gene-expression techniques to identify and characterize the expression of promoting molecules not previously described in the antler velvet. Cross-species microarray analyses of deer samples on human arrays allowed us to build up a list of 90 extracellular or membrane molecules involved in axon growth that were potentially being expressed in the antler. Fifteen of these genes were analysed using PCR and sequencing techniques to confirm their expression in the velvet and to compare it with the expression in other antler and skin samples. Expression of 8 axon growth promoters was confirmed in the velvet, 5 of them not previously described in the antler. In conclusion, our work shows that antler velvet provides growing axons with a variety of promoters of axon growth, sharing many of them with deer's normal and pedicle skin.	[Pita-Thomas, Wolfgang; Fernandez-Martos, Carmen; Yunta, Monica; Maza, Rodrigo M.; Navarro-Ruiz, Rosa; Javier Lopez-Rodriguez, Marcos; Reigada, David; Nieto-Diaz, Manuel] Hosp Nacl Paraplejicos SESCAM, Expt Neurol Unit, Toledo, Spain; [Nieto-Sampedro, Manuel] Inst Cajal Neurociencias CSIC, Neural Plast Lab, Madrid, Spain	Hospital Nacional de Paraplejicos; Consejo Superior de Investigaciones Cientificas (CSIC)	Pita-Thomas, W (corresponding author), Hosp Nacl Paraplejicos SESCAM, Expt Neurol Unit, Toledo, Spain.	mnietod@sescam.jccm.es	Nieto-Diaz, Manuel/R-5163-2017; Maza, Rodrigo Martínez/ABH-3989-2020; Fernandez-Martos, Carmen/J-7770-2014; Reigada, David/AAU-5910-2020; Díaz, Manuel Nieto/ABD-7144-2020	Nieto-Diaz, Manuel/0000-0002-7244-794X; Maza, Rodrigo Martínez/0000-0002-7249-9205; Fernandez-Martos, Carmen/0000-0002-6387-4456; Reigada, David/0000-0001-9041-0705; Yunta, Monica/0000-0002-8060-9582	Castilla-La Mancha Medical Council [ICS 06025, FISCAM PI2008/38]; Spanish Medical Research Foundation [PI081941]; Castilla-La Mancha Medical Research Foundation (FISCAM)	Castilla-La Mancha Medical Council; Spanish Medical Research Foundation; Castilla-La Mancha Medical Research Foundation (FISCAM)	This work was supported by the Castilla-La Mancha Medical Council (projects ICS 06025 and FISCAM PI2008/38) and the Spanish Medical Research Foundation (project PI081941). WPT, MLR and RNR are funded by grants of the Castilla-La Mancha Medical Research Foundation (FISCAM); DRP, MYG, CFM, RMM and MND are contracted researchers of the SESCAM (Castilla-La Mancha Health Service); MNS is research professor of the Spanish Science Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, AFF NET DAT; *AFF, AFF GCOS 1 4 SOFTW; Affymetrix, 2002, STAT ALG DESCR DOC; Albers KM, 2007, NEUROSCIENTIST, V13, P371, DOI 10.1177/10738584070130040901; Allen SP, 2002, DEV BIOL, V251, P409, DOI 10.1006/dbio.2002.0816; [Anonymous], OMIM; [Anonymous], NCBI GEO DAT; [Anonymous], PUBMED; *APPL BIOS, 2006, APPL BIOS REAL TIM P; Baird Andrew, 1994, Current Opinion in Neurobiology, V4, P78, DOI 10.1016/0959-4388(94)90035-3; Barling PM, 2005, CELL BIOL INT, V29, P229, DOI 10.1016/j.cellbi.2004.12.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad B, 2005, BIOINFORMATICS COMPU; BOLSTAD B, 2005, AFFYPLM MODEL BASED; Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Boscher C, 2008, CELL SIGNAL, V20, P1061, DOI 10.1016/j.cellsig.2008.01.008; Bouzaffour M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005824; Bubenik GA., 1990, HORNS PRONGHORNS ANT; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; CHALAZONITIS A, 1992, DEV BIOL, V152, P121, DOI 10.1016/0012-1606(92)90162-A; CHAPUT M, 1988, NATURE, V332, P454, DOI 10.1038/332454a0; Chismar JD, 2002, BIOTECHNIQUES, V33, P516, DOI 10.2144/02333st01_11836a; Clark DE, 2006, ANAT REC PART A, V288A, P1281, DOI 10.1002/ar.a.20393; Copois V, 2007, J BIOTECHNOL, V127, P549, DOI 10.1016/j.jbiotec.2006.07.032; Crawford SE, 2001, J CELL SCI, V114, P4421; Cui Q, 2006, MOL NEUROBIOL, V33, P155, DOI 10.1385/MN:33:2:155; Dionne MS, 2002, DEV BIOL, V251, P283, DOI 10.1006/dbio.2002.0829; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; FAIK P, 1988, NATURE, V332, P455, DOI 10.1038/332455a0; FENG JQ, 1995, BBA-GENE STRUCT EXPR, V1263, P163, DOI 10.1016/0167-4781(95)00106-Q; Feng JQ, 1997, BBA-GENE STRUCT EXPR, V1350, P47, DOI 10.1016/S0167-4781(96)00178-9; Francavilla C, 2007, J CELL SCI, V120, P4388, DOI 10.1242/jcs.010744; Francis SM, 1998, J EXP ZOOL, V281, P36, DOI 10.1002/(SICI)1097-010X(19980501)281:1&lt;36::AID-JEZ6&gt;3.0.CO;2-D; Fu CY, 2007, J HUAZHONG UNIV SCI, V27, P186, DOI 10.1007/s11596-007-0221-z; Garcia RL, 1997, J MOL ENDOCRINOL, V19, P173, DOI 10.1677/jme.0.0190173; Gaspar-Lopez E, 2008, EUR J WILDLIFE RES, V54, P753, DOI 10.1007/s10344-008-0185-8; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gautier L, DESCRIPTION AFFY; GenBank, GENBANK; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; GOSS RJ, 1970, CLIN ORTHOP RELAT R, P227; Goss RJ., 1969, PRINCIPLES REGENERAT; GRAY C, 1992, NEUROSCIENCE, V50, P953, DOI 10.1016/0306-4522(92)90218-Q; Grothe C, 2001, ANAT EMBRYOL, V204, P171, DOI 10.1007/s004290100205; GURNEY ME, 1986, SCIENCE, V234, P566, DOI 10.1126/science.3764429; Ha YH, 2005, CARBOHYD RES, V340, P411, DOI 10.1016/j.carres.2004.11.011; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Huo Y, 1997, Biomed Sci Instrum, V33, P541; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; ISHIHARA A, 1994, BRAIN RES, V639, P21, DOI 10.1016/0006-8993(94)91759-0; Ji W, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh084; Jorgensen JR, 2009, J MOL NEUROSCI, V39, P104, DOI 10.1007/s12031-009-9189-4; Kaneda N, 1996, J BIOCHEM-TOKYO, V119, P1150; Kapanen A, 2002, J BIOMED MATER RES, V59, P78, DOI 10.1002/jbm.1219; Katogi R, 2004, MECH DEVELOP, V121, P861, DOI 10.1016/j.mod.2004.03.015; Kerrison JB, 2005, MOL VIS, V11, P208; Kimpinski K, 1997, J NEUROBIOL, V33, P395, DOI 10.1002/(SICI)1097-4695(199710)33:4<395::AID-NEU5>3.0.CO;2-5; Korpos E, 2005, MATRIX BIOL, V24, P124, DOI 10.1016/j.matbio.2005.01.005; KRIEGLSTEIN K, 1995, EMBO J, V14, P736, DOI 10.1002/j.1460-2075.1995.tb07052.x; Kulahin N, 2008, MOL CELL NEUROSCI, V37, P528, DOI 10.1016/j.mcn.2007.12.001; Lai AKW, 2007, TISSUE CELL, V39, P35, DOI 10.1016/j.tice.2007.01.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lertsburapa T, 2004, J NEUROSCI RES, V75, P624, DOI 10.1002/jnr.20002; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li CY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000148; Li CY, 2000, ANAT RECORD, V260, P62, DOI 10.1002/1097-0185(20000901)260:1<62::AID-AR70>3.0.CO;2-4; Li CY, 2002, ANAT REC, V268, P125, DOI 10.1002/ar.10120; Li CY, 2001, ANAT EMBRYOL, V204, P375, DOI 10.1007/s004290100204; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Lonn P, 2005, NEUROCHEM RES, V30, P753, DOI 10.1007/s11064-005-6868-6; Lord EA, 2007, ANAT REC, V290, P994, DOI 10.1002/ar.20562; Lustig M, 1999, DEV BIOL, V209, P340, DOI 10.1006/dbio.1999.9250; MARTINOU JC, 1990, DEV BRAIN RES, V52, P175, DOI 10.1016/0165-3806(90)90233-O; MASUDANAKAGAWA LM, 1990, P ROY SOC B-BIOL SCI, V241, P201, DOI 10.1098/rspb.1990.0086; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Matsuzawa M, 1999, CELL MOL NEUROBIOL, V19, P209, DOI 10.1023/A:1006925110584; Mey J, 2006, J NEUROBIOL, V66, P757, DOI 10.1002/neu.20238; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; MICHIKAWA M, 1993, J NEUROSCI RES, V35, P530, DOI 10.1002/jnr.490350509; Moody DE, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-27; Nagpal S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh048; Nieto-Diaz M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-89; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Parmigiani G., 2003, ANAL GENE EXPRESSION; Patruno M, 2001, J EXP BIOL, V204, P843; Pearl EJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-66; Pita-Thomas W, 2010, J NEUROSCI RES, V88, P3034, DOI 10.1002/jnr.22459; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Raivich G, 2007, BRAIN RES REV, V53, P287, DOI 10.1016/j.brainresrev.2006.09.005; Reimers M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-166; Sahenk Z, 2008, EXP NEUROL, V212, P552, DOI 10.1016/j.expneurol.2008.04.015; Sanchez-Camacho C, 2005, BRAIN RES REV, V49, P242, DOI 10.1016/j.brainresrev.2004.10.004; SANTAMARIA JA, 1991, J ANAT, V176, P9; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tal TL, 2010, GERONTOLOGY, V56, P231, DOI 10.1159/000259327; Unezaki S, 2009, J NEUROSCI METH, V178, P308, DOI 10.1016/j.jneumeth.2008.12.022; Vacek Z, 1955, CESK MORFOL, V3, P249; *WEIZM I SCI, GENENOTE DAT; Williams SE, 2006, NEURON, V50, P535, DOI 10.1016/j.neuron.2006.03.037; WISLOCKI GB, 1946, J COMP NEUROL, V85, P1, DOI 10.1002/cne.900850102; Xian CJ, 1999, MOL NEUROBIOL, V20, P157, DOI 10.1007/BF02742440; Yabe T, 2002, J NEUROSCI RES, V68, P161, DOI 10.1002/jnr.10210; YOUNG HE, 1989, ANAT REC, V223, P223, DOI 10.1002/ar.1092230215; Yu CQ, 2008, INVEST OPHTH VIS SCI, V49, P3870, DOI 10.1167/iovs.07-1418; PRIMERS3; ZFP91 CNTF; AFFYTOOLS	110	28	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15706	10.1371/journal.pone.0015706	http://dx.doi.org/10.1371/journal.pone.0015706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187928	Green Published, gold, Green Submitted			2022-12-25	WOS:000285575200066
J	Sadikovic, B; Wang, J; El-Hattab, A; Landsverk, M; Douglas, G; Brundage, EK; Craigen, WJ; Schmitt, ES; Wong, LJC				Sadikovic, Bekim; Wang, Jing; El-Hattab, Ayman; Landsverk, Megan; Douglas, Ganka; Brundage, Ellen K.; Craigen, William J.; Schmitt, Eric S.; Wong, Lee-Jun C.			Sequence Homology at the Breakpoint and Clinical Phenotype of Mitochondrial DNA Deletion Syndromes	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; DOUBLE-STRAND BREAKS; MTDNA DELETIONS; SACCHAROMYCES-CEREVISIAE; LAGGING-STRAND; DIRECT REPEATS; CELLS; MYOPATHIES; MUTATIONS; DISEASE	Mitochondrial DNA (mtDNA) deletions are a common cause of mitochondrial disorders. Large mtDNA deletions can lead to a broad spectrum of clinical features with different age of onset, ranging from mild mitochondrial myopathies (MM), progressive external ophthalmoplegia (PEO), and Kearns-Sayre syndrome (KSS), to severe Pearson syndrome. The aim of this study is to investigate the molecular signatures surrounding the deletion breakpoints and their association with the clinical phenotype and age at onset. MtDNA deletions in 67 patients were characterized using array comparative genomic hybridization (aCGH) followed by PCR-sequencing of the deletion junctions. Sequence homology including both perfect and imperfect short repeats flanking the deletion regions were analyzed and correlated with clinical features and patients' age group. In all age groups, there was a significant increase in sequence homology flanking the deletion compared to mtDNA background. The youngest patient group (<6 years old) showed a diffused pattern of deletion distribution in size and locations, with a significantly lower sequence homology flanking the deletion, and the highest percentage of deletion mutant heteroplasmy. The older age groups showed rather discrete pattern of deletions with 44% of all patients over 6 years old carrying the most common 5 kb mtDNA deletion, which was found mostly in muscle specimens (22/41). Only 15% (3/20) of the young patients (<6 years old) carry the 5 kb common deletion, which is usually present in blood rather than muscle. This group of patients predominantly (16 out of 17) exhibit multisystem disorder and/or Pearson syndrome, while older patients had predominantly neuromuscular manifestations including KSS, PEO, and MM. In conclusion, sequence homology at the deletion flanking regions is a consistent feature of mtDNA deletions. Decreased levels of sequence homology and increased levels of deletion mutant heteroplasmy appear to correlate with earlier onset and more severe disease with multisystem involvement.	[Sadikovic, Bekim; Wang, Jing; El-Hattab, Ayman; Landsverk, Megan; Douglas, Ganka; Brundage, Ellen K.; Craigen, William J.; Schmitt, Eric S.; Wong, Lee-Jun C.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	Sadikovic, B (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	ljwong@bcm.edu			Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/35854/2007, SFRH/BD/38543/2007, PTDC/SAU-ESA/64888/2006, PIC/IC/83065/2007]; GlaxoSmithkline; Fundacao Calouste Gulbenkian; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085801] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); GlaxoSmithkline(GlaxoSmithKline); Fundacao Calouste Gulbenkian(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	M. C. and M.J.F. are supported by research grants from Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BD/35854/2007 and SFRH/BD/38543/2007 respectively). This work was partly supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/SAU-ESA/64888/2006 and PIC/IC/83065/2007), Fundacao Calouste Gulbenkian and an unrestricted grant from GlaxoSmithkline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Chinault AC, 2009, GENET MED, V11, P518, DOI 10.1097/GIM.0b013e3181abd83c; DEGOUL F, 1991, NUCLEIC ACIDS RES, V19, P493, DOI 10.1093/nar/19.3.493; Hammans SR, 1994, ESSAYS BIOCHEM, V28, P99; Hanekamp T, 1999, CURR GENET, V34, P438, DOI 10.1007/s002940050418; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465; Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Liang F, 1996, P NATL ACAD SCI USA, V93, P8929, DOI 10.1073/pnas.93.17.8929; Liang MH, 1998, AM J MED GENET, V77, P395, DOI 10.1002/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M; Marie A, 2010, NUCLEIC ACIDS RES, V38, P5706, DOI 10.1093/nar/gkq379; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; Nguyen LH, 2000, J BIOL CHEM, V275, P25900, DOI 10.1074/jbc.M002672200; PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3; Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018; Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016; ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810; Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003; Schroder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Srivastava S, 2007, HUM MOL GENET, V16, P993, DOI 10.1093/hmg/ddm045; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003; Wong LJC, 2001, GENET MED, V3, P399, DOI 10.1097/00125817-200111000-00004; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a	31	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15687	10.1371/journal.pone.0015687	http://dx.doi.org/10.1371/journal.pone.0015687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187929	Green Published, gold			2022-12-25	WOS:000285575200064
J	Taylor, JM; Han, ZY				Taylor, John M.; Han, Ziying			Purinergic Receptor Functionality Is Necessary for Infection of Human Hepatocytes by Hepatitis Delta Virus and Hepatitis B Virus	PLOS ONE			English	Article							P2X(7) RECEPTORS; SURAMIN; ANTAGONIST; ACTIVATION; PHYSIOLOGY; EXPRESSION; KINASES; BINDING; PROTEIN; SYSTEM	Hepatitis B virus (HBV) and hepatitis delta virus (HDV) are major sources of acute and chronic hepatitis. HDV requires the envelope proteins of HBV for the processes of assembly and infection of new cells. Both viruses are able to infect hepatocytes though previous studies have failed to determine the mechanism of entry into such cells. This study began with evidence that suramin, a symmetrical hexasulfated napthylurea, could block HDV entry into primary human hepatocytes (PHH) and was then extrapolated to incorporate findings of others that suramin is one of many compounds that can block activation of purinergic receptors. Thus other inhibitors, pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate (PPADS) and brilliant blue G (BBG), both structurally unrelated to suramin, were tested and found to inhibit HDV and HBV infections of PHH. BBG, unlike suramin and PPADS, is known to be more specific for just one purinergic receptor, P2X7. These studies provide the first evidence that purinergic receptor functionality is necessary for virus entry. Furthermore, since P2X7 activation is known to be a major component of inflammatory responses, it is proposed that HDV and HBV attachment to susceptible cells, might also contribute to inflammation in the liver, that is, hepatitis.	[Taylor, John M.; Han, Ziying] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Taylor, JM (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	john.taylor@fccc.edu			Public Health Service [CA-06927]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JT was supported by Public Health Service grant CA-06927 and by an Appropriation from the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JS, 1999, VIROLOGY, V258, P141, DOI 10.1006/viro.1999.9723; Amstrup J, 2003, BIOCHEM J, V374, P51, DOI 10.1042/BJ20030585; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; BALZARINI J, 1986, INT J CANCER, V37, P451, DOI 10.1002/ijc.2910370318; Barrera A, 2004, J VIROL, V78, P5233, DOI 10.1128/JVI.78.10.5233-5243.2004; BROWNE LE, TRENDS PHARM SCI, V31, P229; Burnstock G, 2010, ACTA PHYSIOL, V199, P93, DOI 10.1111/j.1748-1716.2010.02114.x; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Carroll WA, 2009, PURINERG SIGNAL, V5, P63, DOI 10.1007/s11302-008-9110-6; Chai N, 2007, J VIROL, V81, P4912, DOI 10.1128/JVI.02865-06; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chiao CW, 2008, J PHARMACOL EXP THER, V326, P864, DOI 10.1124/jpet.107.135350; Croon J J, 1982, Acta Leiden, V48, P5; Donnelly-Roberts DL, 2009, BRIT J PHARMACOL, V157, P1203, DOI 10.1111/j.1476-5381.2009.00233.x; Emmett DS, 2008, HEPATOLOGY, V47, P698, DOI 10.1002/hep.22035; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Fleck SL, 2003, J BIOL CHEM, V278, P47670, DOI 10.1074/jbc.M306603200; Friedle Scott A, 2010, Recent Pat CNS Drug Discov, V5, P35; Glebe D, 2007, WORLD J GASTROENTERO, V13, P22, DOI 10.3748/wjg.v13.i1.22; Gripon P, 2005, J VIROL, V79, P1613, DOI 10.1128/JVI.79.3.1613-1622.2005; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Gudima S, 2007, J VIROL, V81, P3608, DOI 10.1128/JVI.02277-06; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Kawamura H, 2006, J IMMUNOL, V176, P2152, DOI 10.4049/jimmunol.176.4.2152; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Leistner CM, 2008, CELL MICROBIOL, V10, P122, DOI 10.1111/j.1462-5822.2007.01023.x; Lenertz LY, 2010, BIOCHEMISTRY-US, V49, P4611, DOI 10.1021/bi902083n; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Loeb KR, 2000, HEPATOLOGY, V32, P626, DOI 10.1053/jhep.2000.9878; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Michel AD, 2009, BRIT J PHARMACOL, V156, P1312, DOI 10.1111/j.1476-5381.2009.00135.x; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; PETCU DJ, 1988, VIROLOGY, V167, P385, DOI 10.1016/0042-6822(88)90099-2; Qu Y, 2009, PURINERG SIGNAL, V5, P163, DOI 10.1007/s11302-009-9132-8; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; RIZZETTO M, 1977, GUT, V18, P997, DOI 10.1136/gut.18.12.997; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Schulze A, 2010, J VIROL, V84, P1989, DOI 10.1128/JVI.01902-09; Seeger C., 2007, FIELDS VIROLOGY, V1, P2977; Shehnaz D, 2000, J PHARMACOL EXP THER, V292, P346; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Taylor J. M., 2007, FIELDS VIROLOGY, P3031; Urban S, 2008, FUTURE VIROL, V3, P253, DOI 10.2217/17460794.3.3.253; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728	49	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15784	10.1371/journal.pone.0015784	http://dx.doi.org/10.1371/journal.pone.0015784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187936	Green Published, Green Submitted, gold			2022-12-25	WOS:000285575200070
J	Pauchet, Y; Wilkinson, P; Chauhan, R; Ffrench-Constant, RH				Pauchet, Yannick; Wilkinson, Paul; Chauhan, Ritika; Ffrench-Constant, Richard H.			Diversity of Beetle Genes Encoding Novel Plant Cell Wall Degrading Enzymes	PLOS ONE			English	Article							MULBERRY LONGICORN BEETLE; CELLULASE GENE; CDNA CLONING; ENZYMATIC-ACTIVITY; APRIONA-GERMARI; EXPRESSION; ORIGIN; RECOGNITION; INHIBITORS; BIOLOGY	Plant cell walls are a heterogeneous mixture of polysaccharides and proteins that require a range of different enzymes to degrade them. Plant cell walls are also the primary source of cellulose, the most abundant and useful biopolymer on the planet. Plant cell wall degrading enzymes (PCWDEs) are therefore important in a wide range of biotechnological processes from the production of biofuels and food to waste processing. However, despite the fact that the last common ancestor of all deuterostomes was inferred to be able to digest, or even synthesize, cellulose using endogenous genes, all model insects whose complete genomes have been sequenced lack genes encoding such enzymes. To establish if the apparent "disappearance" of PCWDEs from insects is simply a sampling problem, we used 454 mediated pyrosequencing to scan the gut transcriptomes of beetles that feed on a variety of plant derived diets. By sequencing the transcriptome of five beetles, and surveying publicly available ESTs, we describe 167 new beetle PCWDEs belonging to eight different enzyme families. This survey proves that these enzymes are not only present in non-model insects but that the multigene families that encode them are apparently undergoing complex birth-death dynamics. This reinforces the observation that insects themselves, and not just their microbial symbionts, are a rich source of PCWDEs. Further it emphasises that the apparent absence of genes encoding PCWDEs from model organisms is indeed simply a sampling artefact. Given the huge diversity of beetles alive today, and the diversity of their lifestyles and diets, we predict that beetle guts will emerge as an important new source of enzymes for use in biotechnology.	[Pauchet, Yannick; Wilkinson, Paul; Chauhan, Ritika; Ffrench-Constant, Richard H.] Univ Exeter, Penryn, England; [Pauchet, Yannick] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany	University of Exeter; Max Planck Society	Pauchet, Y (corresponding author), Univ Exeter, Penryn, England.	ypauchet@ice.mpg.de	Pauchet, Yannick/AAU-9751-2021	Pauchet, Yannick/0000-0002-2918-8946; ffrench-Constant, Richard/0000-0001-5385-9888	Research and Knowledge Transfer office of the University of Exeter	Research and Knowledge Transfer office of the University of Exeter	This work was supported by pump priming funding from the Research and Knowledge Transfer office of the University of Exeter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellincampi D, 2004, BBA-PROTEINS PROTEOM, V1696, P265, DOI 10.1016/j.bbapap.2003.10.011; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Beutel RG, 2009, NATURWISSENSCHAFTEN, V96, P1293, DOI 10.1007/s00114-009-0601-2; Bown DP, 1997, INSECT BIOCHEM MOLEC, V27, P625, DOI 10.1016/S0965-1748(97)00043-X; Calderon-Cortes N, 2010, INSECT MOL BIOL, V19, P323, DOI 10.1111/j.1365-2583.2010.00991.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fujita K, 2006, BIOCHEM BIOPH RES CO, V345, P502, DOI 10.1016/j.bbrc.2006.04.126; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Girard C, 1999, INSECT BIOCHEM MOLEC, V29, P1129, DOI 10.1016/S0965-1748(99)00104-6; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Kristensen JB, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-11; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2004, COMP BIOCHEM PHYS B, V139, P107, DOI 10.1016/j.cbpc.2004.06.015; Lee SJ, 2005, COMP BIOCHEM PHYS B, V140, P551, DOI 10.1016/j.cbpc.2004.12.003; Lo N, 2003, P ROY SOC B-BIOL SCI, V270, pS69, DOI 10.1098/rsbl.2003.0016; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Ohtoko K, 2000, EXTREMOPHILES, V4, P343, DOI 10.1007/s007920070003; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schiott M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-40; Shen ZC, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.21; Shen ZC, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.24; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sugimura M, 2003, EUR J BIOCHEM, V270, P3455, DOI 10.1046/j.1432-1033.2003.03735.x; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	42	107	113	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15635	10.1371/journal.pone.0015635	http://dx.doi.org/10.1371/journal.pone.0015635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179425	Green Published, gold			2022-12-25	WOS:000285572900024
J	Pokrzywa, M; Dacklin, I; Vestling, M; Hultmark, D; Lundgren, E; Cantera, R				Pokrzywa, Malgorzata; Dacklin, Ingrid; Vestling, Monika; Hultmark, Dan; Lundgren, Erik; Cantera, Rafael			Uptake of Aggregating Transthyretin by Fat Body in a Drosophila Model for TTR-Associated Amyloidosis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; BINDING PROTEIN; A-BETA; TOXICITY; POLYNEUROPATHY; NEURODEGENERATION; LOCALIZATION; ACCUMULATION; MELANOGASTER	Background: A functional link has been established between the severe neurodegenerative disorder Familial amyloidotic polyneuropathy and the enhanced propensity of the plasma protein transthyretin (TTR) to form aggregates in patients with single point mutations in the TTR gene. Previous work has led to the establishment of an experimental model based on transgenic expression of normal or mutant forms of human TTR in Drosophila flies. Remarkably, the severity of the phenotype was greater in flies that expressed a single copy than with two copies of the mutated gene. Methodology/Principal Findings: In this study, we analyze the distribution of normal and mutant TTR in transgenic flies, and the ultrastructure of TTR-positive tissues to clarify if aggregates and/or amyloid filaments are formed. We report the formation of intracellular aggregates of 20 nm spherules and amyloid filaments in thoracic adipose tissue and in brain glia, two tissues that do not express the transgene. The formation of aggregates of nanospherules increased with age and was more considerable in flies with two copies of mutated TTR. Treatment of human neuronal cells with protein extracts prepared from TTR flies of different age showed that the extracts from older flies were less toxic than those from younger flies. Conclusions/Significance: These findings suggest that the uptake of TTR from the circulation and its subsequent segregation into cytoplasmic quasi-crystalline arrays of nanospherules is part of a mechanism that neutralizes the toxic effect of TTR.	[Pokrzywa, Malgorzata; Dacklin, Ingrid; Vestling, Monika; Hultmark, Dan; Lundgren, Erik] Umea Univ, Dept Mol Biol, Umea, Sweden; [Pokrzywa, Malgorzata] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Hultmark, Dan] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Cantera, Rafael] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Cantera, Rafael] IIBCE, Montevideo, Uruguay	Umea University; Linkoping University; Tampere University; Stockholm University; Instituto de Investigaciones Biologicas Clemente Estable Uruguay	Pokrzywa, M (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	malgorzata.pokrzywa@liu.se	Hultmark, Dan/C-5058-2013; Pokrzywa, Małgorzata/GQA-6257-2022	Hultmark, Dan/0000-0002-6506-5855; 	Swedish Research Council; Authority for Animal Welfare; Wallenberg Consortium North; patients association FAMY; Stiftelsen Amyl Norrbotten; Agencia Nacional de Investigacian e Innovacian (Uruguay)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Authority for Animal Welfare; Wallenberg Consortium North; patients association FAMY; Stiftelsen Amyl Norrbotten; Agencia Nacional de Investigacian e Innovacian (Uruguay)	This study was supported by grants from the Swedish Research Council, the Authority for Animal Welfare, Wallenberg Consortium North, the patients association FAMY and Stiftelsen Amyl Norrbotten. RC was supported by the SNI program of the Agencia Nacional de Investigacian e Innovacian (Uruguay). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESHIRE SL, 1983, J HISTOCHEM CYTOCHEM, V31, P608, DOI 10.1177/31.5.6341455; Andersson K, 2002, BIOCHEM BIOPH RES CO, V294, P309, DOI 10.1016/S0006-291X(02)00465-5; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Colon W, 1996, CIBA F SYMP, V199, P228; Colon W, 1996, CIBA F SYMP, P199; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; GUSTAVSSON A, 1995, LAB INVEST, V73, P703; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; HAUNERLAND NH, 1995, ANNU REV ENTOMOL, V40, P121, DOI 10.1146/annurev.en.40.010195.001005; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hou X, 2007, FEBS J, V274, P1637, DOI 10.1111/j.1742-4658.2007.05712.x; Inoue S, 1998, J STRUCT BIOL, V124, P1, DOI 10.1006/jsbi.1998.4052; Keeley L.L., 1985, P211; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Kramer Jamie M, 2003, Genet Mol Res, V2, P43; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Matsubara K, 2005, BIOCHEMISTRY-US, V44, P3280, DOI 10.1021/bi048838c; Miller JM, 2002, INSECT MOL BIOL, V11, P67, DOI 10.1046/j.0962-1075.2001.00310.x; Murai KK, 2007, NEUROSCIENTIST, V13, P657, DOI 10.1177/1073858407304393; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Olofsson A, 2001, J BIOL CHEM, V276, P39592, DOI 10.1074/jbc.M103599200; Paulsson JF, 2006, DIABETOLOGIA, V49, P1237, DOI 10.1007/s00125-006-0206-7; Pokrzywa M, 2007, EUR J NEUROSCI, V26, P913, DOI 10.1111/j.1460-9568.2007.05728.x; RAZ A, 1969, J BIOL CHEM, V244, P3230; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Rezaval C, 2007, EUR J NEUROSCI, V25, P683, DOI 10.1111/j.1460-9568.2007.05317.x; SARAIVA MJM, 1995, HUM MUTAT, V5, P191; Sekijima Y, 2003, LAB INVEST, V83, P409, DOI 10.1097/01.LAB.0000059937.11023.1F; SERPELL LC, 1995, J MOL BIOL, V254, P113, DOI 10.1006/jmbi.1995.0604; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sousa MM, 2002, AM J PATHOL, V161, P1935, DOI 10.1016/S0002-9440(10)64469-0; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2002, HISTOL HISTOPATHOL, V17, P239, DOI 10.14670/HH-17.239; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wiseman RL, 2005, BIOCHEMISTRY-US, V44, P16612, DOI 10.1021/bi0511484	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14343	10.1371/journal.pone.0014343	http://dx.doi.org/10.1371/journal.pone.0014343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179560	Green Submitted, Green Published, gold			2022-12-25	WOS:000285381200003
J	Calzolari, M; Bonilauri, P; Bellini, R; Albieri, A; Defilippo, F; Maioli, G; Galletti, G; Gelati, A; Barbieri, I; Tamba, M; Lelli, D; Carra, E; Cordioli, P; Angelini, P; Dottori, M				Calzolari, Mattia; Bonilauri, Paolo; Bellini, Romeo; Albieri, Alessandro; Defilippo, Francesco; Maioli, Giulia; Galletti, Giorgio; Gelati, Antoni; Barbieri, Ilaria; Tamba, Marco; Lelli, Davide; Carra, Elena; Cordioli, Paolo; Angelini, Paola; Dottori, Michele			Evidence of Simultaneous Circulation of West Nile and Usutu Viruses in Mosquitoes Sampled in Emilia-Romagna Region (Italy) in 2009	PLOS ONE			English	Article							PCR ASSAY; AUSTRIA; CULEX; FLAVIVIRUSES; SURVEILLANCE; EMERGENCE	Background: In recent years human diseases due to mosquito-borne viruses were increasingly reported in Emilia-Romagna region (Italy), from the chikungunya virus in 2007 to the West Nile virus (WNV) in 2008. An extensive entomological survey was performed in 2009 to establish the presence and distribution of mosquito arboviruses in this region, with particular reference to flaviviruses. Methodology/Principal Findings: From May 6 to October 31, a total of 190,516 mosquitoes were sampled in georeferenced stations, grouped in 1,789 pools according date of collection, location, and species, and analyzed by reverse transcription polymerase chain reaction (RT-PCR) to detect the presence of RNA belong to Flavivirus genus. WNV was detected in 27 mosquito pools, producing sequences similar to those of birds and human strains obtained in 2008 outbreak, pointed out the probable virus overwintering. Isolation of WNV was achieved from one of these pools. Moreover 56 pools of mosquitoes tested positive for Usutu virus (USUV). Most PCR positive pools consisted of Culex pipiens, which also was the most analyzed mosquito species (81.4% of specimens); interestingly, USUV RNA was also found in two Aedes albopictus mosquito pools. Simultaneous circulation of WNV and USUV in the survey area was highlighted by occurrence of 8 mosquito WNV-and USUV-positive pools and by the overlaying of the viruses "hot spots", obtained by kernel density estimation (KDE) analysis. Land use of sampled stations pointed out a higher proportion of WNV-positive Cx. pipiens pool in rural environments respect the provenience of total sampled pool, while the USUV-positive pools were uniformly captured in the different environments. Conclusions/Significance: Obtained data highlighting the possible role of Cx. pipiens mosquito as the main vector for WNV and USUV in Northern Italy, and the possible involvement of Ae. albopictus mosquito in USUV cycle. The described mosquito-based surveillance could constitute the foundation for a public health alert system targeting mosquito borne arboviruses.	[Calzolari, Mattia; Bonilauri, Paolo; Defilippo, Francesco; Maioli, Giulia; Galletti, Giorgio; Barbieri, Ilaria; Tamba, Marco; Lelli, Davide; Carra, Elena; Cordioli, Paolo; Dottori, Michele] Ist Zooprofilatt Sperimentale Lombardia & dellEmi, Brescia, Italy; [Bellini, Romeo; Albieri, Alessandro] Ctr Agr Ambiente G Nicoli CAA, Crevalcore, Italy; [Gelati, Antoni] Azienda USL Modena, Mirandola, Italy; [Angelini, Paola] DG Sanita & Polit Sociali, Reg Emilia Romagna, Bologna, Italy	IZS Lombardia e Emilia	Calzolari, M (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & dellEmi, Brescia, Italy.	mattia.calzolari@izsler.it	Lelli, Davide DL/K-5178-2016; Calzolari, Mattia/AAB-9487-2019; Tamba, Marco/J-5495-2016; dottori, michele/AAB-3815-2019; Lelli, Davide/AAB-6996-2019; Maioli, Giulia/AAB-7559-2019	Calzolari, Mattia/0000-0001-7489-2556; Tamba, Marco/0000-0002-5878-4595; Lelli, Davide/0000-0002-5775-6058; Maioli, Giulia/0000-0002-7076-9005; Galletti, Giorgio/0000-0003-4522-8976; Dottori, Michele/0000-0002-9975-0367; Bonilauri, Paolo/0000-0002-2625-7993; defilippo, francesco/0000-0002-1898-0997	Regione Emilia-Romagna; CAA [COMM07001]	Regione Emilia-Romagna(Regione Emilia Romagna); CAA	The Regione Emilia-Romagna (ermes.regione.emilia-romagna.it) had partially funded this work to IZSLER (www.izsler.it) and CAA (www.caa.it) by the Regional project on insect borne diseases (COMM07001). No other external funding was utilized for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T. R., 2006, International Journal of Risk Assessment & Management, V6, P253, DOI 10.1504/IJRAM.2006.009546; Angelini P, 2010, EUROSURVEILLANCE, V15, P11; [Anonymous], 2003, MOSQUITOES THEIR CON; Autorino GL, 2002, EMERG INFECT DIS, V8, P1372, DOI 10.3201/eid0812.020234; Bailey T, 1995, INTERACTIVE SPATIAL; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005; Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07; Balenghien T, 2008, VECTOR-BORNE ZOONOT, V8, P589, DOI 10.1089/vbz.2007.0266; Bellini R., 2002, 68 ANN M AM MOSQ CON; Biggerstaff B.J., 2006, POOLEDINFRATE VERSIO; Buckley A, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-71; Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Calistri P, 2010, ZOONOSES PUBLIC HLTH, V57, P211, DOI 10.1111/j.1863-2378.2009.01303.x; CALZOLARI M, 2010, VECTOR BORN IN PRESS; Capobianchi MR, 2010, EUROSURVEILLANCE, V15; Cavrini F, 2009, EUROSURVEILLANCE, V14, P17; *CDC, 2003, GUID SURV PREV CONTR; Chisenhall DM, 2008, J AM MOSQUITO CONTR, V24, P311, DOI 10.2987/5671.1; Chvala S, 2007, VET MICROBIOL, V122, P237, DOI 10.1016/j.vetmic.2007.01.029; Gratz NG, 2006, VECTOR-AND RODENT-BORNE DISEASES OF EUROPE AND NORTH AMERICA: THEIR DISTRIBUTION AND PUBLIC HEALTH BURDEN, P1, DOI 10.2277/ 0521854474; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Gu WD, 2008, T ROY SOC TROP MED H, V102, P817, DOI 10.1016/j.trstmh.2008.03.019; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; KRISZTALOVICS K, 2008, EUROSURVEILLANCE, V13, P7; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; LELLI D, 2009, ATT WORKSH NAZ VIR V; Lelli R, 2008, ZOONOSES PUBLIC HLTH, V55, P361, DOI 10.1111/j.1863-2378.2008.01146.x; Malkinson M, 2002, CURR TOP MICROBIOL, V267, P309; Manarolla G, 2010, VET MICROBIOL, V141, P159, DOI 10.1016/j.vetmic.2009.07.036; Pecorari M, 2009, EUROSURVEILLANCE, V14, P15; Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0; Rizzo C, 2009, EUROSURVEILLANCE, V14, P5; Rizzoli A, 2007, VECTOR-BORNE ZOONOT, V7, P411, DOI 10.1089/vbz.2006.0626; Romi Roberto, 2001, Annali dell'Istituto Superiore di Sanita, V37, P241; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Schaffner E., 2001, MOSQUITOES EUROPE; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; STEINMETZ HW, 2010, VET MICROBIOL; Stojanovich CJ, 1997, MOSQUITOES ITALIAN B; Sutherland GL, 2007, J AM MOSQUITO CONTR, V23, P389, DOI 10.2987/5630.1; TAMBA M, 2010, VECTOR BORN IN PRESS; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang YL, 2006, J CLIN VIROL, V36, P177, DOI 10.1016/j.jcv.2006.02.008; Tiawsirisup S, 2004, VECTOR-BORNE ZOONOT, V4, P190, DOI 10.1089/vbz.2004.4.190; Weissenbock H, 2004, ACTA NEUROPATHOL, V108, P453, DOI 10.1007/s00401-004-0916-1; Weissenbock H, 2003, MICROBES INFECT, V5, P1132, DOI 10.1016/S1286-4579(03)00204-1; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Woodall J.P., 1964, P E AFR ACAD, V2, P141	52	103	105	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14324	10.1371/journal.pone.0014324	http://dx.doi.org/10.1371/journal.pone.0014324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179462	gold, Green Published, Green Submitted			2022-12-25	WOS:000285340000004
J	Dudaniec, RY; Storfer, A; Spear, SF; Richardson, JS				Dudaniec, Rachael Y.; Storfer, Andrew; Spear, Stephen F.; Richardson, John S.			New Microsatellite Markers for Examining Genetic Variation in Peripheral and Core Populations of the Coastal Giant Salamander (Dicamptodon tenebrosus)	PLOS ONE			English	Article							LOCI; RAREFACTION	The Coastal Giant Salamander (Dicamptodon tenebrosus) is classified as threatened at the northern periphery of its range in British Columbia (BC), Canada, primarily due to forestry practices and habitat fragmentation. Characterising dispersal behaviour and population connectivity is therefore a priority for this region, while genetic differentiation in core versus peripheral locations remains unstudied in this wide-ranging species. We present seven new polymorphic microsatellite markers for use in population genetic analyses of D. tenebrosus. We examine locus characteristics and genetic variation in 12 streams at the species' northern range limit in BC, and within two regions representing sub-peripheral (North Cascades) and core localities (South Cascades) in Washington State, United States. In BC, the number of alleles per locus ranged from 2-5 and observed heterozygosity ranged from 0.044-0.825. Genetic differentiation was highest between BC and the South Cascades, and intermediate between BC and the North Cascades. Across loci, mean allelic richness was similar across regions, while private allelic richness was highest in the core locality (corrected for sample size). These new microsatellite loci will be a valuable addition to existing markers for detailed landscape and population genetic analyses of D. tenebrosus across its range.	[Dudaniec, Rachael Y.; Richardson, John S.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Storfer, Andrew; Spear, Stephen F.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	University of British Columbia; Washington State University	Dudaniec, RY (corresponding author), Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada.	rachael.dudaniec@gmail.com	Richardson, John S/G-1513-2012; Dudaniec, Rachael Y/F-4001-2011; Dudaniec, Rachael/AAR-7034-2020	Richardson, John S/0000-0001-8135-7447; Dudaniec, Rachael/0000-0002-1854-6808	Forest Investment Account/Forest Science Program, British Columbia [Y102082]; Cooperative Monitoring, Evaluation and Research Committee [IAA-06-047]	Forest Investment Account/Forest Science Program, British Columbia; Cooperative Monitoring, Evaluation and Research Committee	This work was supported by the Forest Investment Account/Forest Science Program, British Columbia (grant number Y102082; http://www.fia-fsp.ca/), and the Cooperative Monitoring, Evaluation and Research Committee under the Washington Department of Natural Resources Forest Practices Management Program (grant number IAA-06-047 to WSU; http://www.dnr.wa.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Curtis JM, 2000, MOL ECOL, V9, P116, DOI 10.1046/j.1365-294x.2000.00764-6.x; Curtis JMR, 2004, BIOL CONSERV, V115, P45, DOI 10.1016/S0006-3207(03)00092-2; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Gautschi B, 2000, MOL ECOL, V9, P2193, DOI 10.1046/j.1365-294X.2000.105321.x; Gautschi B, 2000, MOL ECOL, V9, P2191, DOI 10.1046/j.1365-294X.2000.105320.x; Hamilton MB, 1999, BIOTECHNIQUES, V27, P500, DOI 10.2144/99273st03; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Steele CA, 2008, MOL ECOL RESOUR, V8, P1071, DOI 10.1111/j.1755-0998.2008.02158.x; Steele CA, 2009, MOL ECOL, V18, P1629, DOI 10.1111/j.1365-294X.2009.04135.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963	18	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2010	5	12							e14333	10.1371/journal.pone.0014333	http://dx.doi.org/10.1371/journal.pone.0014333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694ZI	21179519	gold, Green Published			2022-12-25	WOS:000285340000008
J	Kawaguchi, N; Smith, AJ; Waring, CD; Hasan, MK; Miyamoto, S; Matsuoka, R; Ellison, GM				Kawaguchi, Nanako; Smith, Andrew J.; Waring, Cheryl D.; Hasan, Md Kamrul; Miyamoto, Shinka; Matsuoka, Rumiko; Ellison, Georgina M.			c-kit(pos) GATA-4 High Rat Cardiac Stem Cells Foster Adult Cardiomyocyte Survival through IGF-1 Paracrine Signalling	PLOS ONE			English	Article							GROWTH-FACTOR-I; REGENERATE INFARCTED MYOCARDIUM; BONE-MARROW-CELLS; PROGENITOR CELLS; HEART-FAILURE; MURINE HEART; APOPTOSIS; MECHANISMS; THERAPY; MULTIPOTENT	Background: Resident c-kit positive (c-kit(pos)) cardiac stem cells (CSCs) could be considered the most appropriate cell type for myocardial regeneration therapies. However, much is still unknown regarding their biological properties and potential. Methodology/Principal Findings: We produced clones of high and low expressing GATA-4 CSCs from long-term bulk-cultured c-kit(pos) CSCs isolated from adult rat hearts. When c-kit(pos) GATA-4 high expressing clonal CSCs (cCSCs) were co-cultured with adult rat ventricular cardiomyocytes, we observed increased survival and contractility of the cardiomyocytes, compared to cardiomyocytes cultured alone, co-cultured with fibroblasts or c-kit(pos) GATA-4 low expressing cCSCs. When analysed by ELISA, the concentration of IGF-1 was significantly increased in the c-kit(pos) GATA-4 high cCSC/cardiomyocyte co-cultures and there was a significant correlation between IGF-1 concentration and cardiomyocyte survival. We showed the activation of the IGF-1 receptor and its downstream molecular targets in cardiomyocytes co-cultured with c-kit(pos) GATA-4 high cCSCs but not in cardiomyocytes that were cultured alone, co-cultured with fibroblasts or c-kit(pos) GATA-4 low cCSCs. Addition of a blocking antibody specific to the IGF-1 receptor inhibited the survival of cardiomyocytes and prevented the activation of its signalling in cardiomyocytes in the c-kit(pos) GATA-4 high cCSC/cardiomyocyte co-culture system. IGF-1 supplementation or IGF-1 high conditioned medium taken from the co-culture of c-kit(pos) GATA-4 high cCSCs plus cardiomyocytes did extend the survival and contractility of cardiomyocytes cultured alone and cardiomyocytes co-cultured with c-kit(pos) GATA-4 low cCSCs. Conclusion/Significance: c-kit(pos) GATA-4 high cCSCs exert a paracrine survival effect on cardiomyocytes through induction of the IGF-1R and signalling pathway.	[Kawaguchi, Nanako; Hasan, Md Kamrul; Miyamoto, Shinka; Matsuoka, Rumiko] Tokyo Womens Med Univ, IREIIMS, Tokyo, Japan; [Smith, Andrew J.; Waring, Cheryl D.; Ellison, Georgina M.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Stem Cell & Mol Physiol Lab, Liverpool L3 5UX, Merseyside, England; [Miyamoto, Shinka] Tokyo Womens Med Univ, Heart Inst Japan, Dept Cardiovasc Surg, Tokyo, Japan	Tokyo Women's Medical University; Liverpool John Moores University; Tokyo Women's Medical University	Kawaguchi, N (corresponding author), Tokyo Womens Med Univ, IREIIMS, Tokyo, Japan.	g.m.ellison@ljmu.ac.uk	Ellison-Hughes, Georgina M./B-4597-2016	Ellison-Hughes, Georgina M./0000-0002-2733-3361; Smith, Andrew/0000-0001-7283-5611	Ministry of Education, Culture, Sports, Science and Technology, Japan; British Heart Foundation [PG/06/053, PG 08/085]; European Community [PIRG02-GA-2007-224853]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); British Heart Foundation(British Heart Foundation); European Community(European Commission)	This work was supported by the encouraging Development of Strategic Research Centers, Special Co-ordination Funds for Promoting Science and Technology and a Grant-in Aid for Scientific Research (A), Ministry of Education, Culture, Sports, Science and Technology, Japan; grants to G. M. E from the British Heart Foundation (PG/06/053; PG 08/085) and a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme (PIRG02-GA-2007-224853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2002, CARDIOVASC RES, V55, P787, DOI 10.1016/S0008-6363(02)00493-5; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bernecker Oliver Y, 2003, Cardiovasc Toxicol, V3, P183, DOI 10.1385/CT:3:3:183; Braunwald E, 2000, CIRCULATION, V102, P14; BRAUNWALD E, 1991, AM J CARDIOL, V68, pD1; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Ellison Georgina M, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS52, DOI 10.1038/ncpcardio0773; Ellison GM, 2007, J BIOL CHEM, V282, P11397, DOI 10.1074/jbc.M607391200; Fu YC, 2004, CARDIOVASC RES, V62, P558, DOI 10.1016/j.cardiores.2004.01.039; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Janssens S, 2010, ANNU REV MED, V61, P287, DOI 10.1146/annurev.med.051508.215152; KELLEY C, 1993, DEVELOPMENT, V118, P817; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kubal C, 2006, J THORAC CARDIOV SUR, V132, P1112, DOI 10.1016/j.jtcvs.2006.06.028; Lai VK, 2009, J THORAC CARDIOV SUR, V138, P1400, DOI 10.1016/j.jtcvs.2009.07.013; LaVoie HA, 2004, ENDOCRINOLOGY, V145, P3122, DOI 10.1210/en.2003-1719; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miyamoto S, 2010, STEM CELLS DEV, V19, P105, DOI 10.1089/scd.2009.0041; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Moore XL, 2007, ENDOCRINOLOGY, V148, P1582, DOI 10.1210/en.2006-1324; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nadal-Ginard B, 2006, REV ESP CARDIOL, V59, P1175; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; Reffelmann T, 2009, J AM COLL CARDIOL, V53, P305, DOI 10.1016/j.jacc.2008.10.018; Rosenblatt-Velin N, 2005, J CLIN INVEST, V115, P1724, DOI 10.1172/JCI23418; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Torella Daniele, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS46, DOI 10.1038/ncpcardio0772; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Wu S, 2002, J MOL CELL CARDIOL, V34, P1595, DOI 10.1006/jmcc.2002.2110; Yamaoka M, 2000, J MOL CELL CARDIOL, V32, P881, DOI 10.1006/jmcc.2000.1132; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278	49	68	73	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14297	10.1371/journal.pone.0014297	http://dx.doi.org/10.1371/journal.pone.0014297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179204	Green Published, gold, Green Submitted			2022-12-25	WOS:000285246900010
J	Ko, JK; Choi, KH; Peng, J; He, F; Zhang, Z; Weisleder, N; Lin, JL; Ma, JJ				Ko, Jae-Kyun; Choi, Kyoung-Han; Peng, Jun; He, Feng; Zhang, Zhi; Weisleder, Noah; Lin, Jialing; Ma, Jianjie			Amphipathic Tail-anchoring Peptide and Bcl-2 Homology Domain-3 (BH3) Peptides from Bcl-2 Family Proteins Induce Apoptosis through Different Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL-MEMBRANE; X-L; BCL-2-REGULATED APOPTOSIS; MIMETIC ABT-737; CYTOCHROME-C; BAX; CANCER; ACTIVATION	Bcl-2 homology domain-3 (BH3) peptides are potent cancer therapeutic reagents that target regulators of apoptotic cell death in cancer cells. However, their cytotoxic effects are affected by different expression levels of Bcl-2 family proteins. We recently found that the amphipathic tail-anchoring peptide (ATAP) from Bfl-1, a bifunctional Bcl-2 family member, produced strong pro-apoptotic activity by permeabilizing the mitochondrial outer membrane. Here, we test whether the activity of ATAP requires other cellular factors and whether ATAP has an advantage over the BH3 peptides in targeting cancer cells. Confocal microscopic imaging illustrates specific targeting of ATAP to mitochondria, whereas BH3 peptides show diffuse patterns of cytosolic distribution. Although the pro-apoptotic activities of BH3 peptides are largely inhibited by either overexpression of anti-apoptotic Bcl-2 or Bcl-xL or nullification of pro-apoptotic Bax and Bak in cells, the pro-apoptotic function of ATAP is not affected by these cellular factors. Reconstitution of synthetic ATAP into liposomal membranes results in release of fluorescent molecules of the size of cytochrome c from the liposomes, suggesting that the membrane permeabilizing activity of ATAP does not require additional protein factors. Because ATAP can target to the mitochondrial membrane and its pro-apoptotic activity does not depend on the content of Bcl-2 family proteins, it represents a promising candidate for anti-cancer drugs that can potentially overcome the intrinsic apoptosis-resistant nature of cancer cells.	[Peng, Jun; He, Feng; Zhang, Zhi; Lin, Jialing] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Ko, Jae-Kyun; Choi, Kyoung-Han; Weisleder, Noah; Ma, Jianjie] Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lin, JL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA.	jialing-lin@ouhsc.edu; maj2@umdnj.edu	He, Feng/J-6984-2019; Weisleder, Noah L/A-7098-2013	He, Feng/0000-0003-0276-3303; Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088	National Institutes of Health [RO1-CA095739, RO1-AG028614, GM062964, K99/R00-AR054793]; NATIONAL CANCER INSTITUTE [R01CA095739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR054793, R00AR054793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA095739 and RO1-AG028614 (to J. M.), GM062964 (to J. L.), and K99/R00-AR054793 (to N. W.).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Benz EJ, 2007, CLIN CANCER RES, V13, P7250, DOI 10.1158/1078-0432.CCR-07-2221; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cosulich SC, 1997, CURR BIOL, V7, P913, DOI 10.1016/S0960-9822(06)00410-6; Crisan D, 1996, CLIN LAB MED, V16, P23, DOI 10.1016/S0272-2712(18)30285-3; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Krajewska M, 1996, CANCER RES, V56, P2422; KRAJEWSKI S, 1995, CANCER RES, V55, P4471; Kushnareva YE, 2001, ARCH BIOCHEM BIOPHYS, V386, P251, DOI 10.1006/abbi.2000.2201; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Labi V, 2008, CELL DEATH DIFFER, V15, P977, DOI 10.1038/cdd.2008.37; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Meng XW, 2006, CURR OPIN CELL BIOL, V18, P668, DOI 10.1016/j.ceb.2006.10.008; Muro C, 2003, BIOPHYS J, V84, P2981, DOI 10.1016/S0006-3495(03)70024-1; Oliver CL, 2005, MOL CANCER THER, V4, P23; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Polster BM, 2001, J BIOL CHEM, V276, P37887; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wood DE, 2000, EXP CELL RES, V256, P375, DOI 10.1006/excr.2000.4859; Xu L, 2005, MOL CANCER THER, V4, P197; Yang WS, 2005, J CELL BIOCHEM, V94, P1234, DOI 10.1002/jcb.20381; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Yin H, 2005, J AM CHEM SOC, V127, P10191, DOI 10.1021/ja050122x; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zeitlin BD, 2006, CANCER RES, V66, P8698, DOI 10.1158/0008-5472.CAN-05-3691; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200	49	26	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9038	9048		10.1074/jbc.M110.198457	http://dx.doi.org/10.1074/jbc.M110.198457			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21189256	hybrid, Green Published			2022-12-25	WOS:000288247700035
J	Ayalon, G; Hostettler, JD; Hoffman, J; Kizhatil, K; Davis, JQ; Bennett, V				Ayalon, Gai; Hostettler, Janell D.; Hoffman, Jan; Kizhatil, Krishnakumar; Davis, Jonathan Q.; Bennett, Vann			Ankyrin-B Interactions with Spectrin and Dynactin-4 Are Required for Dystrophin-based Protection of Skeletal Muscle from Exercise Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-RELATED PROTEIN; NEONATAL CARDIOMYOCYTES; MUSCULAR-DYSTROPHIES; CYTOPLASMIC DOMAIN; EPITHELIAL-CELLS; F-ACTIN; MEMBRANE; COMPLEX; ARP1; ORGANIZATION	Costameres are cellular sites of mechanotransduction in heart and skeletal muscle where dystrophin and its membrane-spanning partner dystroglycan distribute intracellular contractile forces into the surrounding extracellular matrix. Resolution of a functional costamere interactome is still limited but likely to be critical for understanding forms of muscular dystrophy and cardiomyopathy. Dystrophin binds a set of membrane-associated proteins (the dystrophin-glycoprotein complex) as well as gamma-actin and microtubules and also is required to align sarcolemmal microtubules with costameres. Ankyrin-B binds to dystrophin, dynactin-4, and microtubules and is required for sarcolemmal association of these proteins as well as dystroglycan. We report here that ankyrin-B interactions with beta 2 spectrin and dynactin-4 are required for localization of dystrophin, dystroglycan, and microtubules at costameres as well as protection of muscle from exercise-induced injury. Knockdown of dynactin-4 in adult mouse skeletal muscle phenocopied depletion of ankyrin-B and resulted in loss of sarcolemmal dystrophin, dystroglycan, and microtubules. Moreover, mutations of ankyrin-B and of dynactin-4 that selectively impaired binary interactions between these proteins resulted in loss of their costamere-localizing activity and increased muscle fiber fragility as a result of loss of costamere-associated dystrophin and dystroglycan. In addition, costamere-association of dynactin-4 did not require dystrophin but did depend on beta 2 spectrin and ankyrin-B, whereas costamere association of ankyrin-B required beta 2 spectrin. Together, these results are consistent with a functional hierarchy beginning with beta 2 spectrin recruitment of ankyrin-B to costameres. Ankyrin-B then interacts with dynactin-4 and dystrophin, whereas dynactin-4 collaborates with dystrophin in coordinating costamere-aligned microtubules.	[Ayalon, Gai; Hostettler, Janell D.; Hoffman, Jan; Kizhatil, Krishnakumar; Davis, Jonathan Q.; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Ayalon, Gai; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Bennett, Vann] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Bennett, Vann] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	benne012@mc.duke.edu	Kizhatil, Krish/AAR-5868-2021	Kizhatil, Krishnakumar/0000-0003-3755-6101	Muscular Dystrophy Association	Muscular Dystrophy Association(Muscular Dystrophy Association)	This work was supported in part by a grant from the Muscular Dystrophy Association.	Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; CRAIG SW, 1983, CELL MOTIL CYTOSKEL, V3, P449, DOI 10.1002/cm.970030513; Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; DAVIS JQ, 1984, J BIOL CHEM, V259, P3550; DAVIS LH, 1991, J BIOL CHEM, V266, P11163; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Garces JA, 1999, CURR BIOL, V9, P1497, DOI 10.1016/S0960-9822(00)80122-0; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Ipsaro JJ, 2010, BLOOD, V115, P4093, DOI 10.1182/blood-2009-11-255604; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Karki S, 2000, J BIOL CHEM, V275, P4834, DOI 10.1074/jbc.275.7.4834; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Percival JM, 2007, TRAFFIC, V8, P1424, DOI 10.1111/j.1600-0854.2007.00622.x; Prins KW, 2009, J CELL BIOL, V186, P363, DOI 10.1083/jcb.200905048; Rybakova IN, 1996, J CELL BIOL, V135, P661, DOI 10.1083/jcb.135.3.661; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Wang R, 2009, MOL CELL, V33, P692, DOI 10.1016/j.molcel.2009.02.016; Zhou DX, 1998, MOL BIOL CELL, V9, P47, DOI 10.1091/mbc.9.1.47	33	35	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7370	7378		10.1074/jbc.M110.187831	http://dx.doi.org/10.1074/jbc.M110.187831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21186323	hybrid, Green Published			2022-12-25	WOS:000287737300053
J	Lin, ZH; Jiang, LG; Yuan, C; Jensen, JK; Zhang, X; Luo, ZP; Furie, BC; Furie, B; Andreasen, PA; Huang, MD				Lin, Zhonghui; Jiang, Longguang; Yuan, Cai; Jensen, Jan K.; Zhang, Xu; Luo, Zhipu; Furie, Barbara C.; Furie, Bruce; Andreasen, Peter A.; Huang, Mingdong			Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; CRYSTAL-STRUCTURE; REACTIVE-CENTER; TUMOR-MARKERS; SERPIN; COMPLEX; TARGET; POLYMERIZATION; FIBRINOLYSIS; VITRONECTIN	Plasminogen activator inhibitor-1 (PAI-1), together with its physiological target urokinase-type plasminogen activator (uPA), plays a pivotal role in fibrinolysis, cell migration, and tissue remodeling and is currently recognized as being among the most extensively validated biological prognostic factors in several cancer types. PAI-1 specifically and rapidly inhibits uPA and tissue-type PA (tPA). Despite extensive structural/functional studies on these two reactions, the underlying structural mechanism has remained unknown due to the technical difficulties of obtaining the relevant structures. Here, we report a strategy to generate a PAI-1.uPA(S195A) Michaelis complex and present its crystal structure at 2.3-angstrom resolution. In this structure, the PAI-1 reactive center loop serves as a bait to attract uPA onto the top of the PAI-1 molecule. The P4-P3' residues of the reactive center loop interact extensively with the uPA catalytic site, accounting for about two-thirds of the total contact area. Besides the active site, almost all uPA exosite loops, including the 37-, 60-, 97-, 147-, and 217-loops, are involved in the interaction with PAI-1. The uPA 37-loop makes an extensive interaction with PAI-1 beta-sheet B, and the 147-loop directly contacts PAI-1 beta-sheet C. Both loops are important for initial Michaelis complex formation. This study lays down a foundation for understanding the specificity of PAI-1 for uPA and tPA and provides a structural basis for further functional studies.	[Lin, Zhonghui; Jiang, Longguang; Yuan, Cai; Zhang, Xu; Luo, Zhipu; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China; [Lin, Zhonghui; Jiang, Longguang; Yuan, Cai; Jensen, Jan K.; Zhang, Xu; Luo, Zhipu; Andreasen, Peter A.; Huang, Mingdong] Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Peoples R China; [Jensen, Jan K.; Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Yuan, Cai; Furie, Barbara C.; Furie, Bruce; Huang, Mingdong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hemostasis & Thrombosis, Boston, MA 02215 USA	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Aarhus University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China.	mhuang@fjirsm.ac.cn	zhang, xu/GYE-3558-2022; Huang, Mingdong/J-4278-2017; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022; Luo, Zhipu/P-9168-2014; Zhang, xiaoyu/GXA-3206-2022	Huang, Mingdong/0000-0003-0085-9141; Jiang, Longguang/0000-0002-4734-3778	Fujian Institute of Research on the Structure of Matter [SZD08003]; Chinese Academy of Sciences [KSCX2-YW-R-082]; Natural Science Foundation of China [30811130467, 30625011, 30770429]; Ministry of Science of Technology [2007CB914304]	Fujian Institute of Research on the Structure of Matter(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science of Technology	This work was supported by Fujian Institute of Research on the Structure of Matter Grant SZD08003, Chinese Academy of Sciences Grant KSCX2-YW-R-082, Natural Science Foundation of China Grants 30811130467, 30625011, and 30770429, and Ministry of Science of Technology Grant 2007CB914304.	AERTGEERTS K, 1995, NAT STRUCT BIOL, V2, P891, DOI 10.1038/nsb1095-891; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; Dewilde M, 2009, J STRUCT BIOL, V165, P126, DOI 10.1016/j.jsb.2008.11.001; Duffy MJ, 2004, CLIN BIOCHEM, V37, P541, DOI 10.1016/j.clinbiochem.2004.05.013; Duffy MJ, 2002, CLIN CHEM, V48, P1194; DUGGAN C, 1995, INT J CANCER, V61, P597, DOI 10.1002/ijc.2910610502; Egelund R, 2001, J BIOL CHEM, V276, P13077, DOI 10.1074/jbc.M009024200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gutierrez LS, 2000, CANCER RES, V60, P5839; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Ibarra CA, 2004, J BIOL CHEM, V279, P3643, DOI 10.1074/jbc.M310601200; Jensen JK, 2008, PROTEIN SCI, V17, P1844, DOI 10.1110/ps.036707.108; Jensen JK, 2002, FEBS LETT, V521, P91, DOI 10.1016/S0014-5793(02)02830-2; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; KEIJER J, 1991, BLOOD, V78, P1254; KVASSMAN JO, 1995, J BIOL CHEM, V270, P27942, DOI 10.1074/jbc.270.46.27942; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEVIN EG, 1987, BLOOD, V70, P1090; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nar H, 2000, J MOL BIOL, V297, P683, DOI 10.1006/jmbi.2000.3604; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ploug M, 2003, CURR PHARM DESIGN, V9, P1499, DOI 10.2174/1381612033454630; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; SHERMAN PM, 1992, J BIOL CHEM, V267, P7588; SPRAGGON G, 1995, STRUCTURE, V3, P681, DOI 10.1016/S0969-2126(01)00203-9; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wendt MD, 2004, J MED CHEM, V47, P303, DOI 10.1021/jm0300072; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Wind T, 2003, EUR J BIOCHEM, V270, P1680, DOI 10.1046/j.1432-1033.2003.03524.x; Xue YF, 1998, STRUCT FOLD DES, V6, P627, DOI 10.1016/S0969-2126(98)00064-1; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Zhao GX, 2007, J STRUCT BIOL, V160, P1, DOI 10.1016/j.jsb.2007.06.003; Zhou A, 2001, J BIOL CHEM, V276, P9115, DOI 10.1074/jbc.M010631200; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	46	51	55	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7027	7032		10.1074/jbc.M110.204537	http://dx.doi.org/10.1074/jbc.M110.204537			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21199867	Green Published, hybrid			2022-12-25	WOS:000287737300019
J	Yadav, UCS; Aguilera-Aguirre, L; Ramana, KV; Boldogh, I; Srivastava, SK				Yadav, Umesh C. S.; Aguilera-Aguirre, Leopoldo; Ramana, Kota V.; Boldogh, Istvan; Srivastava, Satish K.			Aldose Reductase Inhibition Prevents Metaplasia of Airway Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LIPID-PEROXIDATION PRODUCT; INCREASED OXIDATIVE STRESS; SMOOTH-MUSCLE-CELLS; JAK-STAT PATHWAY; ALLERGIC-ASTHMA; MUCUS PRODUCTION; SIGNAL TRANSDUCER; BRONCHIAL-ASTHMA; GENE-EXPRESSION	Background: Goblet cell metaplasia that causes mucus hypersecretion and obstruction in the airway lumen could be life threatening in asthma and chronic obstructive pulmonary disease patients. Inflammatory cytokines such as IL-13 mediate the transformation of airway ciliary epithelial cells to mucin-secreting goblet cells in acute as well as chronic airway inflammatory diseases. However, no effective and specific pharmacologic treatment is currently available. Here, we investigated the mechanisms by which aldose reductase (AR) regulates the mucus cell metaplasia in vitro and in vivo. Methodology/Findings: Metaplasia in primary human small airway epithelial cells (SAEC) was induced by a Th2 cytokine, IL-13, without or with AR inhibitor, fidarestat. After 48 h of incubation with IL-13 a large number of SAEC were transformed into goblet cells as determined by periodic acid-schiff (PAS)-staining and immunohistochemistry using antibodies against Mucin5AC. Further, IL-13 significantly increased the expression of Mucin5AC at mRNA and protein levels. These changes were significantly prevented by treatment of the SAEC with AR inhibitor. AR inhibition also decreased IL-13-induced expression of Muc5AC, Muc5B, and SPDEF, and phosphorylation of JAK-1, ERK1/2 and STAT-6. In a mouse model of ragweed pollen extract (RWE)-induced allergic asthma treatment with fidarestat prevented the expression of IL-13, phosphorylation of STAT-6 and transformation of epithelial cells to goblet cells in the lung. Additionally, while the AR-null mice were resistant, wild-type mice showed goblet cell metaplasia after challenge with RWE. Conclusions: The results show that exposure of SAEC to IL-13 caused goblet cell metaplasia, which was significantly prevented by AR inhibition. Administration of fidarestat to mice prevented RWE-induced goblet cell metaplasia and AR null mice were largely resistant to allergen induced changes in the lung. Thus our results indicate that AR inhibitors such as fidarestat could be developed as therapeutic agents to prevent goblet cell metaplasia in asthma and related pathologies.	[Yadav, Umesh C. S.; Ramana, Kota V.; Srivastava, Satish K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Aguilera-Aguirre, Leopoldo; Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Aguilera-Aguirre, Leopoldo; Boldogh, Istvan] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Yadav, UCS (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA.	ssrivast@utmb.edu	Ramana, Kota/C-5460-2012; Yadav, Umesh/C-7858-2012; Aguilera-Aguirre, Leopoldo/B-9864-2012	Aguilera-Aguirre, Leopoldo/0000-0001-7964-7402; Ramana, Kota/0000-0001-6502-7800	American Asthma Foundation [AAF08-0219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948, P30ES006676] Funding Source: NIH RePORTER	American Asthma Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by American Asthma Foundation (http://americanasthmafoundation.org) grant (AAF08-0219) to SKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar R, 2008, CLIN EXP ALLERGY, V38, P1847, DOI 10.1111/j.1365-2222.2008.03119.x; AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Almolki A, 2004, AM J PHYSIOL-LUNG C, V287, pL26, DOI 10.1152/ajplung.00237.2003; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Chang HH, 2009, J AGR FOOD CHEM, V57, P10471, DOI 10.1021/jf902403p; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Cho YS, 2004, J ALLERGY CLIN IMMUN, V114, P429, DOI 10.1016/j.jaci.2004.04.004; Cohn L, 2002, NOVART FDN SYMP, V248, P201; Dabbagh K, 1999, J IMMUNOL, V162, P6233; Darcan-Nicolaisen Y, 2009, J IMMUNOL, V182, P7501, DOI 10.4049/jimmunol.0713433; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Fujisawa Takao, 2005, Current Drug Targets - Inflammation and Allergy, V4, P505; Fujisawa T, 2008, RESPIROLOGY, V13, P191, DOI 10.1111/j.1440-1843.2008.01237.x; Henricks PAJ, 2001, PULM PHARMACOL THER, V14, P409, DOI 10.1006/pupt.2001.0319; Heo HJ, 2009, PHYTOTHER RES, V23, P1458, DOI 10.1002/ptr.2801; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Hoshino A, 2004, INT IMMUNOL, V16, P1497, DOI 10.1093/intimm/dxh151; Hwang YYC, 2005, FASEB J, V19, P795, DOI 10.1096/fj.04-2780fje; Izuhara K, 2009, CURR MED CHEM, V16, P2867, DOI 10.2174/092986709788803196; Jung WK, 2008, LIFE SCI, V82, P797, DOI 10.1016/j.lfs.2008.01.014; Kim HJ, 2008, AM J RESP CELL MOL, V39, P598, DOI 10.1165/rcmb.2007-0262OC; KONRAD F, 1995, ANAESTHESIST, V44, P651, DOI 10.1007/s001010050200; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Li L, 2010, CANC RES; Mak JCW, 2006, CURR OPIN PULM MED, V12, P7, DOI 10.1097/01.mcp.0000198067.50457.71; Mandal D, 2010, CELL SIGNAL, V22, P1485, DOI 10.1016/j.cellsig.2010.05.017; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; Moon DO, 2008, BIOCHEM BIOPH RES CO, V375, P275, DOI 10.1016/j.bbrc.2008.08.025; Nadeem A, 2003, J ALLERGY CLIN IMMUN, V111, P72, DOI 10.1067/mai.2003.17; Park CS, 2009, ANN ALLERG ASTHMA IM, V103, P238, DOI 10.1016/S1081-1206(10)60188-3; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Pearlman DS, 1999, J ALLERGY CLIN IMMUN, V104, pS132, DOI 10.1016/S0091-6749(99)70308-8; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Ramana KV, 2006, J BIOL CHEM, V281, P33019, DOI 10.1074/jbc.M603819200; Ravindranath TM, 2009, J IMMUNOL, V183, P8128, DOI 10.4049/jimmunol.0900720; Reader JR, 2003, AM J PATHOL, V162, P2069, DOI 10.1016/S0002-9440(10)64338-6; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Shahar E, 2004, ANN ALLERG ASTHMA IM, V92, P654, DOI 10.1016/S1081-1206(10)61432-9; Shum Bennett O. V., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000707; Simon AR, 2002, AM J PHYSIOL-LUNG C, V282, pL1296, DOI 10.1152/ajplung.00315.2001; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Spycher SE, 1997, FASEB J, V11, P181, DOI 10.1096/fasebj.11.2.9039961; Srivastava S, 2000, FREE RADICAL BIO MED, V29, P642, DOI 10.1016/S0891-5849(00)00351-8; Srivastava S, 1995, BIOCHEM BIOPH RES CO, V217, P741, DOI 10.1006/bbrc.1995.2835; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Sugiura H, 2008, ANTIOXID REDOX SIGN, V10, P785, DOI 10.1089/ars.2007.1937; Takeyama K, 2000, J IMMUNOL, V164, P1546, DOI 10.4049/jimmunol.164.3.1546; Tammali R, 2006, CANCER RES, V66, P9705, DOI 10.1158/0008-5472.CAN-06-2105; Turner J, 2009, BIOCHEM SOC T, V37, P877, DOI 10.1042/BST0370877; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wright DT, 1996, AM J PHYSIOL-LUNG C, V271, pL854, DOI 10.1152/ajplung.1996.271.5.L854; Yadav UCS, 2009, J IMMUNOL, V183, P4723, DOI 10.4049/jimmunol.0901177; Yadav UCS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006535; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	56	28	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14440	10.1371/journal.pone.0014440	http://dx.doi.org/10.1371/journal.pone.0014440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203431	Green Published, gold, Green Submitted			2022-12-25	WOS:000285792500016
J	Onodera, S; Hicks, TP				Onodera, Satoru; Hicks, T. Philip			Carbocyanine Dye Usage in Demarcating Boundaries of the Aged Human Red Nucleus	PLOS ONE			English	Article							SUPERIOR COLLICULUS; OLIVARY PROJECTIONS; GAIT MODIFICATIONS; PYRAMIDAL TRACT; RHESUS-MONKEY; MOTOR CORTEX; SPINAL-CORD; BRAIN-STEM; CAT; NEURONS	Background: Though the adult human magnocellular Red nucleus (mNr) is essentially vestigial and its boundaries with neighbouring structures have never been well demarcated, human studies in utero have shown a well developed semilunar mNr wrapping around the caudal parvicellular Red nucleus (pNr), similar to what is seen in quadrupeds. In the present study, we have sought to better delineate the morphological determinants of the adult human Red nucleus (ahRn). Methods and Findings: Serial sections of ahRn show fine myelinated fibers arising from pNr and turning toward the central tegmental tract. Dil was deposited within a well restricted region of ahRn at the fasciculus retroflexus level and the extent of label determined. Nissl-stained serial sections allowed production of a 3-D mNr model, showing rudimentary, vestigial morphology compared with its well developed infant homologue. Dil within this vestigial mNr region at the level of the oculomotor nerve showed labeled giant/large mNr neurons, coarse fiber bundles at the ventral tegmental decussation and lateral lemniscal label. Conclusions: Large amounts of Dil and a long incubation time have proven useful in aged human brain as a marker of long axons and large cell bodies of projecting neurons such as the rubrospinal projection and for clarifying nuclear boundaries of closed nuclei (e. g., the large human pNr). Our 3D model of adult human mNr appeared shrunken in shape and axially rotated compared with the infant mNr, the rotation being a common feature among mammalian mNr.	[Onodera, Satoru] Iwate Med Univ, Sch Med, Dept Anat, Morioka, Iwate 020, Japan; [Hicks, T. Philip] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Hicks, T. Philip] Lakehead Univ, Fac Grad Studies, Thunder Bay, ON P7B 5E1, Canada; [Hicks, T. Philip] No Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada	Iwate Medical University; Lakehead University; Lakehead University; Northern Ontario School of Medicine	Onodera, S (corresponding author), Iwate Med Univ, Sch Med, Dept Anat, Morioka, Iwate 020, Japan.	sonodera@iwate-med.ac.jp						Belhaj-Saif A, 2000, J NEUROPHYSIOL, V83, P3147, DOI 10.1152/jn.2000.83.5.3147; Burman K, 2000, J COMP NEUROL, V423, P197; Burman K, 2000, J COMP NEUROL, V423, P179, DOI 10.1002/1096-9861(20000724)423:2<179::AID-CNE1>3.0.CO;2-#; Drew T, 1996, CAN J PHYSIOL PHARM, V74, P426, DOI 10.1139/cjpp-74-4-426; GROFOVA I., 1960, CESKOSLOVENSKA MORFOL, V8, P215; HEFFNER R, 1975, BRAIN BEHAV EVOLUT, V12, P161, DOI 10.1159/000124401; HOLSTEGE G, 1988, BEHAV BRAIN RES, V28, P33, DOI 10.1016/0166-4328(88)90075-7; Horn KM, 2002, J NEUROPHYSIOL, V87, P469, DOI 10.1152/jn.00949.2000; IGUTI I, 1946, KAIBOUGAKU ZASSI, V23, P1; Jiang MC, 2002, NEUROSCIENCE, V110, P105, DOI 10.1016/S0306-4522(01)00544-9; Lavoie S, 2002, J NEUROPHYSIOL, V88, P1791, DOI 10.1152/jn.2002.88.4.1791; LEIVA J, 1992, ARCH ITAL BIOL, V130, P191; MANNEN H, 1988, DENDROCYTOMYELOARCHI; MASSION J, 1988, BEHAV BRAIN RES, V28, P1, DOI 10.1016/0166-4328(88)90071-X; MILLER RA, 1973, J COMP NEUROL, V152, P327, DOI 10.1002/cne.901520403; MUFSON EJ, 1990, NEUROBIOL AGING, V11, P649, DOI 10.1016/0197-4580(90)90031-T; NATHAN PW, 1982, BRAIN, V105, P223, DOI 10.1093/brain/105.2.223; Ogawa T, 1939, J COMP NEUROL, V70, P181, DOI 10.1002/cne.900700203; OLSZEWSKI J, 1982, CYTOARCHITECHTURE HU; Onodera S, 1999, NEUROSCIENTIST, V5, P217, DOI 10.1177/107385849900500411; Onodera S, 2004, BRAIN RES, V1015, P194, DOI 10.1016/j.brainres.2004.04.042; Onodera S, 1998, J COMP NEUROL, V396, P461; ONODERA S, 1984, J COMP NEUROL, V227, P37, DOI 10.1002/cne.902270106; Onodera S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006623; PADEL Y, 1981, J COMP NEUROL, V202, P421, DOI 10.1002/cne.902020311; Papez JW, 1940, ARCH NEURO PSYCHIATR, V44, P776, DOI 10.1001/archneurpsyc.1940.02280100078006; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; Pong M, 2002, J NEUROPHYSIOL, V87, P453, DOI 10.1152/jn.00950.2000; Ruigrok Tom J. H., 1995, P277; Sarnat H., 2015, J PEDIAT NEUROL, V1, P3, DOI DOI 10.1055/S-0035-1557162; Satoh Y, 2003, BRAIN RES, V978, P51, DOI 10.1016/S0006-8993(03)02763-X; SCHOEN LHR, 1964, PROG BRAIN RES, V11, P203; SOBEL LI, 1977, THESIS ALBANY MED CO; SPENCE SJ, 1988, J COMP NEUROL, V268, P357, DOI 10.1002/cne.902680306; STROMINGER NL, 1979, J COMP NEUROL, V183, P33, DOI 10.1002/cne.901830104; STROMINGER NL, 1985, BRAIN RES, V343, P184, DOI 10.1016/0006-8993(85)91176-X; Tardif E, 2005, EXP BRAIN RES, V166, P316, DOI 10.1007/s00221-005-2373-z; Tomonaga M., 2003, COGNITIVE BEHAV DEV; Ulfig N, 2002, NEUROSIGNALS, V11, P95, DOI 10.1159/000058546; Ulfig N, 2001, ANAT EMBRYOL, V203, P95, DOI 10.1007/s004290000147; van Kan PLE, 2002, EXP BRAIN RES, V142, P151, DOI 10.1007/s00221-001-0924-5; Van Kan PLE, 2001, J NEUROPHYSIOL, V85, P1461, DOI 10.1152/jn.2001.85.4.1461; VERHAART W. J. C., 1938, PSYCHIATR EN NEUROL BLADEN, V42, P335; Voogd J., 2003, HUMAN NERVOUS SYSTEM, P321; Whishaw IQ, 1996, BEHAV BRAIN RES, V74, P79, DOI 10.1016/0166-4328(95)00161-1; Yamaguchi K, 2008, DEV NEUROSCI-BASEL, V30, P325, DOI 10.1159/000142733; Yamaguchi K, 2006, BRAIN DEV-JPN, V28, P431, DOI 10.1016/j.braindev.2006.01.001	47	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e14430	10.1371/journal.pone.0014430	http://dx.doi.org/10.1371/journal.pone.0014430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203458	gold, Green Published, Green Submitted			2022-12-25	WOS:000285579200011
J	Chano, T; Ikebuchi, K; Tomita, Y; Jin, YF; Inaji, H; Ishitobi, M; Teramoto, K; Ochi, Y; Tameno, H; Nishimura, I; Minami, K; Inoue, H; Isono, T; Saitoh, M; Shimada, T; Hisa, Y; Okabe, H				Chano, Tokuhiro; Ikebuchi, Kaichiro; Tomita, Yasuhiko; Jin, Yufen; Inaji, Hideo; Ishitobi, Makoto; Teramoto, Koji; Ochi, Yasuko; Tameno, Hitosuke; Nishimura, Ichiro; Minami, Kahori; Inoue, Hirokazu; Isono, Takahiro; Saitoh, Masao; Shimada, Taketoshi; Hisa, Yasuo; Okabe, Hidetoshi			RB1CC1 Together with RB1 and p53 Predicts Long-Term Survival in Japanese Breast Cancer Patients	PLOS ONE			English	Article							AUTOPHAGY; FIP200; EXPRESSION; CELLS; GENE; COMPLEX; PROTEIN; IDENTIFICATION; TUMORIGENESIS; PHENOTYPE	RB1-inducible coiled-coil 1 (RB1CC1) plays a significant role in the enhancement of the retinoblastoma tumor suppressor (RB1) pathway and is involved in breast cancer development. However, RB1CC1's role in clinical progression of breast cancer has not yet been evaluated, so, as a first step, it is necessary to establish its usefulness as a tool to evaluate breast cancer patients. In this report, we have analyzed the correlation between abnormalities in the RB1CC1 pathway and long-term prognosis, because disease-specific death in later periods (>5 years) of the disease is a serious problem in breast cancer. Breast cancer tissues from a large cohort in Japan were evaluated by conventional immunohistochemical methods for the presence of the molecules involved in the RB1CC1 pathway, including RB1CC1, RB1, p53, and other well-known prognostic markers for breast cancer, such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. The correlation between the immunohistochemical results and clinical outcomes of 323 breast cancer patients was analyzed using a Kaplan-Meier log-rank test and a multivariate Cox proportional hazards regression analysis. Absence of nuclear RB1CC1 expression was associated with the worst prognosis (Log-rank test, Chi-Square value = 17.462, p<0.0001). Dysfunction of either one of RB1CC1, RB1, or p53 was associated with the highest risk for cancer-specific death, especially related to survival lasting more than 5 years (multivariate Cox proportional hazard ratio = 3.951, 95% Confidence Interval = 1.566-9.967, p = 0.0036). Our present data demonstrate that the combined evaluation of RB1CC1, RB1 and p53 by conventional immunohistochemical analysis provides an accurate prediction of the long-term prognoses of breast cancer patients, which can be carried out as a routine clinical examination.	[Chano, Tokuhiro; Ikebuchi, Kaichiro; Ochi, Yasuko; Tameno, Hitosuke; Nishimura, Ichiro; Minami, Kahori; Okabe, Hidetoshi] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan; [Ikebuchi, Kaichiro; Ochi, Yasuko; Tameno, Hitosuke; Shimada, Taketoshi; Hisa, Yasuo] Kyoto Prefectural Univ Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Tomita, Yasuhiko; Jin, Yufen] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka, Japan; [Inaji, Hideo; Ishitobi, Makoto] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Osaka, Japan; [Teramoto, Koji] Shiga Univ Med Sci, Dept Thorac Surg, Otsu, Shiga 52021, Japan; [Inoue, Hirokazu] Shiga Univ Med Sci, Dept Microbiol, Otsu, Shiga 52021, Japan; [Isono, Takahiro] Tokyo Med & Dent Univ, Dept Cent Res Lab, Tokyo, Japan; [Saitoh, Masao] Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Tokyo, Japan	Shiga University of Medical Science; Kyoto Prefectural University of Medicine; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Shiga University of Medical Science; Shiga University of Medical Science; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Chano, T (corresponding author), Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan.	chano@belle.shiga-med.ac.jp	Chano, Tokuhiro/F-5816-2018	Chano, Tokuhiro/0000-0002-9959-1183	Ministry of Education, Culture, Sports, Science, and Technology, Japan [20012025]; Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research	This study was supported in part by KAKENHI (Grant-in-Aid for Scientific Research on Priority Areas; No. 20012025) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bialik S, 2008, ADV EXP MED BIOL, V615, P177, DOI 10.1007/978-1-4020-6554-5_9; BORG A, 1992, CANCER RES, V52, P2991; Ceccarelli C, 1998, J CLIN PATHOL, V51, P818, DOI 10.1136/jcp.51.11.818; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2006, INT J MOL MED, V18, P425; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Derenzini M, 2007, HISTOL HISTOPATHOL, V22, P505, DOI 10.14670/HH-22.505; Elledge RM, 1998, BREAST CANCER RES TR, V52, P79, DOI 10.1023/A:1006163101948; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Martin N, 2008, MOL CELL BIOL, V28, P2771, DOI 10.1128/MCB.01210-07; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Mersin H, 2008, BREAST, V17, P341, DOI 10.1016/j.breast.2007.11.031; MORSELLI E, 2009, BIOCHIM BIOPHYS ACTA; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	33	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15737	10.1371/journal.pone.0015737	http://dx.doi.org/10.1371/journal.pone.0015737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203526	gold, Green Published, Green Submitted			2022-12-25	WOS:000285578000051
J	Berenguer, M; Martinez, L; Giorgetti-Peraldi, S; Le Marchand-Brustel, Y; Govers, R				Berenguer, Marion; Martinez, Laurene; Giorgetti-Peraldi, Sophie; Le Marchand-Brustel, Yannick; Govers, Roland			A Serum Factor Induces Insulin-Independent Translocation of GLUT4 to the Cell Surface which Is Maintained in Insulin Resistance	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; GLUCOSE-TRANSPORTER GLUT4; TYROSINE KINASE-ACTIVITY; 3T3-L1 ADIPOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; SIGNALING PATHWAYS; MUSCLE-CELLS; TNF-ALPHA; C-LAMBDA	In response to insulin, glucose transporter GLUT4 translocates from intracellular compartments towards the plasma membrane where it enhances cellular glucose uptake. Here, we show that sera from various species contain a factor that dose-dependently induces GLUT4 translocation and glucose uptake in 3T3-L1 adipocytes, human adipocytes, myoblasts and myotubes. Notably, the effect of this factor on GLUT4 is fully maintained in insulin-resistant cells. Our studies demonstrate that the serum-induced increase in cell surface GLUT4 levels is not due to inhibition of its internalization and is not mediated by insulin, PDGF, IGF-1, or HGF. Similarly to insulin, serum also augments cell surface levels of GLUT1 and TfR. Remarkably, the acute effect of serum on GLUT4 is largely additive to that of insulin, while it also sensitizes the cells to insulin. In accordance with these findings, serum does not appear to activate the same repertoire of downstream signaling molecules that are implicated in insulin-induced GLUT4 translocation. We conclude that in addition to insulin, at least one other biological proteinaceous factor exists that contributes to GLUT4 regulation and still functions in insulin resistance. The challenge now is to identify this factor.	[Berenguer, Marion; Martinez, Laurene; Le Marchand-Brustel, Yannick; Govers, Roland] Fac Med Nice, INSERM, U895, Mediterranean Res Ctr Mol Med C3M,Avenir Team 9, F-06034 Nice, France; [Giorgetti-Peraldi, Sophie; Le Marchand-Brustel, Yannick] Fac Med Nice, INSERM, U895, Mediterranean Res Ctr Mol Med C3M,Team 7, F-06034 Nice, France; [Berenguer, Marion; Martinez, Laurene; Giorgetti-Peraldi, Sophie; Le Marchand-Brustel, Yannick; Govers, Roland] Univ Nice Sophia Antipolis, Fac Med Signaling & Pathol IFR50, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Berenguer, M (corresponding author), Fac Med Nice, INSERM, U895, Mediterranean Res Ctr Mol Med C3M,Avenir Team 9, U210, F-06034 Nice, France.	govers@unice.fr	Govers, Roland/O-5782-2016	Govers, Roland/0000-0003-1359-5333; Giorgetti-Peraldi, Sophie/0000-0002-2751-2618	Institut National de la Sante et de la Recherche Medicale (INSERM); University of Nice-Sophia-Antipolis; Conseil Regional Provence-Alpes-Cote d'Azur; Conseil General des Alpes Maritimes; Alfediam-Roche Diagnostics award; INSERM/Region Provence-Alpes-Cote d'Azur/Servier	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Nice-Sophia-Antipolis; Conseil Regional Provence-Alpes-Cote d'Azur(Region Provence-Alpes-Cote d'AzurRegion Auvergne-Rhone-Alpes); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); Alfediam-Roche Diagnostics award; INSERM/Region Provence-Alpes-Cote d'Azur/Servier(Institut National de la Sante et de la Recherche Medicale (Inserm)ServierRegion Provence-Alpes-Cote d'Azur)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the University of Nice-Sophia-Antipolis, the Conseil Regional Provence-Alpes-Cote d'Azur, the Conseil General des Alpes Maritimes, and an Alfediam-Roche Diagnostics award. RG is a recipient of an INSERM Avenir grant and LM is supported by an INSERM/Region Provence-Alpes-Cote d'Azur/Servier grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalili L, 2003, BIOCHEM BIOPH RES CO, V307, P127, DOI 10.1016/S0006-291X(03)01124-0; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bertola A, 2007, J BIOL CHEM, V282, P10325, DOI 10.1074/jbc.M611770200; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chen GL, 2003, FEBS LETT, V534, P54, DOI 10.1016/S0014-5793(02)03774-2; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Foran PGP, 1999, J BIOL CHEM, V274, P28087, DOI 10.1074/jbc.274.40.28087; Foster LJ, 2001, J BIOL CHEM, V276, P44212, DOI 10.1074/jbc.M102964200; FROESCH ER, 1963, J CLIN INVEST, V42, P1816, DOI 10.1172/JCI104866; Funaki M, 2004, MOL CELL BIOL, V24, P7567, DOI 10.1128/MCB.24.17.7567-7577.2004; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Govers Roland, 2008, V440, P129, DOI 10.1007/978-1-59745-178-9_10; Hausdorff SF, 1999, J BIOL CHEM, V274, P24677, DOI 10.1074/jbc.274.35.24677; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Johnson AO, 1998, J BIOL CHEM, V273, P17968, DOI 10.1074/jbc.273.28.17968; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; Kayali AG, 1998, J BIOL CHEM, V273, P13808, DOI 10.1074/jbc.273.22.13808; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V209, P343, DOI 10.1006/bbrc.1995.1509; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; KOZKA IJ, 1991, J BIOL CHEM, V266, P11726; Li DL, 2001, J BIOL CHEM, V276, P22883, DOI 10.1074/jbc.M010143200; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Maier VH, 2000, DIABETOLOGIA, V43, P1273, DOI 10.1007/s001250051523; Manchem VP, 2001, DIABETES, V50, P824, DOI 10.2337/diabetes.50.4.824; Martinez L, 2010, BIOCHEM PHARMACOL, V79, P1300, DOI 10.1016/j.bcp.2009.12.013; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NISHIMURA H, 1994, BIOCHEM J, V302, P271, DOI 10.1042/bj3020271; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1427, DOI 10.1210/en.138.4.1427; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Ricort JM, 1996, EUR J BIOCHEM, V239, P17, DOI 10.1111/j.1432-1033.1996.0017u.x; RINDERKNECHT E, 1976, P NATL ACAD SCI USA, V73, P4379, DOI 10.1073/pnas.73.12.4379; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; SATOH S, 1993, J BIOL CHEM, V268, P17820; SEPPLORENZINO L, 1995, J BIOL CHEM, V270, P16580, DOI 10.1074/jbc.270.28.16580; Somwar R, 2001, BIOCHEM J, V359, P639, DOI 10.1042/0264-6021:3590639; Standaert ML, 1999, J BIOL CHEM, V274, P25308, DOI 10.1074/jbc.274.36.25308; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thomson MJ, 1997, J BIOL CHEM, V272, P7759, DOI 10.1074/jbc.272.12.7759; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Tsiani E, 1998, DIABETES, V47, P1676, DOI 10.2337/diabetes.47.11.1676; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Yamaguchi S, 2005, AM J PHYSIOL-ENDOC M, V289, pE643, DOI 10.1152/ajpendo.00456.2004; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15560	10.1371/journal.pone.0015560	http://dx.doi.org/10.1371/journal.pone.0015560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187969	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200040
J	Van Hook, MJ; Berson, DM				Van Hook, Matthew J.; Berson, David M.			Hyperpolarization-Activated Current (I-h) in Ganglion-Cell Photoreceptors	PLOS ONE			English	Article							PACEMAKER CHANNELS; CATION CURRENT; MELANOPSIN CELLS; CAMP MODULATION; LIGHT RESPONSE; CALCIUM INFLUX; BIPOLAR CELLS; HCN CHANNELS; NEURONS; ROD	Intrinsically photosensitive retinal ganglion cells (ipRGCs) express the photopigment melanopsin and serve as the primary retinal drivers of non-image-forming visual functions such as circadian photoentrainment, the pupillary light reflex, and suppression of melatonin production in the pineal. Past electrophysiological studies of these cells have focused on their intrinsic photosensitivity and synaptic inputs. Much less is known about their voltage-gated channels and how these might shape their output to non-image-forming visual centers. Here, we show that rat ipRGCs retrolabeled from the suprachiasmatic nucleus (SCN) express a hyperpolarization-activated inwardly-rectifying current (I-h). This current is blocked by the known I-h blockers ZD7288 and extracellular cesium. As in other systems, including other retinal ganglion cells, I-h in ipRGCs is characterized by slow kinetics and a slightly greater permeability for K+ than for Na+. Unlike in other systems, however, I-h in ipRGCs apparently does not actively contribute to resting membrane potential. We also explore non-specific effects of the common I-h blocker ZD7288 on rebound depolarization and evoked spiking and discuss possible functional roles of I-h in non-image-forming vision. This study is the first to characterize I-h in a well-defined population of retinal ganglion cells, namely SCN-projecting ipRGCs.	[Van Hook, Matthew J.; Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Van Hook, MJ (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	matthew_van_hook@brown.edu		Van Hook, Matthew/0000-0003-1615-4314	National Institutes of Health [R01 EY 12793, R01 EY 17137]; Brown University [1 T32 NS 062443-01]; NATIONAL EYE INSTITUTE [R01EY017137, R01EY012793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS062443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants R01 EY 12793 (DMB), R01 EY 17137 (DMB). MJVH was supported by a Jointly Sponsored Institutional Training Grant 1 T32 NS 062443-01 (Brown University Neuroscience Graduate Program). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akopian A, 1996, J NEUROPHYSIOL, V76, P1828, DOI 10.1152/jn.1996.76.3.1828; Arendt D, 2003, INT J DEV BIOL, V47, P563; ATTWELL D, 1980, J PHYSIOL-LONDON, V309, P287, DOI 10.1113/jphysiol.1980.sp013509; BADER CR, 1979, J PHYSIOL-LONDON, V296, P1; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Cangiano L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001327; Chen L, 2007, NEUROSCIENCE, V150, P299, DOI 10.1016/j.neuroscience.2007.09.015; Demontis GC, 1999, J PHYSIOL-LONDON, V515, P813, DOI 10.1111/j.1469-7793.1999.813ab.x; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Endo T, 2008, J NEUROPHYSIOL, V99, P2066, DOI 10.1152/jn.00556.2007; ENG DL, 1990, J PHYSIOL-LONDON, V421, P185, DOI 10.1113/jphysiol.1990.sp017940; FAIN GL, 1978, NATURE, V272, P467, DOI 10.1038/272467a0; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hardie RC, 2001, J EXP BIOL, V204, P3403; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hogan QH, 2008, BRAIN RES, V1207, P102, DOI 10.1016/j.brainres.2008.02.066; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Koizumi A, 2004, MOL VIS, V10, P328; Lee SC, 2007, J NEUROPHYSIOL, V97, P3790, DOI 10.1152/jn.01241.2006; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Meuth SG, 2006, J NEUROPHYSIOL, V96, P1517, DOI 10.1152/jn.01212.2005; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mitra P, 2007, VISUAL NEUROSCI, V24, P709, DOI 10.1017/S0952523807070654; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; Oi H, 2008, VISUAL NEUROSCI, V25, P95, DOI 10.1017/S095252380808005X; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Perez-Leon JA, 2006, EUR J NEUROSCI, V24, P1117, DOI 10.1111/j.1460-9568.2006.04999.x; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; Sanchez-Alonso JL, 2008, NEUROSCI LETT, V439, P275, DOI 10.1016/j.neulet.2008.05.016; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; Stieber J, 2005, J BIOL CHEM, V280, P34635, DOI 10.1074/jbc.M502508200; Tabata T, 1996, J NEUROPHYSIOL, V75, P1932, DOI 10.1152/jn.1996.75.5.1932; van Welie I, 2006, J PHYSIOL-LONDON, V576, P203, DOI 10.1113/jphysiol.2006.113944; Vugler AA, 2007, EXP NEUROL, V205, P26, DOI 10.1016/j.expneurol.2007.01.032; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Warren EJ, 2003, EUR J NEUROSCI, V17, P1727, DOI 10.1046/j.1460-9568.2003.02594.x; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Weng SJ, 2009, J BIOL RHYTHM, V24, P391, DOI 10.1177/0748730409343767; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005	72	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15344	10.1371/journal.pone.0015344	http://dx.doi.org/10.1371/journal.pone.0015344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187958	gold, Green Published, Green Submitted			2022-12-25	WOS:000285575200038
J	Cvetkovic-Lopes, V; Eggermann, E; Uschakov, A; Grivel, J; Bayer, L; Jones, BE; Serafin, M; Muhlethaler, M				Cvetkovic-Lopes, Vesna; Eggermann, Emmanuel; Uschakov, Aaron; Grivel, Jeremy; Bayer, Laurence; Jones, Barbara E.; Serafin, Mauro; Muehlethaler, Michel			Rat Hypocretin/Orexin Neurons Are Maintained in a Depolarized State by TRPC Channels	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; CATION CHANNEL; CALCIUM INFLUX; SLEEP; OREXIN; ACTIVATION; BRAIN; OREXIN/HYPOCRETIN; HYPOTHALAMUS; INNERVATION	In a previous study we proposed that the depolarized state of the wake-promoting hypocretin/orexin (hcrt/orx) neurons was independent of synaptic inputs as it persisted in tetrodotoxin and low calcium/high magnesium solutions. Here we show first that these cells are hyperpolarized when external sodium is lowered, suggesting that non-selective cation channels (NSCCs) could be involved. As canonical transient receptor channels (TRPCs) are known to form NSCCs, we looked for TRPCs subunits using single-cell RT-PCR and found that TRPC6 mRNA was detectable in a small minority, TRPC1, TRPC3 and TRPC7 in a majority and TRPC4 and 5 in the vast majority (similar to 90%) of hcrt/orx neurons. Using intracellular applications of TRPC antibodies against subunits known to form NSCCs, we then found that only TRPC5 antibodies elicited an outward current, together with hyperpolarization and inhibition of the cells. These effects were blocked by co-application of a TRPC5 antigen peptide. Voltage-clamp ramps in the presence or absence of TRPC5 antibodies indicated the presence of a current with a reversal potential close to -15 mV. Application of the non-selective TRPC channel blocker, flufenamic acid, had a similar effect, which could be occluded in cells pre-loaded with TRPC5 antibodies. Finally, using the same TRPC5 antibodies we found that most hcrt/orx cells show immunostaining for the TRPC5 subunit. These results suggest that hcrt/orx neurons are endowed with a constitutively active non-selective cation current which depends on TRPC channels containing the TRPC5 subunit and which is responsible for the depolarized and active state of these cells.	[Cvetkovic-Lopes, Vesna; Eggermann, Emmanuel; Uschakov, Aaron; Grivel, Jeremy; Bayer, Laurence; Serafin, Mauro; Muehlethaler, Michel] Ctr Med Univ Geneva, Dept Neurosci Fondamentales, Geneva, Switzerland; [Jones, Barbara E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	University of Geneva; McGill University	Cvetkovic-Lopes, V (corresponding author), Ctr Med Univ Geneva, Dept Neurosci Fondamentales, Geneva, Switzerland.	michel.muhlethaler@unige.ch	Jones, Barbara E/A-8033-2017	BAYER, Laurence/0000-0001-5374-3316	Swiss Fonds National [31003A_120726]	Swiss Fonds National	Supported by grant (31003A_120726) from the Swiss Fonds National to M. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Alam MN, 2005, J PHYSIOL-LONDON, V563, P569, DOI 10.1113/jphysiol.2004.076927; Albert AP, 2006, J PHYSIOL-LONDON, V571, P361, DOI 10.1113/jphysiol.2005.102780; Amaral MD, 2007, J NEUROSCI, V27, P5179, DOI 10.1523/JNEUROSCI.5499-06.2007; Beck B, 2008, CELL CALCIUM, V43, P492, DOI 10.1016/j.ceca.2007.08.005; Brown RE, 2001, NEUROPHARMACOLOGY, V40, P457, DOI 10.1016/S0028-3908(00)00178-7; Burlet S, 2002, J NEUROSCI, V22, P2862, DOI 10.1523/JNEUROSCI.22-07-02862.2002; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; de Lecea L, 2005, FEBS J, V272, P5675, DOI 10.1111/j.1742-4658.2005.04981.x; Eggermann E, 2003, J NEUROSCI, V23, P1557; Faber ESL, 2006, NEUROSCIENCE, V137, P781, DOI 10.1016/j.neuroscience.2005.09.027; Facemire CS, 2004, AM J PHYSIOL-RENAL, V286, pF546, DOI 10.1152/ajprenal.00338.2003; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Henny P, 2006, J COMP NEUROL, V499, P645, DOI 10.1002/cne.21131; Horvath TL, 1999, J COMP NEUROL, V415, P145; Jones BE, 2005, HYPOCRETINS: INTEGRATORS OF PHYSIOLOGICAL FUNCTIONS, P289; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Modirrousta M, 2005, EUR J NEUROSCI, V21, P2807, DOI 10.1111/j.1460-9568.2005.04104.x; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Pena F, 2008, MINI-REV MED CHEM, V8, P812, DOI 10.2174/138955708784912166; Peyron C, 1998, J NEUROSCI, V18, P9996; Piccolino M, 1996, TRENDS NEUROSCI, V19, P120, DOI 10.1016/S0166-2236(96)80017-8; Pizzo P, 2001, J NEUROCHEM, V79, P98, DOI 10.1046/j.1471-4159.2001.00539.x; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saleh SN, 2008, J PHYSIOL-LONDON, V586, P2463, DOI 10.1113/jphysiol.2008.152157; Sergeeva OA, 2003, J NEUROCHEM, V85, P1547, DOI 10.1046/j.1471-4159.2003.01806.x; Siegel JM, 2004, J CLIN PSYCHIAT, V65, P4; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Suntsova N, 2007, J NEUROSCI, V27, P1616, DOI 10.1523/JNEUROSCI.3498-06.2007; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Wu GS, 2007, J NEUROSCI, V27, P7447, DOI 10.1523/JNEUROSCI.4266-06.2007; Wu XY, 2002, J BIOL CHEM, V277, P13597, DOI 10.1074/jbc.M110881200; Yan HD, 2009, J NEUROSCI, V29, P10038, DOI 10.1523/JNEUROSCI.1042-09.2009; Zeitzer JM, 2006, TRENDS PHARMACOL SCI, V27, P368, DOI 10.1016/j.tips.2006.05.006; Zhou FW, 2008, J NEUROSCI, V28, P473, DOI 10.1523/JNEUROSCI.3978-07.2008	45	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15673	10.1371/journal.pone.0015673	http://dx.doi.org/10.1371/journal.pone.0015673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179559	gold, Green Submitted, Green Published			2022-12-25	WOS:000285381200035
J	Boyles, RS; Lantz, KM; Poertner, S; Georges, SJ; Andres, AJ				Boyles, Randy S.; Lantz, Kathryn M.; Poertner, Steven; Georges, Stephanie J.; Andres, Andrew J.			Presenilin Controls CBP Levels in the Adult Drosophila Central Nervous System	PLOS ONE			English	Article							LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; NOTCH; CREB; TRANSCRIPTION; ACTIVATION; HYPOTHESIS; GROWTH; GENES	Background: Dominant mutations in both human Presenilin (Psn) genes have been correlated with the formation of amyloid plaques and development of familial early-onset Alzheimer's disease (AD). However, a definitive mechanism whereby plaque formation causes the pathology of familial and sporadic forms of AD has remained elusive. Recent discoveries of several substrates for Psn protease activity have sparked alternative hypotheses for the pathophysiology underlying AD. CBP (CREB-binding protein) is a haplo-insufficient transcriptional co-activator with histone acetly-transferase (HAT) activity that has been proposed to be a downstream target of Psn signaling. Individuals with altered CBP have cognitive deficits that have been linked to several neurological disorders. Methodology/Principal Findings: Using a transgenic RNA-interference strategy to selectively silence CBP, Psn, and Notch in adult Drosophila, we provide evidence for the first time that Psn is required for normal CBP levels and for maintaining specific global acetylations at lysine 8 of histone 4 (H4K8ac) in the central nervous system (CNS). In addition, flies conditionally compromised for the adult-expression of CBP display an altered geotaxis behavior that may reflect a neurological defect. Conclusions/Significance: Our data support a model in which Psn regulates CBP levels in the adult fly brain in a manner that is independent of Notch signaling. Although we do not understand the molecular mechanism underlying the association between Psn and CBP, our results underscore the need to learn more about the basic relationship between Psn-regulated substrates and essential functions of the nervous system.	[Boyles, Randy S.; Lantz, Kathryn M.; Poertner, Steven; Georges, Stephanie J.; Andres, Andrew J.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Boyles, RS (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	andrew.andres@unlv.edu			National Institutes of Health: Nevada INBRE [P20RR16464]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER	National Institutes of Health: Nevada INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	National Institutes of Health: Nevada INBRE: P20RR16464. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NE, 1998, MECH DEVELOP, V74, P3, DOI 10.1016/S0925-4773(98)00054-9; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cheng CS, 2008, GENE DEV, V22, P1110, DOI 10.1101/gad.1677008; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; deCelis JF, 1996, DEVELOPMENT, V122, P359; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; ERLENMEYER L, 1961, SCIENCE, V134, P1068, DOI 10.1126/science.134.3485.1068; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Goodman RH, 2000, GENE DEV, V14, P1553; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; HEITZLER P, 1993, DEVELOPMENT, V117, P1113; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kumar JP, 2004, GENETICS, V168, P877, DOI 10.1534/genetics.104.029850; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Ludlam WH, 2002, MOL CELL BIOL, V22, P3832, DOI 10.1128/MCB.22.11.3832-3841.2002; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Presente A, 2002, GENESIS, V34, P165, DOI 10.1002/gene.10149; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; RUBINSTEIN JH, 1963, AM J DIS CHILD, V105, P588, DOI 10.1001/archpedi.1963.02080040590010; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Vaskova M, 2000, GENETICS, V156, P229; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922; Wulbeck Corinna, 2007, Methods Mol Biol, V362, P495	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14332	10.1371/journal.pone.0014332	http://dx.doi.org/10.1371/journal.pone.0014332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179466	Green Submitted, gold, Green Published			2022-12-25	WOS:000285292500010
J	Brazelle, W; Kreahling, JM; Gemmer, J; Ma, YH; Cress, WD; Haura, E; Altiok, S				Brazelle, William; Kreahling, Jenny M.; Gemmer, Jennifer; Ma, Yihong; Cress, W. Douglas; Haura, Eric; Altiok, Soner			Histone Deacetylase Inhibitors Downregulate Checkpoint Kinase 1 Expression to Induce Cell Death in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							PHASE-I; CHK1; P53; ACTIVATION; AGENTS; LINES; PHOSPHORYLATION; UCN-01; VIVO; RAS	Background: Histone deacetylase inhibitors (HDACis) are promising anticancer drugs; however, the molecular mechanisms leading to HDACi-induced cell death have not been well understood and no clear mechanism of resistance has been elucidated to explain limited efficacy of HDACis in clinical trials. Methods and Findings: Here, we show that protein levels of checkpoint kinase 1 (Chk1), which has a major role in G(2) cell cycle checkpoint regulation, was markedly reduced at the protein and transcriptional levels in lung cancer cells treated with pan-and selective HDACis LBH589, scriptaid, valproic acid, apicidin, and MS-275. In HDACi treated cells Chk1 function was impaired as determined by decreased inhibitory phosphorylation of cdc25c and its downstream target cdc2 and increased expression of cdc25A and phosphorylated histone H3, a marker of mitotic entry. In time course experiments, Chk1 downregulation occurred after HDACi treatment, preceding apoptosis. Ectopic expression of Chk1 overcame HDACi-induced cell death, and pretreating cells with the cdc2 inhibitor purvalanol A blocked entry into mitosis and prevented cell death by HDACis. Finally, pharmacological inhibition of Chk1 showed strong synergistic effect with LBH589 in lung cancer cells. Conclusions: These results define a pathway through which Chk1 inhibition can mediate HDACi-induced mitotic entry and cell death and suggest that Chk1 could be an early pharmacodynamic marker to assess HDACi efficacy in clinical samples.	[Brazelle, William; Kreahling, Jenny M.; Gemmer, Jennifer; Ma, Yihong; Cress, W. Douglas; Haura, Eric; Altiok, Soner] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol & Expt Therapeut Programs, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Brazelle, W (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol & Expt Therapeut Programs, Tampa, FL 33612 USA.	soner.altiok@moffitt.org			Moffitt Cancer Center	Moffitt Cancer Center	work was funded in part by the Moffitt Cancer Center SPORE grant in lung cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell S, 2008, EXPERT OPIN INV DRUG, V17, P1331, DOI [10.1517/13543784.17.9.1331, 10.1517/13543784.17.9.1331 ]; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Dees EC, 2005, CLIN CANCER RES, V11, P664; Deroanne CF, 2002, ONCOGENE, V21, P427, DOI 10.1038/sj.onc.1205108; Edwards A, 2007, MOL CANCER THER, V6, P2515, DOI 10.1158/1535-7163.MCT-06-0761; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Feng JM, 2008, CANCER BIOL THER, V7, P1726, DOI 10.4161/cbt.7.11.6728; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Jia LQ, 1997, MOL CARCINOGEN, V19, P243, DOI 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; Kaneko Y, 1999, ONCOGENE, V18, P3673, DOI 10.1038/sj.onc.1202706; KASHII T, 1994, J CANCER RES CLIN, V120, P143, DOI 10.1007/BF01202192; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Matsuura K, 2008, J BIOL CHEM, V283, P25485, DOI 10.1074/jbc.M803111200; MITSUDOMI T, 1992, ONCOGENE, V7, P171; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Noh EL, 2009, BIOCHEM BIOPH RES CO, V378, P326, DOI 10.1016/j.bbrc.2008.11.057; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Peddibhotla S, 2009, P NATL ACAD SCI USA, V106, P5159, DOI 10.1073/pnas.0806671106; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Qiu L, 1999, BRIT J CANCER, V80, P1252, DOI 10.1038/sj.bjc.6690493; Robbins AR, 2005, CELL CYCLE, V4, P717, DOI 10.4161/cc.4.5.1690; Rubio-Viqueira B, 2007, MOL CANCER THER, V6, P515, DOI 10.1158/1535-7163.MCT-06-0388; Sausville EA, 2001, J CLIN ONCOL, V19, P2319, DOI 10.1200/JCO.2001.19.8.2319; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Stevens FE, 2008, ONCOGENE, V27, P1345, DOI 10.1038/sj.onc.1210779; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Warrener R, 2003, FASEB J, V17, P1550, DOI 10.1096/fj.02-1003fje; Yu XD, 2002, J NATL CANCER I, V94, P504; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	40	59	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14335	10.1371/journal.pone.0014335	http://dx.doi.org/10.1371/journal.pone.0014335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179472	Green Published, gold, Green Submitted			2022-12-25	WOS:000285292500012
J	Ullrich, M; Bundschu, K; Benz, PM; Abesser, M; Freudinger, R; Fischer, T; Ullrich, J; Renne, T; Walter, U; Schuh, K				Ullrich, Melanie; Bundschu, Karin; Benz, Peter M.; Abesser, Marco; Freudinger, Ruth; Fischer, Tobias; Ullrich, Julia; Renne, Thomas; Walter, Ulrich; Schuh, Kai			Identification of SPRED2 (Sprouty-related Protein with EVH1 Domain 2) as a Negative Regulator of the Hypothalamic-Pituitary-Adrenal Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING HORMONE; MAP KINASE ACTIVATION; TRANSGENIC MICE; CHRONIC STRESS; ALDOSTERONE SECRETION; BARTTERS-SYNDROME; BETA-ENDORPHIN; MOUSE MODEL; HPA AXIS; GENE	Sprouty-related proteins with EVH1 (enabled/vasodilator-stimulated phosphoprotein homology 1) domain (SPREDs) are inhibitors of MAPK signaling. To elucidate SPRED2 in vivo function, we characterized body homeostasis in SPRED2(-/-) mice. They showed a doubled daily water uptake, induced by elevated serum osmolality, originating from increased blood salt load. Accordingly, serum aldosterone was doubled, accompanied by augmented adrenal aldosterone synthase (AS) expression. Surprisingly, serum vasopressin (AVP) was unaltered, and, as evidenced by halved angiotensin II (Ang II) levels, the renin angiotensin system (RAS) was down-regulated. Adrenocorticotropic hormone (ACTH) was significantly elevated in SPRED2(-/-) mice, together with its secretagogue corticotropin-releasing hormone (CRH) and its downstream target corticosterone. ERK phosphorylation in brains was augmented, and hypothalamic CRH mRNA levels were elevated, both contributing to the increased CRH release. Our data were supported by CRH promoter reporter assays in hypothalamic mHypoE-44 cells, revealing a SPRED-dependent inhibition of Ets (ERK/E-twenty-six)-dependent transcription. Furthermore, SPRED suppressed CRH production in these cells. In conclusion, our study suggests that SPRED2 deficiency leads to an increased MAPK signaling, which results in an augmented CRH promoter activity. The subsequent CRH overproduction causes an up-regulation of downstream hypothalamic-pituitary-adrenal (HPA) hormone secretion. This constitutes a possible trigger for the observed compulsive grooming in SPRED2(-/-) mice and may, together with hyperplasia of aldosterone-producing cells, contribute to the hyperaldosteronism and homeostatic imbalances.	[Ullrich, Melanie; Benz, Peter M.; Abesser, Marco; Freudinger, Ruth; Fischer, Tobias; Ullrich, Julia; Schuh, Kai] Univ Wurzburg, Inst Physiol 1, D-97070 Wurzburg, Germany; [Bundschu, Karin] Univ Ulm, Inst Biochem & Mol Biol, D-89081 Ulm, Germany; [Renne, Thomas] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden; [Walter, Ulrich] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany	University of Wurzburg; Ulm University; Karolinska Institutet; Karolinska University Hospital; University of Wurzburg	Ullrich, M (corresponding author), Univ Wurzburg, Inst Physiol 1, Roentgenring 9, D-97070 Wurzburg, Germany.	m.ullrich@uni-wuerzburg.de; kai.schuh@uni-wuerzburg.de	Walter, ulrich/W-2478-2017	Walter, ulrich/0000-0001-6784-2307; Renne, Thomas/0000-0003-4594-5975	Deutsche Forschungsgemeinschaft [SCHU1600/2-1]; Stiftung fuer Pathobiochemie und Molekulare Diagnostik of the Deutsche Vereinte Gesellschaft fuer Klinische Chemie und Laboratoriumsmedizin e.V.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Stiftung fuer Pathobiochemie und Molekulare Diagnostik of the Deutsche Vereinte Gesellschaft fuer Klinische Chemie und Laboratoriumsmedizin e.V.	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHU1600/2-1 (to K.S.) and a grant from the Stiftung fuer Pathobiochemie und Molekulare Diagnostik of the Deutsche Vereinte Gesellschaft fuer Klinische Chemie und Laboratoriumsmedizin e.V. (to K.S. and U.W.).	Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Blume A, 2009, ENDOCRINOLOGY, V150, P1841, DOI 10.1210/en.2008-1023; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Bundschu K, 2005, J BIOL CHEM, V280, P28572, DOI 10.1074/jbc.M503640200; Bundschu K, 2006, GENE EXPR PATTERNS, V6, P247, DOI 10.1016/j.modgep.2005.08.003; CURNOW KM, 1991, MOL ENDOCRINOL, V5, P1513, DOI 10.1210/mend-5-10-1513; Denayer E, 2008, J NEUROSCI, V28, P14443, DOI 10.1523/JNEUROSCI.4698-08.2008; Dirks A, 2002, EUR J NEUROSCI, V16, P1751, DOI 10.1046/j.1460-9568.2002.02245.x; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; Engelhardt CM, 2004, HISTOCHEM CELL BIOL, V122, P527, DOI 10.1007/s00418-004-0725-6; Ferreira JG, 2007, J ENDOCRINOL, V192, P647, DOI 10.1677/JOE.1.06961; Gerrits M, 2006, NEUROSCIENCE, V142, P1293, DOI 10.1016/j.neuroscience.2006.07.014; GIROUD CJP, 1956, P SOC EXP BIOL MED, V92, P154; Groenink L, 2002, BIOL PSYCHIAT, V51, P875, DOI 10.1016/S0006-3223(02)01334-3; HANUKOGLU I, 1990, J BIOL CHEM, V265, P20602, DOI 10.1016/S0021-9258(17)30545-8; Hartner A, 2003, NEPHROL DIAL TRANSPL, V18, P1999, DOI 10.1093/ndt/gfg299; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; Hoeflich A, 2009, J MOL ENDOCRINOL, V42, P191, DOI 10.1677/JME-08-0160; Hoffmeyer A, 1998, J BIOL CHEM, V273, P10112, DOI 10.1074/jbc.273.17.10112; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Inoue H, 2005, J EXP MED, V201, P73, DOI 10.1084/jem.20040616; JAMES VH, 1992, ADRENAL GLAND, P71; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; Khan AM, 2004, ENDOCRINOLOGY, V145, P351, DOI 10.1210/en.2003-0539; King JAJ, 2006, J HEPATOL, V44, P758, DOI 10.1016/j.jhep.2005.10.031; King JAJ, 2005, BIOCHEM J, V388, P445, DOI 10.1042/BJ20041284; Lorenz JN, 2002, J BIOL CHEM, V277, P37871, DOI 10.1074/jbc.M205627200; Messiaen L, 2009, JAMA-J AM MED ASSOC, V302, P2111, DOI 10.1001/jama.2009.1663; Nielsen S, 1996, KIDNEY INT, V49, P1718, DOI 10.1038/ki.1996.254; Nobuhisa I, 2004, J EXP MED, V199, P737, DOI 10.1084/jem.20030830; Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200; Papadimitriou A, 2009, NEUROIMMUNOMODULAT, V16, P265, DOI 10.1159/000216184; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Pasmant E, 2009, J MED GENET, V46, P425, DOI 10.1136/jmg.2008.065243; Phoenix TN, 2010, GENE DEV, V24, P45, DOI 10.1101/gad.1839510; QUINN SJ, 1988, ANNU REV PHYSIOL, V50, P409, DOI 10.1146/annurev.ph.50.030188.002205; RIVIER C, 1982, ENDOCRINOLOGY, V110, P272, DOI 10.1210/endo-110-1-272; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Rossi GP, 2008, TRENDS ENDOCRIN MET, V19, P88, DOI 10.1016/j.tem.2008.01.006; Seasholtz A, 2000, J CLIN INVEST, V105, P1187, DOI 10.1172/JCI10002; Sebaai N, 2002, EUR J ENDOCRINOL, V147, P835, DOI 10.1530/eje.0.1470835; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Singru PS, 2008, ENDOCRINOLOGY, V149, P2283, DOI 10.1210/en.2007-1478; SMITH AI, 1988, ENDOCR REV, V9, P159, DOI 10.1210/edrv-9-1-159; Sontia B, 2008, HYPERTENSION, V51, P915, DOI 10.1161/HYPERTENSIONAHA.107.100339; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Spurlock G, 2009, J MED GENET, V46, P431, DOI 10.1136/jmg.2008.065474; STENZELPOORE MP, 1992, ENDOCRINOLOGY, V130, P3378, DOI 10.1210/en.130.6.3378; STENZELPOORE MP, 1994, J NEUROSCI, V14, P2579; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Ullrich Melanie, 2009, Methods Mol Biol, V561, P145, DOI 10.1007/978-1-60327-019-9_10; Ulrich-Lai YM, 2006, AM J PHYSIOL-ENDOC M, V291, pE965, DOI 10.1152/ajpendo.00070.2006; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; van Gaalen MM, 2002, EUR J NEUROSCI, V15, P2007, DOI 10.1046/j.1460-9568.2002.02040.x; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WATERMAN MR, 1989, RECENT PROG HORM RES, V45, P533; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Wotus C, 1998, ENDOCRINOLOGY, V139, P4397, DOI 10.1210/en.139.10.4397; Yang BX, 2006, AM J PHYSIOL-RENAL, V291, pF465, DOI 10.1152/ajprenal.00494.2005; Yun J, 2000, J CLIN INVEST, V106, P1361, DOI 10.1172/JCI9154	64	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9477	9488		10.1074/jbc.M110.171306	http://dx.doi.org/10.1074/jbc.M110.171306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21199868	Green Published, hybrid			2022-12-25	WOS:000288247700075
J	Landeta, O; Landajuela, A; Gil, D; Taneva, S; Di Primo, C; Sot, B; Valle, M; Frolov, VA; Basanez, G				Landeta, Olatz; Landajuela, Ane; Gil, David; Taneva, Stefka; Di Primo, Carmelo; Sot, Begona; Valle, Mikel; Frolov, Vadim A.; Basanez, Gorka			Reconstitution of Proapoptotic BAK Function in Liposomes Reveals a Dual Role for Mitochondrial Lipids in the BAK-driven Membrane Permeabilization Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; PORE FORMATION; OUTER-MEMBRANE; CELL-DEATH; BH3-ONLY PROTEINS; BILAYER-MEMBRANES; INDUCED APOPTOSIS; BCL-2 PROTEINS; BH3 DOMAINS; ACTIVATION	BAK is a key effector of mitochondrial outer membrane permeabilization (MOMP) whose molecular mechanism of action remains to be fully dissected in intact cells, mainly due to the inherent complexity of the intracellular apoptotic machinery. Here we show that the core features of the BAK-driven MOMP pathway can be reproduced in a highly simplified in vitro system consisting of recombinant human BAK lacking the carboxyl-terminal 21 residues (BAK Delta C) and tBID in combination with liposomes bearing an appropriate lipid environment. Using this minimalist reconstituted system we established that tBID suffices to trigger BAK Delta C membrane insertion, oligomerization, and pore formation. Furthermore, we demonstrate that tBID-activated BAK Delta C permeabilizes the membrane by forming structurally dynamic pores rather than a large proteinaceous channel of fixed size. We also identified two distinct roles played by mitochondrial lipids along the molecular pathway of BAK Delta C-induced membrane permeabilization. First, using several independent approaches, we showed that cardiolipin directly interacts with BAK Delta C, leading to a localized structural rearrangement in the protein that "primes" BAK Delta C for interaction with tBID. Second, we provide evidence that selected curvature-inducing lipids present in mitochondrial membranes specifically modulate the energetic expenditure required to create the BAK Delta C pore. Collectively, our results support the notion that BAK functions as a direct effector of MOMP akin to BAX and also adds significantly to the growing evidence indicating that mitochondrial membrane lipids are actively implicated in BCL-2 protein family function.	[Landeta, Olatz; Landajuela, Ane; Taneva, Stefka; Frolov, Vadim A.; Basanez, Gorka] Univ Basque Country, CSIC, Ctr Mixto, Unidad Biofis, Bilbao 48080, Spain; [Frolov, Vadim A.] Univ Basque Country, Dept Bioquim & Biol Mol, Leioa 48940, Spain; [Frolov, Vadim A.] Basque Fdn Sci, Bilbao 48011, Spain; [Gil, David; Valle, Mikel] Parque Tecnol Zamudio, CIC BIOGUNE Struct Biol Unit, Derio 48160, Spain; [Di Primo, Carmelo] Univ Bordeaux, INSERM, U869, Inst Europeen Chim & Biol, F-33607 Pessac, France; [Sot, Begona] MRC Ctr Prot Engn, Cambridge CB2 0QH, England; [Sot, Begona] MRC Lab Mol Biol, Cambridge CB2 0QH, England	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; MRC Laboratory Molecular Biology; MRC Laboratory Molecular Biology	Basanez, G (corresponding author), Unidad Biofis CSIC Univ Basque Country, Barrio Sarriena S N, Leioa 48940, Spain.	gbzbaasg@lg.ehu.es	Carton, David Gil/M-9332-2019; Di primo, Carmelo/M-6984-2018; Frolov, Vadim/ABH-3889-2020; Sot, Begoña/H-2882-2015; Valle, Mikel/F-7598-2011	Carton, David Gil/0000-0003-4241-1302; Di primo, Carmelo/0000-0002-0509-8399; Frolov, Vadim/0000-0002-0653-5669; Sot, Begoña/0000-0001-8763-0651; Valle, Mikel/0000-0001-8268-6912; Landeta, Olatz/0000-0002-5494-0271	Ministerio de Ciencia e Innovacion [BFU2008-01637]; Consejo Superior de Investigaciones Cientificas; Basque government	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejo Superior de Investigaciones Cientificas; Basque government(Basque Government)	This work was supported by Grants BFU2008-01637 from the Ministerio de Ciencia e Innovacion (to G.B.).r Recipient of a predoctoral fellowship from the Consejo Superior de Investigaciones Cientificas.r Recipient of a predoctoral fellowship from the Basque government.	Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Basanez G, 2008, PLOS BIOL, V6, P1148, DOI 10.1371/journal.pbio.0060154; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Christenson E, 2008, J MOL BIOL, V381, P1168, DOI 10.1016/j.jmb.2008.06.037; Cocklin S, 2006, J MOL RECOGNIT, V19, P354, DOI 10.1002/jmr.784; Cristea IM, 2004, CHEM PHYS LIPIDS, V129, P133, DOI 10.1016/j.chemphyslip.2004.02.002; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Garcia-Saez AJ, 2005, BIOPHYS J, V88, P3976, DOI 10.1529/biophysj.104.058008; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gillick K, 2008, J CELL SCI, V121, P618, DOI 10.1242/jcs.021303; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee MT, 2004, BIOCHEMISTRY-US, V43, P3590, DOI 10.1021/bi036153r; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P484, DOI 10.1038/sj.cdd.4402280; Martinez-Caballero S, 2009, J BIOL CHEM, V284, P12235, DOI 10.1074/jbc.M806610200; McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Montero J, 2008, CANCER RES, V68, P5246, DOI 10.1158/0008-5472.CAN-07-6161; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Rich RL, 2008, J MOL RECOGNIT, V21, P355, DOI 10.1002/jmr.928; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Sandra F., 2006, CANCER RES, V65, P2668; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Sobko AA, 2006, J BIOL CHEM, V281, P14408, DOI 10.1074/jbc.M513634200; Sorice M, 2009, FEBS LETT, V583, P2447, DOI 10.1016/j.febslet.2009.07.018; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Terrones O, 2008, J BIOL CHEM, V283, P7790, DOI 10.1074/jbc.M708814200; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	64	61	61	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8213	8230		10.1074/jbc.M110.165852	http://dx.doi.org/10.1074/jbc.M110.165852			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21196599	hybrid, Green Published			2022-12-25	WOS:000288013300052
J	Cosgrove, S; Chotirmall, SH; Greene, CM; McElvaney, NG				Cosgrove, Sonya; Chotirmall, Sanjay H.; Greene, Catherine M.; McElvaney, Noel G.			Pulmonary Proteases in the Cystic Fibrosis Lung Induce Interleukin 8 Expression from Bronchial Epithelial Cells via a Heme/Meprin/Epidermal Growth Factor Receptor/Toll-like Receptor Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL ELASTASE; HEME; HEMOGLOBIN; DISEASE; ELAFIN; METALLOPROTEINASES; INFLAMMATION; SPECIFICITY; INDIVIDUALS; ACTIVATION	A high intrapulmonary protease burden is characteristic of cystic fibrosis (CF), and the resulting dysregulation of the protease/anti-protease balance has serious implications for inflammation in the CF lung. Because of this inflammation, micro-bleeds can occur releasing hemoglobin into the lung. The aim of this study was to investigate the effect of the protease-rich environment of the CF lung on human hemoglobin and to assess the proinflammatory effect of heme on CF bronchial epithelium. Here, we show that the Pseudomonas proteases (Pseudomonas elastase and alkaline protease) and the neutrophil proteases (neutrophil elastase (NE) and proteinase-3) are capable of almost complete degradation of hemoglobin in vitro but that NE is the predominant protease that cleaves hemoglobin in vivo in CF bronchoalveolar lavage fluid. One of the effects of this is the release of heme, and in this study we show that heme stimulates IL-8 and IL-10 protein production from Delta F508 CFBE41o(-) bronchial epithelial cells. In addition, heme-induced IL-8 expression utilizes a novel pathway involving meprin, EGF receptor, and MyD88. Meprin levels are elevated in CF cell lines and bronchial brushings, thus adding to the proinflammatory milieu. Interestingly, alpha(1)-antitrypsin, in addition to its ability to neutralize NE and protease-3, can also bind heme and neutralize heme-induced IL-8 from CFBE41o(-) cells. This study illustrates the proinflammatory effects of micro-bleeds in the CF lung, the process by which this occurs, and a potential therapeutic intervention.	[Cosgrove, Sonya; Chotirmall, Sanjay H.; Greene, Catherine M.; McElvaney, Noel G.] Royal Coll Surgeons Ireland, Beaumont Hosp, Dept Med, Resp Res Div, Dublin 9, Ireland	Royal College of Surgeons - Ireland	Greene, CM (corresponding author), Royal Coll Surgeons Ireland, Beaumont Hosp, Dept Med, Resp Res Div, Dublin 9, Ireland.	cmgreene@rcsi.ie	Greene, Catherine M/D-3513-2012; Chotirmall, Sanjay Haresh/K-4127-2015; McElvaney, Noel/A-6809-2010	Greene, Catherine M/0000-0003-2549-2569; Chotirmall, Sanjay Haresh/0000-0003-0417-7607; mcelvaney, Noel/0000-0002-0152-4370	Science Foundation Ireland; Health Research Board [SFI/08/US/B1676]; Medical Charities Research Group; United States Alpha One Foundation	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Medical Charities Research Group; United States Alpha One Foundation	This work was supported by Science Foundation Ireland, Health Research Board Grant SFI/08/US/B1676, Medical Charities Research Group, and United States Alpha One Foundation.	Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Blishchenko EY, 1997, FEBS LETT, V414, P125, DOI 10.1016/S0014-5793(97)00991-5; BRITIGAN BE, 1993, INFECT IMMUN, V61, P5049, DOI 10.1128/IAI.61.12.5049-5055.1993; Byrne DP, 2010, BIOCHEM J, V425, P257, DOI 10.1042/BJ20090343; Chotirmall SH, 2010, AM J RESP CRIT CARE, V182, P62, DOI 10.1164/rccm.201001-0053OC; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Fischer BM, 2009, CTS-CLIN TRANSL SCI, V2, P333, DOI 10.1111/j.1752-8062.2009.00151.x; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Geraghty P, 2007, J IMMUNOL, V178, P5871, DOI 10.4049/jimmunol.178.9.5871; Greene CM, 2009, BRIT J PHARMACOL, V158, P1048, DOI 10.1111/j.1476-5381.2009.00448.x; Guyot N, 2008, J BIOL CHEM, V283, P32377, DOI 10.1074/jbc.M803707200; Guyot N, 2010, BIOL CHEM, V391, P705, DOI 10.1515/BC.2010.066; Horrigan FT, 2005, J GEN PHYSIOL, V126, P7, DOI 10.1085/jgp.200509262; Huy NT, 2005, ANAL BIOCHEM, V344, P289, DOI 10.1016/j.ab.2005.06.022; Ivanov VT, 1997, BIOPOLYMERS, V43, P171; KAO RC, 1988, J CLIN INVEST, V82, P1963, DOI 10.1172/JCI113816; Kelly E, 2010, RESP MED, V104, P763, DOI 10.1016/j.rmed.2010.01.016; KRAMER G, 1976, P NATL ACAD SCI USA, V73, P3078, DOI 10.1073/pnas.73.9.3078; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; Liebau E, 2005, J BIOL CHEM, V280, P26121, DOI 10.1074/jbc.M503889200; MCELVANEY NG, 1991, LANCET, V337, P392, DOI 10.1016/0140-6736(91)91167-S; NAKAMURA H, 1992, J CLIN INVEST, V89, P1478, DOI 10.1172/JCI115738; Norman LP, 2003, CURR TOP DEV BIOL, V54, P145, DOI 10.1016/S0070-2153(03)54008-X; Oglesby IK, 2010, J IMMUNOL, V184, P1702, DOI 10.4049/jimmunol.0902669; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Rees DD, 1997, J PHARMACOL EXP THER, V283, P1201; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Sil S, 2004, J BIOSCIENCES, V29, P281, DOI 10.1007/BF02702610; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Zani ML, 2009, PROTEIN SCI, V18, P579, DOI 10.1002/pro.64	40	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7692	7704		10.1074/jbc.M110.183863	http://dx.doi.org/10.1074/jbc.M110.183863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193404	Green Published, hybrid			2022-12-25	WOS:000287737300082
J	Pollok, B; Krause, V; Legrain, V; Ploner, M; Freynhagen, R; Melchior, I; Schnitzler, A				Pollok, Bettina; Krause, Vanessa; Legrain, Valery; Ploner, Markus; Freynhagen, Rainer; Melchior, Ilka; Schnitzler, Alfons			Differential Effects of Painful and Non-Painful Stimulation on Tactile Processing in Fibromyalgia Syndrome and Subjects with Masochistic Behaviour	PLOS ONE			English	Article							CO2-LASER STIMULATION; WIDESPREAD PAIN; POTENTIALS; HYPERVIGILANCE; BRAIN; HEAT; PERCEPTION; MODULATION; MECHANISMS; RESPONSES	Background: In healthy subjects repeated tactile stimulation in a conditioning test stimulation paradigm yields attenuation of primary (S1) and secondary (S2) somatosensory cortical activation, whereas a preceding painful stimulus results in facilitation. Methodology/Principal Findings: Since previous data suggest that cognitive processes might affect somatosensory processing in S1, the present study aims at investigating to what extent cortical reactivity is altered by the subjective estimation of pain. To this end, the effect of painful and tactile stimulation on processing of subsequently applied tactile stimuli was investigated in patients with fibromyalgia syndrome (FMS) and in subjects with masochistic behaviour (MB) by means of a 122-channel whole-head magnetoencephalography (MEG) system. Ten patients fulfilling the criteria for the diagnosis of FMS, 10 subjects with MB and 20 control subjects matched with respect to age, gender and handedness participated in the present study. Tactile or brief painful cutaneous laser stimuli were applied as conditioning stimulus (CS) followed by a tactile test stimulus (TS) 500 ms later. While in FMS patients significant attenuation following conditioning tactile stimulation was evident, no facilitation following painful stimulation was found. By contrast, in subjects with MB no attenuation but significant facilitation occurred. Attenuation as well as facilitation applied to cortical responses occurring at about 70 ms but not to early S1 or S2 responses. Additionally, in FMS patients the amount of attenuation was inversely correlated with catastrophizing tendency. Conclusion: The present results imply altered cortical reactivity of the primary somatosensory cortex in FMS patients and MB possibly reflecting differences of individual pain experience.	[Pollok, Bettina; Krause, Vanessa; Schnitzler, Alfons] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Pollok, Bettina; Krause, Vanessa; Schnitzler, Alfons] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany; [Legrain, Valery] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Legrain, Valery] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Ploner, Markus] Tech Univ Munich, Dept Neurol, Munich, Germany; [Freynhagen, Rainer] Benedictus Krankenhaus Tutzing, Pain Ctr Lake Starnberg, Dept Anaesthesiol Crit Care Med Pain Therapy & Pa, Tutzing, Germany; [Melchior, Ilka] Univ Dusseldorf, Dept Anaesthesiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Ghent University; Universite Catholique Louvain; Technical University of Munich; Heinrich Heine University Dusseldorf	Pollok, B (corresponding author), Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany.	bettina.pollok@uni-duesseldorf.de	Schnitzler, Alfons/AAT-1054-2021; Ploner, Markus/C-3281-2013; Pollok, Bettina/B-5290-2012; Schnitzler, Alfons/Q-5520-2019; Schnitzler, Alfons/K-4625-2014	Ploner, Markus/0000-0002-7767-7170; Schnitzler, Alfons/0000-0002-6414-7939; Schnitzler, Alfons/0000-0002-6414-7939; Freynhagen, Rainer/0000-0002-3759-1508	Volkswagenstiftung [I/80919]; Bundesministerium fur Bildung und Forschung (BMFZ) [01GW0533 (TP 4)]	Volkswagenstiftung(Volkswagen); Bundesministerium fur Bildung und Forschung (BMFZ)(Federal Ministry of Education & Research (BMBF))	The study was funded by the Volkswagenstiftung (I/80919) and by the Bundesministerium fur Bildung und Forschung (BMFZ: 01GW0533 (TP 4)). Please note that the Volkswagenstiftung is a non-commercial funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; APKARIAN AV, 1994, SOMATOSENS MOT RES, V11, P259, DOI 10.3109/08990229409051393; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bolanowski SJ, 2000, SOMATOSENS MOT RES, V17, P195; BROMM B, 1984, HUM NEUROBIOL, V3, P33; Carrillo-de-la-Pena MT, 2006, J PAIN, V7, P480, DOI 10.1016/j.jpain.2006.01.452; DeSantana JM, 2008, CURR PAIN HEADACHE R, V12, P338, DOI 10.1007/s11916-008-0057-7; Diers M, 2008, J CLIN NEUROPHYSIOL, V25, P153, DOI 10.1097/WNP.0b013e31817759c5; Dohrenbusch R, 2001, SCHMERZ, V15, P38, DOI 10.1007/s004820170047; Edwards RR, 2006, ARTHRIT RHEUM-ARTHR, V55, P325, DOI 10.1002/art.21865; GIBSON SJ, 1994, PAIN, V58, P185, DOI 10.1016/0304-3959(94)90198-8; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Hari R, 1999, PHILOS T R SOC B, V354, P1145, DOI 10.1098/rstb.1999.0470; Hollins M, 1996, PAIN, V67, P89, DOI 10.1016/0304-3959(96)03083-7; Julien N, 2005, PAIN, V114, P295, DOI 10.1016/j.pain.2004.12.032; Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; Laux L, 1981, STATE TRAIT ANGST IN; Legrain V, 2002, PAIN, V99, P21, DOI 10.1016/S0304-3959(02)00051-9; Lorenz J, 2003, NEUROPHYSIOL CLIN, V33, P293, DOI 10.1016/j.neucli.2003.10.004; Lorenz J, 1998, Z RHEUMATOL, V57, P19; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9; Montoya P, 2006, ARTHRITIS RHEUM-US, V54, P1995, DOI 10.1002/art.21910; Peters ML, 2000, PAIN, V86, P283, DOI 10.1016/S0304-3959(00)00259-1; Ploner M, 2004, J NEUROPHYSIOL, V92, P1825, DOI 10.1152/jn.00260.2004; Rossi A, 1998, NEUROSCI LETT, V248, P155, DOI 10.1016/S0304-3940(98)00354-1; Staud R, 2006, NAT CLIN PRACT RHEUM, V2, P90, DOI 10.1038/ncprheum0091; Staud Roland, 2002, Curr Rheumatol Rep, V4, P299, DOI 10.1007/s11926-002-0038-5; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tiede W, 2010, PAIN, V148, P36, DOI 10.1016/j.pain.2009.08.029; Tommerdahl M, 1996, J NEUROPHYSIOL, V75, P2662, DOI 10.1152/jn.1996.75.6.2662; Tran TD, 2003, CLIN NEUROPHYSIOL, V114, P1704, DOI 10.1016/S1388-2457(03)00151-2; Williams DA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2094; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	35	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e15804	10.1371/journal.pone.0015804	http://dx.doi.org/10.1371/journal.pone.0015804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203391	gold, Green Submitted, Green Published			2022-12-25	WOS:000285792500039
J	Ni, T; Tu, K; Wang, Z; Song, S; Wu, H; Xie, B; Scott, KC; Grewal, SI; Gao, YA; Zhu, J				Ni, Ting; Tu, Kang; Wang, Zhong; Song, Shen; Wu, Han; Xie, Bin; Scott, Kristin C.; Grewal, Shiv I.; Gao, Yuan; Zhu, Jun			The Prevalence and Regulation of Antisense Transcripts in Schizosaccharomyces pombe	PLOS ONE			English	Article							BIDIRECTIONAL PROMOTERS; HISTONE H2A.Z; YEAST GENOME; RNA; GENES; MAPS; IDENTIFICATION; LANDSCAPE; ROLES; FATE	A strand-specific transcriptome sequencing strategy, directional ligation sequencing or DeLi-seq, was employed to profile antisense transcriptome of Schizosaccharomyces pombe. Under both normal and heat shock conditions, we found that polyadenylated antisense transcripts are broadly expressed while distinct expression patterns were observed for protein-coding and non-coding loci. Dominant antisense expression is enriched in protein-coding genes involved in meiosis or stress response pathways. Detailed analyses further suggest that antisense transcripts are independently regulated with respect to their sense transcripts, and diverse mechanisms might be potentially involved in the biogenesis and degradation of antisense RNAs. Taken together, antisense transcription may have profound impacts on global gene regulation in S. pombe.	[Ni, Ting; Tu, Kang; Song, Shen; Wu, Han; Scott, Kristin C.; Zhu, Jun] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Ni, Ting; Tu, Kang; Wu, Han; Zhu, Jun] NHLBI, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Wang, Zhong] DOE Joint Genome Inst, Walnut Creek, CA USA; [Xie, Bin; Gao, Yuan] Johns Hopkins Univ, Div Genom Epigenom & Bioinformat, Lieber Inst Brain Dev, Baltimore, MD USA; [Gao, Yuan] Johns Hopkins Univ, Neuroregenerat & Stem Cell Biol Program, Inst Cell Engn, Baltimore, MD USA; [Grewal, Shiv I.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); United States Department of Energy (DOE); Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ni, T (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA.	jun.zhu@nih.gov	Gao, Yuan/E-1706-2011; Wang, Zhong/E-7897-2011; Wu, Han/E-3455-2013; Wang, Zhong/J-3244-2019	Wu, Han/0000-0002-3972-698X; Wang, Zhong/0000-0002-6307-0458	Department of Defense [BC074085P1]; Susan G. Komen for the Cure [KG081324]; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of Defense (BC074085P1) and Susan G. Komen for the Cure (KG081324) to J.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslett M, 2006, YEAST, V23, P913, DOI 10.1002/yea.1420; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munroe SH, 2006, CELL MOL LIFE SCI, V63, P2102, DOI 10.1007/s00018-006-6070-2; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Osato N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2003-5-1-r5; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shendure J, 2002, GENOME BIOL, V3; Sun M, 2006, GENOME RES, V16, P922, DOI 10.1101/gr.5210006; VIVANCOS AP, 2010, STRANDSPECIFIC DEEP; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	50	43	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15271	10.1371/journal.pone.0015271	http://dx.doi.org/10.1371/journal.pone.0015271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187966	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200029
J	Patel, A; Tikoo, S; Kobinger, G				Patel, Ami; Tikoo, Suresh; Kobinger, Gary			A Porcine Adenovirus with Low Human Seroprevalence Is a Promising Alternative Vaccine Vector to Human Adenovirus 5 in an H5N1 Virus Disease Model	PLOS ONE			English	Article							INFLUENZA-VIRUS; PREEXISTING IMMUNITY; PROTECTIVE EFFICACY; ANTIBODY-RESPONSE; RHESUS-MONKEYS; TOXICITY; GENE; BOVINE; PIGS; IMMUNOGENICITY	Human adenovirus 5 (AdHu5) vectors are robust vaccine platforms however the presence of naturally-acquired neutralizing antibodies may reduce vector efficacy and potential for re-administration. This study evaluates immune responses and protection following vaccination with a replication-incompetent porcine adenovirus 3 (PAV3) vector as an alternative vaccine to AdHu5 using an avian influenza H5N1 disease model. Vaccine efficacy was evaluated in BALB/c mice following vaccination with different doses of the PAV3 vector expressing an optimized A/Hanoi/30408/2005 H5N1 hemagglutinin antigen (PAV3-HA) and compared with an AdHu5-HA control. PAV3-HA rapidly generated antibody responses, with significant neutralizing antibody titers on day 21, and stronger cellular immune responses detected on day 8, compared to AdHu5-HA. The PAV3-HA vaccine, administered 8 days before challenge, demonstrated improved survival and lower virus load. Evaluation of long-term vaccine efficacy at 12 months post-vaccination showed better protection with the PAV3-HA than with the AdHu5-HA vaccine. Importantly, as opposed to AdHu5, PAV3 vector was not significantly neutralized by human antibodies pooled from over 10,000 individuals. Overall, PAV3-based vector is capable of mediating swift, strong immune responses and offer a promising alternative to AdHu5.	[Patel, Ami; Kobinger, Gary] Canadian Sci Ctr Human & Anim Hlth, Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Patel, Ami; Kobinger, Gary] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Tikoo, Suresh] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada	Canadian Science Centre for Human & Animal Health; Public Health Agency of Canada; University of Manitoba; University of Saskatchewan	Patel, A (corresponding author), Canadian Sci Ctr Human & Anim Hlth, Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	gary_kobinger@phac-aspc.gc.ca			Public Health Agency of Canada; Canadian Institutes for Health Research [83142, 310641]	Public Health Agency of Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	Financial support was provided by the Public Health Agency of Canada; Canadian Institutes for Health Research (grant 83142 and team grant 310641 to G. P. K.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao ZJ, 2008, ANTIVIR RES, V79, P12, DOI 10.1016/j.antiviral.2008.02.001; Bangari DS, 2005, BIOCHEM BIOPH RES CO, V327, P960, DOI 10.1016/j.bbrc.2004.12.099; Bangari DS, 2004, VIRUS RES, V105, P127, DOI 10.1016/j.virusres.2004.05.003; Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445; Committee for Proprietary Medicinal Products, 1997, NOT GUID HARM REQ IN; Fattori E, 2006, GENE THER, V13, P1088, DOI 10.1038/sj.gt.3302754; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Hammond JM, 2005, VET J, V169, P17, DOI 10.1016/j.tvjl.2003.09.007; Hammond JM, 2000, VACCINE, V18, P1040, DOI 10.1016/S0264-410X(99)00347-3; Hammond JM, 2001, VACCINE, V19, P3752, DOI 10.1016/S0264-410X(01)00084-6; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Hoelscher MA, 2008, J INFECT DIS, V197, P1185, DOI 10.1086/529522; Kitphati R, 2009, CLIN VACCINE IMMUNOL, V16, P978, DOI 10.1128/CVI.00062-09; Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042; Kodihalli S, 1999, J VIROL, V73, P2094, DOI 10.1128/JVI.73.3.2094-2098.1999; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Moffatt S, 2000, VIROLOGY, V272, P159, DOI 10.1006/viro.2000.0350; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Raviprakash K, 2008, J VIROL, V82, P6927, DOI 10.1128/JVI.02724-07; Reddy PS, 1999, J GEN VIROL, V80, P563, DOI 10.1099/0022-1317-80-3-563; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Roy S, 2006, J GEN VIROL, V87, P2477, DOI 10.1099/vir.0.81989-0; Schwartz JA, 2007, VIROLOGY, V366, P166, DOI 10.1016/j.virol.2007.04.021; SHARMA A, 2010, GENE THER; Sharma A, 2010, VIRUS RES, V153, P134, DOI 10.1016/j.virusres.2010.07.021; Singh N, 2008, MOL THER, V16, P965, DOI 10.1038/mt.2008.12; Takahashi N, 2003, GENE, V303, P89, DOI 10.1016/S0378-1119(02)01107-1; Varnavski AN, 2005, GENE THER, V12, P427, DOI 10.1038/sj.gt.3302347; Varnavski AN, 2002, J VIROL, V76, P5711, DOI 10.1128/JVI.76.11.5711-5719.2002; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Wang DH, 2006, VIROLOGY, V353, P324, DOI 10.1016/j.virol.2006.05.033; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; WHO, 2010, AV INFL; Zakhartchouk AN, 2005, J GEN VIROL, V86, P211, DOI 10.1099/vir.0.80530-0	38	19	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15301	10.1371/journal.pone.0015301	http://dx.doi.org/10.1371/journal.pone.0015301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179494	gold, Green Published, Green Submitted			2022-12-25	WOS:000285381200024
J	Xu, ZY; Yu, JZ; Cho, JM; Yu, J; Kohel, RJ; Percy, RG				Xu, Zhanyou; Yu, John Z.; Cho, Jaemin; Yu, Jing; Kohel, Russell J.; Percy, Richard G.			Polyploidization Altered Gene Functions in Cotton (Gossypium spp.)	PLOS ONE			English	Article							EST-DERIVED MICROSATELLITES; HIRSUTUM L FIBER; CELL ELONGATION; TRANSCRIPTION FACTORS; TRICHOME DEVELOPMENT; MOLECULAR-CLONING; EXPRESSION; IDENTIFICATION; EVOLUTION; MARKERS	Cotton (Gossypium spp.) is an important crop plant that is widely grown to produce both natural textile fibers and cottonseed oil. Cotton fibers, the economically more important product of the cotton plant, are seed trichomes derived from individual cells of the epidermal layer of the seed coat. It has been known for a long time that large numbers of genes determine the development of cotton fiber, and more recently it has been determined that these genes are distributed across At and Dt subgenomes of tetraploid AD cottons. In the present study, the organization and evolution of the fiber development genes were investigated through the construction of an integrated genetic and physical map of fiber development genes whose functions have been verified and confirmed. A total of 535 cotton fiber development genes, including 103 fiber transcription factors, 259 fiber development genes, and 173 SSR-contained fiber ESTs, were analyzed at the subgenome level. A total of 499 fiber related contigs were selected and assembled. Together these contigs covered about 151 Mb in physical length, or about 6.7% of the tetraploid cotton genome. Among the 499 contigs, 397 were anchored onto individual chromosomes. Results from our studies on the distribution patterns of the fiber development genes and transcription factors between the At and Dt subgenomes showed that more transcription factors were from Dt subgenome than At, whereas more fiber development genes were from At subgenome than Dt. Combining our mapping results with previous reports that more fiber QTLs were mapped in Dt subgenome than At subgenome, the results suggested a new functional hypothesis for tetraploid cotton. After the merging of the two diploid Gossypium genomes, the At subgenome has provided most of the genes for fiber development, because it continues to function similar to its fiber producing diploid A genome ancestor. On the other hand, the Dt subgenome, with its non-fiber producing D genome ancestor, provides more transcription factors that regulate the expression of the fiber genes in the At subgenome. This hypothesis would explain previously published mapping results. At the same time, this integrated map of fiber development genes would provide a framework to clone individual full-length fiber genes, to elucidate the physiological mechanisms of the fiber differentiation, elongation, and maturation, and to systematically study the functional network of these genes that interact during the process of fiber development in the tetraploid cottons.	[Xu, Zhanyou; Yu, John Z.; Cho, Jaemin; Yu, Jing; Kohel, Russell J.; Percy, Richard G.] USDA ARS, Crop Germplasm Res Unit, So Plains Agr Res Ctr, College Stn, TX USA	United States Department of Agriculture (USDA)	Xu, ZY (corresponding author), USDA ARS, Crop Germplasm Res Unit, So Plains Agr Res Ctr, College Stn, TX USA.	john.yu@ars.usda.gov			USDA-ARS [6202-21000-025-00D]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by USDA-ARS project "Cotton Genomics and Genetic Analysis" (Project Number: 6202-21000-025-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An C, 2008, THEOR APPL GENET, V116, P1015, DOI 10.1007/s00122-008-0732-4; Applequist WL, 2001, EVOL DEV, V3, P3, DOI 10.1046/j.1525-142x.2001.00079.x; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Beasley JO, 1942, GENETICS, V27, P25; BERLIN J. D., 1986, COTTON PHYSL, V1, P375; Cai WW, 1998, GENOMICS, V54, P387, DOI 10.1006/geno.1998.5620; Cedroni ML, 2003, PLANT MOL BIOL, V51, P313, DOI 10.1023/A:1022051100610; Chee PW, 2004, GENOME, V47, P449, DOI [10.1139/g04-002, 10.1139/G04-002]; Chen ZJ, 2007, NEW PHYTOL, V174, P717, DOI 10.1111/j.1469-8137.2007.02084.x; DONG J, 2001, BACTERIAL ARTIFICIAL; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Feng JX, 2004, ACTA BIOCH BIOPH SIN, V36, P51, DOI 10.1093/abbs/36.1.51; Frelichowski JE, 2006, MOL GENET GENOMICS, V275, P479, DOI 10.1007/s00438-006-0106-z; Fryxell P.A., 1992, RHEEDEA, V2, P108; Gialvalis S., 2001, Journal of Cotton Science, V5, P252; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Guo Ying, 2006, Cotton Science, V18, P67; Han ZG, 2004, MOL GENET GENOMICS, V272, P308, DOI 10.1007/s00438-004-1059-8; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Higginson T, 2003, PLANT J, V35, P177, DOI 10.1046/j.1365-313X.2003.01791.x; HOVAV R, 2008, GENETICS; Hovav R, 2008, PLANTA, V227, P319, DOI 10.1007/s00425-007-0619-7; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; HULSKAMP M, 1994, CELL, V76, P555, DOI 10.1016/0092-8674(94)90118-X; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; JOHN ME, 1992, P NATL ACAD SCI USA, V89, P5769, DOI 10.1073/pnas.89.13.5769; JOHN ME, 1995, PLANT PHYSIOL, V107, P1477, DOI 10.1104/pp.107.4.1477; JOHNSON HB, 1975, BOT REV, V41, P233, DOI 10.1007/BF02860838; Kim HJ, 2004, PLANTA, V218, P516, DOI 10.1007/s00425-003-1133-1; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kohel RJ, 2001, EUPHYTICA, V121, P163, DOI 10.1023/A:1012263413418; KOHEL RJ, 1987, AGRON J, V79, P31, DOI 10.2134/agronj1987.00021962007900010007x; Lee J, 1984, COTTON, P6; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lee JJ, 2006, PLANTA, V223, P418, DOI 10.1007/s00425-005-0098-7; Li CH, 2002, PLANT SCI, V163, P1113, DOI 10.1016/S0168-9452(02)00320-5; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Loguercio LL, 1999, MOL GEN GENET, V261, P660; Lynch M, 2000, GENETICS, V154, P459; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Orford SJ, 1998, BBA-GENE STRUCT EXPR, V1398, P342, DOI 10.1016/S0167-4781(98)00065-7; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Rahman HU, 2006, AUST J AGR RES, V57, P583, DOI 10.1071/AR05135; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Semon M, 2008, P NATL ACAD SCI USA, V105, P8333, DOI 10.1073/pnas.0708705105; Serna L, 2006, TRENDS PLANT SCI, V11, P274, DOI 10.1016/j.tplants.2006.04.008; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Taliercio E, 2006, GENOME, V49, P306, DOI 10.1139/G05-115; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Tomkins JP, 2001, MOL BREEDING, V8, P255, DOI 10.1023/A:1013798716098; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Ulloa M, 2005, J HERED, V96, P132, DOI 10.1093/jhered/esi020; Wang C, 2006, THEOR APPL GENET, V112, P770, DOI 10.1007/s00122-005-0183-0; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Werker E, 2000, ADV BOT RES, V31, P1, DOI 10.1016/S0065-2296(00)31005-9; Wilkins TA, 2005, PHYSIOL PLANTARUM, V124, P295, DOI 10.1111/j.1399-3054.2005.00514.x; Wilkins TA, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P231; Wu AM, 2007, CELL RES, V17, P174, DOI 10.1038/sj.cr.7310119; XU Z, 2008, GENOMICS IN PRESS, V92; Xu ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-108; Xu ZY, 2008, GENOMICS, V92, P173, DOI 10.1016/j.ygeno.2008.05.010; Yamamoto E, 1998, PLANT PHYSIOL, V117, P1525; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; You FM, 2007, BIOINFORMATICS, V23, P240, DOI 10.1093/bioinformatics/btl494; YU J, 2000, CONSTRUCTION COTTON; YU QY, 2009, BMC GENOMICS, V10; Zhao GR, 2001, BIOSCI BIOTECH BIOCH, V65, P2789, DOI 10.1271/bbb.65.2789	82	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14351	10.1371/journal.pone.0014351	http://dx.doi.org/10.1371/journal.pone.0014351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179551	Green Submitted, Green Published, gold			2022-12-25	WOS:000285381200007
J	Kilvaer, TK; Valkov, A; Sorbye, S; Smeland, E; Bremnes, RM; Busund, LT; Donnem, T				Kilvaer, Thomas K.; Valkov, Andrej; Sorbye, Sveinung; Smeland, Eivind; Bremnes, Roy M.; Busund, Lill-Tove; Donnem, Tom			Profiling of VEGFs and VEGFRs as Prognostic Factors in Soft Tissue Sarcoma: VEGFR-3 Is an Independent Predictor of Poor Prognosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; CANCER; EXPRESSION; METASTASIS; MARKER	Background: In non-gastrointestinal stromal tumor soft tissue sarcoma (non-GIST STS) optimal treatment is surgery with wide resection margins. Vascular endothelial growth factors (VEGFs) and receptors (VEGFRs) are known to be key players in the initiation of angiogenesis and lymphangiogenesis. This study investigates the prognostic impact of VEGFs and VEGFRs in non-GIST STS with wide and non-wide resection margins. Methods: Tumor samples from 249 patients with non-GIST STS were obtained and tissue microarrays were constructed for each specimen. Immunohistochemistry was used to evaluate the expressions of VEGF-A, -C and -D and VEGFR-1, -2 and -3. Results: In the univariate analyses, VEGF-A (P = 0.040) in the total material, and VEGF-A (P = 0.018), VEGF-C (P = 0.025) and VEGFR-3 (P = 0.027) in the subgroup with wide resection margins, were significant negative prognostic indicators of disease-specific survival (DSS). In the multivariate analysis, high expression of VEGFR-3 (P = 0.042, HR = 1.907, 95% CI 1.024-3.549) was an independent significant negative prognostic marker for DSS among patients with wide resection margins. Conclusion: VEGFR-3 is a strong and independent negative prognostic marker for non-GIST STSs with wide resection margins.	[Kilvaer, Thomas K.; Valkov, Andrej; Sorbye, Sveinung; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Valkov, Andrej; Sorbye, Sveinung; Busund, Lill-Tove] Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway; [Smeland, Eivind; Bremnes, Roy M.; Donnem, Tom] Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Bremnes, Roy M.; Donnem, Tom] Univ Tromso, Inst Clin Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Kilvaer, TK (corresponding author), Univ Tromso, Inst Med Biol, Tromso, Norway.	tom.donnem@uit.no	Kilvaer, Thomas/AAI-7418-2020; Sorbye, Sveinung Wergeland/AAE-7208-2020	Kilvaer, Thomas/0000-0003-1669-0117; Sorbye, Sveinung Wergeland/0000-0002-8250-3992				Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Chao C, 2001, ANN SURG ONCOL, V8, P260, DOI 10.1007/s10434-001-0260-9; Dickinson IC, 2006, ANZ J SURG, V76, P104, DOI 10.1111/j.1445-2197.2006.03615.x; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; DuBois S, 2007, CANCER-AM CANCER SOC, V109, P813, DOI 10.1002/cncr.22455; Fletcher CDM., 2002, WHO CLASSIFICATION T; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Friedrichs N, 2006, HISTOPATHOLOGY, V49, P87, DOI 10.1111/j.1365-2559.2006.02438.x; Ganjoo K, 2010, CANCER-AM CANCER SOC, V116, P1177, DOI 10.1002/cncr.24859; Graeven U, 1999, J CANCER RES CLIN, V125, P577, DOI 10.1007/s004320050319; Guillou L, 1997, J CLIN ONCOL, V15, P350, DOI 10.1200/JCO.1997.15.1.350; Hayes AJ, 2004, BRIT J SURG, V91, P242, DOI 10.1002/bjs.4398; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hoffman AC, 2009, CLIN CANCER RES, V15, P5191, DOI 10.1158/1078-0432.CCR-08-2534; Itakura E, 2008, J SURG ONCOL, V97, P74, DOI 10.1002/jso.20766; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Leong SPL, 2006, CANCER METAST REV, V25, P221, DOI 10.1007/s10555-006-8502-8; McArthur G, 2007, ANN SURG ONCOL, V14, P2876, DOI 10.1245/s10434-007-9480-y; Ribatti D, 2010, EUR J CANCER, V46, P6, DOI 10.1016/j.ejca.2009.10.022; Sleijfer S, 2008, ONCOLOGIST, V13, P1193, DOI 10.1634/theoncologist.2008-0188; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Thway K, 2009, CLIN ONCOL-UK, V21, P695, DOI 10.1016/j.clon.2009.07.016; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Yoon SS, 2004, ANN ONCOL, V15, P1261, DOI 10.1093/annonc/mdh309; Yudoh K, 2001, BRIT J CANCER, V84, P1610, DOI 10.1054/bjoc.2001.1837	28	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e15368	10.1371/journal.pone.0015368	http://dx.doi.org/10.1371/journal.pone.0015368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179485	gold, Green Submitted, Green Published			2022-12-25	WOS:000285292500024
J	Ferguson, BS; Nam, H; Hopkins, RG; Morrison, RF				Ferguson, Bradley S.; Nam, Heesun; Hopkins, Robin G.; Morrison, Ron F.			Impact of Reference Gene Selection for Target Gene Normalization on Experimental Outcome Using Real-Time qRT-PCR in Adipocytes	PLOS ONE			English	Article							PPAR-GAMMA; QUANTITATIVE PCR; ADIPOSE CONVERSION; 3T3 ADIPOCYTES; RIBOSOMAL-RNA; BETA-ACTIN; RT-PCR; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION	Background: With the current rise in obesity-related morbidities, real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) has become a widely used method for assessment of genes expressed and regulated by adipocytes. In order to measure accurate changes in relative gene expression and monitor intersample variability, normalization to endogenous control genes that do not change in relative expression is commonly used with qRT-PCR determinations. However, historical evidence has clearly demonstrated that the expression profiles of traditional control genes (e.g., beta-actin, GAPDH, alpha-tubulin) are differentially regulated across multiple tissue types and experimental conditions. Methodology/Principal Findings: Therefore, we validated six commonly used endogenous control genes under diverse experimental conditions of inflammatory stress, oxidative stress, synchronous cell cycle progression and cellular differentiation in 3T3-L1 adipocytes using TaqMan qRT-PCR. Under each study condition, we further evaluated the impact of reference gene selection on experimental outcome using examples of target genes relevant to adipocyte function and differentiation. We demonstrate that multiple reference genes are regulated in a condition-specific manner that is not suitable for use in target gene normalization. Conclusion/Significance: Data are presented demonstrating that inappropriate reference gene selection can have profound influence on study conclusions ranging from divergent statistical outcome to inaccurate data interpretation of significant magnitude. This study validated the use of endogenous controls in 3T3-L1 adipocytes and highlights the impact of inappropriate reference gene selection on data interpretation and study conclusions.	[Ferguson, Bradley S.; Nam, Heesun; Hopkins, Robin G.; Morrison, Ron F.] Univ N Carolina, Dept Nutr, Greensboro, NC 27412 USA	University of North Carolina; University of North Carolina Greensboro	Ferguson, BS (corresponding author), Univ N Carolina, Dept Nutr, Greensboro, NC 27412 USA.	rfmorris@uncg.edu	Ferguson, Bradley/V-3803-2019	Ferguson, Bradley/0000-0003-0357-6075	National Institutes of Health NIDDK [R15-DK082799, F31-DK847702]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK082799] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Grants R15-DK082799 (RFM) and F31-DK847702 (BSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER M, 1985, J BIOL CHEM, V260, P1978; Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dheda K, 2004, AM J RESP CRIT CARE, V169, P1167, DOI 10.1164/ajrccm.169.10.958; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; DJIAN P, 1985, J CELL PHYSIOL, V124, P554, DOI 10.1002/jcp.1041240327; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Gorzelniak K, 2001, HORM METAB RES, V33, P625, DOI 10.1055/s-2001-17911; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; MINSHULL J, 1990, EMBO J, V9, P2865, DOI 10.1002/j.1460-2075.1990.tb07476.x; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Taylor DL, 2007, VET IMMUNOL IMMUNOP, V115, P43, DOI 10.1016/j.vetimm.2006.10.007; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TROWBRIDGE IS, 1981, P NATL ACAD SCI-BIOL, V78, P3039, DOI 10.1073/pnas.78.5.3039; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815	39	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15208	10.1371/journal.pone.0015208	http://dx.doi.org/10.1371/journal.pone.0015208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179435	Green Published, Green Submitted, gold			2022-12-25	WOS:000285246900033
J	Tesson, B; Hildebrand, M				Tesson, Benoit; Hildebrand, Mark			Extensive and Intimate Association of the Cytoskeleton with Forming Silica in Diatoms: Control over Patterning on the Meso- and Micro-Scale	PLOS ONE			English	Article							VALVE MORPHOGENESIS; CELL-DIVISION; THALASSIOSIRA-PSEUDONANA; WALL MORPHOGENESIS; MICROTUBULE CENTER; ACTIN; BACILLARIOPHYCEAE; BIOSILICA; MORPHOLOGY; BIOMINERALIZATION	Background: The diatom cell wall, called the frustule, is predominantly made out of silica, in many cases with highly ordered nano- and micro-scale features. Frustules are built intracellularly inside a special compartment, the silica deposition vesicle, or SDV. Molecules such as proteins (silaffins and silacidins) and long chain polyamines have been isolated from the silica and shown to be involved in the control of the silica polymerization. However, we are still unable to explain or reproduce in vitro the complexity of structures formed by diatoms. Methods/Principal Finding: In this study, using fluorescence microscopy, scanning electron microscopy, and atomic force microscopy, we were able to compare and correlate microtubules and microfilaments with silica structure formed in diversely structured diatom species. The high degree of correlation between silica structure and actin indicates that actin is a major element in the control of the silica morphogenesis at the meso and microscale. Microtubules appear to be involved in the spatial positioning on the mesoscale and strengthening of the SDV. Conclusions/Significance: These results reveal the importance of top down control over positioning of and within the SDV during diatom wall formation and open a new perspective for the study of the mechanism of frustule patterning as well as for the understanding of the control of membrane dynamics by the cytoskeleton.	[Tesson, Benoit; Hildebrand, Mark] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Tesson, B (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	mhildebrand@ucsd.edu			Air Force Office of Scientific Research Multidisciplinary University Research Initiative [RF00965521]	Air Force Office of Scientific Research Multidisciplinary University Research Initiative(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI)	This work was supported by Air Force Office of Scientific Research Multidisciplinary University Research Initiative Grant RF00965521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLANK GS, 1983, J PHYCOL, V19, P39, DOI 10.1111/j.0022-3646.1983.00039.x; COHN SA, 1989, PROTOPLASMA, V149, P130, DOI 10.1007/BF01322985; Davis AK, 2008, METAL IONS LIFE SCI, V4, P255; Del Amo Y, 1999, J PHYCOL, V35, P1162; DRUM RW, 1964, J ULTRA MOL STRUCT R, V10, P217, DOI 10.1016/S0022-5320(64)80006-X; EIKE B, 2009, ANGEW CHEM INT EDIT, V48, P9724; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Higgins MJ, 2003, J PHYCOL, V39, P1181, DOI 10.1111/j.0022-3646.2003.03-027.x; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; Hildebrand M, 2007, J PHYCOL, V43, P730, DOI 10.1111/j.1529-8817.2007.00361.x; Hildebrand M, 2006, J MATER RES, V21, P2689, DOI 10.1557/JMR.2006.0333; Hildebrand M, 2009, J STRUCT BIOL, V166, P316, DOI 10.1016/j.jsb.2009.02.014; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221; Kroger N, 1998, PROTIST, V149, P213, DOI 10.1016/S1434-4610(98)70029-X; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Losic D, 2006, J NANOSCI NANOTECHNO, V6, P982, DOI 10.1166/jnn.2006.174; Losic D, 2007, LANGMUIR, V23, P5014, DOI 10.1021/la062666y; Mann D.G., 1990, DIATOMS BIOL MORPHOL, DOI 10.1017/S0025315400059245; Mann DG, 1984, P 7 INT DIATOM S, P113; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; NORTON TA, 1996, PHYCOLOGIA, V35, P353; Pickett-Heaps JD, 1998, J PHYCOL, V34, P995, DOI 10.1046/j.1529-8817.1998.340995.x; PICKETTHEAPS J, 1983, J PHYCOL, V19, P269, DOI 10.1111/j.0022-3646.1983.00269.x; PICKETTHEAPS J, 1981, EUR J CELL BIOL, V25, P150; PICKETTHEAPS J, 1990, PROGR PHYCOLOGICAL R, P1; PICKETTHEAPS JD, 1988, J PHYCOL, V24, P35; PICKETTHEAPS JD, 1994, PROTOPLASMA, V181, P269, DOI 10.1007/BF01666401; PICKETTHEAPS JD, 1979, BIOL CELLULAIRE, V35, P199; PICKETTHEAPS JD, 1988, PROTOPLASMA, V143, P139, DOI 10.1007/BF01291158; Pollock FM, 2005, CELL MOTIL CYTOSKEL, V60, P71, DOI 10.1002/cm.20044; Poulsen N, 2004, J BIOL CHEM, V279, P42993, DOI 10.1074/jbc.M407734200; Poulsen NC, 1999, CELL MOTIL CYTOSKEL, V44, P23, DOI 10.1002/(SICI)1097-0169(199909)44:1<23::AID-CM2>3.3.CO;2-4; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; ROBINSON DH, 1987, TRENDS BIOCHEM SCI, V12, P151, DOI 10.1016/0968-0004(87)90072-7; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; SCHMID AMM, 1979, PROTOPLASMA, V100, P267, DOI 10.1007/BF01279316; SCHMID AMM, 1983, J PHYCOL, V19, P387, DOI 10.1111/j.0022-3646.1983.00387.x; SCHMID AMM, 1980, NOVA HEDWIGIA, V33, P811; Shimizu K, 2001, CHEM BIOL, V8, P1051, DOI 10.1016/S1074-5521(01)00072-2; Sumper M, 2002, SCIENCE, V295, P2430, DOI 10.1126/science.1070026; Tesson B, 2010, J STRUCT BIOL, V169, P62, DOI 10.1016/j.jsb.2009.08.013; Van de Meene AML, 2004, EUR J PHYCOL, V39, P93, DOI 10.1080/09670260310001646522; van de Meene AML, 2002, J PHYCOL, V38, P351, DOI 10.1046/j.1529-8817.2002.01124.x; Walsh CJ, 2007, EUR J CELL BIOL, V86, P85, DOI 10.1016/j.ejcb.2006.10.003; Wenzl S, 2008, ANGEW CHEM INT EDIT, V47, P1729, DOI 10.1002/anie.200704994	49	63	69	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2010	5	12							e14300	10.1371/journal.pone.0014300	http://dx.doi.org/10.1371/journal.pone.0014300			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692UU	21200414	Green Published, Green Submitted, gold			2022-12-25	WOS:000285181400014
J	Nishiya, T; Matsumoto, K; Maekawa, S; Kajita, E; Horinouchi, T; Fujimuro, M; Ogasawara, K; Uehara, T; Miwa, S				Nishiya, Tadashi; Matsumoto, Kazuma; Maekawa, Satoshi; Kajita, Emi; Horinouchi, Takahiro; Fujimuro, Masahiro; Ogasawara, Kouetsu; Uehara, Takashi; Miwa, Soichi			Regulation of Inducible Nitric-oxide Synthase by the SPRY Domain- and SOCS Box-containing Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; PROTEASOMAL DEGRADATION; RAW-264.7 MACROPHAGES; SIGNALING PROPERTIES; INDUCED APOPTOSIS; STRUCTURAL BASIS; PATHWAY; SYSTEM; UBIQUITINATION; RECOGNITION	Inducible nitric-oxide synthase (iNOS, NOS2) plays a prominent role in macrophage bactericidal and tumoricidal activities. A relatively large amount of NO produced via iNOS, however, also targets the macrophage itself for apoptotic cell death. To uncover the intrinsic mechanisms of iNOS regulation, we have characterized the SPRY domain- and SOCS box-containing protein 1 (SPSB1), SPSB2, and SPSB4 that interact with the N-terminal region of iNOS in a D-I-N-N-N sequence-dependent manner. Fluorescence microscopy revealed that these SPSB proteins can induce the subcellular redistribution of iNOS from dense regions to diffused expression in a SOCS box-dependent manner. In immunoprecipitation studies, both Elongin C and Cullin-5, components of the multi-subunit E3 ubiquitin ligase, were found to bind to iNOS via SPSB1, SPSB2, or SPSB4. Consistently, iNOS was polyubiquitinated and degraded in a proteasome-dependent manner when SPSB1, SPSB2, or SPSB4 was expressed. SPSB1 and SPSB4 had a greater effect on iNOS regulation than SPSB2. The iNOS N-terminal fragment (residues 1-124 of human iNOS) could disrupt iNOS-SPSB interactions and inhibit iNOS degradation. In lipopolysaccharide-treated macrophages, this fragment attenuated iNOS ubiquitination and substantially prolonged iNOS lifetime, resulting in a corresponding increase in NO production and enhanced NO-dependent cell death. These results not only demonstrate the mechanism of SPSB-mediated iNOS degradation and the relative contributions of different SPSB proteins to iNOS regulation, but also show that iNOS levels are sophisticatedly regulated by SPSB proteins in activated macrophages to prevent overproduction of NO that could trigger detrimental effects, such as cytotoxicity.	[Nishiya, Tadashi; Matsumoto, Kazuma; Maekawa, Satoshi; Kajita, Emi; Horinouchi, Takahiro; Miwa, Soichi] Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, Sapporo, Hokkaido 0608638, Japan; [Fujimuro, Masahiro] Univ Yamanashi, Dept Mol Cell Biol, Interdisciplinary Grad Sch Med & Engn, Chuo 4093898, Japan; [Ogasawara, Kouetsu] Tohoku Univ, Dept Immunol, IDAC, Sendai, Miyagi 9808575, Japan; [Uehara, Takashi] Okayama Univ, Dept Med Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Hokkaido University; University of Yamanashi; Tohoku University; Okayama University	Nishiya, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, N15W7, Sapporo, Hokkaido 0608638, Japan.	nishiya@med.hokudai.ac.jp	Horinouchi, Takahiro/G-1770-2012; Ogasawara, Kouetsu/G-9892-2011; Fujimuro, Masahiro/AAC-4727-2020; Miwa, Soichi/D-8468-2012	Fujimuro, Masahiro/0000-0002-5165-0789; Uehara, Takashi/0000-0002-8545-4006	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare of Japan; Smoking Research Foundation, Japan; Northtec Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [22310039] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Smoking Research Foundation, Japan; Northtec Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grants-in-Aid for Scientific Research (C) (to T. N.) and (B) (to S. M.) from the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area) from the Ministry of Education, Culture, Sports, Science, and Technology (to T. U.), a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare of Japan (to K. O.), the Smoking Research Foundation, Japan (to S. M.), the Northtec Foundation (to T. N.), and the Takeda Science Foundation (to T. N.). The authors declare no conflict of interest.	ALBINA JE, 1993, J IMMUNOL, V150, P5080; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Chen L, 2009, CELL IMMUNOL, V258, P38, DOI 10.1016/j.cellimm.2009.03.009; Filippakopoulos P, 2010, J MOL BIOL, V401, P389, DOI 10.1016/j.jmb.2010.06.017; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hilbi H, 1997, PARASITOLOGY, V115, pS79, DOI 10.1017/S0031182097001790; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kolodziejski PJ, 2004, P NATL ACAD SCI USA, V101, P18141, DOI 10.1073/pnas.0406711102; Kolodziejski PJ, 2002, P NATL ACAD SCI USA, V99, P12315, DOI 10.1073/pnas.192345199; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Masters SL, 2006, NAT STRUCT MOL BIOL, V13, P77, DOI 10.1038/nsmb1034; MESSMER UK, 1995, MOL PHARMACOL, V47, P757; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nicholson SE, 1998, J LEUKOCYTE BIOL, V63, P665, DOI 10.1002/jlb.63.6.665; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Prabhakar P, 2000, J BIOL CHEM, V275, P19416, DOI 10.1074/jbc.M001952200; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003; SARIH M, 1993, BIOCHEM BIOPH RES CO, V191, P503, DOI 10.1006/bbrc.1993.1246; SCHWARTZ LM, 1990, NEURON, V5, P411, DOI 10.1016/0896-6273(90)90080-Y; Sha YB, 2009, MOL CELL BIOL, V29, P116, DOI 10.1128/MCB.00829-08; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; VODOVOTZ Y, 1995, J IMMUNOL, V154, P2914; Wang DK, 2005, J BIOL CHEM, V280, P16393, DOI 10.1074/jbc.M413897200; Webb JL, 2001, INFECT IMMUN, V69, P6391, DOI 10.1128/IAI.69.10.6391-6400.2001; Wheeler MA, 1997, J CLIN INVEST, V99, P110, DOI 10.1172/JCI119121; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009	43	50	50	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9009	9019		10.1074/jbc.M110.190678	http://dx.doi.org/10.1074/jbc.M110.190678			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21199876	Green Published, hybrid			2022-12-25	WOS:000288247700032
J	Freire, T; Lo-Man, R; Bay, S; Leclerc, C				Freire, Teresa; Lo-Man, Richard; Bay, Sylvie; Leclerc, Claude			Tn Glycosylation of the MUC6 Protein Modulates Its Immunogenicity and Promotes the Induction of Th17-biased T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASES; C-TYPE LECTIN; DENDRITIC-CELLS; GASTRIC MUCIN; BREAST-CANCER; POSTTRANSLATIONAL MODIFICATIONS; THERAPEUTIC PROTEINS; LINKED GLYCOPEPTIDE; ANTIGEN RECOGNITION; ABERRANT EXPRESSION	The Tn antigen (alpha-GalNAc-O-Ser/Thr) is one of the most specific human cancer-associated structures. This antigen, together with mucins, the major carriers of O-glycosylated tumor antigens in adenocarcinomas, are being evaluated as anticancer immunotherapeutic targets. In particular, the MUC6 protein, which is normally expressed only in gastric tissues, has been detected in intestinal, pulmonary, colorectal, and breast carcinomas. To develop anti-cancer vaccines based on the Tn antigen, we produced MUC6 proteins with different Tn density by using mixtures of recombinant ppGalNAc-T1, -T2, and -T7. The obtained glycoproteins were characterized and analyzed for their immunological properties, as compared with the non-glycosylated MUC6. We show that these various MUC6: Tn glycoproteins were well recognized by both MUC6 and Tn-specific antibodies. However, Tn glycosylation of the MUC6 protein strongly affected their immunogenicity by partially abrogating Th1 cell responses, and promoting IL-17 responses. Moreover, the non-glycosylated MUC6 was more efficiently presented than MUC6:Tn glycoproteins to specific T CD4(+) hybridomas, suggesting that Tn glycosylation may affect MUC6 processing or MHC binding of the processed peptides. In conclusion, our results indicate that Tn glycosylation of the MUC6 protein strongly affects its B and T cell immunogenicity, and might favor immune escape of tumor cells.	[Leclerc, Claude] Inst Pasteur, Inserm U1041, Unite Regulat Immunitaire & Vaccinol, Dept Immunol, F-75724 Paris 15, France; [Freire, Teresa; Lo-Man, Richard; Leclerc, Claude] INSERM, U1041, Paris, France; [Freire, Teresa; Bay, Sylvie] Inst Pasteur, Dept Biol Struct & Chim, Unite Chim Biomol, F-75015 Paris, France; [Freire, Teresa; Bay, Sylvie] CNRS, URA 2128, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Leclerc, C (corresponding author), Inst Pasteur, Inserm U1041, Unite Regulat Immunitaire & Vaccinol, Dept Immunol, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	claude.leclerc@pasteur.fr		Freire Gard, Teresa Ines/0000-0002-7808-8845	Institut Pasteur [PIC-PTR 278, PTR 262, DARRI 27237]; Ligue Nationale Contre le Cancer; Mutuelle Generale de l'Education Nationale Union; Fondation pour la Recherche Medicale; Vasand and Kusum Joshi; Comision Honoraria de Lucha contra el Cancer (Uruguay)	Institut Pasteur(European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Mutuelle Generale de l'Education Nationale Union; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Vasand and Kusum Joshi; Comision Honoraria de Lucha contra el Cancer (Uruguay)	This work was supported in part by Institut Pasteur Grants PIC-PTR 278, PTR 262, and DARRI 27237, the Ligue Nationale Contre le Cancer (Equipe Labelisee 2011) (to C. L.), and the Mutuelle Generale de l'Education Nationale Union.; Supported by Ligue Nationale contre le Cancer, Fondation pour la Recherche Medicale, Institut Pasteur, Vasand and Kusum Joshi, and Comision Honoraria de Lucha contra el Cancer (Uruguay). Present address: Dept. Inmunobiologia, Facultad de Medicina, Gral. Flores 2125, 11800 Montevideo, Uruguay.	Ajisaka K, 2000, BIOSCI BIOTECH BIOCH, V64, P1743, DOI 10.1271/bbb.64.1743; Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Baldus SE, 2004, CRIT REV CL LAB SCI, V41, P189, DOI 10.1080/10408360490452040; Bartman AE, 1999, INT J CANCER, V80, P210; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Carbone FR, 1997, GLYCOBIOLOGY, V7, P725, DOI 10.1093/glycob/7.6.725-d; Cheng LM, 2004, FEBS LETT, V566, P17, DOI 10.1016/j.febslet.2004.03.108; Cloos PAC, 2004, BIOGERONTOLOGY, V5, P139, DOI 10.1023/B:BGEN.0000031152.31352.8b; Corthay A, 1998, EUR J IMMUNOL, V28, P2580, DOI 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X; Cudic M, 2002, BIOORGAN MED CHEM, V10, P3859, DOI 10.1016/S0968-0896(02)00388-7; De Groot AS, 2007, TRENDS IMMUNOL, V28, P482, DOI 10.1016/j.it.2007.07.011; Denda-Nagai K, 2010, J BIOL CHEM, V285, P19193, DOI 10.1074/jbc.M110.113613; Dowling W, 2007, J VIROL, V81, P1821, DOI 10.1128/JVI.02098-06; Freire T, 2006, GLYCOBIOLOGY, V16, P390, DOI 10.1093/glycob/cwj082; Freire T, 2006, BIOCONJUGATE CHEM, V17, P559, DOI 10.1021/bc0502661; Freire T, 2005, CANCER RES, V65, P7880, DOI 10.1158/0008-5472.CAN-04-3746; Freire T, 2006, MINI-REV MED CHEM, V6, P1357, DOI 10.2174/138955706778992996; Freire T, 2010, BLOOD, V116, P3526, DOI 10.1182/blood-2010-04-279133; GalliStampino L, 1997, CANCER RES, V57, P3214; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; George SK, 2001, J AM CHEM SOC, V123, P11117, DOI 10.1021/ja015570t; Gerken TA, 2002, J BIOL CHEM, V277, P49850, DOI 10.1074/jbc.M205851200; Grinstead JS, 2003, BIOCHEMISTRY-US, V42, P14293, DOI 10.1021/bi0301237; Guillem P, 2000, INT J CANCER, V88, P856, DOI 10.1002/1097-0215(20001215)88:6<856::AID-IJC3>3.0.CO;2-D; Hamamoto A, 2005, INT J ONCOL, V26, P891; Hanisch FG, 2003, EUR J IMMUNOL, V33, P3242, DOI 10.1002/eji.200324189; HARDING CV, 1993, J IMMUNOL, V151, P2419; HAURUM JS, 1994, J EXP MED, V180, P739, DOI 10.1084/jem.180.2.739; Hermeling S, 2004, PHARM RES-DORDR, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Hiltbold EM, 1999, CELL IMMUNOL, V194, P143, DOI 10.1006/cimm.1999.1512; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; ISHIOKA GY, 1992, J IMMUNOL, V148, P2446; Kagan E, 2005, CANCER IMMUNOL IMMUN, V54, P424, DOI 10.1007/s00262-004-0584-y; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Leclerc C, 1997, J IMMUNOL, V158, P3252; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Lo-Man R, 2004, CANCER RES, V64, P4987, DOI 10.1158/0008-5472.CAN-04-0252; Lo-Man R, 2001, J IMMUNOL, V166, P2849, DOI 10.4049/jimmunol.166.4.2849; Lo-Man R, 2000, INFECT IMMUN, V68, P3079, DOI 10.1128/IAI.68.6.3079-3089.2000; Marcaurelle LA, 2002, GLYCOBIOLOGY, V12, p69R, DOI 10.1093/glycob/12.6.69R; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; MOURITSEN S, 1994, EUR J IMMUNOL, V24, P1066, DOI 10.1002/eji.1830240509; Ninkovic T, 2007, J IMMUNOL, V179, P2380, DOI 10.4049/jimmunol.179.4.2380; OSINAGA E, 1994, BREAST CANCER RES TR, V32, P139, DOI 10.1007/BF00665765; Pang PC, 2009, J PROTEOME RES, V8, P4906, DOI 10.1021/pr9001756; Pereira MB, 2001, J CLIN PATHOL, V54, P210, DOI 10.1136/jcp.54.3.210; Rachagani S, 2009, BIOFACTORS, V35, P509, DOI 10.1002/biof.64; Reis CA, 2000, J HISTOCHEM CYTOCHEM, V48, P377, DOI 10.1177/002215540004800307; Ryan SO, 2009, BIOL CHEM, V390, P611, DOI 10.1515/BC.2009.070; Schuster O, 1999, J BIOMOL NMR, V14, P33, DOI 10.1023/A:1008397304851; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Segal-Eiras A, 1997, Allergol Immunopathol (Madr), V25, P176; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; SPRINGER GF, 1995, CANCER DETECT PREV, V19, P374; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Stepensky D, 2006, CLIN EXP IMMUNOL, V143, P139, DOI 10.1111/j.1365-2249.2005.02965.x; Suzuki N, 1996, J IMMUNOL, V156, P128; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; TORIBARA NW, 1993, J BIOL CHEM, V268, P5879; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Vlad AM, 2002, J EXP MED, V196, P1435, DOI 10.1084/jem.20020493; von Mensdorff-Pouilly S, 2005, GLYCOBIOLOGY, V15, P735, DOI 10.1093/glycob/cwi058; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470	67	37	38	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7797	7811		10.1074/jbc.M110.209742	http://dx.doi.org/10.1074/jbc.M110.209742			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193402	hybrid, Green Published			2022-12-25	WOS:000288013300011
J	Okamoto, Y; Shikano, S				Okamoto, Yukari; Shikano, Sojin			Phosphorylation-dependent C-terminal Binding of 14-3-3 Proteins Promotes Cell Surface Expression of HIV Co-receptor GPR15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM LOCALIZATION; RETENTION/RETRIEVAL SIGNAL; GABA(B) RECEPTORS; MEMBRANE-PROTEINS; COUPLED RECEPTORS; RETENTION MOTIF; ER RETENTION; TRAFFICKING; TRANSPORT; INFECTION	Membrane trafficking is dictated by dynamic molecular interactions involving discrete determinants in the cargo proteins and the intracellular transport machineries. We have previously reported that cell surface expression of GPR15, a G protein-coupled receptor (GPCR) that serves as a co-receptor for HIV, is correlated with the mode III binding of 14-3-3 proteins to the receptor C terminus. Here we provide a mechanistic basis for the role of 14-3-3 in promoting the cell surface expression of GPR15. The Ala mutation of penultimate phospho-Ser (S359A) that abolishes 14-3-3 binding resulted in substantially reduced O-glycosylation and the cell surface expression of GPR15. The surface membrane protein CD8 fused with the C-terminal tail of GPR15(S359A) mutant was re-localized in the endoplasmic reticulum (ER). In the context of S359A mutation, the additional mutations in the upstream stretch of basic residues (RXR motif) restored O-glycosylation and the cell surface expression. The RXR motif was responsible for the interaction with coatomer protein I (COPI), which was inversely correlated with the 14-3-3 binding and cell surface expression. These results suggest that 14-3-3 binding promotes cell surface expression of GPR15 by releasing the receptor from ER retrieval/retention pathway that is mediated by the interaction of RXR motif and COPI. Moreover, 14-3-3 binding substantially increased the stability of GPR15 protein. Thus 14-3-3 proteins play multiple roles in biogenesis and trafficking of an HIV co-receptor GPR15 to control its cell surface density in response to the phosphorylation signal.	[Okamoto, Yukari; Shikano, Sojin] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shikano, S (corresponding author), 900 S Ashland Ave, Chicago, IL 60607 USA.	sshikano@uic.edu			American Cancer Society-Illinois Division/LUNGevity Lung Cancer [2009-07001-00-00]	American Cancer Society-Illinois Division/LUNGevity Lung Cancer(American Cancer Society)	This work was supported in part by American Cancer Society-Illinois Division/LUNGevity Lung Cancer Grant 2009-07001-00-00 (to S. S.).	Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Blaak H, 2005, J VIROL, V79, P1686, DOI 10.1128/JVI.79.3.1686-1700.2005; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Chiaw PK, 2009, CHEM BIOL, V16, P520, DOI 10.1016/j.chembiol.2009.04.005; Chung JJ, 2009, FEBS J, V276, P5547, DOI 10.1111/j.1742-4658.2009.07241.x; Clayton F, 2001, AM J PATHOL, V159, P1933, DOI 10.1016/S0002-9440(10)63040-4; Coblitz B, 2005, J BIOL CHEM, V280, P36263, DOI 10.1074/jbc.M507559200; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dunham JH, 2009, TRENDS BIOTECHNOL, V27, P541, DOI 10.1016/j.tibtech.2009.06.005; Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020; Elbim C, 2008, J IMMUNOL, V181, P8613, DOI 10.4049/jimmunol.181.12.8613; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Godde NJ, 2006, J CELL SCI, V119, P3296, DOI 10.1242/jcs.03065; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Hermosilla R, 2004, TRAFFIC, V5, P993, DOI 10.1111/j.1600-0854.2004.00239.x; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Khalil H, 2005, J CELL SCI, V118, P4679, DOI 10.1242/jcs.02592; Kim YS, 2005, ENDOCRINOLOGY, V146, P3133, DOI 10.1210/en.2004-1455; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Maresca M, 2003, J BIOMED SCI, V10, P156, DOI 10.1159/000068089; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Michelsen K, 2007, J CELL BIOL, V179, P209, DOI 10.1083/jcb.200704142; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; Nakamura T, 2010, J BIOL CHEM, V285, P16145, DOI 10.1074/jbc.M109.081315; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Pagano A, 2001, J NEUROSCI, V21, P1189; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Roth D, 2010, BIOCHEM J, V425, P195, DOI 10.1042/BJ20091064; Schumacher B, 2010, FEBS LETT, V584, P1443, DOI 10.1016/j.febslet.2010.02.065; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Scott MGH, 2004, M S-MED SCI, V20, P78, DOI 10.1051/medsci/200420178; Sharma P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011496; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Stepanchick A, 2010, CELL PHYSIOL BIOCHEM, V26, P363, DOI 10.1159/000320560; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wang YL, 2000, CELL GROWTH DIFFER, V11, P211; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang ZN, 2008, J CELL SCI, V121, P3243, DOI 10.1242/jcs.026856; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	60	29	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7171	7181		10.1074/jbc.M110.199695	http://dx.doi.org/10.1074/jbc.M110.199695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189250	Green Published, hybrid			2022-12-25	WOS:000287737300034
J	Stockholm, D; Edom-Vovard, F; Coutant, S; Sanatine, P; Yamagata, Y; Corre, G; Le Guillou, L; Thi, MANN; Paldi, A				Stockholm, Daniel; Edom-Vovard, Frederique; Coutant, Sophie; Sanatine, Peggy; Yamagata, Yoshiaki; Corre, Guillaume; Le Guillou, Laurent; Thi My Anh Neildez-Nguyen; Paldi, Andras			Bistable Cell Fate Specification as a Result of Stochastic Fluctuations and Collective Spatial Cell Behaviour	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; IN-VITRO; DIFFERENTIATION; NOISE; HETEROGENEITY; EQUILIBRIUM; PLASTICITY; DYNAMICS; MEMORY	Background: In culture, isogenic mammalian cells typically display enduring phenotypic heterogeneity that arises from fluctuations of gene expression and other intracellular processes. This diversity is not just simple noise but has biological relevance by generating plasticity. Noise driven plasticity was suggested to be a stem cell-specific feature. Results: Here we show that the phenotypes of proliferating tissue progenitor cells such as primary mononuclear muscle cells can also spontaneously fluctuate between different states characterized by the either high or low expression of the muscle-specific cell surface molecule CD56 and by the corresponding high or low capacity to form myotubes. Although this capacity is a cell-intrinsic property, the cells switch their phenotype under the constraints imposed by the highly heterogeneous microenvironment created by their own collective movement. The resulting heterogeneous cell population is characterized by a dynamic equilibrium between "high CD56" and "low CD56" phenotype cells with distinct spatial distribution. Computer simulations reveal that this complex dynamic is consistent with a context-dependent noise driven bistable model where local microenvironment acts on the cellular state by encouraging the cell to fluctuate between the phenotypes until the low noise state is found. Conclusions: These observations suggest that phenotypic fluctuations may be a general feature of any non-terminally differentiated cell. The cellular microenvironment created by the cells themselves contributes actively and continuously to the generation of fluctuations depending on their phenotype. As a result, the cell phenotype is determined by the joint action of the cell-intrinsic fluctuations and by collective cell-to-cell interactions.	[Stockholm, Daniel; Edom-Vovard, Frederique; Coutant, Sophie; Sanatine, Peggy; Yamagata, Yoshiaki; Corre, Guillaume; Thi My Anh Neildez-Nguyen; Paldi, Andras] Genethon, Evry, France; [Coutant, Sophie; Yamagata, Yoshiaki; Corre, Guillaume; Thi My Anh Neildez-Nguyen; Paldi, Andras] Univ Evry Val dEssonne, INSERM, U951, Evry, France; [Coutant, Sophie; Yamagata, Yoshiaki; Corre, Guillaume; Thi My Anh Neildez-Nguyen; Paldi, Andras] Ecole Prat Hautes Etud, UMR951, Evry, France; [Le Guillou, Laurent] Univ Paris 06, LAPNE, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Stockholm, D (corresponding author), Genethon, Evry, France.	paldi@genethon.fr	Neildez, Thi My Anh/J-6900-2013; Le Guillou, Laurent/B-7712-2009; corre, guillaume/T-9696-2019; Le Guillou, Laurent/Q-6886-2019; Paldi, Andras/J-5757-2013; Stockholm, Daniel/J-7912-2013	Le Guillou, Laurent/0000-0001-7178-8868; corre, guillaume/0000-0002-0755-8336; Le Guillou, Laurent/0000-0001-7178-8868; Coutant, Sophie/0000-0003-1255-8418	"Region Ile-de-France," "Conseil General de l'Essonne," "Genopole Recherche" of Evry, the University of " Evry Val d'Essonne"; "Fondation pour la Recherche Medicale" (Paris); AXA Research Fellowship	"Region Ile-de-France," "Conseil General de l'Essonne," "Genopole Recherche" of Evry, the University of " Evry Val d'Essonne"(Region Ile-de-France); "Fondation pour la Recherche Medicale" (Paris)(Fondation pour la Recherche Medicale); AXA Research Fellowship(AXA Research Fund)	This study was supported in part by equipment funds from "Region Ile-de-France," "Conseil General de l'Essonne," "Genopole Recherche" of Evry, the University of " Evry Val d'Essonne" and from the "Fondation pour la Recherche Medicale" (Paris). GC is a recipient of an AXA Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Benchaouir R, 2007, CYTOM PART A, V71A, P251, DOI 10.1002/cyto.a.20367; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Capkovic KL, 2008, EXP CELL RES, V314, P1553, DOI 10.1016/j.yexcr.2008.01.021; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; EDOM F, 1994, DEV BIOL, V164, P219, DOI 10.1006/dbio.1994.1193; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Furusawa C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040003; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Iezzi S, 2002, P NATL ACAD SCI USA, V99, P7757, DOI 10.1073/pnas.112218599; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; KANEKO K, 1994, PHYSICA D, V75, pR7, DOI 10.1016/0167-2789(94)90271-2; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; KUPIEC JJ, 1983, SPECULAT SCI TECHNOL, V6, P471; Laforge B, 2005, PROG BIOPHYS MOL BIO, V89, P93, DOI 10.1016/j.pbiomolbio.2004.11.004; Neildez-Nguyen TMA, 2008, DIFFERENTIATION, V76, P33, DOI 10.1111/j.1432-0436.2007.00219.x; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Paldi A, 2003, CELL MOL LIFE SCI, V60, P1775, DOI 10.1007/s00018-003-23147-z; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Stockholm D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000394; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang L, 2009, P NATL ACAD SCI USA, V106, P6638, DOI 10.1073/pnas.0806137106; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	32	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2010	5	12							e14441	10.1371/journal.pone.0014441	http://dx.doi.org/10.1371/journal.pone.0014441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	701CS	21203432	Green Published, Green Submitted, gold			2022-12-25	WOS:000285792500017
J	Murphy, S; Martin, S; Parton, RG				Murphy, Samantha; Martin, Sally; Parton, Robert G.			Quantitative Analysis of Lipid Droplet Fusion: Inefficient Steady State Fusion but Rapid Stimulation by Chemical Fusogens	PLOS ONE			English	Article							PROTEIN-KINASE INHIBITORS; CHOLESTEROL; TRANSPORT; PERILIPIN; LIPOLYSIS; CAVEOLIN; SIZE; PROPRANOLOL; ASSOCIATION; MECHANISM	Lipid droplets (LDs) are dynamic cytoplasmic organelles containing neutral lipids and bounded by a phospholipid monolayer. Previous studies have suggested that LDs can undergo constitutive homotypic fusion, a process linked to the inhibitory effects of fatty acids on glucose transporter trafficking. Using strict quantitative criteria for LD fusion together with refined light microscopic methods and real-time analysis, we now show that LDs in diverse cell types show low constitutive fusogenic activity under normal growth conditions. To investigate the possible modulation of LD fusion, we screened for agents that can trigger fusion. A number of pharmacological agents caused homotypic fusion of lipid droplets in a variety of cell types. This provided a novel cell system to study rapid regulated fusion between homotypic phospholipid monolayers. LD fusion involved an initial step in which the two adjacent membranes became continuous (< 10 s), followed by the slower merging (100 s) of the neutral lipid cores to produce a single spherical LD. These fusion events were accompanied by changes to the LD surface organization. Measurements of LDs undergoing homotypic fusion showed that fused LDs maintained their initial volume, with a corresponding decrease in surface area suggesting rapid removal of membrane from the fused LD. This study provides estimates for the level of constitutive LD fusion in cells and questions the role of LD fusion in vivo. In addition, it highlights the extent of LD restructuring which occurs when homotypic LD fusion is triggered in a variety of cell types.	[Murphy, Samantha] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Murphy, S (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	s.martin@uq.edu.au; R.Parton@imb.uq.edu.au	Parton, Robert G/C-5673-2009; Martin, Sally/A-7150-2010	Parton, Robert G/0000-0002-7494-5248; Martin, Sally/0000-0001-9294-5404	National Health and Medical Research Council of Australia [455865]; Diabetes Australia; Australian Cancer Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia; Australian Cancer Research Foundation	This work was supported by grants from the National Health and Medical Research Council of Australia to RGP and SM (grant number 455865) and from Diabetes Australia to SM. Confocal microscopy was performed at the ACRF/IMB Dynamic Imaging Facility for Cancer Biology, established with funding from the Australian Cancer Research Foundation. The Institute for Molecular Bioscience is a Special Research Centre of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; CHONG PL, 1989, BIOCHEMISTRY-US, V28, P8358, DOI 10.1021/bi00447a014; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Carlo S, 2004, J LIPOSOME RES, V14, P61, DOI 10.1081/LPR-120039704; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; FROST SC, 1985, J BIOL CHEM, V260, P2646; Fukumoto S, 2002, HISTOCHEM CELL BIOL, V118, P423, DOI 10.1007/s00418-002-0462-7; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; HERBETTE LG, 1986, BIOPHYS J, V49, P91, DOI 10.1016/S0006-3495(86)83605-0; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Kellner-Weibel G, 2001, J LIPID RES, V42, P768; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; LIU P, 2007, BIOCHIM BIOPHYS ACTA, V1173, P784; MAK IT, 1988, CIRC RES, V63, P262, DOI 10.1161/01.RES.63.1.262; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; MURPHY S, 2008, BIOCHIM BIOPHYS ACTA, V1791, P441; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Olsen MK, 1998, J CELL PHYSIOL, V176, P525, DOI 10.1002/(SICI)1097-4652(199809)176:3<525::AID-JCP9>3.0.CO;2-Q; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Sturmey RG, 2006, REPRODUCTION, V132, P829, DOI 10.1530/REP-06-0073; SUREWICZ KW, 1981, BIOCHEM PHARMACOL, V30, P839, DOI 10.1016/S0006-2952(81)80004-4; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Vereshchagina N, 2008, J CELL SCI, V121, P3383, DOI 10.1242/jcs.035220; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	45	68	70	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2010	5	12							e15030	10.1371/journal.pone.0015030	http://dx.doi.org/10.1371/journal.pone.0015030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FO	21203462	Green Submitted, Green Published, gold			2022-12-25	WOS:000285579200012
J	Dalken, B; Jabulowsky, RA; Oberoi, P; Benhar, I; Wels, WS				Daelken, Benjamin; Jabulowsky, Robert A.; Oberoi, Pranav; Benhar, Itai; Wels, Winfried S.			Maltose-Binding Protein Enhances Secretion of Recombinant Human Granzyme B Accompanied by In Vivo Processing of a Precursor MBP Fusion Protein	PLOS ONE			English	Article							YEAST PICHIA-PASTORIS; HIGH-LEVEL EXPRESSION; CODON USAGE BIAS; ESCHERICHIA-COLI; METHYLOTROPHIC YEAST; ANTIBODIES; RECEPTOR; SYSTEM; PURIFICATION; ERBB2/HER2	Background: The apoptosis-inducing serine protease granzyme B (GrB) is an important factor contributing to lysis of target cells by cytotoxic lymphocytes. Expression of enzymatically active GrB in recombinant form is a prerequisite for functional analysis and application of GrB for therapeutic purposes. Methods and Findings: We investigated the influence of bacterial maltose-binding protein (MBP) fused to GrB via a synthetic furin recognition motif on the expression of the MBP fusion protein also containing an N-terminal alpha-factor signal peptide in the yeast Pichia pastoris. MBP markedly enhanced the amount of GrB secreted into culture supernatant, which was not the case when GrB was fused to GST. MBP-GrB fusion protein was cleaved during secretion by an endogenous furin-like proteolytic activity in vivo, liberating enzymatically active GrB without the need of subsequent in vitro processing. Similar results were obtained upon expression of a recombinant fragment of the ErbB2/HER2 receptor protein or GST as MBP fusions. Conclusions: Our results demonstrate that combination of MBP as a solubility enhancer with specific in vivo cleavage augments secretion of processed and functionally active proteins from yeast. This strategy may be generally applicable to improve folding and increase yields of recombinant proteins.	[Daelken, Benjamin; Jabulowsky, Robert A.; Oberoi, Pranav; Wels, Winfried S.] Chemotherapeut Forschungsinst Georg Speyer Haus, Frankfurt, Germany; [Benhar, Itai] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel	Tel Aviv University	Dalken, B (corresponding author), Chemotherapeut Forschungsinst Georg Speyer Haus, Frankfurt, Germany.	wels@em.uni-frankfurt.de		Benhar, Itai/0000-0002-0824-7177; Wels, Winfried/0000-0001-9858-3643	Deutsche Forschungsgemeinschaft [DFG WE 2589/2-1]; DFG Graduiertenkolleg [GRK 1172]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Graduiertenkolleg(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft, DFG WE 2589/2-1 and DFG Graduiertenkolleg GRK 1172. The funding agency had no role in conducting the study and in preparing the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bach H, 2001, J MOL BIOL, V312, P79, DOI 10.1006/jmbi.2001.4914; Biburger M, 2005, J MOL BIOL, V346, P1299, DOI 10.1016/j.jmb.2004.12.052; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; Dalken B, 2006, CELL DEATH DIFFER, V13, P576, DOI 10.1038/sj.cdd.4401773; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; Ehrmann M, 1998, MOL MICROBIOL, V29, P685, DOI 10.1046/j.1365-2958.1998.00915.x; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; Gerstmayer B, 1997, FEBS LETT, V407, P63, DOI 10.1016/S0014-5793(97)00294-9; Gerstmayer B, 1997, J IMMUNOL, V158, P4584; Giesubel U, 2006, BIOCHEM J, V394, P563, DOI 10.1042/BJ20050687; HARWERTH IM, 1992, J BIOL CHEM, V267, P15160; Hayhurst A, 2000, PROTEIN EXPRES PURIF, V18, P1, DOI 10.1006/prep.1999.1164; Hoves S, 2010, J LEUKOCYTE BIOL, V87, P237, DOI 10.1189/jlb.0909608; Jacquet A, 1999, PROTEIN EXPRES PURIF, V17, P392, DOI 10.1006/prep.1999.1150; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Krysan DJ, 1999, J BIOL CHEM, V274, P23229, DOI 10.1074/jbc.274.33.23229; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Li ZG, 2010, PROTEIN EXPRES PURIF, V72, P113, DOI 10.1016/j.pep.2010.03.004; Pham CTN, 1998, J BIOL CHEM, V273, P1629, DOI 10.1074/jbc.273.3.1629; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; POWER RF, 1990, J BIOL CHEM, V265, P1419; Pryor KD, 1997, PROTEIN EXPRES PURIF, V10, P309, DOI 10.1006/prep.1997.0759; Rohrbach F, 2005, J IMMUNOL, V174, P5481, DOI 10.4049/jimmunol.174.9.5481; Rosenblum MG, 2009, CURR PHARM DESIGN, V15, P2676, DOI 10.2174/138161209788923958; SAMUELSSON E, 1994, BIOCHEMISTRY-US, V33, P4207, DOI 10.1021/bi00180a013; Shaki-Loewenstein S, 2005, J IMMUNOL METHODS, V303, P19, DOI 10.1016/j.jim.2005.05.004; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sinclair G, 2002, PROTEIN EXPRES PURIF, V26, P96, DOI 10.1016/S1046-5928(02)00526-0; Sorensen HP, 2003, PROTEIN EXPRES PURIF, V32, P252, DOI 10.1016/j.pep.2003.07.001; Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989; Tudyka T, 1997, PROTEIN SCI, V6, P2180; UHLEN M, 1992, Current Opinion in Biotechnology, V3, P363, DOI 10.1016/0958-1669(92)90164-E; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; Yoda T, 2000, J MED VIROL, V60, P475, DOI 10.1002/(SICI)1096-9071(200004)60:4<475::AID-JMV17>3.0.CO;2-B; Zhang Y, 1998, PROTEIN EXPRES PURIF, V12, P159, DOI 10.1006/prep.1997.0834	40	15	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e14404	10.1371/journal.pone.0014404	http://dx.doi.org/10.1371/journal.pone.0014404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203542	gold, Green Submitted, Green Published			2022-12-25	WOS:000285578000011
J	Lenkey, N; Karoly, R; Lukacs, P; Vizi, ES; Sunesen, M; Fodor, L; Mike, A				Lenkey, Nora; Karoly, Robert; Lukacs, Peter; Vizi, E. Sylvester; Sunesen, Morten; Fodor, Laszlo; Mike, Arpad			Classification of Drugs Based on Properties of Sodium Channel Inhibition: A Comparative Automated Patch-Clamp Study	PLOS ONE			English	Article							LOCAL-ANESTHETICS; LIDOCAINE BLOCK; NA+ CHANNELS; ANTIDEPRESSANT DRUGS; SKELETAL-MUSCLE; PHARMACOKINETICS; VOLUNTEERS; MODULATORS; BINDING; LIPOPHILICITY	Background: There is only one established drug binding site on sodium channels. However, drug binding of sodium channels shows extreme promiscuity: similar to 25% of investigated drugs have been found to potently inhibit sodium channels. The structural diversity of these molecules suggests that they may not share the binding site, and/or the mode of action. Our goal was to attempt classification of sodium channel inhibitors by measuring multiple properties of inhibition in electrophysiology experiments. We also aimed to investigate if different properties of inhibition correlate with specific chemical properties of the compounds. Methodology/Principal Findings: A comparative electrophysiological study of 35 compounds, including classic sodium channel inhibitors (anticonvulsants, antiarrhythmics and local anesthetics), as well as antidepressants, antipsychotics and neuroprotective agents, was carried out using rNav1.2 expressing HEK-293 cells and the QPatch automatic patch-clamp instrument. In the multi-dimensional space defined by the eight properties of inhibition (resting and inactivated affinity, potency, reversibility, time constants of onset and offset, use-dependence and state-dependence), at least three distinct types of inhibition could be identified; these probably reflect distinct modes of action. The compounds were clustered similarly in the multi-dimensional space defined by relevant chemical properties, including measures of lipophilicity, aromaticity, molecular size, polarity and electric charge. Drugs of the same therapeutic indication typically belonged to the same type. We identified chemical properties, which were important in determining specific properties of inhibition. State-dependence correlated with lipophilicity, the ratio of the neutral form of molecules, and aromaticity: We noticed that the highly state dependent inhibitors had at least two aromatic rings, logP>4.0, and pKa<8.0. Conclusions/Significance: The correlations of inhibition properties both with chemical properties and therapeutic profiles would not have been evident through the sole determination of IC(50); therefore, recording multiple properties of inhibition may allow improved prediction of therapeutic usefulness.	[Lenkey, Nora; Karoly, Robert; Lukacs, Peter; Vizi, E. Sylvester; Mike, Arpad] Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, Budapest, Hungary; [Sunesen, Morten] Soph Biosci AS, Ballerup, Denmark; [Fodor, Laszlo] Gedeon Richter Plc, Pharmacol & Drug Safety Res, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Gedeon Richter Chemistry Works	Lenkey, N (corresponding author), Hungarian Acad Sci, Inst Expt Med, Dept Pharmacol, Budapest, Hungary.	mike@koki.hu	Mike, Arpad/AAP-6479-2021; Mike, Arpad/N-8604-2013	Mike, Arpad/0000-0002-9095-8161	Hungarian Research Fund [NK 72959]; Janos Bolyai Research Fellowship	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences)	This work was supported by grants from the Hungarian Research Fund (NK 72959), and A. Mike is a recipient of the Janos Bolyai Research Fellowship. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sophion Bioscience A/S, and Gedeon Richter Plc. provided access to the QPatch instruments for performing the experiments.	Ahern CA, 2008, CIRC RES, V102, P86, DOI 10.1161/CIRCRESAHA.107.160663; Bae JW, 2007, INT J CLIN PHARM TH, V45, P110; Bagli M, 1999, J PHARMACOL EXP THER, V291, P547; BEAN BP, 1983, J GEN PHYSIOL, V81, P613, DOI 10.1085/jgp.81.5.613; BOKESCH PM, 1986, J PHARMACOL EXP THER, V237, P773; BROWN CM, 1995, BRIT J PHARMACOL, V115, P1425, DOI 10.1111/j.1476-5381.1995.tb16633.x; Brown ML, 1997, J MED CHEM, V40, P602, DOI 10.1021/jm960692v; Brown ML, 1999, J MED CHEM, V42, P1537, DOI 10.1021/jm980556l; Canal M, 1998, CLIN DRUG INVEST, V15, P455, DOI 10.2165/00044011-199815050-00010; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Clare Jeff J, 2007, SEB Exp Biol Ser, V58, P115; Courtney K.R., 1987, LOCAL ANESTHETICS, P53; COURTNEY KR, 1990, MOL PHARMACOL, V37, P855; COURTNEY KR, 1980, J PHARMACOL EXP THER, V213, P114; COURTNEY KR, 1980, J MOL CELL CARDIOL, V12, P1273, DOI 10.1016/0022-2828(80)90071-1; Dockens RC, 1995, BRIT J CLIN PHARMACO, V40, P598, DOI 10.1111/j.1365-2125.1995.tb05806.x; Dubin AE, 2005, J BIOMOL SCREEN, V10, P168, DOI 10.1177/1087057104272295; EHRING GR, 1988, J PHARMACOL EXP THER, V244, P479; ESTEVEZ F, 1995, ALCOHOL, V12, P541, DOI 10.1016/0741-8329(95)00041-0; Farkas S, 2006, CNS DRUG REV, V12, P218, DOI 10.1111/j.1527-3458.2006.00218.x; FINK M, 1977, PSYCHOPHARMACOLOGY, V54, P249, DOI 10.1007/BF00426572; Hanck DA, 2009, CIRC RES, V105, P492, DOI 10.1161/CIRCRESAHA.109.198572; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HILLE B, 1977, J GEN PHYSIOL, V69, P475, DOI 10.1085/jgp.69.4.475; HOPPU K, 1995, PEDIATR NEUROL, V13, P143, DOI 10.1016/0887-8994(95)00142-3; Huang CJ, 2006, NAT BIOTECHNOL, V24, P439, DOI 10.1038/nbt1194; Ilyin VI, 2006, J PHARMACOL EXP THER, V318, P1083, DOI 10.1124/jpet.106.104737; Jerling M, 2006, CLIN PHARMACOKINET, V45, P469, DOI 10.2165/00003088-200645050-00003; Kasper S, 1993, Eur Neuropsychopharmacol, V3, P13, DOI 10.1016/0924-977X(93)90290-3; Kimbrough JT, 2000, J PHYSIOL-LONDON, V529, P93, DOI 10.1111/j.1469-7793.2000.00093.x; Korsgaard MPG, 2009, COMB CHEM HIGH T SCR, V12, P51, DOI 10.2174/138620709787048037; KUCHARCZYK J, 1991, RADIOLOGY, V179, P221, DOI 10.1148/radiology.179.1.2006281; KUO CC, 1994, MOL PHARMACOL, V46, P716; Kutchinsky J, 2003, ASSAY DRUG DEV TECHN, V1, P685, DOI 10.1089/154065803770381048; LEMBERGER L, 1976, BRIT J CLIN PHARMACO, V3, P215, DOI 10.1111/j.1365-2125.1976.tb00595.x; Lenkey N, 2011, NEUROPHARMACOLOGY, V60, P191, DOI 10.1016/j.neuropharm.2010.08.005; Li HL, 1999, MOL PHARMACOL, V55, P134, DOI 10.1124/mol.55.1.134; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; Liu MY, 2008, CLIN THER, V30, P641, DOI 10.1016/j.clinthera.2008.04.005; Mannhold R, 1999, J MED CHEM, V42, P981, DOI 10.1021/jm981047m; Mathes C, 2009, COMB CHEM HIGH T SCR, V12, P78, DOI 10.2174/138620709787047948; Mike Arpad, 2010, Curr Mol Pharmacol, V3, P129; Pancrazio JJ, 1998, J PHARMACOL EXP THER, V284, P208; Reis M, 2009, THER DRUG MONIT, V31, P42, DOI 10.1097/FTD.0b013e31819114ea; Rojpibulstit M, 2003, CLIN DRUG INVEST, V23, P273, DOI 10.2165/00044011-200323040-00007; SCHWARZ W, 1977, BIOPHYS J, V20, P343, DOI 10.1016/S0006-3495(77)85554-9; Smith JAM, 2006, MOL PHARMACOL, V69, P921, DOI 10.1124/mol.105.019257; Tarnawa Istvan, 2007, Recent Pat CNS Drug Discov, V2, P57, DOI 10.2174/157488907779561754; THUMMEL KE, 2006, GOODMAN GILMANS PHAR, P1888; Trivedi S, 2008, ASSAY DRUG DEV TECHN, V6, P167, DOI 10.1089/adt.2007.090; van de Waterbeemd H, 2001, J COMPUT AID MOL DES, V15, P273, DOI 10.1023/A:1008192010023; Wang GX, 2003, J GEN PHYSIOL, V122, p35A; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Wang YS, 2009, BIOORGAN MED CHEM, V17, P7064, DOI 10.1016/j.bmc.2008.10.031; Waring MJ, 2007, BIOORG MED CHEM LETT, V17, P1759, DOI 10.1016/j.bmcl.2006.12.061; Young JM, 2001, CLIN THER, V23, P532, DOI 10.1016/S0149-2918(01)80059-X; ZAMPONI GW, 1993, BIOPHYS J, V65, P80, DOI 10.1016/S0006-3495(93)81042-7; ZAMPONI GW, 1993, BIOPHYS J, V65, P2335, DOI 10.1016/S0006-3495(93)81292-X; ZAMPONI GW, 1994, BIOPHYS J, V67, P1015, DOI 10.1016/S0006-3495(94)80567-3; Zuliani V, 2009, CURR TOP MED CHEM, V9, P396, DOI 10.2174/156802609788317856	60	36	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15568	10.1371/journal.pone.0015568	http://dx.doi.org/10.1371/journal.pone.0015568			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187965	Green Submitted, Green Published, gold			2022-12-25	WOS:000285575200042
J	Wang, W; Zhu, JQ; Yu, HM; Tan, FQ; Yang, WX				Wang, Wei; Zhu, Jun-Quan; Yu, He-Ming; Tan, Fu-Qing; Yang, Wan-Xi			KIFC1-Like Motor Protein Associates with the Cephalopod Manchette and Participates in Sperm Nuclear Morphogenesis in Octopus tankahkeei	PLOS ONE			English	Article							INTRAMANCHETTE TRANSPORT; SEMINIFEROUS EPITHELIUM; CHROMATIN ORGANIZATION; CANDIDATE MOTORS; DELTA-TUBULIN; KINESIN-II; GERM-CELLS; MYOSIN VA; LAMIN-A; SPERMIOGENESIS	Background: Nuclear morphogenesis is one of the most fundamental cellular transformations taking place during spermatogenesis. In rodents, a microtubule-based perinuclear structure, the manchette, and a C-terminal kinesin motor KIFC1 are believed to play crucial roles in this process. Spermatogenesis in Octopus tankahkeei is a good model system to explore whether evolution has created a cephalopod prototype of mammalian manchette-based and KIFC1-dependent sperm nuclear shaping machinery. Methodology/Principal Findings: We detected the presence of a KIFC1-like protein in the testis, muscle, and liver of O. tankahkeei by Western Blot. Then we tracked its dynamic localization in spermatic cells at various stages using Immunofluorescence and Immunogold Electron Microscopy. The KIFC1-like protein was not expressed at early stages of spermatogenesis when no significant morphological changes occur, began to be present in early spermatid, localized around and in the nucleus of intermediate and late spermatids where the nucleus was dramatically elongated and compressed, and concentrated at one end of final spermatid. Furthermore, distribution of the motor protein during nuclear elongation and condensation overlapped with that of the cephalopod counterpart of manchette at a significant level. Conclusions/Significance: The results support the assumption that the protein is actively involved in sperm nuclear morphogenesis in O. tankahkeei possibly through bridging the manchette-like perinuclear microtubules to the nucleus and assisting in the nucleocytoplasmic trafficking of specific cargoes. This study represents the first description of the role of a motor protein in sperm nuclear shaping in cephalopod.	[Wang, Wei; Zhu, Jun-Quan; Yu, He-Ming] Ningbo Univ, Fac Life Sci & Bioengn, Ningbo 315211, Zhejiang, Peoples R China; [Wang, Wei; Yu, He-Ming; Yang, Wan-Xi] Zhejiang Univ, Sperm Lab, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Tan, Fu-Qing] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China	Ningbo University; Zhejiang University; Zhejiang University	Wang, W (corresponding author), Ningbo Univ, Fac Life Sci & Bioengn, Ningbo 315211, Zhejiang, Peoples R China.	wxyang@spermlab.org	Yang, Wan-Xi/D-4401-2011	Yang, Wan-Xi/0000-0001-9304-195X; Yang, Wan-Xi/0000-0001-5695-0150	Zhejiang Provincial Natural Science Foundation of China [Z307536, Y2100296]; National Natural Science Foundation of China [31072198, 40776079]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the following projects: Zhejiang Provincial Natural Science Foundation of China (Grant No Z307536), National Natural Science Foundation of China (http://www.nsfc.gov.cn) (Grant No. 31072198 and 40776079), and Zhejiang Provincial Natural Science Foundation of China (Grant No Y2100296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cinalli RM, 2008, CELL, V132, P559, DOI 10.1016/j.cell.2008.02.003; Dadoune JP, 2004, INT REV CYTOL, V237, P1, DOI 10.1016/S0074-7696(04)37001-4; Dillon N, 2008, DEV CELL, V15, P182, DOI 10.1016/j.devcel.2008.07.013; Extavour CGM, 2007, INTEGR COMP BIOL, V47, P770, DOI 10.1093/icb/icm027; Fan J, 2004, J CELL SCI, V117, P619, DOI 10.1242/jcs.00892; FAWCETT DW, 1971, DEV BIOL, V26, P220, DOI 10.1016/0012-1606(71)90124-2; FIELDS WG, 1976, CAN J ZOOL, V54, P908, DOI 10.1139/z76-105; Fiserova J, 2010, BIOCHEM SOC T, V38, P829, DOI 10.1042/BST0380829; FRANZEN A, 1977, VERH DTSCH ZOOL GES, P123; Gimenez-Bonafe P, 2004, MOL REPROD DEV, V68, P232, DOI 10.1002/mrd.20068; Gimenez-Bonafe P, 2002, MOL REPROD DEV, V62, P357, DOI 10.1002/mrd.10124; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guttman JA, 2000, J CELL SCI, V113, P2167; Hayasaka S, 2008, ASIAN J ANDROL, V10, P561, DOI 10.1111/j.1745-7262.2008.00392.x; HEALY JM, 1990, HELGOLANDER MEERESUN, V44, P109, DOI 10.1007/BF02365434; HEALY JM, 1989, PHILOS T ROY SOC B, V323, P589, DOI 10.1098/rstb.1989.0038; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; KALLIO M, 1995, ENVIRON MOL MUTAGEN, V25, P106, DOI 10.1002/em.2850250204; Kato A, 2004, DEV BIOL, V269, P196, DOI 10.1016/j.ydbio.2004.01.026; Kierszenbaum Abraham L, 2007, Soc Reprod Fertil Suppl, V65, P33; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, CYTOGENET GENOME RES, V103, P337, DOI 10.1159/000076822; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Kikkawa M, 2008, TRENDS CELL BIOL, V18, P128, DOI 10.1016/j.tcb.2008.01.002; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lie PPY, 2010, PHILOS T R SOC B, V365, P1581, DOI 10.1098/rstb.2009.0261; Martinez-Soler F, 2007, TISSUE CELL, V39, P99, DOI 10.1016/j.tice.2007.01.005; MAXWELL WL, 1975, PROC R SOC SER B-BIO, V191, P527, DOI 10.1098/rspb.1975.0142; MAXWELL WL, 1974, PROC R SOC SER B-BIO, V186, P181, DOI 10.1098/rspb.1974.0045; MEISTRICH ML, 1990, AM J ANAT, V188, P74, DOI 10.1002/aja.1001880109; MEISTRICH ML, 1993, MOL BIOL MALE REPROD, P66; Miller MG, 1999, BIOL REPROD, V60, P1047, DOI 10.1095/biolreprod60.4.1047; Mochida K, 1998, DEV BIOL, V200, P46, DOI 10.1006/dbio.1998.8942; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Nath S, 2007, MOL BIOL CELL, V18, P1839, DOI 10.1091/mbc.E06-06-0524; Navolanic PM, 2000, BIOL REPROD, V62, P1360, DOI 10.1095/biolreprod62.5.1360; Oakley BR, 2000, TRENDS CELL BIOL, V10, P537, DOI 10.1016/S0962-8924(00)01857-2; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Ribes E, 2004, MOL REPROD DEV, V68, P223, DOI 10.1002/mrd.20069; Ribes E, 2002, MOL REPROD DEV, V62, P363, DOI 10.1002/mrd.10103; Rivkin E, 1997, MOL REPROD DEV, V48, P77, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;77::AID-MRD10&gt;3.0.CO;2-T; RUSSELL LD, 1991, AM J ANAT, V192, P97, DOI 10.1002/aja.1001920202; Saade M, 2007, EXP CELL RES, V313, P614, DOI 10.1016/j.yexcr.2006.11.011; Selmi MG, 1996, TISSUE CELL, V28, P613, DOI 10.1016/S0040-8166(96)80064-4; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Smrzka OW, 2000, CURR BIOL, V10, P413, DOI 10.1016/S0960-9822(00)00418-8; Soley JT, 1997, J ANAT, V190, P563, DOI 10.1046/j.1469-7580.1997.19040563.x; Sperry AO, 1996, MOL BIOL CELL, V7, P289, DOI 10.1091/mbc.7.2.289; Swanson WJ, 2002, ANNU REV ECOL SYST, V33, P161, DOI 10.1146/annurev.ecolsys.33.010802.150439; Tanaka H, 2005, CELL MOL LIFE SCI, V62, P344, DOI 10.1007/s00018-004-4394-y; Toshimori K, 2003, ARCH HISTOL CYTOL, V66, P383, DOI 10.1679/aohc.66.383; Tres LL, 1996, MOL REPROD DEV, V44, P395, DOI 10.1002/(SICI)1098-2795(199607)44:3<395::AID-MRD13>3.0.CO;2-#; Vaid KS, 2007, BIOL REPROD, V77, P1037, DOI 10.1095/biolreprod.107.063735; WANG MY, 2007, PROG VET MED, V28, P77; Wang R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-9; Wang W, 2010, COMP BIOCHEM PHYS B, V156, P174, DOI 10.1016/j.cbpb.2010.03.004; White-Cooper H, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P151, DOI 10.1016/B978-0-12-372568-4.00004-5; White-Cooper H, 2010, PHILOS T R SOC B, V365, P1465, DOI 10.1098/rstb.2009.0323; Wilhelmsen K, 2006, J CELL SCI, V119, P5021, DOI 10.1242/jcs.03295; WOUTERSTYROU D, 1988, BIOCHIM BIOPHYS ACTA, V953, P86, DOI 10.1016/0167-4838(88)90012-X; Yang WX, 2006, BIOL REPROD, V74, P684, DOI 10.1095/biolreprod.105.049312; Yang WX, 2003, BIOL REPROD, V69, P1719, DOI 10.1095/biolreprod.102.014878; YOSHIDA T, 1994, J CELL SCI, V107, P625; YU HM, 2010, J CELL BIOL, V32, P251; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3; Zhang YG, 2004, CELL MOTIL CYTOSKEL, V58, P213, DOI 10.1002/cm.20008; Zhu JQ, 2005, J SHELLFISH RES, V24, P1203; Zhu Jun-Quan, 2006, Journal of Fisheries of China, V30, P161; Zou Y, 2002, BIOL REPROD, V66, P843, DOI 10.1095/biolreprod66.3.843	76	14	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2010	5	12							e15616	10.1371/journal.pone.0015616	http://dx.doi.org/10.1371/journal.pone.0015616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EM	21187923	Green Submitted, gold, Green Published			2022-12-25	WOS:000285575200050
J	Minville-Walz, M; Pierre, AS; Pichon, L; Bellenger, S; Fevre, C; Bellenger, J; Tessier, C; Narce, M; Rialland, M				Minville-Walz, Melaine; Pierre, Anne-Sophie; Pichon, Laurent; Bellenger, Sandrine; Fevre, Cecile; Bellenger, Jerome; Tessier, Christian; Narce, Michel; Rialland, Mickael			Inhibition of Stearoyl-CoA Desaturase 1 Expression Induces CHOP-Dependent Cell Death in Human Cancer Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY-ACID SYNTHASE; UNFOLDED PROTEIN RESPONSE; HUMAN-MELANOMA CELLS; INDUCED APOPTOSIS; PROSTATE-CANCER; BREAST-CANCER; PHOSPHATIDYLCHOLINE SYNTHESIS; TRANSCRIPTION FACTOR; TRIGGERS APOPTOSIS	Background: Cancer cells present a sustained de novo fatty acid synthesis with an increase of saturated and monounsaturated fatty acid (MUFA) production. This change in fatty acid metabolism is associated with overexpression of stearoyl-CoA desaturase 1 (Scd1), which catalyses the transformation of saturated fatty acids into monounsaturated fatty acids (e. g., oleic acid). Several reports demonstrated that inhibition of Scd1 led to the blocking of proliferation and induction of apoptosis in cancer cells. Nevertheless, mechanisms of cell death activation remain to be better understood. Principal Findings: In this study, we demonstrated that Scd1 extinction by siRNA triggered abolition of de novo MUFA synthesis in cancer and non-cancer cells. Scd1 inhibition-activated cell death was only observed in cancer cells with induction of caspase 3 activity and PARP-cleavage. Exogenous supplementation with oleic acid did not reverse the Scd1 ablation-mediated cell death. In addition, Scd1 depletion induced unfolded protein response (UPR) hallmarks such as Xbp1 mRNA splicing, phosphorylation of eIF2 alpha and increase of CHOP expression. However, the chaperone GRP78 expression, another UPR hallmark, was not affected by Scd1 knockdown in these cancer cells indicating a peculiar UPR activation. Finally, we showed that CHOP induction participated to cell death activation by Scd1 extinction. Indeed, overexpression of dominant negative CHOP construct and extinction of CHOP partially restored viability in Scd1-depleted cancer cells. Conclusion: These results suggest that inhibition of de novo MUFA synthesis by Scd1 extinction could be a promising anticancer target by inducing cell death through UPR and CHOP activation.	[Minville-Walz, Melaine; Pierre, Anne-Sophie; Pichon, Laurent; Bellenger, Sandrine; Fevre, Cecile; Bellenger, Jerome; Tessier, Christian; Narce, Michel; Rialland, Mickael] Univ Bourgogne, Ctr Rech, INSERM, Lipides Nutr Canc UMR866, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Minville-Walz, M (corresponding author), Univ Bourgogne, Ctr Rech, INSERM, Lipides Nutr Canc UMR866, Dijon, France.	mickael.rialland@u-bourgogne.fr	BELLENGER, Jerome/AAC-9423-2022	BELLENGER, Jerome/0000-0001-8643-6195; Narce, Michel/0000-0002-9986-6247; Rialland, Mickael/0000-0001-9693-9351; Bellenger, Sandrine/0000-0002-4593-5454	INSERM; Region Bourgogne; Centre National Interprofessionnel de l'Economie Laitiare	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Bourgogne(Region Bourgogne-Franche-Comte); Centre National Interprofessionnel de l'Economie Laitiare	This work was supported by grants from INSERM, Region Bourgogne and the Centre National Interprofessionnel de l'Economie Laitiare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaguel FG, 2009, J NEUROSCI RES, V87, P1207, DOI 10.1002/jnr.21918; Ariyama H, 2010, J BIOL CHEM; Baburina I, 1998, J BIOL CHEM, V273, P2169, DOI 10.1074/jbc.273.4.2169; CHAJES V, 1995, INT J CANCER, V63, P169, DOI 10.1002/ijc.2910630204; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Falvella FS, 2002, CARCINOGENESIS, V23, P1933, DOI 10.1093/carcin/23.11.1933; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Griffitts J, 2009, J LIPID RES, V50, P611, DOI 10.1194/jlr.M800265-JLR200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hardy S, 2000, CANCER RES, V60, P6353; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Jiang CC, 2009, CARCINOGENESIS, V30, P197, DOI 10.1093/carcin/bgn220; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; KANNAN R, 1980, CANCER RES, V40, P4606; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Koltun DO, 2009, BIOORG MED CHEM LETT, V19, P2048, DOI 10.1016/j.bmcl.2009.02.019; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Leger S, 2010, BIOORG MED CHEM LETT, V20, P499, DOI 10.1016/j.bmcl.2009.11.111; LI J, 1994, INT J CANCER, V57, P348, DOI 10.1002/ijc.2910570310; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Moore S, 2005, INT J CANCER, V114, P563, DOI 10.1002/ijc.20773; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Ou LH, 2008, J LIPID RES, V49, P985, DOI 10.1194/jlr.M700465-JLR200; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Piyathilake CJ, 2000, HUM PATHOL, V31, P1068, DOI 10.1053/hupa.2000.9842; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Qiao DH, 2002, BBA-MOL CELL BIOL L, V1583, P108, DOI 10.1016/S1388-1981(02)00190-7; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Rashid A, 1997, AM J PATHOL, V150, P201; RIBONI L, 1984, NEUROCHEM PATHOL, V2, P171, DOI 10.1007/BF02834351; ROBERT J, 1983, BIOCHIM BIOPHYS ACTA, V752, P383, DOI 10.1016/0005-2760(83)90268-0; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SABINE JR, 1967, CANCER RES, V27, P793; SAKAI K, 1992, CARCINOGENESIS, V13, P579, DOI 10.1093/carcin/13.4.579; Scaglia N, 2005, J BIOL CHEM, V280, P25339, DOI 10.1074/jbc.M501159200; Scaglia N, 2005, BBA-MOL CELL BIOL L, V1687, P141, DOI 10.1016/j.bbalip.2004.11.015; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; SIPERSTEIN MD, 1984, J LIPID RES, V25, P1462; Swinnen JV, 2000, INT J CANCER, V88, P176, DOI 10.1002/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Szachowicz-Petelska B, 2007, MOL CELL BIOCHEM, V294, P237, DOI 10.1007/s11010-006-9264-x; Thomas KC, 2007, J PHARMACOL EXP THER, V321, P830, DOI 10.1124/jpet.107.119412; van der Sanden MHM, 2004, J BIOL CHEM, V279, P52007, DOI 10.1074/jbc.M405577200; Van der Sanden MHM, 2003, BIOCHEM J, V369, P643, DOI 10.1042/BJ20020285; Vinciguerra M, 2009, J HEPATOL, V50, pS55, DOI 10.1016/S0168-8278(09)60139-2; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Wei Y, 2007, MOL CELL BIOCHEM, V303, P105, DOI 10.1007/s11010-007-9461-2; Yam D, 1997, CANCER LETT, V111, P179, DOI 10.1016/S0304-3835(96)04530-2; Yeung BHY, 2008, ONCOGENE, V27, P6782, DOI 10.1038/onc.2008.290; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	63	74	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e14363	10.1371/journal.pone.0014363	http://dx.doi.org/10.1371/journal.pone.0014363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21179554	gold, Green Published, Green Submitted			2022-12-25	WOS:000285381200011
J	Ochiel, DO; Ochsenbauer, C; Kappes, JC; Ghosh, M; Fahey, JV; Wira, CR				Ochiel, Daniel O.; Ochsenbauer, Christina; Kappes, John C.; Ghosh, Mimi; Fahey, John V.; Wira, Charles R.			Uterine Epithelial Cell Regulation of DC-SIGN Expression Inhibits Transmitted/Founder HIV-1 Trans Infection by Immature Dendritic Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FEMALE REPRODUCTIVE-TRACT; ANTIGEN-PRESENTING CELLS; MENSTRUAL-CYCLE; GENITAL-TRACT; GROWTH-FACTOR; T-CELLS; TGF-BETA; HUMAN ENDOMETRIUM; SPERM TRANSPORT	Background: Sexual transmission accounts for the majority of HIV-1 infections. In over 75% of cases, infection is initiated by a single variant (transmitted/founder virus). However, the determinants of virus selection during transmission are unknown. Host cell-cell interactions in the mucosa may be critical in regulating susceptibility to infection. We hypothesized in this study that specific immune modulators secreted by uterine epithelial cells modulate susceptibility of dendritic cells (DC) to infection with HIV-1. Methodology/Principal Findings: Here we report that uterine epithelial cell secretions (i.e. conditioned medium, CM) decreased DC-SIGN expression on immature dendritic cells via a transforming growth factor beta (TGF-beta) mechanism. Further, CM inhibited dendritic cell-mediated trans infection of HIV-1 expressing envelope proteins of prototypic reference. Similarly, CM inhibited trans infection of HIV-1 constructs expressing envelopes of transmitted/founder viruses, variants that are selected during sexual transmission. In contrast, whereas recombinant TGF-beta 1 inhibited trans infection of prototypic reference HIV-1 by dendritic cells, TGF-beta 1 had a minimal effect on trans infection of transmitted/founder variants irrespective of the reporter system used to measure trans infection. Conclusions/Significance: Our results provide the first direct evidence for uterine epithelial cell regulation of dendritic cell transmission of infection with reference and transmitted/founder HIV-1 variants. These findings have immediate implications for designing strategies to prevent sexual transmission of HIV-1.	[Ochiel, Daniel O.; Ghosh, Mimi; Fahey, John V.; Wira, Charles R.] Dartmouth Med Sch, Dept Physiol, Lebanon, NH USA; [Ochsenbauer, Christina; Kappes, John C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kappes, John C.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Kappes, John C.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	Dartmouth College; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ochiel, DO (corresponding author), Dartmouth Med Sch, Dept Physiol, Lebanon, NH USA.	Daniel.O.Ochiel@Dartmouth.edu			National Institutes of Health [AI51877, AI13541, U01-AI067854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R55AI013541, R01AI071761, R01AI013541, U01AI067854, R37AI013541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication was made possible by National Institutes of Health Grants AI51877 and AI13541 (CRW), and U01-AI067854 (JCK and CO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chevronnay HPG, 2008, ENDOCRINOLOGY, V149, P1015, DOI 10.1210/en.2007-0849; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Coleman KD, 2009, FERTIL STERIL, V92, P1107, DOI 10.1016/j.fertnstert.2008.10.047; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; EDMONDS TG, 2010, VIROLOGY; Fahey JV, 2005, HUM REPROD, V20, P1439, DOI 10.1093/humrep/deh806; Fancke B, 2008, BLOOD, V111, P150, DOI 10.1182/blood-2007-05-089292; Felts RL, 2010, P NATL ACAD SCI USA, V107, P13336, DOI 10.1073/pnas.1003040107; Funderburg N, 2007, P NATL ACAD SCI USA, V104, P18631, DOI 10.1073/PNAS.0702130104; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gelderblom HC, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-60; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hatch SC, 2009, J VIROL, V83, P3496, DOI 10.1128/JVI.02249-08; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Izquierdo-Useros N, 2009, BLOOD, V113, P2732, DOI 10.1182/blood-2008-05-158642; Jameson B, 2002, J VIROL, V76, P1866, DOI 10.1128/JVI.76.4.1866-1875.2002; Jones J, 2007, BIOTECHNIQUES, V43, P589, DOI 10.2144/000112624; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Jones RL, 2000, MOL HUM REPROD, V6, P1107, DOI 10.1093/molehr/6.12.1107; Kaul R, 2010, J LEUKOCYTE BIOL, V88, P427, DOI 10.1189/jlb.0410230; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kim MR, 2005, MOL HUM REPROD, V11, P801, DOI 10.1093/molehr/gah240; Kunz G, 1997, ADV EXP MED BIOL, V424, P267; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Li GL, 2007, BLOOD, V110, P2872, DOI 10.1182/blood-2006-10-050583; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Magerus-Chatinet A, 2007, VIROLOGY, V362, P67, DOI 10.1016/j.virol.2006.11.035; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Miller CJ, 2003, MICROBES INFECT, V5, P59, DOI 10.1016/S1286-4579(02)00056-4; Min L, 2010, J IMMUNOL, V184, P4625, DOI 10.4049/jimmunol.0903873; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Musso T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003271; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; Ochiel DO, 2010, J LEUKOCYTE BIOL, V88, P435, DOI 10.1189/jlb.1009700; Ochsenbauer C, 2009, CURR OPIN HIV AIDS, V4, P418, DOI 10.1097/COH.0b013e32832f011e; Ochsenbauer-Jambor C, 2006, BIOTECHNIQUES, V40, P91, DOI 10.2144/000112072; Petraglia F, 1998, J CLIN ENDOCR METAB, V83, P1194, DOI 10.1210/jc.83.4.1194; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634; RICHARDSON JM, 1995, BIOL REPROD, V53, P488, DOI 10.1095/biolreprod53.3.488; Rieger L, 2004, J SOC GYNECOL INVEST, V11, P488, DOI 10.1016/j.jsgi.2004.05.007; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schaefer TM, 2005, AM J REPROD IMMUNOL, V54, P193, DOI 10.1111/j.1600-0897.2005.00298.x; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; SETTLAGE DS, 1973, FERTIL STERIL, V24, P655; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Strobl H, 1999, MICROBES INFECT, V1, P1283, DOI 10.1016/S1286-4579(99)00256-7; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; UNAIDS, 2008, REP GLOB AIDS EP; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wira C, 2005, JAIDS-J ACQ IMM DEF, V38, pS34, DOI 10.1097/01.qai.0000167040.58181.d5; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yeaman GR, 2004, IMMUNOLOGY, V113, P524, DOI 10.1111/j.1365-2567.2004.01990.x; Yeaman GR, 2003, IMMUNOLOGY, V109, P137, DOI 10.1046/j.1365-2567.2003.01623.x; Yeaman GR, 1998, AIDS RES HUM RETROV, V14, pS57; Zervomanolakis I, 2007, ANN NY ACAD SCI, V1101, P1, DOI 10.1196/annals.1389.032	82	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2010	5	12							e14306	10.1371/journal.pone.0014306	http://dx.doi.org/10.1371/journal.pone.0014306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	694JH	21179465	Green Submitted, Green Published, gold			2022-12-25	WOS:000285292500002
J	Massie, A; Schallier, A; Kim, SW; Fernando, R; Kobayashi, S; Beck, H; De Bundel, D; Vermoesen, K; Bannai, S; Smolders, I; Conrad, M; Plesnila, N; Sato, H; Michotte, Y				Massie, Ann; Schallier, Anneleen; Kim, Seong Woong; Fernando, Ruani; Kobayashi, Sho; Beck, Heike; De Bundel, Dimitri; Vermoesen, Katia; Bannai, Shiro; Smolders, Ilse; Conrad, Marcus; Plesnila, Nikolaus; Sato, Hideyo; Michotte, Yvette			Dopaminergic neurons of system x(c)(-)-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity	FASEB JOURNAL			English	Article						xCT; glutathione; glutamate; Parkinson's disease	METABOTROPIC GLUTAMATE RECEPTORS; TIME-DEPENDENT CHANGES; MOUSE SPINAL-CORD; PARKINSONS-DISEASE; IN-VIVO; GLUTATHIONE DEFICIENCY; SUBTHALAMIC NUCLEUS; TRANSGENIC MICE; CYSTEINE UPTAKE; TRANSPORTER	Malfunctioning of system x(c)(-), responsible for exchanging intracellular glutamate for extracellular cystine, can cause oxidative stress and excitotoxicity, both important phenomena in the pathogenesis of Parkinson's disease (PD). We used mice lacking xCT (xCT(-/-) mice), the specific subunit of system x(c)(-), to investigate the involvement of this antiporter in PD. Although cystine that is imported via system x(c)(-) is reduced to cysteine, the rate-limiting substrate in the synthesis of glutathione, deletion of xCT did not result in decreased glutathione levels in striatum. Accordingly, no signs of increased oxidative stress could be observed in striatum or substantia nigra of xCT(-/-) mice. In sharp contrast to expectations, xCT(-/-) mice were less susceptible to 6-hydroxydopamine (6-OHDA)-induced neurodegeneration in the substantia nigra pars compacta compared to their age-matched wild-type littermates. This reduced sensitivity to a PD-inducing toxin might be related to the decrease of 70% in striatal extracellular glutamate levels that was observed in mice lacking xCT. The current data point toward system x(c)(-) as a possible target for the development of new pharmacotherapies for the treatment of PD and emphasize the need to continue the search for specific ligands for system x(c)(-).-Massie, A., Schallier, A., Kim, S. W., Fernando, R., Kobayashi, S., Beck, H., De Bundel, D., Vermoesen, K., Bannai, S., Smolders, I., Conrad, M., Plesnila, N., Sato, H., Michotte, Y. Dopaminergic neurons of system x(c)(-)-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity. FASEB J. 25, 1359-1369 (2011). www.fasebj.org	[Massie, Ann; Schallier, Anneleen; De Bundel, Dimitri; Vermoesen, Katia; Smolders, Ilse; Michotte, Yvette] Vrije Univ Brussel, Dept Pharmaceut Chem & Drug Anal, Res Grp Expt Pharmacol, B-1090 Brussels, Belgium; [Kim, Seong Woong; Plesnila, Nikolaus] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Fernando, Ruani] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Kobayashi, Sho; Bannai, Shiro; Sato, Hideyo] Yamagata Univ, Fac Agr, Dept Food & Appl Life Sci, Yamagata 990, Japan; [Beck, Heike] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Conrad, Marcus] Inst Clin Mol Biol & Tumor Genet, Helmholtz Ctr Munich, Munich, Germany	Vrije Universiteit Brussel; Royal College of Surgeons - Ireland; Karolinska Institutet; Yamagata University; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Massie, A (corresponding author), Vrije Univ Brussel, Dept Pharmaceut Chem & Drug Anal, Res Grp Expt Pharmacol, Laarbeeklaan 103, B-1090 Brussels, Belgium.	amassie@vub.ac.be	Smolders, Ilse J/J-9399-2013; Michotte, Yvette/G-9818-2013; Plesnila, Nikolaus/T-7522-2019; De Bundel, Dimitri/AAG-9453-2020; Massie, Ann/F-1039-2013; De Bundel, Dimitri/C-5701-2015; Conrad, Marcus/E-8792-2015	Smolders, Ilse J/0000-0003-2140-0751; Conrad, Marcus/0000-0003-1140-5612; Massie, Ann/0000-0002-8418-5879; De Bundel, Dimitri/0000-0002-6234-9908	Brussels Capital Region; Fonds voor Wetenschappelijk Onderzoek (FWO)-Flanders; Vrije Universiteit Brussel	Brussels Capital Region; Fonds voor Wetenschappelijk Onderzoek (FWO)-Flanders(FWO); Vrije Universiteit Brussel	This work was supported by grants of the Brussels Capital Region (Prospective Research for Brussels), Fonds voor Wetenschappelijk Onderzoek (FWO)-Flanders, and the Vrije Universiteit Brussel. A. S. is a research assistant of the FWO-Flanders and K. V. is a research assistant of the Agentschap voor Innovatie door Wetenschap en Technologie (IWT)-Flanders. The authors thank Mr. G. De Smet and Ms. A. De Smet for excellent technical assistance, as well as Dr. M. Watanabe (Hokkaido University School of Medicine, Sapporo, Japan) for providing antibodies.	Albrecht P, 2010, CNS NEUROL DISORD-DR, V9, P373, DOI 10.2174/187152710791292567; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Asanuma M, 1998, NEUROSCIENCE, V85, P907, DOI 10.1016/S0306-4522(97)00665-9; Augustin H, 2007, J NEUROSCI, V27, P111, DOI 10.1523/JNEUROSCI.4770-06.2007; Baker DA, 2002, J NEUROSCI, V22, P9134; BANNAI S, 1986, J BIOL CHEM, V261, P2256; Battaglia G, 2004, J NEUROSCI, V24, P828, DOI 10.1523/JNEUROSCI.3831-03.2004; Bensadoun JC, 1998, EUR J NEUROSCI, V10, P3231, DOI 10.1046/j.1460-9568.1998.00345.x; Blandini F, 2001, FUNCT NEUROL, V16, P99; Blandini F, 2000, PROG NEUROBIOL, V62, P63, DOI 10.1016/S0301-0082(99)00067-2; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Fournier KM, 2004, J BIOL CHEM, V279, P34505, DOI 10.1074/jbc.M404032200; Himi T, 2003, J NEURAL TRANSM, V110, P1337, DOI 10.1007/s00702-003-0049-z; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; LINDEFORS N, 1990, NEUROSCI LETT, V115, P248, DOI 10.1016/0304-3940(90)90463-J; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Massie A, 2008, NEUROREPORT, V19, P1589, DOI 10.1097/WNR.0b013e328312181c; Massie A, 2010, NEUROCHEM INT, V57, P111, DOI 10.1016/j.neuint.2010.04.019; Meshul CK, 1999, NEUROSCIENCE, V88, P1, DOI 10.1016/S0306-4522(98)00189-4; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Qin S, 2006, J NEUROSCI, V26, P3345, DOI 10.1523/JNEUROSCI.5186-05.2006; Rodriguez MC, 1998, ANN NEUROL, V44, pS175, DOI 10.1002/ana.410440726; Rouse ST, 2000, PHARMACOL THERAPEUT, V88, P427, DOI 10.1016/S0163-7258(00)00098-X; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shanker G, 2001, BRAIN RES, V902, P156, DOI 10.1016/S0006-8993(01)02342-3; Shibata T, 1997, J NEUROSCI, V17, P9212; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Sontheimer H, 2003, TRENDS NEUROSCI, V26, P543, DOI 10.1016/j.tins.2003.08.007; Van Hemelrijek A, 2005, J NEUROSCI METH, V144, P63, DOI 10.1016/j.jneumeth.2004.10.013; Vernon AC, 2007, J NEUROCHEM, V103, P1075, DOI 10.1111/j.1471-4159.2007.04860.x; Yamada K, 1998, J NEUROSCI, V18, P5706	36	96	99	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2011	25	4					1359	1369		10.1096/fj.10-177212	http://dx.doi.org/10.1096/fj.10-177212			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	742ZA	21191088				2022-12-25	WOS:000288982800025
J	Kim, DY; Gersbacher, MT; Inquimbert, P; Kovacs, DM				Kim, Doo Yeon; Gersbacher, Manuel T.; Inquimbert, Perrine; Kovacs, Dora M.			Reduced Sodium Channel Na(v)1.1 Levels in BACE1-null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE BACE1; APP TRANSGENIC MICE; ALZHEIMERS-DISEASE; MOLECULAR-MECHANISMS; MULTIPLE-SCLEROSIS; NEURONAL-ACTIVITY; GAMMA-SECRETASE; CELL-ADHESION; MOUSE MODEL	The Alzheimer BACE1 enzyme cleaves numerous substrates, with largely unknown physiological consequences. We have previously identified the contribution of elevated BACE1 activity to voltage-gated sodium channel Na(v)1.1 density and neuronal function. Here, we analyzed physiological changes in sodium channel metabolism in BACE1-null mice. Mechanistically, we first confirmed that endogenous BACE1 requires its substrate, the beta-subunit Na-v beta 2, to regulate levels of the pore-forming alpha-subunit Na(v)1.1 in cultured primary neurons. Next, we analyzed sodium channel alpha-subunit levels in brains of BACE1-null mice at 1 and 3 months of age. At both ages, we found that Na(v)1.1 protein levels were significantly decreased in BACE1-null versus wild-type mouse brains, remaining unchanged in BACE1-heterozygous mouse brains. Interestingly, levels of Na(v)1.2 and Na(v)1.6 alpha-subunits also decreased in 1-month-old BACE1-null mice. In the hippocampus of BACE1-null mice, we found a robust 57% decrease of Na(v)1.1 levels. Next, we performed surface biotinylation studies in acutely dissociated hippocampal slices from BACE1-null mice. Hippocampal surface Na(v)1.1 levels were significantly decreased, but Na(v)1.2 surface levels were increased in BACE1-null mice perhaps as a compensatory mechanism for reduced surface Na(v)1.1. We also found that Na-v beta(2) processing and Na(v)1.1 mRNA levels were significantly decreased in brains of BACE1-null mice. This suggests a mechanism consistent with BACE1 activity regulating mRNA levels of the alpha-subunit Na(v)1.1 via cleavage of cell-surface Na-v beta(2). Together, our data show that endogenous BACE1 activity regulates total and surface levels of voltage-gated sodium channels in mouse brains. Both decreased Na(v)1.1 and elevated surface Na(v)1.2 may result in a seizure phenotype. Our data caution that therapeutic BACE1 activity inhibition in Alzheimer disease patients may affect Na(v)1 metabolism and alter neuronal membrane excitability in Alzheimer disease patients.	Harvard Univ, Massachusetts Gen Hosp, Sch Med,Neurobiol Dis Lab,Genet & Aging Res Unit, Massachusetts Gen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Inquimbert, Perrine] Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital		dora_kovacs@hms.harvard.edu		Inquimbert, Perrine/0000-0003-2625-1468	National Institutes of Health, NIA; NATIONAL INSTITUTE ON AGING [R01AG014713, R21AG031483] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health grants from NIA (to D. M. K. and D. Y. K.).	Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2002, NOVART FDN SYMP, V241, P206; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chen CL, 2002, P NATL ACAD SCI USA, V99, P17072, DOI 10.1073/pnas.212638099; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Davis TH, 2004, J BIOL CHEM, V279, P51424, DOI 10.1074/jbc.M410830200; de Leon M J, 1995, Neuroimaging Clin N Am, V5, P1; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hitt BD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-31; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2010, J NEUROSCI, V30, P8819, DOI 10.1523/JNEUROSCI.1334-10.2010; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; O'Malley HA, 2009, MOL CELL NEUROSCI, V40, P143, DOI 10.1016/j.mcn.2008.10.001; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thomas-Crusells J, 2003, J NEUROSCI METH, V125, P159, DOI 10.1016/S0165-0270(03)00050-5; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Waxman SG, 2004, TRENDS PHARMACOL SCI, V25, P584, DOI 10.1016/j.tips.2004.09.001; WESTENBROEK RE, 1992, J NEUROSCI, V12, P2259, DOI 10.1523/jneurosci.12-06-02259.1992; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wolfe MS, 2008, CURR ALZHEIMER RES, V5, P158, DOI 10.2174/156720508783954767; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zacchetti D, 2007, NEURODEGENER DIS, V4, P117, DOI 10.1159/000101836; Zayas EM, 1996, J CLIN PSYCHIAT, V57, P46	48	66	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8106	8116		10.1074/jbc.M110.134692	http://dx.doi.org/10.1074/jbc.M110.134692			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21190943	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-25	WOS:000288013300041
J	Haeuptle, MA; Welti, M; Troxler, H; Hulsmeier, AJ; Imbach, T; Hennet, T				Haeuptle, Micha A.; Welti, Michael; Troxler, Heinz; Huelsmeier, Andreas J.; Imbach, Timo; Hennet, Thierry			Improvement of Dolichol-linked Oligosaccharide Biosynthesis by the Squalene Synthase Inhibitor Zaragozic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; CONGENITAL DISORDER; SELECTIVE-INHIBITION; GLYCOSYLATION; CHOLESTEROL; DEFICIENCY; PHOSPHATE; GENE; DERIVATIVES; MUTATIONS	The majority of congenital disorders of glycosylation (CDG) are caused by defects of dolichol (Dol)-linked oligosaccharide assembly, which lead to under-occupancy of N-glycosylation sites. Most mutations encountered in CDG are hypomorphic, thus leaving residual activity to the affected biosynthetic enzymes. We hypothesized that increased cellular levels of Dol-linked substrates might compensate for the low biosynthetic activity and thereby improve the output of protein N-glycosylation in CDG. To this end, we investigated the potential of the squalene synthase inhibitor zaragozic acid A to redirect the flow of the polyisoprene pathway toward Dol by lowering cholesterol biosynthesis. The addition of zaragozic acid A to CDG fibroblasts with a Dol-PMan synthase defect led to the formation of longer Dol-P species and to increased Dol-P-Man levels. This treatment was shown to decrease the pathologic accumulation of incomplete Dol pyrophosphate-GlcNAc(2)Man(5) in Dol-P-Man synthase-deficient fibroblasts. Zaragozic acid A treatment also decreased the amount of truncated protein N-linked oligosaccharides in these CDG fibroblasts. The increased cellular levels of Dol-P-Man and possibly the decreased cholesterol levels in zaragozic acid A-treated cells also led to increased availability of the glycosylphosphatidylinositol anchor as shown by the elevated cell-surface expression of the CD59 protein. This study shows that manipulation of the cellular Dol pool, as achieved by zaragozic acid A addition, may represent a valuable approach to improve N-linked glycosylation in CDG cells.	[Haeuptle, Micha A.; Welti, Michael; Huelsmeier, Andreas J.; Imbach, Timo; Hennet, Thierry] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Troxler, Heinz] Childrens Hosp Zurich, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland	University of Zurich; University Children's Hospital Zurich	Hennet, T (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	thennet@access.uzh.ch		Hulsmeier, Andreas J./0000-0001-6987-8979	Swiss National Science Foundation [31003A-116039]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 31003A-116039 (to T. H.).	ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; BAXTER A, 1992, J BIOL CHEM, V267, P11705; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; BERGSTROM JD, 1995, ANNU REV MICROBIOL, V49, P607, DOI 10.1146/annurev.mi.49.100195.003135; CRICK DC, 1995, J NEUROCHEM, V65, P1365; De Praeter CM, 2000, AM J HUM GENET, V66, P1744, DOI 10.1086/302948; DeRossi C, 2006, J BIOL CHEM, V281, P5916, DOI 10.1074/jbc.M511982200; Eklund EA, 2005, GLYCOBIOLOGY, V15, P1084, DOI 10.1093/glycob/cwj006; ELMBERGER PG, 1989, BIOMED CHROMATOGR, V3, P20, DOI 10.1002/bmc.1130030106; Foulquier F, 2009, BBA-MOL BASIS DIS, V1792, P896, DOI 10.1016/j.bbadis.2008.10.020; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Freeze HH, 2009, BBA-MOL BASIS DIS, V1792, P835, DOI 10.1016/j.bbadis.2009.01.004; Grubenmann CE, 2002, HUM MOL GENET, V11, P2331, DOI 10.1093/hmg/11.19.2331; Haeuptle MA, 2008, AM J HUM GENET, V82, P600, DOI 10.1016/j.ajhg.2007.12.021; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Haeuptle MA, 2010, ANAL BIOCHEM, V396, P133, DOI 10.1016/j.ab.2009.09.020; Hansske B, 2002, J CLIN INVEST, V109, P725, DOI 10.1172/JCI200214010; Hardre R, 2007, BIOORG MED CHEM LETT, V17, P152, DOI 10.1016/j.bmcl.2006.09.074; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hulsmeier AJ, 2007, MOL CELL PROTEOMICS, V6, P2132, DOI 10.1074/mcp.M700361-MCP200; Imbach T, 2000, J CLIN INVEST, V105, P233, DOI 10.1172/JCI8691; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Keller RK, 1996, BBA-LIPID LIPID MET, V1303, P169, DOI 10.1016/0005-2760(96)00081-1; Kim S, 2000, J CLIN INVEST, V105, P191, DOI 10.1172/JCI7302; Kinoshita T, 1997, J BIOCHEM-TOKYO, V122, P251; KOGA T, 1990, BIOCHIM BIOPHYS ACTA, V1045, P115, DOI 10.1016/0005-2760(90)90139-O; Korner C, 1998, GLYCOBIOLOGY, V8, P165, DOI 10.1093/glycob/8.2.165; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Leroy JG, 2006, PEDIATR RES, V60, P643, DOI 10.1203/01.pdr.0000246802.57692.ea; LISCUM L, 1995, J BIOL CHEM, V270, P15443, DOI 10.1074/jbc.270.26.15443; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/ng0501-73; Marek KW, 1999, GLYCOBIOLOGY, V9, P1263; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; McTaggart F, 2001, AM J CARDIOL, V87, p28B; MUSCIO F, 1974, J BIOL CHEM, V249, P3746; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Rutschow S, 2002, BIOORGAN MED CHEM, V10, P4043, DOI 10.1016/S0968-0896(02)00269-9; Shang J, 2004, J BIOL CHEM, V279, P9703, DOI 10.1074/jbc.M310837200; Silva M, 2007, CLIN THER, V29, P253, DOI 10.1016/j.clinthera.2007.02.008; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05; Westphal V, 2001, MOL GENET METAB, V73, P77, DOI 10.1006/mgme.2001.3161; YAMADA K, 1986, ANAL BIOCHEM, V156, P380, DOI 10.1016/0003-2697(86)90268-X	44	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6085	6091		10.1074/jbc.M110.165795	http://dx.doi.org/10.1074/jbc.M110.165795			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21183681	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000287476400017
J	Ifkovits, JL; Wu, K; Mauck, RL; Burdick, JA				Ifkovits, Jamie L.; Wu, Katherine; Mauck, Robert L.; Burdick, Jason A.			The Influence of Fibrous Elastomer Structure and Porosity on Matrix Organization	PLOS ONE			English	Article							ELECTROSPUN SCAFFOLDS; NANOFIBROUS SCAFFOLDS; BIODEGRADABLE ELASTOMER; ANNULUS FIBROSUS; TISSUE; CARDIOMYOCYTES; INFILTRATION; REPLACEMENT; ANISOTROPY; FIBERS	Fibrous scaffolds are finding wide use in the field of tissue engineering, as they can be designed to mimic many native tissue properties and structures (e. g., cardiac tissue, meniscus). The influence of fiber alignment and scaffold architecture on cellular interactions and matrix organization was the focus of this study. Three scaffolds were fabricated from the photocrosslinkable elastomer poly(glycerol sebacate) (PGS), with changes in fiber alignment (non-aligned (NA) versus aligned (AL)) and the introduction of a PEO sacrificial polymer population to the AL scaffold (composite (CO)). PEO removal led to an increase in scaffold porosity and maintenance of scaffold anisotropy, as evident through visualization, mechanical testing, and mass loss studies. Hydrated scaffolds possessed moduli that ranged between similar to 3-240 kPa, failing within the range of properties (<300 kPa) appropriate for soft tissue engineering. CO scaffolds were completely degraded as early as 16 days, whereas NA and AL scaffolds had similar to 90% mass loss after 21 days when monitored in vitro. Neonatal cardiomyocytes, used as a representative cell type, that were seeded onto the scaffolds maintained their viability and aligned along the surface of the AL and CO fibers. When implanted subcutaneously in rats, a model that is commonly used to investigate in vivo tissue responses to biomaterials, CO scaffolds were completely integrated at 2 weeks, whereas similar to 13% and similar to 16% of the NA and AL scaffolds, respectively remained acellular. However, all scaffolds were completely populated with cells at 4 weeks post-implantation. Polarized light microscopy was used to evaluate the collagen elaboration and orientation within the scaffold. An increase in the amount of collagen was observed for CO scaffolds and enhanced alignment of the nascent collagen was observed for AL and CO scaffolds compared to NA scaffolds. Thus, these results indicate that the scaffold architecture and porosity are important considerations in controlling tissue formation.	[Ifkovits, Jamie L.; Wu, Katherine; Mauck, Robert L.; Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Mauck, Robert L.] Univ Penn, Dept Orthopaed Surg, McKay Orthopaed Res Lab, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Ifkovits, JL (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	burdick2@seas.upenn.edu		Mauck, Robert/0000-0002-9537-603X	American Heart Association; Ashton Foundation; National Institutes of Health [R01AR056624]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056624] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Ashton Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by an American Heart Association predoctoral fellowship and an Ashton Foundation Fellowship to Jamie Ifkovits and a National Institutes of Health grant (R01AR056624). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032; Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004; Baker BM, 2009, EXPERT REV MED DEVIC, V6, P515, DOI [10.1586/erd.09.39, 10.1586/ERD.09.39]; Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Fromstein JD, 2008, TISSUE ENG PT A, V14, P369, DOI 10.1089/tea.2006.0410; Ifkovits JL, 2009, ACS APPL MATER INTER, V1, P1878, DOI 10.1021/am900403k; Ifkovits JL, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034104; Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821; Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Li JL, 2007, J BIOL CHEM, V282, P34984, DOI 10.1074/jbc.M703513200; MAUCK RL, 2009, TISSUE EN B IN PRESS; METTER RB, ACTA BIOMATER, V6, P1219; Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306; Nam J, 2009, TISSUE ENG PT A, V15, P513, DOI 10.1089/ten.tea.2007.0353; Nerem RM, 2006, TISSUE ENG, V12, P1143, DOI 10.1089/ten.2006.12.1143; Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384; Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]; Rockwood DN, 2008, BIOMATERIALS, V29, P4783, DOI 10.1016/j.biomaterials.2008.08.034; Stankus JJ, 2008, J BIOMAT SCI-POLYM E, V19, P635, DOI 10.1163/156856208784089599; Sundararaghavan H. G., MACROMOL BIOSCI, V10, P265; Tan AR, 2008, J BIOMED MATER RES A, V87A, P1034, DOI 10.1002/jbm.a.31853; Tzezana R, 2008, TISSUE ENG PART C-ME, V14, P281, DOI 10.1089/ten.tec.2008.0201; van Amerongen MJ, 2006, BIOMATERIALS, V27, P2247, DOI 10.1016/j.biomaterials.2005.11.002; Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602; Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801; Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Zhu XL, 2008, BIOMACROMOLECULES, V9, P1795, DOI 10.1021/bm800476u	32	24	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2010	5	12							e15717	10.1371/journal.pone.0015717	http://dx.doi.org/10.1371/journal.pone.0015717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698FG	21203510	Green Published, Green Submitted, gold			2022-12-25	WOS:000285578000049
J	Umeda, T; Takashima, N; Nakagawa, R; Maekawa, M; Ikegami, S; Yoshikawa, T; Kobayashi, K; Okanoya, K; Inokuchi, K; Osumi, N				Umeda, Toshiko; Takashima, Noriko; Nakagawa, Ryoko; Maekawa, Motoko; Ikegami, Shiro; Yoshikawa, Takeo; Kobayashi, Kazuto; Okanoya, Kazuo; Inokuchi, Kaoru; Osumi, Noriko			Evaluation of Pax6 Mutant Rat as a Model for Autism	PLOS ONE			English	Article							MENTAL-RETARDATION; PREPULSE INHIBITION; ULTRASONIC VOCALIZATION; SPECTRUM DISORDERS; RECEPTOR GENE; WAGR SYNDROME; CREST CELLS; MOUSE MODEL; SMALL-EYE; SEROTONIN	Autism is a highly variable brain developmental disorder and has a strong genetic basis. Pax6 is a pivotal player in brain development and maintenance. It is expressed in embryonic and adult neural stem cells, in astrocytes in the entire central nervous system, and in neurons in the olfactory bulb, amygdala, thalamus, and cerebellum, functioning in highly context-dependent manners. We have recently reported that Pax6 heterozygous mutant (rSey(2)/+) rats with a spontaneous mutation in the Pax6 gene, show impaired prepulse inhibition (PPI). In the present study, we further examined behaviors of rSey(2)/+ rats and revealed that they exhibited abnormality in social interaction (more aggression and withdrawal) in addition to impairment in rearing activity and in fear-conditioned memory. Ultrasonic vocalization (USV) in rSey(2)+ rat pups was normal in male but abnormal in female. Moreover, treatment with clozapine successfully recovered the defects in sensorimotor gating function, but not in fear-conditioned memory. Taken together with our prior human genetic data and results in other literatures, rSey(2)/+ rats likely have some phenotypic components of autism.	[Umeda, Toshiko; Osumi, Noriko] Tohoku Univ, Grad Sch Med, Div Dev Neurosci, Sendai, Miyagi 980, Japan; [Takashima, Noriko] RIKEN, Brain Sci Inst, Lab Behav & Dev Disorders, Wako, Saitama, Japan; [Takashima, Noriko; Ikegami, Shiro; Inokuchi, Kaoru] Mitsubishi Kagaku Inst Life Sci MITILS, Tokyo, Japan; [Nakagawa, Ryoko; Okanoya, Kazuo] RIKEN, Brain Sci Inst, Lab Biolinguist, Wako, Saitama, Japan; [Maekawa, Motoko; Yoshikawa, Takeo] RIKEN, Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama, Japan; [Ikegami, Shiro] Saitama Inst Technol, Dept Psychol, Fukaya, Japan; [Kobayashi, Kazuto] Fukushima Med Univ, Inst Biomed Sci, Dept Mol Genet, Sch Med, Fukushima, Japan; [Inokuchi, Kaoru] Toyama Univ, Dept Biochem, Fac Med, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan	Tohoku University; RIKEN; Mitsubishi Kagaku Institute of Life Sciences (MITILS); RIKEN; RIKEN; Saitama Institute Technology; Fukushima Medical University; University of Toyama	Umeda, T (corresponding author), Tohoku Univ, Grad Sch Med, Div Dev Neurosci, Sendai, Miyagi 980, Japan.	osumi@med.tohoku.ac.jp	Yoshikawa, Takeo/F-9599-2019; Osumi, Noriko/T-2823-2019; Inokuchi, Kaoru/AAI-9693-2020	Osumi, Noriko/0000-0003-0548-6452; Inokuchi, Kaoru/0000-0002-5393-3133	Special Coordinate Funds for Promoting Science and Technology; Japanese Science and Technology Agency; MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan	Special Coordinate Funds for Promoting Science and Technology; Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Special Coordinate Funds for Promoting Science and Technology (to N.O.), Japanese Science and Technology Agency (to N.O., T.Y. and K.I.), and Global COE (Centers of Excellence) Program from MEXT (the Ministry of Education, Culture, Sports, Science and Technology) of Japan (to N.O.). T.U. and R.N. are Japan Society for the Promotion of Science Research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GM, 2002, J AM ACAD CHILD PSY, V41, P1513, DOI 10.1097/00004583-200212000-00025; ARRANZ M, 1995, LANCET, V346, P281, DOI 10.1016/S0140-6736(95)92168-0; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Becker A, 1999, PSYCHOPHARMACOLOGY, V144, P333, DOI 10.1007/s002130051015; Becker KG, 2004, MED HYPOTHESES, V62, P309, DOI 10.1016/S0306-9877(03)00332-3; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bouwknecht JA, 2004, EUR J PHARMACOL, V494, P35, DOI 10.1016/j.ejphar.2004.04.036; Brauer D, 2009, J NEURAL TRANSM, V116, P607, DOI 10.1007/s00702-009-0222-0; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Brieden T, 2002, PHARMACOPSYCHIATRY, V35, P83, DOI 10.1055/s-2002-31523; Burnet PWJ, 1996, NEUROSCIENCE, V73, P531, DOI 10.1016/0306-4522(96)00062-0; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; COSTALL B, 1989, PHARMACOL BIOCHEM BE, V33, P573, DOI 10.1016/0091-3057(89)90390-0; Danaceau JP, 2003, J ANAL TOXICOL, V27, P440, DOI 10.1093/jat/27.7.440; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; Dworzynski K, 2009, J AUTISM DEV DISORD, V39, P1197, DOI 10.1007/s10803-009-0736-1; Fischbach BV, 2005, PEDIATRICS, V116, P984, DOI 10.1542/peds.2004-0467; Free SL, 2003, NEUROIMAGE, V20, P2281, DOI 10.1016/j.neuroimage.2003.07.001; Freitag CM, 2010, EUR CHILD ADOLES PSY, V19, P169, DOI 10.1007/s00787-009-0076-x; FRITH U, 1993, SCI AM, V268, P108, DOI 10.1038/scientificamerican0693-108; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Graziano C, 2007, AM J MED GENET A, V143A, P1802, DOI 10.1002/ajmg.a.31808; Guo HL, 2000, BIOCHEM BIOPH RES CO, V273, P661, DOI 10.1006/bbrc.2000.2870; Haba H, 2009, NEUROSCI RES, V65, P116, DOI 10.1016/j.neures.2009.05.011; HANSON I, 1995, TRENDS GENET, V11, P268, DOI 10.1016/S0168-9525(00)89073-3; Hardan AY, 2009, PSYCHIAT RES-NEUROIM, V174, P57, DOI 10.1016/j.pscychresns.2009.03.005; Hartley SL, 2009, J AUTISM DEV DISORD; Huang CH, 2008, AM J MED GENET B, V147B, P903, DOI 10.1002/ajmg.b.30720; Hughes JR, 2009, EPILEPSY BEHAV, V16, P569, DOI 10.1016/j.yebeh.2009.09.023; Ikegami S, 2000, NEUROSCIENCE, V98, P637, DOI 10.1016/S0306-4522(00)00161-5; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Kanakubo S, 2006, GENES CELLS, V11, P919, DOI 10.1111/j.1365-2443.2006.00992.x; Kew JNC, 2000, J NEUROSCI, V20, P4037; Klin A, 2007, J AUTISM DEV DISORD, V37, P748, DOI 10.1007/s10803-006-0229-4; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Maekawa M, 2005, GENES CELLS, V10, P1001, DOI 10.1111/j.1365-2443.2005.00893.x; Maekawa M, 2009, NEUROSCI LETT, V462, P267, DOI 10.1016/j.neulet.2009.07.021; Maekawa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005085; Malandrini A, 2001, CLIN GENET, V60, P151, DOI 10.1034/j.1399-0004.2001.600210.x; MATSUO T, 1993, NAT GENET, V3, P299, DOI 10.1038/ng0493-299; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McEuen JG, 2009, ENDOCRINOLOGY, V150, P3709, DOI 10.1210/en.2008-1721; Mitchell TN, 2003, ANN NEUROL, V53, P658, DOI 10.1002/ana.10576; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nishina S, 1999, BRIT J OPHTHALMOL, V83, P723, DOI 10.1136/bjo.83.6.723; Ospina MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003755; Osumi N, 2001, TOHOKU J EXP MED, V193, P163, DOI 10.1620/tjem.193.163; Osumi N, 1997, DEVELOPMENT, V124, P2961; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; RIGDON GC, 1992, J PHARMACOL EXP THER, V263, P486; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Sakurai K, 2008, J NEUROSCI, V28, P4604, DOI 10.1523/JNEUROSCI.5074-07.2008; Sano H, 2003, J NEUROSCI, V23, P9078; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Senju A, 2009, NEUROSCI BIOBEHAV R, V33, P1204, DOI 10.1016/j.neubiorev.2009.06.001; Shinohara T, 2001, HUM MOL GENET, V10, P1163, DOI 10.1093/hmg/10.11.1163; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Spivak B, 2004, NEUROPSYCHOBIOLOGY, V50, P157, DOI 10.1159/000079108; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Swerdlow NR, 2000, J NEUROSCI, V20, P4325; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Tuoc TC, 2009, J NEUROSCI, V29, P8335, DOI 10.1523/JNEUROSCI.5669-08.2009; Van Steenwinckel J, 2009, NEUROSCIENCE, V161, P838, DOI 10.1016/j.neuroscience.2009.03.087; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wellmann K, 2010, NEUROTOXICOL TERATOL, V32, P158, DOI 10.1016/j.ntt.2009.11.005; Wells CE, 2009, BEHAV BRAIN RES, V197, P234, DOI 10.1016/j.bbr.2008.08.013; WING L, 1981, PSYCHIAT RES, V5, P129, DOI 10.1016/0165-1781(81)90043-3; Xu S, 2008, CYTOGENET GENOME RES, V122, P181, DOI 10.1159/000172086; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; [No title captured]	79	45	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15500	10.1371/journal.pone.0015500	http://dx.doi.org/10.1371/journal.pone.0015500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	21203536	Green Published, gold			2022-12-25	WOS:000285576900031
J	Chung, FT; Lin, HC; Kuo, CH; Yu, CT; Chou, CL; Lee, KY; Kuo, HP; Lin, SM				Chung, Fu-Tsai; Lin, Horng-Chyuan; Kuo, Chih-Hsi; Yu, Chih-Teng; Chou, Chun-Liang; Lee, Kang-Yun; Kuo, Han-Pin; Lin, Shu-Min			Extravascular Lung Water Correlates Multiorgan Dysfunction Syndrome and Mortality in Sepsis	PLOS ONE			English	Article							TRANSPULMONARY THERMODILUTION; ORGAN FAILURE; MICROALBUMINURIA; SCORE; CLASSIFICATION; SEVERITY; OUTCOMES	Background: This study was designated to investigate whether increased extravascular lung water index (EVLWI) may correlate multiple organ dysfunction syndrome (MODS) and mortality in sepsis. Methods: We designed a prospective cohort study in an intensive care unit of a tertiary care hospital. Sixty-seven patients with severe sepsis were included. Data were used to determine an association between EVLWI and the development of MODS and mortality. These connections were determined by the multiple logistic regression, plotting the receiver operating characteristic (ROC) curve and by Spearman test. Results: EVLWI levels were higher in MODS patients on day 1 (median (IQR), 18(12.8-23.9) ml/kg, n = 38, p<0.0001) than in those without (median (IQR), 12.4 (7.9-16.3) ml/kg, n = 29) and day 3 (median (IQR), 17.8 (11.2-22.8) ml/kg, n = 29, p = 0.004) than in those without (median (IQR), 12.4 (8.0-16.3) ml/kg, n = 29). EVLWI was used as an independent predictor of the development of MODS (odds ratio, 1.6; p = 0.005; 95% confidence interval, 1.2 similar to 2.2) during ICU stay. The area under the ROC curve showed that EVLWI levels could predict MODS (0.866) and mortality (0.881) during ICU stay. Meanwhile, the higher of SOFA score, the more EVLWI was found on day 1 (r = 0.7041, p<0.0001) and day 3 (r = 0.7732, p<0.0001). Conclusions: Increased EVLWI levels correlates development of MODS and mortality during the patients' ICU stay. Further more, the potential of novel treatment in severe sepsis with lung injury may develop.	[Chung, Fu-Tsai; Lin, Horng-Chyuan; Kuo, Chih-Hsi; Yu, Chih-Teng; Chou, Chun-Liang; Lee, Kang-Yun; Kuo, Han-Pin; Lin, Shu-Min] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Dept Thorac Med, Taipei, Taiwan; [Chung, Fu-Tsai] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Chung, FT (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Dept Thorac Med, Taipei, Taiwan.	smlin100@gmail.com	Lin, Shu-Min/B-9207-2011					Abid O, 2001, CHEST, V120, P1984, DOI 10.1378/chest.120.6.1984; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; ASTIZ ME, 1995, CRIT CARE MED, V23, P265, DOI 10.1097/00003246-199502000-00011; BOGNAR Z, 2010, BURN IN PRESS, DOI DOI 10.1016/J.BURNS.2010.04.006; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Chen YC, 2009, SHOCK, V31, P139, DOI 10.1097/SHK.0b013e31817d419e; Chung FT, 2008, RESP MED, V102, P956, DOI 10.1016/j.rmed.2008.02.016; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Gullo A, 1996, Acta Anaesthesiol Scand Suppl, V109, P70; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Katzenelson R, 2004, CRIT CARE MED, V32, P1550, DOI 10.1097/01.CCM.0000130995.18334.8B; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krau Stephen D, 2007, Crit Care Nurs Clin North Am, V19, P87, DOI 10.1016/j.ccell.2006.11.002; Kuzkov VV, 2006, CRIT CARE MED, V34, P1647, DOI 10.1097/01.CCM.0000218817.24208.2E; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Lin SM, 2008, CRIT CARE MED, V36, P683, DOI 10.1097/CCM.0B013E31816537D8; Lydon Avine, 2003, Int Anesthesiol Clin, V41, P65; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin GS, 2005, CRIT CARE, V9, pR74, DOI 10.1186/cc3025; Michard F, 2007, CRIT CARE MED, V35, P1186, DOI 10.1097/01.CCM.0000259539.49339.66; Molnar Z, 2003, INTENS CARE MED, V29, P391, DOI 10.1007/s00134-003-1651-0; Neumann P, 1999, INTENS CARE MED, V25, P216, DOI 10.1007/s001340050819; Sakka SG, 2000, INTENS CARE MED, V26, P180, DOI 10.1007/s001340050043; Sakka SG, 2002, CHEST, V122, P2080, DOI 10.1378/chest.122.6.2080; Spapen HD, 2005, CHEST, V127, P1413, DOI 10.1378/chest.127.4.1413; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Volman TJH, 2005, SHOCK, V23, P291, DOI 10.1097/01.shk.0000155350.95435.28; Zimmerman JE, 1996, CRIT CARE MED, V24, P1633, DOI 10.1097/00003246-199610000-00006	31	28	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2010	5	12							e15265	10.1371/journal.pone.0015265	http://dx.doi.org/10.1371/journal.pone.0015265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	695OI	21187890	Green Published, Green Submitted, gold			2022-12-25	WOS:000285381200021
J	Bauer, WR; Nadler, W				Bauer, Wolfgang R.; Nadler, Walter			Thermodynamics of Competitive Molecular Channel Transport: Application to Artificial Nuclear Pores	PLOS ONE			English	Article							DIFFUSION	In an analytical model channel transport is analyzed as a function of key parameters, determining efficiency and selectivity of particle transport in a competitive molecular environment. These key parameters are the concentration of particles, solvent-channel exchange dynamics, as well as particle-in-channel-and interparticle interaction. These parameters are explicitly related to translocation dynamics and channel occupation probability. Slowing down the exchange dynamics at the channel ends, or elevating the particle concentration reduces the in-channel binding strength necessary to maintain maximum transport. Optimized in-channel interaction may even shift from binding to repulsion. A simple equation gives the interrelation of access dynamics and concentration at this transition point. The model is readily transferred to competitive transport of different species, each of them having their individual in-channel affinity. Combinations of channel affinities are determined which differentially favor selectivity of certain species on the cost of others. Selectivity for a species increases if its in-channel binding enhances the species' translocation probablity when compared to that of the other species. Selectivity increases particularly for a wide binding site, long channels, and fast access dynamics. Recent experiments on competitive transport of in-channel binding and inert molecules through artificial nuclear pores serve as a paradigm for our model. It explains qualitatively and quantitatively how binding molecules are favored for transport at the cost of the transport of inert molecules.	[Bauer, Wolfgang R.] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Nadler, Walter] Forschungszentrum Julich, IAS, JSC, D-52425 Julich, Germany	University of Wurzburg; Helmholtz Association; Research Center Julich	Bauer, WR (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany.	w.bauer@medizin.uni-wuerzburg.de			Research Centre 688 of the German Research Foundation	Research Centre 688 of the German Research Foundation	This work was partially supported by the Collaborative Research Centre 688 of the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astier Y, 2006, J AM CHEM SOC, V128, P1705, DOI 10.1021/ja057123+; Bauer WR, 2006, P NATL ACAD SCI USA, V103, P11446, DOI 10.1073/pnas.0601769103; Bauer WR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3026736; Bauer WR, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1940056; Berezhkovskii A. M., 2005, CHEM PHYS, V319; Berezhkovskii AM, 2005, BIOPHYS J, V88, pL17, DOI 10.1529/biophysj.104.057588; Berezhkovskii AM, 2003, J CHEM PHYS, V119, P3943, DOI 10.1063/1.1590957; Berezhkovskii AM, 2002, J CHEM PHYS, V116, P9952, DOI 10.1063/1.1475758; Bezrukov SM, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2766720; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Chou T, 1999, PHYS REV LETT, V82, P3552, DOI 10.1103/PhysRevLett.82.3552; Chou T, 1999, J CHEM PHYS, V110, P606, DOI 10.1063/1.478118; Chou T, 1998, PHYS REV LETT, V80, P85, DOI 10.1103/PhysRevLett.80.85; EISENBERG RS, 1995, J CHEM PHYS, V102, P1767, DOI 10.1063/1.468704; GARDINER CW, 1995, HDB STOCHASTIC METHO; Iqbal SM, 2007, NAT NANOTECHNOL, V2, P243, DOI 10.1038/nnano.2007.78; Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600; Kohli P, 2004, SCIENCE, V305, P984, DOI 10.1126/science.1100024; Kolomeisky AB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.048105; LAUGER P, 1973, BIOCHIM BIOPHYS ACTA, V311, P423, DOI 10.1016/0005-2736(73)90323-4; LEVITT DG, 1986, ANNU REV BIOPHYS BIO, V15, P29; NOBLE RD, 1991, J MEMBRANE SCI, V60, P297, DOI 10.1016/S0376-7388(00)81541-0; Reguera D, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061106; van Kampen N. G., 1981, STOCHASTIC PROCESSES; Zhou HX, 2010, J PHYS CHEM LETT, V1, P1973, DOI 10.1021/jz100683t; Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125; Zilman A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000804; Zilman A, 2009, BIOPHYS J, V96, P1235, DOI 10.1016/j.bpj.2008.09.058	28	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e15160	10.1371/journal.pone.0015160	http://dx.doi.org/10.1371/journal.pone.0015160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179205	Green Published, gold, Green Submitted			2022-12-25	WOS:000285246900031
J	Zhang, Z; Wang, YX; Wang, LS; Gao, PJ				Zhang, Zheng; Wang, Yuxiao; Wang, Lushan; Gao, Peiji			The Combined Effects of Amino Acid Substitutions and Indels on the Evolution of Structure within Protein Families	PLOS ONE			English	Article							STRUCTURE ALIGNMENT; SECONDARY-STRUCTURE; MUTATION-RATE; SEQUENCE; NUCLEOTIDE; FOLDS; INSERTIONS; DELETIONS; DATABASE; SCOP	Background: In the process of protein evolution, sequence variations within protein families can cause changes in protein structures and functions. However, structures tend to be more conserved than sequences and functions. This leads to an intriguing question: what is the evolutionary mechanism by which sequence variations produce structural changes? To investigate this question, we focused on the most common types of sequence variations: amino acid substitutions and insertions/deletions (indels). Here their combined effects on protein structure evolution within protein families are studied. Results: Sequence-structure correlation analysis on 75 homologous structure families (from SCOP) that contain 20 or more non-redundant structures shows that in most of these families there is, statistically, a bilinear correlation between the amount of substitutions and indels versus the degree of structure variations. Bilinear regression of percent sequence non-identity (PNI) and standardized number of gaps (SNG) versus RMSD was performed. The coefficients from the regression analysis could be used to estimate the structure changes caused by each unit of substitution (structural substitution sensitivity, SSS) and by each unit of indel (structural indel sensitivity, SIDS). An analysis on 52 families with high bilinear fitting multiple correlation coefficients and statistically significant regression coefficients showed that SSS is mainly constrained by disulfide bonds, which almost have no effects on SIDS. Conclusions: Structural changes in homologous protein families could be rationally explained by a bilinear model combining amino acid substitutions and indels. These results may further improve our understanding of the evolutionary mechanisms of protein structures.	[Zhang, Zheng; Wang, Yuxiao; Wang, Lushan; Gao, Peiji] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Wang, Yuxiao] UT SW, Div Basic Sci, Dallas, TX USA	Shandong University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, Z (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.	lswang@sdu.edu.cn; gaopj@sdu.edu.cn		Zhang, Zheng/0000-0001-9971-6006	Independent Innovation Foundation of Shandong University [2009jc006]; Scientific Research Reward Fund for Excellent Young and Middle-Aged Scientists in Shandong Province [BS2009SW021]	Independent Innovation Foundation of Shandong University; Scientific Research Reward Fund for Excellent Young and Middle-Aged Scientists in Shandong Province	This work was supported by Independent Innovation Foundation of Shandong University (No. 2009jc006) and Scientific Research Reward Fund for Excellent Young and Middle-Aged Scientists in Shandong Province (Grants No. BS2009SW021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BENNER SA, 1993, J MOL BIOL, V229, P1065, DOI 10.1006/jmbi.1993.1105; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Chung SY, 1996, STRUCTURE, V4, P1123, DOI 10.1016/S0969-2126(96)00119-0; de la CN, 2007, BMCEVOLBIOL, V7, P191; FLORES TP, 1993, PROTEIN SCI, V2, P1811, DOI 10.1002/pro.5560021104; Govindarajan S, 1999, PROTEINS, V35, P408, DOI 10.1002/(SICI)1097-0134(19990601)35:4<408::AID-PROT4>3.0.CO;2-A; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Grishin NV, 1997, J MOL EVOL, V45, P359, DOI 10.1007/PL00006241; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Jiang H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-444; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; Koehl P, 2002, J MOL BIOL, V323, P551, DOI 10.1016/S0022-2836(02)00971-3; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Levitt M, 1998, P NATL ACAD SCI USA, V95, P5913, DOI 10.1073/pnas.95.11.5913; Martinez L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-306; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nachman MW, 2000, GENETICS, V156, P297; Notredame C, 2002, PHARMACOGENOMICS, V3, P131, DOI 10.1517/14622416.3.1.131; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Panchenko AR, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-10; Panchenko AR, 2005, PROTEINS, V61, P535, DOI 10.1002/prot.20644; PASCARELLA S, 1992, J MOL BIOL, V224, P461, DOI 10.1016/0022-2836(92)91008-D; Punta M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000160; Russell RB, 1997, J MOL BIOL, V269, P423, DOI 10.1006/jmbi.1997.1019; RUSSELL RB, 1994, J MOL BIOL, V244, P332, DOI 10.1006/jmbi.1994.1733; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Wood TC, 1999, J MOL BIOL, V291, P977, DOI 10.1006/jmbi.1999.2972; Zhang Z, 2011, MOL BIOL EVOL, V28, P291, DOI 10.1093/molbev/msq196; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745	35	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2010	5	12							e14316	10.1371/journal.pone.0014316	http://dx.doi.org/10.1371/journal.pone.0014316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	693SY	21179197	Green Submitted, Green Published, gold			2022-12-25	WOS:000285246900021
J	Li, MZ; Xia, YL; Gu, YR; Zhang, K; Lang, QL; Chen, L; Guan, JQ; Luo, ZG; Chen, HS; Li, Y; Li, QH; Li, XA; Jiang, AA; Shuai, SR; Wang, JY; Zhu, Q; Zhou, XC; Gao, XL; Li, XW				Li, Mingzhou; Xia, Youlin; Gu, Yiren; Zhang, Kai; Lang, Qiulei; Chen, Lei; Guan, Jiuqiang; Luo, Zonggang; Chen, Haosi; Li, Yang; Li, Qinghai; Li, Xiang; Jiang, An-an; Shuai, Surong; Wang, Jinyong; Zhu, Qi; Zhou, Xiaochuan; Gao, Xiaolian; Li, Xuewei			MicroRNAome of Porcine Pre- and Postnatal Development	PLOS ONE			English	Article							RAPID EVOLUTION; SWINE GENOME; EXPRESSION; TRANSCRIPTOME; DISCOVERY; PATHWAYS; MIR-122; TARGETS; CLONING; MIRNAS	The domestic pig is of enormous agricultural significance and valuable models for many human diseases. Information concerning the pig microRNAome (miRNAome) has been long overdue and elucidation of this information will permit an atlas of microRNA (miRNA) regulation functions and networks to be constructed. Here we performed a comprehensive search for porcine miRNAs on ten small RNA sequencing libraries prepared from a mixture of tissues obtained during the entire pig lifetime, from the fetal period through adulthood. The sequencing results were analyzed using mammalian miRNAs, the precursor hairpins (pre-miRNAs) and the first release of the high-coverage porcine genome assembly (Sscrofa9, April 2009) and the available expressed sequence tag (EST) sequences. Our results extend the repertoire of pig miRNAome to 867 pre-miRNAs (623 with genomic coordinates) encoding for 1,004 miRNAs, of which 777 are unique. We preformed real-time quantitative PCR (q-PCR) experiments for selected 30 miRNAs in 47 tissue-specific samples and found agreement between the sequencing and q-PCR data. This broad survey provides detailed information about multiple variants of mature sequences, precursors, chromosomal organization, development-specific expression, and conservation patterns. Our data mining produced a broad view of the pig miRNAome, consisting of miRNAs and isomiRs and a wealth of information of pig miRNA characteristics. These results are prelude to the advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies.	[Li, Mingzhou; Gu, Yiren; Zhang, Kai; Guan, Jiuqiang; Luo, Zonggang; Li, Yang; Li, Qinghai; Li, Xiang; Jiang, An-an; Shuai, Surong; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China; [Xia, Youlin; Chen, Haosi; Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Lang, Qiulei] Zhejiang Univ, Dept Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Lang, Qiulei; Zhou, Xiaochuan] LC Sci, Houston, TX USA; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Gao, Xiaolian] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Sichuan Agricultural University; University of Houston System; University of Houston; Zhejiang University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, MZ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China.	xgao@uh.edu; xuewei.li@sicau.edu.cn		Li, Mingzhou/0000-0001-8681-7684; Su, Erzheng/0000-0002-3868-567X	National Special Foundation for Transgenic Species of China [2009ZX08009-155B, 2008ZX08006-003]; National Natural Science Foundation of China [30901024, 30771534]; Department Public Benefit Research Foundation of China [NYHYZX07-034]; NIH [R41 DA029063]	National Special Foundation for Transgenic Species of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department Public Benefit Research Foundation of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Special Foundation for Transgenic Species of China (2009ZX08009-155B and 2008ZX08006-003), the National Natural Science Foundation of China (30901024 and 30771534), the Department Public Benefit Research Foundation of China (NYHYZX07-034) to X. L. and M.L., and the NIH (R41 DA029063) to X.Z. and X.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bashir A, 2005, GENOME RES, V15, P998, DOI 10.1101/gr.3493405; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Green RD, 2007, INT J BIOL SCI, V3, P185; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Jiang ZH, 2007, INT J BIOL SCI, V3, P129; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Rocha D, 2006, DRUG DISCOV TODAY, V11, P475, DOI 10.1016/j.drudis.2006.04.009; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharbati-Tehrani S, 2008, BIOCHEM BIOPH RES CO, V375, P484, DOI 10.1016/j.bbrc.2008.08.048; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	51	103	111	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11541	10.1371/journal.pone.0011541	http://dx.doi.org/10.1371/journal.pone.0011541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	21179198	Green Published, Green Submitted, gold			2022-12-25	WOS:000279781600020
J	Liang, YL; Gao, H; Lin, SY; Goss, JA; Brunicardi, FC; Li, KY				Liang, Yulong; Gao, Hong; Lin, Shiaw-Yih; Goss, John A.; Brunicardi, Francis C.; Li, Kaiyi			siRNA-Based Targeting of Cyclin E Overexpression Inhibits Breast Cancer Cell Growth and Suppresses Tumor Development in Breast Cancer Mouse Model	PLOS ONE			English	Article							RNA INTERFERENCE; IN-VIVO; HEPATOCELLULAR-CARCINOMA; LINES; GENE; PHOSPHORYLATION; ACTIVATION; EXPRESSION; STRATEGIES; APOPTOSIS	Cyclin E is aberrantly expressed in many types of cancer including breast cancer. High levels of the full length as well as the low molecular weight isoforms of cyclin E are associated with poor prognosis of breast cancer patients. Notably, cyclin E overexpression is also correlated with triple-negative basal-like breast cancers, which lack specific therapeutic targets. In this study, we used siRNA to target cyclin E overexpression and assessed its ability to suppress breast cancer growth in nude mice. Our results revealed that cyclin E siRNA could effectively inhibit overexpression of both full length and low molecular weight isoforms of cyclin E. We found that depletion of cyclin E promoted apoptosis of cyclin E-overexpressing cells and blocked their proliferation and transformation phenotypes. Significantly, we further demonstrated that administration of cyclin E siRNA could inhibit breast tumor growth in nude mice. In addition, we found that cyclin E siRNA synergistically enhanced the cell killing effects of doxorubicin in cell culture and this combination greatly suppressed the tumor growth in mice. In conclusion, our results indicate that cyclin E, which is overexpressed in 30% of breast cancer, may serve as a novel and effective therapeutic target. More importantly, our study clearly demonstrates a very promising therapeutic potential of cyclin E siRNA for treating the cyclin E-overexpressing breast cancers, including the very malignant triple-negative breast cancers.	[Liang, Yulong; Gao, Hong; Goss, John A.; Brunicardi, Francis C.; Li, Kaiyi] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Lin, Shiaw-Yih] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Liang, YL (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	kli@bcm.tmc.edu	Liang, Yulong/A-2171-2013; Gao, Haichun/A-2160-2014	Liang, Yulong/0000-0001-8219-9575; Gao, Haichun/0000-0002-2647-6563	Susan Komen Breast Cancer Foundation; National Institutes of Health [NIH R01]	Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by grants from the Susan Komen Breast Cancer Foundation (to K. Li) and National Institutes of Health (NIH R01, to K. Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bales E, 2005, CANCER RES, V65, P692; Bedrosian I, 2004, ONCOGENE, V23, P2648, DOI 10.1038/sj.onc.1207408; Bertrand JR, 2002, BIOCHEM BIOPH RES CO, V296, P1000, DOI 10.1016/S0006-291X(02)02013-2; Bortner DM, 1997, MOL CELL BIOL, V17, P453, DOI 10.1128/MCB.17.1.453; Braasch DA, 2002, BIOCHEMISTRY-US, V41, P4503, DOI 10.1021/bi0122112; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Buchholz TA, 2003, CANCER J, V9, P33, DOI 10.1097/00130404-200301000-00007; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Goyal BR, 2009, FUND CLIN PHARMACOL, V23, P367, DOI 10.1111/j.1472-8206.2009.00694.x; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harwell RM, 2000, CANCER RES, V60, P481; Hough SR, 2003, NAT BIOTECHNOL, V21, P731, DOI 10.1038/nbt0703-731b; Jang SJ, 1999, EUR J SURG ONCOL, V25, P157, DOI 10.1053/ejso.1998.0619; Jin W, 2003, BRIT J CANCER, V89, P185, DOI 10.1038/sj.bjc.6601048; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Li KY, 2003, CANCER RES, V63, P3593; Li KY, 1999, ONCOGENE, V18, P2617, DOI 10.1038/sj.onc.1202605; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen NH, 1996, BRIT J CANCER, V74, P874, DOI 10.1038/bjc.1996.451; OVERMOYER BA, 1995, SEMIN ONCOL, V22, P2; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Sauer K, 1995, Prog Cell Cycle Res, V1, P125; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Takahashi N, 2002, CANCER RES, V62, P6909; van Hille B, 1999, ANTI-CANCER DRUG, V10, P551, DOI 10.1097/00001813-199907000-00007; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wilda M, 2002, ONCOGENE, V21, P5716, DOI 10.1038/sj.onc.1205653; Wingate H, 2005, J BIOL CHEM, V280, P15148, DOI 10.1074/jbc.M409789200; Wingate H, 2009, CELL CYCLE, V8, P1062, DOI 10.4161/cc.8.7.8119	42	68	70	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2010	5	9							e12860	10.1371/journal.pone.0012860	http://dx.doi.org/10.1371/journal.pone.0012860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	651YH	21203399	Green Published, Green Submitted, gold			2022-12-25	WOS:000281963200020
J	Tanaka, Y; Taneichi, M; Kasai, M; Kakiuchi, T; Uchida, T				Tanaka, Yuriko; Taneichi, Maiko; Kasai, Michiyuki; Kakiuchi, Terutaka; Uchida, Tetsuya			Liposome-Coupled Antigens Are Internalized by Antigen-Presenting Cells via Pinocytosis and Cross-Presented to CD8(+) T Cells	PLOS ONE			English	Article							IN-VIVO; VACCINE; RECOGNITION; DIPHTHERIA; TRANSPORT; IMMUNITY; TETANUS; BOOSTER; CYTOSOL; WORLD	We have previously demonstrated that antigens chemically coupled to the surface of liposomes consisting of unsaturated fatty acids were cross-presented by antigen-presenting cells (APCs) to CD8(+) T cells, and that this process resulted in the induction of antigen-specific cytotoxic T lymphocytes. In the present study, the mechanism by which the liposome-coupled antigens were cross-presented to CD8(+) T cells by APCs was investigated. Confocal laser scanning microscopic analysis demonstrated that antigens coupled to the surface of unsaturated-fatty-acid-based liposomes received processing at both MHC class I and class II compartments, while most of the antigens coupled to the surface of saturated-fatty-acid-based liposomes received processing at the class II compartment. In addition, flow cytometric analysis demonstrated that antigens coupled to the surface of unsaturated-fatty-acid-liposomes were taken up by APCs even in a 4 degrees C environment; this was not true of saturated-fatty-acid-liposomes. When two kinds of inhibitors, dimethylamiloride (DMA) and cytochalasin B, which inhibit pinocytosis and phagocytosis by APCs, respectively, were added to the culture of APCs prior to the antigen pulse, DMA but not cytochalasin B significantly reduced uptake of liposome-coupled antigens. Further analysis of intracellular trafficking of liposomal antigens using confocal laser scanning microscopy revealed that a portion of liposome-coupled antigens taken up by APCs were delivered to the lysosome compartment. In agreement with the reduction of antigen uptake by APCs, antigen presentation by APCs was significantly inhibited by DMA, and resulted in the reduction of IFN-gamma production by antigen-specific CD8(+) T cells. These results suggest that antigens coupled to the surface of liposomes consisting of unsaturated fatty acids might be pinocytosed by APCs, loaded onto the class I MHC processing pathway, and presented to CD8(+) T cells. Thus, these liposome-coupled antigens are expected to be applicable for the development of vaccines that induce cellular immunity.	[Tanaka, Yuriko; Kakiuchi, Terutaka] Toho Univ, Sch Med, Dept Immunol, Tokyo, Japan; [Taneichi, Maiko; Kasai, Michiyuki; Uchida, Tetsuya] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Tokyo, Japan	Toho University; National Institute of Infectious Diseases (NIID)	Tanaka, Y (corresponding author), Toho Univ, Sch Med, Dept Immunol, Tokyo, Japan.	taneichi@nih.go.jp			Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science [21790963]; Toho University Graduate School of Medicine [08-02]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Toho University Graduate School of Medicine(Toho University)	This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan (to TU), grants-in-aid for young scientists from the Japan Society for the Promotion of Science (21790963 to YT) and the research promotion grant from Toho University Graduate School of Medicine (No. 08-02 to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerbeck H, 1996, VACCINE, V14, P1265, DOI 10.1016/S0264-410X(96)00092-8; BANKOWSKI MK, 1995, SCIENCE, V267, P243; BEVAN MJ, 1987, NATURE, V325, P192, DOI 10.1038/325192b0; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Chen M, 1999, GASTROENTEROLOGY, V116, P135, DOI 10.1016/S0016-5085(99)70237-4; Chen WS, 2004, EUR J IMMUNOL, V34, P194, DOI 10.1002/eji.200324257; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; Gurnani K, 2004, J IMMUNOL, V173, P566, DOI 10.4049/jimmunol.173.1.566; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; Kasturi SP, 2008, NAT IMMUNOL, V9, P461, DOI 10.1038/ni0508-461; MARK A, 1995, VACCINE, V13, P669, DOI 10.1016/0264-410X(94)00017-H; Matsui M, 2010, BIOCHEM BIOPH RES CO, V391, P1494, DOI 10.1016/j.bbrc.2009.12.100; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; Naito S, 1996, INT ARCH ALLERGY IMM, V109, P223, DOI 10.1159/000237241; Nakano Y, 1999, INT ARCH ALLERGY IMM, V120, P199, DOI 10.1159/000024268; Nelson D, 2000, J IMMUNOL, V165, P6123, DOI 10.4049/jimmunol.165.11.6123; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; Nothdurft HD, 1996, J INFECTION, V32, P119, DOI 10.1016/S0163-4453(96)91281-5; Ohno S, 2009, VACCINE, V27, P3912, DOI 10.1016/j.vaccine.2009.04.001; Rock KL, 2006, IMMUNITY, V25, P523, DOI 10.1016/j.immuni.2006.09.003; Rock KL, 2003, NAT IMMUNOL, V4, P941, DOI 10.1038/ni1003-941; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Taneichi M, 2006, J IMMUNOL, V177, P2324, DOI 10.4049/jimmunol.177.4.2324; UCHIDA T, 1985, J IMMUNOL, V134, P772; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Yerly D, 2008, J VIROL, V82, P3147, DOI 10.1128/JVI.02252-07	31	51	51	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2010	5	12							e15225	10.1371/journal.pone.0015225	http://dx.doi.org/10.1371/journal.pone.0015225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698DS	21179411	Green Submitted, Green Published, gold			2022-12-25	WOS:000285572900015
J	Padayatty, SJ; Sun, AY; Chen, Q; Espey, MG; Drisko, J; Levine, M				Padayatty, Sebastian J.; Sun, Andrew Y.; Chen, Qi; Espey, Michael Graham; Drisko, Jeanne; Levine, Mark			Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; RECOMMENDED DIETARY ALLOWANCE; ACUTE OXALATE NEPHROPATHY; ACID-INDUCED HEMOLYSIS; TERMINAL HUMAN CANCER; ASCORBIC-ACID; EXPERIMENTAL POLIOMYELITIS; SUPPLEMENTAL ASCORBATE; SUPPORTIVE TREATMENT; HYDROGEN-PEROXIDE	Background: Anecdotal information and case reports suggest that intravenously administered vitamin C is used by Complementary and Alternate Medicine (CAM) practitioners. The scale of such use in the U. S. and associated side effects are unknown. Methods and Findings: We surveyed attendees at annual CAM Conferences in 2006 and 2008, and determined sales of intravenous vitamin C by major U. S. manufacturers/distributors. We also queried practitioners for side effects, compiled published cases, and analyzed FDA's Adverse Events Database. Of 199 survey respondents (out of 550), 172 practitioners administered IV vitamin C to 11,233 patients in 2006 and 8876 patients in 2008. Average dose was 28 grams every 4 days, with 22 total treatments per patient. Estimated yearly doses used (as 25g/50ml vials) were 318,539 in 2006 and 354,647 in 2008. Manufacturers' yearly sales were 750,000 and 855,000 vials, respectively. Common reasons for treatment included infection, cancer, and fatigue. Of 9,328 patients for whom data is available, 101 had side effects, mostly minor, including lethargy/fatigue in 59 patients, change in mental status in 21 patients and vein irritation/phlebitis in 6 patients. Publications documented serious adverse events, including 2 deaths in patients known to be at risk for IV vitamin C. Due to confounding causes, the FDA Adverse Events Database was uninformative. Total numbers of patients treated in the US with high dose vitamin C cannot be accurately estimated from this study. Conclusions: High dose IV vitamin C is in unexpectedly wide use by CAM practitioners. Other than the known complications of IV vitamin C in those with renal impairment or glucose 6 phosphate dehydrogenase deficiency, high dose intravenous vitamin C appears to be remarkably safe. Physicians should inquire about IV vitamin C use in patients with cancer, chronic, untreatable, or intractable conditions and be observant of unexpected harm, drug interactions, or benefit.	[Padayatty, Sebastian J.; Sun, Andrew Y.; Espey, Michael Graham; Levine, Mark] NIDDK, Mol & Clin Nutr Sect, NIH, Bethesda, MD 20892 USA; [Chen, Qi; Drisko, Jeanne] Univ Kansas, Med Ctr, Program Integrat Med, Kansas City, KS 66103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Kansas; University of Kansas Medical Center	Padayatty, SJ (corresponding author), NIDDK, Mol & Clin Nutr Sect, NIH, Bethesda, MD 20892 USA.	MarkL@intra.niddk.nih.gov	Padayatty, Sebastian J/A-8581-2012; Ganapathy, Suthakar/C-1266-2013; Chen, Qi/D-8278-2015	Padayatty, Sebastian J/0000-0001-8758-3170; Ganapathy, Suthakar/0000-0003-3828-5382; Chen, Qi/0000-0002-7173-8411; Sun, Andrew/0000-0002-7925-6580	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2009, J ALTERN COMPLEM MED, V15, P247, DOI 10.1089/acm.2008.0410; Barnes Patricia M, 2004, Adv Data, P1; Bromley J, 2005, ANN PHARMACOTHER, V39, P1566, DOI 10.1345/aph.1E634; CALLEJA H B, 1960, Ohio State Med J, V56, P821; CAMERON E, 1976, P NATL ACAD SCI USA, V73, P3685, DOI 10.1073/pnas.73.10.3685; CAMERON E, 1972, LANCET, V1, P542; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; CAMPBELL GD, 1975, ANN INTERN MED, V82, P810, DOI 10.7326/0003-4819-82-6-810_1; Canavese C, 2005, AM J KIDNEY DIS, V45, P540, DOI 10.1053/j.ajkd.2004.10.025; CATHCART RF, 1981, MED HYPOTHESES, V7, P1359, DOI 10.1016/0306-9877(81)90126-2; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; DL VP, 2004, JPEN J PARENTER ENTE, V28, P435; Gaby Alan R, 2002, Altern Med Rev, V7, P389; Gonzalez Michael J, 2005, Integr Cancer Ther, V4, P32, DOI 10.1177/1534735404273861; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Hoffer LJ, 2008, ANN ONCOL, V19, P1969, DOI 10.1093/annonc/mdn377; IWAMOTO N, 1994, AM J HEMATOL, V47, P337, DOI 10.1002/ajh.2830470426; IWAMOTO N, 1994, LANCET, V343, P357, DOI 10.1016/S0140-6736(94)91195-9; Jungeblut CW, 1937, J EXP MED, V66, P459, DOI 10.1084/jem.66.4.459; Jungeblut CW, 1939, J EXP MED, V70, P315, DOI 10.1084/jem.70.3.315; Jungeblut CW, 1935, J EXP MED, V62, P517, DOI 10.1084/jem.62.4.517; KLENNER F R, 1949, South Med Surg, V111, P209; KLENNER F R, 1951, South Med Surg, V113, P101; KLENNER FR, 1971, J APPL NUTR, V23, P61; LAWTON JM, 1985, ARCH INTERN MED, V145, P950, DOI 10.1001/archinte.145.5.950; Levine M, 2001, P NATL ACAD SCI USA, V98, P9842, DOI 10.1073/pnas.171318198; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Levine M, 1999, JAMA-J AM MED ASSOC, V281, P1415, DOI 10.1001/jama.281.15.1415; Levine M, 2009, FREE RADICAL BIO MED, V47, P27, DOI 10.1016/j.freeradbiomed.2009.04.001; Levy T E, 2002, VITAMIN C INFECT DIS; MCALLISTER CJ, 1984, JAMA-J AM MED ASSOC, V252, P1684, DOI 10.1001/jama.1984.03350130016019; McCORMICK W J, 1954, Arch Pediatr, V71, P313; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Padayatty SJ, 2006, NEW ENGL J MED, V355, P1065; Padayatty SJ, 2000, J AM COLL NUTR, V19, P423, DOI 10.1080/07315724.2000.10718941; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; PATTERSON JW, 1951, AM J PHYSIOL, V165, P61, DOI 10.1152/ajplegacy.1951.165.1.61; PATTERSON JW, 1950, J BIOL CHEM, V183, P81; Pauling L., 1976, VITAMIN C COMMON COL; REES DC, 1993, BRIT MED J, V306, P841, DOI 10.1136/bmj.306.6881.841; Riordan HD, 1990, J ORTHOMOL MED, V5, P5; RIORDAN NH, 1995, MED HYPOTHESES, V44, P207, DOI 10.1016/0306-9877(95)90137-X; Riordan NH, 2000, J ORTHOMOL MED, V15, P201; Sabin AB, 1939, J EXP MED, V69, P507, DOI 10.1084/jem.69.4.507; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; WITTES RE, 1985, NEW ENGL J MED, V312, P178, DOI 10.1056/NEJM198501173120310; WONG K, 1994, AUST NZ J MED, V24, P410, DOI 10.1111/j.1445-5994.1994.tb01477.x; 2008, NUTR BUSINESS J	51	231	241	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11414	10.1371/journal.pone.0011414	http://dx.doi.org/10.1371/journal.pone.0011414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628650	Green Published, gold, Green Submitted			2022-12-25	WOS:000279589300002
J	Johns, MC; Eick, AA; Blazes, DL; Lee, SE; Perdue, CL; Lipnick, R; Vest, KG; Russell, KL; DeFraites, RF; Sanchez, JL				Johns, Matthew C.; Eick, Angelia A.; Blazes, David L.; Lee, Seung-eun; Perdue, Christopher L.; Lipnick, Robert; Vest, Kelly G.; Russell, Kevin L.; DeFraites, Robert F.; Sanchez, Jose L.			Seasonal Influenza Vaccine and Protection against Pandemic (H1N1) 2009-Associated Illness among US Military Personnel	PLOS ONE			English	Article							T-CELL RESPONSES; AVIAN INFLUENZA; PREEXISTING IMMUNITY; ANTIBODY-RESPONSES; RISK-FACTORS; A H1N1; LIVE; VIRUS; TRIVALENT; INFECTION	Introduction: A novel A/H1N1 virus is the cause of the present influenza pandemic; vaccination is a key countermeasure, however, few data assessing prior seasonal vaccine effectiveness (VE) against the pandemic strain of H1N1 (pH1N1) virus are available. Materials and Methods: Surveillance of influenza-related medical encounter data of active duty military service members stationed in the United States during the period of April-October 2009 with comparison of pH1N1-confirmed cases and location and date-matched controls. Crude odds ratios (OR) and VE estimates for immunized versus non-immunized were calculated as well as adjusted OR (AOR) controlling for sex, age group, and history of prior influenza vaccination. Separate stratified VE analyses by vaccine type (trivalent inactivated [TIV] or live attenuated [LAIV]), age groups and hospitalization status were also performed. For the period of April 20 to October 15, 2009, a total of 1,205 cases of pH1N1-confirmed cases were reported, 966 (80%) among males and over one-half (58%) under 25 years of age. Overall VE for service members was found to be 45% (95% CI, 33 to 55%). Immunization with prior season's TIV (VE = 44%, 95% CI, 32 to 54%) as well as LAIV (VE = 24%, 95% CI, 6 to 38%) were both found to be associated with protection. Of significance, VE against a severe disease outcome was higher (VE = 62%, 95% CI, 14 to 84%) than against milder outcomes (VE = 42%, 95% CI, 29 to 53%). Conclusion: A moderate association with protection against clinically apparent, laboratory-confirmed Pandemic (H1N1) 2009-associated illness was found for immunization with either TIV or LAIV 2008-09 seasonal influenza vaccines. This association with protection was found to be especially apparent for severe disease as compared to milder outcome, as well as in the youngest and older populations. Prior vaccination with seasonal influenza vaccines in 2004-08 was also independently associated with protection.	[Johns, Matthew C.; Blazes, David L.; Vest, Kelly G.; Russell, Kevin L.; Sanchez, Jose L.] Armed Forces Hlth Surveillance Ctr, Div GEIS Operat, Silver Spring, MD USA; [Eick, Angelia A.; Lee, Seung-eun] Armed Forces Hlth Surveillance Ctr, Henry M Jackson Fdn Adv Mil Med, Silver Spring, MD USA; [Perdue, Christopher L.; Lipnick, Robert] Armed Forces Hlth Surveillance Ctr, Div Commun Stand & Training, Silver Spring, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Johns, MC (corresponding author), Armed Forces Hlth Surveillance Ctr, Div GEIS Operat, Silver Spring, MD USA.	matthew.c.johns@us.army.mil		Mulvihill, Daniel/0000-0003-2502-5274; Geeves, Michael/0000-0002-9364-8898	US Military; BBSRC [BB/F011784/1] Funding Source: UKRI	US Military; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the baseline funding of the US Military's Defense Health Program for the Armed Forces Health Surveillance Center (AFHSC). No non-government funding was accepted for this effort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFHSC, 2009, TRI SERV REP EV GUID; Almirall J, 2008, EUR RESPIR J, V31, P1274, DOI 10.1183/09031936.00095807; Bernstein DI, 2003, PEDIATR INFECT DIS J, V22, P28, DOI 10.1097/00006454-200301000-00010; Block SL, 2007, ANTIMICROB AGENTS CH, V51, P4001, DOI 10.1128/AAC.00517-07; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; *CDC, 2010, ADV COMM IMM PRACT P; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Cohen J, 2010, SCIENCE, V327, P1563, DOI 10.1126/science.327.5973.1563; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Eick AA, 2009, VACCINE, V27, P3568, DOI 10.1016/j.vaccine.2009.03.088; Engler RJM, 2008, ARCH INTERN MED, V168, P2405, DOI 10.1001/archinternmed.2008.513; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; Gaydos JC, 2006, EMERG INFECT DIS, V12, P23, DOI 10.3201/eid1201.050965; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gioia C, 2008, EMERG INFECT DIS, V14, P121, DOI 10.3201/eid1401.061283; Goy K, 2008, INFLUENZA OTHER RESP, V2, P115, DOI 10.1111/j.1750-2659.2008.00046.x; Grabenstein JD, 2006, EPIDEMIOL REV, V28, P3, DOI 10.1093/epirev/mxj003; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Iuliano AD, 2009, CLIN INFECT DIS, V49, P1811, DOI 10.1086/649555; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Loeb M, 2010, EMERG INFECT DIS, V16, P719, DOI 10.3201/eid1604.091588; Martinez O, 2009, INT REV IMMUNOL, V28, P69, DOI 10.1080/08830180802593540; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; RUSSELL KL, 2006, TXB MILITARY MED REC, P227; Skowronski DM, 2008, J INFECT DIS, V197, P490, DOI 10.1086/524146; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265; *WHO, 2009, AD HOC POL ADV WORK; WHO, 2009, SUMM REP HIGH LEV CO; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	55	65	66	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2010	5	5							e10722	10.1371/journal.pone.0010722	http://dx.doi.org/10.1371/journal.pone.0010722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598NT	20502705	Green Published, gold, Green Submitted			2022-12-25	WOS:000277845400024
J	Zhang, Y; Zhu, SL; Yan, DM; Liu, GY; Bai, RY; Wang, DY; Chen, L; Zhu, H; An, HQ; Kew, O; Xu, WB				Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Kew, Olen; Xu, Wenbo			Natural Type 3/Type 2 Intertypic Vaccine-Related Poliovirus Recombinants with the First Crossover Sites within the VP1 Capsid Coding Region	PLOS ONE			English	Article							POLIOMYELITIS; GENOMES; VIRUS; CHILD; CIRCULATION; SEROTYPE-2; SEQUENCES; OUTBREAK; MUTATION; STRAINS	Background: Ten uncommon natural type 3/type 2 intertypic poliovirus recombinants were isolated from stool specimens from nine acute flaccid paralysis case patients and one healthy vaccinee in China from 2001 to 2008. Principal Findings: Complete genomic sequences revealed their vaccine-related genomic features and showed that their first crossover sites were randomly distributed in the 39 end of the VP1 coding region. The length of donor Sabin 2 sequences ranged from 55 to 136 nucleotides, which is the longest donor sequence reported in the literature for this type of poliovirus recombination. The recombination resulted in the introduction of Sabin 2 neutralizing antigenic site 3a (NAg3a) into a Sabin 3 genomic background in the VP1 coding region, which may have been altered by some of the type 3-specific antigenic properties, but had not acquired any type 2-specific characterizations. NAg3a of the Sabin 3 strain seems atypical; other wild-type poliovirus isolates that have circulated in recent years have sequences of NAg3a more like the Sabin 2 strain. Conclusions: 10 natural type 3/type 2 intertypic VP1 capsid-recombinant polioviruses, in which the first crossover sites were found to be in the VP1 coding region, were isolated and characterized. In spite of the complete replacement of NAg3a by type 2-specific amino acids, the serotypes of the recombinants were not altered, and they were totally neutralized by polyclonal type 3 antisera but not at all by type 2 antisera. It is possible that recent type 3 wild poliovirus isolates may be a recombinant having NAg3a sequences derived from another strain during between 1967 and 1980, and the type 3/type 2 recombination events in the 39 end of the VP1 coding region may result in a higher fitness.	[Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China; [Zhang, Yong; Zhu, Shuangli; Yan, Dongmei; Liu, Guiyan; Bai, Ruyin; Wang, Dongyan; Chen, Li; Zhu, Hui; An, Hongqiu; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Bai, Ruyin] Taishan Med Univ, Taishan City, Peoples R China; [Kew, Olen] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong First Medical University & Shandong Academy of Medical Sciences; Centers for Disease Control & Prevention - USA	Zhang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	National Key Technology R&D Program of China [2008BAI56B00]; National Key Science and Technology Projects of China [2008ZX10004-008]; World Health Organization [I8/181/978]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	National Key Technology R&D Program of China(National Key Technology R&D Program); National Key Science and Technology Projects of China; World Health Organization(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Key Technology R&D Program of China (Project No. 2008BAI56B00), National Key Science and Technology Projects of China (Project No. 2008ZX10004-008), and a grant I8/181/978 from the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; BALANANT J, 1991, VIROLOGY, V184, P645, DOI 10.1016/0042-6822(91)90434-D; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Cuervo NS, 2001, J VIROL, V75, P5740, DOI 10.1128/JVI.75.13.5740-5751.2001; Dedepsidis E, 2008, FEMS IMMUNOL MED MIC, V52, P343, DOI 10.1111/j.1574-695X.2008.00381.x; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-28; Friedrich F, 1996, ACTA VIROL, V40, P27; FURIONE M, 1993, VIROLOGY, V196, P199; HIRST GK, 1962, COLD SPRING HARB SYM, V27, P303, DOI 10.1101/SQB.1962.027.001.028; JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Karakasiliotis L, 2004, MOL CELL PROBE, V18, P103, DOI 10.1016/j.mcp.2003.09.009; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KOHARA M, 1988, J VIROL, V62, P2828, DOI 10.1128/JVI.62.8.2828-2835.1988; KOHARA M, 1985, J VIROL, V53, P786, DOI 10.1128/JVI.53.3.786-792.1985; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; LIPSKAYA GY, 1991, J MED VIROL, V35, P290, DOI 10.1002/jmv.1890350415; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Martin J, 2002, J VIROL, V76, P10921, DOI 10.1128/JVI.76.21.10921-10928.2002; Martinez CV, 2004, J INFECT DIS, V190, P409, DOI 10.1086/421703; MINOR PD, 1986, J GEN VIROL, V67, P1283, DOI 10.1099/0022-1317-67-7-1283; MINOR PD, 1989, J GEN VIROL, V70, P1117, DOI 10.1099/0022-1317-70-5-1117; MINOR PD, 1992, J GEN VIROL, V73, P3065, DOI 10.1099/0022-1317-73-12-3065; MINOR PD, 1993, DEV BIOL STAND, V78, P17; Minor P, 2009, VACCINE, V27, P2649, DOI 10.1016/j.vaccine.2009.02.071; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shahmahmoodi S, 2008, VIRUS RES, V137, P168, DOI 10.1016/j.virusres.2008.07.006; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao ZX, 2010, VIRUS RES, V150, P56, DOI 10.1016/j.virusres.2010.02.014; TOYODA H, 1984, J MOL BIOL, V174, P561, DOI 10.1016/0022-2836(84)90084-6; VANDERAVOORT HGAM, 1995, J CLIN MICROBIOL, V33, P2562, DOI 10.1128/JCM.33.10.2562-2566.1995; WHO, 2004, POL LAB MAN; YANG CF, 1992, VIRUS RES, V24, P277, DOI 10.1016/0168-1702(92)90124-R; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Zhang Y, 2010, J GEN VIROL, V91, P421, DOI 10.1099/vir.0.014258-0; Zhang Y, 2010, ARCH VIROL, V155, P197, DOI 10.1007/s00705-009-0564-9	43	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2010	5	12							e15300	10.1371/journal.pone.0015300	http://dx.doi.org/10.1371/journal.pone.0015300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	698EY	20463924	Green Published, gold, Green Submitted			2022-12-25	WOS:000285576900026
J	Zhang, Y; Schulte, W; Pink, D; Phipps, K; Zijlstra, A; Lewis, JD; Waisman, DM				Zhang, Yi; Schulte, Wendy; Pink, Desmond; Phipps, Kyle; Zijlstra, Andries; Lewis, John D.; Waisman, David Morton			Sensitivity of Cancer Cells to Truncated Diphtheria Toxin	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; FACTOR FUSION PROTEIN; GROWTH-FACTOR; DENILEUKIN DIFTITOX; CYNOMOLGUS MONKEYS; MOUSE MODEL; IN-VIVO; EXPRESSION; CYTOTOXICITY	Background: Diphtheria toxin (DT) has been utilized as a prospective anti-cancer agent for the targeted delivery of cytotoxic therapy to otherwise untreatable neoplasia. DT is an extremely potent toxin for which the entry of a single molecule into a cell can be lethal. DT has been targeted to cancer cells by deleting the cell receptor-binding domain and combining the remaining catalytic portion with targeting proteins that selectively bind to the surface of cancer cells. It has been assumed that "receptorless'' DT cannot bind to and kill cells. In the present study, we report that "receptorless'' recombinant DT385 is in fact cytotoxic to a variety of cancer cell lines. Methods: In vitro cytotoxicity of DT385 was measured by cell proliferation, cell staining and apoptosis assays. For in vivo studies, the chick chorioallantoic membrane (CAM) system was used to evaluate the effect of DT385 on angiogenesis. The CAM and mouse model system was used to evaluate the effect of DT385 on HEp3 and Lewis lung carcinoma (LLC) tumor growth, respectively. Results: Of 18 human cancer cell lines tested, 15 were affected by DT385 with IC(50) ranging from 0.12-2.8 mu M. Furthermore, high concentrations of DT385 failed to affect growth arrested cells. The cellular toxicity of DT385 was due to the inhibition of protein synthesis and induction of apoptosis. In vivo, DT385 diminished angiogenesis and decreased tumor growth in the CAM system, and inhibited the subcutaneous growth of LLC tumors in mice. Conclusion: DT385 possesses anti-angiogenic and anti-tumor activity and may have potential as a therapeutic agent.	[Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Zhang, Yi; Phipps, Kyle; Waisman, David Morton] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Schulte, Wendy; Pink, Desmond; Zijlstra, Andries; Lewis, John D.] Innovascreen Inc, Halifax, NS, Canada; [Zijlstra, Andries] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Lewis, John D.] Univ Western Ontario, Dept Oncol, London, ON, Canada	Dalhousie University; Dalhousie University; Vanderbilt University; Western University (University of Western Ontario)	Zhang, Y (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	david.waisman@dal.ca	zijlstra, andries/G-4564-2013; Zhang, Yiqiang/D-9613-2012; zhang, yong jie/B-9054-2009	zijlstra, andries/0000-0001-8460-8803; Li, Tao-Sheng/0000-0002-7653-8873; Zhang, Yiqiang/0000-0003-0691-6645; zhang, yong jie/0000-0002-6331-2189; Waisman, David/0000-0002-5097-9662; Zhang, Yong/0000-0002-2692-5437	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation [018176]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	Nova Scotia Health Research Foundation (NSHRF); Dalhousie University; NCIC/Terry Fox Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Nova Scotia Health Research Foundation (NSHRF). YZ is supported by a studentship from the Cancer Research Training Program, Dalhousie University. JDL is supported by grant #018176 from the NCIC/Terry Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley RG, 2003, CANCER RES, V63, P5866; BENITEZKING G, 1989, J CELL SCI, V93, P53; Black JH, 2003, LEUKEMIA, V17, P155, DOI 10.1038/sj.leu.2402744; CHADWICK DE, 1993, LEUKEMIA LYMPHOMA, V11, P249, DOI 10.3109/10428199309087002; Chan CH, 1996, BLOOD, V88, P1445, DOI 10.1182/blood.V88.4.1445.bloodjournal8841445; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Cohen KA, 2004, LEUKEMIA LYMPHOMA, V45, P1647, DOI 10.1080/10428190410001663572; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Duvic M, 2008, FUTURE ONCOL, V4, P457, DOI 10.2217/14796694.4.4.457; Falnes PO, 1998, EMBO J, V17, P615, DOI 10.1093/emboj/17.2.615; Feuring-Buske M, 2000, EXP HEMATOL, V28, P1390, DOI 10.1016/S0301-472X(00)00542-7; FITZGERALD D, 1989, J NATL CANCER I, V81, P1455, DOI 10.1093/jnci/81.19.1455; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GILL DM, 1973, J BIOL CHEM, V248, P654; Gonzalez-Moreno O, 2005, INT J CANCER, V114, P870, DOI 10.1002/ijc.20789; Hall PD, 1999, LEUKEMIA, V13, P629, DOI 10.1038/sj.leu.2401357; Hogge DE, 2006, CLIN CANCER RES, V12, P1284, DOI 10.1158/1078-0432.CCR-05-2070; HONJO T, 1971, J BIOL CHEM, V246, P4251; Hotchkiss CE, 1999, TOXICOL APPL PHARM, V158, P152, DOI 10.1006/taap.1999.8691; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; KIND C, 1975, ANAT EMBRYOL, V147, P127, DOI 10.1007/BF00306727; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kwon M, 2001, BIOCHEMISTRY-US, V40, P13246, DOI 10.1021/bi0113420; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; MADSHUS IH, 1992, CURR TOP MICROBIOL, V175, P1; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; MOYNIHAN MR, 1981, INFECT IMMUN, V32, P575, DOI 10.1128/IAI.32.2.575-582.1981; MURPHY JR, 1986, P NATL ACAD SCI USA, V83, P8258, DOI 10.1073/pnas.83.21.8258; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; PAPPENHEIMER AM, 1993, PROTEIN SCI, V2, P292; Ramage JG, 2003, LEUKEMIA RES, V27, P79, DOI 10.1016/S0145-2126(02)00077-2; Ramakrishnan S, 1996, CANCER RES, V56, P1324; Turturro F, 2007, EXPERT REV ANTICANC, V7, P11, DOI 10.1586/14737140.7.1.11; Urieto JO, 2004, PROTEIN EXPRES PURIF, V33, P123, DOI 10.1016/j.pep.2003.09.003; Wild R, 2004, BREAST CANCER RES TR, V85, P161, DOI 10.1023/B:BREA.0000025407.02896.ec; WILLIAMS DP, 1990, J BIOL CHEM, V265, P20673; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	40	190	199	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2010	5	5							e10498	10.1371/journal.pone.0010498	http://dx.doi.org/10.1371/journal.pone.0010498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592LC	20463924	Green Submitted, Green Published, gold			2022-12-25	WOS:000277379400031
